PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Brewer, C				Brewer, Colin			A health service fit for a queen	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												brewerismo@gmail.com							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2013	346								f1533	10.1136/bmj.f1533	http://dx.doi.org/10.1136/bmj.f1533			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104MT	23471364				2022-12-28	WOS:000315998500003
J	Frenk, J; Moon, S				Frenk, Julio; Moon, Suerie			GLOBAL HEALTH Governance Challenges in Global Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Review									[Frenk, Julio] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Global Hlth Inst, John F Kennedy Sch Govt, Cambridge, MA USA; Harvard Global Hlth Inst, Cambridge, MA USA	Harvard University; Harvard T.H. Chan School of Public Health	Frenk, J (corresponding author), Harvard Univ, Sch Publ Hlth, Kresge 1005,677 Huntington Ave, Boston, MA 02115 USA.	deansoff@hsph.harvard.edu		Moon, Suerie/0000-0001-8504-1212				[Anonymous], 2011, NORW AID STAT; [Anonymous], 2011, OXF INT ANN REP 2010; [Anonymous], 2011, BILL MEL GAT FDN 201; [Anonymous], 2011, WELLC TRUST ANN REP; [Anonymous], 2011, UNITAID ANN REP 2010; [Anonymous], 2011, NIH ALM APPR; [Anonymous], 2011, C BUDG JUST, V2; [Anonymous], 2010, ROCK FDN 2009 ANN RE; [Anonymous], 2011, A6429 WHO; [Anonymous], 2011, CARE INT ANN REP 201; Barrett S, 2007, WHY COOPERATE INCENT; Bernescut B, 2011, GLOBAL FUND ANN REPO; Bloom BR, 2011, NATURE, V473, P143, DOI 10.1038/473143a; CEWG, 2012, RES DEV MEET HLTH NE; Chen L, 1996, POCANTICO RETREAT EN, P9; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Durkheim E., 2013, DIVISION LABOR SOC; Fidler David, 2007, GLOBAL HLTH GOVERNAN, V1, P1; Fidler DP, 2010, CHALLENGES GLOBAL HL; FINKELSTEIN L. S., 1995, GLOBAL GOV, V1, P367, DOI DOI 10.1163/19426720-001-03-90000007; Frenk J, 1997, BRIT MED J, V314, P1404; Frenk J, 2011, ROUTLEDGE HANDBOOK OF GLOBAL PUBLIC HEALTH, P11; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Global Alliance for Vaccines and Immunization (GAVI), 2011, GAVI ALL ANN FIN REP; IMS Institute for Healthcare Informatics, 2011, GLOB US MED OUTL 201; Jamison DT, 1998, LANCET, V351, P514, DOI 10.1016/S0140-6736(97)11451-9; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2010, ANN REP 2009; Keohane Robert O., 1997, THEORETICAL EVOLUTIO, P122; Kickbusch I, 2011, GOVERNANCE HLTH 21 C; Leach-Kemon K, 2012, HEALTH AFFAIR, V31, P228, DOI 10.1377/hlthaff.2011.1154; Lee K, 2007, Glob Public Health, V2, P215, DOI 10.1080/17441690601136947; Lee K, 2009, LANCET, V373, P416, DOI 10.1016/S0140-6736(08)61776-6; McColl K, 2008, LANCET, V371, P2072, DOI 10.1016/S0140-6736(08)60901-0; Medecins San Frontieres, 2011, ACT REP 2011; Moon S, 2010, THESIS HARVARD U CAM; Moon S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001218; Moon S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000193; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P717; Ottersen OP, 2011, LANCET, V378, P1612, DOI 10.1016/S0140-6736(11)61617-6; Provost C., 2011, FUTURE UK AID 2010 2; Smith RD, 2009, LANCET, V373, P684, DOI 10.1016/S0140-6736(08)61779-1; Stiglitz J. E., 1999, GLOBAL PUBLIC GOODS, V308, P308; Szlezak NA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000183; UNICEF, 2011, ANN REP 2010; United Nations Population Fund (UNFPA), 2011, ANN REP 2010; Weiss TG, 2000, THIRD WORLD Q, V21, P795, DOI 10.1080/713701075; World Bank, 2011, WORLD BANK ANN REP 2	48	200	208	11	72	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2013	368	10					936	942		10.1056/NEJMra1109339	http://dx.doi.org/10.1056/NEJMra1109339			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100BG	23465103	Green Submitted, Green Published			2022-12-28	WOS:000315669100009
J	Spence, D				Spence, Des			Kill the QOF	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						British Heart Foundation, 2011, TRENDS COR HEART DIS; Featherstone H., 2012, ALL TOGETHER NOW COM; Imison Candace, 2010, REFERRAL MANAGEMENT; NHS Information Centre, SEARCH CAT PRESCR CO; Office of National Statistics, 2012, SUMM; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001	6	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2013	346								f1498	10.1136/bmj.f1498	http://dx.doi.org/10.1136/bmj.f1498			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104MS	23468302				2022-12-28	WOS:000315998300016
J	Barclay, T; Rowe, JF; Lissauer, JJ; Huber, D; Fressin, F; Howell, SB; Bryson, ST; Chaplin, WJ; Deseret, JM; Lopez, ED; Marcy, GW; Mullally, F; Ragozzine, D; Torres, G; Adams, ER; Agol, E; Barrado, D; Basu, S; Bedding, TR; Buchhave, LA; Charbonneau, D; Christiansen, JL; Christensen-Dalsgaard, J; Ciardi, D; Cochran, WD; Dupree, AK; Elsworth, Y; Everett, M; Fischer, DA; Ford, EB; Fortney, JJ; Geary, JC; Haas, MR; Handberg, R; Hekker, S; Henze, CE; Horch, E; Howard, AW; Hunter, RC; Isaacson, H; Jenkins, JM; Karoff, C; Kawaler, SD; Kjeldsen, H; Klaus, TC; Latham, DW; Li, J; Lillo-Box, J; Lund, MN; Lundkvist, M; Metcalfe, TS; Miglio, A; Morris, RL; Quintana, EV; Stello, D; Smith, JC; Still, M; Thompson, SE				Barclay, Thomas; Rowe, Jason F.; Lissauer, Jack J.; Huber, Daniel; Fressin, Francois; Howell, Steve B.; Bryson, Stephen T.; Chaplin, William J.; Deseret, Jean-Michel; Lopez, Eric D.; Marcy, Geoffrey W.; Mullally, Fergal; Ragozzine, Darin; Torres, Guillermo; Adams, Elisabeth R.; Agol, Eric; Barrado, David; Basu, Sarbani; Bedding, Timothy R.; Buchhave, Lars A.; Charbonneau, David; Christiansen, Jessie L.; Christensen-Dalsgaard, Jorgen; Ciardi, David; Cochran, William D.; Dupree, Andrea K.; Elsworth, Yvonne; Everett, Mark; Fischer, Debra A.; Ford, Eric B.; Fortney, Jonathan J.; Geary, John C.; Haas, Michael R.; Handberg, Rasmus; Hekker, Saskia; Henze, Christopher E.; Horch, Elliott; Howard, Andrew W.; Hunter, Roger C.; Isaacson, Howard; Jenkins, Jon M.; Karoff, Christoffer; Kawaler, Steven D.; Kjeldsen, Hans; Klaus, Todd C.; Latham, David W.; Li, Jie; Lillo-Box, Jorge; Lund, Mikkel N.; Lundkvist, Mia; Metcalfe, Travis S.; Miglio, Andrea; Morris, Robert L.; Quintana, Elisa V.; Stello, Dennis; Smith, Jeffrey C.; Still, Martin; Thompson, Susan E.			A sub-Mercury-sized exoplanet	NATURE			English	Article							TRANSITING PLANET; BLEND SCENARIOS; LIGHT CURVES; VALIDATION; CANDIDATES; COMPANION; STARS	Since the discovery of the first exoplanets(1,2), it has been known that other planetary systems can look quite unlike our own(3). Until fairly recently, we have been able to probe only the upper range of the planet size distribution(4,5), and, since last year, to detect planets that are the size of Earth(6) or somewhat smaller(7). Hitherto, no planets have been found that are smaller than those we see in the Solar System. Here we report a planet significantly smaller than Mercury(8). This tiny planet is the innermost of three that orbit the Sun-like host star, which we have designated Kepler-37. Owing to its extremely small size, similar to that of the Moon, and highly irradiated surface, the planet, Kepler-37b, is probably rocky with no atmosphere or water, similar to Mercury.	[Barclay, Thomas; Rowe, Jason F.; Lissauer, Jack J.; Huber, Daniel; Howell, Steve B.; Bryson, Stephen T.; Mullally, Fergal; Christiansen, Jessie L.; Haas, Michael R.; Henze, Christopher E.; Hunter, Roger C.; Jenkins, Jon M.; Li, Jie; Morris, Robert L.; Quintana, Elisa V.; Smith, Jeffrey C.; Still, Martin; Thompson, Susan E.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Barclay, Thomas; Still, Martin] Bay Area Environm Res Inst, Sonoma, CA 95476 USA; [Rowe, Jason F.; Mullally, Fergal; Christiansen, Jessie L.; Jenkins, Jon M.; Li, Jie; Morris, Robert L.; Quintana, Elisa V.; Smith, Jeffrey C.; Thompson, Susan E.] SETI Inst, Mountain View, CA 94043 USA; [Fressin, Francois; Deseret, Jean-Michel; Ragozzine, Darin; Torres, Guillermo; Adams, Elisabeth R.; Charbonneau, David; Dupree, Andrea K.; Geary, John C.; Latham, David W.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Chaplin, William J.; Elsworth, Yvonne; Hekker, Saskia; Miglio, Andrea] Univ Birmingham, Sch Phys & Astron, Edgbaston B15 2TT, England; [Lopez, Eric D.; Fortney, Jonathan J.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Marcy, Geoffrey W.; Isaacson, Howard] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Ragozzine, Darin; Ford, Eric B.] Univ Florida, Dept Astron, Gainesville, FL 32111 USA; [Agol, Eric] Univ Washington, Dept Astron, Seattle, WA 98195 USA; [Barrado, David] Ctr Astron Hispano Aleman, Calar Alto Observ, E-04004 Almeria, Spain; [Barrado, David; Lillo-Box, Jorge] Ctr Astrobiol, Dept Astrofis, E-28691 Villanueva De La Canada, Spain; [Basu, Sarbani; Fischer, Debra A.] Yale Univ, New Haven, CT 06520 USA; [Bedding, Timothy R.; Stello, Dennis] Univ Sydney, Sch Phys, Sydney Inst Astron, Sydney, NSW 2006, Australia; [Buchhave, Lars A.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Buchhave, Lars A.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Star & Planet Format, DK-1350 Copenhagen, Denmark; [Christensen-Dalsgaard, Jorgen; Handberg, Rasmus; Karoff, Christoffer; Kjeldsen, Hans; Lund, Mikkel N.; Lundkvist, Mia] Aarhus Univ, Dept Phys & Astron, Stellar Astrophys Ctr, DK-8000 Aarhus C, Denmark; [Ciardi, David] CALTECH, NASA Exoplanet Sci Inst, Pasadena, CA 91125 USA; [Cochran, William D.] Univ Texas Austin, McDonald Observ, Austin, TX 78712 USA; [Everett, Mark] Natl Opt Astron Observ, Tucson, AZ 85719 USA; [Hekker, Saskia] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1090 GE Amsterdam, Netherlands; [Horch, Elliott] So Connecticut State Univ, New Haven, CT 06515 USA; [Howard, Andrew W.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Kawaler, Steven D.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Klaus, Todd C.] NASA, Orbital Sci Corp, Ames Res Ctr, Moffett Field, CA 94035 USA; [Metcalfe, Travis S.] White Dwarf Res Corp, Boulder, CO 80301 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Birmingham; University of California System; University of California Santa Cruz; University of California System; University of California Berkeley; State University System of Florida; University of Florida; University of Washington; University of Washington Seattle; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Yale University; University of Sydney; University of Copenhagen; Niels Bohr Institute; University of Copenhagen; Aarhus University; California Institute of Technology; National Aeronautics & Space Administration (NASA); University of Texas System; University of Texas Austin; National Optical Astronomy Observatory; University of Amsterdam; Connecticut State University System; Southern Connecticut State University; University of Hawaii System; Iowa State University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Barclay, T (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	thomas.barclay@nasa.gov; jason.rowe@nasa.gov	Karoff, Christoffer/L-1007-2013; Navascues, David Barrado/C-1439-2017; Lillo-Box, Jorge/I-2841-2015; Huber, Daniel/AAE-9440-2019; Buchhave, Lars A./ABF-2000-2020; Bedding, Timothy/AAU-9400-2021; miglio, andrea/O-9594-2019; Lillo-Box, Jorge/A-2202-2019; Ford, Eric B./AAB-5479-2019; Basu, Sarbani/B-8015-2014; Miglio, Andrea/M-5789-2018; Stello, Dennis/Q-9754-2019; Lund, Mikkel Nørup/AAJ-2112-2021; Cochran, William D/M-4421-2014; Fischer, Debra A/C-1639-2014; Metcalfe, Travis/A-9388-2008; Chaplin, William/M-9160-2018; Fortney, Jonathan/F-8813-2014	Karoff, Christoffer/0000-0003-2009-7965; Navascues, David Barrado/0000-0002-5971-9242; Lillo-Box, Jorge/0000-0003-3742-1987; Huber, Daniel/0000-0001-8832-4488; Buchhave, Lars A./0000-0003-1605-5666; Bedding, Timothy/0000-0001-5222-4661; miglio, andrea/0000-0001-5998-8533; Lillo-Box, Jorge/0000-0003-3742-1987; Ford, Eric B./0000-0001-6545-639X; Basu, Sarbani/0000-0002-6163-3472; Miglio, Andrea/0000-0001-5998-8533; Stello, Dennis/0000-0002-4879-3519; Lund, Mikkel Nørup/0000-0001-9214-5642; Cochran, William D/0000-0001-9662-3496; Fischer, Debra A/0000-0003-2221-0861; Bedding, Timothy/0000-0001-5943-1460; Latham, David/0000-0001-9911-7388; Hekker, Saskia/0000-0002-1463-726X; Lundkvist, Mia Sloth/0000-0002-8661-2571; Metcalfe, Travis/0000-0003-4034-0416; Christensen-Dalsgaard, Jorgen/0000-0001-5137-0966; Chaplin, William/0000-0002-5714-8618; Kawaler, Steven/0000-0002-6536-6367; Christiansen, Jessie/0000-0002-8035-4778; Adams, Elisabeth/0000-0002-9131-5969; Fortney, Jonathan/0000-0002-9843-4354; Agol, Eric/0000-0002-0802-9145; Rowe, Jason/0000-0002-5904-1865; Handberg, Rasmus/0000-0001-8725-4502; Dupree, Andrea/0000-0002-8985-8489; Barclay, Thomas/0000-0001-7139-2724; Mullally, Susan/0000-0001-7106-4683; Ciardi, David/0000-0002-5741-3047	NASA's Science Mission Directorate; NASA; JPL/Caltech; Danish National Research Foundation; ASTERISK; European Research Council; NSF; Science and Technology Facilities Council [ST/J001163/1] Funding Source: researchfish; STFC [ST/J001163/1] Funding Source: UKRI	NASA's Science Mission Directorate; NASA(National Aeronautics & Space Administration (NASA)); JPL/Caltech; Danish National Research Foundation(Danmarks Grundforskningsfond); ASTERISK; European Research Council(European Research Council (ERC)European Commission); NSF(National Science Foundation (NSF)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	Kepler was competitively selected as the tenth Discovery mission. Funding for this mission is provided by NASA's Science Mission Directorate. Some of this work is based on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology under a contract with NASA. Support for this work was provided by NASA through an award. issued by JPL/Caltech. Kepler flux time series data presented in this paper are available from the Mikulski Archive for Space Telescopes (MAST) at the Space Telescope Science Institute (STScI). Funding for the Stellar Astrophysics Centre is provided by The Danish National Research Foundation. The research is supported by the ASTERISK project funded by the European Research Council. E.A. acknowledges support through an NSF Career grant. D.H. is supported by an appointment to the NASA Postdoctoral Program at Ames Research Center.	Ammons SM, 2006, ASTROPHYS J, V638, P1004, DOI 10.1086/498490; Archinal BA, 2011, CELEST MECH DYN ASTR, V109, P101, DOI 10.1007/s10569-010-9320-4; Batalha N. M, 2012, ASTROPHYS S IN PRESS; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Borucki WJ, 2003, ESA SP PUBL, V539, P69; Brown TM, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/4/112; Buchhave LA, 2012, NATURE, V486, P375, DOI 10.1038/nature11121; Chambers J, 2011, EXOPLANETS, P297; Cochran WD, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/7; Fabrycky D. C, 2012, ASTROPHYS J UNPUB; Ford EB, 2005, ASTRON J, V129, P1706, DOI 10.1086/427962; Fressin F, 2013, ASTROPHYS J IN PRESS; Fressin F, 2012, NATURE, V482, P195, DOI 10.1038/nature10780; Fressin F, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/5; Holman MJ, 2005, SCIENCE, V307, P1288, DOI 10.1126/science.1107822; Howard AW, 2012, ASTROPHYS J SUPPL S, V201, DOI 10.1088/0067-0049/201/2/15; Howard AW, 2010, SCIENCE, V330, P653, DOI 10.1126/science.1194854; KJELDSEN H, 1995, ASTRON ASTROPHYS, V293, P87; Koch DG, 2010, ASTROPHYS J LETT, V713, pL79, DOI 10.1088/2041-8205/713/2/L79; Lissauer JJ, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/2/112; Lissauer JJ, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/8; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; Marcy GW, 1996, ASTROPHYS J, V464, pL147, DOI 10.1086/310096; Muirhead PS, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/2/144; Struve O., 1952, OBSERVATORY, V72, P199; Torres G, 2004, ASTROPHYS J, V614, P979, DOI 10.1086/423734; Torres G, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/1/24; ULRICH RK, 1986, ASTROPHYS J, V306, pL37, DOI 10.1086/184700; Valenti JA, 2005, ASTROPHYS J SUPPL S, V159, P141, DOI 10.1086/430500	30	147	147	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2013	494	7438					452	454		10.1038/nature11914	http://dx.doi.org/10.1038/nature11914			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23426260	Green Submitted			2022-12-28	WOS:000315661500032
J	Yoo, SH; Mohawk, JA; Siepka, SM; Shan, YL; Huh, SK; Hong, HK; Kornblum, I; Kumar, V; Koike, N; Xu, M; Nussbaum, J; Liu, XR; Chen, Z; Chen, ZJJ; Green, CB; Takahashi, JS				Yoo, Seung-Hee; Mohawk, Jennifer A.; Siepka, Sandra M.; Shan, Yongli; Huh, Seong Kwon; Hong, Hee-Kyung; Kornblum, Izabela; Kumar, Vivek; Koike, Nobuya; Xu, Ming; Nussbaum, Justin; Liu, Xinran; Chen, Zheng; Chen, Zhijian J.; Green, Carla B.; Takahashi, Joseph S.			Competing E3 Ubiquitin Ligases Govern Circadian Periodicity by Degradation of CRY in Nucleus and Cytoplasm	CELL			English	Article							F-BOX PROTEINS; REV-ERB-ALPHA; CLOCK PROTEIN; CELL-CYCLE; IN-VIVO; REVEALS; UBIQUITYLATION; CRYPTOCHROME; MAMMALS; IDENTIFICATION	Period determination in the mammalian circadian clock involves the turnover rate of the repressors CRY and PER. We show that CRY ubiquitination engages two competing E3 ligase complexes that either lengthen or shorten circadian period in mice. Cloning of a short-period circadian mutant, Past-time, revealed a glycine to glutamate missense mutation in Fbxl21, an F-box protein gene that is a paralog of Fbxl3 that targets the CRY proteins for degradation. While loss of function of FBXL3 leads to period lengthening, mutation of Fbxl21 causes period shortening. FBXL21 forms an SCF E3 ligase complex that slowly degrades CRY in the cytoplasm but antagonizes the stronger E3 ligase activity of FBXL3 in the nucleus. FBXL21 plays a dual role: protecting CRY from FBXL3 degradation in the nucleus and promoting CRY degradation within the cytoplasm. Thus, the balance and cellular compartmentalization of competing E3 ligases for CRY determine circadian period of the clock in mammals.	[Yoo, Seung-Hee; Mohawk, Jennifer A.; Shan, Yongli; Huh, Seong Kwon; Kumar, Vivek; Koike, Nobuya; Liu, Xinran; Green, Carla B.; Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Yoo, Seung-Hee; Mohawk, Jennifer A.; Kornblum, Izabela; Kumar, Vivek; Chen, Zhijian J.; Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Xu, Ming; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Siepka, Sandra M.; Hong, Hee-Kyung] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA; [Nussbaum, Justin; Green, Carla B.] Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; [Chen, Zheng] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Northwestern University; University of Virginia; University of Texas System; University of Texas Health Science Center Houston	Takahashi, JS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	joseph.takahashi@utsouthwestern.edu	Takahashi, Joseph S./Y-2781-2019; Chen, Zhijian/C-6039-2012; Koike, Nobuya/G-1116-2016; Takahashi, Joseph S/E-8482-2012; Kumar, Vivek/P-8749-2014	Takahashi, Joseph S./0000-0003-0384-8878; Chen, Zhijian/0000-0002-8475-8251; Takahashi, Joseph S/0000-0003-0384-8878; Kumar, Vivek/0000-0001-6643-7465; Chen, Jake/0000-0001-8829-7504; Shan, Yongli/0000-0002-5870-2107	NIH [U01 MH61915, R01 MH078024, P50 MH074924, R01 GM090247, R01 GM63692, F32 DA024556]; Howard Hughes Medical Institute; Welch Foundation [I-1389]; American Heart Association [11SDG7600045]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063692, R01GM090247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH061915, R01MH078024, P50MH074924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA024556] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Welch Foundation(The Welch Foundation); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Choogon Lee for generously providing the anti-PER1 antibody, Homin Kim for LRR3 modeling, Junghea Park, Weimin Song, and Yoga Chelliah for excellent technical support, and Yi Liu for editorial comments on the paper. Research was supported by NIH grants (U01 MH61915, P50 MH074924, and R01 MH078024 to J. S. T.; P50 MH074924 and R01 GM090247 to C. B. G.; R01 GM63692 to Z. J. C.; F32 DA024556 to V. K.), the Howard Hughes Medical Institute (J. S. T. and Z. J. C.), the Welch Foundation (I-1389 to Z. J. C.), and the American Heart Association (11SDG7600045 to Z. C.). J. S. T. and Z. J. C. are Investigators, J. A. M. is an Associate, I. K. is a Laboratory Manager, and S.-H. Y., S. M. S., H.-K. H., and V. K. were Associates at the Howard Hughes Medical Institute.	Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Dardente H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003530; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Hong HK, 2007, PLOS GENET, V3, P324, DOI 10.1371/journal.pgen.0030033; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Khan SK, 2012, J BIOL CHEM, V287, P25917, DOI 10.1074/jbc.M112.368001; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Maywood ES, 2011, J NEUROSCI, V31, P1539, DOI 10.1523/JNEUROSCI.4107-10.2011; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Pines J, 2005, NAT CELL BIOL, V7, P731, DOI 10.1038/ncb0805-731; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Popov N, 2010, NAT CELL BIOL, V12, P973, DOI 10.1038/ncb2104; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Tong X, 2012, J BIOL CHEM, V287, P25280, DOI 10.1074/jbc.M112.340786; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zheng XZ, 2012, TRENDS NEUROSCI, V35, P574, DOI 10.1016/j.tins.2012.05.007	36	224	239	0	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 28	2013	152	5					1091	1105		10.1016/j.cell.2013.01.055	http://dx.doi.org/10.1016/j.cell.2013.01.055			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452855	Green Accepted, Bronze			2022-12-28	WOS:000315710300016
J	Edelmann, F; Wachter, R; Schmidt, AG; Kraigher-Krainer, E; Colantonio, C; Kamke, W; Duvinage, A; Stahrenberg, R; Durstewitz, K; Loffler, M; Dungen, HD; Tschope, C; Herrmann-Lingen, C; Halle, M; Hasenfuss, G; Gelbrich, G; Pieske, B				Edelmann, Frank; Wachter, Rolf; Schmidt, Albrecht G.; Kraigher-Krainer, Elisabeth; Colantonio, Caterina; Kamke, Wolfram; Duvinage, Andre; Stahrenberg, Raoul; Durstewitz, Kathleen; Loeffler, Markus; Duengen, Hans-Dirk; Tschoepe, Carsten; Herrmann-Lingen, Christoph; Halle, Martin; Hasenfuss, Gerd; Gelbrich, Goetz; Pieske, Burkert		Aldo-DHF Investigators	Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction The Aldo-DHF Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANGIOTENSIN RECEPTOR BLOCKADE; BRAIN NATRIURETIC PEPTIDE; DOUBLE-BLIND; ALDOSTERONE ANTAGONISM; ALDACTONE EVALUATION; CARDIAC-FUNCTION; I-PRESERVE; DYSFUNCTION; MORTALITY; ECHOCARDIOGRAPHY	Importance Diastolic heart failure (ie, heart failure with preserved ejection fraction) is a common condition without established therapy, and aldosterone stimulation may contribute to its progression. Objective To assess the efficacy and safety of long-term aldosterone receptor blockade in heart failure with preserved ejection fraction. The primary objective was to determine whether spironolactone is superior to placebo in improving diastolic function and maximal exercise capacity in patients with heart failure with preserved ejection fraction. Design and Setting The Aldo-DHF trial, a multicenter, prospective, randomized, double-blind, placebo-controlled trial conducted between March 2007 and April 2012 at 10 sites in Germany and Austria that included 422 ambulatory patients (mean age, 67 [SD, 8] years; 52% female) with chronic New York Heart Association class II or III heart failure, preserved left ventricular ejection fraction of 50% or greater, and evidence of diastolic dysfunction. Intervention Patients were randomly assigned to receive 25 mg of spironolactone once daily (n=213) or matching placebo (n=209) with 12 months of follow-up. Main Outcome Measures The equally ranked co-primary end points were changes in diastolic function (E/e') on echocardiography and maximal exercise capacity (peak (V)over dotO(2)) on cardiopulmonary exercise testing, both measured at 12 months. Results Diastolic function (E/e') decreased from 12.7 (SD, 3.6) to 12.1 (SD, 3.7) with spironolactone and increased from 12.8 (SD, 4.4) to 13.6 (SD, 4.3) with placebo (adjusted mean difference, -1.5; 95% CI, -2.0 to -0.9; P<.001). Peak (V)over dotO(2) did not significantly change with spironolactone vs placebo (from 16.3 [SD, 3.6] mL/min/kg to 16.8 [SD, 4.6] mL/min/kg and from 16.4 [SD, 3.5] mL/min/kg to 16.9 [SD, 4.4] mL/min/kg, respectively; adjusted mean difference, +0.1 mL/min/kg; 95% CI, -0.6 to +0.8 mL/min/kg; P=.81). Spironolactone induced reverse remodeling (left ventricular mass index declined; difference, -6 g/m(2); 95% CI, -10 to -1 g/m(2); P=.009) and improved neuroendocrine activation (N-terminal pro-brain-type natriuretic peptide geometric mean ratio, 0.86; 95% CI, 0.75-0.99; P=.03) but did not improve heart failure symptoms or quality of life and slightly reduced 6-minute walking distance (-15m; 95% CI, -27 to -2m; P=.03). Spironolactone also modestly increased serum potassium levels (+0.2 mmol/L; 95% CI, +0.1 to +0.3; P<.001) and decreased estimated glomerular filtration rate (-5 mL/min/1.73m(2); 95% CI, -8 to -3 mL/min/1.73 m(2); P<.001) without affecting hospitalizations. Conclusions and Relevance In this randomized controlled trial, long-term aldosterone receptor blockade improved left ventricular diastolic function but did not affect maximal exercise capacity, patient symptoms, or quality of life in patients with heart failure with preserved ejection fraction. Whether the improved left ventricular function observed in the Aldo-DHF trial is of clinical significance requires further investigation in larger populations.	[Edelmann, Frank; Wachter, Rolf; Duvinage, Andre; Stahrenberg, Raoul; Durstewitz, Kathleen; Hasenfuss, Gerd] Univ Gottingen, Dept Cardiol & Pneumol, Ctr Heart, Gottingen, Germany; [Edelmann, Frank; Wachter, Rolf; Herrmann-Lingen, Christoph; Hasenfuss, Gerd] Univ Gottingen, German Ctr Cardiovasc Res, Gottingen, Germany; [Herrmann-Lingen, Christoph] Univ Gottingen, Dept Psychosomat Med & Psychotherapy, Gottingen, Germany; [Schmidt, Albrecht G.; Kraigher-Krainer, Elisabeth; Colantonio, Caterina; Pieske, Burkert] Med Univ Graz, Dept Cardiol, A-8010 Graz, Austria; [Kraigher-Krainer, Elisabeth; Pieske, Burkert] Boltzmann Inst Translat Heart Failure Res, Graz, Austria; [Kamke, Wolfram] MediClin Rehabil Ctr Spreewald, Dept Internal Med, Spreewald, Germany; [Loeffler, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04109 Leipzig, Germany; [Gelbrich, Goetz] Univ Leipzig, Clin Trial Ctr, D-04109 Leipzig, Germany; [Duengen, Hans-Dirk] Charite Campus Virchow Klinikum, Dept Internal Med Cardiol, Berlin, Germany; [Tschoepe, Carsten] Charite, Dept Cardiol & Pneumol, D-13353 Berlin, Germany; [Halle, Martin] Tech Univ Munich, Dept Prevent & Rehabil Sports Med, D-80290 Munich, Germany; [Gelbrich, Goetz] Univ Wurzburg, Inst Clin Epidemiol & Biometry, D-97070 Wurzburg, Germany	University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research; University of Gottingen; University of Gottingen; Medical University of Graz; Leipzig University; Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Munich; University of Wurzburg	Pieske, B (corresponding author), Med Univ Graz, Dept Cardiol, Auenbruggerpl 15, A-8010 Graz, Austria.	burkert.pieske@medunigraz.at	Wachter, Rolf/AAA-4037-2020; Herrmann-Lingen, Christoph/ABC-9496-2021; Pasedach, Caroline/Q-1670-2019; Braun-Dullaeus, Ruediger C/G-1844-2013; Böhm, Michael/C-3638-2011; Pieske, Burkert/M-8089-2016	Pasedach, Caroline/0000-0003-3320-8388; Braun-Dullaeus, Ruediger C/0000-0003-3888-6532; Edelmann, Frank/0000-0003-4401-5936; Schmidt, Albrecht/0000-0003-4783-4603; Westermann, Dirk/0000-0002-7542-1956; Wachter, Rolf/0000-0003-2231-2200; Tschope, Carsten/0000-0001-5243-8985; Pieske, Burkert/0000-0002-6466-5306	German-Austrian Heart Failure Study Group; German Competence Network of Heart Failure; Federal Ministry of Education and Research [01GI0205]; Aldo-DHF [FKZ 01KG0506]; University of Gottingen	German-Austrian Heart Failure Study Group; German Competence Network of Heart Failure; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Aldo-DHF; University of Gottingen	This work was supported by the German-Austrian Heart Failure Study Group and the German Competence Network of Heart Failure. Aldo-DHF was funded by the Federal Ministry of Education and Research Grant 01GI0205 (clinical trial program Aldo-DHF [FKZ 01KG0506]). The University of Gottingen was the formal sponsor.	Ahmed A, 2006, EUR HEART J, V27, P178, DOI 10.1093/eurheartj/ehi687; Anand IS, 2011, CIRC-HEART FAIL, V4, P569, DOI 10.1161/CIRCHEARTFAILURE.111.962654; Ather S, 2012, J AM COLL CARDIOL, V59, P998, DOI 10.1016/j.jacc.2011.11.040; Bauersachs J, 2002, J AM COLL CARDIOL, V39, P351, DOI 10.1016/S0735-1097(01)01729-6; Bomback AS, 2007, NAT CLIN PRACT NEPHR, V3, P486, DOI 10.1038/ncpneph0575; Borlaug BA, 2011, EUR HEART J, V32, P670, DOI 10.1093/eurheartj/ehq426; Campbell RT, 2012, J AM COLL CARDIOL, V60, P2349, DOI 10.1016/j.jacc.2012.04.064; Chan AKY, 2007, J AM COLL CARDIOL, V50, P591, DOI 10.1016/j.jacc.2007.03.062; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; Conraads VM, 2012, EUR J HEART FAIL, V14, P219, DOI 10.1093/eurjhf/hfr161; Cook CE, 2008, J MAN MANIP THER, V16, p82E, DOI 10.1179/jmt.2008.16.4.82E; Desai AS, 2011, AM HEART J, V162, P966, DOI 10.1016/j.ahj.2011.09.007; Deswal A, 2011, J CARD FAIL, V17, P634, DOI 10.1016/j.cardfail.2011.04.007; Edelmann F, 2012, EUR HEART J, V33, P203, DOI 10.1093/eurheartj/ehr292; Edelmann F, 2011, CLIN RES CARDIOL, V100, P755, DOI 10.1007/s00392-011-0305-4; Edelmann F, 2010, EUR J HEART FAIL, V12, P874, DOI 10.1093/eurjhf/hfq087; Henkel DM, 2008, CIRC-HEART FAIL, V1, P91, DOI 10.1161/CIRCHEARTFAILURE.107.743146; Holland DJ, 2011, J AM COLL CARDIOL, V57, P1676, DOI 10.1016/j.jacc.2010.10.057; Iellamo Ferdinando, 2010, Curr Heart Fail Rep, V7, P59, DOI 10.1007/s11897-010-0008-6; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Kitzman DW, 2010, CIRC-HEART FAIL, V3, P477, DOI 10.1161/CIRCHEARTFAILURE.109.898916; Lacolley P, 2001, J AM COLL CARDIOL, V37, P662, DOI 10.1016/S0735-1097(00)01129-3; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; Mottram PM, 2004, CIRCULATION, V110, P558, DOI 10.1161/01.CIR.0000138680.89536.A9; Ommen SR, 2000, CIRCULATION, V102, P1788; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Phelan D, 2012, HEART, V98, P1693, DOI 10.1136/heartjnl-2012-302178; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; RECTOR TS, 1993, AM J CARDIOL, V71, P1106, DOI 10.1016/0002-9149(93)90582-W; Solomon SD, 2007, LANCET, V369, P2079, DOI 10.1016/S0140-6736(07)60980-5; Solomon SD, 2012, LANCET, V380, P1387, DOI 10.1016/S0140-6736(12)61227-6; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Tsutamoto T, 2001, J AM COLL CARDIOL, V37, P1228, DOI 10.1016/S0735-1097(01)01116-0; Vizzardi E, 2010, AM J CARDIOL, V106, P1292, DOI 10.1016/j.amjcard.2010.06.052; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wyrwich KW, 1999, J CLIN EPIDEMIOL, V52, P861, DOI 10.1016/S0895-4356(99)00071-2; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Zannad F, 2000, CIRCULATION, V102, P2700, DOI 10.1161/01.CIR.102.22.2700; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566	44	478	494	1	46	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2013	309	8					781	791		10.1001/jama.2013.905	http://dx.doi.org/10.1001/jama.2013.905			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095KD	23443441	Bronze			2022-12-28	WOS:000315332200023
J	Sloane, KL				Sloane, Kelly Lauren			If Only Grown-ups Would Pay Attention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRAJECTORIES		Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA	Johns Hopkins University	Sloane, KL (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	ksloane1@jhmi.edu						Chen JH, 2007, J GERONTOL A-BIOL, V62, P531, DOI 10.1093/gerona/62.5.531; Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087; Hardy SE, 2005, ARCH INTERN MED, V165, P106, DOI 10.1001/archinte.165.1.106; Heschel A.J., 1963, INSECURITY FREEDOM; SILVERSTEIN S, 1981, LIGHT ATTIC	5	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2013	309	8					779	780		10.1001/jama.2013.364	http://dx.doi.org/10.1001/jama.2013.364			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095KD	23443440				2022-12-28	WOS:000315332200022
J	Njor, SH; Olsen, AH; Blichert-Toft, M; Schwartz, W; Vejborg, I; Lynge, E				Njor, Sisse Helle; Olsen, Anne Helene; Blichert-Toft, Mogens; Schwartz, Walter; Vejborg, Ilse; Lynge, Elsebeth			Overdiagnosis in screening mammography in Denmark: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BREAST-CANCER; NATURAL-HISTORY; FOLLOW-UP; TRIAL; OVERTREATMENT; PROGRAMS; SURVIVAL; TRENDS; END	Objective To use data from two longstanding, population based screening programmes to study overdiagnosis in screening mammography. Design Population based cohort study. Setting Copenhagen municipality (from 1991) and Funen County (from 1993), Denmark. Participants 57 763 women targeted by organised screening, aged 56-69 when the screening programmes started, and followed up to 2009. Main outcome measures Overdiagnosis of breast cancer in women targeted by screening, assessed by relative risks compared with historical control groups from screening regions, national control groups from non-screening regions, and historical national control groups. Results In total, 3279 invasive breast carcinomas and ductal carcinomas in situ occurred. The start of screening led to prevalence peaks in breast cancer incidence: relative risk 2.06 (95% confidence interval 1.64 to 2.59) for Copenhagen and 1.84 (1.46 to 2.32) for Funen. During subsequent screening rounds, relative risks were slightly above unity: 1.04 (0.85 to 1.27) for Copenhagen and 1.14 (0.98 to 1.32) for Funen. A compensatory dip was seen after the end of invitation to screening: relative risk 0.80 (0.65 to 0.98) for Copenhagen and 0.67 (0.55 to 0.81) for Funen during the first four years. The relative risk of breast cancer accumulated over the entire follow-up period was 1.06 (0.90 to 1.25) for Copenhagen and 1.01 (0.93 to 1.10) for Funen. Relative risks for participants corrected for selection bias were estimated to be 1.08 for Copenhagen and 1.02 for Funen; for participants followed for at least eight years after the end of screening, they were 1.05 and 1.01. A pooled estimate gave 1.040 (0.99 to 1.09) for all targeted women and 1.023 (0.97 to 1.08) for targeted women followed for at least eight years after the end of screening. Conclusions On the basis of combined data from the two screening programmes, this study indicated that overdiagnosis most likely amounted to 2.3% (95% confidence interval -3% to 8%) in targeted women. Among participants, it was most likely 1-5%. At least eight years after the end of screening were needed to compensate for the excess incidence during screening.	[Njor, Sisse Helle; Lynge, Elsebeth] Univ Copenhagen, Dept Publ Hlth, DK-1014 Copenhagen K, Denmark; [Olsen, Anne Helene] Univ Tromso, Inst Community Med, Tromso, Norway; [Blichert-Toft, Mogens] Danish Breast Canc Cooperat Grp, DK-2100 Copenhagen O, Denmark; [Schwartz, Walter] Odense Univ Hosp, Mammog Screening Clin, DK-5000 Odense, Denmark; [Vejborg, Ilse] Univ Copenhagen Hosp, Diagnost Ctr, DK-2100 Copenhagen O, Denmark	University of Copenhagen; UiT The Arctic University of Tromso; Danish Breast Cancer Cooperative Group (DBCG); University of Southern Denmark; Odense University Hospital; University of Copenhagen	Njor, SH (corresponding author), Univ Copenhagen, Dept Publ Hlth, Ostre Farimagsgade 5, DK-1014 Copenhagen K, Denmark.	sissenj@sund.ku.dk	Njor, Sisse Helle/S-4486-2017	Njor, Sisse Helle/0000-0003-0429-4176; Lynge, Elsebeth/0000-0003-4785-5236	Esper and Olga Boel Foundation	Esper and Olga Boel Foundation	This study was financially supported by the Esper and Olga Boel Foundation. The funding source had no role in the writing of the manuscript or the decision to submit it for publication.	Biesheuvel C, 2007, LANCET ONCOL, V8, P1129, DOI 10.1016/S1470-2045(07)70380-7; BOER R, 1994, LANCET, V343, P979, DOI 10.1016/S0140-6736(94)90105-8; de Gelder R, 2011, EPIDEMIOL REV, V33, P111, DOI 10.1093/epirev/mxr009; Donella P, 2009, EUR J CANCER, V45, P3166, DOI 10.1016/j.ejca.2009.06.014; Duffy SW, 2008, BRIT J CANCER, V99, P1176, DOI 10.1038/sj.bjc.6604638; Harris RJ, 2008, STATA J, V8, P3, DOI 10.1177/1536867X0800800102; Jensen A, 2005, INT J CANCER, V113, P464, DOI 10.1002/ijc.20604; Johnstone PAS, 2000, J SURG ONCOL, V73, P273, DOI 10.1002/(SICI)1096-9098(200004)73:4<273::AID-JSO15>3.0.CO;2-H; Jorgensen Karsten J, 2009, BMC Womens Health, V9, P36, DOI 10.1186/1472-6874-9-36; Lynge E, 1998, APMIS Suppl, V83, P1; Miller AB, 2000, JNCI-J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; Miller AB, 2002, ANN INTERN MED, V137, P305, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00005; Moller B, 2005, EUR J CANCER PREV, V14, P117, DOI 10.1097/00008469-200504000-00007; Moss S, 2005, BREAST CANCER RES, V7, P230, DOI 10.1186/bcr1314; National Cancer Institute Breast Cancer Surveillance Consortium, CANC 22640989 SCREEN; Njor Sisse Helle, 2003, APMIS Suppl, P1; Olsen AH, 2006, BREAST J, V12, P338, DOI 10.1111/j.1075-122X.2006.00272.x; Paci E, 2005, BREAST CANCER RES, V7, P266, DOI 10.1186/bcr1339; Puliti D, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3090; Svendsen AL, 2006, CANCER-AM CANCER SOC, V106, P1883, DOI 10.1002/cncr.21823; Tryggvadottir L, 2010, ACTA ONCOL, V49, P624, DOI 10.3109/02841860903575323; Weedon-Fekjaer H, 2009, ARCH INTERN MED, V169, P996, DOI 10.1001/archinternmed.2009.90; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C; Zahl PH, 2008, ARCH INTERN MED, V168, P2311, DOI 10.1001/archinte.168.21.2311; Zahl PH, 2011, LANCET ONCOL, V12, P1118, DOI 10.1016/S1470-2045(11)70250-9	25	68	70	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2013	346								f1064	10.1136/bmj.f1064	http://dx.doi.org/10.1136/bmj.f1064			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100BJ	23444414	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000315669400002
J	Shakespeare, J				Shakespeare, Judy			PERSONAL VIEW An unsafe ward	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												judy.shakespeare@virginmedia.com							0	6	6	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2013	346								f1243	10.1136/bmj.f1243	http://dx.doi.org/10.1136/bmj.f1243			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100BH	23440269				2022-12-28	WOS:000315669200003
J	Bor, J; Herbst, AJ; Newell, ML; Barnighausen, T				Bor, Jacob; Herbst, Abraham J.; Newell, Marie-Louise; Baernighausen, Till			Increases in Adult Life Expectancy in Rural South Africa: Valuing the Scale-Up of HIV Treatment	SCIENCE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; TREATMENT PROGRAM; COHORT PROFILE; MORTALITY; HEALTH; DELIVERY; DECLINE; TRENDS; LEVEL	The scale-up of antiretroviral therapy (ART) is expected to raise adult life expectancy in populations with high HIV prevalence. Using data from a population cohort of over 101,000 individuals in rural KwaZulu-Natal, South Africa, we measured changes in adult life expectancy for 2000-2011. In 2003, the year before ART became available in the public-sector health system, adult life expectancy was 49.2 years; by 2011, adult life expectancy had increased to 60.5 years-an 11.3-year gain. Based on standard monetary valuation of life, the survival benefits of ART far outweigh the costs of providing treatment in this community. These gains in adult life expectancy signify the social value of ART and have implications for the investment decisions of individuals, governments, and donors.	[Bor, Jacob; Herbst, Abraham J.; Newell, Marie-Louise; Baernighausen, Till] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, ZA-3935 Mtubatuba, KwaZulu Natal, South Africa; [Bor, Jacob; Baernighausen, Till] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Newell, Marie-Louise] UCL, Inst Child Hlth, London WC1N 1EH, England	University of Kwazulu Natal; Harvard University; Harvard T.H. Chan School of Public Health; University of London; University College London	Bor, J (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, POB 198, ZA-3935 Mtubatuba, KwaZulu Natal, South Africa.	jbor@hsph.harvard.edu	Bärnighausen, Till/Y-2388-2019; Herbst, Abraham J/E-4848-2010; Newell, Marie-Louise/AAE-8222-2019	Herbst, Abraham J/0000-0002-5436-9386; Newell, Marie-Louise/0000-0002-1074-7699	Wellcome Trust (Africa Centre for Health and Population Studies); National Institutes of Health [R01 HD058482-01, 1R01MH083539-01]; Harvard Global Health Institute and Harvard Center for Population and Development Studies; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083539] Funding Source: NIH RePORTER	Wellcome Trust (Africa Centre for Health and Population Studies); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Global Health Institute and Harvard Center for Population and Development Studies; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank all the respondents who gave their time to this research and the staff of the Africa Centre for Health and Population Studies and the Hlabisa HIV Care and Treatment Programme. In particular, we thank all data collection and database management coordinators, supervisors, and managers (T. Mutevedzi, C. Newell, Z. Gqwede, H. Madida, L. Sithole, P. Dlamini, P. Gwala, T. Mngomezulu, N. Ntombela, N. Myeni, B. Ntimane), as well as all fieldworkers, verbal autopsy nurses, surveillance trackers, data capturers, document management clerks, and quality controllers. We also thank our funders: the Wellcome Trust (Africa Centre for Health and Population Studies); National Institutes of Health grants R01 HD058482-01 and 1R01MH083539-01 (T. B.); and the Harvard Global Health Institute and Harvard Center for Population and Development Studies (J.B.). Data are archived and accessible at no cost from the Africa Centre for Health and Population Studies. The authors report no conflicts of interest.	Actuarial Society of South Africa, 2011, 2008 AIDS AND DEMOGR; Barnighausen T, 2012, P NATL ACAD SCI USA, V109, P21271, DOI 10.1073/pnas.1209017110; Barnighausen T, 2012, SEX TRANSM INFECT, V88, DOI 10.1136/sextrans-2011-050303; Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Barnighausen T, 2009, AIDS RES HUM RETROV, V25, P405, DOI 10.1089/aid.2008.0211; Baranov V., 2012, PAPER PRESENTED AT T; Barnett T., 2002, AIDS IN THE TWENTY F; Bendavid E, 2012, JAMA-J AM MED ASSOC, V307, P2060, DOI 10.1001/jama.2012.2001; Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207; Bor J, 2012, HEALTH AFFAIR, V31, P1459, DOI 10.1377/hlthaff.2012.0407; Bor J, 2011, TROP MED INT HEALTH, V16, P988, DOI 10.1111/j.1365-3156.2011.02795.x; Condliffe K., 2012, PAPER PRESENTED AT T; Day C., 2011, THE DISTRICT HEALTH; Department of Health, 2010, CLINICAL GUIDELINES; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Efron B, 1993, MONOGRAPHS ON STATIS, V57; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Fortson JG, 2011, REV ECON STAT, V93, P1, DOI 10.1162/REST_a_00067; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Grepin KA, 2012, HEALTH AFFAIR, V31, P1406, DOI 10.1377/hlthaff.2012.0279; Herbst AJ, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-47; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; Houlihan CF, 2011, INT J EPIDEMIOL, V40, P318, DOI 10.1093/ije/dyp402; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Jayachandran S, 2009, Q J ECON, V124, P349, DOI 10.1162/qjec.2009.124.1.349; Johnson LF, 2012, S AFR J HIV MED, P22; Kalbfleisch J. D., 2002, STATISTICAL ANALYSIS; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Klein JP, 2003, SURVIVAL ANALYSIS TE; Mahy M, 2010, SEX TRANSM INFECT, V86, pI67, DOI 10.1136/sti.2010.046060; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Muhwava W, 2008, MONOGRAPH SERIES, V2; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Nash D, 2011, AIDS, V25, P1523, DOI 10.1097/QAD.0b013e32834811b2; Nyirenda M, 2007, AIDS, V21, pS73, DOI 10.1097/01.aids.0000299413.82893.2b; Piot P, 2000, SCIENCE, V288, P2176, DOI 10.1126/science.288.5474.2176; Rosen S, 2008, TROP MED INT HEALTH, V13, P1005, DOI 10.1111/j.1365-3156.2008.02114.x; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Statistics South Africa, 2011, MIDYEAR POPULATION E; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; UNAIDS, 2010, UNAIDS REPORT ON THE; United Nations Department of Economic and Social Affairs Population Division, 2011, WORLD POPULATION PRO; World DataBank, 2012, WORLD DEVELOPMENT IN; World Health Organization, 2012, WORLD HEALTH STATIST; Zaba B, 2012, TROP MED INT HEALTH, V17, pe3, DOI 10.1111/j.1365-3156.2011.02943.x; Zaidi J., 2012, LATE BREAKING ABSTRA	47	407	417	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2013	339	6122					961	965		10.1126/science.1230413	http://dx.doi.org/10.1126/science.1230413			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092UX	23430655	Green Accepted			2022-12-28	WOS:000315149600051
J	Lander, AD				Lander, Arthur D.			How Cells Know Where They Are	SCIENCE			English	Review							MORPHOGEN GRADIENT; RETINOIC ACID; MECHANISMS; MODEL; ROBUSTNESS; BOUNDARIES; UNDERLIES; PRECISION; HINDBRAIN; SIGNALS	Development, regeneration, and even day-to-day physiology require plant and animal cells to make decisions based on their locations. The principles by which cells may do this are deceptively straightforward. But when reliability needs to be high-as often occurs during development-successful strategies tend to be anything but simple. Increasingly, the challenge facing biologists is to relate the diverse diffusible molecules, control circuits, and gene regulatory networks that help cells know where they are to the varied, sometimes stringent, constraints imposed by the need for real-world precision and accuracy.	[Lander, Arthur D.] Univ Calif Irvine, Dept Dev & Cell Biol, Dept Biomed Engn, Irvine, CA 92697 USA; [Lander, Arthur D.] Univ Calif Irvine, Ctr Complex Biol Syst, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Lander, AD (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Dept Biomed Engn, Irvine, CA 92697 USA.	adlander@uci.edu	Lander, Arthur D/C-9008-2011; Lander, Arthur/L-2827-2019	Lander, Arthur D/0000-0002-4380-5525; Lander, Arthur/0000-0002-4380-5525	NIH [P50GM076516, R01GM067247]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067247, P50GM076516] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grants P50GM076516 and R01GM067247.	Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Bergmann S, 2007, PLOS BIOL, V5, P232, DOI 10.1371/journal.pbio.0050046; Biehs B, 1998, DEVELOPMENT, V125, P4245; Bollenbach T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018103; Bollenbach T, 2008, DEVELOPMENT, V135, P1137, DOI 10.1242/dev.012062; Cai AQ, 2012, DEVELOPMENT, V139, P2150, DOI 10.1242/dev.077065; Casali A, 2004, NATURE, V431, P76, DOI 10.1038/nature02835; Eldar A, 2003, DEV CELL, V5, P635, DOI 10.1016/S1534-5807(03)00292-2; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Goldbeter A, 2007, DEV DYNAM, V236, P1495, DOI 10.1002/dvdy.21193; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Gursky VV, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-118; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Holloway DM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001069; Howard M, 2005, J CELL BIOL, V168, P533, DOI 10.1083/jcb.200411122; Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Kruse K, 2004, DEVELOPMENT, V131, P4843, DOI 10.1242/dev.01335; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; Lander AD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002022; Lander D, 2007, B MATH BIOL, V69, P33, DOI 10.1007/s11538-006-9152-2; Lewis J, 2008, SCIENCE, V322, P399, DOI 10.1126/science.1166154; Linville A, 2009, DEV BIOL, V325, P60, DOI 10.1016/j.ydbio.2008.09.022; Monk NAM, 1998, B MATH BIOL, V60, P901, DOI 10.1006/bulm.1998.0046; Muller P, 2012, SCIENCE, V336, P721, DOI 10.1126/science.1221920; Nahmad M, 2011, CURR OPIN GENET DEV, V21, P726, DOI 10.1016/j.gde.2011.10.002; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Rogulja D, 2008, DEV CELL, V15, P309, DOI 10.1016/j.devcel.2008.06.003; Rusakov DA, 1998, P NATL ACAD SCI USA, V95, P8975, DOI 10.1073/pnas.95.15.8975; Schilling TF, 2008, INTEGR COMP BIOL, V48, P658, DOI 10.1093/icb/icn081; Schilling TF, 2012, CURR OPIN GENET DEV, V22, P562, DOI 10.1016/j.gde.2012.11.012; Schwank G, 2011, PLOS BIOL, V9, DOI [10.1371/journal.pbio.100111, 10.1371/journal.pbio.1001111]; Sokolowski TR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002654; Tostevin F, 2007, PLOS COMPUT BIOL, V3, P763, DOI 10.1371/journal.pcbi.0030078; Umulis DM, 2006, P NATL ACAD SCI USA, V103, P11613, DOI 10.1073/pnas.0510398103; White RJ, 2007, PLOS BIOL, V5, P2522, DOI 10.1371/journal.pbio.0050304; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391; Zecca M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000386; Zhang L, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.45; Zhou SH, 2012, CURR BIOL, V22, P668, DOI 10.1016/j.cub.2012.02.065; Zhu AJ, 2004, GENE DEV, V18, P2985, DOI 10.1101/gad.1233104	47	74	75	1	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2013	339	6122					923	927		10.1126/science.1224186	http://dx.doi.org/10.1126/science.1224186			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23430648	Green Accepted, Green Submitted			2022-12-28	WOS:000315149600040
J	Tsubouchi, T; Soza-Ried, J; Brown, K; Piccolo, FM; Cantone, I; Landeira, D; Bagci, H; Hochegger, H; Merkenschlager, M; Fisher, AG				Tsubouchi, Tomomi; Soza-Ried, Jorge; Brown, Karen; Piccolo, Francesco M.; Cantone, Irene; Landeira, David; Bagci, Hakan; Hochegger, Helfrid; Merkenschlager, Matthias; Fisher, Amanda G.			DNA Synthesis Is Required for Reprogramming Mediated by Stem Cell Fusion	CELL			English	Article							SOMATIC-CELLS; HYBRID-CELLS; G1 PHASE; IN-VITRO; PLURIPOTENT CELLS; CYCLE REGULATION; GENE-EXPRESSION; SELF-RENEWAL; ES CELLS; REPLICATION	Embryonic stem cells (ESCs) can instruct the conversion of differentiated cells toward pluripotency following cell-to-cell fusion by a mechanism that is rapid but poorly understood. Here, we used centrifugal elutriation to enrich for mouse ESCs at sequential stages of the cell cycle and showed that ESCs in S/G2 phases have an enhanced capacity to dominantly reprogram lymphocytes and fibroblasts in heterokaryon and hybrid assays. Reprogramming success was associated with an ability to induce precocious nucleotide incorporation within the somatic partner nuclei in heterokaryons. BrdU pulse-labeling experiments revealed that virtually all successfully reprogrammed somatic nuclei, identified on the basis of Oct4 re-expression, had undergone DNA synthesis within 24 hr of fusion with ESCs. This was essential for successful reprogramming because drugs that inhibited DNA polymerase activity effectively blocked pluripotent conversion. These data indicate that nucleotide incorporation is an early and critical event in the epigenetic reprogramming of somatic cells in experimental ESC-heterokaryons.	[Tsubouchi, Tomomi; Soza-Ried, Jorge; Brown, Karen; Piccolo, Francesco M.; Cantone, Irene; Landeira, David; Bagci, Hakan; Merkenschlager, Matthias; Fisher, Amanda G.] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Lymphocyte Dev Grp, London W12 0NN, England; [Tsubouchi, Tomomi; Hochegger, Helfrid] Univ Sussex, MRC Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	Imperial College London; University of Sussex	Fisher, AG (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Lymphocyte Dev Grp, Du Cane Rd, London W12 0NN, England.	amanda.fisher@csc.mrc.ac.uk	Landeira, David/F-5001-2018; Cantone, Irene/AAB-1071-2020; Landeira, David/ADY-5662-2022	Landeira, David/0000-0002-3267-454X; Cantone, Irene/0000-0002-8156-7126; Tsubouchi, Tomomi/0000-0001-9960-3888; Merkenschlager, Matthias/0000-0003-2889-3288; Hochegger, Helfrid/0000-0001-8366-6198	Medical Research Council UK; Human Frontier Science Program; European Research Council; MRC [MR/K015834/1, MC_U120081295, MC_U120027516] Funding Source: UKRI; Medical Research Council [MC_U120027516, MC_U120081295] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Human Frontier Science Program(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank C.F. Pereira, H. Tsubouchi, and E. Petretto for help and discussions; S. Amoils for GG1 and ME2.5 probes for DNA FISH; and T. Carr and members of the CSC FACS facility for advice and technical support. This work was funded by the Medical Research Council UK (F.M.P., K.B., M.M., A.G.F.), the Human Frontier Science Program (T.T. and I.C.), and the European Research Council (A.G.F. and J.S.-R).	Ambrosi DJ, 2007, STEM CELLS, V25, P1104, DOI 10.1634/stemcells.2006-0532; Azuara V, 2003, NAT CELL BIOL, V5, P668, DOI 10.1038/ncb1006; Ballabeni A, 2011, P NATL ACAD SCI USA, V108, P19252, DOI 10.1073/pnas.1116794108; Banfalvi G, 2008, NAT PROTOC, V3, P663, DOI 10.1038/nprot.2008.34; Bar-On O, 2010, CELL CYCLE, V9, P1986, DOI 10.4161/cc.9.10.11727; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; BLOW JJ, 1988, NATURE, V332, P546, DOI 10.1038/332546a0; Brown KE, 2001, NAT CELL BIOL, V3, P602, DOI 10.1038/35078577; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Calder A, 2013, STEM CELLS DEV, V22, P279, DOI 10.1089/scd.2012.0168; Calegari F, 2003, J CELL SCI, V116, P4947, DOI 10.1242/jcs.00825; Campbell K H, 1996, Rev Reprod, V1, P40, DOI 10.1530/ror.0.0010040; Campbell KHS, 2003, REPRODUCTION, P477; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; De Carvalho DD, 2010, TRENDS CELL BIOL, V20, P609, DOI 10.1016/j.tcb.2010.08.003; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Do JT, 2007, STEM CELLS, V25, P1013, DOI 10.1634/stemcells.2006-0691; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Fluckiger AC, 2006, STEM CELLS, V24, P547, DOI 10.1634/stemcells.2005-0194; Foshay KM, 2012, MOL CELL, V46, P159, DOI 10.1016/j.molcel.2012.02.013; Fujii-Yamamoto H, 2005, J BIOL CHEM, V280, P12976, DOI 10.1074/jbc.M412224200; Ganier O, 2011, P NATL ACAD SCI USA, V108, P17331, DOI 10.1073/pnas.1100733108; Ghule PN, 2011, J CELL PHYSIOL, V226, P1149, DOI 10.1002/jcp.22440; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; GURDON JB, 1960, J EMBRYOL EXP MORPH, V8, P505; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; JOHNSON RT, 1970, NATURE, V226, P717, DOI 10.1038/226717a0; Koledova Z, 2010, STEM CELLS DEV, V19, P1663, DOI 10.1089/scd.2010.0136; Koledova Z, 2010, STEM CELLS DEV, V19, P181, DOI 10.1089/scd.2009.0065; Matveeva NM, 1998, MOL REPROD DEV, V50, P128, DOI 10.1002/(SICI)1098-2795(199806)50:2&lt;128::AID-MRD2&gt;3.0.CO;2-M; McNairn AJ, 2003, BIOESSAYS, V25, P647, DOI 10.1002/bies.10305; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; MILLER RA, 1976, CELL, V9, P45, DOI 10.1016/0092-8674(76)90051-9; Neganova I, 2008, J ANAT, V213, P30, DOI 10.1111/j.1469-7580.2008.00931.x; Niehrs C, 2012, TRENDS CELL BIOL, V22, P220, DOI 10.1016/j.tcb.2012.01.002; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Papp B, 2011, CELL RES, V21, P486, DOI 10.1038/cr.2011.28; Pereira CF, 2010, CELL STEM CELL, V6, P547, DOI 10.1016/j.stem.2010.04.013; Pereira CF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000170; Pereira CF, 2009, CURR PROTOC STEM CEL, V1; Piccolo F.M., 2013, MOL CELL; Piccolo FM, 2011, PHILOS T R SOC B, V366, P2260, DOI 10.1098/rstb.2011.0004; RAO PN, 1970, NATURE, V225, P159, DOI 10.1038/225159a0; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Savatier Pierre, 2002, Journal de la Societe de Biologie, V196, P117; SELIG S, 1992, EMBO J, V11, P1217, DOI 10.1002/j.1460-2075.1992.tb05162.x; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Sullivan S, 2006, CLONING STEM CELLS, V8, P174, DOI 10.1089/clo.2006.8.174; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tat PA, 2011, CELL REPROGRAM, V13, P331, DOI 10.1089/cell.2011.0002; Terranova R, 2006, J CELL SCI, V119, P2065, DOI 10.1242/jcs.02945; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yang VS, 2011, CURR BIOL, V21, P692, DOI 10.1016/j.cub.2011.03.026; Yeom YI, 1996, DEVELOPMENT, V122, P881	72	59	60	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 14	2013	152	4					873	883		10.1016/j.cell.2013.01.012	http://dx.doi.org/10.1016/j.cell.2013.01.012			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415233	Green Published, hybrid			2022-12-28	WOS:000314945600020
J	Nikolic, S; van de Ven, G; Heng, K; Kupko, D; Husemann, B; Raymond, JC; Hughes, JP; Falcon-Barroso, J				Nikolic, Sladjana; van de Ven, Glenn; Heng, Kevin; Kupko, Daniel; Husemann, Bernd; Raymond, John C.; Hughes, John P.; Falcon-Barroso, Jesus			An Integral View of Fast Shocks Around Supernova 1006	SCIENCE			English	Article							BALMER-DOMINATED SHOCKS; COLLISIONLESS SHOCKS; AZIMUTHAL VARIATIONS; OPTICAL-EMISSION; HIGH-ENERGY; SN-1006; REMNANTS; ACCELERATION; WAVE; GAS	Supernova remnants are among the most spectacular examples of astrophysical pistons in our cosmic neighborhood. The gas expelled by the supernova explosion is launched with velocities similar to 1000 kilometers per second into the ambient, tenuous interstellar medium, producing shocks that excite hydrogen lines. We have used an optical integral-field spectrograph to obtain high-resolution spatial-spectral maps that allow us to study in detail the shocks in the northwestern rim of supernova 1006. The two-component Ha line is detected at 133 sky locations. Variations in the broad line widths and the broad-to-narrow line intensity ratios across tens of atomic mean free paths suggest the presence of suprathermal protons, the potential seed particles for generating high-energy cosmic rays.	[Nikolic, Sladjana; van de Ven, Glenn] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Heng, Kevin] Univ Bern, Ctr Space & Habitabil, CH-3012 Bern, Switzerland; [Kupko, Daniel; Husemann, Bernd] Leibniz Inst Astrophys Potsdam AIP, D-14482 Potsdam, Germany; [Raymond, John C.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Hughes, John P.] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; [Falcon-Barroso, Jesus] Inst Astrofis Canarias, E-38205 San Cristobal la Laguna, Tenerife, Spain	Max Planck Society; University of Bern; Leibniz Institut fur Astrophysik Potsdam (AIP); Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Rutgers State University New Brunswick; Instituto de Astrofisica de Canarias	Nikolic, S (corresponding author), Max Planck Inst Astron, Konigstuhl 17, D-69117 Heidelberg, Germany.	nikolic@mpia.de	Falcon-Barroso, Jesus/AAD-9660-2019; van de Ven, Glenn/R-5189-2019	Falcon-Barroso, Jesus/0000-0002-0608-9574; van de Ven, Glenn/0000-0003-4546-7731; Knezevic, Sladjana/0000-0003-1416-8069; Raymond, John/0000-0002-7868-1622; Hughes, John P./0000-0002-8816-6800	International Max Planck Research School for Astronomy and Cosmic Physics at the University of Heidelberg; European Southern Observatory Telescopes at the La Silla Paranal Observatory [085.D-0983]	International Max Planck Research School for Astronomy and Cosmic Physics at the University of Heidelberg; European Southern Observatory Telescopes at the La Silla Paranal Observatory	This work was supported by the International Max Planck Research School for Astronomy and Cosmic Physics at the University of Heidelberg. The paper is based on observations made with European Southern Observatory Telescopes at the La Silla Paranal Observatory under program ID 085.D-0983.	Acero F, 2007, ASTRON ASTROPHYS, V475, P883, DOI 10.1051/0004-6361:20077742; Acero F, 2010, ASTRON ASTROPHYS, V516, DOI 10.1051/0004-6361/200913916; Berezhko EG, 2002, ASTRON ASTROPHYS, V395, P943, DOI 10.1051/0004-6361:20021219; BYCHKOV KV, 1979, ASTRON ASTROPHYS, V80, P167; Cappellari M, 2003, MON NOT R ASTRON SOC, V342, P345, DOI 10.1046/j.1365-8711.2003.06541.x; CARGILL PJ, 1988, ASTROPHYS J, V329, pL29, DOI 10.1086/185170; Cassam-Chenai G, 2008, ASTROPHYS J, V680, P1180, DOI 10.1086/588015; CHEVALIER RA, 1978, ASTROPHYS J, V225, pL27, DOI 10.1086/182785; CHEVALIER RA, 1980, ASTROPHYS J, V235, P186, DOI 10.1086/157623; Ghavamian P, 2000, ASTROPHYS J, V535, P266, DOI 10.1086/308811; Ghavamian P, 2002, ASTROPHYS J, V572, P888, DOI 10.1086/340437; Ghavamian P, 2007, ASTROPHYS J, V654, pL69, DOI 10.1086/510740; Heng K, 2007, ASTROPHYS J, V668, P275, DOI 10.1086/521298; Heng K, 2007, ASTROPHYS J, V654, P923, DOI 10.1086/509601; Heng K, 2010, PUBL ASTRON SOC AUST, V27, P23, DOI 10.1071/AS09057; KOYAMA K, 1995, NATURE, V378, P255, DOI 10.1038/378255a0; Lee JJ, 2007, ASTROPHYS J, V659, pL133, DOI 10.1086/517520; Lim AJ, 1996, MON NOT R ASTRON SOC, V280, P103, DOI 10.1093/mnras/280.1.103; Long KS, 2003, ASTROPHYS J, V586, P1162, DOI 10.1086/367832; Morlino G, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/2/137; Petruk O, 2009, MON NOT R ASTRON SOC, V393, P1034, DOI 10.1111/j.1365-2966.2008.14251.x; Raymond JC, 2008, ASTROPHYS J, V682, P408, DOI 10.1086/589645; Raymond JC, 2007, ASTROPHYS J, V659, P1257, DOI 10.1086/512483; Reynolds SP, 2008, ANNU REV ASTRON ASTR, V46, P89, DOI 10.1146/annurev.astro.46.060407.145237; Rothenflug R, 2004, ASTRON ASTROPHYS, V425, P121, DOI 10.1051/0004-6361:20047104; Sollerman J, 2003, ASTRON ASTROPHYS, V407, P249, DOI 10.1051/0004-6361:20030839; van Adelsberg M, 2008, ASTROPHYS J, V689, P1089, DOI 10.1086/592680; Winkler PF, 2003, ASTROPHYS J, V585, P324, DOI 10.1086/345985	28	31	31	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					45	48		10.1126/science.1228297	http://dx.doi.org/10.1126/science.1228297			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23413189	Green Submitted			2022-12-28	WOS:000317061100039
J	Hansel, TT; Johnston, SL; Openshaw, PJ				Hansel, Trevor T.; Johnston, Sebastian L.; Openshaw, Peter J.			Microbes and mucosal immune responses in asthma	LANCET			English	Review							SYNCYTIAL VIRUS-INFECTION; EARLY-LIFE; 1ST YEAR; INTESTINAL MICROBIOTA; ATOPIC SENSITIZATION; RHINOVIRUS INFECTION; VIRAL-INFECTIONS; ALLERGIC DISEASE; EPITHELIAL-CELLS; GUT MICROBIOTA	The substantial increase in the worldwide prevalence of asthma and atopy has been attributed to lifestyle changes that reduce exposure to bacteria. A recent insight is that the largely bacterial microbiome maintains a state of basal immune homoeostasis, which modulates immune responses to microbial pathogens. However, some respiratory viral infections cause bronchiolitis of infancy and childhood wheeze, and can exacerbate established asthma; whereas allergens can partly mimic infectious agents. New insights into the host's innate sensing systems, combined with recently developed methods that characterise commensal and pathogenic microbial exposure, now allow a unified theory for how microbes cause mucosal inflammation in asthma. The respiratory mucosa provides a key microbial interface where epithelial and dendritic cells interact with a range of functionally distinct lymphocytes. Lymphoid cells then control a range of pathways, both innate and specific, which organise the host mucosal immune response. Fundamental to innate immune responses to microbes are the interactions between pathogen-associated molecular patterns and pattern recognition receptors, which are associated with production of type I interferons, proinflammatory cytokines, and the T-helper-2 cell pathway in predisposed people. These coordinated, dynamic immune responses underlie the differing asthma phenotypes, which we delineate in terms of Seven Ages of Asthma. An understanding of the role of microbes in the atopic march towards asthma, and in causing exacerbations of established asthma, provides the rationale for new specific treatments that can be assessed in clinical trials. On the basis of these new ideas, specific host biomarkers might then allow personalised treatment to become a reality for patients with asthma.	[Hansel, Trevor T.; Johnston, Sebastian L.; Openshaw, Peter J.] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, MRC & Asthma UK Ctr Allerg Mech Asthma, NHLI,CRI, London, England	Imperial College London; University of London; King's College London	Hansel, TT (corresponding author), St Marys Hosp, Ctr Resp Infect, ICRRU, Mint Wing, London W2 1NY, England.	t.hansel@imperial.ac.uk	Johnston, Sebastian Lennox/I-2423-2012; Openshaw, Peter/AAL-9442-2020	Johnston, Sebastian Lennox/0000-0003-3009-9200; Openshaw, Peter/0000-0002-7220-2555	Novartis; Merck; GlaxoSmithKline; Dainippon Sumitomo; Boehringer Ingelheim; AstraZeneca; Centocor; MedImmune; Sanofi Pasteur; Synairgen; National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) based at Imperial College NHS Trust and Imperial College London; Welcome Trust [090382/Z/09/Z, 083567/Z/07/Z]; MRC Centre [G1000758]; ERC [233015]; Asthma UK [CH11SJ]; Predicta [260895]; Medical Research Council [G1000758, MC_G1001212] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish; Asthma UK [S06/001] Funding Source: researchfish; MRC [MC_G1001212] Funding Source: UKRI	Novartis(Novartis); Merck(Merck & Company); GlaxoSmithKline(GlaxoSmithKline); Dainippon Sumitomo(Dainippon Sumitomo Pharma Co., Ltd.); Boehringer Ingelheim(Boehringer Ingelheim); AstraZeneca(AstraZeneca); Centocor; MedImmune(AstraZenecaMedimmune); Sanofi Pasteur; Synairgen; National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) based at Imperial College NHS Trust and Imperial College London(National Institute for Health Research (NIHR)); Welcome Trust(Wellcome Trust); MRC Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC(European Research Council (ERC)European Commission); Asthma UK; Predicta; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	In the past 5 years, TTH has been Principal Investigator for respiratory clinical studies sponsored by Novartis, Merck, GlaxoSmithKline, and Dainippon Sumitomo. He has been participated in setting up a spin-off company with Imperial Innovations called Mucosal Diagnostics, and has received support to attend the American Thoracic Society from Boehringer Ingelheim. In the past 5 years, SLJ has received research grants from AstraZeneca, Centocor, GlaxoSmithKline, MedImmune, Sanofi Pasteur, and Synairgen, and he does consultancy work for these companies. He also holds share options in Synairgen. PJO declares that he has no conflicts of interest.; This work was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) based at Imperial College NHS Trust and Imperial College London; the Welcome Trust (grants 090382/Z/09/Z and 083567/Z/07/Z); MRC Centre grant G1000758, ERC FP7 advanced grant 233015 (to SLJ); a Chair from Asthma UK (grant CH11SJ to SLJ); and Predicta FP7 Collaborative Project grant 260895 (to SLJ)	Abrahamsson TR, 2011, CLIN EXP ALLERGY, V41, P1729, DOI 10.1111/j.1365-2222.2011.03827.x; Abrahamsson TR, 2009, J PEDIATR GASTR NUTR, V49, P349, DOI 10.1097/MPG.0b013e31818f091b; Akdis CA, 2012, NAT MED, V18, P736, DOI 10.1038/nm.2754; Auffray C, 2010, CHEST, V137, P1410, DOI 10.1378/chest.09-1850; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130, P91, DOI 10.1016/j.jaci.2012.02.010; Baraldo S, 2012, J ALLERGY CLIN IMMUN, V130, P1307, DOI 10.1016/j.jaci.2012.08.005; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V128, P646, DOI 10.1016/j.jaci.2011.04.060; Bonilla WV, 2012, SCIENCE, V335, P984, DOI 10.1126/science.1215418; Bosch AATM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003057; Boulet LP, 2007, ALLERGY, V62, P1101, DOI 10.1111/j.1398-9995.2007.01499.x; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Brand PLP, 2008, EUR RESPIR J, V32, P1096, DOI 10.1183/09031936.00002108; Brooks C, 2013, CURR OPIN ALLERGY CL, V13, P70, DOI 10.1097/ACI.0b013e32835ad0d2; Bush Andrew, 2009, Proc Am Thorac Soc, V6, P712, DOI 10.1513/pats.200906-046DP; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Byers DE, 2011, CHEST, V140, P768, DOI 10.1378/chest.10-2132; Cameron EJ, 2012, CLIN EXP ALLERGY, V42, P1302, DOI 10.1111/j.1365-2222.2012.03979.x; Catley MC, 2011, PHARMACOL THERAPEUT, V132, P333, DOI 10.1016/j.pharmthera.2011.09.005; Chawes BLK, 2012, J ALLERGY CLIN IMMUN, V130, P354, DOI 10.1016/j.jaci.2012.04.045; Choy DF, 2011, J IMMUNOL, V186, P1861, DOI 10.4049/jimmunol.1002568; Connolly DJ, 2012, CURR OPIN PHARMACOL, V12, P510, DOI 10.1016/j.coph.2012.06.002; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DeMore JP, 2009, J ALLERGY CLIN IMMUN, V124, P245, DOI 10.1016/j.jaci.2009.05.030; Denning DW, 2009, AM J RESP CRIT CARE, V179, P11, DOI 10.1164/rccm.200805-737OC; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; Dunning J, 2010, THORAX, V65, P471, DOI 10.1136/thx.2009.133728; Durham AL, 2011, BBA-GEN SUBJECTS, V1810, P1103, DOI 10.1016/j.bbagen.2011.03.006; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Edwards MR, 2008, CLIN EXP ALLERGY, V38, P1416, DOI 10.1111/j.1365-2222.2008.03064.x; Edwards MR, 2012, NAT REV MICROBIOL, V10, P459, DOI 10.1038/nrmicro2801; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; El Saleeby CM, 2011, J INFECT DIS, V204, P996, DOI 10.1093/infdis/jir494; Essilfie AT, 2012, THORAX, V67, P588, DOI 10.1136/thoraxjnl-2011-200160; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Fahy John V, 2009, Proc Am Thorac Soc, V6, P256, DOI 10.1513/pats.200808-087RM; Folsgaard NV, 2012, CLIN EXP ALLERGY, V42, P1596, DOI 10.1111/j.1365-2222.2012.04048.x; Folsgaard NV, 2012, AM J RESP CRIT CARE, V185, P275, DOI 10.1164/rccm.201108-1471OC; Forbes RL, 2012, THORAX, V67, P209, DOI 10.1136/thoraxjnl-2011-200708; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Geevarghese B, 2012, ANTIVIR THER, V17, P201, DOI 10.3851/IMP2061; Gern JE, 2009, CURR OPIN ALLERGY CL, V9, P73, DOI 10.1097/ACI.0b013e32831f8f1b; Global Initiative for Asthma (GINA), GLOB STRAT ASTHM MAN; Graham BS, 2011, IMMUNOL REV, V239, P149, DOI 10.1111/j.1600-065X.2010.00972.x; Gupta A, 2012, PAEDIATR RESPIR REV, V13, P236, DOI 10.1016/j.prrv.2011.07.003; Habibi MS, 2012, CURR OPIN INFECT DIS, V25, P687, DOI 10.1097/QCO.0b013e32835a1d92; Habibzay M, 2012, MUCOSAL IMMUNOL, V5, P524, DOI 10.1038/mi.2012.28; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Halfhide CP, 2011, J INFECT DIS, V204, P451, DOI 10.1093/infdis/jir280; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hams E, 2012, CURR OPIN PHARMACOL, V12, P503, DOI 10.1016/j.coph.2012.06.001; Han MK, 2012, THORAX, V67, P456, DOI 10.1136/thoraxjnl-2011-201183; Hanabuchi S, 2012, ALLERGOL INT, V61, P19, DOI 10.2332/allergolint.11-RAI-0394; Havstad S, 2011, J ALLERGY CLIN IMMUN, V128, P880, DOI 10.1016/j.jaci.2011.06.039; Hawrylowicz C, 2010, NAT MED, V16, P274, DOI 10.1038/nm0310-274; Heederik D, 2012, J ALLERGY CLIN IMMUN, V130, P44, DOI 10.1016/j.jaci.2012.01.067; Hernandez ML, 2012, J ALLERGY CLIN IMMUN, V130, P869, DOI 10.1016/j.jaci.2012.05.026; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Ho SM, 2010, J ALLERGY CLIN IMMUN, V126, P453, DOI 10.1016/j.jaci.2010.07.030; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Holt PG, 2012, NAT MED, V18, P726, DOI 10.1038/nm.2768; Holtzman MJ, 2012, J CLIN INVEST, V122, P2741, DOI 10.1172/JCI60325; Holtzman MJ, 2011, CURR OPIN IMMUNOL, V23, P487, DOI 10.1016/j.coi.2011.05.010; Hsu SC, 2010, J BIOL CHEM, V285, P7903, DOI 10.1074/jbc.M109.058370; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Hussell T, 2010, LANCET INFECT DIS, V10, P360, DOI 10.1016/S1473-3099(10)70067-0; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ingram JL, 2012, J ALLERGY CLIN IMMUN, V130, P829, DOI 10.1016/j.jaci.2012.06.034; Islam SA, 2012, NAT MED, V18, P705, DOI 10.1038/nm.2760; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Jackson DJ, 2011, J ALLERGY CLIN IMMUN, V128, P1165, DOI 10.1016/j.jaci.2011.10.024; Jartti T, 2012, CURR OPIN PULM MED, V18, P271, DOI 10.1097/MCP.0b013e328351f8d4; Jones SC, 2011, CLIN EXP ALLERGY, V41, P471, DOI 10.1111/j.1365-2222.2011.03718.x; Jones S, 2009, VACCINE, V27, P2506, DOI 10.1016/j.vaccine.2009.02.061; Knutsen AP, 2012, J ALLERGY CLIN IMMUN, V129, P280, DOI 10.1016/j.jaci.2011.12.970; Kraft M, 2011, NEW ENGL J MED, V365, P1141, DOI 10.1056/NEJMe1108666; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lambrecht BN, 2010, LANCET, V376, P835, DOI 10.1016/S0140-6736(10)61226-3; Lee HC, 2012, J ALLERGY CLIN IMMUN, V130, P1187, DOI 10.1016/j.jaci.2012.07.031; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Ly NP, 2011, J ALLERGY CLIN IMMUN, V127, P1087, DOI 10.1016/j.jaci.2011.02.015; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; McGrath KW, 2012, AM J RESP CRIT CARE, V185, P612, DOI 10.1164/rccm.201109-1640OC; McLoughlin RM, 2011, J ALLERGY CLIN IMMUN, V127, P1097, DOI 10.1016/j.jaci.2011.02.012; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Moghaddam A, 2006, NAT MED, V12, P905, DOI 10.1038/nm1456; Molfino NA, 2012, CLIN EXP ALLERGY, V42, P712, DOI 10.1111/j.1365-2222.2011.03854.x; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; Nicholson GC, 2011, J ALLERGY CLIN IMMUN, V128, P800, DOI 10.1016/j.jaci.2011.05.013; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; O'Byrne PM, 2009, CLIN EXP ALLERGY, V39, P181, DOI 10.1111/j.1365-2222.2008.03172.x; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Papadopoulos NG, 2002, AM J RESP CRIT CARE, V165, P1285, DOI 10.1164/rccm.200112-118BC; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Pollard AJ, 2012, LANCET INFECT DIS, V12, P903, DOI 10.1016/S1473-3099(12)70292-X; Prendergast AJ, 2012, NAT REV IMMUNOL, V12, P636, DOI 10.1038/nri3277; Pulimood TB, 2007, J ALLERGY CLIN IMMUN, V120, P610, DOI 10.1016/j.jaci.2007.04.045; Rodrigo GJ, 2011, CHEST, V139, P28, DOI 10.1378/chest.10-1194; Rosenberg HF, 2009, ANTIVIR RES, V83, P1, DOI 10.1016/j.antiviral.2009.04.005; Schadt EE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002132; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Sly PD, 2008, LANCET, V372, P1100, DOI 10.1016/S0140-6736(08)61451-8; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sumino K, 2012, J ALLERGY CLIN IMMUN, V129, P1267, DOI 10.1016/j.jaci.2012.02.033; Sykes A, 2012, J ALLERGY CLIN IMMUN, V129, P1506, DOI 10.1016/j.jaci.2012.03.044; Szefler SJ, 2011, CURR OPIN IMMUNOL, V23, P801, DOI 10.1016/j.coi.2011.07.014; Tan RA, 2011, IMMUNOL ALLERGY CLIN, V31, P481, DOI 10.1016/j.iac.2011.05.010; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; van den Wijngaard CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031197; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Walsh Edward E., 2012, Infectious Disorders - Drug Targets, V12, P98; Walsh KB, 2011, IMMUNOL RES, V51, P15, DOI 10.1007/s12026-011-8240-z; Weinmayr G, 2007, AM J RESP CRIT CARE, V176, P565, DOI 10.1164/rccm.200607-994OC; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wills-Karp M, 2010, MUCOSAL IMMUNOL, V3, P104, DOI 10.1038/mi.2009.138; Wills-Karp M, 2012, J EXP MED, V209, P607, DOI 10.1084/jem.20110079; Woodcock A, 2003, NEW ENGL J MED, V349, P225, DOI 10.1056/NEJMoa023175; Wos M, 2008, AM J RESP CRIT CARE, V177, P1082, DOI 10.1164/rccm.200607-973OC; Wright M, 2011, PEDIATR PULM, V46, P324, DOI 10.1002/ppul.21377; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Zhang YM, 2012, CURR OPIN PULM MED, V18, P6, DOI 10.1097/MCP.0b013e32834dc532	140	119	128	0	90	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 9	2013	381	9869					861	873		10.1016/S0140-6736(12)62202-8	http://dx.doi.org/10.1016/S0140-6736(12)62202-8			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105IL	23428115				2022-12-28	WOS:000316060600035
J	Malchow, S; Leventhal, DS; Nishi, S; Fischer, BI; Shen, L; Paner, GP; Amit, AS; Kang, C; Geddes, JE; Allison, JP; Socci, ND; Savage, PA				Malchow, Sven; Leventhal, Daniel S.; Nishi, Saki; Fischer, Benjamin I.; Shen, Lynn; Paner, Gladell P.; Amit, Ayelet S.; Kang, Chulho; Geddes, Jenna E.; Allison, James P.; Socci, Nicholas D.; Savage, Peter A.			Aire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells	SCIENCE			English	Article							PROSTATE-CANCER; SELF-ANTIGEN; EXPRESSION; SELECTION; GENES	Despite considerable interest in the modulation of tumor-associated Foxp3+ regulatory T cells (T-regs) for therapeutic benefit, little is known about the developmental origins of these cells and the nature of the antigens that they recognize. We identified an endogenous population of antigen-specific T-regs (termed MJ23 T-regs) found recurrently enriched in the tumors of mice with oncogene-driven prostate cancer. MJ23 T-regs were not reactive to a tumor-specific antigen but instead recognized a prostate-associated antigen that was present in tumor-free mice. MJ23 T-regs underwent autoimmune regulator (Aire)-dependent thymic development in both male and female mice. Thus, Aire-mediated expression of peripheral tissue antigens drives the thymic development of a subset of organ-specific T-regs, which are likely coopted by tumors developing within the associated organ.	[Malchow, Sven; Leventhal, Daniel S.; Nishi, Saki; Fischer, Benjamin I.; Shen, Lynn; Paner, Gladell P.; Amit, Ayelet S.; Savage, Peter A.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Kang, Chulho] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; [Geddes, Jenna E.; Allison, James P.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Dept Immunol, New York, NY 10021 USA; [Socci, Nicholas D.] Mem Sloan Kettering Canc Ctr, Bioinformat Core, New York, NY 10021 USA	University of Chicago; University of California System; University of California Berkeley; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Savage, PA (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	psavage@bsd.uchicago.edu		Allison, James/0000-0001-8980-5697	Cancer Research Institute Investigator Award; Cancer Research Foundation Young Investigator Award; American Cancer Society Institutional Research Grant [IRG-58-004]; University of Chicago Comprehensive Cancer Center [P30 CA14599]; MSKCC Comprehensive Cancer Center [P30 CA008748]; Howard Hughes Medical Institute;  [R01 (1R01CA160371-01)]; NATIONAL CANCER INSTITUTE [R01CA160371, P30CA008748, P30CA014599] Funding Source: NIH RePORTER	Cancer Research Institute Investigator Award; Cancer Research Foundation Young Investigator Award; American Cancer Society Institutional Research Grant(American Cancer Society); University of Chicago Comprehensive Cancer Center; MSKCC Comprehensive Cancer Center; Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Bendelac, T. Gajewski, R. Gottschalk, and S. Quezada for critical reading of the manuscript; A. Rudensky for Foxp3<SUP>gfp</SUP> reporter mice (6); C. Benoist for cassette vectors for TCR alpha and TCR beta transgenic mice (23); L. Degenstein for transgenic mouse production; and A. Thomas and N.-L. Yin for deep TCR sequence analysis. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. This work was partially funded by the following sources (to P. A. S.): R01 (1R01CA160371-01), a Cancer Research Institute Investigator Award, a Cancer Research Foundation Young Investigator Award, an American Cancer Society Institutional Research Grant (IRG-58-004), and the University of Chicago Comprehensive Cancer Center (including Support Grant P30 CA14599). N.D.S. was supported by MSKCC Comprehensive Cancer Center (Support Grant P30 CA008748). J.P.A. was supported by funding from the Howard Hughes Medical Institute.	Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; DeVoss J, 2006, J EXP MED, V203, P2727, DOI 10.1084/jem.20061864; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gingrich JR, 1999, PROSTATE CANCER P D, V2, P70, DOI 10.1038/sj/pcan/4500296; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359; Lei Y, 2011, J EXP MED, V208, P383, DOI 10.1084/jem.20102327; Leung MWL, 2009, J EXP MED, V206, P2121, DOI 10.1084/jem.20091033; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Taniguchi RT, 2012, P NATL ACAD SCI USA, V109, P7847, DOI 10.1073/pnas.1120607109; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wong J, 2007, J EXP MED, V204, P2039, DOI 10.1084/jem.20070822; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032	23	224	229	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2013	339	6124					1219	1224		10.1126/science.1233913	http://dx.doi.org/10.1126/science.1233913			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471412	Green Accepted			2022-12-28	WOS:000315709900052
J	Wright, GA; Baker, DD; Palmer, MJ; Stabler, D; Mustard, JA; Power, EF; Borland, AM; Stevenson, PC				Wright, G. A.; Baker, D. D.; Palmer, M. J.; Stabler, D.; Mustard, J. A.; Power, E. F.; Borland, A. M.; Stevenson, P. C.			Caffeine in Floral Nectar Enhances a Pollinator's Memory of Reward	SCIENCE			English	Article							MUSHROOM BODY; PLASTICITY; EVOLUTION; HONEYBEES; COFFEE; BEES	Plant defense compounds occur in floral nectar, but their ecological role is not well understood. We provide evidence that plant compounds pharmacologically alter pollinator behavior by enhancing their memory of reward. Honeybees rewarded with caffeine, which occurs naturally in nectar of Coffea and Citrus species, were three times as likely to remember a learned floral scent as were honeybees rewarded with sucrose alone. Caffeine potentiated responses of mushroom body neurons involved in olfactory learning and memory by acting as an adenosine receptor antagonist. Caffeine concentrations in nectar did not exceed the bees' bitter taste threshold, implying that pollinators impose selection for nectar that is pharmacologically active but not repellent. By using a drug to enhance memories of reward, plants secure pollinator fidelity and improve reproductive success.	[Wright, G. A.; Stabler, D.; Power, E. F.] Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Baker, D. D.; Stabler, D.; Power, E. F.; Borland, A. M.] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Palmer, M. J.] Univ Dundee, Ninewells Med Sch, Med Res Inst, Div Neurosci, Dundee DD1 9SY, Scotland; [Mustard, J. A.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Stevenson, P. C.] Royal Bot Gardens, Jodrell Lab, Richmond TW9 3AB, Surrey, England; [Stevenson, P. C.] Univ Greenwich, Nat Resources Inst, Chatham ME4 4TB, Kent, England	Newcastle University - UK; Newcastle University - UK; University of Dundee; Arizona State University; Arizona State University-Tempe; Royal Botanic Gardens, Kew; University of Greenwich	Wright, GA (corresponding author), Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	jeri.wright@ncl.ac.uk	stevenson, philip c/E-8741-2013; Stevenson, Philip C/E-8822-2013	stevenson, philip c/0000-0002-0736-3619; Stevenson, Philip C/0000-0002-0736-3619; Palmer, Mary/0000-0002-5539-6052; Mustard, Julie A/0000-0002-1412-1140; Power, Eileen/0000-0002-5941-4676; Borland, Anne/0000-0003-4560-9998	Linnean Society of London; UK government Insect Pollinators Initiative [BB/I000968/1];  [BB/1000313/1]; BBSRC [BB/I000445/1, BB/I000968/1, BB/I000313/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I000313/1, BB/I000445/1, BB/I000968/1] Funding Source: researchfish	Linnean Society of London; UK government Insect Pollinators Initiative; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank staff at Centro Agronomico Tropicale de Investigacion et Ensenanza in Costa Rica for access to the Coffea collections and at Technological Education Institute of Crete for access to Citrus orchards; M. Thomson, K. Smith, F. Marion-Poll, and A. Popescu for help with the data collection; M. Thompson for beekeeping; and J. Harvey and C. Connolly for project support. This work was funded in part by the Linnean Society of London and by a UK government Insect Pollinators Initiative grant BB/I000968/1 to G.A.W. and a separate grant to C. Connolly (BB/1000313/1). Methods and additional data are available in the online supplementary materials. All data are archived on the Natural Environment Research Council Environmental Information Data Centre.	Ashihara H, 2001, TRENDS PLANT SCI, V6, P407, DOI 10.1016/S1360-1385(01)02055-6; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Cassenaer S, 2012, NATURE, V482, P47, DOI 10.1038/nature10776; Chittka L, 1997, BEHAV ECOL, V8, P239, DOI 10.1093/beheco/8.3.239; Detzel Andreas, 1993, Chemoecology, V4, P8, DOI 10.1007/BF01245891; Galili DS, 2011, J NEUROSCI, V31, P7240, DOI 10.1523/JNEUROSCI.6667-10.2011; Harborne J. B., 1993, INTRO ECOLOGICAL BIO, V4th; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Hollingsworth RG, 2002, NATURE, V417, P915, DOI 10.1038/417915a; Hopkins R, 2012, SCIENCE, V335, P1090, DOI 10.1126/science.1215198; Kretschmar JA, 1999, PHYTOCHEMISTRY, V52, P19, DOI 10.1016/S0031-9422(99)00119-3; KUNIN WE, 1993, ECOLOGY, V74, P2145, DOI 10.2307/1940859; Menzel R, 2005, J EXP BIOL, V208, P4317, DOI 10.1242/jeb.01908; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Mustard JA, 2012, BEHAV BRAIN RES, V232, P217, DOI 10.1016/j.bbr.2012.04.014; Nehlig A, 1999, NEUROSCI BIOBEHAV R, V23, P563, DOI 10.1016/S0149-7634(98)00050-5; OKAMOTO M, 1994, PHARMACOL TOXICOL, V75, P1, DOI 10.1111/j.1600-0773.1994.tb00316.x; Oleskevich S, 1997, J NEUROPHYSIOL, V78, P528, DOI 10.1152/jn.1997.78.1.528; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Ricketts TH, 2004, P NATL ACAD SCI USA, V101, P12579, DOI 10.1073/pnas.0405147101; Roubik DW, 2002, NATURE, V417, P708, DOI 10.1038/417708a; Rudolph T, 2010, ACTA ANAESTH SCAND, V54, P521, DOI 10.1111/j.1399-6576.2009.02201.x; Simons SB, 2012, NAT NEUROSCI, V15, P23, DOI 10.1038/nn.2962; Singaravelan N, 2005, J CHEM ECOL, V31, P2791, DOI 10.1007/s10886-005-8394-z; Sperlagh B, 2011, CURR TOP MED CHEM, V11, P1034, DOI 10.2174/156802611795347564; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Sullivan RJ, 2008, P ROY SOC B-BIOL SCI, V275, P1231, DOI 10.1098/rspb.2007.1673; Szyszka P, 2011, J NEUROSCI, V31, P7229, DOI 10.1523/JNEUROSCI.6668-10.2011; Szyszka P, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.003.2008; Wright GA, 2010, CURR BIOL, V20, P2234, DOI 10.1016/j.cub.2010.11.040; Wright GA, 2009, FUNCT ECOL, V23, P841, DOI 10.1111/j.1365-2435.2009.01627.x	31	190	196	13	370	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2013	339	6124					1202	1204		10.1126/science.1228806	http://dx.doi.org/10.1126/science.1228806			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471406	Green Submitted, Green Accepted			2022-12-28	WOS:000315709900046
J	Muhlenbruch, B; Jochimsen, MA				Muehlenbruch, Brigitte; Jochimsen, Maren A.			Only wholesale reform will bring equality	NATURE			English	Editorial Material									[Muehlenbruch, Brigitte] European Platform Women Scientists, Brussels, Belgium; [Jochimsen, Maren A.] Univ Duisburg Essen, Essen Coll Gender Studies, D-45117 Essen, Germany	University of Duisburg Essen	Muhlenbruch, B (corresponding author), European Platform Women Scientists, Brussels, Belgium.	brigitte.muehlenbruch@epws.org; maren.a.jochimsen@uni-due.de						[Anonymous], 2011, LANCET, V378, P1826; European Commission, 2009, SHE FIG 2009 STAT IN; European Commission, 2012, STRUCT CHANG RES I E; European Commission, 2021, SHE FIG 2012 GEND RE, DOI [10.2777/06090, DOI 10.2777/06090]; European Platform of Women Scientists, 2012, EPWS POS PAP EU FRAM; European Research Council, 2011, ERC SCI COUNC GEND E; European Science Foundation, 2011, MEMB ORG FOR EUR PEE; Jochimsen M. A., 2009, CEWS BEITRAGE, V5, P11; League of European Research Universities, 2012, WOM RES U EXC GEND B; Nature, 2012, NATURE, V491, P495	10	8	9	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2013	495	7439					40	42		10.1038/495040a	http://dx.doi.org/10.1038/495040a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	105BE	23467155	Bronze			2022-12-28	WOS:000316039800020
J	Doubeni, CA; Weinmann, S; Adams, K; Kamineni, A; Buist, DSM; Ash, AS; Rutter, CM; Doria-Rose, VP; Corley, DA; Greenlee, RT; Chubak, J; Williams, A; Kroll-Desrosiers, AR; Johnson, E; Webster, J; Richert-Boe, K; Levin, TR; Fletcher, RH; Weiss, NS				Doubeni, Chyke A.; Weinmann, Sheila; Adams, Kenneth; Kamineni, Aruna; Buist, Diana S. M.; Ash, Arlene S.; Rutter, Carolyn M.; Doria-Rose, V. Paul; Corley, Douglas A.; Greenlee, Robert T.; Chubak, Jessica; Williams, Andrew; Kroll-Desrosiers, Aimee R.; Johnson, Eric; Webster, Joseph; Richert-Boe, Kathryn; Levin, Theodore R.; Fletcher, Robert H.; Weiss, Noel S.			Screening Colonoscopy and Risk for Incident Late-Stage Colorectal Cancer Diagnosis in Average-Risk Adults A Nested Case-Control Study	ANNALS OF INTERNAL MEDICINE			English	Article							SERVICES TASK-FORCE; FECAL-OCCULT-BLOOD; RANDOMIZED CONTROLLED TRIAL; NATIONAL-INSTITUTES; BETHESDA GUIDELINES; MORTALITY; HEALTH; SIGMOIDOSCOPY; POPULATION; STATEMENT	Background: The effectiveness of screening colonoscopy in average-risk adults is uncertain, particularly for right colon cancer. Objective: To examine the association between screening colonoscopy and risk for incident late-stage colorectal cancer (CRC). Design: Nested case-control study. Setting: Four U.S. health plans. Patients: 1039 average-risk adults enrolled for at least 5 years in one of the health plans. Case patients were aged 55 to 85 years on their diagnosis date (reference date) of stage IIB or higher (late-stage) CRC during 2006 to 2008. One or 2 control patients were selected for each case patient, matched on birth year, sex, health plan, and prior enrollment duration. Measurements: Receipt of CRC screening 3 months to 10 years before the reference date, ascertained through medical record audits. Case patients and control patients were compared on receipt of screening colonoscopy or sigmoidoscopy by using conditional logistic regression that accounted for health history, socioeconomic status, and other screening exposures. Results: In analyses restricted to 471 eligible case patients and their 509 matched control patients, 13 case patients (2.8%) and 46 control patients (9.0%) had undergone screening colonoscopy, which corresponded to an adjusted odds ratio (AOR) of 0.29 (95% CI, 0.15 to 0.58) for any late-stage CRC, 0.36 (CI, 0.16 to 0.80) for right colon cancer, and 0.26 (CI, 0.06 to 1.11; P = 0.069) for left colon/rectum cancer. Ninety-two case patients (19.5%) and 173 control patients (34.0%) had screening sigmoidoscopy, corresponding to an AOR of 0.50 (CI, 0.36 to 0.70) overall, 0.79 (CI, 0.51 to 1.23) for right colon late-stage cancer, and 0.26 (CI, 0.14 to 0.48) for left colon cancer. Limitation: The small number of screening colonoscopies affected the precision of the estimates. Conclusion: Screening with colonoscopy in average-risk persons was associated with reduced risk for diagnosis of incident late-stage CRC, including right-sided colon cancer. For sigmoidoscopy, this association was seen for left CRC, but the association for right colon late-stage cancer was not statistically significant.	Univ Penn, Philadelphia, PA 19104 USA; Meyers Primary Care Inst, Reliant Med Grp, Worcester, MA USA; Univ Massachusetts, Sch Med, Worcester, MA USA; Kaiser Permanente Northwest, Portland, OR USA; HealthPartners Hlth Syst, Minneapolis, MN USA; Grp Hlth Res Inst, Seattle, WA USA; Univ Washington, Seattle, WA 98195 USA; NCI, NIH, Bethesda, MD 20892 USA; Kaiser Permanente, Div Res, Oakland, CA USA; Marshfield Clin Res Fdn, Marshfield, WI USA; Kaiser Permanente, Honolulu, HI USA; Harvard Univ, Sch Med, Boston, MA USA	University of Pennsylvania; University of Massachusetts System; University of Massachusetts Worcester; Kaiser Permanente; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Kaiser Permanente; Kaiser Permanente; Harvard University; Harvard Medical School	Doubeni, CA (corresponding author), Univ Penn, Perelman Sch Med, Dept Family Med & Community Hlth, 3400 Spruce St,Gates 2, Philadelphia, PA 19104 USA.	chyke.doubeni@uphs.upenn.edu	Doubeni, Chyke A/W-6749-2019; Rutter, Carolyn/AAZ-3677-2021; Ash, Arlene/AAG-2914-2019	Doubeni, Chyke A/0000-0001-7495-0285; Ash, Arlene/0000-0002-8448-0253; Kroll-Desrosiers, Aimee/0000-0002-0026-7499; Doria-Rose, Vincent/0000-0002-8802-5143	National Cancer Institute of the National Institutes of Health [UC2CA148576]; National Institutes of Health [K01-CA127118, K01-CA127118-S1, U01-CA151736]; Surveillance, Epidemiology and End Results Program of the National Cancer Institute [N01-CN-67009, N01-PC-35142]; State of Washington; NATIONAL CANCER INSTITUTE [K01CA127118, U01CA151736, R01CA151736, UC2CA148576, RC2CA148576, K05CA092002] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Surveillance, Epidemiology and End Results Program of the National Cancer Institute; State of Washington; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant Support: By grant UC2CA148576 from the National Cancer Institute of the National Institutes of Health. Additional support was provided to Dr. Doubeni through awards K01-CA127118, K01-CA127118-S1, and U01-CA151736, also from the National Institutes of Health. Data collection on cancer incidence for this study was supported in part by data infrastructure developed by the HMO Cancer Research Network at participating sites. Group Health Research Institute's Cancer Surveillance System is funded in part by contracts N01-CN-67009 and N01-PC-35142 from the Surveillance, Epidemiology and End Results Program of the National Cancer Institute, with additional support from the State of Washington.	Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Berg AO, 2009, ANN INTERN MED, V151, P872, DOI [10.7326/0000605-200912150-00165, 10.7326/0003-4819-151-12-200912150-00165]; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Compton CC, 2004, CA-CANCER J CLIN, V54, P295, DOI 10.3322/canjclin.54.6.295; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Doubeni CA, 2007, CANCER-AM CANCER SOC, V109, P612, DOI 10.1002/cncr.22437; Doubeni CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036392; Doubeni CA, 2012, AM J PUBLIC HEALTH, V102, P680, DOI 10.2105/AJPH.2011.300158; Doubeni CA, 2009, CANCER EPIDEM BIOMAR, V18, P2170, DOI 10.1158/1055-9965.EPI-09-0104; Harris R, 2011, JNCI-J NATL CANCER I, V103, P1726, DOI 10.1093/jnci/djr446; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Levin TR, 2006, ANN INTERN MED, V145, P880, DOI 10.7326/0003-4819-145-12-200612190-00004; Lieberman D, 2007, GASTROINTEST ENDOSC, V65, P757, DOI 10.1016/j.gie.2006.12.055; Lipton LR, 2004, J CLIN ONCOL, V22, P4934, DOI 10.1200/JCO.2004.11.084; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; National Cancer Institute, 2010, SEER STAT DAT; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; PRENTICE R, 1976, BIOMETRICS, V32, P599, DOI 10.2307/2529748; Rabeneck L, 2003, AM J GASTROENTEROL, V98, P1400, DOI 10.1016/S0002-9270(03)00227-2; Rex DK, 2002, AM J GASTROENTEROL, V97, P1296, DOI 10.1016/S0002-9270(02)04168-0; Rothman K., 1998, MODERN EPIDEMIOLOGY; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Segnan N, 2011, J NATL CANCER I, V103, P1310, DOI 10.1093/jnci/djr284; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Stock C, 2011, ENDOSCOPY, V43, P771, DOI 10.1055/s-0030-1256504; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; WAGNER EH, 2005, J NATL CANC I MONOGR, V35, P3, DOI DOI 10.1093/JNCIMONOGRAPHS/LGI032; Weiss NS, 1998, AM J EPIDEMIOL, V147, P1099; Weiss NS, 1999, AM J EPIDEMIOL, V149, P1; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244	35	115	117	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2013	158	5	1				312	+		10.7326/0003-4819-158-5-201303050-00003	http://dx.doi.org/10.7326/0003-4819-158-5-201303050-00003			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105HP	23460054	Green Accepted			2022-12-28	WOS:000316057700002
J	Seed, KD; Lazinski, DW; Calderwood, SB; Camilli, A				Seed, Kimberley D.; Lazinski, David W.; Calderwood, Stephen B.; Camilli, Andrew			A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity	NATURE			English	Article							CAS SYSTEMS; PHAGE; INTERFERENCE; ARCHAEA; DEFENSE; RNA; DNA; RESISTANCE; EVOLUTION; PATHOGEN	Bacteriophages (or phages) are the most abundant biological entities on earth, and are estimated to outnumber their bacterial prey by tenfold(1). The constant threat of phage predation has led to the evolution of a broad range of bacterial immunity mechanisms that in turn result in the evolution of diverse phage immune evasion strategies, leading to a dynamic co-evolutionary arms race(2,3). Although bacterial innate immune mechanisms against phage abound, the only documented bacterial adaptive immune system is the CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated proteins) system, which provides sequence-specific protection from invading nudeic acids, including phage(4-11). Here we show a remarkable turn of events, in which a phage-encoded CRISPR/Cas system is used to counteract a phage inhibitory chromosomal island of the bacterial host. A successful lytic infection by the phage is dependent on sequence identity between CRISPR spacers and the target chromosomal island. In the absence of such targeting, the phage-encoded CRISPR/Cas system can acquire new spacers to evolve rapidly and ensure effective targeting of the chromosomal island to restore phage replication.	[Seed, Kimberley D.; Lazinski, David W.; Camilli, Andrew] Tufts Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02111 USA; [Seed, Kimberley D.; Lazinski, David W.; Camilli, Andrew] Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Calderwood, Stephen B.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Calderwood, Stephen B.] Harvard Univ, Sch Med, Boston, MA 02114 USA	Howard Hughes Medical Institute; Tufts University; Tufts University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Camilli, A (corresponding author), Tufts Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02111 USA.	andrew.camilli@tufts.edu			US National Institutes of Health [AI055058, AI045746, AI058935]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055058, R01AI045746, U01AI058935] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank the Tufts University Core Facility for sequencing and computational support. This work was supported by US National Institutes of Health grants AI055058 (A.C.), AI045746 (A.C.) and AI058935 (S.B.C.). A.C. is a Howard Hughes Medical Institute Investigator.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; De Souza Silva O, 2010, PLASMID, V64, P186, DOI 10.1016/j.plasmid.2010.08.001; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P6119, DOI 10.1073/pnas.0502069102; Garcia-Heredia I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033802; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lazinski DW, 2013, BIOTECHNIQUES, V54, P25, DOI 10.2144/000113981; Longini IM, 2002, J INFECT DIS, V186, P246, DOI 10.1086/341206; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nelson EJ, 2009, NAT REV MICROBIOL, V7, P693, DOI 10.1038/nrmicro2204; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Ram G, 2012, P NATL ACAD SCI USA, V109, P16300, DOI 10.1073/pnas.1204615109; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Seed KD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002917; Seed KD, 2011, MBIO, V2, DOI 10.1128/mBio.00334-10; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Stern A, 2011, BIOESSAYS, V33, P43, DOI 10.1002/bies.201000071; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002	30	220	252	0	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2013	494	7438					489	491		10.1038/nature11927	http://dx.doi.org/10.1038/nature11927			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23446421	Green Submitted, Green Accepted			2022-12-28	WOS:000315661500041
J	Dimick, JB; Nicholas, LH; Ryan, AM; Thumma, JR; Birkmeyer, JD				Dimick, Justin B.; Nicholas, Lauren H.; Ryan, Andrew M.; Thumma, Jyothi R.; Birkmeyer, John D.			Bariatric Surgery Complications Before vs After Implementation of a National Policy Restricting Coverage to Centers of Excellence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROSPECTIVE RANDOMIZED-TRIAL; ADMINISTRATIVE DATA; MEDICARE BENEFICIARIES; SURGICAL-PROCEDURES; HOSPITAL VOLUME; GASTRIC BYPASS; OUTCOMES; MORTALITY; SAFETY; RATES	Importance Starting in 2006, the Centers for Medicare & Medicaid Services (CMS) has restricted coverage of bariatric surgery to hospitals designated as centers of excellence (COE) by 2 major professional organizations. Objective To evaluate whether the implementation of the COE component of the national coverage decision was associated with improved bariatric surgery outcomes in Medicare patients. Design, Setting, and Patients Retrospective, longitudinal study using 20042009 hospital discharge data from 12 states (n=321 464 patients) of changes in outcomes in Medicare patients undergoing bariatric surgery (n=6723 before and n=15 854 after implementation of the policy). A difference-in-differences analytic approach was used to evaluate whether the national coverage decision was associated with improved outcomes in Medicare patients above and beyond existing time trends in non-Medicare patients (n=95 558 before and n=155 117 after implementation of the policy). Main Outcome Measures Risk-adjusted rates of any complication, serious complications, and reoperation. Results Bariatric surgery outcomes improved during the study period in both Medicare and non-Medicare patients; however, this change was already under way prior to the CMS coverage decision. After accounting for patient factors, changes in procedure type, and preexisting time trends toward improved outcomes, there were no statistically significant improvements in outcomes after (vs before) implementation of the CMS national coverage decision for any complication (8.0% after vs 7.0% before; relative risk [RR], 1.14 [95% CI, 0.95-1.33]), serious complications (3.3% vs 3.6%, respectively; RR, 0.92 [95% CI, 0.62-1.22]), and reoperation (1.0% vs 1.1%; RR, 0.90 [95% CI, 0.64-1.17]). In a direct assessment comparing outcomes at hospitals designated as COEs (n=179) vs hospitals without the COE designation (n=519), no significant differences were found for any complication (5.5% vs 6.0%, respectively; RR, 0.98 [95% CI, 0.90-1.06]), serious complications (2.2% vs 2.5%; RR, 0.92 [95% CI, 0.84-1.00]), and reoperation (0.83% vs 0.96%; RR, 1.00 [95% CI, 0.86-1.17]). Conclusions and Relevance Among Medicare patients undergoing bariatric surgery, there was no significant difference in the rates of complications and reoperation before vs after the CMS policy of restricting coverage to COEs. Combined with prior studies showing no association of COE designation and outcomes, these results suggest that Medicare should reconsider this policy. JAMA. 2013;309(8):792-799 www.jama.com	[Dimick, Justin B.; Nicholas, Lauren H.; Thumma, Jyothi R.; Birkmeyer, John D.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Ryan, Andrew M.] Weill Cornell Med Coll, Div Outcomes & Effectiveness, New York, NY USA	University of Michigan System; University of Michigan; Cornell University	Dimick, JB (corresponding author), Ctr Healthcare Outcomes & Policy, 2800 Plymouth Rd,Bldg 520,Off 3144, Ann Arbor, MI 48109 USA.	jdimick@umich.edu			Commonwealth Fund; Russell Sage Foundation; Agency for Healthcare Research and Quality; RWJ Foundation; Phelps Memorial Hospital; National Institute on Aging [R01AG039434, K01AG041763]; Agency for Healthcare Research and Quality [K08HS017765]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS017765] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG041763, R01AG039434] Funding Source: NIH RePORTER	Commonwealth Fund; Russell Sage Foundation; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); RWJ Foundation; Phelps Memorial Hospital; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Dimick and Birkmeyer reported serving as consultants and having an equity interest in ArborMetrix Inc, which provided software and analytics for measuring hospital quality and efficiency but had no role in the study. Dr Nicholas reported receiving travel reimbursement from Stanford University, Indiana University, the National Institute on Aging, and the University of Pennsylvania; and receiving institutional grants from the Commonwealth Fund and the Russell Sage Foundation. Dr Ryan reported receiving institutional grants from the Agency for Healthcare Research and Quality, the RWJ Foundation, and the Commonwealth Fund; receiving payment for lectures from Phelps Memorial Hospital; receiving payment for manuscript preparation from the New England Journal of Medicine; and receiving payment for the development of educational presentations from Health Affairs. Ms Thumma did not report any disclosures.; This study was supported by National Institute on Aging grant R01AG039434 awarded to Drs Dimick, Nicholas, and Birkmeyer. Dr Dimick is also supported by career development award K08HS017765 from the Agency for Healthcare Research and Quality. Dr Nicholas is also supported by career development award K01AG041763 from the National Institute on Aging.	Angrisani L, 2007, SURG OBES RELAT DIS, V3, P127, DOI 10.1016/j.soard.2006.12.005; Birkmeyer NJO, 2010, JAMA-J AM MED ASSOC, V304, P435, DOI 10.1001/jama.2010.1034; Colla CH, 2012, JAMA-J AM MED ASSOC, V308, P1015, DOI 10.1001/2012.jama.10812; Dimick JB, 2009, J AM COLL SURGEONS, V209, P702, DOI 10.1016/j.jamcollsurg.2009.09.009; Donald SG, 2007, REV ECON STAT, V89, P221, DOI 10.1162/rest.89.2.221; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Flum DR, 2011, ANN SURG, V254, P860, DOI 10.1097/SLA.0b013e31822f2101; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; Flum DR, 2005, JAMA-J AM MED ASSOC, V294, P1903, DOI 10.1001/jama.294.15.1903; HCUP, OV STAT INP DAT; Hollenbeak CS, 2008, SURGERY, V144, P736, DOI 10.1016/j.surg.2008.05.013; Iezzoni LI, 1997, ANN INTERN MED, V127, P666, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00048; Lanthaler M, 2010, OBES SURG, V20, P1078, DOI 10.1007/s11695-010-0190-3; Livingston EH, 2010, ARCH SURG-CHICAGO, V145, P993, DOI 10.1001/archsurg.2010.218; Livingston EH, 2009, ARCH SURG-CHICAGO, V144, P319, DOI 10.1001/archsurg.2009.23; Livingston EH, 2004, AM J SURG, V188, P105, DOI 10.1016/j.amjsurg.2004.03.001; Mittermair RP, 2009, OBES SURG, V19, P1636, DOI 10.1007/s11695-009-9967-7; Nguyen NT, 2010, ARCH SURG-CHICAGO, V145, P72, DOI 10.1001/archsurg.2009.228; Nguyen NT, 2009, ANN SURG, V250, P631, DOI 10.1097/SLA.0b013e3181b92480; Nguyen NT, 2004, ANN SURG, V240, P586, DOI 10.1097/01.sla.0000140752.74893.24; Pratt Gary M, 2006, Surg Obes Relat Dis, V2, P497, DOI 10.1016/j.soard.2006.07.004; Ryan AM, 2009, HEALTH SERV RES, V44, P821, DOI 10.1111/j.1475-6773.2009.00956.x; Santry HP, 2005, JAMA-J AM MED ASSOC, V294, P1909, DOI 10.1001/jama.294.15.1909; Schirmer Bruce, 2007, Bull Am Coll Surg, V92, P21; Snow JM, 2011, SURG CLIN N AM, V91, P1249, DOI 10.1016/j.suc.2011.08.008; Southern DA, 2004, MED CARE, V42, P355, DOI 10.1097/01.mlr.0000118861.56848.ee; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Weingart SN, 2000, MED CARE, V38, P796, DOI 10.1097/00005650-200008000-00004; Weller WE, 2006, J AM COLL SURGEONS, V202, P753, DOI 10.1016/j.jamcollsurg.2006.02.002; Wooldridge JM, 2013, INTRO ECONOMETRICS M, V5th; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	31	148	148	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2013	309	8					792	799		10.1001/jama.2013.755	http://dx.doi.org/10.1001/jama.2013.755			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095KD	23443442	Green Accepted			2022-12-28	WOS:000315332200024
J	Tanser, F; Barnighausen, T; Grapsa, E; Zaidi, J; Newell, ML				Tanser, Frank; Baernighausen, Till; Grapsa, Erofili; Zaidi, Jaffer; Newell, Marie-Louise			High Coverage of ART Associated with Decline in Risk of HIV Acquisition in Rural KwaZulu-Natal, South Africa	SCIENCE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; COHORT PROFILE; PREVENTION; POPULATION; INFECTIONS; IMPACT; EPIDEMIOLOGY; PREVALENCE; COMMUNITY; PROGRAM	The landmark HIV Prevention Trials Network (HPTN) 052 trial in HIV-discordant couples demonstrated unequivocally that treatment with antiretroviral therapy (ART) substantially lowers the probability of HIV transmission to the HIV-uninfected partner. However, it has been vigorously debated whether substantial population-level reductions in the rate of new HIV infections could be achieved in "real-world" sub-Saharan African settings where stable, cohabiting couples are often not the norm and where considerable operational challenges exist to the successful and sustainable delivery of treatment and care to large numbers of patients. We used data from one of Africa's largest population-based prospective cohort studies (in rural KwaZulu-Natal, South Africa) to follow up a total of 16,667 individuals who were HIV-uninfected at baseline, observing individual HIV seroconversions over the period 2004 to 2011. Holding other key HIV risk factors constant, individual HIV acquisition risk declined significantly with increasing ART coverage in the surrounding local community. For example, an HIV-uninfected individual living in a community with high ART coverage (30 to 40% of all HIV-infected individuals on ART) was 38% less likely to acquire HIV than someone living in a community where ART coverage was low (<10% of all HIV-infected individuals on ART).	[Tanser, Frank; Baernighausen, Till; Grapsa, Erofili; Zaidi, Jaffer; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Durban, South Africa; [Baernighausen, Till] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Newell, Marie-Louise] UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England	University of Kwazulu Natal; Harvard University; Harvard T.H. Chan School of Public Health; University of London; University College London	Tanser, F (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Durban, South Africa.	tanserf@africacentre.ac.za	Tanser, Frank/ABE-8326-2021; Newell, Marie-Louise/AAE-8222-2019; Bärnighausen, Till/Y-2388-2019	Newell, Marie-Louise/0000-0002-1074-7699; Tanser, Frank/0000-0001-9797-0000	National Institute of Child Health and Human Development [1R01-HD058482-01]; Wellcome Trust, UK [082384/Z/07/Z]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058482] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust, UK(Wellcome Trust); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by grant 1R01-HD058482-01 from the National Institute of Child Health and Human Development. Funding for the Africa Centre's Demographic Surveillance Information System and Population-Based HIV Survey was received from the Wellcome Trust, UK (grant 082384/Z/07/Z).	Anglemyer A, 2011, COCHRANE DB SYST REV, V2011; [Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Budtz-Jorgensen E, 2003, STAT MED, V22, P3089, DOI 10.1002/sim.1541; Castel A., 2011, 18 ANN C RETR OPP IN; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Granich R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030216; Granich R, 2011, CURR HIV RES, V9, P446, DOI 10.2174/157016211798038597; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; Hontelez JAC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021919; Houlihan CF, 2011, INT J EPIDEMIOL, V40, P318, DOI 10.1093/ije/dyp402; Katz MH, 2002, AM J PUBLIC HEALTH, V92, P388, DOI 10.2105/AJPH.92.3.388; Law MG, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-10; McGrath N, 2012, 19 INT AIDS C WASH D; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Shelton JD, 2011, SCIENCE, V334, P1645, DOI 10.1126/science.1212353; Smith K, 2011, CURR OPIN HIV AIDS, V6, P315, DOI 10.1097/COH.0b013e32834788e7; South African National Department of Health, 2010, NAT ANT TREATM GUID; SUSSER M, 1991, AM J EPIDEMIOL, V133, P635, DOI 10.1093/oxfordjournals.aje.a115939; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Tanser F, 2011, LANCET, V378, P247, DOI 10.1016/S0140-6736(11)60779-4; Tanser F, 2009, INT J EPIDEMIOL, V38, P1008, DOI 10.1093/ije/dyp148; UNAIDS, 2012, TOG WE WILL END AIDS; United Nations General Assembly, 2011, POL DECL HIV AIDS IN; Venkatesh KK, 2011, AIDS, V25, P1939, DOI 10.1097/QAD.0b013e32834b4ced; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649	33	584	590	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2013	339	6122					966	971		10.1126/science.1228160	http://dx.doi.org/10.1126/science.1228160			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23430656	Green Accepted			2022-12-28	WOS:000315149600052
J	Vickery, KD; Sauser, K; Davis, MM				Vickery, Katherine Diaz; Sauser, Kori; Davis, Matthew M.			Policy Responses to Demand for Health Care Access From the Individual to the Population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Vickery, Katherine Diaz; Sauser, Kori; Davis, Matthew M.] Univ Michigan, Robert Wood Johnson Fdn Clin Scholars Program, Ann Arbor, MI 48109 USA; [Davis, Matthew M.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Davis, Matthew M.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Davis, Matthew M.] Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA; [Vickery, Katherine Diaz] Ann Arbor VA Healthcare Syst, Dept Vet Affairs Ctr Clin Management & Res, Dept Family Med, Ann Arbor, MI USA; [Sauser, Kori] Ann Arbor VA Healthcare Syst, Dept Vet Affairs Ctr Clin Management & Res, Dept Emergency Med, Ann Arbor, MI USA	Robert Wood Johnson Foundation (RWJF); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Vickery, KD (corresponding author), Univ Michigan, Robert Wood Johnson Fdn Clin Scholars Program, 2800 Plymouth Rd,Bldg 10,Room G016, Ann Arbor, MI 48109 USA.	vickeryk@med.umich.edu	Zachrison, Kori/ABC-5938-2021	Sauser Zachrison, Kori/0000-0001-8160-3257				[Anonymous], 1985, WASHINGTON POST, pA20; Bush GW, COMMUNICATION   0710; Fields WW, 2001, ACAD EMERG MED, V8, P1064, DOI 10.1111/j.1553-2712.2001.tb01116.x; Himmelstein D.U., 2005, HLTH AFF, V24, pW5, DOI 10.1377/hlthaff.W5.63; Kaiser Family Foundation, 2015, KAIS HLTH TRACK POLL	5	6	6	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2013	309	7					665	666		10.1001/jama.2012.96863	http://dx.doi.org/10.1001/jama.2012.96863			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091EK	23423410				2022-12-28	WOS:000315032000019
J	Wippich, F; Bodenmiller, B; Trajkovska, MG; Wanka, S; Aebersold, R; Pelkmans, L				Wippich, Frank; Bodenmiller, Bernd; Trajkovska, Maria Gustafsson; Wanka, Stefanie; Aebersold, Ruedi; Pelkmans, Lucas			Dual Specificity Kinase DYRK3 Couples Stress Granule Condensation/Dissolution to mTORC1 Signaling	CELL			English	Article							RNA-BINDING PROTEINS; GERMLINE P GRANULES; PHASE-TRANSITIONS; GENE-EXPRESSION; FAMILY KINASE; PHOSPHORYLATION; RAPAMYCIN; TARGET; CELLS; PHOSPHOPROTEOME	Cytosolic compartmentalization through liquid-liquid unmixing, such as the formation of RNA granules, is involved in many cellular processes and might be used to regulate signal transduction. However, specific molecular mechanisms by which liquid-liquid unmixing and signal transduction are coupled remain unknown. Here, we show that during cellular stress the dual specificity kinase DYRK3 regulates the stability of P-granule-like structures and mTORC1 signaling. DYRK3 displays a cyclic partitioning mechanism between stress granules and the cytosol via a low-complexity domain in its N terminus and its kinase activity. When DYRK3 is inactive, it prevents stress granule dissolution and the release of sequestered mTORC1. When DYRK3 is active, it allows stress granule dissolution, releasing mTORC1 for signaling and promoting its activity by directly phosphorylating the mTORC1 inhibitor PRAS40. This mechanism links cytoplasmic compartmentalization via liquid phase transitions with cellular signaling.	[Wippich, Frank; Bodenmiller, Bernd; Trajkovska, Maria Gustafsson; Wanka, Stefanie; Pelkmans, Lucas] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland; [Wippich, Frank; Aebersold, Ruedi] Swiss Fed Inst Technol, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Pelkmans, L (corresponding author), Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	lucas.pelkmans@imls.uzh.ch		Pelkmans, Lucas/0000-0002-6754-9730; Wippich, Frank/0000-0003-2633-9777	Swiss National Science Foundation; Boehringer Ingelheim Fonds; University of Zurich; European Union; SystemsX.ch RTD project PhosphoNetX	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Boehringer Ingelheim Fonds(Boehringer Ingelheim); University of Zurich; European Union(European Commission); SystemsX.ch RTD project PhosphoNetX	We thank Prisca Liberali for help with the compound screen, Herbert Polzhofer for cloning GFP-DYRK3, Lilli Stergiou for help with the initial phase of this project, and all members of the Pelkmans lab for helpful discussions. We further thank Paul Anderson, Nancy Kedersha, Markku Varjosalo, and Edward Chan for reagents used in this study. F.W. is supported by a ProDoc fellowship from the Swiss National Science Foundation and is a member of the Life Science Zurich Graduate School. B.B. was supported by fellowships of the Boehringer Ingelheim Fonds and the Swiss National Science Foundation. L.P. is supported by the University of Zurich, the Swiss National Science Foundation, and the European Union. This work was supported by the SystemsX.ch RTD project PhosphoNetX.	Alvarez M, 2003, J CELL SCI, V116, P3099, DOI 10.1242/jcs.00618; Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Boulay A, 2004, CANCER RES, V64, P252, DOI 10.1158/0008-5472.CAN-3554-2; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Creasy C., 2007, BLOOD, V110, P510; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Eystathioy T, 2003, RNA, V9, P1171, DOI 10.1261/rna.5810203; Gockler N, 2009, FEBS J, V276, P6324, DOI 10.1111/j.1742-4658.2009.07346.x; Hachet O, 2011, CELL, V145, P1116, DOI 10.1016/j.cell.2011.05.014; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Hyman AA, 2012, SCIENCE, V337, P1047, DOI 10.1126/science.1223728; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Moriya H, 2001, GENE DEV, V15, P1217, DOI 10.1101/gad.884001; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Ramo P, 2009, BIOINFORMATICS, V25, P3028, DOI 10.1093/bioinformatics/btp524; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Stitzel ML, 2006, CURR BIOL, V16, P56, DOI 10.1016/j.cub.2005.11.063; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Takahara T, 2012, MOL CELL, V47, P242, DOI 10.1016/j.molcel.2012.05.019; Taminato A, 2002, MOL BIOL CELL, V13, P2266, DOI 10.1091/mbc.01-11-0555; Voronina E, 2010, DEVELOPMENT, V137, P1441, DOI 10.1242/dev.047654; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang DY, 2005, GENOMICS, V85, P117, DOI 10.1016/j.ygeno.2004.08.021; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	45	356	367	1	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 14	2013	152	4					791	805		10.1016/j.cell.2013.01.033	http://dx.doi.org/10.1016/j.cell.2013.01.033			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415227	Bronze			2022-12-28	WOS:000314945600014
J	Gleeson, D; Friel, S				Gleeson, Deborah; Friel, Sharon			Emerging threats to public health from regional trade agreements	LANCET			English	Editorial Material									[Gleeson, Deborah] La Trobe Univ, Sch Publ Hlth & Human Biosci, Melbourne, Vic 3086, Australia; [Friel, Sharon] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia	La Trobe University; Australian National University	Gleeson, D (corresponding author), La Trobe Univ, Sch Publ Hlth & Human Biosci, Melbourne, Vic 3086, Australia.	d.gleeson@latrobe.edu.au	Gleeson, Deborah/H-7770-2019	Gleeson, Deborah/0000-0001-8021-9130; Friel, Sharon/0000-0002-8345-5435				[Anonymous], 2011, 21 CENTURY REGIONALI; Australian Government Department of Foreign Affairs and Trade, TRANSP PARTN NEG; Australian Government Department of Foreign Affairs and Trade, GILL GOV TRAD POL ST; Baker BK, 2011, PUBLIC INTE IN PRESS; Baldwin R., 2008, MULTILATERALISING RE; Commonwealth of Australia, P MORR AS LTD COMM A; CSDH, 2008, CLOS GAP GEN HLTH EQ; Gleeson DH, 2012, MED J AUSTRALIA, V196, P354, DOI 10.5694/mja11.11635; High Court of Australia. JT International SA v Commonwealth of Australia British American Tobacco Australasia Limited v The Commonwealth, 2012, 43 HCA; Inside US Trade, 2012, INSIDE US TRADE; Kelsey J, 2012, GLOB ALC POL C BANGK; Kitney G, 2012, AUSTR FINANCIAL REV; Koivusalo M, 2009, GLOBALIZATION HLTH P, P105, DOI DOI 10.1001/JAMA.2009.1694; Lopert R, J LAW MED E IN PRESS; Lowe JB, 2012, AUST NZ J PUBL HEAL, V36, P403, DOI 10.1111/j.1753-6405.2012.00905.x; Medecins Sans Frontieres, TRAD AW HLTH US INT; Mitchell A, 2011, BOSTON U INT LAW J, V29, P384; Office of the United States Trade Representative, FACT SHEET US TRANSP; Philip Morris Asia, 2011, NOT ARB AUSTR HONG K; Sell SK, 2007, LIVERP LAW REV, V28, P41, DOI 10.1007/s10991-007-9011-8; Smith RD, 2009, LANCET, V373, P768, DOI 10.1016/S0140-6736(08)61780-8; 't Hoen Ellen, 2002, Chic J Int Law, V3, P27; Trans Pacific Partnership, 2012, TRAD MIN REP LEAD; Trans Pacific Partnership, INV CHAPT L IN PRESS; Voon T, 2012, PUBLIC HEALTH AND PLAIN PACKAGING OF CIGARETTES: LEGAL ISSUES, P109; WHO, 2012, RES DEV MEET HLTH NE; World Bank, POP DAT 2011	27	72	72	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2013	381	9876					1507	1509		10.1016/S0140-6736(13)60312-8	http://dx.doi.org/10.1016/S0140-6736(13)60312-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139TK	23453142				2022-12-28	WOS:000318607300040
J	Robertson, L; Mushati, P; Eaton, JW; Dumba, L; Mavise, G; Makoni, J; Schumacher, C; Crea, T; Monasch, R; Sherr, L; Garnett, GP; Nyamukapa, C; Gregson, S				Robertson, Laura; Mushati, Phyllis; Eaton, Jeffrey W.; Dumba, Lovemore; Mavise, Gideon; Makoni, Jeremiah; Schumacher, Christina; Crea, Tom; Monasch, Roeland; Sherr, Lorraine; Garnett, Geoffrey P.; Nyamukapa, Constance; Gregson, Simon			Effects of unconditional and conditional cash transfers on child health and development in Zimbabwe: a cluster-randomised trial	LANCET			English	Article							MIDDLE-INCOME COUNTRIES; INCENTIVES; BEHAVIOR; HIV; INTERVENTIONS; EDUCATION; POVERTY; POOR	Background Cash-transfer programmes can improve the wellbeing of vulnerable children, but few studies have rigorously assessed their effectiveness in sub-Saharan Africa. We investigated the effects of unconditional cash transfers (UCTs) and conditional cash transfers (CCTs) on birth registration, vaccination uptake, and school attendance in children in Zimbabwe. Methods We did a matched, cluster-randomised controlled trial in ten sites in Manicaland, Zimbabwe. We divided each study site into three clusters. After a baseline survey between July, and September, 2009, clusters in each site were randomly assigned to UCT, CCT, or control, by drawing of lots from a hat. Eligible households contained children younger than 18 years and satisfied at least one other criteria: head of household was younger than 18 years; household cared for at least one orphan younger than 18 years, a disabled person, or an individual who was chronically ill; or household was in poorest wealth quintile. Between January, 2010, and January, 2011, households in UCT clusters collected payments every 2 months. Households in CCT clusters could receive the same amount but were monitored for compliance with several conditions related to child wellbeing. Eligible households in all clusters, including control clusters, had access to parenting skills classes and received maize seed and fertiliser in December, 2009, and August, 2010. Households and individuals delivering the intervention were not masked, but data analysts were. The primary endpoints were proportion of children younger than 5 years with a birth certificate, proportion younger than 5 years with up-to-date vaccinations, and proportion aged 6-12 years attending school at least 80% of the time. This trial is registered with ClinicalTrials.gov, number NCT00966849. Findings 1199 eligible households were allocated to the control group, 1525 to the UCT group, and 1319 to the CCT group. Compared with control clusters, the proportion of children aged 0-4 years with birth certificates had increased by 1.5% (95% CI -7.1 to 10.1) in the UCT group and by 16.4% (7.8-25.0) in the CCT group by the end of the intervention period. The proportions of children aged 0-4 years with complete vaccination records was 3.1% (-3.8 to 9.9) greater in the UCT group and 1.8% (-5.0 to 8.7) greater in the CCT group than in the control group. The proportions of children aged 6-12 years who attended school at least 80% of the time was 7.2% (0.8-13.7) higher in the UCT group and 7.6% (1.2-14.1) in the CCT group than in the control group. Interpretation Our results support strategies to integrate cash transfers into social welfare programming in sub-Saharan Africa, but further evidence is needed for the comparative effectiveness of UCT and CCT programmes in this region.	[Robertson, Laura; Eaton, Jeffrey W.; Garnett, Geoffrey P.; Nyamukapa, Constance; Gregson, Simon] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, London W2 1PG, England; [Mushati, Phyllis; Nyamukapa, Constance; Gregson, Simon] Biomed Res & Training Inst, Harare, Zimbabwe; [Dumba, Lovemore; Mavise, Gideon] Catholic Relief Serv, Harare, Zimbabwe; [Makoni, Jeremiah] Diocese Mutare Community Care Programme, Manicaland, Zimbabwe; [Schumacher, Christina] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Crea, Tom] Boston Coll, Grad Sch Social Work, Chestnut Hill, MA 02167 USA; [Monasch, Roeland] UNICEF, Harare, Zimbabwe; [Sherr, Lorraine] UCL, Dept Infect & Populat Hlth, London, England	Imperial College London; Biomedical Research Training Institute; Johns Hopkins University; Boston College; University of London; University College London	Robertson, L (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, St Marys Campus,Norfolk Pl, London W2 1PG, England.	l.robertson06@imperial.ac.uk	Garnett, Geoffrey P/A-9312-2008	Sherr, Lorraine/0000-0002-5902-8011; Eaton, Jeffrey/0000-0001-7728-728X; Gregson, Simon/0000-0003-2707-0714; Crea, Thomas/0000-0002-8092-7353; Nyamukapa, Constance/0000-0001-6779-4069	Wellcome Trust; World Bank through the Partnership for Child Development; Programme of Support for the Zimbabwe National Action Plan for Orphans and Vulnerable Children; Medical Research Council [MR/K010174/1B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); World Bank through the Partnership for Child Development; Programme of Support for the Zimbabwe National Action Plan for Orphans and Vulnerable Children; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Wellcome Trust, the World Bank through the Partnership for Child Development, and the Programme of Support for the Zimbabwe National Action Plan for Orphans and Vulnerable Children.	Adato M, 2009, AIDS CARE, V21, P60, DOI 10.1080/09540120903112351; Adato M., 2008, WHAT IS POTENTIAL CA; Attanasio O., 2005, IMPACT CONDITIONAL C; Baird S, 2012, CASH CONDITION EVIDE; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Barham T, 2005, IMPACT MEXICAN CONDI; Barham T, 2009, J HEALTH ECON, V28, P611, DOI 10.1016/j.jhealeco.2008.12.010; Behrman JR, 2009, ECON DEV CULT CHANGE, V57, P439, DOI 10.1086/596614; Case A., 2005, DEV SO AFR, V22, P467, DOI DOI 10.1080/03768350500322925; de Brauw A, 2007, MUST CONDITIONAL CAS; Fiszbein A, 2009, CONDITIONAL CASH TRA; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Gregson S., AIDS CARE IN PRESS; Hargreaves JR, 2007, WORLD DEV, V35, P212, DOI 10.1016/j.worlddev.2005.10.021; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Kane RL, 2004, AM J PREV MED, V27, P327, DOI 10.1016/j.amepre.2004.07.002; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Lopman B, 2007, AIDS, V21, pS57, DOI 10.1097/01.aids.0000300536.82354.52; Marteau TM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1415; MILLER C, 2008, IMPACT EVAL IN PRESS; Ministry of Community Development and Social Services and German Agency for Technical Cooperation, 2007, FIN EV REP KAL SOC C; Morris SS, 2004, LANCET, V364, P2030, DOI 10.1016/S0140-6736(04)17515-6; Nyamukapa C, 2005, SOC SCI MED, V60, P2155, DOI 10.1016/j.socscimed.2004.10.005; Ranganathan M, 2012, PREV MED, V55, pS95, DOI 10.1016/j.ypmed.2011.11.015; Samson M, 2004, 37 EC POL RES I; Shibuya K, 2008, LANCET, V371, P789, DOI 10.1016/S0140-6736(08)60356-6; UNICEF, 2005, SURV ORPH OTH VUL CH; World Bank, 2012, WORLD DEV REP 2013 J	29	132	135	1	59	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 13	2013	381	9874					1283	1292		10.1016/S0140-6736(12)62168-0	http://dx.doi.org/10.1016/S0140-6736(12)62168-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122XD	23453283	Bronze, Green Published			2022-12-28	WOS:000317351000031
J	Wang, XF; Wang, LF; Filippenko, AV; Zhang, TM; Zhao, XL				Wang, Xiaofeng; Wang, Lifan; Filippenko, Alexei V.; Zhang, Tianmeng; Zhao, Xulin			Evidence for Two Distinct Populations of Type Ia Supernovae	SCIENCE			English	Article							WHITE-DWARF MODELS; CIRCUMSTELLAR MATERIAL; SODIUM-ABSORPTION; SN 2011FE; RED GIANT; EVOLUTION; STARS; PROGENITORS; DIVERSITY; SN-1991T	Type Ia supernovae (SNe Ia) have been used as excellent standardizable candles for measuring cosmic expansion, but their progenitors are still elusive. Here, we report that the spectral diversity of SNe Ia is tied to their birthplace environments. We found that those with high-velocity ejecta are substantially more concentrated in the inner and brighter regions of their host galaxies than are normal-velocity SNe Ia. Furthermore, the former tend to inhabit larger and more luminous hosts. These results suggest that high-velocity SNe Ia likely originate from relatively younger and more metal-rich progenitors than do normal-velocity SNe Ia and are restricted to galaxies with substantial chemical evolution.	[Wang, Xiaofeng; Zhao, Xulin] Tsinghua Univ, Dept Phys, Beijing 100084, Peoples R China; [Wang, Xiaofeng; Wang, Lifan] Texas A&M Univ, Mitchell Inst Fundamental Phys & Astron, College Stn, TX 77843 USA; [Wang, Lifan] Purple Mt Observ, Nanjing 201008, Jiangsu, Peoples R China; [Filippenko, Alexei V.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Zhang, Tianmeng] Chinese Acad Sci, Natl Astron Observ China, Beijing 100012, Peoples R China	Tsinghua University; Texas A&M University System; Texas A&M University College Station; Chinese Academy of Sciences; Nanjing Institute of Astronomical Optics & Technology, NAOC, CAS; Purple Mountain Observatory, CAS; University of California System; University of California Berkeley; Chinese Academy of Sciences; National Astronomical Observatory, CAS	Wang, XF (corresponding author), Tsinghua Univ, Dept Phys, Beijing 100084, Peoples R China.	wang_xf@mail.tsinghua.edu.cn	Wang, Xiaofeng/J-5390-2015	Zhao, Xulin/0000-0002-3204-2358	National Natural Science Foundation of China (NSFC) [11073013, 11178003]; Major State Basic Research Development Program [2009CB824800, 2013CB834903]; Foundation of Tsinghua University [2011Z02170]; NSF [AST-0708873, AST-1211916]; TABASGO Foundation; Christopher R. Redlich Fund; Division Of Astronomical Sciences [1211916] Funding Source: National Science Foundation	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program(National Basic Research Program of China); Foundation of Tsinghua University; NSF(National Science Foundation (NSF)); TABASGO Foundation; Christopher R. Redlich Fund; Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank I. Dominguez for helpful discussions and C. Wu for assistance with the SDSS images. This work is supported by the National Natural Science Foundation of China (NSFC grants 11073013 and 11178003), the Major State Basic Research Development Program (2009CB824800 and 2013CB834903), and the Foundation of Tsinghua University (2011Z02170). The work of L.W. is supported by NSF grant AST-0708873. A.V.F. is grateful for financial assistance from NSF grant AST-1211916, the TABASGO Foundation, and the Christopher R. Redlich Fund. We dedicate this paper to the memory of our dear friend and colleague, Weidong Li, whose unfailing devotion to the Lick Observatory Supernova Search made this work possible; his premature, tragic passing has deeply saddened us.	Benetti S, 2005, ASTROPHYS J, V623, P1011, DOI 10.1086/428608; Blondin S, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/5/126; Blondin S, 2009, ASTROPHYS J, V693, P207, DOI 10.1088/0004-637X/693/1/207; Bloom JS, 2012, ASTROPHYS J LETT, V744, DOI 10.1088/2041-8205/744/2/L17; BRANCH D, 1993, ASTRON J, V106, P2383, DOI 10.1086/116810; Brown PJ, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/22; FILIPPENKO AV, 1992, ASTRON J, V104, P1543, DOI 10.1086/116339; FILIPPENKO AV, 1992, ASTROPHYS J, V384, pL15, DOI 10.1086/186252; Foley RJ, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/101; Fruchter AS, 2006, NATURE, V441, P463, DOI 10.1038/nature04787; Gerardy CL, 2004, ASTROPHYS J, V607, P391, DOI 10.1086/383488; Gilbert KM, 2006, ASTROPHYS J, V652, P1188, DOI 10.1086/508643; GOUDFROOIJ P, 1994, ASTRON ASTROPHYS SUP, V105, P341; Henry RBC, 1999, PUBL ASTRON SOC PAC, V111, P919, DOI 10.1086/316403; IBEN I, 1984, ASTROPHYS J SUPPL S, V54, P335, DOI 10.1086/190932; Leaman J, 2011, MON NOT R ASTRON SOC, V412, P1419, DOI 10.1111/j.1365-2966.2011.18158.x; Lentz EJ, 2000, ASTROPHYS J, V530, P966, DOI 10.1086/308400; Li WD, 2003, PUBL ASTRON SOC PAC, V115, P453, DOI 10.1086/374200; Li WD, 2011, NATURE, V480, P348, DOI 10.1038/nature10646; Maeda K, 2010, NATURE, V466, P82, DOI 10.1038/nature09122; Mannucci F, 2006, MON NOT R ASTRON SOC, V370, P773, DOI 10.1111/j.1365-2966.2006.10501.x; Matheson T, 2008, ASTRON J, V135, P1598, DOI 10.1088/0004-6256/135/4/1598; Maund JR, 2010, ASTROPHYS J LETT, V725, pL167, DOI 10.1088/2041-8205/725/2/L167; MUNARI U, 1992, ASTROPHYS J, V397, pL87, DOI 10.1086/186551; NOMOTO K, 1982, ASTROPHYS J, V253, P798, DOI 10.1086/159682; Nomoto K, 1997, SCIENCE, V276, P1378, DOI 10.1126/science.276.5317.1378; Nugent PE, 2011, NATURE, V480, P344, DOI 10.1038/nature10644; Patat F, 2007, SCIENCE, V317, P924, DOI 10.1126/science.1143005; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; PHILLIPS MM, 1992, ASTRON J, V103, P1632, DOI 10.1086/116177; Podsiadlowski P, 2008, NEW ASTRON REV, V52, P381, DOI 10.1016/j.newar.2008.06.020; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; Scannapieco E, 2005, ASTROPHYS J, V629, pL85, DOI 10.1086/452632; Schaefer BE, 2012, NATURE, V481, P164, DOI 10.1038/nature10692; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Silverman JM, 2012, MON NOT R ASTRON SOC, V425, P1789, DOI 10.1111/j.1365-2966.2012.21270.x; Simon JD, 2009, ASTROPHYS J, V702, P1157, DOI 10.1088/0004-637X/702/2/1157; Spergel DN, 2007, ASTROPHYS J SUPPL S, V170, P377, DOI 10.1086/513700; Sternberg A, 2011, SCIENCE, V333, P856, DOI 10.1126/science.1203836; Umeda H, 1999, ASTROPHYS J, V513, P861, DOI 10.1086/306887; VANDENHEUVEL EPJ, 1992, ASTRON ASTROPHYS, V262, P97; Wang B, 2010, ASTRON ASTROPHYS, V515, DOI 10.1051/0004-6361/200913976; Wang LF, 2007, SCIENCE, V315, P212, DOI 10.1126/science.1121656; Wang X, 2009, ASTROPHYS J LETT, V699, pL139, DOI 10.1088/0004-637X/699/2/L139; WEBBINK RF, 1984, ASTROPHYS J, V277, P355, DOI 10.1086/161701; Wood PR, 2009, ASTR SOC P, V404, P255; Yoon SC, 2003, ASTRON ASTROPHYS, V412, pL53, DOI 10.1051/0004-6361:20034607; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513; Young LM, 2011, MON NOT R ASTRON SOC, V414, P940, DOI 10.1111/j.1365-2966.2011.18561.x	49	120	123	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129					170	173		10.1126/science.1231502	http://dx.doi.org/10.1126/science.1231502			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23470733	Green Submitted			2022-12-28	WOS:000317341400048
J	Kim, JH; Resende, R; Wennekes, T; Chen, HM; Bance, N; Buchini, S; Watts, AG; Pilling, P; Streltsov, VA; Petric, M; Liggins, R; Barrett, S; McKimm-Breschkin, JL; Niikura, M; Withers, SG				Kim, Jin-Hyo; Resende, Ricardo; Wennekes, Tom; Chen, Hong-Ming; Bance, Nicole; Buchini, Sabrina; Watts, Andrew G.; Pilling, Pat; Streltsov, Victor A.; Petric, Martin; Liggins, Richard; Barrett, Susan; McKimm-Breschkin, Jennifer L.; Niikura, Masahiro; Withers, Stephen G.			Mechanism-Based Covalent Neuraminidase Inhibitors with Broad-Spectrum Influenza Antiviral Activity	SCIENCE			English	Article							VIRUS NEURAMINIDASE; DRUG DESIGN; H1N1 VIRUS; RESISTANT; SIALIDASE; 4-GUANIDINO-NEU5AC2EN; SENSITIVITY; OSELTAMIVIR; MUTATIONS; VARIANT	Influenza antiviral agents play important roles in modulating disease severity and in controlling pandemics while vaccines are prepared, but the development of resistance to agents like the commonly used neuraminidase inhibitor oseltamivir may limit their future utility. We report here on a new class of specific, mechanism-based anti-influenza drugs that function through the formation of a stabilized covalent intermediate in the influenza neuraminidase enzyme, and we confirm this mode of action with structural and mechanistic studies. These compounds function in cell-based assays and in animal models, with efficacies comparable to that of the neuraminidase inhibitor zanamivir and with broad-spectrum activity against drug-resistant strains in vitro. The similarity of their structure to that of the natural substrate and their mechanism-based design make these attractive antiviral candidates.	[Kim, Jin-Hyo; Resende, Ricardo; Wennekes, Tom; Chen, Hong-Ming; Buchini, Sabrina; Withers, Stephen G.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Bance, Nicole; Niikura, Masahiro] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Watts, Andrew G.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England; [Pilling, Pat; Streltsov, Victor A.; Barrett, Susan; McKimm-Breschkin, Jennifer L.] CSIRO, Parkville, Vic 3052, Australia; [Petric, Martin] British Columbia Ctr Dis Control, Prov Hlth Serv Author, Vancouver, BC V5Z 4R4, Canada; [Liggins, Richard] CDRD, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; Simon Fraser University; University of Bath; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Withers, SG (corresponding author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.	withers@chem.ubc.ca	Watts, Andrew/D-2802-2014; Streltsov, Victor/M-9446-2019; Wennekes, Tom/ABD-1448-2021; McKimm-Breschkin, Jennifer L/D-1880-2013; Wennekes, Tom/H-8271-2012; Pilling, Patricia/AAT-7845-2021	Streltsov, Victor/0000-0002-7846-4396; Wennekes, Tom/0000-0002-2368-7728; Wennekes, Tom/0000-0002-2368-7728; McKimm-Breschkin, Jennifer/0000-0002-2345-6786; Watts, Andrew/0000-0003-4299-2717; Barrett, Susan/0000-0003-1132-5268	Canadian Institutes for Health Research; Pfizer CDRD Innovation Fund; Canadian Foundation for Innovation; British Columbia Knowledge Development Fund; Tier 1 Canada Research Chair; Korea Research Foundation [KRF-2005-214-C00215]; Michael Smith Foundation for Health Research; Netherlands Organization for Scientific Research (NWO); Medical Research Council UK [G0600514]; National Health and Medical Research Council Australia [595625]; Medical Research Council [G0600514] Funding Source: researchfish; MRC [G0600514] Funding Source: UKRI	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Pfizer CDRD Innovation Fund; Canadian Foundation for Innovation(Canada Foundation for Innovation); British Columbia Knowledge Development Fund; Tier 1 Canada Research Chair(Canada Research Chairs); Korea Research Foundation(National Research Foundation of Korea); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the Canadian Institutes for Health Research, the Pfizer CDRD Innovation Fund, the Canadian Foundation for Innovation, and the British Columbia Knowledge Development Fund for support of this work. S. G. W. is supported by a Tier 1 Canada Research Chair. J.-H.K. was supported by fellowships from the Korea Research Foundation (KRF-2005-214-C00215) and the Michael Smith Foundation for Health Research. T. W. was supported by the Netherlands Organization for Scientific Research (NWO) through a Rubicon fellowship. Parts of this work were funded by grant G0600514 from the Medical Research Council UK to A. G. W. and J.L.M.-B. and Pandemic influenza grant 595625 from the National Health and Medical Research Council Australia to J.L.M.-B. The authors acknowledge the use of the MX1 beamline at the Australian Synchrotron, Victoria, Australia. The data presented in this paper were tabulated in the main paper and the supplementary materials. Coordinates of the complex have been deposited in the Protein Data Bank with code 3W09. Patent protection for compounds described has been sought by the University of British Columbia under the following applications: PCT/CA2010/001063 "2,3-Fluorinated Glycosides as Neuraminidase Inhibitors and their Use as Anti-Virals" (S. G. W., A. G. W., J.-H.K., and T. W.); PCT/CA2013/050034 "3' Equatorial-Fluorine-Substituted Neuraminidase Inhibitor Compounds, Compositions and Methods for the Use Thereof as Anti-Virals" (S.G.W., H.-M.C., and R.R).	Barrett S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023627; Blick TJ, 1995, VIROLOGY, V214, P475, DOI 10.1006/viro.1995.0058; Brown EG, 2001, P NATL ACAD SCI USA, V98, P6883, DOI 10.1073/pnas.111165798; Chavas LMG, 2010, J MED CHEM, V53, P2998, DOI 10.1021/jm100078r; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Eshaghi A, 2011, EMERG INFECT DIS, V17, P1472, DOI 10.3201/eid1708.102004; Gubareva LV, 1997, J VIROL, V71, P3385, DOI 10.1128/JVI.71.5.3385-3390.1997; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; McKimm-Breschkin JL, 1998, J VIROL, V72, P2456, DOI 10.1128/JVI.72.3.2456-2462.1998; Newstead SL, 2008, J BIOL CHEM, V283, P9080, DOI 10.1074/jbc.M710247200; Nguyen HT, 2010, CLIN INFECT DIS, V51, P983, DOI 10.1086/656439; Tashiro M, 2009, ANTIVIR THER, V14, P751, DOI 10.3851/IMP1194; van der Vries E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002914; van der Vries E, 2010, NEW ENGL J MED, V363, P1381, DOI 10.1056/NEJMc1003749; Varghese JN, 1998, STRUCT FOLD DES, V6, P735, DOI 10.1016/S0969-2126(98)00075-6; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; VONITZSTEIN M, 1993, CARBOHYD RES, V244, P181, DOI 10.1016/0008-6215(93)80014-6; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Watts AG, 2003, J AM CHEM SOC, V125, P7532, DOI 10.1021/ja0344967; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	20	144	151	4	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					71	75		10.1126/science.1232552	http://dx.doi.org/10.1126/science.1232552			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23429702	Green Accepted			2022-12-28	WOS:000317061100047
J	Pierce, NW; Lee, JE; Liu, X; Sweredoski, MJ; Graham, RLJ; Larimore, EA; Rome, M; Zheng, N; Clurman, BE; Hess, S; Shan, SO; Deshaies, RJ				Pierce, Nathan W.; Lee, J. Eugene; Liu, Xing; Sweredoski, Michael J.; Graham, Robert L. J.; Larimore, Elizabeth A.; Rome, Michael; Zheng, Ning; Clurman, Bruce E.; Hess, Sonja; Shan, Shu-ou; Deshaies, Raymond J.			Cand1 Promotes Assembly of New SCF Complexes through Dynamic Exchange of F Box Proteins	CELL			English	Article							UBIQUITIN LIGASE COMPLEX; COP9 SIGNALOSOME; SUBSTRATE; NEDD8; NEDDYLATION; ACTIVATION; CUL1; CRYPTOCHROME; RECOGNITION; DEGRADATION	The modular SCF (Skp1, cullin, and F box) ubiquitin ligases feature a large family of F box protein substrate receptors that enable recognition of diverse targets. However, how the repertoire of SCF complexes is sustained remains unclear. Real-time measurements of formation and disassembly indicate that SCFFbxw7 is extraordinarily stable, but, in the Nedd8-deconjugated state, the cullin-binding protein Cand1 augments its dissociation by one-million-fold. Binding and ubiquitylation assays show that Cand1 is a protein exchange factor that accelerates the rate at which Cul1-Rbx1 equilibrates with multiple F box protein-Skp1 modules. Depletion of Cand1 from cells impedes recruitment of new F box proteins to pre-existing Cul1 and profoundly alters the cellular landscape of SCF complexes. We suggest that catalyzed protein exchange may be a general feature of dynamic macromolecular machines and propose a hypothesis for how substrates, Nedd8, and Cand1 collaborate to regulate the cellular repertoire of SCF complexes.	[Pierce, Nathan W.; Lee, J. Eugene; Liu, Xing; Rome, Michael; Deshaies, Raymond J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Sweredoski, Michael J.; Graham, Robert L. J.; Hess, Sonja] CALTECH, Proteome Explorat Lab, Beckman Inst, Pasadena, CA 91125 USA; [Rome, Michael; Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Deshaies, Raymond J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Larimore, Elizabeth A.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA; [Clurman, Bruce E.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Larimore, Elizabeth A.; Clurman, Bruce E.] Fred Hutchinson Canc Res Ctr, Human Biol, Seattle, WA 98109 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Deshaies, RJ (corresponding author), CALTECH, Div Biol, MC 156-29,1200 East Calif Blvd, Pasadena, CA 91125 USA.	deshaies@caltech.edu	Graham, Robert l/A-7857-2010; Clurman, Bruce/AAV-3854-2021; Hess, Sonja/K-4842-2013; Deshaies, Raymond/B-8354-2014	Hess, Sonja/0000-0002-5904-9816; Deshaies, Raymond/0000-0002-3671-9354; Liu, Xing/0000-0001-9677-4470	Gordon Ross Fellowship; NIH Training Grant; Ruth L. Kirschstein NRSA Fellowship from the NIH [CA138126]; NIH [GM065997, 10565784]; Gordon and Betty Moore Foundation; Beckman Institute; NATIONAL CANCER INSTITUTE [F32CA138126, T32CA080416, R01CA084069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065997] Funding Source: NIH RePORTER	Gordon Ross Fellowship; NIH Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein NRSA Fellowship from the NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Beckman Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Vielmetter of the Caltech Protein Expression Facility for providing Fbxw7-Skp1, beta-TrCP-Skp1, and ubiquitin E1. We thank B. Schulman, L. Busino, M. Pagano, F. Bassermann, O. Schneewind, A. Saha, and W. den Besten for gifts of reagents. We thank G. Smith for assistance with mass spectrometry analyses. We thank all the members of the Deshaies and Shan lab for support and helpful discussions. We thank D. Wolf and T. Kurz for communicating unpublished results. N.W.P. was supported by the Gordon Ross Fellowship, and an NIH Training Grant. J.E.L. was supported by the Ruth L. Kirschstein NRSA Fellowship (CA138126) from the NIH. R.J.D. is an Investigator of the HHMI. This work was supported in part by NIH GM065997 to R.J.D. The Proteome Exploration lab is supported in part by grants from the Gordon and Betty Moore Foundation and the Beckman Institute and an instrumentation grant from NIH (10565784).	Bandau S, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-36; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Bergqvist S, 2009, P NATL ACAD SCI USA, V106, P19328, DOI 10.1073/pnas.0908797106; Bornstein G, 2006, P NATL ACAD SCI USA, V103, P11515, DOI 10.1073/pnas.0603921103; Bosu DR, 2010, DEV BIOL, V346, P113, DOI 10.1016/j.ydbio.2010.07.020; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Chan C, 2009, CURR BIOL, V19, P537, DOI 10.1016/j.cub.2009.02.060; Chua YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016071; Chuang HW, 2004, PLANT CELL, V16, P1883, DOI 10.1105/tpc.021923; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Emberley ED, 2012, J BIOL CHEM, V287, P29679, DOI 10.1074/jbc.M112.352484; Enchev RI, 2012, CELL REPORTS, V2, P616, DOI 10.1016/j.celrep.2012.08.019; Feng SH, 2004, PLANT CELL, V16, P1870, DOI 10.1105/tpc.021949; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Goody RS, 2002, EUR BIOPHYS J BIOPHY, V31, P268, DOI 10.1007/s00249-002-0225-3; Greco TM, 2010, J PROTEOME RES, V9, P2764, DOI 10.1021/pr100134n; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Helmstaedt K, 2011, MOL BIOL CELL, V22, P153, DOI 10.1091/mbc.E10-08-0732; Hewel JA, 2010, MOL CELL PROTEOMICS, V9, P2460, DOI 10.1074/mcp.M900456-MCP200; Kim SH, 2010, DEV BIOL, V346, P247, DOI 10.1016/j.ydbio.2010.07.031; Kulasingam V, 2008, J PROTEOME RES, V7, P640, DOI 10.1021/pr7005999; Lee JE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006460; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Lo SC, 2006, MOL CELL BIOL, V26, P1235, DOI 10.1128/MCB.26.4.1235-1244.2006; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Proft T, 2010, BIOTECHNOL LETT, V32, P1, DOI 10.1007/s10529-009-0116-0; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sandhu C, 2008, J PROTEOME RES, V7, P1529, DOI 10.1021/pr700836q; Schmidt MW, 2009, MOL CELL, V35, P586, DOI 10.1016/j.molcel.2009.07.024; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Siergiejuk E, 2009, EMBO J, V28, P3845, DOI 10.1038/emboj.2009.354; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Wickliffe KE, 2011, TRENDS CELL BIOL, V21, P656, DOI 10.1016/j.tcb.2011.08.008; Yen JL, 2012, MOL CELL, V48, P288, DOI 10.1016/j.molcel.2012.08.015; Zhang WD, 2008, ECON LETT, V99, P1, DOI 10.1016/j.econlet.2007.09.029; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	41	170	173	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					206	215		10.1016/j.cell.2013.02.024	http://dx.doi.org/10.1016/j.cell.2013.02.024			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23453757	Green Accepted, Bronze			2022-12-28	WOS:000316853700017
J	Taruno, A; Vingtdeux, V; Ohmoto, M; Ma, ZM; Dvoryanchikov, G; Li, A; Adrien, L; Zhao, HT; Leung, S; Abernethy, M; Koppel, J; Davies, P; Civan, MM; Chaudhari, N; Matsumoto, I; Hellekant, G; Tordoff, MG; Marambaud, P; Foskett, JK				Taruno, Akiyuki; Vingtdeux, Valerie; Ohmoto, Makoto; Ma, Zhongming; Dvoryanchikov, Gennady; Li, Ang; Adrien, Leslie; Zhao, Haitian; Leung, Sze; Abernethy, Maria; Koppel, Jeremy; Davies, Peter; Civan, Mortimer M.; Chaudhari, Nirupa; Matsumoto, Ichiro; Hellekant, Goeran; Tordoff, Michael G.; Marambaud, Philippe; Foskett, J. Kevin			CALHM1 ion channel mediates purinergic neurotransmission of sweet, bitter and umami tastes	NATURE			English	Article							MODULATOR 1 CALHM1; A-BETA LEVELS; ALZHEIMERS-DISEASE; P2X RECEPTORS; ATP RELEASE; POLYMORPHISM; HOMEOSTASIS; CELLS; COMMUNICATION; HEMICHANNELS	Recognition of sweet, bitter and umami tastes requires the non-vesicular release from taste bud cells of ATP, which acts as a neurotransmitter to activate afferent neural gustatory pathways(1). However, how ATP is released to fulfil this function is not fully understood. Here we show that calcium homeostasis modulator 1 (CALHM1), a voltage-gated ion channel(2,3), is indispensable for taste-stimuli-evoked ATP release from sweet-, bitter- and umami-sensing taste bud cells. Calhm1 knockout mice have severely impaired perceptions of sweet, bitter and umami compounds, whereas their recognition of sour and salty tastes remains mostly normal. Calhm1 deficiency affects taste perception without interfering with taste cell development or integrity. CALHM1 is expressed specifically in sweet/bitter/umami-sensing type II taste bud cells. Its heterologous expression induces a novel ATP permeability that releases ATP from cells in response to manipulations that activate the CALHM1 ion channel. Knockout of Calhm1 strongly reduces voltage-gated currents in type II cells and taste-evoked ATP release from taste buds without affecting the excitability of taste cells by taste stimuli. Thus, CALHM1 is a voltage-gated ATP-release channel required for sweet, bitter and umami taste perception.	[Taruno, Akiyuki; Ma, Zhongming; Li, Ang; Civan, Mortimer M.; Foskett, J. Kevin] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Vingtdeux, Valerie; Adrien, Leslie; Zhao, Haitian; Koppel, Jeremy; Davies, Peter; Marambaud, Philippe] Feinstein Inst Med Res, Study Alzheimers Dis, Litwin Zucker Res Ctr, Manhasset, NY 11030 USA; [Ohmoto, Makoto; Matsumoto, Ichiro; Tordoff, Michael G.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Dvoryanchikov, Gennady; Chaudhari, Nirupa] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; [Leung, Sze; Abernethy, Maria; Hellekant, Goeran] Univ Minnesota, Sch Med, Dept Biomed Sci, Duluth, MN 55812 USA; [Davies, Peter] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Civan, Mortimer M.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Chaudhari, Nirupa] Univ Miami, Miller Sch Med, Program Neurosci, Miami, FL 33136 USA; [Foskett, J. Kevin] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Northwell Health; Monell Chemical Senses Center; University of Miami; University of Minnesota System; University of Minnesota Duluth; Yeshiva University; Albert Einstein College of Medicine; University of Pennsylvania; University of Miami; University of Pennsylvania	Marambaud, P (corresponding author), Feinstein Inst Med Res, Study Alzheimers Dis, Litwin Zucker Res Ctr, Manhasset, NY 11030 USA.	pmaramba@nshs.edu; foskett@mail.med.upenn.edu	Vingtdeux, Valerie/C-2463-2012; Foskett, Kevin/R-2549-2019; Taruno, Akiyuki/AAP-5755-2021	Vingtdeux, Valerie/0000-0003-4550-503X; Taruno, Akiyuki/0000-0002-2342-0265; Foskett, J. Kevin/0000-0002-8854-0268; Marambaud, Philippe/0000-0002-8983-1497; Tordoff, Michael/0000-0003-1977-9520	KeySpan award; US NIH [GM56328, MH059937, NS072775, DC10393, EY13624, R03DC011143, P30 EY001583, P30DC011735]; University of Minnesota; NATIONAL EYE INSTITUTE [R01EY013624, P30EY001583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM056328, R01GM056328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS072775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006308, R01DC010393, R03DC011143, P30DC011735] Funding Source: NIH RePORTER	KeySpan award; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota(University of Minnesota System); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a KeySpan award to P.M., several US NIH grants (GM56328, MH059937, NS072775 to J.K.F.; DC10393 to M.G.T.; EY13624 to M.M.C.; R03DC011143 to I.M.; Core Grant P30 EY001583 to the University of Pennsylvania; Core Grant P30DC011735 to the Monell Chemical Senses Center) and the University of Minnesota's Undergraduate Research Opportunities Program to S.L. and M.A. A.T. and M.O. are JSPS Fellows. We thank R. F. Margolskee for the TRPM5-GFP mice and Y. Ninomiya for comments on the manuscript	BURNSTOCK G, 1990, ANN NY ACAD SCI, V603, P31; Burnstock G, 2011, ADV PHARMACOL, V61, P333, DOI 10.1016/B978-0-12-385526-8.00011-4; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Chizh BA, 2001, PHARMACOL REV, V53, P553; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Cotrina ML, 1998, J NEUROSCI, V18, P8794; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Dreses-Werringloer U, 2008, CELL, V133, P1149, DOI 10.1016/j.cell.2008.05.048; EDWARDS FA, 1992, NATURE, V359, P144, DOI 10.1038/359144a0; EVANS RJ, 1992, NATURE, V357, P503, DOI 10.1038/357503a0; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Koppel J, 2011, MOL MED, V17, P974, DOI 10.2119/molmed.2011.00154; Lambert JC, 2010, J ALZHEIMERS DIS, V22, P247, DOI 10.3233/JAD-2010-100933; Ma ZM, 2012, P NATL ACAD SCI USA, V109, pE1963, DOI 10.1073/pnas.1204023109; Matsumoto I, 2011, NAT NEUROSCI, V14, P685, DOI 10.1038/nn.2820; Moyer BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007682; Romanov RA, 2006, NEUROSCI LETT, V395, P249, DOI 10.1016/j.neulet.2005.10.085; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; Romanov RA, 2012, J CELL SCI, V125, P5514, DOI 10.1242/jcs.111062; Sabirov Ravshan Z, 2005, Purinergic Signal, V1, P311, DOI 10.1007/s11302-005-1557-0; Siebert AP, 2013, J BIOL CHEM, V288, P6140, DOI 10.1074/jbc.M112.409789; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Vandenbeuch A, 2010, J NEUROSCI, V30, P14695, DOI 10.1523/JNEUROSCI.1570-10.2010; Wynn G, 2003, GASTROENTEROLOGY, V125, P1398, DOI 10.1016/j.gastro.2003.07.008; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	27	290	305	21	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2013	495	7440					223	226		10.1038/nature11906	http://dx.doi.org/10.1038/nature11906			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23467090	Green Accepted			2022-12-28	WOS:000316652300048
J	Devoret, MH; Schoelkopf, RJ				Devoret, M. H.; Schoelkopf, R. J.			Superconducting Circuits for Quantum Information: An Outlook	SCIENCE			English	Review							PHOTON; IMPLEMENTATION; SUPERPOSITION; STATES; TIME	The performance of superconducting qubits has improved by several orders of magnitude in the past decade. These circuits benefit from the robustness of superconductivity and the Josephson effect, and at present they have not encountered any hard physical limits. However, building an error-corrected information processor with many such qubits will require solving specific architecture problems that constitute a new field of research. For the first time, physicists will have to master quantum error correction to design and operate complex active systems that are dissipative in nature, yet remain coherent indefinitely. We offer a view on some directions for the field and speculate on its future.	[Devoret, M. H.; Schoelkopf, R. J.] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; [Devoret, M. H.; Schoelkopf, R. J.] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Devoret, M. H.] Coll France, F-75005 Paris, France	Yale University; Yale University; UDICE-French Research Universities; PSL Research University Paris; College de France	Schoelkopf, RJ (corresponding author), Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA.	robert.schoelkopf@yale.edu	Schoelkopf, Robert J/J-8178-2012		U.S. Army Research Office; U.S. National Security Agency Laboratory for Physical Science; U.S. Intelligence Advanced Research Projects Activity; NSF; Yale University	U.S. Army Research Office; U.S. National Security Agency Laboratory for Physical Science; U.S. Intelligence Advanced Research Projects Activity; NSF(National Science Foundation (NSF)); Yale University	We thank L. Frunzio, S. Girvin, L. Glazman, and L. Jiang for their contributions. Supported by the U.S. Army Research Office, U.S. National Security Agency Laboratory for Physical Science, U.S. Intelligence Advanced Research Projects Activity, NSF, and Yale University.	Barreiro JT, 2011, NATURE, V470, P486, DOI 10.1038/nature09801; Bintley D, 2012, PROC SPIE, V8452, DOI 10.1117/12.926613; Bouchiat V, 1998, PHYS SCRIPTA, VT76, P165, DOI 10.1238/Physica.Topical.076a00165; Bravyi S. B., 2001, QUANTUM COMPUTERS CO, V2, P43; Chiorescu I, 2003, SCIENCE, V299, P1869, DOI 10.1126/science.1081045; Cirac JI, 2012, NAT PHYS, V8, P264, DOI 10.1038/nphys2275; Clarke J, 2008, NATURE, V453, P1031, DOI 10.1038/nature07128; Cottet A, 2002, PHYSICA C, V367, P197, DOI 10.1016/S0921-4534(01)01014-0; da Silva MP, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.210404; David Mermin N., 2007, QUANTUM COMPUTER SCI; Devoret MH, 2004, QUANT INF PROC, V3, P381; Diehl S, 2008, NAT PHYS, V4, P878, DOI 10.1038/nphys1073; DiVincenzo DP, 2000, FORTSCHR PHYS, V48, P771, DOI 10.1002/1521-3978(200009)48:9/11<771::AID-PROP771>3.0.CO;2-E; Duan LM, 2004, QUANTUM INF COMPUT, V4, P165; Eichler C, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.220503; Fowler AG, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.032324; Freedman MH, 2001, FOUND COMPUT MATH, V1, P325, DOI 10.1007/s102080010013; Friedman JR, 2000, NATURE, V406, P43, DOI 10.1038/35017505; Gottesman D., 1997, THESIS CALIFORNIA I; Groen JP, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.090506; Haroche S., 2006, EXPLORING QUANTUM; Hatridge M, 2013, SCIENCE, V339, P178, DOI 10.1126/science.1226897; Houck AA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.080502; Jones J., NMR QUANTUM COMPUTAT; Kim Z, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.120501; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Koch J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042319; Kuhr S, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2724816; Lloyd S, 1996, SCIENCE, V273, P1073, DOI 10.1126/science.273.5278.1073; Lucero E, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.247001; Manucharyan VE, 2009, SCIENCE, V326, P113, DOI 10.1126/science.1175552; Mariantoni M, 2011, NAT PHYS, V7, P287, DOI [10.1038/nphys1885, 10.1038/NPHYS1885]; Martinis JM, 2009, QUANTUM INF PROCESS, V8, P81, DOI 10.1007/s11128-009-0105-1; Megrant A, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3693409; Mooij JE, 1999, SCIENCE, V285, P1036, DOI 10.1126/science.285.5430.1036; Murch KW, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.183602; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Nigg SE, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.240502; Paik H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.240501; Palacios-Laloy A, 2010, NAT PHYS, V6, P442, DOI 10.1038/NPHYS1641; Reed MD, 2012, NATURE, V482, P382, DOI 10.1038/nature10786; Rigetti C, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.100506; Sayrin C, 2011, NATURE, V477, P73, DOI 10.1038/nature10376; Schindler P, 2011, SCIENCE, V332, P1059, DOI 10.1126/science.1203329; Schoelkopf RJ, 2008, NATURE, V451, P664, DOI 10.1038/451664a; Sears AP, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.180504; SHOR PW, 1995, PHYS REV A, V52, pR2493, DOI 10.1103/PhysRevA.52.R2493; Steane A, 1996, P ROY SOC A-MATH PHY, V452, P2551, DOI 10.1098/rspa.1996.0136; Steffen M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.100502; van der Wal CH, 2000, SCIENCE, V290, P773, DOI 10.1126/science.290.5492.773; Vijay R, 2012, NATURE, V490, P77, DOI 10.1038/nature11505; Vijay R, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.110502; Vion D, 2002, SCIENCE, V296, P886, DOI 10.1126/science.1069372; Wallraff A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060501; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; You JQ, 2005, PHYS TODAY, V58, P42, DOI 10.1063/1.2155757; Zmuidzinas J, 2012, ANNU REV CONDEN MA P, V3, P169, DOI 10.1146/annurev-conmatphys-020911-125022	65	1271	1317	27	526	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2013	339	6124					1169	1174		10.1126/science.1231930	http://dx.doi.org/10.1126/science.1231930			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471399				2022-12-28	WOS:000315709900038
J	Horwitz, RI; Cullen, MR; Abell, J; Christian, JB				Horwitz, Ralph I.; Cullen, Mark R.; Abell, Jill; Christian, Jennifer B.			(De)Personalized Medicine	SCIENCE			English	Editorial Material							GENOMICS		[Horwitz, Ralph I.] GlaxoSmithKline, Clin Evaluat Sci, King Of Prussia, PA 19406 USA; [Cullen, Mark R.] Stanford Univ, Sch Med, Div Gen Med Disciplines, Stanford, CA 94305 USA; [Abell, Jill] GlaxoSmithKline, Clin Effectiveness & Safety, King Of Prussia, PA 19406 USA; [Christian, Jennifer B.] GlaxoSmithKline, Clin Effectiveness & Safety, Res Triangle Pk, NC 27709 USA	GlaxoSmithKline; Stanford University; GlaxoSmithKline; GlaxoSmithKline	Horwitz, RI (corresponding author), GlaxoSmithKline, Clin Evaluat Sci, King Of Prussia, PA 19406 USA.	mrcullen@stanford.edu		cullen, mark/0000-0001-7996-1864				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Burke W, 2007, JAMA-J AM MED ASSOC, V298, P1682, DOI 10.1001/jama.298.14.1682; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Goodman SN, 1999, ANN INTERN MED, V130, P604, DOI 10.7326/0003-4819-130-7-199904060-00022; Guttmacher AE, 2007, NAT REV GENET, V8, P151, DOI 10.1038/nrg2007; Idaghdour Y, 2010, NAT GENET, V42, P62, DOI 10.1038/ng.495; 1982, JAMA, V247, P1707	7	35	36	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2013	339	6124					1155	1156		10.1126/science.1234106	http://dx.doi.org/10.1126/science.1234106			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471391				2022-12-28	WOS:000315709900030
J	Huang, DY; Nel, A; Cai, CY; Li, QB; Engel, MS				Huang, Diying; Nel, Andre; Cai, Chenyang; Li, Qibin; Engel, Michael S.			Amphibious flies and paedomorphism in the Jurassic period	NATURE			English	Article							NYMPHOMYIIDAE DIPTERA; LARVA; FLY	The species of the Strashilidae (strashilids) have been the most perplexing of fossil insects from the Jurassic period of Russia and China(1,2). They have been widely considered to be ectoparasites of pterosaurs or feathered dinosaurs, based on the putative presence of piercing and sucking mouthparts and hind tibio-basitarsal pincers purportedly used to fix onto the host's hairs or feathers(1-6). Both the supposed host and parasite occur in the Daohugou beds from the Middle Jurassic epoch of China (approximately 165 million years ago)(7,8). Here we analyse the morphology of strashilids from the Daohugou beds, and reach markedly different conclusions; namely that strashilids are highly specialized flies (Diptera) bearing large membranous wings, with substantial sexual dimorphism of the hind legs and abdominal extensions. The idea that they belong to an extinct order(2) is unsupported, and the lineage can be placed within the true flies. In terms of major morphological and inferred behavioural features, strashilids resemble the recent (extant) and relict members of the aquatic fly family Nymphomyiidae. Their ontogeny are distinguished by the persistence in adult males of larval abdominal respiratory gills, representing a unique case of paedomorphism among endopterygote insects. Adult strashilids were probably aquatic or amphibious, shedding their wings after emergence and mating in the water.	[Huang, Diying; Cai, Chenyang; Li, Qibin] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing 210008, Jiangsu, Peoples R China; [Nel, Andre] Museum Natl Hist Nat, CNRS UMR 7205, CP 50, F-75005 Paris, France; [Engel, Michael S.] Univ Kansas, Nat Hist Museum, Div Entomol, Lawrence, KS 66045 USA; [Engel, Michael S.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA	Chinese Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); University of Kansas; University of Kansas	Huang, DY (corresponding author), Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing 210008, Jiangsu, Peoples R China.	dyhuang@nigpas.ac.cn	Engel, Michael S/C-5461-2012	Engel, Michael S/0000-0003-3067-077X	National Basic Research Program of China [2012CB821903]; National Natural Science Foundation of China [91114201, J1210006]; Outstanding Youth Foundation of Jiangsu Province [BK2012049]; Chinese Academy of Sciences [KZCX2-YW-QN104]; US National Science Foundation [DEB-0542909]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Youth Foundation of Jiangsu Province; Chinese Academy of Sciences(Chinese Academy of Sciences); US National Science Foundation(National Science Foundation (NSF))	We are grateful to C. C. Labandeira for suggestions; A. P. Rasnitsyn for early discussions; and J. Sun for reconstructions. Financial support was provided by the National Basic Research Program of China (2012CB821903), the National Natural Science Foundation of China (91114201 and J1210006), the Outstanding Youth Foundation of Jiangsu Province (BK2012049), the Chinese Academy of Sciences (KZCX2-YW-QN104), and the US National Science Foundation (DEB-0542909).	Barclay A, 2005, J KANSAS ENTOMOL SOC, V78, P181, DOI 10.2317/0409.23.1; Cao Cheng-Quan, 2011, Chinese Journal of Applied Entomology, V48, P392; Courtney G. W., 1994, SMITH CONT ZOOL; Crampton G. C., 1922, Transactions of the American Entomological Society, V48, P207; CUTTEN FEA, 1970, CAN J ZOOLOG, V48, P1, DOI 10.1139/z70-001; Daugeron C, 2011, BIOL LETTERS, V7, P11, DOI 10.1098/rsbl.2010.0726; FURTH DG, 1990, SYST ENTOMOL, V15, P443, DOI 10.1111/j.1365-3113.1990.tb00076.x; Gao TP, 2012, CURR BIOL, V22, P732, DOI 10.1016/j.cub.2012.03.012; Grimaldi David, 2005, pi; Huang DY, 2012, NATURE, V483, P201, DOI 10.1038/nature10839; Huang Diying, 2010, Dixue Qianyuan, V17, P149; IDE FP, 1965, CAN ENTOMOL, V97, P496, DOI 10.4039/Ent97496-5; Kevan D.K.M., 1981, Canada Department of Agriculture Research Branch Monograph, P203; KEVAN DKM, 1975, CAN J ZOOL, V53, P853, DOI 10.1139/z75-099; Labandeira Conrad C., 2002, Paleontological Society Papers, V8, P211; Marden JH, 2003, BIOL J LINN SOC, V79, P341, DOI 10.1046/j.1095-8312.2003.00192.x; Poinar GO, 2012, CURR BIOL, V22, pR278, DOI 10.1016/j.cub.2012.03.014; Rasnitsyn A. P., 1992, Psyche (Cambridge), V99, P323, DOI 10.1155/1992/20491; Richmond EA, 1920, B AM MUS NAT HIST, V42, P1; Speidel W., 1998, MEMOIRES SOC ENTOMOL, V38, P25; Stys P., 1980, Acta Universitatis Carolinae Biologica, V1978, P409; Vransky Peter, 2010, AMBA Projekty, V8, P1; Wagner R, 2000, SYST ENTOMOL, V25, P115, DOI 10.1046/j.1365-3113.2000.025001115.x; Wang XL, 2002, CHINESE SCI BULL, V47, P226, DOI 10.1360/02tb9054; WILLMANN R, 1981, Z ZOOL SYST EVOL, V19, P96; WOOD DM, 1991, PROCEEDINGS OF THE SECOND INTERNATIONAL CONGRESS OF DIPTEROLOGY, P255; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447	27	30	33	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2013	495	7439					94	97		10.1038/nature11898	http://dx.doi.org/10.1038/nature11898			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23426262				2022-12-28	WOS:000316039800046
J	Juurlink, DN; Dhalla, IA; Nelson, LS				Juurlink, David N.; Dhalla, Irfan A.; Nelson, Lewis S.			Improving Opioid Prescribing The New York City Recommendations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHRONIC NONCANCER PAIN		[Juurlink, David N.; Dhalla, Irfan A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Juurlink, David N.] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Juurlink, David N.; Dhalla, Irfan A.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Juurlink, David N.] St Michaels Hosp, Sunnybrook Res Inst, Toronto, ON M5B 1W8, Canada; [Dhalla, Irfan A.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Nelson, Lewis S.] NYU, Sch Med, Dept Emergency Med, New York, NY USA	University of Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Sunnybrook Health Science Center; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; New York University	Juurlink, DN (corresponding author), Sunnybrook Hlth Sci Ctr, 2075 Bayview Ave,G-106, Toronto, ON M4N 3M5, Canada.	david.juurlink@ices.on.ca		Nelson, Lewis/0000-0001-9551-3922				[Anonymous], 2012, PRESCR DRUG AB OV PU; Cantrill SV, 2012, ANN EMERG MED, V60, P499, DOI 10.1016/j.annemergmed.2012.06.013; Chou R, 2009, J PAIN, V10, P147, DOI 10.1016/j.jpain.2008.10.007; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Juurlink DN, 2012, J MED TOXICOL, V8, P393, DOI 10.1007/s13181-012-0269-4; Nelson LS, 2012, JAMA-J AM MED ASSOC, V308, P457, DOI 10.1001/jama.2012.8165; Paone D., 2011, OPIOID ANALGESICS NE; Trescott CE, 2011, HEALTH AFFAIR, V30, P1420, DOI 10.1377/hlthaff.2011.0759; Zgierska A, 2012, JAMA-J AM MED ASSOC, V307, P1377, DOI 10.1001/jama.2012.419	9	30	30	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2013	309	9					879	880		10.1001/jama.2013.1139	http://dx.doi.org/10.1001/jama.2013.1139			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099PC	23462783				2022-12-28	WOS:000315632700020
J	Vincent, JL; Opal, SM; Marshall, JC; Tracey, KJ				Vincent, Jean-Louis; Opal, Steven M.; Marshall, John C.; Tracey, Kevin J.			Sepsis definitions: time for change	LANCET			English	Editorial Material									[Vincent, Jean-Louis] Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care, B-1070 Brussels, Belgium; [Opal, Steven M.] Brown Univ, Mem Hosp Rhode Isl, Warren Alpert Med Sch, Div Infect Dis, Pawtucket, RI 02860 USA; [Marshall, John C.] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Dept Surg, Toronto, ON M5B 1W8, Canada; [Tracey, Kevin J.] Feinstein Inst Med Res, Lab Biomed Sci, Manhasset, NY USA	Universite Libre de Bruxelles; Brown University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Northwell Health	Vincent, JL (corresponding author), Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care, Route Lennik 808, B-1070 Brussels, Belgium.	jlvincen@ulb.ac.be		Tracey, Kevin J/0000-0003-1884-6314; Vincent, Jean-Louis/0000-0001-6011-6951	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR018535] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR018535] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Czura CJ, 2011, MOL MED, V17, P2, DOI 10.2119/molmed.2010.00001.commentary; Lai NA, 2011, CRIT CARE RESUSC, V13, P146; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Sprung CL, 2006, INTENS CARE MED, V32, P421, DOI 10.1007/s00134-005-0039-8; Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8204; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354	9	427	478	3	63	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2013	381	9868					774	775		10.1016/S0140-6736(12)61815-7	http://dx.doi.org/10.1016/S0140-6736(12)61815-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	098TC	23472921	Green Accepted			2022-12-28	WOS:000315570900031
J	Flak, MB; Neves, JF; Blumberg, RS				Flak, Magdalena B.; Neves, Joana F.; Blumberg, Richard S.			Welcome to the Microgenderome	SCIENCE			English	Editorial Material							GUT MICROBIOME; EARLY-LIFE		[Flak, Magdalena B.] Harvard Univ, Brigham & Womens Hosp, Div Gastroenterol, Dept Med,Med Sch, Boston, MA 02115 USA; Harvard Digest Dis Ctr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Flak, MB (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Gastroenterol, Dept Med,Med Sch, Boston, MA 02115 USA.	rblumberg@partners.org	Flak, Magdalena B/M-7106-2016; Neves, Joana F/J-9406-2014; Flak, Magdalena/AAG-5272-2020	Flak, Magdalena B/0000-0002-8238-9835; Neves, Joana F/0000-0001-5842-4162; Flak, Magdalena/0000-0002-8238-9835	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044319, P30DK034854, R01DK044319, R01DK051362, R01DK088199, R01DK053056] Funding Source: NIH RePORTER; NIDDK NIH HHS [R37 DK044319, R01 DK088199, R01 DK051362, DK0034854, R01 DK053056, DK051362, DK088199, R01 DK044319, DK044319, P30 DK034854, DK053056, R56 DK053056] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Blumberg R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004184; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; FOX HS, 1992, J EXP MED, V175, P1409, DOI 10.1084/jem.175.5.1409; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336	13	68	68	3	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1044	1045		10.1126/science.1236226	http://dx.doi.org/10.1126/science.1236226			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23449586	Green Accepted			2022-12-28	WOS:000315452000030
J	Shin, J; Ming, GL; Song, HJ				Shin, Jaehoon; Ming, Guo-li; Song, Hongjun			By Hook or by Crook: Multifaceted DNA-Binding Properties of MeCP2	CELL			English	Editorial Material							ADULT BRAIN; CHROMATIN; MUTATIONS	Two new studies reveal novel DNA-binding properties of MeCP2, mutations of which cause Rett syndrome. Baker et al. report critical roles for the AT-hook domain of MeCP2 in chromatin organization and clinical features of Rett syndrome. Mellen et al. find the methyl-CpG-binding domain of MeCP2 interacts with hydroxymethyl-CpG.	[Shin, Jaehoon; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA; [Shin, Jaehoon; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Inst Cell Engn, Baltimore, MD 21205 USA; [Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA; [Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Song, HJ (corresponding author), Johns Hopkins Univ, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA.	shongju1@jhmi.edu	Ming, Guo-li/J-7880-2013		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH084018, R33MH087874, R21MH087874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS047344, R56NS047344, R01NS047344, R01NS048271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG024984] Funding Source: Medline; NICHD NIH HHS [R01 HD069184, HD069184] Funding Source: Medline; NIEHS NIH HHS [ES021957, R21 ES021957] Funding Source: Medline; NIMH NIH HHS [R33 MH087874, P20 MH084018, R21 MH087874] Funding Source: Medline; NINDS NIH HHS [R01 NS048271, R01 NS047344, R56 NS047344, NS047344, R37 NS047344, NS048271] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Baker SA, 2013, CELL, V152, P984, DOI 10.1016/j.cell.2013.01.038; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Nan XS, 2007, P NATL ACAD SCI USA, V104, P2709, DOI 10.1073/pnas.0608056104; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5	10	10	10	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 28	2013	152	5					940	942		10.1016/j.cell.2013.02.017	http://dx.doi.org/10.1016/j.cell.2013.02.017			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452844	Green Accepted, Bronze			2022-12-28	WOS:000315710300003
J	Wolpert, AJ				Wolpert, Ann J.			For the Sake of Inquiry and Knowledge - The Inevitability of Open Access	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									MIT, MIT Lib, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Wolpert, AJ (corresponding author), MIT, MIT Lib, Cambridge, MA 02139 USA.							Suber P., 2012, KNOWLEDGE UNBOUND, DOI 10.1080/00049670.2013.811775; Van Noorden R, 2012, NATURE, V487, P285, DOI 10.1038/487285a	2	42	42	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2013	368	9					785	787		10.1056/NEJMp1211410	http://dx.doi.org/10.1056/NEJMp1211410			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096ET	23445088				2022-12-28	WOS:000315387700001
J	Gerada, C				Gerada, Clare			Andy Burnham's "whole person" care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												cgerada@rcgp.org.uk	Gerada, Clare/O-8264-2019					Delamothe T, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f979; Iacobucci G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f466; Labour Party, 2013, COMMUNICATION   0124	3	2	2	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2013	346								f1239	10.1136/bmj.f1239	http://dx.doi.org/10.1136/bmj.f1239			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100BL	23447343				2022-12-28	WOS:000315669600002
J	Anam, AM; Rabbani, R				Anam, Ahmad Mursel; Rabbani, Raihan			Ogilvie's syndrome in severe dengue	LANCET			English	Editorial Material									[Anam, Ahmad Mursel] Sq Hosp Ltd, Intens Care Unit, Dhaka 1205, Bangladesh; [Rabbani, Raihan] Sq Hosp Ltd, Dept Internal Med, Dhaka 1205, Bangladesh		Anam, AM (corresponding author), Sq Hosp Ltd, Intens Care Unit, 18-F BU Qazi Nuruzzaman Sarak, Dhaka 1205, Bangladesh.	murselanam@gmail.com	Anam, Ahmad Mursel/GYD-7255-2022	ANAM, AHMAD MURSEL/0000-0001-9673-9704				Gulati S, 2007, TROP MED INT HEALTH, V12, P1087, DOI 10.1111/j.1365-3156.2007.01891.x; Maloney Nell, 2005, Clin Colon Rectal Surg, V18, P96, DOI 10.1055/s-2005-870890; Saunders MD, 2005, EVIDENCE BASED GASTR, P303; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; World Health Organization, 2009, DENGUE GUIDELINES DI	5	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 23	2013	381	9867					698	698		10.1016/S0140-6736(12)62031-5	http://dx.doi.org/10.1016/S0140-6736(12)62031-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	093JY	23439104				2022-12-28	WOS:000315189300040
J	Pecoits, E; Konhauser, KO; Aubet, NR; Heaman, LM; Veroslavsky, G; Stern, R; Gingras, MK				Pecoits, Ernesto; Konhauser, Kurt O.; Aubet, Natalie R.; Heaman, Larry M.; Veroslavsky, Gerardo; Stern, Richard; Gingras, Murray K.			Response to Comment on "Bilaterian Burrows and Grazing Behavior at > 585 Million Years Ago"	SCIENCE			English	Editorial Material							URUGUAY	Gaucher et al. suggest that their field observations and petrographic analysis of one thin section do not support an Ediacaran age for the trace fossils-bearing strata of the Tacuari Formation. We have strengthened our conclusion of an Ediacaran age for the Tacuari Formation based on reassessment of new and previously presented field and petrographic evidence.	[Pecoits, Ernesto; Konhauser, Kurt O.; Aubet, Natalie R.; Heaman, Larry M.; Stern, Richard; Gingras, Murray K.] Univ Alberta, Dept Earth & Atmos Sci, Edmonton, AB T6G 2E3, Canada; [Aubet, Natalie R.; Veroslavsky, Gerardo] Univ Rep, Inst Ciencias Geol, Igua 4225, Montevideo 11400, Uruguay	University of Alberta; Universidad de la Republica, Uruguay	Konhauser, KO (corresponding author), Univ Alberta, Dept Earth & Atmos Sci, Edmonton, AB T6G 2E3, Canada.	kurtk@ualberta.ca		Konhauser, Kurt/0000-0001-7722-7068				ANDREIS RR, 1996, EL SISTEMA PERM, P309; Beri A, 2006, AMEGHINIANA, V43, P227; BOSSI J, 2001, CARTA GEOL URUGUAY; DANERS G, 2006, IX CONG ARGENTINO; DESANTAANA H, 1993, REV BRASILEIRA GEOCI, V23, P347; Gaucher C, 2005, GEOL MAG, V142, P539, DOI 10.1017/S0016756805001123; Gaucher C, 2003, PRECAMBRIAN RES, V120, P241, DOI 10.1016/S0301-9268(02)00140-7; Gaucher C, 2008, GONDWANA RES, V13, P488, DOI 10.1016/j.gr.2007.05.008; Gaucher Claudio, 2005, Lat. Am. j. sedimentol. basin anal., V12, P145; Gaucher C, 2013, SCIENCE, V339, P906, DOI 10.1126/science.1230339; Gutierrez PR, 2006, AMEGHINIANA, V43, P611; Oyhantcabal P, 2011, INT J EARTH SCI, V100, P379, DOI 10.1007/s00531-010-0577-3; Pecoits E, 2012, SCIENCE, V336, P1693, DOI 10.1126/science.1216295; Santa Ana H., 2006, CUENCAS SEDIMENTARIA, P147; Veroslavsky G., 2006, REV SOC URU GEOL, V13, P23	15	9	9	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2013	339	6122					906	906		10.1126/science.1230677	http://dx.doi.org/10.1126/science.1230677			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23430639				2022-12-28	WOS:000315149600056
J	Purdy, TP; Peterson, RW; Regal, CA				Purdy, T. P.; Peterson, R. W.; Regal, C. A.			Observation of Radiation Pressure Shot Noise on a Macroscopic Object	SCIENCE			English	Article							QUANTUM-NONDEMOLITION MEASUREMENT; GROUND-STATE; CAVITY; OSCILLATOR; MOTION	The quantum mechanics of position measurement of a macroscopic object is typically inaccessible because of strong coupling to the environment and classical noise. In this work, we monitor a mechanical resonator subject to an increasingly strong continuous position measurement and observe a quantum mechanical back-action force that rises in accordance with the Heisenberg uncertainty limit. For our optically based position measurements, the back-action takes the form of a fluctuating radiation pressure from the Poisson-distributed photons in the coherent measurement field, termed radiation pressure shot noise. We demonstrate a back-action force that is comparable in magnitude to the thermal forces in our system. Additionally, we observe a temporal correlation between fluctuations in the radiation force and in the position of the resonator.	[Purdy, T. P.; Peterson, R. W.; Regal, C. A.] Univ Colorado, JILA, Boulder, CO 80309 USA; [Purdy, T. P.; Peterson, R. W.; Regal, C. A.] NIST, Boulder, CO 80309 USA; [Purdy, T. P.; Peterson, R. W.; Regal, C. A.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder	Purdy, TP (corresponding author), Univ Colorado, JILA, Boulder, CO 80309 USA.	tpp@jila.colorado.edu		REGAL, CINDY/0000-0002-0000-2140; Peterson, Robert/0000-0001-9003-2716	Defense Advanced Research Projects Agency Quantum-Assisted Sensing and Readout program; Office of Naval Research Young Investigator Program; JILA NSF Physics Frontier Center; National Research Council; Clare Boothe Luce foundation	Defense Advanced Research Projects Agency Quantum-Assisted Sensing and Readout program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Office of Naval Research Young Investigator Program(Office of Naval Research); JILA NSF Physics Frontier Center(National Science Foundation (NSF)); National Research Council(Consiglio Nazionale delle Ricerche (CNR)); Clare Boothe Luce foundation	We thank P.-L. Yu for technical assistance and K. Lehnert's group for helpful discussions. This work is supported by: the Defense Advanced Research Projects Agency Quantum-Assisted Sensing and Readout program, the Office of Naval Research Young Investigator Program, and the JILA NSF Physics Frontier Center. T. P. P. thanks the National Research Council for support. C. A. R. thanks the Clare Boothe Luce foundation for support.	Anetsberger G, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.061804; Borkje K, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.013818; Braginksky V, 1978, SOV PHYS JETP, V47, P433; BRAGINSKY VB, 1980, SCIENCE, V209, P547, DOI 10.1126/science.209.4456.547; Brooks DWC, 2012, NATURE, V488, P476, DOI 10.1038/nature11325; CAVES CM, 1981, PHYS REV D, V23, P1693, DOI 10.1103/PhysRevD.23.1693; Chan J, 2011, NATURE, V478, P89, DOI 10.1038/nature10461; FABRE C, 1994, PHYS REV A, V49, P1337, DOI 10.1103/PhysRevA.49.1337; Harry GM, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/8/084006; Heidmann A, 1997, APPL PHYS B-LASERS O, V64, P173, DOI 10.1007/s003400050162; HOLLAND MJ, 1990, PHYS REV A, V42, P2995, DOI 10.1103/PhysRevA.42.2995; JACOBS K, 1994, PHYS REV A, V49, P1961, DOI 10.1103/PhysRevA.49.1961; Khalili FY, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.033840; Kimble HJ, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.022002; Marquardt F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.093902; Murch KW, 2008, NAT PHYS, V4, P561, DOI 10.1038/nphys965; Naik A, 2006, NATURE, V443, P193, DOI 10.1038/nature05027; Purdy TP, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/11/115021; Safavi-Naeini AH, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.033602; Somiya K, 2012, CLASSICAL QUANT GRAV, V29, DOI 10.1088/0264-9381/29/12/124007; Stamper-Kurn D. M., CAVITY OPTOMECHANICS; Teufel JD, 2011, NATURE, V475, P359, DOI 10.1038/nature10261; Teufel JD, 2009, NAT NANOTECHNOL, V4, P820, DOI [10.1038/NNANO.2009.343, 10.1038/nnano.2009.343]; Thompson JD, 2008, NATURE, V452, P72, DOI 10.1038/nature06715; Tittonen I, 1999, PHYS REV A, V59, P1038, DOI 10.1103/PhysRevA.59.1038; Verhagen E, 2012, NATURE, V482, P63, DOI 10.1038/nature10787; Verlot P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.103601; Verlot P, 2011, CR PHYS, V12, P826, DOI 10.1016/j.crhy.2011.03.008; Wilson-Rae I, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.093901; Yamamoto K, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.033849	30	289	292	3	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2013	339	6121					801	804		10.1126/science.1231282	http://dx.doi.org/10.1126/science.1231282			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23413350	Green Submitted			2022-12-28	WOS:000314874400043
J	Cameron, FL; Armstrong, L; Stenhouse, E; Davis, C; Russell, RK				Cameron, F. L.; Armstrong, L.; Stenhouse, E.; Davis, C.; Russell, R. K.			Acute abdominal pain in a child with inflammatory bowel disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SEVERE ULCERATIVE-COLITIS; TOXIC MEGACOLON; CLOSTRIDIUM-DIFFICILE		[Cameron, F. L.; Russell, R. K.] Royal Hosp Sick Children, Dept Paediat Gastroenterol Hepatol & Nutr, Glasgow G3 8SJ, Lanark, Scotland; [Armstrong, L.] Crosshouse Hosp, Dept Paediat, Kilmarnock, Scotland; [Stenhouse, E.] Royal Hosp Sick Children, Dept Paediat Radiol, Glasgow G3 8SJ, Lanark, Scotland; [Davis, C.] Royal Hosp Sick Children, Dept Paediat Surg, Glasgow G3 8SJ, Lanark, Scotland	University of Glasgow; University of Glasgow; University of Glasgow	Cameron, FL (corresponding author), Royal Hosp Sick Children, Dept Paediat Gastroenterol Hepatol & Nutr, Glasgow G3 8SJ, Lanark, Scotland.	fcameron@doctors.org.uk						Ananthakrishnan AN, 2008, GUT, V57, P205, DOI 10.1136/gut.2007.128231; Benchimol EI, 2008, AM J GASTROENTEROL, V103, P1524, DOI 10.1111/j.1572-0241.2008.01807.x; GRANT CS, 1984, AM J SURG, V147, P106, DOI 10.1016/0002-9610(84)90042-4; GRIECO MB, 1980, ANN SURG, V191, P75, DOI 10.1097/00000658-198001000-00015; Hommes DW, 2004, INFLAMM BOWEL DIS, V10, P245, DOI 10.1097/00054725-200405000-00011; JALAN KN, 1969, GASTROENTEROLOGY, V57, P68, DOI 10.1016/s0016-5085(19)33962-9; Kennedy NA, 2012, ALIMENT PHARM THER, V35, P142, DOI 10.1111/j.1365-2036.2011.04906.x; Pascarella F, 2009, J PEDIATR-US, V154, P854, DOI 10.1016/j.jpeds.2008.12.039; Rodemann JF, 2007, CLIN GASTROENTEROL H, V5, P339, DOI 10.1016/j.cgh.2006.12.027; Sheth SG, 1998, LANCET, V351, P509, DOI 10.1016/S0140-6736(97)10475-5; SURAWICZ CM, 1994, GASTROENTEROLOGY, V107, P755, DOI 10.1016/0016-5085(94)90124-4; TRUELOVE SC, 1978, LANCET, V2, P1086; TRUELOVE SC, 1955, BRIT MED J, V2, P1041, DOI 10.1136/bmj.2.4947.1041; Turner D, 2008, GUT, V57, DOI 10.1136/gut.2007.136481; Turner D, 2007, CLIN GASTROENTEROL H, V5, P103, DOI 10.1016/j.cgh.2006.09.033; Turner D, 2011, AM J GASTROENTEROL, V106, P574, DOI 10.1038/ajg.2010.481; Turner D, 2010, GASTROENTEROLOGY, V138, P2282, DOI 10.1053/j.gastro.2010.02.047	17	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2013	346								f563	10.1136/bmj.f563	http://dx.doi.org/10.1136/bmj.f563			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091ZR	23412439				2022-12-28	WOS:000315088800011
J	Loscalzo, J				Loscalzo, Joseph			BASIC IMPLICATIONS OF CLINICAL OBSERVATIONS Venous Thrombosis in the Nephrotic Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GLOMERULAR PERMEABILITY; PATHOPHYSIOLOGY; EXPRESSION		[Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Loscalzo, J (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.		Loscalzo, Joseph/ABD-8980-2021					BRENNER BM, 1978, AM J PHYSIOL, V234, pF455, DOI 10.1152/ajprenal.1978.234.6.F455; COSIO FG, 1985, J LAB CLIN MED, V106, P218; Derow HA, 1939, ARCH INTERN MED, V63, P626, DOI 10.1001/archinte.1939.00180210019002; Dickinson WH, 1885, RENAL URINARY AFFECT, P32; Hamano K, 2002, AM J KIDNEY DIS, V39, P695, DOI 10.1053/ajkd.2002.31986; HUANG F, 1967, NATURE, V216, P87, DOI 10.1038/216087a0; KAUFFMANN R H, 1978, American Journal of Medicine, V65, P607, DOI 10.1016/0002-9343(78)90848-3; KAUFFMANN RH, 1976, AM J MED, V60, P1048, DOI 10.1016/0002-9343(76)90579-9; KENDALL AG, 1971, ARCH INTERN MED, V127, P1021, DOI 10.1001/archinte.127.6.1021; Kerlin BA, 2012, CLIN J AM SOC NEPHRO, V7, P513, DOI 10.2215/CJN.10131011; Rabelink TJ, 1994, KIDNEY INT, V46, P287; Resh M, 2011, THROMB RES, V127, P395, DOI 10.1016/j.thromres.2010.12.020; ROBSON AM, 1974, J CLIN INVEST, V54, P1190, DOI 10.1172/JCI107862; SHATTIL SJ, 1975, J CLIN INVEST, V55, P636, DOI 10.1172/JCI107971; Singhal R, 2006, THROMB RES, V118, P397, DOI 10.1016/j.thromres.2005.03.030; Sraer J D, 1988, Adv Nephrol Necker Hosp, V17, P27; THOMSON C, 1974, Q J MED, V43, P399; VAZIRI ND, 1984, ARCH INTERN MED, V144, P1802, DOI 10.1001/archinte.144.9.1802; VENKATACHALAM MA, 1969, J EXP MED, V130, P381, DOI 10.1084/jem.130.2.381; YASHIRO M, 1994, NEPHROL DIAL TRANSPL, V9, P1842; YOSHIDA N, 1978, BLOOD, V52, P969; Yoshida Y, 2001, NEPHRON, V88, P24, DOI 10.1159/000045954	22	55	61	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2013	368	10					956	958		10.1056/NEJMcibr1209459	http://dx.doi.org/10.1056/NEJMcibr1209459			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100BG	23465106				2022-12-28	WOS:000315669100014
J	Chan, TK				Chan, Tak Kwong			Doctors have a duty to breach patient confidentiality to protect others at risk of HIV infection	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Hong Kong, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Chan, TK (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.	theo@hku.hk						Erin Charles A, 1993, J Appl Philos, V10, P165, DOI 10.1111/j.1468-5930.1993.tb00073.x; General Medical Council, 2009, CONFIDENTIALITY GUID; HM Government, 1988, THE PUBLIC HEALTH IN; Hogben M, 2007, AM J PREV MED, V33, pS89, DOI 10.1016/j.amepre.2007.04.015; Mill JS, 2005, ON LIBERTY 1859; Mulheron R, 2010, MEDICAL NEGLIGENCE: NON-PATIENT AND THIRD PARTY CLAIMS, P1; Przybyla SM, 2012, AIDS CARE; Suzan-Monti M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055225	8	6	6	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2013	346								f1471	10.1136/bmj.f1471	http://dx.doi.org/10.1136/bmj.f1471			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104MS	23468325	Green Submitted			2022-12-28	WOS:000315998300013
J	Coben, JH; Zhu, MT				Coben, Jeffrey H.; Zhu, Motao			Keeping an Eye on Distracted Driving	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CELL PHONE USE; UNITED-STATES		[Coben, Jeffrey H.] W Virginia Univ, Injury Control Res Ctr, Sch Med, Morgantown, WV 26506 USA; [Coben, Jeffrey H.; Zhu, Motao] W Virginia Univ, Injury Control Res Ctr, Sch Publ Hlth, Morgantown, WV 26506 USA	West Virginia University; West Virginia University	Coben, JH (corresponding author), W Virginia Univ, Sch Med, POB 9151, Morgantown, WV 26506 USA.	jcoben@hsc.wvu.edu		zhu, motao/0000-0001-5639-4801	NICHD NIH HHS [R01 HD074594] Funding Source: Medline; NIGMS NIH HHS [U54GM104942, U54 GM104942] Funding Source: Medline; NCIPC CDC HHS [R49 CE002109, R49CE002109, R21CE001820, R21 CE001820] Funding Source: Medline; NCIPC [5R49CE002109-02] Funding Source: Federal RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD074594] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL [R21CE001820, R49CE002109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCIPC CDC HHS; NCIPC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Braitman KA, 2010, TRAFFIC INJ PREV, V11, P543, DOI 10.1080/15389588.2010.504247; Cohen JT, 2003, RISK ANAL, V23, P5, DOI 10.1111/1539-6924.00286; Foss RD, 2009, ACCIDENT ANAL PREV, V41, P419, DOI 10.1016/j.aap.2009.01.004; McCartt AT, 2010, TRAFFIC INJ PREV, V11, P133, DOI 10.1080/15389580903515427; National Highway Traffic Safety Administration, 2010, NAT HIGHW TRAFF SAF; Olson RL, 2009, FMCSARRR09042 US DEP; Wilson FA, 2010, AM J PUBLIC HEALTH, V100, P2213, DOI 10.2105/AJPH.2009.187179	7	21	21	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2013	309	9					877	878		10.1001/jama.2013.491	http://dx.doi.org/10.1001/jama.2013.491			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099PC	23462782	Green Accepted			2022-12-28	WOS:000315632700019
J	Green, BB; Wang, CY; Anderson, ML; Chubak, J; Meenan, RT; Vernon, SW; Fuller, S				Green, Beverly B.; Wang, Ching-Yun; Anderson, Melissa L.; Chubak, Jessica; Meenan, Richard T.; Vernon, Sally W.; Fuller, Sharon			An Automated Intervention With Stepped Increases in Support to Increase Uptake of Colorectal Cancer Screening A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							OCCULT BLOOD-TESTS; PROVIDER-DIRECTED INTERVENTION; PRIMARY-CARE; DECISION AID; COST-EFFECTIVENESS; MULTILEVEL INTERVENTION; TELEPHONE OUTREACH; PATIENT; COLON; RATES	Background: Screening decreases colorectal cancer (CRC) incidence and mortality, yet almost half of age-eligible patients are not screened at recommended intervals. Objective: To determine whether interventions using electronic health records (EHRs), automated mailings, and stepped increases in support improve CRC screening adherence over 2 years. Design: 4-group, parallel-design, randomized, controlled comparative effectiveness trial with concealed allocation and blinded outcome assessments. (ClinicalTrials.gov: NCT00697047) Setting: 21 primary care medical centers. Patients: 4675 adults aged 50 to 73 years not current for CRC screening. Intervention: Usual care, EHR-linked mailings ("automated"), automated plus telephone assistance ("assisted"), or automated and assisted plus nurse navigation to testing completion or refusal ("navigated"). Interventions were repeated in year 2. Measurements: The proportion of participants current for screening in both years, defined as colonoscopy or sigmoidoscopy (year 1) or fecal occult blood testing (FOBT) in year 1 and FOBT, colonoscopy, or sigmoidoscopy (year 2). Results: Compared with those in the usual care group, participants in the intervention groups were more likely to be current for CRC screening for both years with significant increases by intensity (usual care, 26.3% [95% CI, 23.4% to 29.2%]; automated, 50.8% [CI, 47.3% to 54.4%]; assisted, 57.5% [CI, 54.5% to 60.6%]; and navigated, 64.7% [CI, 62.5% to 67.0%]; P < 0.001 for all pairwise comparisons). Increases in screening were primarily due to increased uptake of FOBT being completed in both years (usual care, 3.9% [CI, 2.8% to 5.1%]; automated, 27.5% [CI, 24.9% to 30.0%]; assisted, 30.5% [CI, 27.9% to 33.2%]; and navigated, 35.8% [CI, 33.1% to 38.6%]). Limitation: Participants were required to provide verbal consent and were more likely to be white and to participate in other types of cancer screening, limiting generalizability. Conclusion: Compared with usual care, a centralized, EHR-linked, mailed CRC screening program led to twice as many persons being current for screening over 2 years. Assisted and navigated interventions led to smaller but significant stepped increases compared with the automated intervention only. The rapid growth of EHRs provides opportunities for spreading this model broadly.	Univ Washington, Sch Med, Fred Hutchinson Canc Ctr, Grp Hlth Res Inst,Grp Hlth Phys, Seattle, WA USA; Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA; Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR USA; Univ Texas Houston, Sch Publ Hlth, Houston, TX USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kaiser Permanente; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Green, BB (corresponding author), Grp Hlth Res Inst, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA.	green.b@ghc.org; anderson.melissa@ghc.org			National Cancer Institute of the National Institutes of Health [R01CA121125]; NATIONAL CANCER INSTITUTE [R01CA121125] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant Support: By grant R01CA121125 from the National Cancer Institute of the National Institutes of Health.	Aragones A, 2010, J GEN INTERN MED, V25, P564, DOI 10.1007/s11606-010-1266-4; Baker AN, 2009, QUAL SAF HEALTH CARE, V18, P355, DOI 10.1136/qshc.2008.027649; Baron RC, 2008, AM J PREV MED, V35, pS34, DOI 10.1016/j.amepre.2008.04.002; Baron RC, 2008, AM J PREV MED, V35, pS21, DOI 10.1016/j.amepre.2008.04.004; Basch CE, 2006, AM J PUBLIC HEALTH, V96, P2246, DOI 10.2105/AJPH.2005.067223; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Chao HH, 2009, CLIN COLORECTAL CANC, V8, P22, DOI 10.3816/CCC.2009.n.004; Church TR, 2004, JNCI-J NATL CANCER I, V96, P770, DOI 10.1093/jnci/djh134; Cole SR, 2007, J MED SCREEN, V14, P73, DOI 10.1258/096914107781261927; Coronado GD, 2011, CANCER-AM CANCER SOC, V117, P1745, DOI 10.1002/cncr.25730; Dietrich AJ, 2006, ANN INTERN MED, V144, P563, DOI 10.7326/0003-4819-144-8-200604180-00006; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Ferreira MR, 2005, J CLIN ONCOL, V23, P1548, DOI 10.1200/JCO.2005.07.049; Fiscella K, 2011, J NATL MED ASSOC, V103, P762, DOI 10.1016/S0027-9684(15)30417-X; FREEDMAN JD, 1994, J GEN INTERN MED, V9, P462, DOI 10.1007/BF02599066; Ganz PA, 2005, CANCER, V104, P2072, DOI 10.1002/cncr.21434; Green BB, 2012, AM J PREV MED, V42, P390, DOI 10.1016/j.amepre.2011.11.014; Green BB, 2010, CONTEMP CLIN TRIALS, V31, P589, DOI 10.1016/j.cct.2010.07.012; Hawley ST, 2012, CANCER-AM CANCER SOC, V118, P2726, DOI 10.1002/cncr.26551; Hoffman RM, 2011, AM J MANAG CARE, V17, P49; Hsu C, 2012, J AMBUL CARE MANAG, V35, P99, DOI 10.1097/JAC.0b013e318249e066; Inadomi JM, 2012, ARCH INTERN MED, V172, P575, DOI 10.1001/archinternmed.2012.332; Joseph Djenaba A, 2012, MMWR Suppl, V61, P51; Katz ML, 2012, CANCER EPIDEM BIOMAR, V21, P45, DOI 10.1158/1055-9965.EPI-11-0815; Khankari K, 2007, J GEN INTERN MED, V22, P1410, DOI 10.1007/s11606-007-0295-0; Lairson DR, 2008, CANCER-AM CANCER SOC, V112, P779, DOI 10.1002/cncr.23232; Lane DS, 2008, MED CARE, V46, pS109, DOI 10.1097/MLR.0b013e31817d3fcf; Lasser KE, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-37; Lee JK, 2009, J GEN INTERN MED, V24, P1192, DOI 10.1007/s11606-009-1087-5; Levin TR, 2011, EPIDEMIOL REV, V33, P101, DOI 10.1093/epirev/mxr007; Levy BT, 2012, J AM BOARD FAM MED, V25, P73, DOI 10.3122/jabfm.2012.01.110055; Ling BS, 2009, ARCH INTERN MED, V169, P47, DOI 10.1001/archinternmed.2008.519; Luce BR, 1996, COST EFFECTIVENESS H, P176; Malila N, 2011, WORLD J GASTROENTERO, V18, P18; Miller DP, 2011, AM J PREV MED, V40, P608, DOI 10.1016/j.amepre.2011.02.019; MILLER MF, 1993, AM J MED SCI, V306, P98, DOI 10.1097/00000441-199308000-00006; Misra Swati, 2011, J Prev Med Public Health, V44, P101, DOI 10.3961/jpmph.2011.44.3.101; Mosen DM, 2010, MED CARE, V48, P604, DOI 10.1097/MLR.0b013e3181dbdce7; Ornstein S, 2010, MED CARE, V48, P900, DOI 10.1097/MLR.0b013e3181ec5591; Percac-Lima S, 2009, J GEN INTERN MED, V24, P211, DOI 10.1007/s11606-008-0864-x; Pignone M, 2000, ANN INTERN MED, V133, P761, DOI 10.7326/0003-4819-133-10-200011210-00008; Pignone M, 2011, CANCER-AM CANCER SOC, V117, P3352, DOI 10.1002/cncr.25924; Potter MB, 2011, AM J PREV MED, V41, P9, DOI 10.1016/j.amepre.2011.03.011; Rabeneck L, 2012, CAN J GASTROENTEROL, V26, P131, DOI 10.1155/2012/486328; Roetzheim RG, 2005, ANN FAM MED, V3, P109, DOI 10.1370/afm.240; Ruffin MT, 2007, PREV MED, V45, P267, DOI 10.1016/j.ypmed.2007.07.003; Sabatino SA, 2012, AM J PREV MED, V43, P97, DOI 10.1016/j.amepre.2012.04.009; Sequist TD, 2010, MED CARE, V48, P553, DOI 10.1097/MLR.0b013e3181dbd8eb; Sequist TD, 2009, ARCH INTERN MED, V169, P364, DOI 10.1001/archinternmed.2008.564; Shankaran V, 2009, J CLIN ONCOL, V27, P5370, DOI 10.1200/JCO.2008.20.6458; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Simon SR, 2010, ARCH INTERN MED, V170, P264, DOI 10.1001/archinternmed.2009.522; Smith SK, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5370; Thompson NJ, 2000, PREV MED, V30, P244, DOI 10.1006/pmed.1999.0624; Tu SP, 2006, CANCER-AM CANCER SOC, V107, P959, DOI 10.1002/cncr.22091; van Roan AHC, 2011, PREV MED, V52, P448, DOI 10.1016/j.ypmed.2011.01.032; Vart G, 2012, PREV MED, V55, P87, DOI 10.1016/j.ypmed.2012.05.006; Vernon SW, 2011, ANN BEHAV MED, V41, P284, DOI 10.1007/s12160-010-9258-5; Vogelaar I, 2006, CANCER-AM CANCER SOC, V107, P1624, DOI 10.1002/cncr.22115; Walsh JME, 2010, AM J PREV MED, V39, P1, DOI 10.1016/j.amepre.2010.02.020; Wei EK, 2005, ARCH INTERN MED, V165, P661, DOI 10.1001/archinte.165.6.661; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Wolf MS, 2005, J CLIN ONCOL, V23, P8877, DOI 10.1200/JCO.2005.02.6278; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244	64	144	143	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2013	158	5	1				301	311		10.7326/0003-4819-158-5-201303050-00002	http://dx.doi.org/10.7326/0003-4819-158-5-201303050-00002			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105HP	23460053	Green Accepted			2022-12-28	WOS:000316057700001
J	Ast, T; Cohen, G; Schuldiner, M				Ast, Tslil; Cohen, Galit; Schuldiner, Maya			A Network of Cytosolic Factors Targets SRP-Independent Proteins to the Endoplasmic Reticulum	CELL			English	Article							TAIL-ANCHORED PROTEINS; SIGNAL RECOGNITION PARTICLE; POLYPEPTIDE TRANSLOCATION; MEMBRANE INSERTION; MAMMALIAN-CELLS; ER MEMBRANE; IN-VIVO; YEAST; PATHWAY; TRANSPORT	Translocation into the endoplasmic reticulum (ER) is an initial and crucial biogenesis step for all secreted and endomembrane proteins in eukaryotes. ER insertion can take place through the well-characterized signal recognition particle (SRP)-dependent pathway or the less-studied route of SRP-independent translocation. To better understand the prevalence of the SRP-independent pathway, we systematically defined the translocational dependence of the yeast secretome. By combining hydropathy-based analysis and microscopy, we uncovered that a previously unappreciated fraction of the yeast secretome translocates without the aid of the SRP. Furthermore, we validated a family of SRP-independent substrates-the glycosylphosphatidylinositol (GPI)-anchored proteins. Studying this family, we identified a determinant for ER targeting and uncovered a network of cytosolic proteins that facilitate SRP-independent targeting and translocation. These findings highlight the underappreciated complexity of SRP-independent translocation, which enables this pathway to efficiently cope with its extensive substrate flux.	[Ast, Tslil; Cohen, Galit; Schuldiner, Maya] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Schuldiner, M (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	maya.schuldiner@weizmann.ac.il	Schuldiner, Maya/C-9488-2009	Ast, Tslil/0000-0002-6927-6238; Schuldiner, Maya/0000-0001-9947-115X	Israeli Science Foundation (ISF); Miel du Botton Aynsley fund; ERC-StG [260395]; Adam's Fellowship Program	Israeli Science Foundation (ISF)(Israel Science Foundation); Miel du Botton Aynsley fund; ERC-StG; Adam's Fellowship Program	We are extremely grateful to Shifra Ben-Dor, Silvia Gabriela Chuartzman, and Michal Breker for technical assistance. We would like to thank Howard Riezman and Vladimir Denic for their aid and expertise. We are grateful to Yves Bourbonnais, Morihisa Fujita, Marco A. M. Prado, Tommer Ravid, Randy Schekman, Blanche Schwappach, and Peter Walter for providing us with antibodies, plasmids, and yeast strains. We wish to thank Eitan Bibi and Shulamit Michaeli for helpful discussions and Oren Schuldiner, Yifat Cohen, Shachar Dagan, and Idan Frumkin for critical reading of the manuscript. The microscopic system was purchased through the support of the Israeli Science Foundation (ISF) Legacy Heritage fund and the generous donation of the J&R foundation and the Estate of Lela London. This study was supported by a grant from the Miel du Botton Aynsley fund as well as an ERC-StG-2010 260395. Tslil Ast is supported by the Adam's Fellowship Program.	Becker J, 1996, MOL CELL BIOL, V16, P4378; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Brachmann CB, 1998, YEAST, V14, P115; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; CAPLAN AJ, 1992, CELL, V71, P1143, DOI 10.1016/S0092-8674(05)80063-7; Castillon GA, 2009, TRAFFIC, V10, P186, DOI 10.1111/j.1600-0854.2008.00857.x; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; del Alamo M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001100; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Favaloro V, 2010, J CELL SCI, V123, P1522, DOI 10.1242/jcs.055970; FELDHEIM D, 1994, J CELL BIOL, V126, P935, DOI 10.1083/jcb.126.4.935; Flom GA, 2008, MOL BIOL CELL, V19, P5249, DOI 10.1091/mbc.E08-04-0435; Fujita M, 2006, MOL BIOL CELL, V17, P834, DOI 10.1091/mbc.E05-05-0443; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Goldshmidt H, 2008, J BIOL CHEM, V283, P32085, DOI 10.1074/jbc.M801499200; Hatsuzawa K, 1997, J BIOCHEM-TOKYO, V121, P270; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Hines JK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001309; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber D, 2005, J BACTERIOL, V187, P2983, DOI 10.1128/JB.187.9.2983-2991.2005; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; Johnson N, 2012, J CELL SCI, V125, P3612, DOI 10.1242/jcs.102608; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; Lakkaraju AKK, 2012, MOL BIOL CELL, V23, P2712, DOI 10.1091/mbc.E12-03-0228; Lang S, 2012, J CELL SCI, V125, P1958, DOI 10.1242/jcs.096727; Lee HC, 2001, P NATL ACAD SCI USA, V98, P3471, DOI 10.1073/pnas.051484198; MULLER G, 1987, EMBO J, V6, P2099, DOI 10.1002/j.1460-2075.1987.tb02476.x; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Palazzo AF, 2007, PLOS BIOL, V5, P2862, DOI 10.1371/journal.pbio.0050322; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Perrett S, 2008, CURR OPIN STRUC BIOL, V18, P52, DOI 10.1016/j.sbi.2007.12.005; Plath K, 2000, J CELL BIOL, V151, P167, DOI 10.1083/jcb.151.1.167; Prilusky J, 2009, P NATL ACAD SCI USA, V106, P6662, DOI 10.1073/pnas.0902029106; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Sahi C, 2007, P NATL ACAD SCI USA, V104, P7163, DOI 10.1073/pnas.0702357104; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Shi YF, 2011, MOL BIOL CELL, V22, P4093, DOI 10.1091/mbc.E11-05-0440; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Webb TR, 2008, J CELL SCI, V121, P3140, DOI 10.1242/jcs.035550; Yan W, 1998, J MOL BIOL, V275, P25, DOI 10.1006/jmbi.1997.1447	52	116	118	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 28	2013	152	5					1134	1145		10.1016/j.cell.2013.02.003	http://dx.doi.org/10.1016/j.cell.2013.02.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452858	Bronze			2022-12-28	WOS:000315710300019
J	Day, N				Day, Nicholas			The researcher of the future ... takes advantage of international opportunities	LANCET			English	Editorial Material									[Day, Nicholas] Univ Oxford, Ctr Trop Med, Oxford, England; [Day, Nicholas] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Bangkok 10700, Thailand	University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University	Day, N (corresponding author), Univ Oxford, Ctr Trop Med, Oxford, England.	nickd@tropmedres.ac			Wellcome Trust [089275] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2013	381			1			8	9						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	300DY	23452938	Bronze			2022-12-28	WOS:000330445800006
J	Spence, D				Spence, Des			FROM THE FRONTLINE Bad medicine: antenatal screening	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Dani C, 2009, J PERINAT MED, V37, P599, DOI 10.1515/JPM.2009.117; Department of Health, 2011, AB STAT ENGL WAL 201; Kucik JE, 2013, PEDIATRICS, V131, pE27, DOI 10.1542/peds.2012-1616; RCOG, 2010, TERM PREGN FET ABN E; Wilson JMG, 1968, PRINCIPLES PRACTICE	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2013	346								f1226	10.1136/bmj.f1226	http://dx.doi.org/10.1136/bmj.f1226			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100BJ	23444415				2022-12-28	WOS:000315669400013
J	Jones, CM; Mack, KA; Paulozzi, LJ				Jones, Christopher M.; Mack, Karin A.; Paulozzi, Leonard J.			Pharmaceutical Overdose Deaths, United States, 2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Jones, Christopher M.; Mack, Karin A.; Paulozzi, Leonard J.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Jones, CM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30329 USA.	fjr0@cdc.gov	Mack, Karin A/A-3263-2012; MACK, KARIN/P-9227-2019	Mack, Karin A/0000-0001-9274-3001; 				Becker WC, 2008, DRUG ALCOHOL DEPEN, V94, P38, DOI 10.1016/j.drugalcdep.2007.09.018; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Centers for Disease Control and Prevention. National Vital Statistics System, 2010, NAT VIT STAT SYST 20; Edlund MJ, 2010, J PAIN SYMPTOM MANAG, V40, P279, DOI 10.1016/j.jpainsymman.2010.01.012; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Wysowski DK, 2007, DRUG SAFETY, V30, P533, DOI 10.2165/00002018-200730060-00007	6	506	513	0	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2013	309	7					657	659		10.1001/jama.2013.272	http://dx.doi.org/10.1001/jama.2013.272			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091EK	23423407	Bronze			2022-12-28	WOS:000315032000016
J	Masoodi, N				Masoodi, Nasseer			Review: Cholinesterase inhibitors do not reduce progression to dementia from mild cognitive impairment	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Florida State Univ, Coll Med, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Masoodi, N (corresponding author), Florida State Univ, Coll Med, Tallahassee, FL 32306 USA.		Morling, Jo/AAH-7385-2020	Morling, Jo/0000-0003-0772-2893				Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub2, 10.1002/14651858.CD001190.pub3]	1	3	3	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2013	158	4							JC2-3	10.7326/0003-4819-158-4-201302190-02003	http://dx.doi.org/10.7326/0003-4819-158-4-201302190-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098WR	23420252				2022-12-28	WOS:000315580300002
J	Humayun, M				Humayun, Munir			A Unique Piece of Mars	SCIENCE			English	Editorial Material							ATMOSPHERE; METEORITES		[Humayun, Munir] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32310 USA; [Humayun, Munir] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Humayun, M (corresponding author), Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32310 USA.	humayun@magnet.fsu.edu	Humayun, Munir/A-1247-2007	Humayun, Munir/0000-0001-8516-9435				Agee CB, 2013, SCIENCE, V339, P780, DOI 10.1126/science.1228858; Clayton RN, 1996, GEOCHIM COSMOCHIM AC, V60, P1999, DOI 10.1016/0016-7037(96)00074-9; Farquhar J, 1998, SCIENCE, V280, P1580, DOI 10.1126/science.280.5369.1580; KARLSSON KR, 1992, SCIENCE, V255, P1409, DOI 10.1126/science.11537889; Lapen TJ, 2010, SCIENCE, V328, P347, DOI 10.1126/science.1185395; Leshin LA, 2006, ELEMENTS, V2, P157, DOI 10.2113/gselements.2.3.157; McSween HY, 2009, SCIENCE, V324, P736, DOI 10.1126/science.1165871; McSween HY, 2002, METEORIT PLANET SCI, V37, P7, DOI 10.1111/j.1945-5100.2002.tb00793.x; NIER AO, 1976, SCIENCE, V194, P1298, DOI 10.1126/science.194.4271.1298; Treiman AH, 2000, PLANET SPACE SCI, V48, P1213, DOI 10.1016/S0032-0633(00)00105-7	10	3	3	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2013	339	6121					771	772		10.1126/science.1232490	http://dx.doi.org/10.1126/science.1232490			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23413347				2022-12-28	WOS:000314874400036
J	Kamerow, D				Kamerow, Douglas			Reassessing hospital readmission penalties	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							30-DAY READMISSIONS		RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Joynt KE, 2012, NEW ENGL J MED, V366, P1366, DOI 10.1056/NEJMp1201598; Rau J, 2012, KAISER HLTH NEW 1126; Williams MV, 2013, JAMA-J AM MED ASSOC, V309, P394, DOI 10.1001/jama.2012.233964	5	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2013	346								f1043	10.1136/bmj.f1043	http://dx.doi.org/10.1136/bmj.f1043			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	091ZR	23412742				2022-12-28	WOS:000315088800006
J	Lindenauer, PK; Lagu, T; Rothberg, MB; Avrunin, J; Pekow, PS; Wang, YF; Hines, HMKHJ				Lindenauer, Peter K.; Lagu, Tara; Rothberg, Michael B.; Avrunin, Jill; Pekow, Penelope S.; Wang, Yongfei; Hines, Harlan M. Krumholz Harold J., Jr.			Income inequality and 30 day outcomes after acute myocardial infarction, heart failure, and pneumonia: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PROFILING HOSPITAL PERFORMANCE; CAUSE READMISSION RATES; 30-DAY MORTALITY-RATES; HEALTH; RISK; CARE	Objectives To examine the association between income inequality and the risk of mortality and readmission within 30 days of hospitalization. Design Retrospective cohort study of Medicare beneficiaries in the United States. Hierarchical, logistic regression models were developed to estimate the association between income inequality (measured at the US state level) and a patient's risk of mortality and readmission, while sequentially controlling for patient, hospital, other state, and patient socioeconomic characteristics. We considered a 0.05 unit increase in the Gini coefficient as a measure of income inequality. Setting US acute care hospitals. Participants Patients aged 65 years and older, and hospitalized in 2006-08 with a principal diagnosis of acute myocardial infarction, heart failure, or pneumonia. Main outcome measures Risk of death within 30 days of admission or rehospitalization for any cause within 30 days of discharge. The potential number of excess deaths and readmissions associated with higher levels of inequality in US states in the three highest quarters of income inequality were compared with corresponding data in US states in the lowest quarter. Results Mortality analyses included 555 962 admissions (4348 hospitals) for acute myocardial infarction, 1 092 285 (4484) for heart failure, and 1 146 414 (4520); readmission analyses included 553 037 (4262), 1 345 909 (4494), and 1 345 909 (4524) admissions, respectively. In 2006-08, income inequality in US states (as measured by the average Gini coefficient over three years) varied from 0.41 in Utah to 0.50 in New York. Multilevel models showed no significant association between income inequality and mortality within 30 days of admission for patients with acute myocardial infarction, heart failure, or pneumonia. By contrast, income inequality was associated with rehospitalization (acute myocardial infarction, risk ratio 1.09 (95% confidence interval 1.03 to 1.15), heart failure 1.07 (1.01 to 1.12), pneumonia 1.09 (1.03 to 1.15)). Further adjustment for individual income and educational achievement did not significantly attenuate these findings. Over the three year period, we estimate an excess of 7153 (2297 to 11 733) readmissions for acute myocardial infarction, 17 991 (3410 to 31 772) for heart failure, and 14 127 (4617 to 23 115) for pneumonia, that are associated with inequality levels in US states in the three highest quarters of income inequality, compared with US states in the lowest quarter. Conclusions Among patients hospitalized with acute myocardial infarction, heart failure, and pneumonia, exposure to higher levels of income inequality was associated with increased risk of readmission but not mortality. In view of the observational design of the study, these findings could be biased, owing to residual confounding.	[Lindenauer, Peter K.; Lagu, Tara; Rothberg, Michael B.; Avrunin, Jill; Pekow, Penelope S.] Baystate Med Ctr, Ctr Qual Care Res, Springfield, MA 01199 USA; [Lindenauer, Peter K.; Lagu, Tara; Rothberg, Michael B.] Baystate Med Ctr, Div Gen Internal Med, Springfield, MA 01199 USA; [Lindenauer, Peter K.; Lagu, Tara; Rothberg, Michael B.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Pekow, Penelope S.] Univ Massachusetts, Div Biostat & Epidemiol, Dept Publ Hlth, Amherst, MA 01003 USA; [Wang, Yongfei; Hines, Harlan M. Krumholz Harold J., Jr.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Wang, Yongfei; Hines, Harlan M. Krumholz Harold J., Jr.] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT USA; [Wang, Yongfei; Hines, Harlan M. Krumholz Harold J., Jr.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, Dept Med, New Haven, CT USA; [Wang, Yongfei; Hines, Harlan M. Krumholz Harold J., Jr.] Yale Univ, Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT USA	Baystate Medical Center; Baystate Medical Center; Tufts University; Massachusetts Department of Public Health; University of Massachusetts System; University of Massachusetts Amherst; Yale University; Yale University; Yale University; Yale University	Lindenauer, PK (corresponding author), Baystate Med Ctr, Ctr Qual Care Res, Springfield, MA 01199 USA.	peter.lindenauer@bhs.org	Lagu, Tara/GPT-5173-2022	Lagu, Tara/0000-0001-6155-5796	(Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute [U01 HL105270-02]; National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	(Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	HMK is supported by grant U01 HL105270-02 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: support from the National Heart, Lung, and Blood Institute for the submitted work; PKL, TCL, MBR, JSA, and PSP have no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; HMK is the recipient of a research grant from Medtronic, through Yale University and is chair of a cardiac scientific advisory board for UnitedHealth; PKL, TCL, MBR, JA, PSP, and YW have no other relationships or activities that could appear to have influenced the submitted work.	American Hospital Association, 2012, ANN SURV HOSP DAT; Bernheim SM, 2010, CIRC-CARDIOVASC QUAL, V3, P459, DOI 10.1161/CIRCOUTCOMES.110.957613; Bernstein J., 2008, PULLING APART STATE; Bishaw A, 2008, AM COMMUNITY SURVEY; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Epstein AM, 2011, NEW ENGL J MED, V365, P2287, DOI 10.1056/NEJMsa1101942; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kaiser Family Foundation, 2012, KAIS STAT HLTH FACTS; Kaplan GA, 1996, BRIT MED J, V312, P999; Kawachi I, 1999, AM J PUBLIC HEALTH, V89, P1187, DOI 10.2105/AJPH.89.8.1187; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Kawachi I., 2006, HLTH NATIONS WHY INE; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Kennedy BP, 1996, BRIT MED J, V312, P1004, DOI 10.1136/bmj.312.7037.1004; Kondo N, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4471; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P243, DOI 10.1161/CIRCOUTCOMES.110.957498; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Lindenauer PK, 2011, J HOSP MED, V6, P142, DOI 10.1002/jhm.890; Lindenauer Peter K, 2010, J Hosp Med, V5, pE12, DOI 10.1002/jhm.822; Mellor JM, 2003, HEALTH SERV RES, V38, P137, DOI 10.1111/1475-6773.00109; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Pickett KE, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4320; Pope GC., 2000, DIAGNOSTIC COST GROU; Smith GD, 1996, BRIT MED J, V312, P987; Subramanian SV, 2006, INT J SOC WELF, V15, pS13, DOI 10.1111/j.1468-2397.2006.00440.x; Subramanian SV, 2004, EPIDEMIOL REV, V26, P78, DOI 10.1093/epirev/mxh003; U.S. Census Bureau, 2021, AM COMMUNITY SURVEY; *US CENS BUR, 2008, AM COMM SURV; US Census Bureau, ANN SOCIAL EC S; US Census Bureau, 2011, ANN SOCIAL EC S; Wilkinson R, 2005, IMPACT INEQUALITY MA; Wilkinson R., 1996, UNHEALTHY SOC AFFLIC; WILKINSON RG, 1992, BRIT MED J, V304, P165, DOI 10.1136/bmj.304.6820.165; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	36	89	92	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2013	346								f521	10.1136/bmj.f521	http://dx.doi.org/10.1136/bmj.f521			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	091ZR	23412830	Green Published, hybrid			2022-12-28	WOS:000315088800010
J	Roshanov, PS; Fernandes, N; Wilczynski, JM; Hemens, BJ; You, JJ; Handler, SM; Nieuwlaat, R; Souza, NM; Beyene, J; Van Spall, HGC; Garg, AX; Haynes, RB				Roshanov, Pavel S.; Fernandes, Natasha; Wilczynski, Jeff M.; Hemens, Brian J.; You, John J.; Handler, Steven M.; Nieuwlaat, Robby; Souza, Nathan M.; Beyene, Joseph; Van Spall, Harriette G. C.; Garg, Amit X.; Haynes, R. Brian			Features of effective computerised clinical decision support systems: meta-regression of 162 randomised trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; PRACTITIONER PERFORMANCE; PATIENT OUTCOMES; PREVENTIVE CARE; DIABETES CARE; SAFETY ALERTS; MANAGEMENT; EVENTS; IMPLEMENTATION; GUIDELINES	Objectives To identify factors that differentiate between effective and ineffective computerised clinical decision support systems in terms of improvements in the process of care or in patient outcomes. Design Meta-regression analysis of randomised controlled trials. Data sources A database of features and effects of these support systems derived from 162 randomised controlled trials identified in a recent systematic review. Trialists were contacted to confirm the accuracy of data and to help prioritise features for testing. Main outcome measures "Effective" systems were defined as those systems that improved primary (or 50% of secondary) reported outcomes of process of care or patient health. Simple and multiple logistic regression models were used to test characteristics for association with system effectiveness with several sensitivity analyses. Results Systems that presented advice in electronic charting or order entry system interfaces were less likely to be effective (odds ratio 0.37, 95% confidence interval 0.17 to 0.80). Systems more likely to succeed provided advice for patients in addition to practitioners (2.77, 1.07 to 7.17), required practitioners to supply a reason for over-riding advice (11.23, 1.98 to 63.72), or were evaluated by their developers (4.35, 1.66 to 11.44). These findings were robust across different statistical methods, in internal validation, and after adjustment for other potentially important factors. Conclusions We identified several factors that could partially explain why some systems succeed and others fail. Presenting decision support within electronic charting or order entry systems are associated with failure compared with other ways of delivering advice. Odds of success were greater for systems that required practitioners to provide reasons when over-riding advice than for systems that did not. Odds of success were also better for systems that provided advice concurrently to patients and practitioners. Finally, most systems were evaluated by their own developers and such evaluations were more likely to show benefit than those conducted by a third party.	[Roshanov, Pavel S.] Univ Western Ontario, Schulich Sch Med & Dent, London, ON N6A 3K7, Canada; [Fernandes, Natasha] Univ Ottawa, Fac Med, Ottawa, ON K1H 8M5, Canada; [Wilczynski, Jeff M.] McMaster Univ, Dept Hlth Aging & Soc, Hamilton, ON L8S 4K1, Canada; [Hemens, Brian J.; You, John J.; Nieuwlaat, Robby; Souza, Nathan M.; Beyene, Joseph; Garg, Amit X.; Haynes, R. Brian] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4K1, Canada; [Handler, Steven M.; Nieuwlaat, Robby; Beyene, Joseph] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA USA; [You, John J.; Van Spall, Harriette G. C.] Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; [You, John J.; Garg, Amit X.; Haynes, R. Brian] McMaster Univ, Dept Med, Hamilton, ON L8S 4K1, Canada; [Garg, Amit X.] Univ Western Ontario, Dept Med, London, ON N6A 3K7, Canada; [Garg, Amit X.] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON N6A 3K7, Canada; [Haynes, R. Brian] McMaster Univ, Hlth Informat Res Unit, Hamilton, ON L8S 4K1, Canada	Western University (University of Western Ontario); University of Ottawa; McMaster University; McMaster University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Population Health Research Institute; McMaster University; Western University (University of Western Ontario); Western University (University of Western Ontario); McMaster University	Haynes, RB (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, 1280 Main St W,CRL 133, Hamilton, ON L8S 4K1, Canada.	bhaynes@mcmaster.ca	Garg, Amit X/G-3295-2011	Handler, Steven/0000-0002-3940-3224; Roshanov, Pavel/0000-0003-3908-1955; Van Spall, Harriette Gillian Christine/0000-0002-8370-4569	Canadian Institutes of Health Research Synthesis Grant: Knowledge Translation [KRS 91791]	Canadian Institutes of Health Research Synthesis Grant: Knowledge Translation(Canadian Institutes of Health Research (CIHR))	This study was funded by a Canadian Institutes of Health Research Synthesis Grant: Knowledge Translation KRS 91791.	[Anonymous], 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; Ash JS, 2012, J AM MED INFORM ASSN, V19, P980, DOI 10.1136/amiajnl-2011-000705; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Balas EA, 2000, ARCH INTERN MED, V160, P301, DOI 10.1001/archinte.160.3.301; Beyene J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-64; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Cavalcanti AB, 2009, J CRIT CARE, V24, P371, DOI 10.1016/j.jcrc.2009.05.005; Courvoisier DS, 2011, J CLIN EPIDEMIOL, V64, P993, DOI 10.1016/j.jclinepi.2010.11.012; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.1093/biomet/80.1.27; Flottorp S, 2003, FAM PRACT, V20, P333, DOI 10.1093/fampra/cmg316; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Haynes RB, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-12; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Hemens BJ, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-89; Holbrook Anne, 2005, AMIA Annu Symp Proc, P982; Holbrook A, 2009, CAN MED ASSOC J, V181, P37, DOI 10.1503/cmaj.081272; Hsiao C, 2012, NCHS DATA BRIEF, P111; Isaac T, 2009, ARCH INTERN MED, V169, P305, DOI 10.1001/archinternmed.2008.551; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Kenealy T, 2005, J GEN INTERN MED, V20, P916, DOI 10.1111/j.1525-1497.2005.0197.x; Kesselheim AS, 2011, HEALTH AFFAIR, V30, P2310, DOI 10.1377/hlthaff.2010.1111; Kohn KT, 2000, ERR IS HUMAN BUILDIN; Lee NJ, 2009, ADV NURS SCI, V32, P211, DOI 10.1097/ANS.0b013e3181b0d6bf; Lester WT, 2006, J GEN INTERN MED, V21, P22, DOI 10.1111/j.1525-1497.2005.00268.x; Lester WT, 2004, STUD HEALTH TECHNOL, V107, P232; Liu JLY, 2011, J AM MED INFORM ASSN, V18, P173, DOI 10.1136/jamia.2010.010306; Maiti T, 2008, STAT METHODS MED RES, V17, P621, DOI 10.1177/0962280207084156; Mamlin BW, 2007, CLIN DECISION SUPPOR, P190; MCDONALD CJ, 1976, ANN INTERN MED, V84, P162, DOI 10.7326/0003-4819-84-2-162; MCDONALD CJ, 1986, WESTERN J MED, V145, P823; McKibbon KA, 2012, J AM MED INFORM ASSN, V19, P22, DOI 10.1136/amiajnl-2011-000304; Mollon B, 2009, BMC MED INFORM DECIS, V9, DOI [10.1186/1472-6947-9-1, 10.1186/1472-6947-9-11]; Negassa A, 2007, CONTEMP CLIN TRIALS, V28, P242, DOI 10.1016/j.cct.2006.08.007; Nieuwlaat R, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-90; Osheroff JA, 2007, J AM MED INFORM ASSN, V14, P141, DOI 10.1197/jamia.M2334; Overhage JM, 1997, J AM MED INFORM ASSN, V4, P364, DOI 10.1136/jamia.1997.0040364; Pare G, 2008, METHOD INFORM MED, V47, P251, DOI 10.3414/ME0512; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Peterson KA, 2008, DIABETES CARE, V31, P2238, DOI 10.2337/dc08-2034; Phansalkar S, 2010, J AM MED INFORM ASSN, V17, P493, DOI 10.1136/jamia.2010.005264; Quinn CC, 2008, DIABETES TECHNOL THE, V10, P160, DOI 10.1089/dia.2008.0283; Roshanov PS, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-88; Roshanov PS, 2011, IMPLEMENT SCI, V6, DOI [10.1186/1748-5908-6-92, 10.1186/1748-5908-6-88]; Sahota N, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-91; Scott GPT, 2011, J AM MED INFORM ASSN, V18, P789, DOI 10.1136/amiajnl-2011-000199; Shiffman RN, 1999, J AM MED INFORM ASSN, V6, P99, DOI 10.1136/jamia.1999.0060099; Shojania KG, 2010, CAN MED ASSOC J, V182, pE216, DOI 10.1503/cmaj.090578; Sim I, 2001, J AM MED INFORM ASSN, V8, P527, DOI 10.1136/jamia.2001.0080527; Solberg L I, 2000, Jt Comm J Qual Improv, V26, P171; Souza NM, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-87; StataCorp, 2009, STAT STAT SOFTW REL; STEAD WW, 1994, J AM MED INFORM ASSN, V1, P28, DOI 10.1136/jamia.1994.95236134; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2011, J CLIN EPIDEMIOL, V64, P1464, DOI 10.1016/j.jclinepi.2011.06.016; Strom BL, 2010, ARCH INTERN MED, V170, P1578, DOI 10.1001/archinternmed.2010.324; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Tierney WM, 2005, HEALTH SERV RES, V40, P477, DOI 10.1111/j.1475-6773.2005.0t369.x; TIERNEY WM, 1988, JAMA-J AM MED ASSOC, V259, P1194, DOI 10.1001/jama.259.8.1194; TIERNEY WM, 1990, NEW ENGL J MED, V322, P1499, DOI 10.1056/NEJM199005243222105; TIERNEY WM, 1993, JAMA-J AM MED ASSOC, V269, P379, DOI 10.1001/jama.269.3.379; TIERNEY WM, 1994, J AM MED INFORM ASSN, V1, P353, DOI 10.1136/jamia.1994.95236170; Tierney WM, 2003, J GEN INTERN MED, V18, P967, DOI 10.1111/j.1525-1497.2003.30635.x; Trivedi MH, 2002, METHOD INFORM MED, V41, P435, DOI 10.1055/s-0038-1634216; Van der Sijs H, 2006, J AM MED INFORM ASSN, V13, P138, DOI 10.1197/jamia.M1809; Weingart SN, 2003, ARCH INTERN MED, V163, P2625, DOI 10.1001/archinte.163.21.2625; Wetter T, 2002, ARTIF INTELL MED, V24, P195, DOI 10.1016/S0933-3657(01)00103-8; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wright A, 2008, INT J MED INFORM, V77, P641, DOI 10.1016/j.ijmedinf.2008.01.004	68	218	221	0	52	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2013	346								f657	10.1136/bmj.f657	http://dx.doi.org/10.1136/bmj.f657			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	091ZR	23412440	Green Published, hybrid			2022-12-28	WOS:000315088800012
J	Pietrzynski, G; Graczyk, D; Gieren, W; Thompson, IB; Pilecki, B; Udalski, A; Soszynski, I; Kozlowski, S; Konorski, P; Suchomska, K; Bono, G; Moroni, PGP; Villanova, S; Nardetto, N; Bresolin, F; Kudritzki, RP; Storm, J; Gallenne, A; Smolec, R; Minniti, D; Kubiak, M; Szymanski, MK; Poleski, R; Wyrzykowski, L; Ulaczyk, K; Pietrukowicz, P; Gorski, M; Karczmarek, P				Pietrzynski, G.; Graczyk, D.; Gieren, W.; Thompson, I. B.; Pilecki, B.; Udalski, A.; Soszynski, I.; Kozlowski, S.; Konorski, P.; Suchomska, K.; Bono, G.; Moroni, P. G. Prada; Villanova, S.; Nardetto, N.; Bresolin, F.; Kudritzki, R. P.; Storm, J.; Gallenne, A.; Smolec, R.; Minniti, D.; Kubiak, M.; Szymanski, M. K.; Poleski, R.; Wyrzykowski, L.; Ulaczyk, K.; Pietrukowicz, P.; Gorski, M.; Karczmarek, P.			An eclipsing-binary distance to the Large Magellanic Cloud accurate to two per cent	NATURE			English	Article							HUBBLE-SPACE-TELESCOPE; CONSTANT; PARALLAXES; CALIBRATION; PROJECT; CURVES; STARS; LIGHT	In the era of precision cosmology, it is essential to determine the Hubble constant to an accuracy of three per cent or better(1,2). At present, its uncertainty is dominated by the uncertainty in the distance to the Large Magellanic Cloud (LMC), which, being our second-closest galaxy, serves as the best anchor point for the cosmic distance scale(2,3). Observations of eclipsing binaries offer a unique opportunity to measure stellar parameters and distances precisely and accurately(4,5). The eclipsing-binary method was previously applied to the LMC6,7, but the accuracy of the distance results was lessened by the need to model the bright, early-type systems used in those studies. Here we report determinations of the distances to eight long-period, late-type eclipsing systems in the LMC, composed of cool, giant stars. For these systems, we can accurately measure both the linear and the angular sizes of their components and avoid the most important problems related to the hot, early-type systems. The LMC distance that we derive from these systems (49.97 +/- 0.19 (statistical) +/- 1:11 (systematic) kiloparsecs) is accurate to 2.2 per cent and provides a firm base for a 3-per-cent determination of the Hubble constant, with prospects for improvement to 2 per cent in the future.	[Pietrzynski, G.; Graczyk, D.; Gieren, W.; Pilecki, B.; Villanova, S.; Gallenne, A.] Univ Concepcion, Dept Astron, Concepcion, Chile; [Pietrzynski, G.; Pilecki, B.; Udalski, A.; Soszynski, I.; Kozlowski, S.; Konorski, P.; Suchomska, K.; Kubiak, M.; Szymanski, M. K.; Poleski, R.; Wyrzykowski, L.; Ulaczyk, K.; Pietrukowicz, P.; Gorski, M.; Karczmarek, P.] Univ Warsaw Observ, PL-00478 Warsaw, Poland; [Thompson, I. B.] Carnegie Observ, Pasadena, CA 91101 USA; [Bono, G.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Bono, G.] INAF Osservatorio Astron Roma, I-00040 Monte Porzio Catone, Italy; [Moroni, P. G. Prada] Univ Pisa, Dipartimento Fis, I-56127 Pisa, Italy; [Moroni, P. G. Prada] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Nardetto, N.] UNS CNRS OCA, UMR7293, Lab Lagrange, F-06300 Nice, France; [Bresolin, F.; Kudritzki, R. P.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Storm, J.] Leibniz Inst Astrophys, D-14482 Potsdam, Germany; [Smolec, R.] Nicolaus Copernicus Astron Ctr, PL-00716 Warsaw, Poland; [Minniti, D.] Pontificia Univ Catolica Chile, Dept Astron & Astrofis, Santiago 22, Chile; [Minniti, D.] Vatican Observ, I-00120 Vatican City, Vatican; [Poleski, R.] Ohio State Univ, Columbus, OH 43210 USA	Universidad de Concepcion; University of Warsaw; Warsaw University Observatory; Carnegie Institution for Science; University of Rome Tor Vergata; Istituto Nazionale Astrofisica (INAF); University of Pisa; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; University of Hawaii System; Leibniz Institut fur Astrophysik Potsdam (AIP); Polish Academy of Sciences; Nicolaus Copernicus Astronomical Center of the Polish Academy of Sciences; Pontificia Universidad Catolica de Chile; Vatican Observatory; University System of Ohio; Ohio State University	Pietrzynski, G (corresponding author), Univ Concepcion, Dept Astron, Casilla 160-C, Concepcion, Chile.	pietrzyn@astrouw.edu.pl	Karczmarek, Paulina/B-5696-2015; Poleski, Radoslaw/AAM-7565-2021; Storm, Jesper/AAM-7106-2021; Nardetto, Nicolas/GSE-2085-2022; Kozlowski, Szymon/G-4799-2013; Smolec, Radoslaw/F-1435-2013; Szymański, Michał K/H-6951-2018; Minniti, Dante/AAD-7251-2021; Szymański, Michał Krzysztof/X-5627-2019	Poleski, Radoslaw/0000-0002-9245-6368; Storm, Jesper/0000-0002-8627-6096; Kozlowski, Szymon/0000-0003-4084-880X; Smolec, Radoslaw/0000-0001-7217-4884; Szymański, Michał K/0000-0002-0548-8995; Szymański, Michał Krzysztof/0000-0002-0548-8995; Minniti, Dante/0000-0002-7064-099X; Udalski, Andrzej/0000-0001-5207-5619; Ulaczyk, Krzysztof/0000-0001-6364-408X; Karczmarek, Paulina/0000-0002-0136-0046; Pietrzynski, Grzegorz/0000-0002-9443-4138; Bresolin, Fabio/0000-0002-5068-9833; Gorski, Marek/0000-0002-3125-9088; Gallenne, Alexandre/0000-0001-7853-4094; Pietrukowicz, Pawel/0000-0002-2339-5899; Wyrzykowski, Lukasz/0000-0002-9658-6151; Soszynski, Igor/0000-0002-7777-0842; Pilecki, Bogumil/0000-0003-3861-8124	BASAL Centro de Astrofisica y Tecnologias Afines (CATA); Polish Ministry of Science; Polish National Science Centre; GEMINI-CONICYT fund; European Research Council; Foundation for Polish Science (FOCUS, TEAM)	BASAL Centro de Astrofisica y Tecnologias Afines (CATA)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Polish Ministry of Science(Ministry of Science and Higher Education, Poland); Polish National Science Centre; GEMINI-CONICYT fund; European Research Council(European Research Council (ERC)European Commission); Foundation for Polish Science (FOCUS, TEAM)(Foundation for Polish Science)	We acknowledge financial support for this work from the BASAL Centro de Astrofisica y Tecnologias Afines (CATA), the Polish Ministry of Science, the Foundation for Polish Science (FOCUS, TEAM), the Polish National Science Centre and the GEMINI-CONICYT fund. The OGLE project has received funding from the European Research Council 'Advanced Grant' Program. We thank the staff astronomers at Las Campanas and ESO La Silla, who provided expert support in data acquisition. We thank J. F. Gonzalez for making the IRAF scripts rvbina and spbina available to us. We also thank O. Szewczyk and Z. Kolaczkowski for their help with some of the observations.	Benedict GF, 2007, ASTRON J, V133, P1810, DOI 10.1086/511980; Bonanos AZ, 2011, ASTROPHYS J LETT, V729, DOI 10.1088/2041-8205/729/1/L9; Di Benedetto GP, 2005, MON NOT R ASTRON SOC, V357, P174, DOI 10.1111/j.1365-2966.2005.08632.x; Fitzpatrick EL, 2003, ASTROPHYS J, V587, P685, DOI 10.1086/368309; Freedman WL, 2010, ANNU REV ASTRON ASTR, V48, P673, DOI 10.1146/annurev-astro-082708-101829; Freedman WL, 2001, ASTROPHYS J, V553, P47, DOI 10.1086/320638; Graczyk D, 2011, ACTA ASTRONOM, V61, P103; Groenewegen MAT, 2001, ASTRON ASTROPHYS, V366, P752, DOI 10.1051/0004-6361:20010014; Guinan EF, 1998, ASTROPHYS J, V509, pL21, DOI 10.1086/311760; Komatsu E, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/2/18; Kruszewski A, 1999, ACTA ASTRONOM, V49, P561; LACY CH, 1977, ASTROPHYS J, V213, P458, DOI 10.1086/155176; LUTZ TE, 1973, PUBL ASTRON SOC PAC, V85, P573, DOI 10.1086/129506; Mazzarella JM, 2007, ASTR SOC P, V376, P153; Monson AJ, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/2/146; Paczyliski B., 1997, SPACE TELESCOPE SCI, P273; Pietrzynski G, 2009, ASTROPHYS J, V697, P862, DOI 10.1088/0004-637X/697/1/862; Pojmanski G, 1997, ACTA ASTRONOM, V47, P467; Riess AG, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/119; Schaefer BE, 2008, ASTRON J, V135, P112, DOI 10.1088/0004-6256/135/1/112; Thompson IB, 2001, ASTRON J, V121, P3089, DOI 10.1086/321084; Udalski A, 2008, ACTA ASTRONOM, V58, P89; Van Hamme W, 2007, ASTROPHYS J, V661, P1129, DOI 10.1086/517870; van Leeuwen F, 2007, MON NOT R ASTRON SOC, V379, P723, DOI 10.1111/j.1365-2966.2007.11972.x; Walker AR, 2012, ASTROPHYS SPACE SCI, V341, P43, DOI 10.1007/s10509-011-0961-x; WILSON RE, 1971, ASTROPHYS J, V166, P605, DOI 10.1086/150986	28	480	480	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2013	495	7439					76	79		10.1038/nature11878	http://dx.doi.org/10.1038/nature11878			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23467166	Green Submitted			2022-12-28	WOS:000316039800042
J	Farooq, V; van Klaveren, D; Steyerberg, EW; Meliga, E; Vergouwe, Y; Chieffo, A; Kappetein, AP; Colombo, A; Holmes, DR; Mack, M; Feldman, T; Morice, MC; Stahle, E; Onuma, Y; Morel, MA; Garcia-Garcia, HM; van Es, GA; Dawkins, KD; Mohr, FW; Serruys, PW				Farooq, Vasim; van Klaveren, David; Steyerberg, Ewout W.; Meliga, Emanuele; Vergouwe, Yvonne; Chieffo, Alaide; Kappetein, Arie Pieter; Colombo, Antonio; Holmes, David R., Jr.; Mack, Michael; Feldman, Ted; Morice, Marie-Claude; Stahle, Elisabeth; Onuma, Yoshinobu; Morel, Marie-angele; Garcia-Garcia, Hector M.; van Es, Gerrit Anne; Dawkins, Keith D.; Mohr, Friedrich W.; Serruys, Patrick W.			Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II	LANCET			English	Article							LONG-TERM MORTALITY; LEFT MAIN; ELUTING STENTS; RISK STRATIFICATION; PREDICTIVE ABILITY; 3-VESSEL DISEASE; TASK-FORCE; FOLLOW-UP; REVASCULARIZATION; OUTCOMES	Background The anatomical SYNTAX score is advocated in European and US guidelines as an instrument to help clinicians decide the optimum revascularisation method in patients with complex coronary artery disease. The absence of an individualised approach and of clinical variables to guide decision making between coronary artery bypass graft surgery (CABG) and percutaneous coronary intervention (PCI) are limitations of the SYNTAX score. SYNTAX score II aimed to overcome these limitations. Methods SYNTAX score II was developed by applying a Cox proportional hazards model to results of the randomised all comers SYNTAX trial (n=1800). Baseline features with strong associations to 4-year mortality in either the CABG or the PCI settings (interactions), or in both (predictive accuracy), were added to the anatomical SYNTAX score. Comparisons of 4-year mortality predictions between CABG and PCI were made for each patient. Discriminatory performance was quantified by concordance statistics and internally validated with bootstrap resampling. External validation was done in the multinational all comers DELTA registry (n=2891), a heterogeneous population that included patients with three-vessel disease (26%) or complex coronary artery disease (anatomical SYNTAX score >= 33, 30%) who underwent CABG or PCI. The SYNTAX trial is registered with ClinicalTrials.gov, number NCT00114972. Findings SYNTAX score II contained eight predictors: anatomical SYNTAX score, age, creatinine clearance, left ventricular ejection fraction (LVEF), presence of unprotected left main coronary artery (ULMCA) disease, peripheral vascular disease, female sex, and chronic obstructive pulmonary disease (COPD). SYNTAX score II significantly predicted a difference in 4-year mortality between patients undergoing CABG and those undergoing PCI (p(interaction) 0.0037). To achieve similar 4-year mortality after CABG or PCI, younger patients, women, and patients with reduced LVEF required lower anatomical SYNTAX scores, whereas older patients, patients with ULMCA disease, and those with COPD, required higher anatomical SYNTAX scores. Presence of diabetes was not important for decision making between CABG and PCI (p(interaction) 0.67). SYNTAX score II discriminated well in all patients who underwent CABG or PCI, with concordance indices for internal (SYNTAX trial) validation of 0.725 and for external (DELTA registry) validation of 0.716, which were substantially higher than for the anatomical SYNTAX score alone (concordance indices of 0.567 and 0.612, respectively). A nomogram was constructed that allowed for an accurate individualised prediction of 4-year mortality in patients proposing to undergo CABG or PCI. Interpretation Long-term (4-year) mortality in patients with complex coronary artery disease can be well predicted by a combination of anatomical and clinical factors in SYNTAX score II. SYNTAX score II can better guide decision making between CABG and PCI than the original anatomical SYNTAX score.	[Farooq, Vasim; Onuma, Yoshinobu; Garcia-Garcia, Hector M.; Serruys, Patrick W.] Erasmus Univ, Med Ctr, Thoraxctr, NL-3015 CE Rotterdam, Netherlands; [van Klaveren, David; Steyerberg, Ewout W.; Vergouwe, Yvonne] Erasmus Univ, Med Ctr, Dept Publ Hlth, NL-3015 CE Rotterdam, Netherlands; [Kappetein, Arie Pieter] Erasmus Univ, Med Ctr, Dept Cardiothorac Surg, NL-3015 CE Rotterdam, Netherlands; [Meliga, Emanuele] AO Ordine Mauriziano Umberto I, Turin, Italy; [Chieffo, Alaide; Colombo, Antonio] Ist Sci San Raffaele, I-20132 Milan, Italy; [Holmes, David R., Jr.] Mayo Clin, Rochester, MN USA; [Mack, Michael] Baylor Healthcare Syst, Heart Hosp Baylor Plano, Dallas, TX USA; [Feldman, Ted] Northwestern Univ, Evanston Hosp, Evanston, IL 60201 USA; [Morice, Marie-Claude] Hop Pr Jacques Cartier, Massy, France; [Stahle, Elisabeth] Univ Uppsala Hosp, Uppsala, Sweden; [Morel, Marie-angele; Garcia-Garcia, Hector M.; van Es, Gerrit Anne] Cardialysis, Rotterdam, Netherlands; [Dawkins, Keith D.] Boston Sci Corp, Natick, MA USA; [Mohr, Friedrich W.] Univ Leipzig, Herzzentrum, D-04109 Leipzig, Germany	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; Mauritian Umberto I Hospital; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Mayo Clinic; Baylor Health Care System; NorthShore University Health System; Northwestern University; Jacques Cartier Private Hospital; Uppsala University; Uppsala University Hospital; Cardialysis; Boston Scientific; Heart Center Leipzig GMBH; Leipzig University	Serruys, PW (corresponding author), Erasmus Univ, Med Ctr, NL-3015 CE Rotterdam, Netherlands.	p.w.j.c.serruys@erasmusmc.nl	Kappetein, Arie Pieter/B-5534-2008; Onuma, Yoshinobu/AHB-6273-2022; van Klaveren, David/ABF-3020-2021; Garcia-Garcia, Hector Manuel/AAG-7471-2020; Steyerberg, Ewout W/C-1509-2018; Colombo, Antonio/N-2960-2015	Kappetein, Arie Pieter/0000-0003-3545-2229; Onuma, Yoshinobu/0000-0001-7702-0649; van Klaveren, David/0000-0002-2096-606X; Garcia-Garcia, Hector Manuel/0000-0001-5100-0471; Steyerberg, Ewout W/0000-0002-7787-0122; Colombo, Antonio/0000-0002-2940-2455; chieffo, alaide/0000-0002-3505-9112; Farooq, Vasim/0000-0002-7305-7257	Boston Scientific Corporation; Abbott; Atritech; Edwards; Evalve; Boston Scientific	Boston Scientific Corporation(Boston Scientific); Abbott(Abbott Laboratories); Atritech; Edwards; Evalve; Boston Scientific(Boston Scientific)	Boston Scientific Corporation.; KDD is a full-time employee of, and holds stock in, Boston Scientific. MM has served on the speaker's bureau of Boston Scientific, Cordis, and Medtronic. TF has served on the speaker's bureau of Boston Scientific; has received grant support from Abbott, Atritech, Boston Scientific Corporation, Edwards, and Evalve; and has worked as a consultant for Abbott, Coherex, Intervalve, Square One, and WL Gore. MM's institution has received a research grant from Boston Scientific. The other authors declare that they have no conflicts of interest.	Capodanno D, 2010, AM HEART J, V159, P103, DOI 10.1016/j.ahj.2009.10.021; Chen SL, 2010, JACC-CARDIOVASC INTE, V3, P632, DOI 10.1016/j.jcin.2010.04.006; Chieffo A, 2012, JACC-CARDIOVASC INTE, V5, P718, DOI 10.1016/j.jcin.2012.03.022; Chieffo A, 2010, EUROINTERVENTION, V5, P773, DOI 10.4244/EIJV5I7A130; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2008, NEW ENGL J MED, V358, P2641, DOI 10.1056/NEJMc080368; de Boer SPM, 2011, EUR HEART J, V32, P2161, DOI 10.1093/eurheartj/ehr126; ELLIS J, 1995, LANCET, V346, P407, DOI 10.1016/S0140-6736(95)92781-6; Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585; Farooq V, 2012, PCR EAPCI TXB, P329; Farooq V, 2012, EUR HEART J, V33, P3105, DOI 10.1093/eurheartj/ehs367; Farooq V, 2012, EUR HEART J, V33, P3098, DOI 10.1093/eurheartj/ehs295; Farooq V, 2011, HEART, V97, P1902, DOI 10.1136/heartjnl-2011-300718; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Garg S, 2010, CIRC-CARDIOVASC INTE, V3, P317, DOI 10.1161/CIRCINTERVENTIONS.109.914051; Genereux P, 2011, CIRC-CARDIOVASC INTE, V4, P553, DOI 10.1161/CIRCINTERVENTIONS.111.961862; Hamburger JN, 1997, AM J CARDIOL, V80, P1419, DOI 10.1016/S0002-9149(97)00704-2; Hannan EL, 2008, NEW ENGL J MED, V358, P331, DOI 10.1056/NEJMoa071804; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Harrell Jr F. E., 2012, RMS REGRESSION MODEL; Harrell Jr FE, 2012, HMISC HARRELL MISCEL; Head S, HEART IN PRESS; Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3; Hoffman SN, 2003, J AM COLL CARDIOL, V41, P1293, DOI 10.1016/S0735-1097(03)00157-8; Hougaard P, 1995, Lifetime Data Anal, V1, P255; Lansky AJ, 2012, JACC-CARDIOVASC IMAG, V5, pS62, DOI 10.1016/j.jcmg.2012.02.003; LEAMAN DM, 1981, CIRCULATION, V63, P285, DOI 10.1161/01.CIR.63.2.285; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Medina A, 2006, REV ESP CARDIOL, V59, P183, DOI 10.1157/13084649; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Morice MC, 2010, CIRCULATION, V121, P2645, DOI 10.1161/CIRCULATIONAHA.109.899211; Ong ATL, 2006, AM HEART J, V151, P1194, DOI 10.1016/j.ahj.2005.07.017; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Papadopoulou SL, JACC IMAGIN IN PRESS; Park SJ, 2011, NEW ENGL J MED, V364, P1718, DOI 10.1056/NEJMoa1100452; Patel Manesh R, 2012, J Am Coll Cardiol, V59, P857, DOI 10.1016/j.jacc.2011.12.001; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roques F, 2003, EUR HEART J, V24, P881, DOI 10.1016/S0195-668X(02)00799-6; Serruys PW, 2012, JACC-CARDIOVASC INTE, V5, P606, DOI 10.1016/j.jcin.2012.03.016; Serruys PW, 2009, EUROINTERVENTION, V5, P50, DOI 10.4244/EIJV5I1A9; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502; Serruys PW, N ENGL J ME IN PRESS; Shahian DM, 2012, CIRCULATION, V125, P1491, DOI 10.1161/CIRCULATIONAHA.111.066902; Sianos Georgios, 2005, EuroIntervention, V1, P219; Singh M, 2010, CIRC-CARDIOVASC INTE, V3, P423, DOI 10.1161/CIRCINTERVENTIONS.109.924308; Stefanini GG, 2012, JACC-CARDIOVASC INTE, V5, P301, DOI 10.1016/j.jcin.2011.11.011; Stefanini GG, 2011, LANCET, V378, P1940, DOI 10.1016/S0140-6736(11)61672-3; Steyerberg E., 2009, CLIN PREDICTION MODE; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Tonelli M, 2012, LANCET, V380, P807, DOI 10.1016/S0140-6736(12)60572-8; Weintraub WS, 2012, NEW ENGL J MED, V366, P1467, DOI 10.1056/NEJMoa1110717	56	535	564	3	53	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2013	381	9867					639	650		10.1016/S0140-6736(13)60108-7	http://dx.doi.org/10.1016/S0140-6736(13)60108-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	093JY	23439103				2022-12-28	WOS:000315189300034
J	Holmes, D				Holmes, David			Carissa Etienne: taking the reins at PAHO	LANCET			English	Biographical-Item																		ETIENNE C, PUBLICATION LIST	1	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 23	2013	381	9867					619	619		10.1016/S0140-6736(13)60334-7	http://dx.doi.org/10.1016/S0140-6736(13)60334-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	093JY	23439091				2022-12-28	WOS:000315189300013
J	Dyer, C				Dyer, Clare			COMPENSATION Suing the NHS: can the 1bn pound annual compensation bill continue?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												claredyer4@gmail.com						Dyer C, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f988; Dyer C, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e777; Dyer C, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e411; NHS Litigation Authority, 2012, 10 YEARS MAT CLAIMS; NHS Litigation Authority, 2012, REP ACC 2011 12	5	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2013	346								f978	10.1136/bmj.f978	http://dx.doi.org/10.1136/bmj.f978			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096GZ	23422902				2022-12-28	WOS:000315393500026
J	Clark, H				Clark, Helen			NCDs: a challenge to sustainable human development	LANCET			English	Editorial Material									United Nations Dev Programme, New York, NY 10017 USA		Clark, H (corresponding author), United Nations Dev Programme, 1 United Nations Plaza, New York, NY 10017 USA.	helen.clark@undp.org						Eriksen M, 2012, TOBACCO ATLAS; UNGA, 2012, FUTURE WE WANT; United Nations Development Programme, DISC PAP SO IN PRESS; United Nations Development Programme, 2012, HIV HLTH DEV STRAT N; United Nations General Assembly, 2011, POL DECL HIGH LEV M; World Health Organization, 2012, 65 WORLD HLTH ASS CL	6	86	90	1	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 16	2013	381	9866					510	511		10.1016/S0140-6736(13)60058-6	http://dx.doi.org/10.1016/S0140-6736(13)60058-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089RK	23410604				2022-12-28	WOS:000314927500005
J	Horton, R				Horton, Richard			Non-communicable diseases: 2015 to 2025	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.	richard.horton@lancet.com						Alleyne G, 2013, LANCET; Atun R, 2013, LANCET; Balbus JM, 2013, LANCET, V381, P3, DOI 10.1016/S0140-6736(12)61609-2; Bonita R, 2013, LANCET; Cresswell JA, 2012, LANCET, V380, P1325, DOI 10.1016/S0140-6736(12)60869-1; Di Cesare M, 2013, LANCET; Hogerzeil HV, 2013, LANCET; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Moodie R, 2013, LANCET; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4	10	46	48	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2013	381	9866					509	510		10.1016/S0140-6736(13)60100-2	http://dx.doi.org/10.1016/S0140-6736(13)60100-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089RK	23410603				2022-12-28	WOS:000314927500004
J	Sevenster, D; Beckers, T; Kindt, M				Sevenster, Dieuwke; Beckers, Tom; Kindt, Merel			Prediction Error Governs Pharmacologically Induced Amnesia for Learned Fear	SCIENCE			English	Article							MEMORY RECONSOLIDATION; PROTEIN-SYNTHESIS; EXTINCTION; RESPONSES	Although reconsolidation opens up new avenues to erase excessive fear memory, subtle boundary conditions put constraints on retrieval-induced plasticity. Reconsolidation may only take place when memory reactivation involves an experience that engages new learning (prediction error). Thus far, it has not been possible to determine the optimal degree of novelty required for destabilizing the memory. The occurrence of prediction error could only be inferred from the observation of a reconsolidation process itself. Here, we provide a noninvasive index of memory destabilization that is independent from the occurrence of reconsolidation. Using this index, we show in humans that prediction error is (i) a necessary condition for reconsolidation of associative fear memory and (ii) determined by the interaction between original learning and retrieval. Insight into the process of memory updating is crucial for understanding the optimal and boundary conditions on reconsolidation and provides a clear guide for the development of reconsolidation-based treatments.	[Sevenster, Dieuwke; Beckers, Tom; Kindt, Merel] Univ Amsterdam, Dept Clin Psychol, NL-1018 XA Amsterdam, Netherlands; [Sevenster, Dieuwke; Beckers, Tom; Kindt, Merel] Cognit Sci Ctr Amsterdam, NL-1018 WS Amsterdam, Netherlands; [Beckers, Tom] Katholieke Univ Leuven, Dept Psychol, Univ Leuven, B-3000 Louvain, Belgium	University of Amsterdam; KU Leuven	Kindt, M (corresponding author), Univ Amsterdam, Dept Clin Psychol, Weesperpl 4, NL-1018 XA Amsterdam, Netherlands.	m.kindt@uva.nl	Beckers, Tom/C-6164-2008	Beckers, Tom/0000-0002-9581-1505	Netherlands Organization for Scientific Research	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The authors thank B. Molenkamp for his technical assistance. This study was funded by a Vici grant (M. K.) from the Netherlands Organization for Scientific Research. T. B. is supported by a Vidi grant from the Netherlands Organization for Scientific Research. D. S. collected and analyzed the data. D. S. and M. K. wrote the manuscript.	Ben Mamou C, 2006, NAT NEUROSCI, V9, P1237, DOI 10.1038/nn1778; Biedenkapp JC, 2004, BEHAV NEUROSCI, V118, P956, DOI 10.1037/0735-7044.118.5.956; Bos MGN, 2012, BIOL PSYCHOL, V89, P598, DOI 10.1016/j.biopsycho.2012.01.007; Finnie PSB, 2012, NEUROSCI BIOBEHAV R, V36, P1667, DOI 10.1016/j.neubiorev.2012.03.008; Hupbach A, 2008, LEARN MEMORY, V15, P574, DOI 10.1101/lm.1022308; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Lee JLC, 2008, NAT NEUROSCI, V11, P1264, DOI 10.1038/nn.2205; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Pedreira ME, 2004, LEARN MEMORY, V11, P579, DOI 10.1101/lm.76904; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Sevenster D, 2012, NEUROBIOL LEARN MEM, V97, P338, DOI 10.1016/j.nlm.2012.01.009; Soeter M, 2010, NEUROBIOL LEARN MEM, V30, P4990; Soeter M, 2012, NEUROPSYCHOPHARMACOL, V37, P1204, DOI 10.1038/npp.2011.307; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500	16	207	214	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2013	339	6121					830	833		10.1126/science.1231357	http://dx.doi.org/10.1126/science.1231357			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	088YS	23413355				2022-12-28	WOS:000314874400052
J	McCarthy, M				McCarthy, Michael			Reviving research into US gun violence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												mxmc@mac.com						KELLERMANN AL, 1992, NEW ENGL J MED, V327, P467, DOI 10.1056/NEJM199208133270705; KELLERMANN AL, 1993, NEW ENGL J MED, V329, P1084, DOI 10.1056/NEJM199310073291506; National Academy of Sciences, 1985, INJ AM CONT PUBL HLT; United States Public Health Service, US PUBL HLTH SERV PU, V79-55071	4	2	2	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2013	346								f980	10.1136/bmj.f980	http://dx.doi.org/10.1136/bmj.f980			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	091ZR	23412743				2022-12-28	WOS:000315088800014
J	Ben-Sahra, I; Howell, JJ; Asara, JM; Manning, BD				Ben-Sahra, Issam; Howell, Jessica J.; Asara, John M.; Manning, Brendan D.			Stimulation of de Novo Pyrimidine Synthesis by Growth Signaling Through mTOR and S6K1	SCIENCE			English	Article							PHOSPHATE SYNTHETASE; PROTEIN-KINASE; CELL-GROWTH; SUBSTRATE; BIOSYNTHESIS; ACTIVATION; MECHANISM; COMPLEX; TARGET	Cellular growth signals stimulate anabolic processes. The mechanistic target of rapamycin complex 1 (mTORC1) is a protein kinase that senses growth signals to regulate anabolic growth and proliferation. Activation of mTORC1 led to the acute stimulation of metabolic flux through the de novo pyrimidine synthesis pathway. mTORC1 signaling posttranslationally regulated this metabolic pathway via its downstream target ribosomal protein S6 kinase 1 (S6K1), which directly phosphorylates S1859 on CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamoylase, dihydroorotase), the enzyme that catalyzes the first three steps of de novo pyrimidine synthesis. Growth signaling through mTORC1 thus stimulates the production of new nucleotides to accommodate an increase in RNA and DNA synthesis needed for ribosome biogenesis and anabolic growth.	[Ben-Sahra, Issam; Howell, Jessica J.; Manning, Brendan D.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Asara, John M.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Signal Transduct,Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Manning, BD (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA.	bmanning@hsph.harvard.edu	Manning, Brendan/ABD-6528-2021	Manning, Brendan/0000-0003-3895-5956; Ben-Sahra, Issam/0000-0001-9333-4162; Howell, Jessica/0000-0002-9736-5211	LAM Foundation; NIH [F32-DK095508, P01-CA120964, R01-CA122617]; Dana Farber/Harvard Cancer Center [P30-CA006516]; Sanofi Innovation Award; NATIONAL CANCER INSTITUTE [P30CA006516, R01CA122617, P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK095508] Funding Source: NIH RePORTER	LAM Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Farber/Harvard Cancer Center; Sanofi Innovation Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Yuan and S. Breitkopf for technical assistance with MS/MS and D. Patterson, D. Kwiatkowski, and M. Zbinden for cell lines. This work was supported in part by a grant from the LAM Foundation (I.B.-S.); NIH grants F32-DK095508 (J.J.H.), P01-CA120964 (B. D. M. and J.M.A.), and R01-CA122617 (B. D. M.); Dana Farber/Harvard Cancer Center grant P30-CA006516 (J.M.A.); and a Sanofi Innovation Award (B. D. M.). I.B.-S. and J.J.H. conceived and performed all experiments, analyzed all experimental data, and prepared the manuscript. J.M.A. performed and analyzed the MS/MS experiments. B. D. M. directed the research, reviewed all experimental data, and prepared the manuscript. All authors have reviewed the manuscript and declare no competing financial interests.	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; CARREY EA, 1985, EMBO J, V4, P3735, DOI 10.1002/j.1460-2075.1985.tb04142.x; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; FLOTOW H, 1992, J BIOL CHEM, V267, P3074; Graves LM, 2000, NATURE, V403, P328, DOI 10.1038/35002111; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Iadevaia V, 2012, BIOCHEM SOC T, V40, P168, DOI 10.1042/BST20110682; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352; Mori M, 1978, Methods Enzymol, V51, P111; MUSMANNO LA, 1992, SOMAT CELL MOLEC GEN, V18, P309, DOI 10.1007/BF01235754; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Williamson RA, 1996, TRANSPLANT P, V28, P3088; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484	18	467	486	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2013	339	6125					1323	1328		10.1126/science.1228792	http://dx.doi.org/10.1126/science.1228792			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23429703	Green Accepted			2022-12-28	WOS:000316053400039
J	Taitsman, JK; Grimm, CM; Agrawal, S				Taitsman, Julie K.; Grimm, Christi Macrina; Agrawal, Shantanu			Protecting Patient Privacy and Data Security	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Taitsman, Julie K.; Grimm, Christi Macrina] US Dept HHS, Off Inspector Gen, Washington, DC 20201 USA; [Agrawal, Shantanu] Ctr Medicare Serv, Ctr Program Integr, Baltimore, MD USA; [Agrawal, Shantanu] Ctr Medicaid Serv, Ctr Program Integr, Baltimore, MD USA	Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services	Taitsman, JK (corresponding author), US Dept HHS, Off Inspector Gen, Washington, DC 20201 USA.							Agrawal S, 2012, JAMA-J AM MED ASSOC, V307, P459, DOI 10.1001/jama.2012.78; Lyall S, 2012, NY TIMES; Office for Civil Rights, HLTH INF PRIV NUMB G; Office of Inspector General Office of Audit Services, 2011, AUD INF TECHN SEC IN	4	27	27	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2013	368	11					977	979		10.1056/NEJMp1215258	http://dx.doi.org/10.1056/NEJMp1215258			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104HF	23444980	Bronze			2022-12-28	WOS:000315982100002
J	Bayer, R; Oppenheimer, GM				Bayer, Ronald; Oppenheimer, Gerald M.			Routine HIV Testing, Public Health, and the USPSTF - An End to the Debate	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PREVENTION		[Bayer, Ronald; Oppenheimer, Gerald M.] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, Ctr Hist & Eth Publ Hlth, New York, NY 10027 USA	Columbia University	Bayer, R (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, Ctr Hist & Eth Publ Hlth, New York, NY 10027 USA.							Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Chou R, 2012, ANN INTERN MED, V157, P706, DOI 10.7326/0003-4819-157-10-201211200-00007; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Neff S, 2011, JAMA-J AM MED ASSOC, V305, P1767, DOI 10.1001/jama.2011.564; US Preventive Serv Task Force, 2005, ANN INTERN MED, V143, P32, DOI 10.7326/0003-4819-143-1-200507050-00008	5	16	17	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2013	368	10					881	884		10.1056/NEJMp1214535	http://dx.doi.org/10.1056/NEJMp1214535			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100BG	23425134				2022-12-28	WOS:000315669100001
J	Ortega-Loayza, AG; McCall, CO				Ortega-Loayza, Alex G.; McCall, Calvin O.			Cutaneous Blastomycosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Virginia Commonwealth Univ, Richmond, VA 23284 USA	Virginia Commonwealth University	Ortega-Loayza, AG (corresponding author), Virginia Commonwealth Univ, Richmond, VA 23284 USA.	aortegaloayza2@mcvh-vcu.edu	Loayza, Alex Ortega/AAN-3319-2020	Loayza, Alex Ortega/0000-0001-5028-9269					0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2013	368	10					E13	E13		10.1056/NEJMicm1204813	http://dx.doi.org/10.1056/NEJMicm1204813			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100BG	23465124				2022-12-28	WOS:000315669100011
J	Gulati, A; Jabbour, A; Ismail, TF; Guha, K; Khwaja, J; Raza, S; Morarji, K; Brown, TDH; Ismail, NA; Dweck, MR; Di Pietro, E; Roughton, M; Wage, R; Daryani, Y; O'Hanlon, R; Sheppard, MN; Alpendurada, F; Lyon, AR; Cook, SA; Cowie, MR; Assomull, RG; Pennell, DJ; Prasad, SK				Gulati, Ankur; Jabbour, Andrew; Ismail, Tevfik F.; Guha, Kaushik; Khwaja, Jahanzaib; Raza, Sadaf; Morarji, Kishen; Brown, Tristan D. H.; Ismail, Nizar A.; Dweck, Marc R.; Di Pietro, Elisa; Roughton, Michael; Wage, Ricardo; Daryani, Yousef; O'Hanlon, Rory; Sheppard, Mary N.; Alpendurada, Francisco; Lyon, Alexander R.; Cook, Stuart A.; Cowie, Martin R.; Assomull, Ravi G.; Pennell, Dudley J.; Prasad, Sanjay K.			Association of Fibrosis With Mortality and Sudden Cardiac Death in Patients With Nonischemic Dilated Cardiomyopathy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; HEART-FAILURE; RISK STRATIFICATION; MYOCARDIAL FIBROSIS; TASK-FORCE; PRACTICE GUIDELINES; RHYTHM SOCIETY; PREVENTION; THERAPY	Importance Risk stratification of patients with nonischemic dilated cardiomyopathy is primarily based on left ventricular ejection fraction (LVEF). Superior prognostic factors may improve patient selection for implantable cardioverter-defibrillators (ICDs) and other management decisions. Objective To determine whether myocardial fibrosis (detected by late gadolinium enhancement cardiovascular magnetic resonance [LGE-CMR] imaging) is an independent and incremental predictor of mortality and sudden cardiac death (SCD) in dilated cardiomyopathy. Design, Setting, and Patients Prospective, longitudinal study of 472 patients with dilated cardiomyopathy referred to a UK center for CMR imaging between November 2000 and December 2008 after presence and extent of midwall replacement fibrosis were determined. Patients were followed up through December 2011. Main Outcome Measures Primary end point was all-cause mortality. Secondary end points included cardiovascular mortality or cardiac transplantation; an arrhythmic composite of SCD or aborted SCD (appropriate ICD shock, nonfatal ventricular fibrillation, or sustained ventricular tachycardia); and a composite of HF death, HF hospitalization, or cardiac transplantation. Results Among the 142 patients with midwall fibrosis, there were 38 deaths (26.8%) vs 35 deaths (10.6%) among the 330 patients without fibrosis (hazard ratio [HR], 2.96 [95% CI, 1.87-4.69]; absolute risk difference, 16.2% [95% CI, 8.2%-24.2%]; P<.001) during a median follow-up of 5.3 years (2557 patient-years of follow-up). The arrhythmic composite was reached by 42 patients with fibrosis (29.6%) and 23 patients without fibrosis (7.0%) (HR, 5.24 [95% CI, 3.15-8.72]; absolute risk difference, 22.6% [95% CI, 14.6%-30.6%]; P<.001). After adjustment for LVEF and other conventional prognostic factors, both the presence of fibrosis (HR, 2.43 [95% CI, 1.503.92]; P<.001) and the extent (HR, 1.11 [95% CI, 1.06-1.16]; P<.001) were independently and incrementally associated with all-cause mortality. Fibrosis was also independently associated with cardiovascular mortality or cardiac transplantation (by fibrosis presence: HR, 3.22 [95% CI, 1.95-5.31], P<.001; and by fibrosis extent: HR, 1.15 [95% CI, 1.10-1.20], P<.001), SCD or aborted SCD (by fibrosis presence: HR, 4.61 [95% CI, 2.75-7.74], P<.001; and by fibrosis extent: HR, 1.10 [95% CI, 1.051.16], P<.001), and the HF composite (by fibrosis presence: HR, 1.62 [95% CI, 1.002.61], P=.049; and by fibrosis extent: HR, 1.08 [95% CI, 1.04-1.13], P<.001). Addition of fibrosis to LVEF significantly improved risk reclassification for all-cause mortality and the SCD composite (net reclassification improvement: 0.26 [95% CI, 0.11-0.41]; P=. 001 and 0.29 [95% CI, 0.11-0.48]; P=. 002, respectively). Conclusions and Relevance Assessment of midwall fibrosis with LGE-CMR imaging provided independent prognostic information beyond LVEF in patients with nonischemic dilated cardiomyopathy. The role of LGE-CMR in the risk stratification of dilated cardiomyopathy requires further investigation. JAMA.2013;309(9):896-908 www.jama.com	[Ismail, Tevfik F.; Guha, Kaushik; Sheppard, Mary N.; Lyon, Alexander R.; Cook, Stuart A.; Cowie, Martin R.; Pennell, Dudley J.; Prasad, Sanjay K.] Royal Brompton Hosp, London SW3 6NP, England; [Ismail, Tevfik F.; Guha, Kaushik; Sheppard, Mary N.; Lyon, Alexander R.; Cook, Stuart A.; Cowie, Martin R.; Pennell, Dudley J.; Prasad, Sanjay K.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Dweck, Marc R.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Cook, Stuart A.] Natl Heart Ctr Singapore, Singapore, Singapore	Royal Brompton Hospital; Imperial College London; University of Edinburgh; National Heart Centre Singapore	Prasad, SK (corresponding author), Royal Brompton Hosp, Cardiovasc Magnet Resonance Unit, Sydney St, London SW3 6NP, England.	s.prasad@rbht.nhs.uk	Cook, Stuart/G-9567-2011; Dweck, Marc/AAY-1509-2021; Cowie, Martin R/AAQ-2818-2020; Sheppard, Mary N/AAB-3364-2019; Ismail, Tevfik F/AAG-3303-2020	Cowie, Martin R/0000-0001-7457-2552; Sheppard, Mary N/0000-0003-2724-3881; Ismail, Tevfik F/0000-0002-1691-7599; dweck, marc/0000-0001-9847-5917; Ismail, Nizar/0000-0001-5640-9938; Khwaja, Jahanzaib/0000-0002-4993-7828; Cook, Stuart/0000-0001-6628-194X; Pennell, Dudley/0000-0001-5523-1314	National Institute for Health Research; CORDA; Rosetrees Trust; National Health and Medical Research Council of Australia; Victor Chang Cardiac Research Institute; St Vincent's Clinic Foundation; British Heart Foundation; Biotronik; Boston Scientific; Servier; Fondation Leducq; Medtronic; ResMed; Pfizer; Bayer; Novartis; Bayer Schering; National Institute for Health Research Cardiovascular Biomedical Research Unit at the Royal Brompton; Harefield NHS Foundation Trust; Imperial College, London, England; British Heart Foundation [FS/11/67/28954] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); CORDA; Rosetrees Trust(Rosetrees Trust); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victor Chang Cardiac Research Institute; St Vincent's Clinic Foundation; British Heart Foundation(British Heart Foundation); Biotronik; Boston Scientific(Boston Scientific); Servier(Servier); Fondation Leducq(Leducq Foundation); Medtronic(Medtronic); ResMed; Pfizer(Pfizer); Bayer(Bayer AG); Novartis(Novartis); Bayer Schering(Bayer AG); National Institute for Health Research Cardiovascular Biomedical Research Unit at the Royal Brompton; Harefield NHS Foundation Trust; Imperial College, London, England; British Heart Foundation(British Heart Foundation)	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Gulati reported receiving grant support from the National Institute for Health Research, CORDA, and Rosetrees Trust. Dr Jabbour reported receiving grant support from the National Health and Medical Research Council of Australia, Victor Chang Cardiac Research Institute, and St Vincent's Clinic Foundation. Dr T. Ismail reported receiving grant support from the British Heart Foundation. Dr Guha reported receiving an unrestricted educational grant from Biotronik; payment for an editorial from Boston Scientific; and sponsored attendance by Biotronik and Boston Scientific at national and international conferences. Dr Lyon reported receiving institutional grants from British Heart Foundation, CORDA, and Rosetrees Trust; serving on advisory boards for Roche Pharmaceuticals and Servier; serving as a consultant to Servier and Celladon Inc; receiving an educational grant from Servier; receiving speakers fees from Servier; and receiving travel reimbursement from AstraZeneca, Boston Scientific, and Servier. Dr Cook reported receiving grants from the British Heart Foundation and Fondation Leducq; and serving as a consultant for GlaxoSmithKline. Dr Cowie reported serving as a consultant to GE Healthcare, Servier, Bayer, ResMed, Roche Diagnostics, Pfizer, Boehringer Ingelheim, Novartis, Medtronic, and Boston Scientific; receiving grants from Medtronic and ResMed; and receiving speakers fees from Servier, Pfizer, Bayer, Medtronic, Boston Scientific, Biotronik, Novartis, and ResMed. Dr Assomull reported receiving grant support from the British Heart Foundation. Dr Pennell reported receiving grant support from the National Institute for Health Research and the British Heart Foundation; serving as a consultant to Siemens, Novartis, ApoPharma, AMAG, and Bayer; and serving as the director and owning stock in Cardiovascular Imaging Solutions. Dr Prasad reported receiving grant support from the British Heart Foundation, CORDA, and Rosetrees Trust, and the National Institute for Health Research; and receiving speaking fees from Bayer Schering. No other authors reported disclosures.; This work was supported by the National Institute for Health Research Cardiovascular Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, England.	Aleksova A, 2011, HEART LUNG, V40, P454, DOI 10.1016/j.hrtlng.2010.06.001; Aleksova A, 2009, J CARDIOVASC MED, V10, P699, DOI 10.2459/JCM.0b013e32832bba35; Assomull RG, 2006, J AM COLL CARDIOL, V48, P1977, DOI 10.1016/j.jacc.2006.07.049; Baig MK, 1998, AM HEART J, V135, pS216, DOI 10.1016/S0002-8703(98)70252-2; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Cygankiewicz I, 2009, AM J CARDIOL, V103, P1003, DOI 10.1016/j.amjcard.2008.11.061; de Leeuw N, 2001, TRANSPLANT INT, V14, P299, DOI 10.1007/s001470100339; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; Desai AS, 2004, JAMA-J AM MED ASSOC, V292, P2874, DOI 10.1001/jama.292.23.2874; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Dickstein K, 2010, EUR J HEART FAIL, V12, P1143, DOI [10.1093/eurjhf/hfq192, 10.1093/europace/euq392]; Epstein AE, 2013, CIRCULATION, V127, pE283, DOI 10.1161/CIR.0b013e318276ce9b; European Heart Rhythm Association, 2006, J Am Coll Cardiol, V48, pe247, DOI 10.1016/j.jacc.2006.07.010; Ezekowitz JA, 2007, ANN INTERN MED, V147, P251, DOI 10.7326/0003-4819-147-4-200708210-00007; Felker GM, 2000, NEW ENGL J MED, V342, P1077, DOI 10.1056/NEJM200004133421502; Goldberger JJ, 2008, CIRCULATION, V118, P1497, DOI 10.1161/CIRCULATIONAHA.107.189375; Goldberger JJ, 2011, CIRCULATION, V123, P2423, DOI 10.1161/CIRCULATIONAHA.110.959734; Greenberg H, 2004, J AM COLL CARDIOL, V43, P1459, DOI 10.1016/j.jacc.2003.11.038; Grimm W, 2003, CIRCULATION, V108, P2883, DOI 10.1161/01.CIR.0000100721.52503.85; Grzybowski J, 1996, J Card Fail, V2, P77, DOI 10.1016/S1071-9164(96)80026-1; Hsia Henry H, 2002, Card Electrophysiol Rev, V6, P472, DOI 10.1023/A:1021109130276; Hundley WG, 2010, CIRCULATION, V121, P2462, DOI 10.1161/CIR.0b013e3181d44a8f; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Iles L, 2011, J AM COLL CARDIOL, V57, P821, DOI 10.1016/j.jacc.2010.06.062; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; Lehrke S, 2011, HEART, V97, P727, DOI 10.1136/hrt.2010.205542; Leyva F, 2012, J AM COLL CARDIOL, V60, P1659, DOI 10.1016/j.jacc.2012.05.054; Maceira AM, 2006, J CARDIOVASC MAGN R, V8, P417, DOI 10.1080/10976640600572889; Mahrholdt H, 2005, EUR HEART J, V26, P1461, DOI 10.1093/eurheartj/ehi258; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; McCrohon A, 2003, CIRCULATION, V108, P54, DOI 10.1161/01.CIR.0000078641.19365.4C; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; Mishkin JD, 2009, J AM COLL CARDIOL, V54, P1993, DOI 10.1016/j.jacc.2009.07.039; O'Hanlon R, 2010, J AM COLL CARDIOL, V56, P867, DOI 10.1016/j.jacc.2010.05.010; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pennell DJ, 2010, CIRCULATION, V121, P692, DOI 10.1161/CIRCULATIONAHA.108.811547; Poole JE, 2008, NEW ENGL J MED, V359, P1009, DOI 10.1056/NEJMoa071098; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; RIHAL CS, 1994, CIRCULATION, V90, P2772, DOI 10.1161/01.CIR.90.6.2772; Sanders GD, 2005, NEW ENGL J MED, V353, P1471, DOI 10.1056/NEJMsa051989; Stecker EC, 2011, J INTERV CARD ELECTR, V31, P101, DOI 10.1007/s10840-010-9535-z; Tung R, 2008, J AM COLL CARDIOL, V52, P1111, DOI 10.1016/j.jacc.2008.05.058; UK Department of Health, SENS DRINK REP INT W; White SK, 2012, HEART, V98, P773, DOI 10.1136/heartjnl-2011-301515; Wu KC, 2008, J AM COLL CARDIOL, V51, P2414, DOI 10.1016/j.jacc.2008.03.018	46	685	713	1	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2013	309	9					896	908		10.1001/jama.2013.1363	http://dx.doi.org/10.1001/jama.2013.1363			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099PC	23462786	Bronze			2022-12-28	WOS:000315632700025
J	Nylenna, A				Nylenna, Astrid			Occasional smoking: a new campaign target in Norway	LANCET			English	Editorial Material							LIGHT		Norwegian Directorate Hlth, Dept Primary Prevent, N-0130 Oslo, Norway		Nylenna, A (corresponding author), Norwegian Directorate Hlth, Dept Primary Prevent, N-0130 Oslo, Norway.	astrid.nylenna@helsedir.no						Bjartveit K, 2005, TOB CONTROL, V14, P315, DOI 10.1136/tc.2005.011932; Helleve A., 2010, TAL TOBAKK 1973 2009; Helse og omsorgsdepartementet, 2013, FREMT UT TOB NASJ ST; Hukkinen M, 2009, NICOTINE TOB RES, V11, P797, DOI 10.1093/ntr/ntp065; Schane RE, 2010, CIRCULATION, V121, P1518, DOI 10.1161/CIRCULATIONAHA.109.904235; Schane RE, 2009, ARCH INTERN MED, V169, P1742, DOI 10.1001/archinternmed.2009.315; Shiffman S, 2012, NICOTINE TOB RES, V14, P1372, DOI 10.1093/ntr/nts097; Shiffman S, 2009, NICOTINE TOB RES, V11, P122, DOI 10.1093/ntr/ntn020; Statistics Norway, 2012, SMOK HAB; Undas A, 2011, ARTERIOSCL THROM VAS, V31, pE88, DOI 10.1161/ATVBAHA.111.230631	10	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2013	381	9868					708	709		10.1016/S0140-6736(13)60249-4	http://dx.doi.org/10.1016/S0140-6736(13)60249-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	098TC	23465425				2022-12-28	WOS:000315570900008
J	Haug, C				Haug, Charlotte			The Downside of Open-Access Publishing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Journal Norwegian Med Assoc, Oslo, Norway		Haug, C (corresponding author), Journal Norwegian Med Assoc, Oslo, Norway.			Haug, Charlotte Johanne/0000-0001-8217-7376				Beall J, 2012, NATURE, V489, P179, DOI 10.1038/489179a	1	64	65	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2013	368	9					791	793		10.1056/NEJMp1214750	http://dx.doi.org/10.1056/NEJMp1214750			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096ET	23445091				2022-12-28	WOS:000315387700004
J	Bland, RM; Ndirangu, J; Newell, ML				Bland, Ruth M.; Ndirangu, James; Newell, Marie-Louise			Maximising opportunities for increased antiretroviral treatment in children in an existing HIV programme in rural South Africa	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-HEALTH-CARE; CD4 CELL RESPONSE; THERAPY; INFECTION; OUTCOMES; PREVENTION; MORTALITY	Problem Infants and young children infected with HIV as a result of mother to child transmission are not being identified or started with antiretroviral treatment (ART) in line with HIV guidelines in resource limited settings. Design Retrospective analysis of data from a paediatric cohort before and after an intervention strategy. Setting Rural public HIV treatment programme in the province of KwaZulu-Natal, South Africa. Key measures for improvement Increase in the number of HIV infected infants and children who start HIV treatment each year; increase in the proportion of children starting ART with less immune suppression, shown by higher CD4 counts and less advanced World Health Organization clinical stages for HIV. Strategies for change Late 2008: training in paediatric HIV for all staff in contact with mothers and children; campaigns for increased HIV testing at immunisation and clinics; routine testing of children with tuberculosis and malnutrition for HIV, and HIV testing of all children admitted to hospital. The establishment of a family HIV clinic in late 2007. Effects of change The number of children (1 year to <= 15 years) starting ART each year increased from 43 in 2004 to 254 in 2011; the corresponding number of infants (<1 year) starting treatment increased from 2 to 59. A trend towards increasing CD4 counts at the start of treatment was found. Lessons learnt It is possible to improve the identification of HIV infected children and ensure a prompt start on ART where needed with relatively simple measures and limited implications for staffing and budgets.	[Bland, Ruth M.; Ndirangu, James] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, ZA-3935 Mtubatuba, Kwazulu Natal, South Africa; [Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Africa Ctr, ZA-3935 Mtubatuba, Kwazulu Natal, South Africa; [Bland, Ruth M.] Univ Glasgow, Sch Med, Glasgow G12 8XX, Lanark, Scotland; [Newell, Marie-Louise] UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1E 6BT, England	University of Kwazulu Natal; University of Kwazulu Natal; University of Glasgow; University of London; University College London	Bland, RM (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, POB 198, ZA-3935 Mtubatuba, Kwazulu Natal, South Africa.	rbland@africacentre.ac.za	Newell, Marie-Louise/AAE-8222-2019	Newell, Marie-Louise/0000-0002-1074-7699; Bland, Ruth/0000-0003-1675-9268; Ndirangu, James/0000-0002-2768-5631	Wellcome Trust [050524, 097410] Funding Source: Medline; PEPFAR Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission); PEPFAR		Arrive E, 2008, JAIDS-J ACQ IMM DEF, V49, P523, DOI 10.1097/QAI.0b013e31818aadce; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Cooke GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007101; Coovadia H, 2008, LANCET, V372, P866, DOI 10.1016/S0140-6736(08)61373-2; Ginsburg AS, 2007, AIDS, V21, P2529, DOI 10.1097/QAD.0b013e3282f155f4; Horwood C, 2003, B WORLD HEALTH ORGAN, V81, P858; Horwood C, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-62; Houlihan CF, 2011, INT J EPIDEMIOL, V40, P318, DOI 10.1093/ije/dyp402; Houlihan CF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-23; Janssen N, 2010, ARCH DIS CHILD, V95, P414, DOI 10.1136/adc.2009.169367; Johnson L., 2012, SO AFRICAN J HIV MED, V13; Joint United Nations Programme on HIV/AIDS, AIDS EP UPD 2009; Kiboneka A, 2008, AIDS, V22, P2493, DOI 10.1097/QAD.0b013e328318f148; National Department of Health, 2010, GUID MAN HIV CHILDR; Ndirangu J, 2009, TROP MED INT HEALTH, V14, P1383, DOI 10.1111/j.1365-3156.2009.02382.x; Newell ML, 2006, J INFECT DIS, V193, P954, DOI 10.1086/500842; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Prendergast A, 2008, AIDS, V22, P1333, DOI 10.1097/QAD.0b013e32830437df; Rollins N, 2007, AIDS, V21, P1341, DOI 10.1097/QAD.0b013e32814db7d4; Rollins NC, 2007, JAIDS-J ACQ IMM DEF, V44, P321, DOI 10.1097/QAI.0b013e31802ea4b0; Tanser F, 2012, C RETR OPP INF SEATT; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; Wilkinson D, 1997, S AFR MED J, V87, P456; World Health Organisation, 2006, ANT THER HIV INF INF; World Health Organization, ANT THER HIV INF INF	26	5	5	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2013	346								f550	10.1136/bmj.f550	http://dx.doi.org/10.1136/bmj.f550			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100BL	23447354				2022-12-28	WOS:000315669600011
J	Arnold, C				Arnold, Carrie			Profile: ECCRI-cardiovascular research at the heart of Emory	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 23	2013	381	9867					616	616		10.1016/S0140-6736(13)60331-1	http://dx.doi.org/10.1016/S0140-6736(13)60331-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	093JY	23444489				2022-12-28	WOS:000315189300012
J	Cemma, M; Brumell, JH				Cemma, Marija; Brumell, John H.			Bacterial Escape Artists Set Afire	SCIENCE			English	Editorial Material							INFLAMMASOME ACTIVATION; CASPASE-11		[Cemma, Marija; Brumell, John H.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Cemma, Marija; Brumell, John H.] Univ Toronto, Toronto, ON M5S 1A8, Canada; [Cemma, Marija; Brumell, John H.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Brumell, John H.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Cemma, M (corresponding author), Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	john.brumell@sickkids.ca						Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Case CL, 2013, P NATL ACAD SCI USA, V110, P1851, DOI 10.1073/pnas.1211521110; Cassidy SKB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002628; Cemma M, 2012, CURR BIOL, V22, pR540, DOI 10.1016/j.cub.2012.06.001; Davis MJ, 2012, J IMMUNOL, V189, P4488, DOI 10.4049/jimmunol.1103158; Gurung P, 2012, J BIOL CHEM, V287, P34474, DOI 10.1074/jbc.M112.401406; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; LaRock CN, 2012, CELL HOST MICROBE, V12, P799, DOI 10.1016/j.chom.2012.10.020; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Srikanth CV, 2010, SCIENCE, V330, P390, DOI 10.1126/science.1194598; Yazdi AS, 2010, J INNATE IMMUN, V2, P228, DOI 10.1159/000283688	15	2	2	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2013	339	6122					912	913		10.1126/science.1235639	http://dx.doi.org/10.1126/science.1235639			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23430642				2022-12-28	WOS:000315149600034
J	Buysse, DJ				Buysse, Daniel J.			Insomnia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COGNITIVE-BEHAVIORAL THERAPY; OLDER-ADULTS; TREATMENT EFFICACY; NONPHARMACOLOGICAL INTERVENTIONS; COMPARATIVE METAANALYSIS; PERSISTENT INSOMNIA; SEDATIVE HYPNOTICS; CONTROLLED-TRIAL; 6 MG; SLEEP	Importance Insomnia is one of the most prevalent health concerns in the population and in clinical practice. Clinicians may be reluctant to address insomnia because of its many potential causes, unfamiliarity with behavioral treatments, and concerns about pharmacologic treatments. Objective To review the assessment, diagnosis, and treatment of insomnia in adults. Evidence Review Systematic review to identify and summarize previously published quantitative reviews (meta-analyses) of behavioral and pharmacologic treatments for insomnia. Findings Insomnia is a common clinical condition characterized by difficulty initiating or maintaining sleep, accompanied by symptoms such as irritability or fatigue during wakefulness. The prevalence of insomnia disorder is approximately 10% to 20%, with approximately 50% having a chronic course. Insomnia is a risk factor for impaired function, development of other medical and mental disorders, and increased health care costs. The etiology and pathophysiology of insomnia involve genetic, environmental, behavioral, and physiological factors culminating in hyperarousal. The diagnosis of insomnia is established by a thorough history of sleep behaviors, medical and psychiatric problems, and medications, supplemented by a prospective record of sleep patterns (sleep diary). Quantitative literature reviews (meta-analyses) support the efficacy of behavioral, cognitive, and pharmacologic interventions for insomnia. Brief behavioral interventions and Internet-based cognitive-behavioral therapy both show promise for use in primary care settings. Among pharmacologic interventions, the most evidence exists for benzodiazepine receptor agonist drugs, although persistent concerns focus on their safety relative to modest efficacy. Behavioral treatments should be used whenever possible, and medications should be limited to the lowest necessary dose and shortest necessary duration. Conclusions and Relevance Clinicians should recognize insomnia because of its effects on function and health. A thorough clinical history is often sufficient to identify factors that contribute to insomnia. Behavioral treatments should be used when possible. Hypnotic medications are also efficacious but must be carefully monitored for adverse effects. JAMA. 2013;309(7):706-716 www.jama.com	[Buysse, Daniel J.] Univ Pittsburgh, Sch Med, Neurosci Clin & Translat Res Ctr, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Buysse, DJ (corresponding author), Western Psychiat Inst & Clin, 3811 OHara St, Pittsburgh, PA 15213 USA.	buyssedj@upmc.edu	Buysse, Daniel/AAJ-1608-2021	Buysse, Daniel/0000-0002-3288-1864	Astellas; Servier; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR052155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH024652, R34MH080958, R01MH078961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG020677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033064] Funding Source: NIH RePORTER	Astellas(Astellas Pharmaceuticals); Servier(Servier); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Buysse reports having served as a paid consultant on scientific advisory boards for the following companies: Eisai, Merck, Pfizer, Philips Respironics, Purdue Pharma, and General Sleep Corp. He has also spoken at single-sponsored educational meetings for Astellas and Servier.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Ancoli-Israel S, 2005, SLEEP MED, V6, P107, DOI 10.1016/j.sleep.2004.10.015; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Buscemi N, 2005, J GEN INTERN MED, V20, P1151, DOI 10.1111/j.1525-1497.2005.0243.x; Buscemi N, 2007, J GEN INTERN MED, V22, P1335, DOI 10.1007/s11606-007-0251-z; Buysse DJ, 2011, ARCH INTERN MED, V171, P887, DOI 10.1001/archinternmed.2010.535; Buysse DJ, 2011, PRINCIPLES PRACTICES, P492; Carney CE, 2010, MED PSYCHIATRY, P342; Carney CE, 2012, SLEEP, V35, P287, DOI 10.5665/sleep.1642; Charney D.S., 2006, HYPNOTICS SEDATIVES, P401; Cheng SK, 2012, PSYCHOTHER PSYCHOSOM, V81, P206, DOI 10.1159/000335379; Dundar Y, 2004, HEALTH TECHNOL ASSES, V8, P1; Edinger JD, 2011, ARCH GEN PSYCHIAT, V68, P992, DOI 10.1001/archgenpsychiatry.2011.64; Edinger JD, 2003, SLEEP MED REV, V7, P203, DOI 10.1053/smrv.2002.0253; Espie CA, 2006, SLEEP MED REV, V10, P215, DOI 10.1016/j.smrv.2006.03.002; Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; Glass JR, 2008, J CLIN PSYCHOPHARM, V28, P182, DOI 10.1097/JCP.0b013e31816a9e4f; Hajak G, 2003, ADDICTION, V98, P1371, DOI 10.1046/j.1360-0443.2003.00491.x; Harvey AG, 2002, BEHAV RES THER, V40, P869, DOI 10.1016/S0005-7967(01)00061-4; HOHAGEN F, 1994, SLEEP, V17, P551; Holbrook AM, 2000, CAN MED ASSOC J, V162, P225; Irwin MR, 2006, HEALTH PSYCHOL, V25, P3, DOI 10.1037/0278-6133.25.1.3; Kessler RC, 2011, SLEEP, V34, P1161, DOI 10.5665/SLEEP.1230; Kripke DF, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000850; Krystal AD., 2011, PRINCIPLES PRACTICES, P916; Krystal AD, 2008, SLEEP, V31, P79, DOI 10.1093/sleep/31.1.79; Krystal AD, 2011, SLEEP, V34, P1433, DOI 10.5665/SLEEP.1294; Krystal AD, 2009, SLEEP MED REV, V13, P265, DOI 10.1016/j.smrv.2008.08.001; Laugsand LE, 2011, CIRCULATION, V124, P2073, DOI 10.1161/CIRCULATIONAHA.111.025858; Licata SC, 2008, PHARMACOL BIOCHEM BE, V90, P74, DOI 10.1016/j.pbb.2008.01.001; Lichstein KL, 2003, BEHAV RES THER, V41, P427, DOI 10.1016/S0005-7967(02)00023-2; McCrae CS, 2001, SLEEP MED REV, V5, P47, DOI 10.1053/smrv.2000.0146; Mendelson W., 2011, PRINCIPLES PRACTICES; Mitchell MD, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-40; Montgomery P, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003161, 10.1002/14651858.CD003161]; Morin CM, 2011, CAN J PSYCHIAT, V56, P540, DOI 10.1177/070674371105600905; Morin CM, 2009, JAMA-J AM MED ASSOC, V301, P2005, DOI 10.1001/jama.2009.682; Morin CM, 2009, ARCH INTERN MED, V169, P447, DOI 10.1001/archinternmed.2008.610; Morin CM, 2004, AM J PSYCHIAT, V161, P332, DOI 10.1176/appi.ajp.161.2.332; MORIN CM, 1994, AM J PSYCHIAT, V151, P1172; Morin CM, 2003, INSOMNIA CLIN GUIDE; Morphy H, 2007, SLEEP, V30, P274; MURTAGH DRR, 1995, J CONSULT CLIN PSYCH, V63, P79, DOI 10.1037/0022-006X.63.1.79; National Institutes of Health, 2005, NIH STAT OF THE SCI; Nofzinger EA, 2004, AM J PSYCHIAT, V161, P2126, DOI 10.1176/appi.ajp.161.11.2126; Nowell PD, 1997, JAMA-J AM MED ASSOC, V278, P2170; Ohayon MM, 1996, CAN J PSYCHIAT, V41, P457, DOI 10.1177/070674379604100711; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Ohayon MM, 2005, ARCH INTERN MED, V165, P35, DOI 10.1001/archinte.165.1.35; Okajima I, 2011, SLEEP BIOL RHYTHMS, V9, P24, DOI 10.1111/j.1479-8425.2010.00481.x; Ozminkowski RJ, 2007, SLEEP, V30, P263, DOI 10.1093/sleep/30.3.263; Pallesen S, 1998, PSYCHOTHERAPY, V35, P472, DOI 10.1037/h0087829; Perlis ML, 2005, COGNITIVE BEHAV TREA; Richardson GS, 2008, J CLIN SLEEP MED, V4, P456; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Ritterband LM, 2009, ARCH GEN PSYCHIAT, V66, P692, DOI 10.1001/archgenpsychiatry.2009.66; Roehrs T, 2002, SLEEP MED, V3, P61, DOI 10.1016/S1389-9457(01)00125-3; Rosa RR, 2000, PSYCHOSOM MED, V62, P474, DOI 10.1097/00006842-200007000-00004; Roth T, 2007, SLEEP, V30, P1555, DOI 10.1093/sleep/30.11.1555; Roth T, 2006, SLEEP MED, V7, P312, DOI 10.1016/j.sleep.2006.01.003; Roth T, 2006, BIOL PSYCHIAT, V60, P1364, DOI 10.1016/j.biopsych.2006.05.039; Roth T, 2011, BIOL PSYCHIAT, V69, P592, DOI 10.1016/j.biopsych.2010.10.023; Sarsour K, 2011, SLEEP, V34, P443, DOI 10.1093/sleep/34.4.443; Sateia MJ, 2010, MED PSYCHIATRY, P1, DOI 10.3109/9781420080803; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Smith MT, 2002, AM J PSYCHIAT, V159, P5, DOI 10.1176/appi.ajp.159.1.5; SPIELMAN AJ, 1987, PSYCHIAT CLIN N AM, V10, P541; Taibi DM, 2007, SLEEP MED REV, V11, P209, DOI 10.1016/j.smrv.2007.03.002; Troxel WM, 2010, SLEEP, V33, P1633, DOI 10.1093/sleep/33.12.1633; van Straten A, 2009, SLEEP MED REV, V13, P61, DOI 10.1016/j.smrv.2008.04.006; Vgontzas AN, 2009, SLEEP, V32, P491, DOI 10.1093/sleep/32.4.491; Vincent N, 2001, SLEEP, V24, P411, DOI 10.1093/sleep/24.4.411; Walsh JK, 2007, SLEEP, V30, P959, DOI 10.1093/sleep/30.8.959; Walsh JK, 2011, SLEEP, V34, P997, DOI 10.5665/SLEEP.1150; Walsh JK, 1998, HUM PSYCHOPHARM CLIN, V13, P191, DOI 10.1002/(SICI)1099-1077(199804)13:3<191::AID-HUP972>3.0.CO;2-X; Walsh JK, 2011, PRINCIPLES PRACTICES, P905	76	464	501	33	287	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2013	309	7					706	716		10.1001/jama.2013.193	http://dx.doi.org/10.1001/jama.2013.193			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	091EK	23423416	Green Accepted, Green Published			2022-12-28	WOS:000315032000026
J	Conti, B; Hansen, M				Conti, Bruno; Hansen, Malene			A Cool Way to Live Long	CELL			English	Editorial Material							LIFE-SPAN; TEMPERATURE; TRPA1	In this issue, Xiao et al. challenge the notion that cold temperatures promote longevity solely through thermodynamic effects. They show that low temperatures activate a cold-sensitive cation channel, TRPA-1, which triggers a complex signaling pathway in both neurons and nonneuronal cells to extend the lifespan of Caenorhabditis elegans.	[Conti, Bruno] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Hansen, Malene] Sanford Burnham Med Res Inst, Del E Webb Neurosci Aging & Stem Cell Res Ctr, Program Dev & Aging, La Jolla, CA 92037 USA	Scripps Research Institute; Sanford Burnham Prebys Medical Discovery Institute	Conti, B (corresponding author), Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.	bconti@scripps.edu; mhansen@sanfordburnham.org		Conti, Bruno/0000-0002-9185-5201	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028040, R01AG039756, R01AG038664] Funding Source: NIH RePORTER; NIA NIH HHS [AG038664, AG039756, AG028040, R01 AG038664] Funding Source: Medline; NIDDK NIH HHS [DK094026] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bartfai Tamas, 2012, Frontiers in Genetics, V3, P184, DOI 10.3389/fgene.2012.00184; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; Fernandes ES, 2012, BRIT J PHARMACOL, V166, P510, DOI 10.1111/j.1476-5381.2012.01851.x; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Lee SJ, 2009, CURR BIOL, V19, P715, DOI 10.1016/j.cub.2009.03.041; LIU RK, 1966, NATURE, V212, P1277, DOI 10.1038/2121277a0; Loeb J, 1916, P NATL ACAD SCI USA, V2, P456, DOI 10.1073/pnas.2.8.456; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Xiao R, 2013, CELL, V152, P806, DOI 10.1016/j.cell.2013.01.020	12	7	9	1	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 14	2013	152	4					671	672		10.1016/j.cell.2013.01.050	http://dx.doi.org/10.1016/j.cell.2013.01.050			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415218	Bronze			2022-12-28	WOS:000314945600003
J	Glickman, Y; Kotler, S; Akerman, N; Ozeri, R				Glickman, Yinnon; Kotler, Shlomi; Akerman, Nitzan; Ozeri, Roee			Emergence of a Measurement Basis in Atom-Photon Scattering	SCIENCE			English	Article							SINGLE-PHOTON; DECOHERENCE; INTERFEROMETER; ENTANGLEMENT	After measurement, a wave-function is postulated to collapse on a predetermined set of states-the measurement basis. Using quantum process tomography, we show how a measurement basis emerges in the evolution of the electronic spin of a single trapped atomic ion after spontaneous photon scattering and detection. This basis is determined by the excitation laser polarization and the direction along which the photon was detected. Quantum tomography of the combined spin-photon state reveals that although photon scattering entangles all superpositions of the measurement-basis states with the scattered photon polarization, the measurement-basis states themselves remain classically correlated with it. Our findings shed light on the process of quantum measurement in atom-photon interactions.	[Glickman, Yinnon; Kotler, Shlomi; Akerman, Nitzan; Ozeri, Roee] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Ozeri, R (corresponding author), Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel.	roee.ozeri@weizmann.ac.il	Kotler, Shlomi/I-4393-2014	Kotler, Shlomi/0000-0002-0191-5777	Israeli Science Foundation; Minerva Foundation; German-Israeli Foundation for scientific research; Crown Photonics Center	Israeli Science Foundation(Israel Science Foundation); Minerva Foundation; German-Israeli Foundation for scientific research(German-Israeli Foundation for Scientific Research and Development); Crown Photonics Center	Y.G. and S.K. have equally contributed to this work. We thank N. Davidsson and D. Stamper-Kurn for useful comments on the manuscript. We gratefully acknowledge the support by the Israeli Science Foundation, the Minerva Foundation, the German-Israeli Foundation for scientific research, the Crown Photonics Center, and M. Kushner Schnur, Mexico.	Akerman N, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.103601; Akerman N, 2012, APPL PHYS B-LASERS O, V107, P1167, DOI 10.1007/s00340-011-4807-6; Blinov BB, 2004, NATURE, V428, P153, DOI 10.1038/nature02377; Brune M, 1996, PHYS REV LETT, V77, P4887, DOI 10.1103/PhysRevLett.77.4887; CHAPMAN MS, 1995, PHYS REV LETT, V75, P3783, DOI 10.1103/PhysRevLett.75.3783; Cohen-Tannoudji Claude, 2006, QUANTUM MECH, V2, P1048; Hume DB, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.120502; Keselman A, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/7/073027; Kokorowski DA, 2001, PHYS REV LETT, V86, P2191, DOI 10.1103/PhysRevLett.86.2191; Lidar DA, 1998, PHYS REV LETT, V81, P2594, DOI 10.1103/PhysRevLett.81.2594; Mei M, 2001, PHYS REV LETT, V86, P559, DOI 10.1103/PhysRevLett.86.559; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Ozeri R, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.030403; Plenio MB, 2007, QUANTUM INF COMPUT, V7, P1; Uys H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.200401; Volz J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.030404; Zurek WH, 2003, REV MOD PHYS, V75, P715, DOI 10.1103/RevModPhys.75.715	19	6	6	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2013	339	6124					1187	1191		10.1126/science.1229650	http://dx.doi.org/10.1126/science.1229650			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471403	Green Submitted			2022-12-28	WOS:000315709900042
J	De Cock, KM; El-Sadr, WM				De Cock, Kevin M.; El-Sadr, Wafaa M.			When to Start ART in Africa - An Urgent Research Priority	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ANTIRETROVIRAL THERAPY		[De Cock, Kevin M.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [El-Sadr, Wafaa M.] Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY USA	Centers for Disease Control & Prevention - USA; Columbia University	De Cock, KM (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069466, UM1AI068619] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 CL999999] Funding Source: Medline; NIAID NIH HHS [UM1 AI069466, UM1 AI068619] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2012, GUID US ANT AG HIV 1; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; WHO, 2010, ANT THER HIV INF AD	4	55	55	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2013	368	10					886	889		10.1056/NEJMp1300458	http://dx.doi.org/10.1056/NEJMp1300458			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100BG	23425131	Green Accepted, Green Published			2022-12-28	WOS:000315669100003
J	Eccles, SR				Eccles, Sinan Robert			PICTURE QUIZ A dangerous complication of thoracocentesis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PULMONARY-EDEMA; REEXPANSION; PNEUMOTHORAX		Wrexham Maelor Hosp, Dept Resp Med, Wrexham LL13 7TD, Clwyd, Wales		Eccles, SR (corresponding author), Wrexham Maelor Hosp, Dept Resp Med, Wrexham LL13 7TD, Clwyd, Wales.	sinaneccles@gmail.com						Aggarwal D, 2008, OPUS 12 SCI, V2, P10; Baik JH, 2010, KOREAN J RADIOL, V11, P164, DOI 10.3348/kjr.2010.11.2.164; Echevarria Carlos, 2008, Interact Cardiovasc Thorac Surg, V7, P485, DOI 10.1510/icvts.2008.178087; Havelock T, 2010, THORAX, V65, P61, DOI 10.1136/thx.2010.137026; Komatsu T, 2010, CAN RESPIR J, V17, P53, DOI 10.1155/2010/259195; O'Driscoll BR, 2008, THORAX, V63, DOI 10.1136/thx.2008.102947; Papakonstantinou DK, 2007, INT J CARDIOL, V114, P398, DOI 10.1016/j.ijcard.2005.11.084; SMOLLEJUETTNER FM, 1991, THORAC CARDIOV SURG, V39, P162, DOI 10.1055/s-2007-1013955; SUZUKI S, 1992, CHEST, V101, P275, DOI 10.1378/chest.101.1.275; Tarver RD, 1996, J THORAC IMAG, V11, P198, DOI 10.1097/00005382-199601130-00004	10	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2013	346								f1048	10.1136/bmj.f1048	http://dx.doi.org/10.1136/bmj.f1048			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104MN	23462407				2022-12-28	WOS:000315997600001
J	Kalantarian, S; Stern, TA; Mansour, M; Ruskin, JN				Kalantarian, Shadi; Stern, Theodore A.; Mansour, Moussa; Ruskin, Jeremy N.			Cognitive Impairment Associated With Atrial Fibrillation A Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							VASCULAR RISK-FACTORS; C-REACTIVE PROTEIN; POSTSTROKE DEMENTIA; CEREBRAL INFARCTION; HEART-FAILURE; UNITED-STATES; STROKE; DECLINE; POPULATION; FREQUENCY	Background: Atrial fibrillation (AF) has been linked with an increased risk for cognitive impairment and dementia. Purpose: To complete a meta-analysis of studies examining the association between AF and cognitive impairment. Data Sources: Search of MEDLINE, PsycINFO, Cochrane Library, CINAHL, and EMBASE databases and hand search of article references. Study Selection: Prospective and nonprospective studies reporting adjusted risk estimates for the association between AF and cognitive impairment. Data Extraction: Two abstracters independently extracted data on study characteristics, risk estimates, methods of AF and outcome ascertainment, and methodological quality. Data Synthesis: Twenty-one studies were included in the meta-analysis. Atrial fibrillation was significantly associated with a higher risk for cognitive impairment in patients with first-ever or recurrent stroke (relative risk [RR], 2.70 [95% CI, 1.82 to 4.00]) and in a broader population including patients with or without a history of stroke (RR, 1.40 [CI, 1.19 to 1.64]). The association in the latter group remained significant independent proof of clinical stroke history (RR, 1.34 [CI, 1.13 to 1.58]). However, there was significant heterogeneity among studies of the broader population (I-2 = 69.4%). Limiting the analysis to prospective studies yielded similar results (RR, 1.36 [CI, 1.12 to 1.65]). Restricting the analysis to studies of dementia eliminated the significant heterogeneity (P = 0.137) but did not alter the pooled estimate substantially (RR, 1.38 [CI, 1.22 to 1.56]). Limitations: There is an inherent bias because of confounding variables in observational studies. There was significant heterogeneity among included studies. Conclusion: Evidence suggests that AF is associated with a higher risk for cognitive impairment and dementia, with or without a history of clinical stroke. Further studies are required to elucidate the association between AF and subtypes of dementia as well as the cause of cognitive impairment.	[Ruskin, Jeremy N.] Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, Boston, MA 02114 USA; Massachusetts Gen Hosp, Inst Heart Vasc & Stroke Care, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Ruskin, JN (corresponding author), Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, 55 Fruit St,GRB 109, Boston, MA 02114 USA.	jruskin@partners.org			Deane Institute for Integrative Research in Atrial Fibrillation and Stroke at Massachusetts General Hospital; Harvard Catalyst; Harvard Clinical and Translational Science Center (National Institutes of Health) [UL1 RR 025758]; Harvard University; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER	Deane Institute for Integrative Research in Atrial Fibrillation and Stroke at Massachusetts General Hospital; Harvard Catalyst; Harvard Clinical and Translational Science Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Grant Support: By the Deane Institute for Integrative Research in Atrial Fibrillation and Stroke at Massachusetts General Hospital. This work was conducted with support from Harvard Catalyst and the Harvard Clinical and Translational Science Center (National Institutes of Health Award UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health care centers).	Abba K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008122.pub2; Altieri M, 2004, NEUROLOGY, V62, P2193, DOI 10.1212/01.WNL.0000130501.79012.1A; Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Anderson JL, 2004, AM J CARDIOL, V94, P1255, DOI 10.1016/j.amjcard.2004.07.108; Barba R, 2000, STROKE, V31, P1494, DOI 10.1161/01.STR.31.7.1494; Barber M, 2004, J THROMB HAEMOST, V2, P1873, DOI 10.1111/j.1538-7836.2004.00993.x; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Bilato C, 2009, AM J CARDIOL, V104, P1092, DOI 10.1016/j.amjcard.2009.05.058; Brands AMA, 2005, DIABETES CARE, V28, P726, DOI 10.2337/diacare.28.3.726; Bunch TJ, 2010, HEART RHYTHM, V7, P433, DOI 10.1016/j.hrthm.2009.12.004; Cacciatore F, 1998, J AM GERIATR SOC, V46, P1343, DOI 10.1111/j.1532-5415.1998.tb05999.x; Centers of Disease Control and Prevention/National Center for Health Statistics, CLASS DIS FUNCT DIS; Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x; Crandall MA, 2009, PACE, V32, P648, DOI 10.1111/j.1540-8159.2009.02339.x; de Leeuw FE, 2000, NEUROLOGY, V54, P1795, DOI 10.1212/WNL.54.9.1795; Debette Stephanie, 2007, Congest Heart Fail, V13, P205, DOI 10.1111/j.1527-5299.2007.06612.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dublin S, 2011, J AM GERIATR SOC, V59, P1369, DOI 10.1111/j.1532-5415.2011.03508.x; Duron E, 2008, VASC HEALTH RISK MAN, V4, P363; Elias Merrill F, 2006, J Stroke Cerebrovasc Dis, V15, P214, DOI 10.1016/j.jstrokecerebrovasdis.2006.05.009; ELIAS MF, 1993, AM J EPIDEMIOL, V138, P353, DOI 10.1093/oxfordjournals.aje.a116868; EZEKOWITZ MD, 1995, CIRCULATION, V92, P2178, DOI 10.1161/01.CIR.92.8.2178; Farina E, 1997, ACTA NEUROL SCAND, V96, P310; FEINBERG WM, 1990, ARCH INTERN MED, V150, P2340, DOI 10.1001/archinte.150.11.2340; Forti P, 2007, ARCH GERONTOL GERIAT, V44, P155, DOI 10.1016/j.archger.2007.01.023; Hebert LE, 2001, ALZ DIS ASSOC DIS, V15, P169, DOI 10.1097/00002093-200110000-00002; Inzitari D, 1998, STROKE, V29, P2087, DOI 10.1161/01.STR.29.10.2087; Jozwiak A, 2006, AM J CARDIOL, V98, P1238, DOI 10.1016/j.amjcard.2006.05.058; Khan Maria, 2012, BMC Res Notes, V5, P89, DOI 10.1186/1756-0500-5-89; Knopman D, 2001, NEUROLOGY, V56, P42, DOI 10.1212/WNL.56.1.42; Kwok CS, 2011, NEUROLOGY, V76, P914, DOI 10.1212/WNL.0b013e31820f2e38; LAVY S, 1980, STROKE, V11, P35, DOI 10.1161/01.STR.11.1.35; Li J, 2011, NEUROLOGY, V76, P1485, DOI 10.1212/WNL.0b013e318217e7a4; Marengoni A, 2011, NEUROBIOL AGING, V32, P1336, DOI 10.1016/j.neurobiolaging.2009.08.002; Marzona I, 2012, CAN MED ASSOC J, V184, pE329, DOI 10.1503/cmaj.111173; Mizrahi EH, 2011, AM J ALZHEIMERS DIS, V26, P623, DOI 10.1177/1533317511432733; Ott A, 1997, STROKE, V28, P316, DOI 10.1161/01.STR.28.2.316; Park H, 2007, AGE AGEING, V36, P157, DOI 10.1093/ageing/afl164; Peters R, 2009, J HYPERTENS, V27, P2055, DOI 10.1097/HJH.0b013e32832f4f02; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sterne JAC, 2011, COCHRANE HDB SYSTEMA; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tang WK, 2006, J GERIATR PSYCH NEUR, V19, P65, DOI 10.1177/0891988706286230; Thompson S, 2011, INT J EPIDEMIOL, V40, P765, DOI 10.1093/ije/dyq248; Tilvis RS, 2004, J GERONTOL A-BIOL, V59, P268; Tooth L, 2005, AM J EPIDEMIOL, V161, P280, DOI 10.1093/aje/kwi042; Vogels RLC, 2007, EUR J HEART FAIL, V9, P440, DOI 10.1016/j.ejheart.2006.11.001; Zhou DHD, 2004, J NEUROL, V251, P421, DOI 10.1007/s00415-004-0337-z	51	266	285	2	39	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2013	158	5	1				338	+		10.7326/0003-4819-158-5-201303050-00007	http://dx.doi.org/10.7326/0003-4819-158-5-201303050-00007			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105HP	23460057	Green Accepted			2022-12-28	WOS:000316057700005
J	McDonald, KM; Matesic, B; Contopoulos-Ioannidis, DG; Lonhart, J; Schmidt, E; Pineda, N; Ioannidis, JPA				McDonald, Kathryn M.; Matesic, Brian; Contopoulos-Ioannidis, Despina G.; Lonhart, Julia; Schmidt, Eric; Pineda, Noelle; Ioannidis, John P. A.			Patient Safety Strategies Targeted at Diagnostic Errors A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Article							COMPUTER-AIDED DIAGNOSIS; PROSPECTIVE RANDOMIZED-TRIAL; TERTIARY TRAUMA SURVEY; EARLY PAIN RELIEF; SURGICAL PATHOLOGY; DECISION-SUPPORT; ABDOMINAL-PAIN; PRIMARY-CARE; 2ND OPINION; PREDICTIVE INSTRUMENT	Missed, delayed, or incorrect diagnosis can lead to inappropriate patient care, poor patient outcomes, and increased cost. This systematic review analyzed evaluations of interventions to prevent diagnostic errors. Searches used MEDLINE (1966 to October 2012), the Agency for Healthcare Research and Quality's Patient Safety Network, bibliographies, and prior systematic reviews. Studies that evaluated any intervention to decrease diagnostic errors in any clinical setting and with any study design were eligible, provided that they addressed a patient-related outcome. Two independent reviewers extracted study data and rated study quality. There were 109 studies that addressed 1 or more intervention categories: personnel changes (n = 6), educational interventions (n = 11), technique (n = 23), structured process changes (n = 27), technology-based systems interventions (n = 32), and review methods (n = 38). Of 14 randomized trials, which were rated as having mostly low to moderate risk of bias, 11 reported interventions that reduced diagnostic errors. Evidence seemed strongest for technology-based systems (for example, text message alerting) and specific techniques (for example, testing equipment adaptations). Studies provided no information on harms, cost, or contextual application of interventions. Overall, the review showed a growing field of diagnostic error research and categorized and identified promising interventions that warrant evaluation in large studies across diverse settings. Ann Intern Med. 2013;158:381-389. www.annals.org	Stanford Univ, Stanford Ctr Hlth Policy, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; Stanford Univ, Sch Humanities & Sci, Stanford, CA 94305 USA; Palo Alto Med Fdn, Res Inst, Palo Alto, CA 94301 USA	Stanford University; Stanford University; Stanford University; Stanford University; Palo Alto Medical Foundation Research Institute	McDonald, KM (corresponding author), Stanford Univ, 117 Encina Commons, Stanford, CA 94305 USA.	Kathryn.McDonald@stanford.edu	Schmidt, Eric/AAX-1584-2020; Ioannidis, John P. A./G-9836-2011	Schmidt, Eric/0000-0002-9181-6771; Marlow, Julia/0000-0001-7540-3929	AHRQ, U.S. Department of Health and Human Services [HHSA-290-2007-100621]; AHRQ	AHRQ, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Financial Support: From the AHRQ, U.S. Department of Health and Human Services (contract HHSA-290-2007-100621).; Potential Conflicts of Interest: Ms. McDonald: Grant (money to institution): AHRQ. Mr. Schmidt: Grant (money to institution): AHRQ. All other authors had no disclosures to report. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOflnterestForms.do?msNum=M12-2571.	ATTARD AR, 1992, BRIT MED J, V305, P554, DOI 10.1136/bmj.305.6853.554; Bachur RG, 2012, PEDIATRICS, V129, P877, DOI 10.1542/peds.2011-3375; Beigi B, 2007, EUR J OPHTHALMOL, V17, P485, DOI 10.1177/112067210701700401; Biffl WL, 2003, J TRAUMA, V54, P38, DOI 10.1097/00005373-200301000-00005; Bishop TF, 2011, JAMA-J AM MED ASSOC, V305, P2427, DOI 10.1001/jama.2011.813; Bogusevicius A, 2002, EUR J SURG, V168, P78; Borgstein PJ, 1997, SURG ENDOSC-ULTRAS, V11, P923, DOI 10.1007/s004649900488; Brossner C, 2000, EUR UROL, V37, P65, DOI 10.1159/000020102; Bruner JM, 1997, CANCER, V79, P796, DOI 10.1002/(SICI)1097-0142(19970215)79:4<796::AID-CNCR17>3.0.CO;2-V; Buchner AM, 2011, GASTROINTEST ENDOSC, V73, P1223, DOI 10.1016/j.gie.2011.01.060; Callen JL, 2012, J GEN INTERN MED, V27, P1334, DOI 10.1007/s11606-011-1949-5; Canon CL, 2003, AM J ROENTGENOL, V181, P1607, DOI 10.2214/ajr.181.6.1811607; CAREWMCCOLL M, 1983, BRIT J CLIN PRACT, V37, P375; Casalino LP, 2009, ARCH INTERN MED, V169, P1123, DOI 10.1001/archinternmed.2009.130; Chem CH, 2005, ANN EMERG MED, V45, P15, DOI 10.1016/j.annemergmed.2004.08.012; Ciatto S, 1995, J Med Screen, V2, P99; Cosby KS, 2003, ANN EMERG MED, V42, P815, DOI 10.1016/S0196-0644(03)00635-8; Cupples TE, 2005, AM J ROENTGENOL, V185, P944, DOI 10.2214/AJR.04.1300; David Consuelo V, 2011, Dermatol Online J, V17, P1; de Vries EN, 2011, ANN SURG, V253, P624, DOI 10.1097/SLA.0b013e3182068880; DELACEY G, 1980, BRIT J RADIOL, V53, P304, DOI 10.1259/0007-1285-53-628-304; Dudley M, 1997, J ACCID EMERG MED, V14, P307; Duijm LEM, 2007, J NATL CANCER I, V99, P1162, DOI 10.1093/jnci/djm050; Ely JW, 2011, ACAD MED, V86, P307, DOI 10.1097/ACM.0b013e31820824cd; ENDERSON BL, 1990, J TRAUMA, V30, P666, DOI 10.1097/00005373-199006000-00002; Espinosa JA, 2000, BRIT MED J, V320, P737, DOI 10.1136/bmj.320.7237.737; Etchells E, 2011, BMJ QUAL SAF, V20, P924, DOI 10.1136/bmjqs.2010.051110; Fenton JJ, 2007, NEW ENGL J MED, V356, P1399, DOI 10.1056/NEJMoa066099; Fitzgerald M, 2011, ARCH SURG-CHICAGO, V146, P218, DOI 10.1001/archsurg.2010.333; Fridriksson S, 2001, ACTA NEUROL SCAND, V103, P238; GALASKO CSB, 1971, BRIT MED J, V1, P643, DOI 10.1136/bmj.1.5750.643; Garcia EA, 2011, J CLIN HYPERTENS, V13, P487, DOI 10.1111/j.1751-7176.2011.00443.x; Giardina TD, 2011, JAMA-J AM MED ASSOC, V306, P2502, DOI 10.1001/jama.2011.1797; GLEADHILL DNS, 1987, BRIT MED J, V294, P943, DOI 10.1136/bmj.294.6577.943; Goodyear N, 2008, ARCH PATHOL LAB MED, V132, P1792, DOI 10.1043/1543-2165-132.11.1792; Graber ML, 2012, BMJ QUAL SAF, V21, P535, DOI 10.1136/bmjqs-2011-000149; Graber ML, 2009, ADV HEALTH SCI EDUC, V14, P107, DOI 10.1007/s10459-009-9183-1; Gur D, 2004, J NATL CANCER I, V96, P185, DOI 10.1093/jnci/djh067; Hamady ZZR, 2005, EJSO-EUR J SURG ONC, V31, P74, DOI 10.1016/j.ejso.2004.08.010; Hewett DG, 2010, GASTROINTEST ENDOSC, V72, P775, DOI 10.1016/j.gie.2010.04.030; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Howard Janet, 2006, J Trauma Nurs, V13, P89; Itri JN, 2011, AM J ROENTGENOL, V197, pW696, DOI 10.2214/AJR.11.6962; Jacobs MJE, 2002, BRIT J ORAL MAX SURG, V40, P156, DOI 10.1054/bjom.2001.0751; Jiang YL, 2001, RADIOLOGY, V220, P787, DOI 10.1148/radiol.220001257; Johnson AJ, 2011, INT ORTHOP, V35, P1621, DOI 10.1007/s00264-010-1175-5; Kakeda S, 2004, AM J ROENTGENOL, V182, P505, DOI 10.2214/ajr.182.2.1820505; KLASSEN TP, 1993, ANN EMERG MED, V22, P1524, DOI 10.1016/S0196-0644(05)81252-1; Kline JA, 2012, J THROMB HAEMOST, V10, P572, DOI 10.1111/j.1538-7836.2012.04647.x; Kokki H, 2005, ARCH PEDIAT ADOL MED, V159, P320, DOI 10.1001/archpedi.159.4.320; KUNDEL HL, 1990, INVEST RADIOL, V25, P890, DOI 10.1097/00004424-199008000-00004; Kuperman GJ, 1999, J AM MED INFORM ASSN, V6, P512, DOI 10.1136/jamia.1999.0060512; Kwek BH, 2003, ANN ACAD MED SINGAP, V32, P438; Larson EM, 2011, INT J TUBERC LUNG D, V15, P1504, DOI 10.5588/ijtld.11.0015; LEAPER DJ, 1972, BRIT MED J, V4, P350, DOI 10.1136/bmj.4.5836.350; Leufkens AM, 2011, GASTROINTEST ENDOSC, V73, P480, DOI 10.1016/j.gie.2010.09.004; Lewis G, 1996, FAM PRACT, V13, P120, DOI 10.1093/fampra/13.2.120; LIND AC, 1995, AM J CLIN PATHOL, V104, P560; LINVER MN, 1992, RADIOLOGY, V184, P39, DOI 10.1148/radiology.184.1.1609100; Lufkin KC, 1998, ANN EMERG MED, V31, P202, DOI 10.1016/S0196-0644(98)70307-5; MacLean JE, 2011, J CYST FIBROS, V10, P333, DOI 10.1016/j.jcf.2011.04.002; Major K, 2002, AM SURGEON, V68, P1057; Manion E, 2008, AM J SURG PATHOL, V32, P732, DOI 10.1097/PAS.0b013e31815a04f5; MCCARTHY PL, 1990, J PEDIATR-US, V116, P200, DOI 10.1016/S0022-3476(05)82875-6; MCPHEE SJ, 1989, ARCH INTERN MED, V149, P1866, DOI 10.1001/archinte.149.8.1866; Meier FA, 2011, ADV ANAT PATHOL, V18, P406, DOI 10.1097/PAP.0b013e318229bf20; Metcalfe J., 1994, METACOGNITION KNOWIN; Moore LJ, 2009, J TRAUMA, V66, P1539, DOI 10.1097/TA.0b013e3181a3ac4b; Mueller CA, 2010, CROAT MED J, V51, P493, DOI 10.3325/cmj.2010.51.493; Murphy R, 2010, BRIT J RADIOL, V83, P331, DOI 10.1259/bjr/65634575; Nam YS, 2001, DIS COLON RECTUM, V44, P86, DOI 10.1007/BF02234827; Naughton CK, 2000, J UROLOGY, V164, P388, DOI 10.1016/S0022-5347(05)67367-3; Nishikawa RM, 2012, AM J ROENTGENOL, V198, P708, DOI 10.2214/AJR.11.6423; Nordrum I, 2004, HUM PATHOL, V35, P129, DOI 10.1016/j.humpath.2003.08.010; Olsson SE, 2006, CLIN PHYSIOL FUNCT I, V26, P151, DOI 10.1111/j.1475-097X.2006.00669.x; Parameswaran L, 2008, HUM PATHOL, V39, P579, DOI 10.1016/j.humpath.2007.08.015; Park HI, 2008, ANN CLIN LAB SCI, V38, P149; Peldschus K, 2005, CHEST, V128, P1517, DOI 10.1378/chest.128.3.1517; Perno JF, 2005, PEDIATR EMERG CARE, V21, P367, DOI 10.1097/01.pec.0000166726.84308.cf; Phillips RL, 2004, QUAL SAF HEALTH CARE, V13, P121, DOI 10.1136/qshc.2003.008029; Piliouras P, 2011, AUSTRALAS J DERMATOL, V52, P191, DOI 10.1111/j.1440-0960.2011.00790.x; Piva E, 2009, AM J CLIN PATHOL, V131, P432, DOI 10.1309/AJCPYS80BUCBXTUH; Poon EG, 2002, J AM MED INFORM ASSN, V9, P217, DOI 10.1197/jamia.M1009; POZEN MW, 1984, NEW ENGL J MED, V310, P1273, DOI 10.1056/NEJM198405173102001; Presti JC, 2000, J UROLOGY, V163, P163, DOI 10.1016/S0022-5347(05)67995-5; Prieto VG, 2003, AM J CLIN PATHOL, V120, P203, DOI 10.1309/J1Q0V35EUTMVR193; Raab SS, 2006, AM J CLIN PATHOL, V125, P526, DOI 10.1309/TKNM9GRGPL2JT95Y; Raab SS, 2006, ARCH PATHOL LAB MED, V130, P337; Raab SS, 2006, AM J OBSTET GYNECOL, V194, P57, DOI 10.1016/j.ajog.2005.06.069; Raab SS, 2008, AM J CLIN PATHOL, V130, P905, DOI 10.1309/AJCPPIA5D7MYKDWF; Raab SS, 2008, ARCH PATHOL LAB MED, V132, P16, DOI 10.1043/1543-2165(2008)132[16:TEOCMO]2.0.CO;2; Ramnarayan Padmanabhan, 2006, BMC Med Inform Decis Mak, V6, P37, DOI 10.1186/1472-6947-6-37; Ravery V, 2000, J UROLOGY, V164, P393, DOI 10.1016/S0022-5347(05)67368-5; Resnick NM, 1996, NEUROUROL URODYNAM, V15, P599, DOI 10.1002/(SICI)1520-6777(1996)15:6<599::AID-NAU2>3.0.CO;2-A; ROBSON N, 1985, CLIN RADIOL, V36, P479, DOI 10.1016/S0009-9260(85)80192-6; Rollman BL, 2002, J GEN INTERN MED, V17, P493, DOI 10.1046/j.1525-1497.2002.10421.x; Ross PD, 1996, J BONE MINER RES, V11, P1793; Sakr M, 1999, LANCET, V354, P1321, DOI 10.1016/S0140-6736(99)02447-2; Schiff GD., 2005, ADV PATIENT SAF; Schiff GD, 2009, ARCH INTERN MED, V169, P1881, DOI 10.1001/archinternmed.2009.333; Schriger DL, 2001, ANN EMERG MED, V37, P132, DOI 10.1067/mem.2001.112255; Selbst SM, 2005, PEDIATR EMERG CARE, V21, P214; Selker HP, 1998, ANN INTERN MED, V129, P845, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00002; SELTZER SE, 1981, AM J ROENTGENOL, V137, P129, DOI 10.2214/ajr.137.1.129; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849; Singh H, 2012, BMJ QUAL SAF, V21, P160, DOI 10.1136/bmjqs-2011-000150; Singh H, 2010, PEDIATRICS, V126, P70, DOI 10.1542/peds.2009-3218; Singh H, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-49; Singh P, 2006, BRIT DENT J, V201, P717, DOI 10.1038/sj.bdj.4814304; Soundappan SVS, 2004, J TRAUMA, V57, P114, DOI 10.1097/01.TA.0000108992.51091.F7; Swanson JO, 2012, AM J ROENTGENOL, V198, P1121, DOI 10.2214/AJR.11.6724; Tehrani AS, 2011, 33 ANN M SOC MED DEC; Thaler T, 2010, J ELECTROCARDIOL, V43, P676, DOI 10.1016/j.jelectrocard.2010.05.007; Thiesse P, 1997, J CLIN ONCOL, V15, P3507, DOI 10.1200/JCO.1997.15.12.3507; THOMAS DC, 1981, J CHRON DIS, V34, P617, DOI 10.1016/0021-9681(81)90061-8; THOMAS HG, 1992, INJURY, V23, P47, DOI 10.1016/0020-1383(92)90126-D; Thomas SH, 2003, J AM COLL SURGEONS, V196, P18, DOI 10.1016/S1072-7515(02)01480-1; Trotter MJ, 2003, ARCH PATHOL LAB MED, V127, P1489; Tsai JJ, 2005, AM J KIDNEY DIS, V46, P820, DOI 10.1053/j.ajkd.2005.07.039; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Ursprung R, 2005, QUAL SAF HEALTH CARE, V14, P284, DOI 10.1136/qshc.2004.012542; Vermeulen B, 1999, RADIOLOGY, V210, P639, DOI 10.1148/radiology.210.3.r99fe54639; Vernon DD, 1999, PEDIATRICS, V103, P20, DOI 10.1542/peds.103.1.20; Weatherburn G, 2000, J ACCID EMERG MED, V17, P180; WELLWOOD J, 1992, ANN ROY COLL SURG, V74, P40; Westra WH, 2002, HEAD NECK-J SCI SPEC, V24, P684, DOI 10.1002/hed.10105; WEXLER JR, 1975, AM J DIS CHILD, V129, P203, DOI 10.1001/archpedi.1975.02120390037008; Zheng YP, 2012, AM J GASTROENTEROL, V107, P554, DOI 10.1038/ajg.2011.461	129	92	93	0	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2013	158	5	2				381	+		10.7326/0003-4819-158-5-201303051-00004	http://dx.doi.org/10.7326/0003-4819-158-5-201303051-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105HX	23460094				2022-12-28	WOS:000316058600004
J	Lauberth, SM; Nakayama, T; Wu, XL; Ferris, AL; Tang, ZY; Hughes, SH; Roeder, RG				Lauberth, Shannon M.; Nakayama, Takahiro; Wu, Xiaolin; Ferris, Andrea L.; Tang, Zhanyun; Hughes, Stephen H.; Roeder, Robert G.			H3K4me3 Interactions with TAF3 Regulate Preinitiation Complex Assembly and Selective Gene Activation	CELL			English	Article							RNA-POLYMERASE-II; CHROMATIN IN-VITRO; HISTONE MODIFICATIONS; CORE PROMOTER; DEPENDENT TRANSCRIPTION; BINDING MODULES; DNA-DAMAGE; P53; APOPTOSIS; TRIMETHYLATION	Histone modifications regulate chromatin-dependent processes, yet the mechanisms by which they contribute to specific outcomes remain unclear. H3K4me3 is a prominent histone mark that is associated with active genes and promotes transcription through interactions with effector proteins that include initiation factor TFIID. We demonstrate that H3K4me3-TAF3 interactions direct global TFIID recruitment to active genes, some of which are p53 targets. Further analyses show that (1) H3K4me3 enhances p53-dependent transcription by stimulating preinitiation complex (PIC) formation; (2) H3K4me3, through TAF3 interactions, can act either independently or cooperatively with the TATA box to direct PIC formation and transcription; and (3) H3K4me3-TAF3/TFIID interactions regulate gene-selective functions of p53 in response to genotoxic stress. Our findings indicate a mechanism by which H3K4me3 directs PIC assembly for the rapid induction of specific p53 target genes.	[Lauberth, Shannon M.; Nakayama, Takahiro; Tang, Zhanyun; Roeder, Robert G.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA; [Wu, Xiaolin] SAIC Frederick Inc, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Ferris, Andrea L.; Hughes, Stephen H.] NCI, HIV Drug Resistance Program, Ctr Canc Res, Frederick, MD 21702 USA	Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Roeder, RG (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA.	roeder@rockefeller.edu		Lauberth, Shannon/0000-0003-4131-8536	NRSA [CA 09673]; NIH, Center for Cancer Research, National Cancer Institute; NIH [CA129325, DK071900]; Leukemia and Lymphoma Society [7132-08]; NATIONAL CANCER INSTITUTE [ZIABC011426, R01CA129325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071900] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Tomoyoshi Nakadai and Zhu Xie for technical assistance and Sohail Malik, Beth Moorefield, Christina Hughes, and Michael Rauchman for insightful discussions of the project. This work was supported by NRSA Training Grant CA 09673 to S. L., the Intramural Research Program of the NIH, Center for Cancer Research, National Cancer Institute to S. H. H., and by grants from the NIH (CA129325 and DK071900) and the Leukemia and Lymphoma Society (7132-08) to R.G.R.	An WJ, 2004, METHOD ENZYMOL, V377, P460; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Deato MDE, 2008, MOL CELL, V32, P96, DOI 10.1016/j.molcel.2008.09.009; Deato MDE, 2007, GENE DEV, V21, P2137, DOI 10.1101/gad.1583407; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Espinoza CA, 2004, NAT STRUCT MOL BIOL, V11, P822, DOI 10.1038/nsmb812; Ferris AL, 2010, P NATL ACAD SCI USA, V107, P3135, DOI 10.1073/pnas.0914142107; Gangloff YG, 2001, MOL CELL BIOL, V21, P5109, DOI 10.1128/MCB.21.15.5109-5121.2001; Hart DO, 2009, DEV DYNAM, V238, P2540, DOI 10.1002/dvdy.22083; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hsu JY, 2008, GENE DEV, V22, P2353, DOI 10.1101/gad.1681808; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kundu TK, 2000, MOL CELL, V6, P551, DOI 10.1016/S1097-2765(00)00054-X; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lin JJ, 2011, GENE DEV, V25, P2198, DOI 10.1101/gad.17554711; Liu Z, 2011, CELL, V146, P720, DOI 10.1016/j.cell.2011.08.005; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; OSHEAGREENFIELD A, 1992, J BIOL CHEM, V267, P1391; Prives C, 1999, J PATHOL, V187, P112; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; van Ingen H, 2008, STRUCTURE, V16, P1245, DOI 10.1016/j.str.2008.04.015; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Vermeulen M, 2010, EPIGENOMICS-UK, V2, P395, DOI 10.2217/EPI.10.11; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	43	250	257	1	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 28	2013	152	5					1021	1036		10.1016/j.cell.2013.01.052	http://dx.doi.org/10.1016/j.cell.2013.01.052			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452851	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000315710300011
J	Sampaolesi, M; Blot, S; D'Antona, G; Granger, N; Tonlorenzi, R; Innocenzi, A; Mognol, P; Thibaud, JL; Galvez, BG; Barthelemy, I; Perani, L; Mantero, S; Guttinger, M; Pansarasa, O; Rinaldi, C; De Angelis, MGC; Torrente, Y; Bordignon, C; Bottinelli, R; Cossu, G				Sampaolesi, Maurilio; Blot, Stephane; D'Antona, Giuseppe; Granger, Nicolas; Tonlorenzi, Rossana; Innocenzi, Anna; Mognol, Paolo; Thibaud, Jean-Lauren; Galvez, Beatriz G.; Barthelemy, Ines; Perani, Laura; Mantero, Sara; Guttinger, Maria; Pansarasa, Orietta; Rinaldi, Chiara; De Angelis, M. Gabriella Cusella; Torrente, Yvan; Bordignon, Claudio; Bottinelli, Roberto; Cossu, Giulio			Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs (vol 444, pg 574, 2006)	NATURE			English	Correction													Mantero, Sara/F-6587-2013; Bottinelli, Roberto/AAC-1904-2020; Tonlorenzi, Rossana/AAN-2241-2020; Perani, Laura/AAN-2838-2020; Blot, Stephane/F-7420-2011; Sampaolesi, Maurilio/H-6509-2013	Bottinelli, Roberto/0000-0002-4960-7490; Perani, Laura/0000-0001-8616-3377; Granger, Nicolas/0000-0002-3036-3908; Blot, Stephane/0000-0002-8982-0317; Sampaolesi, Maurilio/0000-0002-2422-3757; Barthelemy, Ines/0000-0002-4747-5893				Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282	1	4	4	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2013	494	7438					506	506		10.1038/nature11976	http://dx.doi.org/10.1038/nature11976			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23426261	Bronze			2022-12-28	WOS:000315661500046
J	Spruijt, CG; Gnerlich, F; Smits, AH; Pfaffeneder, T; Jansen, PWTC; Bauer, C; Munzel, M; Wagner, M; Muller, M; Khan, F; Eberl, HC; Mensinga, A; Brinkman, AB; Lephikov, K; Muller, U; Walter, J; Boelens, R; van Ingen, H; Leonhardt, H; Carell, T; Vermeulen, M				Spruijt, Cornelia G.; Gnerlich, Felix; Smits, Arne H.; Pfaffeneder, Toni; Jansen, Pascal W. T. C.; Bauer, Christina; Muenzel, Martin; Wagner, Mirko; Mueller, Markus; Khan, Fariha; Eberl, H. Christian; Mensinga, Anneloes; Brinkman, Arie B.; Lephikov, Konstantin; Mueller, Udo; Walter, Joern; Boelens, Rolf; van Ingen, Hugo; Leonhardt, Heinrich; Carell, Thomas; Vermeulen, Michiel			Dynamic Readers for 5-(Hydroxy)Methylcytosine and Its Oxidized Derivatives	CELL			English	Article							EMBRYONIC STEM-CELLS; HEMI-METHYLATED DNA; ONCOMETABOLITE 2-HYDROXYGLUTARATE; INTERACTION PROTEOMICS; MAMMALIAN DNA; PROTEIN; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; QUANTIFICATION; CHROMATIN	Tet proteins oxidize 5-methylcytosine (mC) to generate 5-hydroxymethyl (hmC), 5-formyl (fC), and 5-carboxylcytosine (caC). The exact function of these oxidative cytosine bases remains elusive. We applied quantitative mass-spectrometry-based proteomics to identify readers for mC and hmC in mouse embryonic stem cells (mESC), neuronal progenitor cells (NPC), and adult mouse brain tissue. Readers for these modifications are only partially overlapping, and some readers, such as Rfx proteins, display strong specificity. Interactions are dynamic during differentiation, as for example evidenced by the mESC-specific binding of Klf4 to mC and the NPC-specific binding of Uhrf2 to hmC, suggesting specific biological roles for mC and hmC. Oxidized derivatives of mC recruit distinct transcription regulators as well as a large number of DNA repair proteins in mouse ES cells, implicating the DNA damage response as a major player in active DNA demethylation.	[Spruijt, Cornelia G.; Smits, Arne H.; Jansen, Pascal W. T. C.; Mensinga, Anneloes; Vermeulen, Michiel] UMC Utrecht, Dept Mol Canc Res Prote & Chromatin Biol, NL-3584 CG Utrecht, Netherlands; [Gnerlich, Felix; Pfaffeneder, Toni; Muenzel, Martin; Wagner, Mirko; Mueller, Markus; Carell, Thomas] Univ Munich, Fak Chem & Pharm, Ctr Integrated Prot Sci, D-81377 Munich, Germany; [Bauer, Christina; Mueller, Udo; Leonhardt, Heinrich] Univ Munich, Fak Biol, Ctr Integrated Prot Sci, D-82152 Planegg Martinsried, Germany; [Khan, Fariha] Pir Mehr Ali Shah Arid Agr Univ Rawalpindi, Univ Inst Biochem & Biotechnol, Rawalpindi, Pakistan; [Khan, Fariha; Boelens, Rolf; van Ingen, Hugo] Univ Utrecht, Bijvoet Ctr Biomol Res, NMR Spect Res Grp, NL-3584 CH Utrecht, Netherlands; [Eberl, H. Christian] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Brinkman, Arie B.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Mol Biol, NL-6525 GA Nijmegen, Netherlands; [Lephikov, Konstantin; Walter, Joern] Univ Saarland, D-66123 Saarbrucken, Germany	Utrecht University; Utrecht University Medical Center; University of Munich; University of Munich; Arid Agriculture University; Utrecht University; Max Planck Society; Radboud University Nijmegen; Saarland University	Carell, T (corresponding author), Univ Munich, Fak Chem & Pharm, Ctr Integrated Prot Sci, Marchioninistr 15, D-81377 Munich, Germany.	thomas.carell@lmu.de; m.vermeulen-3@umcutrecht.nl	Leonhardt, Heinrich/B-2791-2014; van Ingen, Hugo/Q-2883-2016; Lepikhov, Konstantin/AAN-3634-2021; Walter, Jörn/AFN-6428-2022; Muenzel, Martin/B-3360-2011; Vermeulen, Michiel/C-8883-2013; Pfaffeneder, Toni/D-6171-2014; Boelens, Rolf/B-4702-2009; Khan, Fariha/V-8742-2019; Brinkman, Arie/V-1533-2018; Carell, Thomas/G-4799-2012	van Ingen, Hugo/0000-0002-0808-3811; Walter, Jörn/0000-0003-0563-7417; Vermeulen, Michiel/0000-0003-0836-6894; Boelens, Rolf/0000-0002-6939-8913; Brinkman, Arie/0000-0002-9875-1835; Carell, Thomas/0000-0001-7898-2831; Spruijt, Cornelia/0000-0002-1789-670X; Muenzel, Martin/0000-0002-4504-8281; Eberl, H. Christian/0000-0002-4159-5958; Muller, Markus/0000-0002-3579-3317; Smits, Arne H/0000-0001-5011-0898; Bauer, Christina/0000-0001-9511-2491	DFG Normalverfahren [CA275/8-4, SFB 749, SFB 646]; Volkswagen Foundation; Deutsche Forschungsgemeinschaft (DFG) [SFB 646, SPP 1463]; Fonds der Chemischen Industrie; International Research Support Initiative Program from the Higher Education Commission, Pakistan; Dutch Science Foundation Chemical Sciences, NWO-CW; DFG [WA1029/6, SPP1356]; Netherlands Organization for Scientific Research (NWO-VIDI); ERC	DFG Normalverfahren(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); International Research Support Initiative Program from the Higher Education Commission, Pakistan; Dutch Science Foundation Chemical Sciences, NWO-CW; DFG(German Research Foundation (DFG)); Netherlands Organization for Scientific Research (NWO-VIDI)(Netherlands Organization for Scientific Research (NWO)); ERC(European Research Council (ERC)European Commission)	We would like to thank Dr. Jiemin Wong for providing constructs. We are very thankful to Dr. Nikolay Outchkourov for providing NPCs, and we thank Tony Hyman and Ina Poser for providing the BAC-GFP WDR76 cell line. We would also like to thank Deepani Poramba Liyanage for support. Furthermore, we would like to thank all group members that contributed to fruitful discussions and Susan Kloet for critical reading of the manuscript. We thank the PRIDE team for their help uploading the raw mass spec data. Work in the Vermeulen lab is supported by a grant from the Netherlands Organization for Scientific Research (NWO-VIDI) and an ERC Starting Grant. The Carell group thanks the DFG Normalverfahren CA275/8-4, SFB 749, SFB 646, and the Volkswagen Foundation for financial support. Work in the Leonhardt group is supported by the SFB 646 and SPP 1463 grants from The Deutsche Forschungsgemeinschaft (DFG). M. Munzel and T. P. thank the Fonds der Chemischen Industrie for predoctoral fellowships. F. K. is supported through the International Research Support Initiative Program from the Higher Education Commission, Pakistan. H. v. I. is supported by a Veni fellowship from the Dutch Science Foundation Chemical Sciences, NWO-CW. K. L. and J. W. thank the DFG (WA1029/6) for support through SPP1356.	Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Bartels SJJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025884; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Bertonati C, 2009, PROTEINS, V75, P760, DOI 10.1002/prot.22287; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Defossez PA, 2011, PROG MOL BIOL TRANSL, V101, P377, DOI 10.1016/B978-0-12-387685-0.00012-3; Dejosez M, 2008, CELL, V133, P1162, DOI 10.1016/j.cell.2008.05.047; Dennis K, 2001, GENE DEV, V15, P2940, DOI 10.1101/gad.929101; Eberl HC, 2013, MOL CELL, V49, P368, DOI 10.1016/j.molcel.2012.10.026; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Frauer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021306; Gajiwala KS, 2000, NATURE, V403, P916, DOI 10.1038/35002634; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hubner NC, 2011, METHODS, V53, P453, DOI 10.1016/j.ymeth.2010.12.016; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jones DL, 2011, J NEUROPHYSIOL, V105, P1984, DOI 10.1152/jn.00056.2011; KASTAN MB, 1991, CANCER RES, V51, P6304; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Konstandin N, 2011, LEUKEMIA, V25, P1649, DOI 10.1038/leu.2011.134; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Myant K, 2011, GENOME RES, V21, P83, DOI 10.1101/gr.108498.110; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Pichler G, 2011, J CELL BIOCHEM, V112, P2585, DOI 10.1002/jcb.23185; Potts RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024515; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sengupta PK, 1999, J BIOL CHEM, V274, P36649, DOI 10.1074/jbc.274.51.36649; Smits AH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks941; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Toyota H, 2012, CELL MOL BIOL LETT, V17, P36, DOI 10.2478/s11658-011-0034-8; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang B, 2011, J COMP NEUROL, V519, P2320, DOI 10.1002/cne.22618; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Zhang JQ, 2011, CELL RES, V21, P1723, DOI 10.1038/cr.2011.176	51	723	745	6	178	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 28	2013	152	5					1146	1159		10.1016/j.cell.2013.02.004	http://dx.doi.org/10.1016/j.cell.2013.02.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23434322	Bronze			2022-12-28	WOS:000315710300020
J	Jodra, S; Alvarez, C				Jodra, Soraya; Alvarez, Carlos			Pott's Disease of the Thoracic Spine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jodra, Soraya; Alvarez, Carlos] Univ Hosp 12 Octubre, Madrid, Spain	Hospital Universitario 12 de Octubre	Jodra, S (corresponding author), Univ Hosp 12 Octubre, Madrid, Spain.								0	4	4	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2013	368	8					756	756		10.1056/NEJMicm1207442	http://dx.doi.org/10.1056/NEJMicm1207442			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092CG	23425168				2022-12-28	WOS:000315095800010
J	Spence, D				Spence, Des			The cause of clinical variance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Hawkes N, 2012, URGENT REFERRALS SUS	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2013	346								f1122	10.1136/bmj.f1122	http://dx.doi.org/10.1136/bmj.f1122			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096GZ	23422901				2022-12-28	WOS:000315393500014
J	Johnson, AMF; Olefsky, JM				Johnson, Andrew M. F.; Olefsky, Jerrold M.			The Origins and Drivers of Insulin Resistance	CELL			English	Review							DIET-INDUCED OBESITY; HIGH-FAT DIET; NECROSIS-FACTOR-ALPHA; KILLER T-CELLS; ADIPOSE-TISSUE; GUT MICROBIOTA; METABOLIC-SYNDROME; PPAR-GAMMA; MOLECULAR-MECHANISMS; GLUCOSE-TOLERANCE	Obesity-induced insulin resistance is the major determinant of metabolic syndrome, which precedes the development of type 2 diabetes mellitus and is thus the driving force behind the emerging diabetes epidemic. The precise causes of insulin resistance are varied, and the relative importance of each is a matter of ongoing research. Here, we offer a Perspective on the heterogeneous etiology of insulin resistance, focusing in particular on the role of inflammation, lipid metabolism, and the gastrointestinal microbiota.	[Johnson, Andrew M. F.; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jolefsky@ucsd.edu			 [DK033651];  [DK074868];  [DK-063491];  [DK-09062]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303, P50HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R01DK033651, R37DK033651, F32DK009062, P01DK074868] Funding Source: NIH RePORTER	; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants DK033651, DK074868, DK-063491, and DK-09062.	Amar J, 2011, DIABETOLOGIA, V54, P3055, DOI 10.1007/s00125-011-2329-8; Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bernstein LE, 2006, ARCH INTERN MED, V166, P902, DOI 10.1001/archinte.166.8.902; Blumberg R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004184; Boden G, 2002, AM J PHYSIOL-ENDOC M, V283, pE12, DOI 10.1152/ajpendo.00429.2001; Burcelin R, 2012, SEMIN IMMUNOL, V24, P67, DOI 10.1016/j.smim.2011.11.011; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Dominguez H, 2005, J VASC RES, V42, P517, DOI 10.1159/000088261; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Forsythe LKS, 2008, NUTR RES REV, V21, P117, DOI 10.1017/S0954422408138732; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Gordon JI, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004347; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Ji YW, 2012, J BIOL CHEM, V287, P13561, DOI 10.1074/jbc.M112.350066; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Kotas ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025478; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Lemon KP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004183; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li H, 2008, METABOLISM, V57, P1704, DOI 10.1016/j.metabol.2008.07.029; Li JV, 2011, GUT, V60, P1214, DOI 10.1136/gut.2010.234708; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mantell BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019831; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Milanski M, 2012, DIABETES, V61, P1455, DOI 10.2337/db11-0390; Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Muoio DM, 2012, CELL METAB, V15, P595, DOI 10.1016/j.cmet.2012.04.010; Neyrinck AM, 2009, BIOCHEM BIOPH RES CO, V385, P351, DOI 10.1016/j.bbrc.2009.05.070; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Saltiel AR, 2012, CELL METAB, V15, P798, DOI 10.1016/j.cmet.2012.03.001; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schipper HS, 2012, J CLIN INVEST, V122, P3343, DOI 10.1172/JCI62739; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serino M, 2012, GUT, V61, P543, DOI 10.1136/gutjnl-2011-301012; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Simon GM, 2012, P NATL ACAD SCI USA, V109, P11133, DOI 10.1073/pnas.1208669109; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Solomon DH, 2011, JAMA-J AM MED ASSOC, V305, P2525, DOI 10.1001/jama.2011.878; Stanley TL, 2011, J CLIN ENDOCR METAB, V96, pE146, DOI 10.1210/jc.2010-1170; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Strissel KJ, 2010, OBESITY, V18, P1918, DOI 10.1038/oby.2010.1; Teixeira-Lemos E, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-12; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tripathy D, 2003, DIABETES, V52, P2882, DOI 10.2337/diabetes.52.12.2882; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Asseldonk EJP, 2011, J CLIN ENDOCR METAB, V96, P2119, DOI 10.1210/jc.2010-2992; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	99	417	457	13	299	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 14	2013	152	4					673	684		10.1016/j.cell.2013.01.041	http://dx.doi.org/10.1016/j.cell.2013.01.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415219	Bronze			2022-12-28	WOS:000314945600004
J	Kirk, GD; Mehta, SH; Astemborski, J; Galai, N; Washington, J; Higgins, Y; Balagopal, A; Thomas, DL				Kirk, Gregory D.; Mehta, Shruti H.; Astemborski, Jacquie; Galai, Noya; Washington, Jonathan; Higgins, Yvonne; Balagopal, Ashwin; Thomas, David L.			HIV, Age, and the Severity of Hepatitis C Virus-Related Liver Disease A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							INJECTION-DRUG USERS; HUMAN-IMMUNODEFICIENCY; NATURAL-HISTORY; TRANSIENT ELASTOGRAPHY; TELOMERE LENGTH; UNITED-STATES; INFECTION; FIBROSIS; PROGRESSION; COINFECTION	Background: Persons with HIV infection have been reported to develop age-related diseases at younger ages than those without HIV. Whether this finding is related to HIV infection or failure to control for other risk factors is unknown. Objective: To investigate whether persons with HIV infection develop hepatitis C virus (HCV)-related liver disease at younger ages than similar persons without HIV. Design: Comparison of the severity of liver fibrosis by age among persons who have HCV with and without HIV followed concurrently in the same protocol. Setting: Observational cohort from Baltimore, Maryland, participating in the ALIVE (AIDS Linked to the IntraVenous Experience) study. Participants: 1176 current and former injection drug users with antibodies to HCV. Measurements: Liver fibrosis assessed semiannually from 2006 to 2011 by elastography (FibroScan, Echosens, Paris, France) and using previously validated thresholds for clinically significant fibrosis and cirrhosis; concurrent assessment of medical history, alcohol and illicit drug use, HCV RNA levels, hepatitis B virus surface antigen level, body mass index, and (for those with HIV) CD4(+) lymphocyte count and HIV RNA levels. Results: Among 1176 participants with antibodies to HCV, the median age was 49 years and 34% were coinfected with HIV and HCV. Participants contributed 5634 valid liver fibrosis measurements. The prevalence of clinically significant fibrosis without cirrhosis (12.9% vs. 9.5%) and of cirrhosis (19.5% vs. 11.0%) was greater in persons coinfected with HIV and HCV than in those with only HCV (P < 0.001). Increasing age and HIV infection were independently associated with liver fibrosis, as were daily alcohol use, chronic hepatitis B virus infection, body mass index greater than 25 kg/m(2), and greater plasma HCV RNA levels. When these factors were kept constant, persons with HIV had liver fibrosis measurements equal to those of persons without HIV, who were, on average, 9.2 years older. Limitation: The process of liver fibrosis began before the study in most persons. Conclusion: In this cohort, persons who have HCV with HIV have liver fibrosis stages similar to those without HIV who are nearly a decade older.	Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Johns Hopkins Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Thomas, DL (corresponding author), Johns Hopkins Sch Med, Div Infect Dis, Room 437,1830 Monument St, Baltimore, MD 21205 USA.		Galai, Noya/HII-8086-2022		National Institute on Drug Abuse; United States Public Health Service, National Institute of Drug Abuse [R01-DA-016078, R01-DA-04334, R01-DA-12568]; American Cancer Society [MRSG-07-284-01-CCE]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004334, R01DA016078, R01DA012568, U01DA036297] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); United States Public Health Service, National Institute of Drug Abuse; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institute on Drug Abuse.; By United States Public Health Service, National Institute of Drug Abuse (R01-DA-016078, R01-DA-04334, and R01-DA-12568). Dr. Kirk was supported by the American Cancer Society (MRSG-07-284-01-CCE). Support of reagents for HCV RNA testing was generously provided by Abbott Molecular.	Alberti A, 2002, ANN INTERN MED, V137, P961, DOI 10.7326/0003-4819-137-12-200212170-00009; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Darby SC, 1997, LANCET, V350, P1425, DOI 10.1016/S0140-6736(97)05413-5; Di Martino V, 2001, HEPATOLOGY, V34, P1193, DOI 10.1053/jhep.2001.29201; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Garfein RS, 1996, AM J PUBLIC HEALTH, V86, P655, DOI 10.2105/AJPH.86.5.655; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Goedert JJ, 2002, BLOOD, V100, P1584; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hisada M, 2005, HEPATOLOGY, V42, P1446, DOI 10.1002/hep.20938; Hoare M, 2010, J HEPATOL, V53, P252, DOI 10.1016/j.jhep.2010.03.005; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Hulten E, 2009, HEART, V95, P1826, DOI 10.1136/hrt.2009.177774; Justice AC, 2012, CLIN INFECT DIS, V54, P984, DOI 10.1093/cid/cir989; Kirk Gregory D, 2011, Proc Am Thorac Soc, V8, P326, DOI 10.1513/pats.201009-061WR; Kirk GD, 2009, CLIN INFECT DIS, V48, P963, DOI 10.1086/597350; Lichterfeld M, 2008, BLOOD, V112, P3679, DOI 10.1182/blood-2008-01-135442; Martin J, 2010, ANN INTERN MED, V153, P477, DOI 10.7326/0003-4819-153-7-201010050-00013; McMahon BJ, 2010, GASTROENTEROLOGY, V138, P922, DOI 10.1053/j.gastro.2009.10.056; Mehta SH, 2012, ANTIVIR THER, V17, P813, DOI 10.3851/IMP2085; Mehta SH, 2011, J INFECT DIS, V203, P587, DOI 10.1093/infdis/jiq112; Moore RD, 1996, ANN INTERN MED, V124, P633, DOI 10.7326/0003-4819-124-7-199604010-00003; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Pradat P, 2007, LIVER INT, V27, P335, DOI 10.1111/j.1478-3231.2006.01430.x; Qurishi N, 2003, LANCET, V362, P1708, DOI 10.1016/S0140-6736(03)14844-1; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; SHAKIL AO, 1995, ANN INTERN MED, V123, P330, DOI 10.7326/0003-4819-123-5-199509010-00002; Shiels MS, 2010, ANN INTERN MED, V153, P452, DOI 10.7326/0003-4819-153-7-201010050-00008; Thomas DL, 2000, J INFECT DIS, V181, P844, DOI 10.1086/315314; THOMAS DL, 1995, MEDICINE, V74, P212, DOI 10.1097/00005792-199507000-00005; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; VLAHOV D, 1991, J DRUG ISSUES, V21, P759, DOI 10.1177/002204269102100406; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com; Wilson LE, 2006, HEPATOLOGY, V43, P788, DOI 10.1002/hep.21091; Wolthers KC, 1996, SCIENCE, V274, P1543, DOI 10.1126/science.274.5292.1543; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	39	135	139	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 7	2013	158	9					658	+		10.7326/0003-4819-158-9-201305070-00604	http://dx.doi.org/10.7326/0003-4819-158-9-201305070-00604			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146WV	23440167	Green Accepted			2022-12-28	WOS:000319126900003
J	Morgan, GA; Campbell, BA; Carter, LM; Plaut, JJ; Phillips, RJ				Morgan, Gareth A.; Campbell, Bruce A.; Carter, Lynn M.; Plaut, Jeffrey J.; Phillips, Roger J.			3D Reconstruction of the Source and Scale of Buried Young Flood Channels on Mars	SCIENCE			English	Article							CERBERUS FOSSAE; STRATIGRAPHY; PLAINS; WATER; LAVA	Outflow channels on Mars are interpreted as the product of gigantic floods due to the catastrophic eruption of groundwater that may also have initiated episodes of climate change. Marte Vallis, the largest of the young martian outflow channels (<500 million years old), is embayed by lava flows that hinder detailed studies and comparisons with older channel systems. Understanding Marte Vallis is essential to our assessment of recent Mars hydrologic activity during a period otherwise considered to be cold and dry. Using data from the Shallow Radar sounder on the Mars Reconnaissance Orbiter, we present a three-dimensional (3D) reconstruction of buried channels on Mars and provide estimates of paleohydrologic parameters. Our work shows that Cerberus Fossae provided the waters that carved Marte Vallis, and it extended an additional 180 kilometers to the east before the emplacement of the younger lava flows. We identified two stages of channel incision and determined that channel depths were more than twice those of previous estimates.	[Morgan, Gareth A.; Campbell, Bruce A.] Smithsonian Inst, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; [Carter, Lynn M.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Plaut, Jeffrey J.] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Phillips, Roger J.] SW Res Inst, Planetary Sci Directorate, Boulder, CO USA	Smithsonian Institution; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Morgan, GA (corresponding author), Smithsonian Inst, Ctr Earth & Planetary Studies, Washington, DC 20560 USA.	morganga@si.edu	Carter, Lynn/D-2937-2012	Carter, Lynn/0000-0002-6245-4142	NASA Mars Reconnaissance Orbiter Project	NASA Mars Reconnaissance Orbiter Project	C. Chazen and T. Watters provided very helpful reviews of earlier versions of the paper. Comments and suggestions by four anonymous referees were extremely beneficial. Thanks are also extended to P. Russell for his technical assistance. Funding for this work was provided by the NASA Mars Reconnaissance Orbiter Project. The SHARAD data and MOLA altimetry are available through NASA's Planetary Data system.	Baker V. R., 1978, CHANNELED SCABLAND G; Berman DC, 2002, ICARUS, V159, P1, DOI 10.1006/icar.2002.6920; Burr DM, 2002, ICARUS, V159, P53, DOI 10.1006/icar.2002.6921; Campbell B, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003177; CARR MH, 1979, J GEOPHYS RES, V84, P2995, DOI 10.1029/JB084iB06p02995; Carrier W. D., 1991, LUNAR SOURCEBOOK, V457-567; Carter LM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041234; Fuller ER, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001842; Fulthorpe CS, 2004, GEOLOGY, V32, P1013, DOI 10.1130/G20822.1; Jaeger WL, 2010, ICARUS, V205, P230, DOI 10.1016/j.icarus.2009.09.011; Leverington DW, 2011, GEOMORPHOLOGY, V132, P51, DOI 10.1016/j.geomorph.2011.05.022; Murray JB, 2005, NATURE, V434, P352, DOI 10.1038/nature03379; Plescia JB, 2003, ICARUS, V164, P79, DOI 10.1016/S0019-1035(03)00139-8; Rotto S., 1995, GEOLOGIC GEOMORPHIC; Scott D. H., 1986, GEOLOGICAL MAP W EQU; Seu R, 2004, PLANET SPACE SCI, V52, P157, DOI 10.1016/j.pss.2003.08.024; Seu R, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002745; Tanaka K.L., 2005, GEOLOGIC MAP NO PLAI; TANAKA KL, 1986, J GEOPHYS RES-SOLID, V91, pE139, DOI 10.1029/JB091iB13p0E139; Ulaby F.T., 1988, MICROWAVE DIELECTRIC; Vaucher J, 2009, ICARUS, V204, P418, DOI 10.1016/j.icarus.2009.06.032; Warner N, 2009, EARTH PLANET SC LETT, V288, P58, DOI 10.1016/j.epsl.2009.09.008	22	22	24	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 3	2013	340	6132					607	610		10.1126/science.1234787	http://dx.doi.org/10.1126/science.1234787			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23470730				2022-12-28	WOS:000318268900047
J	Rummel, MJ; Niederle, N; Maschmeyer, G; Banat, GA; von Grunhagen, U; Losem, C; Kofahl-Krause, D; Heil, G; Welslau, M; Balser, C; Kaiser, U; Weidmann, E; Durk, H; Ballo, H; Stauch, M; Roller, F; Barth, J; Hoelzer, D; Hinke, A; Brugger, W				Rummel, Mathias J.; Niederle, Norbert; Maschmeyer, Georg; Banat, G. Andre; von Gruenhagen, Ulrich; Losem, Christoph; Kofahl-Krause, Dorothea; Heil, Gerhard; Welslau, Manfred; Balser, Christina; Kaiser, Ulrich; Weidmann, Eckhart; Duerk, Heinz; Ballo, Harald; Stauch, Martina; Roller, Fritz; Barth, Juergen; Hoelzer, Dieter; Hinke, Axel; Brugger, Wolfram		Study Grp Indolent Lymphomas StiL	Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial	LANCET			English	Article							ADVANCED FOLLICULAR LYMPHOMA; NON-HODGKINS-LYMPHOMA; B-CELL; II MULTICENTER; CHEMOTHERAPY; SURVIVAL; CYCLOPHOSPHAMIDE; MAINTENANCE; VINCRISTINE; COMBINATION	Background Rituximab plus chemotherapy, most often CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), is the first-line standard of care for patients with advanced indolent lymphoma, and for elderly patients with mantle-cell lymphoma. Bendamustine plus rituximab is effective for relapsed or refractory disease. We compared bendamustine plus rituximab with CHOP plus rituximab (R-CHOP) as first-line treatment for patients with indolent and mantle-cell lymphomas. Methods We did a prospective, multicentre, randomised, open-label, non-inferiority trial at 81 centres in Germany between Sept 1, 2003, and Aug 31, 2008. Patients aged 18 years or older with a WHO performance status of 2 or less were eligible if they had newly diagnosed stage III or IV indolent or mantle-cell lymphoma. Patients were stratified by histological lymphoma subtype, then randomly assigned according to a prespecified randomisation list to receive either intravenous bendamustine (90 mg/m(2) on days 1 and 2 of a 4-week cycle) or CHOP (cycles every 3 weeks of cyclophosphamide 750 mg/m(2), doxorubicin 50 mg/m(2), and vincristine 1.4 mg/m(2) on day 1, and prednisone 100 mg/day for 5 days) for a maximum of six cycles. Patients in both groups received rituximab 375 mg/m(2) on day 1 of each cycle. Patients and treating physicians were not masked to treatment allocation. The primary endpoint was progression-free survival, with a non-inferiority margin of 10%. Analysis was per protocol. This study is registered with ClinicalTrials.gov, number NCT00991211, and the Federal Institute for Drugs and Medical Devices of Germany, BfArM 4021335. Findings 274 patients were assigned to bendamustine plus rituximab (261 assessed) and 275 to R-CHOP (253 assessed). At median follow-up of 45 months (IQR 25-57), median progression-free survival was significantly longer in the bendamustine plus rituximab group than in the R-CHOP group (69.5 months [26.1 to not yet reached] vs 31.2 months [15.2-65.7]; hazard ratio 0.58, 95% CI 0.44-0.74; p<0.0001). Bendamustine plus rituximab was better tolerated than R-CHOP, with lower rates of alopecia (0 patients vs 245 (100%) of 245 patients who recieved >= 3 cycles; p<0.0001), haematological toxicity (77 [30%] vs 173 [68%]; p<0.0001), infections (96 [37%] vs 127 [50%]); p=0.0025), peripheral neuropathy (18 [7%] vs 73 [29%]; p<0.0001), and stomatitis (16 [6%] vs 47 [19%]; p<0.0001). Erythematous skin reactions were more common in patients in the bendamustine plus rituximab group than in those in the R-CHOP group (42 [16%] vs 23 [9%]; p=0.024). Interpretation In patients with previously untreated indolent lymphoma, bendamustine plus rituximab can be considered as a preferred first-line treatment approach to R-CHOP because of increased progression-free survival and fewer toxic effects.	[Rummel, Mathias J.; Banat, G. Andre; Barth, Juergen] Hosp Justus Liebig Univ, Med Klin 4, Giessen, Germany; [Roller, Fritz] Hosp Justus Liebig Univ, Dept Radiol, Giessen, Germany; [Niederle, Norbert] Klinikum Leverkusen, Leverkusen, Germany; [Maschmeyer, Georg] Klinikum Ernst Von Bergmann, Potsdam, Germany; [Kofahl-Krause, Dorothea] Hannover Med Sch, Hannover, Germany; [Heil, Gerhard] Klinikum Ludenscheid, Ludenscheid, Germany; [Kaiser, Ulrich] St Bernward Krankenhaus, Hildesheim, Germany; [Weidmann, Eckhart] Krankenhaus NW Frankfurt, Frankfurt, Germany; [Duerk, Heinz] St Marien Hosp, Hamm, Germany; [Hoelzer, Dieter] Hosp Johann Wolfgang Goethe Univ, Frankfurt, Germany; [Hinke, Axel] Wissenschaftlicher Serv Pharma GmbH, Langenfeld, Germany; [Brugger, Wolfram] Univ Freiburg, Acad Teaching Hosp, Schwarzwald Baar Klinikum Villingen Schwenningen, D-79106 Freiburg, Germany	Klinikum Ernst von Bergmann; Hannover Medical School; Krankenhaus Nordwest; St. Marien Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Freiburg	Rummel, MJ (corresponding author), Univ Hosp, Med Klin 4, D-35392 Giessen, Germany.	mathias.rummel@innere.med.uni-giessen.de			Roche Pharma AG; Ribosepharm/Mundipharma GmbH; Roche; Mundipharma	Roche Pharma AG(Roche Holding); Ribosepharm/Mundipharma GmbH; Roche(Roche Holding); Mundipharma	Roche Pharma AG, Ribosepharm/Mundipharma GmbH.; MJR has received honoraria and research grants from Roche and Mundipharma. WB has received honoraria from Roche and Mundipharma. All other authors declare that they have no conflicts of interest.; Roche Pharma AG and Ribosepharm/Mundipharma GmbH provided financial support for this study. We thank the study investigators, coordinators, nurses, and patients and their families for their contributions; the team of the StiL study group office, including Caroline Zorb, Elke Metzler, and Helene Weikum, and in particular Ingeborg Dietz for her long-term support; and Mark Smith of Gardiner-Caldwell Communications (Stockport, UK) for editorial assistance.	[Anonymous], 2010, STAT FACT SHEETS NON; Cheson BD, 2009, J CLIN ONCOL, V27, P1492, DOI 10.1200/JCO.2008.18.7252; Czuczman MS, 1999, J CLIN ONCOL, V17, P268, DOI 10.1200/JCO.1999.17.1.268; Dreyling M, 2008, ANN ONCOL, V19, P41, DOI 10.1093/annonc/mdn193; Dreyling M, 2009, ANN ONCOL, V20, P119, DOI 10.1093/annonc/mdp148; Friedberg JW, 2008, J CLIN ONCOL, V26, P204, DOI 10.1200/JCO.2007.12.5070; Friedberg JW, 2009, J CLIN ONCOL, V27, P1202, DOI 10.1200/JCO.2008.18.1495; Ghielmini M, 2013, ANN ONCOL, V24, P561, DOI [10.1093/annonc/mds517, 10.1093/annonc/mdr388]; Harris NL, 1999, ANN ONCOL, V10, P1419, DOI 10.1023/A:1008375931236; Herold M, 2007, J CLIN ONCOL, V25, P1986, DOI 10.1200/JCO.2006.06.4618; Hesketh PJ, 2004, SUPPORT CARE CANCER, V12, P543, DOI 10.1007/s00520-003-0562-5; Hiddemann W, 2005, BLOOD, V106, P3725, DOI 10.1182/blood-2005-01-0016; Horning SJ, 2008, J CLIN ONCOL, V26, P4537, DOI 10.1200/JCO.2008.16.1398; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kahl BS, 2010, CANCER-AM CANCER SOC, V116, P106, DOI 10.1002/cncr.24714; Marcus R, 2005, BLOOD, V105, P1417, DOI 10.1182/blood-2004-08-3175; Marcus R, 2008, J CLIN ONCOL, V26, P4579, DOI 10.1200/JCO.2007.13.5376; Robinson KS, 2008, J CLIN ONCOL, V26, P4473, DOI 10.1200/JCO.2008.17.0001; Rummel MJ, 2005, J CLIN ONCOL, V23, P3383, DOI 10.1200/JCO.2005.08.100; Salles G, 2011, LANCET, V377, P42, DOI 10.1016/S0140-6736(10)62175-7; Salles G, 2008, BLOOD, V112, P4824, DOI 10.1182/blood-2008-04-153189; Schulz H, 2007, JNCI-J NATL CANCER I, V99, P706, DOI 10.1093/jnci/djk152; Solal-Celigny P, 2004, BLOOD, V104, P1258, DOI 10.1182/blood-2003-12-4434; Weiner GJ, 2010, SEMIN HEMATOL, V47, P115, DOI 10.1053/j.seminhematol.2010.01.011; Zelenetz AD, 2010, J NATL COMPR CANC NE, V8, P288, DOI 10.6004/jnccn.2010.0021	25	955	992	3	60	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 6	2013	381	9873					1203	1210		10.1016/S0140-6736(12)61763-2	http://dx.doi.org/10.1016/S0140-6736(12)61763-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122WU	23433739				2022-12-28	WOS:000317350100030
J	Clarke, D; Whitney, H; Sutton, G; Robert, D				Clarke, Dominic; Whitney, Heather; Sutton, Gregory; Robert, Daniel			Detection and Learning of Floral Electric Fields by Bumblebees	SCIENCE			English	Article							ELECTROSTATIC FORCES; FLOWERS; COLOR; BEES; CUE	Insects use several senses to forage, detecting floral cues such as color, shape, pattern, and volatiles. We report a formerly unappreciated sensory modality in bumblebees (Bombus terrestris), detection of floral electric fields. These fields act as floral cues, which are affected by the visit of naturally charged bees. Like visual cues, floral electric fields exhibit variations in pattern and structure, which can be discriminated by bumblebees. We also show that such electric field information contributes to the complex array of floral cues that together improve a pollinator's memory of floral rewards. Because floral electric fields can change within seconds, this sensory modality may facilitate rapid and dynamic communication between flowers and their pollinators.	[Clarke, Dominic; Whitney, Heather; Sutton, Gregory; Robert, Daniel] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	University of Bristol	Robert, D (corresponding author), Univ Bristol, Sch Biol Sci, Woodland Rd, Bristol BS8 1UG, Avon, England.	d.robert@bristol.ac.uk			Leverhulme Trust [RPG 173]; European Research Council; Association for the Study of Animal Behaviour; Royal Society of London	Leverhulme Trust(Leverhulme Trust); European Research Council(European Research Council (ERC)European Commission); Association for the Study of Animal Behaviour; Royal Society of London(Royal Society of London)	This work was sponsored by a grant from the Leverhulme Trust (RPG 173). H. W. is supported by the European Research Council and Association for the Study of Animal Behaviour. D. R. is supported by the Royal Society of London. The authors declare no conflict of interest. All data are available in the supplementary materials. We thank K. Strickland for help with data collection and C. Evans for illustrative work. We thank A. Radford, J. Matthews, and S. Rands for reading the manuscript and helpful feedback.	Aristotle, 1970, HIST ANIMALIUM; Bowker GE, 2007, ATMOS ENVIRON, V41, P1587, DOI 10.1016/j.atmosenv.2006.10.047; COLIN ME, 1991, J BIOELECTRICITY, V10, P17, DOI 10.3109/15368379109031397; CORBET SA, 1982, PLANT CELL ENVIRON, V5, P125, DOI 10.1111/1365-3040.ep11571488; Erikson E. H., 1983, HDB POLLINATION BIOL; FROMM J, 1995, PLANT PHYSIOL, V109, P375, DOI 10.1104/pp.109.2.375; GANMOR S, 1995, CAN AGR ENG, V37, P189; Leonard AS, 2011, FUNCT ECOL, V25, P1293, DOI 10.1111/j.1365-2435.2011.01885.x; Leonard AS, 2011, CURR ZOOL, V57, P215, DOI 10.1093/czoolo/57.2.215; Leonard AS, 2011, J EXP BIOL, V214, P113, DOI 10.1242/jeb.047407; Raguso RA, 2004, CURR OPIN PLANT BIOL, V7, P434, DOI 10.1016/j.pbi.2004.05.010; Rycroft MJ, 2000, J ATMOS SOL-TERR PHY, V62, P1563, DOI 10.1016/S1364-6826(00)00112-7; Simon R, 2011, SCIENCE, V333, P631, DOI 10.1126/science.1204210; Stankovic B, 1997, PLANT PHYSIOL, V115, P1083, DOI 10.1104/pp.115.3.1083; Stout JC, 2001, ANIM BEHAV, V62, P183, DOI 10.1006/anbe.2001.1729; Vaknin Y, 2000, PLANT SYST EVOL, V222, P133, DOI 10.1007/BF00984099; von Arx M, 2012, P NATL ACAD SCI USA, V109, P9471, DOI 10.1073/pnas.1121624109; WASER NM, 1983, NATURE, V302, P422, DOI 10.1038/302422a0; Wedzony M, 1998, ACTA PHYSIOL PLANT, V20, P291, DOI 10.1007/s11738-998-0061-x; WEISS MR, 1995, AM J BOT, V82, P167, DOI 10.2307/2445525; Whitney HM, 2009, SCIENCE, V323, P130, DOI 10.1126/science.1166256; Willmer P, 2009, CURR BIOL, V19, P919, DOI 10.1016/j.cub.2009.03.070; Yes'kov Ye. K., 1976, Biophysics, V21, P1124	23	157	166	4	364	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 5	2013	340	6128					66	69		10.1126/science.1230883	http://dx.doi.org/10.1126/science.1230883			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23429701				2022-12-28	WOS:000317061100045
J	Rocha, EPC				Rocha, Eduardo P. C.			With a Little Help from Prokaryotes	SCIENCE			English	Editorial Material							LATERAL GENE-TRANSFER; EXCHANGE; GENOMES		[Rocha, Eduardo P. C.] Inst Pasteur, Dept Genomes & Genet, F-75015 Paris, France; [Rocha, Eduardo P. C.] CNRS, UMR3525, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Rocha, EPC (corresponding author), Inst Pasteur, Dept Genomes & Genet, F-75015 Paris, France.	erocha@pasteur.fr	Rocha, Eduardo/B-7009-2009	Rocha, Eduardo/0000-0001-7704-822X				Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Danchin EGJ, 2010, P NATL ACAD SCI USA, V107, P17651, DOI 10.1073/pnas.1008486107; Doolittle WE, 1998, TRENDS GENET, V14, P307; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Lind PA, 2010, MOL MICROBIOL, V75, P1078, DOI 10.1111/j.1365-2958.2009.07030.x; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; Nowack ECM, 2012, P NATL ACAD SCI USA, V109, P5340, DOI 10.1073/pnas.1118800109; Ochman H, 2005, P NATL ACAD SCI USA, V102, P6595, DOI 10.1073/pnas.0502035102; Sanchez-Gracia A, 2005, TRENDS GENET, V21, P200, DOI 10.1016/j.tig.2005.02.001; Schonknecht G, 2013, SCIENCE, V339, P1207, DOI 10.1126/science.1231707; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Szollosi GJ, 2012, P NATL ACAD SCI USA, V109, P17513, DOI 10.1073/pnas.1202997109; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284	15	9	10	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2013	339	6124					1154	1155		10.1126/science.1234938	http://dx.doi.org/10.1126/science.1234938			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471390				2022-12-28	WOS:000315709900029
J	Scally, G				Scally, Gabriel			Adulteration of food: what it doesn't say on the tin	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ W England, WHO Collaborating Ctr Hlth Urban Environm, Bristol BS16 1QY, Avon, England	University of West England	Scally, G (corresponding author), Univ W England, WHO Collaborating Ctr Hlth Urban Environm, Bristol BS16 1QY, Avon, England.	gabriel.scally@btinternet.com						Academy of Medical Royal Colleges, 2013, MEAS MED PROF PRESCR; Cabinet Office Strategy Unit, 2008, FOOD MATT STRAT 21 C; Policy Commission on the Future of Farming and Food, 2002, FARM FOOD SUST FUT	3	5	5	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2013	346								f1463	10.1136/bmj.f1463	http://dx.doi.org/10.1136/bmj.f1463			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104MS	23468296	Green Submitted			2022-12-28	WOS:000315998300012
J	Miake-Lye, IM; Hempel, S; Ganz, DA; Shekelle, PG				Miake-Lye, Isomi M.; Hempel, Susanne; Ganz, David A.; Shekelle, Paul G.			Inpatient Fall Prevention Programs as a Patient Safety Strategy A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Article							CLUSTER RANDOMIZED-TRIAL; ACUTE-CARE; MULTIFACTORIAL INTERVENTION; METHODOLOGICAL QUALITY; NURSING GUIDELINE; RISK-ASSESSMENT; REDUCING FALLS; INJURIES; HOSPITALS; MULTIDISCIPLINARY	Falls are common among inpatients. Several reviews, including 4 meta-analyses involving 19 studies, show that multicomponent programs to prevent falls among inpatients reduce relative risk for falls by as much as 30%. The purpose of this updated review is to reassess the benefits and harms of fall prevention programs in acute care settings and to identify factors associated with successful implementation of these programs. We searched for new evidence using PubMed from 2005 to September 2012. Two new, large, randomized, controlled trials supported the conclusions of the existing meta-analyses. An optimal bundle of components was not identified. Harms were not systematically examined, but potential harms included increased use of restraints and sedating drugs and decreased efforts to mobilize patients. Eleven studies showed that the following themes were associated with successful implementation: leadership support, engagement of front-line staff in program design, guidance of the prevention program by a multidisciplinary committee, pilot-testing interventions, use of information technology systems to provide data about falls, staff education and training, and changes in nihilistic attitudes about fall prevention. Future research would advance knowledge by identifying optimal bundles of component interventions for particular patients and by determining whether effectiveness relies more on the mix of the components or use of certain implementation strategies. Ann Intern Med. 2013;158:390-396. www.annals.org	Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Shekelle, Paul G.] RAND Corp, Santa Monica, CA 90401 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; RAND Corporation	Shekelle, PG (corresponding author), RAND Corp, Santa Monica, CA 90401 USA.	shekelle@rand.org		Hempel, Susanne/0000-0003-1597-5110	AHRQ, U.S. Department of Health and Human Services [HHSA-290-2007-10062I, HHSA-290-2010-00017I, HHSA-290-32001T]; Veterans Affairs Health Services Research & Development Service, Veterans Health Administration, U.S. Department of Veterans Affairs through the Veterans Affairs Greater Los Angeles Health Services Research  Development Center of Excellence [VA CD2 08-012-1]; AHRQ; AHRQ, Veterans Affairs Health Services Research and Development Service; Veterans Affairs; Centers for Medicare & Medicaid Services; National Institute of Nursing Research; Office of the National Coordinator	AHRQ, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Veterans Affairs Health Services Research & Development Service, Veterans Health Administration, U.S. Department of Veterans Affairs through the Veterans Affairs Greater Los Angeles Health Services Research  Development Center of Excellence; AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ, Veterans Affairs Health Services Research and Development Service; Veterans Affairs(US Department of Veterans Affairs); Centers for Medicare & Medicaid Services; National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Office of the National Coordinator	Financial Support: From the AHRQ, U.S. Department of Health and Human Services (contracts HHSA-290-2007-10062I, HHSA-290-2010-00017I, and HHSA-290-32001T). Dr. Ganz was supported by a Career Development Award from the Veterans Affairs Health Services Research & Development Service, Veterans Health Administration, U.S. Department of Veterans Affairs through the Veterans Affairs Greater Los Angeles Health Services Research & Development Center of Excellence (project VA CD2 08-012-1).; Potential Conflicts of Interest: Dr. Hempel: Grant (money to institution): AHRQ. Dr. Ganz: Grant (money to institution): AHRQ, Veterans Affairs Health Services Research and Development Service. Dr. Shekelle: Consultancy: ECRI Institute; Employment: Veterans Affairs; Grants/grants pending: AHRQ, Veterans Affairs, Centers for Medicare & Medicaid Services, National Institute of Nursing Research, Office of the National Coordinator; Royalties: UpToDate. Ms. Miake-Lye: None disclosed. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum = M12-2569.	Ang E, 2011, J ADV NURS, V67, P1984, DOI 10.1111/j.1365-2648.2011.05646.x; Barker A, 2009, QUAL SAF HEALTH CARE, V18, P467, DOI 10.1136/qshc.2007.025676; Barry E, 2001, Ir Med J, V94, P174; Brandis S, 1999, J Qual Clin Pract, V19, P215, DOI 10.1046/j.1440-1762.1999.00337.x; Browne JA, 2004, J NURS CARE QUAL, V19, P218, DOI 10.1097/00001786-200407000-00008; Cameron ID, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub2; Capan K, 2007, J CLIN OUTCOMES MANA, V14, P155; Coussement J, 2008, J AM GERIATR SOC, V56, P29, DOI 10.1111/j.1532-5415.2007.01508.x; Cumming RG, 2008, BMJ-BRIT MED J, V336, P758, DOI 10.1136/bmj.39499.546030.BE; Dempsey J, 2004, J CLIN NURS, V13, P479, DOI 10.1046/j.1365-2702.2003.00868.x; DiBardino D, 2012, J HOSP MED, V7, P497, DOI 10.1002/jhm.1917; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Dykes PC, 2010, JAMA-J AM MED ASSOC, V304, P1912, DOI 10.1001/jama.2010.1567; Fonda D, 2006, MED J AUSTRALIA, V184, P379, DOI 10.5694/j.1326-5377.2006.tb00286.x; Gillies GL, 2000, QUALITY IMPERATIVE M; Grenier-Sennelier C, 2002, INT J QUAL HEALTH C, V14, P419, DOI 10.1093/intqhc/14.5.419; Gutierrez F, 2008, CRIT CARE NURS Q, V31, P127, DOI 10.1097/01.CNQ.0000314473.72001.b4; Haines TP, 2004, BMJ-BRIT MED J, V328, P676, DOI 10.1136/bmj.328.7441.676; Healey F, 2004, AGE AGEING, V33, P390, DOI 10.1093/ageing/afh130; Hempel S, 2012, REV EVIDENCE FALLS P; Koh SLS, 2009, SINGAP MED J, V50, P425; Kolin MM, 2010, J NURS ADMIN, V40, P384, DOI 10.1097/NNA.0b013e3181ee4468; Krauss MJ, 2008, INFECT CONT HOSP EP, V29, P539, DOI 10.1086/588222; MCCOLLAM ME, 1995, NURS CLIN N AM, V30, P507; Mitchell A, 1996, J CLIN NURS, V5, P213, DOI 10.1111/j.1365-2702.1996.tb00254.x; Morse J. M., 1997, PREVENTING PATIENT F; Moyer VA, 2012, ANN INTERN MED, V157, P197, DOI 10.7326/0003-4819-157-3-201208070-00462; National Database of Nursing Quality Indicators, 2012, GUID DAT COLL AM NUR; Neily J, 2005, JT COMM J QUAL PATIE, V31, P275, DOI 10.1016/S1553-7250(05)31035-X; O'Connell B, 2001, Int J Nurs Pract, V7, P126, DOI 10.1046/j.1440-172X.2001.00300.x; Oliver D, 1997, BMJ-BRIT MED J, V315, P1049, DOI 10.1136/bmj.315.7115.1049; Oliver D, 2002, AGE AGEING, V31, P75, DOI 10.1093/ageing/31.1.75; Oliver D, 2007, BRIT MED J, V334, P82, DOI 10.1136/bmj.39049.706493.55; Oliver D, 2010, CLIN GERIATR MED, V26, P645, DOI 10.1016/j.cger.2010.06.005; Rauch Kathleen, 2009, J Healthc Qual, V31, P36; Schwendimann R, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-69; Schwenk M, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-50; Semin-Goossens A, 2003, J NURS CARE QUAL, V18, P217, DOI 10.1097/00001786-200307000-00008; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shekelle PG, 2010, AHRQ PUBLICATION; Shekelle PG, 2013, MAKING HLTH CARE SAF; Shojania KG, 2007, ANN INTERN MED, V147, P224, DOI 10.7326/0003-4819-147-4-200708210-00179; Shojarna KG, 2001, EVID REP TECHNOL ASS, P1; SHORTELL SM, 1995, HEALTH SERV RES, V30, P377; Stenvall M, 2007, OSTEOPOROSIS INT, V18, P167, DOI 10.1007/s00198-006-0226-7; Tinetti ME, 2012, ANN INTERN MED, V157, P213, DOI 10.7326/0003-4819-157-3-201208070-00014; Uden G, 1999, J ADV NURS, V29, P145, DOI 10.1046/j.1365-2648.1999.00874.x; van der Helm J, 2006, JT COMM J QUAL PATIE, V32, P152, DOI 10.1016/S1553-7250(06)32020-X; van Gaal BGI, 2011, INT J NURS STUD, V48, P1040, DOI 10.1016/j.ijnurstu.2011.02.017; van Gaal BGI, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-58; Vassallo M, 2004, J AM GERIATR SOC, V52, P335, DOI 10.1111/j.1532-5415.2004.52102.x; von Renteln-Kruse W, 2007, J AM GERIATR SOC, V55, P2068, DOI 10.1111/j.1532-5415.2007.01424.x; Weinberg J, 2011, JT COMM J QUAL PATIE, V37, P317, DOI 10.1016/S1553-7250(11)37040-7; Whitlock EP, 2008, ANN INTERN MED, V148, P776, DOI 10.7326/0003-4819-148-10-200805200-00010; Williams TA, 2007, J CLIN NURS, V16, P316, DOI 10.1111/j.1365-2702.2005.01410.x; World Health Organization, 2012, VIOL INJ PREV FALLS; Zecevic AA, 2006, GERONTOLOGIST, V46, P367, DOI 10.1093/geront/46.3.367	57	172	181	4	44	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2013	158	5	2				390	+		10.7326/0003-4819-158-5-201303051-00005	http://dx.doi.org/10.7326/0003-4819-158-5-201303051-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	105HX	23460095				2022-12-28	WOS:000316058600005
J	Wennberg, JE; Staiger, DO; Sharp, SM; Gottlieb, DJ; Bevan, G; McPherson, K; Welch, HG				Wennberg, John E.; Staiger, Douglas O.; Sharp, Sandra M.; Gottlieb, Daniel J.; Bevan, Gwyn; McPherson, Klim; Welch, H. Gilbert			Observational intensity bias associated with illness adjustment: cross sectional analysis of insurance claims	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GEOGRAPHIC-VARIATION; MORTALITY; RISK; SERVICES; FORMULA; DEATH; RATES	Objective To determine the bias associated with frequency of visits by physicians in adjusting for illness, using diagnoses recorded in administrative databases. Setting Claims data from the US Medicare program for services provided in 2007 among 306 US hospital referral regions. Design Cross sectional analysis. Participants 20% sample of fee for service Medicare beneficiaries residing in the United States in 2007 (n=5 153 877). Main outcome measures The effect of illness adjustment on regional mortality and spending rates using standard and visit corrected illness methods for adjustment. The standard method adjusts using comorbidity measures based on diagnoses listed in administrative databases; the modified method corrects these measures for the frequency of visits by physicians. Three conventions for measuring comorbidity are used: the Charlson comorbidity index, Iezzoni chronic conditions, and hierarchical condition categories risk scores. Results The visit corrected Charlson comorbidity index explained more of the variation in age, sex, and race mortality across the 306 hospital referral regions than did the standard index (R-2=0.21 v 0.11, P<0.001) and, compared with sex and race adjusted mortality, reduced regional variation, whereas adjustment using the standard Charlson comorbidity index increased it. Although visit corrected and age, sex, and race adjusted mortality rates were similar in hospital referral regions with the highest and lowest fifths of visits, adjustment using the standard index resulted in a rate that was 18% lower in the highest fifth (46.4 v 56.3 deaths per 1000, P<0.001). Age, sex, and race adjusted spending as well as visit corrected spending was more than 30% greater in the highest fifth of visits than in the lowest fifth, but only 12% greater after adjustment using the standard index. Similar results were obtained using the Iezzoni and the hierarchical condition categories conventions for measuring comorbidity. Conclusion The rates of visits by physicians introduce substantial bias when regional mortality and spending rates are adjusted for illness using comorbidity measures based on the observed number of diagnoses recorded in Medicare's administrative database. Adjusting without correction for regional variation in visit rates tends to make regions with high rates of visits seem to have lower mortality and lower costs, and vice versa. Visit corrected comorbidity measures better explain variation in age, sex, and race mortality than observed measures, and reduce observational intensity bias.	[Wennberg, John E.; Sharp, Sandra M.; Gottlieb, Daniel J.; Welch, H. Gilbert] Audrey & Theodor Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Dartmouth Inst, Hanover, NH 03755 USA; [Staiger, Douglas O.] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA; [Bevan, Gwyn] Univ London London Sch Econ & Polit Sci, Dept Management, London WC2A 2AE, England; [McPherson, Klim] Univ Oxford New Coll, Nuffield Dept Obstet & Gynaecol, Oxford OX1 3BN, England	Dartmouth College; Dartmouth College; University of London; London School Economics & Political Science; University of Oxford	Wennberg, JE (corresponding author), Audrey & Theodor Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Dartmouth Inst, Hanover, NH 03755 USA.	john.e.wennberg@Dartmouth.edu			National Institute on Aging [PO1-AG19783]; Robert Wood Johnson Foundation; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was partially supported by the National Institute on Aging (grant PO1-AG19783) and the Robert Wood Johnson Foundation. The funders had no role in the design and conduct of the study; the collection, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript.	[Anonymous], 2013, 0865 GAO; Baker LC, 2011, HEALTH AFFAIR, V30, P1689, DOI 10.1377/hlthaff.2011.0216; Bevan G, 2009, FINANC ACCOUNT MANAG, V25, P391, DOI 10.1111/j.1468-0408.2009.00484.x; Centers for Medicare & Medicaid Services, 2013, RISK ADJ; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Department of Health and Social Security, 1976, 1 RAWP RARP DEP HLTH, P2013; Dixon J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6608; Gottlieb DJ, 2010, HEALTH AFFAIR, V29, P537, DOI 10.1377/hlthaff.2009.0609; Heijink R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-73; IEZZONI LI, 1994, HEALTH SERV RES, V29, P435; Institute for Healthcare Improvement, 2003, BREAKTHROUGH SERIES; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; Koster M, 2008, LAKARTIDNINGEN; Lilford R, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2016; Mohammed MA, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b780; MORGAN M, 1987, J EPIDEMIOL COMMUN H, V41, P269, DOI 10.1136/jech.41.4.269; Nicholl J, 2007, J EPIDEMIOL COMMUN H, V61, P1010, DOI 10.1136/jech.2007.061747; Ong MK, 2009, CIRC-CARDIOVASC QUAL, V2, P548, DOI 10.1161/CIRCOUTCOMES.108.825612; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Romley JA, 2011, ANN INTERN MED, V154, P160, DOI 10.7326/0003-4819-154-3-201102010-00005; Schmidt M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e356; Silber JH, 2010, HEALTH SERV RES, V45, P1872, DOI 10.1111/j.1475-6773.2010.01180.x; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Taleb N.N., 2010, BLACK SWAN IMPACT HI, DOI DOI 10.1176/PS.2009.60.11.1564; The Canadian Institute for Health Information, 2007, HSMR NEW APPR MEAS H; Van de Ven WPMM, 2000, HANDB ECON, V17, P755; van de Ven WPMM, 2008, HEALTH AFFAIR, V27, P771, DOI 10.1377/hlthaff.27.3.771; Welch HG, 2011, JAMA-J AM MED ASSOC, V305, P1113, DOI 10.1001/jama.2011.307; WELCH WP, 1993, NEW ENGL J MED, V328, P621, DOI 10.1056/NEJM199303043280906; Wennberg J. E., 2010, TRACKING MED RES QUE, P191; WENNBERG JE, 1984, NEW ENGL J MED, V311, P295, DOI 10.1056/NEJM198408023110505; WENNBERG JE, 1987, LANCET, V1, P1185, DOI 10.1016/s0140-6736(87)92152-0; WENNBERG JE, 1982, SOC SCI MED, V16, P811, DOI 10.1016/0277-9536(82)90234-9; Wennberg JE, 2008, TRACKING CARE PATIEN; Wennberg JE, 2010, TRACKING MED RES QUE; Whittington J, 2005, IHI INNOVATION SER 2	36	50	50	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 21	2013	346								f549	10.1136/bmj.f549	http://dx.doi.org/10.1136/bmj.f549			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096HP	23430282	Green Published, hybrid			2022-12-28	WOS:000315395100006
J	Rowland, K				Rowland, Kate			The PLAN score predicted death and severe disability in patients with acute ischemic stroke	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Rowland, K (corresponding author), Univ Chicago, Chicago, IL 60637 USA.		Rowland, Kate/Q-6256-2019; O'Donnell, Martin/ABE-7459-2020	Rowland, Kate/0000-0002-1383-0279; O'Donnell, Martin/0000-0002-7347-7761					0	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2013	158	4							JC13	10.7326/0003-4819-158-4-201302190-02013	http://dx.doi.org/10.7326/0003-4819-158-4-201302190-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098WR	23420250				2022-12-28	WOS:000315580300012
J	Talmud, PJ; Shah, S; Whittall, R; Futema, M; Howard, P; Cooper, JA; Harrison, SC; Li, K; Drenos, F; Karpe, F; Neil, HAW; Descamps, OS; Langenberg, C; Lench, N; Kivimaki, M; Whittaker, J; Hingorani, AD; Kumari, M; Humphries, SE				Talmud, Philippa J.; Shah, Sonia; Whittall, Ros; Futema, Marta; Howard, Philip; Cooper, Jackie A.; Harrison, Seamus C.; Li, KaWah; Drenos, Fotios; Karpe, Frederik; Neil, H. Andrew W.; Descamps, Olivier S.; Langenberg, Claudia; Lench, Nicholas; Kivimaki, Mika; Whittaker, John; Hingorani, Aroon D.; Kumari, Meena; Humphries, Steve E.			Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study	LANCET			English	Article							LIPID-LEVELS; DISEASE; ATHEROSCLEROSIS; DIAGNOSIS; DEFECTS; RISK; ASSOCIATION; RECEPTOR; IMPACT; STATIN	Background Familial hypercholesterolaemia is a common autosomal-dominant disorder caused by mutations in three known genes. DNA-based cascade testing is recommended by UK guidelines to identify affected relatives; however, about 60% of patients are mutation-negative. We assessed the hypothesis that familial hypercholesterolaemia can also be caused by an accumulation of common small-effect LDL-C-raising alleles. Methods In November, 2011, we assembled a sample of patients with familial hypercholesterolaemia from three UK-based sources and compared them with a healthy control sample from the UK Whitehall II (WHII) study. We also studied patients from a Belgian lipid clinic (Hopital de Jolimont, Haine St-Paul, Belgium) for validation analyses. We genotyped participants for 12 common LDL-C-raising alleles identified by the Global Lipid Genetics Consortium and constructed a weighted LDL-C-raising gene score. We compared the gene score distribution among patients with familial hypercholesterolaemia with no confirmed mutation, those with an identified mutation, and controls from WHII. Findings We recruited 321 mutation-negative UK patients (451 Belgian), 319 mutation-positive UK patients (273 Belgian), and 3020 controls from WHII. The mean weighted LDL-C gene score of the WHII participants (0.90 [SD 0.23]) was strongly associated with LDL-C concentration (p=1.4 x 10(-77); R-2=0.11). Mutation-negative UK patients had a significantly higher mean weighted LDL-C score (1.0 [SD 0.21]) than did WHII controls (p=4.5 x 10(-16)), as did the mutation-negative Belgian patients (0.99 [0.19]; p=5.2 x 10(-20)). The score was also higher in UK (0.95 [0.20]; p=1.6 x 10(-5)) and Belgian (0.92 [0.20]; p=0.04) mutation-positive patients than in WHII controls. 167 (52%) of 321 mutation-negative UK patients had a score within the top three deciles of the WHII weighted LDL-C gene score distribution, and only 35 (11%) fell within the lowest three deciles. Interpretation In a substantial proportion of patients with familial hypercholesterolaemia without a known mutation, their raised LDL-C concentrations might have a polygenic cause, which could compromise the efficiency of cascade testing. In patients with a detected mutation, a substantial polygenic contribution might add to the variable penetrance of the disease.	[Talmud, Philippa J.; Whittall, Ros; Futema, Marta; Howard, Philip; Cooper, Jackie A.; Harrison, Seamus C.; Li, KaWah; Drenos, Fotios; Humphries, Steve E.] UCL, Inst Cardiovasc Sci, Ctr Cardiovasc Genet, London WC1E 6JF, England; [Shah, Sonia; Humphries, Steve E.] UCL, Genet Inst, Dept Genet Environm & Evolut, London WC1E 6JF, England; [Karpe, Frederik] Oxford Univ Hosp NHS Trust, NIHR Oxford Biomed Res Ctr, Oxford, England; [Neil, H. Andrew W.] Univ Oxford, Dept Primary Care Hlth Sci, Sch Primary Care Res, Oxford, England; [Descamps, Olivier S.] Ctr Rech Med Jolimont, Haine St Paul, Belgium; [Langenberg, Claudia] Addenbrookes Hosp, MRC Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Langenberg, Claudia; Hingorani, Aroon D.] UCL, Genet Epidemiol Grp, Dept Epidemiol & Publ Hlth, London WC1E 6JF, England; [Lench, Nicholas] Great Ormond St Hosp Sick Children, North East Thames Reg Genet Serv, London WC1N 3JH, England; [Kivimaki, Mika; Kumari, Meena] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6JF, England; [Whittaker, John] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; [Whittaker, John] GlaxoSmithKline, Quantitat Sci, Stevenage, Herts, England	University of London; University College London; University of London; University College London; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; Groupe Jolimont; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; GlaxoSmithKline	Humphries, SE (corresponding author), UCL, Inst Cardiovasc Sci, Ctr Cardiovasc Genet, Rayne Bldg, London WC1E 6JF, England.	s.humphries@ucl.ac.uk	Shah, Sonia/N-7547-2013; Futema, Marta/AAD-7557-2022; Langenberg, Claudia/ABG-9067-2021; Lench, Nicholas/AAB-1791-2021; Whittaker, John C/B-8609-2012; Kivimaki, Mika/B-3607-2012; Victora, Cesar Gomes/Y-2455-2019	Shah, Sonia/0000-0001-5860-4526; Langenberg, Claudia/0000-0002-5017-7344; Whittaker, John C/0000-0002-3529-2379; Kivimaki, Mika/0000-0002-4699-5627; Victora, Cesar Gomes/0000-0002-2465-2180; Hingorani, Aroon/0000-0001-8365-0081; Talmud, Philippa/0000-0002-5560-1933; Lench, Nicholas/0000-0002-6108-0759; Futema, Marta/0000-0002-2120-2088; Humphries, Stephen E/0000-0002-8221-6547; Kumari, Meena/0000-0001-9716-1035; Karpe, Fredrik/0000-0002-2751-1770; Drenos, Fotios/0000-0003-2469-5516	British Heart Foundation; Pfizer; AstraZeneca; Schering-Plough; National Institute for Health Research; Medical Research Council; Health and Safety Executive; Department of Health; National Heart Lung and Blood Institute; National Institute on Aging; Agency for Health Care Policy Research; John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status; Health, Unilever; Department of Trade and Industry; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [MR/K013351/1, MC_UU_12015/1] Funding Source: UKRI; British Heart Foundation [RG/08/008/25291, FS/11/16/28696] Funding Source: researchfish; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [MC_UU_12015/1, MR/K013351/1] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013196, R01AG013196] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); Pfizer(Pfizer); AstraZeneca(AstraZeneca); Schering-Plough(Merck & CompanySchering Plough Corporation); National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health and Safety Executive; Department of Health; National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Health Care Policy Research(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status; Health, Unilever(Unilever); Department of Trade and Industry; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	British Heart Foundation, Pfizer, AstraZeneca, Schering-Plough, National Institute for Health Research, Medical Research Council, Health and Safety Executive, Department of Health, National Heart Lung and Blood Institute, National Institute on Aging, Agency for Health Care Policy Research, John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health, Unilever, and Departments of Health and Trade and Industry.	Alonso R, 2008, ATHEROSCLEROSIS, V200, P315, DOI 10.1016/j.atherosclerosis.2007.12.024; Benn M, 2012, J CLIN ENDOCR METAB, V97, P3956, DOI 10.1210/jc.2012-1563; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Damgaard D, 2005, ATHEROSCLEROSIS, V180, P155, DOI 10.1016/j.atherosclerosis.2004.12.001; Department of Health, HLTH SRUV ENGL 2003; Descamps OS, 2003, EUR J CLIN INVEST, V33, P1, DOI 10.1046/j.1365-2362.2003.01094.x; Descamps OS, 2001, EUR J CLIN INVEST, V31, P958, DOI 10.1046/j.1365-2362.2001.00915.x; Gill PJ, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3228; Graham CA, 2005, ATHEROSCLEROSIS, V182, P331, DOI 10.1016/j.atherosclerosis.2005.02.016; Hadfield SG, 2008, ANN CLIN BIOCHEM, V45, P199, DOI 10.1258/acb.2007.007078; Hadfield SG, 2009, ANN CLIN BIOCHEM, V46, P24, DOI 10.1258/acb.2008.008094; HEART UK, SAV LIV SAV FAM HLTH; Huijgen R, 2012, EUR HEART J, V33, P2325, DOI 10.1093/eurheartj/ehs038; Humphries SE, 2006, J MED GENET, V43, P943, DOI 10.1136/jmg.2006.038356; Leren Trond P, 2004, Semin Vasc Med, V4, P75; Marks D, 2006, J MED SCREEN, V13, P156, DOI 10.1258/096914106778440617; Marks D, 2003, ATHEROSCLEROSIS, V168, P1, DOI 10.1016/S0021-9150(02)00330-1; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Marques-Pinheiro A, 2010, EUR J HUM GENET, V18, P1236, DOI 10.1038/ejhg.2010.94; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; National Institute for Health and Clinical Excellence (NICE), NICE CLIN GUID CG71; Neil A, 2008, EUR HEART J, V29, P2625, DOI 10.1093/eurheartj/ehn422; Neil HAW, 2004, HEART, V90, P1431, DOI 10.1136/hrt.2003.022764; Nherera L, 2010, CURR MED RES OPIN, V26, P529, DOI 10.1185/03007990903494934; Rios J, 2010, HUM MOL GENET, V19, P4313, DOI 10.1093/hmg/ddq352; Seed M, 2012, PRIM CARE CARDIOVASC, V5, P181; Smilde TJ, 2001, LANCET, V357, P577, DOI 10.1016/S0140-6736(00)04053-8; Soutar AK, 2007, NAT CLIN PRACT CARD, V4, P214, DOI 10.1038/ncpcardio0836; Starr B, 2008, CLIN CHEM LAB MED, V46, P791, DOI 10.1515/CCLM.2008.135; Talmud PJ, 2009, AM J HUM GENET, V85, P628, DOI 10.1016/j.ajhg.2009.10.014; Taylor A, 2010, CLIN GENET, V77, P572, DOI 10.1111/j.1399-0004.2009.01356.x; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Umans-Eckenhausen MAW, 2001, LANCET, V357, P165, DOI 10.1016/S0140-6736(00)03587-X; Versmissen J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2423; Wierzbicki AS, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1095; WILLIAMS RR, 1993, AM J CARDIOL, V72, P171, DOI 10.1016/0002-9149(93)90155-6	37	393	398	1	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2013	381	9874					1293	1301		10.1016/S0140-6736(12)62127-8	http://dx.doi.org/10.1016/S0140-6736(12)62127-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122XD	23433573				2022-12-28	WOS:000317351000032
J	Tylianakis, JM				Tylianakis, Jason M.			The Global Plight of Pollinators	SCIENCE			English	Editorial Material									Univ Canterbury, Sch Biol Sci, Christchurch 8140, New Zealand	University of Canterbury	Tylianakis, JM (corresponding author), Univ Canterbury, Sch Biol Sci, Private Bag 4800, Christchurch 8140, New Zealand.	jason.tylianakis@canterbury.ac.nz	Tylianakis, Jason/B-6634-2011	Tylianakis, Jason/0000-0001-7402-5620				Aebil A, 2012, TRENDS ECOL EVOL, V27, P142, DOI 10.1016/j.tree.2011.11.017; Aizen MA, 2012, SCIENCE, V335, P1486, DOI 10.1126/science.1215320; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; Holden C, 2006, SCIENCE, V314, P397, DOI 10.1126/science.314.5798.397; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; MORSE RA, 1991, TRENDS ECOL EVOL, V6, P337, DOI 10.1016/0169-5347(91)90043-W; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007	12	63	67	5	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1532	1533		10.1126/science.1235464	http://dx.doi.org/10.1126/science.1235464			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23449995				2022-12-28	WOS:000316731600029
J	Kloosterman, B; Abelenda, JA; Gomez, MDC; Oortwijn, M; de Boer, JM; Kowitwanich, K; Horvath, BM; van Eck, HJ; Smaczniak, C; Prat, S; Visser, RGF; Bachem, CWB				Kloosterman, Bjorn; Abelenda, Jose A.; Carretero Gomez, Maria del Mar; Oortwijn, Marian; de Boer, Jan M.; Kowitwanich, Krissana; Horvath, Beatrix M.; van Eck, Herman J.; Smaczniak, Cezary; Prat, Salome; Visser, Richard G. F.; Bachem, Christian W. B.			Naturally occurring allele diversity allows potato cultivation in northern latitudes	NATURE			English	Article							FLOWERING-TIME; ARABIDOPSIS; CONSTANS; TUBERIZATION; GENE; PLANTS; FKF1	Potato (Solanum tuberosum L.) originates from the Andes and evolved short-day-dependent tuber formation as a vegetative propagation strategy. Here we describe the identification of a central regulator underlying a major-effect quantitative trait locus for plant maturity and initiation of tuber development. We show that this gene belongs to the family of DOF (DNA-binding with one finger) transcription factors' and regulates tuberization and plant life cycle length, by acting as a mediator between the circadian clock and the StSP6A mobile tuberization signal(2). We also show that natural allelic variants evade post-translational light regulation, allowing cultivation outside the geographical centre of origin of potato. Potato is a member of the Solanaceae family and is one of the world's most important food crops. This annual plant originates from the Andean regions of South America(3). Potato develops tubers from underground stems called stolons. Its equatorial origin makes potato essentially short-day dependent for tuberization and potato will not make tubers in the long-day conditions of spring and summer in the northern latitudes. When introduced in temperate zones, wild material will form tubers in the course of the autumnal shortening of day-length. Thus, one of the first selected traits in potato leading to a European potato type(4) is likely to have been long-day acclimation for tuberization. Potato breeders can exploit the naturally occurring variation in tuberization onset and life cycle length, allowing varietal breeding for different latitudes, harvest times and markets.	[Kloosterman, Bjorn; Carretero Gomez, Maria del Mar; Oortwijn, Marian; de Boer, Jan M.; Kowitwanich, Krissana; van Eck, Herman J.; Visser, Richard G. F.; Bachem, Christian W. B.] Wageningen UR, Dept Plant Sci, Lab Plant Breeding, NL-6700 AJ Wageningen, Netherlands; [Abelenda, Jose A.; Prat, Salome] CSIC, Ctr Nacl Biotecnol, Dept Genet Mol & Plantas, E-28049 Madrid, Spain; [Horvath, Beatrix M.] Univ Utrecht, NL-3508 TC Utrecht, Netherlands; [van Eck, Herman J.; Visser, Richard G. F.] Ctr BioSyst Genom, NL-6700 AB Wageningen, Netherlands; [Smaczniak, Cezary] Wageningen UR, Dept Plant Sci, Mol Biol Lab, NL-6700 AJ Wageningen, Netherlands	Wageningen University & Research; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Utrecht University; Centre for BioSystems Genomics; Wageningen University & Research	Bachem, CWB (corresponding author), Wageningen UR, Dept Plant Sci, Lab Plant Breeding, POB 386, NL-6700 AJ Wageningen, Netherlands.	Christian.Bachem@wur.nl	Abelenda, Jose A/L-8315-2017; Prat, Salome/L-9240-2014; van Eck, Herman/C-5940-2008; Visser, Richard GF/B-3423-2012; Smaczniak, Cezary/K-1774-2014	Abelenda, Jose A/0000-0001-7952-4891; Prat, Salome/0000-0003-2684-5485; van Eck, Herman/0000-0002-6530-0616; Visser, Richard GF/0000-0002-0213-4016; Smaczniak, Cezary/0000-0002-4663-8275; Bachem, Christian/0000-0002-3077-6833	Technology Foundation STW [WGC.7795, WPB.5283]; FP6 integrated Project [EU-Sol PL016214]; Almeria University Fund	Technology Foundation STW(Technologiestichting STW); FP6 integrated Project(European Commission); Almeria University Fund	We would like to thank K. Kaufman, G. Angenent, N. Mansoori Zangir, J. Uitdewilligen and R. Hutten for help and advice in the planning and execution of the project. Thanks also go to V. Ghasemi Omran and I. Pereira-Bertram for their expert technical assistance and to T. Bisseling for critical reading of the manuscript. We gratefully acknowledge the Dutch potato breeding companies, Argrico Research B.V., HZPC Holland B.V. and Meijer B.V. for the execution of the field trials. The project was supported by the Technology Foundation STW (grant no. WGC.7795 and WPB.5283) and FP6 integrated Project EU-Sol PL016214. M.d.M.C.G. received additional support from Almeria University Fund.	Abelenda JA, 2011, CURR OPIN BIOTECH, V22, P287, DOI 10.1016/j.copbio.2010.11.013; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Gonzalez-Schain ND, 2012, PLANT J, V70, P678, DOI 10.1111/j.1365-313X.2012.04909.x; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Inui H, 2010, FEBS LETT, V584, P2393, DOI 10.1016/j.febslet.2010.04.031; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Lifschitz E, 2006, J EXP BOT, V57, P3405, DOI 10.1093/jxb/erl106; Martinez-Garcia JF, 2002, P NATL ACAD SCI USA, V99, P15211, DOI 10.1073/pnas.222390599; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Rodriguez-Falcon M, 2006, ANNU REV PLANT BIOL, V57, P151, DOI 10.1146/annurev.arplant.57.032905.105224; Salaman Redcliffe N., 1989, HIST SOCIAL INFLUENC; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Song YH, 2012, SCIENCE, V336, P1045, DOI 10.1126/science.1219644; Spooner DM, 2005, P NATL ACAD SCI USA, V102, P14694, DOI 10.1073/pnas.0507400102; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Takase T, 2011, PLANT J, V67, P608, DOI 10.1111/j.1365-313X.2011.04618.x; Visker MHPW, 2003, THEOR APPL GENET, V106, P317, DOI 10.1007/s00122-002-1021-2; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yanagisawa S, 2004, PLANT CELL PHYSIOL, V45, P386, DOI 10.1093/pcp/pch055; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996	23	219	232	7	199	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2013	495	7440					246	250		10.1038/nature11912	http://dx.doi.org/10.1038/nature11912			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23467094				2022-12-28	WOS:000316652300053
J	Cho, YS; Hwang, S; Herrmann, HJ; Kahng, B				Cho, Y. S.; Hwang, S.; Herrmann, H. J.; Kahng, B.			Avoiding a Spanning Cluster in Percolation Models	SCIENCE			English	Article							EXPLOSIVE PERCOLATION	When dynamics in a system proceeds under suppressive external bias, the system can undergo an abrupt phase transition, as can happen when an epidemic spreads. Recently, an explosive percolation (EP) model was introduced to understand such phenomena. The order of the EP transition has not been clarified in a unified framework covering low-dimensional systems and the mean-field limit. We introduce a stochastic model in which a rule for dynamics is designed to avoid the formation of a spanning cluster through competitive selection in Euclidean space. We use heuristic arguments to show that in the thermodynamic limit and depending on a control parameter, the EP transition can be either continuous or discontinuous if d < d(c) and is always continuous if d >= d(c), where d is the spatial dimension and d(c) is the upper critical dimension.	[Cho, Y. S.; Hwang, S.; Kahng, B.] Seoul Natl Univ, Dept Phys & Astron, Seoul 151747, South Korea; [Herrmann, H. J.] ETH, Inst Bldg Mat, CH-8093 Zurich, Switzerland	Seoul National University (SNU); Swiss Federal Institutes of Technology Domain; ETH Zurich	Kahng, B (corresponding author), Seoul Natl Univ, Dept Phys & Astron, Seoul 151747, South Korea.	bkahng@snu.ac.kr	cho, young sul/M-5111-2017		National Research Foundation through the Acceleration Research Program [2010-0015066]; Seoul Science Foundation; Global Frontier Program	National Research Foundation through the Acceleration Research Program; Seoul Science Foundation; Global Frontier Program	We thank the referees for useful comments. Supported by National Research Foundation grant 2010-0015066 awarded through the Acceleration Research Program, the Seoul Science Foundation, and the Global Frontier Program (Y.S.C.).	Achlioptas D, 2009, SCIENCE, V323, P1453, DOI 10.1126/science.1167782; Araujo NAM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.035701; Araujo NAM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.095703; Azar Y, 1999, SIAM J COMPUT, V29, P180, DOI 10.1137/S0097539795288490; Bastas N, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.066112; Chen W, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.115701; Cho YS, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.275703; Cho YS, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.135702; Choi W, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.020102; da Costa RA, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.255701; ERDOS P, 1960, B INT STATIST INST, V38, P343; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gomez-Gardenes J, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.128701; Grassberger P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.225701; Lee HK, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.020101; Martino R, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036315; Mitzenmacher M, 2001, IEEE T PARALL DISTR, V12, P1094, DOI 10.1109/71.963420; Nagler J, 2011, NAT PHYS, V7, P265, DOI [10.1038/nphys1860, 10.1038/NPHYS1860]; Pan RK, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046112; Panagiotou K., 2011, ELECT NOTES DISCRETE, V38, P699, DOI [10.1016/j.endm.2011.10.017, DOI 10.1016/J.ENDM.2011.10.017]; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Radicchi F, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.168701; Riordan O, 2012, ANN APPL PROBAB, V22, P1450, DOI 10.1214/11-AAP798; Riordan O, 2011, SCIENCE, V333, P322, DOI 10.1126/science.1206241; Rozenfeld HD, 2010, EUR PHYS J B, V75, P305, DOI 10.1140/epjb/e2010-00156-8; Schrenk KJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00348; STAUFFER D, 1994, INTRO PERCOLATION TH; Ziff RM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.045701	28	97	99	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2013	339	6124					1185	1187		10.1126/science.1230813	http://dx.doi.org/10.1126/science.1230813			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471402	Green Submitted			2022-12-28	WOS:000315709900041
J	Nielsen, M; Alberico, E; Baumann, W; Drexler, HJ; Junge, H; Gladiali, S; Beller, M				Nielsen, Martin; Alberico, Elisabetta; Baumann, Wolfgang; Drexler, Hans-Joachim; Junge, Henrik; Gladiali, Serafino; Beller, Matthias			Low-temperature aqueous-phase methanol dehydrogenation to hydrogen and carbon dioxide	NATURE			English	Article							RUTHENIUM COMPLEXES; AMMONIA-BORANE; CATALYSTS; ALCOHOLS; OXIDATION; LIGAND; WATER; ACTIVATION; OSMIUM; ESTERS	Hydrogen produced from renewable resources is a promising potential source of clean energy. With the help of low-temperature proton-exchange membrane fuel cells, Molecular hydrogen can be converted efficiently to produce electricity(1-5). The implementation of sustainable hydrogen production and subsequent hydrogen conversion to energy is called "hydrogen economy"(2). Unfortunately, its physical properties make the transport and handling of hydrogen gas difficult. To overcome this, methanol can be used as a material for the storage of hydrogen, because it is a liquid at room temperature and contains 12.6 per cent hydrogen. However, the state-of-the-art method for the production of hydrogen from methanol (methanol reforming) is conducted at high temperatures (over 200 degrees Celsius) and high pressures (25-50 bar), which limits its potential applications(6-8). Here we describe an efficient low-temperature aqueous-phase methanol dehydrogenation process, which is facilitated by ruthenium complexes. Hydrogen generation by this method proceeds at 65-95 degrees Celsius and ambient pressure with excellent catalyst turnover frequencies (4,700 per hour) and turnover numbers (exceeding 350,000). This would make the delivery of hydrogen on mobile devices-and hence the use of methanol as a practical hydrogen carrier-feasible.	[Nielsen, Martin; Alberico, Elisabetta; Baumann, Wolfgang; Drexler, Hans-Joachim; Junge, Henrik; Beller, Matthias] Univ Rostock, Leibniz Inst Katalyse Eingetragener Verein, D-18059 Rostock, Germany; [Alberico, Elisabetta] CNR, Ist Chim Biomol, I-07040 Sassari, Italy; [Gladiali, Serafino] Univ Sassari, Dipartimento Chim & Farm, I-07100 Sassari, Italy	Leibniz Institut fur Katalyse e.V. an der Universitat Rostock (LIKAT); University of Rostock; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); University of Sassari	Beller, M (corresponding author), Univ Rostock, Leibniz Inst Katalyse Eingetragener Verein, Albert Einstein Str 29A, D-18059 Rostock, Germany.	matthias.beller@catalysis.de	Nielsen, Martin/H-7522-2013; Junge, Henrik/C-4652-2016; , 000/AAG-9847-2019	Nielsen, Martin/0000-0002-3170-1198; Junge, Henrik/0000-0002-7603-1984; 	Alexander von Humboldt Foundation; BMBF; Ministry of Science and Education of Mecklenburg-Western Pommerania	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); BMBF(Federal Ministry of Education & Research (BMBF)); Ministry of Science and Education of Mecklenburg-Western Pommerania	M.N. thanks the Alexander von Humboldt Foundation for financial support. We thank the BMBF and the Ministry of Science and Education of Mecklenburg-Western Pommerania for the basic funding of this project.	ASHCROFT AT, 1991, NATURE, V352, P225, DOI 10.1038/352225a0; Baratta W, 2005, ANGEW CHEM INT EDIT, V44, P6214, DOI 10.1002/anie.200502118; Baratta W, 2011, CHEM-EUR J, V17, P3474, DOI 10.1002/chem.201003022; Bertoli M, 2011, ORGANOMETALLICS, V30, P3479, DOI 10.1021/om200437n; Boddien A, 2011, SCIENCE, V333, P1733, DOI 10.1126/science.1206613; Cortright RD, 2002, NATURE, V418, P964, DOI 10.1038/nature01009; Denney MC, 2006, J AM CHEM SOC, V128, P12048, DOI 10.1021/ja062419g; European Commission, 2007, EUR HYDR FUEL CELL T; Florusse LJ, 2004, SCIENCE, V306, P469, DOI 10.1126/science.1102076; Friedrich A, 2009, J AM CHEM SOC, V131, P17552, DOI 10.1021/ja908644n; Fujita K, 2011, ORG LETT, V13, P2278, DOI 10.1021/ol2005424; Gunanathan C, 2007, SCIENCE, V317, P790, DOI 10.1126/science.1145295; Gunanathan C, 2011, ACCOUNTS CHEM RES, V44, P588, DOI 10.1021/ar2000265; Kass M, 2009, ANGEW CHEM INT EDIT, V48, P905, DOI 10.1002/anie.200805108; Kawahara R, 2012, J AM CHEM SOC, V134, P3643, DOI 10.1021/ja210857z; Maenaka Y, 2012, J AM CHEM SOC, V134, P9417, DOI 10.1021/ja302788c; MORTON D, 1988, J CHEM SOC CHEM COMM, P1154, DOI 10.1039/c39880001154; Muradov NZ, 2008, INT J HYDROGEN ENERG, V33, P6804, DOI 10.1016/j.ijhydene.2008.08.054; Nielsen M, 2012, ANGEW CHEM INT EDIT, V51, P5711, DOI 10.1002/anie.201200625; Nielsen M, 2011, ANGEW CHEM INT EDIT, V50, P9593, DOI 10.1002/anie.201104722; Olah GA, 2011, J AM CHEM SOC, V133, P12881, DOI 10.1021/ja202642y; Palo DR, 2007, CHEM REV, V107, P3992, DOI 10.1021/cr050198b; Pingween M., 2008, HYDROGEN FUEL CELL A, P295; Reece SY, 2011, SCIENCE, V334, P645, DOI 10.1126/science.1209816; Shabaker JW, 2003, J CATAL, V215, P344, DOI 10.1016/S0021-9517(03)00032-0; Spasyuk D, 2012, ANGEW CHEM INT EDIT, V51, P2772, DOI 10.1002/anie.201108956; Stolten D., 2010, HYDROGEN FUEL CELLS; United States Department of Energy, 2002, NAT VIS AM TRANS HYD; Welch GC, 2006, SCIENCE, V314, P1124, DOI 10.1126/science.1134230; Zhang J, 2005, J AM CHEM SOC, V127, P10840, DOI 10.1021/ja052862b	30	542	552	41	945	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2013	495	7439					85	89		10.1038/nature11891	http://dx.doi.org/10.1038/nature11891			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23446345				2022-12-28	WOS:000316039800044
J	Sullivan, N; Schoelles, KM				Sullivan, Nancy; Schoelles, Karen M.			Preventing In-Facility Pressure Ulcers as a Patient Safety Strategy A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Article							TERM-CARE FACILITIES; NURSING-HOME; PROGRAM; DOCUMENTATION; MANAGEMENT; FEEDBACK; OUTCOMES	Complications from hospital-acquired pressure ulcers cause 60 000 deaths and significant morbidity annually in the United States. The objective of this systematic review is to review evidence regarding multicomponent strategies for preventing pressure ulcers and to examine the importance of contextual aspects of programs that aim to reduce facility-acquired pressure ulcers. CINAHL, the Cochrane Library, EMBASE, MEDLINE, and PreMEDLINE were searched for articles published from 2000 to 2012. Studies (any design) that implemented multicomponent initiatives to prevent pressure ulcers in adults in U. S. acute and long-term care settings and that reported pressure ulcer rates at least 6 months after implementation were selected. Two reviewers extracted study data and rated quality of evidence. Findings from 26 implementation studies (moderate strength of evidence) suggested that the integration of several core components improved processes of care and reduced pressure ulcer rates. Key components included the simplification and standardization of pressure ulcer-specific interventions and documentation, involvement of multidisciplinary teams and leadership, use of designated skin champions, ongoing staff education, and sustained audit and feedback. Ann Intern Med. 2013;158:410-416. www.annals.org	[Sullivan, Nancy; Schoelles, Karen M.] ECRI Inst, Evidence Based Practice Ctr, Plymouth Meeting, PA 19462 USA		Sullivan, N (corresponding author), ECRI Inst, Evidence Based Practice Ctr, 5200 Butler Pike, Plymouth Meeting, PA 19462 USA.	nsullivan@ecri.org			AHRQ, U.S. Department of Health and Human Services [HHSA-290-2007-10062I]; RAND Corporation; RAND	AHRQ, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); RAND Corporation; RAND	Financial Support: From the AHRQ, U.S. Department of Health and Human Services (contract HHSA-290-2007-10062I).; Potential Conflicts of Interest: Ms. Sullivan: None disclosed. Dr. Schoelles: Support for travel to meetings for the study or other purposes (money to institution): RAND Corporation; Other (money to institution): work done by several ECRI staff on Making Health Care Safer II: An Updated Critical Analysis of the Evidence for Patient Safety Practices for the AHRQ supported by RAND. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M12-2655.	Abel Robert L, 2005, J Am Med Dir Assoc, V6, P181, DOI 10.1016/j.jamda.2005.03.011; Ackerman Carol L, 2011, Medsurg Nurs, V20, P86; Advancing Excellence in America's Nursing Homes, 2008, ADV EXC AM NURS HOM; Agostini JV, 2001, AHRQ PUBLICATION, V01-E058; American Medical Directors Association, 2008, PRESS ULC LONG TERM; [Anonymous], 2007, ON TIM PREV PRESS UL; Association for the Advancement of Wound Care, 2010, ASS ADV WOUND CAR GU; Ayello EA, 2021, EVIDENCE BASED GERIA, V6th; Bales I, 2009, J Wound Care, V18, P137; Ballard N, 2008, J NURS CARE QUAL, V23, P92, DOI 10.1097/01.NCQ.0000303811.39737.b4; Catania K, 2007, AM J NURS, V107, P44, DOI 10.1097/01.NAJ.0000271182.90068.a1; Chicano SG, 2009, J WOUND OSTOMY CONT, V36, P45, DOI 10.1097/01.WON.0000345175.51117.ca; Courtney Bobby A, 2006, Nurs Manage, V37, ppassim, DOI 10.1097/00006247-200604000-00010; Delmore B, 2011, J WOUND OSTOMY CONT, V38, P505, DOI 10.1097/WON.0b013e31822ad2ab; Dibsie LG, 2008, CRIT CARE NURS Q, V31, P140, DOI 10.1097/01.CNQ.0000314474.79624.f2; Gibbons W, 2006, JT COMM J QUAL PATIE, V32, P488, DOI 10.1016/S1553-7250(06)32064-8; Haesler E., 2019, PREVENTION TREATMENT; Hiser B, 2006, OSTOMY WOUND MANAG, V52, P48; Horn SD, 2010, ADV SKIN WOUND CARE, V23, P120, DOI 10.1097/01.ASW.0000363516.47512.67; Institute for Clinical Systems Improvement, 2012, PRESS ULC PREV TREAT; Institute for Healthcare Improvement, 2011, WHAT IS BUNDL; Institute for Healthcare Improvement, 2011, HOW TO GUID PREV PRE; Institute for Healthcare Improvement, 2007, PREV PRESS ULC; Jankowski IM, 2011, JT COMM J QUAL PATIE, V37, P253, DOI 10.1016/S1553-7250(11)37033-X; Kelleher AD, 2012, J WOUND OSTOMY CONT, V39, P152, DOI 10.1097/WON.0b013e3182435409; LeMaster KM, 2007, JT COMM J QUAL PATIE, V33, P611, DOI 10.1016/S1553-7250(07)33070-5; Lyder CH., 2008, PATIENT SAFETY QUALI; Lyder CH, 2011, INFECT CONTROL  0810; Lyder CH, 2009, ADV SKIN WOUND CARE, V22, P476, DOI 10.1097/01.ASW.0000361385.97489.51; Lyder Courtney H, 2004, Jt Comm J Qual Saf, V30, P205; Lynch Sandra, 2010, Nursing, V40, P61, DOI 10.1097/01.NURSE.0000387754.83476.77; McInerney Joan A, 2008, Adv Skin Wound Care, V21, P75, DOI 10.1097/01.ASW.0000305410.58350.34; Milne CT, 2009, OSTOMY WOUND MANAG, V55, P50; National Pressure Ulcer Advisory Panel, 2007, PRESS ULC PREV POINT; Niederhauser A, 2012, ADV SKIN WOUND CARE, V25, P167, DOI 10.1097/01.ASW.0000413598.97566.d7; Ogrinc G, 2008, QUAL SAF HEALTH CARE, V17, P13, DOI 10.1136/qshc.2008.029058; PORTEROGRADY T, 1995, J NURS ADMIN, V25, P8, DOI 10.1097/00005110-199507000-00002; Pressure Ulcer Guideline Panel Agency for Health Care Policy and Research, 1992, PRESS ULC AD PRED PR; Rantz MJ, 2010, J AM MED DIR ASSOC, V11, P485, DOI 10.1016/j.jamda.2009.11.010; Rantz MJ, 2001, GERONTOLOGIST, V41, P525, DOI 10.1093/geront/41.4.525; Reddy M, 2006, JAMA-J AM MED ASSOC, V296, P974, DOI 10.1001/jama.296.8.974; Registered Nurses Association of Ontario, 2005, RISK ASS PREV PRESS; Registered Nurses' Association of Ontario, 2011, RISK ASS PREV PRESS; Rosen J, 2006, J AM MED DIR ASSOC, V7, P141, DOI 10.1016/j.jamda.2005.08.003; Ryden MB, 2000, GERONTOLOGIST, V40, P654, DOI 10.1093/geront/40.6.654; Sharkey S, 2011, ADV SKIN WOUND CARE, V24, P182, DOI 10.1097/01.ASW.0000396244.65415.7f; Soban LM, 2011, JT COMM J QUAL PATIE, V37, P245, DOI 10.1016/S1553-7250(11)37032-8; Stier Lori, 2004, Outcomes Manag, V8, P28; Terry K, 2010, WHAT IS DMAIC ISIXSI; Tippet AW, 2009, OSTOMY WOUND MANAG, V55, P52; Walsh NS, 2009, J WOUND OSTOMY CONT, V36, P385, DOI 10.1097/WON.0b013e3181aaef91; Wound Ostomy Continence Nurses Society, 2010, GUID PREV MAN PRESS; Xakellis G C, 1996, Adv Wound Care, V9, P18; Young J, 2010, J WOUND OSTOMY CONT, V37, P495, DOI 10.1097/WON.0b013e3181edadcf	54	120	127	4	28	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2013	158	5	2				410	+		10.7326/0003-4819-158-5-201303051-00008	http://dx.doi.org/10.7326/0003-4819-158-5-201303051-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105HX	23460098				2022-12-28	WOS:000316058600008
J	Chinthapalli, K				Chinthapalli, Krishna			The Liverpool care pathway: what do specialists think?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												kchinthapalli@bmj.com	Chinthapalli, Krishna/P-8428-2019	Chinthapalli, Krishna/0000-0003-4136-4882				[Anonymous], 2012, DAILY TELEGRAPH; Bingham J., 2012, DAILY TELEGRAPH; Chan R, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008006.pub2, 10.1002/14651858.CD008006.pub4]; DAVIES HTO, 1994, BRIT MED J, V309, P1579, DOI 10.1136/bmj.309.6968.1579a; Department of Health, 2013, LIV CAR PATHW IND RE; Department of Health, 2011, OP FRAM NHS ENGL 201; Ellershaw J, 2003, BRIT MED J, V326, P30, DOI 10.1136/bmj.326.7379.30; Heatherwood and Wexham Park Hospitals NHS Foundation Trust, 2012, LIV CAR PATHW CQUINS; McCartney M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7316; MILLS M, 1994, BRIT MED J, V309, P583, DOI 10.1136/bmj.309.6954.583; National End of Life Care Programme, 2012, LEARN PEOPL EXP LAST; National Institute for Health and Clinical Excellence, 2011, GUID COMM END LIF CA; Phillips M., 2012, DAILY MAIL; Royal Brompton and Harefield NHS Foundation Trust, QUAL ACC 2010 11; Torjesen I, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f175; VanGeest JB, 2007, EVAL HEALTH PROF, V30, P303, DOI 10.1177/0163278707307899	16	11	11	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2013	346								f1184	10.1136/bmj.f1184	http://dx.doi.org/10.1136/bmj.f1184			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	149WE	23449644				2022-12-28	WOS:000319351300002
J	Carroll, MW				Carroll, Michael W.			Creative Commons and the Openness of Open Access	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									American Univ, Washington Coll Law, Washington, DC 20016 USA	American University	Carroll, MW (corresponding author), American Univ, Washington Coll Law, Washington, DC 20016 USA.			Carroll, Michael/0000-0002-7472-0153				The University of California San Francisco, OP ACC POL; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001	2	23	24	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2013	368	9					789	791		10.1056/NEJMp1300040	http://dx.doi.org/10.1056/NEJMp1300040			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096ET	23445090				2022-12-28	WOS:000315387700003
J	Siria, A; Poncharal, P; Biance, AL; Fulcrand, R; Blase, X; Purcell, ST; Bocquet, L				Siria, Alessandro; Poncharal, Philippe; Biance, Anne -Laure; Fulcrand, Remy; Blase, Xavier; Purcell, Stephen T.; Bocquet, Lyderic			Giant osmotic energy conversion measured in a single transmembrane boron nitride nanotube	NATURE			English	Article							CARBON NANOTUBES; REVERSE ELECTRODIALYSIS; POWER-GENERATION; WATER TRANSPORT; FLOW; MEMBRANES	New models of fluid transport are expected to emerge from the confinement of liquids at the nanoscale(1,2), with potential applications in ultrafiltration, desalination and energy conversion(3). Nevertheless, advancing our fundamental understanding of fluid transport on the smallest scales requires mass and ion dynamics to be ultimately characterized across an individual channel to avoid averaging over many pores. A major challenge for nanofluidics thus lies in building distinct and well-controlled nanochannels, amenable to the systematic exploration of their properties. Here we describe the fabrication and use of a hierarchical nanofluidic device made of a boron nitride nanotube that pierces an ultrathin membrane and connects two fluid reservoirs. Such a transmembrane geometry allows the detailed study of fluidic transport through a single nanotube under diverse forces, including electric fields, pressure drops and chemical gradients. Using this device, we discover very large, osmotically induced electric currents generated by salinity gradients, exceeding by two orders of magnitude their pressure-driven counterpart. We show that this result originates in the anomalously high surface charge carried by the nanotube's internal surface in water at large pH, which we independently quantify in conductance measurements. The nano-assembly route using nanostructures as building blocks opens the way to studying fluid, ionic and molecule transport on the nanoscale, and may lead to biomimetic functionalities. Our results furthermore suggest that boron nitride nanotubes could be used as membranes for osmotic power harvesting under salinity gradients.	[Siria, Alessandro; Poncharal, Philippe; Biance, Anne -Laure; Fulcrand, Remy; Purcell, Stephen T.; Bocquet, Lyderic] Univ Lyon 1, CNRS, Inst Lumiere Mat, UMR5306, F-69622 Villeurbanne, France; [Blase, Xavier] CNRS, Inst Neel, UPR 2940, F-38042 Grenoble, France; [Blase, Xavier] Univ Grenoble 1, F-38042 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Bocquet, L (corresponding author), Univ Lyon 1, CNRS, Inst Lumiere Mat, UMR5306, F-69622 Villeurbanne, France.	lyderic.bocquet@univ-lyon1.fr	Fulcrand, Remy/D-5372-2015; Biance, Anne-Laure/J-8884-2017; siria, alessandro/C-7030-2014; Blase, Xavier/H-3588-2018; bocquet, lyderic/A-2241-2012	Blase, Xavier/0000-0002-0201-9093; bocquet, lyderic/0000-0003-3577-5335	ERC-AG project Micromegas; French ANR under the programme P3N	ERC-AG project Micromegas; French ANR under the programme P3N(French National Research Agency (ANR))	L.B. acknowledges support from ERC-AG project Micromegas and the French ANR under the programme P3N. We thank D. Cornu, M. Bechelany, A. Brioude for providing the boron nitride nanotubes, D. Guillot for building the experimental fluidic set-up and P. Vincent for assistance with the SEM. L.B. thanks Bocquet for discussions on boron nitride chemistry. We thank L Auvray, E. Charlaix, C. Cottin-Bizonne, J. Gierak, D. M. Huang, L. Joly, A. Madouri, R. Net, J. Palacci and C. Ybert for many discussions. We thank the Centre Lyonnais de Microscopie for providing access to the dual-beam FIB.	ALTUG I, 1967, J PHYS CHEM-US, V71, P4260, DOI 10.1021/j100872a016; ANDERSON JL, 1989, ANNU REV FLUID MECH, V21, P61; Arenal R, 2010, ADV PHYS, V59, P101, DOI 10.1080/00018730903562033; Bechelany M, 2007, J PHYS CHEM C, V111, P13378, DOI 10.1021/jp074178k; Bocquet L, 2010, CHEM SOC REV, V39, P1073, DOI 10.1039/b909366b; Bonthuis DJ, 2012, LANGMUIR, V28, P16049, DOI 10.1021/la3020089; Crimp MJ, 1999, J MATER SCI, V34, P2621, DOI 10.1023/A:1004656817379; Dekker C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/nnano.2007.27; FAIR JC, 1971, J CHEM PHYS, V54, P3307, DOI 10.1063/1.1675344; Falk K, 2010, NANO LETT, V10, P4067, DOI 10.1021/nl1021046; Hilder TA, 2009, SMALL, V5, P2183, DOI 10.1002/smll.200900349; Holt JK, 2006, SCIENCE, V312, P1034, DOI 10.1126/science.1126298; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; Hunter R. J., 1991, FDN COLLOID SCI, VI and II; Joseph S, 2008, NANO LETT, V8, P452, DOI 10.1021/nl072385q; Karnik R, 2007, NANO LETT, V7, P547, DOI 10.1021/nl062806o; Kim DK, 2010, MICROFLUID NANOFLUID, V9, P1215, DOI 10.1007/s10404-010-0641-0; Li J, 2001, NATURE, V412, P166, DOI 10.1038/35084037; Liu HT, 2010, SCIENCE, V327, P64, DOI 10.1126/science.1181799; Logan BE, 2012, NATURE, V488, P313, DOI 10.1038/nature11477; Majumder M, 2005, NATURE, V438, P44, DOI 10.1038/43844a; Rasaiah JC, 2008, ANNU REV PHYS CHEM, V59, P713, DOI 10.1146/annurev.physchem.59.032607.093815; Schasfoort RBM, 1999, SCIENCE, V286, P942, DOI 10.1126/science.286.5441.942; Schmidt TM, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.113407; Siwy Z, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.198103; Sparreboom W, 2009, NAT NANOTECHNOL, V4, P713, DOI [10.1038/NNANO.2009.332, 10.1038/nnano.2009.332]; Stein D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.035901; Wang J, 2012, J PHYS CHEM C, V116, P14382, DOI 10.1021/jp302793s; Whitby M, 2008, NANO LETT, V8, P2632, DOI 10.1021/nl080705f; Won CY, 2007, J AM CHEM SOC, V129, P2748, DOI 10.1021/ja0687318	30	721	730	45	905	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2013	494	7438					455	458		10.1038/nature11876	http://dx.doi.org/10.1038/nature11876			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23446417				2022-12-28	WOS:000315661500033
J	Schuetz, P; Briel, M; Mueller, B				Schuetz, Philipp; Briel, Matthias; Mueller, Beat			Clinical Outcomes Associated With Procalcitonin Algorithms to Guide Antibiotic Therapy in Respiratory Tract Infections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Schuetz, Philipp; Mueller, Beat] Kantonsspital Aarau, Med Univ Dept, CH-5001 Aarau, Switzerland; [Briel, Matthias] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, Basel, Switzerland; [Briel, Matthias] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	Kantonsspital Aarau AG (KSA); University of Basel; McMaster University	Schuetz, P (corresponding author), Kantonsspital Aarau, Med Univ Dept, Tellstr, CH-5001 Aarau, Switzerland.	schuetzph@gmail.com	Briel, Matthias/AAT-9284-2021; schuetz, philipp/C-8475-2013; Mueller, Beat/G-2662-2012	schuetz, philipp/0000-0001-6400-4949; Briel, Matthias/0000-0002-2070-5230				Becker KL, 2004, J CLIN ENDOCR METAB, V89, P1512, DOI 10.1210/jc.2002-021444; Heyland DK, 2011, CRIT CARE MED, V39, P1792, DOI 10.1097/CCM.0b013e31821201a5; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Muller F, 2010, CHEST, V138, P121, DOI 10.1378/chest.09-2920; Schuetz P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007498.pub2; Schuetz P, 2011, ARCH INTERN MED, V171, P1322, DOI 10.1001/archinternmed.2011.318; Woodhead M, 2011, CLIN MICROBIOL INFEC, V17, pE1, DOI 10.1111/j.1469-0691.2011.03672.x	7	62	78	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2013	309	7					717	718		10.1001/jama.2013.697	http://dx.doi.org/10.1001/jama.2013.697			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091EK	23423417				2022-12-28	WOS:000315032000027
J	Aaron, SD				Aaron, Shawn D.			Review: Corticosteroid plus LABA inhalers, vs LABAs alone, reduce morbidity in COPD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute	Aaron, SD (corresponding author), Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada.								0	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2013	158	4							JC9	10.7326/0003-4819-158-4-201302190-02009	http://dx.doi.org/10.7326/0003-4819-158-4-201302190-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098WR	23420259				2022-12-28	WOS:000315580300008
J	Khazanie, P; Granger, CB				Khazanie, Prateeti; Granger, Christopher B.			A 10-year exercise program improved oxygen consumption and quality of life in stable chronic heart failure	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Khazanie, Prateeti; Granger, Christopher B.] Duke Univ, Sch Med, Durham, NC 27706 USA	Duke University	Khazanie, P (corresponding author), Duke Univ, Sch Med, Durham, NC 27706 USA.		Granger, Christopher B/D-3458-2014	Granger, Christopher B/0000-0002-0045-3291				Davies EJ, 2010, EUR J HEART FAIL, V12, P706, DOI 10.1093/eurjhf/hfq056; O'Connor CM, 2009, JAMA-J AM MED ASSOC, V301, P1439, DOI 10.1001/jama.2009.454	2	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2013	158	4							JC2-6	10.7326/0003-4819-158-4-201302190-02006	http://dx.doi.org/10.7326/0003-4819-158-4-201302190-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098WR	23420254				2022-12-28	WOS:000315580300005
J	Ackermann, M; Ajello, M; Allafort, A; Baldini, L; Ballet, J; Barbiellini, G; Baring, MG; Bastieri, D; Bechtol, K; Bellazzini, R; Blandford, RD; Bloom, ED; Bonamente, E; Borgland, AW; Bottacini, E; Brandt, TJ; Bregeon, J; Brigida, M; Bruel, P; Buehler, R; Busetto, G; Buson, S; Caliandro, GA; Cameron, RA; Caraveo, PA; Casandjian, JM; Cecchi, C; Celik, O; Charles, E; Chaty, S; Chaves, RCG; Chekhtman, A; Cheung, CC; Chiang, J; Chiaro, G; Cillis, AN; Ciprini, S; Claus, R; Cohen-Tanugi, J; Cominsky, LR; Conrad, J; Corbel, S; Cutini, S; D'Ammando, F; de Angelis, A; de Palma, F; Dermer, CD; Silva, EDE; Drell, PS; Drlica-Wagner, A; Falletti, L; Favuzzi, C; Ferrara, EC; Franckowiak, A; Fukazawa, Y; Funk, S; Fusco, P; Gargano, F; Germani, S; Giglietto, N; Giommi, P; Giordano, F; Giroletti, M; Glanzman, T; Godfrey, G; Grenier, IA; Grondin, MH; Grove, JE; Guiriec, S; Hadasch, D; Hanabata, Y; Harding, AK; Hayashida, M; Hayashi, K; Hays, E; Hewitt, JW; Hill, AB; Hughes, RE; Jackson, MS; Jogler, T; Johannesson, G; Johnson, AS; Kamae, T; Kataoka, J; Katsuta, J; Knodlseder, J; Kuss, M; Lande, J; Larsson, S; Latronico, L; Lemoine-Goumard, M; Longo, F; Loparco, F; Lovellette, MN; Lubrano, P; Madejski, GM; Massaro, F; Mayer, M; Mazziotta, MN; McEnery, JE; Mehault, J; Michelson, PF; Mignani, RP; Mitthumsiri, W; Mizuno, T; Moiseev, AA; Monzani, ME; Morselli, A; Moskalenko, IV; Murgia, S; Nakamori, T; Nemmen, R; Nuss, E; Ohno, M; Ohsugi, T; Omodei, N; Orienti, M; Orlando, E; Ormes, JF; Paneque, D; Perkins, JS; Pesce-Rollins, M; Piron, F; Pivato, G; Raino, S; Rando, R; Razzano, M; Razzaque, S; Reimer, A; Reimer, O; Ritz, S; Romoli, C; Sanchez-Conde, M; Schulz, A; Sgro, C; Simeon, PE; Siskind, EJ; Smith, DA; Spandre, G; Spinelli, P; Stecker, FW; Strong, AW; Suson, DJ; Tajima, H; Takahashi, H; Takahashi, T; Tanaka, T; Thayer, JG; Thayer, JB; Thompson, DJ; Thorsett, SE; Tibaldo, L; Tibolla, O; Tinivella, M; Troja, E; Uchiyama, Y; Usher, TL; Vandenbroucke, J; Vasileiou, V; Vianello, G; Vitale, V; Waite, AP; Werner, M; Winer, BL; Wood, KS; Wood, M; Yamazaki, R; Yang, Z; Zimmer, S				Ackermann, M.; Ajello, M.; Allafort, A.; Baldini, L.; Ballet, J.; Barbiellini, G.; Baring, M. G.; Bastieri, D.; Bechtol, K.; Bellazzini, R.; Blandford, R. D.; Bloom, E. D.; Bonamente, E.; Borgland, A. W.; Bottacini, E.; Brandt, T. J.; Bregeon, J.; Brigida, M.; Bruel, P.; Buehler, R.; Busetto, G.; Buson, S.; Caliandro, G. A.; Cameron, R. A.; Caraveo, P. A.; Casandjian, J. M.; Cecchi, C.; Celik, O.; Charles, E.; Chaty, S.; Chaves, R. C. G.; Chekhtman, A.; Cheung, C. C.; Chiang, J.; Chiaro, G.; Cillis, A. N.; Ciprini, S.; Claus, R.; Cohen-Tanugi, J.; Cominsky, L. R.; Conrad, J.; Corbel, S.; Cutini, S.; D'Ammando, F.; de Angelis, A.; de Palma, F.; Dermer, C. D.; do Couto e Silva, E.; Drell, P. S.; Drlica-Wagner, A.; Falletti, L.; Favuzzi, C.; Ferrara, E. C.; Franckowiak, A.; Fukazawa, Y.; Funk, S.; Fusco, P.; Gargano, F.; Germani, S.; Giglietto, N.; Giommi, P.; Giordano, F.; Giroletti, M.; Glanzman, T.; Godfrey, G.; Grenier, I. A.; Grondin, M. -H.; Grove, J. E.; Guiriec, S.; Hadasch, D.; Hanabata, Y.; Harding, A. K.; Hayashida, M.; Hayashi, K.; Hays, E.; Hewitt, J. W.; Hill, A. B.; Hughes, R. E.; Jackson, M. S.; Jogler, T.; Johannesson, G.; Johnson, A. S.; Kamae, T.; Kataoka, J.; Katsuta, J.; Knoedlseder, J.; Kuss, M.; Lande, J.; Larsson, S.; Latronico, L.; Lemoine-Goumard, M.; Longo, F.; Loparco, F.; Lovellette, M. N.; Lubrano, P.; Madejski, G. M.; Massaro, F.; Mayer, M.; Mazziotta, M. N.; McEnery, J. E.; Mehault, J.; Michelson, P. F.; Mignani, R. P.; Mitthumsiri, W.; Mizuno, T.; Moiseev, A. A.; Monzani, M. E.; Morselli, A.; Moskalenko, I. V.; Murgia, S.; Nakamori, T.; Nemmen, R.; Nuss, E.; Ohno, M.; Ohsugi, T.; Omodei, N.; Orienti, M.; Orlando, E.; Ormes, J. F.; Paneque, D.; Perkins, J. S.; Pesce-Rollins, M.; Piron, F.; Pivato, G.; Raino, S.; Rando, R.; Razzano, M.; Razzaque, S.; Reimer, A.; Reimer, O.; Ritz, S.; Romoli, C.; Sanchez-Conde, M.; Schulz, A.; Sgro, C.; Simeon, P. E.; Siskind, E. J.; Smith, D. A.; Spandre, G.; Spinelli, P.; Stecker, F. W.; Strong, A. W.; Suson, D. J.; Tajima, H.; Takahashi, H.; Takahashi, T.; Tanaka, T.; Thayer, J. G.; Thayer, J. B.; Thompson, D. J.; Thorsett, S. E.; Tibaldo, L.; Tibolla, O.; Tinivella, M.; Troja, E.; Uchiyama, Y.; Usher, T. L.; Vandenbroucke, J.; Vasileiou, V.; Vianello, G.; Vitale, V.; Waite, A. P.; Werner, M.; Winer, B. L.; Wood, K. S.; Wood, M.; Yamazaki, R.; Yang, Z.; Zimmer, S.			Detection of the Characteristic Pion-Decay Signature in Supernova Remnants	SCIENCE			English	Article							GAMMA-RAY EMISSION; LARGE-AREA TELESCOPE; IC 443; COSMIC-RAYS; FERMI LAT; SNR W44; ACCELERATION; CLOUDS; DISCOVERY; RADIATION	Cosmic rays are particles (mostly protons) accelerated to relativistic speeds. Despite wide agreement that supernova remnants (SNRs) are the sources of galactic cosmic rays, unequivocal evidence for the acceleration of protons in these objects is still lacking. When accelerated protons encounter interstellar material, they produce neutral pions, which in turn decay into gamma rays. This offers a compelling way to detect the acceleration sites of protons. The identification of pion-decay gamma rays has been difficult because high-energy electrons also produce gamma rays via bremsstrahlung and inverse Compton scattering. We detected the characteristic pion-decay feature in the gamma-ray spectra of two SNRs, IC 443 and W44, with the Fermi Large Area Telescope. This detection provides direct evidence that cosmic-ray protons are accelerated in SNRs.	[Ackermann, M.; Mayer, M.; Schulz, A.] Deutsch Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany; [Ajello, M.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Allafort, A.; Bechtol, K.; Blandford, R. D.; Bloom, E. D.; Borgland, A. W.; Bottacini, E.; Buehler, R.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; do Couto e Silva, E.; Drell, P. S.; Drlica-Wagner, A.; Franckowiak, A.; Funk, S.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Hill, A. B.; Jogler, T.; Johnson, A. S.; Kamae, T.; Katsuta, J.; Lande, J.; Madejski, G. M.; Massaro, F.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Omodei, N.; Orlando, E.; Paneque, D.; Reimer, A.; Reimer, O.; Sanchez-Conde, M.; Simeon, P. E.; Tajima, H.; Tanaka, T.; Thayer, J. G.; Thayer, J. B.; Uchiyama, Y.; Usher, T. L.; Vandenbroucke, J.; Vianello, G.; Waite, A. P.; Wood, M.] Stanford Univ, Dept Phys, Kavli Inst Particle Astrophys & Cosmol, WW Hansen Expt Phys Lab, Stanford, CA 94305 USA; [Allafort, A.; Bechtol, K.; Blandford, R. D.; Bloom, E. D.; Borgland, A. W.; Bottacini, E.; Buehler, R.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; do Couto e Silva, E.; Drell, P. S.; Drlica-Wagner, A.; Franckowiak, A.; Funk, S.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Hill, A. B.; Jogler, T.; Johnson, A. S.; Kamae, T.; Katsuta, J.; Lande, J.; Madejski, G. M.; Massaro, F.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Omodei, N.; Orlando, E.; Paneque, D.; Reimer, A.; Reimer, O.; Sanchez-Conde, M.; Simeon, P. E.; Tajima, H.; Tanaka, T.; Thayer, J. G.; Thayer, J. B.; Uchiyama, Y.; Usher, T. L.; Vandenbroucke, J.; Vianello, G.; Waite, A. P.; Wood, M.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Baldini, L.] Univ Pisa, I-56127 Pisa, Italy; [Baldini, L.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Ballet, J.; Casandjian, J. M.; Chaty, S.; Chaves, R. C. G.; Corbel, S.; Grenier, I. A.] Univ Paris Diderot, Serv Astrophys, Lab AIM, CEA Saclay,CEA IRFU,CNRS, F-91191 Gif Sur Yvette, France; [Barbiellini, G.; Longo, F.] Ist Nazl Fis Nucl, Sezione Trieste, I-34127 Trieste, Italy; [Barbiellini, G.; Longo, F.] Univ Trieste, Dipartimento Fis, I-34127 Trieste, Italy; [Baring, M. G.] Rice Univ, Dept Phys & Astron, Houston, TX 77251 USA; [Bastieri, D.; Busetto, G.; Buson, S.; Rando, R.; Tibaldo, L.] Ist Nazl Fis Nucl, Sez Padova, I-35131 Padua, Italy; [Bastieri, D.; Busetto, G.; Buson, S.; Chiaro, G.; Pivato, G.; Rando, R.; Romoli, C.; Tibaldo, L.] Univ Padua, Dipartimento Fis & Astron G Galilei, I-35131 Padua, Italy; [Bellazzini, R.; Bregeon, J.; Kuss, M.; Pesce-Rollins, M.; Razzano, M.; Sgro, C.; Spandre, G.; Tinivella, M.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Bonamente, E.; Cecchi, C.; D'Ammando, F.; Germani, S.; Lubrano, P.] Ist Nazl Fis Nucl, Sez Perugia, I-06123 Perugia, Italy; [Bonamente, E.; Cecchi, C.; Ciprini, S.; Germani, S.; Lubrano, P.] Univ Perugia, Dipartimento Fis, I-06123 Perugia, Italy; [Brandt, T. J.; Celik, O.; Cillis, A. N.; Ferrara, E. C.; Guiriec, S.; Harding, A. K.; Hays, E.; Hewitt, J. W.; McEnery, J. E.; Nemmen, R.; Perkins, J. S.; Stecker, F. W.; Thompson, D. J.; Troja, E.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Raino, S.; Spinelli, P.] Univ & Politecn Bari, Dipartimento Fis M Merlin, I-70126 Bari, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Gargano, F.; Giglietto, N.; Giordano, F.; Loparco, F.; Mazziotta, M. N.; Raino, S.; Spinelli, P.] Ist Nazl Fis Nucl, Sez Bari, I-70126 Bari, Italy; [Bruel, P.] Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; [Caliandro, G. A.; Hadasch, D.] Inst Ciencies Espai IEEE CSIC, Barcelona 08193, Spain; [Caraveo, P. A.] INAF Ist Astrofis Spaziale & Fis Cosm, I-20133 Milan, Italy; [Celik, O.; Moiseev, A. A.; Perkins, J. S.] CRESST, Greenbelt, MD 20771 USA; [Celik, O.; Moiseev, A. A.; Perkins, J. S.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Celik, O.; Perkins, J. S.] Univ Maryland Baltimore Cty, Dept Phys, Baltimore, MD 21250 USA; [Celik, O.; Perkins, J. S.] Univ Maryland Baltimore Cty, Ctr Space Sci & Technol, Baltimore, MD 21250 USA; [Chekhtman, A.; Razzaque, S.] George Mason Univ, Coll Sci, Ctr Earth Observing & Space Res, Fairfax, VA 22030 USA; [Chekhtman, A.; Cheung, C. C.; Razzaque, S.] USN, Res Lab, Washington, DC 20375 USA; [Cheung, C. C.] USN, Acad Sci, Natl Res Council, Washington, DC 20001 USA; [Chiaro, G.] Ist Nazl Fis Nucl, I-35131 Padua, Italy; [Cillis, A. N.] Inst Astron & Fis Espacio, RA-1428 Buenos Aires, DF, Argentina; [Ciprini, S.] ASI Sci Data Ctr, I-00044 Rome, Italy; [Cohen-Tanugi, J.; Falletti, L.; Mehault, J.; Nuss, E.; Piron, F.; Vasileiou, V.] Univ Montpellier 2, CNRS, IN2P3, Lab Universe & Particules Montpellier, Montpellier, France; [Cominsky, L. R.] Sonoma State Univ, Dept Phys & Astron, Rohnert Pk, CA 94928 USA; [Conrad, J.; Larsson, S.; Yang, Z.; Zimmer, S.] Stockholm Univ, Dept Phys, AlbaNova, SE-10691 Stockholm, Sweden; [Conrad, J.; Jackson, M. S.; Larsson, S.; Yang, Z.; Zimmer, S.] Oskar Klein Ctr Cosmoparticle Phys, AlbaNova, SE-10691 Stockholm, Sweden; [Conrad, J.] Royal Swedish Acad Sci, Stockholm, Sweden; [Corbel, S.] Inst Univ France, F-75005 Paris, France; [Cutini, S.; Giommi, P.] Agenzia Spaziale Italiana ASI Sci Data Ctr, I-00044 Rome, Italy; [D'Ammando, F.] IASF Palermo, I-90146 Palermo, Italy; [D'Ammando, F.] INAF Ist Astrofis Spaziale & Fis Cosm, I-00133 Rome, Italy; [de Angelis, A.] Univ Udine, Dipartimento Fis, I-33100 Udine, Italy; [de Angelis, A.] Ist Nazl Fis Nucl, Sez Trieste, Grp Coll Udine, I-33100 Udine, Italy; [Dermer, C. D.; Grove, J. E.; Lovellette, M. N.; Wood, K. S.] USN, Res Lab, Div Space Sci, Washington, DC 20375 USA; [Fukazawa, Y.; Hanabata, Y.; Hayashi, K.; Takahashi, H.] Hiroshima Univ, Dept Phys Sci, Hiroshima 7398526, Japan; [Giroletti, M.; Orienti, M.] INAF Ist Radioastron, I-40129 Bologna, Italy; [Grondin, M. -H.] Max Planck Inst Kernphys, D-69029 Heidelberg, Germany; [Grondin, M. -H.] Heidelberg Univ, Landessternwarte, D-69117 Heidelberg, Germany; [Hayashida, M.] Kyoto Univ, Grad Sch Sci, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan; [Hill, A. B.] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England; [Hughes, R. E.; Winer, B. L.] Ohio State Univ, Dept Phys, Ctr Cosmol & Astroparticle Phys, Columbus, OH 43210 USA; [Jackson, M. S.] Royal Inst Technol KTH, Dept Phys, AlbaNova, SE-10691 Stockholm, Sweden; [Johannesson, G.] Univ Iceland, Inst Sci, IS-107 Reykjavik, Iceland; [Kataoka, J.; Nakamori, T.] Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Knoedlseder, J.] CNRS, IRAP, F-31028 Toulouse 4, France; [Knoedlseder, J.] Univ Toulouse, UPS OMP, IRAP, GAHEC, F-31028 Toulouse, France; [Larsson, S.] Stockholm Univ, Dept Astron, SE-10691 Stockholm, Sweden; [Latronico, L.] Ist Nazl Fis Nucl, Sez Torino, I-10125 Turin, Italy; [Lemoine-Goumard, M.; Smith, D. A.] Univ Bordeaux 1, CNRS, IN2P3, Ctr Etud Nucl Bordeaux Gradignan, F-33175 Gradignan, France; [McEnery, J. E.; Moiseev, A. A.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [McEnery, J. E.; Moiseev, A. A.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Mignani, R. P.] Univ Coll London, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; [Mizuno, T.; Ohsugi, T.] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Hiroshima 7398526, Japan; [Morselli, A.; Vitale, V.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, I-00133 Rome, Italy; [Ohno, M.; Takahashi, T.] JAXA, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Ormes, J. F.] Univ Denver, Dept Phys & Astron, Denver, CO 80208 USA; [Paneque, D.] Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany; [Perkins, J. S.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Razzano, M.; Ritz, S.] Univ Calif Santa Cruz, Dept Phys, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Razzano, M.; Ritz, S.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Reimer, A.; Reimer, O.; Werner, M.] Leopold Franzens Univ Innsbruck, Inst Astro & Teilchenphys, A-6020 Innsbruck, Austria; [Reimer, A.; Reimer, O.; Werner, M.] Leopold Franzens Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria; [Siskind, E. J.] NYCB Real Time Comp Inc, Lattingtown, NY 11560 USA; [Stecker, F. W.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Strong, A. W.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; Purdue Univ Calumet, Dept Chem & Phys, Hammond, IN 46323 USA; [Tajima, H.] Nagoya Univ, Solar Terr Environm Lab, Nagoya, Aichi 4648601, Japan; [Tanaka, T.] Kyoto Univ, Grad Sch Sci, Dept Phys, Sakyo Ku, Kyoto 6068502, Japan; [Thorsett, S. E.] Willamette Univ, Dept Phys, Salem, OR 97031 USA; [Tibolla, O.] Univ Wurzburg, Inst Theoret Phys & Astrophys, D-97074 Wurzburg, Germany; [Troja, E.] NASA, Postdoctoral Program, Washington, DC USA; [Vianello, G.] Consorzio Interuniv Fis Spaziale, I-10133 Turin, Italy; [Vitale, V.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Yamazaki, R.] Aoyama Gakuin Univ, Dept Phys & Math, Sagamihara, Kanagawa 2525258, Japan	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of California System; University of California Berkeley; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Pisa; Istituto Nazionale di Fisica Nucleare (INFN); UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Istituto Nazionale di Fisica Nucleare (INFN); University of Trieste; Rice University; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); University of Perugia; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Politecnico di Bari; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Istituto Nazionale Astrofisica (INAF); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County; George Mason University; United States Department of Defense; United States Navy; Naval Research Laboratory; National Academies of Sciences, Engineering & Medicine; United States Department of Defense; United States Navy; Istituto Nazionale di Fisica Nucleare (INFN); Instituto de Astronomia y Fisica del Espacio (IAFE); Agenzia Spaziale Italiana (ASI); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; California State University System; Sonoma State University; Stockholm University; Oskar Klein Centre; Royal Swedish Academy of Sciences; Institut Universitaire de France; Agenzia Spaziale Italiana (ASI); Istituto Nazionale Astrofisica (INAF); University of Udine; Istituto Nazionale di Fisica Nucleare (INFN); United States Department of Defense; United States Navy; Naval Research Laboratory; Hiroshima University; Istituto Nazionale Astrofisica (INAF); Max Planck Society; Ruprecht Karls University Heidelberg; Kyoto University; University of Southampton; University System of Ohio; Ohio State University; Royal Institute of Technology; University of Iceland; Waseda University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Stockholm University; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of London; University College London; Hiroshima University; Istituto Nazionale di Fisica Nucleare (INFN); Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of Denver; Max Planck Society; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of Innsbruck; University of Innsbruck; University of California System; University of California Los Angeles; Max Planck Society; Purdue University System; Purdue University; Nagoya University; Kyoto University; Willamette University; University of Wurzburg; National Aeronautics & Space Administration (NASA); University of Rome Tor Vergata; Aoyama Gakuin University	Funk, S (corresponding author), Stanford Univ, Dept Phys, Kavli Inst Particle Astrophys & Cosmol, WW Hansen Expt Phys Lab, Stanford, CA 94305 USA.	funk@slac.stanford.edu; ttanaka@cr.scphys.kyoto-u.ac.jp; uchiyama@slac.stanford.edu	Reimer, Anita/K-5822-2015; Massaro, Francesco/L-9102-2016; Gargano, Fabio/O-8934-2015; Sgrò, Carmelo/K-3395-2016; Cutini, Sara/ABB-1787-2020; Bastieri, Denis/AAC-5917-2020; Morselli, Aldo/G-6769-2011; Takahashi, Hiromitsu H/T-2713-2017; Moskalenko, Igor V/A-1301-2007; Tajima, Hiroyasu/I-6228-2014; Giglietto, Nicola/Y-2425-2019; Funk, Stefan/B-7629-2015; Gargano, Fabio/AAD-5121-2021; cohen-tanugi, Johann/ABB-1481-2021; Fukazawa, Yasushi/G-2081-2017; Nemmen, Rodrigo/O-6841-2014; Orlando, Elena/R-5594-2016; Caraveo, Patrizia/AAL-5708-2020; Hadasch, Daniela/N-7819-2016; Stecker, Floyd W/D-3169-2012; Mazziotta, Mario N/O-8867-2015; Jóhannesson, Guðlaugur/O-8741-2015; Hays, Elizabeth/D-3257-2012; Rando, Riccardo/O-1302-2019; Loparco, Francesco/O-8847-2015; Reimer, Olaf/A-3117-2013; Jóhannesson, Guðlaugur/ABC-7216-2020; Troja, Eleonora/AAB-3604-2020; Rando, Riccardo/M-7179-2013; Troja, Eleonora/I-5282-2017; Funk, Stefan/AAI-1568-2021; giglietto, nicola/I-8951-2012; Chaty, Sylvain/B-8671-2016; giommi, paolo/L-1006-2018	Reimer, Anita/0000-0001-8604-7077; Massaro, Francesco/0000-0002-1704-9850; Gargano, Fabio/0000-0002-5055-6395; Cutini, Sara/0000-0002-1271-2924; Bastieri, Denis/0000-0002-6954-8862; Morselli, Aldo/0000-0002-7704-9553; Takahashi, Hiromitsu H/0000-0001-6314-5897; Moskalenko, Igor V/0000-0001-6141-458X; Tajima, Hiroyasu/0000-0002-1721-7252; Giglietto, Nicola/0000-0002-9021-2888; Funk, Stefan/0000-0002-2012-0080; Gargano, Fabio/0000-0002-5055-6395; cohen-tanugi, Johann/0000-0001-9022-4232; Fukazawa, Yasushi/0000-0002-0921-8837; Nemmen, Rodrigo/0000-0003-3956-0331; Orlando, Elena/0000-0001-6406-9910; Caraveo, Patrizia/0000-0003-2478-8018; Hadasch, Daniela/0000-0001-8663-6461; Mazziotta, Mario N/0000-0001-9325-4672; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Rando, Riccardo/0000-0001-6992-818X; Loparco, Francesco/0000-0002-1173-5673; Reimer, Olaf/0000-0001-6953-1385; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Troja, Eleonora/0000-0002-1869-7817; Troja, Eleonora/0000-0002-1869-7817; Funk, Stefan/0000-0002-2012-0080; giglietto, nicola/0000-0002-9021-2888; Cecchi, Claudia/0000-0002-2192-8233; SPINELLI, Paolo/0000-0001-6688-8864; Monzani, Maria Elena/0000-0002-8254-5308; RAZZANO, MASSIMILIANO/0000-0003-4825-1629; Tanaka, Takaaki/0000-0002-4383-0368; Sgro', Carmelo/0000-0001-5676-6214; Omodei, Nicola/0000-0002-5448-7577; D'Ammando, Filippo/0000-0001-7618-7527; Vianello, Giacomo/0000-0002-2553-0839; Ciprini, Stefano/0000-0002-0712-2479; de Palma, Francesco/0000-0001-5898-2834; Buson, Sara/0000-0002-3308-324X; Hill, Adam/0000-0003-3470-4834; Romoli, Carlo/0000-0003-2541-4499; Murgia, Simona/0000-0003-0516-9422; Giroletti, Marcello/0000-0002-8657-8852; Baldini, Luca/0000-0002-9785-7726; Tibaldo, Luigi/0000-0001-7523-570X; Ackermann, Markus/0000-0001-8952-588X; Fusco, Piergiorgio/0000-0002-9383-2425; De Angelis, Alessandro/0000-0002-3288-2517; Charles, Eric/0000-0002-3925-7802; orienti, monica/0000-0003-4470-7094; Pesce-Rollins, Melissa/0000-0003-1790-8018; Chaty, Sylvain/0000-0002-5769-8601; Casandjian, Jean-Marc/0000-0003-1404-0524; Raino', Silvia/0000-0002-9181-0345; giommi, paolo/0000-0002-2265-5003; Mignani, Roberto/0000-0002-8685-583X; Cameron, Robert/0000-0003-0942-2747; Larsson, Stefan/0000-0003-0716-107X; Thorsett, Stephen/0000-0002-2025-9613; Spandre, Gloria/0000-0003-0802-3453; Buehler, Rolf/0000-0003-4425-6641; Cheung, Chi (Teddy)/0000-0002-4377-0174; Ajello, Marco/0000-0002-6584-1703; Sanchez-Conde, Miguel/0000-0002-3849-9164; Grenier, Isabelle/0000-0003-3274-674X; Razzaque, Soebur/0000-0002-0130-2460; Tibolla, Omar/0000-0002-9074-0584	NASA; U.S. Department of Energy (United States); CEA/Irfu; IN2P3/CNRS (France); ASI; INFN (Italy); MEXT; KEK; JAXA (Japan); K. A. Wallenberg Foundation; Swedish Research Council; National Space Board (Sweden); STFC [ST/H00260X/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/H00260X/1] Funding Source: researchfish	NASA(National Aeronautics & Space Administration (NASA)); U.S. Department of Energy (United States)(United States Department of Energy (DOE)); CEA/Irfu(French Atomic Energy Commission); IN2P3/CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); ASI(Agenzia Spaziale Italiana (ASI)); INFN (Italy)(Istituto Nazionale di Fisica Nucleare (INFN)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KEK(High Energy Accelerator Research Organization (KEK)); JAXA (Japan); K. A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Space Board (Sweden); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The Fermi LAT Collaboration acknowledges support from a number of agencies and institutes for both development and the operation of the LAT as well as scientific data analysis. These include NASA and the U.S. Department of Energy (United States); CEA/Irfu and IN2P3/CNRS (France); ASI and INFN (Italy); MEXT, KEK, and JAXA (Japan); and the K. A. Wallenberg Foundation, the Swedish Research Council, and the National Space Board (Sweden). Additional support from INAF in Italy and CNES in France for science analysis during the operations phase is also gratefully acknowledged. Fermi LAT data are available from the Fermi Science Support Center (http://fermi.gsfc.nasa.gov/ssc).	Abdo AA, 2010, ASTROPHYS J, V712, P459, DOI 10.1088/0004-637X/712/1/459; Abdo AA, 2010, SCIENCE, V327, P1103, DOI 10.1126/science.1182787; Abdo AA, 2009, ASTROPHYS J LETT, V706, pL1, DOI 10.1088/0004-637X/706/1/L1; Acciari VA, 2009, ASTROPHYS J LETT, V698, pL133, DOI 10.1088/0004-637X/698/2/L133; Ackermann M, 2012, ASTROPHYS J SUPPL S, V203, DOI 10.1088/0067-0049/203/1/4; AHARONIAN FA, 1994, ASTRON ASTROPHYS, V285, P645; Albert J, 2007, ASTROPHYS J, V664, pL87, DOI 10.1086/520957; Castelletti G, 2007, ASTRON ASTROPHYS, V471, P537, DOI 10.1051/0004-6361:20077062; DERMER CD, 1986, ASTRON ASTROPHYS, V157, P223; DRURY LO, 1994, ASTRON ASTROPHYS, V287, P959; Gabici S, 2009, MON NOT R ASTRON SOC, V396, P1629, DOI 10.1111/j.1365-2966.2009.14832.x; Giuliani A, 2011, ASTROPHYS J LETT, V742, DOI 10.1088/2041-8205/742/2/L30; Helder EA, 2009, SCIENCE, V325, P719, DOI 10.1126/science.1173383; Lande J, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/5; Malkov MA, 2001, REP PROG PHYS, V64, P429, DOI 10.1088/0034-4885/64/4/201; Mattox JR, 1996, ASTROPHYS J, V461, P396, DOI 10.1086/177068; Mori M, 2009, ASTROPART PHYS, V31, P341, DOI 10.1016/j.astropartphys.2009.03.004; Morlino G, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201117855; NAITO T, 1994, J PHYS G NUCL PARTIC, V20, P477, DOI 10.1088/0954-3899/20/3/009; Nolan PL, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/2/31; Ohira Y, 2011, MON NOT R ASTRON SOC, V410, P1577, DOI 10.1111/j.1365-2966.2010.17539.x; Seta M, 1998, ASTROPHYS J, V505, P286, DOI 10.1086/306141; Stecker F. W., 1971, NASA SPEC PUBL, V249; Tavani M, 2010, ASTROPHYS J LETT, V710, pL151, DOI 10.1088/2041-8205/710/2/L151; Uchiyama Y, 2007, NATURE, V449, P576, DOI 10.1038/nature06210; Uchiyama Y, 2012, ASTROPHYS J LETT, V749, DOI 10.1088/2041-8205/749/2/L35; Uchiyama Y, 2010, ASTROPHYS J LETT, V723, pL122, DOI 10.1088/2041-8205/723/1/L122; Warren JS, 2005, ASTROPHYS J, V634, P376, DOI 10.1086/496941	29	482	495	5	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2013	339	6121					807	811		10.1126/science.1231160	http://dx.doi.org/10.1126/science.1231160			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23413352	Green Submitted, Green Published			2022-12-28	WOS:000314874400045
J	Childs, AM; Gosset, D; Webb, Z				Childs, Andrew M.; Gosset, David; Webb, Zak			Universal Computation by Multiparticle Quantum Walk	SCIENCE			English	Article								A quantum walk is a time-homogeneous quantum-mechanical process on a graph defined by analogy to classical random walk. The quantum walker is a particle that moves from a given vertex to adjacent vertices in quantum superposition. We consider a generalization to interacting systems with more than one walker, such as the Bose-Hubbard model and systems of fermions or distinguishable particles with nearest-neighbor interactions, and show that multiparticle quantum walk is capable of universal quantum computation. Our construction could, in principle, be used as an architecture for building a scalable quantum computer with no need for time-dependent control.	[Childs, Andrew M.; Gosset, David] Univ Waterloo, Dept Combinator & Optimizat, Waterloo, ON N2L 3G1, Canada; [Childs, Andrew M.; Gosset, David; Webb, Zak] Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada; [Webb, Zak] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada	University of Waterloo; University of Waterloo; University of Waterloo	Gosset, D (corresponding author), Univ Waterloo, Dept Combinator & Optimizat, Waterloo, ON N2L 3G1, Canada.	dngosset@gmail.com	Childs, Andrew M/B-6329-2009	Childs, Andrew M/0000-0002-9903-837X	MITACS; Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Research and Innovation; Ontario Ministry of Training, Colleges, and Universities; U.S. Army Research Office	MITACS; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Ontario Ministry of Training, Colleges, and Universities; U.S. Army Research Office	This work was supported in part by MITACS; Natural Sciences and Engineering Research Council of Canada; the Ontario Ministry of Research and Innovation; the Ontario Ministry of Training, Colleges, and Universities; and the U.S. Army Research Office.	Aaronson S, 2011, ACM S THEORY COMPUT, P333; Aharonov D., 2001, PROC 33 ANN ACM S TH, ppp 50; Ahlbrecht A, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/7/073050; Ambainis A., 2001, P 33 ANN ACM S THEOR, V01, P37, DOI DOI 10.1145/380752.380757; Ambainis A, 2007, SIAM J COMPUT, V37, P210, DOI 10.1137/S0097539705447311; Bakr WS, 2009, NATURE, V462, P74, DOI 10.1038/nature08482; Blumer BA, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.062302; Brennen GK, 1999, PHYS REV LETT, V82, P1060, DOI 10.1103/PhysRevLett.82.1060; Bromberg Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.253904; Childs AM., 2003, P 35 ANN ACM S THEOR, ppp 59; Childs AM, 2012, J MATH PHYS, V53, DOI 10.1063/1.4757665; Childs AM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.180501; CHUANG IL, 1995, PHYS REV A, V52, P3489, DOI 10.1103/PhysRevA.52.3489; Do B, 2005, J OPT SOC AM B, V22, P499, DOI 10.1364/JOSAB.22.000499; Farhi E, 1998, PHYS REV A, V58, P915, DOI 10.1103/PhysRevA.58.915; Farhi E., 2008, THEORY COMPUTING, V4, P169, DOI DOI 10.4086/T0C.2008.V004A008; Gamble JK, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.052313; Hoffman AJ, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.053602; Ionicioiu R, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.050301; Karski M, 2009, SCIENCE, V325, P174, DOI 10.1126/science.1174436; Lahini Y, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.011603; Mizel A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.070502; Omar Y, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.042304; Owens JO, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/7/075003; Pathak PK, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.032351; Perets HB, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.170506; Peruzzo A, 2010, SCIENCE, V329, P1500, DOI 10.1126/science.1193515; Rohde PP, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/013001; Sansoni L, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.010502; Smith J., 2011, ELECT NOTES DISCRETE, V38, P795; Valiente M, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.042102	33	251	258	10	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2013	339	6121					791	794		10.1126/science.1229957	http://dx.doi.org/10.1126/science.1229957			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23413349	Green Submitted			2022-12-28	WOS:000314874400040
J	Basler, M; Ho, BT; Mekalanos, JJ				Basler, Marek; Ho, Brian T.; Mekalanos, John J.			Tit-for-Tat: Type VI Secretion System Counterattack during Bacterial Cell-Cell Interactions	CELL			English	Article							PSEUDOMONAS-AERUGINOSA; PROTEIN SECRETION; ESCHERICHIA-COLI; TARGET-CELLS; INHIBITION; GROWTH; ACTIVATION; TRANSPORT; APPARATUS; DYNAMICS	The bacterial type VI secretion system (T6SS) is a dynamic organelle that bacteria use to target prey cells for inhibition via translocation of effector proteins. Time-lapse fluorescence microscopy has documented striking dynamics of opposed T6SS organelles in adjacent sister cells of Pseudomonas aeruginosa. Such cell-cell interactions have been termed "T6SS dueling" and likely reflect a biological process that is driven by T6SS antibacterial attack. Here, we show that T6SS dueling behavior strongly influences the ability of P. aeruginosa to prey upon heterologous bacterial species. We show that, in the case of P. aeruginosa, T6SS-dependent killing of either Vibrio cholerae or Acinetobacter baylyi is greatly stimulated by T6SS activity occurring in those prey species. Our data suggest that, in P. aeruginosa, T6SS organelle assembly and lethal counterattack are regulated by a signal that corresponds to the point of attack of the T6SS apparatus elaborated by a second aggressive T6SS(+) bacterial cell.	[Basler, Marek; Ho, Brian T.; Mekalanos, John J.] Harvard Univ, Dept Microbiol & Immunobiol, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Mekalanos, JJ (corresponding author), Harvard Univ, Dept Microbiol & Immunobiol, Sch Med, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	john_mekalanos@hms.harvard.edu	Ho, Brian/M-1976-2019; Basler, Marek/A-3559-2012	Ho, Brian/0000-0003-4979-780X; Basler, Marek/0000-0001-5414-2088	NIAID [AI-018045, AI-26289]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R22AI018045, R01AI018045, R37AI018045, R01AI026289] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Casey Gifford for constructing pEXG2-Delta tagT plasmid. We also thank Russell Vance and Stephen Lory for helpful discussions and Tom Bernhardt and David Rudner for access to microscopic resources and tips for optimal use. This work was supported by NIAID grants AI-018045 and AI-26289 to J.J.M.	Aoki SK, 2009, J BACTERIOL, V191, P1777, DOI 10.1128/JB.01437-08; Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Aoki SK, 2008, MOL MICROBIOL, V70, P323, DOI 10.1111/j.1365-2958.2008.06404.x; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Basler M, 2012, SCIENCE, V337, P815, DOI 10.1126/science.1222901; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Casabona M.G, 2012, ENV MICROBIOL; Chou S, 2012, CELL REP, V1, P656, DOI 10.1016/j.celrep.2012.05.016; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; Ding JJ, 2012, J BIOL CHEM, V287, P26911, DOI 10.1074/jbc.M112.368043; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Gibbs KA, 2008, SCIENCE, V321, P256, DOI 10.1126/science.1160033; Gibbs KA, 2011, J BACTERIOL, V193, P3286, DOI 10.1128/JB.01167-10; Hsu FS, 2009, MOL MICROBIOL, V72, P1111, DOI 10.1111/j.1365-2958.2009.06701.x; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Li M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002613; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Metzgar D, 2004, NUCLEIC ACIDS RES, V32, P5780, DOI 10.1093/nar/gkh881; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Murdoch SL, 2011, J BACTERIOL, V193, P6057, DOI 10.1128/JB.05671-11; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Silverman JM, 2011, MOL MICROBIOL, V82, P1277, DOI 10.1111/j.1365-2958.2011.07889.x; URATANI Y, 1984, J BACTERIOL, V157, P632, DOI 10.1128/JB.157.2.632-636.1984; Wintermute EH, 2010, GENE DEV, V24, P2603, DOI 10.1101/gad.1985210; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023876	39	321	334	3	121	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 14	2013	152	4					884	894		10.1016/j.cell.2013.01.042	http://dx.doi.org/10.1016/j.cell.2013.01.042			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415234	Green Accepted, Bronze			2022-12-28	WOS:000314945600021
J	Kamberov, YG; Wang, SJ; Tan, JZ; Gerbault, P; Wark, A; Tan, LZ; Yang, YJ; Li, SL; Tang, K; Chen, H; Powell, A; Itan, Y; Fuller, D; Lohmueller, J; Mao, JH; Schachar, A; Paymer, M; Hostetter, E; Byrne, E; Burnett, M; McMahon, AP; Thomas, MG; Lieberman, DE; Jin, L; Tabin, CJ; Morgan, BA; Sabeti, PC				Kamberov, Yana G.; Wang, Sijia; Tan, Jingze; Gerbault, Pascale; Wark, Abigail; Tan, Longzhi; Yang, Yajun; Li, Shilin; Tang, Kun; Chen, Hua; Powell, Adam; Itan, Yuval; Fuller, Dorian; Lohmueller, Jason; Mao, Junhao; Schachar, Asa; Paymer, Madeline; Hostetter, Elizabeth; Byrne, Elizabeth; Burnett, Melissa; McMahon, Andrew P.; Thomas, Mark G.; Lieberman, Daniel E.; Jin, Li; Tabin, Clifford J.; Morgan, Bruce A.; Sabeti, Pardis C.			Modeling Recent Human Evolution in Mice by Expression of a Selected EDAR Variant	CELL			English	Article							ECTODYSPLASIN-A RECEPTOR; TO-HIP RATIO; NF-KAPPA-B; POSITIVE SELECTION; ECTODERMAL DYSPLASIA; STATISTICAL EVALUATION; ETHNIC-DIFFERENCES; HAIR THICKNESS; HUMAN GENOME; BODY-WEIGHT	An adaptive variant of the human Ectodysplasin receptor, EDARV370A, is one of the strongest candidates of recent positive selection from genome-wide scans. We have modeled EDAR370A in mice and characterized its phenotype and evolutionary origins in humans. Our computational analysis suggests the allele arose in central China approximately 30,000 years ago. Although EDAR370A has been associated with increased scalp hair thickness and changed tooth morphology in humans, its direct biological significance and potential adaptive role remain unclear. We generated a knockin mouse model and find that, as in humans, hair thickness is increased in EDAR370A mice. We identify new biological targets affected by the mutation, including mammary and eccrine glands. Building on these results, we find that EDAR370A is associated with an increased number of active eccrine glands in the Han Chinese. This interdisciplinary approach yields unique insight into the generation of adaptive variation among modern humans.	[Kamberov, Yana G.; Wark, Abigail; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Kamberov, Yana G.; Burnett, Melissa; Morgan, Bruce A.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Kamberov, Yana G.; Morgan, Bruce A.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Boston, MA 02114 USA; [Burnett, Melissa] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Kamberov, Yana G.; Wang, Sijia; Tan, Longzhi; Lohmueller, Jason; Schachar, Asa; Paymer, Madeline; Hostetter, Elizabeth; Byrne, Elizabeth; Sabeti, Pardis C.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Kamberov, Yana G.; Lieberman, Daniel E.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Kamberov, Yana G.; Wang, Sijia; Schachar, Asa; Paymer, Madeline; Sabeti, Pardis C.] Harvard Univ, Ctr Syst Biol, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Mao, Junhao; McMahon, Andrew P.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Tan, Jingze; Yang, Yajun; Li, Shilin; Jin, Li] Fudan Univ, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Gerbault, Pascale; Itan, Yuval; Thomas, Mark G.] UCL, Dept Genet Evolut & Environm, London WC1H 0PY, England; [Powell, Adam] UCL, UCL Genet Inst UGI, London WC1H 0PY, England; [Fuller, Dorian] UCL, Inst Archaeol, London WC1H 0PY, England; [Tang, Kun; Jin, Li] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai 200031, Peoples R China; [Chen, Hua] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Sabeti, Pardis C.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard University; Fudan University; University of London; University College London; University of London; University College London; University of London; University College London; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Jin, L (corresponding author), Fudan Univ, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China.	lijin.fudan@gmail.com; bruce.morgan@cbrc2.mgh.harvard.edu; pardis@broadinstitute.org	Sabeti, Pardis/GQH-8610-2022; Tang, Kun/GSD-3218-2022; Jin, Li/C-1468-2009; Fuller, Dorian Q/C-1908-2008; Jin, Li/M-5063-2019; Fuller, Dorian/AAF-7400-2019; McMahon, Andrew P/ABE-7520-2020; Thomas, Mark G/A-2219-2012	Jin, Li/0000-0002-4546-2415; Fuller, Dorian Q/0000-0002-4859-080X; Fuller, Dorian/0000-0002-4859-080X; Thomas, Mark G/0000-0002-2452-981X; Gerbault, Pascale/0000-0003-3824-0870; Tan, Longzhi/0000-0002-5618-1299; Lohmueller, Jason/0000-0001-6089-9992; Chen, Hua/0000-0002-9829-6561	Harvard University Science and Engineering Committee Seed Fund for Interdisciplinary Science; Packard Foundation Fellowship in Science and Engineering; NIH Innovator Award [1DP2OD006514-01]; BIRT Award from NIAMS [AR055256-04S1]; NIH grant [R37 HD032443]; American School of Prehistoric Research; NSFC [30890034]; MOST [2011BAI09B00]; MOH [201002007]; AXA Research Fund; LeCHE Marie Curie FP7; NIH [R37 054364]; NERC [NE/G005540/1] Funding Source: UKRI; Natural Environment Research Council [NE/G005540/1] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055256] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006514] Funding Source: NIH RePORTER	Harvard University Science and Engineering Committee Seed Fund for Interdisciplinary Science; Packard Foundation Fellowship in Science and Engineering; NIH Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BIRT Award from NIAMS; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American School of Prehistoric Research; NSFC(National Natural Science Foundation of China (NSFC)); MOST; MOH; AXA Research Fund(AXA Research Fund); LeCHE Marie Curie FP7; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was funded by a grant from the Harvard University Science and Engineering Committee Seed Fund for Interdisciplinary Science to CJT, PCS, BAM and DEL; a Packard Foundation Fellowship in Science and Engineering and an NIH Innovator Award 1DP2OD006514-01 to PCS; a BIRT Award AR055256-04S1 from NIAMS to BAM; an NIH grant R37 HD032443 to CJT; and funding from the American School of Prehistoric Research to DEL. Human association study work was additionally supported by NSFC 30890034; MOST 2011BAI09B00; MOH 201002007 to LJ. YI was funded by an AXA Research Fund postdoctoral fellowship and PG by the LeCHE Marie Curie FP7 framework. Work in APM's laboratory was supported by an NIH R37 054364 grant. We acknowledge the UCL Legion High Performance Computing Facility and support services and thank O. Bar Yosef, C. Zhao, E. Rohling, S. Schaffner, L. Gaffney, C. Edwards, J. Vitti, S. Tabrizi and A. Tariela for feedback on the manuscript and A. Carpenter, C. Wahlby, and M. Morgan for data analysis help. The authors declare no conflict of interest.	Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; ANDERSON P, 1983, CURR ANTHROPOL, V24, P25, DOI 10.1086/202933; Beaumont MA, 2002, GENETICS, V162, P2025; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Bryk J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002209; Cann HM, 2002, SCIENCE, V296, P261; CARRIER DR, 1984, CURR ANTHROPOL, V25, P483, DOI 10.1086/203165; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chang SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007591; Chen H, 2012, THEOR POPUL BIOL, V81, P179, DOI 10.1016/j.tpb.2011.11.004; Chen ZJ, 2004, AM J EPIDEMIOL, V159, P140, DOI 10.1093/aje/kwh028; CLARKE A, 1987, ARCH DIS CHILD, V62, P989, DOI 10.1136/adc.62.10.989; Cluzeau C, 2012, BRIT J DERMATOL, V166, P678, DOI 10.1111/j.1365-2133.2011.10620.x; Cluzeau C, 2011, HUM MUTAT, V32, P70, DOI 10.1002/humu.21384; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Cox RD, 2003, CURR OPIN GENET DEV, V13, P278, DOI 10.1016/S0959-437X(03)00051-0; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; Cui CY, 2003, HUM MOL GENET, V12, P2931, DOI 10.1093/hmg/ddg325; Dixson BJ, 2011, ARCH SEX BEHAV, V40, P1271, DOI 10.1007/s10508-010-9680-6; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Fujimoto A, 2008, HUM GENET, V124, P179, DOI 10.1007/s00439-008-0537-1; Fujimoto A, 2008, HUM MOL GENET, V17, P835, DOI 10.1093/hmg/ddm355; Furnham A, 1998, SEX ROLES, V39, P311, DOI 10.1023/A:1018810723493; Furnham A, 2006, PERS INDIV DIFFER, V41, P443, DOI 10.1016/j.paid.2006.02.007; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; GRUNEBERG H, 1971, J EMBRYOL EXP MORPH, V25, P1; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Itan Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000491; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; JUNIPER K, 1964, AM J DIG DIS, V9, P31, DOI 10.1007/BF02232677; Kimura R, 2009, AM J HUM GENET, V85, P528, DOI 10.1016/j.ajhg.2009.09.006; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kondo S, 2001, CURR BIOL, V11, P1202, DOI 10.1016/S0960-9822(01)00324-4; Kuno Y., 1956, HUMAN PERSPIRATION; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lefevre CM, 2010, ANNU REV GENOM HUM G, V11, P219, DOI 10.1146/annurev-genom-082509-141806; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Maskarinec G, 2001, INT J EPIDEMIOL, V30, P959, DOI 10.1093/ije/30.5.959; Mauldin EA, 2009, AM J MED GENET A, V149A, P2045, DOI 10.1002/ajmg.a.32916; Mikkola ML, 2011, ADV EXP MED BIOL, V691, P23, DOI 10.1007/978-1-4419-6612-4_3; Mou C, 2008, HUM MUTAT, V29, P1405, DOI 10.1002/humu.20795; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Neville MC, 1998, J MAMMARY GLAND BIOL, V3, P109, DOI 10.1023/A:1018786604818; O'Rourke DH, 2010, CURR BIOL, V20, pR202, DOI 10.1016/j.cub.2009.11.051; Oftedal OT, 2002, J MAMMARY GLAND BIOL, V7, P225, DOI 10.1023/A:1022896515287; OKADA N, 1983, ARCH DERMATOL RES, V275, P130, DOI 10.1007/BF00412889; Park JH, 2012, J HUM GENET, V57, P508, DOI 10.1038/jhg.2012.60; Peter BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003011; Pispa J, 2003, GENE EXPR PATTERNS, V3, P675, DOI 10.1016/S1567-133X(03)00092-9; Prodi DA, 2008, J INVEST DERMATOL, V128, P2268, DOI 10.1038/jid.2008.60; RANDALL WC, 1946, J CLIN INVEST, V25, P761, DOI 10.1172/JCI101760; Ray N, 2010, MOL BIOL EVOL, V27, P337, DOI 10.1093/molbev/msp238; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Sun YB, 2012, NAT GEOSCI, V5, P46, DOI [10.1038/NGEO1326, 10.1038/ngeo1326]; Sundberg, 1994, HDB MOUSE MUTATIONS; Voutilainen M, 2012, P NATL ACAD SCI USA, V109, P5744, DOI 10.1073/pnas.1110627109; Wang XF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-223; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Yuan DX, 2004, SCIENCE, V304, P575, DOI 10.1126/science.1091220	68	168	180	3	125	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 14	2013	152	4					691	702		10.1016/j.cell.2013.01.016	http://dx.doi.org/10.1016/j.cell.2013.01.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415220	Bronze, Green Accepted			2022-12-28	WOS:000314945600006
J	Yosef, N; Shalek, AK; Gaublomme, JT; Jin, HL; Lee, YJ; Awasthi, A; Wu, C; Karwacz, K; Xiao, S; Jorgolli, M; Gennert, D; Satija, R; Shakya, A; Lu, DY; Trombetta, JJ; Pillai, MR; Ratcliffe, PJ; Coleman, ML; Bix, M; Tantin, D; Park, H; Kuchroo, VK; Regev, A				Yosef, Nir; Shalek, Alex K.; Gaublomme, Jellert T.; Jin, Hulin; Lee, Youjin; Awasthi, Amit; Wu, Chuan; Karwacz, Katarzyna; Xiao, Sheng; Jorgolli, Marsela; Gennert, David; Satija, Rahul; Shakya, Arvind; Lu, Diana Y.; Trombetta, John J.; Pillai, Meenu R.; Ratcliffe, Peter J.; Coleman, Mathew L.; Bix, Mark; Tantin, Dean; Park, Hongkun; Kuchroo, Vijay K.; Regev, Aviv			Dynamic regulatory network controlling T(H)17 cell differentiation	NATURE			English	Article							GENOME-WIDE ANALYSIS; TRANSCRIPTION-FACTOR; GENE-EXPRESSION; T-CELLS; TARGET GENES; PLATFORM; GAMMA; INDUCTION; DISCOVERY; DATABASE	Despite their importance, the molecular circuits that control the differentiation of naive T cells remain largely unknown. Recent studies that reconstructed regulatory networks in mammalian cells have focused on short-term responses and relied on perturbation-based approaches that cannot be readily applied to primary T cells. Here we combine transcriptional profiling at high temporal resolution, novel computational algorithms, and innovative nanowire-based perturbation tools to systematically derive and experimentally validate a model of the dynamic regulatory network that controls the differentiation of mouse T(H)17 cells, a proinflammatory T-cell subset that has been implicated in the pathogenesis of multiple autoimmune diseases. The T(H)17 transcriptional network consists of two self-reinforcing, but mutually antagonistic, modules, with 12 novel regulators, the coupled action of which may be essential for maintaining the balance between T(H)17 and other CD41 T-cell subsets. Our study identifies and validates 39 regulatory factors, embeds them within a comprehensive temporal network and reveals its organizational principles; it also highlights novel drug targets for controlling T(H)17 cell differentiation.	[Yosef, Nir; Gennert, David; Satija, Rahul; Lu, Diana Y.; Trombetta, John J.; Park, Hongkun; Kuchroo, Vijay K.; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Yosef, Nir; Jin, Hulin; Lee, Youjin; Awasthi, Amit; Wu, Chuan; Karwacz, Katarzyna; Xiao, Sheng; Kuchroo, Vijay K.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Shalek, Alex K.; Gaublomme, Jellert T.; Jorgolli, Marsela; Park, Hongkun] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Shalek, Alex K.; Gaublomme, Jellert T.; Jorgolli, Marsela; Park, Hongkun] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Shakya, Arvind; Tantin, Dean] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA; [Pillai, Meenu R.; Bix, Mark] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Ratcliffe, Peter J.; Coleman, Mathew L.] Univ Oxford, Oxford OX3 7BN, England; [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02140 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard University; Utah System of Higher Education; University of Utah; St Jude Children's Research Hospital; University of Oxford; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Park, H (corresponding author), Broad Inst MIT & Harvard, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	Hongkun_Park@harvard.edu; vkuchroo@rics.bwh.harvard.edu; aregev@broad.mit.edu	Coleman, Mathew L/C-1676-2014; Park, Hongkun/R-9842-2019; Satija, Rahul/AAF-9564-2019; Shalek, Alex/Y-2434-2019; Wu, Chuan/H-6379-2013	Coleman, Mathew L/0000-0001-6020-9023; Park, Hongkun/0000-0001-9576-8829; Shalek, Alex/0000-0001-5670-8778; Ratcliffe, Peter/0000-0002-2853-806X; Shakya, Arvind/0000-0001-7993-6159; Wu, Chuan/0000-0003-2288-353X; Bix, Mark/0000-0003-4617-0497	NHGRI [1P50HG006193-01]; NIH Pioneer Awards [5DP1OD003893-03, DP1OD003958-01]; NIH [NS 30843, NS045937, AI073748, AI45757]; National MS Society [RG2571]; HHMI; Klarman Cell Observatory; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD075541] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045757, R01AI100873, P01AI073748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK090105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS030843, R01NS030843, R37NS030843, R01NS045937] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958, DP1OD003893] Funding Source: NIH RePORTER; British Heart Foundation [RG/11/1/28684] Funding Source: researchfish	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH Pioneer Awards; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National MS Society(National Multiple Sclerosis Society); HHMI(Howard Hughes Medical Institute); Klarman Cell Observatory; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation)	We thank L. Gaffney and L. Solomon for artwork, the Broad's Genomics Platform for sequencing, and D. Kozoriz for cell sorting. Work was supported by NHGRI (1P50HG006193-01 to H. P. and A. R.), NIH Pioneer Awards (5DP1OD003893-03 to H. P., DP1OD003958-01 to A. R.), NIH (NS 30843, NS045937, AI073748 and AI45757 to V. K. K.), National MS Society (RG2571 to V. K. K.), HHMI (A. R.), and the Klarman Cell Observatory (A. R.).	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Chechik G, 2009, J COMPUT BIOL, V16, P279, DOI 10.1089/cmb.2008.13TT; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Choi SJ, 2005, MOL CELL BIOCHEM, V271, P23, DOI 10.1007/s11010-005-3456-7; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Dardalhon V, 2001, GENE THER, V8, P190, DOI 10.1038/sj.gt.3301378; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hu Si-Ming, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P1185; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Jing Y, 2012, BIOTECHNOL PROGR, V28, P490, DOI 10.1002/btpr.747; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jux B, 2009, J IMMUNOL, V182, P6709, DOI 10.4049/jimmunol.0713344; Kim U, 1996, NATURE, V383, P542, DOI 10.1038/383542a0; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Leek JT, 2006, BIOINFORMATICS, V22, P507, DOI 10.1093/bioinformatics/btk005; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; McManus MT, 2002, J IMMUNOL, V169, P5754, DOI 10.4049/jimmunol.169.10.5754; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; O'Shea JJ, 2009, MICROBES INFECT, V11, P599, DOI 10.1016/j.micinf.2009.04.007; Okamoto M, 2009, NAT IMMUNOL, V10, P872, DOI 10.1038/ni.1747; Peleg T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000635; Peters A, 2011, CURR OPIN IMMUNOL, V23, P702, DOI 10.1016/j.coi.2011.08.007; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Shalek AK, 2012, NANO LETT, V12, P6498, DOI 10.1021/nl3042917; Shalek AK, 2010, P NATL ACAD SCI USA, V107, P1870, DOI 10.1073/pnas.0909350107; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Teitell MA, 2003, TRENDS IMMUNOL, V24, P546, DOI 10.1016/j.it.2003.08.002; Waldner H, 1997, J IMMUNOL, V159, P3100; Wang VEH, 2004, P NATL ACAD SCI USA, V101, P2005, DOI 10.1073/pnas.0307304101; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wilkins MR, 1999, METH MOL B, V112, P531; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wu C, 2013, NATURE; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Zheng GY, 2008, BIOINFORMATICS, V24, P2416, DOI 10.1093/bioinformatics/btn439; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	65	461	481	2	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2013	496	7446					461	+		10.1038/nature11981	http://dx.doi.org/10.1038/nature11981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23467089	Green Accepted, Green Submitted			2022-12-28	WOS:000317984400033
J	Dewilde, WJM; Oirbans, T; Verheugt, FWA; Kelder, JC; De Smet, BJGL; Herrman, JP; Adriaenssens, T; Vrolix, M; Heestermans, AACM; Vis, MM; Tijsen, JGP; van 't Hof, AW; ten Berg, JM				Dewilde, Willem J. M.; Oirbans, Tom; Verheugt, Freek W. A.; Kelder, Johannes C.; De Smet, Bart J. G. L.; Herrman, Jean-Paul; Adriaenssens, Tom; Vrolix, Mathias; Heestermans, Antonius A. C. M.; Vis, Marije M.; Tijsen, Jan G. P.; van 't Hof, Arnoud W.; ten Berg, Jurrien M.		WOEST Study Investigators	Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial	LANCET			English	Article							DUAL-ANTIPLATELET THERAPY; RHYTHM ASSOCIATION EHRA; DRUG-ELUTING STENTS; ATRIAL-FIBRILLATION; EUROPEAN-SOCIETY; TASK-FORCE; ANTITHROMBOTIC THERAPY; WORKING GROUP; CONSENSUS DOCUMENT; HEART-ASSOCIATION	Background If percutaneous coronary intervention (PCI) is required in patients taking oral anticoagulants, antiplatelet therapy with aspirin and clopidogrel is indicated, but such triple therapy increases the risk of serious bleeding. We investigated the safety and efficacy of clopidogrel alone compared with clopidogrel plus aspirin. Methods We did an open-label, multicentre, randomised, controlled trial in 15 centres in Belgium and the Netherlands. From November, 2008, to November, 2011, adults receiving oral anticoagulants and undergoing PCI were assigned clopidogrel alone (double therapy) or clopidogrel plus aspirin (triple therapy). The primary outcome was any bleeding episode within 1 year of PCI, assessed by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00769938. Findings 573 patients were enrolled and 1-year data were available for 279 (98.2%) patients assigned double therapy and 284 (98.3%) assigned triple therapy. Mean ages were 70.3 (SD 7.0) years and 69.5 (8.0) years, respectively. Bleeding episodes were seen in 54 (19.4%) patients receiving double therapy and in 126 (44.4%) receiving triple therapy (hazard ratio [HR] 0.36, 95% CI 0.26-0.50, p<0.0001). In the double-therapy group, six (2.2%) patients had multiple bleeding events, compared with 34 (12.0%) in the triple-therapy group. 11 (3.9%) patients receiving double therapy required at least one blood transfusion, compared with 27 (9.5%) patients in the triple-therapy group (odds ratio from Kaplan-Meier curve 0.39, 95% CI 0.17-0.84, p=0.011). Interpretation Use of clopiogrel without aspirin was associated with a significant reduction in bleeding complications and no increase in the rate of thrombotic events.	[Dewilde, Willem J. M.] Twee Steden Hosp, Dept Cardiol, Tilburg, Netherlands; [Oirbans, Tom; Kelder, Johannes C.; ten Berg, Jurrien M.] St Antonius Hosp, Dept Cardiol, Nieuwegein, Netherlands; [Verheugt, Freek W. A.; Herrman, Jean-Paul] Onze Lieve Vrouwe Gasthuis OLVG, Dept Cardiol, Amsterdam, Netherlands; [De Smet, Bart J. G. L.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9713 AV Groningen, Netherlands; [De Smet, Bart J. G. L.] Meander Hosp, Amersfoort, Netherlands; [Adriaenssens, Tom] Catholic Univ Louvain, Dept Cardiol, B-3000 Louvain, Belgium; [Vrolix, Mathias] Hosp Oost Limburg ZOL, Dept Cardiol, Genk, Belgium; [Heestermans, Antonius A. C. M.] Med Ctr Alkmaar, Dept Cardiol, Alkmaar, Netherlands; [Vis, Marije M.; Tijsen, Jan G. P.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [van 't Hof, Arnoud W.] Isala Hosp, Dept Cardiol, Zwolle, Netherlands	St. Antonius Hospital Utrecht; University of Groningen; Universite Catholique Louvain; East Limburg Hospital; Medical Center Of Alkmaar; University of Amsterdam; Academic Medical Center Amsterdam	Dewilde, WJM (corresponding author), St Antonius Hosp, 1 Koekoekslaan, NL-3435 CM Nieuwegein, Netherlands.	willemdewilde@yahoo.com	Verheugt, F.W.A./H-8105-2014		Antonius Ziekenhuis Foundation; Strect Foundation	Antonius Ziekenhuis Foundation; Strect Foundation	Antonius Ziekenhuis Foundation, Strect Foundation.	Berger PB, 2010, CIRCULATION, V121, P2575, DOI 10.1161/CIRCULATIONAHA.109.895342; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Dewilde W, 2009, AM HEART J, V158, P713, DOI 10.1016/j.ahj.2009.09.001; Doyle BJ, 2009, J AM COLL CARDIOL, V53, P2019, DOI 10.1016/j.jacc.2008.12.073; Faxon DP, 2011, THROMB HAEMOSTASIS, V106, P572, DOI 10.1160/TH11-04-0262; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Hurlen M, 2002, NEW ENGL J MED, V347, P969, DOI 10.1056/NEJMoa020496; Karjalainen PP, 2007, EUR HEART J, V28, P726, DOI 10.1093/eurheartj/ehl488; Kukreja N, 2009, AM J CARDIOL, V103, P203, DOI 10.1016/j.amjcard.2008.08.068; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Lip GYH, 2011, THROMB HAEMOSTASIS, V106, P997, DOI 10.1160/TH11-10-0690; Lip Gregory Y H, 2008, BMJ, V337, pa840, DOI 10.1136/bmj.39533.570602.BE; Lip GYH, 2010, THROMB HAEMOSTASIS, V103, P13, DOI 10.1160/TH09-08-0580; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Miller CS, 2012, AM J CARDIOL, V110, P453, DOI 10.1016/j.amjcard.2012.03.049; Orford JL, 2004, AM HEART J, V147, P463, DOI 10.1016/j.ahj.2003.06.004; Park SJ, 2010, NEW ENGL J MED, V362, P1374, DOI 10.1056/NEJMoa1001266; Patel MR, 2009, CIRCULATION, V119, P1330, DOI 10.1161/CIRCULATIONAHA.108.191768; Roldan V, 2008, THROMB HAEMOSTASIS, V100, P754, DOI 10.1160/TH08-06-0363; Roy P, 2008, AM J CARDIOL, V102, P1614, DOI 10.1016/j.amjcard.2008.07.063; Rubboli A, 2005, CARDIOLOGY, V104, P101, DOI 10.1159/000086918; Ruiz-Nodar JM, 2008, J AM COLL CARDIOL, V51, P818, DOI 10.1016/j.jacc.2007.11.035; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; Smith SC, 2006, CIRCULATION, V113, P156, DOI 10.1161/CIRCULATIONAHA.105.170815; Steg PG, 2011, EUR HEART J, V32, P1854, DOI 10.1093/eurheartj/ehr204; Thygesen K, 2007, EUR HEART J, V28, P2525; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Urban P, 1998, CIRCULATION, V98, P2126, DOI 10.1161/01.CIR.98.20.2126; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589; van Es RF, 2002, LANCET, V360, P109, DOI 10.1016/S0140-6736(02)09409-6; Wallentin L, 2010, LANCET, V376, P975, DOI 10.1016/S0140-6736(10)61194-4; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	38	1197	1270	0	50	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 30	2013	381	9872					1107	1115		10.1016/S0140-6736(12)62177-1	http://dx.doi.org/10.1016/S0140-6736(12)62177-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122WL	23415013				2022-12-28	WOS:000317348900029
J	Ding, L; Morrison, SJ				Ding, Lei; Morrison, Sean J.			Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches	NATURE			English	Article							B-CELL; STEM/PROGENITOR CELLS; CRE RECOMBINASE; FACTOR-I; MICE; IDENTIFICATION; LYMPHOPOIESIS; OSTEOBLASTS; MAINTENANCE; EXPRESSION	Although haematopoietic stem cells (HSCs) are commonly assumed to reside within a specialized microenvironment, or niche(1), most published experimental manipulations of the HSC niche have affected the function of diverse restricted progenitors. This raises the fundamental question, of whether HSCs1 and restricted progenitors(2,3) reside within distinct, specialized niches or whether they share a common niche. Here we assess the physiological sources of the chemokine CXCL12 for HSC and restricted progenitor maintenance. Cxcl12(DsRed) knock-in mice (DsRed-Express2 recombined into the Cxcl12 locus) showed that Cxcl12 was primarily expressed by perivascular stromal cells and, at lower levels, by endothelial cells, osteoblasts and some haematopoietic cells. Conditional deletion of Cxcl12 from haematopoietic cells or nestin-cre-expressing cells had little or no effect on HSCs or restricted progenitors. Deletion of Cxcl12 from endothelial cells depleted HSCs but not myeloerythroid or lymphoid progenitors. Deletion of Cxcl12 from perivascular stromal cells depleted HSCs and certain restricted progenitors and mobilized these cells into circulation. Deletion of Cxcl12 from osteoblasts depleted certain early lymphoid progenitors but not HSCs or myeloerythroid progenitors, and did not mobilize these cells into circulation. Different stem and progenitor cells thus reside in distinct cellular niches in bone marrow: HSCs occupy a perivascular niche and early lymphoid progenitors occupy an endosteal niche.	[Ding, Lei; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Childrens Res Inst, Howard Hughes Med Inst, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Morrison, SJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Childrens Res Inst, Howard Hughes Med Inst, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	sean.morrison@utsouthwestern.edu	Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329	Howard Hughes Medical Institute (HHMI); US National Heart, Lung and Blood Institute [5R01-HL097760]; Helen Hay Whitney Foundation; HHMI; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097760] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); US National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Helen Hay Whitney Foundation; HHMI(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Howard Hughes Medical Institute (HHMI) and the US National Heart, Lung and Blood Institute (5R01-HL097760). L.D. was supported by a Helen Hay Whitney Foundation Fellowship and by the HHMI. We thank M. White and D. Adams for flow cytometry, E. Hughes and T. Saunders at the University of Michigan transgenic core for helping to generate Cxcl12<SUP>DsRed</SUP> and Cxcl12<SUP>fl</SUP> mice, and S. Grove, R. Coolon, S. Manning, M. Gross and K. Correll for managing the mouse colony.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Greenbaum A., 2013, NATURE; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Kawabata T, 1999, P NATL ACAD SCI USA, V96, P5663, DOI 10.1073/pnas.96.10.5663; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384	30	788	816	7	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2013	495	7440					231	235		10.1038/nature11885	http://dx.doi.org/10.1038/nature11885			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23434755	Green Accepted			2022-12-28	WOS:000316652300050
J	Mercuri, E; Muntoni, F				Mercuri, Eugenio; Muntoni, Francesco			Muscular dystrophies	LANCET			English	Article							WALKER-WARBURG-SYNDROME; LOW BONE-DENSITY; LAMIN A/C GENE; MUSCLE MRI; DEFECTIVE GLYCOSYLATION; SUDDEN-DEATH; MITOCHONDRIAL DYSFUNCTION; MEMBRANE REPAIR; CALCIUM-RELEASE; PROTEIN COMPLEX	Muscular dystrophies are a heterogeneous group of inherited disorders that share similar clinical features and dystrophic changes on muscle biopsy. An improved understanding of their molecular bases has led to more accurate definitions of the clinical features associated with known subtypes. Knowledge of disease-specific complications, implementation of anticipatory care, and medical advances have changed the standard of care, with an overall improvement in the clinical course, survival, and quality of life of affected people. A better understanding of the mechanisms underlying the molecular pathogenesis of several disorders and the availability of preclinical models are leading to several new experimental approaches, some of which are already in clinical trials. In this Seminar, we provide a comprehensive review that integrates clinical manifestations, molecular pathogenesis, diagnostic strategy, and therapeutic developments.	[Mercuri, Eugenio] Univ Cattolica Sacro Cuore, Dept Paediat Neurol, Rome, Italy; [Mercuri, Eugenio; Muntoni, Francesco] UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London WC1N 1EH, England; [Mercuri, Eugenio; Muntoni, Francesco] Great Ormond St Hosp Children Fdn Trust, London, England	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Muntoni, F (corresponding author), UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, 30 Guilford St, London WC1N 1EH, England.	f.muntoni@ucl.ac.uk	Sorimachi, Hiroyuki/C-6448-2009; Mercuri, Eugenio/G-1351-2015	Sorimachi, Hiroyuki/0000-0001-9509-6727; Mercuri, Eugenio/0000-0002-9851-5365	European Union; UK Medical Research Council; Wellcome Trust; Association Francaise Contre les Myopathies; Muscular Dystrophy Campaign; Great Ormond Street Hospital Biomedical Research Centre; Muscular Dystrophy Association USA; GlaxoSmithKline; Trophos; British Heart Foundation; AVI BioPharma; PTC Therapeutics; Parent Project NL; SMA Europe; Italian Telethon; Medical Research Council [MR/K000608/1] Funding Source: researchfish; MRC [MR/K000608/1] Funding Source: UKRI	European Union(European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Great Ormond Street Hospital Biomedical Research Centre; Muscular Dystrophy Association USA(Muscular Dystrophy Association); GlaxoSmithKline(GlaxoSmithKline); Trophos; British Heart Foundation(British Heart Foundation); AVI BioPharma; PTC Therapeutics; Parent Project NL; SMA Europe; Italian Telethon(Fondazione Telethon); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	FM has served on scientific advisory boards for Acceleron Pharma, Genzyme, AVI BioPharma, Debiopharma Group, GlaxoSmithKline, Prosensa, Servier, and Santhera Pharmaceuticals; he receives research support from the European Union, the UK Medical Research Council, the Wellcome Trust, the Association Francaise Contre les Myopathies, the Muscular Dystrophy Campaign, the Great Ormond Street Hospital Biomedical Research Centre, and the Muscular Dystrophy Association USA; he is receiving funding for trials from GlaxoSmithKline, Trophos, and the British Heart Foundation; and has received funding for trials from AVI BioPharma and PTC Therapeutics. EM has served on scientific advisory boards for Acceleron Pharma, Prosensa, and PTC Therapeutics; he receives research support from the European Union, Parent Project NL, SMA Europe, and Italian Telethon; he is receiving funding for trials from GlaxoSmithKline; and has received funding for trials from Trophos and PTC Therapeutics.	Aartsma-Rus A, 2012, METHODS MOL BIOL, V867, P97, DOI 10.1007/978-1-61779-767-5_7; Aartsma-Rus A, 2010, RNA BIOL, V7, P453, DOI 10.4161/rna.7.4.12264; Abbott D, 2012, NEUROMUSCULAR DISORD, V22, P445, DOI 10.1016/j.nmd.2012.02.004; Andersson DC, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-9; Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104; Angelini C, 2010, NEUROL RES, V32, P41, DOI 10.1179/174313209X380847; Bach JR, 2011, RESP CARE, V56, P744, DOI 10.4187/respcare.00831; Baker NL, 2005, HUM MOL GENET, V14, P279, DOI 10.1093/hmg/ddi025; Balci B, 2005, NEUROMUSCULAR DISORD, V15, P271, DOI 10.1016/j.nmd.2005.01.013; Beckmann JS, 2008, NEUROMUSCULAR DISORD, V18, P913, DOI 10.1016/j.nmd.2008.08.005; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Bertrand AT, 2011, BIOCHEM SOC T, V39, P1687, DOI 10.1042/BST20110670; Bhakta D, 2010, AM HEART J, V160, P1137, DOI 10.1016/j.ahj.2010.07.032; Bianchi ML, 2011, OSTEOPOROSIS INT, V22, P529, DOI 10.1007/s00198-010-1275-5; Bianchi Maria Luisa, 2011, Neuromuscul Disord, V21, P298, DOI 10.1016/j.nmd.2011.02.006; Bianchi ML, 2003, OSTEOPOROSIS INT, V14, P761, DOI 10.1007/s00198-003-1443-y; Biggar W D, 2005, Neuromuscul Disord, V15, P80, DOI 10.1016/j.nmd.2004.09.010; Birnkrant DJ, 2010, PEDIATR PULM, V45, P739, DOI 10.1002/ppul.21254; Bolduc V, 2010, AM J HUM GENET, V86, P213, DOI 10.1016/j.ajhg.2009.12.013; Bonne G, 2000, ANN NEUROL, V48, P170, DOI 10.1002/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO;2-J; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Bonnemann CG, 2009, ENCY NEUROSCIENCE, P67; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Brockington M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014434; Bushby K, 2003, NEUROMUSCULAR DISORD, V13, P664, DOI 10.1016/S0960-8966(02)00213-4; Bushby Kate, 2011, Clin Investig (Lond), V1, P1217; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Ciafaloni E, 2009, J PEDIATR-US, V155, P380, DOI 10.1016/j.jpeds.2009.02.007; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Clement EM, 2012, NEUROMUSCULAR DISORD, V22, P522, DOI 10.1016/j.nmd.2012.01.010; Clement E, 2008, ANN NEUROL, V64, P573, DOI 10.1002/ana.21482; Cyrulnik SE, 2008, J INT NEUROPSYCH SOC, V14, P853, DOI 10.1017/S135561770808106X; de Bernabe DBV, 2003, J MED GENET, V40, P845; de Haan W, 2010, CLIN GENET, V77, P436, DOI 10.1111/j.1399-0004.2009.01365_3.x; De Pasquale L, 2012, NEUROLOGY, V78, P1309, DOI 10.1212/WNL.0b013e3182518302; Demir E, 2002, AM J HUM GENET, V70, P1446, DOI 10.1086/340608; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Duboc D, 2005, J AM COLL CARDIOL, V45, P855, DOI 10.1016/j.jacc.2004.09.078; Duboc D, 2007, AM HEART J, V154, P596, DOI 10.1016/j.ahj.2007.05.014; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; Eagle M, 2007, NEUROMUSCULAR DISORD, V17, P470, DOI 10.1016/j.nmd.2007.03.002; Easthope-Mowatt Y, 2010, NEUROMUSCULAR DISORD, V20, pS7, DOI 10.1016/j.nmd.2010.07.272; EMERY AEH, 1966, J NEUROL NEUROSUR PS, V29, P338, DOI 10.1136/jnnp.29.4.338; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Emery AEH, 1998, BRIT MED J, V317, P991, DOI 10.1136/bmj.317.7164.991; Erb M, 2009, J PHARMACOL EXP THER, V331, P787, DOI 10.1124/jpet.109.160754; Fanin M, 2005, NEUROMUSCULAR DISORD, V15, P218, DOI 10.1016/j.nmd.2004.11.003; Finanger EL, 2012, PHYS MED REH CLIN N, V23, P1, DOI 10.1016/j.pmr.2011.11.004; Finsterer J, 2010, PEDIATRICS, V126, P538, DOI 10.1542/peds.2010-0208; Fischer D, 2005, J NEUROL, V252, P538, DOI 10.1007/s00415-005-0684-4; Foley AR, 2011, ANN NEUROL, V69, P206, DOI 10.1002/ana.22283; Geranmayeh F, 2010, NEUROMUSCULAR DISORD, V20, P241, DOI 10.1016/j.nmd.2010.02.001; Godfrey C, 2007, BRAIN, V130, P2725, DOI 10.1093/brain/awm212; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Golzio PG, 2007, EUROPACE, V9, P1158, DOI 10.1093/europace/eum236; Gordon KE, 2011, PEDIATRICS, V127, pE353, DOI 10.1542/peds.2010-1666; Grumati P, 2011, AUTOPHAGY, V7, P426, DOI 10.4161/auto.7.4.14392; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Guglieri M, 2008, CURR OPIN NEUROL, V21, P576, DOI 10.1097/WCO.0b013e32830efdc2; Han R, 2007, CURR OPIN CELL BIOL, V19, P409, DOI 10.1016/j.ceb.2007.07.001; Han RZ, 2011, SKELET MUSCLE, V1, DOI [10.1186/2044-5040-1-10, 10.1186/2044-5040-1-35]; Hawker GA, 2005, ARCH PHYS MED REHAB, V86, P284, DOI 10.1016/j.apmr.2004.04.021; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; Hermans MCE, 2010, NEUROMUSCULAR DISORD, V20, P479, DOI 10.1016/j.nmd.2010.04.008; Hicks D, 2011, BRAIN, V134, P171, DOI 10.1093/brain/awq294; Huang YC, 2008, HUM MOL GENET, V17, P1855, DOI 10.1093/hmg/ddn081; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Jimenez-Mallebrera C, 2009, BRAIN PATHOL, V19, P596, DOI 10.1111/j.1750-3639.2008.00198.x; Kan HE, 2009, NEUROMUSCULAR DISORD, V19, P357, DOI 10.1016/j.nmd.2009.02.009; Khairallah M, 2007, J MOL CELL CARDIOL, V43, P119, DOI 10.1016/j.yjmcc.2007.05.015; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Krahn M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000951; Kramerova I, 2012, HUM MOL GENET, V21, P3193, DOI 10.1093/hmg/dds144; Kramerova I, 2008, HUM MOL GENET, V17, P3271, DOI 10.1093/hmg/ddn223; Linssen WHJP, 1997, BRAIN, V120, P1989, DOI 10.1093/brain/120.11.1989; Mahjneh I, 2001, NEUROMUSCULAR DISORD, V11, P20, DOI 10.1016/S0960-8966(00)00157-7; Manzur AY, 2009, J NEUROL NEUROSUR PS, V80, P706, DOI 10.1136/jnnp.2008.158329; Manzur AY, 2008, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD14003725.PUB14651853; Marini JC, 2009, NAT REV ENDOCRINOL, V5, P241, DOI 10.1038/nrendo.2009.58; Mazzone E, 2011, NEUROLOGY, V77, P250, DOI 10.1212/WNL.0b013e318225ab2e; Mercuri E, 2005, NEUROMUSCULAR DISORD, V15, P164, DOI 10.1016/j.nmd.2004.10.008; Mercuri E, 2004, ARCH NEUROL-CHICAGO, V61, P690, DOI 10.1001/archneur.61.5.690; Mercuri E, 2009, NEUROLOGY, V72, P1802, DOI 10.1212/01.wnl.0000346518.68110.60; Mercuri E, 2007, J MAGN RESON IMAGING, V25, P433, DOI 10.1002/jmri.20804; Mercuri E, 2012, ANN NEUROL, V72, P9, DOI 10.1002/ana.23548; Meune C, 2006, NEW ENGL J MED, V354, P209, DOI 10.1056/NEJMc052632; Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054; Moorwood C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026169; Moxley RT, 2005, NEUROLOGY, V64, P13, DOI 10.1212/01.WNL.0000148485.00049.B7; Muntoni F, 2004, NEUROMUSCULAR DISORD, V14, P635, DOI 10.1016/j.nmd.2004.06.009; MUNTONI F, 1994, LANCET, V344, P340, DOI 10.1016/S0140-6736(94)91382-X; Muntoni F, 2010, Neuromuscul Disord, V20, P355, DOI 10.1016/j.nmd.2010.03.005; Muntoni F, 2002, LANCET, V360, P1419, DOI 10.1016/S0140-6736(02)11397-3; Muntoni F, 2007, CURR OPIN NEUROL, V20, P590, DOI 10.1097/WCO.0b013e3282efc157; Muntoni F, 2011, CURR OPIN NEUROL, V24, P437, DOI 10.1097/WCO.0b013e32834a95e3; Muntoni F, 2011, NAT REV DRUG DISCOV, V10, P621, DOI 10.1038/nrd3459; Nadeau A, 2009, NEUROLOGY, V73, P25, DOI 10.1212/WNL.0b013e3181aae851; Odom GL, 2011, MOL THER, V19, P36, DOI 10.1038/mt.2010.205; Olsen DB, 2006, J NEUROL, V253, P1437, DOI 10.1007/s00415-006-0230-z; Pane M, 2012, J PEDIATR-US, V161, P705, DOI 10.1016/j.jpeds.2012.03.020; PHILPOT J, 1995, NEUROMUSCULAR DISORD, V5, P301, DOI 10.1016/0960-8966(94)00069-L; Poppe M, 2004, ANN NEUROL, V56, P738, DOI 10.1002/ana.20283; Poppe M, 2003, NEUROLOGY, V60, P1246, DOI 10.1212/01.WNL.0000058902.88181.3D; Rahbek Jes, 2005, Pediatr Rehabil, V8, P17, DOI 10.1080/13638490400010191; Romfh Anitra, 2010, Curr Heart Fail Rep, V7, P212, DOI 10.1007/s11897-010-0028-2; Rufo A, 2011, J BONE MINER RES, V26, P1891, DOI 10.1002/jbmr.410; Sarkozy A, 2008, NEUROMUSCULAR DISORD, V18, P819, DOI 10.1016/j.nmd.2008.07.006; Schwartz M, 2005, NEUROLOGY, V64, P1635, DOI 10.1212/01.WNL.0000157654.59374.E5; Scoto M, 2011, NEUROLOGY, V76, P2073, DOI 10.1212/WNL.0b013e31821f467c; Sharma A, 2010, ARTERIOSCL THROM VAS, V30, P2196, DOI 10.1161/ATVBAHA.110.208108; Soderpalm AC, 2012, ACTA PAEDIATR, V101, P424, DOI 10.1111/j.1651-2227.2011.02532.x; Spitali P, 2012, CELL, V148, P1085, DOI 10.1016/j.cell.2012.02.014; Stubgen JP, 2010, J NEUROL, V257, P1457, DOI 10.1007/s00415-010-5544-1; Sveen ML, 2006, ANN NEUROL, V59, P808, DOI 10.1002/ana.20824; Tawil R, 1997, NEUROLOGY, V48, P38, DOI 10.1212/wnl.48.1.38; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522; Tawil Rabi, 2010, Neuromuscul Disord, V20, P471, DOI 10.1016/j.nmd.2010.04.007; Tiepolo T, 2009, BRIT J PHARMACOL, V157, P1045, DOI 10.1111/j.1476-5381.2009.00316.x; Tinsley JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019189; TOME FMS, 1994, CR ACAD SCI III-VIE, V317, P351; Udd B, 2012, NEUROMUSCULAR DISORD, V22, P5, DOI 10.1016/j.nmd.2011.10.003; Udd Bjarne, 2011, Handb Clin Neurol, V101, P239, DOI 10.1016/B978-0-08-045031-5.00016-5; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Van Reeuwijk J, 2006, HUM MUTAT, V27, P453, DOI 10.1002/humu.20313; van Reeuwijk J, 2005, CLIN GENET, V67, P281, DOI 10.1111/j.1399-0004.2004.00368.x; van Reeuwijk J, 2007, HUM GENET, V121, P685, DOI 10.1007/s00439-007-0362-y; Vanegas OC, 2001, P NATL ACAD SCI USA, V98, P7516; Voit T, 2001, NEUROMUSCULAR DISORD, V11, P11, DOI 10.1016/S0960-8966(00)00158-9; Wallace LM, 2012, MOL THER, V20, P1417, DOI 10.1038/mt.2012.68; Wang CH, 2010, J CHILD NEUROL, V25, P1559, DOI 10.1177/0883073810381924; Ward S, 2005, THORAX, V60, P1019, DOI 10.1136/thx.2004.037424; Wein N, 2010, HUM MUTAT, V31, P136, DOI 10.1002/humu.21160; Weisleder Noah, 2009, Commun Integr Biol, V2, P225; Weisleder N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003921; Yilmaz A, 2012, HEART, V98, P420, DOI 10.1136/heartjnl-2011-300254; Yoskovitz G, 2012, AM J CARDIOL, V109, P1644, DOI 10.1016/j.amjcard.2012.01.392; Zaim S, 2008, AM J PHYS MED REHAB, V87, P325, DOI 10.1097/PHM.0b013e318168b9d4	141	280	288	3	51	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 9	2013	381	9869					845	860		10.1016/S0140-6736(12)61897-2	http://dx.doi.org/10.1016/S0140-6736(12)61897-2			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105IL	23465426				2022-12-28	WOS:000316060600034
J	Hao, SJ; Cui, LS; Jiang, DQ; Han, XD; Ren, Y; Jiang, J; Liu, YN; Liu, ZY; Mao, SC; Wang, YD; Li, Y; Ren, XB; Ding, XD; Wang, S; Yu, C; Shi, XB; Du, MS; Yang, F; Zheng, YJ; Zhang, Z; Li, XD; Brown, DE; Li, J				Hao, Shijie; Cui, Lishan; Jiang, Daqiang; Han, Xiaodong; Ren, Yang; Jiang, Jiang; Liu, Yinong; Liu, Zhenyang; Mao, Shengcheng; Wang, Yandong; Li, Yan; Ren, Xiaobing; Ding, Xiangdong; Wang, Shan; Yu, Cun; Shi, Xiaobin; Du, Minshu; Yang, Feng; Zheng, Yanjun; Zhang, Ze; Li, Xiaodong; Brown, Dennis E.; Li, Ju			A Transforming Metal Nanocomposite with Large Elastic Strain, Low Modulus, and High Strength	SCIENCE			English	Article							ALLOYS; DEFORMATION; PLASTICITY; TOUGHNESS; NANOTUBES; LIMIT; WIRES	Freestanding nanowires have ultrahigh elastic strain limits (4 to 7%) and yield strengths, but exploiting their intrinsic mechanical properties in bulk composites has proven to be difficult. We exploited the intrinsic mechanical properties of nanowires in a phase-transforming matrix based on the concept of elastic and transformation strain matching. By engineering the microstructure and residual stress to couple the true elasticity of Nb nanowires with the pseudoelasticity of a NiTi shape-memory alloy, we developed an in situ composite that possesses a large quasi-linear elastic strain of over 6%, a low Young's modulus of similar to 28 gigapascals, and a high yield strength of similar to 1.65 gigapascals. Our elastic strain-matching approach allows the exceptional mechanical properties of nanowires to be exploited in bulk materials.	[Hao, Shijie; Cui, Lishan; Jiang, Daqiang; Jiang, Jiang; Liu, Zhenyang; Wang, Shan; Yu, Cun; Shi, Xiaobin; Du, Minshu; Yang, Feng; Zheng, Yanjun] China Univ Petr, State Key Lab Heavy Oil Proc, Beijing 102249, Peoples R China; [Han, Xiaodong; Mao, Shengcheng; Zhang, Ze] Beijing Univ Technol, Inst Microstruct & Properties Adv Mat, Beijing 100124, Peoples R China; [Ren, Yang] Argonne Natl Lab, Xray Sci Div, Argonne, IL 60439 USA; [Liu, Yinong] Univ Western Australia, Sch Mech & Chem Engn, Crawley, WA 6009, Australia; [Wang, Yandong] Univ Sci & Technol Beijing, State Key Lab Adv Met & Mat, Beijing 100083, Peoples R China; [Li, Yan] Beihang Univ, Sch Mat Sci & Engn, Beijing 100191, Peoples R China; [Ren, Xiaobing; Ding, Xiangdong] Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China; [Ren, Xiaobing; Ding, Xiangdong] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710049, Peoples R China; [Ren, Xiaobing] Natl Inst Mat Sci, Ferro Phys Grp, Tsukuba, Ibaraki 3050047, Japan; [Zhang, Ze] Zhejiang Univ, State Key Lab Silicon Mat, Hangzhou 310058, Zhejiang, Peoples R China; [Li, Xiaodong] Univ S Carolina, Dept Mech Engn, Columbia, SC 29208 USA; [Brown, Dennis E.] No Illinois Univ, Dept Phys, De Kalb, IL 60115 USA; [Li, Ju] MIT, Dept Nucl Sci & Engn, Cambridge, MA 02139 USA; [Li, Ju] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA	China University of Petroleum; Beijing University of Technology; United States Department of Energy (DOE); Argonne National Laboratory; University of Western Australia; University of Science & Technology Beijing; Beihang University; Xi'an Jiaotong University; Xi'an Jiaotong University; National Institute for Materials Science; Zhejiang University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Northern Illinois University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Cui, LS (corresponding author), China Univ Petr, State Key Lab Heavy Oil Proc, Beijing 102249, Peoples R China.	lishancui63@126.com; xdhan@bjut.edu.cn; ren@aps.anl.gov; liju@mit.edu	Ren, Xiaobing/B-6072-2009; Jiang, Daqiang/G-5511-2014; Liu, Yinong/G-6637-2011; ran, shi/G-9380-2013; Du, Minshu/W-6566-2019; Ren, Yang/ABD-5801-2021; han, xiao/HDN-9782-2022; wang, yandong/G-9404-2013; Li, Ju/A-2993-2008; Ren, Xiaobing/AAE-8533-2020; Mao, Shengcheng/I-2619-2012; Shengcheng, Mao/D-1436-2011; Ding, Xiangdong/K-4971-2013	Ren, Xiaobing/0000-0002-4973-2486; Liu, Yinong/0000-0002-8784-8543; Du, Minshu/0000-0001-9896-7575; Ren, Yang/0000-0001-9831-6035; wang, yandong/0000-0002-4758-4352; Li, Ju/0000-0002-7841-8058; Ren, Xiaobing/0000-0002-4973-2486; Ding, Xiangdong/0000-0002-1220-3097; Mao, Shengcheng/0000-0002-1505-5165; Jiang, Daqiang/0000-0003-4899-3868; Yu, Cun/0000-0003-0084-6746	National Natural Science Foundation of China (NSFC) [51231008]; National 973 programs of China [2012CB619400, 2009CB623700]; NSFC [51071175, 51001119, 50831001, 10825419]; NSF [DMR-1008104, DMR-1120901]; Beijing High-level Talents [PHR20100503]; Beijing 211 project; Institute for NanoScience, Engineering, and Technology (INSET) of Northern Illinois University; U.S. Department of Energy, Office of Science [DE-AC02-06CH11357];  [PXM201101420409000053]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National 973 programs of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); NSF(National Science Foundation (NSF)); Beijing High-level Talents; Beijing 211 project; Institute for NanoScience, Engineering, and Technology (INSET) of Northern Illinois University; U.S. Department of Energy, Office of Science(United States Department of Energy (DOE)); 	We thank G. H. Wu, H. B. Xu, and Y. F. Zheng for valuable discussions on the deformation mechanism of NICSMA. This work is supported by the key program project of National Natural Science Foundation of China (NSFC) (51231008), the National 973 programs of China (2012CB619400 and 2009CB623700), and the NSFC (51071175, 51001119, 50831001, and 10825419). J.L. also acknowledges support by NSF DMR-1008104 and DMR-1120901. X.D.H. acknowledges support by the Beijing High-level Talents (PHR20100503), the Beijing PXM201101420409000053, and Beijing 211 project. D.E.B. acknowledges support by the Institute for NanoScience, Engineering, and Technology (INSET) of Northern Illinois University. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, under contract no. DE-AC02-06CH11357.	Ashby M. F., 2005, MAT SELECTION MECH D; Aydiner CC, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3074374; Coleman JN, 2006, ADV MATER, V18, P689, DOI 10.1002/adma.200501851; Dzenis Y, 2008, SCIENCE, V319, P419, DOI 10.1126/science.1151434; Hofmann DC, 2008, NATURE, V451, P1085, DOI 10.1038/nature06598; Koziol K, 2007, SCIENCE, V318, P1892, DOI 10.1126/science.1147635; Niinomi M, 2011, INT J BIOMATER, V2011, DOI 10.1155/2011/836587; Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2; Otsuka K, 2005, PROG MATER SCI, V50, P511, DOI 10.1016/j.pmatsci.2004.10.001; PIAO M, 1992, MATER T JIM, V33, P337, DOI 10.2320/matertrans1989.33.337; Podsiadlo P, 2007, SCIENCE, V318, P80, DOI 10.1126/science.1143176; Richter G, 2009, NANO LETT, V9, P3048, DOI 10.1021/nl9015107; Saito T, 2003, SCIENCE, V300, P464, DOI 10.1126/science.1081957; Scheuerlein C, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2766685; Thilly L, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2202720; Thilly L, 2009, ACTA MATER, V57, P3157, DOI 10.1016/j.actamat.2009.03.021; Tian L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1619; Vidal V, 2009, SCRIPTA MATER, V60, P171, DOI 10.1016/j.scriptamat.2008.09.032; Walters DA, 1999, APPL PHYS LETT, V74, P3803, DOI 10.1063/1.124185; Wayman C.M., 1998, SHAPE MEMORY MAT; Wong EW, 1997, SCIENCE, V277, P1971, DOI 10.1126/science.277.5334.1971; Yue YH, 2011, NANO LETT, V11, P3151, DOI 10.1021/nl201233u; Zhu T, 2010, PROG MATER SCI, V55, P710, DOI 10.1016/j.pmatsci.2010.04.001	23	200	217	24	763	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2013	339	6124					1191	1194		10.1126/science.1228602	http://dx.doi.org/10.1126/science.1228602			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471404				2022-12-28	WOS:000315709900043
J	Zhao, W; Li, QT; Ayers, S; Gu, YF; Shi, Z; Zhu, QY; Chen, YD; Wang, HY; Wang, RF				Zhao, Wei; Li, Qingtian; Ayers, Stephen; Gu, Yifeng; Shi, Zhong; Zhu, Qingyuan; Chen, Yidong; Wang, Helen Y.; Wang, Rong-Fu			Jmjd3 Inhibits Reprogramming by Upregulating Expression of INK4a/Arf and Targeting PHF20 for Ubiquitination	CELL			English	Article							PLURIPOTENT STEM-CELLS; CHROMATIN; PROTEIN; WDR5; UTX; IDENTIFICATION; CONTRIBUTES; GENERATION; DISTINCT; FAMILY	Although somatic cell reprogramming to generate inducible pluripotent stem cells (iPSCs) is associated with profound epigenetic changes, the roles and mechanisms of epigenetic factors in this process remain poorly understood. Here, we identify Jmjd3 as a potent negative regulator of reprogramming. Jmjd3-deficient MEFs produced significantly more iPSC colonies than did wild-type cells, whereas ectopic expression of Jmjd3 markedly inhibited reprogramming. We show that the inhibitory effects of Jmjd3 are produced through both histone demethylase-dependent and -independent pathways. The latter pathway involves Jmjd3 targeting of PHF20 for ubiquitination and degradation via recruitment of an E3 ligase, Trim26. Importantly, PHF20-deficient MEFs could not be converted to fully reprogrammed iPSCs, even with knockdown of Jmjd3, Ink4a, or p21, indicating that PHF20 is required for reprogramming. Our findings demonstrate, to the best of our knowledge, a previously unrecognized role of Jmjd3 in cellular reprogramming and provide molecular insight into the mechanisms by which the Jmjd3-PHF20 axis controls this process.	[Zhao, Wei; Li, Qingtian; Gu, Yifeng; Zhu, Qingyuan; Wang, Helen Y.; Wang, Rong-Fu] Methodist Hosp, Res Inst, Ctr Inflammat & Epigenet, Houston, TX 77030 USA; [Ayers, Stephen] Methodist Hosp, Res Inst, Houston, TX 77030 USA; [Shi, Zhong] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Chen, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Chen, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA	The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Wang, RF (corresponding author), Methodist Hosp, Res Inst, Ctr Inflammat & Epigenet, 6535 Fannin, Houston, TX 77030 USA.	rwang3@tmhs.org	Zhao, Wei/F-4848-2014; Ayers, Stephen D/O-4535-2014	Ayers, Stephen D/0000-0003-1390-8969	National Cancer Institute; NIH [R01CA09327, R01CA101795, R01CA116408, R01CA121191, R01 DA030338]; Cancer Prevention and Research Institute of Texas [RP121048]; Methodist Hospital Research Institute; NATIONAL CANCER INSTITUTE [R01CA116408, R01CA101795, R01CA090327, R01CA121191, P01CA094237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030338] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Methodist Hospital Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank Dr. Yi Li at Baylor College of Medicine for providing Tet-O-Myc transgenic mice, Dr. Mark Bedford at M. D. Anderson Cancer Center for PHF20 KO mice, Dr. Dan Liu at Baylor College of Medicine for assistance with shRNA screening, and Dr. Paul Webb for assistance in ChIP-seq experiments. We would also like to thank John Gilbert and Adebusola A. Ajibade for their critical reading of this manuscript. This work was in part supported by grants from National Cancer Institute, NIH (R01CA09327, R01CA101795, R01CA116408, R01CA121191, and R01 DA030338), and Cancer Prevention and Research Institute of Texas (RP121048) to R.-F. W. and from The Methodist Hospital Research Institute.	Adams-Cioaba MA, 2012, FEBS LETT, V586, P859, DOI 10.1016/j.febslet.2012.02.012; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Badeaux AI, 2012, J BIOL CHEM, V287, P429, DOI 10.1074/jbc.M111.271163; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Fischer U, 2001, CLIN EXP IMMUNOL, V126, P206, DOI 10.1046/j.1365-2249.2001.01635.x; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li Y, 2013, CELL SIGNAL, V25, P74, DOI 10.1016/j.cellsig.2012.09.009; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Park S, 2012, J BIOL CHEM, V287, P11151, DOI 10.1074/jbc.M111.333922; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Trievel RC, 2009, NAT STRUCT MOL BIOL, V16, P678, DOI 10.1038/nsmb0709-678; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wang Y, 2002, J IMMUNOL, V169, P1102, DOI 10.4049/jimmunol.169.2.1102; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	39	121	126	1	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 28	2013	152	5					1037	1050		10.1016/j.cell.2013.02.006	http://dx.doi.org/10.1016/j.cell.2013.02.006			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452852	Green Accepted, Bronze			2022-12-28	WOS:000315710300012
J	Beaglehole, R; Bonita, R; Horton, R				Beaglehole, Robert; Bonita, Ruth; Horton, Richard			Independent global accountability for NCDs	LANCET			English	Editorial Material									[Beaglehole, Robert; Bonita, Ruth] Univ Auckland, Auckland 1, New Zealand; [Horton, Richard] The Lancet, London NW1 7BY, England	University of Auckland	Beaglehole, R (corresponding author), Univ Auckland, Auckland 1, New Zealand.	r.beaglehole@auckland.ac.uk						Alleyne G, 2013, LANCET; Beaglehole R, 2012, LANCET, V380, P1283, DOI 10.1016/S0140-6736(12)61692-4; Beyer P, 2016, OPTIONS GLOBAL DEV S; Bonita R, 2013, LANCET; Commission on Information and Accountability for Women's and Children's Health, 2011, KEEP PROM MEAS RES; Di Cesare M, 2013, LANCET; Moodie R, 2013, LANCET; The NCD Alliance, PROP GLOB COORD MECH; UNAIDS, 2009, 2010 2011 PERF MON F; *UNDP, MILL DEV GOALS; United Nations General Assembly,, 2012, NOT SECR GEN TRANSM; United Nations Secretary-General Ban Kin-moon, 2010, GLOB STRAT WOM CHILD; WHO, 2013, DRAFT PLAN PREV CONT; World Health Organization, 2012, 65 WORLD HLTH ASS DE; World Health Organization (WHO), STEPWISE APPR SURV S	15	25	25	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 23	2013	381	9867					602	605		10.1016/S0140-6736(13)60101-4	http://dx.doi.org/10.1016/S0140-6736(13)60101-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	093JY	23410610				2022-12-28	WOS:000315189300005
J	Ryan, KK; Seeley, RJ				Ryan, Karen K.; Seeley, Randy J.			Food as a Hormone	SCIENCE			English	Editorial Material							ENERGY HOMEOSTASIS; FATTY-ACIDS; PPAR-GAMMA; OBESITY; BALANCE; GPR120		[Ryan, Karen K.; Seeley, Randy J.] Univ Cincinnati, Metab Dis Inst, Cincinnati, OH 45237 USA	University System of Ohio; University of Cincinnati	Ryan, KK (corresponding author), Univ Cincinnati, Metab Dis Inst, Cincinnati, OH 45237 USA.	randy.seeley@uc.edu	Ryan, Karen/A-4626-2014	Ryan, Karen/0000-0003-4563-3744; Seeley, Randy/0000-0002-3721-5625	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL111319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093848] Funding Source: NIH RePORTER; NHLBI NIH HHS [R00 HL111319, K99 HL111319, HL111319] Funding Source: Medline; NIDDK NIH HHS [R01 DK093848, DK093848] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Blouet C, 2008, CELL METAB, V8, P459, DOI 10.1016/j.cmet.2008.10.004; Buckley JD, 2010, NUTRIENTS, V2, P1212, DOI 10.3390/nu2121212; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Dann SG, 2006, FEBS LETT, V580, P2821, DOI 10.1016/j.febslet.2006.04.068; Diano S, 2011, NAT MED, V17, P1121, DOI 10.1038/nm.2421; Heppner KM, 2012, ENDOCRINOLOGY, V153, P4687, DOI 10.1210/en.2012-1194; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ryan KK, 2012, CELL METAB, V15, P137, DOI 10.1016/j.cmet.2011.12.013; Ryan KK, 2011, NAT MED, V17, P623, DOI 10.1038/nm.2349; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552	15	35	39	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2013	339	6122					918	919		10.1126/science.1234062	http://dx.doi.org/10.1126/science.1234062			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23430646	Green Accepted			2022-12-28	WOS:000315149600038
J	Pauly, D; Hilborn, R; Branch, TA				Pauly, Daniel; Hilborn, Ray; Branch, Trevor A.			Does catch reflect abundance?	NATURE			English	Editorial Material							GLOBAL FISHERIES; OCEAN; US		[Pauly, Daniel] Univ British Columbia, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada; [Hilborn, Ray; Branch, Trevor A.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	University of British Columbia; University of Washington; University of Washington Seattle	Pauly, D (corresponding author), Univ British Columbia, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada.	d.pauly@fisheries.ubc.ca; rayh@uw.edu; tbranch@uw.edu	Hilborn, Ray W/D-6332-2013; Pauly, Daniel Marc/AAY-2316-2021	Pauly, Daniel/0000-0003-3756-4793				Branch TA, 2011, CONSERV BIOL, V25, P777, DOI 10.1111/j.1523-1739.2011.01687.x; Froese R, 2012, MAR BIOL, V159, P1283, DOI 10.1007/s00227-012-1909-6; Grainger R.J., 1996, CHRONICLES MARINE FI; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Kleisner K, 2012, FISH FISH; Nicol S, 2012, FISH FISH, V13, P30, DOI 10.1111/j.1467-2979.2011.00406.x; Pauly D, 1996, FISH RES, V25, P25, DOI 10.1016/0165-7836(95)00436-X; Sumaila UR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040542; Walters C, 1996, REV FISH BIOL FISHER, V6, P125; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Zeller D, 2011, FISH RES, V108, P356, DOI 10.1016/j.fishres.2010.10.024; Zeller D, 2007, FISH B-NOAA, V105, P266	13	210	217	1	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					303	306		10.1038/494303a	http://dx.doi.org/10.1038/494303a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	095CS	23426308				2022-12-28	WOS:000315312900015
J	Milburn, GJ				Milburn, Gerard J.			Demonstrating Uncertainty	SCIENCE			English	Editorial Material									Univ Queensland, Ctr Engn Quantum Syst, Brisbane, Qld 4072, Australia	University of Queensland	Milburn, GJ (corresponding author), Univ Queensland, Ctr Engn Quantum Syst, Brisbane, Qld 4072, Australia.	milburn@physics.uq.edu.au	MIlburn, Gerard J/B-6381-2008	MIlburn, Gerard J/0000-0002-5404-9681				Aspelmeyer M, 2012, PHYS TODAY, V65, P29, DOI 10.1063/PT.3.1640; CAVES CM, 1980, REV MOD PHYS, V52, P341, DOI 10.1103/RevModPhys.52.341; Meystre P., 2001, ATOM OPTICS; Purdy TP, 2013, SCIENCE, V339, P801, DOI 10.1126/science.1231282	4	0	0	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2013	339	6121					770	771		10.1126/science.1234109	http://dx.doi.org/10.1126/science.1234109			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23413346				2022-12-28	WOS:000314874400035
J	Schonknecht, G; Chen, WH; Ternes, CM; Barbier, GG; Shrestha, RP; Stanke, M; Brautigam, A; Baker, BJ; Banfield, JF; Garavito, RM; Carr, K; Wilkerson, C; Rensing, SA; Gagneul, D; Dickenson, NE; Oesterhelt, C; Lercher, MJ; Weber, APM				Schoenknecht, Gerald; Chen, Wei-Hua; Ternes, Chad M.; Barbier, Guillaume G.; Shrestha, Roshan P.; Stanke, Mario; Braeutigam, Andrea; Baker, Brett J.; Banfield, Jillian F.; Garavito, R. Michael; Carr, Kevin; Wilkerson, Curtis; Rensing, Stefan A.; Gagneul, David; Dickenson, Nicholas E.; Oesterhelt, Christine; Lercher, Martin J.; Weber, Andreas P. M.			Gene Transfer from Bacteria and Archaea Facilitated Evolution of an Extremophilic Eukaryote	SCIENCE			English	Article							GALDIERIA-SULPHURARIA; CYANIDIUM-CALDARIUM; GENOME; ALGA; ENVIRONMENTS; FAMILY	Some microbial eukaryotes, such as the extremophilic red alga Galdieria sulphuraria, live in hot, toxic metal-rich, acidic environments. To elucidate the underlying molecular mechanisms of adaptation, we sequenced the 13.7-megabase genome of G. sulphuraria. This alga shows an enormous metabolic flexibility, growing either photoautotrophically or heterotrophically on more than 50 carbon sources. Environmental adaptation seems to have been facilitated by horizontal gene transfer from various bacteria and archaea, often followed by gene family expansion. At least 5% of protein-coding genes of G. sulphuraria were probably acquired horizontally. These proteins are involved in ecologically important processes ranging from heavy-metal detoxification to glycerol uptake and metabolism. Thus, our findings show that a pan-domain gene pool has facilitated environmental adaptation in this unicellular eukaryote.	[Schoenknecht, Gerald; Ternes, Chad M.] Oklahoma State Univ, Dept Bot, Stillwater, OK 74078 USA; [Schoenknecht, Gerald; Braeutigam, Andrea; Weber, Andreas P. M.] Univ Dusseldorf, Inst Plant Biochem, D-40225 Dusseldorf, Germany; [Chen, Wei-Hua; Lercher, Martin J.] Univ Dusseldorf, Inst Comp Sci, D-40225 Dusseldorf, Germany; [Chen, Wei-Hua] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Barbier, Guillaume G.; Shrestha, Roshan P.; Wilkerson, Curtis; Weber, Andreas P. M.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Stanke, Mario] Ernst Moritz Arndt Univ Greifswald, Inst Math & Informat, D-17487 Greifswald, Germany; [Baker, Brett J.] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA; [Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Garavito, R. Michael] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Carr, Kevin; Wilkerson, Curtis] Michigan State Univ, Plant Biol Labs, Res Technol Support Facil, E Lansing, MI 48824 USA; [Rensing, Stefan A.] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Rensing, Stefan A.] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Gagneul, David] Univ Lille 1, UMR USTL INRA Stress Abiot & Differenciat Vegetau, F-59650 Villeneuve Dascq, France; [Dickenson, Nicholas E.] Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA; [Oesterhelt, Christine] CyanoBiofuels GmbH, D-12489 Berlin, Germany; [Lercher, Martin J.; Weber, Andreas P. M.] Univ Dusseldorf, Cluster Excellence Plant Sci CEPLAS, D-40225 Dusseldorf, Germany; [Barbier, Guillaume G.] Novozymes Inc, Davis, CA 95618 USA; [Shrestha, Roshan P.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92037 USA; [Rensing, Stefan A.] Univ Marburg, Fac Biol, D-35032 Marburg, Germany	Oklahoma State University System; Oklahoma State University - Stillwater; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; European Molecular Biology Laboratory (EMBL); Michigan State University; Ernst Moritz Arndt Universitat Greifswald; University of Michigan System; University of Michigan; University of California System; University of California Berkeley; Michigan State University; Michigan State University; University of Freiburg; University of Freiburg; INRAE; Universite de Lille - ISITE; Universite de Lille; Oklahoma State University System; Oklahoma State University - Stillwater; Heinrich Heine University Dusseldorf; University of Cologne; Novozymes; University of California System; University of California San Diego; Scripps Institution of Oceanography; Philipps University Marburg	Schonknecht, G (corresponding author), Oklahoma State Univ, Dept Bot, Stillwater, OK 74078 USA.	gerald.schoenknecht@okstate.edu; andreas.weber@uni-duesseldorf.de	Baker, Brett/P-1783-2014; Chen, Weihua/GRS-9256-2022; Lercher, Martin/K-7939-2013; Weber, Andreas PM/A-6250-2011; Stanke, Mario/P-7876-2019; Weber, Andreas Paul Michael/O-3043-2019; Schoenknecht, Gerald/L-8848-2013; Bräutigam, Andrea/H-2685-2012	Baker, Brett/0000-0002-5971-1021; Lercher, Martin/0000-0003-3940-1621; Weber, Andreas PM/0000-0003-0970-4672; Stanke, Mario/0000-0001-8696-0384; Weber, Andreas Paul Michael/0000-0003-0970-4672; Schoenknecht, Gerald/0000-0003-3762-4880; Bräutigam, Andrea/0000-0002-5309-0527; Banfield, Jill/0000-0001-8203-8771; Dickenson, Nicholas/0000-0003-1572-6077; Chen, Wei-Hua/0000-0003-2168-6147; Gagneul, David/0000-0002-9288-0986	NSF [EF 0332882, MCB 0925298]; Deutsche Forschungsgemeinschaft (DFG) [CRC TR1, IRTG 1525/1, WE2231/7-1, EXC 1028, CRC 680]; DFG Mercator Fellowship; College of Arts and Sciences, Oklahoma State University (OSU)	NSF(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG Mercator Fellowship; College of Arts and Sciences, Oklahoma State University (OSU)	This work was made possible by NSF grant EF 0332882 (to A.P.M.W.). Partial support came from the Deutsche Forschungsgemeinschaft (DFG) (CRC TR1, IRTG 1525/1 and WE2231/7-1 to A.P.M.W., EXC 1028 to M.J.L. and A. P. M. W., CRC 680 to M.J.L., and a DFG Mercator Fellowship to G. S.). G. S. appreciates support from NSF (MCB 0925298) and the College of Arts and Sciences, Oklahoma State University (OSU). We thank M. Hanikenne and E. Koonin for helpful discussion, and A. Doust and P. Pelser for advice on phylogenetic analyses. We are grateful to B. Sears for introduction to and assistance with CsCl purification of bisbenzamide-treated nuclear DNA. Some of the computing for this project was performed at the OSU High Performance Computing Center. Sequence data have been deposited at DNA Data Bank of Japan, EMBL, and GenBank under accession ADNM00000000 (SRA012465). The version described in this paper is the first version, ADNM01000000.	Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; DOEMEL WN, 1971, J GEN MICROBIOL, V67, P17, DOI 10.1099/00221287-67-1-17; ENAMI I, 1986, PLANT CELL PHYSIOL, V27, P1351, DOI 10.1093/oxfordjournals.pcp.a077233; GROSS W, 1995, PLANT CELL PHYSIOL, V36, P633; Gross W, 2000, HYDROBIOLOGIA, V433, P31, DOI 10.1023/A:1004054317446; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Keeling PJ, 2009, CURR OPIN GENET DEV, V19, P613, DOI 10.1016/j.gde.2009.10.001; Koonin EV, 1997, SCIENCE, V275, P1489, DOI 10.1126/science.275.5305.1489; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; McCoy JG, 2009, PROTEINS, V74, P368, DOI 10.1002/prot.22147; Oesterhelt C, 2008, PLANTA, V227, P353, DOI 10.1007/s00425-007-0622-z; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686; Pinto G., 2007, V11, P487; Reeb V, 2010, CELL ORIG LIFE EXTRE, V13, P409, DOI 10.1007/978-90-481-3795-4_22; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284; Ye J, 2012, TRENDS PLANT SCI, V17, P155, DOI 10.1016/j.tplants.2011.12.003	19	287	297	8	303	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2013	339	6124					1207	1210		10.1126/science.1231707	http://dx.doi.org/10.1126/science.1231707			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471408	Green Submitted			2022-12-28	WOS:000315709900048
J	Amador, A; Perl, YS; Mindlin, GB; Margoliash, D				Amador, Ana; Sanz Perl, Yonatan; Mindlin, Gabriel B.; Margoliash, Daniel			Elemental gesture dynamics are encoded by song premotor cortical neurons	NATURE			English	Article							BRAIN-STEM; GENERATION; INTEGRATION; MECHANISMS; FREQUENCY; RESPONSES; NUCLEUS; NETWORK; SLEEP; MODEL	Quantitative biomechanical models can identify control parameters that are used during movements, and movement parameters that are encoded by premotor neurons. We fit a mathematical dynamical systems model including subsyringeal pressure, syringeal biomechanics and upper-vocal-tract filtering to the songs of zebra finches. This reduces the dimensionality of singing dynamics, described as trajectories (motor 'gestures') in a space of syringeal pressure and tension. Here we assess model performance by characterizing the auditory response 'replay' of song premotor HVC neurons to the presentation of song variants in sleeping birds, and by examining HVC activity in singing birds. HVC projection neurons were excited and interneurons were suppressed within a few milliseconds of the extreme time points of the gesture trajectories. Thus, the HVC precisely encodes vocal motor output through activity at the times of extreme points of movement trajectories. We propose that the sequential activity of HVC neurons is used as a 'forward' model, representing the sequence of gestures in song to make predictions on expected behaviour and evaluate feedback.	[Amador, Ana; Margoliash, Daniel] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Sanz Perl, Yonatan; Mindlin, Gabriel B.] Univ Buenos Aires, FCEN, Dept Phys, RA-1428 Buenos Aires, DF, Argentina	University of Chicago; University of Buenos Aires	Margoliash, D (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1027 East 57th St, Chicago, IL 60637 USA.	dan@bigbird.uchicago.edu		Sanz Perl, Yonatan/0000-0002-1270-5564; Amador, Ana/0000-0002-1040-2359; Mindlin, Gabo/0000-0002-7808-5708	Human Frontiers Science Program cross-disciplinary fellowship; ANCyT; CONICET; UBA; NIDCD; NSF/CRCNS;  [NIDCD006876]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006876] Funding Source: NIH RePORTER	Human Frontiers Science Program cross-disciplinary fellowship; ANCyT(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UBA(University of Buenos Aires); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NSF/CRCNS(National Science Foundation (NSF)NSF - Office of the Director (OD)); ; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are grateful to R. H. R. Hahnloser for help-with the microdrives and techniques used to record from singing birds. We thank H. D. I. Abarbanel, T. Q. Gentner, H. C. Nusbaum and S. E Palmer for valuable comments on the manuscript. This work was supported by a Human Frontiers Science Program cross-disciplinary fellowship award to A.A., NIDCD006876, ANCyT, CONICET and UBA awards to G.B.M. and Y.S.P., and NIDCD and NSF/CRCNS awards to D.M.	Amador A, 2008, J NEUROPHYSIOL, V99, P2383, DOI 10.1152/jn.01002.2007; Amador A, 2008, CHAOS, V18, DOI 10.1063/1.3041023; Ashmore RC, 2005, J NEUROSCI, V25, P8543, DOI 10.1523/JNEUROSCI.1668-05.2005; Bauer EE, 2008, J NEUROSCI, V28, P1509, DOI 10.1523/JNEUROSCI.3838-07.2008; Brainard MS, 2000, NATURE, V404, P762, DOI 10.1038/35008083; Coleman MJ, 2007, J NEUROSCI, V27, P10024, DOI 10.1523/JNEUROSCI.2215-07.2007; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Elemans CPH, 2010, J NEUROSCI, V30, P13246, DOI 10.1523/JNEUROSCI.1130-10.2010; Fee MS, 1998, NATURE, V395, P67, DOI 10.1038/25725; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Fiete IR, 2004, J NEUROPHYSIOL, V92, P2274, DOI 10.1152/jn.01133.2003; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; HARTLEY RS, 1989, J COMP PHYSIOL A, V165, P15, DOI 10.1007/BF00613795; Hatsopoulos NG, 2007, J NEUROSCI, V27, P5105, DOI 10.1523/JNEUROSCI.3570-06.2007; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Laje R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051921; Leyton ASF, 1917, Q J EXP PHYSIOL, V11, P135, DOI 10.1113/expphysiol.1917.sp000240; MARGOLIASH D, 1992, J NEUROSCI, V12, P4309; MARGOLIASH D, 1986, J NEUROSCI, V6, P1643; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; Mindlin GB, 2005, PHYS BIRDSONG; Mulliken GH, 2008, P NATL ACAD SCI USA, V105, P8170, DOI 10.1073/pnas.0802602105; Nick TA, 2005, J NEUROBIOL, V62, P469, DOI 10.1002/neu.20115; Nishikawa K, 2007, INTEGR COMP BIOL, V47, P16, DOI 10.1093/icb/icm024; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Prather JF, 2009, NAT NEUROSCI, V12, P221, DOI 10.1038/nn.2246; Riede T, 2006, P NATL ACAD SCI USA, V103, P5543, DOI 10.1073/pnas.0601262103; Roberts TF, 2008, J NEUROSCI, V28, P3479, DOI 10.1523/JNEUROSCI.0177-08.2008; Perl YS, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.051909; Shank SS, 2009, NATURE, V458, P73, DOI 10.1038/nature07615; Sitt JD, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011905; Suthers RA, 2002, P NATL ACAD SCI USA, V99, P5680, DOI 10.1073/pnas.042103199; Suthers RA, 1999, PHILOS T ROY SOC B, V354, P927, DOI 10.1098/rstb.1999.0444; VU ET, 1994, J NEUROSCI, V14, P6924; Wild JM, 2004, ANN NY ACAD SCI, V1016, P438, DOI 10.1196/annals.1298.016; WILLIAMS H, 1993, J NEUROBIOL, V24, P903, DOI 10.1002/neu.480240704; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	40	127	127	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2013	495	7439					59	64		10.1038/nature11967	http://dx.doi.org/10.1038/nature11967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23446354	Green Accepted			2022-12-28	WOS:000316039800039
J	Shekelle, PG; Pronovost, PJ; Wachter, RM; McDonald, KM; Schoelles, K; Dy, SM; Shojania, K; Reston, JT; Adams, AS; Angood, PB; Bates, DW; Bickman, L; Carayon, P; Donaldson, L; Duan, NH; Farley, DO; Greenhalgh, T; Haughom, JL; Lake, E; Lilford, R; Lohr, KN; Meyer, GS; Miller, MR; Neuhauser, DV; Ryan, G; Saint, S; Shortell, SM; Stevens, DP; Walshe, K				Shekelle, Paul G.; Pronovost, Peter J.; Wachter, Robert M.; McDonald, Kathryn M.; Schoelles, Karen; Dy, Sydney M.; Shojania, Kaveh; Reston, James T.; Adams, Alyce S.; Angood, Peter B.; Bates, David W.; Bickman, Leonard; Carayon, Pascale; Donaldson, Liam; Duan, Naihua; Farley, Donna O.; Greenhalgh, Trisha; Haughom, John L.; Lake, Eileen; Lilford, Richard; Lohr, Kathleen N.; Meyer, Gregg S.; Miller, Marlene R.; Neuhauser, Duncan V.; Ryan, Gery; Saint, Sanjay; Shortell, Stephen M.; Stevens, David P.; Walshe, Kieran			The Top Patient Safety Strategies That Can Be Encouraged for Adoption Now	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SYSTEMATIC REVIEWS		[Shekelle, Paul G.] RAND Corp, Santa Monica, CA 90401 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Stanford Ctr Hlth Policy, Stanford, CA USA; Ctr Primary Care & Outcomes Res, Stanford, CA USA; Kaiser Permanente, Oakland, CA 94612 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; Johns Hopkins Univ, Baltimore, MD 21231 USA; Johns Hopkins Childrens Ctr, Baltimore, MD 21287 USA; ECRI Inst, Plymouth Meeting, PA 19462 USA; RAND Corp, Pittsburgh, PA 15213 USA; Univ Penn, Philadelphia, PA 19104 USA; [Shojania, Kaveh] Univ Toronto, Toronto, ON, Canada; Natl Qual Forum, Washington, DC USA; Harvard Univ, Brigham & Womens Hosp, Boston, MA 02115 USA; Vanderbilt Univ, Peabody Coll, Nashville, TN 37203 USA; Univ Wisconsin, Madison, WI 53706 USA; Univ London Imperial Coll Sci Technol & Med, London W2 1NY, England; Univ London, London, England; Univ Birmingham, Birmingham B15 2TT, W Midlands, England; Univ Manchester, Manchester Business Sch, Manchester M15 6PB, Lancs, England; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; PeaceHlth Med Grp, Eugene, OR USA; Res Triangle Inst Int, Res Triangle Pk, NC 27709 USA; Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03766 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI 48105 USA; Univ Michigan, Ann Arbor, MI 48109 USA	RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California San Francisco; Kaiser Permanente; University of California System; University of California Berkeley; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; RAND Corporation; University of Pennsylvania; University of Toronto; Harvard University; Brigham & Women's Hospital; Vanderbilt University; Vanderbilt University Peabody College; University of Wisconsin System; University of Wisconsin Madison; Imperial College London; University of London; University of Birmingham; University of Manchester; New York State Psychiatry Institute; Research Triangle Institute; Dartmouth College; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Shekelle, PG (corresponding author), RAND Corp, 1776 Main St, Santa Monica, CA 90401 USA.	shekelle@rand.org	Greenhalgh, Trisha/B-1825-2015; Saint, Sanjay/AAF-5126-2019; Bates, David/AAE-7283-2019	Greenhalgh, Trisha/0000-0003-2369-8088; Bickman, Leonard/0000-0002-0746-3791; Lohr, Kathleen/0000-0002-3825-0713; Duan, Naihua/0000-0001-9411-2924; Lilford, Richard/0000-0002-0634-984X; Walshe, Kieran/0000-0002-0696-480X	Engineering and Physical Sciences Research Council [EP/F063822/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10008, NF-SI-0512-10031] Funding Source: researchfish; EPSRC [EP/F063822/1] Funding Source: UKRI; PHS HHS [HHSA-290-2007-10062I] Funding Source: Medline	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Agency for Healthcare Research and Quality, 2011, AHRQ PUBLICATION, V10; Cochrane Effective Practice and Organisation of Care Group (EPOC), 2012, REVIEWS; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Shekelle PG, 2011, ANN INTERN MED, V154, P693, DOI 10.7326/0003-4819-154-10-201105170-00011; Shekelle PG, 2013, MAKING HEALTH CARE S; Shojania KG, 2007, ANN INTERN MED, V147, P224, DOI 10.7326/0003-4819-147-4-200708210-00179; SHOJANIA KG, 2001, EVID REP TECHNOL ASS, V1, P1; Whitlock EP, 2008, ANN INTERN MED, V148, P776, DOI 10.7326/0003-4819-148-10-200805200-00010	10	194	196	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2013	158	5	2				365	+		10.7326/0003-4819-158-5-201303051-00001	http://dx.doi.org/10.7326/0003-4819-158-5-201303051-00001			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105HX	23460091	Green Submitted			2022-12-28	WOS:000316058600001
J	van Ginneken, E; Gray, BH				van Ginneken, Ewout; Gray, Bradford H.			Coverage for Undocumented Migrants Becomes More Urgent	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							UNITED-STATES; IMMIGRANTS		[van Ginneken, Ewout] Berlin Univ Technol, D-10623 Berlin, Germany; Urban Inst, Washington, DC 20037 USA	Technical University of Berlin; Urban Institute	van Ginneken, E (corresponding author), Berlin Univ Technol, Str 17,Juni 135, D-10623 Berlin, Germany.	ewout.vanginneken@tu-berlin.de						Bernstein N., 2011, NY TIMES        0330, pA1; Bustamante Arturo Vargas, 2012, Virtual Mentor, V14, P318, DOI 10.1001/virtualmentor.2012.14.4.stas1-1204; CAPPS R, 2009, IMMIGRANTS HLTH CARE; Gray BH, 2012, HLTH CARE UNDOCUMENT; Institute of Medicine, 2009, AM UN CRIS COSTS HLT; Karl-Trummer Ursula, 2010, 2 LANDSCAPES NOWHERE; Martin E, 2010, HLTH REFORM WHAT IS; McWilliams JM, 2009, MILBANK Q, V87, P443, DOI 10.1111/j.1468-0009.2009.00564.x; Stimpson JP, 2010, HEALTH AFFAIR, V29, P544, DOI 10.1377/hlthaff.2009.0400; Zuckerman S, 2011, HEALTH AFFAIR, V30, P1997, DOI 10.1377/hlthaff.2011.0604	10	8	8	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2013	158	5	1				347	+		10.7326/0003-4819-158-5-201303050-00008	http://dx.doi.org/10.7326/0003-4819-158-5-201303050-00008			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	105HP	23460058				2022-12-28	WOS:000316057700006
J	Friedman, WE				Friedman, William E.			One Genome, Two Ontogenies	SCIENCE			English	Editorial Material									[Friedman, William E.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Friedman, William E.] Arnold Arboretum Harvard Univ, Boston, MA 02131 USA	Harvard University; Harvard University	Friedman, WE (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	ned@oeb.harvard.edu		Friedman, William Edward/0000-0003-0374-3427				Friedman WE, 2004, AM J BOT, V91, P1726, DOI 10.3732/ajb.91.10.1726; GRAHAM L. E., 2009, ALGAE; Hay A, 2010, DEVELOPMENT, V137, P3153, DOI 10.1242/dev.030049; LEE JHW, 2008, J HYDRO-ENVIRON RES, V2, P133, DOI DOI 10.1016/S1570-6443(08)00079-8; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Mosquna A, 2009, DEVELOPMENT, V136, P2433, DOI 10.1242/dev.035048; Mukherjee K, 2009, MOL BIOL EVOL, V26, P2775, DOI 10.1093/molbev/msp201; Okano Y, 2009, P NATL ACAD SCI USA, V106, P16321, DOI 10.1073/pnas.0906997106; Sakakibara K, 2013, SCIENCE, V339, P1067, DOI 10.1126/science.1230082; Timme RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029696	10	9	9	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1045	1046		10.1126/science.1234992	http://dx.doi.org/10.1126/science.1234992			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23449587				2022-12-28	WOS:000315452000031
J	Blumenthal, MS				Blumenthal, Marjory S.			Move with the times	NATURE			English	Editorial Material									Georgetown Univ, Washington, DC USA	Georgetown University	Blumenthal, MS (corresponding author), Georgetown Univ, Washington, DC USA.	blumentm@georgetown.edu							0	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2013	494	7438					423	424		10.1038/494423a	http://dx.doi.org/10.1038/494423a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23446400	Bronze			2022-12-28	WOS:000315661500014
J	Colbert, JA; Adler, JN				Colbert, James A.; Adler, Jonathan N.			Mammography Screening - Polling Results	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809	1	15	15	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2013	368	9					E12	E12		10.1056/NEJMclde1301407	http://dx.doi.org/10.1056/NEJMclde1301407			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096ET	23445113				2022-12-28	WOS:000315387700017
J	Roehr, B				Roehr, Bob			CLINICAL TRIALS The appeal of large simple trials	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												BobRoehr@aol.com						D'Avolio L, 2012, J AM MED INFORM ASSN, V19, pE170, DOI 10.1136/amiajnl-2011-000623; Kass NE, 2013, HASTINGS CENT REP, V43, pS4, DOI 10.1002/hast.133; van Staa TP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e55	3	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 28	2013	346								f1317	10.1136/bmj.f1317	http://dx.doi.org/10.1136/bmj.f1317			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100BM	23449675				2022-12-28	WOS:000315669700004
J	Schoenberger, SD; Agarwal, A				Schoenberger, Scott D.; Agarwal, Anita			Talc Retinopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Schoenberger, Scott D.; Agarwal, Anita] Vanderbilt Eye Inst, Nashville, TN 37232 USA	Vanderbilt University	Schoenberger, SD (corresponding author), Vanderbilt Eye Inst, Nashville, TN 37232 USA.	anita.agarwal@vanderbilt.edu							0	6	6	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2013	368	9					852	852		10.1056/NEJMicm1203394	http://dx.doi.org/10.1056/NEJMicm1203394			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096ET	23445096				2022-12-28	WOS:000315387700011
J	Elshaug, AG; McWilliams, JM; Landon, BE				Elshaug, Adam G.; McWilliams, J. Michael; Landon, Bruce E.			The Value of Low-Value Lists	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Elshaug, Adam G.; McWilliams, J. Michael; Landon, Bruce E.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [McWilliams, J. Michael] Brigham & Womens Hosp, Dept Med, Div Gen Internal Med & Primary Care, Boston, MA 02115 USA; [Landon, Bruce E.] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; [Elshaug, Adam G.] Commonwealth Fund, New York, NY USA; [Elshaug, Adam G.] Univ Adelaide, Sch Populat Hlth, Adelaide, SA, Australia	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Commonwealth Fund; University of Adelaide	Elshaug, AG (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	elshaug@hcp.med.harvard.edu	Elshaug, Adam G/A-5714-2008	Elshaug, Adam/0000-0002-4939-5379	NATIONAL INSTITUTE ON AGING [K08AG038354] Funding Source: NIH RePORTER; NIA NIH HHS [K08AG038354] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Al-Khatib SM, 2011, JAMA-J AM MED ASSOC, V305, P43, DOI 10.1001/jama.2010.1915; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Elshaug AG, 2012, MED J AUSTRALIA, V197, P556, DOI 10.5694/mja12.11083; Elshaug AG, 2011, NEW ENGL J MED, V364, P1390, DOI 10.1056/NEJMp1101475; Garber AM, 2011, HEALTH AFFAIR, V30, P2243, DOI 10.1377/hlthaff.2010.0255; Garner S, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4519; Landon BE, 2012, NEW ENGL J MED, V366, P393, DOI 10.1056/NEJMp1112637; Song ZR, 2012, HEALTH AFFAIR, V31, P1885, DOI 10.1377/hlthaff.2012.0327; Volpp KG, 2012, JAMA-J AM MED ASSOC, V308, P1635, DOI 10.1001/jama.2012.13616	9	73	74	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2013	309	8					775	776		10.1001/jama.2013.828	http://dx.doi.org/10.1001/jama.2013.828			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095KD	23443439				2022-12-28	WOS:000315332200020
J	Taggart, DP				Taggart, David P.			CABG or stents in coronary artery disease: end of the debate?	LANCET			English	Editorial Material							BYPASS GRAFT-SURGERY; INTERVENTION; REVASCULARIZATION; MULTIVESSEL		Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg Sci, Oxford OX3 9DU, England	University of Oxford	Taggart, DP (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg Sci, Oxford OX3 9DU, England.	david.taggart@ouh.nhs.uk						Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585; Farooq V, 2013, LANCET, V381, P639, DOI 10.1016/S0140-6736(13)60108-7; Farooq V, 2012, EUR HEART J, V33, P3098, DOI 10.1093/eurheartj/ehs295; Hillis LD, 2011, J AM COLL CARDIOL, V58, pE123, DOI 10.1016/j.jacc.2011.08.009; Kolh P, 2010, EUR J CARDIO-THORAC, V38, pS1, DOI 10.1016/j.ejcts.2010.08.019; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Pursnani S, 2012, CIRC-CARDIOVASC INTE, V5, P476, DOI 10.1161/CIRCINTERVENTIONS.112.970954; Taggart DP, 2006, ANN THORAC SURG, V82, P1966, DOI 10.1016/j.athoracsur.2006.06.035; Taggart DP, 2001, LANCET, V358, P870, DOI 10.1016/S0140-6736(01)06069-X; Trikalinos TA, 2009, LANCET, V373, P911, DOI 10.1016/S0140-6736(09)60319-6; Weintraub WS, 2012, NEW ENGL J MED, V366, P1467, DOI 10.1056/NEJMoa1110717	11	18	20	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2013	381	9867					605	607		10.1016/S0140-6736(13)60258-5	http://dx.doi.org/10.1016/S0140-6736(13)60258-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	093JY	23439089				2022-12-28	WOS:000315189300006
J	Gaucher, C; Poire, DG; Bossi, J; Sanchez Bettucci, L; Beri, A				Gaucher, Claudio; Poire, Daniel G.; Bossi, Jorge; Sanchez Bettucci, Leda; Beri, Angeles			Comment on "Bilaterian Burrows and Grazing Behavior at > 585 Million Years Ago"	SCIENCE			English	Editorial Material							PARANA BASIN; S BRAZIL; URUGUAY	Pecoits et al. (Reports, 29 June 2012, p. 1693) describe bilaterian trace fossils and assign them an Ediacaran age based on the age of a granite interpreted as intrusive. We argue that the granite is not intrusive but in fact represents the basement of the sedimentary succession. Moreover, we show that identical trace fossils occur in nearby Carboniferous-Permian glacigenic rocks.	[Gaucher, Claudio; Sanchez Bettucci, Leda; Beri, Angeles] Univ Rep Igua 4225, Fac Ciencias, Dept Geol, Montevideo, Uruguay; [Poire, Daniel G.] Univ Nacl La Plata CONICET, Ctr Invest Geol, La Plata, Argentina; [Bossi, Jorge] Univ Rep, Fac Agron, Dept Suelos Aguas, Montevideo, Uruguay	Universidad de la Republica, Uruguay; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Universidad de la Republica, Uruguay	Gaucher, C (corresponding author), Univ Rep Igua 4225, Fac Ciencias, Dept Geol, Montevideo, Uruguay.	gaucher@chasque.net	BETTUCCI, Leda SANCHEZ/L-5247-2013	BETTUCCI, Leda SANCHEZ/0000-0001-6855-8447; Poire, Daniel G./0000-0003-0966-122X				BALISTIERI P, 2001, XI CONG LATIONOAM; Beri A, 2010, GEOL ACTA, V8, P419, DOI 10.1344/105.000001580; Beri A., 1996, REV ESP MICROPALEONT, V28, P67; Beri A, 2011, REV PALAEOBOT PALYNO, V167, P16, DOI 10.1016/j.revpalbo.2011.05.004; BOSSI J, 2010, VI CONG URUGUAYO; BOSSI J, 2001, CARTA GEOL URUGUAY; Braun A, 2003, NEUES JAHRB GEOL P-M, P739; Buatois LA, 2010, GEOL SOC AM SPEC PAP, V468, P149, DOI 10.1130/2010.2468(07); Lima JHD, 2012, REV BRAS PALEONTOLOG, V15, P5, DOI 10.4072/rbp.2012.1.01; Frei R, 2011, EARTH PLANET SC LETT, V312, P114, DOI 10.1016/j.epsl.2011.10.009; Gaucher C, 2004, GONDWANA RES, V7, P715, DOI 10.1016/S1342-937X(05)71058-3; Netto RG, 2009, PALAEOGEOGR PALAEOCL, V272, P240, DOI 10.1016/j.palaeo.2008.10.028; Oyhantcabal P, 2011, INT J EARTH SCI, V100, P379, DOI 10.1007/s00531-010-0577-3; Pecoits E, 2012, SCIENCE, V336, P1693, DOI 10.1126/science.1216295; PRECIOZZI F, 1985, CARTA GEOESTRUCT	15	22	23	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2013	339	6122					906	906		10.1126/science.1230339	http://dx.doi.org/10.1126/science.1230339			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23430638	Green Published			2022-12-28	WOS:000315149600055
J	Griffin, WST				Griffin, W. Sue T.			Neuroinflammatory Cytokine Signaling and Alzheimer's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Griffin, W. Sue T.] Univ Arkansas Med Sci, Donald W Reynolds Dept Geriatr, Little Rock, AR 72205 USA; [Griffin, W. Sue T.] Univ Arkansas Med Sci, Inst Aging, Little Rock, AR 72205 USA; [Griffin, W. Sue T.] Cent Arkansas Vet Healthcare Syst, GRECC, Little Rock, AR USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Griffin, WST (corresponding author), Univ Arkansas Med Sci, Donald W Reynolds Dept Geriatr, Little Rock, AR 72205 USA.							Griffin W Sue T, 2010, US Neurol, V6, P19; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Vlad SC, 2008, NEUROLOGY, V70, P1672, DOI 10.1212/01.wnl.0000311269.57716.63; vom Berg J, 2012, NAT MED, V18, P1812, DOI 10.1038/nm.2965	4	73	76	2	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2013	368	8					770	771		10.1056/NEJMcibr1214546	http://dx.doi.org/10.1056/NEJMcibr1214546			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092CG	23425171				2022-12-28	WOS:000315095800014
J	Tammemagi, MC; Katki, HA; Hocking, WG; Church, TR; Caporaso, N; Kvale, PA; Chaturvedi, AK; Silvestri, GA; Riley, TL; Commins, J; Berg, CD				Tammemaegi, Martin C.; Katki, Hormuzd A.; Hocking, William G.; Church, Timothy R.; Caporaso, Neil; Kvale, Paul A.; Chaturvedi, Anil K.; Silvestri, Gerard A.; Riley, Tom L.; Commins, John; Berg, Christine D.			Selection Criteria for Lung-Cancer Screening	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RISK PREDICTION MODEL; RANDOMIZED PROSTATE; INCREMENTAL VALUE; CHEST RADIOGRAPH; OVARIAN; VALIDATION; MORTALITY	BACKGROUND The National Lung Screening Trial (NLST) used risk factors for lung cancer (e. g., >= 30 pack-years of smoking and <15 years since quitting) as selection criteria for lung-cancer screening. Use of an accurate model that incorporates additional risk factors to select persons for screening may identify more persons who have lung cancer or in whom lung cancer will develop. METHODS We modified the 2011 lung-cancer risk-prediction model from our Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial to ensure applicability to NLST data; risk was the probability of a diagnosis of lung cancer during the 6-year study period. We developed and validated the model (PLCOM2012) with data from the 80,375 persons in the PLCO control and intervention groups who had ever smoked. Discrimination (area under the receiver-operating-characteristic curve [AUC]) and calibration were assessed. In the validation data set, 14,144 of 37,332 persons (37.9%) met NLST criteria. For comparison, 14,144 highest-risk persons were considered positive (eligible for screening) according to PLCOM2012 criteria. We compared the accuracy of PLCOM2012 criteria with NLST criteria to detect lung cancer. Cox models were used to evaluate whether the reduction in mortality among 53,202 persons undergoing low-dose computed tomographic screening in the NLST differed according to risk. RESULTS The AUC was 0.803 in the development data set and 0.797 in the validation data set. As compared with NLST criteria, PLCOM2012 criteria had improved sensitivity (83.0% vs. 71.1%, P<0.001) and positive predictive value (4.0% vs. 3.4%, P = 0.01), without loss of specificity (62.9% and. 62.7%, respectively; P = 0.54); 41.3% fewer lung cancers were missed. The NLST screening effect did not vary according to PLCOM2012 risk (P = 0.61 for interaction). CONCLUSIONS The use of the PLCOM2012 model was more sensitive than the NLST criteria for lung-cancer detection.	[Tammemaegi, Martin C.] Brock Univ, Dept Community Hlth Sci, St Catharines, ON L2S 3A1, Canada; [Katki, Hormuzd A.; Caporaso, Neil; Chaturvedi, Anil K.] NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA; [Berg, Christine D.] NCI, Early Detect Res Grp, Canc Prevent Div, NIH, Rockville, MD USA; [Riley, Tom L.; Commins, John] Informat Management Serv Inc, Rockville, MD USA; [Hocking, William G.] Marshfield Clin Res Fdn, Marshfield, WI USA; [Church, Timothy R.] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; [Kvale, Paul A.] Henry Ford Hlth Syst, Detroit, MI USA; [Silvestri, Gerard A.] Med Univ S Carolina, Charleston, SC USA	Brock University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.; University of Minnesota System; University of Minnesota Twin Cities; Henry Ford Health System; Henry Ford Hospital; Medical University of South Carolina	Tammemagi, MC (corresponding author), Brock Univ, Dept Community Hlth Sci, Walker Complex S,Rm 306,500 Glenridge Ave, St Catharines, ON L2S 3A1, Canada.	martin.tammemagi@brocku.ca	Church, Timothy/AAH-7017-2020; Chaturvedi, Anil/J-2024-2015; Berg, Christine/K-1047-2014; Katki, Hormuzd A/B-4003-2015; wang, edwin/G-5372-2010	Church, Timothy/0000-0003-3292-5035; Chaturvedi, Anil/0000-0003-2696-8899; Tammemagi, Martin/0000-0002-4989-5058; Hocking, William/0000-0002-0690-3759	National Cancer Institute (NCI); Division of Cancer Prevention; Intramural Research Program of the Division of Cancer Epidemiology and Genetics; Cancer Imaging Program, Division of Cancer Treatment and Diagnosis [U01-CA-80098, U01-CA-79778]; NATIONAL CANCER INSTITUTE [ZIACP010181] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Division of Cancer Prevention(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Cancer Imaging Program, Division of Cancer Treatment and Diagnosis; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial was supported by the National Cancer Institute (NCI), in part by contracts with the Division of Cancer Prevention and by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics. The American College of Radiology Imaging Network component of the National Lung Screening Trial (NLST) was supported by grants provided under a cooperative agreement with the Cancer Imaging Program, Division of Cancer Treatment and Diagnosis (U01-CA-80098 and U01-CA-79778). The Lung Screening Study sites of the NLST were supported by contracts with the Early Detection Research Group and Biometry Research Group, Division of Cancer Prevention (N01-CN-25514, to the University of Colorado-Denver; N01-CN-25522, to Georgetown University; N01-CN-25515, to the Pacific Health Research and Education Institute; N01-CN-25512, to the Henry Ford Health System; N01-CN-25513, to the University of Minnesota; N01-CN-25516, to Washington University in St. Louis; N01-CN-25511, to the University of Pittsburgh; N01-CN-25524, to the University of Utah; N01-CN-25518, to the Marshfield Clinic Research Foundation; N01-CN-75022, to the University of Alabama at Birmingham; N01-CN-25476, to Westat; and N02-CN-63300, to Information Management Services).	Aberle DR, 2011, J NATL CANCER I, V103, P1560, DOI 10.1093/jnci/djr347; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Bach PB, 2003, JNCI-J NATL CANCER I, V95, P470, DOI 10.1093/jnci/95.6.470; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Cassidy A, 2008, BRIT J CANCER, V98, P270, DOI 10.1038/sj.bjc.6604158; Cronin KA, 2006, JNCI-J NATL CANCER I, V98, P637, DOI 10.1093/jnci/djj163; Etzel CJ, 2008, CANCER PREV RES, V1, P255, DOI 10.1158/1940-6207.CAPR-08-0082; Fritz APC., 2013, INT CLASSIFICATION D; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Hocking WG, 2010, JNCI-J NATL CANCER I, V102, P722, DOI 10.1093/jnci/djq126; Jaklitsch MT, 2012, J THORAC CARDIOV SUR, V144, P33, DOI 10.1016/j.jtcvs.2012.05.060; Oken MM, 2011, JAMA-J AM MED ASSOC, V306, P1865, DOI 10.1001/jama.2011.1591; Oken MM, 2005, JNCI-J NATL CANCER I, V97, P1832, DOI 10.1093/jnci/dji430; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207; Percy C., 1990, INT CLASSIFICATION D; Pinsky PF, 2007, AM J EPIDEMIOL, V165, P874, DOI 10.1093/aje/kwk075; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Royston P., 2008, MULTIVARIABLE MODEL; Spitz MR, 2007, JNCI-J NATL CANCER I, V99, P715, DOI 10.1093/jnci/djk153; Spitz MR, 2008, CANCER PREV RES, V1, P250, DOI 10.1158/1940-6207.CAPR-08-0060; Tammemagi CM, 2011, JNCI-J NATL CANCER I, V103, P1058, DOI 10.1093/jnci/djr173; Tammemagi MC, 2011, CANCER PREV RES, V4, P552, DOI 10.1158/1940-6207.CAPR-10-0183; Tammemagi MC, 2009, J THORAC ONCOL, V4, P710, DOI 10.1097/JTO.0b013e31819e77ce; Wood DE, 2012, J NATL COMPR CANC NE, V10, P240, DOI 10.6004/jnccn.2012.0022	28	545	563	2	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2013	368	8					728	736		10.1056/NEJMoa1211776	http://dx.doi.org/10.1056/NEJMoa1211776			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092CG	23425165	Bronze, Green Accepted			2022-12-28	WOS:000315095800007
J	Heath, I				Heath, Iona			LIFE AND DEATH Not safe in their hands	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												iona.heath22@yahoo.co.uk							0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 20	2013	346								f1004	10.1136/bmj.f1004	http://dx.doi.org/10.1136/bmj.f1004			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096HL	23427123				2022-12-28	WOS:000315394700008
J	Lane, R				Lane, Richard			Robert Beaglehole and Ruth Bonita: NCD champions	LANCET			English	Biographical-Item																		BEAGLEHOLE R, PUBLICATION LIST	1	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 16	2013	381	9866					527	527		10.1016/S0140-6736(13)60136-1	http://dx.doi.org/10.1016/S0140-6736(13)60136-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089RK	23410605				2022-12-28	WOS:000314927500013
J	Grossman, SR; Andersen, KG; Shlyakhter, I; Tabrizi, S; Winnicki, S; Yen, A; Park, DJ; Griesemer, D; Karlsson, EK; Wong, SH; Cabili, M; Adegbola, RA; Bamezai, RNK; Hill, AVS; Vannberg, FO; Rinn, JL; Lander, ES; Schaffner, SF; Sabeti, PC				Grossman, Sharon R.; Andersen, Kristian G.; Shlyakhter, Ilya; Tabrizi, Shervin; Winnicki, Sarah; Yen, Angela; Park, Daniel J.; Griesemer, Dustin; Karlsson, Elinor K.; Wong, Sunny H.; Cabili, Moran; Adegbola, Richard A.; Bamezai, Rameshwar N. K.; Hill, Adrian V. S.; Vannberg, Fredrik O.; Rinn, John L.; Lander, Eric S.; Schaffner, Stephen F.; Sabeti, Pardis C.		1000 Genomes Project	Identifying Recent Adaptations in Large-Scale Genomic Data	CELL			English	Article							RECENT POSITIVE SELECTION; HUMAN GENE-EXPRESSION; LARGE NONCODING RNAS; CHRONIC HEPATITIS-B; WIDE ASSOCIATION; POSTTRANSLATIONAL MODIFICATION; POPULATION GENOMICS; NATURAL-SELECTION; SUSCEPTIBILITY; VARIANTS	Although several hundred regions of the human genome harbor signals of positive natural selection, few of the relevant adaptive traits and variants have been elucidated. Using full-genome sequence variation from the 1000 Genomes (1000G) Project and the composite of multiple signals (CMS) test, we investigated 412 candidate signals and leveraged functional annotation, protein structure modeling, epigenetics, and association studies to identify and extensively annotate candidate causal variants. The resulting catalog provides a tractable list for experimental follow-up; it includes 35 high-scoring nonsynonymous variants, 59 variants associated with expression levels of a nearby coding gene or lincRNA, and numerous variants associated with susceptibility to infectious disease and other phenotypes. We experimentally characterized one candidate nonsynonymous variant in Toll-like receptor 5 (TLR5) and show that it leads to altered NF-kappa B signaling in response to bacterial flagellin.	[Grossman, Sharon R.; Andersen, Kristian G.; Shlyakhter, Ilya; Tabrizi, Shervin; Winnicki, Sarah; Yen, Angela; Park, Daniel J.; Karlsson, Elinor K.; Cabili, Moran; Rinn, John L.; Lander, Eric S.; Schaffner, Stephen F.; Sabeti, Pardis C.] Broad Inst & Harvard, Cambridge, MA 02142 USA; [Grossman, Sharon R.; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Yen, Angela] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Grossman, Sharon R.; Griesemer, Dustin] Harvard Univ, Sch Med, Div Hlth Sci & Technol, Boston, MA 02115 USA; [Cabili, Moran; Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Andersen, Kristian G.; Shlyakhter, Ilya; Tabrizi, Shervin; Winnicki, Sarah; Park, Daniel J.; Griesemer, Dustin; Karlsson, Elinor K.; Sabeti, Pardis C.] Harvard Univ, Dept Organism & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02138 USA; [Wong, Sunny H.; Hill, Adrian V. S.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Adegbola, Richard A.] MRC Labs, Fajara, Gambia; [Bamezai, Rameshwar N. K.] Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India; [Vannberg, Fredrik O.] Georgia Inst Technol, Ctr Integrat Genom, Sch Biol, Atlanta, GA 30332 USA; [Rinn, John L.] Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Sabeti, Pardis C.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Cambridge, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; University of Oxford; Wellcome Centre for Human Genetics; MRC Laboratory Molecular Biology; Jawaharlal Nehru University, New Delhi; University System of Georgia; Georgia Institute of Technology; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard T.H. Chan School of Public Health	Grossman, SR (corresponding author), Broad Inst & Harvard, Cambridge, MA 02142 USA.	grossman@broadinstitute.org; psabeti@oeb.harvard.edu	Wong, Sunny H/N-3754-2015; Andersen, Kristian/D-5006-2009; Sabeti, Pardis/GQH-8610-2022; Schaffner, Stephen F/D-1189-2011	Wong, Sunny H/0000-0002-3354-9310; Andersen, Kristian/0000-0001-6431-5982; Rinn, John/0000-0002-7231-7539; Tabrizi, Shervin/0000-0003-2780-8432; Grossman, Sharon/0000-0001-6422-1134; Karlsson, Elinor/0000-0002-4343-3776; Schaffner, Stephen/0000-0001-6699-3568	Burroughs Wellcome Fund Career Award; Packard Foundation Fellowship in Science and Engineering; Broad Institute SPARC award; NIH Innovator Award [1DP2OD006514-01, BAA-NIAID-DAIT-NIHAI2009061]; NIGMS [T32GM007753]; Carlsberg Foundation fellowship; NSF; American Cancer Society Fellowship; Wellcome Trust; UK Medical Research Council; UK National Institute for Health Research; European Commission; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006514] Funding Source: NIH RePORTER	Burroughs Wellcome Fund Career Award(Burroughs Wellcome Fund); Packard Foundation Fellowship in Science and Engineering; Broad Institute SPARC award; NIH Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Carlsberg Foundation fellowship; NSF(National Science Foundation (NSF)); American Cancer Society Fellowship(American Cancer Society); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute for Health Research(National Institute for Health Research (NIHR)); European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	P.C.S. and her lab are supported by a Burroughs Wellcome Fund Career Award, a Packard Foundation Fellowship in Science and Engineering, a Broad Institute SPARC award, an NIH Innovator Award 1DP2OD006514-01, and BAA-NIAID-DAIT-NIHAI2009061. S.R.G. is supported by NIGMS T32GM007753, K.G.A. by a Carlsberg Foundation fellowship, D.J.P. by NSF, and E.K.K. by an American Cancer Society Fellowship. The mycobacterial disease studies analyzed were supported by funding from the Wellcome Trust, the UK Medical Research Council, the UK National Institute for Health Research, and the European Commission; we thank the many collaborators who contributed to generating these data sets. We would like to thank S. Hart for help with figures, C. Edwards for reviews of the text, and L. Ward and C. O'Dushlaine for technical guidance.	Abu-Maziad A, 2010, PEDIATR RES, V68, P323, DOI 10.1203/00006450-201011001-00632; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Currat M, 2002, AM J HUM GENET, V70, P207, DOI 10.1086/338304; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; Edelmann MJ, 2010, FEBS J, V277, P2515, DOI 10.1111/j.1742-4658.2010.07665.x; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Gusev A, 2012, MOL BIOL EVOL, V29, P473, DOI 10.1093/molbev/msr133; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kamberov YG, 2013, CELL, V152, P691, DOI 10.1016/j.cell.2013.01.016; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Koedel U, 2000, J INFECT DIS, V182, P1437, DOI 10.1086/315877; Kunz S, 2005, J VIROL, V79, P14282, DOI 10.1128/JVI.79.22.14282-14296.2005; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Liu W, 2004, INT J TUBERC LUNG D, V8, P428; Loizou L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018670; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ohashi J, 2004, AM J HUM GENET, V74, P1198, DOI 10.1086/421330; Okugawa S, 2006, CELL MICROBIOL, V8, P1571, DOI 10.1111/j.1462-5822.2006.00731.x; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Png E, 2011, HUM MOL GENET, V20, P3893, DOI 10.1093/hmg/ddr302; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Vernot B, 2012, GENOME RES, V22, P1689, DOI 10.1101/gr.134890.111; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WANG YX, 1995, HUM MOL GENET, V4, P657, DOI 10.1093/hmg/4.4.657; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Wong SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000979; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753	54	237	241	1	171	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 14	2013	152	4					703	713		10.1016/j.cell.2013.01.035	http://dx.doi.org/10.1016/j.cell.2013.01.035			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415221	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000314945600007
J	Oh, YS; Gao, P; Lee, KW; Ceglia, I; Seo, JS; Zhang, X; Ahn, JH; Chait, BT; Patel, DJ; Kim, Y; Greengard, P				Oh, Yong-Seok; Gao, Pu; Lee, Ko-Woon; Ceglia, Ilaria; Seo, Ji-Seon; Zhang, Xiaozhu; Ahn, Jung-Hyuck; Chait, Brian T.; Patel, Dinshaw J.; Kim, Yong; Greengard, Paul			SMARCA3, a Chromatin-Remodeling Factor, Is Required for p11-Dependent Antidepressant Action	CELL			English	Article							HILAR MOSSY CELLS; HIPPOCAMPAL NEUROGENESIS; TRANSCRIPTION FACTOR; DENTATE GYRUS; ANIMAL-MODEL; P11; EXPRESSION; DEPRESSION; NEURONS; COMPLEX	p11, through unknown mechanisms, is required for behavioral and cellular responses to selective serotonin reuptake inhibitors (SSRIs). We show that SMARCA3, a chromatin-remodeling factor, is a target for the p11/annexin A2 heterotetrameric complex. Determination of the crystal structure indicates that SMARCA3 peptide binds to a hydrophobic pocket in the heterotetramer. Formation of this complex increases the DNA-binding affinity of SMARCA3 and its localization to the nuclear matrix fraction. In the dentate gyrus, both p11 and SMARCA3 are highly enriched in hilar mossy cells and basket cells. The SSRI fluoxetine induces expression of p11 in both cell types and increases the amount of the ternary complex of p11/annexin A2/SMARCA3. SSRI-induced neurogenesis and behavioral responses are abolished by constitutive knockout of SMARCA3. Our studies indicate a central role for a chromatin-remodeling factor in the SSRI/p11 signaling pathway and suggest an approach to the development of improved antidepressant therapies.	[Oh, Yong-Seok; Lee, Ko-Woon; Ceglia, Ilaria; Seo, Ji-Seon; Zhang, Xiaozhu; Kim, Yong; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA; [Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA; [Gao, Pu; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Ahn, Jung-Hyuck] Ewha Womans Univ, Sch Med, Dept Biochem, Seoul 158710, South Korea	Rockefeller University; Rockefeller University; Memorial Sloan Kettering Cancer Center; Ewha Womans University	Kim, Y (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA.	kimyo@rockefeller.edu; greengard@rockefeller.edu	Seo, Ji-Seon/AAM-5949-2020	Oh, Yong-Seok/0000-0002-9039-2014; Kim, Yong/0000-0002-1387-2962; Ceglia, Ilaria/0000-0003-0692-9518	DOD/USAMRAA Grant [W81XWH-09-1-0392, W81XWH-09-1-0402]; JPB Foundation; Fisher Center Foundation; NIH [MH090963, DA10044, AG09464]; Maloris Foundation; Abby Rockefeller Mauze Trust; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH090963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	DOD/USAMRAA Grant; JPB Foundation; Fisher Center Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maloris Foundation; Abby Rockefeller Mauze Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by DOD/USAMRAA Grant W81XWH-09-1-0392 to Y.K.; DOD/USAMRAA Grant W81XWH-09-1-0402 to P. Greengard; the JPB Foundation to P. Greengard; the Fisher Center Foundation to P. Greengard; NIH grants (MH090963, DA10044, and AG09464) to Y.K. and P. Greengard; and the Maloris Foundation and the Abby Rockefeller Mauze Trust to D.J.P. We thank the staff at beamline 24ID-C of the Advanced Photon Source at the Argonne National Laboratory and beamline X29 of the National Synchrotron Light Source at the Brookhaven National Laboratory for assistance with data collection. We thank Daesoo Kim, Eric Schmidt, Jennifer Wagner-Schmidt, and Yotam Sagi for their helpful advice and discussion, and Elisabeth Griggs for technical assistance. We would like to thank Ji-Eun Kim for the mass spectrometry analysis. Finally, we would like to acknowledge Rada Norinsky and the Rockefeller University Transgenics Services Laboratory for their excellent IVF services; and Henry Zebroski III and Nagarajan Chandramouli from The Rockefeller University Proteomics Resource Center.	Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Barlow CA, 2010, TRENDS CELL BIOL, V20, P25, DOI 10.1016/j.tcb.2009.09.009; Benaud C, 2004, J CELL BIOL, V164, P133, DOI 10.1083/jcb.200307098; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Bessa JM, 2009, MOL PSYCHIATR, V14, P764, DOI 10.1038/mp.2008.119; Bjarkam CR, 2003, HIPPOCAMPUS, V13, P21, DOI 10.1002/hipo.10042; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Das S, 2010, BIOCHEMISTRY-US, V49, P2216, DOI 10.1021/bi9013038; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Debauve G, 2008, CELL MOL LIFE SCI, V65, P591, DOI 10.1007/s00018-007-7392-4; Ding H, 1996, DNA CELL BIOL, V15, P429, DOI 10.1089/dna.1996.15.429; Egeland M, 2010, BIOL PSYCHIAT, V67, P1048, DOI 10.1016/j.biopsych.2010.01.024; GAGE FH, 1980, BRAIN RES BULL, V5, P771, DOI 10.1016/0361-9230(80)90220-8; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Girard C, 2002, EMBO J, V21, P4439, DOI 10.1093/emboj/cdf469; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Hanson ND, 2011, NEUROPSYCHOPHARMACOL, V36, P2589, DOI 10.1038/npp.2011.220; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; Henze DA, 2007, PROG BRAIN RES, V163, P199, DOI 10.1016/S0079-6123(07)63012-X; Houser CR, 2007, PROG BRAIN RES, V163, P217, DOI 10.1016/S0079-6123(07)63013-1; Jost M, 1996, BBA-MOL CELL RES, V1313, P283, DOI 10.1016/0167-4889(96)00101-2; KATZ RJ, 1982, PHARMACOL BIOCHEM BE, V16, P965, DOI 10.1016/0091-3057(82)90053-3; KUBE E, 1992, J BIOL CHEM, V267, P14175; Liu J, 2007, MOL CELL BIOCHEM, V303, P211, DOI 10.1007/s11010-007-9477-7; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Rando OJ, 2002, P NATL ACAD SCI USA, V99, P2824, DOI 10.1073/pnas.032662899; Rescher U, 2008, PFLUG ARCH EUR J PHY, V455, P575, DOI 10.1007/s00424-007-0313-4; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Rezvanpour A, 2009, PROTEIN SCI, V18, P2528, DOI 10.1002/pro.267; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SCHARFMAN HE, 1995, J NEUROPHYSIOL, V74, P179, DOI 10.1152/jn.1995.74.1.179; Schmidt EF, 2012, CELL, V149, P1152, DOI 10.1016/j.cell.2012.03.038; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Surget A, 2011, MOL PSYCHIATR, V16, P1177, DOI 10.1038/mp.2011.48; Svenningsson P, 2006, SCIENCE, V311, P77, DOI 10.1126/science.1117571; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; Warner-Schmidt JL, 2010, BIOL PSYCHIAT, V68, P528, DOI 10.1016/j.biopsych.2010.04.029; Zaidi SK, 2007, NAT REV CANCER, V7, P454, DOI 10.1038/nrc2149; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	44	65	67	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 14	2013	152	4					831	843		10.1016/j.cell.2013.01.014	http://dx.doi.org/10.1016/j.cell.2013.01.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415230	Green Accepted, Bronze			2022-12-28	WOS:000314945600017
J	Serretti, A; Fabbri, C				Serretti, Alessandro; Fabbri, Chiara			Shared genetics among major psychiatric disorders	LANCET			English	Editorial Material							ASSOCIATION; CHANNELS; TRAITS		[Serretti, Alessandro; Fabbri, Chiara] Univ Bologna, Dept Biomed & NeuroMotor Sci, I-40123 Bologna, Italy	University of Bologna	Serretti, A (corresponding author), Univ Bologna, Dept Biomed & NeuroMotor Sci, I-40123 Bologna, Italy.	alessandro.serretti@unibo.it	Fabbri, Chiara/AAB-7807-2019; Serretti, Alessandro/G-3955-2017	Fabbri, Chiara/0000-0003-0276-7865; Serretti, Alessandro/0000-0003-4363-3759				Bagot RC, 2010, J AM ACAD CHILD PSY, V49, P752, DOI 10.1016/j.jaac.2010.06.001; Casamassima F, 2010, AM J MED GENET B, V153B, P1373, DOI 10.1002/ajmg.b.31122; Cross-Disorder Group of the Psychiatrics Genomics Consortium, 2013, LANCET; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Holmans P, 2010, ADV GENET, V72, P141, DOI [10.1016/S0065-2660(10)72007-1, 10.1016/B978-0-12-380862-2.00007-2]; NAT'L HUMAN GENOME RES. INST, CAT PUBL GEN WID ASS; Rowe SJ, 2012, CURR GENOMICS, V13, P213, DOI 10.2174/138920212800543101; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Weng LJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-99	9	35	35	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2013	381	9875					1339	1341		10.1016/S0140-6736(13)60223-8	http://dx.doi.org/10.1016/S0140-6736(13)60223-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130EF	23453886				2022-12-28	WOS:000317894800008
J	Smoller, JW; Craddock, N; Kendler, K; Lee, PH; Neale, BM; Nurnberger, JI; Ripke, S; Santangelo, S; Sullivan, PF; Purcell, S; Anney, R; Buitelaar, J; Fanous, A; Faraone, SV; Hoogendijk, W; Lesch, KP; Levinson, DF; Perlis, RH; Rietschel, M; Riley, B; Sonuga-Barke, E; Schachar, R; Schulze, TG; Thapar, A; Neale, M; Bender, P; Cichon, S; Daly, MJ; Kelsoe, J; Lehner, T; O'Donovan, M; Gejman, P; Sebat, J; Sklar, P; Devlin, B				Smoller, Jordan W.; Craddock, Nicholas; Kendler, Kenneth; Lee, Phil Hyoun; Neale, Benjamin M.; Nurnberger, John I.; Ripke, Stephan; Santangelo, Susan; Sullivan, Patrick F.; Purcell, Shaun; Anney, Richard; Buitelaar, Jan; Fanous, Ayman; Faraone, Stephen V.; Hoogendijk, Witte; Lesch, Klaus-Peter; Levinson, Douglas F.; Perlis, Roy H.; Rietschel, Marcella; Riley, Brien; Sonuga-Barke, Edmund; Schachar, Russell; Schulze, Thomas G.; Thapar, Anita; Neale, Michael; Bender, Patrick; Cichon, Sven; Daly, Mark J.; Kelsoe, John; Lehner, Thomas; O'Donovan, Mick; Gejman, Pablo; Sebat, Jonathan; Sklar, Pamela; Devlin, Bernie		Psychiatric Genomics Consortium	Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis	LANCET			English	Article							AUTISM SPECTRUM DISORDERS; BIPOLAR DISORDER; GENETIC-CONTROL; SCHIZOPHRENIA; ASSOCIATION; METAANALYSIS; CACNA1C; EXPRESSION; TWIN	Background Findings from family and twin studies suggest that genetic contributions to psychiatric disorders do not in all cases map to present diagnostic categories. We aimed to identify specific variants underlying genetic effects shared between the five disorders in the Psychiatric Genomics Consortium: autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia. Methods We analysed genome-wide single-nucleotide polymorphism (SNP) data for the five disorders in 33 332 cases and 27 888 controls of European ancestory. To characterise allelic effects on each disorder, we applied a multinomial logistic regression procedure with model selection to identify the best-fitting model of relations between genotype and phenotype. We examined cross-disorder effects of genome-wide significant loci previously identified for bipolar disorder and schizophrenia, and used polygenic risk-score analysis to examine such effects from a broader set of common variants. We undertook pathway analyses to establish the biological associations underlying genetic overlap for the five disorders. We used enrichment analysis of expression quantitative trait loci (eQTL) data to assess whether SNPs with cross-disorder association were enriched for regulatory SNPs in post-mortem brain-tissue samples. Findings SNPs at four loci surpassed the cutoff for genome-wide significance (p<5x10(-8)) in the primary analysis: regions on chromosomes 3p21 and 10q24, and SNPs within two L-type voltage-gated calcium channel subunits, CACNA1C and CACNB2. Model selection analysis supported effects of these loci for several disorders. Loci previously associated with bipolar disorder or schizophrenia had variable diagnostic specificity. Polygenic risk scores showed cross-disorder associations, notably between adult-onset disorders. Pathway analysis supported a role for calcium channel signalling genes for all five disorders. Finally, SNPs with evidence of cross-disorder association were enriched for brain eQTL markers. Interpretation Our findings show that specific SNPs are associated with a range of psychiatric disorders of childhood onset or adult onset. In particular, variation in calcium-channel activity genes seems to have pleiotropic effects on psychopathology. These results provide evidence relevant to the goal of moving beyond descriptive syndromes in psychiatry, and towards a nosology informed by disease cause.	[Smoller, Jordan W.] Massachusetts Gen Hosp, Simches Res Bldg, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Smoller, JW (corresponding author), Massachusetts Gen Hosp, Simches Res Bldg, Boston, MA 02114 USA.	jsmoller@hms.harvard.edu	McQuillin, Andrew/C-1623-2008; Pickard, Benjamin S/K-3923-2014; Jamain, Stéphane/L-1822-2019; Fanous, Ayman H/O-1263-2017; Meier, Sandra/AAB-1242-2021; Etain, Bruno/L-6647-2017; McMahon, Francis J/A-7290-2009; Kuntsi, Jonna/G-9750-2011; Lohoff, Falk W/M-7951-2016; Ripke, Stephan/AAK-5486-2021; Hickie, Ian B/K-8975-2015; Mattheisen, Manuel/B-4949-2012; Zhang, Peng/N-2920-2014; Thapar, Anita/AAH-5555-2020; Visscher, Peter/ABB-6151-2020; Konte, Bettina/AAT-1142-2021; Sonuga-Barke, Edmund j/D-9137-2011; Nolen, Willem A/E-9006-2014; Mattheisen, Manuel/S-3725-2019; Middeldorp, Christel M/L-7728-2017; Degenhardt, Franziska/H-4169-2017; Andreassen, Ole A./AAY-7531-2020; Hansen, Thomas Folkmann/O-5965-2014; Franke, Barbara/D-4836-2009; van Os, Jim/C-2113-2014; Ruderfer, Douglas M/M-5795-2016; Melle, Ingrid S/B-4858-2011; Greenwood, Tiffany/F-6356-2012; Lesch, Klaus-Peter/J-4906-2013; Holmans, Peter/F-4518-2015; Faraone, Stephen/AAE-7334-2019; Bergen, Sarah/I-8313-2012; Medland, Sarah E/C-7630-2013; BELLIVIER, FRANK/H-5197-2012; de Geus, Eco J.C./M-9318-2015; Kähler, Anna K/J-2874-2012; Schalling, Martin/F-1518-2015; Mattingsdal, Morten/Q-9367-2016; Kendler, Kenneth/AAF-2876-2019; Jamain, Stéphane/P-3710-2017; Wray, Naomi/C-8639-2015; van Grootheest, Gerard/C-6942-2014; Hartmann, Annette/AAS-6331-2021; Neale, Michael/AAD-5056-2020; O'Donovan, Michael C/P-7005-2018; Breen, Gerome D/A-5540-2010; Mahon, Pamela Belmonte/O-9806-2018; Daly, Mark J/B-2453-2017; Sigurdsson, Engilbert/D-2486-2014; Nyholt, Dale/J-3174-2017	McQuillin, Andrew/0000-0003-1567-2240; Pickard, Benjamin S/0000-0002-2374-6329; Etain, Bruno/0000-0002-5377-1488; McMahon, Francis J/0000-0002-9469-305X; Kuntsi, Jonna/0000-0002-0113-8162; Hickie, Ian B/0000-0001-8832-9895; Mattheisen, Manuel/0000-0002-8442-493X; Zhang, Peng/0000-0003-1182-1392; Thapar, Anita/0000-0002-3689-737X; Visscher, Peter/0000-0002-2143-8760; Konte, Bettina/0000-0001-5287-308X; Mattheisen, Manuel/0000-0002-8442-493X; Middeldorp, Christel M/0000-0002-6218-0428; Hansen, Thomas Folkmann/0000-0001-6703-7762; Franke, Barbara/0000-0003-4375-6572; Ruderfer, Douglas M/0000-0002-2365-386X; Melle, Ingrid S/0000-0002-9783-548X; Greenwood, Tiffany/0000-0002-6080-6503; Lesch, Klaus-Peter/0000-0001-8348-153X; Holmans, Peter/0000-0003-0870-9412; Faraone, Stephen/0000-0002-9217-3982; Bergen, Sarah/0000-0002-5888-0034; Medland, Sarah E/0000-0003-1382-380X; de Geus, Eco J.C./0000-0001-6022-2666; Schalling, Martin/0000-0001-5011-2922; Mattingsdal, Morten/0000-0003-4440-0324; Jamain, Stéphane/0000-0002-4321-4100; Wray, Naomi/0000-0001-7421-3357; van Grootheest, Gerard/0000-0003-4350-6661; O'Donovan, Michael C/0000-0001-7073-2379; Breen, Gerome D/0000-0003-2053-1792; Mahon, Pamela Belmonte/0000-0002-3947-441X; Daly, Mark J/0000-0002-0949-8752; Sigurdsson, Engilbert/0000-0001-9404-7982; Morken, Gunnar/0000-0003-1972-5901; Craig, Ian/0000-0002-4063-1005; Tozzi, Federica/0000-0002-3536-2920; Stefansson, Hreinn/0000-0002-9331-6666; Zammit, Stanley/0000-0002-2647-9211; MacIntyre, Donald J/0000-0001-6963-1335; lichtenstein, paul/0000-0003-3037-5287; Agartz, Ingrid/0000-0002-9839-5391; Posthuma, Danielle/0000-0001-7582-2365; Backlund, Lena/0000-0001-9399-5024; Nyholt, Dale/0000-0001-7159-3040; KELLER, MATTHEW/0000-0002-6075-9882; BELLIVIER, FRANK/0000-0002-3660-6640; Hamilton, Steven/0000-0001-8106-6260; Willemsen, Gonneke/0000-0003-3755-0236; Andreassen, Ole A./0000-0002-4461-3568; Nothen, Markus/0000-0002-8770-2464; Anney, Richard/0000-0002-6083-407X	NIMH [U01 MH085520]; National Institutes of Health (USA); National Institute of Mental Health; MRC [G0701420, G1000708, G1000718] Funding Source: UKRI; Medical Research Council [G1000718, G0701420, G0801418B, G9817803B] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH106595, K99MH101367, R01MH077139, R01MH094400, U01MH094421, ZIAMH002843, K24MH094614, R01MH100027, R01MH083094, U01MH085520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K05AA017688] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	National Institute of Mental Health.r We thank the study participants, and the research staff at the many study sites. This work was supported by NIMH grant U01 MH085520. Numerous grants from the National Institutes of Health (USA), and similar numbers of government grants from other countries, and substantial private and foundation support enabled this work.	Athanasiu L, 2010, J PSYCHIATR RES, V44, P748, DOI 10.1016/j.jpsychires.2010.02.002; Bigos KL, 2010, ARCH GEN PSYCHIAT, V67, P939, DOI 10.1001/archgenpsychiatry.2010.96; Breen G, 2011, NAT GENET, V43, P3, DOI 10.1038/ng0111-3; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; BURNHAM K.P., 2002, MODEL SELECTION MULT, V2nd, DOI DOI 10.1007/B97636; Cichon S, 2011, AM J HUM GENET, V88, P396, DOI [10.1016/j.ajhg.2011.01.017, 10.1016/j.ajhg.2011.03.001]; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Erk S, 2010, ARCH GEN PSYCHIAT, V67, P803, DOI 10.1001/archgenpsychiatry.2010.94; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Green EK, 2010, MOL PSYCHIATR, V15, P1016, DOI 10.1038/mp.2009.49; Huang J, 2010, AM J PSYCHIAT, V167, P1254, DOI 10.1176/appi.ajp.2010.09091335; Kendler KS, 2005, PSYCHIAT GENETICS RE; King BH, 2011, BRAIN RES, V1380, P34, DOI 10.1016/j.brainres.2010.11.031; Lee MTM, 2011, MOL PSYCHIATR, V16, P548, DOI 10.1038/mp.2010.43; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Liao P, 2010, PFLUG ARCH EUR J PHY, V460, P353, DOI 10.1007/s00424-009-0753-0; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; Liu Y, 2011, MOL PSYCHIATR, V16, P2, DOI 10.1038/mp.2009.107; MAIER W, 1993, ARCH GEN PSYCHIAT, V50, P871; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; McMahon FJ, 2010, NAT GENET, V42, P128, DOI 10.1038/ng.523; Muhleisen TW, 2012, SCHIZOPHR RES, V138, P69, DOI 10.1016/j.schres.2012.03.007; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Neale BM, 2010, J AM ACAD CHILD PSY, V49, P884, DOI 10.1016/j.jaac.2010.06.008; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Nyegaard M, 2010, MOL PSYCHIATR, V15, P119, DOI 10.1038/mp.2009.69; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Quen Jacques M., 1990, PSYCHIAT TXB STUDENT; Rapoport J, 2009, J AM ACAD CHILD PSY, V48, P10, DOI 10.1097/CHI.0b013e31818b1c63; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rommelse NNJ, 2010, EUR CHILD ADOLES PSY, V19, P281, DOI 10.1007/s00787-010-0092-x; Ronald A, 2008, J CHILD PSYCHOL PSYC, V49, P535, DOI 10.1111/j.1469-7610.2007.01857.x; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Scott LJ, 2009, P NATL ACAD SCI USA, V106, P7501, DOI 10.1073/pnas.0813386106; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smoller JW, 2003, AM J MED GENET C, V123C, P48, DOI 10.1002/ajmg.c.20013; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Thimm M, 2011, PSYCHOL MED, V41, P1551, DOI 10.1017/S0033291710002217; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Willemsen MH, 2011, J MED GENET, V48, P810, DOI 10.1136/jmedgenet-2011-100294; Williams NM, 2012, AM J PSYCHIAT, V169, P195, DOI 10.1176/appi.ajp.2011.11060822; Wray NR, 2012, EUR J HUM GENET, V20, P668, DOI 10.1038/ejhg.2011.257; Zeng Z, 2011, MOL PSYCHIATR, V16, P473, DOI 10.1038/mp.2010.86; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004	50	1945	1965	14	523	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2013	381	9875					1371	1379		10.1016/S0140-6736(12)62129-1	http://dx.doi.org/10.1016/S0140-6736(12)62129-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130EF	23453885	Green Submitted, Green Accepted			2022-12-28	WOS:000317894800034
J	Fox, KAA				Fox, Keith A. A.			Dual or single antiplatelet therapy with anticoagulation?	LANCET			English	Editorial Material							EUROPEAN-SOCIETY		Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh EH16 4SB, Midlothian, Scotland	University of Edinburgh	Fox, KAA (corresponding author), Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh EH16 4SB, Midlothian, Scotland.	k.a.a.fox@ed.ac.uk	Fox, keith A A/I-3742-2013	Fox, Keith/0000-0002-0140-2752				Dewilde WJM, 2013, LANCET; Doyle BJ, 2009, J AM COLL CARDIOL, V53, P2019, DOI 10.1016/j.jacc.2008.12.073; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Steg PG, 2011, EUR HEART J, V32, P1854, DOI 10.1093/eurheartj/ehr204; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; WIJNS W, 2010, EUR HEART J, V31, P2501, DOI DOI 10.1093/EURHEARTJ/EHQ277	7	13	15	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 30	2013	381	9872					1080	1081		10.1016/S0140-6736(13)60054-9	http://dx.doi.org/10.1016/S0140-6736(13)60054-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122WL	23415014				2022-12-28	WOS:000317348900008
J	Roberts, LF; VanRooyen, MJ				Roberts, Les F.; VanRooyen, Michael J.			Ensuring Public Health Neutrality Perspective	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Roberts, Les F.] Columbia Univ, Mailman Sch Publ Hlth, Heilbrunn Dept Populat & Family Hlth, Program Forced Migrat & Hlth, New York, NY 10027 USA; [VanRooyen, Michael J.] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA	Columbia University; Harvard University; Brigham & Women's Hospital	Roberts, LF (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Heilbrunn Dept Populat & Family Hlth, Program Forced Migrat & Hlth, New York, NY 10027 USA.							[Anonymous], 2012, MINUTES SOURCE ABBOT; [Anonymous], 1969, NY TIMES; [Anonymous], 2012, RE CHIN ACH HAT CAMP; Galeota WR, 1968, CONVERSATION LI BAR	4	4	4	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2013	368	12					1073	1075		10.1056/NEJMp1300197	http://dx.doi.org/10.1056/NEJMp1300197			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108TH	23444981				2022-12-28	WOS:000316318600012
J	Greenbaum, A; Hsu, YMS; Day, RB; Schuettpelz, LG; Christopher, MJ; Borgerding, JN; Nagasawa, T; Link, DC				Greenbaum, Adam; Hsu, Yen-Michael S.; Day, Ryan B.; Schuettpelz, Laura G.; Christopher, Matthew J.; Borgerding, Joshua N.; Nagasawa, Takashi; Link, Daniel C.			CXCL12 in early mesenchymal progenitors is. required for haematopoietic stem-cell maintenance	NATURE			English	Article							BONE-MARROW; MICE; REGENERATION; ENGRAFTMENT; QUIESCENCE; EXPRESSION; REVEALS; CXCR4; FETAL	Haematopoietic stem cells (HSCs) primarily reside in the bone marrow where signals generated by stromal cells regulate their self-renewal, proliferation and trafficking. Endosteal osteoblasts(1,2) and perivascular stromal cells including endothelial cells(3), CXCL12-abundant reticular cells(4,5), leptin-receptor-positive stromal cells(6), and nestin-green fluorescent protein (GFP) -positive mesenchymal progenitors(7) have all been implicated in HSC maintenance. However, it is unclear whether specific haematopoietic progenitor cell (HPC) subsets reside in distinct niches defined by the surrounding stromal cells and the regulatory molecules they produce. CXCL12 (chemokine (C-X-C motif) ligand 12) regulates both HSCs and lymphoid progenitors and is expressed by all of these stromal cell populations(7-11). Here we selectively deleted Cxcl12 from candidate niche stromal cell populations and characterized the effect on HPCs. Deletion of Cxcl12 from mineralizing osteoblasts has no effect on HSCs or lymphoid progenitors. Deletion of Cxcl12 from osterix-expressing stromal cells, which include CXCL12-abundant reticular cells and osteoblasts, results in constitutive HPC mobilization and a loss of B-lymphoid progenitors, but HSC function is normal. Cxcl12 deletion from endothelial cells results in a modest loss of long-term repopulating activity. Strikingly, deletion of Cxcl12 from nestin-negative mesenchymal progenitors using Prx1-cre (Pod also known as Prrx1) is associated with a marked loss of HSCs, long-term repopulating activity, HSC quiescence and common lymphoid progenitors. These data suggest that osterix-expressing stromal cells comprise a distinct niche that supports B-lymphoid progenitors and retains HPCs in the bone marrow, and that expression of CXCL12 from stromal cells in the perivascular region, including endothelial cells and mesenchymal progenitors, supports HSCs.	[Greenbaum, Adam; Day, Ryan B.; Christopher, Matthew J.; Borgerding, Joshua N.; Link, Daniel C.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Hsu, Yen-Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Schuettpelz, Laura G.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Nagasawa, Takashi] Kyoto Univ, Inst Frontier Med Sci, Dept Immunobiol & Hematol, Kyoto 6068507, Japan; [Nagasawa, Takashi] Japan Sci & Technol Agcy, Core Res Evolutionary Sci & Technol, Tokyo 1020075, Japan	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Kyoto University; Japan Science & Technology Agency (JST)	Link, DC (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	dlink@dom.wustl.edu	Greenbaum, Adam/S-4034-2016	Day, Ryan/0000-0002-4376-4663; Greenbaum, Adam/0000-0002-1634-4743; Nagasawa, Takashi/0000-0002-1085-0960	NIH [RO1 HL60772, F30 HL097423]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL112552, F30HL097423, R01HL060772] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22390096] Funding Source: KAKEN	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. Woloszynek, F. Liu, A. Khalaf and M. Romine for technical assistance; G. Callis, S. Oh and M. Vig for technical advice; J. Tucker-Davis for animal care; and T. Clemens for the Oc-cre mice. This work was supported by NIH grants RO1 HL60772 (D.C.L.) and F30 HL097423 (A.G.).	Ara T, 2003, J IMMUNOL, V170, P4649, DOI 10.4049/jimmunol.170.9.4649; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bonig H, 2004, BLOOD, V104, P2299, DOI 10.1182/blood-2004-04-1605; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Ding L., 2013, NATURE; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Kawabata T, 1999, P NATL ACAD SCI USA, V96, P5663, DOI 10.1073/pnas.96.10.5663; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Lehmann S, 2007, LEUKEMIA, V21, P1931, DOI 10.1038/sj.leu.2404852; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; Zhan M, 2004, BIOCHEM BIOPH RES CO, V317, P198, DOI 10.1016/j.bbrc.2004.03.034; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200	29	852	883	10	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2013	495	7440					227	230		10.1038/nature11926	http://dx.doi.org/10.1038/nature11926			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23434756	Green Accepted			2022-12-28	WOS:000316652300049
J	Chittka, L; Peng, F				Chittka, Lars; Peng, Fei			Caffeine Boosts Bees' Memories	SCIENCE			English	Editorial Material							MUSHROOM BODIES; HONEYBEES; RESPONSES; ACCURACY; SPEED		[Chittka, Lars; Peng, Fei] Queen Mary Univ London, Sch Biol & Chem Sci, Psychol Div, London E1 4NS, England	University of London; Queen Mary University London	Chittka, L (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Psychol Div, Mile End Rd, London E1 4NS, England.	l.chittka@qmul.ac.uk	Chittka, Lars/C-3110-2012	Chittka, Lars/0000-0001-8153-1732; Peng, Fei/0000-0002-1637-5611				Chittka L, 2005, PLOS BIOL, V3, P564, DOI 10.1371/journal.pbio.0030137; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; Giurfa M, 2013, TRENDS NEUROSCI, V36, P285, DOI 10.1016/j.tins.2012.12.011; Gumbert A, 1999, P ROY SOC B-BIOL SCI, V266, P1711, DOI 10.1098/rspb.1999.0836; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; Hourcade B, 2010, J NEUROSCI, V30, P6461, DOI 10.1523/JNEUROSCI.0841-10.2010; Ings TC, 2008, CURR BIOL, V18, P1520, DOI 10.1016/j.cub.2008.07.074; Oleskevich S, 1999, J NEUROPHYSIOL, V82, P1091, DOI 10.1152/jn.1999.82.2.1091; Parker MO, 2012, BEHAVIOUR, V149, P1037, DOI 10.1163/1568539X-00003010; Simons SB, 2012, NAT NEUROSCI, V15, P23, DOI 10.1038/nn.2962; Singaravelan N, 2005, J CHEM ECOL, V31, P2791, DOI 10.1007/s10886-005-8394-z; Wright GA, 2013, SCIENCE, V339, P1202, DOI 10.1126/science.1228806	12	5	7	4	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2013	339	6124					1157	1159		10.1126/science.1234411	http://dx.doi.org/10.1126/science.1234411			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471393				2022-12-28	WOS:000315709900032
J	You, DZ; Anthony, D; Wardlaw, T; Jenkins, R				You, Danzhen; Anthony, David; Wardlaw, Tessa; Jenkins, Robert			The changing face of global child demographics	LANCET			English	Editorial Material									[You, Danzhen; Anthony, David; Wardlaw, Tessa; Jenkins, Robert] UNICEF, New York, NY 10017 USA	UNICEF	You, DZ (corresponding author), UNICEF, New York, NY 10017 USA.	dyou@unicef.org						[Anonymous], 2012, UNICEF PROGR REPORT; [Anonymous], 2011, WORLD POP PROSP 2010; United Nations Children's Fund, 2012, LEV TRENDS CHILD MOR; You D, 2012, GENERATION 2025 CRIT	4	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 2	2013	381	9868					701	703		10.1016/S0140-6736(13)60226-3	http://dx.doi.org/10.1016/S0140-6736(13)60226-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	098TC	23472907				2022-12-28	WOS:000315570900004
J	Arie, S				Arie, Sophie			Inquiry launched into newspaper story about babies on "death pathway"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sophiearie@fmail.co.uk						[Anonymous], 2012, BMJ, V345, pe7319, DOI 10.1136/bmj.e7319	1	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2013	346								f1273	10.1136/bmj.f1273	http://dx.doi.org/10.1136/bmj.f1273			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	149WE	23447346				2022-12-28	WOS:000319351300004
J	Corral-Santana, JM; Casares, J; Munoz-Darias, T; Rodriguez-Gil, P; Shahbaz, T; Torres, MAP; Zurita, C; Tyndall, AA				Corral-Santana, J. M.; Casares, J.; Munoz-Darias, T.; Rodriguez-Gil, P.; Shahbaz, T.; Torres, M. A. P.; Zurita, C.; Tyndall, A. A.			A Black Hole Nova Obscured by an Inner Disk Torus	SCIENCE			English	Article							ACCRETION DISKS; MASS; BINARY	Stellar-mass black holes (BHs) are mostly found in x-ray transients, a subclass of x-ray binaries that exhibit violent outbursts. None of the 50 galactic BHs known show eclipses, which is surprising for a random distribution of inclinations. Swift J1357.2-093313 is a very faint x-ray transient detected in 2011. On the basis of spectroscopic evidence, we show that it contains a BH in a 2.8-hour orbital period. Further, high-time-resolution optical light curves display profound dips without x-ray counterparts. The observed properties are best explained by the presence of an obscuring toroidal structure moving outward in the inner disk, seen at very high inclination. This observational feature should play a key role in models of inner accretion flows and jet collimation mechanisms in stellar-mass BHs.	[Corral-Santana, J. M.; Casares, J.; Rodriguez-Gil, P.; Shahbaz, T.; Zurita, C.] Inst Astrofis Canarias, E-38205 San Cristobal la Laguna, SC de Tenerife, Spain; [Corral-Santana, J. M.; Casares, J.; Rodriguez-Gil, P.; Shahbaz, T.; Zurita, C.] Univ La Laguna, Dept Astrofis, E-38206 San Cristobal la Laguna, SC de Tenerife, Spain; [Munoz-Darias, T.] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England; [Torres, M. A. P.] SRON Netherlands Inst Space Res, SRON, NL-3584 CA Utrecht, Netherlands; [Torres, M. A. P.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Tyndall, A. A.] Univ Manchester, Jodrell Bank Ctr Astrophys, Manchester M13 9PL, Lancs, England; [Tyndall, A. A.] European So Observ, Santiago 19001, Chile; [Tyndall, A. A.] Isaac Newton Grp Telescopes, E-38700 SC De La Palma, Spain	Instituto de Astrofisica de Canarias; Universidad de la Laguna; University of Southampton; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Manchester; Jodrell Bank Centre for Astrophysics; European Southern Observatory; Isaac Newton Group of Telescopes	Corral-Santana, JM (corresponding author), Inst Astrofis Canarias, E-38205 San Cristobal la Laguna, SC de Tenerife, Spain.	jcorral@iac.es	Casares, Jorge/GVT-2693-2022; Muñoz-Darias, Teo/AAE-1950-2019; Casares, Jorge/N-4012-2014; Torres, Manuel Angel Perez/AAE-5006-2019; Corral-Santana, Jesus M/A-6956-2016; Shahbaz, Tariq/Z-3108-2019; Rodriguez-Gil, Pablo/H-7709-2015	Muñoz-Darias, Teo/0000-0002-3348-4035; Torres, Manuel Angel Perez/0000-0002-5297-2683; Corral-Santana, Jesus M/0000-0003-1038-9104; Shahbaz, Tariq/0000-0003-1331-5442; Casares, Jorge/0000-0001-5031-0128; Rodriguez-Gil, Pablo/0000-0002-4717-5102	Spanish Ministerio de Ciencia e Innovacion (MICINN) [AYA2010-18080]; Spanish MICINN under the Consolider-Ingenio Program [CSD2006-00070]; Science and Technology Facilities Council [ST/G009465/1] Funding Source: researchfish; STFC [ST/G009465/1] Funding Source: UKRI	Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish MICINN under the Consolider-Ingenio Program; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work made use of the Image Reduction and Analysis Facility (IRAF) and the MOLLY software developed by T. R. Marsh. We thank P. Charles, G. Ponti, and D. M. Russell for their useful comments; G. Perez and M. Leal for their help with fig. S3 and movie S1; and I. Negueruela and C. Gonzalez-Fernandez for obtaining the Intermediate Dispersion Spectrograph (IDS) spectra. Based on observations made with the INT and WHT, operated by the Isaac Newton Group; the LT, operated by the Liverpool John Moores University with financial support from the UK Science and Technology Facilities Council; and the MT, operated by the University of Leuven and the Observatory of Geneva. All of them are installed at the Spanish Observatorio del Roque de Los Muchachos (on the island of La Palma) of the Instituto de Astrofisica de Canarias (IAC). The photometry taken on 26 April 2011 is based on observations made with the INT under the Spanish IAC Director's Discretionary Time. T. M. D. acknowledges funding via a European Union Marie Curie Intra-European Fellowship under contract no. 2011-301355. This research was supported by the Spanish Ministerio de Ciencia e Innovacion (MICINN) under grant AYA2010-18080 and partly funded by the Spanish MICINN under the Consolider-Ingenio 2010 Program grant CSD2006-00070: "First science with the GTC" (www.iac.es/consolider-ingenio-gtc/).	ANTONUCCI R, 1993, ANNU REV ASTRON ASTR, V31, P473, DOI 10.1146/annurev.aa.31.090193.002353; BARDEEN JM, 1975, ASTROPHYS J, V195, pL65, DOI 10.1086/181711; deJong JA, 1996, ASTRON ASTROPHYS, V314, P484; Foulkes SB, 2006, MON NOT R ASTRON SOC, V366, P1399, DOI 10.1111/j.1365-2966.2005.09910.x; FRANK J, 1987, ASTRON ASTROPHYS, V178, P137; Fryer CL, 2001, ASTROPHYS J, V554, P548, DOI 10.1086/321359; Gelino DM, 2006, ASTROPHYS J, V642, P438, DOI 10.1086/500924; Ingram A, 2009, MON NOT R ASTRON SOC, V397, pL101, DOI 10.1111/j.1745-3933.2009.00693.x; Kalogera V, 1996, ASTROPHYS J, V470, pL61, DOI 10.1086/310296; King A., 1997, XRAY BINARIES, P419; King AR, 2006, MON NOT R ASTRON SOC, V366, pL31, DOI 10.1111/J.1745-3933.2005.00126.X; Krimm H. A., 2011, ASTRON TELEGRAM, V3142, P1; Krimm H. A., 2011, ASTRON TELEGRAM, V3138, P1; Lense J., 1918, PHYZ, V19, P156; Livio M, 1999, ASTROPHYS J, V512, P100, DOI 10.1086/306777; McClintock J. E., 2006, COMPACT STELLAR XRAY, P157, DOI DOI 10.2277/0521826594; McClintock J. E., 1997, XRAY BINARIES, P58; Meier DL, 2001, ASTROPHYS J, V548, pL9, DOI 10.1086/318921; MILGROM M, 1978, ASTRON ASTROPHYS, V67, pL25; Narayan R, 2005, ASTROPHYS J, V623, P1017, DOI 10.1086/428709; Ozel F, 2010, ASTROPHYS J, V725, P1918, DOI 10.1088/0004-637X/725/2/1918; OROSZ JA, 1995, ASTROPHYS J, V446, pL59, DOI 10.1086/187930; OROSZ JA, 1994, ASTROPHYS J, V436, P848, DOI 10.1086/174962; Orosz JA, 2007, NATURE, V449, P872, DOI 10.1038/nature06218; Padilla MA, 2013, MON NOT R ASTRON SOC, V428, P3083, DOI 10.1093/mnras/sts255; Ponti G, 2012, MON NOT R ASTRON SOC, V422, pL11, DOI 10.1111/j.1745-3933.2012.01224.x; Sivakoff G. R., 2011, ASTRON TELEGRAM, V3147, P1; Smak J., 1969, Acta Astronomica, V19, P155; Torres MAP, 2004, ASTROPHYS J, V612, P1026, DOI 10.1086/422740; VANPARADIJS J, 1988, ASTRON ASTROPHYS SUP, V76, P185; WHITE NE, 1985, SPACE SCI REV, V40, P167, DOI 10.1007/BF00212883	31	73	75	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1048	1051		10.1126/science.1228222	http://dx.doi.org/10.1126/science.1228222			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23449588	Green Submitted			2022-12-28	WOS:000315452000033
J	Saibil, HR				Saibil, Helen R.			Machinery to Reverse Irreversible Aggregates	SCIENCE			English	Editorial Material							PROTEIN DISAGGREGATION; HSP70; MECHANISM		Univ London Birkbeck Coll, London WC1E 7HX, England	University of London; Birkbeck University London	Saibil, HR (corresponding author), Univ London Birkbeck Coll, London WC1E 7HX, England.	h.saibil@mail.cryst.bbk.ac.uk						Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Lee U, 2005, PLANT CELL, V17, P559, DOI 10.1105/tpc.104.027540; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Oguchi Y, 2012, NAT STRUCT MOL BIOL, V19, P1338, DOI 10.1038/nsmb.2441; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Rosenzweig R, 2013, SCIENCE, V339, P1080, DOI 10.1126/science.1233066; Seyffer F, 2012, NAT STRUCT MOL BIOL, V19, P1347, DOI 10.1038/nsmb.2442; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002	12	9	9	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1040	1041		10.1126/science.1236012	http://dx.doi.org/10.1126/science.1236012			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23449583				2022-12-28	WOS:000315452000027
J	Baradaran, R; Berrisford, JM; Minhas, GS; Sazanov, LA				Baradaran, Rozbeh; Berrisford, John M.; Minhas, Gurdeep S.; Sazanov, Leonid A.			Crystal structure of the entire respiratory complex I	NATURE			English	Article							NADH-QUINONE OXIDOREDUCTASE; ELECTRON-TRANSPORT CHAIN; THERMUS-THERMOPHILUS; HYDROPHILIC DOMAIN; ESCHERICHIA-COLI; MITOCHONDRIA; SUBUNITS; UBIQUINONE; STOICHIOMETRY; MECHANISM	Complex I is the first and largest enzyme of the respiratory chain and has a central role in cellular energy production through the coupling of NADH:ubiquinone electron transfer to proton translocation. It is also implicated in many common human neurodegenerative diseases. Here, we report the first crystal structure of the entire, intact complex I (from Thermus thermophilus) at 3.3 angstrom resolution. The structure of the 536-kDa complex comprises 16 different subunits, with a total of 64 transmembrane helices and 9 iron-sulphur clusters. The core fold of subunit Nqo8 (ND1 in humans) is, unexpectedly, similar to a half-channel of the antiporter-like subunits. Small subunits nearby form a linked second half-channel, which completes the fourth proton-translocation pathway (present in addition to the channels in three antiporter-like subunits). The quinone-binding site is unusually long, narrow and enclosed. The quinone headgroup binds at the deep end of this chamber, near iron-sulphur cluster N2. Notably, the chamber is linked to the fourth channel by a 'funnel' of charged residues. The link continues over the entire membrane domain as a flexible central axis of charged and polar residues, and probably has a leading role in the propagation of conformational changes, aided by coupling elements. The structure suggests that a unique, out-of-the-membrane quinone-reaction chamber enables the redox energy to drive concerted long-range conformational changes in the four antiporter-like domains, resulting in translocation of four protons per cycle.	[Baradaran, Rozbeh; Berrisford, John M.; Minhas, Gurdeep S.; Sazanov, Leonid A.] Wellcome Trust Res Labs, MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England	Wellcome Trust Sanger Institute	Sazanov, LA (corresponding author), Wellcome Trust Res Labs, MRC, Mitochondrial Biol Unit, MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	sazanov@mrc-mbu.cam.ac.uk	Sazanov, Leonid A/ABF-2125-2021	Sazanov, Leonid A/0000-0002-0977-7989; Berrisford, John/0000-0003-4442-5871; Baradaran, Rozbeh/0000-0002-6096-9169	Medical Research Council; MRC [MC_U105674180] Funding Source: UKRI; Medical Research Council [MC_U105674180] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council. We thank the European Synchrotron Radiation Facility (ESRF) and the Swiss Light Source (SLS) for provision of synchrotron radiation facilities. We are grateful to the staff of beamlines ID29, ID23-2 (ESRF) and X06SA (SLS) for assistance.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; Angerer H, 2012, BBA-BIOENERGETICS, V1817, P1776, DOI 10.1016/j.bbabio.2012.03.021; Angerer H, 2011, BIOCHEM J, V437, P279, DOI 10.1042/BJ20110359; Bai F, 2010, SCIENCE, V327, P685, DOI 10.1126/science.1182105; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Berrisford JM, 2008, BIOCHEMISTRY-US, V47, P10262, DOI 10.1021/bi801160u; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Efremov RG, 2012, BBA-BIOENERGETICS, V1817, P1785, DOI 10.1016/j.bbabio.2012.02.015; Efremov RG, 2011, CURR OPIN STRUC BIOL, V21, P532, DOI 10.1016/j.sbi.2011.07.002; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I; Galkin A, 2006, BBA-BIOENERGETICS, V1757, P1575, DOI 10.1016/j.bbabio.2006.10.001; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Hirst J, 2010, BIOCHEM J, V425, P327, DOI 10.1042/BJ20091382; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; Kashani-Poor N, 2001, J BIOL CHEM, V276, P24082, DOI 10.1074/jbc.M102296200; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Moser CC, 2006, BBA-BIOENERGETICS, V1757, P1096, DOI 10.1016/j.bbabio.2006.04.015; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nouws J, 2012, BRAIN, V135, P12, DOI 10.1093/brain/awr261; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Ohnishi T, 2010, FEBS LETT, V584, P4131, DOI 10.1016/j.febslet.2010.08.039; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Sazanov L. A, 2012, STRUCTURAL PERSPECTI; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; Schapira AHV, 1998, BBA-BIOENERGETICS, V1364, P261, DOI 10.1016/S0005-2728(98)00032-2; Sekiguchi K, 2009, BBA-BIOENERGETICS, V1787, P1106, DOI 10.1016/j.bbabio.2009.02.016; Verkhovsky M, 2012, BBA-BIOENERGETICS, V1817, P1550, DOI 10.1016/j.bbabio.2012.04.013; Vinogradov AD, 1998, BBA-BIOENERGETICS, V1364, P169, DOI 10.1016/S0005-2728(98)00026-7; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Wikstrom M, 2012, P NATL ACAD SCI USA, V109, P4431, DOI 10.1073/pnas.1120949109; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; Yip CY, 2011, J BIOL CHEM, V286, P5023, DOI 10.1074/jbc.M110.194993; Zhang L, 1996, PROTEINS, V24, P433, DOI 10.1002/(SICI)1097-0134(199604)24:4<433::AID-PROT3>3.0.CO;2-F	45	555	562	11	261	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2013	494	7438					443	448		10.1038/nature11871	http://dx.doi.org/10.1038/nature11871			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23417064	Green Accepted			2022-12-28	WOS:000315661500030
J	Murphy, JP				Murphy, John P.			TUMBLEWEEDS AND INDELICATE QUESTIONS	NATURE			English	Editorial Material																			0	0	0	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2013	494	7438					512	512		10.1038/494512a	http://dx.doi.org/10.1038/494512a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23446423	Bronze			2022-12-28	WOS:000315661500047
J	Johnson, RH; Chien, FL; Bleyer, A				Johnson, Rebecca H.; Chien, Franklin L.; Bleyer, Archie			Incidence of Breast Cancer With Distant Involvement Among Women in the United States, 1976 to 2009	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AGE	Importance Evidence from the US National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) database suggests that the incidence of advanced breast cancer in young women is increasing. Objective To quantify this trend and analyze it as a function of stage at diagnosis, race/ethnicity, residence, and hormone receptor status. Design, Setting, and Patients Breast cancer incidence, incidence trends, and survival rates as a function of age and extent of disease at diagnosis were obtained from 3 SEER registries that provide data spanning 1973-2009, 1992-2009, and 2000-2009. SEER defines localized as disease confined to the breast, regional to contiguous and adjacent organ spread (eg, lymph nodes, chest wall), and distant disease to remote metastases (bone, brain, lung, etc). Main Outcome Measure Breast cancer incidence trends in the United States. Results In the United States, the incidence of breast cancer with distant involvement at diagnosis increased in 25- to 39-year-old women from 1.53 (95% CI, 1.01 to 2.21) per 100 000 in 1976 to 2.90 (95% CI, 2.31 to 3.59) per 100 000 in 2009. This is an absolute difference of 1.37 per 100 000, representing an average compounded increase of 2.07% per year (95% CI, 1.57% to 2.58%; P<.001) over the 34-year interval. No other age group or extent-of-disease subgroup of the same age range had a similar increase. For 25- to 39-year-olds, there was an increased incidence in distant disease among all races and ethnicities evaluated, especially non-Hispanic white and African American, and this occurred in both metropolitan and nonmetropolitan areas. Incidence for women with estrogen receptor-positive subtypes increased more than for women with estrogen receptor-negative subtypes. Conclusion and Relevance Based on SEER data, there was a small but statistically significant increase in the incidence of breast cancer with distant involvement in the United States between 1976 and 2009 for women aged 25 to 39 years, without a corresponding increase in older women. JAMA. 2013;309(8):800-805 www.jama.com	[Johnson, Rebecca H.; Chien, Franklin L.] Univ Washington, Seattle Childrens Hosp, Seattle, WA 98195 USA; [Chien, Franklin L.] Swarthmore Coll, Swarthmore, PA 19081 USA; [Bleyer, Archie] St Charles Hlth Syst, Cent Oregon, Portland, OR USA; [Bleyer, Archie] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; Swarthmore College; Oregon Health & Science University	Johnson, RH (corresponding author), Seattle Childrens Hosp, MB 8501,POB 5371, Seattle, WA 98105 USA.	rebecca.johnson@seattlechildrens.com			Seattle Children's Guild Association	Seattle Children's Guild Association	Mr Chien's salary was funded by the Seattle Children's Guild Association Teen Cancer Grant.	Anders CK, 2009, SEMIN ONCOL, V36, P237, DOI 10.1053/j.seminoncol.2009.03.001; [Anonymous], 2000, POP EST STAT INT EST; [Anonymous], SEER DAT 1973 2009 I; Bleyer A, 2008, NAT REV CANCER, V8, P288, DOI 10.1038/nrc2349; Bouchardy C, 2007, BRIT J CANCER, V96, P1743, DOI 10.1038/sj.bjc.6603783; Department of Health and Human Services National Institutes of Health National Cancer Institute LiveStrong Young Adult Alliance, CLOS GAP RES CAR IMP; Fredholm H, 2009, PLOS ONE, V4, pA38, DOI 10.1371/journal.pone.0007695; Jung SY, 2012, CANCER CAUSE CONTROL, V23, P103, DOI 10.1007/s10552-011-9859-8; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; National Cancer Institute, 2018, SEER STAT DAT INC SE; People and society: United States, PEOPL SOC US; Welch HG, 2011, OVERDIAGNOSED MAKING, P84	12	219	224	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2013	309	8					800	805		10.1001/jama.2013.776	http://dx.doi.org/10.1001/jama.2013.776			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095KD	23443443	Bronze			2022-12-28	WOS:000315332200025
J	Bower, P; Kontopantelis, E; Sutton, A; Kendrick, T; Richards, DA; Gilbody, S; Knowles, S; Cuijpers, P; Andersson, G; Christensen, H; Meyer, B; Huibers, M; Smit, F; van Straten, A; Warmerdam, L; Barkham, M; Bilich, L; Lovell, K; Liu, ETH				Bower, Peter; Kontopantelis, Evangelos; Sutton, Alex; Kendrick, Tony; Richards, David A.; Gilbody, Simon; Knowles, Sarah; Cuijpers, Pim; Andersson, Gerhard; Christensen, Helen; Meyer, Bjoern; Huibers, Marcus; Smit, Filip; van Straten, Annemieke; Warmerdam, Lisanne; Barkham, Michael; Bilich, Linda; Lovell, Karina; Liu, Emily Tung-Hsueh			Influence of initial severity of depression on effectiveness of low intensity interventions: meta-analysis of individual patient data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COGNITIVE-BEHAVIORAL THERAPY; GUIDED SELF-HELP; PRIMARY-CARE; STEPPED CARE; CLINICAL EFFECTIVENESS; CONTROLLED-TRIAL; ANXIETY; SYMPTOMS; INTERNET; BIBLIOTHERAPY	Objective To assess how initial severity of depression affects the benefit derived from low intensity interventions for depression. Design Meta-analysis of individual patient data from 16 datasets comparing low intensity interventions with usual care. Setting Primary care and community settings. Participants 2470 patients with depression. Interventions Low intensity interventions for depression (such as guided self help by means of written materials and limited professional support, and internet delivered interventions). Main outcome measures Depression outcomes (measured with the Beck Depression Inventory or Center for Epidemiologic Studies Depression Scale), and the effect of initial depression severity on the effects of low intensity interventions. Results Although patients were referred for low intensity interventions, many had moderate to severe depression at baseline. We found a significant interaction between baseline severity and treatment effect (coefficient -0.1 (95% CI -0.19 to -0.002)), suggesting that patients who are more severely depressed at baseline demonstrate larger treatment effects than those who are less severely depressed. However, the magnitude of the interaction (equivalent to an additional drop of around one point on the Beck Depression Inventory for a one standard deviation increase in initial severity) was small and may not be clinically significant. Conclusions The data suggest that patients with more severe depression at baseline show at least as much clinical benefit from low intensity interventions as less severely depressed patients and could usefully be offered these interventions as part of a stepped care model.	[Bower, Peter; Kontopantelis, Evangelos; Knowles, Sarah] Univ Manchester, NIHR Sch Primary Care Res, Manchester Acad Hlth Sci Ctr, Manchester M13 9PL, Lancs, England; [Sutton, Alex] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Kendrick, Tony] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Richards, David A.] Univ Exeter, Sch Med, Exeter, Devon, England; [Gilbody, Simon] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Gilbody, Simon] Hull York Med Sch, Kingston Upon Hull, N Humberside, England; [Cuijpers, Pim; van Straten, Annemieke; Warmerdam, Lisanne] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Cuijpers, Pim; van Straten, Annemieke; Warmerdam, Lisanne] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Cuijpers, Pim; van Straten, Annemieke; Warmerdam, Lisanne] Vrije Univ Amsterdam, Med Ctr Amsterdam, Amsterdam, Netherlands; [Andersson, Gerhard] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Andersson, Gerhard] Karolinska Inst, Stockholm, Sweden; [Christensen, Helen] Univ New S Wales, Black Dog Inst, Randwick, NSW, Australia; [Meyer, Bjoern] GAIA AG, Res Dept, Hamburg, Germany; [Meyer, Bjoern] City Univ London, Dept Psychol, London EC1V 0HB, England; [Huibers, Marcus] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Huibers, Marcus] Maastricht Univ, Dept Clin Psychol Sci, Maastricht, Netherlands; [Barkham, Michael] Univ Sheffield, Ctr Psychol Serv Res, Sheffield, S Yorkshire, England; [Bilich, Linda] Univ Wollongong, Wollongong, NSW, Australia; [Lovell, Karina] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester M13 9PL, Lancs, England; [Liu, Emily Tung-Hsueh] Fu Jen Catholic Univ, Coll Med, Taipei, Taiwan	University of Manchester; University of Leicester; University of Hull; University of York - UK; University of Exeter; University of York - UK; University of Hull; University of York - UK; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Linkoping University; Karolinska Institutet; Black Dog Institute; University of New South Wales Sydney; City University London; Vrije Universiteit Amsterdam; Maastricht University; University of Sheffield; University of Wollongong; University of Manchester; Fu Jen Catholic University	Bower, P (corresponding author), Univ Manchester, NIHR Sch Primary Care Res, Manchester Acad Hlth Sci Ctr, Manchester M13 9PL, Lancs, England.	peter.bower@manchester.ac.uk	Richards, David/B-4807-2009; Meyer, Björn/C-8787-2012; Lovell, Karina S E/E-6410-2012; Christensen, Helen/F-5053-2012; Bower, Peter/A-1508-2011; Cuijpers, Pim/G-1703-2013; Andersson, Gerhard/J-8529-2012; van Straten, Annemieke/P-8495-2019; Kontopantelis, Evangelos/H-2966-2019; Gilbody, Simon/AAY-3720-2021; Kendrick, Tony/H-8558-2014	Richards, David/0000-0002-8821-5027; Meyer, Björn/0000-0003-1100-0260; Lovell, Karina S E/0000-0001-8821-895X; Christensen, Helen/0000-0003-0435-2065; Bower, Peter/0000-0001-9558-3349; Andersson, Gerhard/0000-0003-4753-6745; van Straten, Annemieke/0000-0001-6875-2215; Kontopantelis, Evangelos/0000-0001-6450-5815; Gilbody, Simon/0000-0002-8236-6983; Kendrick, Tony/0000-0003-1618-9381; Barkham, Michael/0000-0003-1687-6376; Knowles, Sarah/0000-0002-0863-5866; Sutton, Alexander/0000-0002-8934-9940; Huibers, Marcus/0000-0002-9150-4049; Cuijpers, Pim/0000-0001-5497-2743	UK National Institute of Health Research (NIHR) School for Primary Care Research; Medical Research Council [G0401181, MC_PC_13042, G0701013, MR/K006665/1] Funding Source: researchfish; National Institute for Health Research [06/43/05, 06/43/504, SPCR-006, NF-SI-0611-10203] Funding Source: researchfish; MRC [MR/K006665/1, G0401181, G0701013] Funding Source: UKRI	UK National Institute of Health Research (NIHR) School for Primary Care Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Targeting Depression Interventions In Stepped care (TARDIS) study was funded as part of the UK National Institute of Health Research (NIHR) School for Primary Care Research. The research team were independent from the funding agency. The views expressed in this publication are those of the authors and not necessarily those of the NHS, NIHR, or Department of Health.	Adamson SJ, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1864; Ahmed I, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7762; Anderson L, 2005, BRIT J GEN PRACT, V55, P387; Andersson G, 2005, BRIT J PSYCHIAT, V187, P456, DOI 10.1192/bjp.187.5.456; Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196; [Anonymous], 1996, GLOBAL BURDEN DIS CO; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Bilich LL, 2008, CLIN PSYCHOL PSYCHOT, V15, P61, DOI 10.1002/cpp.562; Bower P, 2005, BRIT J PSYCHIAT, V186, P11, DOI 10.1192/bjp.186.1.11; Bower P, 2001, BRIT J GEN PRACT, V51, P838; Brookes S, 2011, J CLIN EPIDEMIOL, V57, P229; Christensen H, 2004, BRIT MED J, V328, P265, DOI 10.1136/bmj.37945.566632.EE; Christensen H, 2010, OXFORD GUIDE LOW INT; Cuijpers P, 1997, J BEHAV THER EXP PSY, V28, P139, DOI 10.1016/S0005-7916(97)00005-0; Cuijpers P, 2010, PSYCHOL MED, V40, P1943, DOI 10.1017/S0033291710000772; Davison GC, 2000, J CONSULT CLIN PSYCH, V68, P580, DOI 10.1037/0022-006X.68.4.580; de Graaf LE, 2009, BRIT J PSYCHIAT, V195, P73, DOI 10.1192/bjp.bp.108.054429; Donders A, 2012, J CLIN EPIDEMIOL, V59, P1087; Driessen E, 2010, J CONSULT CLIN PSYCH, V78, P668, DOI 10.1037/a0020570; Evans C, 2002, BRIT J PSYCHIAT, V180, P51, DOI 10.1192/bjp.180.1.51; Gadbury G L, 2003, Obes Rev, V4, P175, DOI 10.1046/j.1467-789X.2003.00109.x; Gellatly J, 2007, PSYCHOL MED, V37, P1217, DOI 10.1017/S0033291707000062; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Kaltenthaler E, 2006, HEALTH TECHNOL ASSES, V10, P1, DOI 10.3310/hta10330; Kaltenthaler E, 2002, Health Technol Assess, V6, P1; King M, 2005, JAMA-J AM MED ASSOC, V293, P1089, DOI 10.1001/jama.293.9.1089; Kontopantelis E, STATA J IN PRESS; Kraemer HC, 2002, ARCH GEN PSYCHIAT, V59, P877, DOI 10.1001/archpsyc.59.10.877; Leach C, 2006, BRIT J CLIN PSYCHOL, V45, P153, DOI 10.1348/014466505X35335; Levin W, 2011, PSYCHOL MED, V41, P1373, DOI 10.1017/S0033291710001935; Liu ETH, 2009, COGNITIVE THER RES, V33, P449, DOI 10.1007/s10608-008-9228-4; Lovell K, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-91; Mead N, 2005, PSYCHOL MED, V35, P1633, DOI 10.1017/S003329170500560X; Meyer B, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1151; National Institute for Health and Clinical Excellence, 2010, DEPR TREATM MAN DEPR; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; Proudfoot J, 2004, BRIT J PSYCHIAT, V185, P46, DOI 10.1192/bjp.185.1.46; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Richards A, 2003, BRIT J GEN PRACT, V53, P764; Richards DA, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-3; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Salkovskis P, 2006, PSYCHOL MED, V36, P325, DOI 10.1017/S0033291705006422; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Simmonds M, 2011, STAT MED, V26, P2982; Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944; Stata Press, 2012, MULTIPLEIMPUTATION R; StataCorp, 2009, STAT STAT SOFTW 11 1; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; STEWART LA, 1995, STAT MED, V14, P2057, DOI 10.1002/sim.4780141902; Sun X, 2012, BMJ-BRIT MED J, V342, pd1569; Sun X, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1553; Sutton AJ, 2008, STAT MED, V27, P651, DOI 10.1002/sim.2916; Vernmark K, 2010, BEHAV RES THER, V48, P368, DOI 10.1016/j.brat.2010.01.005; Vickers AJ, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-90; Warmerdam L, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.954; Whitehead A., 2002, METAANALYSIS CONTROL; Willemse GRWM, 2004, BRIT J PSYCHIAT, V185, P416, DOI 10.1192/bjp.185.5.416; Williamson P, 2012, J HEALTH SERV RES PO, V17, P1, DOI 10.1258/jhsrp.2011.011131; Wood L, 2012, BMJ-BRIT MED J, V336, P601	62	186	188	1	42	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2013	346								f540	10.1136/bmj.f540	http://dx.doi.org/10.1136/bmj.f540			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100BJ	23444423	Green Submitted, Green Published, hybrid, Green Accepted			2022-12-28	WOS:000315669400021
J	Hunter, L; Gordon, J; Peck, S; Ang, D; Lin, JF				Hunter, Larry; Gordon, Joel; Peck, Stephen; Ang, Daniel; Lin, Jung-Fu			Using the Earth as a Polarized Electron Source to Search for Long-Range Spin-Spin Interactions	SCIENCE			English	Article							THERMODYNAMIC PARAMETERS; CORE; DENSITY; IRON	Many particle-physics models that extend the standard model predict the existence of long-range spin-spin interactions. We propose an approach that uses the Earth as a polarized spin source to investigate these interactions. Using recent deep-Earth geophysics and geochemistry results, we create a comprehensive map of electron polarization within the Earth induced by the geomagnetic field. We examine possible long-range interactions between these spin-polarized geoelectrons and the spin-polarized electrons and nucleons in three laboratory experiments. By combining our model and the results from these experiments, we establish bounds on torsion gravity and possible long-range spin-spin forces associated with the virtual exchange of either spin-one axial bosons or unparticles.	[Hunter, Larry; Gordon, Joel; Peck, Stephen; Ang, Daniel] Amherst Coll, Dept Phys, Amherst, MA 01002 USA; [Lin, Jung-Fu] Univ Texas Austin, Dept Geol Sci, Jackson Sch Geosci, Austin, TX 78712 USA	Amherst College; University of Texas System; University of Texas Austin	Hunter, L (corresponding author), Amherst Coll, Dept Phys, Amherst, MA 01002 USA.	lrhunter@amherst.edu	Lin, Jung-Fu/B-4917-2011	Lin, Jung-Fu/0000-0002-0163-5329; Ang, Daniel/0000-0002-7501-7507	Amherst College; NSF [PHY-0855465, PHY-1205824]; U.S. NSF [EAR-1056670, EAR-1053446]; Energy Frontier Research in Extreme Environments (EFree); Carnegie/DOE Alliance Center (CDAC)	Amherst College; NSF(National Science Foundation (NSF)); U.S. NSF(National Science Foundation (NSF)); Energy Frontier Research in Extreme Environments (EFree); Carnegie/DOE Alliance Center (CDAC)(United States Department of Energy (DOE))	We thank S. Maus, R. Jeanloz, B. Buffett, W. Loinaz, and P. Crowley for useful conversations. We thank A. Anderson, D. Hanneke, and N. Bern for computational and graphics assistance, and C. Lu and J. Yang for compiling mineral physics data and helping with Fig. 2, respectively. We thank N. Fortson and B. Heckel for providing the updated neutron and proton bounds from (20). We thank the editors and reviewers for constructive suggestions. This work was supported by funds from the Amherst College Dean of Faculty and the NSF under grants PHY-0855465 and PHY-1205824. J.-F.L acknowledges support from the U.S. NSF (EAR-1056670 and EAR-1053446), Energy Frontier Research in Extreme Environments (EFree), and the Carnegie/DOE Alliance Center (CDAC). The data presented here are available on request from lrhunter@amherst.edu.	Alfe D, 1998, PHYS REV B, V58, P8248, DOI 10.1103/PhysRevB.58.8248; BIRCH F, 1986, J GEOPHYS RES-SOLID, V91, P4949, DOI 10.1029/JB091iB05p04949; BOBRAKOV VF, 1991, JETP LETT+, V53, P294; Brown JM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.151604; BROWN JM, 1981, GEOPHYS J ROY ASTR S, V66, P579, DOI 10.1111/j.1365-246X.1981.tb04891.x; Buffett BA, 2000, SCIENCE, V288, P2007, DOI 10.1126/science.288.5473.2007; CHUI TCP, 1993, PHYS REV LETT, V71, P3247, DOI 10.1103/PhysRevLett.71.3247; Cramer C. E., 2007, THESIS U WASHINGTON; Dobrescu BA, 2006, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2006/11/005; Donley E. A., 2012, OPTICAL MAGNETOMETRY; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Flambaum V, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.105021; Gando A, 2011, NAT GEOSCI, V4, P647, DOI 10.1038/ngeo1205; Georgi H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.221601; Glenday AG, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.261801; Heckel BR, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.092006; Hou LS, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.201101; Hulot G., 2007, TREATISE GEOPHYS, V5; Irifune T, 2010, SCIENCE, V327, P193, DOI 10.1126/science.1181443; JEANLOZ R, 1989, PHILOS T R SOC A, V328, P377, DOI 10.1098/rsta.1989.0042; Karshenboim SG, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.062119; Khriplovich IB, 2012, PHYS LETT B, V709, P111, DOI 10.1016/j.physletb.2012.01.072; KIBBLE TW, 1961, J MATH PHYS, V2, P212, DOI 10.1063/1.1703702; Kimball DFJ, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.062714; Kittel C, 2007, INTRO SOLID STATE PH, V7th; Lay T, 2008, NAT GEOSCI, V1, P25, DOI 10.1038/ngeo.2007.44; Ledbetter MP, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.040402; Liao Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.191804; Lin JF, 2008, PHYS EARTH PLANET IN, V170, P248, DOI 10.1016/j.pepi.2008.01.005; Mao Z, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049915; Maus S., 2010, US UK WORLD MAGNETIC; MOODY JE, 1984, PHYS REV D, V30, P130, DOI 10.1103/PhysRevD.30.130; Murakami M, 2012, NATURE, V485, P90, DOI 10.1038/nature11004; NEVILLE DE, 1982, PHYS REV D, V25, P573, DOI 10.1103/PhysRevD.25.573; Peck SK, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.012109; Poirier J.-P., 2000, INTRO PHYS EARTHS IN; RAMSEY NF, 1979, PHYSICA A, V96, P285, DOI 10.1016/0378-4371(79)90217-6; RINGWOOD AE, 1991, GEOCHIM COSMOCHIM AC, V55, P2083, DOI 10.1016/0016-7037(91)90090-R; Stacey F. D., 2008, PHYS EARTH; Tian Y, 2012, PHYS EARTH PLANET IN, V200, P72, DOI 10.1016/j.pepi.2012.04.004; Vasilakis G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.261801; VENEMA BJ, 1992, PHYS REV LETT, V68, P135, DOI 10.1103/PhysRevLett.68.135; WINELAND DJ, 1991, PHYS REV LETT, V67, P1735, DOI 10.1103/PhysRevLett.67.1735; Yu YGG, 2012, EARTH PLANET SC LETT, V331, P1, DOI 10.1016/j.epsl.2012.03.002	44	53	55	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2013	339	6122					928	932		10.1126/science.1227460	http://dx.doi.org/10.1126/science.1227460			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23430649	Green Submitted			2022-12-28	WOS:000315149600041
J	Drolet, BC; Khokhar, MT; Fischer, SA				Drolet, Brian C.; Khokhar, Mamoona T.; Fischer, Staci A.			The 2011 Duty-Hour Requirements - A Survey of Residency Program Directors	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NATIONAL-SURVEY		[Drolet, Brian C.] Brown Univ, Rhode Isl Hosp, Dept Plast Surg, Providence, RI 02903 USA; [Khokhar, Mamoona T.] Brown Univ, Rhode Isl Hosp, Dept Surg, Providence, RI 02903 USA; [Fischer, Staci A.] Brown Univ, Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA; [Drolet, Brian C.; Khokhar, Mamoona T.; Fischer, Staci A.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02903 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Drolet, BC (corresponding author), Brown Univ, Rhode Isl Hosp, Dept Plast Surg, Providence, RI 02903 USA.							Antiel RM, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMp1008305; Drolet BC, 2012, NEW ENGL J MED, V366, DOI 10.1056/NEJMp1202848; Drolet BC, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMp1011413; Nasca P., 2010, BASICS ZYNADDSUBFX; Nasca TJ, 2012, NEW ENGL J MED, V366, P1051, DOI 10.1056/NEJMsr1200117	5	32	33	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2013	368	8					694	697		10.1056/NEJMp1214483	http://dx.doi.org/10.1056/NEJMp1214483			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	092CG	23425162				2022-12-28	WOS:000315095800003
J	Kim, S; Brostromer, E; Xing, D; Jin, JS; Chong, SS; Ge, H; Wang, SY; Gu, C; Yang, LJ; Gao, YQ; Su, XD; Sun, YJ; Xie, XS				Kim, Sangjin; Brostroemer, Erik; Xing, Dong; Jin, Jianshi; Chong, Shasha; Ge, Hao; Wang, Siyuan; Gu, Chan; Yang, Lijiang; Gao, Yi Qin; Su, Xiao-dong; Sun, Yujie; Xie, X. Sunney			Probing Allostery Through DNA	SCIENCE			English	Article							T7 RNA-POLYMERASE; GLUCOCORTICOID-RECEPTOR; CRYSTAL-STRUCTURE; BINDING; PROTEIN; ENDONUCLEASE; REPRESSOR; PROMOTER; OPERATOR; MODEL	Allostery is well documented for proteins but less recognized for DNA-protein interactions. Here, we report that specific binding of a protein on DNA is substantially stabilized or destabilized by another protein bound nearby. The ternary complex's free energy oscillates as a function of the separation between the two proteins with a periodicity of similar to 10 base pairs, the helical pitch of B-form DNA, and a decay length of similar to 15 base pairs. The binding affinity of a protein near a DNA hairpin is similarly dependent on their separation, which-together with molecular dynamics simulations-suggests that deformation of the double-helical structure is the origin of DNA allostery. The physiological relevance of this phenomenon is illustrated by its effect on gene expression in live bacteria and on a transcription factor's affinity near nucleosomes.	[Kim, Sangjin; Brostroemer, Erik; Chong, Shasha; Wang, Siyuan; Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Xing, Dong; Jin, Jianshi; Ge, Hao; Su, Xiao-dong; Sun, Yujie; Xie, X. Sunney] Peking Univ, Sch Life Sci, Biodynam Opt Imaging Ctr BIOPIC, Beijing 100871, Peoples R China; [Jin, Jianshi] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China; [Ge, Hao] Peking Univ, Beijing Int Ctr Math Res, Beijing 100871, Peoples R China; [Gu, Chan; Yang, Lijiang; Gao, Yi Qin] Peking Univ, Coll Chem & Mol Engn, Inst Theoret & Computat Chem, Beijing 100871, Peoples R China	Harvard University; Peking University; Peking University; Peking University; Peking University	Su, XD (corresponding author), Peking Univ, Sch Life Sci, Biodynam Opt Imaging Ctr BIOPIC, Beijing 100871, Peoples R China.	xdsu@pku.edu.cn; sun_yujie@pku.edu.cn; xie@chemistry.harvard.edu	Yang, Lijiang/AAS-2662-2020; gao, yi/HCI-8298-2022	Kim, Sangjin/0000-0002-8444-7891; Wang, Siyuan (Steven)/0000-0001-6550-4064; Jin, Jianshi/0000-0003-4697-8760; Gu, Chan/0000-0002-4212-2394; Chong, Shasha/0000-0002-5372-311X	NIH; Peking University; Thousand Youth Talents Program; Major State Basic Research Development Program [2011CB809100]; National Natural Science Foundation of China [31170710, 31271423, 21125311]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peking University(Peking University); Thousand Youth Talents Program; Major State Basic Research Development Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank K. Wood for his early involvement and J. Hynes, A. Szabo, C. Bustamante, and J. Gelles for helpful discussions. This work is supported by NIH Director's Pioneer Award to X. S. X., Peking University for BIOPIC, Thousand Youth Talents Program for Y.S., as well as the Major State Basic Research Development Program (2011CB809100), National Natural Science Foundation of China (31170710, 31271423, 21125311).	Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Daber R, 2007, J MOL BIOL, V370, P609, DOI 10.1016/j.jmb.2007.04.028; Durniak KJ, 2008, SCIENCE, V322, P553, DOI 10.1126/science.1163433; Garcia HG, 2012, CELL REP, V2, P150, DOI 10.1016/j.celrep.2012.06.004; HOGAN M, 1979, NATURE, V278, P521, DOI 10.1038/278521a0; Jia YP, 1996, J BIOL CHEM, V271, P30451, DOI 10.1074/jbc.271.48.30451; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kalodimos CG, 2002, EMBO J, V21, P2866, DOI 10.1093/emboj/cdf318; Kim SJ, 2007, NAT METHODS, V4, P397, DOI 10.1038/NMETH1037; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Koslover EF, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.178102; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Miller J.H., 1972, EXPT MOL GENETICS; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Moretti R, 2008, ACS CHEM BIOL, V3, P220, DOI 10.1021/cb700258r; Muller J, 1996, J MOL BIOL, V257, P21, DOI 10.1006/jmbi.1996.0143; NEWMAN M, 1995, SCIENCE, V269, P656, DOI 10.1126/science.7624794; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Parekh BS, 1996, P NATL ACAD SCI USA, V93, P1173, DOI 10.1073/pnas.93.3.1173; POHL F, 1972, P NATL ACAD SCI USA, V69, P3805, DOI 10.1073/pnas.69.12.3805; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Rudnick J, 1999, BIOPHYS J, V76, P1725, DOI 10.1016/S0006-3495(99)77334-0; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Tang GQ, 2006, BIOCHEMISTRY-US, V45, P4936, DOI 10.1021/bi0522910; TRAVERS AA, 1989, ANNU REV BIOCHEM, V58, P427, DOI 10.1146/annurev.biochem.58.1.427; Ujvari A, 2000, J MOL BIOL, V295, P1173, DOI 10.1006/jmbi.1999.3418; Viadiu H, 1998, NAT STRUCT BIOL, V5, P910, DOI 10.1038/2352; WINKLER FK, 1993, EMBO J, V12, P1781, DOI 10.1002/j.1460-2075.1993.tb05826.x	33	170	171	2	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2013	339	6121					816	819		10.1126/science.1229223	http://dx.doi.org/10.1126/science.1229223			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23413354	Green Accepted, Green Submitted			2022-12-28	WOS:000314874400048
J	Xiao, R; Zhang, B; Dong, YM; Gong, JK; Xu, T; Liu, JF; Xu, XZS				Xiao, Rui; Zhang, Bi; Dong, Yongming; Gong, Jianke; Xu, Tao; Liu, Jianfeng; Xu, X. Z. Shawn			A Genetic Program Promotes C. elegans Longevity at Cold Temperatures via a Thermosensitive TRP Channel	CELL			English	Article							RESTRICTION-INDUCED LONGEVITY; LIFE-SPAN; CAENORHABDITIS-ELEGANS; DAF-16; RECEPTOR; EXPRESSION; IDENTIFICATION; DIAPAUSE; KINASE; METABOLISM	Both poikilotherms and homeotherms live longer at lower body temperatures, highlighting a general role of temperature reduction in lifespan extension. However, the underlying mechanisms remain unclear. One prominent model is that cold temperatures reduce the rate of chemical reactions, thereby slowing the rate of aging. This view suggests that cold-dependent lifespan extension is simply a passive thermodynamic process. Here, we challenge this view in C. elegans by showing that genetic programs actively promote longevity at cold temperatures. We find that TRPA-1, a cold-sensitive TRP channel, detects temperature drop in the environment to extend lifespan. This effect requires cold-induced, TRPA-1-mediated calcium influx and a calcium-sensitive PKC that signals to the transcription factor DAF-16/FOXO. Human TRPA1 can functionally substitute for worm TRPA-1 in promoting longevity. Our results reveal a previously unrecognized function for TRP channels, link calcium signaling to longevity, and, importantly, demonstrate that genetic programs contribute to lifespan extension at cold temperatures.	[Xiao, Rui; Zhang, Bi; Dong, Yongming; Gong, Jianke; Xu, X. Z. Shawn] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Xu, X. Z. Shawn] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Zhang, Bi; Gong, Jianke; Xu, Tao; Liu, Jianfeng] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Xu, Tao] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Huazhong University of Science & Technology; Chinese Academy of Sciences; Institute of Biophysics, CAS	Xu, XZS (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	shawnxu@umich.edu	Dong, Yongming/H-9502-2013; Liu, Jianfeng/E-2786-2012	Dong, Yongming/0000-0002-6510-0913; Zhang, Bi/0000-0002-3961-5227; Xiao, Rui/0000-0001-5541-6685	AHA postdoctoral fellowship; Program of Introducing Talents of Discipline to Universities from the Ministry of Education of China; NIGMS; NIA; NSFC; Pew scholar program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036956, T32AG000114] Funding Source: NIH RePORTER	AHA postdoctoral fellowship(American Heart Association); Program of Introducing Talents of Discipline to Universities from the Ministry of Education of China; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NSFC(National Natural Science Foundation of China (NSFC)); Pew scholar program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Ao-Lin Hsu for providing reagents and critically reading the manuscript, Jiandie Lin, Xiaowei Chen, and Zhaoyu Li for technical assistance, and Sean Curran and Gary Ruvkun for daf-16 strains. Some strains were obtained from the CGC and Knockout Consortiums in the US and Japan. R.X. was supported by an AHA postdoctoral fellowship. This work was supported by the Program of Introducing Talents of Discipline to Universities from the Ministry of Education of China (J.L.) and grants from the NIGMS (X.Z.S.X.), NIA (Ao-Lin Hsu), NSFC (T.X. and X.Z.S.X.), and Pew scholar program (X.Z.S.X.).	AAMODT EJ, 1991, SCIENCE, V252, P579, DOI 10.1126/science.2020855; Alam H, 2010, CELL METAB, V12, P30, DOI 10.1016/j.cmet.2010.05.004; Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; Antebi A, 2000, GENE DEV, V14, P1512; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Chatzigeorgiou M, 2010, NAT NEUROSCI, V13, P861, DOI 10.1038/nn.2581; Clandinin TR, 1998, CELL, V92, P523, DOI 10.1016/S0092-8674(00)80945-9; Conti B, 2008, CELL MOL LIFE SCI, V65, P1626, DOI 10.1007/s00018-008-7536-1; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Earley S, 2009, CIRC RES, V104, P987, DOI 10.1161/CIRCRESAHA.108.189530; Feng ZY, 2006, CELL, V127, P621, DOI 10.1016/j.cell.2006.09.035; FIRE A, 1989, EMBO J, V8, P3419, DOI 10.1002/j.1460-2075.1989.tb08506.x; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Gallio M, 2011, CELL, V144, P614, DOI 10.1016/j.cell.2011.01.028; Gilleard JS, 1997, MOL CELL BIOL, V17, P2301, DOI 10.1128/MCB.17.4.2301; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hsu AL, 2009, NEUROBIOL AGING, V30, P1498, DOI 10.1016/j.neurobiolaging.2007.12.007; Jia KL, 2002, DEVELOPMENT, V129, P221; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kindt KS, 2007, NAT NEUROSCI, V10, P568, DOI 10.1038/nn1886; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Lee BH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000213; Lee SJ, 2009, CURR BIOL, V19, P715, DOI 10.1016/j.cub.2009.03.041; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Li J, 2008, PLOS BIOL, V6, P1870, DOI 10.1371/journal.pbio.0060233; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Loeb J, 1916, P NATL ACAD SCI USA, V2, P456, DOI 10.1073/pnas.2.8.456; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Satterlee JS, 2004, CURR BIOL, V14, P62, DOI 10.1016/j.cub.2003.12.030; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Stokes A, 2006, CELL SIGNAL, V18, P1584, DOI 10.1016/j.cellsig.2005.12.009; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042; Wu DQ, 2009, AGING CELL, V8, P666, DOI 10.1111/j.1474-9726.2009.00523.x; Xiao R, 2009, PFLUG ARCH EUR J PHY, V458, P851, DOI 10.1007/s00424-009-0678-7	59	152	160	1	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 14	2013	152	4					806	817		10.1016/j.cell.2013.01.020	http://dx.doi.org/10.1016/j.cell.2013.01.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415228	Green Accepted, Bronze			2022-12-28	WOS:000314945600015
J	Atkin, W; Dadswell, E; Wooldrage, K; Kralj-Hans, I; von Wagner, C; Edwards, R; Yao, GQ; Kay, C; Burling, D; Faiz, O; Teare, J; Lilford, RJ; Morton, D; Wardle, J; Halligan, S				Atkin, Wendy; Dadswell, Edward; Wooldrage, Kate; Kralj-Hans, Ines; von Wagner, Christian; Edwards, Rob; Yao, Guiqing; Kay, Clive; Burling, David; Faiz, Omar; Teare, Julian; Lilford, Richard J.; Morton, Dion; Wardle, Jane; Halligan, Steve		SIGGAR Investigators	Computed tomographic colonography versus colonoscopy for investigation of patients with symptoms suggestive of colorectal cancer (SIGGAR): a multicentre randomised trial	LANCET			English	Article							CT COLONOGRAPHY; BARIUM ENEMA; OLDER; ACCEPTABILITY; METAANALYSIS; PERFORMANCE	Background Colonoscopy is the gold-standard test for investigation of symptoms suggestive of colorectal cancer; computed tomographic colonography (CTC) is an alternative, less invasive test. However, additional investigation after CTC is needed to confirm suspected colonic lesions, and this is an important factor in establishing the feasibility of CTC as an alternative to colonoscopy. We aimed to compare rates of additional colonic investigation after CTC or colonoscopy for detection of colorectal cancer or large (>= 10 mm) polyps in symptomatic patients in clinical practice. Methods This pragmatic multicentre randomised trial recruited patients with symptoms suggestive of colorectal cancer from 21 UK hospitals. Eligible patients were aged 55 years or older and regarded by their referring clinician as suitable for colonoscopy. Patients were randomly assigned (2: 1) to colonoscopy or CTC by computer-generated random numbers, in blocks of six, stratified by trial centre and sex. We analysed the primary outcome-the rate of additional colonic investigation-by intention to treat. The trial is an International Standard Randomised Controlled Trial, number 95152621. Findings 1610 patients were randomly assigned to receive either colonoscopy (n=1072) or CTC (n=538). 30 patients withdrew consent, leaving for analysis 1047 assigned to colonoscopy and 533 assigned to CTC. 160 (30.0%) patients in the CTC group had additional colonic investigation compared with 86 (8.2%) in the colonoscopy group (relative risk 3.65, 95% CI 2.87-4.65; p<0.0001). Almost half the referrals after CTC were for small (<10 mm) polyps or clinical uncertainty, with low predictive value for large polyps or cancer. Detection rates of colorectal cancer or large polyps in the trial cohort were 11% for both procedures. CTC missed 1 of 29 colorectal cancers and colonoscopy missed none (of 55). Serious adverse events were rare. Interpretation Guidelines are needed to reduce the referral rate after CTC. For most patients, however, CTC provides a similarly sensitive, less invasive alternative to colonoscopy.	[Atkin, Wendy; Dadswell, Edward; Wooldrage, Kate; Kralj-Hans, Ines] Univ London Imperial Coll Sci Technol & Med, London W2 1PG, England; [von Wagner, Christian; Wardle, Jane; Halligan, Steve] UCL, London, England; [Edwards, Rob] Univ London, London, England; [Yao, Guiqing; Lilford, Richard J.; Morton, Dion] Univ Birmingham, Birmingham, W Midlands, England; [Kay, Clive] Bradford Teaching Hosp NHS Fdn Trust, Bradford, W Yorkshire, England; [Burling, David; Faiz, Omar] St Marks Hosp, Harrow, Middx, England; [Teare, Julian] Imperial Coll Healthcare NHS Trust, London, England	Imperial College London; University of London; University College London; University of London; University of Birmingham; Imperial College London; Imperial College London	Atkin, W (corresponding author), Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Canc Screening & Prevent Res Grp, Norfolk Pl, London W2 1PG, England.	w.atkin@imperial.ac.uk	Halligan, Steve/C-5875-2009	Halligan, Steve/0000-0003-0632-5108; Atkin, Wendy/0000-0001-9073-9658; Travis, Simon/0000-0002-2690-4361; Buchanan, Gordon/0000-0003-3797-2121; Lilford, Richard/0000-0002-0634-984X; Taylor, Stuart/0000-0002-6765-8806; Wooldrage, Kate/0000-0001-8209-3113; Kralj-Hans, Ines/0000-0001-7401-6281; Von Wagner, Christian/0000-0002-7971-0691; teare, Julian/0000-0003-3551-9139	NIHR Health Technology Assessment Programme; NIHR Biomedical Research Centres funding scheme; Cancer Research UK; EPSRC Multidisciplinary Assessment of Technology Centre for Healthcare; NIHR Collaborations for Leadership in Applied Health Research and Care; NIHR Health Technology Assessment (HTA) Programme [02/02/01]; Cancer Research UK Population Research Committee Programme Grant [C8171/A10391]; NIHR HTA Programme; EPSRC Multidisciplinary Assessment of Technology Centre for Healthcare (MATCH); NIHR Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country; Cancer Research UK [14134] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/F063822/1] Funding Source: researchfish; Medical Research Council [G0800808] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10008, 02/02/01] Funding Source: researchfish; EPSRC [EP/F063822/1] Funding Source: UKRI; MRC [G0800808] Funding Source: UKRI	NIHR Health Technology Assessment Programme(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centres funding scheme; Cancer Research UK(Cancer Research UK); EPSRC Multidisciplinary Assessment of Technology Centre for Healthcare(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NIHR Collaborations for Leadership in Applied Health Research and Care; NIHR Health Technology Assessment (HTA) Programme; Cancer Research UK Population Research Committee Programme Grant; NIHR HTA Programme; EPSRC Multidisciplinary Assessment of Technology Centre for Healthcare (MATCH)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NIHR Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country; Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	NIHR Health Technology Assessment Programme, NIHR Biomedical Research Centres funding scheme, Cancer Research UK, EPSRC Multidisciplinary Assessment of Technology Centre for Healthcare, and NIHR Collaborations for Leadership in Applied Health Research and Care.; We thank the radiologists and endoscopists who completed the case report forms, the research nurses who were responsible for data collection, and the trial participants and referring clinicians for their support of the study. We also thank Willie Hamilton (Professor of Primary Care Diagnostics, University of Exeter), Brian Saunders (Consultant Gastroenterologist, The North West London Hospitals NHS Trust), and Roland Valori (Consultant Gastroenterologist, Gloucestershire Hospitals NHS Foundation Trust) for many helpful discussions and advice. This research was undertaken jointly by Imperial College London and University College London. It was funded mainly by the NIHR Health Technology Assessment (HTA) Programme (project number 02/02/01), and will be published in full in Health Technology Assessment. Researchers at University College received a proportion of funding from the NIHR Biomedical Research Centres funding scheme, and additional funding for researchers at Imperial College was provided by a Cancer Research UK Population Research Committee Programme Grant (number C8171/A10391). The economic analysis was funded by the NIHR HTA Programme, the EPSRC Multidisciplinary Assessment of Technology Centre for Healthcare (MATCH), and the NIHR Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of Cancer Research UK, MATCH, EPSRC, the HTA Programme, NIHR, NHS, or the Department of Health. Medicsight, Viatronix, Bracco UK, and Barco provided equipment.	American College of Radiology, 2009, ACR PRACT GUID PERF; Anderson JC, 2001, GASTROINTEST ENDOSC, V54, P558, DOI 10.1067/mge.2001.118950; Barish MA, 2005, AM J ROENTGENOL, V184, P786, DOI 10.2214/ajr.184.3.01840786; Bowles CJA, 2004, GUT, V53, P277, DOI 10.1136/gut.2003.016436; Brenner H, 2010, ANN INTERN MED, V152, P697, DOI 10.7326/0003-4819-152-11-201006010-00002; Bressler B, 2007, GASTROENTEROLOGY, V132, P96, DOI 10.1053/j.gastro.2006.10.027; Burling D, 2010, CLIN RADIOL, V65, P474, DOI 10.1016/j.crad.2009.12.003; Doshi T, 2007, RADIOLOGY, V244, P165, DOI 10.1148/radiol.2441061122; Fletcher JG, 2010, AM J ROENTGENOL, V195, P117, DOI 10.2214/AJR.09.3659; Gavin DR, 2013, GUT, V62, P242, DOI 10.1136/gutjnl-2011-301848; Gluecker TM, 2003, RADIOLOGY, V227, P378, DOI 10.1148/radiol.2272020293; Halligan S, 2005, RADIOLOGY, V237, P893, DOI 10.1148/radiol.2373050176; Halligan S, HLHT RECHNO IN PRESS; Halligan S, 2013, LANCET; Halligan S, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-32; Hur C, 2005, CLIN GASTROENTEROL H, V3, P1124, DOI 10.1016/S1542-3565(05)00534-3; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Joint Advisory Group on Gastrointestinal Endoscopy, 2006, GUID TRAIN APPR ASS; Joint Advisory Group on GI Endoscopy, BSG QUAL SAF IND END; Kim DH, 2010, RADIOLOGY, V254, P493, DOI 10.1148/radiol.09091478; Lee KJ, 2005, BRIT MED J, V330, P142, DOI 10.1136/bmj.330.7483.142; Levin TR, 2006, ANN INTERN MED, V145, P880, DOI 10.7326/0003-4819-145-12-200612190-00004; Medicines and Healthcare products Regulatory Agency, DEV B REP ADV INC DI; Moll FL, 2011, EUR J VASC ENDOVASC, V41, pS1, DOI 10.1016/j.ejvs.2010.09.011; Mulhall BP, 2005, ANN INTERN MED, V142, P635, DOI 10.7326/0003-4819-142-8-200504190-00013; Nagata K, 2009, ACAD RADIOL, V16, P780, DOI 10.1016/j.acra.2008.12.027; Office for National Statistics, 2011, INF PAP SUMM QUAL RE; Office for National Statistics, 2009, CANC STAT REG ENG MB, V40; Office for National Statistics, 2011, BIRTHS DEATHS ENGL W; Pendse DA, 2013, EUR J RADIOL, V82, P1159, DOI 10.1016/j.ejrad.2012.04.011; Pickhardt PJ, 2011, RADIOLOGY, V259, P393, DOI 10.1148/radiol.11101887; Plumb AA, 2013, CLIN RADIOL, V68, P479, DOI 10.1016/j.crad.2012.10.018; Rabeneck L, 2010, FRONTLINE GASTROENTE, V1, P52, DOI 10.1136/fg.2009.000257; Rex DK, 1997, GASTROENTEROLOGY, V112, P17, DOI 10.1016/S0016-5085(97)70213-0; Shah HA, 2007, GASTROENTEROLOGY, V132, P2297, DOI 10.1053/j.gastro.2007.03.032; Svensson MH, 2002, RADIOLOGY, V222, P337, DOI 10.1148/radiol.2222010669; Tolan DJM, 2007, AM J ROENTGENOL, V189, P1104, DOI 10.2214/AJR.07.2026; van Gelder RE, 2004, RADIOLOGY, V233, P328, DOI 10.1148/radiol.2331031208; Verma A, 2012, GASTROENTEROLOGY, V3, P124; von Wagner C, 2012, RADIOLOGY, V263, P723, DOI 10.1148/radiol.12111523; von Wagner C, 2011, EUR RADIOL, V21, P2046, DOI 10.1007/s00330-011-2154-y; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; Xiong T, 2006, BRIT J RADIOL, V79, P948, DOI 10.1259/bjr/58438178	43	158	160	0	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 6	2013	381	9873					1194	1202		10.1016/S0140-6736(12)62186-2	http://dx.doi.org/10.1016/S0140-6736(12)62186-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122WU	23414650				2022-12-28	WOS:000317350100029
J	Boetius, A; Albrecht, S; Bakker, K; Bienhold, C; Felden, J; Fernandez-Mendez, M; Hendricks, S; Katlein, C; Lalande, C; Krumpen, T; Nicolaus, M; Peeken, I; Rabe, B; Rogacheva, A; Rybakova, E; Somavilla, R; Wenzhofer, F				Boetius, Antje; Albrecht, Sebastian; Bakker, Karel; Bienhold, Christina; Felden, Janine; Fernandez-Mendez, Mar; Hendricks, Stefan; Katlein, Christian; Lalande, Catherine; Krumpen, Thomas; Nicolaus, Marcel; Peeken, Ilka; Rabe, Benjamin; Rogacheva, Antonina; Rybakova, Elena; Somavilla, Raquel; Wenzhoefer, Frank		RV Polarstern ARK27-3-Shipboard Sc	Export of Algal Biomass from the Melting Arctic Sea Ice	SCIENCE			English	Article							PHYTOPLANKTON; SEDIMENT; CLIMATE; OCEAN; DEEP; FATE	In the Arctic, under-ice primary production is limited to summer months and is restricted not only by ice thickness and snow cover but also by the stratification of the water column, which constrains nutrient supply for algal growth. Research Vessel Polarstern visited the ice-covered eastern-central basins between 82 degrees to 89 degrees N and 30 degrees to 130 degrees E in summer 2012, when Arctic sea ice declined to a record minimum. During this cruise, we observed a widespread deposition of ice algal biomass of on average 9 grams of carbon per square meter to the deep-sea floor of the central Arctic basins. Data from this cruise will contribute to assessing the effect of current climate change on Arctic productivity, biodiversity, and ecological function.	[Boetius, Antje; Bienhold, Christina; Fernandez-Mendez, Mar; Hendricks, Stefan; Katlein, Christian; Lalande, Catherine; Krumpen, Thomas; Nicolaus, Marcel; Peeken, Ilka; Rabe, Benjamin; Somavilla, Raquel; Wenzhoefer, Frank] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, D-27515 Bremerhaven, Germany; [Boetius, Antje; Bienhold, Christina; Fernandez-Mendez, Mar] Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; [Boetius, Antje; Felden, Janine; Peeken, Ilka] Univ Bremen, Ctr Marine Environm Sci, MARUM, D-28334 Bremen, Germany; [Albrecht, Sebastian] FIELAX Gesell Wissensch Datenverarbeitung mbH, D-27568 Bremerhaven, Germany; [Bakker, Karel] NIOZ Royal Netherlands Inst Sea Res, NL-1790 AB Den Burg, Netherlands; [Rogacheva, Antonina; Rybakova, Elena] Russian Acad Sci, PP Shirshov Oceanol Inst, Moscow 117997, Russia	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Max Planck Society; University of Bremen; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Russian Academy of Sciences; Shirshov Institute of Oceanology	Boetius, A (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, D-27515 Bremerhaven, Germany.	antje.boetius@awi.de	Rabe, Benjamin/G-2999-2011; Somavilla, Raquel/G-2675-2016; Nicolaus, Marcel/A-3658-2013; Martí, Montserrat Roca/AAD-2094-2022; Attard, Karl Michael/ABE-6044-2021; Rybakova, Elena/AAD-1922-2019; Krumpen, Thomas/D-5163-2011; Hendricks, Stefan/D-5168-2011; Katlein, Christian/AAY-8731-2020; Kremenetskaia, Antonina/H-5654-2018; Galgani, Luisa/J-4026-2017; Boetius, Antje/D-5459-2013; Attard, Karl/AAO-8314-2021; Puigcorbé, Viena/I-9349-2016	Rabe, Benjamin/0000-0001-5794-9856; Somavilla, Raquel/0000-0002-8719-4105; Nicolaus, Marcel/0000-0003-0903-1746; Martí, Montserrat Roca/0000-0002-4719-9358; Attard, Karl Michael/0000-0002-8009-5462; Krumpen, Thomas/0000-0001-6234-8756; Hendricks, Stefan/0000-0002-1412-3146; Kremenetskaia, Antonina/0000-0001-8851-3318; Galgani, Luisa/0000-0001-5239-6893; Boetius, Antje/0000-0003-2117-4176; Puigcorbé, Viena/0000-0001-5892-2305; Bienhold, Christina/0000-0003-2269-9468; Degen, Renate/0000-0001-7380-9378; Katlein, Christian/0000-0003-2422-0414; Rybakova, Elena/0000-0001-9695-149X; Fernandez-Mendez, Mar/0000-0002-4968-1156; Peeken, Ilka/0000-0003-1531-1664	PACES (Polar Regions and Coasts in a Changing Earth System) program of the Helmholtz Association; European Research Council [294757]; Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie [03F0605E]	PACES (Polar Regions and Coasts in a Changing Earth System) program of the Helmholtz Association; European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie(Federal Ministry of Education & Research (BMBF))	We thank the captain and crew of RV Polarstern expedition IceArc (ARK27-3) as well as our helicopter and meteorology teams for their excellent support with work at sea. This study was funded by the PACES (Polar Regions and Coasts in a Changing Earth System) program of the Helmholtz Association. Additional funds were made available to A.B. by the European Research Council Advanced Investigator grant 294757 and the Leibniz program of the Deutsche Forschungsgemeinschaft, and to B.R. for the Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie project 03F0605E. Supplementary data are available at http://doi.pangaea.de/10.1594/PANGAEA.803293.	Ambrose WG, 2005, POLAR BIOL, V28, P784, DOI 10.1007/s00300-005-0002-8; Arrigo KR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035028; Boetius A, 1998, DEEP-SEA RES PT I, V45, P239, DOI 10.1016/S0967-0637(97)00052-6; Bourgain P, 2011, DEEP-SEA RES PT I, V58, P745, DOI 10.1016/j.dsr.2011.05.001; Cooperative Institute for Research in Environmental Sciences at the University of Colorado at Boulder, 2012, NAT SNOW IC DAT CTR; DEMING JW, 1992, NATO ADV SCI I C-MAT, V360, P11; Fahl K, 2007, DEEP-SEA RES PT I, V54, P1256, DOI 10.1016/j.dsr.2007.04.014; Fischer JP, 2009, BIOGEOSCIENCES, V6, P1467, DOI 10.5194/bg-6-1467-2009; Glover AG, 2010, ADV MAR BIOL, V58, P1, DOI [10.1016/B978-0-12-381015-1.00001-0, 10.1016/S0065-2881(10)58001-5]; Gosselin M, 1997, DEEP-SEA RES PT II, V44, P1623, DOI 10.1016/S0967-0645(97)00054-4; GUTT J, 1995, POLAR BIOL, V15, P247; Hegseth EN, 1998, POLAR RES, V17, P113, DOI 10.1111/j.1751-8369.1998.tb00266.x; Klages M, 2004, ORGANIC CARBON CYCLE IN THE ARCTIC OCEAN, P139; Lalande C, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040570; LEGENDRE L, 1992, POLAR BIOL, V12, P429; Maslanik J, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047735; Melnikov I.A., 1997, ARCTIC SEA ICE SYSTE; MELNIKOV IA, 1987, OCEANOLOGY, V0027; Mundy CJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038837; Nansen F., 1906, VIDENSKAB SELSKAB MN, V1; Nicolaus M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053738; Nicolaus M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC006074; Rabe B, 2011, DEEP-SEA RES PT I, V58, P173, DOI 10.1016/j.dsr.2010.12.002; Rosel A, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007869; Rogacheva A, 2012, J MAR BIOL ASSOC UK, V92, P1183, DOI 10.1017/S0025315411000427; Ruhl HA, 2008, P NATL ACAD SCI USA, V105, P17006, DOI 10.1073/pnas.0803898105; Rysgaard S, 2001, MAR ECOL PROG SER, V223, P15, DOI 10.3354/meps223015; SYVERTSEN EE, 1991, POLAR RES, V10, P277, DOI 10.1111/j.1751-8369.1991.tb00653.x; Tremblay JE, 2009, NATO SCI PEACE SECUR, P73, DOI 10.1007/978-1-4020-9460-6_7; Wang MY, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037820; Wassmann P, 2006, PROG OCEANOGR, V71, P232, DOI 10.1016/j.pocean.2006.10.003; Wassmann P, 2011, GLOBAL CHANGE BIOL, V17, P1235, DOI 10.1111/j.1365-2486.2010.02311.x; Wassmann P, 2010, POLAR BIOL, V33, P1641, DOI 10.1007/s00300-010-0839-3; Wei CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015323; Wenzhofer F, 2002, DEEP-SEA RES PT I, V49, P1255, DOI 10.1016/S0967-0637(02)00025-0; Wigham BD, 2003, J MAR BIOL ASSOC UK, V83, P175, DOI 10.1017/S0025315403006957h; Witte U, 2003, NATURE, V424, P763, DOI 10.1038/nature01799	38	283	305	7	310	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1430	1432		10.1126/science.1231346	http://dx.doi.org/10.1126/science.1231346			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23413190				2022-12-28	WOS:000316740700042
J	Al-Gazali, L; Valian, V; Barres, B; Wu, LA; Andrei, EY; Handelsman, J; Moss-Racusin, C; Husu, L				Al-Gazali, Lihadh; Valian, Virginia; Barres, Ben; Wu, Ling-An; Andrei, Eva Y.; Handelsman, Jo; Moss-Racusin, Corinne; Husu, Liisa			Scientists of the world speak up for equality	NATURE			English	Editorial Material							MALLEABILITY; PREJUDICE		[Al-Gazali, Lihadh] United Arab Emirates Univ, Al Ain, U Arab Emirates; [Valian, Virginia] CUNY Hunter Coll, New York, NY 10021 USA; [Valian, Virginia] CUNY, Grad Ctr, New York, NY USA; [Barres, Ben] Stanford Univ, Stanford, CA 94305 USA; [Wu, Ling-An] Chinese Acad Sci, Inst Phys, Beijing 100080, Peoples R China; [Andrei, Eva Y.] Rutgers State Univ, Piscataway, NJ 08855 USA; [Handelsman, Jo; Moss-Racusin, Corinne] Yale Univ, New Haven, CT USA; [Husu, Liisa] Univ Orebro, GEXcel Ctr Gender Excellence, Orebro, Sweden	United Arab Emirates University; City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Stanford University; Chinese Academy of Sciences; Institute of Physics, CAS; Rutgers State University New Brunswick; Yale University; Orebro University	Al-Gazali, L (corresponding author), United Arab Emirates Univ, Al Ain, U Arab Emirates.		Valian, Virginia/ABD-1669-2021	Valian, Virginia/0000-0002-2128-5856				Dasgupta N, 2001, J PERS SOC PSYCHOL, V81, P800, DOI 10.1037/0022-3514.81.5.800; Husu L, 2005, ADV GEND RES, V9, P161, DOI 10.1016/S1529-2126(05)09007-7; Rudman LA, 2001, J PERS SOC PSYCHOL, V81, P856, DOI 10.1037/0022-3514.81.5.856	3	19	20	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2013	495	7439					35	38						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	105BE	23467153	Bronze			2022-12-28	WOS:000316039800018
J	Patterson, AP; Tabak, LA; Fauci, AS; Collins, FS; Howard, S				Patterson, Amy P.; Tabak, Lawrence A.; Fauci, Anthony S.; Collins, Francis S.; Howard, Sally			A Framework for Decisions About Research with HPAI H5N1 Viruses	SCIENCE			English	Editorial Material							TRANSMISSION; PAUSE		[Patterson, Amy P.; Tabak, Lawrence A.; Fauci, Anthony S.; Collins, Francis S.] NIH, Bethesda, MD 20892 USA; [Howard, Sally] US Dept HHS, Washington, DC 20201 USA	National Institutes of Health (NIH) - USA	Patterson, AP (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.	pattersa@od.nih.gov			Intramural NIH HHS [Z99 OD999999, Z99 AI999999] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000739] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		[Anonymous], 2012, GAIN OF FUNCT RES HI; [Anonymous], 2009, REP TRANSF TASK FORC, P40; Center for Disease Control and Prevention, HIGHL PATH AV INFL A; Centers for Disease Control and Prevention (CDC) HHS, 2012, FED REG, V77, P63783; Food and Agriculture Organization of the United Nations (FAO), 2012, H5N1 HIGHL PATH AV I; Fouchier RAM, 2013, NATURE, V493, P609, DOI 10.1038/nature11858; Fouchier RAM, 2012, SCIENCE, V335, P400, DOI [10.1126/science.1219412, 10.1126/science.335.6067.400]; Fouchier RAM, 2012, NATURE, V481, P443, DOI 10.1038/481443a; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; National Institute of Health, 2013, NIH GUID RES INV REC; Office of Biotechnology Activities NIH, 2012, US GOV POL OV LIF SC	12	20	20	3	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1036	1037		10.1126/science.1236194	http://dx.doi.org/10.1126/science.1236194			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23429700	Green Accepted			2022-12-28	WOS:000315452000025
J	Sakakibara, K; Ando, S; Yip, HK; Tamada, Y; Hiwatashi, Y; Murata, T; Deguchi, H; Hasebe, M; Bowman, JL				Sakakibara, Keiko; Ando, Sayuri; Yip, Hoichong Karen; Tamada, Yosuke; Hiwatashi, Yuji; Murata, Takashi; Deguchi, Hironori; Hasebe, Mitsuyasu; Bowman, John L.			KNOX2 Genes Regulate the Haploid-to-Diploid Morphological Transition in Land Plants	SCIENCE			English	Article							EXPRESSION; PROTEINS; CELL; LOCALIZATION; DNA	Unlike animals, land plants undergo an alternation of generations, producing multicellular bodies in both haploid (1n: gametophyte) and diploid (2n: sporophyte) generations. Plant body plans in each generation are regulated by distinct developmental programs initiated at either meiosis or fertilization, respectively. In mosses, the haploid gametophyte generation is dominant, whereas in vascular plants-including ferns, gymnosperms, and angiosperms-the diploid sporophyte generation is dominant. Deletion of the class 2 KNOTTED1-LIKE HOMEOBOX (KNOX2) transcription factors in the moss Physcomitrella patens results in the development of gametophyte bodies from diploid embryos without meiosis. Thus, KNOX2 acts to prevent the haploid-specific body plan from developing in the diploid plant body, indicating a critical role for the evolution of KNOX2 in establishing an alternation of generations in land plants.	[Sakakibara, Keiko; Deguchi, Hironori] Hiroshima Univ, Dept Biol Sci, Grad Sch Sci, Higashihiroshima 7398526, Japan; [Sakakibara, Keiko; Bowman, John L.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3800, Australia; [Sakakibara, Keiko; Ando, Sayuri; Hasebe, Mitsuyasu] Japan Sci & Technol Agcy, ERATO, Okazaki, Aichi 4448585, Japan; [Sakakibara, Keiko; Ando, Sayuri; Tamada, Yosuke; Hiwatashi, Yuji; Murata, Takashi; Hasebe, Mitsuyasu] Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; [Yip, Hoichong Karen; Bowman, John L.] Univ Calif Davis, Sect Plant Biol, Davis, CA 95616 USA; [Tamada, Yosuke; Hiwatashi, Yuji; Murata, Takashi; Hasebe, Mitsuyasu] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448585, Japan	Hiroshima University; Monash University; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); University of California System; University of California Davis; Graduate University for Advanced Studies - Japan	Sakakibara, K (corresponding author), Hiroshima Univ, Dept Biol Sci, Grad Sch Sci, Higashihiroshima 7398526, Japan.	bara@hiroshima-u.ac.jp; john.bowman@monash.edu	Sakakibara, Keiko/Q-5748-2018; Tamada, Yosuke/A-4144-2010	Sakakibara, Keiko/0000-0003-4420-9351; Hasebe, Mitsuyasu/0000-0001-7425-8758; Murata, Takashi/0000-0002-1543-0439; Tamada, Yosuke/0000-0002-4845-4867; Bowman, John/0000-0001-7347-3691; HIWATASHI, YUJI/0000-0002-3996-0549	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS) KAKENHI grant; Australian Research Council [FF0561326]; Grants-in-Aid for Scientific Research [24770077] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS) KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Australian Research Council(Australian Research Council); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Kabeya for technical assistance of flow cytometry; C. L. Volk Murayama for translation of references; D. R. Smyth, Y. Eshed, M. Shimamura, and T. Nishiyama for critical comments on the manuscript; and the Model Plant Research Facility of the National Institute for Basic Biology for experimental facilities. This research was partly supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); the Japan Society for the Promotion of Science (JSPS) KAKENHI grant (to K. S., Y. T., H. D, and M. H.); and the Australian Research Council grant FF0561326 (J.L.B.). K. S. was a JSPS research fellow. Sequence data associated with this manuscript have been submitted to the DNA Data Bank of Japan.	Allen CE, 1935, BOT REV, V1, P269; [Anonymous], 1894, ANN BOT, DOI DOI 10.1093/OXFORDJOURNALS.AOB.A090708; Bellaoui M, 2001, PLANT CELL, V13, P2455, DOI 10.1105/tpc.13.11.2455; Bower F. O., 1908, ORIGIN LAND FLORA TH; Graham L, 1993, ORIGIN LAND PLANTS; Hackbusch J, 2005, P NATL ACAD SCI USA, V102, P4908, DOI 10.1073/pnas.0501181102; Hay A, 2010, DEVELOPMENT, V137, P3153, DOI 10.1242/dev.030049; Hofmeister W. F. B., 1862, GERMINATION DEV FRUC; Ishikawa M, 2011, PLANT CELL, V23, P2924, DOI 10.1105/tpc.111.088005; JEFFERSON RA, 1987, EMBO J, V6, P3901; Karol KG, 2001, SCIENCE, V294, P2351, DOI 10.1126/science.1065156; LEE JHW, 2008, J HYDRO-ENVIRON RES, V2, P133, DOI DOI 10.1016/S1570-6443(08)00079-8; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Mosquna A, 2009, DEVELOPMENT, V136, P2433, DOI 10.1242/dev.035048; Mukherjee K, 2009, MOL BIOL EVOL, V26, P2775, DOI 10.1093/molbev/msp201; Nishimura Y, 2012, PLANT CELL, V24, P2401, DOI 10.1105/tpc.112.097865; Okano Y, 2009, P NATL ACAD SCI USA, V106, P16321, DOI 10.1073/pnas.0906997106; Pagnussat GC, 2007, PLANT CELL, V19, P3578, DOI 10.1105/tpc.107.054890; Pringsheim N., 1876, MONATSBER K AKAD WIS, V1876, P425; Sakakibara K, 2008, EVOL DEV, V10, P555, DOI 10.1111/j.1525-142X.2008.00271.x; Serikawa KA, 1997, PLANT J, V11, P853, DOI 10.1046/j.1365-313X.1997.11040853.x; Singer SD, 2007, PLANT CELL REP, V26, P1155, DOI 10.1007/s00299-007-0312-0; Smith HMS, 2002, P NATL ACAD SCI USA, V99, P9579, DOI 10.1073/pnas.092271599; STEIL W. N., 1939, BOT REV, V5, P433, DOI 10.1007/BF02878704; Truernit E, 2006, PLANT MOL BIOL, V60, P1, DOI 10.1007/s11103-005-1673-9; Zhao H, 2001, GENE DEV, V15, P2767, DOI 10.1101/gad.919501	26	94	98	2	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1067	1070		10.1126/science.1230082	http://dx.doi.org/10.1126/science.1230082			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23449590				2022-12-28	WOS:000315452000039
J	Qi, LS; Larson, MH; Gilbert, LA; Doudna, JA; Weissman, JS; Arkin, AP; Lim, WA				Qi, Lei S.; Larson, Matthew H.; Gilbert, Luke A.; Doudna, Jennifer A.; Weissman, Jonathan S.; Arkin, Adam P.; Lim, Wendell A.			Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression	CELL			English	Article							FLUORESCENT PROTEIN; ADAPTIVE IMMUNITY; TRANSCRIPTION; BACTERIA; SYSTEMS; INTERFERENCE; EVOLUTION; CLEAVAGE; ARCHAEA; COMPLEX	Targeted gene regulation on a genome-wide scale is a powerful strategy for interrogating, perturbing, and engineering cellular systems. Here, we develop a method for controlling gene expression based on Cas9, an RNA-guided DNA endonuclease from a type II CRISPR system. We show that a catalytically dead Cas9 lacking endonuclease activity, when coexpressed with a guide RNA, generates a DNA recognition complex that can specifically interfere with transcriptional elongation, RNA polymerase binding, or transcription factor binding. This system, which we call CRISPR interference (CRISPRi), can efficiently repress expression of targeted genes in Escherichia coli, with no detectable off-target effects. CRISPRi can be used to repress multiple target genes simultaneously, and its effects are reversible. We also show evidence that the system can be adapted for gene repression in mammalian cells. This RNA-guided DNA recognition platform provides a simple approach for selectively perturbing gene expression on a genome-wide scale.	[Qi, Lei S.; Lim, Wendell A.] Univ Calif San Francisco, UCSF Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA; [Qi, Lei S.; Larson, Matthew H.; Gilbert, Luke A.; Weissman, Jonathan S.; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Larson, Matthew H.; Gilbert, Luke A.; Weissman, Jonathan S.; Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Arkin, Adam P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Qi, Lei S.; Larson, Matthew H.; Gilbert, Luke A.; Doudna, Jennifer A.; Weissman, Jonathan S.; Arkin, Adam P.; Lim, Wendell A.] Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Doudna, Jennifer A.; Arkin, Adam P.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Qi, LS (corresponding author), Univ Calif San Francisco, UCSF Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA.	stanley.qi@ucsf.edu	Arkin, Adam P/A-6751-2008; Wilson, Matthew H/K-3193-2013; Larson, Matthew/C-8289-2014; Arkin, Adam/M-9941-2019; Qi, Lei S/AAC-5088-2019; Gilbert, Luke/AAC-5300-2019	Arkin, Adam P/0000-0002-4999-2931; Larson, Matthew/0000-0002-6778-2604; Arkin, Adam/0000-0002-4999-2931; Qi, Lei S/0000-0002-3965-3223; Gilbert, Luke/0000-0001-5854-0825; Weissman, Jonathan/0000-0003-2445-670X	NIH [P50 GM081879]; Howard Hughes Medical Institute; NSF SynBERC [EEC-0540879]; Howard Hughes Collaborative Initiative Award; Ruth L. Kirschstein National Research Service Award; UCSF Center for Systems and Synthetic Biology; NATIONAL CANCER INSTITUTE [U01CA168370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879, F32GM100611] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NSF SynBERC(National Science Foundation (NSF)); Howard Hughes Collaborative Initiative Award(Howard Hughes Medical Institute); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Center for Systems and Synthetic Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Martin Jinek for discussion and distribution of Cas9 and dCas9 genes and Connie Lee for discussion and critical reading of the manuscript. The authors also thank Leonardo Morsut and Esteban Toro for technical advice and help. L. S. Q. acknowledges support from the UCSF Center for Systems and Synthetic Biology. This work was supported by NIH P50 GM081879 (L. S. Q. and W. A. L.), Howard Hughes Medical Institute (L. A. G., J. A. D., J. S. W., and W. A. L.), NSF SynBERC EEC-0540879 (A. P. A. and W. A. L.), a Howard Hughes Collaborative Initiative Award (J. S. W.), and a Ruth L. Kirschstein National Research Service Award (M. H. L.). J. A. D. is a founder of Caribou Biosciences and a member of its scientific advisory board. None of the other authors have a financial interest related to this work. The authors have filed a patent related to this work.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cho SW, 2013, NAT BIOTECHNOL; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hwang W.Y., 2013, NAT BIOTECHNOL; Jiang W., 2013, NAT BIOTECHNOL; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Lewis M, 2005, CR BIOL, V328, P521, DOI 10.1016/j.crvi.2005.04.004; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P11063, DOI 10.1073/pnas.1106501108; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NUDLER E, 1994, SCIENCE, V265, P793, DOI 10.1126/science.8047884; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Qi L, 2012, NAT BIOTECHNOL, V30, P1002, DOI 10.1038/nbt.2355; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	29	2730	3210	65	1153	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 28	2013	152	5					1173	1183		10.1016/j.cell.2013.02.022	http://dx.doi.org/10.1016/j.cell.2013.02.022			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452860	Bronze, Green Accepted			2022-12-28	WOS:000315710300022
J	Osborn, HA; Papsin, BC				Osborn, Heather A.; Papsin, Blake C.			Acute Onset of Retrosternal and Epigastric Pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ESOPHAGEAL-PERFORATION; CHILDREN		[Osborn, Heather A.; Papsin, Blake C.] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON M5G 2N2, Canada	University of Toronto	Osborn, HA (corresponding author), Univ Toronto, Dept Otolaryngol Head & Neck Surg, St George Campus,190 Elizabeth St,Room 3S438,RFE, Toronto, ON M5G 2N2, Canada.	h.osborn@utoronto.ca	Edwards, Heather/AFW-5006-2022	(Osborn) Edwards, Heather/0000-0002-1513-6205				Antonis JHA, 2006, J PEDIATR SURG, V41, P1620, DOI 10.1016/j.jpedsurg.2006.05.003; Broadbent K, 2011, AUST FAM PHYSICIAN, V40, P605; Carrott PW, 2011, THORAC SURG CLIN, V21, P541, DOI 10.1016/j.thorsurg.2011.08.002; Garey CL, 2010, J SURG RES, V164, P13, DOI 10.1016/j.jss.2010.05.049; Loh HJ, 2004, MED J AUSTRALIA, V181, P554, DOI 10.5694/j.1326-5377.2004.tb06445.x; ORISCELLO RG, 1988, NEW ENGL J MED, V319, P450	6	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2013	309	8					823	824		10.1001/jama.2013.737	http://dx.doi.org/10.1001/jama.2013.737			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095KD	23443446				2022-12-28	WOS:000315332200028
J	Andreae, MO				Andreae, Meinrat O.			The Aerosol Nucleation Puzzle	SCIENCE			English	Editorial Material							NANOPARTICLES		Max Planck Inst Chem, Biogeochem Dept, D-55020 Mainz, Germany	Max Planck Society	Andreae, MO (corresponding author), Max Planck Inst Chem, Biogeochem Dept, D-55020 Mainz, Germany.	m.andreae@mpic.de	Andreae, Meinrat O./B-1068-2008	Andreae, Meinrat O./0000-0003-1968-7925				Kazil J, 2010, ATMOS CHEM PHYS, V10, P10733, DOI 10.5194/acp-10-10733-2010; Keskinen H., 2012, ATMOS CHEM PHYS DISC, V12, P31071, DOI [10.5194/acpd-12-31071-2012, DOI 10.5194/ACPD-12-31071-2012]; Kulmala M, 2013, SCIENCE, V339, P943, DOI 10.1126/science.1227385; Merikanto J, 2009, ATMOS CHEM PHYS, V9, P8601, DOI 10.5194/acp-9-8601-2009; Pohlker C, 2012, SCIENCE, V337, P1075, DOI 10.1126/science.1223264; Smith JN, 2010, P NATL ACAD SCI USA, V107, P6634, DOI 10.1073/pnas.0912127107; Zhang RY, 2012, CHEM REV, V112, P1957, DOI 10.1021/cr2001756; Zhang RY, 2010, SCIENCE, V328, P1366, DOI 10.1126/science.1189732	8	34	34	2	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2013	339	6122					911	912		10.1126/science.1233798	http://dx.doi.org/10.1126/science.1233798			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23430641				2022-12-28	WOS:000315149600033
J	Kulmala, M; Kontkanen, J; Junninen, H; Lehtipalo, K; Manninen, HE; Nieminen, T; Petaja, T; Sipila, M; Schobesberger, S; Rantala, P; Franchin, A; Jokinen, T; Jarvinen, E; Aijala, M; Kangasluoma, J; Hakala, J; Aalto, PP; Paasonen, P; Mikkila, J; Vanhanen, J; Aalto, J; Hakola, H; Makkonen, U; Ruuskanen, T; Mauldin, RL; Duplissy, J; Vehkamaki, H; Back, J; Kortelainen, A; Riipinen, I; Kurten, T; Johnston, MV; Smith, JN; Ehn, M; Mentel, TF; Lehtinen, KEJ; Laaksonen, A; Kerminen, VM; Worsnop, DR				Kulmala, Markku; Kontkanen, Jenni; Junninen, Heikki; Lehtipalo, Katrianne; Manninen, Hanna E.; Nieminen, Tuomo; Petaja, Tuukka; Sipila, Mikko; Schobesberger, Siegfried; Rantala, Pekka; Franchin, Alessandro; Jokinen, Tuija; Jarvinen, Emma; Aijala, Mikko; Kangasluoma, Juha; Hakala, Jani; Aalto, Pasi P.; Paasonen, Pauli; Mikkila, Jyri; Vanhanen, Joonas; Aalto, Juho; Hakola, Hannele; Makkonen, Ulla; Ruuskanen, Taina; Mauldin, Roy L., III; Duplissy, Jonathan; Vehkamaki, Hanna; Back, Jaana; Kortelainen, Aki; Riipinen, Ilona; Kurten, Theo; Johnston, Murray V.; Smith, James N.; Ehn, Mikael; Mentel, Thomas F.; Lehtinen, Kari E. J.; Laaksonen, Ari; Kerminen, Veli-Matti; Worsnop, Douglas R.			Direct Observations of Atmospheric Aerosol Nucleation	SCIENCE			English	Article							SULFURIC-ACID; PARTICLE FORMATION; SMEAR-II; CLUSTERS; GROWTH; CLIMATE; AMINE; RATES; WATER; NANOPARTICLES	Atmospheric nucleation is the dominant source of aerosol particles in the global atmosphere and an important player in aerosol climatic effects. The key steps of this process occur in the sub-2-nanometer (nm) size range, in which direct size-segregated observations have not been possible until very recently. Here, we present detailed observations of atmospheric nanoparticles and clusters down to 1-nm mobility diameter. We identified three separate size regimes below 2-nm diameter that build up a physically, chemically, and dynamically consistent framework on atmospheric nucleation-more specifically, aerosol formation via neutral pathways. Our findings emphasize the important role of organic compounds in atmospheric aerosol formation, subsequent aerosol growth, radiative forcing and associated feedbacks between biogenic emissions, clouds, and climate.	[Kulmala, Markku; Kontkanen, Jenni; Junninen, Heikki; Lehtipalo, Katrianne; Manninen, Hanna E.; Nieminen, Tuomo; Petaja, Tuukka; Sipila, Mikko; Schobesberger, Siegfried; Rantala, Pekka; Franchin, Alessandro; Jokinen, Tuija; Jarvinen, Emma; Aijala, Mikko; Kangasluoma, Juha; Hakala, Jani; Aalto, Pasi P.; Paasonen, Pauli; Ruuskanen, Taina; Mauldin, Roy L., III; Duplissy, Jonathan; Vehkamaki, Hanna; Kurten, Theo; Ehn, Mikael; Kerminen, Veli-Matti; Worsnop, Douglas R.] Univ Helsinki, Dept Phys, FIN-00014 Helsinki, Finland; [Mikkila, Jyri; Vanhanen, Joonas] Airmodus Oy, Helsinki, Finland; [Aalto, Juho] SMEAR Stn II, Hyytiala, Finland; [Hakola, Hannele; Makkonen, Ulla; Lehtinen, Kari E. J.; Laaksonen, Ari; Worsnop, Douglas R.] Finnish Meteorol Inst, Helsinki, Finland; [Mauldin, Roy L., III] Univ Colorado, Boulder, CO 80309 USA; [Back, Jaana] Univ Helsinki, Dept Forest Sci, FIN-00014 Helsinki, Finland; [Kortelainen, Aki; Smith, James N.; Lehtinen, Kari E. J.; Laaksonen, Ari; Worsnop, Douglas R.] Univ Eastern Finland, Kuopio, Finland; [Riipinen, Ilona] Univ Stockholm, Stockholm, Sweden; [Kurten, Theo] Univ Helsinki, Dept Chem, FIN-00014 Helsinki, Finland; [Johnston, Murray V.] Univ Delaware, Newark, DE USA; [Smith, James N.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Ehn, Mikael; Mentel, Thomas F.] Forschungszentrum Julich, IEK 8, D-52425 Julich, Germany; [Worsnop, Douglas R.] Aerodyne Res Inc, Billerica, MA 01821 USA; [Nieminen, Tuomo] Helsinki Inst Phys, Helsinki, Finland	University of Helsinki; Finnish Meteorological Institute; University of Colorado System; University of Colorado Boulder; University of Helsinki; University of Eastern Finland; Stockholm University; University of Helsinki; University of Delaware; National Center Atmospheric Research (NCAR) - USA; Helmholtz Association; Research Center Julich; Aerodyne Research; Helsinki Institute of Physics	Kulmala, M (corresponding author), Univ Helsinki, Dept Phys, FIN-00014 Helsinki, Finland.	markku.kulmala@helsinki.fi	Worsnop, Douglas R/D-2817-2009; Laaksonen, Ari/B-5094-2011; Bäck, Jaana K/A-7405-2010; Kontkanen, Jenni/AAL-1368-2020; kangasluoma, juha/W-7450-2019; Franchin, Alessandro/GVR-8219-2022; Franchin, Alessandro/K-1765-2013; Aalto, Pasi P/A-1539-2009; Petäjä, Tuukka/A-8009-2008; Franchin, Alessandro/AAH-3069-2019; Lehtinen, Kari/O-9559-2018; Kurtén, Theo C/G-2120-2012; Jokinen, Tuija/B-3365-2014; Vehkamäki, Hanna/A-8262-2008; Ehn, Mikael/N-2571-2016; Paasonen, Pauli/M-2972-2013; Hakola, Hannele/N-7502-2014; Nieminen, Tuomo J/D-1618-2011; Smith, James/C-5614-2008; Nieminen, Tuomo/AAB-8686-2020; Kerminen, Veli-Matti/M-9026-2014; Riipinen, Ilona/ABD-5564-2021; Sipilä, Mikko/G-3024-2010; Duplissy, Jonathan/A-1723-2010; Järvinen, Emma/G-7120-2014; Riipinen, Ilona/I-9379-2012; Schobesberger, Siegfried/L-4454-2014; Kangasluoma, Juha/AAY-7941-2021; Makkonen, Ulla/AAV-9196-2021; Kulmala, Markku T/I-7671-2016; Mentel, Thomas F/A-3576-2011; Junninen, Heikki/C-2157-2014	Worsnop, Douglas R/0000-0002-8928-8017; Laaksonen, Ari/0000-0002-1657-2383; Bäck, Jaana K/0000-0002-6107-667X; Kontkanen, Jenni/0000-0002-5373-3537; Aalto, Pasi P/0000-0001-8826-9108; Petäjä, Tuukka/0000-0002-1881-9044; Kurtén, Theo C/0000-0002-6416-4931; Jokinen, Tuija/0000-0002-1280-1396; Vehkamäki, Hanna/0000-0002-5018-1255; Ehn, Mikael/0000-0002-0215-4893; Paasonen, Pauli/0000-0002-4625-9590; Smith, James/0000-0003-4677-8224; Nieminen, Tuomo/0000-0002-2713-715X; Sipilä, Mikko/0000-0002-8594-7003; Duplissy, Jonathan/0000-0001-8819-0264; Järvinen, Emma/0000-0001-5171-1759; Schobesberger, Siegfried/0000-0002-5777-4897; Kangasluoma, Juha/0000-0002-1639-1187; Kulmala, Markku T/0000-0003-3464-7825; Mentel, Thomas F/0000-0003-0810-3541; Junninen, Heikki/0000-0001-7178-9430; Lehtipalo, Katrianne/0000-0002-1660-2706; Rantala, Pekka/0000-0002-7243-0611	European Research Council [227463-ATMNUCLE, 257360-MOCAPAF]; Academy of Finland Centre of Excellence program;  [1118615];  [1127372]	European Research Council(European Research Council (ERC)European Commission); Academy of Finland Centre of Excellence program(Academy of Finland); ; 	This work was funded by the European Research Council Project (grant nos. 227463-ATMNUCLE and 257360-MOCAPAF). We thank the Academy of Finland Centre of Excellence program and related projects (grants nos. 1118615 and 1127372) for support.	Bzdek BR, 2011, ATMOS CHEM PHYS, V11, P8735, DOI 10.5194/acp-11-8735-2011; Carslaw KS, 2010, ATMOS CHEM PHYS, V10, P1701, DOI 10.5194/acp-10-1701-2010; Dal Maso M, 2005, BOREAL ENVIRON RES, V10, P323; Donahue NM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048115; Ehn M, 2012, ATMOS CHEM PHYS, V12, P5113, DOI 10.5194/acp-12-5113-2012; Hari P, 2005, BOREAL ENVIRON RES, V10, P315; Hirsikko A, 2011, ATMOS CHEM PHYS, V11, P767, DOI 10.5194/acp-11-767-2011; Kazil J, 2010, ATMOS CHEM PHYS, V10, P10733, DOI 10.5194/acp-10-10733-2010; Kerminen VM, 2010, ATMOS CHEM PHYS, V10, P10829, DOI 10.5194/acp-10-10829-2010; Kuang C, 2012, ATMOS CHEM PHYS, V12, P3573, DOI 10.5194/acp-12-3573-2012; Kulmala M, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003961; Kulmala M, 2004, ATMOS CHEM PHYS, V4, P557, DOI 10.5194/acp-4-557-2004; Kulmala M, 2000, NATURE, V404, P66, DOI 10.1038/35003550; Kulmala M, 2004, J AEROSOL SCI, V35, P143, DOI 10.1016/j.jaerosci.2003.10.003; Kulmala M, 2007, SCIENCE, V318, P89, DOI 10.1126/science.1144124; Kurten T, 2008, ATMOS CHEM PHYS, V8, P4095, DOI 10.5194/acp-8-4095-2008; Loukonen V, 2010, ATMOS CHEM PHYS, V10, P4961, DOI 10.5194/acp-10-4961-2010; Makkonen R, 2012, ATMOS CHEM PHYS, V12, P1515, DOI 10.5194/acp-12-1515-2012; Merikanto J, 2009, ATMOS CHEM PHYS, V9, P8601, DOI 10.5194/acp-9-8601-2009; Metzger A, 2010, P NATL ACAD SCI USA, V107, P6646, DOI 10.1073/pnas.0911330107; Ortega IK, 2012, ATMOS CHEM PHYS, V12, P225, DOI 10.5194/acp-12-225-2012; Paasonen P, 2012, ATMOS CHEM PHYS, V12, P9113, DOI 10.5194/acp-12-9113-2012; Paasonen P, 2010, ATMOS CHEM PHYS, V10, P11223, DOI 10.5194/acp-10-11223-2010; Petaja T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.228302; Sipila M, 2010, SCIENCE, V327, P1243, DOI 10.1126/science.1180315; Spracklen DV, 2006, ATMOS CHEM PHYS, V6, P5631, DOI 10.5194/acp-6-5631-2006; Wagner PE, 2001, J PHYS CHEM B, V105, P11656, DOI 10.1021/jp011460x; Wang L, 2010, NAT GEOSCI, V3, P238, DOI 10.1038/NGEO778; Weber RJ, 1996, CHEM ENG COMMUN, V151, P53, DOI 10.1080/00986449608936541; Zhang RY, 2012, CHEM REV, V112, P1957, DOI 10.1021/cr2001756; Zhao J, 2011, ATMOS CHEM PHYS, V11, P10823, DOI 10.5194/acp-11-10823-2011	31	706	721	25	910	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2013	339	6122					943	946		10.1126/science.1227385	http://dx.doi.org/10.1126/science.1227385			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23430652				2022-12-28	WOS:000315149600045
J	Rodriguez, PL; Harada, T; Christian, DA; Pantano, DA; Tsai, RK; Discher, DE				Rodriguez, Pia L.; Harada, Takamasa; Christian, David A.; Pantano, Diego A.; Tsai, Richard K.; Discher, Dennis E.			Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles	SCIENCE			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; SIGNAL-REGULATORY PROTEIN; IN-VIVO; CD47; CELLS; MEMBRANE; TARGET; ALPHA; ENGRAFTMENT; ACTIVATION	Foreign particles and cells are cleared from the body by phagocytes that must also recognize and avoid clearance of "self" cells. The membrane protein CD47 is reportedly a "marker of self" in mice that impedes phagocytosis of self by signaling through the phagocyte receptor CD172a. Minimal "Self" peptides were computationally designed from human CD47 and then synthesized and attached to virus-size particles for intravenous injection into mice that express a CD172a variant compatible with hCD47. Self peptides delay macrophage-mediated clearance of nanoparticles, which promotes persistent circulation that enhances dye and drug delivery to tumors. Self-peptide affinity for CD172a is near the optimum measured for human CD172a variants, and Self peptide also potently inhibits nanoparticle uptake mediated by the contractile cytoskeleton. The reductionist approach reveals the importance of human Self peptides and their utility in enhancing drug delivery and imaging.	[Rodriguez, Pia L.; Harada, Takamasa; Christian, David A.; Pantano, Diego A.; Tsai, Richard K.; Discher, Dennis E.] Univ Penn, Mol & Cell Biophys & NanoBioPolymers Lab, Philadelphia, PA 19104 USA; [Discher, Dennis E.] Univ Penn, Pharmacol Sci Grad Grp, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Discher, DE (corresponding author), Univ Penn, Mol & Cell Biophys & NanoBioPolymers Lab, Philadelphia, PA 19104 USA.	discher@seas.upenn.edu	Christian, David/AAE-6425-2019	discher, dennis/0000-0001-6163-2229	NIH [R01-EB007049, R01-HL062352, P01-DK032094, NCATS-8UL1TR000003, P30-DK090969]; NSF (Materials Research Science and Engineering Center, and Nano Science and Engineering Center-Nano Bio Interface Center); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK032094, P30DK090969] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF (Materials Research Science and Engineering Center, and Nano Science and Engineering Center-Nano Bio Interface Center); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The assistance of A. Secreto, J. Glover, and G. Danet-Desnoyers of the Stem Cell Xenograft Core at the University of Pennsylvania is very gratefully acknowledged as is technical assistance of K. Hsu, P. Bhoorasingh, and V. Carnevale. Support from the NIH (R01-EB007049, R01-HL062352, P01-DK032094, NCATS-8UL1TR000003, P30-DK090969) and NSF (Materials Research Science and Engineering Center, and Nano Science and Engineering Center-Nano Bio Interface Center) is also very gratefully acknowledged. P. L. R., D. A. P., and D. E. D. are authors on a patent applied for by the University of Pennsylvania on the Self peptide with first disclosure filed on 16 August 2010.	Armstrong JK, 2007, CANCER-AM CANCER SOC, V110, P103, DOI 10.1002/cncr.22739; Bartlett DW, 2007, P NATL ACAD SCI USA, V104, P15549, DOI 10.1073/pnas.0707461104; Bentley AA, 2010, MOL BIOL EVOL, V27, P2187, DOI 10.1093/molbev/msq107; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Cameron CM, 2005, VIROLOGY, V337, P55, DOI 10.1016/j.virol.2005.03.037; Cox D, 2001, SEMIN IMMUNOL, V13, P339, DOI 10.1006/smim.2001.0330; Glodek AM, 2010, BLOOD, V116, P6063, DOI 10.1182/blood-2010-04-273904; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Hong RL, 1999, CLIN CANCER RES, V5, P3645; KLIBANOV AL, 1991, BIOCHIM BIOPHYS ACTA, V1062, P142, DOI 10.1016/0005-2736(91)90385-L; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; MACDONALD IC, 1991, MICROVASC RES, V42, P60, DOI 10.1016/0026-2862(91)90075-M; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Mouro-Chanteloup I, 2003, BLOOD, V101, P338, DOI 10.1182/blood-2002-04-1285; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Photos PJ, 2003, J CONTROL RELEASE, V90, P323, DOI 10.1016/S0168-3659(03)00201-3; Rossin R, 2008, J NUCL MED, V49, P103, DOI 10.2967/jnumed.107.045302; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; Stachelek SJ, 2011, BIOMATERIALS, V32, P4317, DOI 10.1016/j.biomaterials.2011.02.053; Strowig T, 2011, P NATL ACAD SCI USA, V108, P13218, DOI 10.1073/pnas.1109769108; Subramanian S, 2006, BLOOD, V107, P2548, DOI 10.1182/blood-2005-04-1463; Subramanian S, 2007, J BIOL CHEM, V282, P1805, DOI 10.1074/jbc.M603923200; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043; Turk MJ, 2004, CANCER LETT, V213, P165, DOI 10.1016/j.canlet.2003.12.028; TURRINI F, 1993, BLOOD, V81, P3146; Wilflingseder D, 2007, J IMMUNOL, V178, P7840, DOI 10.4049/jimmunol.178.12.7840; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109	31	661	727	18	601	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2013	339	6122					971	975		10.1126/science.1229568	http://dx.doi.org/10.1126/science.1229568			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23430657	Green Accepted			2022-12-28	WOS:000315149600053
J	Munjal, K; Carr, B				Munjal, Kevin; Carr, Brendan			Realigning Reimbursement Policy and Financial Incentives to Support Patient-Centered Out-of-Hospital Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Munjal, Kevin] Mt Sinai Med Ctr, Dept Emergency Med, New York, NY 10029 USA; [Carr, Brendan] Univ Penn, Perelman Sch Med, Ctr Emergency Care Policy & Res, Dept Emergency Med & Epidemiol, Philadelphia, PA 19104 USA; [Carr, Brendan] US Dept HHS, Off Assistant Secretary Preparedness & Response, Washington, DC 20201 USA	Icahn School of Medicine at Mount Sinai; University of Pennsylvania	Munjal, K (corresponding author), Mt Sinai Med Ctr, Dept Emergency Med, 1 Gustave L Levy Pl, New York, NY 10029 USA.	kevin.munjal@mountsinai.org	Munjal, Kevin/L-4715-2016					Agency for Healthcare Research & Quality, 2010, MED EXP PAN SURV TAB; [Anonymous], 2007, EMERGENCY MED SERVIC; Centers for Medicare & Medicaid Services, 2010, AMB BILL GUID DEC 20; Delbridge TR, 1998, ANN EMERG MED, V31, P251, DOI 10.1016/S0196-0644(98)70316-6; Joint Committee on Rural Emergency Care (JCREC), 2010, DEV COMM PAR PROGR; Levinson DR, 2006, MEDICARE PAYMENTS AM; Munjal KG, 2011, PREHOSP EMERG CARE, V15, P371, DOI 10.3109/10903127.2011.561403; US Government Accountability Office, 2012, AMB PROV COSTS MED M	8	29	28	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2013	309	7					667	668		10.1001/jama.2012.211273	http://dx.doi.org/10.1001/jama.2012.211273			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091EK	23423411				2022-12-28	WOS:000315032000020
J	Zarychanski, R; Abou-Setta, AM; Turgeon, AF; Houston, BL; McIntyre, L; Marshall, JC; Fergusson, DA				Zarychanski, Ryan; Abou-Setta, Ahmed M.; Turgeon, Alexis F.; Houston, Brett L.; McIntyre, Lauralyn; Marshall, John C.; Fergusson, Dean A.			Association of Hydroxyethyl Starch Administration With Mortality and Acute Kidney Injury in Critically Ill Patients Requiring Volume Resuscitation A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							MODIFIED FLUID GELATIN; RENAL-FUNCTION; SEVERE SEPSIS; 6-PERCENT HYDROXYETHYLSTARCH; PENTOXIFYLLINE INFUSION; ADHESION MOLECULES; ALBUMIN; THERAPY; PENTASTARCH; COAGULATION	Importance Hydroxyethyl starch is commonly used for volume resuscitation yet has been associated with serious adverse events, including acute kidney injury and death. Clinical trials of hydroxyethyl starch are conflicting. Moreover, multiple trials from one investigator have been retracted because of scientific misconduct. Objectives To evaluate the association of hydroxyethyl starch use with mortality and acute kidney injury. Data Sources Randomized controlled trials from MEDLINE, EMBASE, CENTRAL, Global Health, HealthStar, Scopus, Web of Science, the International Clinical Trials Registry Platform (inception to October 2012), reference lists of relevant articles, and gray literature. Study Selection Two reviewers independently identified randomized controlled trials comparing hydroxyethyl starch with other resuscitation fluids in critically ill patients receiving acute volume resuscitation. Data Extraction Two reviewers independently extracted trial-level data including population characteristics, interventions, outcomes, and funding sources. Risk of bias was assessed using the risk of bias tool; the strength of evidence was adjudicated using the GRADE methodology. Results We included 38 eligible trials comparing hydroxyethyl starch to crystalloids, albumin, or gelatin. The majority of trials were categorized as having an unclear risk or high risk of bias. For the 10 880 patients in studies contributing mortality data, the risk ratio (RR) for death among patients randomized to receive hydroxyethyl starch was 1.07 (95% CI, 1.00 to 1.14; I-2, 0%; absolute risk [AR], 1.20%; 95% CI, -0.26% to 2.66%). This summary effect measure included results from 7 trials performed by an investigator whose subsequent research had been retracted because of scientific misconduct. When we excluded these 7 trials that involved 590 patients, hydroxyethyl starch was found to be associated with increased mortality among 10 290 patients (RR, 1.09; 95% CI, 1.02 to 1.17; I-2, 0%; AR, 1.51%; 95% CI, 0.02% to 3.00%), increased renal failure among 8725 patients (RR, 1.27; 95% CI, 1.09 to 1.47; I-2, 26%; AR, 5.45%; 95% CI, 0.44% to 10.47%), and increased use of renal replacement therapy among 9258 patients (RR, 1.32; 95% CI, 1.15 to 1.50; I-2, 0%; AR, 3.12%; 95% CI, 0.47% to 5.78%). Conclusion and Relevance In critically ill patients requiring acute volume resuscitation, use of hydroxyethyl starch compared with other resuscitation solutions was not associated with a decrease in mortality. Moreover, after exclusion of 7 trials performed by an investigator whose research has been retracted because of scientific misconduct, hydroxyethyl starch was associated with a significant increased risk of mortality and acute kidney injury. Clinical use of hydroxyethyl starch for acute volume resuscitation is not warranted due to serious safety concerns. JAMA. 2013;309(7):678-688 www.jama.com	[Zarychanski, Ryan] Univ Manitoba, Dept Internal Med, Sect Crit Care, Winnipeg, MB R3E 0V9, Canada; [Zarychanski, Ryan] Univ Manitoba, Dept Internal Med, Sect Hematol & Med Oncol, Winnipeg, MB R3E 0V9, Canada; [Zarychanski, Ryan; Abou-Setta, Ahmed M.] Univ Manitoba, George & Fay Yee Ctr Healthcare Innovat, Winnipeg, MB R3E 0V9, Canada; [Zarychanski, Ryan; Abou-Setta, Ahmed M.] Winnipeg Reg Hlth Author, Winnipeg, MB, Canada; [Zarychanski, Ryan] Cancercare Manitoba, Winnipeg, MB, Canada; [Turgeon, Alexis F.] Univ Laval, Hop Enfants Jesus, CHU Quebec, Ctr Rech,Dept Anesthesiol,Div Crit Care Med, Quebec City, PQ, Canada; [Houston, Brett L.] Univ Manitoba, Fac Med, Winnipeg, MB R3E 0V9, Canada; [McIntyre, Lauralyn; Fergusson, Dean A.] Univ Ottawa, Dept Med, Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Marshall, John C.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Marshall, John C.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	University of Manitoba; University of Manitoba; University of Manitoba; CancerCare Manitoba Foundation; Laval University; University of Manitoba; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Zarychanski, R (corresponding author), Univ Manitoba, Dept Internal Med, Sect Crit Care, ON2056-675 McDermot Ave, Winnipeg, MB R3E 0V9, Canada.	ryan.zarychanski@cancercare.mb.ca	Zarychanski, Ryan/AAB-6369-2022; McIntyre, Lauralyn/AAR-7710-2021	McIntyre, Lauralyn/0000-0001-7421-1407; Fergusson, Dean/0000-0002-3389-2485; Houston, Brett/0000-0002-8776-4083; Zarychanski, Ryan/0000-0001-9455-6138; NOIRI, Eisei/0000-0002-9515-7582	Fonds de la Recherche du Quebec - Sante du (FRQ-S); Bristol-Myers Squibb; Abbott Laboratories; Canadian Institutes of Health Research (CIHR)	Fonds de la Recherche du Quebec - Sante du (FRQ-S); Bristol-Myers Squibb(Bristol-Myers Squibb); Abbott Laboratories(Abbott Laboratories); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Zarychanski and McIntyre reported that they receive salary support from the Canadian Institutes of Health Research (CIHR). Dr Turgeon reported that he receives salary support from the Fonds de la Recherche du Quebec - Sante du (FRQ-S). Dr McIntyre reported that she has received unrestricted grant support from Bristol-Myers Squibb and Abbott Laboratories.	[Anonymous], 2011, COMMUNICATION; [Anonymous], 2010, LANCET, V375, P445; [Anonymous], 2012, HOSP PRES RES FIN RE; Asfar P, 2000, INTENS CARE MED, V26, P1282, DOI 10.1007/s001340000606; BEARDS SC, 1994, CRIT CARE MED, V22, P600, DOI 10.1097/00003246-199404000-00015; BERARD JP, 1995, ANN FRANCAISES ANAES, V14, pR335; Boldt J, 1998, INTENS CARE MED, V24, P28, DOI 10.1007/s001340050511; Boldt J, 1996, INTENS CARE MED, V22, P1075, DOI 10.1007/s001340050216; Boldt J, 1996, ANAESTHESIA, V51, P529, DOI 10.1111/j.1365-2044.1996.tb12557.x; BOLDT J, 1995, BRIT J ANAESTH, V75, P740, DOI 10.1093/bja/75.6.740; Boldt J, 1996, CRIT CARE MED, V24, P385, DOI 10.1097/00003246-199603000-00005; Boldt J, 1996, BRIT J ANAESTH, V77, P480, DOI 10.1093/bja/77.4.480; Boldt J, 1996, ANESTH ANALG, V83, P254, DOI 10.1097/00000539-199608000-00010; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Bunn F, 2012, COCHRANE DB SYST REV, V7; Carli P, 2000, J EUROPEEN URGENCES, V13, P101; Carlisle JB, 2012, ANAESTHESIA, V67, P521, DOI 10.1111/j.1365-2044.2012.07128.x; Chen Jiong, 2006, Zhonghua Shao Shang Za Zhi, V22, P333; Cittanova ML, 1996, LANCET, V348, P1620, DOI 10.1016/S0140-6736(96)07588-5; Dolecek M, 2009, HEPATO-GASTROENTEROL, V56, P1622; Du XJ, 2011, PANCREAS, V40, P1220, DOI 10.1097/MPA.0b013e3182217f17; Dubin Arnaldo, 2010, J Crit Care, V25, DOI 10.1016/j.jcrc.2010.04.007; FALK JL, 1988, J CLIN PHARMACOL, V28, P412, DOI 10.1002/j.1552-4604.1988.tb05751.x; Gattas DJ, 2012, ANESTH ANALG, V114, P159, DOI 10.1213/ANE.0b013e318236b4d6; Gondos T, 2010, EUR J ANAESTH, V27, P794, DOI 10.1097/EJA.0b013e32833b3504; Guidet B, 2012, CRIT CARE, V16, DOI 10.1186/cc11358; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hartog CS, 2012, INTENS CARE MED, V38, P1258, DOI 10.1007/s00134-012-2614-0; HAUPT MT, 1982, CRIT CARE MED, V10, P159, DOI 10.1097/00003246-198203000-00004; Hayashino Y, 2005, J EPIDEMIOL, V15, P235, DOI 10.2188/jea.15.235; Heradstveit BE, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-29; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Inal MT, 2010, J CRIT CARE, V25, DOI 10.1016/j.jcrc.2009.06.013; James MFM, 2011, BRIT J ANAESTH, V107, P693, DOI 10.1093/bja/aer229; Jungheinrich C, 2005, CLIN PHARMACOKINET, V44, P681, DOI 10.2165/00003088-200544070-00002; Kamann Stefanie, 2007, J Dtsch Dermatol Ges, V5, P204, DOI 10.1111/j.1610-0387.2007.06239.x; Li Feng, 2008, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V20, P472; Lv Jie, 2012, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V24, P38; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; McIntyre LA, 2008, CAN J ANAESTH, V55, P819, DOI 10.1007/BF03034053; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Molnar Z, 2004, INTENS CARE MED, V30, P1356, DOI 10.1007/s00134-004-2278-5; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; NAGY KK, 1993, CIRC SHOCK, V40, P289; Perel P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub5; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; RACKOW EC, 1989, CRIT CARE MED, V17, P394, DOI 10.1097/00003246-198905000-00003; Rama-Maceiras P, 2009, REV ESP ANEST REANIM, V56, P372, DOI 10.1016/S0034-9356(09)70410-4; RANDELL T, 1990, ACTA ANAESTH SCAND, V34, P592, DOI 10.1111/j.1399-6576.1990.tb03151.x; Sadaka F., 2012, EFFECT 3 DIFFERENT F; Siegemund M., 2012, BASES TRIAL BASEL ST; Sirtl C, 1999, BRIT J ANAESTH, V82, P510, DOI 10.1093/bja/82.4.510; van der Heijden M, 2009, CRIT CARE MED, V37, P1275, DOI 10.1097/CCM.0b013e31819cedfd; Veneman TF, 2004, WIEN KLIN WOCHENSCHR, V116, P305, DOI 10.1007/BF03040900; VERMEULEN LC, 1995, ARCH INTERN MED, V155, P373, DOI 10.1001/archinte.155.4.373; Vlachou E, 2010, BURNS, V36, P984, DOI 10.1016/j.burns.2010.04.001; Younes RN, 1998, WORLD J SURG, V22, P2; Zarychanski R, SERIOUS ADVERSE EVEN; Zarychanski Ryan, 2009, Open Med, V3, pe196; Zhao G, 2011, HPB OXFORD S2, V13, P1; Zhu Guo-chao, 2011, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V23, P150	66	410	448	3	74	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2013	309	7					678	688		10.1001/jama.2013.430	http://dx.doi.org/10.1001/jama.2013.430			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091EK	23423413	Bronze			2022-12-28	WOS:000315032000023
J	Hayden, JA; van der Windt, DA; Cartwright, JL; Cote, P; Bombardier, C				Hayden, Jill A.; van der Windt, Danielle A.; Cartwright, Jennifer L.; Cote, Pierre; Bombardier, Claire			Assessing Bias in Studies of Prognostic Factors	ANNALS OF INTERNAL MEDICINE			English	Review							CHRONIC KIDNEY-DISEASE; SYSTEMATIC REVIEWS; QUALITY ASSESSMENT; CAROTID BRUITS; METAANALYSIS; RISK; OSTEOARTHRITIS; EPIDEMIOLOGY; PROGRESSION; OVERWEIGHT	Previous work has identified 6 important areas to consider when evaluating validity and bias in studies of prognostic factors: participation, attrition, prognostic factor measurement, confounding measurement and account, outcome measurement, and analysis and reporting. This article describes the Quality In Prognosis Studies tool, which includes questions related to these areas that can inform judgments of risk of bias in prognostic research. A working group comprising epidemiologists, statisticians, and clinicians developed the tool as they considered prognosis studies of low back pain. Forty-three groups reviewing studies addressing prognosis in other topic areas used the tool and provided feedback. Most reviewers (74%) reported that reaching consensus on judgments was easy. Median completion time per study was 20 minutes; interrater agreement (kappa statistic) reported by 9 review teams varied from 0.56 to 0.82 (median, 0.75). Some reviewers reported challenges making judgments across prompting items, which were addressed by providing comprehensive guidance and examples. The refined Quality In Prognosis Studies tool may be useful to assess the risk of bias in studies of prognostic factors.	Dalhousie Univ, Halifax, NS B3H 1V7, Canada; Keele Univ, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England; Univ Ontario Inst Technol, Oshawa, ON L1H 7K4, Canada; Univ Toronto, Toronto, ON, Canada; Inst Work & Hlth, Toronto, ON, Canada	Dalhousie University; Keele University; Ontario Tech University; University of Toronto; Institute for Work & Health	Hayden, JA (corresponding author), Dalhousie Univ, Dept Epidemiol & Community Hlth, 5790 Univ Ave,Room 222, Halifax, NS B3H 1V7, Canada.	jhayden@dal.ca	Côté, Pierre/AAG-5358-2021	Côté, Pierre/0000-0002-6986-6676; Hayden, Jill Alison/0000-0001-7026-144X; Bombardier, Claire/0000-0001-5083-2137; van der Windt, Danielle/0000-0002-7248-6703	Nova Scotia Cochrane Resource Centre by the Nova Scotia Health Research Foundation; Canadian Chiropractic Research Foundation; Dalhousie University; MRC [G0902393] Funding Source: UKRI; Medical Research Council [G0902393] Funding Source: researchfish	Nova Scotia Cochrane Resource Centre by the Nova Scotia Health Research Foundation; Canadian Chiropractic Research Foundation; Dalhousie University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Dr. Hayden received infrastructure funding through the Nova Scotia Cochrane Resource Centre provided by the Nova Scotia Health Research Foundation and holds a Research Professorship in Epidemiology funded by the Canadian Chiropractic Research Foundation and Dalhousie University. Dr. van der Windt is a member of the Prognosis Research Strategy Initiative Medical Research Council, Prognosis Research Strategy Initiative Partnership (G0902393/99558).	Chapple CM, 2011, ARTHRIT CARE RES, V63, P1115, DOI 10.1002/acr.20492; Clay FJ, 2010, INJURY, V41, P787, DOI 10.1016/j.injury.2010.04.005; Elshout G, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-33; Gieteling MJ, 2011, J PEDIATR GASTR NUTR, V52, P154, DOI 10.1097/MPG.0b013e3181e82a28; Hartling L, 2012, VALIDITY INTERRATER; Hayden JA, 2008, J CLIN EPIDEMIOL, V61, P552, DOI 10.1016/j.jclinepi.2007.08.005; Hayden JA, 2009, J CLIN EPIDEMIOL, V62, P781, DOI 10.1016/j.jclinepi.2008.09.004; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Hayden JA, 2007, METHODOLOGICAL ISSUE; Hemingway H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000286; Hemingway H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4184; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Jeejeebhoy FM, 2011, RESUSCITATION, V82, P801, DOI 10.1016/j.resuscitation.2011.01.028; Jimenez D, 2009, CHEST, V136, P974, DOI 10.1378/chest.09-0608; Johnson SR, 2008, J RHEUMATOL, V35, P1584; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Kamper SJ, 2011, SPINE, V36, pS268, DOI 10.1097/BRS.0b013e3182388202; Mathew A, 2008, KIDNEY INT, V73, P1069, DOI 10.1038/ki.2008.29; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Moulaert VRMP, 2009, RESUSCITATION, V80, P297, DOI 10.1016/j.resuscitation.2008.10.034; National Institute for Health and Clinical Excellence, 2009, GUID MAN, P218; Nijrolder I, 2008, J PSYCHOSOM RES, V64, P335, DOI 10.1016/j.jpsychores.2007.11.001; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Pickett CA, 2008, LANCET, V371, P1587, DOI 10.1016/S0140-6736(08)60691-1; Pickett CA, 2010, STROKE, V41, P2295, DOI 10.1161/STROKEAHA.110.585554; Proper KI, 2011, AM J PREV MED, V40, P174, DOI 10.1016/j.amepre.2010.10.015; Riley RD, 2009, BRIT J CANCER, V100, P1219, DOI 10.1038/sj.bjc.6604999; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Shamliyan T, 2012, J CLIN EPIDEMIOL, V65, P610, DOI 10.1016/j.jclinepi.2011.10.017; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Spee Leo A A, 2010, Pediatrics, V125, pe651, DOI 10.1542/peds.2010-0941; van Drongelen A, 2011, SCAND J WORK ENV HEA, V37, P263, DOI 10.5271/sjweh.3143; van Duijvenbode DC, 2009, INT J OBESITY, V33, P807, DOI 10.1038/ijo.2009.121; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wright AA, 2009, ARTHRIT RHEUM-ARTHR, V61, P925, DOI 10.1002/art.24641	35	911	919	4	53	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2013	158	4					280	286		10.7326/0003-4819-158-4-201302190-00009	http://dx.doi.org/10.7326/0003-4819-158-4-201302190-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098WR	23420236				2022-12-28	WOS:000315580300019
J	Jeanloz, R; Fung, I; Bowyer, TW; Wofsy, SC				Jeanloz, Raymond; Fung, Inez; Bowyer, Theodore W.; Wofsy, Steven C.			Beyond Arms-Control Monitoring	SCIENCE			English	Editorial Material							AEROSOL; DUST; MICROORGANISMS; CLIMATE		[Jeanloz, Raymond; Fung, Inez] Univ Calif Berkeley, Berkeley, CA 94707 USA; [Jeanloz, Raymond] Stanford Univ, Hoover Inst, Stanford, CA 94305 USA; [Bowyer, Theodore W.] Pacific NW Natl Lab, Richland, WA 99354 USA; [Wofsy, Steven C.] Harvard Univ, Cambridge, MA 02138 USA	University of California System; University of California Berkeley; Stanford University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Harvard University	Jeanloz, R (corresponding author), Univ Calif Berkeley, Berkeley, CA 94707 USA.	jeanloz@berkeley.edu						Betts M., 2010, 2 OP SKIES REV C VIE; Cwiertny DM, 2008, ANNU REV PHYS CHEM, V59, P27, DOI 10.1146/annurev.physchem.59.032607.093630; Dahlman O., 2011, DETECT DETER CAN COU; Drell S. D., 2011, ARMS CONTROL TODAY, V41, P15; Federyakov S., 2010, 2 OP SKIES REV C VIE; Griffin DW, 2007, CLIN MICROBIOL REV, V20, P459, DOI 10.1128/CMR.00039-06; JACOB DJ, 1987, J GEOPHYS RES-ATMOS, V92, P6614, DOI 10.1029/JD092iD06p06614; Morris CE, 2011, BIOGEOSCIENCES, V8, P17, DOI 10.5194/bg-8-17-2011; Organization for Security and Co-operation in Europe, 2012, OP SK TREAT OBS FLIG; Posfai M, 2010, ANNU REV EARTH PL SC, V38, P17, DOI 10.1146/annurev.earth.031208.100032; Prather KA, 2008, ANNU REV ANAL CHEM, V1, P485, DOI 10.1146/annurev.anchem.1.031207.113030; Prospero JM, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000095; Ravi S, 2011, REV GEOPHYS, V49, DOI 10.1029/2010RG000328; Stohl A., 2011, ATMOS CHEM PHYS DISC, V11, P28319, DOI DOI 10.5194/ACPD-11-28319-2011; Strode SA, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017382; Wofsy SC, 2011, PHILOS T R SOC A, V369, P2073, DOI 10.1098/rsta.2010.0313	16	2	2	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2013	339	6121					761	762		10.1126/science.1228731	http://dx.doi.org/10.1126/science.1228731			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	088YS	23413340				2022-12-28	WOS:000314874400029
J	Cai, QL; Guo, ZJ; Li, G; Zhou, MY; Shang, ZQ; Sun, G; Niu, YJ				Cai, Qiliang; Guo, Zhanjun; Li, Gang; Zhou, Maoyi; Shang, Zhiqun; Sun, Guang; Niu, Yuanjie			Seminal vesicle carcinoma	LANCET			English	Editorial Material									[Cai, Qiliang; Guo, Zhanjun; Li, Gang; Shang, Zhiqun; Sun, Guang; Niu, Yuanjie] Tianjin Med Univ, Hosp 2, Dept Urol, Tianjin 300211, Peoples R China; [Zhou, Maoyi] Weifang Med Univ, Affiliated Hosp, Med Imaging Ctr, Weifang, Peoples R China	Tianjin Medical University; Weifang Medical University	Niu, YJ (corresponding author), Tianjin Med Univ, Hosp 2, Dept Urol, Tianjin 300211, Peoples R China.	qlcwwtg@gmail.com	shang, zhiqun/J-6631-2018						0	1	1	0	30	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 27	2013	382	9889					338	338		10.1016/S0140-6736(12)61994-1	http://dx.doi.org/10.1016/S0140-6736(12)61994-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193FT	23415604				2022-12-28	WOS:000322544900031
J	Joynt, KE; Jha, AK				Joynt, Karen E.; Jha, Ashish K.			A Path Forward on Medicare Readmissions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HOSPITAL READMISSION; RATES		[Joynt, Karen E.; Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Joynt, Karen E.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Jha, Ashish K.] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Joynt, Karen E.; Jha, Ashish K.] Vet Affairs Boston Healthcare Syst, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Joynt, KE (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.							Arbaje AI, 2008, GERONTOLOGIST, V48, P495, DOI 10.1093/geront/48.4.495; Glass D, 2012, REFINING HOSP READMI; Jha AK, 2009, NEW ENGL J MED, V361, P2637, DOI 10.1056/NEJMsa0904859; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Krumholz HM, 2013, JAMA-J AM MED ASSOC, V309, P587, DOI 10.1001/jama.2013.333	5	241	242	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 28	2013	368	13					1175	1177		10.1056/NEJMp1300122	http://dx.doi.org/10.1056/NEJMp1300122			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	116FU	23465069				2022-12-28	WOS:000316869000004
J	Flesken-Nikitin, A; Hwang, CI; Cheng, CY; Michurina, TV; Enikolopov, G; Nikitin, AY				Flesken-Nikitin, Andrea; Hwang, Chang-Il; Cheng, Chieh-Yang; Michurina, Tatyana V.; Enikolopov, Grigori; Nikitin, Alexander Yu			Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche	NATURE			English	Article							ALDEHYDE DEHYDROGENASE-ACTIVITY; SELF-RENEWAL; ORIGIN; MARKER; CARCINOGENESIS; IDENTIFICATION; CARCINOMAS; P53	Epithelial ovarian cancer (EOC) is the fifth leading cause of cancer deaths among women in the United States, but its pathogenesis is poorly understood(1-3). Some epithelial cancers are known to occur in transitional zones between two types of epithelium, whereas others have been shown to originate in epithelial tissue stem cells'. The stem cell niche of the ovarian surface epithelium (OSE), which is ruptured and regenerates during ovulation, has not yet been defined unequivocally. Here we identify the hilum region of the mouse ovary, the transitional (or junction) area between the OSE, mesothelium and tubal (oviductal) epithelium, as a previously unrecognized stem cell niche of the OSE. We find that cells of the hilum OSE are cycling slowly and express stem and/or progenitor cell markers ALDH1, LGR5, LEF1, CD 133 and CK6B. These cells display long-term stem cell properties ex vivo and in vivo, as shown by our serial sphere generation and long-term lineage-tracing assays. Importantly, the hilum cells show increased transformation potential after inactivation of tumour suppressor genes Trp53 and Rb1, whose pathways are altered frequently in the most aggressive and common type of human EOC, high-grade serous adenocarcinomea(7,8). Our study supports experimentally the idea that susceptibility of transitional zones to malignant transformation may be explained by the presence of stem cell niches in those areas. Identification of a stem cell niche for the OSE may have important implications for understanding EOC pathogenesis.	[Flesken-Nikitin, Andrea; Hwang, Chang-Il; Cheng, Chieh-Yang; Nikitin, Alexander Yu] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA; [Flesken-Nikitin, Andrea; Hwang, Chang-Il; Cheng, Chieh-Yang; Nikitin, Alexander Yu] Cornell Univ, Cornell Stem Cell Program, Ithaca, NY 14853 USA; [Michurina, Tatyana V.; Enikolopov, Grigori] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Michurina, Tatyana V.; Enikolopov, Grigori] Moscow Inst Phys & Technol, NBIC, Moscow 123182, Russia	Cornell University; Cornell University; Cold Spring Harbor Laboratory; Moscow Institute of Physics & Technology	Nikitin, AY (corresponding author), Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA.	an58@cornell.edu	Enikolopov, Grigori/P-5731-2019	Enikolopov, Grigori/0000-0001-8178-8917; Hwang, Chang-il/0000-0002-5710-7672	NYSTEM; US National Institutes of Health (NIH); National Cancer Institute (NCI) [CA096823, CA112354]; NYSTEM [CO23050, N1 1G-160]; Marsha Rivkin Center for Ovarian Cancer Research; NIH National Institute of Mental Health [MH092928]; NIH National Institute on Aging [AG040209]; Russian Ministry of Education and Science;  [NIH NICHD T32HD052471]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052471] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA096823, R01CA112354, R56CA096823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040209] Funding Source: NIH RePORTER	NYSTEM; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NYSTEM; Marsha Rivkin Center for Ovarian Cancer Research; NIH National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank T. lumbar for critical reading of this manuscript, J. Choi for help with immunostainings, L Sayam (NYSTEM supported" FACS Core) for help with FAGS experiments and F. M. Vermeyfen (Cornell Statistical Consulting Unit) for help with statistical analysis. This work was supported by grants from the US National Institutes of Health (NIH) and National Cancer Institute (NCI) (CA096823 and CA112354), NYSTEM (CO23050 and N1 1G-160) and the Marsha Rivkin Center for Ovarian Cancer Research to A.Yu.N.; the NIH National Institute of Mental Health (MH092928), NIH National Institute on Aging (AG040209), NYSTEM (CO24323) and Russian Ministry of Education and Science to G.E.; and,postdoctoral fellowships to A.F.-N. (NIH NICHD T32HD052471) and C-.I.H. (Cornell Comparative Cancer Biology Training Program).	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Auersperg N, 2008, GYNECOL ONCOL, V110, P452, DOI 10.1016/j.ygyno.2008.05.031; Auersperg N, 2011, INT J GYNECOL PATHOL, V30, P12, DOI 10.1097/PGP.0b013e3181f45f3e; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Bullough W. S., 1942, JOUR ENDOCRINOL, V3, P141, DOI 10.1677/joe.0.0030141; Burger PE, 2009, STEM CELLS, V27, P2220, DOI 10.1002/stem.135; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; Corti S, 2006, STEM CELLS, V24, P975, DOI 10.1634/stemcells.2005-0217; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Dubeau L, 2008, LANCET ONCOL, V9, P1191, DOI 10.1016/S1470-2045(08)70308-5; Flesken-Nikitin A, 2003, CANCER RES, V63, P3459; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Seidman JD, 2011, INT J GYNECOL PATHOL, V30, P4, DOI 10.1097/PGP.0b013e3181f29d2a; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Storms RW, 1999, P NATL ACAD SCI USA, V96, P9118, DOI 10.1073/pnas.96.16.9118; Szabova L, 2012, CANCER RES, V72, P4141, DOI 10.1158/0008-5472.CAN-11-3834; Szotek PP, 2008, P NATL ACAD SCI USA, V105, P12469, DOI 10.1073/pnas.0805012105; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781	30	240	248	4	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2013	495	7440					241	245		10.1038/nature11979	http://dx.doi.org/10.1038/nature11979			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23467088	Green Accepted			2022-12-28	WOS:000316652300052
J	Monroe, C; Kim, J				Monroe, C.; Kim, J.			Scaling the Ion Trap Quantum Processor	SCIENCE			English	Review							ENTANGLED STATES; ARCHITECTURE; COMPUTATION; WAVELENGTH; OPERATIONS	Trapped atomic ions are standards for quantum information processing, serving as quantum memories, hosts of quantum gates in quantum computers and simulators, and nodes of quantum communication networks. Quantum bits based on trapped ions enjoy a rare combination of attributes: They have exquisite coherence properties, they can be prepared and measured with nearly 100% efficiency, and they are readily entangled with each other through the Coulomb interaction or remote photonic interconnects. The outstanding challenge is the scaling of trapped ions to hundreds or thousands of qubits and beyond, at which scale quantum processors can outperform their classical counterparts in certain applications. We review the latest progress and prospects in that effort, with the promise of advanced architectures and new technologies, such as microfabricated ion traps and integrated photonics.	[Monroe, C.] Univ Maryland, Dept Phys, JQI, College Pk, MD 20742 USA; [Monroe, C.] NIST, College Pk, MD 20742 USA; [Kim, J.] Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA; [Kim, J.] Appl Quantum Technol, Durham, NC 27707 USA	University System of Maryland; University of Maryland College Park; National Institute of Standards & Technology (NIST) - USA; Duke University	Monroe, C (corresponding author), Univ Maryland, Dept Phys, JQI, College Pk, MD 20742 USA.	monroe@umd.edu	Monroe, Christopher R/G-8105-2011		U.S. Army Research Office (ARO) [W911NF0710576]; Defense Advanced Research Projects Agency (DARPA) Optical Lattice Emulator Program, ARO [W911NF0410234]; Intelligence Advanced Research Projects Activity Multi-Qubit Coherent Operations program, ARO Multidisciplinary University Initiative [W911NF0910406, W31P4Q1210017]; DARPA Quiness Program; NSF Physics Frontier Center at JQI; Division Of Physics [0822671] Funding Source: National Science Foundation	U.S. Army Research Office (ARO); Defense Advanced Research Projects Agency (DARPA) Optical Lattice Emulator Program, ARO; Intelligence Advanced Research Projects Activity Multi-Qubit Coherent Operations program, ARO Multidisciplinary University Initiative; DARPA Quiness Program; NSF Physics Frontier Center at JQI(National Science Foundation (NSF)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the U.S. Army Research Office (ARO) award W911NF0710576 with funds from the Defense Advanced Research Projects Agency (DARPA) Optical Lattice Emulator Program, ARO award W911NF0410234 with funds from the Intelligence Advanced Research Projects Activity Multi-Qubit Coherent Operations program, ARO Multidisciplinary University Initiative award W911NF0910406 on Hybrid Quantum Optical Circuits, Army Contracting Command award W31P4Q1210017 with funds from the DARPA Quiness Program, and the NSF Physics Frontier Center at JQI.	Amini JM, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/033031; Benhelm J, 2008, NAT PHYS, V4, P463, DOI 10.1038/nphys961; Blakestad RB, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.032314; Blatt R, 2008, NATURE, V453, P1008, DOI 10.1038/nature07125; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Cabrillo C, 1999, PHYS REV A, V59, P1025, DOI 10.1103/PhysRevA.59.1025; Chiaverini J, 2005, QUANTUM INFORM COMPU, V5, P419; Cirac JI, 2012, NAT PHYS, V8, P264, DOI 10.1038/nphys2275; CIRAC JI, 1995, PHYS REV LETT, V74, P4091, DOI 10.1103/PhysRevLett.74.4091; De Greve K, 2012, NATURE, V491, P421, DOI 10.1038/nature11577; Deslauriers L, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.103007; Duan LM, 2010, REV MOD PHYS, V82, P1209, DOI 10.1103/RevModPhys.82.1209; Garcia-Ripoll JJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.157901; Haffner H, 2008, PHYS REP, V469, P155, DOI 10.1016/j.physrep.2008.09.003; Herskind PF, 2011, OPT LETT, V36, P3045, DOI 10.1364/OL.36.003045; Jechow A, 2011, OPT LETT, V36, P1371, DOI 10.1364/OL.36.001371; Kielpinski D, 2002, NATURE, V417, P709, DOI 10.1038/nature00784; Kim J, 2005, QUANTUM INFORM COMPU, V5, P515; Kim J, 2003, IEEE PHOTONIC TECH L, V15, P1537, DOI 10.1109/LPT.2003.818653; Kim T, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.063423; Knoernschild C, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3494526; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Merrill JT, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/10/103005; Moehring DL, 2007, NATURE, V449, P68, DOI 10.1038/nature06118; Monroe CR, 2008, SCI AM, V299, P64, DOI 10.1038/scientificamerican0808-64; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Schmidt PO, 2005, SCIENCE, V309, P749, DOI 10.1126/science.1114375; Schmidt-Kaler F, 2003, NATURE, V422, P408, DOI 10.1038/nature01494; Seidelin S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.253003; Simon C, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.110405; Turchette QA, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.063418; Walther A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.080501; Weitenberg C, 2011, NATURE, V471, P319, DOI 10.1038/nature09827; Yavuz DD, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.063001; Zhu SL, 2006, EUROPHYS LETT, V73, P485, DOI 10.1209/epl/i2005-10424-4	43	412	424	12	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2013	339	6124					1164	1169		10.1126/science.1231298	http://dx.doi.org/10.1126/science.1231298			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471398				2022-12-28	WOS:000315709900037
J	Arya, M; Kalsi, J; Kelly, J; Muneer, A				Arya, Manit; Kalsi, Jas; Kelly, John; Muneer, Asif			Malignant and premalignant lesions of the penis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SQUAMOUS-CELL CARCINOMA; MALE CIRCUMCISION; HIV PREVENTION; GLANS-PENIS; CANCER; MEN; TRIAL; RISK; INVOLVEMENT; SURVIVAL		[Arya, Manit] Univ Coll London Hosp, London & Barts Canc Inst, London, England; [Kalsi, Jas] Wexham Pk Hosp, Slough, Berks, England; [Kelly, John; Muneer, Asif] Univ Coll London Hosp, London, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Arya, M (corresponding author), Univ Coll London Hosp, London & Barts Canc Inst, London, England.	manit_arya@hotmail.com						Agrawal A, 2000, BJU INT, V85, P299, DOI 10.1046/j.1464-410x.2000.00413.x; Alnajjar HM, 2012, EUR UROL, V62, P923, DOI 10.1016/j.eururo.2012.02.052; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Baldur-Felskov B, 2012, CANCER CAUSE CONTROL, V23, P273, DOI 10.1007/s10552-011-9876-7; Depasquale I, 2000, BJU INT, V86, P459, DOI 10.1046/j.1464-410X.2000.00772.x; Dillner J, 2000, SCAND J UROL NEPHROL, V34, P189, DOI 10.1080/00365590050509913; Engels EA, 2006, AIDS, V20, P1645, DOI 10.1097/01.aids.0000238411.75324.59; European Association of Urology, 2012, ONL GUID; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hegarty PK, 2006, BJU INT, V98, P526, DOI 10.1111/j.1464-410X.2006.06296.x; HORENBLAS S, 1994, J UROLOGY, V151, P1239, DOI 10.1016/S0022-5347(17)35221-7; Kayes O, 2007, EUR UROL, V51, P1313, DOI 10.1016/j.eururo.2006.11.014; Lucky MA, 2009, SEX TRANSM INFECT, V85, P527, DOI 10.1136/sti.2009.036061; Maddineni Satish B, 2009, BMC Urol, V9, P8, DOI 10.1186/1471-2490-9-8; MADEN C, 1993, JNCI-J NATL CANCER I, V85, P19, DOI 10.1093/jnci/85.1.19; MALEK RS, 1992, LASER SURG MED, V12, P246, DOI 10.1002/lsm.1900120303; Minhas S, 2005, BJU INT, V96, P1040, DOI 10.1111/j.1464-410X.2005.05769.x; Minhas S, 2010, UROLOGY, V76, pS24, DOI 10.1016/j.urology.2010.04.007; Miralles-Guri C, 2009, J CLIN PATHOL, V62, P870, DOI 10.1136/jcp.2008.063149; OPJORDSMOEN S, 1994, BRIT J UROL, V74, P652, DOI 10.1111/j.1464-410X.1994.tb09200.x; RAVI R, 1993, BRIT J UROL, V72, P817, DOI 10.1111/j.1464-410X.1993.tb16273.x; Sadeghi R, 2012, CLIN NUCL MED, V37, P436, DOI 10.1097/RLU.0b013e318238f6ea; Smith Y, 2007, EUR UROL, V52, P1179, DOI 10.1016/j.eururo.2007.02.038; Sobin L, 2009, TNM CLASSIFICATION M; STERN RS, 1990, NEW ENGL J MED, V322, P1093, DOI 10.1056/NEJM199004193221601; Tabatabaei S, 2005, J UROLOGY, V174, P923, DOI 10.1097/01.ju.0000170234.14519.19	27	29	30	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2013	346								f1149	10.1136/bmj.f1149	http://dx.doi.org/10.1136/bmj.f1149			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104MS	23468288				2022-12-28	WOS:000315998300007
J	Parrenin, F; Masson-Delmotte, V; Kohler, P; Raynaud, D; Paillard, D; Schwander, J; Barbante, C; Landais, A; Wegner, A; Jouzel, J				Parrenin, F.; Masson-Delmotte, V.; Koehler, P.; Raynaud, D.; Paillard, D.; Schwander, J.; Barbante, C.; Landais, A.; Wegner, A.; Jouzel, J.			Synchronous Change of Atmospheric CO2 and Antarctic Temperature During the Last Deglacial Warming	SCIENCE			English	Article							ABRUPT CLIMATE-CHANGE; EPICA DOME-C; POLAR ICE; FIRN; AIR; CONSTRAINTS; DELTA-N-15; DIFFERENCE; GREENLAND; CORES	Understanding the role of atmospheric CO2 during past climate changes requires clear knowledge of how it varies in time relative to temperature. Antarctic ice cores preserve highly resolved records of atmospheric CO2 and Antarctic temperature for the past 800,000 years. Here we propose a revised relative age scale for the concentration of atmospheric CO2 and Antarctic temperature for the last deglacial warming, using data from five Antarctic ice cores. We infer the phasing between CO2 concentration and Antarctic temperature at four times when their trends change abruptly. We find no significant asynchrony between them, indicating that Antarctic temperature did not begin to rise hundreds of years before the concentration of atmospheric CO2, as has been suggested by earlier studies.	[Parrenin, F.; Raynaud, D.] Lab Glaciol & Geophys Environm CNRS UJF, Grenoble, France; [Masson-Delmotte, V.; Paillard, D.; Landais, A.; Jouzel, J.] Lab Sci Climat & Environm CEA CNRS UVSQ IPSL, Gif Sur Yvette, France; [Koehler, P.; Wegner, A.] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [Schwander, J.] Univ Bern, Inst Phys, Bern, Switzerland; [Barbante, C.] Univ Venice, Dept Environm Sci, I-30123 Venice, Italy; [Barbante, C.] Univ Venice, Inst Dynam Environm Proc CNR, I-30123 Venice, Italy	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bern; Universita Ca Foscari Venezia; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Dinamica dei Processi Ambientali (IDPA-CNR); Universita Ca Foscari Venezia	Parrenin, F (corresponding author), Lab Glaciol & Geophys Environm CNRS UJF, Grenoble, France.	parrenin@ujf-grenoble.fr	Masson-Delmotte, Valerie L/G-1995-2011; raynaud, dominique/ABG-4718-2020; Raynaud, Dominique/H-9626-2016; Köhler, Peter/F-7293-2010; Paillard, Didier/G-4776-2012; Parrenin, Frédéric/H-3054-2014; Barbante, Carlo/B-3195-2011	Masson-Delmotte, Valerie L/0000-0001-8296-381X; Köhler, Peter/0000-0003-0904-8484; Paillard, Didier/0000-0002-9995-2794; Parrenin, Frédéric/0000-0002-9489-3991; Barbante, Carlo/0000-0003-4177-2288; LANDAIS, Amaelle/0000-0002-5620-5465	French Agence Nationale de la Recherche [ANR-07-BLAN-0125, ANR-09-SYSC-001]; European Union	French Agence Nationale de la Recherche(French National Research Agency (ANR)); European Union(European Commission)	We thank O. Watanabe, B. Stenni, and EPICA community members for giving access to, respectively, the DF1, TALDICE, and EDML isotopic data; L. Loulergue, D. Buiron, and T. Blunier for giving access to, respectively, the EDC-EDML, TALDICE, and GRIP CH<INF>4</INF> data; G. Dreyfus for giving access to the delta<SUP>15</SUP>N isotopic data; and G. Delaygue, J. Chappellaz, S. Barker, and A. Ganopolski for helpful discussions. This work greatly benefited from constructive comments by two anonymous reviewers. This work had support from the French Agence Nationale de la Recherche (project ANR-07-BLAN-0125 "Dome A" and ANR-09-SYSC-001 "ADAGE"). This work is a contribution to EPICA, a joint European Science Foundation/European Commission scientific program, funded by the European Union and by national contributions from Belgium, Denmark, France, Germany, Italy, the Netherlands, Norway, Sweden, Switzerland, and the United Kingdom. Main logistical support was provided by the Institut Paul Emile Victor and the Programma Nazionale Ricerche in Antartide at Dome C. We thank the technical teams in the field and at the different laboratories. This is EPICA publication no. 291.	Barker S, 2011, SCIENCE, V334, P347, DOI 10.1126/science.1203580; Bazin L., 2012, CLIM PAST DISCUSS, V8, P5963, DOI DOI 10.5194/CPD-8-5963-2012; Caillon N, 2003, SCIENCE, V299, P1728, DOI 10.1126/science.1078758; CRAIG H, 1988, SCIENCE, V242, P1675, DOI 10.1126/science.242.4886.1675; Dreyfus GB, 2010, QUATERNARY SCI REV, V29, P28, DOI 10.1016/j.quascirev.2009.10.012; Fischer H, 1999, SCIENCE, V283, P1712, DOI 10.1126/science.283.5408.1712; Fischer H, 2010, QUATERNARY SCI REV, V29, P193, DOI 10.1016/j.quascirev.2009.06.007; Goujon C, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003319; Horhold MW, 2012, EARTH PLANET SC LETT, V325, P93, DOI 10.1016/j.epsl.2011.12.022; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kohler P, 2011, CLIM PAST, V7, P473, DOI 10.5194/cp-7-473-2011; Kohler P, 2010, QUATERNARY SCI REV, V29, P129, DOI 10.1016/j.quascirev.2009.09.026; Landais A, 2006, QUATERNARY SCI REV, V25, P49, DOI 10.1016/j.quascirev.2005.06.007; Loulergue L, 2007, CLIM PAST, V3, P527, DOI 10.5194/cp-3-527-2007; Loulergue L, 2008, NATURE, V453, P383, DOI 10.1038/nature06950; Lourantou A, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003545; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Myhre G, 1998, GEOPHYS RES LETT, V25, P2715, DOI 10.1029/98GL01908; Parrenin F, 2007, CLIM PAST, V3, P243, DOI 10.5194/cp-3-243-2007; Parrenin F, 2012, CLIM PAST, V8, P1239, DOI 10.5194/cp-8-1239-2012; Pedro JB, 2012, CLIM PAST, V8, P1213, DOI 10.5194/cp-8-1213-2012; Raisbeck GM, 2007, CLIM PAST, V3, P541, DOI 10.5194/cp-3-541-2007; Severinghaus JP, 2010, EARTH PLANET SC LETT, V293, P359, DOI 10.1016/j.epsl.2010.03.003; Severinghaus JP, 2003, GEOCHIM COSMOCHIM AC, V67, P325, DOI 10.1016/S0016-7037(02)00965-1; Shakun JD, 2012, NATURE, V484, P49, DOI 10.1038/nature10915; SOWERS T, 1992, J GEOPHYS RES-ATMOS, V97, P15683, DOI 10.1029/92JD01297; Stocker TF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000920; Svensson A, 2008, CLIM PAST, V4, P47, DOI 10.5194/cp-4-47-2008; Veres D., 2012, CLIM PAST DISCUSS, V8, P6011, DOI DOI 10.5194/CPD-8-6011-2012	29	200	210	16	311	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1060	1063		10.1126/science.1226368	http://dx.doi.org/10.1126/science.1226368			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23449589	Green Submitted			2022-12-28	WOS:000315452000037
J	Kafri, R; Levy, J; Ginzberg, MB; Oh, S; Lahav, G; Kirschner, MW				Kafri, Ran; Levy, Jason; Ginzberg, Miriam B.; Oh, Seungeun; Lahav, Galit; Kirschner, Marc W.			Dynamics extracted from fixed cells reveal feedback linking cell growth to cell cycle	NATURE			English	Article							MASS	Biologists have long been concerned about what constrains variation in cell size, but progress in this field has been slow and stymied by experimental limitations'. Here we describe a new method, ergodic rate analysis (ERA), that uses single-cell measurements of fixed steady-state populations to accurately infer the rates of molecular events, including rates of cell growth. ERA exploits the fact that the number of cells in a particular state is related to the average transit time through that state(2). With this method, it is possible to calculate full time trajectories of any feature that can be labelled in fixed cells, for example levels of phosphoproteins or total cellular mass. Using ERA we find evidence for a size-discriminatory process at the G1/S transition that acts to decrease cell-to-cell size variation.	[Kafri, Ran; Ginzberg, Miriam B.; Oh, Seungeun; Lahav, Galit; Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Levy, Jason] Univ Ottawa, Dept Math & Stat, Ottawa, ON K1N 6N5, Canada	Harvard University; Harvard Medical School; University of Ottawa	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	marc@hms.harvard.edu		Oh, Seungeun/0000-0002-4064-9301; Ginzberg, Miriam/0000-0001-8431-3714	National Institute of General Medical Sciences [GM26875]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083303, R01GM026875, R37GM026875] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Klein, Y. Merbl, S. Tal and J. Toettcher for consistent and valuable insights at the beginning of and throughout this project. We thank J. Waters and the staff of The Nikon Imaging Center at Harvard Medical School for help and support. We especially thank R. Ward for her critique of the paper and the National Institute of General Medical Sciences (GM26875) for support of this work.	Deen, 2012, ANAL TRANSPORT PHENO; HENDRIX RW, 1974, NATURE, V247, P145, DOI 10.1038/247145a0; Jacobberger JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030870; KILLANDER D, 1965, EXP CELL RES, V40, P12, DOI 10.1016/0014-4827(65)90285-5; Mir M, 2011, P NATL ACAD SCI USA, V108, P13124, DOI 10.1073/pnas.1100506108; Mitchison JM, 2003, INT REV CYTOL, V226, P165, DOI 10.1016/S0074-7696(03)01004-0; MITCHISON JM, 1971, BIOL CELL CYCLE, P128; Popescu G, 2008, AM J PHYSIOL-CELL PH, V295, pC538, DOI 10.1152/ajpcell.00121.2008; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Son S, 2012, NAT METHODS, V9, P910, DOI 10.1038/nmeth.2133; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294	11	146	146	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2013	494	7438					480	483		10.1038/nature11897	http://dx.doi.org/10.1038/nature11897			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23446419	Green Accepted			2022-12-28	WOS:000315661500039
J	Phillip, M; Battelino, T; Atlas, E; Kordonouri, O; Bratina, N; Miller, S; Biester, T; Stefanija, MA; Muller, I; Nimri, R; Danne, T				Phillip, Moshe; Battelino, Tadej; Atlas, Eran; Kordonouri, Olga; Bratina, Natasa; Miller, Shahar; Biester, Torben; Stefanija, Magdalena Avbelj; Muller, Ido; Nimri, Revital; Danne, Thomas			Nocturnal Glucose Control with an Artificial Pancreas at a Diabetes Camp	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INSULIN-PUMP THERAPY; YOUNG-CHILDREN; HYPOGLYCEMIA; ADOLESCENTS; VARIABILITY; MANAGEMENT; ACCURACY; EFFICACY; PARENTS; SYSTEM	BACKGROUND Recent studies have shown that an artificial-pancreas system can improve glucose control and reduce nocturnal hypoglycemia. However, it is not known whether such results can be replicated in settings outside the hospital. METHODS In this multicenter, multinational, randomized, crossover trial, we assessed the short-term safety and efficacy of an artificial pancreas system for control of nocturnal glucose levels in patients (10 to 18 years of age) with type 1 diabetes at a diabetes camp. In two consecutive overnight sessions, we randomly assigned 56 patients to receive treatment with an artificial pancreas on the first night and a sensor-augmented insulin pump (control) on the second night or to the reverse order of therapies on the first and second nights. Thus, all the patients received each treatment in a randomly assigned order. The primary end points were the number of hypoglycemic events (defined as a sensor glucose value of < 63 mg per deciliter [3.5 mmol per liter] for at least 10 consecutive minutes), the time spent with glucose levels below 60 mg per deciliter (3.3 mmol per liter), and the mean overnight glucose level for individual patients. RESULTS On nights when the artificial pancreas was used, versus nights when the sensor-augmented insulin pump was used, there were significantly fewer episodes of nighttime glucose levels below 63 mg per deciliter (7 vs. 22) and significantly shorter periods when glucose levels were below 60 mg per deciliter (P = 0.003 and P = 0.02, respectively, after adjustment for multiplicity). Median values for the individual mean overnight glucose levels were 126.4 mg per deciliter (interquartile range, 115.7 to 139.1 [7.0 mmol per liter; interquartile range, 6.4 to 7.7]) with the artificial pancreas and 140.4 mg per deciliter (interquartile range, 105.7 to 167.4 [7.8 mmol per liter; interquartile range, 5.9 to 9.3]) with the sensor-augmented pump. No serious adverse events were reported. CONCLUSIONS Patients at a diabetes camp who were treated with an artificial-pancreas system had less nocturnal hypoglycemia and tighter glucose control than when they were treated with a sensor-augmented insulin pump. (Funded by Sanofi and others; ClinicalTrials.gov number, NCT01238406.)	[Phillip, Moshe; Atlas, Eran; Miller, Shahar; Muller, Ido; Nimri, Revital] Schneider Childrens Med Ctr Israel, Natl Ctr Childhood Diabet, Jesse Z & Sara Lea Shafer Inst Endocrinol & Diabe, IL-49202 Petah Tiqwa, Israel; [Phillip, Moshe] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Battelino, Tadej; Bratina, Natasa; Stefanija, Magdalena Avbelj] Univ Childrens Hosp, Univ Med Ctr, Dept Pediat Endocrinol Diabet & Metab, Ljubljana, Slovenia; [Battelino, Tadej; Bratina, Natasa; Stefanija, Magdalena Avbelj] Univ Ljubljana, Fac Med, Ljubljana, Slovenia; [Kordonouri, Olga; Biester, Torben; Danne, Thomas] Kinder & Jugendkrankenhaus, Diabet Ctr Children & Adolescents, Hannover, Germany	Tel Aviv University; Sackler Faculty of Medicine; University Medical Centre Ljubljana; University of Ljubljana	Phillip, M (corresponding author), Schneider Childrens Med Ctr Israel, Natl Ctr Childhood Diabet, Jesse Z & Sara Lea Shafer Inst Endocrinol & Diabe, 14 Kaplan St, IL-49202 Petah Tiqwa, Israel.	mosheph@post.tau.ac.il	Biester, Torben/I-4660-2019	Biester, Torben/0000-0001-8051-5562; Battelino, Tadej/0000-0002-0273-4732; Avbelj Stefanija, Magdalena/0000-0002-0836-5114	Sanofi; Slovenian National Research Agency [P3-0343]	Sanofi(Sanofi-Aventis); Slovenian National Research Agency(Slovenian Research Agency - Slovenia)	Supported in part by Sanofi. Medtronic Diabetes supplied software to interface with the Paradigm Veo system; and Intel Israel, Dell Israel, and Yael Software and Systems donated laptops for the study. Drs. Battelino, Bratina, and Stefanija were supported in part by a grant (P3-0343) from the Slovenian National Research Agency.	[Anonymous], 2011, GUID IND FOOD DRUG A; Atlas E, 2010, DIABETES CARE, V33, P1072, DOI 10.2337/dc09-1830; Barnard K, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-50; Battelino T, 2011, DIABETES CARE, V34, P795, DOI 10.2337/dc10-1989; Beck RW, 2010, DIABETES CARE, V33, P1004, DOI 10.2337/dc09-2081; Bergenstal RM, 2010, NEW ENGL J MED, V363, P1092; Bergenstal RM, 2010, NEW ENGL J MED, V363, P311, DOI 10.1056/NEJMoa1002853; Ciambra Roberta, 2005, Acta Biomed, V76 Suppl 3, P81; Davis EA, 1997, DIABETES CARE, V20, P22, DOI 10.2337/diacare.20.1.22; Deiss D, 2004, PEDIATR DIABETES, V5, P117, DOI 10.1111/j.1399-543X.2004.00053.x; Elleri D, 2011, DIABETES TECHNOL THE, V13, P419, DOI 10.1089/dia.2010.0176; Elleri D, 2010, DIABETES TECHNOL THE, V12, P35, DOI 10.1089/dia.2009.0084; Gunasekera H, 2006, J PAEDIATR CHILD H, V42, P643, DOI 10.1111/j.1440-1754.2006.00948.x; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hovorka R, 2012, DIABETES TECHNOL THE; Hovorka R, 2011, BMJ-BRIT MED J, V13, P342; Hovorka R, 2010, LANCET, V375, P743, DOI 10.1016/S0140-6736(09)61998-X; Hughes Colleen S, 2010, J Diabetes Sci Technol, V4, P1146; Keenan DB, 2012, DIABETES TECHNOL THE, V14, P225, DOI 10.1089/dia.2011.0199; Kovatchev Boris, 2010, J Diabetes Sci Technol, V4, P1374; Kovatchev BP, 2006, DIABETES CARE, V29, P2433, DOI 10.2337/dc06-1085; Kovatchev BP, 2004, DIABETES CARE, V27, P1922, DOI 10.2337/diacare.27.8.1922; Magni Lalo, 2008, J Diabetes Sci Technol, V2, P630; Mauras N, 2012, DIABETES CARE, V35, P204, DOI 10.2337/dc11-1746; McCall AL, 2006, DIABETES TECHNOL THE, V8, P644, DOI 10.1089/dia.2006.8.644; Miller AR, 2011, DIABETIC MED, V28, P480, DOI 10.1111/j.1464-5491.2010.03220.x; Miller S, 2011, DIABETES TECHNOL THE, V13, P983, DOI 10.1089/dia.2010.0216; Monaghan MC, 2009, FAM SYST HEALTH, V27, P28, DOI 10.1037/a0014770; Nimri R, 2012, DIABETES TECHNOL THE, V14, P728, DOI 10.1089/dia.2012.0004; Phillip M, 2007, DIABETES CARE, V30, P1653, DOI 10.2337/dc07-9922; Phillip M, 2012, PEDIATR DIABETES, V13, P215, DOI 10.1111/j.1399-5448.2011.00849.x; Pickup JC, 2012, NEW ENGL J MED, V366, P1616, DOI 10.1056/NEJMct1113948; Robertson K, 2009, PEDIATR DIABETES, V10, P154, DOI 10.1111/j.1399-5448.2009.00567.x; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sovik O, 1999, DIABETES CARE, V22, pB40; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017	36	264	266	2	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2013	368	9					824	833		10.1056/NEJMoa1206881	http://dx.doi.org/10.1056/NEJMoa1206881			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096ET	23445093	Bronze			2022-12-28	WOS:000315387700008
J	Kwak, H; Fuda, NJ; Core, LJ; Lis, JT				Kwak, Hojoong; Fuda, Nicholas J.; Core, Leighton J.; Lis, John T.			Precise Maps of RNA Polymerase Reveal How Promoters Direct Initiation and Pausing	SCIENCE			English	Article							TRANSCRIPTION ELONGATION; DROSOPHILA-MELANOGASTER; NUCLEOSOME ORGANIZATION; HSP70 PROMOTER; CORE PROMOTER; TATA ELEMENT; IN-VIVO; GENES; DOWNSTREAM; RESOLUTION	Transcription regulation occurs frequently through promoter-associated pausing of RNA polymerase II (Pol II). We developed a precision nuclear run-on and sequencing (PRO-seq) assay to map the genome-wide distribution of transcriptionally engaged Pol II at base pair resolution. Pol II accumulates immediately downstream of promoters, at intron-exon junctions that are efficiently used for splicing, and over 3' polyadenylation sites. Focused analyses of promoters reveal that pausing is not fixed relative to initiation sites, nor is it specified directly by the position of a particular core promoter element or the first nucleosome. Core promoter elements function beyond initiation, and when optimally positioned they act collectively to dictate the position and strength of pausing. This "complex interaction" model was tested with insertional mutagenesis of the Drosophila Hsp70 core promoter.	[Kwak, Hojoong; Fuda, Nicholas J.; Core, Leighton J.; Lis, John T.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Core, LJ (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	ljc37@cornell.edu; jtl10@cornell.edu			NIH [GM25232, HG004845]; Howard Hughes Medical Institute fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025232, R37GM025232] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute fellowship(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grants GM25232 and HG004845 (J.T.L.) and a Howard Hughes Medical Institute fellowship (H. K.). Sequence data are in the Gene Expression Omnibus (GEO) database under accession number GSE42117. Part of this work is included in a broader U.S. patent application (12/554,472, "Genome-wide Method for Mapping of Engaged RNA Polymerases Quantitatively and at High Resolution"), which refers to variants of the method that we use here.	Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Core LJ, 2012, CELL REP, V2, P1025, DOI 10.1016/j.celrep.2012.08.034; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; EMANUEL PA, 1993, P NATL ACAD SCI USA, V90, P8449, DOI 10.1073/pnas.90.18.8449; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Hendrix DA, 2008, P NATL ACAD SCI USA, V105, P7762, DOI 10.1073/pnas.0802406105; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kornblihtt AR, 2006, NAT STRUCT MOL BIOL, V13, P5, DOI 10.1038/nsmb0106-5; Larschan E, 2011, NATURE, V471, P115, DOI 10.1038/nature09757; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nechaev S, 2011, BBA-GENE REGUL MECH, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sharma S., 2012, THESIS CORNELL U ITH; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Wu CH, 2001, MOL CELL BIOL, V21, P1593, DOI 10.1128/MCB.21.5.1593-1602.2001; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	29	425	429	1	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2013	339	6122					950	953		10.1126/science.1229386	http://dx.doi.org/10.1126/science.1229386			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23430654	Green Accepted			2022-12-28	WOS:000315149600047
J	Henschke, CI; Yip, R; Yankelevitz, DF; Smith, JP				Henschke, Claudia I.; Yip, Rowena; Yankelevitz, David F.; Smith, James P.		Int Early Lung Canc Action Program	Definition of a Positive Test Result in Computed Tomography Screening for Lung Cancer A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							BASE-LINE	Background: Low-dose computed tomography screening for lung cancer can reduce mortality among high-risk persons, but "false-positive" findings may result in unnecessary evaluations with attendant risks. The effect of alternative thresholds for defining a positive result on the rates of positive results and cancer diagnoses is unknown. Objective: To assess the frequency of positive results and potential delays in diagnosis in the baseline round of screening by using more restrictive thresholds. Design: Prospective cohort study. Setting: Multi-institutional International Early Lung Cancer Action Program. Patients: 21 136 participants with baseline computed tomography performed between 2006 and 2010. Measurements: The frequency of solid and part-solid pulmonary nodules and the rate of lung cancer diagnosis by using current (5 mm) and more restrictive thresholds of nodule diameter. Results: The frequency of positive results in the baseline round by using the current definition of positive result (any parenchymal, solid or part-solid, noncalcified nodule >= 5.0 mm) was 16% (3396/21 136). When alternative threshold values of 6.0, 7.0, 8.0 and 9.0 mm were used, the frequencies of positive results were 10.2% (95% CI, 9.8% to 10.6%), 7.1% (CI, 6.7% to 7.4%), 5.1% (CI, 4.8% to 5.4%), and 4.0% (CI, 3.7% to 4.2%), respectively. Use of these alternative definitions would have reduced the work-up by 36%, 56%, 68%, and 75%, respectively. Concomitantly, lung cancer diagnostics would have been delayed by at most 9 months for 0%, 5.0% (CI, 1.1% to 9.0%), 5.9% (CI, 1.7 to 10.1%), and 6.7% (CI, 2.2% to 11.2%) of the cases of cancer, respectively. Limitation: This was a retrospective analysis and thus whether delays in diagnosis would have altered outcomes cannot be determined. Conclusion: These findings suggest that using a threshold of 7 or 8 mm to define positive results in the baseline round of computed tomography screening for lung cancer should be prospectively evaluated to determine whether the benefits of decreasing further work-up outweigh the consequent delay in diagnosis in some patients.	Mt Sinai Med Ctr, New York, NY 10029 USA; Mt Sinai Sch Med, New York, NY 10029 USA; Weill Cornell Med Coll, New York, NY 10065 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cornell University	Henschke, CI (corresponding author), Mt Sinai Sch Med, Dept Radiol, 1 Gustave L Levy Pl, New York, NY 10029 USA.	Claudia.Henschke@mountsinai.org	Zulueta, Javier J/H-5127-2011	Zulueta, Javier J/0000-0003-3182-3555; Aye, Ralph/0000-0003-3726-6673	Flight Attendant Medical Research Institute; American Legacy Foundation; Department of Energy [DE-FG02-96SF21260]; Israel Cancer Association; Rogers Family Fund; Yad-Hanadiv Foundation; Jacob and Malka Goldfarb Charitable Foundation; Auen/Berger Foundation; Princess Margaret Foundation; Berger Foundation; Mills Peninsula Hospital Foundation; Columbia University Medical Center; Mount Sinai Medical Center; Weill Medical College of Cornell University; Cornell University; New York Presbyterian Hospital; Swedish Hospital; Christiana Care Helen F. Graham Cancer Center; Holy Cross Hospital; Eisenhower Hospital; Jackson Memorial Hospital Health System; Evanston Northwestern Healthcare	Flight Attendant Medical Research Institute; American Legacy Foundation; Department of Energy(United States Department of Energy (DOE)); Israel Cancer Association; Rogers Family Fund; Yad-Hanadiv Foundation; Jacob and Malka Goldfarb Charitable Foundation; Auen/Berger Foundation; Princess Margaret Foundation; Berger Foundation; Mills Peninsula Hospital Foundation; Columbia University Medical Center; Mount Sinai Medical Center; Weill Medical College of Cornell University(General Electric); Cornell University; New York Presbyterian Hospital; Swedish Hospital; Christiana Care Helen F. Graham Cancer Center; Holy Cross Hospital; Eisenhower Hospital; Jackson Memorial Hospital Health System; Evanston Northwestern Healthcare	In part by the Flight Attendant Medical Research Institute, the American Legacy Foundation, Department of Energy (DE-FG02-96SF21260), Israel Cancer Association, The Rogers Family Fund, Yad-Hanadiv Foundation, Jacob and Malka Goldfarb Charitable Foundation, Auen/Berger Foundation, Princess Margaret Foundation, Berger Foundation, Mills Peninsula Hospital Foundation, Columbia University Medical Center, Mount Sinai Medical Center, Weill Medical College of Cornell University, Cornell University, New York Presbyterian Hospital, Swedish Hospital, Christiana Care Helen F. Graham Cancer Center, Holy Cross Hospital, Eisenhower Hospital, Jackson Memorial Hospital Health System, and Evanston Northwestern Healthcare.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; [Anonymous], 2010, NY TIMES, pA34; Carter D, 2007, LUNG CANCER, V56, P193, DOI 10.1016/j.lungcan.2006.12.001; Harris G, 2010, NY TIMES, P1; Henschke CI, 2004, RADIOLOGY, V231, P164, DOI 10.1148/radiol.2311030634; Henschke CI, 2002, LUNG CANCER-J IASLC, V35, P143, DOI 10.1016/S0169-5002(01)00416-0; Henschke CI, 2002, AM J ROENTGENOL, V178, P1053, DOI 10.2214/ajr.178.5.1781053; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Henschke CI., INT EARLY LUNG CANC; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Henschke CI, 2012, RADIOLOGY, V263, P578, DOI 10.1148/radiol.12102489; International Early Lung Cancer Action Program Investigators, INT EARL LUNG CANC A; Libby DM, 2006, CHEST, V129, P1039, DOI 10.1378/chest.129.4.1039; Miettinen OS, 2011, EPIDEMIOLOGIC RES TE; New York Early Cancer Action Inv, 2007, RADIOLOGY, V243, P239, DOI 10.1148/radiol.2431060467; Parker-Pope T, 2010, NY TIMES, pD5; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Vazquez M, 2009, LUNG CANCER, V64, P148, DOI 10.1016/j.lungcan.2008.08.009	18	156	162	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2013	158	4					246	252		10.7326/0003-4819-158-4-201302190-00004	http://dx.doi.org/10.7326/0003-4819-158-4-201302190-00004			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098WR	23420233				2022-12-28	WOS:000315580300015
J	Meyers, MA; McKittrick, J; Chen, PY				Meyers, Marc Andre; McKittrick, Joanna; Chen, Po-Yu			Structural Biological Materials: Critical Mechanics-Materials Connections	SCIENCE			English	Review							SACRIFICIAL BONDS; COLLAGEN FIBRILS; MINERAL BRIDGES; TOUGHNESS; BEHAVIOR; NACRE; FRACTURE; DESIGN; MODEL; DEFORMATION	Spider silk is extraordinarily strong, mollusk shells and bone are tough, and porcupine quills and feathers resist buckling. How are these notable properties achieved? The building blocks of the materials listed above are primarily minerals and biopolymers, mostly in combination; the first weak in tension and the second weak in compression. The intricate and ingenious hierarchical structures are responsible for the outstanding performance of each material. Toughness is conferred by the presence of controlled interfacial features (friction, hydrogen bonds, chain straightening and stretching); buckling resistance can be achieved by filling a slender column with a lightweight foam. Here, we present and interpret selected examples of these and other biological materials. Structural bio-inspired materials design makes use of the biological structures by inserting synthetic materials and processes that augment the structures' capability while retaining their essential features. In this Review, we explain this idea through some unusual concepts.	[Meyers, Marc Andre; McKittrick, Joanna] Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA; [Meyers, Marc Andre; McKittrick, Joanna] Univ Calif San Diego, Mat Sci & Engn Program, La Jolla, CA 92093 USA; [Meyers, Marc Andre] Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA; [Chen, Po-Yu] Natl Tsing Hua Univ, Dept Mat Sci & Engn, Hsinchu 30013, Taiwan	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National Tsing Hua University	Meyers, MA (corresponding author), Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA.	mameyers@ucsd.edu	Meyers, Marc A/A-2970-2016	Meyers, Marc A/0000-0003-1698-5396; McKittrick, Joanna/0000-0002-1442-3472	NSF [1006931]; National Science Council, Taiwan [NSC-100-2218-E-007-016-MY3, NSC-101-2628-E-007-017-MY3]	NSF(National Science Foundation (NSF)); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	We thank W. Yang and C.-H. Lu for help with the figures. This work is funded by the NSF, Ceramics Program grant 1006931 (M. A. M. and J.M.), and the National Science Council, Taiwan, grants NSC-100-2218-E-007-016-MY3 and NSC-101-2628-E-007-017-MY3 (P.-Y.C.).	Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; Aizenberg J, 2010, MRS BULL, V35, P323, DOI 10.1557/mrs2010.555; Aladin DMK, 2010, J ORTHOP RES, V28, P497, DOI 10.1002/jor.21010; [Anonymous], 2010, CELLULAR MAT NATURE; ARRUDA EM, 1993, J MECH PHYS SOLIDS, V41, P389, DOI 10.1016/0022-5096(93)90013-6; Arzt E, 2006, MAT SCI ENG C-BIO S, V26, P1245, DOI 10.1016/j.msec.2005.08.033; Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361; Chan EP, 2007, MRS BULL, V32, P496, DOI 10.1557/mrs2007.84; Chen PY, 2009, ACTA BIOMATER, V5, P693, DOI 10.1016/j.actbio.2008.09.011; Chen PY, 2008, ACTA BIOMATER, V4, P587, DOI 10.1016/j.actbio.2007.12.010; Chen PY, 2012, PROG MATER SCI, V57, P1492, DOI 10.1016/j.pmatsci.2012.03.001; Chiadini F, 2010, BIOINSPIR BIOMIM, V5, DOI 10.1088/1748-3182/5/2/026002; Currey J, 2001, NATURE, V414, P699, DOI 10.1038/414699a; Currey J., 2002, BONE STRUCTURE MECH; CURREY JD, 1984, PHILOS T ROY SOC B, V304, P509, DOI 10.1098/rstb.1984.0042; Erb RM, 2012, SCIENCE, V335, P199, DOI 10.1126/science.1210822; Evans AG, 2001, J MATER RES, V16, P2475, DOI 10.1557/JMR.2001.0339; Fantner GE, 2005, NAT MATER, V4, P612, DOI 10.1038/nmat1428; Fratzl P, 1998, J STRUCT BIOL, V122, P119, DOI 10.1006/jsbi.1998.3966; Fung YC., 2013, BIOMECHANICS MECH PR; Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100; Gautieri A, 2011, NANO LETT, V11, P757, DOI 10.1021/nl103943u; Gibson J.L., 1997, CELLULAR SOLIDS STRU, DOI [10.1017/cbo9781139878326, DOI 10.1017/CBO9781139878326]; HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311; JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056; Jin K, 2012, LANGMUIR, V28, P5737, DOI 10.1021/la204040p; KARAM GN, 1995, INT J SOLIDS STRUCT, V32, P1259, DOI 10.1016/0020-7683(94)00147-O; Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]; Launey ME, 2010, ACTA BIOMATER, V6, P1505, DOI 10.1016/j.actbio.2009.11.026; Launey ME, 2010, ANNU REV MATER RES, V40, P25, DOI [10.1146/annurev-matsci-070909-104427, 10.1146/annurev-matsci-070909-10442]; Lee SJ, 2005, FLUID DYN RES, V37, P246, DOI 10.1016/j.fluiddyn.2005.05.002; Lin AYM, 2009, J MECH BEHAV BIOMED, V2, P607, DOI 10.1016/j.jmbbm.2009.04.003; Lingham-Soliar T, 2010, P ROY SOC B-BIOL SCI, V277, P1161, DOI 10.1098/rspb.2009.1980; Melnick CA, 1996, J MATER RES, V11, P2903, DOI 10.1557/JMR.1996.0367; Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002; Miserez A, 2009, NAT MATER, V8, P910, DOI [10.1038/NMAT2547, 10.1038/nmat2547]; Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865; Nalla RK, 2005, BIOMATERIALS, V26, P217, DOI 10.1016/j.biomaterials.2004.02.017; Nikolov S, 2010, ADV MATER, V22, P519, DOI 10.1002/adma.200902019; Oeffner J, 2012, J EXP BIOL, V215, P785, DOI 10.1242/jeb.063040; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; Porter MM, 2012, MAT SCI ENG A-STRUCT, V556, P741, DOI 10.1016/j.msea.2012.07.058; PURSLOW PP, 1978, J EXP BIOL, V72, P251; Qiao L, 2008, J INORG MATER, V23, P337, DOI 10.3724/SP.J.1077.2008.00337; Raabe D, 2005, ACTA MATER, V53, P4281, DOI 10.1016/j.actamat.2005.05.027; Sasaki N, 1996, J BIOMECH, V29, P1131, DOI 10.1016/0021-9290(96)00024-3; Schaffer TE, 1997, CHEM MATER, V9, P1731, DOI 10.1021/cm960429i; Seki Y, 2005, ACTA MATER, V53, P5281, DOI 10.1016/j.actamat.2005.04.048; Sethi S, 2008, NANO LETT, V8, P822, DOI 10.1021/nl0727765; Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84; Song F, 2001, ACTA MECH SINICA, V17, P251; Sun TL, 2005, ACCOUNTS CHEM RES, V38, P644, DOI 10.1021/ar040224c; Thompson JB, 2001, NATURE, V414, P773, DOI 10.1038/414773a; Timoshenko S., 1936, THEORY ELASTIC STABI; Vincent J. F. V., 1991, STRUCTURAL BIOMATERI; Viswanath PR, 2002, PROG AEROSP SCI, V38, P571, DOI 10.1016/S0376-0421(02)00048-9; Yang W, 2013, ACTA BIOMATER, V9, P5297, DOI 10.1016/j.actbio.2012.09.004	57	667	688	69	1214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2013	339	6121					773	779		10.1126/science.1220854	http://dx.doi.org/10.1126/science.1220854			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23413348				2022-12-28	WOS:000314874400037
J	Telford, MJ				Telford, Maximilian J.			The Animal Tree of Life	SCIENCE			English	Editorial Material							RIBOSOMAL-RNA SEQUENCES; EARLY EMERGENCE		UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England	University of London; University College London	Telford, MJ (corresponding author), UCL, Dept Genet Evolut & Environm, Mortimer St, London WC1E 6BT, England.	m.telford@ucl.ac.uk						Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Balavoine G, 1997, CR ACAD SCI III-VIE, V320, P83, DOI 10.1016/S0764-4469(99)80090-0; Darwin C., 1857, DARWIN CORRES PROJEC; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; FELSENSTEIN J, 1978, SYST ZOOL, V27, P27, DOI 10.2307/2412810; FIELD KG, 1988, SCIENCE, V239, P748, DOI 10.1126/science.3277277; Halanych KM, 1996, BIOL BULL-US, V190, P1, DOI 10.2307/1542669; Holland P. H., 2011, ANIMAL KINGDOM; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; OHAMA T, 1984, NUCLEIC ACIDS RES, V12, P5101, DOI 10.1093/nar/12.12.5101; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Telford MJ, 2011, TRENDS GENET, V27, P186, DOI 10.1016/j.tig.2011.02.003	15	4	4	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2013	339	6121					764	766		10.1126/science.1234378	http://dx.doi.org/10.1126/science.1234378			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23413342				2022-12-28	WOS:000314874400031
J	Bateson, D; McNamee, K; Briggs, P				Bateson, Deborah; McNamee, Kathleen; Briggs, Paula			Newer non-oral hormonal contraception	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							USERS		[Bateson, Deborah] Family Planning NSW, Sydney, NSW 2131, Australia; [Bateson, Deborah] Univ Sydney, Discipline Obstet Gynaecol & Neonatol, Sydney, NSW 2006, Australia; [McNamee, Kathleen] Family Planning Victoria, Box Hill, Vic 3128, Australia; [McNamee, Kathleen] Monash Med Ctr, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia	University of Sydney; Monash University	Bateson, D (corresponding author), Family Planning NSW, Sydney, NSW 2131, Australia.	deborahb@fpnsw.org.au	Bateson, Deborah/A-4563-2018	Bateson, Deborah/0000-0003-1035-7110				Affandi B, 1998, CONTRACEPTION, V58, p99S, DOI 10.1016/S0010-7824(98)00123-1; [Anonymous], 2011, CONTRACEPTIVE TECHNO; BRACKEN MB, 1990, OBSTET GYNECOL, V76, P552; Curtis Kathryn M., 2010, Morbidity and Mortality Weekly Report, V59, P1; *FAC SEX REPR HEAL, 2009, MAN UNSCH BLEED WOM; Faculty of Sexual and Reproductive Healthcare, 2007, INTR CONTR; Faculty of Sexual and Reproductive Healthcare, RISK VEN THROMB US N; Faculty of Sexual and Reproductive Healthcare, UK MED EL CRIT CONTR; Faculty of Sexual and Reproductive Healthcare clinical guidance, 2011, DRUG INT HORM CONTR; Faculty of Sexual and Reproductive Healthcare of the Royal College of Obstetricians and Gynaecologists, 2010, CONTR WOM AG 40 YEAR; Faculty of Sexual & Reproductive Healthcare, 2011, COMB HORM CONTR; Faculty of Sexual & Reproductive Healthcare, 2008, PROGR ONL INJ CONTR; Faculty of Sexual & Reproductive Healthcare Clinical Effectiveness Unit, 2008, PROG ONL IMPL; Hannaford PC, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c927; Lidegaard O, 2012, NEW ENGL J MED, V366, P2257, DOI 10.1056/NEJMoa1111840; Lidegaard O, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2990; Lopez LM, 2010, COCHRANE DB SYST REV, V3, DOI [DOI 10.10002/14651858.CD003552.PUB3, 10.10002/14651858.CD003552.pub3]; National Institute for Health and Clinical Excellence, 2005, LONG ACT REV CONTR E, V30; National Institute for Health and Clinical Excellence, 2007, HEAV MENSTR BLEED, V44; Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021; Varma R, 2006, EUR J OBSTET GYN R B, V125, P9, DOI 10.1016/j.ejogrb.2005.10.029	21	2	2	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2013	346								f341	10.1136/bmj.f341	http://dx.doi.org/10.1136/bmj.f341			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	091ZR	23412438				2022-12-28	WOS:000315088800008
J	Black, RE				Black, Robert E.			The future of the US response to global HIV/AIDS	LANCET			English	Editorial Material									Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Black, RE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	rblack@jhsph.edu		Black, Robert/0000-0001-9926-7984				amfAR, 2018, ZIMB DAT PEPFAR MON; Office of the Global AIDS Coordinator, 2012, PEPFAR BLUEPR CREAT	2	16	16	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 31	2013	382	9894					751	753		10.1016/S0140-6736(13)60184-1	http://dx.doi.org/10.1016/S0140-6736(13)60184-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215VP	23434311				2022-12-28	WOS:000324239200008
J	Garibaldi, LA; Steffan-Dewenter, I; Winfree, R; Aizen, MA; Bommarco, R; Cunningham, SA; Kremen, C; Carvalheiro, LG; Harder, LD; Afik, O; Bartomeus, I; Benjamin, F; Boreux, V; Cariveau, D; Chacoff, NP; Dudenhoffer, JH; Freitas, BM; Ghazoul, J; Greenleaf, S; Hipolito, J; Holzschuh, A; Howlett, B; Isaacs, R; Javorek, SK; Kennedy, CM; Krewenka, KM; Krishnan, S; Mandelik, Y; Mayfield, MM; Motzke, I; Munyuli, T; Nault, BA; Otieno, M; Petersen, J; Pisanty, G; Potts, SG; Rader, R; Ricketts, TH; Rundlof, M; Seymour, CL; Schuepp, C; Szentgyorgyi, H; Taki, H; Tscharntke, T; Vergara, CH; Viana, BF; Wanger, TC; Westphal, C; Williams, N; Klein, AM				Garibaldi, Lucas A.; Steffan-Dewenter, Ingolf; Winfree, Rachael; Aizen, Marcelo A.; Bommarco, Riccardo; Cunningham, Saul A.; Kremen, Claire; Carvalheiro, Luisa G.; Harder, Lawrence D.; Afik, Ohad; Bartomeus, Ignasi; Benjamin, Faye; Boreux, Virginie; Cariveau, Daniel; Chacoff, Natacha P.; Dudenhoeffer, Jan H.; Freitas, Breno M.; Ghazoul, Jaboury; Greenleaf, Sarah; Hipolito, Juliana; Holzschuh, Andrea; Howlett, Brad; Isaacs, Rufus; Javorek, Steven K.; Kennedy, Christina M.; Krewenka, Kristin M.; Krishnan, Smitha; Mandelik, Yael; Mayfield, Margaret M.; Motzke, Iris; Munyuli, Theodore; Nault, Brian A.; Otieno, Mark; Petersen, Jessica; Pisanty, Gideon; Potts, Simon G.; Rader, Romina; Ricketts, Taylor H.; Rundlof, Maj; Seymour, Colleen L.; Schueepp, Christof; Szentgyoergyi, Hajnalka; Taki, Hisatomo; Tscharntke, Teja; Vergara, Carlos H.; Viana, Blandina F.; Wanger, Thomas C.; Westphal, Catrin; Williams, Neal; Klein, Alexandra M.			Wild Pollinators Enhance Fruit Set of Crops Regardless of Honey Bee Abundance	SCIENCE			English	Article							BIODIVERSITY	The diversity and abundance of wild insect pollinators have declined in many agricultural landscapes. Whether such declines reduce crop yields, or are mitigated by managed pollinators such as honey bees, is unclear. We found universally positive associations of fruit set with flower visitation by wild insects in 41 crop systems worldwide. In contrast, fruit set increased significantly with flower visitation by honey bees in only 14% of the systems surveyed. Overall, wild insects pollinated crops more effectively; an increase in wild insect visitation enhanced fruit set by twice as much as an equivalent increase in honey bee visitation. Visitation by wild insects and honey bees promoted fruit set independently, so pollination by managed honey bees supplemented, rather than substituted for, pollination by wild insects. Our results suggest that new practices for integrated management of both honey bees and diverse wild insect assemblages will enhance global crop yields.	[Garibaldi, Lucas A.] UNRN, Mitre 630, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Garibaldi, Lucas A.] Consejo Nacl Invest Cient & Tecn, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Steffan-Dewenter, Ingolf; Holzschuh, Andrea] Univ Wurzburg, Bioctr, Dept Anim Ecol & Trop Biol, D-97074 Wurzburg, Germany; [Winfree, Rachael; Benjamin, Faye; Cariveau, Daniel] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA; [Aizen, Marcelo A.] Univ Nacl Comahue, CRUB, Lab Ecotono, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Aizen, Marcelo A.] Inst Invest Biodiversidad & Medioambiente INIBIOM, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Bommarco, Riccardo; Rundlof, Maj] Swedish Univ Agr Sci, Dept Ecol, SE-75007 Uppsala, Sweden; [Cunningham, Saul A.] CSIRO Ecosyst Sci, Canberra, ACT, Australia; [Kremen, Claire; Greenleaf, Sarah] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Carvalheiro, Luisa G.] Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England; [Carvalheiro, Luisa G.] Nat Biodivers Ctr, NL-2300 RA Leiden, Netherlands; [Harder, Lawrence D.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Afik, Ohad; Mandelik, Yael; Pisanty, Gideon] Hebrew Univ Jerusalem, Dept Entomol, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Bartomeus, Ignasi] Rutgers State Univ, Dept Entomol Evolut & Nat Resources, New Brunswick, NJ 08901 USA; [Boreux, Virginie; Klein, Alexandra M.] Leuphana Univ, Inst Ecol, D-21335 Luneburg, Germany; [Boreux, Virginie; Ghazoul, Jaboury; Krishnan, Smitha] ETH, Dept Environm Syst Sci, CH-8092 Zurich, Switzerland; [Chacoff, Natacha P.] Univ Nacl Tucuman, Inst Ecol Reg, Fac Ciencias Nat, RA-4017 Yerba Buena, Tucuman, Argentina; [Chacoff, Natacha P.] Univ Nacl Tucuman, IML, RA-4017 Yerba Buena, Tucuman, Argentina; [Dudenhoeffer, Jan H.] Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland; [Freitas, Breno M.] Univ Fed Ceara, Dept Zootecnia CCA, BR-60356000 Fortaleza, Ceara, Brazil; [Hipolito, Juliana; Viana, Blandina F.] Univ Fed Bahia, Dept Zool, Inst Biol, BR-40170110 Salvador, BA, Brazil; [Howlett, Brad] New Zealand Inst Plant & Food Res, Christchurch, New Zealand; [Isaacs, Rufus] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Javorek, Steven K.] Agr & Agri Food Canada, Atlantic Food & Hort Res Ctr, Kentville, NS, Canada; [Kennedy, Christina M.] Nature Conservancy, Dev Design Program, Ft Collins, CO 80524 USA; [Krewenka, Kristin M.; Motzke, Iris; Tscharntke, Teja; Wanger, Thomas C.; Westphal, Catrin] Univ Gottingen, Dept Crop Sci, D-37077 Gottingen, Germany; [Mayfield, Margaret M.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Mayfield, Margaret M.] Univ Queensland, Ctr Ecol, Brisbane, Qld, Australia; [Munyuli, Theodore] DS Bukavu, CRSN Lwiro, Natl Ctr Res Nat Sci, Dept Biol, Sud Kivu, DEM REP CONGO; [Nault, Brian A.; Petersen, Jessica] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA; [Potts, Simon G.] Univ Reading, Sch Agr Policy & Dev, Reading RG6 6AR, Berks, England; [Rader, Romina] Stockholm Univ, Dept Phys Geog & Quaternary Geol, SE-10691 Stockholm, Sweden; [Ricketts, Taylor H.] Univ Vermont, Gund Inst Ecol Econ, Burlington, VT 05401 USA; [Rundlof, Maj] Lund Univ, Dept Biol, SE-22362 Lund, Sweden; [Seymour, Colleen L.] South African Natl Inst Biodivers, Appl Biodivers Res Div, ZA-7735 Claremont, South Africa; [Schueepp, Christof] Univ Bern, Inst Ecol & Evolut, CH-3012 Bern, Switzerland; [Schueepp, Christof] Univ Koblenz Landau, D-76829 Landau, Germany; [Szentgyoergyi, Hajnalka] Jagiellonian Univ, Inst Environm Sci, PL-30387 Krakow, Poland; [Taki, Hisatomo] Forestry & Forest Prod Res Inst, Dept Forest Entomol, Tsukuba, Ibaraki 3058687, Japan; [Vergara, Carlos H.] Univ Americas Puebla, Dept Ciencias Quim Biol, Cholula, Mexico; [Williams, Neal] Univ Calif Davis, Dept Entomol, Davis, CA 96616 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Wurzburg; Rutgers State University New Brunswick; Universidad Nacional del Comahue; Swedish University of Agricultural Sciences; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of California System; University of California Berkeley; University of Leeds; Naturalis Biodiversity Center; University of Calgary; Hebrew University of Jerusalem; Rutgers State University New Brunswick; Leuphana University Luneburg; Swiss Federal Institutes of Technology Domain; ETH Zurich; Universidad Nacional de Tucuman; Universidad Nacional de Tucuman; Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture; Universidade Federal do Ceara; Universidade Federal da Bahia; New Zealand Institute for Plant & Food Research Ltd; Michigan State University; Agriculture & Agri Food Canada; Nature Conservancy; University of Gottingen; University of Queensland; University of Queensland; Cornell University; University of Reading; Stockholm University; University of Vermont; Lund University; University of Bern; University of Koblenz & Landau; Jagiellonian University; Forestry & Forest Products Research Institute - Japan; Universidad Americas Puebla (UDLAP); University of California System; University of California Davis	Garibaldi, LA (corresponding author), UNRN, Mitre 630, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina.	lgaribaldi@unrn.edu.ar	Holzschuh, Andrea/X-8989-2018; Mayfield, Margaret M/B-7386-2012; Ghazoul, Jaboury/B-2121-2018; Bommarco, Riccardo/E-7109-2016; Cunningham, Saul A/B-9947-2009; Klein, Alexandra-Maria/J-5871-2016; Chacoff, Natacha/K-7595-2019; Carvalheiro, Luisa/D-9414-2012; Felipe Viana, Blandina Felipe/AFM-0275-2022; Tscharntke, Teja/N-5123-2014; Westphal, Catrin/F-9560-2015; Howlett, Brad/F-1150-2018; Hipólito, Juliana/AAQ-1457-2020; Viana, Blandina/M-6537-2013; Garibaldi, Lucas A/D-7302-2013; rader, romina/AAL-8067-2020; Harder, Lawrence/H-9715-2012; Potts, Simon/ABF-9221-2020; Isaacs, Rufus/AAF-4646-2019; Potts, Simon G/C-7250-2008; Freitas, Breno M/F-9509-2012; Szentgyörgyi, Hajnalka/AAK-2579-2020; Rundlöf, Maj/AAB-7401-2022; Felipe Viana, Blandina Felipe/AAH-2606-2022; Rader, Romina/X-6428-2019; Krishnan, Smitha/O-2282-2017; Cariveau, Daniel/AAB-9336-2020	Holzschuh, Andrea/0000-0002-5235-4746; Mayfield, Margaret M/0000-0002-5101-6542; Bommarco, Riccardo/0000-0001-8888-0476; Cunningham, Saul A/0000-0003-0703-6893; Klein, Alexandra-Maria/0000-0003-2139-8575; Chacoff, Natacha/0000-0002-1115-6989; Carvalheiro, Luisa/0000-0001-7655-979X; Felipe Viana, Blandina Felipe/0000-0002-4924-1257; Westphal, Catrin/0000-0002-2615-1339; Howlett, Brad/0000-0002-0694-135X; Hipólito, Juliana/0000-0002-0721-3143; Viana, Blandina/0000-0002-4924-1257; Harder, Lawrence/0000-0002-2303-5076; Potts, Simon/0000-0002-2045-980X; Isaacs, Rufus/0000-0001-7523-4643; Potts, Simon G/0000-0002-2045-980X; Freitas, Breno M/0000-0002-9932-2207; Szentgyörgyi, Hajnalka/0000-0002-5753-800X; Rundlöf, Maj/0000-0003-3014-1544; Felipe Viana, Blandina Felipe/0000-0002-4924-1257; Rader, Romina/0000-0001-9056-9118; Krishnan, Smitha/0000-0002-2851-6813; Aizen, Marcelo/0000-0001-9079-9749; Dudenhoffer, Jan-Hendrik/0000-0003-1548-1436; Krewenka, Kristin/0000-0002-1913-1057; Steffan-Dewenter, Ingolf/0000-0003-1359-3944; Garibaldi, Lucas Alejandro/0000-0003-0725-4049; Bartomeus, Ignasi/0000-0001-7893-4389; Otieno, Mark/0000-0002-8509-3298; Kennedy, Christina/0000-0001-8902-8728; Seymour, Colleen/0000-0002-6729-2576	Division Of Environmental Biology [0918442] Funding Source: National Science Foundation; Office Of The Director [1101317] Funding Source: National Science Foundation	Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))		Aebil A, 2012, TRENDS ECOL EVOL, V27, P142, DOI 10.1016/j.tree.2011.11.017; Aizen MA, 2007, ECOLOGY, V88, P271, DOI 10.1890/06-1017; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Bluthgen N, 2011, BASIC APPL ECOL, V12, P282, DOI 10.1016/j.baae.2010.11.001; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Chacoff NP, 2008, P ROY SOC B-BIOL SCI, V275, P907, DOI 10.1098/rspb.2007.1547; Delaplane K. S., 2000, Crop pollination by bees., DOI 10.1079/9780851994482.0000; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Garibaldi LA, 2011, P NATL ACAD SCI USA, V108, P5909, DOI 10.1073/pnas.1012431108; Goodwin RM, 2011, NEW ZEAL J CROP HORT, V39, P7, DOI 10.1080/01140671.2010.520164; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; Hoehn P, 2008, P ROY SOC B-BIOL SCI, V275, P2283, DOI 10.1098/rspb.2008.0405; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein Alexandra-Maria, 2009, P195; Kremen C, 2011, CONSERV BIOL, V25, P607, DOI 10.1111/j.1523-1739.2011.01657.x; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Morris WF, 2010, ECOLOGY, V91, P1276, DOI 10.1890/08-2278.1; MORSE RA, 1991, TRENDS ECOL EVOL, V6, P337, DOI 10.1016/0169-5347(91)90043-W; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Roberts L, 2011, SCIENCE, V333, P540, DOI 10.1126/science.333.6042.540; Rucker RR, 2012, AM J AGR ECON, V94, P956, DOI 10.1093/ajae/aas031; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Winfree R, 2009, P R SOC B, V276, P229, DOI 10.1098/rspb.2008.0709; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x; Wratten SD, 2012, AGR ECOSYST ENVIRON, V159, P112, DOI 10.1016/j.agee.2012.06.020	28	1329	1397	37	1417	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1608	+		10.1126/science.1230200	http://dx.doi.org/10.1126/science.1230200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23449997	Green Published, Green Submitted			2022-12-28	WOS:000316731600049
J	Schmitz, RJ; Schultz, MD; Urich, MA; Nery, JR; Pelizzola, M; Libiger, O; Alix, A; McCosh, RB; Chen, HM; Schork, NJ; Ecker, JR				Schmitz, Robert J.; Schultz, Matthew D.; Urich, Mark A.; Nery, Joseph R.; Pelizzola, Mattia; Libiger, Ondrej; Alix, Andrew; McCosh, Richard B.; Chen, Huaming; Schork, Nicholas J.; Ecker, Joseph R.			Patterns of population epigenomic diversity	NATURE			English	Article							GENOME-WIDE ASSOCIATION; DNA METHYLATION; ARABIDOPSIS-THALIANA; EPIGENETIC MUTATION; NATURAL VARIATION; GENE; ELEMENTS; MODEL; DEMETHYLATION; PLANTS	Natural epigenetic variation provides a source for the generation of phenotypic diversity, but to understand its contribution to such diversity, its interaction with genetic variation requires further investigation. Here we report population-wide DNA sequencing of genomes, transcriptomes and methylomes of wild Arabidopsis thaliana accessions. Single cytosine methylation polymorphisms are not linked to genotype. However, the rate of linkage disequilibrium decay amongst differentially methylated regions targeted by RNA-directed DNA methylation is similar to the rate for single nucleotide polymorphisms. Association analyses of these RNA-directed DNA methylation regions with genetic variants identified thousands of methylation quantitative trait loci, which revealed the population estimate of genetically dependent methylation variation. Analysis of invariably methylated transposons and genes across this population indicates that loci targeted by RNA-directed DNA methylation are epigenetically activated in pollen and seeds, which facilitates proper development of these structures.	[Schmitz, Robert J.; Urich, Mark A.; Alix, Andrew; McCosh, Richard B.; Ecker, Joseph R.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Schmitz, Robert J.; Schultz, Matthew D.; Urich, Mark A.; Nery, Joseph R.; Pelizzola, Mattia; Chen, Huaming; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Schultz, Matthew D.] Univ Calif San Diego, Bioinformat Program, La Jolla, CA 92093 USA; [Libiger, Ondrej; Schork, Nicholas J.] Scripps Res Inst, Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Libiger, Ondrej; Schork, Nicholas J.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Salk Institute; University of California System; University of California San Diego; Scripps Research Institute; Scripps Research Institute; Howard Hughes Medical Institute; Salk Institute	Ecker, JR (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	ecker@salk.edu	Schmitz, Robert/AAY-7659-2020; Nery, Joseph/AAE-8422-2019; Ecker, Joseph R/B-9144-2008	Schmitz, Robert/0000-0001-7538-6663; Nery, Joseph/0000-0003-0153-5659; Ecker, Joseph R/0000-0001-5799-5895; Schork, Nicholas/0000-0003-0920-5013; McCosh, Richard/0000-0003-2404-2603; Chen, Huaming/0000-0001-5289-7882; Pelizzola, Mattia/0000-0001-6672-9636	NIH [F32HG004830, K99GM100000]; NSF IGERT [DGE-0504645]; NIH/NCRR [UL1 RR025774]; NSF [MCB-0929402, MCB-1122246]; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation [GBMF3034]; Div Of Molecular and Cellular Bioscience [1122246] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG004830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM100000] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF IGERT(National Science Foundation (NSF)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Luo, R. Dowen and N. Krogan for critical reading of this manuscript; B. Coullahan for technical assistance with SOLiD RNA-seq; O. Loudet for seeds; and S. Ossowski, K. Schneeberger and D. Weigel for assistance in establishing a variant calling pipeline. R.J.S. was supported by NIH postdoctoral fellowships F32HG004830 and K99GM100000. M.D.S. was supported by an NSF IGERT training grant (DGE-0504645). O.L. and N.J.S. were supported by NIH/NCRR grant number UL1 RR025774. This work was supported by the NSF (MCB-0929402 and MCB-1122246), the Howard Hughes Medical Institute and the Gordon and Betty Moore Foundation (grant GBMF3034 to J.R.E.). J.R.E. is a HHMI-GBMF Investigator.	Ahmed I, 2011, NUCLEIC ACIDS RES, V39, P6919, DOI 10.1093/nar/gkr324; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; BENDER J, 1995, CELL, V83, P725, DOI 10.1016/0092-8674(95)90185-X; Calarco JP, 2012, CELL, V151, P194, DOI 10.1016/j.cell.2012.09.001; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Genereux DP, 2005, P NATL ACAD SCI USA, V102, P5802, DOI 10.1073/pnas.0502036102; Ibarra CA, 2012, SCIENCE, V337, P1360, DOI 10.1126/science.1224839; Johannes F, 2008, NAT REV GENET, V9, P883, DOI 10.1038/nrg2467; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; Mirouze M, 2009, NATURE, V461, P427, DOI 10.1038/nature08328; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Reinders J, 2009, GENE DEV, V23, P939, DOI 10.1101/gad.524609; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Schultz MD, 2012, TRENDS GENET, V28, P583, DOI 10.1016/j.tig.2012.10.012; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Woo HR, 2007, GENE DEV, V21, P267, DOI 10.1101/gad.1512007; Woo HR, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-92; Xiao WY, 2003, DEV CELL, V5, P891, DOI 10.1016/S1534-5807(03)00361-7; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	37	360	379	1	219	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 14	2013	495	7440					193	198		10.1038/nature11968	http://dx.doi.org/10.1038/nature11968			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23467092	Green Accepted, hybrid			2022-12-28	WOS:000316652300042
J	Stajic, J				Stajic, Jelena			INTRODUCTION The Future of Quantum Information Processing	SCIENCE			English	Editorial Material																			0	35	36	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2013	339	6124					1163	1163		10.1126/science.339.6124.1163	http://dx.doi.org/10.1126/science.339.6124.1163			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471397				2022-12-28	WOS:000315709900036
J	Mwenda, AS; Ilkul, JH				Mwenda, Aruyaru Stanley; Ilkul, John Hamad			Obstructive Ileal Ascariasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Consolata Hosp, Nyeri, Kenya		Mwenda, AS (corresponding author), Consolata Hosp, Nyeri, Kenya.			Stanley Mwenda, Aruyaru/0000-0003-0554-603X					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2013	368	10					943	943		10.1056/NEJMicm1205279	http://dx.doi.org/10.1056/NEJMicm1205279			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100BG	23465104				2022-12-28	WOS:000315669100010
J	Shah, DJ; Kim, HW; James, O; Parker, M; Wu, E; Bonow, RO; Judd, RM; Kim, RJ				Shah, Dipan J.; Kim, Han W.; James, Olga; Parker, Michele; Wu, Edwin; Bonow, Robert O.; Judd, Robert M.; Kim, Raymond J.			Prevalence of Regional Myocardial Thinning and Relationship With Myocardial Scarring in Patients With Coronary Artery Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; LEFT-VENTRICULAR DYSFUNCTION; INFARCT EXPANSION; HIBERNATING MYOCARDIUM; REVASCULARIZATION; VIABILITY; PATTERNS; RECOVERY; ANGIOPLASTY; EXTENSION	Importance Regional left ventricular (LV) wall thinning is believed to represent chronic transmural myocardial infarction and scar tissue. However, recent case reports using delayed-enhancement cardiovascular magnetic resonance (CMR) imaging raise the possibility that thinning may occur with little or no scarring. Objective To evaluate patients with regional myocardial wall thinning and to determine scar burden and potential for functional improvement. Design, Setting, and Patients Investigator-initiated, prospective, 3-center study conducted from August 2000 through January 2008 in 3 parts to determine (1) in patients with known coronary artery disease (CAD) undergoing CMR viability assessment, the prevalence of regional wall thinning (end-diastolic wall thickness <= 5.5 mm), (2) in patients with thinning, the presence and extent of scar burden, and (3) in patients with thinning undergoing coronary revascularization, any changes in myocardial morphology and contractility. Main Outcomes and Measures Scar burden in thinned regions assessed using delayed-enhancement CMR and changes in myocardial morphology and function assessed using cine-CMR after revascularization. Results Of 1055 consecutive patients with CAD screened, 201 (19% [95% CI, 17% to 21%]) had regional wall thinning. Wall thinning spanned a mean of 34% (95% CI, 32% to 37% [SD, 15%]) of LV surface area. Within these regions, the extent of scarring was 72% (95% CI, 69% to 76% [SD, 25%]); however, 18% (95% CI, 13% to 24%) of thinned regions had limited scar burden (<= 50% of total extent). Among patients with thinning undergoing revascularization and follow-up cine-CMR (n=42), scar extent within the thinned region was inversely related to regional (r=-0.72, P<.001) and global (r=-0.53, P<.001) contractile improvement. End-diastolic wall thickness in thinned regions with limited scar burden increased from 4.4 mm (95% CI, 4.1 to 4.7) to 7.5 mm (95% CI, 6.9 to 8.1) after revascularization (P<.001), resulting in resolution of wall thinning. On multivariable analysis, scar extent had the strongest association with contractile improvement (slope coefficient, -0.03 [95% CI, -0.04 to -0.02]; P<.001) and reversal of thinning (slope coefficient, -0.05 [95% CI, -0.06 to -0.04]; P<.001). Conclusions and Relevance Among patients with CAD referred for CMR and found to have regional wall thinning, limited scar burden was present in 18% and was associated with improved contractility and resolution of wall thinning after revascularization. These findings, which are not consistent with common assumptions, warrant further investigation. JAMA. 2013;309(9):909-918 www.jama.com	[Shah, Dipan J.; Kim, Han W.; James, Olga; Parker, Michele; Judd, Robert M.; Kim, Raymond J.] Duke Univ, Med Ctr, Duke Cardiovasc Magnet Resonance Ctr, Durham, NC USA; [Kim, Han W.; Parker, Michele; Judd, Robert M.; Kim, Raymond J.] Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA; [Judd, Robert M.; Kim, Raymond J.] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; [Wu, Edwin; Bonow, Robert O.] Northwestern Univ, Div Cardiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Shah, Dipan J.] Methodist DeBakey Heart & Vasc Ctr, Houston, TX USA	Duke University; Duke University; Duke University; Northwestern University; Feinberg School of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center	Kim, RJ (corresponding author), Duke Cardiovasc MRI Ctr, DUMC 3934, Durham, NC 27710 USA.	raymond.kim@duke.edu	Kim, Raymond J/B-1426-2008	Wu, Edwin/0000-0002-0771-8395	Siemens Medical Solutions; Astellas Pharmaceuticals; Methodist Hospital Research Institute; AstraZeneca; Lantheus Medical Imaging; Takeda; National Institutes of Health [NIH-NHLBI R01-HL64726]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064726] Funding Source: NIH RePORTER	Siemens Medical Solutions(Siemens AG); Astellas Pharmaceuticals(Astellas Pharmaceuticals); Methodist Hospital Research Institute; AstraZeneca(AstraZeneca); Lantheus Medical Imaging; Takeda(Takeda Pharmaceutical Company Ltd); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs R. J. Kim and Judd reported that they are inventors named on a US patent, owned by Northwestern University, for delayed-enhancement cardiovascular magnetic resonance imaging. Dr Shah reported serving as a consultant to Astellas Pharmaceuticals; receiving grants pending from Siemens Medical Solutions, Astellas Pharmaceuticals, and Methodist Hospital Research Institute; and receiving payment for lectures from AstraZeneca, Lantheus Medical Imaging, and Takeda. No other authors reported disclosures.; Ms Parker and Drs Judd and R. J. Kim are supported by National Institutes of Health grant NIH-NHLBI R01-HL64726.	Baer FM, 1998, J AM COLL CARDIOL, V31, P1040, DOI 10.1016/S0735-1097(98)00032-1; Bello D, 2003, CIRCULATION, V108, P1945, DOI 10.1161/01.CIR.0000095029.57483.60; Bolognese L, 2002, CIRCULATION, V106, P2351, DOI 10.1161/01.CIR.0000036014.90197.FA; Bonow RO, 2011, NEW ENGL J MED, V364, P1617, DOI 10.1056/NEJMoa1100358; Carlucclo E, 2006, J AM COLL CARDIOL, V47, P969, DOI 10.1016/j.jacc.2005.09.064; Cwajg JM, 2000, J AM COLL CARDIOL, V35, P1152, DOI 10.1016/S0735-1097(00)00525-8; EATON LW, 1981, CIRC RES, V49, P80, DOI 10.1161/01.RES.49.1.80; Fieno DS, 2004, J AM COLL CARDIOL, V43, P2124, DOI 10.1016/j.jacc.2004.01.043; GRIMM RH, 1987, CIRCULATION, V75, P6; HOCHMAN JS, 1982, CIRCULATION, V65, P1446, DOI 10.1161/01.CIR.65.7.1446; HUTCHINS GM, 1978, AM J CARDIOL, V41, P1127, DOI 10.1016/0002-9149(78)90869-X; John AS, 2005, CIRCULATION, V111, pE24, DOI 10.1161/01.CIR.0000153385.62524.85; KEANE D, 1995, CIRCULATION, V91, P2174, DOI 10.1161/01.CIR.91.8.2174; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Kim RJ, 2004, HEART, V90, P137, DOI 10.1136/hrt.2003.023101; La Canna G, 2000, EUR HEART J, V21, P1358, DOI 10.1053/euhj.1999.2038; Myerson SG, 2002, HYPERTENSION, V39, P750, DOI 10.1161/hy0302.104674; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; PIROLO JS, 1986, J AM COLL CARDIOL, V7, P349, DOI 10.1016/S0735-1097(86)80504-6; RENTROP KP, 1985, J AM COLL CARDIOL, V5, P587; Rizzello V, 2004, CIRCULATION, V110, P2383, DOI 10.1161/01.CIR.0000145115.29952.14; Schinkel AFL, 2010, AM J MED, V123, P978, DOI 10.1016/j.amjmed.2010.03.025; Schmidt M, 2004, MAGN RESON IMAGING, V22, P229, DOI 10.1016/j.mri.2003.07.006; Schvartzman PR, 2003, AM HEART J, V146, P535, DOI 10.1016/S0002-8703(03)00318-1; SELVESTER RH, 1985, ARCH INTERN MED, V145, P1877, DOI 10.1001/archinte.145.10.1877; Sheifer SE, 2000, J AM COLL CARDIOL, V35, P119, DOI 10.1016/S0735-1097(99)00524-0; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; WEISMAN HF, 1987, PROG CARDIOVASC DIS, V30, P73, DOI 10.1016/0033-0620(87)90004-1; WEISMAN HF, 1988, CIRCULATION, V78, P186, DOI 10.1161/01.CIR.78.1.186	29	72	77	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2013	309	9					909	918		10.1001/jama.2013.1381	http://dx.doi.org/10.1001/jama.2013.1381			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099PC	23462787	Green Accepted			2022-12-28	WOS:000315632700026
J	Kelton, JG; Arnold, DM; Bates, SM				Kelton, John G.; Arnold, Donald M.; Bates, Shannon M.			Nonheparin Anticoagulants for Heparin-Induced Thrombocytopenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TISSUE FACTOR; ANTIBODIES; MICROPARTICLES; FONDAPARINUX; SCORE; COMPLICATIONS; MANAGEMENT; THERAPY; COMPLEX; RISK	A 57-year-old man remains in the hospital after experiencing complications from knee-replacement surgery 7 days ago. Low-molecular-weight heparin prophylaxis is initiated on the first postoperative day. Compression ultrasonography performed for left leg swelling noted on day 7 shows a proximal deep-vein thrombosis. A complete blood count reveals that his platelet count has decreased from 300x10(9) per liter to 125x10(9) per liter, and an enzyme immunoassay for heparin-induced thrombocytopenia shows a high titer of antibodies against platelet factor 4 (PF4)-heparin complexes. The patient has normal renal function. The physician in the intensive care unit wonders about the best treatment.	[Kelton, John G.; Arnold, Donald M.; Bates, Shannon M.] McMaster Univ, Dept Med, Michael G DeGroote Sch Med, Hamilton, ON L8S 4K1, Canada; [Arnold, Donald M.] Canadian Blood Serv, Hamilton, ON, Canada; [Bates, Shannon M.] Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada	McMaster University; Canadian Blood Services; McMaster University	Kelton, JG (corresponding author), McMaster Univ, Fac Hlth Sci, Michael G DeGroote Sch Med, Med Ctr, 1280 Main St W,Rm 2E1, Hamilton, ON L8S 4K1, Canada.			Arnold, Donald/0000-0003-0943-8853				AMIRAL J, 1992, THROMB HAEMOSTASIS, V68, P95; [Anonymous], 2012, ARG PRESCR INF; Arepally GM, 2001, BLOOD, V98, P1252, DOI 10.1182/blood.V98.4.1252; Arepally GM, 2006, NEW ENGL J MED, V355, P809, DOI 10.1056/NEJMcp052967; Crespo EM, 2009, AM HEART J, V157, P651, DOI 10.1016/j.ahj.2009.01.005; Cuker A, 2010, J THROMB HAEMOST, V8, P2642, DOI 10.1111/j.1538-7836.2010.04059.x; Cuker A, 2012, BLOOD, V120, P4160, DOI 10.1182/blood-2012-07-443051; Cuker A, 2011, THROMB HAEMOSTASIS, V106, P993, DOI 10.1160/TH11-09-0677; Cuker A, 2011, J THROMB THROMBOLYS, V31, P353, DOI 10.1007/s11239-011-0569-6; Garcia DA, 2012, CHEST, V141, P1369; GREINACHER A, 1992, THROMB HAEMOSTASIS, V67, P545; Guyatt GH, 2012, CHEST, V141, p53S, DOI 10.1378/chest.11-2288; Hui P, 2011, CHEST, V139, P271, DOI 10.1378/chest.10-2243; Kasthuri RS, 2012, BLOOD, V119, P5285, DOI 10.1182/blood-2011-06-359430; Keeling D, 2006, BRIT J HAEMATOL, V134, P351, DOI 10.1111/j.1365-2141.2006.06169.x; Keeling D, 2006, BRIT J HAEMATOL, V133, P259, DOI 10.1111/j.1365-2141.2006.06018.x; Kelton JG, 2012, J THROMB HAEMOST, V10, P1446, DOI 10.1111/j.1538-7836.2012.04759.x; KELTON JG, 1988, BLOOD, V72, P925; KELTON JG, 1994, BLOOD, V83, P3232; Kelton JG, 2008, BLOOD, V112, P2607, DOI 10.1182/blood-2008-02-078014; Kelton JG, 2008, BLOOD COAGUL FIBRIN, V19, P471, DOI 10.1097/MBC.0b013e3282a167cc; Lewis BE, 2003, ARCH INTERN MED, V163, P1849, DOI 10.1001/archinte.163.15.1849; Lewis BE, 2001, CIRCULATION, V103, P1838; Lillo-de Louet A, 2004, J THROMB HAEMOST, V2, P1882, DOI 10.1111/j.1538-7836.2004.00949.x; Linkins LA, 2012, CHEST S, V141, pe495S; Lo GK, 2006, J THROMB HAEMOST, V4, P759, DOI 10.1111/j.1538-7836.2006.01787.x; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; Paolucci F, 2002, CLIN PHARMACOKINET, V41, P11, DOI 10.2165/00003088-200241002-00002; SHERIDAN D, 1986, BLOOD, V67, P27; Warkentin TE, 2008, J THROMB HAEMOST, V6, P1304, DOI 10.1111/j.1538-7836.2008.03025.x; Warkentin TE, 2011, CHEST, V139, P1261; Warkentin TE, 2000, BLOOD, V96, P1703, DOI 10.1182/blood.V96.5.1703.h8001703_1703_1708; Warkentin TE, 2001, ANN INTERN MED, V135, P502, DOI 10.7326/0003-4819-135-7-200110020-00009; Warkentin TE, 2001, NEW ENGL J MED, V344, P1286, DOI 10.1056/NEJM200104263441704; Warkentin TE, 2005, J LAB CLIN MED, V146, P341, DOI 10.1016/j.lab.2005.08.003; Warkentin TE, 1998, SEMIN HEMATOL, V35, P9; WARKENTIN TE, 1994, BLOOD, V84, P3691, DOI 10.1182/blood.V84.11.3691.bloodjournal84113691; Warkentin TE, 2003, ARCH INTERN MED, V163, P2518, DOI 10.1001/archinte.163.20.2518; Warkentin TE, 1997, ANN INTERN MED, V127, P804, DOI 10.7326/0003-4819-127-9-199711010-00005; Warkentin TE, 1996, AM J MED, V101, P502, DOI 10.1016/S0002-9343(96)00258-6; Warkentin TE, 2012, THROMB HAEMOSTASIS, V108, P394, DOI 10.1160/TH12-03-0201; Warkentin TE, 2012, AM J HEMATOL, V87, pS92, DOI 10.1002/ajh.23127; Warkentin TE, 2011, CHEST, V140, P366, DOI 10.1378/chest.10-1599; Warkentin TE, 2010, HEMATOL ONCOL CLIN N, V24, P755, DOI 10.1016/j.hoc.2010.05.009	45	75	85	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2013	368	8					737	744		10.1056/NEJMct1206642	http://dx.doi.org/10.1056/NEJMct1206642			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092CG	23425166				2022-12-28	WOS:000315095800008
J	Schulman, S; Kearon, C; Kakkar, AK; Schellong, S; Eriksson, H; Baanstra, D; Kvamme, AM; Friedman, J; Mismetti, P; Goldhaber, SZ				Schulman, Sam; Kearon, Clive; Kakkar, Ajay K.; Schellong, Sebastian; Eriksson, Henry; Baanstra, David; Kvamme, Anne Mathilde; Friedman, Jeffrey; Mismetti, Patrick; Goldhaber, Samuel Z.		RE-MEDY & RE-SONATE Trials Invest	Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORAL ANTICOAGULANT-THERAPY; MOLECULAR-WEIGHT HEPARIN; LONG-TERM; UNFRACTIONATED HEPARIN; ATRIAL-FIBRILLATION; PULMONARY-EMBOLISM; INITIAL TREATMENT; RANDOMIZED-TRIAL; 1ST EPISODE; PREVENTION	BACKGROUND Dabigatran, which is administered in a fixed dose and does not require laboratory monitoring, may be suitable for extended treatment of venous thromboembolism. METHODS In two double-blind, randomized trials, we compared Dabigatran at a dose of 150 mg twice daily with warfarin (active-control study) or with placebo (placebo-control study) in patients with venous thromboembolism who had completed at least 3 initial months of therapy. RESULTS In the active-control study, recurrent venous thromboembolism occurred in 26 of 1430 patients in the Dabigatran group (1.8%) and 18 of 1426 patients in the warfarin group (1.3%) (hazard ratio with Dabigatran, 1.44; 95% confidence interval [CI], 0.78 to 2.64; P = 0.01 for noninferiority). Major bleeding occurred in 13 patients in the Dabigatran group (0.9%) and 25 patients in the warfarin group (1.8%) (hazard ratio, 0.52; 95% CI, 0.27 to 1.02). Major or clinically relevant bleeding was less frequent with Dabigatran (hazard ratio, 0.54; 95% CI, 0.41 to 0.71). Acute coronary syndromes occurred in 13 patients in the Dabigatran group (0.9%) and 3 patients in the warfarin group (0.2%) (P = 0.02). In the placebo-control study, recurrent venous thromboembolism occurred in 3 of 681 patients in the Dabigatran group (0.4%) and 37 of 662 patients in the placebo group (5.6%) (hazard ratio, 0.08; 95% CI, 0.02 to 0.25; P<0.001). Major bleeding occurred in 2 patients in the Dabigatran group (0.3%) and 0 patients in the placebo group. Major or clinically relevant bleeding occurred in 36 patients in the Dabigatran group (5.3%) and 12 patients in the placebo group (1.8%) (hazard ratio, 2.92; 95% CI, 1.52 to 5.60). Acute coronary syndromes occurred in 1 patient each in the Dabigatran and placebo groups. CONCLUSIONS Dabigatran was effective in the extended treatment of venous thromboembolism and carried a lower risk of major or clinically relevant bleeding than warfarin but a higher risk than placebo. (Funded by Boehringer Ingelheim; RE-MEDY and RE-SONATE ClinicalTrials.gov numbers, NCT00329238 and NCT00558259, respectively.)	[Schulman, Sam; Kearon, Clive] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Schulman, Sam; Kearon, Clive] Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada; [Schulman, Sam] Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden; [Eriksson, Henry] Sahlgrens Univ Hosp, Dept Med, Gothenburg, Sweden; [Kakkar, Ajay K.] Thrombosis Res Inst, London, England; [Kakkar, Ajay K.] UCL, London WC1E 6BT, England; [Schellong, Sebastian] Municipal Hosp Friedrichstadt, Med Div 2, Dresden, Germany; [Baanstra, David] Boehringer Ingelheim GmbH & Co KG, Clin Res, Alkmaar, Netherlands; [Kvamme, Anne Mathilde] Boehringer Ingelheim GmbH & Co KG, Clin Res, Asker, Norway; [Friedman, Jeffrey] Boehringer Ingelheim GmbH & Co KG, Ridgefield, CT USA; [Mismetti, Patrick] Bellevue Hosp, Dept Vasc Pathol, St Etienne, France; [Goldhaber, Samuel Z.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Goldhaber, Samuel Z.] Harvard Univ, Sch Med, Boston, MA USA	McMaster University; McMaster University; Karolinska Institutet; Karolinska University Hospital; Sahlgrenska University Hospital; Thrombosis Research Institute; University of London; University College London; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; CHU de St Etienne; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Schulman, S (corresponding author), HHS Gen Hosp, Thrombosis Serv, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	schulms@mcmaster.ca	Schulman, Sam/I-7559-2019; Zanatta, Nilo/P-7137-2017; Stanisław, Gluszek/S-3303-2019; Waage, Anders/D-7705-2013; Nijziel, Marten R./D-2128-2016; Kaynar, Leylagul/F-6991-2013; Szopiński, Piotr/X-6579-2018; Beyer-Westendorf, Jan/K-7569-2019	Schulman, Sam/0000-0002-8512-9043; Zanatta, Nilo/0000-0002-0959-9043; Stanisław, Gluszek/0000-0001-7752-0459; Nijziel, Marten R./0000-0001-9069-4939; Kaynar, Leylagul/0000-0002-2035-9462; Szopiński, Piotr/0000-0001-6001-0823; Beyer-Westendorf, Jan/0000-0002-6983-9993; Harenberg, Job/0000-0003-4590-4225; Dees, Adriaan/0000-0001-9164-4538; Safwenberg, Urban/0000-0002-7314-1870; Meijer, Karina/0000-0001-9447-0465; Marco, Pascual/0000-0002-3412-7566; Ritchie, Bruce/0000-0003-4754-1050; Farkas, Katalin/0000-0001-5577-6808; Mateo, Jose/0000-0002-4227-3256	Boehringer Ingelheim	Boehringer Ingelheim(Boehringer Ingelheim)	Funded by Boehringer Ingelheim; RE-MEDY and RE-SONATE ClinicalTrials.gov numbers, NCT00329238 and NCT00558259, respectively.)	Agnelli G, 2003, ANN INTERN MED, V139, P19, DOI 10.7326/0003-4819-139-1-200307010-00008; Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Buller HR, 2007, NEW ENGL J MED, V357, P1094; Buller HR, 2004, ANN INTERN MED, V140, P867, DOI 10.7326/0003-4819-140-11-200406010-00007; Buller HR, 2003, NEW ENGL J MED, V349, P1695; BULLER HR, 2004, NEW ENGL J MED, V350, P423; Connolly SJ, 2010, NEW ENGL J MED, V363, P1877; Connolly SJ, 2010, NEW ENGL J MED, V363, P1875, DOI 10.1056/NEJMc1007378; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Fiessinger JN, 2005, JAMA-J AM MED ASSOC, V293, P681, DOI 10.1001/jama.293.6.681; Hohnloser SH, 2012, CIRCULATION, V125, P669, DOI 10.1161/CIRCULATIONAHA.111.055970; Hutten BA, 2000, COCHRANE DB SYST REV, V3; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Kearon C, 2008, CHEST, V134, P892, DOI DOI 10.1378/CHEST.08-0658; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Kearon C, 2006, JAMA-J AM MED ASSOC, V296, P935, DOI 10.1001/jama.296.8.935; Ost D, 2005, JAMA-J AM MED ASSOC, V294, P706, DOI 10.1001/jama.294.6.706; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; Schulman S, 2003, NEW ENGL J MED, V349, P1713, DOI 10.1056/NEJMoa030104; Schulman S, 1997, NEW ENGL J MED, V336, P393, DOI 10.1056/NEJM199702063360601; Schulman S, 2011, AM SOC HEM ANN M SAN; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Uchino K, 2012, ARCH INTERN MED, V172, P397, DOI 10.1001/archinternmed.2011.1666	25	695	736	1	79	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2013	368	8					709	718		10.1056/NEJMoa1113697	http://dx.doi.org/10.1056/NEJMoa1113697			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092CG	23425163	Green Published			2022-12-28	WOS:000315095800005
J	Fairfield, KM				Fairfield, Kathleen M.			Daily multivitamin supplements did not reduce risk for major CV events over > 10 years in men	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MORTALITY		Maine Med Ctr, Portland, ME 04102 USA	Maine Medical Center	Fairfield, KM (corresponding author), Maine Med Ctr, Portland, ME 04102 USA.							Holmquist C, 2003, J NUTR, V133, P2650, DOI 10.1093/jn/133.8.2650; Muntwyler J, 2002, ARCH INTERN MED, V162, P1472, DOI 10.1001/archinte.162.13.1472; Park SY, 2011, AM J EPIDEMIOL, V173, P906, DOI 10.1093/aje/kwq447; Watkins ML, 2000, AM J EPIDEMIOL, V152, P149, DOI 10.1093/aje/152.2.149	4	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2013	158	4							JC2-8	10.7326/0003-4819-158-4-201302190-02008	http://dx.doi.org/10.7326/0003-4819-158-4-201302190-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098WR	23420255				2022-12-28	WOS:000315580300007
J	Bruin, JAN; Sakai, H; Perry, RS; Mackenzie, AP				Bruin, J. A. N.; Sakai, H.; Perry, R. S.; Mackenzie, A. P.			Similarity of Scattering Rates in Metals Showing T-Linear Resistivity	SCIENCE			English	Article							QUANTUM CRITICAL-BEHAVIOR; HAAS-VAN-ALPHEN; PHASE-FORMATION; TEMPERATURE; CONDUCTIVITY; CRITICALITY; DISORDER; STATE	Many exotic compounds, such as cuprate superconductors and heavy fermion materials, exhibit a linear in temperature (T) resistivity, the origin of which is not well understood. We found that the resistivity of the quantum critical metal Sr3Ru2O7 is also T-linear at the critical magnetic field of 7.9 T. Using the precise existing data for the Fermi surface topography and quasiparticle velocities of Sr3Ru2O7, we show that in the region of the T-linear resistivity, the scattering rate per kelvin is well approximated by the ratio of the Boltzmann constant to the Planck constant divided by 2 pi. Extending the analysis to a number of other materials reveals similar results in the T-linear region, in spite of large differences in the microscopic origins of the scattering.	[Bruin, J. A. N.; Sakai, H.; Mackenzie, A. P.] Univ St Andrews, Sch Phys & Astron, Scottish Univ Phys Alliance, St Andrews KY16 9SS, Fife, Scotland; [Perry, R. S.] Univ Edinburgh, Sch Phys & Astron, Scottish Univ Phys Alliance, Edinburgh EH9 3JZ, Midlothian, Scotland	University of St Andrews; University of Edinburgh	Bruin, JAN (corresponding author), Univ St Andrews, Sch Phys & Astron, Scottish Univ Phys Alliance, St Andrews KY16 9SS, Fife, Scotland.		Mackenzie, Andrew P/K-6742-2015; Sakai, Hideaki/G-1008-2014	Mackenzie, Andrew P/0000-0001-8000-4949; Sakai, Hideaki/0000-0001-9839-1377; Bruin, Jan/0000-0002-9476-118X	UK Engineering and Physical Sciences Research Council; Canon Foundation Europe; Marubun Research Promotion Foundation; Royal Society-Wolfson Merit Award; Engineering and Physical Sciences Research Council [EP/G007357/1, EP/I031014/1] Funding Source: researchfish; EPSRC [EP/I031014/1, EP/G007357/1] Funding Source: UKRI	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Canon Foundation Europe; Marubun Research Promotion Foundation; Royal Society-Wolfson Merit Award(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We are pleased to acknowledge the help of M. Baenitz, M. Nicklas, and C. Klausnitzer of the Max Planck Institute for the Chemical Physics of Solids in Dresden, where the high-temperature resistivity measurements on Sr<INF>3</INF>Ru<INF>2</INF>O<INF>7</INF> were performed, and useful discussions with J. Orenstein, S. A. Kivelson, C. A. Hooley, and J. Zaanen. The research was supported by the UK Engineering and Physical Sciences Research Council. H. S. gratefully acknowledges fellowships from the Canon Foundation Europe and Marubun Research Promotion Foundation, and A. P. M. acknowledges the receipt of a Royal Society-Wolfson Merit Award.	Adler SS, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.182301; Andreev AV, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.256804; Brooks JS, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126501; Cao C, 2011, SCIENCE, V331, P58, DOI 10.1126/science.1195219; Capogna L, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.076602; Cooper RA, 2009, SCIENCE, V323, P603, DOI 10.1126/science.1165015; Daou R, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.026401; Doiron-Leyraud N, 2010, EUR PHYS J B, V78, P23, DOI 10.1140/epjb/e2010-10571-4; Gegenwart P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.136402; Grigera SA, 2004, SCIENCE, V306, P1154, DOI 10.1126/science.1104306; Grigera SA, 2001, SCIENCE, V294, P329, DOI 10.1126/science.1063539; HLUBINA R, 1995, PHYS REV B, V51, P9253, DOI 10.1103/PhysRevB.51.9253; Homes CC, 2004, NATURE, V430, P539, DOI 10.1038/nature02673; Kaminski A, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.014517; Kasahara S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.184519; Kima JS, 2000, SOLID STATE COMMUN, V114, P413, DOI 10.1016/S0038-1098(00)00084-3; Kimura N, 2000, PHYSICA B, V281, P710, DOI 10.1016/S0921-4526(99)01229-6; Kitagawa K, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.127001; Kovtun PK, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.111601; Liu HL, 1999, J PHYS-CONDENS MAT, V11, P239, DOI 10.1088/0953-8984/11/1/020; McCollam A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.186401; Mercure JF, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.235103; ORENSTEIN J, 1990, PHYS REV B, V42, P6342, DOI 10.1103/PhysRevB.42.6342; Perry RS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.166602; Rosch A, 1999, PHYS REV LETT, V82, P4280, DOI 10.1103/PhysRevLett.82.4280; Rost AW, 2011, P NATL ACAD SCI USA, V108, P16549, DOI 10.1073/pnas.1112775108; Rost AW, 2009, SCIENCE, V325, P1360, DOI 10.1126/science.1176627; Schafer T, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.063618; Schafer T, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/12/126001; SCHLESINGER Z, 1990, PHYS REV B, V41, P11237, DOI 10.1103/PhysRevB.41.11237; Settai R, 2001, J PHYS-CONDENS MAT, V13, pL627, DOI 10.1088/0953-8984/13/27/103; Shishido H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.057008; Takashita M, 1996, J PHYS SOC JPN, V65, P515, DOI 10.1143/JPSJ.65.515; Tamai A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.026407; Tanatar MA, 2007, SCIENCE, V316, P1320, DOI 10.1126/science.1140762; TAYLOR PL, 1963, PROC R SOC LON SER-A, V275, P209, DOI 10.1098/rspa.1963.0165; Teaney D. A., ARXIV09052433V1; Valla T, 1999, SCIENCE, V285, P2110, DOI 10.1126/science.285.5436.2110; van der Marel D, 2003, NATURE, V425, P271, DOI 10.1038/nature01978; Zaanen J, 2004, NATURE, V430, P512, DOI 10.1038/430512a	43	235	235	13	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2013	339	6121					804	807		10.1126/science.1227612	http://dx.doi.org/10.1126/science.1227612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23413351	Green Submitted			2022-12-28	WOS:000314874400044
J	Chou, R; Hartung, D; Rahman, B; Wasson, N; Cottrell, EB; Fu, RW				Chou, Roger; Hartung, Daniel; Rahman, Basmah; Wasson, Ngoc; Cottrell, Erika Barth; Fu, Rongwei			Comparative Effectiveness of Antiviral Treatment for Hepatitis C Virus Infection in Adults: A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							SUSTAINED VIROLOGICAL RESPONSE; PEGYLATED INTERFERON ALPHA-2A; RANDOMIZED CONTROLLED-TRIAL; RIBAVIRIN COMBINATION THERAPY; HCV-RELATED CIRRHOSIS; PLUS RIBAVIRIN; PEGINTERFERON ALPHA-2B; HEPATOCELLULAR-CARCINOMA; INITIAL TREATMENT; NAIVE PATIENTS	Background: Multiple treatments are available for chronic hepatitis C virus (HCV) infection. Purpose: To compare benefits and harms of antiviral regimens for chronic HCV infection in treatment-naive adults. Data Sources: English-language literature from MEDLINE (1947 to August 2012), the Cochrane Library Database, Embase, Scopus, PsychINFO, and clinical trial registries. Study Selection: Randomized trials of antiviral treatments and cohort studies examining associations between sustained virologic response (SVR) after therapy and clinical outcomes. Data Extraction: Several investigators abstracted study details and quality by using predefined criteria. Data Synthesis: No trial evaluated effectiveness of treatment on long-term clinical outcomes. Dual therapy with pegylated interferon alfa-2b plus ribavirin was associated with a lower likelihood of SVR than was pegylated interferon alfa-2a plus ribavirin (absolute difference, 8 percentage points [ 95% CI, 3 to 14 percentage points]) on the basis of 7 poor-to fair-quality trials. For genotype 2 or 3 infection, dual therapy for 12 to 16 weeks was associated with a lower likelihood of SVR than was therapy for 24 weeks, and lower doses of pegylated interferon alfa-2b were less effective than standard doses (2 to 4 fair-quality trials). For genotype 1 infection, fair-quality trials found that triple therapy with pegylated interferon, ribavirin, and either boceprevir (2 trials) or telaprevir (4 trials) was associated with a higher likelihood of SVR than was dual therapy (absolute difference, 22 to 31 percentage points). Compared with dual therapy, boceprevir triple therapy increased risk for hematologic adverse events and telaprevir triple therapy increased risk for anemia and rash. A large well-designed cohort study and 18 smaller cohort studies found that an SVR after antiviral therapy was associated with lower risk for all-cause mortality than was no SVR. Limitations: Trials involved highly selected populations. Observational studies did not always adequately control for confounders. Conclusion: SVR rates for genotype 1 infection are higher with triple therapy that includes a protease inhibitor than with standard dual therapy. An SVR after antiviral therapy appears associated with improved clinical outcomes.	[Chou, Roger; Hartung, Daniel; Rahman, Basmah; Wasson, Ngoc; Cottrell, Erika Barth; Fu, Rongwei] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Chou, R (corresponding author), 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA.	chour@ohsu.edu		Chou, Roger/0000-0001-9889-8610; Rahman, Basmah/0000-0002-3576-2086	AHRQ Rockville, Maryland [290-2007-10057-I]	AHRQ Rockville, Maryland	By AHRQ (contract 290-2007-10057-I, task order 8), Rockville, Maryland.	Abergel A, 2006, J VIRAL HEPATITIS, V13, P811, DOI 10.1111/j.1365-2893.2006.00768.x; Agency for Healthcare Research and Quality, 2012, AHRQ PUBLICATION, V12-EC017; Andriulli A, 2009, J VIRAL HEPATITIS, V16, P28, DOI 10.1111/j.1365-2893.2008.01044.x; [Anonymous], 2002, HEPATOLOGY, V36, pS3, DOI 10.1053/jhep.2002.37117; [Anonymous], 2002, PEGASYS PACK INS; [Anonymous], 2005, PEG INTR PACK INS; Arase Y, 2007, INTERVIROLOGY, V50, P16, DOI 10.1159/000096308; Ascione A, 2010, GASTROENTEROLOGY, V138, P116, DOI 10.1053/j.gastro.2009.10.005; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Bhandari M, 2004, CAN MED ASSOC J, V170, P477; Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Cardoso AC, 2010, J HEPATOL, V52, P652, DOI 10.1016/j.jhep.2009.12.028; Chou R, 2012, COMP EFFECTIVENESS A; Chou R, 2012, SCREENING HEPATITIS; Coverdale SA, 2004, AM J GASTROENTEROL, V99, P636, DOI 10.1111/j.1572-0241.2004.04085.x; Dalgard O, 2008, HEPATOLOGY, V47, P35, DOI 10.1002/hep.21975; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; El Braks R, 2007, WORLD J GASTROENTERO, V13, P5648, DOI 10.3748/wjg.v13.i42.5648; Escudero A, 2008, J GASTROEN HEPATOL, V23, P861, DOI 10.1111/j.1440-1746.2008.05397.x; Fe RW, 2011, J CLIN EPIDEMIOL, V64, P1187, DOI 10.1016/j.jclinepi.2010.08.010; Ferenci P, 2008, HEPATOLOGY, V47, P1816, DOI 10.1002/hep.22262; Fernandez-Rodriguez CM, 2010, AM J GASTROENTEROL, V105, P2164, DOI 10.1038/ajg.2010.294; Foster GR, 2004, ALIMENT PHARM THER, V20, P825, DOI 10.1111/j.1365-2036.2004.02170.x; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hasegawa E, 2007, HEPATOL RES, V37, P793, DOI 10.1111/j.1872-034X.2007.00140.x; Helbling B, 2006, J VIRAL HEPATITIS, V13, P762, DOI 10.1111/j.1365-2893.2006.00753.x; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hung CH, 2006, J VIRAL HEPATITIS, V13, P409, DOI 10.1111/j.1365-2893.2005.00707.x; Imazeki F, 2003, HEPATOLOGY, V38, P493, DOI 10.1053/jhep.2003.50329; Innes HA, 2011, HEPATOLOGY, V54, P2281, DOI [10.1002/hep.24776, 10.1002/hep.24561]; Izumi N, 2005, INTERVIROLOGY, V48, P59, DOI 10.1159/000082096; Jacobson IM, 2007, HEPATOLOGY, V46, P971, DOI 10.1002/hep.21932; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kamal SM, 2011, LIVER INT, V31, P401, DOI 10.1111/j.1478-3231.2010.02435.x; Kasahara A, 2004, J VIRAL HEPATITIS, V11, P148, DOI 10.1046/j.1365-2893.2003.00481.x; Kawaoka T, 2009, J GASTROEN HEPATOL, V24, P366, DOI 10.1111/j.1440-1746.2008.05650.x; Khan AQ, 2007, GASTROENTEROLOGY, V132, pA200; Kim WR, 2002, HEPATOLOGY, V36, pS30, DOI 10.1053/jhep.2002.36791; Krawitt EL, 2006, AM J GASTROENTEROL, V101, P1268, DOI 10.1111/j.1572-0241.2006.00614.x; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; Kwo PY, 2010, LANCET, V376, P705, DOI 10.1016/S0140-6736(10)60934-8; Lagging M, 2008, HEPATOLOGY, V47, P1837, DOI 10.1002/hep.22253; Lam KD, 2010, HEPATOLOGY, V52, P1573, DOI 10.1002/hep.23889; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Mach TH, 2011, POL ARCH MED WEWN, V121, P434, DOI 10.20452/pamw.1109; Magni C, 2009, HEPATOLOGY, V50, p720A; Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608; Manns M, 2011, J HEPATOL, V55, P554, DOI 10.1016/j.jhep.2010.12.024; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marcellin P, 2011, GASTROENTEROLOGY, V140, P459, DOI 10.1053/j.gastro.2010.10.046; Maruoka D, 2012, J GASTROEN HEPATOL, V27, P291, DOI 10.1111/j.1440-1746.2011.06871.x; McHutchison J, 2008, J VIRAL HEPATITIS, V15, P475, DOI 10.1111/j.1365-2893.2008.00973.x; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Mecenate F, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-21; Meyer-Wyss B, 2006, J VIRAL HEPATITIS, V13, P457, DOI 10.1111/j.1365-2893.2005.00709.x; Mimidis Konstantinos, 2006, J Gastrointestin Liver Dis, V15, P213; Miyase S, 2012, J GASTROENTEROL, V47, P1014, DOI 10.1007/s00535-012-0560-9; Morgan TR, 2010, HEPATOLOGY, V52, P833, DOI 10.1002/hep.23744; Pembrey L, 2005, J HEPATOL, V43, P515, DOI 10.1016/j.jhep.2005.06.002; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Rumi MG, 2010, GASTROENTEROLOGY, V138, P108, DOI [10.1053/j.gastro.2009.08.071, 10.1053/j.gastro.2010.04.037]; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403; Shiratori Y, 2005, ANN INTERN MED, V142, P105, DOI 10.7326/0003-4819-142-2-200501180-00009; Sood A, 2008, J GASTROEN HEPATOL, V23, P203, DOI 10.1111/j.1440-1746.2007.05057.x; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Sun X, 2012, INTERVENTIONS IMPROV; U.S. Food and Drug Administration, 2011, APPR VICTR BOC DIR A; U.S. Food and Drug Administration, 2011, APPR INC TEL DIR ACT; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003; von Wagner M, 2005, GASTROENTEROLOGY, V129, P522, DOI 10.1053/j.gastro.2005.05.008; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Yenice Necati, 2006, Turk J Gastroenterol, V17, P94; Yoshida H, 2002, GASTROENTEROLOGY, V123, P483, DOI 10.1053/gast.2002.34785; Yu ML, 2006, ANTIVIR THER, V11, P985; Yu ML, 2007, GUT, V56, P553, DOI 10.1136/gut.2006.102558; Zeuzem S, 2004, GASTROENTEROLOGY, V127, P1724, DOI 10.1053/j.gastro.2004.09.050	86	94	97	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2013	158	2					114	123		10.7326/0003-4819-158-2-201301150-00576	http://dx.doi.org/10.7326/0003-4819-158-2-201301150-00576			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077LO	23437439				2022-12-28	WOS:000314029400018
J	Kern, J; Alonso-Mori, R; Tran, R; Hattne, J; Gildea, RJ; Echols, N; Glockner, C; Hellmich, J; Laksmono, H; Sierra, RG; Lassalle-Kaiser, B; Koroidov, S; Lampe, A; Han, GY; Gul, S; DiFiore, D; Milathianaki, D; Fry, AR; Miahnahri, A; Schafer, DW; Messerschmidt, M; Seibert, MM; Koglin, JE; Sokaras, D; Weng, TC; Sellberg, J; Latimer, MJ; Grosse-Kunstleve, RW; Zwart, PH; White, WE; Glatzel, P; Adams, PD; Bogan, MJ; Williams, GJ; Boutet, S; Messinger, J; Zouni, A; Sauter, NK; Yachandra, VK; Bergmann, U; Yano, J				Kern, Jan; Alonso-Mori, Roberto; Tran, Rosalie; Hattne, Johan; Gildea, Richard J.; Echols, Nathaniel; Gloeckner, Carina; Hellmich, Julia; Laksmono, Hartawan; Sierra, Raymond G.; Lassalle-Kaiser, Benedikt; Koroidov, Sergey; Lampe, Alyssa; Han, Guangye; Gul, Sheraz; DiFiore, Doerte; Milathianaki, Despina; Fry, Alan R.; Miahnahri, Alan; Schafer, Donald W.; Messerschmidt, Marc; Seibert, M. Marvin; Koglin, Jason E.; Sokaras, Dimosthenis; Weng, Tsu-Chien; Sellberg, Jonas; Latimer, Matthew J.; Grosse-Kunstleve, Ralf W.; Zwart, Petrus H.; White, William E.; Glatzel, Pieter; Adams, Paul D.; Bogan, Michael J.; Williams, Garth J.; Boutet, Sebastien; Messinger, Johannes; Zouni, Athina; Sauter, Nicholas K.; Yachandra, Vittal K.; Bergmann, Uwe; Yano, Junko			Simultaneous Femtosecond X-ray Spectroscopy and Diffraction of Photosystem II at Room Temperature	SCIENCE			English	Article							OXYGEN-EVOLVING COMPLEX; CRYSTAL-STRUCTURE; SYNTHETIC MODEL; MN4CA CLUSTER; RESOLUTION; WATER; TRANSITION; LIGATION; DIOXYGEN; CORE	Intense femtosecond x-ray pulses produced at the Linac Coherent Light Source (LCLS) were used for simultaneous x-ray diffraction (XRD) and x-ray emission spectroscopy (XES) of microcrystals of photosystem II (PS II) at room temperature. This method probes the overall protein structure and the electronic structure of the Mn4CaO5 cluster in the oxygen-evolving complex of PS II. XRD data are presented from both the dark state (S-1) and the first illuminated state (S-2) of PS II. Our simultaneous XRD-XES study shows that the PS II crystals are intact during our measurements at the LCLS, not only with respect to the structure of PS II, but also with regard to the electronic structure of the highly radiation-sensitive Mn4CaO5 cluster, opening new directions for future dynamics studies.	[Kern, Jan; Tran, Rosalie; Hattne, Johan; Gildea, Richard J.; Echols, Nathaniel; Lassalle-Kaiser, Benedikt; Lampe, Alyssa; Han, Guangye; Gul, Sheraz; Grosse-Kunstleve, Ralf W.; Zwart, Petrus H.; Adams, Paul D.; Sauter, Nicholas K.; Yachandra, Vittal K.; Yano, Junko] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Kern, Jan; Alonso-Mori, Roberto; Milathianaki, Despina; Fry, Alan R.; Miahnahri, Alan; Schafer, Donald W.; Messerschmidt, Marc; Seibert, M. Marvin; Koglin, Jason E.; White, William E.; Bogan, Michael J.; Williams, Garth J.; Boutet, Sebastien; Bergmann, Uwe] SLAC Natl Accelerator Lab, LCLS, Menlo Pk, CA 94025 USA; [Gloeckner, Carina; Hellmich, Julia; DiFiore, Doerte; Zouni, Athina] Tech Univ Berlin, Max Volmer Lab Biophys Chem, D-10623 Berlin, Germany; [Laksmono, Hartawan; Sierra, Raymond G.; Bogan, Michael J.] SLAC Natl Accelerator Lab, PULSE Inst, Menlo Pk, CA 94025 USA; [Koroidov, Sergey; Messinger, Johannes] Umea Univ, Kemiskt Biologiskt Ctr, Inst Kemi, Umea, Sweden; [Sokaras, Dimosthenis; Weng, Tsu-Chien; Sellberg, Jonas; Latimer, Matthew J.] SLAC Natl Accelerator Lab, SSRL, Menlo Pk, CA 94025 USA; [Sellberg, Jonas] Stockholm Univ, AlbaNova, Dept Phys, S-10691 Stockholm, Sweden; [Glatzel, Pieter] European Synchrotron Radiat Facil, F-38043 Grenoble 9, France	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Technical University of Berlin; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Umea University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stockholm University; European Synchrotron Radiation Facility (ESRF)	Yachandra, VK (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	vkyachandra@lbl.gov; bergmann@slac.stanford.edu; jyano@lbl.gov	Messinger, Johannes/AAC-4221-2019; Gildea, Richard/J-6862-2012; Messerschmidt, Marc/F-3796-2010; Lassalle, Benedikt/I-3748-2015; Koroidov, Sergey/U-1115-2018; alonso-mori, roberto/G-2638-2013; Sauter, Nicholas K/K-3430-2012; Zwart, Peter/F-7123-2013; Messerschmidt, Marc/Y-8929-2019; Sokaras, Dimosthenis/G-6037-2010; Sellberg, Jonas A/C-6506-2009; Milathianaki, Despina/AAG-5381-2021; Adams, Paul David/A-1977-2013; Glatzel, Pieter/E-9958-2010; Kern, Jan/G-2586-2013	Messinger, Johannes/0000-0003-2790-7721; Gildea, Richard/0000-0001-5038-6958; Messerschmidt, Marc/0000-0002-8641-3302; Lassalle, Benedikt/0000-0003-2141-2496; Koroidov, Sergey/0000-0003-4823-2188; alonso-mori, roberto/0000-0002-5357-0934; Messerschmidt, Marc/0000-0002-8641-3302; Sokaras, Dimosthenis/0000-0001-8117-1933; Sellberg, Jonas A/0000-0003-2793-5052; Adams, Paul David/0000-0001-9333-8219; Glatzel, Pieter/0000-0001-6532-8144; Kern, Jan/0000-0002-7272-1603; Hattne, Johan/0000-0002-8936-0912; Seibert, Mark Marvin/0000-0003-0251-0744	Office of Science, Office of Basic Energy Sciences (OBES), Division of Chemical Sciences, Geosciences, and Biosciences (CSGB) of the Department of Energy (DOE) [DE-AC02-05CH11231]; Laboratory Directed Research and Development award; NIH [GM055302, P41GM103393, GM095887, GM102520]; Deutsche Forschungsgemeinschaft Cluster of Excellence "UniCat"; Alexander von Humboldt Foundation; Solar Fuels Strong Research Environment (Umeal University); Artificial Leaf Project (K&A Wallenberg Foundation); LCLS; AMOS program; CSGB Division; OBES; DOE; SLAC Laboratory Directed Research and Development Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095887, R01GM102520, R56GM055302, R01GM055302, P41GM103393] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences (OBES), Division of Chemical Sciences, Geosciences, and Biosciences (CSGB) of the Department of Energy (DOE)(United States Department of Energy (DOE)); Laboratory Directed Research and Development award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft Cluster of Excellence "UniCat"; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Solar Fuels Strong Research Environment (Umeal University); Artificial Leaf Project (K&A Wallenberg Foundation); LCLS; AMOS program; CSGB Division; OBES; DOE(United States Department of Energy (DOE)); SLAC Laboratory Directed Research and Development Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We dedicate this paper to G. Renger (1937-2013) for his enthusiasm and support. This work was supported by the Director, Office of Science, Office of Basic Energy Sciences (OBES), Division of Chemical Sciences, Geosciences, and Biosciences (CSGB) of the Department of Energy (DOE) under contract DE-AC02-05CH11231 (J.Y. and V.K.Y.) for x-ray methodology and instrumentation; a Laboratory Directed Research and Development award to N.K.S; NIH grant GM055302 (V.K.Y.) for PS II biochemistry, structure, and mechanism and NIH grant P41GM103393 (U. B.); and grants GM095887 and GM102520 (N.K.S.) for data-processing methods. We thank the Deutsche Forschungsgemeinschaft Cluster of Excellence "UniCat," coordinated by the Technische Universitat Berlin and Sfb1078, TP A5 (A.Z.); the Alexander von Humboldt Foundation (J.K.); and the Solar Fuels Strong Research Environment (Umeal University), the Artificial Leaf Project (K&A Wallenberg Foundation), and Vetenskapsradet and Energimyndigheten (J.M.) for supporting this project. The injector work was supported by LCLS (M.J.B., D. W. S.) and the AMOS program, CSGB Division, OBES, DOE (M.J.B), and through the SLAC Laboratory Directed Research and Development Program (M.J.B., H. L.). Experiments were carried out at the LCLS at SLAC National Accelerator Laboratory operated by Stanford University on behalf of DOE, OBES. We thank K. Sauer for continuing scientific discussions. The atomic coordinates and structure factors have been deposited in the Protein Data Bank (www.pdb.org) with ID codes 4IXQ (dark state, S1) and 4IXR (first illuminated state, S2). See the supplementary materials for author contributions and full acknowledgments.	Alonso-Mori R, 2012, P NATL ACAD SCI USA, V109, P19103, DOI 10.1073/pnas.1211384109; Alonso-Mori R, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4737630; Barty A, 2012, NAT PHOTONICS, V6, P35, DOI [10.1038/nphoton.2011.297, 10.1038/NPHOTON.2011.297]; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; Boutet S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/035024; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; Corbett MC, 2007, ACTA CRYSTALLOGR D, V63, P951, DOI 10.1107/S0907444907035160; Debus RJ, 2008, COORDIN CHEM REV, V252, P244, DOI 10.1016/j.ccr.2007.09.022; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Glatzel P, 2005, COORDIN CHEM REV, V249, P65, DOI 10.1016/j.ccr.2004.04.011; Grabolle M, 2006, J BIOL CHEM, V281, P4580, DOI 10.1074/jbc.M509724200; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hart P, 2012, PROC SPIE, V8504, DOI 10.1117/12.930924; Hunter MS, 2011, BIOPHYS J, V100, P198, DOI 10.1016/j.bpj.2010.10.049; Kanady JS, 2011, SCIENCE, V333, P733, DOI 10.1126/science.1206036; Kern J, 2012, P NATL ACAD SCI USA, V109, P9721, DOI 10.1073/pnas.1204598109; Kirian RA, 2011, ACTA CRYSTALLOGR A, V67, P131, DOI 10.1107/S0108767310050981; Lizasa M, 2010, BIOCHEMISTRY-US, V49, P3074, DOI 10.1021/bi1002647; Meharenna YT, 2010, BIOCHEMISTRY-US, V49, P2984, DOI 10.1021/bi100238r; Messinger J, 2001, J AM CHEM SOC, V123, P7804, DOI 10.1021/ja004307+; Mukherjee S, 2012, P NATL ACAD SCI USA, V109, P2257, DOI 10.1073/pnas.1115290109; Pushkar Y, 2010, ANGEW CHEM INT EDIT, V49, P800, DOI 10.1002/anie.200905366; Renger G, 2012, ADV PHOTOSYNTH RESP, V34, P359, DOI 10.1007/978-94-007-1579-0_17; Sierra RG, 2012, ACTA CRYSTALLOGR D, V68, P1584, DOI 10.1107/S0907444912038152; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Yano J, 2008, INORG CHEM, V47, P1711, DOI 10.1021/ic7016837; Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	29	322	343	19	374	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					491	495		10.1126/science.1234273	http://dx.doi.org/10.1126/science.1234273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23413188	Green Accepted			2022-12-28	WOS:000318016700046
J	Hamasaki, M; Furuta, N; Matsuda, A; Nezu, A; Yamamoto, A; Fujita, N; Oomori, H; Noda, T; Haraguchi, T; Hiraoka, Y; Amano, A; Yoshimori, T				Hamasaki, Maho; Furuta, Nobumichi; Matsuda, Atsushi; Nezu, Akiko; Yamamoto, Akitsugu; Fujita, Naonobu; Oomori, Hiroko; Noda, Takeshi; Haraguchi, Tokuko; Hiraoka, Yasushi; Amano, Atsuo; Yoshimori, Tamotsu			Autophagosomes form at ER-mitochondria contact sites	NATURE			English	Article							ENDOPLASMIC-RETICULUM; MEMBRANE; LC3; DISSECTION; PROTEINS; ATG14L; CELLS	Autophagy is a tightly regulated intracellular bulk degradation/recycling system that has fundamental roles in cellular homeostasis(1). Autophagy is initiated by isolation membranes, which form and elongate as they engulf portions of the cytoplasm and organelles. Eventually isolation membranes dose to form double membrane-bound autophagosomes and fuse with lysosomes to degrade their contents. The physiological role of autophagy has been determined since its discovery, but the origin of autophagosomal membranes has remained unclear. At present, there is much controversy about the organelle from which the membranes originate-the endoplasmic reticulum (ER), mitochondria and plasma membrane(1,2). Here we show that autophagosomes form at the ER-mitochondria contact site in mammalian cells. Imaging data reveal that the pre-autophagosome/autophagosome marker ATG14 (also known as ATG14L) relocalizes to the ER-mitochondria contact site after starvation, and the autophagosome-formation marker ATG5 also localizes at the site until formation is complete. Subcellular fractionation showed that ATG14 co-fractionates in the mitochondria-associated ER membrane(3-5) fraction under starvation conditions. Disruption of the ER-mitochondria contact site prevents the formation of ATG14 puncta. The ER-resident SNARE protein syntaxin 17 (STX17) binds ATG14 and recruits it to the ER-mitochondria contact site. These results provide new insight into organelle biogenesis by demonstrating that the ER-mitochondria contact site is important in autophagosome formation.	[Hamasaki, Maho; Nezu, Akiko; Fujita, Naonobu; Noda, Takeshi; Yoshimori, Tamotsu] Osaka Univ, Grad Sch Med, Dept Genet, Suita, Osaka 5650871, Japan; [Hamasaki, Maho; Nezu, Akiko; Fujita, Naonobu; Noda, Takeshi; Yoshimori, Tamotsu] Osaka Univ, Grad Sch Frontier Biosci, Lab Intracellular Membrane Dynam, Suita, Osaka 5650871, Japan; [Furuta, Nobumichi; Amano, Atsuo] Osaka Univ, Grad Sch Dent, Ctr Oral Frontier Sci, Dept Oral Frontier Biol, Suita, Osaka 5650871, Japan; [Matsuda, Atsushi; Haraguchi, Tokuko; Hiraoka, Yasushi] Natl Inst Informat & Commun Technol, Nishi Ku, Kobe, Hyogo 6512492, Japan; [Matsuda, Atsushi; Haraguchi, Tokuko; Hiraoka, Yasushi] Osaka Univ, Grad Sch Frontier Biosci, Nucl Dynam Grp, Suita, Osaka 5650871, Japan; [Yamamoto, Akitsugu] Nagahama Inst Biosci & Technol, Fac Biosci, Dept Cell Biol, Nagahama, Shiga 5260829, Japan; [Oomori, Hiroko] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Amano, Atsuo] Osaka Univ, Grad Sch Dent, Dept Prevent Dent, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; National Institute of Information & Communications Technology (NICT) - Japan; Osaka University; Osaka University; Osaka University	Yoshimori, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Genet, 2-2 Yaniadaoka, Suita, Osaka 5650871, Japan.	amanoa@dent.osaka-u.ac.jp; tamyoshi@fbs.osaka-u.ac.jp	Yoshimori, Tamotsu/K-9626-2014; Fujita, Naonobu/A-1218-2010; Hiraoka, Yasushi/B-5111-2009; Noda, Takeshi/B-7240-2008	Yoshimori, Tamotsu/0000-0001-9787-3788; Hiraoka, Yasushi/0000-0001-9407-8228; Noda, Takeshi/0000-0003-3581-7961; Fujita, Naonobu/0000-0003-1914-8438; Matsuda, Atsushi/0000-0003-0510-213X; Hamasaki, Maho/0000-0002-5646-5136	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank all members of the Amano and Yoshimori laboratories for discussions. We thank O. Kunitaki and K. Miura for continuous help throughout the research. We also thank P. Karagiannis for proofreading. This research was supported by grants-in-aid for Scientific Research (A) and (B) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Furuta N, 2010, MOL BIOL CELL, V21, P1001, DOI 10.1091/mbc.E09-08-0693; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kageyama S, 2011, MOL BIOL CELL, V22, P2290, DOI 10.1091/mbc.E10-11-0893; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Steegmaier M, 2000, MOL BIOL CELL, V11, P2719, DOI 10.1091/mbc.11.8.2719; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Yamamoto A, 2010, METHODS MOL BIOL, V657, P225, DOI 10.1007/978-1-60761-783-9_18; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180	26	1124	1167	9	225	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					389	393		10.1038/nature11910	http://dx.doi.org/10.1038/nature11910			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23455425				2022-12-28	WOS:000316650500047
J	Benartzi, S; Thaler, RH				Benartzi, Shlomo; Thaler, Richard H.			Behavioral Economics and the Retirement Savings Crisis	SCIENCE			English	Editorial Material									[Benartzi, Shlomo] Univ Calif Los Angeles, Anderson Sch Management, Behav Decis Making Grp, Los Angeles, CA 90095 USA; [Benartzi, Shlomo] Allianz Global Investors Ctr Behav Finance, New York, NY 10019 USA; [Thaler, Richard H.] Univ Chicago, Booth Sch Business, Chicago, IL 60637 USA	University of California System; University of California Los Angeles; Allianz SE; University of Chicago	Benartzi, S (corresponding author), Univ Calif Los Angeles, Anderson Sch Management, Behav Decis Making Grp, Los Angeles, CA 90095 USA.	benartzi@savemoretomorrow.org						[Anonymous], 2012, PENSIONS INVESTMENTS; Benartzi Shlomo, 2012, SAVE MORE TOMORROW P; Chetty R., 2012, 18565 NBER; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Madrian BC, 2001, Q J ECON, V116, P1149, DOI 10.1162/003355301753265543; Munnell Alicia H., 2012, PENSION COVERAGE PRO; MUNNELL ALICIA H., 2012, NATL RETIREMENT RISK; Novy-Marx R, 2011, J FINANC, V66, P1211, DOI 10.1111/j.1540-6261.2011.01664.x; Plan Sponsor Council of America, 2012, 55 ANN SURV; Plan Sponsor Council of America, 2011, 54 ANN SURV; Thaler RH, 2004, J POLIT ECON, V112, pS164, DOI 10.1086/380085; Thaler RH., 2021, NUDGE FINAL EDITION; Vanguard Group, 2012, AM SAV; Volpp KG, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-272; Volpp KG, 2008, JAMA-J AM MED ASSOC, V300, P2631, DOI 10.1001/jama.2008.804	15	112	116	9	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2013	339	6124					1152	1153		10.1126/science.1231320	http://dx.doi.org/10.1126/science.1231320			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	100OG	23471389				2022-12-28	WOS:000315709900028
J	Keren, I; Wu, YX; Inocencio, J; Mulcahy, LR; Lewis, K				Keren, Iris; Wu, Yanxia; Inocencio, Julio; Mulcahy, Lawrence R.; Lewis, Kim			Killing by Bactericidal Antibiotics Does Not Depend on Reactive Oxygen Species	SCIENCE			English	Article							ESCHERICHIA-COLI; PERSISTER CELLS; DEATH; TOLERANCE; RESISTANCE; LETHALITY; MECHANISM; LYSIS	Bactericidal antibiotics kill by modulating their respective targets. This traditional view has been challenged by studies that propose an alternative, unified mechanism of killing, whereby toxic reactive oxygen species (ROS) are produced in the presence of antibiotics. We found no correlation between an individual cell's probability of survival in the presence of antibiotic and its level of ROS. An ROS quencher, thiourea, protected cells from antibiotics present at low concentrations, but the effect was observed under anaerobic conditions as well. There was essentially no difference in survival of bacteria treated with various antibiotics under aerobic or anaerobic conditions. This suggests that ROS do not play a role in killing of bacterial pathogens by antibiotics.	[Keren, Iris; Wu, Yanxia; Inocencio, Julio; Mulcahy, Lawrence R.; Lewis, Kim] Northeastern Univ, Dept Biol, Antimicrobial Discovery Ctr, Boston, MA 02115 USA	Northeastern University	Lewis, K (corresponding author), Northeastern Univ, Dept Biol, Antimicrobial Discovery Ctr, Boston, MA 02115 USA.	k.lewis@neu.edu	Wu, yanxia/HGA-0318-2022		NIH [T-R01AI085585-01]; Army Research Office [W9911NF-09-1-0265, 55631-LS-RIP]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085585] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank V. Isabella for helpful discussion of the manuscript. This work was supported by NIH grant T-R01AI085585-01 and by Army Research Office grants W9911NF-09-1-0265 and 55631-LS-RIP.	Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; DAMPER PD, 1981, ANTIMICROB AGENTS CH, V20, P803, DOI 10.1128/AAC.20.6.803; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; DAVIS BD, 1986, P NATL ACAD SCI USA, V83, P6164, DOI 10.1073/pnas.83.16.6164; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Grant SS, 2012, P NATL ACAD SCI USA, V109, P12147, DOI 10.1073/pnas.1203735109; Hooper DC, 2001, CLIN INFECT DIS, V32, pS9, DOI 10.1086/319370; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Lewis K, 2012, NATURE, V485, P439, DOI 10.1038/485439a; Liu YL, 2012, ANTIMICROB AGENTS CH, V56, P6048, DOI 10.1128/AAC.00754-12; POOLMAN B, 1993, FEMS MICROBIOL REV, V12, P125, DOI 10.1111/j.1574-6976.1993.tb00015.x; ROWEN RC, 1987, PHARMACOTHERAPY, V7, P92; Sampson TR, 2012, ANTIMICROB AGENTS CH, V56, P5642, DOI 10.1128/AAC.00756-12; Uehara T, 2009, J BACTERIOL, V191, P5094, DOI 10.1128/JB.00505-09; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; Wang XH, 2009, ANTIMICROB AGENTS CH, V53, P1395, DOI 10.1128/AAC.01087-08; Wiuff C, 2005, ANTIMICROB AGENTS CH, V49, P1483, DOI 10.1128/AAC.49.4.1483-1494.2005	23	358	372	13	219	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2013	339	6124					1213	1216		10.1126/science.1232688	http://dx.doi.org/10.1126/science.1232688			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471410				2022-12-28	WOS:000315709900050
J	Liu, YY; Imlay, JA				Liu, Yuanyuan; Imlay, James A.			Cell Death from Antibiotics Without the Involvement of Reactive Oxygen Species	SCIENCE			English	Article							INTRACELLULAR HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; BACTERICIDAL ANTIBIOTICS; HYDROXYL RADICALS; DNA-DAMAGE; SUPEROXIDE; MECHANISM; ENZYMES	Recent observations have suggested that classic antibiotics kill bacteria by stimulating the formation of reactive oxygen species (ROS). If true, this notion might guide new strategies to improve antibiotic efficacy. In this study, the model was directly tested. Contrary to the hypothesis, antibiotic treatment did not accelerate the formation of hydrogen peroxide in Escherichia coli and did not elevate intracellular free iron, an essential reactant for the production of lethal damage. Lethality persisted in the absence of oxygen, and DNA repair mutants were not hypersensitive, undermining the idea that toxicity arose from oxidative DNA lesions. We conclude that these antibiotic exposures did not produce ROS and that lethality more likely resulted from the direct inhibition of cell-wall assembly, protein synthesis, and DNA replication.	[Liu, Yuanyuan; Imlay, James A.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Imlay, JA (corresponding author), Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA.	jimlay@illinois.edu	liu, yuanyuan/GWZ-5838-2022		National Institutes of Health [GM49060]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM049640, R01GM049640] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Hassett (University of Cincinnati) for helpful conversations about this topic, and J. Collins, G. Walker, and members of their laboratories for generously sharing ideas, unpublished data, and strains. We also thank M. Nilges of the Illinois EPR Research Center for assistance. This work was supported by GM49060 from the National Institutes of Health. The authors declare no conflict of interest.	Albesa I, 2004, BIOCHEM BIOPH RES CO, V317, P605, DOI 10.1016/j.bbrc.2004.03.085; ANBAR M, 1967, INT J APPL RADIAT IS, V18, P493, DOI 10.1016/0020-708X(67)90115-9; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Davies BW, 2009, MOL CELL, V36, P845, DOI 10.1016/j.molcel.2009.11.024; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Drlica K, 1999, CURR OPIN MICROBIOL, V2, P504, DOI 10.1016/S1369-5274(99)00008-9; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Goswami M, 2006, ANTIMICROB AGENTS CH, V50, P949, DOI 10.1128/AAC.50.3.949-954.2006; Grant SS, 2012, P NATL ACAD SCI USA, V109, P12147, DOI 10.1073/pnas.1203735109; Ikemura K, 2008, J AM CHEM SOC, V130, P14384, DOI 10.1021/ja805735g; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jang SJ, 2007, J BIOL CHEM, V282, P929, DOI 10.1074/jbc.M607646200; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; KUO CF, 1987, J BIOL CHEM, V262, P4724; LIOCHEV SI, 1994, FREE RADICAL BIO MED, V16, P29, DOI 10.1016/0891-5849(94)90239-9; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; Seaver LC, 2004, J BIOL CHEM, V279, P48742, DOI 10.1074/jbc.M408754200; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Sobota JM, 2011, P NATL ACAD SCI USA, V108, P5402, DOI 10.1073/pnas.1100410108; TABER HW, 1987, MICROBIOL REV, V51, P439, DOI 10.1128/MMBR.51.4.439-457.1987; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; Wang XH, 2010, J ANTIMICROB CHEMOTH, V65, P520, DOI 10.1093/jac/dkp486; Yamada M, 2012, MOL MICROBIOL, V86, P1364, DOI 10.1111/mmi.12061; Yeom J, 2010, J BIOL CHEM, V285, P22689, DOI 10.1074/jbc.M110.127456; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	29	386	401	13	298	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2013	339	6124					1210	1213		10.1126/science.1232751	http://dx.doi.org/10.1126/science.1232751			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471409	Green Accepted			2022-12-28	WOS:000315709900049
J	Marcott, SA; Shakun, JD; Clark, PU; Mix, AC				Marcott, Shaun A.; Shakun, Jeremy D.; Clark, Peter U.; Mix, Alan C.			A Reconstruction of Regional and Global Temperature for the Past 11,300 Years	SCIENCE			English	Article							HIGH-RESOLUTION; CLIMATE-CHANGE; ASIAN MONSOON; HOLOCENE; CIRCULATION; RECORD; VALUES	Surface temperature reconstructions of the past 1500 years suggest that recent warming is unprecedented in that time. Here we provide a broader perspective by reconstructing regional and global temperature anomalies for the past 11,300 years from 73 globally distributed records. Early Holocene (10,000 to 5000 years ago) warmth is followed by similar to 0.7 degrees C cooling through the middle to late Holocene (<5000 years ago), culminating in the coolest temperatures of the Holocene during the Little Ice Age, about 200 years ago. This cooling is largely associated with similar to 2 degrees C change in the North Atlantic. Current global temperatures of the past decade have not yet exceeded peak interglacial values but are warmer than during similar to 75% of the Holocene temperature history. Intergovernmental Panel on Climate Change model projections for 2100 exceed the full distribution of Holocene temperature under all plausible greenhouse gas emission scenarios.	[Marcott, Shaun A.; Clark, Peter U.; Mix, Alan C.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Shakun, Jeremy D.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Oregon State University; Harvard University	Marcott, SA (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	marcotts@science.oregonstate.edu	Marcott, Shaun A/L-7098-2015	Marcott, Shaun A/0000-0003-3264-0523	NSF	NSF(National Science Foundation (NSF))	We thank J. Alder, T. Bauska, E. Brook, C. Buizert, V. Ersek, S. Hostetler, P. Huybers, N. Pisias, J. Rosen, G. Schmidt, A. Schmittner, M. Tingley, and our reviewers for invaluable insight and helpful discussion. The data sets provided by T. Barrows, J.-H. Kim, Y. Kubota, I. Larocque, G. Leduc, M. McGlone, T. Rodrigues, C. Ruhlemann, J. Sachs, R. Schneider, H. Sepp, J. Tierney, M. Yamamoto, B. Vinther, and C. Waelbrock, as well as the data sets compiled from the National Oceanic and Atmospheric Administration Climate Data Center and PANGAEA databases, made this research possible. Funding for this work was provided by the NSF Paleoclimate Program for the Paleovar Project.	Ammann CM, 2007, CLIMATIC CHANGE, V85, P71, DOI 10.1007/s10584-007-9276-x; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Castellano E, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005259; Cruz FW, 2005, NATURE, V434, P63, DOI 10.1038/nature03365; Dykoski CA, 2005, EARTH PLANET SC LETT, V233, P71, DOI 10.1016/j.epsl.2005.01.036; Esper J, 2002, SCIENCE, V295, P2250, DOI 10.1126/science.1066208; Esper J., 2004, EOS, V85, P113, DOI DOI 10.1029/2004EO120002; Esper J, 2012, NAT CLIM CHANGE, V2, P862, DOI [10.1038/NCLIMATE1589, 10.1038/nclimate1589]; Frank DC, 2004, EOS, V85, P120; Ganopolski A, 1998, SCIENCE, V280, P1916, DOI 10.1126/science.280.5371.1916; Griffiths ML, 2009, NAT GEOSCI, V2, P636, DOI 10.1038/NGEO605; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Holmgren K, 2003, QUATERNARY SCI REV, V22, P2311, DOI 10.1016/S0277-3791(03)00204-X; Hoogakker BAA, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2011PA002155; Huang SP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019781; Jansen E, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P433; Kaufman DS, 2004, QUATERNARY SCI REV, V23, P529, DOI 10.1016/j.quascirev.2003.09.007; Leduc G, 2010, QUATERNARY SCI REV, V29, P989, DOI 10.1016/j.quascirev.2010.01.004; Ljungqvist FC, 2011, GEOGRAFIE-PRAGUE, V116, P91; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Mantsis DF, 2011, J CLIMATE, V24, P2830, DOI 10.1175/2010JCLI3986.1; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Partin JW, 2007, NATURE, V449, P452, DOI 10.1038/nature06164; Ramaswamy V., 2001, RAD FORCING CLIMAGE; Renssen H, 2005, CLIM DYNAM, V24, P23, DOI 10.1007/s00382-004-0485-y; Schneider T, 2001, J CLIMATE, V14, P853, DOI 10.1175/1520-0442(2001)014<0853:AOICDE>2.0.CO;2; Steinhilber F, 2012, P NATL ACAD SCI USA, V109, P5967, DOI 10.1073/pnas.1118965109; Tzedakis PC, 2012, NAT GEOSCI, V5, P138, DOI [10.1038/ngeo1358, 10.1038/NGEO1358]; Wahl ER, 2006, SCIENCE, V312, DOI 10.1126/science.1120866; Wahl ER, 2007, CLIMATIC CHANGE, V85, P33, DOI 10.1007/s10584-006-9105-7; Wang YJ, 2005, SCIENCE, V308, P854, DOI 10.1126/science.1106296; Wanner H, 2008, QUATERNARY SCI REV, V27, P1791, DOI 10.1016/j.quascirev.2008.06.013; Zielinski GA, 1996, QUATERNARY RES, V45, P109, DOI 10.1006/qres.1996.0013	37	953	1036	39	809	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2013	339	6124					1198	1201		10.1126/science.1228026	http://dx.doi.org/10.1126/science.1228026			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471405	Green Submitted			2022-12-28	WOS:000315709900045
J	Bava, FA; Eliscovich, C; Ferreira, PG; Minana, B; Ben-Dov, C; Guigo, R; Valcarcel, J; Mendez, R				Bava, Felice-Alessio; Eliscovich, Carolina; Ferreira, Pedro G.; Minana, Belen; Ben-Dov, Claudia; Guigo, Roderic; Valcarcel, Juan; Mendez, Raul			CPEB1 coordinates alternative 3 ' -UTR formation with translational regulation	NATURE			English	Article							MESSENGER-RNAS; UNTRANSLATED REGIONS; CYTOPLASMIC POLYADENYLATION; CHROMOSOME SEGREGATION; CELLS; MECHANISMS; INSIGHTS; COMPLEX	More than half of mammalian genes generate multiple messenger RNA isoforms that differ in their 3' untranslated regions (3' UTRs) and therefore in regulatory sequences(1), often associated with cell proliferation and cancer(2,3); however, the mechanisms coordinating alternative 3'-UTR processing for specific mRNA populations remain poorly defined. Here we report that the cytoplasmic-polyadenylation element binding protein 1 (CPEB1), an RNA-binding protein that regulates mRNA translation(4), also controls alternative 3'-UTR processing. CPEB1 shuttles to the nudeus(5,6), where it co-localizes with splicing factors and mediates shortening of hundreds of mRNA 3' UTRs, thereby modulating their translation efficiency in the cytoplasm. CPEB1-mediated 3'-UTR shortening correlates with cell proliferation and tumorigenesis. CPEB1 binding to pre-mRNAs not only directs the use of alternative polyadenylation sites, but also changes alternative splicing by preventing U2AF65 recruitment. Our results reveal a novel function of CPEB1 in mediating alternative 3'-UTR processing, which is coordinated with regulation of mRNA translation, through its dual nuclear and cytoplasmic functions.	[Bava, Felice-Alessio; Mendez, Raul] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Eliscovich, Carolina; Ferreira, Pedro G.; Minana, Belen; Ben-Dov, Claudia; Guigo, Roderic; Valcarcel, Juan] UPF, Ctr Genom Regulat CRG, Barcelona 08003, Spain; [Valcarcel, Juan; Mendez, Raul] Passeig Lluis Co 23, ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Mendez, R (corresponding author), Inst Res Biomed IRB Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain.	raul.mendez@irbbarcelona.org	minana, belen/K-5530-2015; Valcarcel, Juan/O-9814-2014; Ferreira, Pedro G/J-6379-2013; bava, felice alessio/AAB-5212-2022; Guigo, Roderic/D-1303-2010; Ferreira, Pedro/HDO-1346-2022	minana, belen/0000-0001-7676-5788; Valcarcel, Juan/0000-0001-5398-3571; Ferreira, Pedro G/0000-0003-3838-8664; Guigo, Roderic/0000-0002-5738-4477; Mendez, Raul/0000-0002-1952-6905	Consolider; MICINN; Generalitat de Catalunya; RNAREG; AICR; EURASNET; Fundacion Marcelino Botin; National Institutes of Health; Instituto de Salud Carlos III; "la Caixa" predoctoral fellowship; FCT-Portugal; Spanish MICINN; Worldwide Cancer Research [11-0086] Funding Source: researchfish; ICREA Funding Source: Custom	Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya); RNAREG; AICR; EURASNET; Fundacion Marcelino Botin; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); "la Caixa" predoctoral fellowship(La Caixa Foundation); FCT-Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Worldwide Cancer Research; ICREA(ICREA)	We thank A. Nebreda, R. Gomis, T. Yates, M. Fernandez, V. Giangarra, J. P. Tavanez, F. Lai, I. Novoa, J. La Cava and members of the Valcarcel and Mendez laboratories for comments on the manuscript and other contributions. We also thank the Ultrasequencing Units (CRG, IRB) and the Microscopy Units (CRG, IRB) for technical assistance. This work was funded by research grants as follows: from Consolider, MICINN and Generalitat de Catalunya to J.V., R.G. and R.M.; from RNAREG to J.V. and R.M.; from AICR to R.M.; from EURASNET and Fundacion Marcelino Botin to J.V.; and from the National Institutes of Health and Instituto de Salud Carlos III to R.G. F.-A.B. holds a "la Caixa" predoctoral fellowship, and P.G.F was supported by a FCT-Portugal postdoctoral grant and by a Spanish MICINN Consolider grant.	Barnard DC, 2004, CELL, V119, P641, DOI 10.1016/j.cell.2004.10.029; Belloc E, 2008, NATURE, V452, P1017, DOI 10.1038/nature06809; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Eliscovich C, 2008, NAT CELL BIOL, V10, P858, DOI 10.1038/ncb1746; Ernoult-Lange M, 2009, MOL BIOL CELL, V20, P176, DOI 10.1091/mbc.E08-09-0904; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; Ji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008419; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Li M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007701; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lin CL, 2010, RNA, V16, P338, DOI 10.1261/rna.1779810; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Novoa I, 2010, NAT CELL BIOL, V12, P447, DOI 10.1038/ncb2046; Paronetto MP, 2011, MOL CELL, V43, P353, DOI 10.1016/j.molcel.2011.05.035; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; RUSKIN B, 1988, CELL, V52, P207, DOI 10.1016/0092-8674(88)90509-0; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Weill L, 2012, NAT STRUCT MOL BIOL, V19, P577, DOI 10.1038/nsmb.2311	23	107	109	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2013	495	7439					121	125		10.1038/nature11901	http://dx.doi.org/10.1038/nature11901			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23434754				2022-12-28	WOS:000316039800052
J	Crump, C; Sundquist, K; Winkleby, MA; Sundquist, J				Crump, Casey; Sundquist, Kristina; Winkleby, Marilyn A.; Sundquist, Jan			Mental disorders and vulnerability to homicidal death: Swedish nationwide cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PSYCHIATRIC MEDICATION PRESCRIPTION; CRIMINAL VICTIMIZATION; ACCIDENTAL DEATH; YOUNG ADULTHOOD; CLINICAL SURVEY; ILLNESS; SUICIDE; POPULATION; MORTALITY; PEOPLE	Objective To determine the risk of people with mental disorders being victims of homicide. Design National cohort study. Setting Sweden. Participants Entire adult population (n=7 253 516). Main outcome measures Homicidal death during eight years of follow-up (2001-08); hazard ratios for the association between mental disorders and homicidal death, with adjustment for sociodemographic confounders; potential modifying effect of comorbid substance use. Results 615 homicidal deaths occurred in 54.4 million person years of follow-up. Mortality rates due to homicide (per 100 000 person years) were 2.8 among people with mental disorders compared with 1.1 in the general population. After adjustment for sociodemographic confounders, any mental disorder was associated with a 4.9-fold (95% confidence interval 4.0 to 6.0) risk of homicidal death, relative to people without mental disorders. Strong associations were found irrespective of age, sex, or other sociodemographic characteristics. Although the risk of homicidal death was highest among people with substance use disorders (approximately ninefold), the risk was also increased among those with personality disorders (3.2-fold), depression (2.6-fold), anxiety disorders (2.2-fold), or schizophrenia (1.8-fold) and did not seem to be explained by comorbid substance use. Sociodemographic risk factors included male sex, being unmarried, and low socioeconomic status. Conclusions In this large cohort study, people with mental disorders, including those with substance use disorders, personality disorders, depression, anxiety disorders, or schizophrenia, had greatly increased risks of homicidal death. Interventions to reduce violent death among people with mental disorders should tackle victimisation and homicidal death in addition to suicide and accidents, which share common risk factors.	[Crump, Casey] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA; [Sundquist, Kristina; Sundquist, Jan] Lund Univ, Skane Univ Hosp, Ctr Primary Hlth Care Res, Malmo, Sweden; [Winkleby, Marilyn A.] Stanford Univ, Stanford Prevent Res Ctr, Stanford, CA 94305 USA	Stanford University; Lund University; Skane University Hospital; Stanford University	Crump, C (corresponding author), Stanford Univ, Dept Med, 211 Quarry Rd,Suite 405,MC 5985, Palo Alto, CA 94304 USA.	kccrump@stanford.edu	Crump, Casey/AAO-8802-2021	Crump, Casey/0000-0002-2990-1166	National Institute of Drug Abuse [R01DA030005]; Swedish Research Council; ALF project grant, Lund, Sweden; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030005] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF project grant, Lund, Sweden; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by grants from the National Institute of Drug Abuse (R01DA030005), the Swedish Research Council, and ALF project grant, Lund, Sweden. The funding agencies had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript. The researchers were independent of the funding agencies.	Angermeyer MC, 2006, ACTA PSYCHIAT SCAND, V113, P163, DOI 10.1111/j.1600-0447.2005.00699.x; Asnis GM, 1997, PSYCHIAT CLIN N AM, V20, P405, DOI 10.1016/S0193-953X(05)70320-8; BLACK DW, 1985, ARCH GEN PSYCHIAT, V42, P71; Choe JY, 2008, PSYCHIAT SERV, V59, P153, DOI 10.1176/ps.2008.59.2.153; CORRIGAN PW, 1994, HOSP COMMUNITY PSYCH, V45, P273; Crump C, 2011, JAMA-J AM MED ASSOC, V306, P1233, DOI 10.1001/jama.2011.1331; Crump C, 2011, ANN EPIDEMIOL, V21, P231, DOI 10.1016/j.annepidem.2011.01.005; Crump C, 2010, INT J EPIDEMIOL, V39, P1522, DOI 10.1093/ije/dyq103; Fazel S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000120; GARRETT JM, 1997, STATA TECHNICAL B, V35, P9; Gau SSF, 2004, BRIT J PSYCHIAT, V185, P422, DOI 10.1192/bjp.185.5.422; Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; HIDAY VA, 1995, J HEALTH SOC BEHAV, V36, P122, DOI 10.2307/2137220; Hiday VA, 1999, PSYCHIATR SERV, V50, P62, DOI 10.1176/ps.50.1.62; HILLARD JR, 1985, HOSP COMMUNITY PSYCH, V36, P640; Hiroeh U, 2001, LANCET, V358, P2110, DOI 10.1016/S0140-6736(01)07216-6; HOLDING TA, 1977, BRIT J PSYCHIAT, V130, P244, DOI 10.1192/bjp.130.3.244; Knox KL, 2003, BMJ-BRIT MED J, V327, P1376, DOI 10.1136/bmj.327.7428.1376; Lamb HR, 2002, PSYCHIATR SERV, V53, P1266, DOI 10.1176/appi.ps.53.10.1266; Lindqvist P, 2002, FORENSIC SCI INT, V128, P136, DOI 10.1016/S0379-0738(02)00188-3; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Maniglio R, 2009, ACTA PSYCHIAT SCAND, V119, P180, DOI 10.1111/j.1600-0447.2008.01300.x; MARTIN RL, 1985, ARCH GEN PSYCHIAT, V42, P58; Monahan J, 1992, Bull Am Acad Psychiatry Law, V20, P191; National Records of Scotland, 2011, CHANG COD CAUS DEATH; Neeleman J, 1998, LANCET, V351, P93, DOI 10.1016/S0140-6736(97)06364-2; Neeleman J, 2001, INT J EPIDEMIOL, V30, P154, DOI 10.1093/ije/30.1.154; Papadopoulos FC, 2009, PSYCHIAT RES, V169, P154, DOI 10.1016/j.psychres.2008.06.038; RORSMAN B, 1982, NEUROPSYCHOBIOLOGY, V8, P233, DOI 10.1159/000117904; Ruschena D, 1998, BRIT J PSYCHIAT, V172, P331, DOI 10.1192/bjp.172.4.331; Shaw J, 2006, BRIT J PSYCHIAT, V188, P143, DOI 10.1192/bjp.188.2.143; Shaw J, 1999, BRIT MED J, V318, P1240; Stone DH, 2006, INJURY PREV, V12, P327, DOI 10.1136/ip.2006.012344; Swinson N, 2011, BRIT J PSYCHIAT, V198, P485, DOI 10.1192/bjp.bp.110.085357; Taylor PJ, 1999, BRIT J PSYCHIAT, V174, P9, DOI 10.1192/bjp.174.1.9; Teplin LA, 2005, ARCH GEN PSYCHIAT, V62, P911, DOI 10.1001/archpsyc.62.8.911; Varnik P, 2012, INJURY PREV, V18, P321, DOI 10.1136/injuryprev-2011-040070	38	33	33	1	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2013	346								f557	10.1136/bmj.f557	http://dx.doi.org/10.1136/bmj.f557			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104MN	23462204	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000315997600031
J	Mitja, O; Asiedu, K; Mabey, D				Mitja, Oriol; Asiedu, Kingsley; Mabey, David			Yaws	LANCET			English	Article							SINGLE-DOSE AZITHROMYCIN; TREPONEMA-PALLIDUM; MACROLIDE RESISTANCE; SECONDARY SYPHILIS; SEQUENCE CONSERVATION; ENDEMIC SYPHILIS; PROTEIN ANTIGENS; PERTENUE; PENICILLIN; GENE	Yaws is an infectious disease caused by Treponema pallidum pertenue-a bacterium that closely resembles the causative agent of syphilis-and is spread by skin-to-skin contact in humid tropical regions. Yaws causes disfiguring, and sometimes painful lesions of the skin and bones. As with syphilis, clinical manifestations can be divided into three stages; however, unlike syphilis, mother-to-child transmission does not occur. A major campaign to eradicate yaws in the 1950s and 1960s, by mass treatment of affected communities with longacting, injectable penicillin, reduced the number of cases by 95% worldwide, but yaws has reappeared in recent years in Africa, Asia, and the western Pacific. In 2012, one oral dose of azithromycin was shown to be as effective as intramuscular penicillin in the treatment of the disease, and WHO launched a new initiative to eradicate yaws by 2020.	[Mitja, Oriol] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Mitja, Oriol] Newcrest Min, Lihir Med Ctr InternationalSOS, Lihir Isl, Papua N Guinea; [Asiedu, Kingsley] WHO, Dept Control Neglected Trop Dis, CH-1211 Geneva, Switzerland; [Mabey, David] Univ London London Sch Hyg & Trop Med, Dept Clin Res, London WC1E 7HT, England	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; World Health Organization; University of London; London School of Hygiene & Tropical Medicine	Mabey, D (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Clin Res, Keppel St, London WC1E 7HT, England.		Mitjà, Oriol/W-4181-2018	Mitjà, Oriol/0000-0003-3266-8868; Mabey, David/0000-0002-0031-8276; Mitja, Oriol/0000-0002-6469-529X				Abdolrasouli A, 2013, EMERG INFECT DIS, V19, P162, DOI 10.3201/eid1901.120756; ALDER JD, 1989, J INFECT DIS, V160, P289, DOI 10.1093/infdis/160.2.289; AMPOFO O, 1950, NATURE, V165, P398, DOI 10.1038/165398b0; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P125; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P189; [Anonymous], 1957, J TROP MED HYG, V60, P26; Anselmi M, 2003, TROP MED INT HEALTH, V8, P634, DOI 10.1046/j.1365-3156.2003.01073.x; Arteaga C, 1998, J RADIOL, V79, P1363; AUTIER P, 1989, ANN SOC BELG MED TR, V69, P319; Backhouse JL, 1998, AM J TROP MED HYG, V59, P388, DOI 10.4269/ajtmh.1998.59.388; BACKHOUSE JL, 1995, J CLIN MICROBIOL, V33, P1875, DOI 10.1128/JCM.33.7.1875-1878.1995; BAKERZANDER SA, 1983, INFECT IMMUN, V42, P634, DOI 10.1128/IAI.42.2.634-638.1983; BROWN WJ, 1963, PUBLIC HEALTH REP, V78, P911, DOI 10.2307/4591974; Cameron CE, 1999, INFECT IMMUN, V67, P3168, DOI 10.1128/IAI.67.6.3168-3170.1999; Cameron CE, 2000, J INFECT DIS, V181, P1401, DOI 10.1086/315399; Capuano C, 2011, J TROP MED-US, V2011, DOI 10.1155/2011/642832; Castellani A, 1905, BRIT MED J, V1905, P1280; Castellani A, 1907, J HYG-CAMBRIDGE, V7, P0558, DOI 10.1017/S0022172400033520; Castro AR, 2010, J CLIN MICROBIOL, V48, P4615, DOI 10.1128/JCM.00624-10; Cejkova D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001471; Centurion-Lara A, 1998, J INFECT DIS, V177, P1036, DOI 10.1086/515247; Centurion-Lara A, 2000, J BACTERIOL, V182, P2332, DOI 10.1128/JB.182.8.2332-2335.2000; Centurion-Lara A, 2006, J CLIN MICROBIOL, V44, P3377, DOI 10.1128/JCM.00784-06; CHAN JK, 1982, BRIT J VENER DIS, V58, P292; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; D'MELLO J M, 1955, Bull World Health Organ, V13, P1003; de Melo FL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000575; de Noray G, 2003, Med Trop (Mars), V63, P159; dos Santos MML, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-61; EAGLE H, 1948, J BACTERIOL, V55, P341, DOI 10.1128/JB.55.3.341-346.1948; EDINGTON GM, 1954, T ROY SOC TROP MED H, V48, P419, DOI 10.1016/0035-9203(54)90143-1; EDORH AA, 1994, B SOC PATHOL EXOT, V87, P17; ENGELKENS HJH, 1990, GENITOURIN MED, V66, P264; ENGELKENS HJH, 1993, GENITOURIN MED, V69, P102; ENGELKENS HJH, 1991, GENITOURIN MED, V67, P403; Engelkens HJH, 1999, CLIN DERMATOL, V17, P143, DOI 10.1016/S0738-081X(99)00007-3; Evans JR, 2011, COCHRANE DB SYST REV, V3; Fanella S, 2012, EMERG INFECT DIS, V18, P1002, DOI 10.3201/eid1806.111421; Fegan D, 2010, TROP DOCT, V40, P68, DOI 10.1258/td.2009.090249; Fribourg-Blanc A, 1969, Primates Med, V3, P113; GARNER MF, 1972, BRIT J VENER DIS, V48, P479; Garner MF, 1972, P N G MED J, V5, P171; Gerstl S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006338; Giacani L, 2012, J BACTERIOL, V194, P4208, DOI 10.1128/JB.00863-12; Gip L S, 1989, Med J Malaysia, V44, P307; Goff CW, 1967, DIS ANTIQUITY, P170; Guerrier G, 2011, NEW ZEAL MED J, V124, P29; HACKETT C J, 1953, Bull World Health Organ, V8, P129; HACKETT C J, 1956, Bull World Health Organ, V15, P869; Harper KN, 2008, FEMS IMMUNOL MED MIC, V53, P322, DOI 10.1111/j.1574-695X.2008.00427.x; Harper KN, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000148; HASSELMANN CM, 1957, BRIT J VENER DIS, V33, P5; Herring AJ, 2006, SEX TRANSM INFECT, V82, pV7, DOI 10.1136/sti.2006.022707; Heymans R, 2010, J CLIN MICROBIOL, V48, P497, DOI 10.1128/JCM.00720-09; HILL K R, 1953, Bull World Health Organ, V8, P17; HILL K. R., 1951, West Indian Medical Journal, V1, P81; Hinman AR, 1988, ERADICATION INFECT D, P19; Hoang MP, 2004, J CUTAN PATHOL, V31, P595, DOI 10.1111/j.0303-6987.2004.00236.x; HOVINDHOUGEN K, 1976, ACTA PATH MICRO IM B, V84, P101; Hudson B J, 1990, P N G Med J, V33, P59; HUDSON EH, 1964, BRIT J VENER DIS, V40, P43; Ito S, 2011, SEX TRANSM INFECT, V87, P412, DOI 10.1136/sextrans-2011-050035; Izard J, 2009, J BACTERIOL, V191, P7566, DOI 10.1128/JB.01031-09; John St RK, 1984, HDB ENDEMIC TREPONEM; Kiddugavu MG, 2005, SEX TRANSM DIS, V32, P1, DOI 10.1097/01.olq.0000148297.48590.d8; Knauf S, 2012, VET PATHOL, V49, P292, DOI 10.1177/0300985811402839; Kumm H, 1936, AM J TROP MED, V16, P1; LaFond RE, 2006, CLIN MICROBIOL REV, V19, P29, DOI 10.1128/CMR.19.1.29-49.2006; Levrero F, 2007, AM J PHYS ANTHROPOL, V132, P568, DOI 10.1002/ajpa.20560; LI H Y, 1955, Bull World Health Organ, V12, P905; [林上奇 LIN Shangqi], 2006, [中华放射学杂志, Chinese Journal of Radiology], V40, P414; Liu J, 2010, J MOL BIOL, V403, P546, DOI 10.1016/j.jmb.2010.09.020; LOUGHLIN EH, 1951, AM J TROP MED, V31, P20; LUKEHART SA, 1980, J IMMUNOL, V124, P454; Lukehart SA, 2004, NEW ENGL J MED, V351, P154, DOI 10.1056/NEJMoa040216; Mabey D, 2006, SEX TRANSM INFECT, V82, pV13, DOI 10.1136/sti.2006.022467; Mabey D, 2012, LANCET, V379, P295, DOI 10.1016/S0140-6736(11)61842-4; Magnuson Harold J., 1948, AMER JOUR SYPHILIS GONORRHEA AND VENEREAL DIS, V32, P1; Manirakiza Alexandre, 2011, BMC Res Notes, V4, P543, DOI 10.1186/1756-0500-4-543; Manning Laurens A., 2002, Papua New Guinea Medical Journal, V45, P206; Marra CM, 2006, J INFECT DIS, V194, P1771, DOI 10.1086/509512; Martinez SA, 1982, OTOLARYNGOL CLIN N A, V27, P220; Matejkova P, 2009, J MED MICROBIOL, V58, P832, DOI 10.1099/jmm.0.007542-0; McDonnell R., 1881, SELECTION WORKS A CO, P431; MEDINA R, 1959, Arch Venez Med Trop Parasitol Med, V3, P290; MEHEUS A, 1985, REV INFECT DIS, V7, pS284; Meheus AZ, 2010, INFECT DIS; Mikalova L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015713; Ministry of Health Division of Planning and Policy National Health Statistics Office-Solomon Islands, 2008, ANN HLTH REP 2007; Mitja O, 2012, LANCET, V379, P342, DOI 10.1016/S0140-6736(11)61624-3; Mitja O, 2011, AM J TROP MED HYG, V85, P113, DOI 10.4269/ajtmh.2011.11-0062; Mitja O, 2011, EMERG INFECT DIS, V17, P1083, DOI [10.3201/eid1706.101575, 10.3201/eid/1706.101575]; Mitja O, 2011, CLIN INFECT DIS, V52, P771, DOI 10.1093/cid/ciq246; Mulligan CJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000184; Muniz ES, 2012, HIST CIENC SAUDE-MAN, V19, P197, DOI 10.1590/S0104-59702012000100011; NIEMEL PLA, 1979, BRIT J VENER DIS, V55, P99; NOORDHOEK GT, 1990, INFECT IMMUN, V58, P2011, DOI 10.1128/IAI.58.6.2011-2013.1990; NOORDHOEK GT, 1990, J CLIN MICROBIOL, V28, P1600, DOI 10.1128/JCM.28.7.1600-1607.1990; NOORDHOEK GT, 1989, MICROB PATHOGENESIS, V6, P29, DOI 10.1016/0882-4010(89)90005-3; NORRIS SJ, 1988, ANTIMICROB AGENTS CH, V32, P68, DOI 10.1128/AAC.32.1.68; Norris Steven J., 1995, P636; OVCINNIKOV NM, 1970, BRIT J VENER DIS, V46, P349; Pearce L, 1925, J EXP MED, V41, P673, DOI 10.1084/jem.41.5.673; Pillay A, 2011, J CLIN MICROBIOL, V49, P4013, DOI 10.1128/JCM.01121-11; Pilnick AR, 2021, SCI REP-UK, V11, DOI [10.1038/s41598-021-90564-1, 10.1155/2014/139030, 10.18280/isi.270101]; Piso W, 1648, HIST NATURALIS BRASI, P35; Powell A., 1923, P ROY SOC MED, V16, P415; REIN C R, 1949, J Natl Med Assoc, V41, P60; Riedner G, 2005, NEW ENGL J MED, V353, P1236, DOI 10.1056/NEJMoa044284; ROMAN GC, 1986, REV INFECT DIS, V8, P760; Rosen T, 1998, ANTIMICROBIAL THERAP, P471; ROTHSCHILD BM, 1995, NATURE, V378, P343, DOI 10.1038/378343b0; Satter EK, 2010, PEDIATR DERMATOL, V27, P364, DOI 10.1111/j.1525-1470.2010.01184.x; SCHELL RF, 1979, BRIT J VENER DIS, V55, P316; Scolnik D, 2003, CLIN INFECT DIS, V36, P1232, DOI 10.1086/374338; SEHGAL VN, 1990, CLIN DERMATOL, V8, P166, DOI 10.1016/0738-081X(90)90055-6; SEPETJIAN M, 1969, B WORLD HEALTH ORGAN, V40, P141; Singh AE, 1999, CLIN MICROBIOL REV, V12, P187, DOI 10.1128/CMR.12.2.187; SMITH JL, 1971, BRIT J VENER DIS, V47, P226; Stamm LV, 2010, ANTIMICROB AGENTS CH, V54, P583, DOI 10.1128/AAC.01095-09; STAMM LV, 1985, INFECT IMMUN, V47, P799, DOI 10.1128/IAI.47.3.799-807.1985; STAMM LV, 1988, ANTIMICROB AGENTS CH, V32, P164, DOI 10.1128/AAC.32.2.164; Stamm LV, 2000, ANTIMICROB AGENTS CH, V44, P806, DOI 10.1128/AAC.44.3.806-807.2000; STEINER BM, 1986, SEX TRANSM DIS, V13, P245, DOI 10.1097/00007435-198610000-00007; Sydenham T, 1848, WORKS T SYDENHAM, P29; The Carter Center, 20 M INT TASK FORC D; THORNBURG RW, 1983, INFECT IMMUN, V42, P623, DOI 10.1128/IAI.42.2.623-627.1983; Toure B, 2007, Bull Soc Pathol Exot, V100, P130; Turner TB, 1957, BIOL TREPONEMATOSES; Van Damme K, 2009, SEX TRANSM DIS, V36, P775, DOI 10.1097/OLQ.0b013e3181bd11dd; Vester B, 2001, ANTIMICROB AGENTS CH, V45, P1, DOI 10.1128/AAC.45.1.1-12.2001; VORST FA, 1985, REV INFECT DIS, V7, pS327; WHITTET HB, 1988, J LARYNGOL OTOL, V102, P1147, DOI 10.1017/S0022215100107558; WHO, 2013, SUSTAINING THE DRIVE TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: SECOND WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1; WHO, 1986, YAWS OTH END TREP AF; WHO, 2007, INF CONS YAWS; WHO, 1978, RES DEC WHA31 58 CON; WHO, 2012, YAWS FORG DIS; WHO, 1953, B WORLD HEALTH ORGAN, V8, P1; Wicher K, 2000, INFECT IMMUN, V68, P3219, DOI 10.1128/IAI.68.6.3219-3225.2000; WIDYWIRSKI R, 1985, REV INFECT DIS, V7, pS227; Yin YP, CLIN INFECT IN PRESS; ZAHRA A, 1956, Bull World Health Organ, V15, P911	143	76	76	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2013	381	9868					763	773		10.1016/S0140-6736(12)62130-8	http://dx.doi.org/10.1016/S0140-6736(12)62130-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098TC	23415015				2022-12-28	WOS:000315570900030
J	Pincock, S				Pincock, Stephen			Profile Basil Hetzel: vanquishing iodine deficiency disorders	LANCET			English	Biographical-Item														Pincock, Stephen/0000-0003-1655-2902					0	0	0	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 2	2013	381	9868					717	717		10.1016/S0140-6736(13)60569-3	http://dx.doi.org/10.1016/S0140-6736(13)60569-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	098TC	23472909				2022-12-28	WOS:000315570900012
J	Goudemand, N; Romano, C; Brayard, A; Hochuli, PA; Bucher, H				Goudemand, N.; Romano, C.; Brayard, A.; Hochuli, P. A.; Bucher, H.			Comment on "Lethally Hot Temperatures During the Early Triassic Greenhouse"	SCIENCE			English	Editorial Material							ANHUI PROVINCE; CHAOHU		[Goudemand, N.; Romano, C.; Hochuli, P. A.; Bucher, H.] Univ Zurich, Palaeontol Inst & Museum, CH-8006 Zurich, Switzerland; [Brayard, A.] Univ Bourgogne, CNRS, UMR Biogeosci 6282, F-21000 Dijon, France	University of Zurich; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Goudemand, N (corresponding author), Univ Zurich, Palaeontol Inst & Museum, Karl Schmid Str 4, CH-8006 Zurich, Switzerland.	goudemand@pim.uzh.ch	Romano, Carlo/H-8903-2012; Brayard, Arnaud/AAH-3075-2020; Romano, Carlo/M-6179-2013; Bucher, Hugo F.R./O-2212-2013; Brayard, Arnaud/E-4711-2011	Romano, Carlo/0000-0003-4438-2736; Brayard, Arnaud/0000-0003-1304-6553; Bucher, Hugo F.R./0000-0001-9164-5258; Goudemand, Nicolas/0000-0002-2956-5852				Galfetti T, 2007, EARTH PLANET SC LETT, V258, P593, DOI 10.1016/j.epsl.2007.04.023; Goudemand N, 2012, PALAEONTOLOGY, V55, P1021, DOI 10.1111/j.1475-4983.2012.01174.x; Goudemand N, 2012, GEOBIOS-LYON, V45, P199, DOI 10.1016/j.geobios.2011.06.001; Li QG, 2009, PALAEONTOLOGY, V52, P369, DOI 10.1111/j.1475-4983.2009.00848.x; Sun YD, 2012, SCIENCE, V338, P366, DOI 10.1126/science.1224126; Tong JN, 2011, ACTA GEOL SIN-ENGL, V85, P399, DOI 10.1111/j.1755-6724.2011.00408.x; Tong JN, 2006, J PALEONTOL, V80, P146, DOI 10.1666/0022-3360(2006)080[0146:FFFTLT]2.0.CO;2; Trotter JA, 2008, SCIENCE, V321, P550, DOI 10.1126/science.1155814	8	20	20	3	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123								10.1126/science.1232924	http://dx.doi.org/10.1126/science.1232924			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23449580				2022-12-28	WOS:000315452000021
J	Burrell, RA; McClelland, SE; Endesfelder, D; Groth, P; Weller, MC; Shaikh, N; Domingo, E; Kanu, N; Dewhurst, SM; Gronroos, E; Chew, SK; Rowan, AJ; Schenk, A; Sheffer, M; Howell, M; Kschischo, M; Behrens, A; Helleday, T; Bartek, J; Tomlinson, IR; Swanton, C				Burrell, Rebecca A.; McClelland, Sarah E.; Endesfelder, David; Groth, Petra; Weller, Marie-Christine; Shaikh, Nadeem; Domingo, Enric; Kanu, Nnennaya; Dewhurst, Sally M.; Gronroos, Eva; Chew, Su Kit; Rowan, Andrew J.; Schenk, Arne; Sheffer, Michal; Howell, Michael; Kschischo, Maik; Behrens, Axel; Helleday, Thomas; Bartek, Jiri; Tomlinson, Ian R.; Swanton, Charles			Replication stress links structural and numerical cancer chromosomal instability	NATURE			English	Article							DNA-DAMAGE RESPONSE; SEGREGATION ERRORS; EVOLUTION; ORIGINS	Cancer chromosomal instability (CIN) results in an increased rate of change of chromosome number and structure and generates intratumour heterogeneity(1,2). CIN is observed in most solid tumours and is associated with both poor prognosis and drug resistance(3,4). Understanding a mechanistic basis for CIN is therefore paramount. Here we find evidence for impaired replication fork progression and increased DNA replication stress in CIN+ colorectal cancer (CRC) cells relative to CIN- CRC cells, with structural chromosome abnormalities precipitating chromosome missegregation in mitosis. We identify three new CIN-suppressor genes (PIGN (also known as MCD4), MEX3C (RKHD2) and ZNF516 (KIAA0222)) encoded on chromosome 18q that are subject to frequent copy number loss in CIN+ CRC. Chromosome 18q loss was temporally associated with aneuploidy onset at the adenoma-carcinoma transition. CIN-suppressor gene silencing leads to DNA replication stress, structural chromosome abnormalities and chromosome missegregation. Supplementing cells with nucleosides, to alleviate replication-associated damage(5), reduces the frequency of chromosome segregation errors after CIN-suppressor gene silencing, and attenuates segregation errors and DNA damage in CIN+ cells. These data implicate a central role for replication stress in the generation of structural and numerical CIN, which may inform new therapeutic approaches to limit intratumour heterogeneity.	[Burrell, Rebecca A.; McClelland, Sarah E.; Endesfelder, David; Shaikh, Nadeem; Kanu, Nnennaya; Dewhurst, Sally M.; Gronroos, Eva; Chew, Su Kit; Rowan, Andrew J.; Howell, Michael; Behrens, Axel; Swanton, Charles] Canc Res UK London Res Inst, London WC2A 3LY, England; [Endesfelder, David; Schenk, Arne; Kschischo, Maik] Univ Appl Sci Koblenz, Dept Math & Technol, D-53424 Remagen, Germany; [Groth, Petra; Weller, Marie-Christine; Helleday, Thomas] Karolinska lnstitutet, Sci Life Lab, Div Translat Med & Chem Biol, Dept Med Biochem & Biophys, S-17121 Stockholm, Sweden; [Domingo, Enric; Tomlinson, Ian R.] Wellcome Trust Ctr Human Genet, Mol & Populat Genet & NIHR Biomed Res Ctr, Oxford OX3 7BN, England; [Chew, Su Kit; Swanton, Charles] UCL Canc Inst, London WC1E 6BT, England; [Sheffer, Michal] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Bartek, Jiri] Danish Canc Soc, Res Ctr, DK-2100 Copenhagen, Denmark; [Bartek, Jiri] Palacky Univ Olomouc, Inst Mol & Translat Med, CZ-77515 Olomouc, Czech Republic	Cancer Research UK; Karolinska Institutet; University of Oxford; Wellcome Centre for Human Genetics; University of London; University College London; Weizmann Institute of Science; Danish Cancer Society; Palacky University Olomouc	Swanton, C (corresponding author), Canc Res UK London Res Inst, 44 Lincolns Inn Fields, London WC2A 3LY, England.	charles.swanton@cancer.org.uk	Helleday, Thomas/D-5224-2013; Bartek, Jiri/G-5870-2014; Gronroos, Eva/E-9351-2013; Domingo, Enric/A-9099-2018; Gronroos, Eva/P-6951-2015	Domingo, Enric/0000-0003-4390-8767; Howell, Michael/0000-0003-0912-0079; Sheffer, Michal/0000-0001-5934-9950; Swanton, Charles/0000-0002-4299-3018; Helleday, Thomas/0000-0002-7384-092X; Behrens, Axel/0000-0002-1557-1143; Shaikh, Nadeem/0000-0003-1797-2271; Gronroos, Eva/0000-0001-8303-5409	Cancer Research UK; Medical Research Council; EU; Prostate Cancer Foundation; Breast Cancer Research Foundation; Oxford Biomedical Research Centre; Danish Cancer Society; Lundbeck Foundation; European Commission; Swedish Cancer Society; Swedish Research Council; Torsten and Ragnar Soderberg Foundation; Cancer Research UK [16459, 15679] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); Prostate Cancer Foundation; Breast Cancer Research Foundation; Oxford Biomedical Research Centre; Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten and Ragnar Soderberg Foundation; Cancer Research UK(Cancer Research UK)	We thank A. Straube for reagents. C.S. is a senior Medical Research Council clinical research fellow and is funded by Cancer Research UK, the Medical Research Council, EU FP7 (projects PREDICT and RESPONSIFY), Prostate Cancer Foundation, and the Breast Cancer Research Foundation. We thank A. Futreal and The Wellcome Trust Sanger Centre and The Cancer Genome Atlas Research Network for providing genomics data. I.P.T. is supported by the Oxford Biomedical Research Centre and Cancer Research UK. J.B. is funded by the Danish Cancer Society, the Lundbeck Foundation, and the European Commission (FP7 projects DDResponse, Biomedreg and Infla-Care). T.H. is funded by the Swedish Cancer Society, the Swedish Research Council and the Torsten and Ragnar Soderberg Foundation.	Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Bunz F, 2002, CANCER RES, V62, P1129; Chan KL, 2009, CELL CYCLE, V8, P3065, DOI 10.4161/cc.8.19.9513; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Dereli-Oz A, 2011, MOL ONCOL, V5, P308, DOI 10.1016/j.molonc.2011.05.002; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gisselsson D, 2008, CHROMOSOMA, V117, P511, DOI 10.1007/s00412-008-0169-1; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Harrigan JA, 2011, J CELL BIOL, V193, P97, DOI 10.1083/jcb.201011083; Ichijima Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008821; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Kawabata T, 2011, MOL CELL, V41, P543, DOI 10.1016/j.molcel.2011.02.006; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Pampalona J, 2010, GENE CHROMOSOME CANC, V49, P368, DOI 10.1002/gcc.20749; Pasello G, 2009, MODERN PATHOL, V22, P58, DOI 10.1038/modpathol.2008.150; Rowan A, 2005, CLIN GASTROENTEROL H, V3, P1115, DOI 10.1016/S1542-3565(05)00618-X; Sigoillot FD, 2012, NAT METHODS, V9, P363, DOI [10.1038/NMETH.1898, 10.1038/nmeth.1898]; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Thompson SL, 2011, CHROMOSOME RES, V19, P433, DOI 10.1007/s10577-010-9179-y; Tort F, 2006, CANCER RES, V66, P10258, DOI 10.1158/0008-5472.CAN-06-2178; Yatsuoka T, 2000, AM J GASTROENTEROL, V95, P2080	27	518	532	2	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2013	494	7438					492	496		10.1038/nature11935	http://dx.doi.org/10.1038/nature11935			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23446422	Green Accepted			2022-12-28	WOS:000315661500042
J	Davis, M				Davis, Mike			A History of Future Cities	NATURE			English	Book Review												michael.davis@ucr.edu						Brook D., 2013, HIST FUTURE CITIES	1	0	0	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2013	494	7438					427	428		10.1038/494427a	http://dx.doi.org/10.1038/494427a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099YI	23446402	Bronze			2022-12-28	WOS:000315661500016
J	Hirano, A; Yumimoto, K; Tsunematsu, R; Matsumoto, M; Oyama, M; Kozuka-Hata, H; Nakagawa, T; Lanjakornsiripan, D; Nakayama, KI; Fukada, Y				Hirano, Arisa; Yumimoto, Kanae; Tsunematsu, Ryosuke; Matsumoto, Masaki; Oyama, Masaaki; Kozuka-Hata, Hiroko; Nakagawa, Tomoki; Lanjakornsiripan, Darin; Nakayama, Keiichi I.; Fukada, Yoshitaka			FBXL21 Regulates Oscillation of the Circadian Clock through Ubiquitination and Stabilization of Cryptochromes	CELL			English	Article							F-BOX PROTEINS; PHOSPHORYLATION; DEGRADATION; MAMMALS; MCRY2; MECHANISM; PACEMAKER; REVEALS; RHYTHMS; PERIOD	In the mammalian circadian clockwork, CRY1 and CRY2 repressor proteins are regulated by posttranslational modifications for temporally coordinated transcription of clock genes. Previous studies revealed that FBXL3, an F-box-type E3 ligase, ubiquitinates CRYs and mediates their degradation. Here, we found that FBXL21 also ubiquitinates CRYs but counteracts FBXL3. Fbxl21(-/-) mice exhibited normal periodicity of wheel-running rhythms with compromised organization of daily activities, while an extremely long-period phenotype of Fbxl3(-/-) mice was attenuated in Fbxl3/Fbxl21 double-knockout mice. The double knockout destabilized the behavioral rhythms progressively and sometimes elicited arrhythmicity. Surprisingly, FBXL21 stabilized CRYs and antagonized the destabilizing action by FBXL3. Predominantly cytosolic distribution of FBXL21 contrasts with nuclear localization of FBXL3. These results emphasize the physiological importance of antagonizing actions between FBXL21 and FBXL3 on CRYs, and their combined actions at different subcellular locations stabilize oscillation of the circadian clock.	[Hirano, Arisa; Nakagawa, Tomoki; Lanjakornsiripan, Darin; Fukada, Yoshitaka] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; [Yumimoto, Kanae; Tsunematsu, Ryosuke; Matsumoto, Masaki; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; [Oyama, Masaaki; Kozuka-Hata, Hiroko] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo 1088639, Japan	University of Tokyo; Kyushu University; University of Tokyo	Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp; sfukada@mail.ecc.u-tokyo.ac.jp	吉孝, 深田/G-5090-2014	Kozuka-Hata, Hiroko/0000-0002-9286-6594; Oyama, Masaaki/0000-0001-6478-3735; Matsumoto, Masaki/0000-0002-6987-0288	Global COE program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT, Japan; JSPS	Global COE program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT, Japan; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank Kentaro Hirose and Drs. Daisuke Kojima and Masaki Torii for their help with data analysis. We are grateful to Drs. Joseph S. Takahashi and Seung-Hee Yoo for communicating their unpublished results on Fbxl21 and to Drs. Steve A. Kay and Tsuyoshi Hirota for providing us with CRY1-Luc expression vectors. We also thank Jun Nakano and Drs. Hikari Yoshitane and Kimiko Shimizu for critical comments on the manuscript. This work was supported in part by Grants-in-Aid for Scientific research and by the Global COE program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT, Japan. A. H. is supported by JSPS Research Fellowships for Young Scientists.	Baker CL, 2012, FEMS MICROBIOL REV, V36, P95, DOI 10.1111/j.1574-6976.2011.00288.x; Behrends C, 2011, NAT STRUCT MOL BIOL, V18, P520, DOI 10.1038/nsmb.2066; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Dardente H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003530; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Harada Y, 2005, J BIOL CHEM, V280, P31714, DOI 10.1074/jbc.M506225200; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Ito S, 2012, MOL PLANT, V5, P573, DOI 10.1093/mp/sss013; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kon N, 2008, NAT CELL BIOL, V10, P1463, DOI 10.1038/ncb1806; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kurabayashi N, 2006, CHRONOBIOL INT, V23, P129, DOI 10.1080/07420520500464478; Kurabayashi N, 2010, MOL CELL BIOL, V30, P1757, DOI 10.1128/MCB.01047-09; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Nolan PM, 2009, MAMM GENOME, V20, P67, DOI 10.1007/s00335-008-9166-1; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Reischl S, 2011, FEBS LETT, V585, P1393, DOI 10.1016/j.febslet.2011.02.038; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; TAKAHASHI JS, 1995, ANNU REV NEUROSCI, V18, P531, DOI 10.1146/annurev.neuro.18.1.531; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Yoo SH, 2013, CELL, V152, P1091, DOI 10.1016/j.cell.2013.01.055	33	173	188	1	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 28	2013	152	5					1106	1118		10.1016/j.cell.2013.01.054	http://dx.doi.org/10.1016/j.cell.2013.01.054			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452856	Bronze			2022-12-28	WOS:000315710300017
J	Pasternak, B; Svanstrom, H; Hviid, A				Pasternak, Bjorn; Svanstrom, Henrik; Hviid, Anders			Ondansetron in Pregnancy and Risk of Adverse Fetal Outcomes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NAUSEA; REGISTRATION; MEDICATIONS; SAFETY	BACKGROUND Ondansetron is frequently used to treat nausea and vomiting during pregnancy, but the safety of this drug for the fetus has not been well studied. METHODS We investigated the risk of adverse fetal outcomes associated with ondansetron administered during pregnancy. From a historical cohort of 608,385 pregnancies in Denmark, women who were exposed to ondansetron and those who were not exposed were included, in a 1: 4 ratio, in propensity-score-matched analyses of spontaneous abortion (1849 exposed women vs. 7396 unexposed women), stillbirth (1915 vs. 7660), any major birth defect (1233 vs. 4932), preterm delivery (1792 vs. 7168), and birth of infants at low birth weight and small for gestational age (1784 vs. 7136). In addition, estimates were adjusted for hospitalization for nausea and vomiting during pregnancy (as a proxy for severity) and the use of other antiemetics. RESULTS Receipt of ondansetron was not associated with a significantly increased risk of spontaneous abortion, which occurred in 1.1% of exposed women and 3.7% of unexposed women during gestational weeks 7 to 12 (hazard ratio, 0.49; 95% confidence interval [CI], 0.27 to 0.91) and in 1.0% and 2.1%, respectively, during weeks 13 to 22 (hazard ratio, 0.60; 95% CI, 0.29 to 1.21). Ondansetron also conferred no significantly increased risk of stillbirth (0.3% for exposed women and 0.4% for unexposed women; hazard ratio, 0.42; 95% CI, 0.10 to 1.73), any major birth defect (2.9% and 2.9%, respectively; prevalence odds ratio, 1.12; 95% CI, 0.69 to 1.82), preterm delivery (6.2% and 5.2%; prevalence odds ratio, 0.90; 95% CI, 0.66 to 1.25), delivery of a low-birth-weight infant (4.1% and 3.7%; prevalence odds ratio, 0.76; 95% CI, 0.51 to 1.13), or delivery of a small-for-gestational-age infant (10.4% and 9.2%; prevalence odds ratio, 1.13; 95% CI, 0.89 to 1.44). CONCLUSIONS Ondansetron taken during pregnancy was not associated with a significantly increased risk of adverse fetal outcomes. (Funded by the Danish Medical Research Council.)	[Pasternak, Bjorn; Svanstrom, Henrik; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark	Statens Serum Institut	Pasternak, B (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	bjp@ssi.dk	Pasternak, Bjorn/H-5739-2012; Hviid, Anders/AAH-4319-2020	Pasternak, Bjorn/0000-0002-2097-8466; Hviid, Anders/0000-0002-7509-9127	Danish Medical Research Council [11-115854]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by a grant from the Danish Medical Research Council (11-115854, to Dr. Pasternak).	Anderka M, 2012, BIRTH DEFECTS RES A, V94, P22, DOI 10.1002/bdra.22865; [Anonymous], EUROPEAN SURVEILLANC; Austin PC, 2009, BIOMETRICAL J, V51, P171, DOI 10.1002/bimj.200810488; Buhimschi CS, 2009, OBSTET GYNECOL, V113, P166, DOI 10.1097/AOG.0b013e31818d6788; Chan RL, 2010, HUM REPROD, V25, P2907, DOI 10.1093/humrep/deq260; Einarson A, 2004, BJOG-INT J OBSTET GY, V111, P940, DOI 10.1111/j.1471-0528.2004.00236.x; GADSBY R, 1993, BRIT J GEN PRACT, V43, P245; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Knudsen LB, 1998, DAN MED BULL, V45, P320; Lacroix R, 2000, AM J OBSTET GYNECOL, V182, P931, DOI 10.1016/S0002-9378(00)70349-8; Larsen H, 2003, SCAND J PUBLIC HEALT, V31, P12, DOI 10.1080/14034940210134194; Lohse Sarah Rytter, 2010, Clin Epidemiol, V2, P247, DOI 10.2147/CLEP.S13815; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Magee LA, 2002, AM J OBSTET GYNECOL, V186, pS256, DOI 10.1067/mob.2002.122596; Mitchell AA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.029; Niebyl JR, 2010, NEW ENGL J MED, V363, P1544, DOI 10.1056/NEJMcp1003896; Pedersen CB, 2006, DAN MED BULL, V53, P441; Rassen JA, 2012, PHARMACOEPIDEM DR S, V21, P69, DOI 10.1002/pds.3263; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; WEIGEL RM, 1989, BRIT J OBSTET GYNAEC, V96, P1312, DOI 10.1111/j.1471-0528.1989.tb03229.x	20	120	126	2	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2013	368	9					814	823		10.1056/NEJMoa1211035	http://dx.doi.org/10.1056/NEJMoa1211035			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096ET	23445092				2022-12-28	WOS:000315387700007
J	Drife, JO				Drife, James Owen			Retirement: the four year itch	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												J.O.Drife@leeds.ac.uk							0	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2013	346								f1318	10.1136/bmj.f1318	http://dx.doi.org/10.1136/bmj.f1318			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100BL	23447353				2022-12-28	WOS:000315669600008
J	Ganz, RA; Peters, JH; Horgan, S; Bemelman, WA; Dunst, CM; Edmundowicz, SA; Lipham, JC; Luketich, JD; Melvin, WS; Oelschlager, BK; Schlack-Haerer, SC; Smith, CD; Smith, CC; Dunn, D; Taiganides, PA				Ganz, Robert A.; Peters, Jeffrey H.; Horgan, Santiago; Bemelman, Willem A.; Dunst, Christy M.; Edmundowicz, Steven A.; Lipham, John C.; Luketich, James D.; Melvin, W. Scott; Oelschlager, Brant K.; Schlack-Haerer, Steven C.; Smith, C. Daniel; Smith, Christopher C.; Dunn, Dan; Taiganides, Paul A.			Esophageal Sphincter Device for Gastroesophageal Reflux Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIREFLUX SURGERY; SURGICAL-TREATMENT; CLINICAL-TRIAL; UNITED-STATES; FUNDOPLICATION; GERD; AUGMENTATION; FEASIBILITY; SYMPTOMS; EXPOSURE	BACKGROUND Patients with gastroesophageal reflux disease who have a partial response to proton-pump inhibitors often seek alternative therapy. We evaluated the safety and effectiveness of a new magnetic device to augment the lower esophageal sphincter. METHODS We prospectively assessed 100 patients with gastroesophageal reflux disease before and after sphincter augmentation. The study did not include a concurrent control group. The primary outcome measure was normalization of esophageal acid exposure or a 50% or greater reduction in exposure at 1 year. Secondary outcomes were 50% or greater improvement in quality of life related to gastroesophageal reflux disease and a 50% or greater reduction in the use of proton-pump inhibitors at 1 year. For each outcome, the prespecified definition of successful treatment was achievement of the outcome in at least 60% of the patients. The 3-year results of a 5-year study are reported. RESULTS The primary outcome was achieved in 64% of patients (95% confidence interval [CI], 54 to 73). For the secondary outcomes, a reduction of 50% or more in the use of proton-pump inhibitors occurred in 93% of patients, and there was improvement of 50% or more in quality-of-life scores in 92%, as compared with scores for patients assessed at baseline while they were not taking proton-pump inhibitors. The most frequent adverse event was dysphagia (in 68% of patients postoperatively, in 11% at 1 year, and in 4% at 3 years). Serious adverse events occurred in six patients, and in six patients the device was removed. CONCLUSIONS In this single-group evaluation of 100 patients before and after sphincter augmentation with a magnetic device, exposure to esophageal acid decreased, reflux symptoms improved, and use of proton-pump inhibitors decreased. Follow-up studies are needed to assess long-term safety. (Funded by Torax Medical; ClinicalTrials.gov number, NCT00776997.)	[Ganz, Robert A.] Minnesota Gastroenterol, Plymouth, MN 55446 USA; [Dunn, Dan] Abbott NW Hosp, Minneapolis, MN 55407 USA; [Peters, Jeffrey H.] Univ Rochester, Sch Med & Dent, Dept Surg, Rochester, NY USA; [Horgan, Santiago] Univ Calif San Diego, Dept Surg, La Jolla, CA 92093 USA; [Lipham, John C.] Univ So Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90033 USA; [Bemelman, Willem A.] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands; [Dunst, Christy M.] Oregon Clin, Gastrointestinal & Minimally Invas Surg Div, Portland, OR USA; [Edmundowicz, Steven A.] Washington Univ, Sch Med, Div Gastroenterol, St Louis, MO 63130 USA; [Luketich, James D.] Univ Pittsburgh, Div Thorac Surg, Pittsburgh, PA USA; [Melvin, W. Scott] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA; [Taiganides, Paul A.] Knox Reg Heartburn Treatment Ctr, Mt Vernon, OH USA; [Oelschlager, Brant K.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Schlack-Haerer, Steven C.] Gundersen Lutheran Med Ctr, Dept Gastroenterol, La Crosse, WI USA; [Smith, C. Daniel] Mayo Clin Florida, Dept Surg, Jacksonville, FL USA; [Smith, Christopher C.] Albany Surg Ctr, So Reflux Ctr, Albany, GA USA	University of Rochester; University of California System; University of California San Diego; University of Southern California; University of Amsterdam; Academic Medical Center Amsterdam; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; Ohio State University; University of Washington; University of Washington Seattle; Gundersen Lutheran Medical Center; Mayo Clinic	Ganz, RA (corresponding author), Minnesota Gastroenterol, 15700 37th Ave N,Suite 300, Plymouth, MN 55446 USA.		Bemelman, Wilhelmus Adrianus/AAA-1635-2021; luketich, james/AAY-6230-2020	Bemelman, Wilhelmus Adrianus/0000-0002-1037-9945; Edmundowicz, Steven/0000-0002-6541-3485	Torax Medical	Torax Medical	Supported by Torax Medical.	Ayazi S, 2010, ANN SURG, V252, P57, DOI 10.1097/SLA.0b013e3181e3e411; Bonavina L, 2010, ANN SURG, V252, P857, DOI 10.1097/SLA.0b013e3181fd879b; Bonavina L, 2008, J GASTROINTEST SURG, V12, P2133, DOI 10.1007/s11605-008-0698-1; Castell DO, 2002, AM J GASTROENTEROL, V97, P575; DeMeester T R, 1997, Dis Esophagus, V10, P1; DEMEESTER TR, 1979, AM J SURG, V137, P39, DOI 10.1016/0002-9610(79)90008-4; DEMEESTER TR, 1986, ANN SURG, V204, P9, DOI 10.1097/00000658-198607000-00002; DODDS WJ, 1982, NEW ENGL J MED, V307, P1547, DOI 10.1056/NEJM198212163072503; Everhart JE, 2009, GASTROENTEROLOGY, V136, P376, DOI 10.1053/j.gastro.2008.12.015; Finks JF, 2006, SURG ENDOSC, V20, P1698, DOI 10.1007/s00464-006-0042-3; Galmiche JP, 2011, JAMA-J AM MED ASSOC, V305, P1969, DOI 10.1001/jama.2011.626; Ganz RA, 2008, GASTROINTEST ENDOSC, V67, P287, DOI 10.1016/j.gie.2007.07.027; Kahrilas PJ, 2008, NEW ENGL J MED, V359, P1700, DOI 10.1056/NEJMcp0804684; Kahrilas PJ, 2000, SURGERY, V127, P200, DOI 10.1067/msy.2000.102045; Katz PO, 2010, J GASTROINTEST SURG, V14, P62, DOI 10.1007/s11605-009-1015-3; Oberg S, 1997, ANN SURG, V226, P522, DOI 10.1097/00000658-199710000-00013; Pandolifino JE, 2006, GASTROENTEROLOGY, V131, P1725, DOI 10.1053/j.gastro.2006.09.009; SAMELSON SL, 1983, ANN SURG, V197, P254, DOI 10.1097/00000658-198303000-00002; Stefanidis D, 2010, SURG ENDOSC, V24, P2647, DOI 10.1007/s00464-010-1267-8; Toghanian S, 2011, CLIN DRUG INVEST, V31, P703, DOI 10.2165/11595480-000000000-00000; Vakil N, 2003, AM J MED, V114, P1, DOI 10.1016/S0002-9343(02)01390-6; Velanovich V, 1998, J Gastrointest Surg, V2, P141, DOI 10.1016/S1091-255X(98)80004-8; Wang YR, 2011, DIS ESOPHAGUS, V24, P215, DOI 10.1111/j.1442-2050.2010.01123.x	23	171	185	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2013	368	8					719	727		10.1056/NEJMoa1205544	http://dx.doi.org/10.1056/NEJMoa1205544			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092CG	23425164	Green Published			2022-12-28	WOS:000315095800006
J	Alleyne, G; Binagwaho, A; Haines, A; Jahan, S; Nugent, R; Rojhani, A; Stuckler, D				Alleyne, George; Binagwaho, Agnes; Haines, Andy; Jahan, Selim; Nugent, Rachel; Rojhani, Ariella; Stuckler, David		Lancet NCD Action Grp	Embedding non-communicable diseases in the post-2015 development agenda	LANCET			English	Article							MILLENNIUM DEVELOPMENT GOALS; SUSTAINABLE DEVELOPMENT; HEALTH-BENEFITS; LATIN-AMERICA; TOBACCO; COSTS; BURDEN; SUMMIT; TRAVEL; POOR	The post-2015 development agenda will build on the Millennium Development Goals (MDGs), in which health is a core component. This agenda will focus on human development, incorporate the components of the Millennium Declaration, and will be made sustainable by support from the social, economic, and environmental domains of activity, represented graphically as the strands of a triple helix. The approaches to prevention and control of non-communicable diseases (NCDs) have been elaborated in the political declaration of the UN high-level meeting on NCDs and governments have adopted a goal of 25% reduction in relative mortality from NCDs by 2025 (the 25 by 25 goal), but a strong movement is needed based on the evidence already available, enhanced by effective partnerships, and with political support to ensure that NCDs are embedded in the post-2015 human development agenda. NCDs should be embedded in the post-2015 development agenda, since they are leading causes of death and disability, have a negative effect on health, and, through their effect on the societal, economic, and the environmental domains, impair the sustainability of development. Some drivers of unsustainable development, such as the transport, food and agriculture, and energy sectors, also increase the risk of NCDs.	[Alleyne, George] Pan Amer Hlth Org, Washington, DC 20037 USA; [Binagwaho, Agnes] Minist Hlth, Kigali, Rwanda; [Binagwaho, Agnes] Harvard Univ, Sch Med, Boston, MA USA; [Haines, Andy] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Haines, Andy] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1, England; [Jahan, Selim] United Nations Dev Programme, New York, NY USA; [Nugent, Rachel] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Rojhani, Ariella] NCD Alliance, New York, NY USA; [Stuckler, David] Univ Cambridge, Dept Sociol, Cambridge, England	Pan American Health Organization; Harvard University; Harvard Medical School; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Washington; University of Washington Seattle; University of Cambridge	Alleyne, G (corresponding author), Pan Amer Hlth Org, 525 23rd St, Washington, DC 20037 USA.	alleyned@paho.org		Nugent, Rachel/0000-0001-6421-9077; Stuckler, David/0000-0002-1288-8401; Haines, Andy/0000-0002-8053-4605				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Aboderin A, 2002, LIFE COURSE PERSPECT; Adams W.M., P IUCN REN THINK M Z; Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5; [Anonymous], 2012, SUST DEV GOALS; [Anonymous], 2010, HLTH NUTR POPUL SER; [Anonymous], 2000, DEV FREEDOM; [Anonymous], 2010, KEEP PROM UN ACH MIL; [Anonymous], 2011, MILL DEV GOALS REP; [Anonymous], 2012, REPORT SECRETARY GEN; Barcelo A, 2003, B WORLD HEALTH ORGAN, V81, P19; Beaglehole R, 2013, LANCET; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Binagwaho A, 2012, B WORLD HEALTH ORGAN, V90, P623, DOI 10.2471/BLT.11.097253; Bloom D, 2011, GLOB EC BURD NONC DI; Bonu S, 2005, HEALTH POLICY PLANN, V20, P41, DOI 10.1093/heapol/czi005; Bonu S, 2004, HEALTH POLICY, V70, P67, DOI 10.1016/j.healthpol.2004.02.003; Burkhauser RV, 2005, J GERONTOL B-PSYCHOL, V60, pS238, DOI 10.1093/geronb/60.5.S238; Chapple A, 2004, BMJ-BRIT MED J, V328, P1470, DOI 10.1136/bmj.38111.639734.7C; Chen S, 2008, DEV WORLD IS POORER; Clark H, 2012, COMMUNICATION; CSDH, 2008, CLOS GAP GEN HLTH EQ; de Garcia-Belaunde M, 2002, DIABETES VOICE, V47, P44; DeFries R, 2010, P NATL ACAD SCI USA, V107, P19627, DOI 10.1073/pnas.1011163107; Di Cesare M, 2013, LANCET; Easterly W, 2009, WORLD DEV, V37, P26, DOI 10.1016/j.worlddev.2008.02.009; Edwards P, 2009, INT J EPIDEMIOL, V38, P1137, DOI 10.1093/ije/dyp172; Efroymson D, 2001, TOB CONTROL, V10, P212, DOI 10.1136/tc.10.3.212; FAO, 2006, LIV LONG SHAD; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Friel S, 2009, LANCET, V374, P2016, DOI 10.1016/S0140-6736(09)61753-0; Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; Glassman A, 2010, HEALTH AFFAIR, V29, P2142, DOI 10.1377/hlthaff.2010.1038; Grabow ML, 2012, ENVIRON HEALTH PERSP, V120, P68, DOI 10.1289/ehp.1103440; Gwatkin DR, 2005, LANCET, V365, P813, DOI 10.1016/S0140-6736(05)17992-6; Haines A, 2012, LANCET, V379, P2189, DOI 10.1016/S0140-6736(12)60779-X; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; Horton R, 2007, LANCET, V370, P1881, DOI 10.1016/S0140-6736(07)61701-2; Hulme D, 2010, 110 WORLD POV I; Hulme D, 2007, HE MAKING MILLENNIUM; Jahan S, 2012, DOES IT MAKE SENSE H; Jarrett J, 2012, LANCET, V379, P2198, DOI 10.1016/S0140-6736(12)60766-1; Jha P, 2012, CHRONIC DIS COPENHAG; Kanbur R., 2011, POOR COUNTRIES POOR; Kates RW, 2005, ENVIRONMENT, V47, P8; Kimmel PL, 2001, KIDNEY INT, V59, P1599, DOI 10.1046/j.1523-1755.2001.0590041599.x; Lecours N, 2012, TOB CONTROL, V21, P191, DOI 10.1136/tobaccocontrol-2011-050318; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Markandya A, 2009, LANCET, V374, P2006, DOI 10.1016/S0140-6736(09)61715-3; Mendis S., 2011, GLOB ATL CARD DIS PR; Moon Ban Ki, 2011, BAN KI MOON REM GEN; NCD Alliance, 2012, BRIEF PAP TACKL NONC; Neal C., 2010, CANC STIGMA SILENCE; Neumayer E., 2010, HUMAN DEV SUSTAINABI; Nugent R., 2011, BRINGING AGR TABLE A; Nussbaum Martha, 2007, HARVARD HUMAN RIGHTS, V20, P21; Ooms G, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-17; Organization WH, 2009, GLOB HLTH RISKS MORT; Partners In Health, 2011, PIH GUID CHRON CAR I; Pollard A, C PAPERS 10 YEARS WA; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Sen A, 2010, FOREWORD HLTH SOCIAL; Sevak P, 2003, SOC SECUR BULL, V65, P31; Spogard R, 2012, GOVERNANCE DEMOCRACY; Steiner A, 2011, RIO 20 REFOCUSING EC; Stuckler D, 2011, SICK SOC RESP GLOB C; Stuckler D, 2011, CK SOC RESPONDING GL; Stuckler D, 2008, MILBANK Q, V86, P273, DOI 10.1111/j.1468-0009.2008.00522.x; Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241; Suhrcke M., 2006, CHRONIC DIS EC PERSP; Sumner A, 2011, POVERTY MIDDLE INCOM; ul Haq M., 1995, REFLECTIONS HUMAN DE; UN, 2011, ACC PROGR MILL DEV G; UN Environment Programme, 2012, RIO DECL ENV DEV; UN Secret ary General, 2011, RES PEOPL RES PLAN R; UNDP, 1990, HUM DEV REP; UNDP (United Nations Development Programme), 2003, MILL DEV GOALS COMP; United Nations, 1992, C ENV DEV 1992 RIO D; United Nations, 2011, REPORT SPECIAL RAPPO; United Nations General Assembly, 2009, GLOB HLTH FOR POL ST; Vandemoortele J., 2009, TAKING MDGS 2015 HAS; von Schirnding Y, 2002, LANCET, V360, P632, DOI 10.1016/S0140-6736(02)09777-5; von Schirnding Y, 2005, GLOBALIZATION HEALTH, V1, DOI 10.1186/1744-8603-1-8; WHO, 2005, PREV CHROM DIS VIT I; WHO, 2010, HUM PAP REL CANC RWA; WHO, 2012, MEAS HLTH GAINS SUST; WHO, 2012, LESS LEARN EX MULT P; Wilkinson P, 2009, LANCET, V374, P1917, DOI 10.1016/S0140-6736(09)61713-X; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8; World Bank, 2001, WORLD DEV REP 2000; World Bank, 2011, GROW DANG NONC DIS A; World Commission on Environment and Development, 1987, OUR COMMON FUTURE; World Health Organization, 2011, GLOBAL STATUS REPORT; World Health Organization, 2012, 65 WORLD HLTH ASS; World Health Organization, 2009, MORT BURD DIS EST WH	99	132	135	0	41	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2013	381	9866					566	574		10.1016/S0140-6736(12)61806-6	http://dx.doi.org/10.1016/S0140-6736(12)61806-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089RK	23410606				2022-12-28	WOS:000314927500032
J	Crothers, DM				Crothers, Donald M.			Fine Tuning Gene Regulation	SCIENCE			English	Editorial Material							LONG-RANGE INTERACTIONS; DNA; MODEL		Yale Univ, Dept Chem, New Haven, CT 06511 USA	Yale University	Crothers, DM (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06511 USA.	donald.crothers@yale.edu						Garcia HG, 2012, CELL REP, V2, P150, DOI 10.1016/j.celrep.2012.06.004; Kim S, 2013, SCIENCE, V339, P816, DOI 10.1126/science.1229223; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Parekh BS, 1996, P NATL ACAD SCI USA, V93, P1173, DOI 10.1073/pnas.93.3.1173; POHL F, 1972, P NATL ACAD SCI USA, V69, P3805, DOI 10.1073/pnas.69.12.3805; Rudnick J, 1999, BIOPHYS J, V76, P1725, DOI 10.1016/S0006-3495(99)77334-0; Wang YM, 2005, NANOTECHNOLOGY, V16, P1993, DOI 10.1088/0957-4484/16/10/003; Wang YM, 2005, P NATL ACAD SCI USA, V102, P9796, DOI 10.1073/pnas.0502917102	8	4	4	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2013	339	6121					766	767		10.1126/science.1232663	http://dx.doi.org/10.1126/science.1232663			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23413343				2022-12-28	WOS:000314874400032
J	Auyeung, VC; Ulitsky, I; McGeary, SE; Bartel, DP				Auyeung, Vincent C.; Ulitsky, Igor; McGeary, Sean E.; Bartel, David P.			Beyond Secondary Structure: Primary-Sequence Determinants License Pri-miRNA Hairpins for Processing	CELL			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; CHRONIC LYMPHOCYTIC-LEUKEMIA; IN-VITRO SELECTION; MESSENGER-RNA; SR PROTEINS; MICROPROCESSOR COMPLEX; DROSHA-DGCR8 COMPLEX; MICRORNA PRECURSORS; MAMMALIAN-CELLS; MOLECULAR-BASIS	To use microRNAs to downregulate mRNA targets, cells must first process these similar to 22 nt RNAs from primary transcripts (pri-miRNAs). These transcripts form RNA hairpins important for processing, but additional determinants must distinguish pri-miRNAs from the many other hairpin-containing transcripts expressed in each cell. Illustrating the complexity of this recognition, we show that most Caenorhabditis elegans pri-miRNAs lack determinants required for processing in human cells. To find these determinants, we generated many variants of four human pri-miRNAs, sequenced millions that retained function, and compared them with the starting variants. Our results confirmed the importance of pairing in the stem and revealed three primary-sequence determinants, including an SRp20-binding motif (CNNC) found downstream of most pri-miRNA hairpins in bilaterian animals, but not in nematodes. Adding this and other determinants to C. elegans pri-miRNAs imparted efficient processing in human cells, thereby confirming the importance of primary-sequence determinants for distinguishing pri-miRNAs from other hairpin-containing transcripts.	[Auyeung, Vincent C.; Ulitsky, Igor; McGeary, Sean E.; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Auyeung, Vincent C.; Ulitsky, Igor; McGeary, Sean E.; Bartel, David P.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Auyeung, Vincent C.; Ulitsky, Igor; McGeary, Sean E.; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Auyeung, Vincent C.] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu	Ulitsky, Igor/HCH-7453-2022	Ulitsky, Igor/0000-0003-0555-6561; Auyeung, Vincent/0000-0001-6273-1595	NIH [GM067031, T32GM007753]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067031, T32GM007753] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Shechner, C. Jan, O. Rissland, D. Weinberg, J. Ruby, J. Nam, and V.N. Kim for valuable discussions; O. Rissland for comments on this manuscript; L. Schoenfeld and J. Lassar for technical assistance; J. Stevenin for 9G8 antibody; V.N. Kim and T. Tuschl for plasmids; the Whitehead Institute Genome Technology Core for sequencing; and E. Spooner for mass spectrometry. This work was supported by NIH grants GM067031 and T32GM007753. D.B. is an Investigator of the Howard Hughes Medical Institute.	Anko ML, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r17; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bedard KM, 2007, EMBO J, V26, P459, DOI 10.1038/sj.emboj.7601494; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Cavaloc Y, 1999, RNA, V5, P468, DOI 10.1017/S1355838299981967; CAVALOC Y, 1994, EMBO J, V13, P2639, DOI 10.1002/j.1460-2075.1994.tb06554.x; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Chung WJ, 2011, GENOME RES, V21, P286, DOI 10.1101/gr.113050.110; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Feng Y, 2011, BBA-GENE REGUL MECH, V1809, P700, DOI 10.1016/j.bbagrm.2011.05.015; Gottwein E, 2006, J VIROL, V80, P5321, DOI 10.1128/JVI.02734-05; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hargous Y, 2006, EMBO J, V25, P5126, DOI 10.1038/sj.emboj.7601385; HEINRICHS V, 1995, EMBO J, V14, P3987, DOI 10.1002/j.1460-2075.1995.tb00070.x; Hofacker IL, 2006, BIOINFORMATICS, V22, P1172, DOI 10.1093/bioinformatics/btl023; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jia R, 2010, INT J BIOL SCI, V6, P806; Jumaa H, 1999, CURR BIOL, V9, P899, DOI 10.1016/S0960-9822(99)80394-7; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Lamontagne B, 2004, J BIOL CHEM, V279, P2231, DOI 10.1074/jbc.M309324200; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2007, METHOD ENZYMOL, V427, P89, DOI 10.1016/S0076-6879(07)27005-3; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; PAN T, 1992, BIOCHEMISTRY-US, V31, P3887, DOI 10.1021/bi00131a001; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Pitt JN, 2010, SCIENCE, V330, P376, DOI 10.1126/science.1192001; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Schaal TD, 1999, MOL CELL BIOL, V19, P1705; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Sun GH, 2009, RNA, V15, P1640, DOI 10.1261/rna.1560209; Swartz JE, 2007, J BIOL CHEM, V282, P19844, DOI 10.1074/jbc.M701660200; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Wu H, 2010, MOL CELL, V38, P67, DOI 10.1016/j.molcel.2010.02.021; WYATT JR, 1992, GENE DEV, V6, P2542, DOI 10.1101/gad.6.12b.2542; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; ZAHLER AM, 1993, MOL CELL BIOL, V13, P4023, DOI 10.1128/MCB.13.7.4023; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zeng Y, 2005, J BIOL CHEM, V280, P27595, DOI 10.1074/jbc.M504714200; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zykovich A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp802	63	276	291	1	67	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 14	2013	152	4					844	858		10.1016/j.cell.2013.01.031	http://dx.doi.org/10.1016/j.cell.2013.01.031			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415231	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000314945600018
J	Landau, DA; Carter, SL; Stojanov, P; McKenna, A; Stevenson, K; Lawrence, MS; Sougnez, C; Stewart, C; Sivachenko, A; Wang, LL; Wan, YZ; Zhang, WD; Shukla, SA; Vartanov, A; Fernandes, SM; Saksena, G; Cibulskis, K; Tesar, B; Gabriel, S; Hacohen, N; Meyerson, M; Lander, ES; Neuberg, D; Brown, JR; Getz, G; Wu, CJ				Landau, Dan A.; Carter, Scott L.; Stojanov, Petar; McKenna, Aaron; Stevenson, Kristen; Lawrence, Michael S.; Sougnez, Carrie; Stewart, Chip; Sivachenko, Andrey; Wang, Lili; Wan, Youzhong; Zhang, Wandi; Shukla, Sachet A.; Vartanov, Alexander; Fernandes, Stacey M.; Saksena, Gordon; Cibulskis, Kristian; Tesar, Bethany; Gabriel, Stacey; Hacohen, Nir; Meyerson, Matthew; Lander, Eric S.; Neuberg, Donna; Brown, Jennifer R.; Getz, Gad; Wu, Catherine J.			Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia	CELL			English	Article							ACUTE MYELOID-LEUKEMIA; COPY-NUMBER ALTERATION; B-CELL LYMPHOMA; CLONAL EVOLUTION; SOMATIC MUTATIONS; GENOMIC ABERRATIONS; MULTIPLE-MYELOMA; CANCER GENES; PROGRESSION; HETEROGENEITY	Clonal evolution is a key feature of cancer progression and relapse. We studied intratumoral heterogeneity in 149 chronic lymphocytic leukemia (CLL) cases by integrating whole-exome sequence and copy number to measure the fraction of cancer cells harboring each somatic mutation. We identified driver mutations as predominantly clonal (e.g., MYD88, trisomy 12, and del(13q)) or subclonal (e.g., SF3B1 and TP53), corresponding to earlier and later events in CLL evolution. We sampled leukemia cells from 18 patients at two time points. Ten of twelve CLL cases treated with chemotherapy (but only one of six without treatment) underwent clonal evolution, predominantly involving subclones with driver mutations (e.g., SF3B1 and TP53) that expanded over time. Furthermore, presence of a subclonal driver mutation was an independent risk factor for rapid disease progression. Our study thus uncovers patterns of clonal evolution in CLL, providing insights into its stepwise transformation, and links the presence of subclones with adverse clinical outcomes.	[Landau, Dan A.; Wang, Lili; Wan, Youzhong; Zhang, Wandi; Shukla, Sachet A.; Wu, Catherine J.] Dana Farber Canc Inst, Canc Vaccine Ctr, Boston, MA 02115 USA; [Landau, Dan A.; Stojanov, Petar; Wang, Lili; Wan, Youzhong; Zhang, Wandi; Vartanov, Alexander; Fernandes, Stacey M.; Tesar, Bethany; Brown, Jennifer R.; Wu, Catherine J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Stevenson, Kristen; Neuberg, Donna] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Landau, Dan A.; Carter, Scott L.; Stojanov, Petar; McKenna, Aaron; Lawrence, Michael S.; Sougnez, Carrie; Stewart, Chip; Sivachenko, Andrey; Shukla, Sachet A.; Saksena, Gordon; Cibulskis, Kristian; Gabriel, Stacey; Hacohen, Nir; Meyerson, Matthew; Lander, Eric S.; Getz, Gad] Broad Inst, Cambridge, MA 02139 USA; [Landau, Dan A.] Yale Canc Ctr, Dept Hematol, New Haven, CT 06510 USA; [Landau, Dan A.] Univ Paris Diderot, F-75013 Paris, France; [Brown, Jennifer R.; Wu, Catherine J.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Sch Med, Boston, MA 02115 USA; [Hacohen, Nir] Harvard Univ, Div Allergy Immunol & Rheumatol, Dept Med, Massachusetts Gen Hosp,Med Sch, Boston, MA 02114 USA; [Getz, Gad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Yale University; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Getz, G (corresponding author), Broad Inst, Cambridge, MA 02139 USA.	gadgetz@broadinstitute.org; cwu@partners.org	Stojanov, Petar/GQI-4462-2022; Cibulskis, Kristian/AAC-7380-2019; Lawrence, Michael/AAC-8202-2020	Stojanov, Petar/0000-0001-7815-776X; Cibulskis, Kristian/0000-0003-1343-1582; Meyerson, Matthew/0000-0002-9133-8108; Vartanov, Alexander/0000-0001-5744-4882	American Society of Hematology (ASH) Research Award for Fellows-in-Training; ACS Postdoctoral Fellowship; NIH [K23 CA115682]; Melton and Rosenbach Funds; Blavatnik Family Foundation; AACR (SU2C Innovative Research Grant); NHLBI [1RO1HL103532-01]; NCI [1R01CA155010-01A1]; Damon-Runyon Cancer Research Foundation [CI-38-07]; NATIONAL CANCER INSTITUTE [R01CA155010, K23CA115682] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103532] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	American Society of Hematology (ASH) Research Award for Fellows-in-Training; ACS Postdoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melton and Rosenbach Funds; Blavatnik Family Foundation; AACR (SU2C Innovative Research Grant); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Damon-Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	D.A.L. dedicates this manuscript to the loving memory of his mother Nina, who passed away during the final stages of this work. We thank all members of the Broad Institute's Biological Samples, Genetic Analysis, and Genome Sequencing Platforms, who made this work possible (NHGRI-U54HG003067). D.A.L. is supported by an American Society of Hematology (ASH) Research Award for Fellows-in-Training and an ACS Postdoctoral Fellowship. J.R.B. is supported by NIH K23 CA115682, the Melton and Rosenbach Funds, and is an ASH Scholar and a LLS Clinical Research Scholar. C.J.W. acknowledges support from the Blavatnik Family Foundation, AACR (SU2C Innovative Research Grant), NHLBI (1RO1HL103532-01), NCI (1R01CA155010-01A1), and is a clinical investigator supported in part by the Damon-Runyon Cancer Research Foundation (CI-38-07).	Alami R, 2003, P NATL ACAD SCI USA, V100, P5920, DOI 10.1073/pnas.0736105100; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; BOS JL, 1989, CANCER RES, V49, P4682; Brown JR, 2012, CLIN CANCER RES, V18, P3791, DOI 10.1158/1078-0432.CCR-11-2342; Carter S.L., 2011, NATURE PRECEDINGS; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Cibulskis K., 2013, NAT BIOTECH; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Deutsch AJA, 2007, BLOOD, V109, P3500, DOI 10.1182/blood-2006-06-030494; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Dohner Hartmut, 2005, Clin Adv Hematol Oncol, V3, P103; Egan JB, 2012, BLOOD, V120, P1060, DOI 10.1182/blood-2012-01-405977; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Geisler C, 1999, JNCI-J NATL CANCER I, V91, P861; Gerlinger M, 2010, BRIT J CANCER, V103, P1139, DOI 10.1038/sj.bjc.6605912; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gerstung M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1814; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Grossmann V, 2011, BLOOD, V118, P6153, DOI 10.1182/blood-2011-07-365320; Grubor V, 2009, BLOOD, V113, P1294, DOI 10.1182/blood-2008-05-158865; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hosgood HD, 2009, LEUKEMIA RES, V33, P1609, DOI 10.1016/j.leukres.2009.03.013; Jablonski D, 2001, P NATL ACAD SCI USA, V98, P5393, DOI 10.1073/pnas.101092598; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Marechal Y, 2011, IMMUNOBIOLOGY, V216, P103, DOI 10.1016/j.imbio.2010.03.012; Masica DL, 2011, CANCER RES, V71, P4550, DOI 10.1158/0008-5472.CAN-11-0180; McCarthy H, 2003, BLOOD, V101, P4903, DOI 10.1182/blood-2002-09-2906; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nowak MA, 2004, SCIENCE, V303, P793, DOI 10.1126/science.1093411; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Schuh A, 2012, BLOOD, V120, P4191, DOI 10.1182/blood-2012-05-433540; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shanafelt TD, 2008, J CLIN ONCOL, V26, pE5, DOI 10.1200/JCO.2008.16.7874; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stilgenbauer S, 2007, HAEMATOLOGICA, V92, P1242, DOI 10.3324/haematol.10720; Unoki M, 2003, ONCOGENE, V22, P2172, DOI 10.1038/sj.onc.1206222; Vincent TL, 2008, INT J ONCOL, V32, P729; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Wu CJ, 2012, BLOOD, V120, P4117, DOI 10.1182/blood-2012-09-452805	59	989	1008	4	120	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 14	2013	152	4					714	726		10.1016/j.cell.2013.01.019	http://dx.doi.org/10.1016/j.cell.2013.01.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415222	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000314945600008
J	Vaks, A; Gutareva, OS; Breitenbach, SFM; Avirmed, E; Mason, AJ; Thomas, AL; Osinzev, AV; Kononov, AM; Henderson, GM				Vaks, A.; Gutareva, O. S.; Breitenbach, S. F. M.; Avirmed, E.; Mason, A. J.; Thomas, A. L.; Osinzev, A. V.; Kononov, A. M.; Henderson, G. M.			Speleothems Reveal 500,000-Year History of Siberian Permafrost	SCIENCE			English	Article							ISOTOPE STAGE 11; MILLENNIAL-SCALE; LAKE ELGYGYTGYN; CLIMATE-CHANGE; RECORD; VARIABILITY; BAIKAL; CARBON	Soils in permafrost regions contain twice as much carbon as the atmosphere, and permafrost has an important influence on the natural and built environment at high northern latitudes. The response of permafrost to warming climate is uncertain and occurs on time scales longer than those assessed by direct observation. We dated periods of speleothem growth in a north-south transect of caves in Siberia to reconstruct the history of permafrost in past climate states. Speleothem growth is restricted to full interglacial conditions in all studied caves. In the northernmost cave (at 60 degrees N), no growth has occurred since Marine Isotopic Stage (MIS) 11. Growth at that time indicates that global climates only slightly warmer than today are sufficient to thaw extensive regions of permafrost.	[Vaks, A.; Mason, A. J.; Thomas, A. L.; Henderson, G. M.] Univ Oxford, Dept Earth Sci, Oxford OX1 3AN, England; [Gutareva, O. S.; Kononov, A. M.] Russian Acad Sci, Siberian Branch, Inst Earths Crust, Irkutsk 664033, Russia; [Breitenbach, S. F. M.] Swiss Fed Inst Technol Zurich ETH Zurich, CH-8092 Zurich, Switzerland; [Avirmed, E.] Mongolian Acad Sci, Inst Geog, Ulaanbaatar 210620, Mongolia	University of Oxford; Irkutsk Science Centre of the Russian Academy of Sciences; Institute of Earth's Crust of Siberian Branch of the Russian Academy of Sciences; Russian Academy of Sciences; Swiss Federal Institutes of Technology Domain; ETH Zurich; Mongolian Academy of Sciences	Vaks, A (corresponding author), Univ Oxford, Dept Earth Sci, Oxford OX1 3AN, England.	anton.vaks@earth.ox.ac.uk	Kononov, Aleksandr M/K-1614-2015; Breitenbach, Sebastian F.M./C-2529-2014; Breitenbach, Sebastian/AAB-1420-2019; Kononov, Michael/I-2413-2018; Gutareva, Oxana/GRO-0001-2022	Kononov, Aleksandr M/0000-0003-2379-4782; Kononov, Michael/0000-0002-3243-0342; Henderson, Gideon/0000-0002-6279-7137; Thomas, Alexander/0000-0002-0734-9593; Vaks, Anton/0000-0002-2982-5220	University of Oxford; NERC [NE/G013829/1]; Royal Society [JP080831]; Russian Foundation for Basic Research [09-05-92605 KO_a]; NERC [NE/K005057/1] Funding Source: UKRI; Natural Environment Research Council [NE/K005057/1, NE/G013829/1] Funding Source: researchfish	University of Oxford; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society(Royal Society of London); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This article is dedicated to the memory of Prof. Y. Trzhcinski, who during the last months of his life made a big effort to establish the cooperation between the University of Oxford and Institute of Earth's Crust (IEC) in Irkutsk. We thank D. Sokolnikov and other "Arabica" members, E. Kozireva (IEC), V. Alexioglo, and V. Balaev from Lensk for their help during the fieldwork in Siberia; the Mongolian Speleological Society for their help with the fieldwork in Mongolia; J. Fritz and L. Zehnder (ETH Zurich) for preparing Fig. 1 and for assistance with XRD analyses, respectively; and C. Day, V. Ersek, L. Zanna, P. Holdship, O. Green, S. Wyatt, Y. Nakajima, P. Pousada Solino, J. Cox, S. Usher, M. Chung, and others from University of Oxford for the help with the laboratory work, administration and computing issues, obtainment of funding, and fruitful discussions. Supported by NERC Fellowship NE/G013829/1, Royal Society grant JP080831, and Russian Foundation for Basic Research joint grant 09-05-92605 KO_a.	Anisimov O, 2006, AMBIO, V35, P169, DOI 10.1579/0044-7447(2006)35[169:PACCTR]2.0.CO;2; [Anonymous], 2007, PHILIPS MODERN SCH A; Brown J., 2001, CIRCUM ARCTIC MAP PE; Cliff RA, 2010, QUAT GEOCHRONOL, V5, P452, DOI 10.1016/j.quageo.2009.12.002; de Vernal A, 2008, SCIENCE, V320, P1622, DOI 10.1126/science.1153929; Dickson AJ, 2009, NAT GEOSCI, V2, P428, DOI 10.1038/NGEO527; Dorjotov D., 2004, GEOGRAPHIC ATALS MON; Gilichinsky DA, 2007, QUATERNARY SCI REV, V26, P1547, DOI 10.1016/j.quascirev.2007.04.004; Grosse G., 2011, EOS T AM GEOPHYS UN, V92, P73, DOI [10.1002/ppp.689.Rowland, DOI 10.1029/2011EO090001, 10.1029/2011EO090001]; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Jones A, 2010, SOIL ATLAS NO CIRCUM; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lauriol B, 1997, CAN J EARTH SCI, V34, P902, DOI 10.1139/e17-075; LAURITZEN SE, 1995, QUATERNARY RES, V43, P133, DOI 10.1006/qres.1995.1015; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001071; Loulergue L, 2008, NATURE, V453, P383, DOI 10.1038/nature06950; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Mackay AW, 2008, J QUATERNARY SCI, V23, P365, DOI 10.1002/jqs.1174; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Medina-Elizalde M, 2005, SCIENCE, V310, P1009, DOI 10.1126/science.1115933; Melles M, 2012, SCIENCE, V337, P315, DOI 10.1126/science.1222135; Nowaczyk NR, 2002, GEOPHYS J INT, V150, P109, DOI 10.1046/j.1365-246X.2002.01625.x; Ortlieb L, 1996, QUATERNARY SCI REV, V15, P857, DOI 10.1016/S0277-3791(96)00062-5; Prokopenko AA, 2001, QUATERNARY RES, V55, P123, DOI 10.1006/qres.2000.2212; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Raymo ME, 2012, NATURE, V483, P453, DOI 10.1038/nature10891; Romanovsky VE, 2010, PERMAFROST PERIGLAC, V21, P106, DOI 10.1002/ppp.689; Schuur EAG, 2008, BIOSCIENCE, V58, P701, DOI 10.1641/B580807; Schwarcz H.P., 1986, HDB ENV ISOTOPE GEOC, V2, P271; Vaks A, 2010, QUATERNARY SCI REV, V29, P2647, DOI 10.1016/j.quascirev.2010.06.014; Vasil'chuk YK, 2004, NUCL INSTRUM METH B, V223, P650, DOI 10.1016/j.nimb.2004.04.120; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; Wu NQ, 2007, QUATERNARY SCI REV, V26, P1884, DOI 10.1016/j.quascirev.2007.04.006	33	78	81	2	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129					183	186		10.1126/science.1228729	http://dx.doi.org/10.1126/science.1228729			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23429705	Green Submitted, Green Published			2022-12-28	WOS:000317341400052
J	Alivisatos, AP; Chun, MY; Church, GM; Deisseroth, K; Donoghue, JP; Greenspan, RJ; McEuen, PL; Roukes, ML; Sejnowski, TJ; Weiss, PS; Yuste, R				Alivisatos, A. Paul; Chun, Miyoung; Church, George M.; Deisseroth, Karl; Donoghue, John P.; Greenspan, Ralph J.; McEuen, Paul L.; Roukes, Michael L.; Sejnowski, Terrence J.; Weiss, Paul S.; Yuste, Rafael			The Brain Activity Map	SCIENCE			English	Editorial Material									[Alivisatos, A. Paul] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Alivisatos, A. Paul] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Chun, Miyoung] Kavli Fdn, Oxnard, CA 93030 USA; [Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Church, George M.] Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA; [Donoghue, John P.] Vet Affairs Med Ctr, Rehabil Res & Dev Serv, Providence, RI 02908 USA; [Donoghue, John P.] Brown Univ, Dept Neurosci, Brown Inst Brain Sci, Providence, RI 02912 USA; [Donoghue, John P.] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Greenspan, Ralph J.] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA; [McEuen, Paul L.] Cornell Univ, Dept Phys, Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14850 USA; [Roukes, Michael L.] CALTECH, Kavli Nanosci Inst, Pasadena, CA 91125 USA; [Roukes, Michael L.] CALTECH, Dept Phys, Pasadena, CA 91125 USA; [Roukes, Michael L.] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Roukes, Michael L.] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA; [Sejnowski, Terrence J.] Salk Inst Biol Studies, Computat Neurobiol Lab, HHMI, La Jolla, CA 92037 USA; [Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Weiss, Paul S.] Univ Calif Los Angeles, Dept Chem & Biochem, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Weiss, Paul S.] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; [Yuste, Rafael] Columbia Univ, Kavli Inst Brain Sci, Dept Biol Sci & Neurosci, HHMI, New York, NY 10027 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University; Brown University; University of California System; University of California San Diego; Cornell University; California Institute of Technology; California Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Columbia University; Howard Hughes Medical Institute	Alivisatos, AP (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA.	alivis@berkeley.edu; terry@salk.edu; rafaelyuste@columbia.edu	Alivisatos, Paul/N-8863-2015; Sejnowski, Terrence/AAV-5558-2021; Weiss, Paul/P-8016-2019; Weiss, Paul S/A-2575-2011	Alivisatos, Paul/0000-0001-6895-9048; Weiss, Paul/0000-0001-5527-6248; Weiss, Paul S/0000-0001-5527-6248; church, george/0000-0001-6232-9969	Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [DP1 EY024503] Funding Source: Medline; NIGMS NIH HHS [DP1 GM105376] Funding Source: Medline; NATIONAL EYE INSTITUTE [DP1EY024503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM105376] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; Andrews AM, 2012, ACS NANO, V6, P8463, DOI 10.1021/nn304724q; Battelle, 2011, EC IMP HUM GEN PROJ; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Koch C, 2012, NATURE, V483, P397, DOI 10.1038/483397a; Lozano AM, 2012, J NEUROSURG, V116, P315, DOI 10.3171/2011.10.JNS102122	6	144	152	4	200	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1284	1285		10.1126/science.1236939	http://dx.doi.org/10.1126/science.1236939			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23470729	Green Accepted			2022-12-28	WOS:000316053400025
J	Awschalom, DD; Bassett, LC; Dzurak, AS; Hu, EL; Petta, JR				Awschalom, David D.; Bassett, Lee C.; Dzurak, Andrew S.; Hu, Evelyn L.; Petta, Jason R.			Quantum Spintronics: Engineering and Manipulating Atom-Like Spins in Semiconductors	SCIENCE			English	Review							SOLID-STATE SPIN; SINGLE-SHOT READOUT; ELECTRON-SPIN; NUCLEAR-SPIN; DOT SPIN; COHERENT MANIPULATION; COUPLED ELECTRON; DIAMOND; SILICON; ENTANGLEMENT	The past decade has seen remarkable progress in isolating and controlling quantum coherence using charges and spins in semiconductors. Quantum control has been established at room temperature, and electron spin coherence times now exceed several seconds, a nine-order-of-magnitude increase in coherence compared with the first semiconductor qubits. These coherence times rival those traditionally found only in atomic systems, ushering in a new era of ultracoherent spintronics. We review recent advances in quantum measurements, coherent control, and the generation of entangled states and describe some of the challenges that remain for processing quantum information with spins in semiconductors.	[Awschalom, David D.; Bassett, Lee C.] Univ Calif Santa Barbara, Ctr Spintron & Quantum Computat, Santa Barbara, CA 93106 USA; [Dzurak, Andrew S.] Univ New S Wales, Ctr Quantum Computat & Commun Technol, Sch Elect Engn & Telecommun, Sydney, NSW 2052, Australia; [Hu, Evelyn L.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Petta, Jason R.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	University of California System; University of California Santa Barbara; University of New South Wales Sydney; Harvard University; Princeton University	Awschalom, DD (corresponding author), Univ Calif Santa Barbara, Ctr Spintron & Quantum Computat, Santa Barbara, CA 93106 USA.	awsch@physics.ucsb.edu	Dzurak, Andrew S/C-5973-2009; Petta, Jason R/J-6663-2013; Hu, Evelyn/AAD-8459-2019; Bassett, Lee/AAD-6466-2019	Dzurak, Andrew S/0000-0003-1389-5096; Petta, Jason R/0000-0002-6416-0789; Bassett, Lee/0000-0001-8729-1530	Air Force Office of Scientific Research; Defense Advanced Research Projects Agency (DARPA); Australian Research Council [CE11E0096]; U.S. Army Research Office [W911NF-08-1-0527]; Army Research Office [W911NF-08-1-0189]; NSF [DMR-0819860, DMR-0846341]; DARPA QuEST grant [HR0011-09-1-0007]; Sloan Foundation; Packard Foundation	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Australian Research Council(Australian Research Council); U.S. Army Research Office; Army Research Office; NSF(National Science Foundation (NSF)); DARPA QuEST grant; Sloan Foundation(Alfred P. Sloan Foundation); Packard Foundation(The David & Lucile Packard Foundation)	D.D.A., L.C.B., and E.L.H. acknowledge support from the Air Force Office of Scientific Research and the Defense Advanced Research Projects Agency (DARPA); A.S.D. from the Australian Research Council (project CE11E0096) and the U.S. Army Research Office (contract W911NF-08-1-0527); and J.R.P. from the Sloan and Packard Foundations, Army Research Office grant W911NF-08-1-0189, NSF grants DMR-0819860 and DMR-0846341, and DARPA QuEST grant HR0011-09-1-0007.	Aharonovich I, 2011, NAT PHOTONICS, V5, P397, DOI [10.1038/NPHOTON.2011.54, 10.1038/nphoton.2011.54]; Balasubramanian G, 2009, NAT MATER, V8, P383, DOI [10.1038/nmat2420, 10.1038/NMAT2420]; Bassett LC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.266403; Berezovsky J, 2008, SCIENCE, V320, P349, DOI 10.1126/science.1154798; Bluhm H, 2011, NAT PHYS, V7, P109, DOI 10.1038/NPHYS1856; Bose S, 2007, CONTEMP PHYS, V48, P13, DOI 10.1080/00107510701342313; Buckley BB, 2010, SCIENCE, V330, P1212, DOI 10.1126/science.1196436; Childress L, 2006, SCIENCE, V314, P281, DOI 10.1126/science.1131871; De Greve K, 2012, NATURE, V491, P421, DOI 10.1038/nature11577; de Lange G, 2010, SCIENCE, V330, P60, DOI 10.1126/science.1192739; DiCarlo L, 2010, NATURE, V467, P574, DOI 10.1038/nature09416; Fuchs GD, 2011, NAT PHYS, V7, P789, DOI 10.1038/nphys2026; Fuchs GD, 2010, NAT PHYS, V6, P668, DOI 10.1038/NPHYS1716; Fushman I, 2008, SCIENCE, V320, P769, DOI 10.1126/science.1154643; Dutt MVG, 2007, SCIENCE, V316, P1312, DOI 10.1126/science.1139831; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Hanson R, 2008, NATURE, V453, P1043, DOI 10.1038/nature07129; Hennessy K, 2007, NATURE, V445, P896, DOI 10.1038/nature05586; Hermelin S, 2011, NATURE, V477, P435, DOI 10.1038/nature10416; Jelezko F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.076401; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Koehl WF, 2011, NATURE, V479, P84, DOI 10.1038/nature10562; Ladd TD, 2010, PHYS STATUS SOLIDI B, V247, P1543, DOI 10.1002/pssb.200983258; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Maune BM, 2012, NATURE, V481, P344, DOI 10.1038/nature10707; Maurer PC, 2012, SCIENCE, V336, P1283, DOI 10.1126/science.1220513; McNeil RPG, 2011, NATURE, V477, P439, DOI 10.1038/nature10444; Moore G. E., 1965, ELECTRONICS, V38, P1, DOI DOI 10.1109/JPROC.1998.658762; Morello A, 2010, NATURE, V467, P687, DOI 10.1038/nature09392; Morton JJL, 2011, NATURE, V479, P345, DOI 10.1038/nature10681; Nadj-Perge S, 2010, NATURE, V468, P1084, DOI 10.1038/nature09682; Neumann P, 2010, SCIENCE, V329, P542, DOI 10.1126/science.1189075; Petersson KD, 2012, NATURE, V490, P380, DOI 10.1038/nature11559; Petta JR, 2010, SCIENCE, V327, P669, DOI 10.1126/science.1183628; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Pfaff W, 2013, NAT PHYS, V9, P29, DOI [10.1038/nphys2444, 10.1038/NPHYS2444]; Pla JJ, 2012, NATURE, V489, P541, DOI 10.1038/nature11449; Press D, 2008, NATURE, V456, P218, DOI 10.1038/nature07530; Rabl P, 2010, NAT PHYS, V6, P602, DOI 10.1038/NPHYS1679; Raussendorf R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.190504; Reithmaier JP, 2004, NATURE, V432, P197, DOI 10.1038/nature02969; Robledo L, 2011, NATURE, V477, P574, DOI 10.1038/nature10401; Ryan CA, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.200402; Shulman MD, 2012, SCIENCE, V336, P202, DOI 10.1126/science.1217692; Steger M, 2012, SCIENCE, V336, P1280, DOI 10.1126/science.1217635; Togan E, 2010, NATURE, V466, P730, DOI 10.1038/nature09256; Toyli DM, 2010, NANO LETT, V10, P3168, DOI 10.1021/nl102066q; Trifunovic L, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.011006; Tyryshkin AM, 2012, NAT MATER, V11, P143, DOI [10.1038/nmat3182, 10.1038/NMAT3182]; Vahala KJ, 2003, NATURE, V424, P839, DOI 10.1038/nature01939; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Weber JR, 2010, P NATL ACAD SCI USA, V107, P8513, DOI 10.1073/pnas.1003052107	56	520	534	20	558	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2013	339	6124					1174	1179		10.1126/science.1231364	http://dx.doi.org/10.1126/science.1231364			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471400				2022-12-28	WOS:000315709900039
J	Winthrop, KL; Baddley, JW; Chen, L; Liu, LY; Grijalva, CG; Delzell, E; Beukelman, T; Patkar, NM; Xie, FL; Saag, KG; Herrinton, LJ; Solomon, DH; Lewis, JD; Curtis, JR				Winthrop, Kevin L.; Baddley, John W.; Chen, Lang; Liu, Liyan; Grijalva, Carlos G.; Delzell, Elizabeth; Beukelman, Timothy; Patkar, Nivedita M.; Xie, Fenglong; Saag, Kenneth G.; Herrinton, Lisa J.; Solomon, Daniel H.; Lewis, James D.; Curtis, Jeffrey R.			Association Between the Initiation of Anti-Tumor Necrosis Factor Therapy and the Risk of Herpes Zoster	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; RHEUMATOID-ARTHRITIS; INFECTION; SAFETY; VACCINATION; IMPACT; RATES	Importance Herpes zoster reactivation disproportionately affects patients with rheumatoid arthritis (RA). It is unclear whether anti-tumor necrosis factor (anti-TNF) therapy elevates herpes zoster risk. Objectives To ascertain whether initiation of anti-TNF therapy compared with non-biologic comparators is associated with increased herpes zoster risk. Design, Setting, and Patients We identified new users of anti-TNF therapy among cohorts of patients with RA, inflammatory bowel disease, and psoriasis, psoriatic arthritis, or ankylosing spondylitis from 1998 through 2007 within a large US multi-institutional collaboration combining data from Kaiser Permanente Northern California, Pharmaceutical Assistance Contract for the Elderly, Tennessee Medicaid, and national Medicaid/Medicare programs. We compared herpes zoster incidence between new anti-TNF users (n=33,324) and patients initiating nonbiologic disease-modifying antirheumatic drugs (DMARDs) (n=25 742) within each inflammatory disease cohort (last participant follow-up December 31, 2007). Within these cohorts, we used Cox regression models to compare propensity score-adjusted herpes zoster incidence between new anti-TNF and nonbiologic DMARD users while controlling for baseline corticosteroid use. Main Outcome Measures Incidence of herpes zoster cases occurring after initiation of new anti-TNF or nonbiologic DMARD therapy. Results Among 33 324 new users of anti-TNF therapy, we identified 310 herpes zoster cases. Crude incidence rates among anti-TNF users were 12.1 per 1000 patient-years (95% CI, 10.7-13.6) for RA, 11.3 per 1000 patient-years (95% CI, 7.7-16.7) for inflammatory bowel disease, and 4.4 per 1000 patient-years (95% CI, 2.8-7.0) for psoriasis, psoriatic arthritis, or ankylosing spondylitis. Baseline use of corticosteroids of 10 mg/d or greater among all disease indications was associated with elevated risk (adjusted hazard ratio [HR], 2.13 [95% CI, 1.64-2.75]) compared with no baseline use. For patients with RA, adjusted incidence rates were similar between anti-TNF and nonbiologic DMARD initiators (adjusted HR, 1.00 [95% CI, 0.77-1.29]) and comparable between all 3 anti-TNF therapies studied. Across all disease indications, the adjusted HR was 1.09 (95% CI, 0.88-1.36). Conclusion and Relevance Among patients with RA and other inflammatory diseases, those who initiated anti-TNF therapies were not at higher risk of herpes zoster compared with patients who initiated nonbiologic treatment regimens. JAMA. 2013;309(9):887-895 www.jama.com	[Winthrop, Kevin L.] Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR 97239 USA; [Winthrop, Kevin L.] Oregon Hlth & Sci Univ, Div Publ Hlth & Prevent Med, Portland, OR 97239 USA; [Winthrop, Kevin L.] Oregon Hlth & Sci Univ, Div Ophthalmol, Portland, OR 97239 USA; [Baddley, John W.; Chen, Lang; Delzell, Elizabeth; Beukelman, Timothy; Patkar, Nivedita M.; Xie, Fenglong; Saag, Kenneth G.; Curtis, Jeffrey R.] Univ Alabama Birmingham, Dept Med, Birmingham, AL USA; [Liu, Liyan; Herrinton, Lisa J.] Kaiser Permanente No Calif, Ctr Hlth Res, Oakland, CA USA; [Grijalva, Carlos G.] Vanderbilt Univ, Dept Prevent Med, Nashville, TN USA; [Solomon, Daniel H.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Lewis, James D.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Alabama System; University of Alabama Birmingham; Kaiser Permanente; Vanderbilt University; Harvard University; Brigham & Women's Hospital; University of Pennsylvania	Winthrop, KL (corresponding author), Oregon Hlth & Sci Univ, Casey Eye Inst, 3375 SW Terwilliger Blvd, Portland, OR 97239 USA.	Winthrop@ohsu.edu		Grijalva, Carlos/0000-0002-2329-7797; Beukelman, Timothy/0000-0001-9463-6306	Pfizer; Amgen; National Institutes of Health; Novartis; Genentech; Horizon; Merck; Apollo Health Resources Ltd; Centocor; Procter and Gamble; Lilly; Consortium of Rheumatology Researchers of North America Inc.; Takeda; Shire; Roche/Genentech; UCB Pharma; Bristol-Myers Squibb; Crescendo; Abbott; US Food and Drug Administration (FDA); US Department of Health and Human Services (DHHS); Agency for Healthcare Research and Quality (AHRQ) [U18 HS17919]; AHRQ [1K08HS017552-01, R01HS018517]; National Institutes of Health (NIH) [AR053351]; NIH via the University of Alabama at Birmingham Center for Clinical and Translational Science [5KL2 RR025776-03]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [5P60AR56116]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS017919, K08HS017552, R01HS018517] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR053351, K24AR052361, P60AR056116] Funding Source: NIH RePORTER	Pfizer(Pfizer); Amgen(Amgen); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis(Novartis); Genentech(Roche HoldingGenentech); Horizon; Merck(Merck & Company); Apollo Health Resources Ltd; Centocor; Procter and Gamble(Procter & Gamble); Lilly(Eli Lilly); Consortium of Rheumatology Researchers of North America Inc.; Takeda(Takeda Pharmaceutical Company Ltd); Shire; Roche/Genentech(Roche HoldingGenentech); UCB Pharma(UCB Pharma SA); Bristol-Myers Squibb(Bristol-Myers Squibb); Crescendo(European Commission); Abbott(Abbott Laboratories); US Food and Drug Administration (FDA)(United States Department of Health & Human Services); US Department of Health and Human Services (DHHS); Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH via the University of Alabama at Birmingham Center for Clinical and Translational Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Winthrop reported that he has consulted for Genentech, Abbott, Pfizer, UCB Pharma, and Amgen and received research grant support from Pfizer. Dr Baddley reported that he has consulted for Pfizer and Merck. Dr Delzell reported that she has received research and other support from Amgen. Dr Grijalva reported that he has received research grant support from National Institutes of Health. Dr Beukelman reported that he has received research support from Pfizer and National Institutes of Health and consultant fees from Novartis and Genentech. Dr Saag reported that he has received research support from Amgen, Genentech, Horizon, Merck, National Institutes of Health, and Apollo Health Resources Ltd, consulted for Amgen, Abbott, Ardea, Lilly, Merck, Regeneron, Savient, and URL Pharma, and has served on the board for National Osteoporosis Foundation. Dr Herrinton reported that she has received research support from Centocor, Genentech, and Procter and Gamble and has served as an expert witness for Hoffman La Roche. Dr Solomon reported that he has received research support from Amgen, Lilly, and the Consortium of Rheumatology Researchers of North America Inc. He serves in unpaid roles on trials funded by Pfizer and Novartis. Dr Lewis reported that he has received research support from Centocor, Takeda, and Shire and consultant honoraria from Abbott, Amgen, Millennium Pharmaceuticals, Prometheus, and Pfizer. Dr Curtis reported that he has received consultant fees from Roche/Genentech, UCB Pharma, Centocor, Consortium of Rheumatology Researchers of North America Inc, Amgen, Pfizer, Bristol-Myers Squibb, Crescendo, and Abbott. No other disclosures were reported.; This work was supported by the US Food and Drug Administration (FDA), US Department of Health and Human Services (DHHS), and by grant U18 HS17919 from the Agency for Healthcare Research and Quality (AHRQ), administered through the AHRQ Centers for Education and Research on Therapeutics Program. Dr Winthrop's work on this article was funded by grant 1K08HS017552-01 from AHRQ. Dr Curtis was supported by grant AR053351 from the National Institutes of Health (NIH) and by grant R01HS018517 from AHRQ. Dr Beukelman was supported by grant 5KL2 RR025776-03 from NIH via the University of Alabama at Birmingham Center for Clinical and Translational Science. Dr Grijalva was supported by grant 5P60AR56116 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases.	Buttgereit F, 2002, ANN RHEUM DIS, V61, P718, DOI 10.1136/ard.61.8.718; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DONAHUE JG, 1995, ARCH INTERN MED, V155, P1605, DOI 10.1001/archinte.155.15.1605; Grijalva CG, 2011, JAMA-J AM MED ASSOC, V306, P2331, DOI 10.1001/jama.2011.1692; Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1; Herrinton LJ, 2011, PHARMACOEPIDEM DR S, V20, P1199, DOI 10.1002/pds.2196; Lin YC, 2012, ORAL ONCOL, V48, P535, DOI 10.1016/j.oraloncology.2012.01.008; McDonald JR, 2009, CLIN INFECT DIS, V48, P1364, DOI 10.1086/598331; Mullooly JP, 2005, EPIDEMIOL INFECT, V133, P245, DOI 10.1017/S095026880400281X; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Salmon-Ceron D, 2011, ANN RHEUM DIS, V70, P616, DOI 10.1136/ard.2010.137422; Schmader KE, 2002, CLIN J PAIN, V18, P350, DOI 10.1097/00002508-200211000-00002; Schmader KE, 2007, CLIN J PAIN, V23, P490, DOI 10.1097/AJP.0b013e318065b6c9; Schmader KE, 2012, CLIN INFECT DIS, V54, P922, DOI 10.1093/cid/cir970; Schmajuk G, 2011, JAMA-J AM MED ASSOC, V305, P480, DOI 10.1001/jama.2011.67; Smitten AL, 2007, ARTHRIT RHEUM-ARTHR, V57, P1431, DOI 10.1002/art.23112; Strangfeld A, 2011, ANN RHEUM DIS, V70, P1914, DOI 10.1136/ard.2011.151043; Strangfeld A, 2009, JAMA-J AM MED ASSOC, V301, P737, DOI 10.1001/jama.2009.146; Winthrop KL, 2010, ANN RHEUM DIS, V69, P1735, DOI 10.1136/ard.2010.133843; Winthrop KL, 2009, NAT REV RHEUMATOL, V5, P405, DOI 10.1038/nrrheum.2009.105; Yawn BP, 2007, MAYO CLIN PROC, V82, P1341, DOI 10.4065/82.11.1341; Zhang J, 2012, JAMA-J AM MED ASSOC, V308, P43, DOI 10.1001/jama.2012.7304; Zhang J, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3497	23	139	146	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2013	309	9					887	895		10.1001/jama.2013.1099	http://dx.doi.org/10.1001/jama.2013.1099			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099PC	23462785	Green Accepted, Green Published			2022-12-28	WOS:000315632700024
J	Wong, PF; Chong, LY; Stansby, G				Wong, Peng Foo; Chong, Lee-Yee; Stansby, Gerard			Antiplatelet Therapy to Prevent Cardiovascular Events and Mortality in Patients With Intermittent Claudication	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wong, Peng Foo] James Cook Univ Hosp, Dept Vasc Surg, Middlesbrough TS4 3BW, Cleveland, England; [Chong, Lee-Yee] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Stansby, Gerard] Freeman Rd Hosp, Dept Vasc Surg, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	James Cook University Hospital; Royal College of Physicians; Newcastle Freeman Hospital; Newcastle University - UK	Wong, PF (corresponding author), James Cook Univ Hosp, Dept Vasc Surg, Marton Rd, Middlesbrough TS4 3BW, Cleveland, England.	pwong23@hotmail.com		Wong, Peng/0000-0001-9906-9910; Stansby, Gerard/0000-0001-5539-3049				Alonso-Coello P, 2012, CHEST, V141, pE669S, DOI 10.1378/chest.11-2307; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bell AD, 2011, CAN J CARDIOL, V27, pS1, DOI 10.1016/j.cjca.2010.12.015; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; National Institute for Health and Clinical Excellence, 2010, CLOP MOD REL DIP PRE; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; Serneri GGN, 2004, EUR HEART J, V25, P1845, DOI 10.1016/j.ehj.2004.07.013; Wong PF, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001272.pub2	9	7	7	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2013	309	9					926	927		10.1001/jama.2013.1490	http://dx.doi.org/10.1001/jama.2013.1490			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099PC	23462789				2022-12-28	WOS:000315632700028
J	Davies, HTO; Mannion, R				Davies, Huw Talfryn Oakley; Mannion, Russell			Will prescriptions for cultural change improve the NHS?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ORGANIZATIONAL CULTURE; CARE; PERFORMANCE; MANAGEMENT; BLAME		[Davies, Huw Talfryn Oakley] Univ St Andrews, Sch Management, St Andrews KY16 9RJ, Fife, Scotland; [Mannion, Russell] Univ Birmingham, Hlth Serv Management Ctr, Birmingham B15 2RT, W Midlands, England	University of St Andrews; University of Birmingham	Davies, HTO (corresponding author), Univ St Andrews, Sch Management, St Andrews KY16 9RJ, Fife, Scotland.	hd@st-and.ac.uk		Davies, Huw/0000-0002-2653-3695; Mannion, Russell/0000-0002-0680-8049				Adler NE, 2009, MILBANK Q, V87, P49, DOI 10.1111/j.1468-0009.2009.00547.x; Ashkanasy N.M., 2000, HDB ORG CULTURE CLIM; Bate P., 2008, ORG QUALITY IMPROVEM; Braithwaite J, 2010, CULTURE CLIMATE HLTH; Davies HTO, 2000, QUAL HEALTH CARE, V9, P111, DOI 10.1136/qhc.9.2.111; Davies HTO, 2003, BMJ-BRIT MED J, V326, P646, DOI 10.1136/bmj.326.7390.646; Degeling P, 2003, BRIT MED J, V326, P649, DOI 10.1136/bmj.326.7390.649; Delamothe T, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f979; Exworthy M, 2002, POLICY POLIT, V30, P79, DOI 10.1332/0305573022501584; Francis R., 2013, REPORT MID STAFFORDS; Francis R., 2010, INDEPENDENT INQUIRY; Harrison S, 1992, JUST MANAGING POWER; Hosken A., 2013, BBC NEWS; Jacobs R, 2013, SOC SCI MED, V76, P115, DOI 10.1016/j.socscimed.2012.10.014; Jung T, 2009, PUBLIC ADMIN REV, V69, P1087, DOI 10.1111/j.1540-6210.2009.02066.x; Kennedy I, 2001, LEARNING BRISTOL REP; Kmietowicz Z, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f849; Mannion R, 2012, INTERN MED J, V42, P569, DOI 10.1111/j.1445-5994.2012.02766.x; Mannion Russell, 2005, J Health Serv Res Policy, V10, P18; Mannion R, 2009, J ROY SOC MED, V102, P332, DOI 10.1258/jrsm.2009.090066; Marshall M.N., 2004, CULTURES PERFORMANCE; Martin J., 2002, ORG CULTURE MAPPING; Morgan PI, 2008, HUM RELAT, V61, P39, DOI 10.1177/0018726707085945; Powell AE, 2012, SOC SCI MED, V75, P807, DOI 10.1016/j.socscimed.2012.03.049; Schein EH., 2010, ORG CULTURE LEADERSH; SCOTT JT, 2003, HEALTHCARE PERFORMAN; Scott T, 2003, INT J QUAL HEALTH C, V15, P111, DOI 10.1093/intqhc/mzg021; Scott Tim, 2003, J Health Serv Res Policy, V8, P105, DOI 10.1258/135581903321466085; Wachter RM, 2009, NEW ENGL J MED, V361, P1401, DOI 10.1056/NEJMsb0903885; Wilkinson J., 2011, ARE CLIN ENGAGED QUA	30	52	52	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2013	346								f1305	10.1136/bmj.f1305	http://dx.doi.org/10.1136/bmj.f1305			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	149WE	23457210	Green Submitted			2022-12-28	WOS:000319351300007
J	Dumesic, PA; Natarajan, P; Chen, CB; Drinnenberg, IA; Schiller, BJ; Thompson, J; Moresco, JJ; Yates, JR; Bartel, DP; Madhani, HD				Dumesic, Phillip A.; Natarajan, Prashanthi; Chen, Changbin; Drinnenberg, Ines A.; Schiller, Benjamin J.; Thompson, James; Moresco, James J.; Yates, John R., III; Bartel, David P.; Madhani, Hiten D.			Stalled Spliceosomes Are a Signal for RNAi-Mediated Genome Defense	CELL			English	Article							TRANSPOSABLE ELEMENTS; C-ELEGANS; GENE; PROTEIN; INTRON; YEAST; INTERFERENCE; EXPRESSION; EVOLUTION; INTERACTS	Using the yeast Cryptococcus neoformans, we describe a mechanism by which transposons are initially targeted for RNAi-mediated genome defense. We show that intron-containing mRNA precursors template siRNA synthesis. We identify a Spliceosome-Coupled And Nuclear RNAi (SCANR) complex required for siRNA synthesis and demonstrate that it physically associates with the spliceosome. We find that RNAi target transcripts are distinguished by suboptimal introns and abnormally high occupancy on spliceosomes. Functional investigations demonstrate that the stalling of mRNA precursors on spliceosomes is required for siRNA accumulation. Lariat debranching enzyme is also necessary for siRNA production, suggesting a requirement for processing of stalled splicing intermediates. We propose that recognition of mRNA precursors by the SCANR complex is in kinetic competition with splicing, thereby promoting siRNA production from transposon transcripts stalled on spliceosomes. Disparity in the strength of expression signals encoded by transposons versus host genes offers an avenue for the evolution of genome defense.	[Dumesic, Phillip A.; Natarajan, Prashanthi; Chen, Changbin; Schiller, Benjamin J.; Madhani, Hiten D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Drinnenberg, Ines A.; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Thompson, James; Moresco, James J.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	University of California System; University of California San Francisco; Massachusetts Institute of Technology (MIT); Whitehead Institute; Scripps Research Institute	Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	hitenmadhani@gmail.com		Moresco, James/0000-0003-1178-1642; Madhani, Hiten/0000-0001-7400-6657	National Center for Research Resources [5P41RR011823-17]; National Institute of General Medical Sciences [8 P41 GM103533-17]; National Institute on Aging [R01AG027463-04]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM061835, R01GM071801, P41GM103533, T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027463] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Madhani and Guthrie labs, P. O'Farrell, J. Reuter, and S. Coyle for critical reading of the manuscript and helpful discussions; N. Nguyen for media preparation; and X. Wang and J. Heitman for strains and plasmids. Mass spectrometry experiments were supported by the National Center for Research Resources (5P41RR011823-17), the National Institute of General Medical Sciences (8 P41 GM103533-17), and the National Institute on Aging (R01AG027463-04). P. A. D. and H. D. M. designed the study. C. C., I. A. D., and D. P. B. performed high-throughput sequencing shown in Figure 1. J. T., J. J. M., and J. R. Y. performed mass spectrometry analyses shown in Figures 2, 3, and 4. P. N. performed subcellular localization of tagged proteins shown in Figures 2, 3, 4, and S1. B. J. S. performed bioinformatic analyses shown in Figures 1, 5, and 7 and Tables S1 and S2. P. A. D. performed experiments shown in Figures 2, 3, 4, 5, 6, 7, S2, S3, and S4. P. A. D. and H. D. M. wrote the manuscript. All authors contributed to editing the manuscript.	Bayne EH, 2008, SCIENCE, V322, P602, DOI 10.1126/science.1164029; Behm-Ansmant I, 2006, COLD SPRING HARB SYM, V71, P523, DOI 10.1101/sqb.2006.71.013; Belancio VP, 2008, GENE, V411, P38, DOI 10.1016/j.gene.2007.12.022; Belancio VP, 2006, NUCLEIC ACIDS RES, V34, P1512, DOI 10.1093/nar/gkl027; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Burns C, 2005, FUNGAL GENET BIOL, V42, P191, DOI 10.1016/j.fgb.2004.11.005; Cam HP, 2009, CELL, V136, P610, DOI 10.1016/j.cell.2009.02.004; CELLINI A, 1986, EMBO J, V5, P1023, DOI 10.1002/j.1460-2075.1986.tb04317.x; CHAPMAN KB, 1991, CELL, V65, P483, DOI 10.1016/0092-8674(91)90466-C; Chua K, 2001, MOL CELL BIOL, V21, P1509, DOI 10.1128/MCB.21.5.1509-1514.2001; Chun CD, 2010, METHOD ENZYMOL, V470, P797, DOI 10.1016/S0076-6879(10)70033-1; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Conley AB, 2008, TRENDS GENET, V24, P53, DOI 10.1016/j.tig.2007.11.008; Connelly C, 1996, CELL, V86, P275, DOI 10.1016/S0092-8674(00)80099-9; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; GIERL A, 1990, TRENDS GENET, V6, P155, DOI 10.1016/0168-9525(90)90150-5; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Hogg R, 2010, BIOCHEM SOC T, V38, P1110, DOI 10.1042/BST0381110; Hughes SS, 2008, MOL BIOL EVOL, V25, P247, DOI 10.1093/molbev/msm220; Irimia M, 2007, TRENDS GENET, V23, P321, DOI 10.1016/j.tig.2007.04.001; Janbon G, 2010, FUNGAL GENET BIOL, V47, P1070, DOI 10.1016/j.fgb.2010.10.005; Kapitonov VV, 2004, DNA CELL BIOL, V23, P311, DOI 10.1089/104454904323090949; Kelly WG, 2007, CHROMOSOME RES, V15, P633, DOI 10.1007/s10577-007-1143-0; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Khurana JS, 2011, CELL, V147, P1551, DOI 10.1016/j.cell.2011.11.042; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Lu SH, 2003, RNA, V9, P618, DOI 10.1261/rna.5260303; Lugones LG, 1999, MOL MICROBIOL, V32, P681, DOI 10.1046/j.1365-2958.1999.01373.x; Maiti M, 2007, GENE DEV, V21, P590, DOI 10.1101/gad.1497607; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Mayas RM, 2010, P NATL ACAD SCI USA, V107, P10020, DOI 10.1073/pnas.0906022107; MENSSEN A, 1990, EMBO J, V9, P3051, DOI 10.1002/j.1460-2075.1990.tb07501.x; Nam K, 1997, MOL CELL BIOL, V17, P809, DOI 10.1128/MCB.17.2.809; Nolan T, 2008, NUCLEIC ACIDS RES, V36, P532, DOI 10.1093/nar/gkm1071; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; PURUGGANAN M, 1992, GENETICA, V86, P295, DOI 10.1007/BF00133728; Robert VJP, 2005, GENE DEV, V19, P782, DOI 10.1101/gad.332305; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; She XY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000624; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Tabach Y., 2012, NATURE; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Valencia P, 2008, P NATL ACAD SCI USA, V105, P3386, DOI 10.1073/pnas.0800250105; Wang XY, 2010, GENE DEV, V24, P2566, DOI 10.1101/gad.1970910; Warf MB, 2012, GENOME RES, V22, P1488, DOI 10.1101/gr.134841.111; Warnecke T, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r29; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141	50	117	121	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 28	2013	152	5					957	968		10.1016/j.cell.2013.01.046	http://dx.doi.org/10.1016/j.cell.2013.01.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23415457	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000315710300006
J	Wang, Q				Wang, Qiang			Nuclear safety lies in greater transparency	NATURE			English	Editorial Material									Chinese Acad Sci Urumqi, Western Res Ctr Energy & Ecoenvironm Policy, Xinjiang Inst Ecol & Geog, Xinjiang, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Wang, Q (corresponding author), Chinese Acad Sci Urumqi, Western Res Ctr Energy & Ecoenvironm Policy, Xinjiang Inst Ecol & Geog, Xinjiang, Peoples R China.	wang_q@ms.xjb.ac.cn	WANG, Qiang/F-4618-2011	WANG, Qiang/0000-0002-8751-8093					0	15	15	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2013	494	7438					403	403		10.1038/494403a	http://dx.doi.org/10.1038/494403a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23446380	Bronze			2022-12-28	WOS:000315661500004
J	Yang, J; Ortega-Hernandez, J; Butterfield, NJ; Zhang, XG				Yang, Jie; Ortega-Hernandez, Javier; Butterfield, Nicholas J.; Zhang, Xi-guang			Specialized appendages in fuxianhuiids and the head organization of early euarthropods	NATURE			English	Article							LIMULUS-POLYPHEMUS CHELICERATA; ARTHROPOD HEAD; NERVOUS-SYSTEM; EVOLUTION; ORIGIN; XIPHOSURA; PHYLOGENY; CHARACTER; CRUSTACEA; REGION	The organization of the head provides critical data for resolving the phylogenetic relationships and evolutionary history of extinct and extant euarthropods(1,2). The early Cambrian-period fuxianhuiids are regarded as basal representatives of stem-group Euarthropode(3-7), and their anterior morphology therefore offers key insights for reconstructing the ancestral condition of the euarthropod head(1-3,8-11) However, the paired post-antennal structures in Fuxianhuia protensa remain controversial(3,8,10); they have been interpreted as both 'great appendages'(1,2) and as gut diverticulae(4,12,13). Here we describe Chengjiangocaris kunmingensis sp. nov. and Fuxianhuia xiaoshibaensis sp. nov. from a new early Cambrian (Stage 3) fossil Lagerstatte in Yunnan, China. Numerous specimens of both species show a unique 'taphonomic dissection' of the anterodorsal head shield, revealing the cephalic organization in detail. We demonstrate the presence of a pair of specialized post-antennal appendages (SPAs) in the fuxianhuiid head, which attach at either side of the posteriorly directed mouth, behind the hypostome. Preserved functional articulations indicate a well-defined but restricted range of limb movement, suggestive of a simple type of sweep feeding. The organization of the SPAs in fuxianhuiids is incompatible with the (deutocerebral) anterior raptorial appendages of megacheirans(2,9,14,15), and argue against the presence of protocerebral limbs in the fuxianhuiids(1,2,9). The positions of the fuxianhuiid antennae and SPAs indicate that they are segmentally homologous to the deutocerebral and tritocerebral appendages of crown-group Euarthropoda respectively(2,11,16,17). These findings indicate that antenniform deutocerebral appendages with many podomeres are a plesiomorphic feature of the ancestral euarthropod head.	[Yang, Jie; Zhang, Xi-guang] Yunnan Univ, Key Lab Palaeobiol, Kunming 650091, Peoples R China; [Ortega-Hernandez, Javier; Butterfield, Nicholas J.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	Yunnan University; University of Cambridge	Zhang, XG (corresponding author), Yunnan Univ, Key Lab Palaeobiol, Kunming 650091, Peoples R China.	xgzhang@ynu.edu.cn	Butterfield, Nicholas/AAV-8215-2021	Butterfield, Nicholas/0000-0002-3046-7520	National Natural Science Foundation of China [41272027]; Ministry of Education of China [20115301110005]; CONACYT (Consejo Nacional de Ciencia y Tecnologia, Mexico); University of Cambridge Trusts; Darwin College, University of Cambridge	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); CONACYT (Consejo Nacional de Ciencia y Tecnologia, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Cambridge Trusts; Darwin College, University of Cambridge(University of Cambridge)	This study is supported by the National Natural Science Foundation of China (41272027), and the PhD Fund of the Ministry of Education of China (20115301110005). J.O.-H. is funded by CONACYT (Consejo Nacional de Ciencia y Tecnologia, Mexico), the University of Cambridge Trusts and Darwin College, University of Cambridge. We thank C. Shen, T. Lan and J.-B Hou for assistance in the field.	Bergstrom J, 2008, GFF, V130, P189; Bitsch J, 2010, ACTA ZOOL-STOCKHOLM, V91, P249, DOI 10.1111/j.1463-6395.2009.00402.x; Budd GE, 2002, NATURE, V417, P271, DOI 10.1038/417271a; Budd GE, 2008, PALAEONTOLOGY, V51, P561, DOI 10.1111/j.1475-4983.2008.00752.x; Budd GE, 2009, NATURE, V457, P812, DOI 10.1038/nature07890; CHEN JY, 1995, SCIENCE, V268, P1339, DOI 10.1126/science.268.5215.1339; Chen JY, 2004, LETHAIA, V37, P3, DOI 10.1080/00241160410004764; Daley AC, 2009, SCIENCE, V323, P1597, DOI 10.1126/science.1169514; Eriksson BJ, 2010, DEV GENES EVOL, V220, P117, DOI 10.1007/s00427-010-0329-1; Harzsch S, 2005, ARTHROPOD STRUCT DEV, V34, P327, DOI 10.1016/j.asd.2005.01.006; Harzsch S, 2000, ARTHROPOD STRUCT DEV, V29, P307, DOI 10.1016/S1467-8039(01)00015-9; Haug JT, 2012, PALAEONTOLOGY, V55, P369, DOI 10.1111/j.1475-4983.2011.01124.x; Hou X. -G., 2004, CAMBRIAN FOSSILS CHE; Hou Xianguang, 1997, Fossils and Strata, V45, P1; Legg DA, 2012, P ROY SOC B-BIOL SCI, V279, P4699, DOI 10.1098/rspb.2012.1958; Liu JN, 2011, NATURE, V470, P526, DOI 10.1038/nature09704; Liu Y, 2010, ARTHROPOD STRUCT DEV, V39, P382, DOI 10.1016/j.asd.2010.05.008; Liu Y, 2009, ARTHROPOD STRUCT DEV, V38, P401, DOI 10.1016/j.asd.2009.04.001; Ma XY, 2012, NATURE, V490, P258, DOI 10.1038/nature11495; Mittmann B, 2003, DEV GENES EVOL, V213, P9, DOI 10.1007/s00427-002-0285-5; Olesen Jorgen, 2009, Arthropod Systematics & Phylogeny, V67, P3; Popadic A, 1998, DEV GENES EVOL, V208, P142, DOI 10.1007/s004270050165; Posnien N, 2009, EVOL DEV, V11, P480, DOI 10.1111/j.1525-142X.2009.00356.x; Scholtz G, 2005, CRUSTACEAN ISS, V16, P139, DOI 10.1201/9781420037548.ch6; Scholtz G, 2006, DEV GENES EVOL, V216, P395, DOI 10.1007/s00427-006-0085-4; Stein M, 2010, ZOOL J LINN SOC-LOND, V158, P477, DOI 10.1111/j.1096-3642.2009.00562.x; Steinmetz PRH, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-14; Waloszek D, 2005, ARTHROPOD STRUCT DEV, V34, P189, DOI 10.1016/j.asd.2005.01.005; Waloszek D, 2007, PALAEOGEOGR PALAEOCL, V254, P273, DOI 10.1016/j.palaeo.2007.03.027	29	77	78	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2013	494	7438					468	471		10.1038/nature11874	http://dx.doi.org/10.1038/nature11874			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23446418				2022-12-28	WOS:000315661500036
J	Miller, E; Andrews, N; Stellitano, L; Stowe, J; Marie, A; Shneerson, J; Verity, C				Miller, Elizabeth; Andrews, Nick; Stellitano, Lesley; Stowe, Julia; Marie, Anne; Shneerson, John; Verity, Christopher			Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EPIDEMIOLOGY; COHORT; H1N1	Objective To evaluate the risk of narcolepsy in children and adolescents in England targeted for vaccination with ASO3 adjuvanted pandemic A/H1N1 2009 vaccine (Pandemrix) from October 2009. Design Retrospective analysis. Clinical information and results of sleep tests were extracted from hospital notes between August 2011 and February 2012 and reviewed by an expert panel to confirm the diagnosis. Vaccination and clinical histories were obtained from general practitioners. Setting Sleep centres and paediatric neurology centres in England. Participants Children and young people aged 4-18 with onset of narcolepsy from January 2008. Main outcome measures The odds of vaccination in those with narcolepsy compared with the age matched English population after adjustment for clinical conditions that were indications for vaccination. The incidence of narcolepsy within six months of vaccination compared with the incidence outside this period measured with the self controlled cases series method. Results Case notes for 245 children and young people were reviewed; 75 had narcolepsy (56 with cataplexy) and onset after 1 January 2008. Eleven had been vaccinated before onset; seven within six months. In those with a diagnosis by July 2011 the odds ratio was 14.4 (95% confidence interval 4.3 to 48.5) for vaccination at any time before onset and 16.2 (3.1 to 84.5) for vaccination within six months before onset. The relative incidence from the self controlled cases series analysis in those with a diagnosis by July 2011 with onset from October 2008 to December 2010 was 9.9 (2.1 to 47.9). The attributable risk was estimated as between 1 in 57 500 and 1 in 52 000 doses. Conclusion The increased risk of narcolepsy after vaccination with ASO3 adjuvanted pandemic A/H1N1 2009 vaccine indicates a causal association, consistent with findings from Finland. Because of variable delay in diagnosis, however, the risk might be overestimated by more rapid referral of vaccinated children.	[Miller, Elizabeth; Stellitano, Lesley; Stowe, Julia; Marie, Anne; Verity, Christopher] Hlth Protect Agcy, Immunisat Hepatitis & Blood Safety Dept, London NW9 5EQ, England; [Andrews, Nick] Hlth Protect Agcy, Stat Modelling & Econ Dept, London NW9 5EQ, England; [Stellitano, Lesley; Marie, Anne; Verity, Christopher] Addenbrookes Hosp, PIND Res Grp, Cambridge CB2 0QQ, England; [Stowe, Julia] UCL, Gen & Adolescent Paediat Unit, Inst Child Hlth, London NW1 2PF, England; [Shneerson, John] Papworth Hosp, Resp Support & Sleep Ctr, Cambridge CB23 3RE, England	Health Protection Agency; Health Protection Agency; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; Papworth Hospital	Miller, E (corresponding author), Hlth Protect Agcy, Immunisat Hepatitis & Blood Safety Dept, London NW9 5EQ, England.	liz.miller@hpa.org.uk		Stowe, Julia/0000-0002-3999-6461	Department of Health; Health Protection Agency; Department of Health research and development directorate [039/0031]	Department of Health; Health Protection Agency; Department of Health research and development directorate	The study was funded by the Department of Health policy research programme and the Health Protection Agency. The views expressed in the publication are those of the authors and not necessarily those of the Department of Health, England. The funding source had no role in data collection, data analysis, data interpretation, or writing of the report. CV, JS, AMW, and LS were supported by a grant from the Department of Health research and development directorate (No 039/0031).	ALLSOPP MR, 1992, ARCH DIS CHILD, V67, P302, DOI 10.1136/adc.67.3.302; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Andrews N, 2012, BIOLOGICALS, V40, P389, DOI 10.1016/j.biologicals.2011.08.010; [Anonymous], 2010, PANDEMIC H1N1 SWINE; Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; Bardage C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5956; Chief Medical Officer's Update, 2009, H1N1 SWIN FLU VACC P; Dauvilliers Y, 2010, SLEEP, V33, P1428, DOI 10.1093/sleep/33.11.1428; Doherty L, 2010, Ir Med J, V103, P112; Doherty L, 2010, IRAN MED J, V103, P112; European Medicines Agency, 2011, PAND ASS REP; Farrington CP, 2004, VACCINE, V22, P2064, DOI 10.1016/j.vaccine.2004.01.017; Farrington CP, 1996, AM J EPIDEMIOL, V143, P1165; Fleming DM, 2010, J PUBLIC HEALTH-UK, V32, P90, DOI 10.1093/pubmed/fdp087; Furuta H, 2001, PSYCHIAT CLIN NEUROS, V55, P241, DOI 10.1046/j.1440-1819.2001.00841.x; Global Advisory Committee on Vaccine Safety, 2011, STAT NARC VACC; Han F, 2011, ANN NEUROL, V70, P410, DOI 10.1002/ana.22587; Hardelid P, 2012, VACCINE, V30, P1371, DOI 10.1016/j.vaccine.2011.12.038; Longstreth WT, 2007, SLEEP, V30, P13, DOI 10.1093/sleep/30.1.13; Medical Products Agency, OCC NARC CAT CHILDR; Morrish E, 2004, SLEEP MED, V5, P37, DOI 10.1016/j.sleep.2003.06.002; National Institute for Health and Welfare recommends discontinuation of Pandemrix vaccinations. National Institute for Health and Welfare, 2010, NAT I HLTH WELF REC; National Narcolepsy Study Steering Committee, INV INCR INC NARC CH; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; Partinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033723; Picchioni D, 2007, NEUROEPIDEMIOLOGY, V29, P185, DOI 10.1159/000111581; Population Estimates Unit, 2009, EST RES POP MID 2009; Salisbury D, 2006, IMMUNISATION INFECT, P193; Silber MH, 2002, SLEEP, V25, P197, DOI 10.1093/sleep/25.2.197; Wijnans L, 2013, VACCINE, V31, P1246, DOI 10.1016/j.vaccine.2012.12.015	30	192	194	0	33	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2013	346								f794	10.1136/bmj.f794	http://dx.doi.org/10.1136/bmj.f794			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100BJ	23444425	hybrid			2022-12-28	WOS:000315669400023
J	Mohr, FW; Morice, MC; Kappetein, AP; Feldman, TE; Stahle, E; Colombo, A; Mack, MJ; Holmes, DR; Morel, MA; Van Dyck, N; Houle, VM; Dawkins, KD; Serruys, PW				Mohr, Friedrich W.; Morice, Marie-Claude; Kappetein, A. Pieter; Feldman, Ted E.; Stahle, Elisabeth; Colombo, Antonio; Mack, Michael J.; Holmes, David R., Jr.; Morel, Marie-angele; Van Dyck, Nic; Houle, Vicki M.; Dawkins, Keith D.; Serruys, Patrick W.			Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial	LANCET			English	Article							DRUG-ELUTING STENTS; MULTIVESSEL DISEASE; DIABETIC-PATIENTS; REVASCULARIZATION THERAPIES; SURGICAL REVASCULARIZATION; OUTCOMES; ANGIOPLASTY; STRATEGIES; STENOSIS; IMPLANTATION	Background We report the 5-year results of the SYNTAX trial, which compared coronary artery bypass graft surgery (CABG) with percutaneous coronary intervention (PCI) for the treatment of patients with left main coronary disease or three-vessel disease, to confirm findings at 1 and 3 years. Methods The randomised, clinical SYNTAX trial with nested registries took place in 85 centres in the USA and Europe. A cardiac surgeon and interventional cardiologist at each centre assessed consecutive patients with de-novo three-vessel disease or left main coronary disease to determine suitability for study treatments. Eligible patients suitable for either treatment were randomly assigned (1: 1) by an interactive voice response system to either PCI with a first-generation paclitaxel-eluting stent or to CABG. Patients suitable for only one treatment option were entered into either the PCI-only or CABG-only registries. We analysed a composite rate of major adverse cardiac and cerebrovascular events (MACCE) at 5-year follow-up by Kaplan-Meier analysis on an intention-to-treat basis. This study is registered with ClinicalTrials.gov, number NCT00114972. Findings 1800 patients were randomly assigned to CABG (n=897) or PCI (n=903). More patients who were assigned to CABG withdrew consent than did those assigned to PCI (50 vs 11). After 5 years' follow-up, Kaplan-Meier estimates of MACCE were 26.9% in the CABG group and 37.3% in the PCI group (p<0.0001). Estimates of myocardial infarction (3.8% in the CABG group vs 9.7% in the PCI group; p<0.0001) and repeat revascularisation (13.7% vs 25.9%; p<0.0001) were significantly increased with PCI versus CABG. All-cause death (11.4% in the CABG group vs 13.9% in the PCI group; p=0.10) and stroke (3.7% vs 2.4%; p=0.09) were not significantly different between groups. 28.6% of patients in the CABG group with low SYNTAX scores had MACCE versus 32.1% of patients in the PCI group (p=0.43) and 31.0% in the CABG group with left main coronary disease had MACCE versus 36.9% in the PCI group (p=0.12); however, in patients with intermediate or high SYNTAX scores, MACCE was significantly increased with PCI (intermediate score, 25.8% of the CABG group vs 36.0% of the PCI group; p=0.008; high score, 26.8% vs 44.0%; p<0.0001). Interpretation CABG should remain the standard of care for patients with complex lesions (high or intermediate SYNTAX scores). For patients with less complex disease (low SYNTAX scores) or left main coronary disease (low or intermediate SYNTAX scores), PCI is an acceptable alternative. All patients with complex multivessel coronary artery disease should be reviewed and discussed by both a cardiac surgeon and interventional cardiologist to reach consensus on optimum treatment.	[Mohr, Friedrich W.] Univ Leipzig, Herzzentrum, D-04289 Leipzig, Germany; [Morice, Marie-Claude] Hop Pr Jacques Cartier, Massy, France; [Kappetein, A. Pieter; Serruys, Patrick W.] Erasmus Univ, Med Ctr Rotterdam, Rotterdam, Netherlands; [Feldman, Ted E.] Northwestern Univ, Evanston Hosp, Evanston, IL 60201 USA; [Stahle, Elisabeth] Univ Uppsala Hosp, Uppsala, Sweden; [Colombo, Antonio] Ist Sci San Raffaele, I-20132 Milan, Italy; [Mack, Michael J.] Baylor Healthcare Syst, Heart Hosp Baylor Plano, Dallas, TX USA; [Holmes, David R., Jr.] Mayo Clin, Rochester, MN USA; [Morel, Marie-angele] Cardialysis, Rotterdam, Netherlands; [Van Dyck, Nic; Houle, Vicki M.; Dawkins, Keith D.] Boston Sci, Natick, MA USA	Heart Center Leipzig GMBH; Leipzig University; Jacques Cartier Private Hospital; Erasmus University Rotterdam; Erasmus MC; NorthShore University Health System; Northwestern University; Uppsala University; Uppsala University Hospital; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Baylor Health Care System; Mayo Clinic; Cardialysis; Boston Scientific	Mohr, FW (corresponding author), Univ Leipzig, Herzzentrum, D-04289 Leipzig, Germany.	mohrf@medizin.uni-leipzig.de	Kappetein, Arie Pieter/B-5534-2008; Colombo, Antonio/N-2960-2015	Kappetein, Arie Pieter/0000-0003-3545-2229; Colombo, Antonio/0000-0002-2940-2455	Boston Scientific; Abbott	Boston Scientific(Boston Scientific); Abbott(Abbott Laboratories)	TEF has received consulting and lecture fees and research support from Boston Scientific and Abbott. NVD, VMH, and KDD own stock in and are full-time employees of Boston Scientific. All other authors declare that they have no conflicts of interest.	Bair TL, 2007, CIRCULATION, V116, pI226, DOI 10.1161/CIRCULATIONAHA.106.681346; Booth J, 2008, CIRCULATION, V118, P381, DOI 10.1161/CIRCULATIONAHA.107.739144; Boudriot E, 2011, J AM COLL CARDIOL, V57, P538, DOI 10.1016/j.jacc.2010.09.038; Buszman PE, 2008, J AM COLL CARDIOL, V51, P538, DOI 10.1016/j.jacc.2007.09.054; Chieffo A, 2010, JACC-CARDIOVASC INTE, V3, P595, DOI 10.1016/j.jcin.2010.03.014; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; Eagle Kim A, 2004, Circulation, V110, pe340; Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585; Farooq V, 2011, SEMIN THORAC CARDIOV, V23, P99, DOI 10.1053/j.semtcvs.2011.08.001; Favaloro R G, 1968, Ann Thorac Surg, V5, P334; Garg S, 2011, EUROINTERVENTION, V6, P1060, DOI 10.4244/EIJV6I9A185; GRUNTZIG AR, 1979, NEW ENGL J MED, V301, P61, DOI 10.1056/NEJM197907123010201; Hannan EL, 2008, NEW ENGL J MED, V358, P331, DOI 10.1056/NEJMoa071804; Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316; Hueb W, 2010, CIRCULATION, V122, P949, DOI 10.1161/CIRCULATIONAHA.109.911669; Kappetein AP, 2011, EUR HEART J, V32, P2125, DOI 10.1093/eurheartj/ehr213; Kapur A, 2010, J AM COLL CARDIOL, V55, P432, DOI 10.1016/j.jacc.2009.10.014; Kapur A, 2010, J CARDIOVASC MED, V11, P26, DOI 10.2459/JCM.0b013e328330ea32; Mauri L, 2012, NEW ENGL J MED, V366, P1538, DOI 10.1056/NEJMe1202866; Moshkovitz Y, 2012, ANN THORAC SURG, V94, P1455, DOI 10.1016/j.athoracsur.2012.05.026; Ong ATL, 2006, AM HEART J, V151, P1194, DOI 10.1016/j.ahj.2005.07.017; Park DW, 2011, J AM COLL CARDIOL, V57, P128, DOI 10.1016/j.jacc.2010.09.022; Park DW, 2010, J AM COLL CARDIOL, V56, P117, DOI 10.1016/j.jacc.2010.04.004; Park SJ, 2011, NEW ENGL J MED, V364, P1718, DOI 10.1056/NEJMoa1100452; Rodriguez AE, 2005, J AM COLL CARDIOL, V46, P582, DOI 10.1016/j.jacc.2004.12.081; Rodriguez Alfredo E, 2006, EuroIntervention, V2, P53; Serruys PW, 2012, JACC-CARDIOVASC INTE, V5, P606, DOI 10.1016/j.jcin.2012.03.016; Serruys PW, 2010, J AM COLL CARDIOL, V55, P1093, DOI 10.1016/j.jacc.2009.11.049; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Serruys PW, 2005, J AM COLL CARDIOL, V46, P575, DOI 10.1016/j.jacc.2004.12.082; Smith JM, 2006, INT J MED ROBOT COMP, V2, P197, DOI 10.1002/rcs.78; Smith PK, 2006, ANN THORAC SURG, V82, P1420, DOI 10.1016/j.athoracsur.2006.04.044; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; Weintraub WS, 2012, NEW ENGL J MED, V366, P1467, DOI 10.1056/NEJMoa1110717; Wu XF, 2010, AM J CARDIOL, V105, P1728, DOI 10.1016/j.amjcard.2010.01.353; Yan TD, 2011, J THORAC CARDIOV SUR, V141, P1134, DOI 10.1016/j.jtcvs.2010.07.001; Yi G, 2012, AM J CARDIOL, V109, P819, DOI 10.1016/j.amjcard.2011.10.045	37	1130	1233	3	115	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2013	381	9867					629	638		10.1016/S0140-6736(13)60141-5	http://dx.doi.org/10.1016/S0140-6736(13)60141-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	093JY	23439102				2022-12-28	WOS:000315189300033
J	Dicks, L				Dicks, Lynn			Bees, lies and evidence-based policy	NATURE			English	Editorial Material									Univ Cambridge, Nat Environm Res Council, Cambridge CB2 1TN, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Cambridge	Dicks, L (corresponding author), Univ Cambridge, Nat Environm Res Council, Cambridge CB2 1TN, England.	lvd22@cam.ac.uk	Dicks, Lynn V./AFH-5289-2022	Dicks, Lynn/0000-0002-8304-4468	Natural Environment Research Council [NE/J500665/1] Funding Source: researchfish; NERC [NE/J500665/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))			0	34	34	1	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					283	283		10.1038/494283a	http://dx.doi.org/10.1038/494283a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	095CS	23426287	Bronze			2022-12-28	WOS:000315312900004
J	Rider, T; Baig, I; Sayer, C; Crown, A				Rider, Tom; Baig, Irfan; Sayer, Charlie; Crown, Anna			PICTURE QUIZ Pathological finger fracture	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY HYPERPARATHYROIDISM; MANAGEMENT		[Rider, Tom; Baig, Irfan; Sayer, Charlie; Crown, Anna] Royal Sussex Cty Hosp, Brighton BN2 5BE, E Sussex, England	University of Brighton	Rider, T (corresponding author), Royal Sussex Cty Hosp, Brighton BN2 5BE, E Sussex, England.	bsms345@doctors.org.uk						Bilezikian JP, 2009, J CLIN ENDOCR METAB, V94, P335, DOI 10.1210/jc.2008-1763; BRASIER AR, 1988, AM J MED, V84, P654, DOI 10.1016/0002-9343(88)90100-3; Choi J, 2012, CANCER CONTROL, V19, P102, DOI 10.1177/107327481201900204; Hong WS, 2011, SKELETAL RADIOL, V40, P205, DOI 10.1007/s00256-010-0979-0; Marcocci C, 2011, NEW ENGL J MED, V365, P2389, DOI 10.1056/NEJMcp1106636; Pallan S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1013; Zamagni E, 2012, BRIT J HAEMATOL, V159, P499, DOI 10.1111/bjh.12007	7	1	1	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 20	2013	346								f1024	10.1136/bmj.f1024	http://dx.doi.org/10.1136/bmj.f1024			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096HL	23427124				2022-12-28	WOS:000315394700011
J	Edelaar, P				Edelaar, Pim			Comment on "Evolutionary Trade-Offs, Pareto Optimality, and the Geometry of Phenotype Space"	SCIENCE			English	Editorial Material								Shoval et al. (Reports, 1 June 2012, p. 1157) showed how configurations of phenotypes may identify tasks that trade off with each other, using randomizations assuming independence of data points. I argue that this assumption may not be correct for most and possibly all examples and led to pseudoreplication and inflated significance levels. Improved statistical testing is necessary to assess how the theory applies to empirical data.	[Edelaar, Pim] Univ Pablo Olavide, ES-41013 Seville, Spain; [Edelaar, Pim] Estn Biol Donana EBD CSIC, ES-41092 Seville, Spain	Universidad Pablo de Olavide; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Edelaar, P (corresponding author), Univ Pablo Olavide, Carretera Utrera Km 1, ES-41013 Seville, Spain.	edelaar@upo.es	Edelaar, Pim/P-5650-2014	Edelaar, Pim/0000-0003-4649-6366				Freckleton RP, 2009, J EVOLUTION BIOL, V22, P1367, DOI 10.1111/j.1420-9101.2009.01757.x; Harvey P.H., 1991, COMP METHOD EVOLUTIO; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; Quinn GP, 2003, EXPT DESIGN DATA ANA; Shoval O, 2012, SCIENCE, V336, P1157, DOI 10.1126/science.1217405; WILSON EO, 1980, BEHAV ECOL SOCIOBIOL, V7, P143, DOI 10.1007/BF00299520	6	6	6	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2013	339	6121								10.1126/science.1228281	http://dx.doi.org/10.1126/science.1228281			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	088YS	23413338				2022-12-28	WOS:000314874400024
J	Gomez, JA; Wapinski, OL; Yang, YW; Bureau, JF; Gopinath, S; Monack, DM; Chang, HY; Brahic, M; Kirkegaard, K				Gomez, J. Antonio; Wapinski, Orly L.; Yang, Yul W.; Bureau, Jean-Francois; Gopinath, Smita; Monack, Denise M.; Chang, Howard Y.; Brahic, Michel; Kirkegaard, Karla			The NeST Long ncRNA Controls Microbial Susceptibility and Epigenetic Activation of the Interferon-gamma Locus	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; THEILERS VIRUS-INFECTION; INTERGENIC NONCODING RNA; GENOME-WIDE ASSOCIATION; T-CELL SUBSET; GENE-EXPRESSION; SALMONELLA-TYPHIMURIUM; IFNG LOCUS; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS	Long noncoding RNAs (IncRNAs) are increasingly appreciated as regulators of cell-specific gene expression. Here, an enhancer-like IncRNA termed NeST (nettoie Salmonella pas Theiler's [cleanup Salmonella not Theiler's]) is shown to be causal for all phenotypes conferred by murine viral susceptibility locus Tmevp3. This locus was defined by crosses between SJL/J and B10.S mice and contains several candidate genes, including NeST. The SJL/J-derived locus confers higher IncRNA expression, increased interferon-gamma (IFN-gamma) abundance in activated CD8(+) T cells, increased Theiler's virus persistence, and decreased Salmonella enterica pathogenesis. Transgenic expression of NeST IncRNA alone was sufficient to confer all phenotypes of the SJL/J locus. NeST RNA was found to bind WDR5, a component of the histone H3 lysine 4 methyltransferase complex, and to alter histone 3 methylation at the IFN-gamma locus. Thus, this IncRNA regulates epigenetic marking of IFN-gamma-encoding chromatin, expression of IFN-gamma, and susceptibility to a viral and a bacterial pathogen.	[Gomez, J. Antonio; Gopinath, Smita; Monack, Denise M.; Brahic, Michel; Kirkegaard, Karla] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Wapinski, Orly L.; Yang, Yul W.; Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Bureau, Jean-Francois] Inst Pasteur, Dept Virol, F-75724 Paris 15, France	Stanford University; Howard Hughes Medical Institute; Stanford University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Kirkegaard, K (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	karlak@stanford.edu		Gopinath, Smita/0000-0003-3672-3780; Monack, Denise/0000-0003-3804-2209	Gates Foundation; Stanford University DARE program; National Science Foundation; Stanford Medical Science Training Program; NIH Training Grant; National Society for Multiple Sclerosis; Scleroderma Research Foundation; NIH Director's Pioneer Award; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000827] Funding Source: NIH RePORTER	Gates Foundation(Bill & Melinda Gates Foundation); Stanford University DARE program; National Science Foundation(National Science Foundation (NSF)); Stanford Medical Science Training Program; NIH Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Society for Multiple Sclerosis; Scleroderma Research Foundation; NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Holden Maecker, Roberto Mateo, and Peter Sarnow for comments on the manuscript. We also thank Laura Attardi for experimental advice, Nigel Killeen for plasmids, Mary Vadeboncoeur and Grete Sonderstrup for their transgenics expertise, Shyamalia Roy for Salmonella titering and the Human Immune Monitoring Core for Luminex assays. Individuals involved in this work were supported by scholarships from the Gates Foundation and the Stanford University DARE program (J.A.G.), the National Science Foundation (O.L.W.), the Stanford Medical Science Training Program (Y.W.Y.), and an NIH Training Grant (S.G.). H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute. Research funding was provided by the National Society for Multiple Sclerosis (K.K. and M.B.), the Scleroderma Research Foundation (H.Y.C.), and an NIH Director's Pioneer Award (K.K.).	Arpaia N, 2011, CELL, V144, P675, DOI 10.1016/j.cell.2011.01.031; Balasubramani A, 2010, IMMUNOL REV, V238, P216, DOI 10.1111/j.1600-065X.2010.00961.x; Bihl F, 1999, GENETICS, V152, P385; Brahic M, 2005, ANNU REV MICROBIOL, V59, P279, DOI 10.1146/annurev.micro.59.030804.121242; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; BUREAU JF, 1992, J VIROL, V66, P4698, DOI 10.1128/JVI.66.8.4698-4704.1992; BUREAU JF, 1993, NAT GENET, V5, P87, DOI 10.1038/ng0993-87; Cagliani R, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-171; Chang B, 2008, HUM MOL GENET, V17, P3929, DOI 10.1093/hmg/ddn295; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P17095, DOI 10.1073/pnas.0502129102; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Collier SP, 2012, J IMMUNOL, V189, P2084, DOI 10.4049/jimmunol.1200774; Davila E, 2005, J IMMUNOL, V174, P7292, DOI 10.4049/jimmunol.174.11.7292; Dean M, 2002, ANNU REV GENOM HUM G, V3, P263, DOI 10.1146/annurev.genom.3.022502.103149; Foster N, 2005, J INTERF CYTOK RES, V25, P31, DOI 10.1089/jir.2005.25.31; Frehel C, 2002, CELL MICROBIOL, V4, P541, DOI 10.1046/j.1462-5822.2002.00213.x; Frisullo G, 2010, HUM IMMUNOL, V71, P437, DOI 10.1016/j.humimm.2010.01.024; Goris A, 2002, GENES IMMUN, V3, P470, DOI 10.1038/sj.gene.6363913; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Joosten SA, 2007, P NATL ACAD SCI USA, V104, P8029, DOI 10.1073/pnas.0702257104; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Latiano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022688; Levillayer F, 2007, GENETICS, V176, P1835, DOI 10.1534/genetics.107.073536; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Martinat C, 2002, J VIROL, V76, P12823, DOI 10.1128/JVI.76.24.12823-12833.2002; MCALLISTER A, 1989, MICROB PATHOGENESIS, V7, P381, DOI 10.1016/0882-4010(89)90041-7; Miao EA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00085; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; O'Geen H, 2011, METHODS MOL BIOL, V791, P265, DOI 10.1007/978-1-61779-316-5_20; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Orozco G, 2005, HUM IMMUNOL, V66, P1235, DOI 10.1016/j.humimm.2006.02.003; Pereira MSF, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00033; Qureshi IA, 2010, BRAIN RES, V1338, P20, DOI 10.1016/j.brainres.2010.03.110; Rodriguez M, 2003, J VIROL, V77, P12252, DOI 10.1128/JVI.77.22.12252-12265.2003; Rossi CP, 1997, J VIROL, V71, P3336, DOI 10.1128/JVI.71.4.3336-3340.1997; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Sekimata M, 2009, IMMUNITY, V31, P551, DOI 10.1016/j.immuni.2009.08.021; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Singer SM, 1998, DIABETES, V47, P1570, DOI 10.2337/diabetes.47.10.1570; Sirota M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000792; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; SUBBAIAH TV, 1964, NATURE, V201, P1298, DOI 10.1038/2011298a0; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Trandem K, 2011, J IMMUNOL, V186, P3642, DOI 10.4049/jimmunol.1003292; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Vigneau S, 2003, J VIROL, V77, P5632, DOI 10.1128/JVI.77.10.5632-5638.2003; Vigneau S, 2001, GENOMICS, V78, P206, DOI 10.1006/geno.2001.6656; Wang K, 2010, HUM MOL GENET, V19, P2059, DOI 10.1093/hmg/ddq078; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660; Xystrakis E, 2004, BLOOD, V104, P3294, DOI 10.1182/blood-2004-03-1214; Zhou WS, 2004, P NATL ACAD SCI USA, V101, P2440, DOI 10.1073/pnas.0306002101	61	480	511	5	106	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 14	2013	152	4					743	754		10.1016/j.cell.2013.01.015	http://dx.doi.org/10.1016/j.cell.2013.01.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415224	Green Accepted, Bronze			2022-12-28	WOS:000314945600010
J	Gusarov, I; Gautier, L; Smolentseva, O; Shamovsky, I; Eremina, S; Mironov, A; Nudler, E				Gusarov, Ivan; Gautier, Laurent; Smolentseva, Olga; Shamovsky, Ilya; Eremina, Svetlana; Mironov, Alexander; Nudler, Evgeny			Bacterial Nitric Oxide Extends the Lifespan of C. elegans	CELL			English	Article							HEAT-SHOCK FACTOR; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; OXIDATIVE STRESS; S-NITROSYLATION; RNA-SEQ; LONGEVITY; DISEASE; POPULATIONS; EXTENSION	Nitric oxide (NO) is an important signaling molecule in multicellular organisms. Most animals produce NO from L-arginine via a family of dedicated enzymes known as NO synthases (NOSes). A rare exception is the roundworm Caenorhabditis elegans, which lacks its own NOS. However, in its natural environment, C. elegans feeds on Bacilli that possess functional NOS. Here, we demonstrate that bacterially derived NO enhances C. elegans longevity and stress resistance via a defined group of genes that function under the dual control of HSF-1 and DAF-16 transcription factors. Our work provides an example of interspecies signaling by a small molecule and illustrates the lifelong value of commensal bacteria to their host.	[Gusarov, Ivan; Gautier, Laurent; Smolentseva, Olga; Shamovsky, Ilya; Nudler, Evgeny] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Eremina, Svetlana; Mironov, Alexander] State Res Inst Genet & Select Ind Microorganisms, Moscow 117545, Russia	New York University; National Research Centre - Kurchatov Institute; Institute of Genetics & Selection of Industrial Microorganisms	Nudler, E (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA.	evgeny.nudler@nyumc.org	Eremina, Svetlana/AAT-7430-2021; Gusarov, Ivan/AAJ-6282-2020; Mironov, Alexander/G-8531-2013	Mironov, Alexander/0000-0003-3914-1380; Nudler, Evgeny/0000-0002-8811-3071	BGRF; Dynasty Foundation; Robertson Foundation; NIH	BGRF; Dynasty Foundation; Robertson Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Zuojian Tang, Ekaterina Avetissova, Olga Katkova-Zhukotskaya, and Saamia Alam for technical assistance and the Caenorhabditis Genetics Center (University of Wisconsin) for providing strains. This work was supported by the BGRF, Dynasty Foundation, Robertson Foundation, and NIH (E.N.).	Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; BRENNER S, 1974, GENETICS, V77, P71; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Crane BR, 2010, ANNU REV BIOCHEM, V79, P445, DOI 10.1146/annurev-biochem-062608-103436; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; FABIAN TJ, 1994, J GERONTOL, V49, pB145, DOI 10.1093/geronj/49.4.B145; Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-26; Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5; Garigan D, 2002, GENETICS, V161, P1101; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; Gusarov I, 2008, J BIOL CHEM, V283, P13140, DOI 10.1074/jbc.M710178200; Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439; Halaschek-Wiener J, 2005, GENOME RES, V15, P603, DOI 10.1101/gr.3274805; Hanafy K A, 2001, Med Sci Monit, V7, P801; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Johnson EG, 2008, CHEM BIOL, V15, P43, DOI 10.1016/j.chembiol.2007.11.014; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kerwin J, 1995, J MED CHEM, V88, P4343; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; Kurapati R, 2000, J GERONTOL A-BIOL, V55, pB552, DOI 10.1093/gerona/55.11.B552; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Larsen PL, 2002, SCIENCE, V295, P120, DOI 10.1126/science.1064653; Lee SJ, 2009, CELL METAB, V10, P379, DOI 10.1016/j.cmet.2009.10.003; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lim MH, 2006, NAT CHEM BIOL, V2, P375, DOI 10.1038/nchembio794; Lima B, 2010, CIRC RES, V106, P633, DOI 10.1161/CIRCRESAHA.109.207381; LOWENSTEIN CJ, 1994, ANN INTERN MED, V120, P227, DOI 10.7326/0003-4819-120-3-199402010-00009; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Marshall HE, 2000, FASEB J, V14, P1889, DOI 10.1096/fj.00.011rev; McColl G, 2010, CELL METAB, V12, P260, DOI 10.1016/j.cmet.2010.08.004; MONCADA S, 1991, EUR J CLIN INVEST, V21, P361, DOI 10.1111/j.1365-2362.1991.tb01383.x; MONCADA S, 1991, PHARMACOL REV, V43, P109; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Mukhopadhyay A, 2006, EXP GERONTOL, V41, P928, DOI 10.1016/j.exger.2006.05.020; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Olsen A, 2006, BIOGERONTOLOGY, V7, P221, DOI 10.1007/s10522-006-9018-x; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Reece SY, 2009, BIOCHEMISTRY-US, V48, P5483, DOI 10.1021/bi900385g; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Samuelson AV, 2007, GENE DEV, V21, P2976, DOI 10.1101/gad.1588907; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Shatalin K, 2008, P NATL ACAD SCI USA, V105, P1009, DOI 10.1073/pnas.0710950105; SIALA A, 1974, J GEN MICROBIOL, V81, P183, DOI 10.1099/00221287-81-1-183; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Tatar M, 1997, NATURE, V390, P30, DOI 10.1038/36237; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; van der Linden AM, 2008, GENETICS, V180, P1475, DOI 10.1534/genetics.108.094771; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; WONG A, 1995, GENETICS, V139, P1247; Xu QB, 1997, J CLIN INVEST, V100, P1089, DOI 10.1172/JCI119619; Yokoyama K, 2002, FEBS LETT, V516, P53, DOI 10.1016/S0014-5793(02)02470-5	65	125	129	2	73	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 14	2013	152	4					818	830		10.1016/j.cell.2012.12.043	http://dx.doi.org/10.1016/j.cell.2012.12.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415229	Bronze			2022-12-28	WOS:000314945600016
J	Kupfer, DJ; Kuhl, EA; Regier, DA				Kupfer, David J.; Kuhl, Emily A.; Regier, Darrel A.			DSM-5-The Future Arrived	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CRITERIA; MEDICINE		[Kupfer, David J.] Univ Pittsburgh, Sch Med, Dept Psychiat, Western Psychiat Inst & Clin, Pittsburgh, PA 15213 USA; [Kuhl, Emily A.; Regier, Darrel A.] Amer Psychiat Assoc, Amer Psychiat Inst Res & Educ, Div Res, Arlington, VA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC	Kupfer, DJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Psychiat, Western Psychiat Inst & Clin, 3811 OHara St,Room 210, Pittsburgh, PA 15213 USA.	kupferdj@upmc.edu	Regier, Darrel A./HHT-1027-2022					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI [10.1176/appi.books.9780890425596.744053, DOI 10.1176/APPI.BOOKS.9780890425596.744053]; Hudson JI, 2012, INT J EAT DISORDER, V45, P139, DOI 10.1002/eat.20890; Huerta M, 2012, AM J PSYCHIAT, V169, P1056, DOI 10.1176/appi.ajp.2012.12020276; Kupfer DJ, 2013, ANNU REV MED, V64, P385, DOI 10.1146/annurev-med-050911-161945; Kupfer DJ, 2011, AM J PSYCHIAT, V168, P672, DOI 10.1176/appi.ajp.2011.11020219; Kupfer DJ, 2010, JAMA-J AM MED ASSOC, V303, P1974, DOI 10.1001/jama.2010.646; Regier DA, 2009, AM J PSYCHIAT, V166, P645, DOI 10.1176/appi.ajp.2009.09020279; Zisook S, 2012, DEPRESS ANXIETY, V29, P425, DOI 10.1002/da.21927	9	55	57	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2013	309	16					1691	1692		10.1001/jama.2013.2298	http://dx.doi.org/10.1001/jama.2013.2298			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130IG	23440257	Bronze			2022-12-28	WOS:000317906700023
J	Estruch, R; Ros, E; Salas-Salvado, J; Covas, MI; Corella, D; Aros, F; Gomez-Gracia, E; Ruiz-Gutierrez, V; Fiol, M; Lapetra, J; Lamuela-Raventos, RM; Serra-Majem, L; Pinto, X; Basora, J; Munoz, MA; Sorli, JV; Martinez, JA; Martinez-Gonzalez, MA				Estruch, Ramon; Ros, Emilio; Salas-Salvado, Jordi; Covas, Maria-Isabel; Corella, Dolores; Aros, Fernando; Gomez-Gracia, Enrique; Ruiz-Gutierrez, Valentina; Fiol, Miquel; Lapetra, Jose; Maria Lamuela-Raventos, Rosa; Serra-Majem, Lluis; Pinto, Xavier; Basora, Josep; Angel Munoz, Miguel; Sorli, Jose V.; Alfredo Martinez, Jose; Angel Martinez-Gonzalez, Miguel		PREDIMED Study Investigators	RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet (Retracted article. See vol. 378, pg. 2441, 2018)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Retracted Publication							OLIVE OIL INTAKE; METABOLIC SYNDROME; RISK-FACTORS; STYLE DIET; ADHERENCE; INTERVENTION; HEALTH; POPULATION; REDUCTION; BENEFITS	BACKGROUND Observational cohort studies and a secondary prevention trial have shown an inverse association between adherence to the Mediterranean diet and cardiovascular risk. We conducted a randomized trial of this diet pattern for the primary prevention of cardiovascular events. METHODS In a multicenter trial in Spain, we randomly assigned participants who were at high cardiovascular risk, but with no cardiovascular disease at enrollment, to one of three diets: a Mediterranean diet supplemented with extra-virgin olive oil, a Mediterranean diet supplemented with mixed nuts, or a control diet (advice to reduce dietary fat). Participants received quarterly individual and group educational sessions and, depending on group assignment, free provision of extra-virgin olive oil, mixed nuts, or small nonfood gifts. The primary end point was the rate of major cardiovascular events (myocardial infarction, stroke, or death from cardiovascular causes). On the basis of the results of an interim analysis, the trial was stopped after a median follow-up of 4.8 years. RESULTS A total of 7447 persons were enrolled (age range, 55 to 80 years); 57% were women. The two Mediterranean-diet groups had good adherence to the intervention, according to self-reported intake and biomarker analyses. A primary end-point event occurred in 288 participants. The multivariable-adjusted hazard ratios were 0.70 (95% confidence interval [CI], 0.54 to 0.92) and 0.72 (95% CI, 0.54 to 0.96) for the group assigned to a Mediterranean diet with extra-virgin olive oil (96 events) and the group assigned to a Mediterranean diet with nuts (83 events), respectively, versus the control group (109 events). No diet-related adverse effects were reported. CONCLUSIONS Among persons at high cardiovascular risk, a Mediterranean diet supplemented with extra-virgin olive oil or nuts reduced the incidence of major cardiovascular events. (Funded by the Spanish government's Instituto de Salud Carlos III and others; Controlled-Trials.com number, ISRCTN35739639.)	[Estruch, Ramon; Ros, Emilio; Salas-Salvado, Jordi; Covas, Maria-Isabel; Corella, Dolores; Fiol, Miquel; Lapetra, Jose; Maria Lamuela-Raventos, Rosa; Basora, Josep; Sorli, Jose V.; Alfredo Martinez, Jose] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Estruch, Ramon; Salas-Salvado, Jordi; Aros, Fernando; Gomez-Gracia, Enrique; Ruiz-Gutierrez, Valentina; Maria Lamuela-Raventos, Rosa; Serra-Majem, Lluis; Pinto, Xavier; Basora, Josep; Sorli, Jose V.; Alfredo Martinez, Jose; Angel Martinez-Gonzalez, Miguel] Inst Salud Carlos III, PREDIMED Prevenc Dieta Mediterranea Network RD 06, Madrid, Spain; [Estruch, Ramon] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Hosp Clin, Dept Internal Med, Barcelona, Spain; [Ros, Emilio] Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Lipid Clin,Dept Endocrinol & Nutr, Barcelona, Spain; [Salas-Salvado, Jordi] Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, Hosp Univ St Joan, Dept Human Nutr, E-43201 Reus, Spain; [Covas, Maria-Isabel] Inst Recerca Hosp del Mar, Cardiovasc & Nutr Res Grp, Barcelona, Spain; [Corella, Dolores] Univ Valencia, Dept Prevent Med, Valencia, Spain; [Aros, Fernando] Univ Hosp Alava, Dept Cardiol, Vitoria, Spain; [Gomez-Gracia, Enrique] Univ Malaga, Dept Prevent Med, E-29071 Malaga, Spain; [Ruiz-Gutierrez, Valentina] CSIC, Inst Grasa, E-41080 Seville, Spain; [Fiol, Miquel] Univ Balearic Isl, Inst Hlth Sci IUNICS, Palma De Mallorca, Spain; [Fiol, Miquel] Hosp Son Espases, Palma De Mallorca, Spain; [Lapetra, Jose] San Pablo Hlth Ctr, Primary Care Div Seville, Dept Family Med, Seville, Spain; [Maria Lamuela-Raventos, Rosa] Univ Barcelona, Inst Invest Nutr & Seguridad Alimentaria, Sch Pharm, Dept Nutr & Food Sci,Xarxa Referencia Tecnol Alim, Barcelona, Spain; [Serra-Majem, Lluis] Univ Palmas de Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain; [Pinto, Xavier] Hosp Univ Bellvitge, Lipids & Vasc Risk Unit, Barcelona, Spain; [Basora, Josep] Inst Invest Atencio Primaria Jordi Gol, Catalan Inst Hlth, Primary Care Div, Tarragona, Spain; [Angel Munoz, Miguel] Inst Invest Atencio Primaria Jordi Gol, Catalan Inst Hlth, Primary Care Div, Barcelona, Spain; [Sorli, Jose V.] Valencia Inst Hlth, Primary Care Div, Valencia, Spain; [Alfredo Martinez, Jose] Univ Navarra, Dept Nutr & Food Sci, E-31080 Pamplona, Spain; [Alfredo Martinez, Jose] Univ Navarra, Dept Physiol, E-31080 Pamplona, Spain; [Alfredo Martinez, Jose] Univ Navarra, Dept Toxicol, E-31080 Pamplona, Spain; [Angel Martinez-Gonzalez, Miguel] Univ Navarra, Dept Prevent Med, E-31080 Pamplona, Spain; [Angel Martinez-Gonzalez, Miguel] Univ Navarra, Dept Publ Hlth, E-31080 Pamplona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Instituto de Salud Carlos III; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Valencia; Universidad de Malaga; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de la Grasa (IG); Universitat de les Illes Balears; Hospital Universitari Son Espases; University of Barcelona; Universidad de Las Palmas de Gran Canaria; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Navarra; University of Navarra; University of Navarra; University of Navarra; University of Navarra	Estruch, R (corresponding author), Hosp Clin Barcelona, Dept Internal Med, Villarroel 170, Barcelona 08036, Spain.	restruch@clinic.ub.es; mamartinez@unav.es	Fiol, Miguel/F-6793-2016; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Bes-Rastrollo, Maira/A-1329-2009; Serra-Majem, Lluis/I-6708-2019; Mitjavila, Maria Teresa/D-7474-2014; Pintó, Xavier/AGI-4297-2022; Razquin, Cristina/H-2366-2017; Sanchez-Villegas, Almudena/T-6733-2019; perez, miguel/GXF-5077-2022; Martí, Amelia/H-1192-2017; Muñoz, Miguel Angel/X-3511-2019; Lapetra, Jose/F-2552-2015; Prieto, Rafel M./J-3995-2017; Ortega-Calvo, Manuel/D-6960-2015; Casas, Rosa/ABD-1915-2020; Babio, Nancy/AAN-2715-2020; Fito, Montserrat/C-1822-2012; Ortega-Calvo, Manuel/I-4089-2019; Algorta, Jaime/K-9002-2012; IBIS, ATENCION PRIMARIA/I-3524-2016; Robles-Sardin, Alma E/M-7714-2015; Salas-Salvado, Jordi/C-7229-2017; Corbella, Emili/AGI-4105-2022; Santos-Lozano, JM/J-9312-2018; Sorlí, José V/L-8758-2014; Algorta, Jaime/CAF-7793-2022; González, Carlos A A/O-4651-2014; Estruch, Ramon/AAZ-3723-2020; Martínez-Lapiscina, Elena H/L-1161-2014; Deschepper, Reginald/B-8103-2013; Bulló, Mònica/F-2925-2016; Carrasco, Paula/D-7864-2019; ZAZPE, ITZIAR/B-1970-2017; Lamuela-Raventos, Rosa M/F-3986-2016; Toledo, Estefania/H-6211-2014	Fiol, Miguel/0000-0002-5370-1391; Bes-Rastrollo, Maira/0000-0002-9139-4206; Serra-Majem, Lluis/0000-0002-9658-9061; Mitjavila, Maria Teresa/0000-0002-1550-6253; Pintó, Xavier/0000-0002-2216-2444; Razquin, Cristina/0000-0003-3480-2645; Sanchez-Villegas, Almudena/0000-0001-7733-9238; Martí, Amelia/0000-0001-9832-7981; Muñoz, Miguel Angel/0000-0002-4083-3248; Prieto, Rafel M./0000-0001-8814-900X; Ortega-Calvo, Manuel/0000-0003-2391-0106; Casas, Rosa/0000-0002-0211-9166; Babio, Nancy/0000-0003-3527-5277; Fito, Montserrat/0000-0002-1817-483X; Ortega-Calvo, Manuel/0000-0003-2391-0106; Algorta, Jaime/0000-0002-7042-5675; Robles-Sardin, Alma E/0000-0003-2044-7793; Salas-Salvado, Jordi/0000-0003-2700-7459; Corbella, Emili/0000-0001-8818-1907; Santos-Lozano, JM/0000-0001-7097-5653; Sorlí, José V/0000-0002-0130-2006; Algorta, Jaime/0000-0002-7042-5675; González, Carlos A A/0000-0003-2822-9715; Martínez-Lapiscina, Elena H/0000-0003-4272-0826; Deschepper, Reginald/0000-0002-4222-3945; Bulló, Mònica/0000-0002-0218-7046; Basora, Josep/0000-0003-0278-1149; Fernandez-Crehuet Navajas, Joaquin/0000-0002-1173-9906; Carrasco, Paula/0000-0002-7170-4318; ZAZPE, ITZIAR/0000-0002-8787-2981; Costa, Bernardo/0000-0003-1985-8376; Cabre Vila, Juan Jose/0000-0003-1082-6861; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808; Lamuela-Raventos, Rosa M/0000-0002-1287-4560; Solanich, Xavier/0000-0002-2572-2187; Martin Lujan, Francisco M/0000-0003-0359-3588; Fernandez-Ballart, Joan D./0000-0002-1320-6484; Marrugat, Jaume/0000-0003-3320-554X; Toledo, Estefania/0000-0002-6263-4434; Medina-Remon, Alexander/0000-0003-1985-7592	Spanish government, Instituto de Salud Carlos III (ISCIII) [RTIC G03/140, RTIC RD 06/0045]; Centro Nacional de Investigaciones Cardiovasculares [CNIC 06/2007]; Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional [PI04-2239, PI 05/2584, CP06/00100, PI07/0240, PI07/1138, PI07/0954, PI 07/0473, PI10/01407, PI10/02658, PI11/01647, P11/02505]; Ministerio de Ciencia e Innovacion [AGL-2009-13906-C02, AGL2010-22319-C03]; Fundacion Mapfre, Consejeria de Salud de la Junta de Andalucia [PI0105/2007]; Public Health Division of the Department of Health of the Autonomous Government of Catalonia, Generalitat Valenciana [ACOMP06109, GVACOMP2010-181, GVACOMP2011-151, CS2010-AP-111, CS2011-AP-042]; Regional Government of Navarra [P27/2011]	Spanish government, Instituto de Salud Carlos III (ISCIII); Centro Nacional de Investigaciones Cardiovasculares; Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Mapfre, Consejeria de Salud de la Junta de Andalucia; Public Health Division of the Department of Health of the Autonomous Government of Catalonia, Generalitat Valenciana; Regional Government of Navarra	Supported by the official funding agency for biomedical research of the Spanish government, Instituto de Salud Carlos III (ISCIII), through grants provided to research networks specifically developed for the trial (RTIC G03/140, to Dr. Estruch; RTIC RD 06/0045, to Dr. Martinez-Gonzalez and through Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y Nutricion [CIBERobn]), and by grants from Centro Nacional de Investigaciones Cardiovasculares (CNIC 06/2007), Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional (PI04-2239, PI 05/2584, CP06/00100, PI07/0240, PI07/1138, PI07/0954, PI 07/0473, PI10/01407, PI10/02658, PI11/01647, and P11/02505), Ministerio de Ciencia e Innovacion (AGL-2009-13906-C02 and AGL2010-22319-C03), Fundacion Mapfre 2010, Consejeria de Salud de la Junta de Andalucia (PI0105/2007), Public Health Division of the Department of Health of the Autonomous Government of Catalonia, Generalitat Valenciana (ACOMP06109, GVACOMP2010-181, GVACOMP2011-151, CS2010-AP-111, and CS2011-AP-042), and Regional Government of Navarra (P27/2011).	Martinez-Gonzalez MA, 2012, INT J EPIDEMIOL, V41, P377, DOI 10.1093/ije/dyq250; Bendinelli B, 2011, AM J CLIN NUTR, V93, P275, DOI 10.3945/ajcn.110.000521; Buckland G, 2012, BRIT J NUTR, V108, P2075, DOI 10.1017/S000711451200298X; Buckland G, 2012, AM J CLIN NUTR, V96, P142, DOI 10.3945/ajcn.111.024216; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; DELORGERIL, 1995, LANCET, V345, P738; DELORGERIL M, 1994, LANCET, V343, P1454, DOI 10.1016/S0140-6736(94)92580-1; Esposito K, 2004, JAMA-J AM MED ASSOC, V292, P1440, DOI 10.1001/jama.292.12.1440; Esposito K, 2010, DIABETES RES CLIN PR, V89, P97, DOI 10.1016/j.diabres.2010.04.019; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; Fito M, 2007, ARCH INTERN MED, V167, P1195, DOI 10.1001/archinte.167.11.1195; Fuentes F, 2001, ANN INTERN MED, V134, P1115, DOI 10.7326/0003-4819-134-12-200106190-00011; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI 10.1001/jama.288.23.2998; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P655, DOI 10.1001/jama.295.6.655; Jacobs DR, 2009, AM J CLIN NUTR, V89, pS1543, DOI 10.3945/ajcn.2009.26736B; Kastorini CM, 2011, AM HEART J, V162, P717, DOI 10.1016/j.ahj.2011.07.012; Kastorini CM, 2011, J AM COLL CARDIOL, V57, P1299, DOI 10.1016/j.jacc.2010.09.073; Kris-Etherton P, 2001, CIRCULATION, V103, P1823, DOI 10.1161/01.CIR.103.13.1823; Kris-Etherton PN, 2008, J NUTR, V138, p1746S; Martinez-Gonzalez MA, 2008, BMJ-BRIT MED J, V336, P1348, DOI 10.1136/bmj.39561.501007.BE; Mena MP, 2009, AM J CLIN NUTR, V89, P248, DOI 10.3945/ajcn.2008.26094; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Mueller-Nordhorn J, 2008, EUR HEART J, V29, P1316, DOI 10.1093/eurheartj/ehm604; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Ros E, 2010, CURR ATHEROSCLER REP, V12, P397, DOI 10.1007/s11883-010-0132-5; Salas-Salvado J, 2008, ARCH INTERN MED, V168, P2449, DOI 10.1001/archinte.168.22.2449; Salas-Salvado J, 2011, DIABETES CARE, V34, P14, DOI 10.2337/dc10-1288; Samieri C, 2011, NEUROLOGY, V77, P418, DOI 10.1212/WNL.0b013e318220abeb; Schroder H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566; Serra-Majem L, 2006, NUTR REV, V64, pS27, DOI 10.1301/nr.2006.feb.S27-S47; Shai I, 2009, NEW ENGL J MED, V361, P2681; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673; Trichopoulou A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2337; Vincent-Baudry S, 2005, AM J CLIN NUTR, V82, P964, DOI 10.1093/ajcn/82.5.964; WILLETT WC, 1995, AM J CLIN NUTR, V61, p1402S, DOI 10.1093/ajcn/61.6.1402S; Zazpe I, 2008, J AM DIET ASSOC, V108, P1134, DOI 10.1016/j.jada.2008.04.011	37	2844	2910	19	1249	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 4	2013	368	14					1279	1290		10.1056/NEJMoa1200303	http://dx.doi.org/10.1056/NEJMoa1200303			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117YT	23432189	Green Published			2022-12-28	WOS:000316989900005
J	Burkle, LA; Marlin, JC; Knight, TM				Burkle, Laura A.; Marlin, John C.; Knight, Tiffany M.			Plant-Pollinator Interactions over 120 Years: Loss of Species, Co-Occurrence, and Function	SCIENCE			English	Article							HABITAT FRAGMENTATION; NETWORK STRUCTURE; LIFE-HISTORY; PHENOLOGY; RESPONSES; WORLD	Using historic data sets, we quantified the degree to which global change over 120 years disrupted plant-pollinator interactions in a temperate forest understory community in Illinois, USA. We found degradation of interaction network structure and function and extirpation of 50% of bee species. Network changes can be attributed to shifts in forb and bee phenologies resulting in temporal mismatches, nonrandom species extinctions, and loss of spatial co-occurrences between extant species in modified landscapes. Quantity and quality of pollination services have declined through time. The historic network showed flexibility in response to disturbance; however, our data suggest that networks will be less resilient to future changes.	[Burkle, Laura A.; Knight, Tiffany M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Burkle, Laura A.] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA; [Marlin, John C.] Univ Illinois, Illinois Sustainable Technol Ctr, Champaign, IL 61820 USA	Washington University (WUSTL); Montana State University System; Montana State University Bozeman; University of Illinois System; University of Illinois Urbana-Champaign	Burkle, LA (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	laura.burkle@montana.edu			NSF [DEB 0934376, 06-520 DRL-0739874]; NSF	NSF(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	M. Bujnak, A. David, M. Dust, J. Hopwood, M. Jean, R. Jean, S. Mulhern, Z. Portman, and J. Wray provided exceptional help in the field and laboratory. M. Arduser and J. Gibbs aided in bee identification. Historic data and specimen access were provided by J. Memmott and P. Tinerella, respectively. Access to current data is available at http://datadryad.org. We are grateful to Beaver Dam State Park, Moores Cemetery Woods, Bethel Ridge Cemetery, Culp Conservancy Woods, E. Swiatkowsk, and the Parlodi family for field site access. Funding was provided by NSF DEB 0934376 and NSF 06-520 DRL-0739874. Three anonymous reviewers provided comments on earlier drafts.	Aizen MA, 2012, SCIENCE, V335, P1486, DOI 10.1126/science.1215320; Bartomeus I, 2011, P NATL ACAD SCI USA, V108, P20645, DOI 10.1073/pnas.1115559108; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 1996, J ANIM ECOL, V65, P465, DOI 10.2307/5781; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Cagnolo L, 2009, CONSERV BIOL, V23, P1167, DOI 10.1111/j.1523-1739.2009.01214.x; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Encinas-Viso F, 2012, ECOL LETT, V15, P198, DOI 10.1111/j.1461-0248.2011.01726.x; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; INOUYE DW, 1978, ECOLOGY, V59, P672, DOI 10.2307/1938769; Inouye DW, 2003, AM J BOT, V90, P905, DOI 10.3732/ajb.90.6.905; Kiers ET, 2010, ECOL LETT, V13, P1459, DOI 10.1111/j.1461-0248.2010.01538.x; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Marlin JC, 2001, CONSERV ECOL, V5, part. no.; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Miller-Rushing AJ, 2008, J ECOL, V96, P1289, DOI 10.1111/j.1365-2745.2008.01436.x; Miller-Rushing AJ, 2008, ECOLOGY, V89, P332, DOI 10.1890/07-0068.1; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Penuelas J, 2002, GLOBAL CHANGE BIOL, V8, P531, DOI 10.1046/j.1365-2486.2002.00489.x; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Robertson C., 1929, FLOWERS INSECTS LIST; ROBERTSON CHARLES, 1926, PSYCHE, V33, P116, DOI 10.1155/1926/95452; ROBERTSON CHARLES, 1929, PSYCHE, V36, P112; Roy DB, 2000, GLOB CHANGE BIOL, V6, P407, DOI 10.1046/j.1365-2486.2000.00322.x; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Williams NM, 2010, BIOL CONSERV, V143, P2280, DOI 10.1016/j.biocon.2010.03.024	31	631	668	33	922	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1611	1615		10.1126/science.1232728	http://dx.doi.org/10.1126/science.1232728			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23449999	Green Submitted			2022-12-28	WOS:000316731600050
J	Memczak, S; Jens, M; Elefsinioti, A; Torti, F; Krueger, J; Rybak, A; Maier, L; Mackowiak, SD; Gregersen, LH; Munschauer, M; Loewer, A; Ziebold, U; Landthaler, M; Kocks, C; le Noble, F; Rajewsky, N				Memczak, Sebastian; Jens, Marvin; Elefsinioti, Antigoni; Torti, Francesca; Krueger, Janna; Rybak, Agnieszka; Maier, Luisa; Mackowiak, Sebastian D.; Gregersen, Lea H.; Munschauer, Mathias; Loewer, Alexander; Ziebold, Ulrike; Landthaler, Markus; Kocks, Christine; le Noble, Ferdinand; Rajewsky, Nikolaus			Circular RNAs are a large class of animal RNAs with regulatory potency	NATURE			English	Article							BINDING PROTEIN; MESSENGER-RNA; NONCODING RNA; GENE; TRANSCRIPTS; EXPRESSION; MICRORNAS; SEQUENCE; DIFFERENTIATION; DISCOVERY	Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.	[Memczak, Sebastian; Jens, Marvin; Elefsinioti, Antigoni; Torti, Francesca; Krueger, Janna; Rybak, Agnieszka; Maier, Luisa; Mackowiak, Sebastian D.; Gregersen, Lea H.; Munschauer, Mathias; Loewer, Alexander; Ziebold, Ulrike; Landthaler, Markus; Kocks, Christine; le Noble, Ferdinand; Rajewsky, Nikolaus] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Rajewsky, N (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	rajewsky@mdc-berlin.de	Loewer, Alexander/AAL-6943-2021; Munschauer, Mathias/AAK-2789-2020; Mackowiak, Sebastian D/S-3266-2017; Gregersen, Lea H/AAI-2386-2021; le Noble, Ferdinand/L-7867-2017; Landthaler, Markus/A-1427-2010; Ziebold, Ulrike/N-4487-2013	Loewer, Alexander/0000-0002-8819-3040; Munschauer, Mathias/0000-0001-6143-4548; Mackowiak, Sebastian D/0000-0003-1673-5389; Gregersen, Lea H/0000-0002-1205-604X; Landthaler, Markus/0000-0002-1075-8734; Jens, Marvin/0000-0002-6660-8743; Memczak, Sebastian/0000-0001-9518-7135; Rybak-Wolf, Agnieszka/0000-0002-1192-5290; Rajewsky, Nikolaus/0000-0002-4785-4332	Max-Delbruck-Center (MDC); MDC-NYU; BMBF [1210182]; DFG [KFO218]; Helmholtz Association for the 'MDC Systems Biology Network', MSBN; BMBF support for the DZHK; Center for Stroke Research Berlin; BMBF for the Berlin Institute for Medical Systems Biology [0315362C]	Max-Delbruck-Center (MDC); MDC-NYU; BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Helmholtz Association for the 'MDC Systems Biology Network', MSBN(Helmholtz Association); BMBF support for the DZHK; Center for Stroke Research Berlin; BMBF for the Berlin Institute for Medical Systems Biology(Federal Ministry of Education & Research (BMBF))	We thank M. Feldkamp and C. Langnick (laboratory of W. Chen)for Illumina sequencing runs. We thank J. Kjems for sending us a plasmid encoding circular human CDR1as for our zebrafish experiments. We thank K. Meier for technical assistance with zebrafish experiments and A. Sporbert from the confocal imaging facility. We thank A. Ivanov for assisting in bioinformatic analysis. N.R. thanks E. Westhof for useful discussions. We acknowledge the following funding sources: PhD program of the Max-Delbruck-Center (MDC) (S.M., F.T., L.H.G.); the MDC-NYU exchange program (MM.); BMBF project 1210182, 'MiRNAs as therapeutic targets' (A.E); DFG for KFO218 (U.Z.); Helmholtz Association for the 'MDC Systems Biology Network', MSBN (S.D.M.); BMBF support for the DZHK (F.I.N. and N.R.); Center for Stroke Research Berlin (J.K., F.I.N.). Funding for the group of M.L. is supported by BMBF-funding for the Berlin Institute for Medical Systems Biology (0315362C).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chacon MR, 2012, DEVELOPMENT, V139, P3200, DOI 10.1242/dev.080564; Chao CW, 1998, MOL MED, V4, P614, DOI 10.1007/BF03401761; COCQUERELLE C, 1993, FASEB J, V7, P155, DOI 10.1096/fasebj.7.1.7678559; Danan M, 2012, NUCLEIC ACIDS RES, V40, P3131, DOI 10.1093/nar/gkr1009; DROPCHO EJ, 1987, P NATL ACAD SCI USA, V84, P4552, DOI 10.1073/pnas.84.13.4552; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert MS, 2010, CURR BIOL, V20, pR858, DOI 10.1016/j.cub.2010.08.052; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; GRABOWSKI PJ, 1981, CELL, V23, P467, DOI 10.1016/0092-8674(81)90142-2; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Huang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027288; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; IWAI Y, 1993, J IMMUNOL, V150, P4386; Jacobs T, 2007, J NEUROSCI, V27, P8604, DOI 10.1523/JNEUROSCI.0765-07.2007; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kaufman M.H., 1999, ANATOMICAL BASIS MOU; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; NIGRO JM, 1991, CELL, V64, P607, DOI 10.1016/0092-8674(91)90244-S; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; SANGER HL, 1976, P NATL ACAD SCI USA, V73, P3852, DOI 10.1073/pnas.73.11.3852; Schambra U., 2008, PRENATAL MOUSE BRAIN; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Suzuki H, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl151; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Vivancos AP, 2010, GENOME RES, V20, P989, DOI 10.1101/gr.094318.109; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	51	4890	5273	47	1161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					333	338		10.1038/nature11928	http://dx.doi.org/10.1038/nature11928			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23446348				2022-12-28	WOS:000316650500035
J	Robitaille, AM; Christen, S; Shimobayashi, M; Cornu, M; Fava, LL; Moes, S; Prescianotto-Baschong, C; Sauer, U; Jenoe, P; Hall, MN				Robitaille, Aaron M.; Christen, Stefan; Shimobayashi, Mitsugu; Cornu, Marion; Fava, Luca L.; Moes, Suzette; Prescianotto-Baschong, Cristina; Sauer, Uwe; Jenoe, Paul; Hall, Michael N.			Quantitative Phosphoproteomics Reveal mTORC1 Activates de Novo Pyrimidine Synthesis	SCIENCE			English	Article							NUCLEOTIDE BIOSYNTHESIS; PHOSPHATE SYNTHETASE; GROWTH; KINASE; PHOSPHORYLATION; PROLIFERATION; ASSOCIATION; FIBROBLASTS; MECHANISM; RIBOSOME	The Ser-Thr kinase mammalian target of rapamycin (mTOR) controls cell growth and metabolism by stimulating glycolysis and synthesis of proteins and lipids. To further understand the central role of mTOR in cell physiology, we used quantitative phosphoproteomics to identify substrates or downstream effectors of the two mTOR complexes. mTOR controlled the phosphorylation of 335 proteins, including CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase). CAD catalyzes the first three steps in de novo pyrimidine synthesis. mTORC1 indirectly phosphorylated CAD-S1859 through S6 kinase (S6K). CAD-S1859 phosphorylation promoted CAD oligomerization and thereby stimulated de novo synthesis of pyrimidines and progression through S phase of the cell cycle in mammalian cells. Thus, mTORC1 also stimulates the synthesis of nucleotides to control cell proliferation.	[Robitaille, Aaron M.; Shimobayashi, Mitsugu; Cornu, Marion; Fava, Luca L.; Moes, Suzette; Prescianotto-Baschong, Cristina; Jenoe, Paul; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Christen, Stefan; Sauer, Uwe] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland	University of Basel; Swiss Federal Institutes of Technology Domain; ETH Zurich	Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	m.hall@unibas.ch	Sauer, Uwe/Y-3556-2019; Fava, Luca/E-2876-2017	Fava, Luca/0000-0002-6741-1723; Shimobayashi, Mitsugu/0000-0002-6936-0990; Robitaille, Aaron Mark/0000-0003-2774-2066; Hall, Michael N/0000-0002-2998-0757	Werner Siemens Foundation; Societe Francophone du Diabete-Association de Langue Francaise pour L'Etude du Diabete et des Maladies Metaboliques; Swiss Cancer League; Louis Jeantet Foundation; Swiss National Science Foundation; SystemsX.ch project YeastX	Werner Siemens Foundation; Societe Francophone du Diabete-Association de Langue Francaise pour L'Etude du Diabete et des Maladies Metaboliques; Swiss Cancer League; Louis Jeantet Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch project YeastX	We acknowledge support from the Werner Siemens Foundation (A. M. R.), the Societe Francophone du Diabete-Association de Langue Francaise pour L'Etude du Diabete et des Maladies Metaboliques (M. C.), the Swiss Cancer League, the Louis Jeantet Foundation, the Swiss National Science Foundation, and the SystemsX.ch project YeastX. We declare no conflicts of interest. The phosphoproteomic data, including UniProt accession numbers reported in this paper, are deposited in the supplementary materials.	Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; CARREY EA, 1985, EMBO J, V4, P3735, DOI 10.1002/j.1460-2075.1985.tb04142.x; Cybulski N, 2012, METHODS MOL BIOL, V821, P267, DOI 10.1007/978-1-61779-430-8_16; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Espeillac C, 2011, J CLIN INVEST, V121, P2821, DOI 10.1172/JCI44203; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Graves LM, 2000, NATURE, V403, P328, DOI 10.1038/35002111; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kim J, 2011, ANNU REV BIOCHEM, V80, P1001, DOI 10.1146/annurev-biochem-062209-094414; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LEE L, 1985, P NATL ACAD SCI USA, V82, P6802, DOI 10.1073/pnas.82.20.6802; MITCHELL AD, 1975, EXP CELL RES, V93, P105, DOI 10.1016/0014-4827(75)90428-0; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Ramirez-Valle F, 2010, MOL CELL BIOL, V30, P3151, DOI 10.1128/MCB.00322-09; Ruhl M, 2012, BIOTECHNOL BIOENG, V109, P763, DOI 10.1002/bit.24344; SMITH ML, 1979, J CELL PHYSIOL, V101, P293, DOI 10.1002/jcp.1041010210; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang PF, 2009, BIOCHEMISTRY-US, V48, P766, DOI 10.1021/bi801831r; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	23	339	351	3	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1320	1323		10.1126/science.1228771	http://dx.doi.org/10.1126/science.1228771			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23429704				2022-12-28	WOS:000316053400038
J	Hubbard, BP; Gomes, AP; Dai, H; Li, J; Case, AW; Considine, T; Riera, TV; Lee, JE; Yen, ES; Lamming, DW; Pentelute, BL; Schuman, ER; Stevens, LA; Ling, AJY; Armour, SM; Michan, S; Zhao, HZ; Jiang, Y; Sweitzer, SM; Blum, CA; Disch, JS; Ng, PY; Howitz, KT; Rolo, AP; Hamuro, Y; Moss, J; Perni, RB; Ellis, JL; Vlasuk, GP; Sinclair, DA				Hubbard, Basil P.; Gomes, Ana P.; Dai, Han; Li, Jun; Case, April W.; Considine, Thomas; Riera, Thomas V.; Lee, Jessica E.; Yen, Sook E.; Lamming, Dudley W.; Pentelute, Bradley L.; Schuman, Eli R.; Stevens, Linda A.; Ling, Alvin J. Y.; Armour, Sean M.; Michan, Shaday; Zhao, Huizhen; Jiang, Yong; Sweitzer, Sharon M.; Blum, Charles A.; Disch, Jeremy S.; Ng, Pui Yee; Howitz, Konrad T.; Rolo, Anabela P.; Hamuro, Yoshitomo; Moss, Joel; Perni, Robert B.; Ellis, James L.; Vlasuk, George P.; Sinclair, David A.			Evidence for a Common Mechanism of SIRT1 Regulation by Allosteric Activators	SCIENCE			English	Article							SMALL-MOLECULE ACTIVATORS; MITOCHONDRIAL-FUNCTION; DEACETYLASE ACTIVITY; RESVERATROL; SIRTUINS; SURVIVAL; TRANSCRIPTION; ACETYLATION; MODULATION; SRT1720	A molecule that treats multiple age-related diseases would have a major impact on global health and economics. The SIRT1 deacetylase has drawn attention in this regard as a target for drug design. Yet controversy exists around the mechanism of sirtuin-activating compounds (STACs). We found that specific hydrophobic motifs found in SIRT1 substrates such as PGC-1 alpha and FOXO3a facilitate SIRT1 activation by STACs. A single amino acid in SIRT1, Glu(230), located in a structured N-terminal domain, was critical for activation by all previously reported STAC scaffolds and a new class of chemically distinct activators. In primary cells reconstituted with activation-defective SIRT1, the metabolic effects of STACs were blocked. Thus, SIRT1 can be directly activated through an allosteric mechanism common to chemically diverse STACs.	[Hubbard, Basil P.; Gomes, Ana P.; Li, Jun; Lamming, Dudley W.; Ling, Alvin J. Y.; Armour, Sean M.; Michan, Shaday; Sinclair, David A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Gomes, Ana P.; Rolo, Anabela P.] Univ Coimbra, Dept Life Sci, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal; [Dai, Han; Case, April W.; Considine, Thomas; Riera, Thomas V.; Schuman, Eli R.; Blum, Charles A.; Disch, Jeremy S.; Ng, Pui Yee; Perni, Robert B.; Ellis, James L.; Vlasuk, George P.] Sirtris, Cambridge, MA 02139 USA; [Lee, Jessica E.; Yen, Sook E.; Hamuro, Yoshitomo] ExSAR Corp, Monmouth Jct, NJ 08852 USA; [Pentelute, Bradley L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Stevens, Linda A.; Moss, Joel] NHLBI, NIH, Cardiovasc & Pulm Branch, Bethesda, MD 20892 USA; [Zhao, Huizhen; Jiang, Yong; Sweitzer, Sharon M.] GlaxoSmithKline, Collegeville, PA 19426 USA; [Howitz, Konrad T.] BIOMOL Res Labs Inc, Plymouth Meeting, PA 19462 USA; [Rolo, Anabela P.] Univ Aveiro, Dept Biol, P-3810193 Aveiro, Portugal; [Sinclair, David A.] Univ New S Wales, Dept Pharmacol, Sydney, NSW 2052, Australia	Harvard University; Harvard Medical School; Universidade de Coimbra; Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); GlaxoSmithKline; Universidade de Aveiro; University of New South Wales Sydney	Sinclair, DA (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	david_sinclair@hms.harvard.edu	Li, Jun/B-8055-2014; Li, Jun/AAF-9234-2021; Rolo, Anabela/AAU-6567-2020; Lamming, Dudley/O-7191-2015; Rolo, Anabela/D-6062-2011	Li, Jun/0000-0002-0179-4151; Rolo, Anabela/0000-0003-3535-9630; Lamming, Dudley/0000-0002-0079-4467; Rolo, Anabela/0000-0003-3535-9630; Disch, Jeremy/0000-0002-0357-1672; Sinclair, David/0000-0002-9936-436X; Lee, Jessica/0000-0002-8567-1633; Hubbard, Basil/0000-0003-4353-9674; Riera, Thomas/0000-0001-7427-2728	Glenn Foundation for Medical Research; Ellison Medical Foundation; Juvenile Diabetes Research Foundation; United Mitochondrial Disease Foundation; NIH; NIAID; NSERC fellowship; Portuguese Science and Technology Foundation; Intramural Research Program; NIH/NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019719, R37AG028730, R01AG028730, P01AG027916] Funding Source: NIH RePORTER	Glenn Foundation for Medical Research; Ellison Medical Foundation(Lawrence Ellison Foundation); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); United Mitochondrial Disease Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NSERC fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Portuguese Science and Technology Foundation(Portuguese Foundation for Science and Technology); Intramural Research Program; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by the Glenn Foundation for Medical Research, the Ellison Medical Foundation, the Juvenile Diabetes Research Foundation, the United Mitochondrial Disease Foundation, NIH and NIAID grants, an NSERC fellowship (B. P. H.), the Portuguese Science and Technology Foundation (A. P. G.), the Intramural Research Program, and NIH/NHLBI (L. A. S. and J.M.). D. A. S. is a consultant and inventor on patents licensed to Sirtris, a GSK company. H. D., A. W. C., T. C., T. V. R., E. R. S., H.Z., Y.J., S. M. S., C. A. B., J.S.D., P.Y.N., R. B. P., J.L.E., and G. P. V. are employees of Sirtris, a GSK company. Dedicated to the memories of Jana Perni and Harmon Rasnow. A patent application on the PNC1-OPT sirtuin assay has been filed by Harvard Medical School with D. A. S. and B. P. H. as inventors. Patent applications related to sirtuin activators have been filed by Sirtris and Biomol. Natural Sirt1 activators will be provided upon request. Synthetic STACs are provided under a material transfer agreement from Sirtris.	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bernier M, 2011, J BIOL CHEM, V286, P19270, DOI 10.1074/jbc.M110.200311; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Dai H, 2010, J BIOL CHEM, V285, P32695, DOI 10.1074/jbc.M110.133892; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; Ghosh HS, 2011, SCI REP-UK, V1, DOI 10.1038/srep00150; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kang H, 2011, MOL CELL, V44, P203, DOI 10.1016/j.molcel.2011.07.038; Kume S, 2007, J BIOL CHEM, V282, P151, DOI 10.1074/jbc.M605904200; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Minor RK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00070; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Pan M, 2012, J BIOL CHEM, V287, P2468, DOI 10.1074/jbc.M111.285031; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Sebastian C, 2012, J BIOL CHEM, V287, P42444, DOI 10.1074/jbc.R112.402768; SUGAWARA K, 1981, J BIOCHEM-TOKYO, V89, P771, DOI 10.1093/oxfordjournals.jbchem.a133257; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	29	465	482	4	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2013	339	6124					1216	1219		10.1126/science.1231097	http://dx.doi.org/10.1126/science.1231097			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471411	Green Accepted, Green Published			2022-12-28	WOS:000315709900051
J	Ziff, RM				Ziff, Robert M.			Getting the Jump on Explosive Percolation	SCIENCE			English	Editorial Material									Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ziff, RM (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	rziff@umich.edu						Achlioptas D, 2009, SCIENCE, V323, P1453, DOI 10.1126/science.1167782; Araujo NAM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.095703; Boettcher S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1774; Broadbent S.R., 1957, P CAMB PHILOS SOC, V53, P629, DOI [DOI 10.1017/S0305004100032680, 10.1017/S0305004100032680]; Cho YS, 2013, SCIENCE, V339, P1185, DOI 10.1126/science.1230813; Cho YS, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.135702; da Costa RA, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.255701; Flory PJ, 1941, J AM CHEM SOC, V63, P3091, DOI 10.1021/ja01856a062; Grassberger P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.225701; Radicchi F, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.168701; Riordan O, 2011, SCIENCE, V333, P322, DOI 10.1126/science.1206241; STAUFFER D, 1994, INTRO PERCOLATION TH; Ziff RM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.045701	13	8	8	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2013	339	6124					1159	1160		10.1126/science.1235032	http://dx.doi.org/10.1126/science.1235032			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471394				2022-12-28	WOS:000315709900033
J	Boon, RA; Iekushi, K; Lechner, S; Seeger, T; Fischer, A; Heydt, S; Kaluza, D; Treguer, K; Carmona, G; Bonauer, A; Horrevoets, AJG; Didier, N; Girmatsion, Z; Biliczki, P; Ehrlich, JR; Katus, HA; Muller, OJ; Potente, M; Zeiher, AM; Hermeking, H; Dimmeler, S				Boon, Reinier A.; Iekushi, Kazuma; Lechner, Stefanie; Seeger, Timon; Fischer, Ariane; Heydt, Susanne; Kaluza, David; Treguer, Karine; Carmona, Guillaume; Bonauer, Angelika; Horrevoets, Anton J. G.; Didier, Nathalie; Girmatsion, Zenawit; Biliczki, Peter; Ehrlich, Joachim R.; Katus, Hugo A.; Mueller, Oliver J.; Potente, Michael; Zeiher, Andreas M.; Hermeking, Heiko; Dimmeler, Stefanie			MicroRNA-34a regulates cardiac ageing and function	NATURE			English	Article							MYOCARDIAL-INFARCTION; HEART FUNCTION; APOPTOSIS; P53; ANGIOGENESIS; PHOSPHATASE; ACTIVATION; SENESCENCE; EXPRESSION; COMPONENT	Ageing is the predominant risk factor for cardiovascular diseases(1) and contributes to a significantly worse outcome in patients with acute myocardial infarction(2). MicroRNAs (miRNAs) have emerged as crucial regulators of cardiovascular function and some miRNAs have key roles in ageing(3,4). We propose that altered expression of miRNAs in the heart during ageing contributes to the age-dependent decline in cardiac function. Here we show that miR-34a is induced in the ageing heart and that in vivo silencing or genetic deletion of miR-34a reduces age-associated cardiomyocyte cell death. Moreover, miR-34a inhibition reduces cell death and fibrosis following acute myocardial infarction and improves recovery of myocardial function. Mechanistically, we identified PNUTS (also known as PPP1R10) as a novel direct miR-34a target, which reduces telomere shortening, DNA damage responses and cardiomyocyte apoptosis, and improves functional recovery after acute myocardial infarction. Together, these results identify age-induced expression of miR-34a and inhibition of its target PNUTS as a key mechanism that regulates cardiac contractile function during ageing and after acute myocardial infarction, by inducing DNA damage responses and telomere attrition.	[Boon, Reinier A.; Iekushi, Kazuma; Seeger, Timon; Fischer, Ariane; Heydt, Susanne; Kaluza, David; Treguer, Karine; Carmona, Guillaume; Bonauer, Angelika; Potente, Michael; Dimmeler, Stefanie] Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, D-60590 Frankfurt, Germany; [Lechner, Stefanie; Hermeking, Heiko] Univ Munich, Inst Pathol, D-80337 Munich, Germany; [Seeger, Timon; Girmatsion, Zenawit; Biliczki, Peter; Ehrlich, Joachim R.; Potente, Michael; Zeiher, Andreas M.] Goethe Univ Frankfurt, Dept Cardiol, D-60590 Frankfurt, Germany; [Horrevoets, Anton J. G.] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands; [Didier, Nathalie] Univ Paris 06, INSERM, Myol Grp, Inst Myol,UMR S787, Paris, France; [Katus, Hugo A.; Mueller, Oliver J.] Univ Heidelberg Hosp, D-69120 Heidelberg, Germany; [Katus, Hugo A.; Mueller, Oliver J.; Zeiher, Andreas M.; Dimmeler, Stefanie] German Ctr Cardiovasc Res DZHK, D-13347 Berlin, Germany	Goethe University Frankfurt; University of Munich; Goethe University Frankfurt; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research	Dimmeler, S (corresponding author), Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, D-60590 Frankfurt, Germany.	dimmeler@em.uni-frankfurt.de	Boon, Reinier A/E-8423-2011; Müller, Oliver/AAA-4399-2021; Müller, Oliver J./H-4739-2016	Boon, Reinier A/0000-0001-7944-9748; Müller, Oliver/0000-0001-8223-2638; Dimmeler, Stefanie/0000-0002-1045-2436; DIDIER, Nathalie/0000-0003-4144-7581; Potente, Michael/0000-0002-5689-0036	Netherlands Organization for Scientific Research (NWO); Japanese Heart Foundation; Excellence Cluster Cardiopulmonary System [Exc 147-1]; European Research Council; German Center for Cardiovascular Research DZHK; European Union [241440]; German Centre for Cardiovascular Research (DZHK); German Ministry of Education and Research (BMBF); ERC; DFG; Deutsche Krebshilfe; Rudolf-Bartling-Stiftung	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Japanese Heart Foundation; Excellence Cluster Cardiopulmonary System(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); German Center for Cardiovascular Research DZHK; European Union(European Commission); German Centre for Cardiovascular Research (DZHK); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); ERC(European Research Council (ERC)European Commission); DFG(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Rudolf-Bartling-Stiftung	We thank M. Muhly-Reinholz, A. Knau, B. Zimmermann, N. Reinfeld and F. Gehring for technical assistance, F. W. Alt for providing SIRT1 mutant mice and D. Sassoon and G. Marazzi for conceptual advice. R.A.B. was supported by the Netherlands Organization for Scientific Research (NWO) and K.I. by a Research Grant Abroad of the Japanese Heart Foundation. This study was supported by a start-up grant of the Excellence Cluster Cardiopulmonary System (Exc 147-1) to R.A.B., by the European Research Council (Advanced grant "Angiomirs") and the German Center for Cardiovascular Research DZHK and the European Union FP7 project Endostem (Grant no. 241440) to S.D. H.A.K. and O.J.M. are supported by the German Centre for Cardiovascular Research (DZHK) and by the German Ministry of Education and Research (BMBF). M.P. is supported by the Max Planck Society, the Fondation Leducq (ARTEMIS) and an ERC Starting Grant (ANGIOMET). H.H. is supported by the DFG, the Deutsche Krebshilfe and the Rudolf-Bartling-Stiftung.	Bernardo BC, 2012, P NATL ACAD SCI USA, V109, P17615, DOI 10.1073/pnas.1206432109; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Boon RA, 2011, CIRC RES, V109, P1115, DOI 10.1161/CIRCRESAHA.111.255737; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; De Leon G, 2008, CANCER BIOL THER, V7, P833, DOI 10.4161/cbt.7.6.5839; Dimmeler S., 2013, EMBO MOL MED; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2012, NAT REV CANCER, V12, P613, DOI 10.1038/nrc3318; Hsu CP, 2010, CIRCULATION, V122, P2170, DOI 10.1161/CIRCULATIONAHA.110.958033; Ito T, 2010, BIOCHEM BIOPH RES CO, V398, P735, DOI 10.1016/j.bbrc.2010.07.012; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kim H, 2009, NAT STRUCT MOL BIOL, V16, P372, DOI 10.1038/nsmb.1575; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lakatta Edward G, 2002, Heart Fail Rev, V7, P29; Landsverk HB, 2010, EMBO REP, V11, P868, DOI 10.1038/embor.2010.134; Oh H, 2003, P NATL ACAD SCI USA, V100, P5378, DOI 10.1073/pnas.0836098100; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Shukla PC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1601; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; van Almen GC, 2011, AGING CELL, V10, P769, DOI 10.1111/j.1474-9726.2011.00714.x; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Wellenius GA, 2008, AM HEART J, V156, P483, DOI 10.1016/j.ahj.2008.04.009; Xu QF, 2012, J AM COLL CARDIOL, V59, P2107, DOI 10.1016/j.jacc.2012.02.033; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Zhao T, 2010, AM J PHYSIOL-ENDOC M, V299, pE110, DOI 10.1152/ajpendo.00192.2010	26	570	595	3	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2013	495	7439					107	110		10.1038/nature11919	http://dx.doi.org/10.1038/nature11919			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23426265				2022-12-28	WOS:000316039800049
J	Nugent, P; Belmabkhout, Y; Burd, SD; Cairns, AJ; Luebke, R; Forrest, K; Pham, T; Ma, SQ; Space, B; Wojtas, L; Eddaoudi, M; Zaworotko, MJ				Nugent, Patrick; Belmabkhout, Youssef; Burd, Stephen D.; Cairns, Amy J.; Luebke, Ryan; Forrest, Katherine; Pham, Tony; Ma, Shengqian; Space, Brian; Wojtas, Lukasz; Eddaoudi, Mohamed; Zaworotko, Michael J.			Porous materials with optimal adsorption thermodynamics and kinetics for CO2 separation	NATURE			English	Article							METAL-ORGANIC FRAMEWORKS; CARBON-DIOXIDE CAPTURE; COORDINATION POLYMER; PORE-SIZE; DESIGN; ADSORBENTS; ISOMERISM; METHANE; 13X	The energy costs associated with the separation and purification of industrial commodities, such as gases, fine chemicals and fresh water, currently represent around 15 per cent of global energy production, and the demand for such commodities is projected to triple by 2050 (ref. 1). The challenge of developing effective separation and purification technologies that have much smaller energy footprints is greater for carbon dioxide (CO2) than for other gases; in addition to its involvement in climate change, CO2, is an impurity in natural gas, biogas (natural gas produced from biomass), syngas (CO/H-2, the main source of hydrogen in refineries) and many other gas streams. In the context of porous crystalline materials that can exploit both equilibrium and kinetic selectivity, size selectivity and targeted molecular recognition are attractive characteristics for CO2 separation and capture, as exemplified by zeolites 5A and 13X (ref. 2), as well as metal-organic materials (MOMs)(3-9). Here we report that a crystal engineering(7) or reticular chemistry(5,9) strategy that controls pore functionality and size in a series of MOMs with coordinately saturated metal centres and periodically arrayed hexafluorosilicate (SiF62-) anions enables a 'sweet spot' of kinetics and thermodynamics that offers high volumetric uptake at low CO2 partial pressure (less than 0.15 bar). Most importantly, such MOMs offer an unprecedented CO2 sorption selectivity over N-2, H-2 and CH4, even in the presence of moisture. These MOMs are therefore relevant to CO2 separation in the context of post-combustion (flue gas, CO2/N-2), pre-combustion (shifted synthesis gas stream, CO2/H-2) and natural gas upgrading (natural gas clean-up, CO2/CH4).	[Nugent, Patrick; Burd, Stephen D.; Forrest, Katherine; Pham, Tony; Ma, Shengqian; Space, Brian; Wojtas, Lukasz; Eddaoudi, Mohamed; Zaworotko, Michael J.] Univ S Florida, Dept Chem, Tampa, FL 33620 USA; [Belmabkhout, Youssef; Cairns, Amy J.; Luebke, Ryan; Eddaoudi, Mohamed] 4700 King Abdullah Univ Sci & Technol KAUST, Div Phys Sci & Engn, Adv Membranes & Porous Mat Ctr, Thuwal 239556900, Saudi Arabia	State University System of Florida; University of South Florida; King Abdullah University of Science & Technology	Eddaoudi, M (corresponding author), Univ S Florida, Dept Chem, 4202 East Fowler Ave, Tampa, FL 33620 USA.	mohamed.eddaoudi@kaust.edu.sa; xtal@usf.edu	Ma, Shengqian/B-4022-2012; Eddaoudi, Mohamed/D-2298-2009; Space, Brian/AFU-1654-2022; Pham, Tony/A-3787-2014; Nugent, Patrick/I-8308-2015; Zaworotko, Michael/A-7448-2009; Luebke, Ryan/F-4333-2011	Ma, Shengqian/0000-0002-1897-7069; Eddaoudi, Mohamed/0000-0003-1916-9837; Space, Brian/0000-0003-0246-7408; Nugent, Patrick/0000-0002-1585-2762; Zaworotko, Michael/0000-0002-1360-540X; Luebke, Ryan/0000-0002-1285-3321; Wojtas, Lukasz/0000-0003-0545-0302	KAUST [FIC/2010/06]; XSEDE [TG-DMR090028]; National Science Foundation/Department of Energy [NSF/CHE-0822838]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Division Of Chemistry [0822838] Funding Source: National Science Foundation	KAUST(King Abdullah University of Science & Technology); XSEDE; National Science Foundation/Department of Energy(National Science Foundation (NSF)United States Department of Energy (DOE)); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This publication is based on work supported by KAUST award number FIC/2010/06 (ME. and M.J.Z.) and KAUST start up funds (RE.). B.S. acknowledges computational resources made available by an XSEDE grant (number TG-DMR090028). Single-crystal diffraction experiments on SIFSIX-2-Cu-I were conducted at the Advanced Photon Source on beamline 15ID-B of ChemMatCARS Sector 15, which is principally supported by the National Science Foundation/Department of Energy under grant number NSF/CHE-0822838. Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under contract number DE-AC02-06CH11357.	Belmabkhout Y, 2010, IND ENG CHEM RES, V49, P359, DOI 10.1021/ie900837t; Burd SD, 2012, J AM CHEM SOC, V134, P3663, DOI 10.1021/ja211340t; Caskey SR, 2008, J AM CHEM SOC, V130, P10870, DOI 10.1021/ja8036096; Cavenati S, 2004, J CHEM ENG DATA, V49, P1095, DOI 10.1021/je0498917; Coe BJ, 2004, DALTON T, P2935, DOI 10.1039/b409432h; Eddaoudi M, 2002, SCIENCE, V295, P469, DOI 10.1126/science.1067208; Farha OK, 2012, J AM CHEM SOC, V134, P15016, DOI 10.1021/ja3055639; Han SG, 2012, ACS COMB SCI, V14, P263, DOI 10.1021/co3000192; Herm ZR, 2011, J AM CHEM SOC, V133, P5664, DOI 10.1021/ja111411q; Ho MT, 2008, IND ENG CHEM RES, V47, P4883, DOI 10.1021/ie070831e; Jagiello J, 2004, CARBON, V42, P1227, DOI 10.1016/j.carbon.2004.01.022; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; Kizzie AC, 2011, LANGMUIR, V27, P6368, DOI 10.1021/la200547k; Lassig D., 2011, ANGEW CHEM, V123, P10528; Li H, 1999, NATURE, V402, P276, DOI 10.1038/46248; Llewellyn PL, 2008, LANGMUIR, V24, P7245, DOI 10.1021/la800227x; Ma SQ, 2007, J AM CHEM SOC, V129, P1858, DOI 10.1021/ja067435s; MacGillivray L.R, 2010, METAL ORGANIC FRAMEW; Merel J, 2008, IND ENG CHEM RES, V47, P209, DOI 10.1021/ie071012x; Moulton B, 2001, CHEM REV, V101, P1629, DOI 10.1021/cr9900432; MYERS AL, 1965, AICHE J, V11, P121, DOI 10.1002/aic.690110125; Noro S, 2000, ANGEW CHEM INT EDIT, V39, P2082; SUBRAMANIAN S, 1995, ANGEW CHEM INT EDIT, V34, P2127, DOI 10.1002/anie.199521271; Sumida K, 2012, CHEM REV, V112, P724, DOI 10.1021/cr2003272; Taylor P, 2010, ENERGY TECHNOLOGY PE; Uemura K, 2009, EUR J INORG CHEM, P2329, DOI 10.1002/ejic.200900144; Vaidhyanathan R, 2010, SCIENCE, V330, P650, DOI 10.1126/science.1194237; Xiang SC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1956; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650; Yazaydin AO, 2009, CHEM MATER, V21, P1425, DOI 10.1021/cm900049x	30	1683	1720	137	3335	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2013	495	7439					80	84		10.1038/nature11893	http://dx.doi.org/10.1038/nature11893			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23446349				2022-12-28	WOS:000316039800043
J	Guisbert, KSK; Sontheimer, EJ				Guisbert, Karen S. Kim; Sontheimer, Erik J.			Quit Stalling or You'll Be Silenced	CELL			English	Editorial Material							GENOME; RNAI	The use of small RNAs to program gene regulation and genome defense necessitates ever-changing choices about the sequences used for small-RNA biogenesis. Dumesic et al. now reveal stalled spliceosomes as a trigger for small-RNA biogenesis in the pathogenic fungus Cryptococcus neoformans.	[Guisbert, Karen S. Kim; Sontheimer, Erik J.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	Northwestern University	Sontheimer, EJ (corresponding author), Northwestern Univ, Dept Mol Biosci, 2205 Tech Dr, Evanston, IL 60208 USA.	erik@northwestern.edu		Kim Guisbert, Karen/0000-0001-9907-9502; Sontheimer, Erik/0000-0002-0881-0310				Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Bayne EH, 2008, SCIENCE, V322, P602, DOI 10.1126/science.1164029; Dumesic PA, 2013, CELL, V152, P957, DOI 10.1016/j.cell.2013.01.046; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Shepard PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-242; Tabach Y, 2013, NATURE, V493, P694, DOI 10.1038/nature11779; Wang XY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002885; Wang XY, 2010, GENE DEV, V24, P2566, DOI 10.1101/gad.1970910	10	1	1	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 28	2013	152	5					938	939		10.1016/j.cell.2013.02.025	http://dx.doi.org/10.1016/j.cell.2013.02.025			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452843	Bronze			2022-12-28	WOS:000315710300002
J	Hao, YH; Doyle, JM; Ramanathan, S; Gomez, TS; Jia, D; Xu, M; Chen, ZJJ; Billadeau, DD; Rosen, MK; Potts, PR				Hao, Yi-Heng; Doyle, Jennifer M.; Ramanathan, Saumya; Gomez, Timothy S.; Jia, Da; Xu, Ming; Chen, Zhijian J.; Billadeau, Daniel D.; Rosen, Michael K.; Potts, Patrick Ryan			Regulation of WASH-Dependent Actin Polymerization and Protein Trafficking by Ubiquitination	CELL			English	Article							ALDRICH-SYNDROME PROTEIN; RET FINGER PROTEIN; ARP2/3 COMPLEX; WAVE COMPLEX; MAGEL2 GENE; RETROMER; ACTIVATION; MECHANISMS; CANCER; FAMILY	Endosomal protein trafficking is an essential cellular process that is deregulated in several diseases and targeted by pathogens. Here, we describe a role for ubiquitination in this process. We find that the E3 RING ubiquitin ligase, MAGE-L2-TRIM27, localizes to endosomes through interactions with the retromer complex. Knockdown of MAGE-L2-TRIM27 or the Ube2O E2 ubiquitin-conjugating enzyme significantly impaired retromer-mediated transport. We further demonstrate that MAGE-L2-TRIM27 ubiquitin ligase activity is required for nucleation of endosomal F-actin by the WASH regulatory complex, a known regulator of retromer-mediated transport. Mechanistic studies showed that MAGE-L2-TRIM27 facilitates K63-linked ubiquitination of WASH K220. Significantly, disruption of WASH ubiquitination impaired endosomal F-actin nucleation and retromer-dependent transport. These findings provide a cellular and molecular function for MAGE-L2-TRIM27 in retrograde transport, including an unappreciated role of K63-linked ubiquitination and identification of an activating signal of the WASH regulatory complex.	[Hao, Yi-Heng; Doyle, Jennifer M.; Ramanathan, Saumya; Potts, Patrick Ryan] UT Southwestern Dallas, Dept Physiol, Dallas, TX 75390 USA; [Jia, Da; Rosen, Michael K.] UT Southwestern Dallas, Dept Biophys, Dallas, TX 75390 USA; [Xu, Ming; Chen, Zhijian J.] UT Southwestern Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Chen, Zhijian J.; Rosen, Michael K.] UT Southwestern Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Potts, Patrick Ryan] UT Southwestern Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Gomez, Timothy S.; Billadeau, Daniel D.] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Gomez, Timothy S.; Billadeau, Daniel D.] Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA	Howard Hughes Medical Institute; Mayo Clinic; Mayo Clinic	Potts, PR (corresponding author), UT Southwestern Dallas, Dept Physiol, Dallas, TX 75390 USA.	ryan.potts@utsouthwestern.edu	Potts, Patrick R/P-4707-2018; Chen, Zhijian/C-6039-2012; 高, 雨莉/HGU-8187-2022	Potts, Patrick R/0000-0002-2024-8885; Chen, Zhijian/0000-0002-8475-8251; Jia, Da/0000-0002-2205-1998	Cancer Prevention and Research Initiative of Texas [R1117]; Department of Defense [CA110261]; Howard Hughes Medical Institute; Mayo Foundation; Michael L. Rosenberg Scholar in Medical Research fund; NIH [R01-AI065474, R01-GM063692, R01-GM56322]; Sara and Frank McKnight Fellowship; Welch Foundation [I-1544, I-1389]; NATIONAL CANCER INSTITUTE [R01CA110261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056322, R01GM063692] Funding Source: NIH RePORTER	Cancer Prevention and Research Initiative of Texas; Department of Defense(United States Department of Defense); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Mayo Foundation; Michael L. Rosenberg Scholar in Medical Research fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sara and Frank McKnight Fellowship; Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Mitsuaki Tabuchi (Kawasaki Medical School, Japan) for providing the retromer construct. We also thank Potts lab members for helpful discussions and critical reading of the manuscript. This work was supported by the Cancer Prevention and Research Initiative of Texas R1117 (P. R. P.), Department of Defense CA110261 (P. R. P.), Howard Hughes Medical Institute (M. K. R.), Mayo Foundation (D. D. B.), Michael L. Rosenberg Scholar in Medical Research fund (P. R. P.), NIH R01-AI065474 (D. D. B.), NIH R01-GM063692 (Z. J. C.), NIH R01-GM56322 (M. K. R.), Sara and Frank McKnight Fellowship (P. R. P.), and Welch Foundation I-1544 (M. K. R.) and I-1389 (Z.J.C.).	Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Bischof JM, 2007, HUM MOL GENET, V16, P2713, DOI 10.1093/hmg/ddm225; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Boccaccio I, 1999, HUM MOL GENET, V8, P2497, DOI 10.1093/hmg/8.13.2497; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Boudinot P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022022; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chen ZC, 2010, NATURE, V468, P533, DOI 10.1038/nature09623; Cory GOC, 2003, MOL CELL, V11, P1229, DOI 10.1016/S1097-2765(03)00172-2; Cullen PJ, 2012, NAT CELL BIOL, V14, P29, DOI 10.1038/ncb2374; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Duleh S.N., 2012, REGULATION INTEGRIN; Duleh SN, 2010, CYTOSKELETON, V67, P193, DOI 10.1002/cm.20437; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Gomez TS, 2012, MOL BIOL CELL, V23, P3215, DOI 10.1091/mbc.E12-02-0101; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Harbers M, 2001, J BIOL CHEM, V276, P48596, DOI 10.1074/jbc.M108077200; Harbour ME, 2012, BIOCHEM J, V442, P209, DOI 10.1042/BJ20111761; Ismail AM, 2009, NAT STRUCT MOL BIOL, V16, P561, DOI 10.1038/nsmb.1587; Jia D, 2010, P NATL ACAD SCI USA, V107, P10442, DOI 10.1073/pnas.0913293107; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kozlov SV, 2007, NAT GENET, V39, P1266, DOI 10.1038/ng2114; Krutzfeldt M, 2005, MOL CELL, V18, P213, DOI 10.1016/j.molcel.2005.03.009; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Liu R, 2009, DEVELOPMENT, V136, P2849, DOI 10.1242/dev.035246; Markson G, 2009, GENOME RES, V19, P1905, DOI 10.1101/gr.093963.109; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; Saenko V, 2003, MUTAT RES-FUND MOL M, V527, P81, DOI 10.1016/S0027-5107(03)00056-3; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Small SA, 2008, ARCH NEUROL-CHICAGO, V65, P323, DOI 10.1001/archneurol.2007.64; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; TAKAHASHI M, 1987, MOL CELL BIOL, V7, P1378, DOI 10.1128/MCB.7.4.1378; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Zech T, 2011, J CELL SCI, V124, P3753, DOI 10.1242/jcs.080986; Zha FK, 2006, J IMMUNOL, V176, P1072, DOI 10.4049/jimmunol.176.2.1072; Zoumpoulidou G, 2012, JNCI-J NATL CANCER I, V104, P941, DOI 10.1093/jnci/djs224	46	162	171	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 28	2013	152	5					1051	1064		10.1016/j.cell.2013.01.051	http://dx.doi.org/10.1016/j.cell.2013.01.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452853	Green Accepted, Bronze			2022-12-28	WOS:000315710300013
J	Risaliti, G; Harrison, FA; Madsen, KK; Walton, DJ; Boggs, SE; Christensen, FE; Craig, WW; Grefenstette, BW; Hailey, CJ; Nardini, E; Stern, D; Zhang, WW				Risaliti, G.; Harrison, F. A.; Madsen, K. K.; Walton, D. J.; Boggs, S. E.; Christensen, F. E.; Craig, W. W.; Grefenstette, B. W.; Hailey, C. J.; Nardini, E.; Stern, Daniel; Zhang, W. W.			A rapidly spinning supermassive black hole at the centre of NGC 1365	NATURE			English	Article							ACTIVE GALACTIC NUCLEI; EMISSION-LINES; 1H 0707-495; ABSORPTION; REGION; MODEL; MCG-6-30-15; REFLECTION; NGC-1365; SIZE	Broad X-ray emission lines from neutral and partially ionized iron observed in active galaxies have been interpreted as fluorescence produced by the reflection of hard X-rays off the inner edge of an accretion disk(1-7). In this model, line broadening and distortion result from rapid rotation and relativistic effects near the black hole, the line shape being sensitive to its spin. Alternative models in which the distortions result from absorption by intervening structures provide an equally good description of the data(8,9), and there has been no general agreement on which is correct. Recent claims(10) that the black hole(11,12) (2 X 10(6) solar masses) at the centre of the galaxy NGC 1365 is rotating at close to its maximum possible speed rest on the assumption of relativistic reflection. Here we report X-ray observations of NGC 1365 that reveal the relativistic disk features through broadened Fe-line emission and an associated Compton scattering excess of 10-30 kiloelectronvolts. Using temporal and spectral analyses, we disentangle continuum changes due to time-variable absorption from reflection, which we find arises from a region within 2.5 gravitational radii of the rapidly spinning black hole. Absorption-dominated models that do not include relativistic disk reflection can be ruled out both statistically and on physical grounds.	[Risaliti, G.] INAF Osservatoria Astrofis Arcetri, I-50125 Florence, Italy; [Risaliti, G.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Harrison, F. A.; Madsen, K. K.; Walton, D. J.; Grefenstette, B. W.] CALTECH, Cahill Ctr Astrophys, Pasadena, CA 91125 USA; [Boggs, S. E.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Christensen, F. E.; Craig, W. W.] Tech Univ Denmark, DTU Space Natl Space Inst, DK-2800 Lyngby, Denmark; [Craig, W. W.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Hailey, C. J.] Columbia Univ, Columbia Astrophys Lab, New York, NY 10027 USA; [Nardini, E.] Keele Univ, Astrophys Grp, Sch Phys & Geog Sci, Keele ST5 5BG, Staffs, England; [Stern, Daniel] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Zhang, W. W.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	Istituto Nazionale Astrofisica (INAF); Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; California Institute of Technology; University of California System; University of California Berkeley; Technical University of Denmark; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Columbia University; Keele University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Risaliti, G (corresponding author), INAF Osservatoria Astrofis Arcetri, Largo Enrico Fermi 5, I-50125 Florence, Italy.	risaliti@arcetri.astro.it; fiona@srl.caltech.edu	christensen, finn/AAB-8622-2020; Boggs, Steven E/E-4170-2015	Boggs, Steven E/0000-0001-9567-4224; Nardini, Emanuele/0000-0001-9226-8992; Stern, Daniel/0000-0003-2686-9241; Risaliti, Guido/0000-0002-3556-977X	NASA [NNG08FD60C]; National Aeronautics and Space Administration; ESA Member States; STFC [ST/F00723X/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/F00723X/1] Funding Source: researchfish	NASA(National Aeronautics & Space Administration (NASA)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); ESA Member States(European Space Agency); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported under NASA grant number NNG08FD60C, and made use of data from the Nuclear Spectroscopic Telescope Array (NuSTAR) mission, a project led by Caltech, managed by the Jet Propulsion Laboratory, and funded by the National Aeronautics and Space Administration. We thank the NuSTAR Operations, Software and Calibration teams for support with execution and analysis of these observations. This work also made use of observations obtained with XMM-Newton, an ESA science mission with instruments and contributions directly funded by ESA Member States and NASA.	Alonso-Herrero A, 2012, MON NOT R ASTRON SOC, V425, P311, DOI 10.1111/j.1365-2966.2012.21464.x; Bassani L, 1999, ASTROPHYS J SUPPL S, V121, P473, DOI 10.1086/313202; Brenneman LW, 2013, MON NOT R ASTRON SOC, V429, P2662, DOI 10.1093/mnras/sts555; Brenneman LW, 2006, ASTROPHYS J, V652, P1028, DOI 10.1086/508146; Brenneman LW, 2009, ASTROPHYS J, V702, P1367, DOI 10.1088/0004-637X/702/2/1367; Chiang CY, 2011, MON NOT R ASTRON SOC, V414, P2345, DOI 10.1111/j.1365-2966.2011.18553.x; Fabian AC, 2009, NATURE, V459, P540, DOI 10.1038/nature08007; FABIAN AC, 1989, MON NOT R ASTRON SOC, V238, P729, DOI 10.1093/mnras/238.3.729; Harrison F. A., ASTROPHYS J UNPUB; Jaasen F, 2001, ASTRON ASTROPHYS, V365, pL1, DOI 10.1051/0004-6361:20000036; Kaspi S, 2005, ASTROPHYS J, V629, P61, DOI 10.1086/431275; LAOR A, 1991, ASTROPHYS J, V376, P90, DOI 10.1086/170257; MAGDZIARZ P, 1995, MON NOT R ASTRON SOC, V273, P837, DOI 10.1093/mnras/273.3.837; Maiolino R, 2010, ASTRON ASTROPHYS, V517, DOI 10.1051/0004-6361/200913985; Miller L, 2008, ASTRON ASTROPHYS, V483, P437, DOI 10.1051/0004-6361:200809590; Miller L, 2010, MON NOT R ASTRON SOC, V408, P1928, DOI 10.1111/j.1365-2966.2010.17261.x; Miniutti G, 2004, MON NOT R ASTRON SOC, V349, P1435, DOI 10.1111/j.1365-2966.2004.07611.x; Murphy KD, 2009, MON NOT R ASTRON SOC, V397, P1549, DOI 10.1111/j.1365-2966.2009.15025.x; Reynolds CS, 2008, ASTROPHYS J, V675, P1048, DOI 10.1086/527344; Risaliti G, 2007, ASTROPHYS J, V659, P111; Risaliti G, 2005, ASTROPHYS J, V630, pL129, DOI 10.1086/491646; Risaliti G, 2009, ASTROPHYS J, V696, P160, DOI 10.1088/0004-637X/696/1/160; Schulz H, 1999, ASTRON ASTROPHYS, V346, P764; Volonteri M, 2005, ASTROPHYS J, V620, P69, DOI 10.1086/426858; Walton DJ, 2013, MON NOT R ASTRON SOC, V428, P2901, DOI 10.1093/mnras/sts227; Walton DJ, 2010, MON NOT R ASTRON SOC, V408, P601, DOI 10.1111/j.1365-2966.2010.17148.x; Wang JF, 2009, ASTROPHYS J, V694, P718, DOI 10.1088/0004-637X/694/2/718	27	219	222	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2013	494	7438					449	451		10.1038/nature11938	http://dx.doi.org/10.1038/nature11938			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23446416	Green Submitted, Green Accepted			2022-12-28	WOS:000315661500031
J	Walters, C; Berjak, P; Pammenter, N; Kennedy, K; Raven, P				Walters, Christina; Berjak, Patricia; Pammenter, Norman; Kennedy, Kathryn; Raven, Peter			Preservation of Recalcitrant Seeds	SCIENCE			English	Editorial Material							CRYOPRESERVATION		[Walters, Christina] ARS, USDA, Natl Ctr Genet Resources Preservat, Ft Collins, CO 80521 USA; [Berjak, Patricia; Pammenter, Norman] Univ KwaZulu Natal, Sch Life Sci, ZA-4001 Durban, South Africa; [Kennedy, Kathryn] Ctr Plant Conservat, St Louis, MO 63166 USA; [Raven, Peter] Missouri Bot Garden, St Louis, MO 63166 USA	United States Department of Agriculture (USDA); University of Kwazulu Natal; Missouri Botanical Gardens	Walters, C (corresponding author), ARS, USDA, Natl Ctr Genet Resources Preservat, Ft Collins, CO 80521 USA.	christina.walters@ars.usda.gov		Walters, Christina/0000-0002-9035-945X				Benson EE, 2008, CRIT REV PLANT SCI, V27, P141, DOI 10.1080/07352680802202034; Berjak P, 2008, ANN BOT-LONDON, V101, P213, DOI 10.1093/aob/mcm168; Berjak P, 2011, SEED SCI RES, V21, P187, DOI 10.1017/S0960258511000110; Daws MI, 2006, ANN BOT-LONDON, V97, P667, DOI 10.1093/aob/mcl022; Dickie John B., 2002, P239, DOI 10.1079/9780851995342.0239; Engelmann F, 2011, METHODS MOL BIOL, V710, P155, DOI 10.1007/978-1-61737-988-8_13; Hamilton KN, 2013, PLANT SPEC BIOL, V28, P51, DOI 10.1111/j.1442-1984.2011.00353.x; Hong T.D., 1996, IPGRI TECHNICAL B, V1; Kramer AT, 2009, TRENDS PLANT SCI, V14, P599, DOI 10.1016/j.tplants.2009.08.005; Li DZ, 2009, TRENDS PLANT SCI, V14, P614, DOI 10.1016/j.tplants.2009.09.005; NORMAH M N, 1986, Pertanika, V9, P299; Pence VC, 2011, IN VITRO CELL DEV-PL, V47, P176, DOI 10.1007/s11627-010-9323-6; Pennisi E, 2010, SCIENCE, V329, P1274, DOI 10.1126/science.329.5997.1274; Reed BM, 2011, IN VITRO CELL DEV-PL, V47, P1, DOI 10.1007/s11627-010-9337-0; Richards CM, 2009, TREE GENET GENOMES, V5, P339, DOI 10.1007/s11295-008-0190-9; Towill LE, 2004, SCI PRAC ECOL REST, P180; Tweddle JC, 2003, J ECOL, V91, P294, DOI 10.1046/j.1365-2745.2003.00760.x; Walters Christina, 2008, P465, DOI 10.1007/978-0-387-72276-4_18; Walters Christina, 2008, Biodiversity (Ottawa), V9, P68; Weisenberger L., 2008, POLISH J NAT SCI S, V5, P281	20	113	124	6	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2013	339	6122					915	916		10.1126/science.1230935	http://dx.doi.org/10.1126/science.1230935			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23430644				2022-12-28	WOS:000315149600036
J	Wright, JD; Ananth, CV; Lewin, SN; Burke, WM; Lu, YS; Neugut, AI; Herzog, TJ; Hershman, DL				Wright, Jason D.; Ananth, Cande V.; Lewin, Sharyn N.; Burke, William M.; Lu, Yu-Shiang; Neugut, Alfred I.; Herzog, Thomas J.; Hershman, Dawn L.			Robotically Assisted vs Laparoscopic Hysterectomy Among Women With Benign Gynecologic Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TREATMENT FAILURE; PROPENSITY SCORE; OUTCOMES; MORTALITY; THERAPY; RISK; BIAS	Importance Although robotically assisted hysterectomy for benign gynecologic conditions has been reported, little is known about the incorporation of the procedure into practice, its complication profile, or its costs compared with other routes of hysterectomy. Objectives To analyze the uptake of robotically assisted hysterectomy, to determine the association between use of robotic surgery and rates of abdominal and laparoscopic hysterectomy, and to compare the in-house complications of robotically assisted hysterectomy vs abdominal and laparoscopic procedures. Design, Setting, and Patients Cohort study of 264 758 women who underwent hysterectomy for benign gynecologic disorders at 441 hospitals across the United States from 2007 to 2010. Main Outcome Measures Uptake of and factors associated with utilization of robotically assisted hysterectomy. Complications, transfusion, reoperation, length of stay, death, and cost for women who underwent robotic hysterectomy compared with both abdominal and laparoscopic procedures were analyzed. Results Use of robotically assisted hysterectomy increased from 0.5% in 2007 to 9.5% of all hysterectomies in 2010. During the same time period, laparoscopic hysterectomy rates increased from 24.3% to 30.5%. Three years after the first robotic procedure at hospitals where robotically assisted hysterectomy was performed, robotically assisted hysterectomy accounted for 22.4% of all hysterectomies. The rates of abdominal hysterectomy decreased both in hospitals where robotic-assisted hysterectomy was performed as well as in those where it was not performed. In a propensity score-matched analysis, the overall complication rates were similar for robotic-assisted and laparoscopic hysterectomy(5.5% vs 5.3%; relative risk [RR], 1.03; 95% CI, 0.86-1.24). Although patients who underwent a robotic-assisted hysterectomy were less likely to have a length of stay longer than 2 days (19.6% vs 24.9%; RR, 0.78, 95% CI, 0.67-0.92), transfusion requirements (1.4% vs 1.8%; RR, 0.80; 95% CI, 0.55-1.16) and the rate of discharge to a nursing facility (0.2% vs 0.3%; RR, 0.79; 95% CI, 0.35-1.76) were similar. Total costs associated with robotically assisted hysterectomy were $2189 (95% CI, $2030-$2349) more per case than for laparoscopic hysterectomy. Conclusions and Relevance Between 2007 and 2010, the use of robotically assisted hysterectomy for benign gynecologic disorders increased substantially. Robotically assisted and laparoscopic hysterectomy had similar morbidity profiles, but the use of robotic technology resulted in substantially more costs. JAMA. 2013;309(7):689-698 www.jama.com	[Wright, Jason D.; Ananth, Cande V.; Lewin, Sharyn N.; Burke, William M.; Lu, Yu-Shiang; Herzog, Thomas J.] Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10032 USA; [Neugut, Alfred I.; Hershman, Dawn L.] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Wright, Jason D.; Lewin, Sharyn N.; Neugut, Alfred I.; Herzog, Thomas J.; Hershman, Dawn L.] Columbia Univ Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Neugut, Alfred I.; Hershman, Dawn L.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University	Wright, JD (corresponding author), Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, Div Gynecol Oncol, 161 Ft Washington Ave,8th Floor, New York, NY 10032 USA.	jw2459@columbia.edu	Hershman, Dawn/AAG-2114-2020		National Cancer Institute [R01CA134964]; NATIONAL CANCER INSTITUTE [R01CA134964] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by a grant from the National Cancer Institute (R01CA134964).	[Anonymous], 2009, Obstet Gynecol, V114, P1156, DOI 10.1097/AOG.0b013e3181c33c72; [Anonymous], CONS PRIC IND 2011; Barbash GI, 2010, NEW ENGL J MED, V363, P701, DOI 10.1056/NEJMp1006602; Barnett JC, 2010, OBSTET GYNECOL, V116, P685, DOI 10.1097/AOG.0b013e3181ee6e4d; Boggess JF, 2009, OBSTET GYNECOL, V114, P585, DOI 10.1097/AOG.0b013e3181b47030; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Geppert B, 2011, ACTA OBSTET GYN SCAN, V90, P1210, DOI 10.1111/j.1600-0412.2011.01253.x; Giep BN, 2010, J ROBOT SURG, V4, P167, DOI 10.1007/s11701-010-0206-y; Hemmila MR, 2010, ARCH SURG-CHICAGO, V145, P939, DOI 10.1001/archsurg.2010.193; Hu JC, 2009, JAMA-J AM MED ASSOC, V302, P1557, DOI 10.1001/jama.2009.1451; Jacoby VL, 2009, OBSTET GYNECOL, V114, P1041, DOI 10.1097/AOG.0b013e3181b9d222; Jin Linda X, 2011, J Healthc Qual, V33, P48, DOI 10.1111/j.1945-1474.2011.00148.x; Jonsdottir GM, 2011, OBSTET GYNECOL, V117, P1142, DOI 10.1097/AOG.0b013e3182166055; Kilic GS, 2011, OBSTET GYNECOL INT, V2011, DOI 10.1155/2011/683703; Koenker R., 2005, ECONOMETRIC SOC MONO; Kolata G., 2010, NY TIMES, pA1; Kollef MH, 2012, INFECT CONT HOSP EP, V33, P250, DOI 10.1086/664049; Lau S, 2012, OBSTET GYNECOL, V119, P717, DOI 10.1097/AOG.0b013e31824c0956; Lim PC, 2011, GYNECOL ONCOL, V120, P413, DOI 10.1016/j.ygyno.2010.11.034; Lindenauer PK, 2010, JAMA-J AM MED ASSOC, V303, P2359, DOI 10.1001/jama.2010.796; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Liu HQ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008978.pub2; Maeso S, 2010, ANN SURG, V252, P254, DOI 10.1097/SLA.0b013e3181e6239e; Nezhat C, 2009, JSLS-J SOC LAPAROEND, V13, P125; Nieboer TE, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003677.pub4, 10.1002/14651858.CD003677.pub5]; Pasic RP, 2010, J MINIM INVAS GYN, V17, P730, DOI 10.1016/j.jmig.2010.06.009; Payne TN, 2008, J MINIM INVAS GYN, V15, P286, DOI 10.1016/j.jmig.2008.01.008; Payne TN, 2010, OBSTET GYNECOL, V115, P535, DOI 10.1097/AOG.0b013e3181cf45ad; Reza M, 2010, BRIT J SURG, V97, P1772, DOI 10.1002/bjs.7269; Rothberg MB, 2010, JAMA-J AM MED ASSOC, V303, P2035, DOI 10.1001/jama.2010.672; Sarlos D, 2011, CURR OPIN OBSTET GYN, V23, P283, DOI 10.1097/GCO.0b013e328348a26e; Sarlos D, 2010, EUR J OBSTET GYN R B, V150, P92, DOI 10.1016/j.ejogrb.2010.02.012; Shah NT, 2011, OBSTET GYNECOL INT, V2011, DOI 10.1155/2011/570464; Shashoua AR, 2009, JSLS-J SOC LAPAROEND, V13, P364; Soto E, 2011, J GYNECOL ONCOL, V22, P253, DOI 10.3802/jgo.2011.22.4.253; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Stukenborg GJ, 2005, SURGERY, V138, P498, DOI 10.1016/j.surg.2005.04.004; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Wright JD, 2012, J CLIN ONCOL, V30, P783, DOI 10.1200/JCO.2011.36.7508; Wu JM, 2007, OBSTET GYNECOL, V110, P1091, DOI 10.1097/01.AOG.0000285997.38553.4b	40	367	373	4	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2013	309	7					689	698		10.1001/jama.2013.186	http://dx.doi.org/10.1001/jama.2013.186			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091EK	23423414				2022-12-28	WOS:000315032000024
J	Navarese, EP; Gurbel, PA; Andreotti, F; Tantry, U; Jeong, YH; Kozinski, M; Engstrom, T; Di Pasquale, G; Kochman, W; Ardissino, D; Kedhi, E; Stone, GW; Kubica, J				Navarese, Eliano P.; Gurbel, Paul A.; Andreotti, Felicita; Tantry, Udaya; Jeong, Young-Hoon; Kozinski, Marek; Engstrom, Thomas; Di Pasquale, Giuseppe; Kochman, Waclaw; Ardissino, Diego; Kedhi, Elvin; Stone, Gregg W.; Kubica, Jacek			Optimal Timing of Coronary Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndromes A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							UNSTABLE ANGINA; MYOCARDIAL-INFARCTION; INTERVENTION; ANGIOGRAPHY; IMMEDIATE; OUTCOMES; CATHETERIZATION; ANGIOPLASTY	Background: The optimal timing of coronary intervention in patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACSs) is a matter of debate. Conflicting results among published studies partly relate to different risk profiles of the studied populations. Purpose: To do the most comprehensive meta-analysis of current evidence on early versus delayed invasive treatment in NSTE-ACS. Data Sources: MEDLINE, PubMed Central, and Google Scholar databases; conference proceedings; ClinicalTrials.gov registry; and Current Controlled Trials registry through May 2012. Study Selection: Available randomized, controlled trials (RCTs) and observational studies comparing early versus delayed intervention in the NSTE-ACS population. Data Extraction: Data were extracted for populations, interventions, outcomes, and risk of bias. All-cause mortality was the pre-specified primary end point. The longest follow-up available in each study was chosen. The odds ratio with 95% CI was the effect measure. Data Synthesis: Seven RCTs (5370 patients) and 4 observational studies (77 499 patients) were included. Early intervention was less than 20 hours after hospitalization or randomization for RCTs and 24 hours or less for observational studies. Meta-analysis of the RCTs was inconclusive for a survival benefit associated with the early invasive strategy (odds ratio, 0.83 [95% CI, 0.64 to 1.09]; P = 0.180); a similar result emerged from the observational studies. With early versus late intervention, the odds ratios in the RCTs were 1.15 (CI, 0.65 to 2.01; P = 0.63) and 0.76 (CI, 0.56 to 1.04; P = 0.090) for myocardial infarction and major bleeding during follow-up, respectively. Limitation: Current evidence from RCTs is limited by the small overall sample size, low numbers of events in some trials, and heterogeneity in the timing of intervention and in patient risk profiles. Conclusion: At present, there is insufficient evidence either in favor of or against an early invasive approach in the NSTE-ACS population. A more definitive RCT is warranted to guide clinical practice.	Nicolaus Copernicus Univ, Ludwik Rydygier Coll Med, PL-85094 Bydgoszcz, Poland; Sinai Hosp Baltimore, Sinai Ctr Thrombosis Res, Baltimore, MD USA; Univ Cattolica Sacro Cuore, I-00168 Rome, Italy; Rigshosp, DK-2100 Copenhagen, Denmark; Osped Maggiore Bologna, Unita Osped Cardiol, I-40133 Bologna, Italy; Med Univ Gdansk, Swissmed Hosp, PL-80215 Gdansk, Poland; Univ Parma, Azienda Osped, I-43100 Parma, Italy; Maasstad Ziekenhuis, NL-3079 DZ Rotterdam, Netherlands; Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY 10022 USA; Cardiovasc Res Fdn, New York, NY USA	Nicolaus Copernicus University; Sinai Center Thrombosis Research; Sinai Hospital of Baltimore; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Rigshospitalet; University of Copenhagen; AUSL di Bologna; Fahrenheit Universities; Medical University Gdansk; University of Parma; University Hospital of Parma; Maasstad Hospital; Columbia University; NewYork-Presbyterian Hospital; Cardiovascular Research Foundation (CRF)	Navarese, EP (corresponding author), Nicolaus Copernicus Univ, Ludwik Rydygier Coll Med, Dept Internal Med & Cardiol, Sklodowskiej Curie St 9, PL-85094 Bydgoszcz, Poland.	eliano.navarese@alice.it	Ardissino, Diego/AAC-4041-2022; Jeong, Young-Hoon/F-3476-2015; Kozinski, Marek/G-4203-2014; Kubica, Jacek/D-6906-2014; Andreotti, Felicita/A-9962-2019; Jeong, Young-Hoon/AAO-4401-2020	Jeong, Young-Hoon/0000-0003-0403-3726; Kozinski, Marek/0000-0002-6460-4802; Kubica, Jacek/0000-0001-8250-754X; Andreotti, Felicita/0000-0002-1456-6430; Engstrom, Thomas/0000-0001-5436-9194; Kochman, Waclaw/0000-0002-7706-0648; Navarese, Eliano/0000-0002-2355-4589; solinas, emilia/0000-0003-3532-1317	AstraZeneca; Bayer; Eli Lilly; Pfizer; Daiichi Sankyo; Boehringer-Ingelheim; Otsuka; Accumetrics; Haemonetics; Sanofi-Aventis; Daiichi Sankyo/Eli Lilly; Nanospher; Bristol-Myers Squibb-Pfizer	AstraZeneca(AstraZeneca); Bayer(Bayer AG); Eli Lilly(Eli Lilly); Pfizer(Pfizer); Daiichi Sankyo(Daiichi Sankyo Company Limited); Boehringer-Ingelheim(Boehringer Ingelheim); Otsuka(Otsuka Pharmaceutical); Accumetrics; Haemonetics; Sanofi-Aventis(Sanofi-Aventis); Daiichi Sankyo/Eli Lilly(Daiichi Sankyo Company LimitedEli Lilly); Nanospher; Bristol-Myers Squibb-Pfizer(Bristol-Myers SquibbPfizer)	Potential Conflicts of Interest: Dr. Gurbel: Consultancy: Daiichi Sankyo, Eli Lilly, Pozen, Novartis, Bayer, AstraZeneca, Accumetrics, Nanosphere, Sanofi-Aventis, Boehringer Ingelheim, Merck, Medtronic, Iverson Genetics, CSL, Haemonetics. Dr. Andreotti: Board membership: Bayer; Consultancy: Bayer, Bristol-Myers Squibb-Pfizer, Eli Lilly, Daiichi Sankyo; Payment for lectures: AstraZeneca, Bayer, Eli Lilly, Pfizer, Daiichi Sankyo. Dr. Jeong: Grant: Boehringer-Ingelheim, Otsuka, Accumetrics, Haemonetics; Consulting fee or honorarium: Sanofi-Aventis, Daiichi Sankyo/Eli Lilly, Nanospher, Haemonetics, Otsuka; Support for travel to meetings for the study or other purposes: Haemonetics. Dr. Ardissino: Grant (money to institution): Eli Lilly, AstraZeneca, Sanofi-Aventis, Boston Scientific, Medtronic, Bayer; Consulting fee or honorarium: Eli Lilly, AstraZeneca, Sanofi-Aventis, Boston Scientific; Payment for lectures, including service on speakers bureaus: Eli Lilly, AstraZeneca, Sanofi-Aventis, Boston Scientific, Medtronic, Bayer. Dr. Stone: Consultancy: Osprey Pharmaceuticals, Reva, Merck, Boston Scientific, Abbott Vascular, AstraZeneca, Eli Lilly-Daiichi Sankyo partnership, Bristol-Myers Squibb-Sanofi-Aventis partnership, Otsuka, The Medicines Company, Ortho-McNeil, Gilead Sciences, InspireMD, TherOx, Atrium, Volcano, InfraReDx, Medtronic, Genentech, GlaxoSmithKline, Miracor, MPP Group, Lutonix, Velomedix, CSI, St. Jude, Thoratec; Honoraria: Edwards LifeSciences, Vascular Solutions; Stock/stock options: CoreValve, Biostar I and II funds, MedFocus I, II, and Accelerator funds, Caliber, FlowCardia, Ovalum, Guided Delivery Systems, Arstasis, MiCardia, AccessClosure, Embrella Cardiovascular, VNT. All other authors have no disclosures. Disclosures can also be viewed at www. acponline. org/authors/icmje/ConflictOf InterestForms.do?msNum = M12-0590.	Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Katritsis DG, 2011, EUR HEART J, V32, P32, DOI 10.1093/eurheartj/ehq276; Levine GN, 2011, CIRCULATION, V124, pE574, DOI 10.1161/CIR.0b013e31823ba622; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mehta SR, 2009, NEW ENGL J MED, V360, P2165, DOI 10.1056/NEJMoa0807986; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Montalescot G, 2005, AM J CARDIOL, V95, P1397, DOI 10.1016/j.amjcard.2005.02.004; Montalescot G, 2009, JAMA-J AM MED ASSOC, V302, P947, DOI 10.1001/jama.2009.1267; Navarese EP, 2011, QJM-INT J MED, V104, P193, DOI 10.1093/qjmed/hcq258; Neumann FJ, 2003, JAMA-J AM MED ASSOC, V290, P1593, DOI 10.1001/jama.290.12.1593; Riezebos RK, 2009, HEART, V95, P807, DOI 10.1136/hrt.2008.154815; Ryan JW, 2005, CIRCULATION, V112, P3049, DOI 10.1161/CIRCULATIONAHA.105.582346; Sorajja P, 2010, J AM COLL CARDIOL, V55, P1416, DOI 10.1016/j.jacc.2009.11.063; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Thiele H, 2012, EUR HEART J, V33, P2035, DOI 10.1093/eurheartj/ehr418; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Tricoci P, 2007, CIRCULATION, V116, P2669, DOI 10.1161/CIRCULATIONAHA.107.690081; van't Hof AWJ, 2003, EUR HEART J, V24, P1401, DOI 10.1016/S0195-668X(03)00259-8; Wallentin L, 2000, LANCET, V356, P9, DOI 10.1016/S0140-6736(00)02427-2; Zhang Jun, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P865	25	118	122	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2013	158	4					261	270		10.7326/0003-4819-158-4-201302190-00006	http://dx.doi.org/10.7326/0003-4819-158-4-201302190-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098WR	23420234				2022-12-28	WOS:000315580300017
J	Petry, S; Groen, AC; Ishihara, K; Mitchison, TJ; Vale, RD				Petry, Sabine; Groen, Aaron C.; Ishihara, Keisuke; Mitchison, Timothy J.; Vale, Ronald D.			Branching Microtubule Nucleation in Xenopus Egg Extracts Mediated by Augmin and TPX2	CELL			English	Article							MITOTIC SPINDLE FORMATION; TUBULIN RING COMPLEX; GTP-BOUND RAN; GAMMA-TUBULIN; SELF-ORGANIZATION; AURORA-A; IMPORTIN-ALPHA; HUMAN-CELLS; IN-VITRO; GENERATION	The microtubules that comprise mitotic spindles in animal cells are nucleated at centrosomes and by spindle assembly factors that are activated in the vicinity of chromatin. Indirect evidence has suggested that microtubules also might be nucleated from pre-existing microtubules throughout the spindle, but this process has not been observed directly. Here, we demonstrate microtubule nucleation from the sides of existing microtubules in meiotic Xenopus egg extracts. Daughter microtubules grow at a low branch angle and with the same polarity as mother filaments. Branching microtubule nucleation requires gamma-tubulin and augmin and is stimulated by factors previously implicated in chromatin-stimulated nucleation, guanosine triphosphate(GTP)-bound Ran and its effector, TPX2. Because of the rapid amplification of microtubule numbers and the preservation of microtubule polarity, microtubule-dependent microtubule nucleation is well suited for spindle assembly and maintenance.	[Petry, Sabine; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Petry, Sabine; Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Petry, Sabine; Groen, Aaron C.; Ishihara, Keisuke; Mitchison, Timothy J.; Vale, Ronald D.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Groen, Aaron C.; Ishihara, Keisuke; Mitchison, Timothy J.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Marine Biological Laboratory - Woods Hole; Harvard University; Harvard Medical School	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 600 16th St, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu	Ishihara, Keisuke/I-5656-2019	Ishihara, Keisuke/0000-0002-8481-8680	NIH [GM38499, GM39565]; Evans Foundation Fellowship at MBL; Life Science Research Foundation fellowship; HHMI; K99 NIH grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038499, R01GM039565, R37GM039565, R37GM038499, K99GM100013] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Evans Foundation Fellowship at MBL; Life Science Research Foundation fellowship; HHMI(Howard Hughes Medical Institute); K99 NIH grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Steve Ross and Nikon, Inc., for generously providing a microscope to conduct initial studies at the MBL, Woods Hole. We thank Rebecca Heald, Kara Helmke, and Jeremy Wilbur (UC Berkeley) for generous help with Xenopus egg extracts, providing vectors, and suggestions. We also thank Chris Field and Ani Nguyen (Harvard Medical School) for help with Xenopus egg extracts, and Jim and Cathy Galbraith (NIH) and Nico Stuurman (UCSF) for microscopy assistance. This work was supported by NIH grants GM38499 to R.D.V. and GM39565 to T.J.M., an Evans Foundation Fellowship at MBL to R.D.V. and T.J.M., and a Life Science Research Foundation fellowship sponsored by HHMI and a K99 NIH grant to S.P.	Athale CA, 2008, SCIENCE, V322, P1243, DOI 10.1126/science.1161820; Bird AW, 2008, J CELL BIOL, V182, P289, DOI 10.1083/jcb.200802005; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; BRINKLEY BR, 1985, ANNU REV CELL BIOL, V1, P145, DOI 10.1146/annurev.cellbio.1.1.145; Brugues J, 2012, CELL, V149, P554, DOI 10.1016/j.cell.2012.03.027; Brunet S, 2004, MOL BIOL CELL, V15, P5318, DOI 10.1091/mbc.E04-05-0385; Bucciarelli E, 2009, CURR BIOL, V19, P1839, DOI 10.1016/j.cub.2009.09.043; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; Chan J, 2009, PLANT CELL, V21, P2298, DOI 10.1105/tpc.109.069716; Clausen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000244; Dinarina A, 2009, CELL, V138, P502, DOI 10.1016/j.cell.2009.05.027; Eckerdt F, 2008, CURR BIOL, V18, P519, DOI 10.1016/j.cub.2008.02.077; Edelstein A., 2010, CURR PROTOCOLS MOL B, V98; Gell C, 2010, METHOD CELL BIOL, V95, P221, DOI 10.1016/S0091-679X(10)95013-9; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Greenan G, 2010, CURR BIOL, V20, P353, DOI 10.1016/j.cub.2009.12.050; Groen AC, 2009, MOL BIOL CELL, V20, P2766, DOI 10.1091/mbc.E09-01-0043; Groen AC, 2004, CURR BIOL, V14, P1801, DOI 10.1016/j.cub.2004.10.002; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Ho CMK, 2011, PLANT CELL, V23, P2606, DOI 10.1105/tpc.111.086892; Hotta T, 2012, PLANT CELL, V24, P1494, DOI 10.1105/tpc.112.096610; Janson ME, 2005, J CELL BIOL, V169, P297, DOI 10.1083/jcb.200410119; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; KARSENTI E, 1984, J CELL BIOL, V98, P1730, DOI 10.1083/jcb.98.5.1730; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Keating TJ, 2000, NAT CELL BIOL, V2, P352, DOI 10.1038/35014045; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; Kollman JM, 2010, NATURE, V466, P879, DOI 10.1038/nature09207; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; Loughlin R, 2010, J CELL BIOL, V191, P1239, DOI 10.1083/jcb.201006076; Megraw TL, 2001, CURR BIOL, V11, P116, DOI 10.1016/S0960-9822(01)00017-3; Moritz M, 2000, NAT CELL BIOL, V2, P365, DOI 10.1038/35014058; Murata T, 2005, NAT CELL BIOL, V7, P961, DOI 10.1038/ncb1306; Nakaoka Y, 2012, PLANT CELL, V24, P1478, DOI 10.1105/tpc.112.098509; Needleman DJ, 2010, MOL BIOL CELL, V21, P323, DOI 10.1091/mbc.E09-09-0816; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; Petry S, 2011, P NATL ACAD SCI USA, V108, P14473, DOI 10.1073/pnas.1110412108; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; SAWIN KE, 1991, J CELL BIOL, V112, P941, DOI 10.1083/jcb.112.5.941; Schatz CA, 2003, EMBO J, V22, P2060, DOI 10.1093/emboj/cdg195; Tirnauer JS, 2004, MOL BIOL CELL, V15, P1776, DOI 10.1091/mbc.E03-11-0824; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Tulu US, 2006, CURR BIOL, V16, P536, DOI 10.1016/j.cub.2006.01.060; Uehara R, 2010, J CELL BIOL, V191, P259, DOI 10.1083/jcb.201004150; Uehara R, 2009, P NATL ACAD SCI USA, V106, P6998, DOI 10.1073/pnas.0901587106; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; Weis K, 1996, EMBO J, V15, P7120, DOI 10.1002/j.1460-2075.1996.tb01103.x; Wiese C, 2000, NAT CELL BIOL, V2, P358, DOI 10.1038/35014051; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Zhang H, 2011, CHROMOSOME RES, V19, P335, DOI 10.1007/s10577-011-9190-y; Zhu H, 2008, J CELL BIOL, V183, P835, DOI 10.1083/jcb.200807046	61	219	222	0	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 14	2013	152	4					768	777		10.1016/j.cell.2012.12.044	http://dx.doi.org/10.1016/j.cell.2012.12.044			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415226	Green Accepted, Bronze			2022-12-28	WOS:000314945600012
J	Creamean, JM; Suski, KJ; Rosenfeld, D; Cazorla, A; DeMott, PJ; Sullivan, RC; White, AB; Ralph, FM; Minnis, P; Comstock, JM; Tomlinson, JM; Prather, KA				Creamean, Jessie M.; Suski, Kaitlyn J.; Rosenfeld, Daniel; Cazorla, Alberto; DeMott, Paul J.; Sullivan, Ryan C.; White, Allen B.; Ralph, F. Martin; Minnis, Patrick; Comstock, Jennifer M.; Tomlinson, Jason M.; Prather, Kimberly A.			Dust and Biological Aerosols from the Sahara and Asia Influence Precipitation in the Western U.S.	SCIENCE			English	Article							ATMOSPHERIC ICE NUCLEI; OROGRAPHIC ENHANCEMENT; LIQUID WATER; MIXED-PHASE; CLOUD; PARTICLES; SUPPRESSION; DEPOSITION; RANGE; RADAR	Winter storms in California's Sierra Nevada increase seasonal snowpack and provide critical water resources and hydropower for the state. Thus, the mechanisms influencing precipitation in this region have been the subject of research for decades. Previous studies suggest Asian dust enhances cloud ice and precipitation, whereas few studies consider biological aerosols as an important global source of ice nuclei (IN). Here, we show that dust and biological aerosols transported from as far as the Sahara were present in glaciated high-altitude clouds coincident with elevated IN concentrations and ice-induced precipitation. This study presents the first direct cloud and precipitation measurements showing that Saharan and Asian dust and biological aerosols probably serve as IN and play an important role in orographic precipitation processes over the western United States.	[Creamean, Jessie M.; Suski, Kaitlyn J.; Cazorla, Alberto; Prather, Kimberly A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Rosenfeld, Daniel] Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel; [DeMott, Paul J.] Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA; [Sullivan, Ryan C.] Carnegie Mellon Univ, Ctr Atmospher Particle Studies, Pittsburgh, PA 15213 USA; [White, Allen B.; Ralph, F. Martin] NOAA, PSD, ESRL, Boulder, CO 80305 USA; [Ralph, F. Martin; Prather, Kimberly A.] Univ Calif San Diego, SIO, La Jolla, CA 92093 USA; [Minnis, Patrick] NASA, Langley Res Ctr, Hampton, VA 23681 USA; [Comstock, Jennifer M.; Tomlinson, Jason M.] Pacific NW Natl Lab, Atmospher Sci & Global Change Div, Richland, WA 99352 USA	University of California System; University of California San Diego; Hebrew University of Jerusalem; Colorado State University; Carnegie Mellon University; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California San Diego; National Aeronautics & Space Administration (NASA); NASA Langley Research Center; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Prather, KA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	kprather@ucsd.edu	Tomlinson, Jason M/C-6566-2009; Rosenfeld, Daniel/F-6077-2016; Minnis, Patrick/G-1902-2010; Studies, Center for Atmospheric Particle/AAR-6731-2020; Rosenfeld, Daniel/AAJ-4617-2021; DeMott, Paul J/C-4389-2011; Prather, Kim/A-3892-2008; Cazorla, Alberto/G-2097-2017; Sullivan, Ryan/B-4674-2008	Tomlinson, Jason M/0000-0002-0734-3298; Rosenfeld, Daniel/0000-0002-0784-7656; Minnis, Patrick/0000-0002-4733-6148; Rosenfeld, Daniel/0000-0002-0784-7656; DeMott, Paul J/0000-0002-3719-1889; Prather, Kim/0000-0003-3048-9890; Cazorla, Alberto/0000-0002-0901-1609; Sullivan, Ryan/0000-0003-0701-7158; Creamean, Jessie/0000-0003-3819-5600; Comstock, Jennifer/0000-0002-4183-7355	California Energy Commission [CEC 500-09-043]; Atmospheric System Research (ASR)/U.S. Department of Energy (DOE) program; ASR/DOE program [DE-SC0000991/003]; NASA MAPS Program	California Energy Commission; Atmospheric System Research (ASR)/U.S. Department of Energy (DOE) program; ASR/DOE program; NASA MAPS Program	Funding was provided by the California Energy Commission under contract CEC 500-09-043. D. R. was funded under the Atmospheric System Research (ASR)/U.S. Department of Energy (DOE) program. P. M. was supported by the ASR/DOE program under DE-SC0000991/003 and the NASA MAPS Program. J. Mayer, E. Fitzgerald, D. Collins, and J. Cahill provided assistance with UCSD/SIO equipment setup. The authors gratefully acknowledge the NOAA Air Resources Laboratory (ARL) for the provision of the HYSPLIT transport and dispersion model and READY website (www.arl.noaa.gov/ready.php) used in this publication and the Office of Naval Research for provision of NAAPS data. J. Ayers and R. Palikonda (Science Systems and Applications) provided GOES-11 cloud top heights used for HYSPLIT back trajectory analysis and %Ice in cloud. The deployment of the NOAA and UCSD/SIO equipment at the Sugar Pine site involved many field staff, particularly C. King (NOAA/ESRL/PSD). The deployment of the DOE Gulfstream-1 involved many PNNL/Atmospheric Radiation Measurement field staff, particularly E. Dukes, J. Hubbe, C. Kluzek, H. Jonsson, M. Pekour, and B. Schmid. M. Hubbell and B. Svancara flew the G-1 for the CalWater flight campaign. D. Collins and R. Spackman provided insightful discussions during the editing stages of this manuscript. T. Lersch of R. J. Lee provided TEM analyses of collected IN. Data available in this paper are available in the supplementary materials.	Andreae MO, 2008, EARTH-SCI REV, V89, P13, DOI 10.1016/j.earscirev.2008.03.001; Ault AP, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015351; Borys RD, 2000, ATMOS ENVIRON, V34, P2593, DOI 10.1016/S1352-2310(99)00492-6; Choi YS, 2010, P NATL ACAD SCI USA, V107, P11211, DOI 10.1073/pnas.1006241107; CHOULARTON TW, 1986, Q J ROY METEOR SOC, V112, P335, DOI 10.1002/qj.49711247204; DeMott PJ, 2010, P NATL ACAD SCI USA, V107, P11217, DOI 10.1073/pnas.0910818107; DeMott PJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017410; DESHLER T, 1990, J APPL METEOROL, V29, P288, DOI 10.1175/1520-0450(1990)029&lt;0288:PROWOC&gt;2.0.CO;2; Dore AJ, 1999, ATMOS ENVIRON, V33, P3301, DOI 10.1016/S1352-2310(98)00294-5; Draxler R., 2013, HYSPLIT HYBRID SINGL; Fowler D, 1995, WATER AIR SOIL POLL, V85, P2107, DOI 10.1007/BF01186145; Gard E, 1997, ANAL CHEM, V69, P4083, DOI 10.1021/ac970540n; Givati A, 2004, J APPL METEOROL, V43, P1038, DOI [10.1175/1520-0450(2004)043<1038:QPSDTA>2.0.CO;2, 10.1175/1520-0450(2004)043&lt;1038:QPSDTA&gt;2.0.CO;2]; Guan B, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044696; Hallar AG, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048166; Hara K, 2012, ATMOS ENVIRON, V47, P20, DOI 10.1016/j.atmosenv.2011.11.050; Hoose C, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/024009; HOSLER CL, 1957, J METEOROL, V14, P415, DOI 10.1175/1520-0469(1957)014<0415:OTAOIC>2.0.CO;2; Houze R. A., 1993, CLOUD DYNAMICS; Hsu SC, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051962; Husar RB, 2001, J GEOPHYS RES-ATMOS, V106, P18317, DOI 10.1029/2000JD900788; Iannone R, 2011, ATMOS CHEM PHYS, V11, P1191, DOI 10.5194/acp-11-1191-2011; Isono K., 1959, J METEOR SOC JAPAN, V37, P211, DOI DOI 10.2151/JMSJ1923.37.6_211; Korolev A, 2007, J ATMOS SCI, V64, P3372, DOI 10.1175/JAS4035.1; Lau KM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018567; McKendry IG, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007129; MEYERS MP, 1992, J APPL METEOROL, V31, P708, DOI 10.1175/1520-0450(1992)031<0708:NPINPI>2.0.CO;2; Morris CE, 2004, J PHYS IV, V121, P87, DOI 10.1051/jp4:2004121004; Pinsky M, 1998, ATMOS RES, V49, P99, DOI 10.1016/S0169-8095(98)00073-8; Pratt KA, 2009, NAT GEOSCI, V2, P397, DOI 10.1038/NGEO521; Pratt KA, 2009, ANAL CHEM, V81, P1792, DOI 10.1021/ac801942r; Prospero JM, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000095; Reinking RF, 2000, J APPL METEOROL, V39, P733, DOI 10.1175/1520-0450(2000)039<0733:IOSEOG>2.0.CO;2; REYNOLDS DW, 1986, B AM METEOROL SOC, V67, P513, DOI 10.1175/1520-0477(1986)067<0513:AROTSC>2.0.CO;2; Rogers DC, 2001, J ATMOS OCEAN TECH, V18, P725, DOI 10.1175/1520-0426(2001)018<0725:ACFDCF>2.0.CO;2; Rosenfeld D, 2000, SCIENCE, V287, P1793, DOI 10.1126/science.287.5459.1793; Rosenfeld D, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049423; Saleeby SM, 2009, J APPL METEOROL CLIM, V48, P903, DOI 10.1175/2008JAMC1989.1; Sun JM, 2001, J GEOPHYS RES-ATMOS, V106, P10325, DOI 10.1029/2000JD900665; Uno I, 2011, ATMOS CHEM PHYS, V11, P7333, DOI 10.5194/acp-11-7333-2011; Uno I, 2009, NAT GEOSCI, V2, P557, DOI 10.1038/NGEO583; White AB, 2000, J ATMOS OCEAN TECH, V17, P1226, DOI 10.1175/1520-0426(2000)017<1226:ETDROA>2.0.CO;2; White AB, 2003, J HYDROMETEOROL, V4, P264, DOI 10.1175/1525-7541(2003)4<264:CORPOB>2.0.CO;2; Wiacek A, 2010, ATMOS CHEM PHYS, V10, P8649, DOI 10.5194/acp-10-8649-2010	44	400	409	22	414	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1572	1578		10.1126/science.1227279	http://dx.doi.org/10.1126/science.1227279			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23449996				2022-12-28	WOS:000316731600040
J	He, Y; Fang, J; Taatjes, DJ; Nogales, E				He, Yuan; Fang, Jie; Taatjes, Dylan J.; Nogales, Eva			Structural visualization of key steps in human transcription initiation	NATURE			English	Article							RNA-POLYMERASE-II; DNA-BINDING DOMAIN; PREINITIATION COMPLEX; ELECTRON-MICROSCOPY; CONFORMATIONAL FLEXIBILITY; SUBUNIT ARCHITECTURE; ANGSTROM RESOLUTION; ACCURATE INITIATION; PROMOTER CLEARANCE; ELONGATION COMPLEX	Eukaryotic transcription initiation requires the assembly of general transcription factors into a pre-initiation complex that ensures the accurate loading of RNA polymerase II (Pol II) at the transcription start site. The molecular mechanism and function of this assembly have remained elusive due to lack of structural information. Here we have used an in vitro reconstituted system to study the stepwise assembly of human TBP, TFIIA, TFIIB, Pol II, TFIIF, TFIIE and TFIIH onto promoter DNA using cryo-electron microscopy. Our structural analyses provide pseudo-atomic models at various stages of transcription initiation that illuminate critical molecular interactions, including how TFIIF engages Pol II and promoter DNA to stabilize both the closed pre-initiation complex and the open-promoter complex, and to regulate start-site selection. Comparison of open versus closed pre-initiation complexes, combined with the localization of the TFIIH helicases XPD and XPB, support a DNA translocation model of XPB and explain its essential role in promoter opening.	[He, Yuan; Nogales, Eva] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA 94720 USA; [Fang, Jie; Nogales, Eva] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Taatjes, Dylan J.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80303 USA; [Nogales, Eva] Univ Calif Berkeley, QB3 Inst, Berkeley, CA 94720 USA; [Nogales, Eva] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Colorado System; University of Colorado Boulder; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Nogales, E (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA 94720 USA.	ENogales@lbl.gov	He, Yuan/C-7341-2015; He, Yuan/GVT-7268-2022	He, Yuan/0000-0002-1455-3963; He, Yuan/0000-0002-1455-3963	NIGMS [GM63072]; NCI [CA127364]; NATIONAL CANCER INSTITUTE [P01CA112181, R01CA127364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063072] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Inouye for providing us with recombinant TFIIF and TFIIE; P. Grob and T. Houweling for electron microscopy and computer support, respectively; T. Goddard for help with Chimera; and members of the Nogales laboratory for technical advice on image processing. We are thankful to J. Kadonaga, J. Goodrich and M. Cianfrocco for their comments on the manuscript. We thank P. Cooper both for biochemical advice and for her comments on the manuscript. This work was funded by NIGMS (GM63072 to E.N.) and by NCI (CA127364 to D. J. T.). E.N. is a Howard Hughes Medical Institute Investigator.	Andel F, 1999, SCIENCE, V286, P2153, DOI 10.1126/science.286.5447.2153; Andrecka J, 2009, NUCLEIC ACIDS RES, V37, P5803, DOI 10.1093/nar/gkp601; Bernecky C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000603; Bleichenbacher M, 2003, J MOL BIOL, V332, P783, DOI 10.1016/S0022-2836(03)00887-8; BURATOWSKI S, 1991, P NATL ACAD SCI USA, V88, P7509, DOI 10.1073/pnas.88.17.7509; Chakraborty A, 2012, SCIENCE, V337, P591, DOI 10.1126/science.1218716; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Chung WH, 2003, MOL CELL, V12, P1003, DOI 10.1016/S1097-2765(03)00387-3; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Fernandez-Tornero C, 2010, EMBO J, V29, P3762, DOI 10.1038/emboj.2010.266; Forget D, 1997, P NATL ACAD SCI USA, V94, P7150, DOI 10.1073/pnas.94.14.7150; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Freire-Picos MA, 2005, NUCLEIC ACIDS RES, V33, P5045, DOI 10.1093/nar/gki825; Gaiser F, 2000, J MOL BIOL, V302, P1119, DOI 10.1006/jmbi.2000.4110; Ghazy MA, 2004, MOL CELL BIOL, V24, P10975, DOI 10.1128/MCB.24.24.10975-10985.2004; GIARDINA C, 1993, SCIENCE, V261, P759, DOI 10.1126/science.8342041; Gibbons BJ, 2012, P NATL ACAD SCI USA, V109, P1949, DOI 10.1073/pnas.1105266109; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; Goodrich JA, 1996, CELL, V84, P825, DOI 10.1016/S0092-8674(00)81061-2; Groft CM, 1998, P NATL ACAD SCI USA, V95, P9117, DOI 10.1073/pnas.95.16.9117; Grohmann D, 2011, MOL CELL, V43, P263, DOI 10.1016/j.molcel.2011.05.030; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Juven-Gershon T, 2006, NAT METHODS, V3, P917, DOI 10.1038/NMETH937; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Kostek SA, 2006, STRUCTURE, V14, P1691, DOI 10.1016/j.str.2006.09.011; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Mallick SP, 2005, ULTRAMICROSCOPY, V104, P8, DOI 10.1016/j.ultramic.2005.02.004; MATSUI T, 1980, J BIOL CHEM, V255, P1992; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Orlicky SM, 2001, J BIOL CHEM, V276, P10097, DOI 10.1074/jbc.M003165200; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Revyakin A, 2012, GENE DEV, V26, P1691, DOI 10.1101/gad.194936.112; Robert F, 1996, J BIOL CHEM, V271, P8517, DOI 10.1074/jbc.271.15.8517; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; SUN ZW, 1995, P NATL ACAD SCI USA, V92, P3127, DOI 10.1073/pnas.92.8.3127; TAN SY, 1994, P NATL ACAD SCI USA, V91, P9808, DOI 10.1073/pnas.91.21.9808; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; TYREE CM, 1993, GENE DEV, V7, P1254, DOI 10.1101/gad.7.7a.1254; van Dijk M, 2009, NUCLEIC ACIDS RES, V37, pW235, DOI 10.1093/nar/gkp287; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Yan Q, 1999, J BIOL CHEM, V274, P35668, DOI 10.1074/jbc.274.50.35668	63	192	193	1	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2013	495	7442					481	+		10.1038/nature11991	http://dx.doi.org/10.1038/nature11991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23446344	Green Accepted, Green Submitted			2022-12-28	WOS:000316682800039
J	Quill, TE; Abernethy, AP				Quill, Timothy E.; Abernethy, Amy P.			Generalist plus Specialist Palliative Care - Creating a More Sustainable Model	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Quill, Timothy E.] Univ Rochester, Med Ctr, Dept Med, Palliat Care Div, Rochester, NY 14642 USA; [Abernethy, Amy P.] Duke Univ, Med Ctr, Duke Ctr Learning Hlth Care, Durham, NC USA; [Abernethy, Amy P.] Duke Univ, Med Ctr, Duke Canc Care Res Program, Durham, NC USA	University of Rochester; Duke University; Duke University	Quill, TE (corresponding author), Univ Rochester, Med Ctr, Dept Med, Palliat Care Div, Rochester, NY 14642 USA.			Abernethy, Amy/0000-0001-6930-8722				Back AL, 2009, J CLIN ONCOL, V27, P1137, DOI 10.1200/JCO.2008.20.2408; Kamal AH, 2012, J PAIN SYMPTOM MANAG; Morrison RS, 2011, HEALTH AFFAIR, V30, P454, DOI 10.1377/hlthaff.2010.0929; Quill Timothy E, 2003, J Palliat Med, V6, P365, DOI 10.1089/109662103322144682; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678	5	850	852	3	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 28	2013	368	13					1173	1175		10.1056/NEJMp1215620	http://dx.doi.org/10.1056/NEJMp1215620			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	116FU	23465068				2022-12-28	WOS:000316869000003
J	Crossland, EJW; Noel, N; Sivaram, V; Leijtens, T; Alexander-Webber, JA; Snaith, HJ				Crossland, Edward J. W.; Noel, Nakita; Sivaram, Varun; Leijtens, Tomas; Alexander-Webber, Jack A.; Snaith, Henry J.			Mesoporous TiO2 single crystals delivering enhanced mobility and optoelectronic device performance	NATURE			English	Article							METAL-OXIDES; SOLAR-CELLS; DYE; EFFICIENCY; CR2O3	Mesoporous ceramics and semiconductors enable low-cost solar power, solar fuel, (photo)catalyst and electrical energy storage technologies(1). State-of-the-art, printable high-surface-area electrodes are fabricated from thermally sintered pre-formed nanocrystals(2-5). Mesoporosity provides the desired highly accessible surfaces but many applications also demand long-range electronic connectivity and structural coherence(6). A mesoporous single-crystal (MSC) semiconductor can meet both criteria. Here we demonstrate a general synthetic method of growing semiconductor MSCs of anatase TiO2 based on seeded nucleation and growth inside a mesoporous template immersed in a dilute reaction solution. We show that both isolated MSCs and ensembles incorporated into films have substantially higher conductivities and electron mobilities than does nanocrystalline TiO2. Conventional nanocrystals, unlike MSCs, require in-film thermal sintering to reinforce electronic contact between particles, thus increasing fabrication cost, limiting the use of flexible substrates and precluding, for instance, multijunction solar cell processing. Using MSC films processed entirely below 150 degrees C, we have fabricated all-solid-state, low-temperature sensitized solar cells that have 7.3 per cent efficiency, the highest efficiency yet reported. These high-surface-area anatase single crystals will find application in many different technologies, and this generic synthetic strategy extends the possibility of mesoporous single-crystal growth to a range of functional ceramics and semiconductors.	[Crossland, Edward J. W.; Noel, Nakita; Sivaram, Varun; Leijtens, Tomas; Alexander-Webber, Jack A.; Snaith, Henry J.] Univ Oxford, Clarendon Lab, Oxford OX1 3PU, England	University of Oxford	Snaith, HJ (corresponding author), Univ Oxford, Clarendon Lab, Parks Rd, Oxford OX1 3PU, England.	h.snaith1@physics.ox.ac.uk	Snaith, Henry J/A-7367-2016; Noel, Nakita K./F-3990-2014	Snaith, Henry J/0000-0001-8511-790X; Noel, Nakita K./0000-0002-8570-479X; Alexander-Webber, Jack/0000-0002-9374-7423	European Community [246124]; European Research Council (HYPER) [279881]; Rhodes Trust; Engineering and Physical Sciences Research Council; Government of the Republic of Trinidad and Tobago	European Community(European Commission); European Research Council (HYPER); Rhodes Trust; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Government of the Republic of Trinidad and Tobago	This work was funded by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 246124 of the SANS project, the European Research Council (HYPER project number 279881), the Rhodes Trust, the Engineering and Physical Sciences Research Council, and the Government of the Republic of Trinidad and Tobago. We thank C. Ducati for help with indexing of electron diffraction patterns.	Arora H, 2010, SCIENCE, V330, P214, DOI 10.1126/science.1193369; Bian ZF, 2011, ANGEW CHEM INT EDIT, V50, P1105, DOI 10.1002/anie.201004972; BOGUSH GH, 1988, J NON-CRYST SOLIDS, V104, P95, DOI 10.1016/0022-3093(88)90187-1; Crossland EJW, 2009, NANO LETT, V9, P2807, DOI 10.1021/nl803174p; Dickinson C, 2006, CHEM MATER, V18, P3088, DOI 10.1021/cm060014p; Docampo P., J PHYS CHEM IN PRESS; Docampo P, 2010, ADV FUNCT MATER, V20, P1787, DOI 10.1002/adfm.200902089; Finnemore AS, 2009, ADV MATER, V21, P3928, DOI 10.1002/adma.200900615; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; Jiang CY, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3693399; Jiao K, 2005, CHEM COMMUN, P5618, DOI 10.1039/b512080b; Kondo JN, 2008, CHEM MATER, V20, P835, DOI 10.1021/cm702176m; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Li DL, 2004, NAT MATER, V3, P65, DOI 10.1038/nmat1043; Liu G, 2011, CHEM COMMUN, V47, P6763, DOI 10.1039/c1cc10665a; Lu AH, 2006, ADV MATER, V18, P1793, DOI 10.1002/adma.200600148; Nakade S, 2002, J PHYS CHEM B, V106, P10004, DOI 10.1021/jp020051d; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Schmidt-Mende L, 2005, ADV MATER, V17, P813, DOI 10.1002/adma.200401410; Schuth F, 2003, ANGEW CHEM INT EDIT, V42, P3604, DOI 10.1002/anie.200300593; Tian BZ, 2003, ADV MATER, V15, P1370, DOI 10.1002/adma.200305211; Weickert J, 2011, ADV MATER, V23, P1810, DOI 10.1002/adma.201003991; Yang HG, 2008, NATURE, V453, P638, DOI 10.1038/nature06964; Yang PD, 1998, NATURE, V396, P152; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688; Yu JC, 2004, CHEM MATER, V16, P1523, DOI 10.1021/cm049955x; Yue W, 2007, CHEM MATER, V19, P2359, DOI 10.1021/cm070124b; Yue WB, 2009, CHEM MATER, V21, P2540, DOI 10.1021/cm900197p; Yue WB, 2008, PROG NAT SCI-MATER, V18, P1329, DOI 10.1016/j.pnsc.2008.05.010; Zhang DQ, 2009, CHEM COMMUN, P4381, DOI 10.1039/b907963g	30	678	692	33	1683	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2013	495	7440					215	219		10.1038/nature11936	http://dx.doi.org/10.1038/nature11936			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23467091				2022-12-28	WOS:000316652300046
J	O'Leary, JM; Siddiqi, OK; de Ferranti, S; Landzberg, MJ; Opotowsky, AR				O'Leary, Jared M.; Siddiqi, Omar K.; de Ferranti, Sarah; Landzberg, Michael J.; Opotowsky, Alexander R.			The Changing Demographics of Congenital Heart Disease Hospitalizations in the United States, 1998 Through 2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							ADULTS		[O'Leary, Jared M.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Siddiqi, Omar K.] Boston Med Ctr, Dept Med, Boston, MA USA; [de Ferranti, Sarah; Landzberg, Michael J.; Opotowsky, Alexander R.] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Boston Medical Center; Harvard University; Boston Children's Hospital	O'Leary, JM (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	joleary8@partners.org	Opotowsky, Alexander/AAL-1481-2020	Opotowsky, Alexander/0000-0002-6107-2281; Siddiqi, Omar/0000-0001-7813-1623				[Anonymous], 2001, J AM COLL CARDIOL, V37, P1161; Gatzoulis MA, 1999, HEART, V81, P57, DOI 10.1136/hrt.81.1.57; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Opotowsky AR, 2009, J AM COLL CARDIOL, V54, P460, DOI 10.1016/j.jacc.2009.04.037; Somerville J, 1997, ANNU REV MED, V48, P283; Warnes CA, 2001, J AM COLL CARDIOL, V37, P1170, DOI 10.1016/S0735-1097(01)01272-4	6	74	75	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2013	309	10					984	986		10.1001/jama.2013.564	http://dx.doi.org/10.1001/jama.2013.564			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	103SH	23471480	Bronze			2022-12-28	WOS:000315938700020
J	Kwan, JL; Lo, LS; Sampson, M; Shojania, KG				Kwan, Janice L.; Lo, Lisha; Sampson, Margaret; Shojania, Kaveh G.			Medication Reconciliation During Transitions of Care as a Patient Safety Strategy A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Article							ADVERSE DRUG EVENTS; HOSPITAL DISCHARGE PROGRAM; PATIENTS AFTER-DISCHARGE; PHARMACIST INTERVENTION; CLINICAL PHARMACISTS; ERRORS; ADMISSION; DISCREPANCIES; INFORMATION; QUALITY	Medication reconciliation identifies and resolves unintentional discrepancies between patients' medication lists across transitions in care. The purpose of this review is to summarize evidence about the effectiveness of hospital-based medication reconciliation interventions. Searches encompassed MEDLINE through November 2012 and EMBASE and the Cochrane Central Register of Controlled Trials through July 2012. Eligible studies evaluated the effects of hospital-based medication reconciliation on unintentional discrepancies with nontrivial risks for harm to patients or 30-day postdischarge emergency department visits and readmission. Two reviewers evaluated study eligibility, abstracted data, and assessed study quality. Eighteen studies evaluating 20 interventions met the selection criteria. Pharmacists performed medication reconciliation in 17 of the 20 interventions. Most unintentional discrepancies identified had no clinical significance. Medication reconciliation alone probably does not reduce postdischarge hospital utilization but may do so when bundled with interventions aimed at improving care transitions. Ann Intern Med. 2013;158:397-403. www.annals.org	[Kwan, Janice L.; Shojania, Kaveh G.] Univ Toronto, Toronto, ON M5G 2L3, Canada; Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada	University of Toronto; University of Ottawa; Children's Hospital of Eastern Ontario	Shojania, KG (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Med, Room H468,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	kaveh.shojania@sunnybrook.ca	Sampson, Margaret/A-9128-2011	Sampson, Margaret/0000-0003-2550-9893	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services [HHSA-290-2007-10062I]; University of California, Los Angeles-RAND Evidence-Based Practice Centre	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); University of California, Los Angeles-RAND Evidence-Based Practice Centre	Financial Support: From the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services (contract HHSA-290-2007-10062I).; Potential Conflicts of Interest: Dr. Shojania: Other: Agency for Healthcare Research and Quality as a subcontract from the University of California, Los Angeles-RAND Evidence-Based Practice Centre. All other authors have no disclosures. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M12-2634.	Abdel-Qader DH, 2010, DRUG SAFETY, V33, P1027, DOI 10.2165/11538310-000000000-00000; Accreditation Canada, 2012, REQ ORG PRACT 2012; [Anonymous], 2006, ACT PAT SAF HIGH 5S; Bayoumi I, 2009, ANN PHARMACOTHER, V43, P1667, DOI 10.1345/aph.1M059; Bell CM, 2011, JAMA-J AM MED ASSOC, V306, P840, DOI 10.1001/jama.2011.1206; Climente-Marti M, 2010, ANN PHARMACOTHER, V44, P1747, DOI 10.1345/aph.1P184; Coffey M, 2009, ACAD PEDIATR, V9, P360, DOI 10.1016/j.acap.2009.04.007; Coleman EA, 2005, ARCH INTERN MED, V165, P1842, DOI 10.1001/archinte.165.16.1842; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; Cornish PL, 2005, ARCH INTERN MED, V165, P424, DOI 10.1001/archinte.165.4.424; Dedhia P, 2009, J AM GERIATR SOC, V57, P1540, DOI 10.1111/j.1532-5415.2009.02430.x; Etchells E, 2012, BMJ QUAL SAF, V21, P448, DOI 10.1136/bmjqs-2011-000585; Femandes O, 2012, HEALTHC Q, P15; Forster AJ, 2004, CAN MED ASSOC J, V170, P345; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Gillespie U, 2009, ARCH INTERN MED, V169, P894, DOI 10.1001/archinternmed.2009.71; Gleason KM, 2004, AM J HEALTH-SYST PH, V61, P1689, DOI 10.1093/ajhp/61.16.1689; Gleason KM, 2010, J GEN INTERN MED, V25, P441, DOI 10.1007/s11606-010-1256-6; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Institute for Healthcare Improvement, 2006, OV 100000 LIV CAMP; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Jamtvedt G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub2; Kaboli PJ, 2006, ARCH INTERN MED, V166, P955, DOI 10.1001/archinte.166.9.955; Karnon J, 2009, J EVAL CLIN PRACT, V15, P299, DOI 10.1111/j.1365-2753.2008.01000.x; Koehler BE, 2009, J HOSP MED, V4, P211, DOI 10.1002/jhm.427; Kramer JS, 2007, AM J HEALTH-SYST PH, V64, P404, DOI 10.2146/ajhp060506; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Kripalani S, 2012, ANN INTERN MED, V157, P1, DOI 10.7326/0003-4819-157-1-201207030-00003; Kucukarslan SN, 2003, ARCH INTERN MED, V163, P2014, DOI 10.1001/archinte.163.17.2014; Kwan Y, 2007, ARCH INTERN MED, V167, P1034, DOI 10.1001/archinte.167.10.1034; Leape LL, 1999, JAMA-J AM MED ASSOC, V282, P267, DOI 10.1001/jama.282.3.267; Lee JY, 2010, ANN PHARMACOTHER, V44, P1887, DOI 10.1345/aph.1P314; Midlov P, 2012, INT J CLIN PHARM-NET, V34, P113, DOI 10.1007/s11096-011-9599-6; Mueller SK, 2012, ARCH INTERN MED, V172, P1057, DOI 10.1001/archinternmed.2012.2246; NORRIS CM, 2001, PHARM J, V267, P857; Pippins JR, 2008, J GEN INTERN MED, V23, P1414, DOI 10.1007/s11606-008-0687-9; Ranji SR, 2008, MED CARE, V46, P847, DOI 10.1097/MLR.0b013e318178eabd; Schnipper JL, 2011, J AM MED INFORM ASSN, V18, P309, DOI 10.1136/amiajnl-2010-000040; Schnipper JL, 2009, ARCH INTERN MED, V169, P771, DOI 10.1001/archinternmed.2009.51; Schnipper JL, 2006, ARCH INTERN MED, V166, P565, DOI 10.1001/archinte.166.5.565; Shojania KG, 2010, CAN MED ASSOC J, V182, pE216, DOI 10.1503/cmaj.090578; Showalter JW, 2011, J GEN INTERN MED, V26, P718, DOI 10.1007/s11606-011-1712-y; Steinman MA, 2006, MED CARE, V44, P617, DOI 10.1097/01.mlr.0000215846.25591.22; Steurbaut S, 2010, ANN PHARMACOTHER, V44, P1596, DOI 10.1345/aph.1P192; Stone BL, 2010, ARCH DIS CHILD, V95, P250, DOI 10.1136/adc.2009.167528; Tam VC, 2005, CAN MED ASSOC J, V173, P510, DOI 10.1503/cmaj.045311; The Joint Commission, 2011, 2011 NAT PAT SAF GOA; van Walraven C, 2010, J HOSP MED, V5, P398, DOI 10.1002/jhm.716; Vira T, 2006, QUAL SAF HEALTH CARE, V15, P122, DOI 10.1136/qshc.2005.015347; Walker PC, 2009, ARCH INTERN MED, V169, P2003, DOI 10.1001/archinternmed.2009.398; Wong JD, 2008, ANN PHARMACOTHER, V42, P1373, DOI 10.1345/aph.1L190	52	287	298	2	67	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2013	158	5	2				397	+		10.7326/0003-4819-158-5-201303051-00006	http://dx.doi.org/10.7326/0003-4819-158-5-201303051-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105HX	23460096				2022-12-28	WOS:000316058600006
J	Shekelle, PG				Shekelle, Paul G.			Nurse-Patient Ratios as a Patient Safety Strategy A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Article							INTENSIVE-CARE-UNIT; STAFFING LEVELS; HOSPITAL MORTALITY; OUTCOMES EVIDENCE; HEALTH-CARE; QUALITY; COST; ASSOCIATION; IMPACT; RISK	A small percentage of patients die during hospitalization or shortly thereafter, and it is widely believed that more or better nursing care could prevent some of these deaths. The author systematically reviewed the evidence about nurse staffing ratios and in-hospital death through September 2012. From 550 titles, 87 articles were reviewed and 15 new studies that augmented the 2 existing reviews were selected. The strongest evidence supporting a causal relationship between higher nurse staffing levels and decreased inpatient mortality comes from a longitudinal study in a single hospital that carefully accounted for nurse staffing and patient comorbid conditions and a meta-analysis that found a "dose-response relationship" in observational studies of nurse staffing and death. No studies reported any serious harms associated with an increase in nurse staffing. Limiting any stronger conclusions is the lack of an evaluation of an intervention to increase nurse staffing ratios. The formal costs of increasing the nurse-patient ratio cannot be calculated because there has been no evaluation of an intentional change in nurse staffing to improve patient outcomes. Ann Intern Med. 2013;158:404-409. www.annals.org	[Shekelle, Paul G.] RAND Corp, Santa Monica, CA 90401 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Shekelle, PG (corresponding author), RAND Corp, 1776 Main St, Santa Monica, CA 90401 USA.	shekelle@rand.org			Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services [HHSA-290-2007-10062I]; Agency for Healthcare Research and Quality; Veterans Affairs; Centers for Medicare & Medicaid Services; National Institute of Nursing Research; Office of the National Coordinator	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Veterans Affairs(US Department of Veterans Affairs); Centers for Medicare & Medicaid Services; National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Office of the National Coordinator	Financial Support: From the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services (contract HHSA-290-2007-10062I).; Potential Conflicts of Interest: Consultancy: ECRI Institute; Employment: Veterans Affairs; Grants/grants pending: Agency for Healthcare Research and Quality, Veterans Affairs, Centers for Medicare & Medicaid Services, National Institute of Nursing Research, Office of the National Coordinator; Royalties: UpToDate. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M12-2574.	Aiken LH, 2003, JAMA-J AM MED ASSOC, V290, P1617, DOI 10.1001/jama.290.12.1617; Aiken LH, 2002, NURS OUTLOOK, V50, P187, DOI 10.1067/mno.2002.126696; Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; Aiken LH, 1997, MED CARE, V35, pNS6, DOI 10.1097/00005650-199711001-00002; Aiken LH, 2008, J NURS ADMIN, V38, P223, DOI 10.1097/01.NNA.0000312773.42352.d7; Aiken LH, 2010, HEALTH SERV RES, V45, P904, DOI 10.1111/j.1475-6773.2010.01114.x; Burnes Bolton Linda, 2007, Policy Polit Nurs Pract, V8, P238, DOI 10.1177/1527154407312737; Butler M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007019.pub2; Cho SH, 2008, NURS RES, V57, P322, DOI 10.1097/01.NNR.0000313498.17777.71; Cook A, 2012, J HEALTH ECON, V31, P340, DOI 10.1016/j.jhealeco.2012.01.005; Cummings GG, 2010, INT J NURS STUD, V47, P363, DOI 10.1016/j.ijnurstu.2009.08.006; Despins LA, 2010, J ADV NURS, V66, P465, DOI 10.1111/j.1365-2648.2009.05215.x; Donaldson Nancy, 2005, Policy Polit Nurs Pract, V6, P198, DOI 10.1177/1527154405280107; Duffield C, 2011, APPL NURS RES, V24, P244, DOI 10.1016/j.apnr.2009.12.004; Estabrooks CA, 2005, NURS RES, V54, P74; Flynn M, 2009, J NURS MANAGE, V17, P759, DOI 10.1111/j.1365-2834.2009.01023.x; Furukawa MF, 2010, HEALTH SERV RES, V45, P941, DOI 10.1111/j.1475-6773.2010.01110.x; Griffiths P, 2009, INT J NURS STUD, V46, P1289, DOI 10.1016/j.ijnurstu.2009.07.007; Halm M, 2005, CLIN NURSE SPEC, V19, P241, DOI 10.1097/00002800-200509000-00007; Hamilton KES, 2007, ARCH DIS CHILD-FETAL, V92, pF99, DOI 10.1136/adc.2006.102988; Harless DW, 2010, MED CARE, V48, P659, DOI 10.1097/MLR.0b013e3181dbe200; Kane RL, 2007, MED CARE, V45, P1195, DOI 10.1097/MLR.0b013e3181468ca3; Kiekkas P, 2008, J NURS SCHOLARSHIP, V40, P385, DOI 10.1111/j.1547-5069.2008.00254.x; Mark Barbara A, 2007, Policy Polit Nurs Pract, V8, P83, DOI 10.1177/1527154407303499; McGahan M, 2012, AUST CRIT CARE, V25, P64, DOI 10.1016/j.aucc.2012.03.003; Needleman J, 2002, NEW ENGL J MED, V346, P1715, DOI 10.1056/NEJMsa012247; Needleman J, 2011, NEW ENGL J MED, V364, P1037, DOI 10.1056/NEJMsa1001025; Person SD, 2004, MED CARE, V42, P4, DOI 10.1097/01.mlr.0000102369.67404.b0; Rafferty AM, 2007, INT J NURS STUD, V44, P175, DOI 10.1016/j.ijnurstu.2006.08.003; Rothberg MB, 2005, MED CARE, V43, P785, DOI 10.1097/01.mlr.0000170408.35854.fa; Sasichay-Akkadechanunt T, 2003, J NURS ADMIN, V33, P478, DOI 10.1097/00005110-200309000-00008; Schilling PL, 2010, MED CARE, V48, P224, DOI 10.1097/MLR.0b013e3181c162c0; Shamliyan TA, 2009, NURS ECON, V27, P302; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Stone PW, 2008, CLIN INFECT DIS, V47, P937, DOI 10.1086/591696; Stone PW, 2007, MED CARE, V45, P571, DOI 10.1097/MLR.0b013e3180383667; Tarnow-Mordi WO, 2000, LANCET, V356, P185, DOI 10.1016/S0140-6736(00)02478-8; Thornlow DK, 2009, INT J NURS STUD, V46, P1528, DOI 10.1016/j.ijnurstu.2009.06.015; Fugulin FMT, 2011, REV ESC ENFERM USP, V45, P1582, DOI 10.1590/S0080-62342011000700007; Tourangeau A E, 2002, Can J Nurs Res, V33, P71; Tourangeau AE., 2011, NURSING OUTCOMES STA; Tourangeau AE, 2007, J ADV NURS, V57, P32, DOI 10.1111/j.1365-2648.2006.04084.x; Twigg D, 2011, INT J NURS STUD, V48, P540, DOI 10.1016/j.ijnurstu.2010.07.013; Unruh LY, 2012, NURS RES, V61, P3, DOI 10.1097/NNR.0b013e3182358968; Van den Heede K, 2010, J ADV NURS, V66, P1291, DOI 10.1111/j.1365-2648.2010.05307.x; Whitlock EP, 2008, ANN INTERN MED, V148, P776, DOI 10.7326/0003-4819-148-10-200805200-00010	46	116	122	1	53	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2013	158	5	2				404	+		10.7326/0003-4819-158-5-201303051-00007	http://dx.doi.org/10.7326/0003-4819-158-5-201303051-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	105HX	23460097				2022-12-28	WOS:000316058600007
J	Atwood, SX; Li, MC; Lee, A; Tang, JY; Oro, AE				Atwood, Scott X.; Li, Mischa; Lee, Alex; Tang, Jean Y.; Oro, Anthony E.			GLI activation by atypical protein kinase C iota/lambda regulates the growth of basal cell carcinomas	NATURE			English	Article							HEDGEHOG PATHWAY; GENE; RESISTANCE	Growth of basal cell carcinomas (BCCs) requires high levels of hedgehog (HH) signalling through the transcription factor GLI(1). Although inhibitors of membrane protein smoothened (SMO) effectively suppress HH signalling, early tumour resistance illustrates the need for additional downstream targets for therapy(1-6). Here we identify atypical protein kinase C (aPKC-iota/lambda) as a novel GLI regulator in mammals. aPKC-iota/lambda and its polarity signalling partners' co-localize at the centrosome and form a complex with missing-in-metastasis (MIM), a scaffolding protein that potentiates HH signalling(8,9). Genetic or pharmacological loss of aPKC-iota/lambda function blocks HH signalling and proliferation of BCC cells. Prkci is a HH target gene that forms a positive feedback loop with GLI and exists at increased levels in BCCs. Genome-wide transcriptional profiling shows that aPKC-iota/lambda? and SMO control the expression of similar genes in tumour cells. aPKC-iota/lambda functions downstream of SMO to phosphorylate and activate GLI1, resulting in maximal DNA binding and transcriptional activation. Activated aPKC-iota/lambda. is upregulated in SMO-inhibitor-resistant tumours and targeting aPKC-iota/lambda suppresses signalling and growth of resistant BCC cell lines. These results demonstrate that aPKC-iota/lambda is critical for HH-dependent processes and implicates aPKC-iota/lambda as a new, tumour-selective therapeutic target for the treatment of SMO-inhibitor-resistant cancers. [GRAPHICS] .	[Atwood, Scott X.; Li, Mischa; Lee, Alex; Tang, Jean Y.; Oro, Anthony E.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA	Stanford University	Oro, AE (corresponding author), Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA.	satwood@stanford.edu; oro@stanford.edu		Tang, Jean/0000-0002-5510-6502; Atwood, Scott/0000-0001-7407-9792; Lee, Alexander/0000-0002-4583-0740; Oro, Anthony/0000-0002-6261-138X; Li Covington, Mischa/0000-0001-5452-4529	NIH NRSA [1F32CA14208701]; NIH [AR052785, AR046786]; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046786, R01AR054780, R01AR052785] Funding Source: NIH RePORTER	NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We would like to thank K. Qun for bioinformatics assistance, J. Kim for archival BCC tissue, A. Chang and S. Aasi for clinical trial operations, K. Chang for technical assistance, and H. Chang and P. Khavari for reading the manuscript. This work was supported by NIH NRSA 1F32CA14208701 (S.X.A.) and NIH grants AR052785 and AR046786 (A.E.O.).	Aszterbaum M, 1999, NAT MED, V5, P1285, DOI 10.1038/15242; Atwood SX, 2012, J CELL BIOL, V199, P193, DOI 10.1083/jcb.201207140; Atwood SX, 2009, CURR BIOL, V19, P723, DOI 10.1016/j.cub.2009.03.056; Bershteyn M, 2010, DEV CELL, V19, P270, DOI 10.1016/j.devcel.2010.07.009; Buonamici S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001599; Callahan CA, 2004, GENE DEV, V18, P2724, DOI 10.1101/gad.1221804; Chang ALS, 2012, ARCH DERMATOL, V148, P1324, DOI 10.1001/archdermatol.2012.2354; Dijkgraaf GJP, 2011, CANCER RES, V71, P435, DOI 10.1158/0008-5472.CAN-10-2876; Kim J, 2010, CANCER CELL, V17, P388, DOI 10.1016/j.ccr.2010.02.027; Kim J, 2010, P NATL ACAD SCI USA, V107, P13432, DOI 10.1073/pnas.1006822107; Lee EY, 2010, P NATL ACAD SCI USA, V107, P9736, DOI 10.1073/pnas.1004602107; Little AS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001752; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Po A, 2010, EMBO J, V29, P2646, DOI 10.1038/emboj.2010.131; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Standaert ML, 1999, J BIOL CHEM, V274, P25308, DOI 10.1074/jbc.274.36.25308; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Wang GY, 2011, J INVEST DERMATOL, V131, P2298, DOI 10.1038/jid.2011.204; Winklmayr M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-2; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386	21	187	194	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2013	494	7438					484	488		10.1038/nature11889	http://dx.doi.org/10.1038/nature11889			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23446420	Green Accepted, Green Submitted			2022-12-28	WOS:000315661500040
J	Liu, XJ; Zhang, Y; Han, WX; Tang, AH; Shen, JL; Cui, ZL; Vitousek, P; Erisman, JW; Goulding, K; Christie, P; Fangmeier, A; Zhang, FS				Liu, Xuejun; Zhang, Ying; Han, Wenxuan; Tang, Aohan; Shen, Jianlin; Cui, Zhenling; Vitousek, Peter; Erisman, Jan Willem; Goulding, Keith; Christie, Peter; Fangmeier, Andreas; Zhang, Fusuo			Enhanced nitrogen deposition over China	NATURE			English	Article							CYCLE; FERTILIZER; AGROECOSYSTEMS; ENVIRONMENT; MANAGEMENT; IMPACTS; SOIL	China is experiencing intense air pollution caused in large part by anthropogenic emissions of reactive nitrogen(1,2). These emissions result in the deposition of atmospheric nitrogen (N) in terrestrial and aquatic ecosystems, with implications for human and ecosystem health, greenhouse gas balances and biological diversity(1,3-5). However, information on the magnitude and environmental impact of N deposition in China is limited. Here we use nationwide data sets on bulk N deposition, plant foliar N and crop N uptake (from long-term unfertilized soils) to evaluate N deposition dynamics and their effect on ecosystems across China between 1980 and 2010. We find that the average annual bulk deposition of N increased by approximately 8 kilograms of nitrogen per hectare (P < 0.001) between the 1980s (13.2 kilograms of nitrogen per hectare) and the 2000s (21.1 kilograms of nitrogen Per hectare). Nitrogen deposition rates in the industrialized and agriculturally intensified regions of China are as high as the peak levels of deposition in northwestern Europe in the 1980s(6), before the introduction of mitigation measures(7,8). Nitrogen from ammonium (NH4+) is the dominant form of N in bulk deposition, but the rate of increase is largest for deposition of N from nitrate (NO3-), in agreement with decreased ratios of NH3 to NOx emissions since 1980. We also find that the impact of N deposition on Chinese ecosystems includes significantly increased plant foliar N concentrations in natural and semi-natural (that is, non-agricultural) ecosystems and increased crop N uptake from long-term-unfertilized crop-lands. China and other economies are facing a continuing challenge to reduce emissions of reactive nitrogen, N deposition and their negative effects on human health and the environment.	[Liu, Xuejun; Zhang, Ying; Han, Wenxuan; Tang, Aohan; Shen, Jianlin; Cui, Zhenling; Christie, Peter; Zhang, Fusuo] China Agr Univ, Coll Resources & Environm Sci, Beijing 100193, Peoples R China; [Vitousek, Peter] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Erisman, Jan Willem] Vrije Univ Amsterdam, NL-1081 HV Amsterdam, Netherlands; [Erisman, Jan Willem] Louis Bolk Inst, NL-3972 LA Driebergen, Netherlands; [Goulding, Keith] Rothamsted Res, Sustainable Soils & Grassland Syst Dept, Harpenden AL5 2JQ, Herts, England; [Christie, Peter] Agri Food & Biosci Inst, Agri Environm Branch, Belfast BT9 5PX, Antrim, North Ireland; [Fangmeier, Andreas] Univ Hohenheim, Inst Landscape & Plant Ecol, D-70593 Stuttgart, Germany	China Agricultural University; Stanford University; Vrije Universiteit Amsterdam; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Agri-Food & Biosciences Institute; University Hohenheim	Zhang, FS (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing 100193, Peoples R China.	zhangfs@cau.edu.cn	Han, Wenxuan/B-8791-2016; Goulding, Keith WT/B-2635-2012; Christie, Peter/B-7919-2008; Liu, Xuejun/AAA-7412-2022; Shen, Jianlin/G-1820-2014; Erisman, Jan Willem/N-5093-2019; Zhang, Fusuo/AAV-4517-2021	Han, Wenxuan/0000-0001-8678-7147; Goulding, Keith WT/0000-0002-6465-1465; Christie, Peter/0000-0002-1939-7277; Shen, Jianlin/0000-0002-5853-094X; Erisman, Jan Willem/0000-0001-5058-7012; Zhang, Ying/0000-0002-9964-9381; zhang, fusuo/0000-0001-8971-0129; Fangmeier, Andreas/0000-0003-3794-9466	Chinese National Basic Research Program [2009CB118606]; NSFC [31121062, 41071151, 40973054];  [GK 1070]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005196] Funding Source: researchfish; BBSRC [BBS/E/C/00005189, BBS/E/C/00005196] Funding Source: UKRI	Chinese National Basic Research Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank X. Chen, A. Bleeker, X. Ju, J. Shen and R. Jiang for their comments on an earlier version of the manuscript or assistance during the manuscript revision, and we thank H. Liu, J. Lu, F. Chen, L. Wu and S. Qiu for providing data from long-term experiments. The authors also acknowledge all those who provided local assistance or technical help to the CAU-organized Deposition Network. This work was financially supported by the Chinese National Basic Research Program (2009CB118606), an Innovative Group Grant from the NSFC (31121062, 41071151, 40973054) and the Sino-German Research Training Group (GK 1070).	Bleeker A, 2009, ATMOSPHERIC AMMONIA, P123, DOI 10.1007/978-1-4020-9121-6_11; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Compton JE, 2011, ECOL LETT, V14, P804, DOI 10.1111/j.1461-0248.2011.01631.x; Cooper OR, 2010, NATURE, V463, P344, DOI 10.1038/nature08708; Erisman JW, 2005, SCI CHINA SER C, V48, P827, DOI 10.1007/BF03187122; Erisman JW, 1995, STUDIES ENV SCI, V63, P9; Frink CR, 1999, P NATL ACAD SCI USA, V96, P1175, DOI 10.1073/pnas.96.4.1175; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Goulding KWT, 1998, NEW PHYTOL, V139, P49, DOI 10.1046/j.1469-8137.1998.00182.x; Han WX, 2011, ECOL LETT, V14, P788, DOI 10.1111/j.1461-0248.2011.01641.x; He CE, 2007, AGR ECOSYST ENVIRON, V121, P395, DOI 10.1016/j.agee.2006.12.016; Hietz P, 2011, SCIENCE, V334, P664, DOI 10.1126/science.1211979; Holland EA, 2005, ECOL APPL, V15, P38, DOI 10.1890/03-5162; Howard C. M., 2011, EUROPEAN NITROGEN AS, DOI [10.1017/CBO9780511976988, DOI 10.1017/CBO9780511976988]; Jenkinson DS, 2004, SOIL SCI SOC AM J, V68, P865, DOI 10.2136/sssaj2004.0865; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Kim TW, 2011, SCIENCE, V334, P505, DOI 10.1126/science.1206583; Klimont Z, 2001, WATER AIR SOIL POLL, V130, P193, DOI 10.1023/A:1013886429786; Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a; Liu XJ, 2006, AGR ECOSYST ENVIRON, V113, P370, DOI 10.1016/j.agee.2005.11.002; Liu XJ, 2011, ENVIRON POLLUT, V159, P2251, DOI 10.1016/j.envpol.2010.08.002; Matson P, 2002, AMBIO, V31, P113, DOI 10.1639/0044-7447(2002)031[0113:TGONDC]2.0.CO;2; Pitcairn C, 2006, ENVIRON POLLUT, V144, P941, DOI 10.1016/j.envpol.2006.01.049; Richter A, 2005, NATURE, V437, P129, DOI 10.1038/nature04092; Schjorring JK, 1998, NEW PHYTOL, V139, P59, DOI 10.1046/j.1469-8137.1998.00173.x; Schlesinger WH, 2009, P NATL ACAD SCI USA, V106, P203, DOI 10.1073/pnas.0810193105; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Zhang FuSuo, 2008, Acta Pedologica Sinica, V45, P915; Zhang Q, 2012, NATURE, V484, P161, DOI 10.1038/484161a; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067	30	1629	2130	190	2896	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2013	494	7438					459	462		10.1038/nature11917	http://dx.doi.org/10.1038/nature11917			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23426264				2022-12-28	WOS:000315661500034
J	Merbl, Y; Refour, P; Patel, H; Springer, M; Kirschner, MW				Merbl, Yifat; Refour, Phillipe; Patel, Hevan; Springer, Michael; Kirschner, Marc W.			Profiling of Ubiquitin-like Modifications Reveals Features of Mitotic Control	CELL			English	Article							PROTEIN FAT10; TRANSCRIPTIONAL ACTIVITY; PROTEASOMAL DEGRADATION; AURORA-B; SUMOYLATION; SUMO; IDENTIFICATION; EXPRESSION; APOPTOSIS; DISEASE	Ubiquitin and ubiquitin-like (Ubl) protein modifications affect protein stability, activity, and localization, but we still lack broad understanding of the functions of Ubl modifications. We have profiled the protein targets of ubiquitin and six additional Ubls in mitosis using a functional assay that utilizes active mammalian cell extracts and protein microarrays and identified 1,500 potential substrates; 80-200 protein targets were exclusive to each Ubl. The network structure is nonrandom, with most targets mapping to a single Ubl. There are distinct molecular functions for each Ubl, suggesting divergent biological roles. Analysis of differential profiles between mitosis and G1 highlighted a previously underappreciated role for the Ubl, FAT10, in mitotic regulation. In addition to its role as a resource for Ubl modifications, our study provides a systematic approach to analyze changes in posttranslational modifications at various cellular states.	[Merbl, Yifat; Refour, Phillipe; Patel, Hevan; Springer, Michael; Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave,Warren Alpert 536, Boston, MA 02115 USA.	marc@hms.harvard.edu		Merbl, Yifat/0000-0002-3465-2221	NIH [GM039023]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039023] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jennifer Waters and the Nikon Imaging Center at Harvard Medical School for help with light microscope. We thank Anthony Hyman and Ina Poser for providing BAC clones. We thank Einav Laser for her support and Allon Klein, Shay Tal, Ana Hernandez, and Shai Shen-Orr for important scientific discussions and for their advice. We thank Kai Li, Sean Irwin, Tao Wu, and Weiping Wang for technical support. We thank Becky Ward and Shay Tal for critically reading this manuscript and for their insightful comments. This work was supported by the NIH grant GM039023.	Aichem A, 2012, J CELL SCI, V125, P4576, DOI 10.1242/jcs.107789; Aichem A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1012; Ban R, 2011, GENES CELLS, V16, P652, DOI 10.1111/j.1365-2443.2011.01521.x; Bogunovic D, 2012, SCIENCE, V337, P1684, DOI 10.1126/science.1224026; Buchsbaum S, 2012, MOL BIOL CELL, V23, P225, DOI 10.1091/mbc.E11-07-0609; Canaan A, 2006, MOL CELL BIOL, V26, P5180, DOI 10.1128/MCB.00966-05; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Durfee LA, 2010, MOL CELL, V38, P722, DOI 10.1016/j.molcel.2010.05.002; Edelmann MJ, 2008, BBA-MOL BASIS DIS, V1782, P809, DOI 10.1016/j.bbadis.2008.08.010; Fernandez-Miranda G, 2010, J CELL SCI, V123, P2823, DOI 10.1242/jcs.065565; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Girdwood DWH, 2004, SEMIN CELL DEV BIOL, V15, P201, DOI 10.1016/j.semcdb.2003.12.001; Girnita L, 2003, P NATL ACAD SCI USA, V100, P8247, DOI 10.1073/pnas.1431613100; Gocke CB, 2005, J BIOL CHEM, V280, P5004, DOI 10.1074/jbc.M411718200; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Hattori N, 2004, LANCET, V364, P722, DOI 10.1016/S0140-6736(04)16901-8; Hipp MS, 2005, MOL CELL BIOL, V25, P3483, DOI 10.1128/MCB.25.9.3483-3491.2005; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Huang DT, 2009, MOL CELL, V33, P483, DOI 10.1016/j.molcel.2009.01.011; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Kumar S, 1999, J BIOL CHEM, V274, P18785, DOI 10.1074/jbc.274.26.18785; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Lamsoul I, 2005, MOL CELL BIOL, V25, P10391, DOI 10.1128/MCB.25.23.10391-10406.2005; Lee CGL, 2003, ONCOGENE, V22, P2592, DOI 10.1038/sj.onc.1206337; Lee PCW, 2011, MOL CELL, V43, P392, DOI 10.1016/j.molcel.2011.05.034; Li TW, 2011, ARCH BIOCHEM BIOPHYS, V509, P164, DOI 10.1016/j.abb.2011.02.017; Liu YC, 1999, P NATL ACAD SCI USA, V96, P4313, DOI 10.1073/pnas.96.8.4313; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Merbl Y, 2009, P NATL ACAD SCI USA, V106, P2543, DOI 10.1073/pnas.0812892106; Morimoto M, 2000, BIOCHEM BIOPH RES CO, V270, P1093, DOI 10.1006/bbrc.2000.2576; Murakami H, 2005, PIGM CELL RES, V18, P265, DOI 10.1111/j.1600-0749.2005.00234.x; Okumura F, 2007, GENE DEV, V21, P255, DOI 10.1101/gad.1521607; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Park KM, 2007, MOL CELLS, V23, P170; Pelzer C, 2010, SUBCELL BIOCHEM, V54, P238, DOI 10.1007/978-1-4419-6676-6_19; Qing X, 2011, EXP MOL PATHOL, V90, P51, DOI 10.1016/j.yexmp.2010.09.005; Raasi S, 2001, J BIOL CHEM, V276, P35334, DOI 10.1074/jbc.M105139200; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Ren JW, 2006, J BIOL CHEM, V281, P11413, DOI 10.1074/jbc.M507218200; Ross MJ, 2006, J AM SOC NEPHROL, V17, P996, DOI 10.1681/ASN.2005070692; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Snyder A, 2009, J VIROL, V83, P11983, DOI 10.1128/JVI.00034-09; Storey JD, 2007, BIOSTATISTICS, V8, P414, DOI 10.1093/biostatistics/kxl019; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Yang SH, 2006, E SCHERING RES FDN W, V57, P193; Yao Q, 2011, J BIOL CHEM, V286, P27342, DOI 10.1074/jbc.M111.220848; Zhang DW, 2006, ONCOGENE, V25, P2318, DOI 10.1038/sj.onc.1209220	50	73	78	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 28	2013	152	5					1160	1172		10.1016/j.cell.2013.02.007	http://dx.doi.org/10.1016/j.cell.2013.02.007			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452859	Green Accepted, Bronze			2022-12-28	WOS:000315710300021
J	Boland, MV; Ervin, AM; Friedman, DS; Jampel, HD; Hawkins, BS; Vollenweider, D; Chelladurai, Y; Ward, D; Suarez-Cuervo, C; Robinson, KA				Boland, Michael V.; Ervin, Ann-Margret; Friedman, David S.; Jampel, Henry D.; Hawkins, Barbara S.; Vollenweider, Daniela; Chelladurai, Yohalakshmi; Ward, Darcy; Suarez-Cuervo, Catalina; Robinson, Karen A.			Comparative Effectiveness of Treatments for Open-Angle Glaucoma: A Systematic Review for the U.S. Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							QUALITY-OF-LIFE; COLLABORATIVE INITIAL GLAUCOMA; TRIALS COMPARING LATANOPROST; OCULAR HYPERTENSION; PROSTAGLANDIN ANALOGS; INTRAOCULAR-PRESSURE; RANDOMIZED-TRIAL; METAANALYSIS; BRIMONIDINE; TIMOLOL	Background: Glaucoma is an acquired degeneration of the optic nerve and a leading cause of blindness worldwide. Medical and surgical treatments that decrease intraocular pressure may prevent visual impairment and blindness. Purpose: To compare the effectiveness of medical, laser, and surgical treatments in adults with open-angle glaucoma with regard to decreasing intraocular pressure and preventing optic nerve damage, vision loss, and visual impairment. Data Sources: MEDLINE, CENTRAL, and an existing database for systematic reviews (through 2 March 2011); MEDLINE, EMBASE, LILACS, and CENTRAL for primary studies (through 30 July 2012). Study Selection: English-language systematic reviews; randomized, controlled trials; and quasi-randomized, controlled trials for most outcomes and observational studies for quality of life and harms. Data Extraction: Two investigators abstracted or checked information about study design, participants, and outcomes and assessed risk of bias and strength of evidence. Data Synthesis: High-level evidence suggests that medical, laser, and surgical treatments decrease intraocular pressure and that medical treatment and trabeculectomy reduce the risk for optic nerve damage and visual field loss compared with no treatment. The direct effect of treatments on visual impairment and the comparative efficacy of different treatments are not clear. Harms of medical treatment are primarily local (ocular redness, irritation); surgical treatment carries a small risk for more serious complications. Limitation: Heterogeneous outcome definitions and measurements among the included studies; exclusion of many treatment studies that did not stratify results by glaucoma type. Conclusion: Medical and surgical treatments for open-angle glaucoma lower intraocular pressure and reduce the risk for optic nerve damage over the short to medium term. Which treatments best prevent visual disability and improve patient-reported outcomes is unclear.	Johns Hopkins Univ Hosp, Sch Med, Wilmer Eye Inst, Baltimore, MD 21287 USA; Johns Hopkins Univ Hosp, Bloomberg Sch Publ Hlth, Baltimore, MD 21287 USA; Johns Hopkins Univ Hosp, Sch Med, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Robinson, KA (corresponding author), Johns Hopkins Univ Hosp, Bloomberg Sch Publ Hlth, Evidence Based Practice Ctr, 1830 E Monument St,Suite 8068, Baltimore, MD 21287 USA.			Boland, Michael/0000-0003-2506-7095; Friedman, David/0000-0002-2055-5797	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services [HHSA 290 2007 10061]; Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By contract HHSA 290 2007 10061 from the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.; Primary Funding Source: Agency for Healthcare Research and Quality.	Allaire C, 2012, EUR J OPHTHALMOL, V22, P19, DOI 10.5301/ejo.5000041; Aptel F, 2008, J GLAUCOMA, V17, P667, DOI 10.1097/IJG.0b013e3181666557; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Boland M. V., 2012, TREATMENT GLAUCOMA C; Burr J, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004399.pub2; Centofanti M, 2005, OPHTHALMOLOGY, V112, P366, DOI 10.1016/j.ophtha.2004.11.030; Chai C, 2010, J GLAUCOMA, V19, P519, DOI 10.1097/IJG.0b013e3181ca7694; Cheng JW, 2008, CLIN THER, V30, P622, DOI 10.1016/j.clinthera.2008.04.006; Cheng JW, 2010, OPHTHALMOLOGICA, V224, P138, DOI 10.1159/000236039; Cox JA, 2008, BRIT J OPHTHALMOL, V92, P729, DOI 10.1136/bjo.2008.139329; Digiuni M, 2012, J GLAUCOMA; Ervin AM., 2012, SCREENING GLAUCOMA C; Eyawo O, 2009, CLIN OPHTHALMOL, V3, P447; Fung AT, 2007, BRIT J OPHTHALMOL, V91, P62, DOI 10.1136/bjo.2006.096693; Gdih GA, 2011, OPHTHALMOLOGY, V118, P71, DOI 10.1016/j.ophtha.2010.04.008; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hodge WG, 2008, BRIT J OPHTHALMOL, V92, P7, DOI 10.1136/bjo.2007.123737; Honrubia F, 2009, BRIT J OPHTHALMOL, V93, P316, DOI 10.1136/bjo.2007.135111; Hyman LG, 2005, OPHTHALMOLOGY, V112, P1505, DOI 10.1016/j.ophtha.2005.03.028; Jampel HD, 2003, TREATMENT COEXISTING, P1; Janz NK, 2007, OPHTHALMOLOGY, V114, P2213, DOI 10.1016/j.ophtha.2007.02.014; Janz NK, 2001, OPHTHALMOLOGY, V108, P1954, DOI 10.1016/S0161-6420(01)00874-0; Javitt JC, 2000, J GLAUCOMA, V9, P224; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Katz LJ, 2012, CURR MED RES OPIN, V28, P781, DOI 10.1185/03007995.2012.681036; Kirwan JF, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003433.pub2; Krupin T, 2011, AM J OPHTHALMOL, V151, P671, DOI 10.1016/j.ajo.2010.09.026; Li N, 2006, CLIN EXP OPHTHALMOL, V34, P755, DOI 10.1111/j.1442-9071.2006.01237.x; Li T, 2010, THESIS J HOPKINS U B; Loon SC, 2008, CLIN EXP OPHTHALMOL, V36, P281, DOI 10.1111/j.1442-9071.2008.01720.x; Maier PC, 2005, BMJ-BRIT MED J, V331, P134, DOI 10.1136/bmj.38506.594977.E0; OConnell D, 2019, NEWCASTLE OTTAWA SCA; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1980, INVEST OPHTH VIS SCI, V19, P505; Rolim de Moura C, 2007, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003919; Roughead EE, 2012, OPHTHAL EPIDEMIOL, V19, P74, DOI 10.3109/09286586.2011.638743; Shaarawy T., 2009, GUIDELINES DESIGN RE; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P1090, DOI 10.1001/archopht.1991.01080080050026; Stewart WC, 2010, EUR J OPHTHALMOL, V20, P124, DOI 10.1177/112067211002000117; Vass C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003167.pub3; Whitlock EP, 2008, ANN INTERN MED, V148, P776, DOI 10.7326/0003-4819-148-10-200805200-00010; Wilkins M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002897.pub2; Wormald R, 2000, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001132; Zhang WY, 2001, BRIT J OPHTHALMOL, V85, P983, DOI 10.1136/bjo.85.8.983	46	153	158	4	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2013	158	4					271	279		10.7326/0003-4819-158-4-201302190-00008	http://dx.doi.org/10.7326/0003-4819-158-4-201302190-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098WR	23420235				2022-12-28	WOS:000315580300018
J	Cheung, AM				Cheung, Angela M.			In recently postmenopausal women, HRT reduced a composite of death, MI, or heart failure at 10 years	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL		[Cheung, Angela M.] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Health Network Toronto	Cheung, AM (corresponding author), Univ Toronto, Univ Hlth Network, Toronto, ON, Canada.							[Anonymous], 2012, HORM THER HAS MAN FA; LaCroix AZ, 2011, JAMA-J AM MED ASSOC, V305, P1305, DOI 10.1001/jama.2011.382; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321	4	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2013	158	4							JC2	10.7326/0003-4819-158-4-201302190-02002	http://dx.doi.org/10.7326/0003-4819-158-4-201302190-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098WR	23420251				2022-12-28	WOS:000315580300001
J	Paolino, N; O'Malley, PG				Paolino, Nathalie; O'Malley, Patrick G.			Review: Nonpharmacologic caregiver interventions improve dementia symptoms and caregiver reactions	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Paolino, Nathalie; O'Malley, Patrick G.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Paolino, N (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.							Raina P, 2008, ANN INTERN MED, V148, P379, DOI 10.7326/0003-4819-148-5-200803040-00009; Sink KM, 2005, JAMA-J AM MED ASSOC, V293, P596, DOI 10.1001/jama.293.5.596	2	1	1	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2013	158	4							JC4	10.7326/0003-4819-158-4-201302190-02004	http://dx.doi.org/10.7326/0003-4819-158-4-201302190-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098WR	23420257				2022-12-28	WOS:000315580300003
J	O'Neill, LAJ				O'Neill, Luke A. J.			Sensing the Dark Side of DNA	SCIENCE			English	Editorial Material							DI-GMP		Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland	Trinity College Dublin	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland.	laoneill@tcd.ie		O'Neill, Luke/0000-0002-4333-2748				Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chen ZH, 2012, NATURE, V488, P680, DOI 10.1038/nature11313; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Mechnikov I., 1908, NOBEL PRIZE ACCEPTAN; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963	8	40	56	3	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2013	339	6121					763	764		10.1126/science.1234724	http://dx.doi.org/10.1126/science.1234724			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23413341				2022-12-28	WOS:000314874400030
J	Sedgwick, P				Sedgwick, Philip			Sample size: how many participants are needed in a trial?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Ctr Med & Healthcare Educ, London, England	St Georges University London; University of London	Sedgwick, P (corresponding author), Univ London, Ctr Med & Healthcare Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Sedgwick P., 2010, BMJ-BRIT MED J, V340, pc2059; Sedgwick P, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2981; Wen LM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3732	3	9	9	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 15	2013	346								f1041	10.1136/bmj.f1041	http://dx.doi.org/10.1136/bmj.f1041			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	091ZW	23418280				2022-12-28	WOS:000315089600003
J	Shoval, O; Sheftel, H; Shinar, G; Hart, Y; Ramote, O; Mayo, A; Dekel, E; Kavanagh, K; Alon, U				Shoval, Oren; Sheftel, Hila; Shinar, Guy; Hart, Yuval; Ramote, Omer; Mayo, Avi; Dekel, Erez; Kavanagh, Kathryn; Alon, Uri			Response to Comment on "Evolutionary Trade-Offs, Pareto Optimality, and the Geometry of Phenotype Space"	SCIENCE			English	Editorial Material							DARWINS FINCHES	Edelaar raises concerns about the way we tested our theory. Our mathematical theorem predicts that despite the high dimensionality of trait space, trade-offs between tasks lead to phenotypes in low-dimensional regions in trait space, such as lines and triangles. We address Edelaar's questions with statistical tests that eliminate pseudoreplication concerns, finding that our predictions remain convincingly supported.	[Shoval, Oren; Sheftel, Hila; Shinar, Guy; Hart, Yuval; Ramote, Omer; Mayo, Avi; Dekel, Erez; Alon, Uri] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Kavanagh, Kathryn] Univ Massachusetts Dartmouth, Dept Biol, Dartmouth, MA 02747 USA	Weizmann Institute of Science; University of Massachusetts System; University Massachusetts Dartmouth	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	urialon@weizmann.ac.il	mayo, avi/N-3756-2019	mayo, avi/0000-0002-4479-3423				Edelaar P, 2013, SCIENCE, V339, DOI 10.1126/science.1228281; Grant P.R., 1999, RECOGNITION STATES L, V2; GRANT PR, 1985, BIOL J LINN SOC, V25, P1, DOI 10.1111/j.1095-8312.1985.tb00384.x; Petren K, 2005, MOL ECOL, V14, P2943, DOI 10.1111/j.1365-294X.2005.02632.x; Shoval O, 2012, SCIENCE, V336, P1157, DOI 10.1126/science.1217405; WILSON EO, 1980, BEHAV ECOL SOCIOBIOL, V7, P143, DOI 10.1007/BF00299520; Zaslaver A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000545	7	6	6	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2013	339	6121								10.1126/science.1228921	http://dx.doi.org/10.1126/science.1228921			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	088YS	23413339				2022-12-28	WOS:000314874400025
J	Cox, B; Martens, E; Nemery, B; Vangronsveld, J; Nawrot, TS				Cox, Bianca; Martens, Evelyne; Nemery, Benoit; Vangronsveld, Jaco; Nawrot, Tim S.			Impact of a stepwise introduction of smoke-free legislation on the rate of preterm births: analysis of routinely collected birth data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; MYOCARDIAL-INFARCTION; SECONDHAND SMOKE; GESTATIONAL-AGE; PASSIVE SMOKING; PREGNANT-WOMEN; AIR-POLLUTION; EXPOSURE; RISK; ASSOCIATION	Objective To investigate the incidence of preterm delivery in the Belgian population after implementation of smoke-free legislation in three phases (in public places and most workplaces January 2006, in restaurants January 2007, and in bars serving food January 2010). Design Logistic regression analyses on routinely collected birth data from January 2002 to December 2011. Setting Flanders, Belgium. Population All live born singleton births delivered at 24-44 weeks of gestation (n=606 877, with n=448 520 spontaneous deliveries). Main outcome measures Preterm birth (gestational age <37 weeks). Results We found reductions in the risk of preterm birth after the introduction of each phase of the smoking ban. No decreasing trend was evident in the years or months before the bans. We observed a step change in the risk of spontaneous preterm delivery of -3.13% (95% CI -4.37% to -1.87%; P<0.01) on 1 January 2007 (ban on smoking in restaurants), and an annual slope change of -2.65% (-5.11% to -0.13%; P=0.04) after 1 January 2010 (ban on smoking in bars serving food). The analysis for all births gave similar results: a step change of -3.18% (-5.38% to -0.94%; P<0.01) on 1 January 2007, and an annual slope change of -3.50% (-6.35% to -0.57%; P=0.02) after 1 January 2010. These changes could not be explained by personal factors (infant sex, maternal age, parity, socioeconomic status, national origin, level of urbanisation); time related factors (underlying trends, month of the year, day of the week); or population related factors (public holidays, influenza epidemics, and short term changes in apparent temperature and particulate air pollution). Conclusion Our study shows a consistent pattern of reduction in the risk of preterm delivery with successive population interventions to restrict smoking. This finding is not definitive but it supports the notion that smoking bans have public health benefits from early life.	[Cox, Bianca; Vangronsveld, Jaco; Nawrot, Tim S.] Hasselt Univ, Ctr Environm Sci, B-3590 Diepenbeek, Belgium; [Martens, Evelyne] Study Ctr Perinatal Epidemiol, Brussels, Belgium; [Nemery, Benoit; Nawrot, Tim S.] Univ Leuven KU Leuven, Dept Publ Hlth, Louvain, Belgium	Hasselt University; KU Leuven	Nawrot, TS (corresponding author), Hasselt Univ, Ctr Environm Sci, B-3590 Diepenbeek, Belgium.	tim.nawrot@uhasselt.be	Nemery, Benoit/D-1224-2013; Cox, Bianca/A-9480-2015; Vangronsveld, Jaco/ABE-5907-2020; Nemery, Benoit/N-3155-2019; Nawrot, Tim/AAA-4531-2019	Cox, Bianca/0000-0001-9824-6276; Vangronsveld, Jaco/0000-0003-4423-8363; Nemery, Benoit/0000-0003-0571-4689; Nawrot, Tim/0000-0002-3583-3593	Flemish Scientific fund [FWO: G.0.873.11.N.10/1.5.158.09.N.00]; ERC starting grant (ENVIRONAGE); Hasselt University Fund (BOF)	Flemish Scientific fund; ERC starting grant (ENVIRONAGE); Hasselt University Fund (BOF)	The Study Centre for Perinatal Epidemiology is financed and commissioned by the Flemish Centre for Care and Health (Agentschap Zorg en Gezondheid). This study was supported by grants from the Flemish Scientific fund (FWO: G.0.873.11.N.10/1.5.158.09.N.00), ERC starting grant (ENVIRONAGE), and Hasselt University Fund (BOF).	Ahluwalia IB, 1997, AM J EPIDEMIOL, V146, P42; Anonymous, 2009, Morbidity and Mortality Weekly Report, V57, P1373; Ashford KB, 2010, JOGNN-J OBST GYN NEO, V39, P525, DOI 10.1111/j.1552-6909.2010.01169.x; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Barone-Adesi F, 2006, EUR HEART J, V27, P2468, DOI 10.1093/eurheartj/ehl201; Basu R, 2010, AM J EPIDEMIOL, V172, P1108, DOI 10.1093/aje/kwq170; Cammu H, 2002, AM J OBSTET GYNECOL, V186, P240, DOI 10.1067/mob.2002.119643; Charafeddine R, 2012, HLTH INTERVIEW SURG; Charrier L, 2010, J PUBLIC HEALTH POL, V31, P51, DOI 10.1057/jphp.2009.43; Crane JMG, 2011, BJOG-INT J OBSTET GY, V118, P865, DOI 10.1111/j.1471-0528.2011.02941.x; Crump C, 2011, JAMA-J AM MED ASSOC, V306, P1233, DOI 10.1001/jama.2011.1331; Dadvand P, 2011, ENVIRON HEALTH PERSP, V119, P1449, DOI 10.1289/ehp.1003241; Dexia Bank NV, 2007, SOC TYP GEM; El-Mohandes AAE, 2010, PEDIATRICS, V125, P721, DOI 10.1542/peds.2009-1809; Engle WA, 2007, PEDIATRICS, V120, P1390, DOI 10.1542/peds.2007-2952; Fantuzzi G, 2007, PAEDIATR PERINAT EP, V21, P194, DOI 10.1111/j.1365-3016.2007.00815.x; Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; Gallus S, 2007, PREV MED, V45, P198, DOI 10.1016/j.ypmed.2007.03.009; Halleux JM, 2009, SOCIAAL EC ENQUETE 2; Hanke W, 1999, HUM EXP TOXICOL, V18, P265, DOI 10.1191/096032799678840020; Harrel F.E., 2001, REGRESSION MODELING; Haw SJ, 2007, BRIT MED J, V335, P549, DOI 10.1136/bmj.39315.670208.47; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jaakkola JJK, 2001, ENVIRON HEALTH PERSP, V109, P557, DOI 10.2307/3455027; Janssen S, 2008, ATMOS ENVIRON, V42, P4884, DOI 10.1016/j.atmosenv.2008.02.043; Kabir Z, 2009, BJOG-INT J OBSTET GY, V116, P1782, DOI 10.1111/j.1471-0528.2009.02374.x; KALKSTEIN LS, 1986, B AM METEOROL SOC, V67, P842, DOI 10.1175/1520-0477(1986)067<0842:AEOSDI>2.0.CO;2; Keirse MJNC, 2009, PAEDIATR PERINAT EP, V23, P522, DOI 10.1111/j.1365-3016.2009.01067.x; Kharrazi M, 2004, EPIDEMIOLOGY, V15, P660, DOI 10.1097/01.ede.0000142137.39619.60; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Lang JM, 1996, EPIDEMIOLOGY, V7, P369, DOI 10.1097/00001648-199607000-00006; Lee BE, 2003, EPIDEMIOLOGY, P14; Leonardi-Bee J, 2008, ARCH DIS CHILD-FETAL, V93, pF351, DOI 10.1136/adc.2007.133553; Liu SL, 2003, ENVIRON HEALTH PERSP, V111, P1773, DOI 10.1289/ehp.6251; Mackay D, 2010, NEW ENGL J MED, V363, P1139, DOI 10.1056/NEJMoa1002861; Mackay DF, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001175; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; McIntire DD, 2008, OBSTET GYNECOL, V111, P35, DOI 10.1097/01.AOG.0000297311.33046.73; Meyers DG, 2009, J AM COLL CARDIOL, V54, P1249, DOI 10.1016/j.jacc.2009.07.022; Mons U, 2012, TOB CONTROL; Nawrot TS, 2011, LANCET, V377, P732, DOI 10.1016/S0140-6736(10)62296-9; Sagiv SK, 2005, ENVIRON HEALTH PERSP, V113, P602, DOI 10.1289/ehp.7646; Sargent RP, 2004, BMJ-BRIT MED J, V328, P977, DOI 10.1136/bmj.38055.715683.55; Schick S, 2005, TOB CONTROL, V14, P396, DOI 10.1136/tc.2005.011288; Shah NR, 2000, AM J OBSTET GYNECOL, V182, P465, DOI 10.1016/S0002-9378(00)70240-7; Sheldon T, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5503; Sims M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2161; Van Casteren V, 2010, ARCH PUBLIC HEALTH, V68, P62, DOI 10.1186/0778-7367-68-2-62; VILLAR J, 1986, EARLY HUM DEV, V14, P307, DOI 10.1016/0378-3782(86)90193-3; Vlaamse Liga tegen Kanker, 2011, GEDW MEER WET; Windham GC, 2000, EPIDEMIOLOGY, V11, P427, DOI 10.1097/00001648-200007000-00011; Xu XP, 1995, ARCH ENVIRON HEALTH, V50, P407, DOI 10.1080/00039896.1995.9935976	52	33	33	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2013	346								f441	10.1136/bmj.f441	http://dx.doi.org/10.1136/bmj.f441			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091ZR	23412829	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000315088800009
J	Yuan, H; Marmorstein, R				Yuan, Hua; Marmorstein, Ronen			Red Wine, Toast of the Town (Again)	SCIENCE			English	Editorial Material							SMALL-MOLECULE ACTIVATORS; SACCHAROMYCES-CEREVISIAE; DEACETYLASE ACTIVITY; LIFE-SPAN; SIRT1; RESVERATROL; LONGEVITY; SURVIVAL; SIRTUINS; SRT1720		[Yuan, Hua; Marmorstein, Ronen] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	The Wistar Institute	Yuan, H (corresponding author), Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA.	marmor@wistar.org			NIA NIH HHS [P01 AG031862] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG031862] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kang H, 2011, MOL CELL, V44, P203, DOI 10.1016/j.molcel.2011.07.038; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Minor RK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00070; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Pan M, 2012, J BIOL CHEM, V287, P2468, DOI 10.1074/jbc.M111.285031; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Yuan H, 2012, J BIOL CHEM, V287, P42428, DOI 10.1074/jbc.R112.372300	17	12	12	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2013	339	6124					1156	1157		10.1126/science.1236463	http://dx.doi.org/10.1126/science.1236463			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471392	Green Accepted			2022-12-28	WOS:000315709900031
J	Kirkcaldy, RD; Zaidi, A; Hook, EW; Holmes, KH; Soge, O; del Rio, C; Hall, G; Papp, J; Bolan, G; Weinstock, HS				Kirkcaldy, Robert D.; Zaidi, Akbar; Hook, Edward W., III; Holmes, King H.; Soge, Olusegun; del Rio, Carlos; Hall, Geraldine; Papp, John; Bolan, Gail; Weinstock, Hillard S.			Neisseria gonorrhoeae Antimicrobial Resistance Among Men Who Have Sex With Men and Men Who Have Sex Exclusively With Women: The Gonococcal Isolate Surveillance Project, 2005-2010	ANNALS OF INTERNAL MEDICINE			English	Article							HIGH-LEVEL RESISTANCE; UNITED-STATES; SUSCEPTIBILITY; PENICILLIN; STRAINS; EPIDEMIOLOGY; EMERGENCE; CEFIXIME; PENA	Background: Gonorrhea treatment has been complicated by antimicrobial resistance in Neisseria gonorrhoeae. Gonococcal fluoroquinolone resistance emerged more rapidly among men who have sex with men (MSM) than men who have sex exclusively with women (MSW). Objective: To determine whether N. gonorrhoeae urethral isolates from MSM were more likely than isolates from MSW to exhibit resistance to or elevated minimum inhibitory concentrations (MICs) of antimicrobials used to treat gonorrhea. Design: 6 years of surveillance data from the Gonococcal Isolate Surveillance Project. Setting: Publicly funded sexually transmitted disease clinics in 30 U.S. cities. Patients: Men with a total of 34 600 episodes of symptomatic urethral gonorrhea. Measurements: Percentage of isolates exhibiting resistance or elevated MICs and adjusted odds ratios for resistance or elevated MICs among isolates from MSM compared with isolates from MSW. Results: In all U. S. regions except the West, isolates from MSM were significantly more likely to exhibit elevated MICs of ceftriaxone and azithromycin than isolates from MSW (P < 0.050). Isolates from MSM had a high prevalence of resistance to ciprofloxacin, penicillin, and tetracycline and were significantly more likely to exhibit antimicrobial resistance than isolates from MSW (P < 0.001). Limitations: Sentinel surveillance may not be representative of all patients with gonorrhea. HIV status, travel history, and antimicrobial use data were missing for some patients. Conclusion: Men who have sex with men are vulnerable to the emerging threat of antimicrobial-resistant N. gonorrhoeae. Because antimicrobial susceptibility testing is not routinely done in clinical practice, clinicians should monitor for treatment failures among MSM diagnosed with gonorrhea. Strengthened prevention strategies for MSM and new antimicrobial treatment options are needed.	[Kirkcaldy, Robert D.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Emory Univ, Atlanta, GA 30322 USA; Univ Alabama Birmingham, Birmingham, AL USA; Jefferson Cty Dept Hlth, Birmingham, AL USA; Univ Washington, Seattle, WA 98195 USA; Cleveland Clin, Cleveland, OH 44106 USA	Centers for Disease Control & Prevention - USA; Emory University; University of Alabama System; University of Alabama Birmingham; University of Washington; University of Washington Seattle; Cleveland Clinic Foundation	Kirkcaldy, RD (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,Mailstop E-02, Atlanta, GA 30333 USA.	rkirkcaldy@cdc.gov	del Rio, Carlos/B-3763-2012; Papp, John/AAA-3073-2019; Kirkcaldy, Bob/ABB-1483-2020	del Rio, Carlos/0000-0002-0153-3517; Papp, John/0000-0002-7495-5454; Kirkcaldy, Robert/0000-0002-1749-4647	Centers for Disease Control and Prevention; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [H25PS001412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial Support: By the Centers for Disease Control and Prevention.	Akasaka S, 2001, J Infect Chemother, V7, P49, DOI 10.1007/s101560170034; Ameyama S, 2002, ANTIMICROB AGENTS CH, V46, P3744, DOI 10.1128/AAC.46.12.3744-3749.2002; Braunstein SL, 2011, SEX TRANSM DIS, V38, P385, DOI 10.1097/OLQ.0b013e31820b8eba; Centers for Disease Control and Prevention, 2012, 2011 SEX TRANSM DIS; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1041; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI, V29, P84; CURRAN JW, 1979, SEX TRANSM DIS, V6, P174, DOI 10.1097/00007435-197904000-00024; del Rio C., 2007, Morbidity and Mortality Weekly Report, V56, P332; del Rio Carlos, 2012, Morbidity and Mortality Weekly Report, V61, P590; Diep BA, 2008, ANN INTERN MED, V148, P249, DOI 10.7326/0003-4819-148-4-200802190-00204; Dowell D, 2012, AM J PUBLIC HEALTH, V102, P148, DOI 10.2105/AJPH.2011.300283; FAGAN D, 1985, GENITOURIN MED, V61, P363; Gaudreau C, 2011, EMERG INFECT DIS, V17, P1747, DOI 10.3201/eid1709.102034; HANDSFIELD HH, 1980, SEX TRANSM DIS, V7, P1, DOI 10.1097/00007435-198001000-00001; Health Protection Agency, 2011, GRASP 2010 REP GON R; Ison CA, 2011, EURO SURVEILL, V16; Johnson LF, 2008, SEX TRANSM DIS, V35, P946, DOI 10.1097/OLQ.0b013e3181812d15; Katz AR, 2012, CLIN INFECT DIS, V54, P841, DOI 10.1093/cid/cir929; Katz Kenneth A., 2011, Morbidity and Mortality Weekly Report, V60, P579; KNAPP JS, 1994, ANTIMICROB AGENTS CH, V38, P2200, DOI 10.1128/AAC.38.9.2200; KNAPP JS, 1987, J INFECT DIS, V155, P819, DOI 10.1093/infdis/155.4.819; Mansergh G, 2001, AM J PUBLIC HEALTH, V91, P953, DOI 10.2105/AJPH.91.6.953; MARTIN JE, 1970, J INFECT DIS, V122, P459, DOI 10.1093/infdis/122.5.459; MCFARLAND L, 1983, J CLIN MICROBIOL, V18, P121, DOI 10.1128/JCM.18.1.121-127.1983; MORSE SA, 1982, INFECT IMMUN, V37, P432, DOI 10.1128/IAI.37.2.432-438.1982; MORSE SA, 1986, ANTIMICROB AGENTS CH, V30, P664, DOI 10.1128/AAC.30.5.664; Ohnishi M, 2011, ANTIMICROB AGENTS CH, V55, P3538, DOI 10.1128/AAC.00325-11; PERINE PL, 1979, SEX TRANSM DIS, V6, P152; Ratelle S., 2004, Morbidity and Mortality Weekly Report, V53, P335; SHAFER WM, 1995, MICROBIOL-UK, V141, P907, DOI 10.1099/13500872-141-4-907; Soge OO, 2012, SEX TRANSM DIS, V39, P877, DOI 10.1097/OLQ.0b013e3182685d2b; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; Truong HHM, 2008, J TRAVEL MED, V15, P454, DOI 10.1111/j.1708-8305.2008.00245.x; Unemo M, 2010, EURO SURVEILL, V15; Unemo M, 2012, ANTIMICROB AGENTS CH, V56, P1273, DOI 10.1128/AAC.05760-11; Warner L, 2006, SEX TRANSM DIS, V33, P36, DOI 10.1097/01.olq.0000187908.42622.fd; WATSON RA, 1979, MIL MED, V144, P785; Weinstock HS, 2004, J INFECT DIS, V189, P2174, DOI 10.1086/420789; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; Yokoi S, 2007, EMERG INFECT DIS, V13, P1275	40	68	70	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2013	158	5	1				321	328		10.7326/0003-4819-158-5-201303050-00004	http://dx.doi.org/10.7326/0003-4819-158-5-201303050-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105HP	23460055	Green Accepted			2022-12-28	WOS:000316057700003
J	Morgan, RL; Baack, B; Smith, BD; Yartel, A; Pitasi, M; Falck-Ytter, Y				Morgan, Rebecca L.; Baack, Brittney; Smith, Bryce D.; Yartel, Anthony; Pitasi, Marc; Falck-Ytter, Yngve			Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma A Meta-analysis of Observational Studies	ANNALS OF INTERNAL MEDICINE			English	Review							SUSTAINED VIROLOGICAL RESPONSE; PLUS RIBAVIRIN THERAPY; TERM-FOLLOW-UP; ALPHA-FETOPROTEIN LEVELS; HCV-RELATED CIRRHOSIS; INTERFERON THERAPY; UNITED-STATES; ANTIVIRAL THERAPY; RISK-FACTOR; MORTALITY	Background: Hepatitis C virus (HCV) is a leading cause of hepatocellular carcinoma (HCC). In the United States, this form of cancer occurs in approximately 15 000 persons annually. A systematic review of the evidence is needed to assess the benefits of treatment of HCV-infected persons on development of HCC. Purpose: To systematically review observational studies to determine the association between response to HCV therapy and development of HCC among persons at any stage of fibrosis and those with advanced liver disease. Data Sources: MEDLINE, EMBASE, CINAHL, the Cochrane Library, Web of Science, and the Database of Abstracts of Reviews and Effectiveness from inception through February 2012. Study Selection: English-language observational studies that compared therapy-derived sustained virologic response (SVR) with no response to therapy among HCV-infected persons, targeted an adult population, and had an average follow-up of at least 2 years. Data Extraction: Two investigators independently extracted data into uniform relative risk measures. The Grading of Recommendations Assessment, Development and Evaluation framework was used to determine the quality of the evidence. Data Synthesis: Thirty studies fulfilled the inclusion criteria, and 18 provided adjusted effect estimates that were used to calculate pooled relative risks. Among HCV-infected persons, SVR was associated with reduced risk for HCC (relative risk for all persons, 0.24 [95% CI, 0.18 to 0.31], moderate-quality evidence; advanced liver disease hazard ratio, 0.23 [CI, 0.16 to 0.35], moderate-quality evidence). Limitation: In the meta-analyses, some variables could not be controlled for because of the observational design of the included studies. Conclusion: Sustained virologic response after treatment among HCV-infected persons at any stage of fibrosis is associated with reduced HCC. The evidence was determined to be of moderate quality.	[Morgan, Rebecca L.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Case Western Reserve Univ, Louis Stokes Vet Affairs Med Ctr, Cleveland, OH 44106 USA; Case Western Reserve Univ, Univ Hosp, Case Med Ctr, Cleveland, OH 44106 USA	Centers for Disease Control & Prevention - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; University Hospitals of Cleveland	Morgan, RL (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,MS G-37, Atlanta, GA 30333 USA.	evf5@cdc.gov	Falck-Ytter, Yngve/GZH-0993-2022; Yngve Falck-Ytter, AGAF/AAC-5362-2019	Yngve Falck-Ytter, AGAF/0000-0002-4688-3211; Yartel, Anthony/0000-0001-6586-9362; Morgan, Rebecca/0000-0002-1012-4897	Centers for Disease Control and Prevention; Division of Viral Hepatitis at the Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Division of Viral Hepatitis at the Centers for Disease Control and Prevention	Primary Funding Source: Centers for Disease Control and Prevention.; Financial Support: By the Division of Viral Hepatitis at the Centers for Disease Control and Prevention.	Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Armstrong GL, 2000, HEPATOLOGY, V31, P777, DOI 10.1002/hep.510310332; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Asahina Y, 2010, HEPATOLOGY, V52, P518, DOI 10.1002/hep.23691; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Bruno S, 2001, J HEPATOL, V34, P748, DOI 10.1016/S0168-8278(01)00062-9; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Bruno S, 2009, AM J GASTROENTEROL, V104, P1147, DOI 10.1038/ajg.2009.31; Calvaruso V, 2011, DIGEST LIVER DIS, V43, pS99, DOI 10.1016/S1590-8658(11)60108-4; Camma C, 2004, CURR PHARM DESIGN, V10, P2123, DOI 10.2174/1381612043384321; Cardoso AC, 2010, J HEPATOL, V52, P652, DOI 10.1016/j.jhep.2009.12.028; Centers for Disease Control and Prevention, 2012, VIT HEP SURV US 2010, P1; Cheinquer N, 2010, BRAZ J INFECT DIS, V14, P457, DOI 10.1590/S1413-86702010000500006; Coverdale SA, 2004, AM J GASTROENTEROL, V99, P636, DOI 10.1111/j.1572-0241.2004.04085.x; D'Ambrosio R, 2011, ANTIVIR THER, V16, P677, DOI 10.3851/IMP1807; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dohmen K, 2011, HEPATOLOGY, V54, p1400A; El Braks R, 2007, WORLD J GASTROENTERO, V13, P5648, DOI 10.3748/wjg.v13.i42.5648; El-Serag HB, 2007, HEPATOL RES, V37, pS88, DOI 10.1111/j.1872-034X.2007.00168.x; Everson GT, 2006, HEPATOLOGY, V44, P1675, DOI 10.1002/hep.21440; Ferlay JSH, 2008, IARC CANCERBASE; Fernandez-Rodriguez CM, 2010, AM J GASTROENTEROL, V105, P2164, DOI 10.1038/ajg.2010.294; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Giannini E, 2001, J GASTROEN HEPATOL, V16, P399, DOI 10.1046/j.1440-1746.2001.02463.x; Greenland S, 1998, MODERN EPIDEMIOLOGY, P231; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hasegawa E, 2007, HEPATOL RES, V37, P793, DOI 10.1111/j.1872-034X.2007.00140.x; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Hung CH, 2006, J VIRAL HEPATITIS, V13, P409, DOI 10.1111/j.1365-2893.2005.00707.x; Hung CH, 2011, INT J CANCER, V128, P2344, DOI 10.1002/ijc.25585; Iacobellis A, 2011, CLIN GASTROENTEROL H, V9, P249, DOI 10.1016/j.cgh.2010.10.036; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; JAMIL KM, 2007, GUT S2, V56, pA126; Kashiwagi Kenichiro, 2003, Journal of Infection and Chemotherapy, V9, P333, DOI 10.1007/s10156-003-0271-5; Kawamura Y, 2010, AM J MED, V123, P951, DOI 10.1016/j.amjmed.2010.05.013; Kramer JR, 2011, GASTROENTEROLOGY, V140, pS899; Kurokawa M, 2009, HEPATOL RES, V39, P432, DOI 10.1111/j.1872-034X.2008.00477.x; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; McGarry LJ, 2012, HEPATOLOGY, V55, P1344, DOI 10.1002/hep.25510; Morgan TR, 2010, HEPATOLOGY, V52, P833, DOI 10.1002/hep.23744; Namikawa M, 2012, J GASTROEN HEPATOL, V27, P69, DOI 10.1111/j.1440-1746.2011.06802.x; Ng V, 2011, CLIN GASTROENTEROL H, V9, P923, DOI 10.1016/j.cgh.2011.05.028; OConnell D, 2019, NEWCASTLE OTTAWA SCA; Okanoue T, 2002, HEPATOL RES, V23, P62, DOI 10.1016/S1386-6346(02)00016-5; Osaki Y, 2012, J GASTROENTEROL, V47, P444, DOI 10.1007/s00535-011-0505-8; Pearlman BL, 2011, CLIN INFECT DIS, V52, P889, DOI 10.1093/cid/cir076; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Pradat P, 2007, J VIRAL HEPATITIS, V14, P556, DOI 10.1111/j.1365-2893.2006.00829.x; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Rein DB, 2011, DIGEST LIVER DIS, V43, P66, DOI 10.1016/j.dld.2010.05.006; Shindo M, 2001, HEPATOLOGY, V33, P1299, DOI 10.1053/jhep.2001.24100; Shiratori Y, 2005, ANN INTERN MED, V142, P105, DOI 10.7326/0003-4819-142-2-200501180-00009; Singal AG, 2010, CLIN GASTROENTEROL H, V8, P280, DOI 10.1016/j.cgh.2009.11.018; Singal AK, 2010, CLIN GASTROENTEROL H, V8, P192, DOI 10.1016/j.cgh.2009.10.026; Sinn DH, 2008, LIVER INT, V28, P1363, DOI 10.1111/j.1478-3231.2008.01860.x; Takahashi H, 2011, J GASTROENTEROL, V46, P790, DOI 10.1007/s00535-011-0381-2; Tamura Y, 2009, DIGEST DIS SCI, V54, P2530, DOI 10.1007/s10620-008-0642-y; Tateyama M, 2011, J GASTROENTEROL, V46, P92, DOI 10.1007/s00535-010-0293-6; The GRADE Working Group, 2019, GRADE HDB GRADING QU; Thomas David L, 2005, Clin Liver Dis, V9, P383, DOI 10.1016/j.cld.2005.05.003; Thomas DL, 2005, CLIN LIVER DIS, V9, pvi; VANDERMEER AJP, 2012, J HEPATOL S2, V56, pS363; Velosa J, 2011, DIGEST DIS SCI, V56, P1853, DOI 10.1007/s10620-011-1621-2; Woods BS, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-54; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003; Zhang CH, 2011, INT J CANCER, V129, P1254, DOI 10.1002/ijc.25767	68	592	612	1	56	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2013	158	5	1				329	+		10.7326/0003-4819-158-5-201303050-00005	http://dx.doi.org/10.7326/0003-4819-158-5-201303050-00005			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105HP	23460056				2022-12-28	WOS:000316057700004
J	Reston, JT; Schoelles, KM				Reston, James T.; Schoelles, Karen M.			In-Facility Delirium Prevention Programs as a Patient Safety Strategy A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Article							HOSPITALIZED OLDER PATIENTS; ELDER LIFE PROGRAM; REDUCING DELIRIUM; HIP FRACTURE; MULTICOMPONENT INTERVENTION; POSTOPERATIVE DELIRIUM; CARE; PEOPLE; TRIAL	Delirium, an acute decline in attention and cognition, occurs among hospitalized patients at rates estimated to range from 14% to 56% and increases the risk for morbidity and mortality. The purpose of this systematic review was to evaluate the effectiveness and safety of in-facility multicomponent delirium prevention programs. A search of 6 databases (including MEDLINE, EMBASE, and CINAHL) was conducted through September 2012. Randomized, controlled trials; controlled clinical trials; interrupted time series; and controlled before-after studies with a prospective postintervention portion were eligible for inclusion. The evidence from 19 studies that met the inclusion criteria suggests that most multicomponent interventions are effective in preventing onset of delirium in at-risk patients in a hospital setting. Evidence was insufficient to determine the benefit of such programs in other care settings. Future comparative effectiveness studies with standardized protocols are needed to identify which components in multicomponent interventions are most effective for delirium prevention. Ann Intern Med. 2013;158:375-380. www.annals.org	[Reston, James T.; Schoelles, Karen M.] ECRI Inst, Plymouth Meeting, PA 19462 USA		Reston, JT (corresponding author), ECRI Inst, 5200 Butler Pike, Plymouth Meeting, PA 19462 USA.	jreston@ecri.org			AHRQ, U.S. Department of Health and Human Services [HHSA-290-2007-10062I]; Rand Corporation	AHRQ, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Rand Corporation	Financial Support: From AHRQ, U.S. Department of Health and Human Services (contract HHSA-290-2007-10062I).; Potential Conflicts of Interest: Dr. Reston: Grant (money to institution): AHRQ, U.S. Department of Health and Human Services. Dr. Schoelles: Support for travel to meetings for the study or other purposes (money to institution): Rand Corporation. Other (money to institution): Rand Corporation. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M12-2566.	Allen KR, 2011, J CLIN OUTCOMES MANA, P253; Bjorkelund KB, 2010, ACTA ANAESTH SCAND, V54, P678, DOI 10.1111/j.1399-6576.2010.02232.x; Black P, 2011, J ADV NURS, V67, P1091, DOI 10.1111/j.1365-2648.2010.05558.x; Chen CCH, 2011, J AM COLL SURGEONS, V213, P245, DOI 10.1016/j.jamcollsurg.2011.05.004; Colombo R, 2012, MINERVA ANESTESIOL, V78, P1026; Deschodt M, 2012, J AM GERIATR SOC, V60, P733, DOI 10.1111/j.1532-5415.2012.03899.x; Gagnon P, 2012, PSYCHO-ONCOLOGY, V21, P187, DOI 10.1002/pon.1881; Harari D, 2007, AGE AGEING, V36, P190, DOI 10.1093/ageing/afl163; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Inouye SK, 2003, ARCH INTERN MED, V163, P958, DOI 10.1001/archinte.163.8.958; Lapane KL, 2011, J AM GERIATR SOC, V59, P1238, DOI 10.1111/j.1532-5415.2011.03418.x; Leslie DL, 2008, ARCH INTERN MED, V168, P27, DOI 10.1001/archinternmed.2007.4; Lundstrom M, 2005, J AM GERIATR SOC, V53, P622, DOI 10.1111/j.1532-5415.2005.53210.x; Lundstrom M, 2007, AGING CLIN EXP RES, V19, P178; Marcantonio ER, 2001, J AM GERIATR SOC, V49, P516, DOI 10.1046/j.1532-5415.2001.49108.x; Needham DM, 2010, ARCH PHYS MED REHAB, V91, P536, DOI 10.1016/j.apmr.2010.01.002; Rizzo JA, 2001, MED CARE, V39, P740, DOI 10.1097/00005650-200107000-00010; Rubin FH, 2011, J AM GERIATR SOC, V59, P359, DOI 10.1111/j.1532-5415.2010.03243.x; Rudolph JL, 2011, ANESTH ANALG, V112, P1202, DOI 10.1213/ANE.0b013e3182147f6d; Tabet N, 2005, AGE AGEING, V34, P152, DOI 10.1093/ageing/afi031; Tabet N, 2006, INT J GERIATR PSYCH, V21, P493, DOI 10.1002/gps.1532; Martinez FT, 2012, AGE AGEING, V41, P629, DOI 10.1093/ageing/afs060; Vidan MT, 2009, J AM GERIATR SOC, V57, P2029, DOI 10.1111/j.1532-5415.2009.02485.x; Wong D. M., 2005, AUSTRALASIAN J AGEIN, V24, P174	24	71	73	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2013	158	5	2				375	+		10.7326/0003-4819-158-5-201303051-00003	http://dx.doi.org/10.7326/0003-4819-158-5-201303051-00003			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	105HX	23460093				2022-12-28	WOS:000316058600003
J	Biggs, D; Courchamp, F; Martin, R; Possingham, HP				Biggs, Duan; Courchamp, Franck; Martin, Rowan; Possingham, Hugh P.			Legal Trade of Africa's Rhino Horns	SCIENCE			English	Editorial Material							CONSERVATION		[Biggs, Duan; Possingham, Hugh P.] Univ Queensland, Australian Res Council Ctr Excellence Environm De, Ctr Biodivers & Conservat Sci, Brisbane, Qld 4072, Australia; [Courchamp, Franck] Univ Paris Sud, UMR CNRS 8079, Orsay, France	University of Queensland; UDICE-French Research Universities; Universite Paris Saclay	Biggs, D (corresponding author), Univ Queensland, Australian Res Council Ctr Excellence Environm De, Ctr Biodivers & Conservat Sci, Brisbane, Qld 4072, Australia.	ancientantwren@gmail.com	Possingham, Hugh/B-1337-2008; Biggs, Duan/F-9445-2011; Courchamp, Franck/ABE-7204-2020; POSSINGHAM, HUGH/R-8310-2019	Possingham, Hugh/0000-0001-7755-996X; Courchamp, Franck/0000-0001-7605-4548; POSSINGHAM, HUGH/0000-0001-7755-996X; Biggs, Duan/0000-0003-3177-4677				Brown G., 2001, PROTECTING ENDANGERE, P32; Bulte EH, 2005, CONSERV BIOL, V19, P1222, DOI 10.1111/j.1523-1739.2005.00149.x; Burn RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024165; Child B, 2012, S AFR J SCI, V108, P1, DOI 10.4102/sajs.v108i7/8.1338; CITES, 2011, 61 M STAND COMM GEN; CITES, 1992, 8 M COP KYT JAP 2 13, P16; Costello C, 2012, NATURE, V481, P139, DOI 10.1038/481139a; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Cussen M, 2000, AM J ECON SOCIOL, V59, P525, DOI 10.1111/1536-7150.00041; Daly B. G., 2011, PERSPECTIVE DEHORNIN; Damania R, 2007, ECOL ECON, V62, P461, DOI 10.1016/j.ecolecon.2006.07.007; Ferreira SM, 2012, PACHYDERM, P52; Ferreira SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045989; Fischer C, 2010, REV ENV ECON POLICY, V4, P103, DOI 10.1093/reep/rep023; Leader-Williams N., 1992, WORLD TRADE RHINO HO; LINDSAY P., 2011, STUDY DEHORNING AFRI; Loh Jonathan, 1994, Traffic Bulletin, V14, P55; Marshall Leon, 2012, NEWSWATCH       1211; Martin R., 2012, LEGAL TRADE RHINO HO; Martin R. B., 2010, WHITE RHINO CONSERVA; Milliken T., 2009, AFRICAN ASIAN RHINOC; Milliken T., 2012, S AFRICA VIET NAM RH; MILNERGULLAND EJ, 1992, P ROY SOC B-BIOL SCI, V249, P83, DOI 10.1098/rspb.1992.0087; Nowell K, 2012, SPECIES TRADE CONSER; Peake D.A., 2012, DECISION MAKING MECH; Rivalan P, 2007, NATURE, V447, P529, DOI 10.1038/447529a; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Ruggiero V., 1998, NEW EUROPEAN CRIMONO; Smith RJ, 2003, NATURE, V426, P67, DOI 10.1038/nature02025; Wasser S, 2010, SCIENCE, V327, P1331, DOI 10.1126/science.1187811; Webb G.W, 2002, CROC P 16 WORK M CRO, P1	32	154	155	1	230	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1038	1039		10.1126/science.1229998	http://dx.doi.org/10.1126/science.1229998			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	097CQ	23449582				2022-12-28	WOS:000315452000026
J	Bostwick, JM				Bostwick, J. Michael			Recommend the Medicinal Use of Marijuana	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA	Mayo Clinic	Bostwick, JM (corresponding author), Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA.			DuPont, Robert/0000-0002-3345-0759					0	25	25	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2013	368	9					866	867						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096ET	23425133				2022-12-28	WOS:000315387700015
J	Frank, M				Frank, Martin			Open but Not Free - Publishing in the 21st Century	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Amer Physiol Soc, Bethesda, MD 20814 USA		Frank, M (corresponding author), Amer Physiol Soc, Bethesda, MD 20814 USA.							Anderson K, 2012, HALL MIRRORS TRYING; [Anonymous], 2011, HEAD OP ROAD COSTS B; Davis Philip M, 2012, Physiologist, V55, P163; Laakso M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-124; Ware M, 2012, STM REPORT OVERVIEW	5	39	40	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2013	368	9					787	789		10.1056/NEJMp1211259	http://dx.doi.org/10.1056/NEJMp1211259			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096ET	23445089				2022-12-28	WOS:000315387700002
J	Karpova, A; Mikhaylova, M; Bera, S; Bar, J; Reddy, PP; Behnisch, T; Rankovic, V; Spilker, C; Bethge, P; Sahin, J; Kaushik, R; Zuschratter, W; Kahne, T; Naumann, M; Gundelfinger, ED; Kreutz, MR				Karpova, Anna; Mikhaylova, Marina; Bera, Sujoy; Baer, Julia; Reddy, Pasham Parameshwar; Behnisch, Thomas; Rankovic, Vladan; Spilker, Christina; Bethge, Philipp; Sahin, Jale; Kaushik, Rahul; Zuschratter, Werner; Kaehne, Thilo; Naumann, Michael; Gundelfinger, Eckart D.; Kreutz, Michael R.			Encoding and Transducing the Synaptic or Extrasynaptic Origin of NMDA Receptor Signals to the Nucleus	CELL			English	Article							NEUROFILAMENT TRIPLET PROTEINS; CREB PHOSPHORYLATION; ALPHA-INTERNEXIN; TRANSLOCATION; ACTIVATION; EXPRESSION; PLASTICITY; SUBUNIT; PATHWAY; CASCADE	The activation of N-methyl-D-aspartate-receptors (NMDARs) in synapses provides plasticity and cell survival signals, whereas NMDARs residing in the neuronal membrane outside synapses trigger neuro-degeneration. At present, it is unclear how these opposing signals are transduced to and discriminated by the nucleus. In this study, we demonstrate that Jacob is a protein messenger that encodes the origin of synaptic versus extrasynaptic NMDAR signals and delivers them to the nucleus. Exclusively synaptic, but not extrasynaptic, NMDAR activation induces phosphorylation of Jacob at serine-180 by ERK1/2. Long-distance trafficking of Jacob from synaptic, but not extrasynaptic, sites depends on ERK activity, and association with fragments of the intermediate filament alpha-internexin hinders dephosphorylation of the Jacob/ERK complex during nuclear transit. In the nucleus, the phosphorylation state of Jacob determines whether it induces cell death or promotes cell survival and enhances synaptic plasticity.	[Karpova, Anna; Mikhaylova, Marina; Bera, Sujoy; Baer, Julia; Reddy, Pasham Parameshwar; Rankovic, Vladan; Spilker, Christina; Bethge, Philipp; Sahin, Jale; Kaushik, Rahul; Kreutz, Michael R.] Leibniz Inst Neurobiol, RG Neuroplast, D-39118 Magdeburg, Germany; [Zuschratter, Werner] Leibniz Inst Neurobiol, Special Lab Electron & Laserscanning Microscopy, D-39118 Magdeburg, Germany; [Gundelfinger, Eckart D.] Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, D-39118 Magdeburg, Germany; [Mikhaylova, Marina] Univ Utrecht, Fac Sci, NL-3584 CH Utrecht, Netherlands; [Behnisch, Thomas] Fudan Univ, Inst Brain Sci, Shanghai 200032, Peoples R China; [Behnisch, Thomas] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China; [Kaehne, Thilo; Naumann, Michael] Univ Magdeburg, Inst Expt Internal Med, D-39120 Magdeburg, Germany	Leibniz Institut fur Neurobiologie (LIN); Leibniz Institut fur Neurobiologie (LIN); Leibniz Institut fur Neurobiologie (LIN); Utrecht University; Fudan University; Fudan University; Otto von Guericke University	Kreutz, MR (corresponding author), Leibniz Inst Neurobiol, RG Neuroplast, D-39118 Magdeburg, Germany.	kreutz@lin-magdeburg.de	Kaushik, Rahul/AAF-2376-2020; Behnisch, Thomas/G-3688-2018; Naumann, Michael/B-5285-2011; Kaehne, Thilo/E-4858-2012; Mikhaylova, Marina/AAM-4368-2020; Rankovic, Vladan/S-4353-2019	Kaushik, Rahul/0000-0002-4944-8549; Behnisch, Thomas/0000-0002-7842-3252; Naumann, Michael/0000-0002-8060-2313; Mikhaylova, Marina/0000-0001-7646-1346; Rankovic, Vladan/0000-0003-0285-5232; Spilker, Christina/0000-0002-7996-7673	DFG [SFB 779 TPB8, SFB854 TP7, TP4, TP8, GRK1167, Kr1879/3-1, TPZ]; DIP grant; EU FP7 MC-ITN NPlast; European Regional Development Fund (ERDF); Vorhaben: CBBS; NSFC [31271197]; Schram Foundation; European Molecular Biology Organization (EMBO) [EMBO ALTF 884-2011]; Marie Curie Actions (EMBOCOFUND) [GA-2010-267146]	DFG(German Research Foundation (DFG)); DIP grant; EU FP7 MC-ITN NPlast; European Regional Development Fund (ERDF)(European Commission); Vorhaben: CBBS; NSFC(National Natural Science Foundation of China (NSFC)); Schram Foundation; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Marie Curie Actions (EMBOCOFUND)	We want to thank C. Borutzki, M. Marunde, and S. Hochmuth for technical assistance; N. Ziv for helpful discussion; J. Lindquist for proofreading: M. Tsuda, A. Fejtova, D. Ivanova, J. Wiedemann, and U. Thomas for providing constructs; M. Hupe for assistance in alpha-internexin experiments; A. C. Lehmann for help with cloning; and Y. Chen and P. Yuan Xiang for assistance in electrophysiology. This work was supported by the DFG (SFB 779 TPB8 to M. R. K.; TPZ to T. K. and M. N.; SFB854 TP7 to M. R. K.; TP4 to M. N.; TP8 to E. D. G.; GRK1167 and Kr1879/3-1 to M. R. K.); DIP grant to E. D. G. and M. R. K.; EU FP7 MC-ITN NPlast to M. R. K.; European Regional Development Fund (ERDF 2007-2013); Vorhaben: CBBS to A. K. and C. S.; NSFC 31271197 to T. B.; and the Schram Foundation to M. R. K. M. M. is the recipient of a European Molecular Biology Organization (EMBO) long-term fellowship (EMBO ALTF 884-2011) and is supported by Marie Curie Actions (EMBOCOFUND2010, GA-2010-267146).	Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Behnisch T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017276; Benson DL, 1996, J NEUROCYTOL, V25, P181, DOI 10.1007/BF02284795; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Dieterich DC, 2008, PLOS BIOL, V6, P286, DOI 10.1371/journal.pbio.0060034; El Gaamouch F, 2012, J NEUROSCI, V32, P10767, DOI 10.1523/JNEUROSCI.5622-11.2012; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Harris AZ, 2008, J NEUROPHYSIOL, V99, P524, DOI 10.1152/jn.01169.2007; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Jeffrey RA, 2009, J NEUROSCI, V29, P15613, DOI 10.1523/JNEUROSCI.3314-09.2009; Jordan BA, 2009, TRENDS NEUROSCI, V32, P392, DOI 10.1016/j.tins.2009.04.001; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kindler S, 2009, J BIOL CHEM, V284, P25431, DOI 10.1074/jbc.M109.022137; Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Li SM, 2006, J NEUROSCI, V26, P1721, DOI 10.1523/JNEUROSCI.3990-05.2006; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; Okamoto SI, 2009, NAT MED, V15, P1407, DOI 10.1038/nm.2056; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Perlson E, 2006, J MOL BIOL, V364, P938, DOI 10.1016/j.jmb.2006.09.056; Rauner C, 2011, J BIOL CHEM, V286, P7558, DOI 10.1074/jbc.M110.182600; Ronicke R, 2011, NEUROBIOL AGING, V32, P2219, DOI 10.1016/j.neurobiolaging.2010.01.011; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Thompson KR, 2004, NEURON, V44, P997, DOI 10.1016/j.neuron.2004.11.025; Wang CC, 2011, NEURON, V72, P789, DOI 10.1016/j.neuron.2011.09.023; Wiegert JS, 2007, J BIOL CHEM, V282, P29621, DOI 10.1074/jbc.M701448200; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Yuan AD, 2006, J NEUROSCI, V26, P10006, DOI 10.1523/JNEUROSCI.2580-06.2006; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhang SJ, 2011, J NEUROSCI, V31, P4978, DOI 10.1523/JNEUROSCI.2672-10.2011	36	136	136	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 28	2013	152	5					1119	1133		10.1016/j.cell.2013.02.002	http://dx.doi.org/10.1016/j.cell.2013.02.002			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452857	Bronze			2022-12-28	WOS:000315710300018
J	Nathan, JA; Spinnenhim, V; Schmidtke, G; Basler, M; Groettrup, M; Goldberg, AL				Nathan, James A.; Spinnenhim, Valentina; Schmidtke, Gunter; Basler, Michael; Groettrup, Marcus; Goldberg, Alfred L.			Immuno- and Constitutive Proteasomes Do Not Differ in Their Abilities to Degrade Ubiquitinated Proteins	CELL			English	Article							26S PROTEASOMES; PEPTIDASE ACTIVITIES; OXIDATIVE-STRESS; TRIMS PRECURSORS; CELL-PROTEINS; INTERFERON; IMMUNOPROTEASOME; ISG15; AMINOPEPTIDASE; EXPRESSION	Immunoproteasomes are alternative forms of proteasomes that have an enhanced ability to generate antigenic peptides. Recently, Seifert and colleagues reported surprising observations concerning the functions of immunoproteasomes and cellular responses to interferon-gamma: (1) that immunoproteasomes degrade ubiquitinated proteins faster than the constitutive proteasomes, (2) that polyubiquitin conjugates accumulate after interferon-gamma treatment but then are preferentially degraded by immunoproteasomes, and (3) that immunoproteasome deficiency causes the formation of inclusions and more severe experimental autoimmune encephalomyelitis (EAE). In contrast, we find that polyubiquitin conjugates do not transiently accumulate following IFN gamma-treatment and that immunoproteasomes do not prevent the formation of intracellular inclusions or protect against EAE. Furthermore, purified 26S constitutive and immunoproteasomes bind ubiquitin conjugates similarly and degrade them at similar rates. We conclude that, although immunoproteasomes can increase the generation of peptides appropriate for MHC class I presentation, they do not degrade ubiquitinated proteins more efficiently than constitutive particles.	[Nathan, James A.; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Nathan, James A.] Addenbrookes Hosp, NIHR Cambridge Biomed Res Ctr, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Spinnenhim, Valentina; Schmidtke, Gunter; Basler, Michael; Groettrup, Marcus] Univ Konstanz, Dept Biol, Div Immunol, D-78457 Constance, Germany; [Basler, Michael; Groettrup, Marcus] Univ Konstanz, Biotechnol Inst Thurgau, CH-8280 Kreuzlingen, Switzerland	Harvard University; Harvard Medical School; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Konstanz	Groettrup, M (corresponding author), Univ Konstanz, Dept Biol, Div Immunol, D-78457 Constance, Germany.	marcus.groettrup@uni-konstanz.de; alfred_goldberg@hms.harvard.edu	Groettrup, Marcus/AAT-2623-2020	Basler, Michael/0000-0002-9428-2349; Nathan, James Alexander/0000-0002-0248-1632	National Institute of General Medical Sciences [5R01 GM51923]; ALS Association [K2Y740]; Fidelity Biosciences Research Initiative; German Research Foundation [GR 1517/12-1]; Swiss Multiple Sclerosis Society; Swiss National Science Foundation [31003A_138451]; Medical Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER; MRC [G0802822] Funding Source: UKRI; Medical Research Council [G0802822] Funding Source: researchfish	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ALS Association; Fidelity Biosciences Research Initiative; German Research Foundation(German Research Foundation (DFG)); Swiss Multiple Sclerosis Society; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	These studies were made possible by grants from the National Institute of General Medical Sciences (5R01 GM51923), the ALS Association (K2Y740), the Fidelity Biosciences Research Initiative, the German Research Foundation (GR 1517/12-1), the Swiss Multiple Sclerosis Society, and the Swiss National Science Foundation (31003A_138451). J. A. N. has been supported by the Medical Research Council with a Clinician Scientist Fellowship. V. S. is a member of the Konstanz Research School Chemical Biology. Confocal microscopy images were acquired at the Bioimaging Center of the University of Konstanz. We acknowledge that Ulrike Seifert and Peter-Michael Kloetzel, who supervised V. S. as a diploma student, agreed to the reference of the part of her diploma thesis work that is mentioned in this manuscript.	AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; Basler M, 2006, J IMMUNOL, V176, P6665, DOI 10.4049/jimmunol.176.11.6665; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; DRISCOLL J, 1993, NATURE, V365, P262, DOI 10.1038/365262a0; Durfee LA, 2010, MOL CELL, V38, P722, DOI 10.1016/j.molcel.2010.05.002; Espejo C, 2002, EXP NEUROL, V177, P21, DOI 10.1006/exnr.2002.7982; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Frausto RF, 2007, J NEUROIMMUNOL, V192, P124, DOI 10.1016/j.jneuroim.2007.09.024; GACZYNSKA M, 1994, P NATL ACAD SCI USA, V91, P9213, DOI 10.1073/pnas.91.20.9213; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; GROETTRUP M, 1995, J BIOL CHEM, V270, P23808, DOI 10.1074/jbc.270.40.23808; Groettrup M, 2010, NAT REV IMMUNOL, V10, P72, DOI 10.1038/nri2687; Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030; JOHNSTON JA, 1995, J BIOL CHEM, V270, P8172, DOI 10.1074/jbc.270.14.8172; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kincaid EZ, 2012, NAT IMMUNOL, V13, P129, DOI 10.1038/ni.2203; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lam YA, 2005, METHOD ENZYMOL, V398, P379, DOI 10.1016/S0076-6879(05)98031-2; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Skaug B, 2010, CELL, V143, P187, DOI 10.1016/j.cell.2010.09.033; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; van Deventer S, 2010, CELL, V142, P517, DOI 10.1016/j.cell.2010.08.002; VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4; Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102	38	74	74	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 28	2013	152	5					1184	1194		10.1016/j.cell.2013.01.037	http://dx.doi.org/10.1016/j.cell.2013.01.037			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452861	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000315710300023
J	Calvert, M; Blazeby, J; Altman, DG; Revicki, DA; Moher, D; Brundage, MD				Calvert, Melanie; Blazeby, Jane; Altman, Douglas G.; Revicki, Dennis A.; Moher, David; Brundage, Michael D.		CONSORT PRO Grp	Reporting of Patient-Reported Outcomes in Randomized Trials The CONSORT PRO Extension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; LOW-BACK-PAIN; PHASE-III; EUROPEAN-ORGANIZATION; CLINICAL-TRIAL; MISSING DATA; CANCER; THERAPY; GEMCITABINE; PACLITAXEL	The CONSORT (Consolidated Standards of Reporting Trials) Statement aims to improve the reporting of randomized controlled trials (RCTs); however, it lacks guidance on the reporting of patient-reported outcomes (PROs), which are often inadequately reported in trials, thus limiting the value of these data. In this article, we describe the development of the CONSORT PRO extension based on the methodological framework for guideline development proposed by the Enhancing the Quality and Transparency of Health Research (EQUATOR) Network. Five CONSORT PRO checklist items are recommended for RCTs in which PROs are primary or important secondary end points. These recommendations urge that the PROs be identified as a primary or secondary outcome in the abstract, that a description of the hypothesis of the PROs and relevant domains be provided (ie, if a multidimensional PRO tool has been used), that evidence of the PRO instrument's validity and reliability be provided or cited, that the statistical approaches for dealing with missing data be explicitly stated, and that PRO-specific limitations of study findings and generalizability of results to other populations and clinical practice be discussed. Examples and an updated CONSORT flow diagram with PRO items are provided. It is recommended that the CONSORT PRO guidance supplement the standard CONSORT guidelines for reporting RCTs with PROs as primary or secondary outcomes. Improved reporting of PRO data should facilitate robust interpretation of the results from RCTs and inform patient care. JAMA. 2013;309(8):814-822	[Calvert, Melanie] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England; [Blazeby, Jane] Univ Bristol, Sch Social & Community Med, Bristol BS8 1TH, Avon, England; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford OX1 2JD, England; [Revicki, Dennis A.] United BioSource Corp, Outcomes Res, Bethesda, MD USA; [Moher, David] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Brundage, Michael D.] Queens Univ, Canc Res Inst, Kingston, ON, Canada	University of Birmingham; University of Bristol; University of Oxford; United Biosource Corporation; University of Ottawa; Ottawa Hospital Research Institute; Queens University - Canada	Brundage, MD (corresponding author), Queens Canc Res Inst, Level 2,10 Stuart St, Kingston, ON K7L 3N6, Canada.	michael.brundage@krcc.on.ca	Moher, David/I-3408-2019; Blazeby, Jane/H-6703-2019; Calvert, Melanie/F-7055-2011	Moher, David/0000-0003-2434-4206; Blazeby, Jane/0000-0002-3354-3330; Calvert, Melanie/0000-0002-1856-837X; Efficace, Fabio/0000-0002-5065-5166	UK Medical Research Council Hubs for Trials Methodology Research; Canadian Institutes of Health Research; University of Ottawa Research Chair; Cancer Research UK [C5529]; Cancer Care Ontario Research Chair award; MRC [MR/J004871/1, G0800808] Funding Source: UKRI; Medical Research Council [UD99999939, MR/J004871/1, G0800808] Funding Source: researchfish	UK Medical Research Council Hubs for Trials Methodology Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Ottawa Research Chair; Cancer Research UK(Cancer Research UK); Cancer Care Ontario Research Chair award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council Hubs for Trials Methodology Research and the Canadian Institutes of Health Research. Dr Moher is funded, in part, through a University of Ottawa Research Chair. Dr Altman is supported by grant C5529 from Cancer Research UK. Dr Brundage is supported by a Cancer Care Ontario Research Chair award.	Au HJ, 2009, J CLIN ONCOL, V27, P1822, DOI 10.1200/JCO.2008.19.6048; Basch E, 2010, NEW ENGL J MED, V362, P865, DOI 10.1056/NEJMp0911494; Bischoff EWMA, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7642; Bottomley A, 2004, J CLIN ONCOL, V22, P2576, DOI 10.1200/JCO.2004.02.037; Bottomley A, 2009, J CLIN ONCOL, V27, P2916, DOI 10.1200/JCO.2008.20.2069; Brundage M, 2013, QUAL LIFE RES, V22, P1161, DOI 10.1007/s11136-012-0252-1; Brundage M, 2011, QUAL LIFE RES, V20, P653, DOI 10.1007/s11136-010-9793-3; Chalder M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2758; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Cocks K, 2008, EUR J CANCER, V44, P1793, DOI 10.1016/j.ejca.2008.05.008; Davies HE, 2012, JAMA-J AM MED ASSOC, V307, P2383, DOI 10.1001/jama.2012.5535; de Boer AGEM, 2004, J CLIN ONCOL, V22, P4202, DOI 10.1200/jco.2004.11.102; Engel J, 2012, JAMA-J AM MED ASSOC, V307, P922, DOI 10.1001/jama.2012.220; Fairclough DL, 2004, STAT METHODS MED RES, V13, P115, DOI 10.1191/0962280204sm357ra; Fairclough DL, 2002, DESIGN ANAL QUALITY; Fielding S, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-51; Freemantle N, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3529; Guyatt GH, 1997, JAMA-J AM MED ASSOC, V277, P1232, DOI 10.1001/jama.277.15.1232; Holroyd KA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4871; Jellema P, 2005, BMJ-BRIT MED J, V331, P84, DOI 10.1136/bmj.38495.686736.E0; Lipscomb J, 2007, J CLIN ONCOL, V25, P5133, DOI 10.1200/JCO.2007.12.4644; Marshall M, 2000, BRIT J PSYCHIAT, V176, P249, DOI 10.1192/bjp.176.3.249; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Moinpour CM, 2012, QUAL LIFE RES, V21, P765, DOI 10.1007/s11136-011-9999-z; Moinpour CM, 2010, J CLIN ONCOL, V28, P3611, DOI 10.1200/JCO.2009.25.8285; Mutrie N, 2007, BMJ-BRIT MED J, V334, P517, DOI 10.1136/bmj.39094.648553.AE; Revicki DA, 2007, J DERMATOL TREAT, V18, P341, DOI 10.1080/09546630701646172; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Sculpher M J, 2004, Health Technol Assess, V8, piii; Sculpher MJ, 2004, HEALTH TECHNOL ASSES, V8, P1; Sprangers MAG, 2002, MAYO CLIN PROC, V77, P561, DOI 10.4065/77.6.561; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Turner L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000030.pub2; van der Roer N, 2008, EUR SPINE J, V17, P1193, DOI 10.1007/s00586-008-0718-6; Welton AJ, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1190	37	713	726	1	56	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2013	309	8					814	822		10.1001/jama.2013.879	http://dx.doi.org/10.1001/jama.2013.879			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095KD	23443445				2022-12-28	WOS:000315332200027
J	Hogerzeil, HV; Liberman, J; Wirtz, VJ; Kishore, SP; Selvaraj, S; Kiddell-Monroe, R; Mwangi-Powell, FN; von Schoen-Angerer, T				Hogerzeil, Hans V.; Liberman, Jonathan; Wirtz, Veronika J.; Kishore, Sandeep P.; Selvaraj, Sakthi; Kiddell-Monroe, Rachel; Mwangi-Powell, Faith N.; von Schoen-Angerer, Tido		Lancet NCD Action Grp	Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration	LANCET			English	Article							MIDDLE-INCOME COUNTRIES; SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; CARDIOVASCULAR-DISEASE; PREVENTION; DRUGS; CHALLENGES; ADHERENCE; SETTINGS; COSTS	Access to medicines and vaccines to prevent and treat non-communicable diseases (NCDs) is unacceptably low worldwide. In the 2011 UN political declaration on the prevention and control of NCDs, heads of government made several commitments related to access to essential medicines, technologies, and vaccines for such diseases. 30 years of experience with policies for essential medicines and 10 years of scaling up of HIV treatment have provided the knowledge needed to address barriers to long-term effective treatment and prevention of NCDs. More medicines can be acquired within existing budgets with efficient selection, procurement, and use of generic medicines. Furthermore, low-income and middle-income countries need to increase mobilisation of domestic resources to cater for the many patients with NCDs who do not have access to treatment. Existing initiatives for HIV treatment off er useful lessons that can enhance access to pharmaceutical management of NCDs and improve adherence to long-term treatment of chronic illness; policy makers should also address unacceptable inequities in access to controlled opioid analgesics. In addition to off-patent medicines, governments can promote access to new and future on-patent medicinal products through coherent and equitable health and trade policies, particularly those for intellectual property. Frequent conflicts of interest need to be identified and managed, and indicators and targets for access to NCD medicines should be used to monitor progress. Only with these approaches can a difference be made to the lives of hundreds of millions of current and future patients with NCDs.	[Hogerzeil, Hans V.] Univ Groningen, Univ Med Ctr Groningen, Dept Global Hlth, NL-9713 AV Groningen, Netherlands; [Liberman, Jonathan] Canc Council Victoria, McCabe Ctr Law & Canc, Melbourne, Vic, Australia; [Liberman, Jonathan] Union Int Canc Control, Melbourne, Vic, Australia; [Wirtz, Veronika J.] Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico; [Kishore, Sandeep P.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Cambridge, MA 02138 USA; [Kishore, Sandeep P.] Young Profess Chron Dis Network, New York, NY USA; [Selvaraj, Sakthi] Publ Hlth Fdn India, New Delhi, India; [Kiddell-Monroe, Rachel] Univ Allied Essential Med, Montreal, PQ, Canada; [Mwangi-Powell, Faith N.] African Palliat Care Assoc, Kampala, Uganda; [Mwangi-Powell, Faith N.] Open Soc Fdn, New York, NY USA; [von Schoen-Angerer, Tido] Med Sans Frontieres, Geneva, Switzerland	University of Groningen; Cancer Council Victoria; Instituto Nacional de Salud Publica; Harvard University; Public Health Foundation of India; Doctors Without Borders	Hogerzeil, HV (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Global Hlth, NL-9713 AV Groningen, Netherlands.	h.v.hogerzeil@umcg.nl	Selvaraj, Sakthivel/ABD-5873-2021; Selvaraj, Sakthivel/ABE-6897-2020; Wirtz, Veornika/AAG-9712-2019	Selvaraj, Sakthivel/0000-0001-5940-1958; von Schoen-Angerer, Tido/0000-0003-3601-7480; Wirtz, Veronika J./0000-0002-0863-8768				Abdraimova A, 2009, REPORT RAPID ASSESSM; Alleyne G, 2013, LANCET; [Anonymous], 2001, MACR HLTH INV HLTH E; [Anonymous], 2008, HLTH POLICY B EUROPE; Atun R, 2013, LANCET; Barrington J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-298; Berne Declaration HAI IBFAN IFMSA KEI MSF TWN UAEM, 2011, NGO LETT CONFL INT F; Beyer P, 2016, OPTIONS GLOBAL DEV S; Bigdeli M, 2012, HLTH POLICY PLAN; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Cameron A., 2011, WORLD MED SITUATION; Cameron Alexandra, 2010, 35 WHO; Caudron JM, 2008, TROP MED INT HEALTH, V13, P1062, DOI 10.1111/j.1365-3156.2008.02106.x; Chaudhuri S, 2011, MULTINATIONALS MONOP; Colombo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034974; Di Cesare M, 2013, LANCET; Downing NS, 2012, ARCH INTERN MED, V172, P724, DOI 10.1001/archinternmed.2012.187; Ferraz Octavio Luiz Motta, 2009, Health Hum Rights, V11, P33; Ford N, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-33; Ford N, 2009, LANCET, V374, P2064, DOI 10.1016/S0140-6736(09)61671-8; Frenk J, 2012, LANCET, V380, P862, DOI 10.1016/S0140-6736(12)61341-5; Frost LS, 2008, DO GOOD HLTH TECHNOL; Gale EAM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3974; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Goroff M, 2010, HEALTH AFFAIR, V29, P2206, DOI 10.1377/hlthaff.2009.0896; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Health Action International and World Health Organization, 2008, MED PRIC AV AFF PRIC; Heath I, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4239; Hogerzeil HV, 2006, LANCET, V368, P305, DOI 10.1016/S0140-6736(06)69076-4; Hogerzeil HV, 2006, B WORLD HEALTH ORGAN, V84, P371, DOI 10.2471/BLT.06.031153; Intellectual Property Watch, 2012, DRUG SAF NEEDS GLOB; International Narcotics Control Board, 2010, REP INT NARC CONTR B; Kishore SP, 2011, J AM COLL CARDIOL, V57, P1980, DOI 10.1016/j.jacc.2010.12.029; Laing RO, 2001, HEALTH POLICY PLANN, V16, P13, DOI 10.1093/heapol/16.1.13; Liberman J, 2011, PUBLIC HEALTH, V125, P840, DOI 10.1016/j.puhe.2011.09.032; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lonn E, 2010, CIRCULATION, V122, P2078, DOI 10.1161/CIRCULATIONAHA.109.873232; Lu Y, 2011, WORLD MED SITUATION; Marquez PV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5812; Maxmen A, 2012, NATURE, V489, P16, DOI 10.1038/489016a; MDG Gap Task Force, 2011, GLOB PARTN DEV TIM D; MDG Gap Task Force, 2010, GLOB PARTN DEV CRIT; MDG Gap Task Force, 2009, STRENGTH GLOB PARTN; MDG Gap Task Force, 2008, MILL DEV GOAL 8 DEL; Mills EJ, 2012, LANCET INFECT DIS, V12, P97, DOI 10.1016/S1473-3099(11)70354-1; Moodie R, 2013, LANCET; Moon S, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-39; O'Brien M, LANCET ONCO IN PRESS; Office of the UN High Commissioner for Human Rights, 1966, INT COV EC SOC CULT; Office of the United Nations High Commissioner for Human Rights, 1989, CONV RIGHTS CHILD; Outterson K, 2008, AM J LAW MED, V34, P279, DOI 10.1177/009885880803400208; Panchagnula R, 2004, METHOD FIND EXP CLIN, V26, P703, DOI 10.1358/mf.2004.26.9.872568; Perehudoff SK, 2010, B WORLD HEALTH ORGAN, V88, P800, DOI 10.2471/BLT.10.078733; Prime Minister, 2012, DECISION NO 418QD TT; Quick JD, 2011, WHAT AIDS DEC TEACH; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Roderick P, 2012, LANCET, V380, pE2, DOI 10.1016/S0140-6736(12)61513-X; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Smith RD, 2009, LANCET, V373, P684, DOI 10.1016/S0140-6736(08)61779-1; Stop Stock-Outs, 2012, ENS ACC ESS MED ALL; Szabo L, 2006, PRICES SOAR CANC DRU; Twagirumukiza M, 2010, TROP MED INT HEALTH, V15, P350, DOI 10.1111/j.1365-3156.2009.02453.x; Twagirumukiza M, 2009, AM J TROP MED HYG, V81, P776, DOI 10.4269/ajtmh.2009.09-0109; UN, 2009, REP SPEC RAPP RIGHT; UN Committee on Economic, 2000, GEN COMM 14 RIGHT HI; UN General Assembly, 2010, 64265 UN GEN ASS; United Nations Office of Drugs and Crime. Commission on Narcotic Drugs, 2011, ENS AV CONTR MED REL; United States Agency for International Development, 2009, SURV QUAL SEL ANT ME; Wagner AK, 2011, HEALTH POLICY, V100, P151, DOI 10.1016/j.healthpol.2010.08.004; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Waning B, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-35; WHO, 2010, WOR HEALT REP, P1; WHO, CONST WORLD HLTH ORG; WHO, 2011, REP EXP COMM SELUS E; WHO, 2007, MOD QUAL ASS SYST PR; WHO, 2010, ASS MED REG AG SUBS; WHO, 2007, EV BUS STRENGTH HLTH; WHO, 2012, RES DEV MEET HLTH NE; WHO, 2009, CONSTR SCAL HLTH REL; WHO Expert Committee on Specifi cations for Pharmaceutical Preparations, 2005, 39 WHO EXP COMM; World Health Organization, 2011, SCAL NONC DIS MUCH W; World Health Organization, 2011, PRIOR RES AG PREV CO; World Health Organization, 2011, ENS BAL NAT POL CONT; World Health Organization, 2012, CONT IS IS MON INC L; World Health Organization, 2008, MED TERM STRAT PLAN; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	86	120	125	2	56	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2013	381	9867					680	689		10.1016/S0140-6736(12)62128-X	http://dx.doi.org/10.1016/S0140-6736(12)62128-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	093JY	23410612				2022-12-28	WOS:000315189300038
J	Fan, Y; Li, H; Miguez-Macho, G				Fan, Y.; Li, H.; Miguez-Macho, G.			Global Patterns of Groundwater Table Depth	SCIENCE			English	Article							SPECIES DISTRIBUTION; WATER; FORESTS; VEGETATION; DIVERSITY; ECOLOGY; GROWTH; AMAZON; PLANTS; DRY	Shallow groundwater affects terrestrial ecosystems by sustaining river base-flow and root-zone soil water in the absence of rain, but little is known about the global patterns of water table depth and where it provides vital support for land ecosystems. We present global observations of water table depth compiled from government archives and literature, and fill in data gaps and infer patterns and processes using a groundwater model forced by modern climate, terrain, and sea level. Patterns in water table depth explain patterns in wetlands at the global scale and vegetation gradients at regional and local scales. Overall, shallow groundwater influences 22 to 32% of global land area, including similar to 15% as groundwater-fed surface water features and 7 to 17% with the water table or its capillary fringe within plant rooting depths.	[Fan, Y.; Li, H.] Rutgers State Univ, Dept Earth & Planetary Sci, New Brunswick, NJ 08854 USA; [Miguez-Macho, G.] Univ Santiago de Compostela, Nonlinear Phys Grp, Fac Phys, Galicia, Spain	Rutgers State University New Brunswick; Universidade de Santiago de Compostela	Fan, Y (corresponding author), Rutgers State Univ, Dept Earth & Planetary Sci, New Brunswick, NJ 08854 USA.	yingfan@rci.rutgers.edu	Miguez-Macho, Gonzalo/AAA-3295-2019; Miguez-Macho, Gonzalo/K-7008-2017	Miguez-Macho, Gonzalo/0000-0002-4259-7883; Miguez-Macho, Gonzalo/0000-0002-4259-7883	U.S. National Science Foundation [NSF-AGS-1045110, NSF-OCE-10409088]; U.S. Environmental Protection Agency [EPA-STAR-RD834190]; European Commission FP7 (GLOWASIS); Rutgers University Board of Trustees [651201]; Climate Simulation Laboratory at NCAR's Computational and Information Systems Laboratory; National Science Foundation; Directorate For Geosciences [1049088] Funding Source: National Science Foundation; Div Atmospheric & Geospace Sciences [1045110] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); U.S. Environmental Protection Agency(United States Environmental Protection Agency); European Commission FP7 (GLOWASIS); Rutgers University Board of Trustees; Climate Simulation Laboratory at NCAR's Computational and Information Systems Laboratory; National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank many individuals for making and providing observations (full acknowledgement is in the supplementary materials) and P. Doll for providing recharge estimates. Funding comes from U.S. National Science Foundation (NSF-AGS-1045110 and NSF-OCE-10409088), U.S. Environmental Protection Agency (EPA-STAR-RD834190), European Commission FP7 (GLOWASIS), and a Rutgers University Board of Trustees grant (651201). Computation used the Extreme Science and Engineering Discovery Environment (XSEDE) supported by U.S. National Science Foundation (NSF-OCI-1053575) and the Climate Simulation Laboratory at NCAR's Computational and Information Systems Laboratory, sponsored by the National Science Foundation and other agencies. Observations, code, and model results are accessible at https://glowasis.deltares.nl/thredds/catalog/opendap/opendap/Equilibrium_Water_Table/catalog.html.	Arndt SK, 2004, OECOLOGIA, V141, P385, DOI 10.1007/s00442-004-1655-7; Bakker MR, 2006, PLANT SOIL, V286, P37, DOI 10.1007/s11104-006-9024-4; Bobrov AA, 1999, PROTIST, V150, P125, DOI 10.1016/S1434-4610(99)70016-7; Carter JL, 2009, TREE PHYSIOL, V29, P1407, DOI 10.1093/treephys/tpp076; Doll P, 2008, HYDROL EARTH SYST SC, V12, P863, DOI 10.5194/hess-12-863-2008; Dwire KA, 2006, WETLANDS, V26, P131, DOI 10.1672/0277-5212(2006)26[131:PSDIRT]2.0.CO;2; Elmore AJ, 2003, ECOL APPL, V13, P443, DOI 10.1890/1051-0761(2003)013[0443:RPOPCR]2.0.CO;2; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Fan Y, 2011, CLIM DYNAM, V37, P253, DOI 10.1007/s00382-010-0829-8; Faure H, 2002, GLOBAL PLANET CHANGE, V33, P47, DOI 10.1016/S0921-8181(02)00060-7; Giordano M, 2009, ANNU REV ENV RESOUR, V34, P153, DOI 10.1146/annurev.environ.030308.100251; Gleeson T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045565; Green TR, 2011, J HYDROL, V405, P532, DOI 10.1016/j.jhydrol.2011.05.002; Grogan James, 2006, Acta Amaz., V36, P483, DOI 10.1590/S0044-59672006000400009; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; HUGHES FMR, 1988, J BIOGEOGR, V15, P127, DOI 10.2307/2845053; Jirka S, 2007, J VEG SCI, V18, P183, DOI 10.1111/j.1654-1103.2007.tb02529.x; Jobbagy EG, 2011, ECOL APPL, V21, P678, DOI 10.1890/09-1427.1; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; MacDonald AM, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024009; Martre D. C., 1999, WATER SA, V25, P137; Miguez-Macho G, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017540; Miguez-Macho G, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017539; Mishra HS, 1999, IRRIGATION SCI, V18, P117, DOI 10.1007/s002710050052; Orellana F, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000383; Paine CET, 2009, J TROP ECOL, V25, P171, DOI 10.1017/S0266467408005798; Pelissier R, 2002, PLANT ECOL, V162, P143, DOI 10.1023/A:1020399603500; Rossatto DR, 2012, ENVIRON EXP BOT, V77, P259, DOI 10.1016/j.envexpbot.2011.11.025; Sobrado MA, 2010, J TROP ECOL, V26, P215, DOI 10.1017/S0266467409990538; Stave J, 2005, FOREST ECOL MANAG, V212, P367, DOI 10.1016/j.foreco.2005.03.023; Stromberg JC, 1996, ECOL APPL, V6, P113, DOI 10.2307/2269558; Taylor R. G., 2012, NAT CLIM CHANGE, V3; WINTER TC, 1998, 1139 USGS	33	559	578	39	569	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2013	339	6122					940	943		10.1126/science.1229881	http://dx.doi.org/10.1126/science.1229881			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23430651				2022-12-28	WOS:000315149600044
J	Moore, W				Moore, Wendy			PAST CARING Dark satanic mills	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												wendymoore@ntlworld.com						Thackrah Charles Turner, 1957, THE LIFE WORK AND TI	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2013	346								f1202	10.1136/bmj.f1202	http://dx.doi.org/10.1136/bmj.f1202			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096HT	23435604				2022-12-28	WOS:000315395500007
J	Manjunath, A; Skinner, R; Probert, J				Manjunath, Aditya; Skinner, Richard; Probert, John			10-MINUTE CONSULTATION Assessment and management of renal colic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Manjunath, Aditya; Probert, John] Weston Gen Hosp, Dept Urol, Weston Super Mare BS23 4TQ, Somerset, England; [Skinner, Richard] West St Hlth Ctr, Bargoed, M Glam, Wales		Manjunath, A (corresponding author), Weston Gen Hosp, Dept Urol, Weston Super Mare BS23 4TQ, Somerset, England.	aditya.m@doctors.org.uk						Holdgate A, 2004, BRIT MED J, V328, P1401, DOI 10.1136/bmj.38119.581991.55; Wright PJ, 2002, BMJ-BRIT MED J, V325, P1408, DOI 10.1136/bmj.325.7377.1408; Xafis K, 2008, EMERG MED J, V25, P640, DOI 10.1136/emj.2006.043703	3	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 21	2013	346								f985	10.1136/bmj.f985	http://dx.doi.org/10.1136/bmj.f985			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096HP	23430331				2022-12-28	WOS:000315395100005
J	Olson, APJ; Tierney, LM				Olson, Andrew P. J.; Tierney, Lawrence M., Jr.			Remarkably Wise	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Olson, Andrew P. J.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Tierney, Lawrence M., Jr.] San Francisco VA Med Ctr, Med Serv, San Francisco, CA USA; [Tierney, Lawrence M., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Olson, APJ (corresponding author), Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA.	olso5714@umn.edu		Olson, Andrew/0000-0002-7226-5783					0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2013	309	7					669	670		10.1001/jama.2013.196	http://dx.doi.org/10.1001/jama.2013.196			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091EK	23423412				2022-12-28	WOS:000315032000021
J	Khalid, U; Deswal, A				Khalid, Umair; Deswal, Anita			Review: In systolic heart failure, low-sodium diets increase mortality compared with normal-sodium diets	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Khalid, Umair] Baylor Coll Med, Houston, TX 77030 USA; Vet Affairs Med Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Khalid, U (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.							Bernstein AM, 2010, AM J CLIN NUTR, V92, P1172, DOI 10.3945/ajcn.2010.29367; Chakeabarti S, 2010, J CARD FAIL, V16, pS53, DOI 10.1016/j.cardfail.2010.04.004	2	2	4	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2013	158	4							JC7	10.7326/0003-4819-158-4-201302190-02007	http://dx.doi.org/10.7326/0003-4819-158-4-201302190-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098WR	23420258				2022-12-28	WOS:000315580300006
J	Baker, DN; Kanekal, SG; Hoxie, VC; Henderson, MG; Li, X; Spence, HE; Elkington, SR; Friedel, RHW; Goldstein, J; Hudson, MK; Reeves, GD; Thorne, RM; Kletzing, CA; Claudepierre, SG				Baker, D. N.; Kanekal, S. G.; Hoxie, V. C.; Henderson, M. G.; Li, X.; Spence, H. E.; Elkington, S. R.; Friedel, R. H. W.; Goldstein, J.; Hudson, M. K.; Reeves, G. D.; Thorne, R. M.; Kletzing, C. A.; Claudepierre, S. G.			A Long-Lived Relativistic Electron Storage Ring Embedded in Earth's Outer Van Allen Belt	SCIENCE			English	Article							RADIATION BELT; INNER; ACCELERATION; PROTONS; CRRES	Since their discovery more than 50 years ago, Earth's Van Allen radiation belts have been considered to consist of two distinct zones of trapped, highly energetic charged particles. The outer zone is composed predominantly of megaelectron volt (MeV) electrons that wax and wane in intensity on time scales ranging from hours to days, depending primarily on external forcing by the solar wind. The spatially separated inner zone is composed of commingled high-energy electrons and very energetic positive ions (mostly protons), the latter being stable in intensity levels over years to decades. In situ energy-specific and temporally resolved spacecraft observations reveal an isolated third ring, or torus, of high-energy (>2 MeV) electrons that formed on 2 September 2012 and persisted largely unchanged in the geocentric radial range of 3.0 to similar to 3.5 Earth radii for more than 4 weeks before being disrupted (and virtually annihilated) by a powerful interplanetary shock wave passage.	[Baker, D. N.; Hoxie, V. C.; Li, X.; Elkington, S. R.] Univ Colorado, Lab Atmospher & Space Phys, Boulder, CO 80309 USA; [Kanekal, S. G.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Henderson, M. G.; Friedel, R. H. W.; Reeves, G. D.] Los Alamos Natl Lab, Los Alamos, NM USA; [Spence, H. E.] Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA; [Goldstein, J.] SW Res Inst, Space Sci & Engn Div, San Antonio, TX USA; [Hudson, M. K.] Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA; [Thorne, R. M.] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA USA; [Kletzing, C. A.] Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; [Claudepierre, S. G.] Aerosp Corp, Los Angeles, CA 90009 USA	University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; United States Department of Energy (DOE); Los Alamos National Laboratory; University System Of New Hampshire; University of New Hampshire; Southwest Research Institute; Dartmouth College; University of California System; University of California Los Angeles; University of Iowa; Aerospace Corporation - USA	Baker, DN (corresponding author), Univ Colorado, Lab Atmospher & Space Phys, Boulder, CO 80309 USA.	daniel.baker@lasp.colorado.edu	Claudepierre, Seth G/A-6109-2012; Spence, Harlan E/A-1942-2011; Reeves, Geoffrey D/E-8101-2011; Henderson, Michael G/A-3948-2011; Friedel, Reiner HW/D-1410-2012	Claudepierre, Seth G/0000-0001-5513-5947; Spence, Harlan E/0000-0002-2526-2205; Reeves, Geoffrey D/0000-0002-7985-8098; Henderson, Michael G/0000-0003-4975-9029; Friedel, Reiner HW/0000-0002-5228-0281; Kletzing, Craig/0000-0002-4136-3348	RBSP-Energetic Particle Composition and Thermal Plasma Suite; Johns Hopkins University Applied Physics Laboratory (JHU/APL) [967399, 921649]; NASA [NAS5-01072]	RBSP-Energetic Particle Composition and Thermal Plasma Suite; Johns Hopkins University Applied Physics Laboratory (JHU/APL)(Johns Hopkins University); NASA(National Aeronautics & Space Administration (NASA))	This work was supported by RBSP-Energetic Particle Composition and Thermal Plasma Suite funding provided by the Johns Hopkins University Applied Physics Laboratory (JHU/APL) contract no. 967399, Electric and Magnetic Field Instrument Suite and Integrated Science (EMFISIS) work was supported on JHU/APL contract no. 921649, and both were funded under NASA's Prime contract no. NAS5-01072. All Van Allen Probes observations used in this study, along with display and analysis software, are publicly available at the Web site www.rbsp-ect.lanl.gov.	Baker DN, 2012, SPACE WEATHER, V10, DOI 10.1029/2012SW000804; BAKER DN, 1994, GEOPHYS RES LETT, V21, P409, DOI 10.1029/93GL03532; BAKER DN, 1993, IEEE T GEOSCI REMOTE, V31, P531, DOI 10.1109/36.225519; BLAKE JB, 1992, GEOPHYS RES LETT, V19, P821, DOI 10.1029/92GL00624; Brautigam DH, 2002, J ATMOS SOL-TERR PHY, V64, P1709, DOI 10.1016/S1364-6826(02)00121-9; Denton RE, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA017274; FREDEN SC, 1959, PHYS REV LETT, V3, P9, DOI 10.1103/PhysRevLett.3.9; Friedel RHW, 2002, J ATMOS SOL-TERR PHY, V64, P265, DOI 10.1016/S1364-6826(01)00088-8; Goldstein J, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2005JA011282; Goldstein J, 2006, SPACE SCI REV, V124, P203, DOI 10.1007/s11214-006-9105-y; Horne RB, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010811; Horne RB, 2005, NATURE, V437, P227, DOI 10.1038/nature03939; JOHNSON MH, 1992, J SPACECRAFT ROCKETS, V29, P556, DOI 10.2514/3.55641; Li X, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016934; Li XL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026294; LI XL, 1993, GEOPHYS RES LETT, V20, P2423, DOI 10.1029/93GL02701; LYONS LR, 1973, J GEOPHYS RES, V78, P2142, DOI 10.1029/JA078i013p02142; Mauk BH, 2013, SPACE SCI REV, V179, P3, DOI 10.1007/s11214-012-9908-y; Millan RM, 2012, SPACE SCI REV, V173, P103, DOI 10.1007/s11214-012-9941-x; MULLEN EG, 1991, IEEE T NUCL SCI, V38, P1713, DOI 10.1109/23.124167; Shprits YY, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024256; Thorne RM, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044990; VAMPOLA AL, 1992, GEOPHYS RES LETT, V19, P625, DOI 10.1029/92GL00121; VANALLEN JA, 1958, JET PROPULSION, V28, P588, DOI 10.2514/8.7396; VANALLEN JA, 1959, NATURE, V183, P430, DOI 10.1038/183430a0; VANALLEN JA, 1959, J GEOPHYS RES, V64, P1683, DOI 10.1029/JZ064i011p01683	26	192	196	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129					186	190		10.1126/science.1233518	http://dx.doi.org/10.1126/science.1233518			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23450000	Green Submitted			2022-12-28	WOS:000317341400053
J	Lin, OS				Lin, Otto S.			Virtual colonoscopy: stamp of approval or word of warning?	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; CONTRAST BARIUM ENEMA; CT COLONOGRAPHY; TOMOGRAPHIC COLONOGRAPHY; PATIENT ACCEPTABILITY; COLORECTAL-CANCER; METAANALYSIS		[Lin, Otto S.] Virginia Mason Med Ctr, Inst Digest Dis, Seattle, WA 98101 USA; [Lin, Otto S.] Univ Washington, Sch Med, Div Gastroenterol, Seattle, WA USA	Virginia Mason Medical Center; University of Washington; University of Washington Seattle	Lin, OS (corresponding author), Virginia Mason Med Ctr, Inst Digest Dis, Seattle, WA 98101 USA.	otto.lin@vmmc.org						Atkin W, 2013, LANCET; Benson M, 2010, AM J GASTROENTEROL, V105, P2578, DOI 10.1038/ajg.2010.362; de Wijkerslooth TR, 2012, GUT, V61, P1552, DOI 10.1136/gutjnl-2011-301308; Forbes GM, 2006, MED J AUSTRALIA, V184, P546, DOI 10.5694/j.1326-5377.2006.tb00377.x; Halligan S, 2013, LANCET; Kim DH, 2007, NEW ENGL J MED, V357, P1403, DOI 10.1056/NEJMoa070543; Lin OS, 2012, J GEN INTERN MED, V27, P1349, DOI 10.1007/s11606-012-2115-4; Pickhardt PJ, 2011, RADIOLOGY, V259, P393, DOI 10.1148/radiol.11101887; Rosman AS, 2007, AM J MED, V120, P203, DOI 10.1016/j.amjmed.2006.05.061; Scott RG, 2004, AM J GASTROENTEROL, V99, P1145, DOI 10.1111/j.1572-0241.2004.30253.x; Stoop EM, 2012, LANCET ONCOL, V13, P55, DOI 10.1016/S1470-2045(11)70283-2; Taylor SA, 2003, AM J ROENTGENOL, V181, P913, DOI 10.2214/ajr.181.4.1810913; von Wagner C, 2012, RADIOLOGY, V263, P723, DOI 10.1148/radiol.12111523; von Wagner C, 2011, EUR RADIOL, V21, P2046, DOI 10.1007/s00330-011-2154-y; Zalis ME, 2005, RADIOLOGY, V236, P3, DOI 10.1148/radiol.2361041926	15	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 6	2013	381	9873					1161	1163		10.1016/S0140-6736(13)60056-2	http://dx.doi.org/10.1016/S0140-6736(13)60056-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122WU	23414649				2022-12-28	WOS:000317350100005
J	Winther, AML; Bublitz, M; Karlsen, JL; Moller, JV; Hansen, JB; Nissen, P; Buch-Pedersen, MJ				Winther, Anne-Marie L.; Bublitz, Maike; Karlsen, Jesper L.; Moller, Jesper V.; Hansen, John B.; Nissen, Poul; Buch-Pedersen, Morten J.			The sarcolipin-bound calcium pump stabilizes calcium sites exposed to the cytoplasm	NATURE			English	Article							SARCOPLASMIC-RETICULUM; CA-2+ PUMP; PHOSPHOLAMBAN; CA2+-ATPASE; CA2+; BINDING; MECHANISM; ATPASE; PHOSPHORYLATION; ASSOCIATION	The contraction and relaxation of muscle cells is controlled by the successive rise and fall of cytosolic Ca2+, initiated by the release of Ca2+ from the sarcoplasmic reticulum and terminated by re-sequestration of Ca2+ into the sarcoplasmic reticulum. as the main mechanism of Ca2+ removal. Re-sequestration requires active transport and is catalysed by the sarcoplasmic reticulum Ca2+-ATPase (SERCA), which has a key role in defining the contractile properties of skeletal and heart muscle tissue. The activity of SERCA is regulated by two small, homologous membrane proteins called phospholamban (PLB, also known as PLN) and sarcolipin (SLN)(1,2). Detailed structural information explaining this regulatory mechanism has been lacking, and the structural features defining the pathway through which cytoplasmic Ca2+ enters the intramembranous binding sites of SERCA have remained unknown. Here we report the crystal structure of rabbit SERCA1a (also known as ATP2A1) in complex with SLN at 3.1 angstrom resolution. The regulatory SLN traps the Ca2+-ATPase in a previously undescribed E1 state, with exposure of the Ca2+ sites through an open cytoplasmic pathway stabilized by Mg2+. The structure suggests a mechanism for selective Ca2+ loading and activation of SERCA, and provides new insight into how SLN and PLB inhibition arises from stabilization of this E1 intermediate state without bound Ca2+. These findings may prove useful in studying how autoinhibitory domains of other ion pumps modulate transport across biological membranes.	[Winther, Anne-Marie L.; Hansen, John B.; Buch-Pedersen, Morten J.] Pcovery, DK-1871 Frederiksberg, Denmark; [Winther, Anne-Marie L.; Bublitz, Maike; Karlsen, Jesper L.; Moller, Jesper V.; Nissen, Poul] Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPkin, DK-8000 Aarhus C, Denmark; [Winther, Anne-Marie L.; Bublitz, Maike; Karlsen, Jesper L.; Nissen, Poul] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Moller, Jesper V.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark	Danmarks Grundforskningsfond; Aarhus University; Aarhus University	Nissen, P (corresponding author), Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPkin, DK-8000 Aarhus C, Denmark.	pn@mb.au.dk; mbp@pcovery.com		Bublitz, Maike/0000-0003-3161-418X; Lund Winther, Anne-Marie/0000-0002-5776-0989; Nissen, Poul/0000-0003-0948-6628	Danish Council for Independent Research (Technology and Production Sciences); Danish National Advanced Technology Foundation; ERC; Danish Research Council for Strategic Research	Danish Council for Independent Research (Technology and Production Sciences)(Det Frie Forskningsrad (DFF)); Danish National Advanced Technology Foundation; ERC(European Research Council (ERC)European Commission); Danish Research Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	We thank the staff at beamlines 911-3 at MaxLab and X06SA at the Swiss Light Source. We are grateful to N. Hogholm Jonassen, C. Olesen, B. Nielsen and A.-M. Nielsen for assistance with experimental procedures, and to H. Tidow and P. Gourdon for discussions on autoinhibition. We also thank P. Vangheluwe, H. Young, M. le Maire and E. Carafoli for discussions on PLB and SLN. A.-M.L.W. was supported by postdoctoral fellowships from the Danish Council for Independent Research (Technology and Production Sciences) and the Danish National Advanced Technology Foundation. P.N. is supported by an ERC advanced research grant (BIOMEMOS). Further support was obtained from the Fungalfight and Spotlight projects of the Danish Research Council for Strategic Research.	Andersen JP, 1995, BIOSCIENCE REP, V15, P243, DOI 10.1007/BF01788358; Asahi M, 1999, J BIOL CHEM, V274, P32855, DOI 10.1074/jbc.274.46.32855; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bhupathy P, 2009, J MOL CELL CARDIOL, V47, P723, DOI 10.1016/j.yjmcc.2009.07.014; Buffy JJ, 2006, J MOL BIOL, V358, P420, DOI 10.1016/j.jmb.2006.02.005; Chen ZH, 2003, J BIOL CHEM, V278, P48348, DOI 10.1074/jbc.M309545200; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; DUPONT Y, 1982, BIOCHIM BIOPHYS ACTA, V688, P75, DOI 10.1016/0005-2736(82)90580-6; Einholm AP, 2007, J BIOENERG BIOMEMBR, V39, P357, DOI 10.1007/s10863-007-9106-x; Fuzesi M, 2005, J BIOL CHEM, V280, P18291, DOI 10.1074/jbc.M500080200; Glaves JP, 2011, J MOL BIOL, V405, P707, DOI 10.1016/j.jmb.2010.11.014; HENDERSON IMJ, 1994, BIOCHEM J, V297, P625, DOI 10.1042/bj2970625; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Kimura Y, 1998, J BIOL CHEM, V273, P14238, DOI 10.1074/jbc.273.23.14238; Lamberth S, 2000, HELV CHIM ACTA, V83, P2141, DOI 10.1002/1522-2675(20000906)83:9<2141::AID-HLCA2141>3.0.CO;2-W; Mascioni A, 2002, BIOCHEMISTRY-US, V41, P475, DOI 10.1021/bi011243m; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; Peinelt C, 2002, BIOPHYS J, V82, P170, DOI 10.1016/S0006-3495(02)75384-8; Smith GA, 2001, BIOCHEM J, V354, P539, DOI 10.1042/0264-6021:3540539; TADA M, 1989, BIOESSAYS, V10, P157, DOI 10.1002/bies.950100505; Tidow H, 2012, NATURE, V491, P468, DOI 10.1038/nature11539; TOYOFUKU T, 1994, J BIOL CHEM, V269, P3088; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Wu CC, 2008, STRUCTURE, V16, P976, DOI 10.1016/j.str.2008.02.025; Young HS, 2001, BIOPHYS J, V81, P884, DOI 10.1016/S0006-3495(01)75748-7; Zhang ZS, 2000, BIOCHEMISTRY-US, V39, P8758, DOI 10.1021/bi000185m	30	147	153	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2013	495	7440					265	269		10.1038/nature11900	http://dx.doi.org/10.1038/nature11900			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23455424				2022-12-28	WOS:000316652300057
J	Moynihan, D				Moynihan, Donald			A central agency, is crucial for disaster response	NATURE			English	Editorial Material									Univ Wisconsin Madison, La Follette Sch Publ Affairs, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Moynihan, D (corresponding author), Univ Wisconsin Madison, La Follette Sch Publ Affairs, Madison, WI 53706 USA.	dmoynihan@lafollette.wisc.edu							0	5	5	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2013	495	7439					7	7		10.1038/495007a	http://dx.doi.org/10.1038/495007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	105BE	23467129	Bronze			2022-12-28	WOS:000316039800002
J	Cruz, M; Covinsky, K; Widera, EW; Stijacic-Cenzer, I; Lee, SJ				Cruz, Marisa; Covinsky, Kenneth; Widera, Eric W.; Stijacic-Cenzer, Irena; Lee, Sei J.			Predicting 10-Year Mortality for Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							VALIDATION; INDEX		[Cruz, Marisa] Univ Calif San Francisco, Div Endocrinol, San Francisco, CA 94143 USA; [Covinsky, Kenneth; Widera, Eric W.; Stijacic-Cenzer, Irena; Lee, Sei J.] Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cruz, M (corresponding author), Univ Calif San Francisco, Div Endocrinol, San Francisco, CA 94143 USA.	sei.lee@ucsf.edu			NATIONAL INSTITUTE ON AGING [K23AG040779, K24AG029812] Funding Source: NIH RePORTER; NIA NIH HHS [K24 AG029812, K23AG040779, K24AG029812, K23 AG040779] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011, 10.2337/dc12-s004]; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801; Schonberg MA, 2011, J AM GERIATR SOC, V59, P1444, DOI 10.1111/j.1532-5415.2011.03523.x; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966	5	95	95	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2013	309	9					874	876		10.1001/jama.2013.1184	http://dx.doi.org/10.1001/jama.2013.1184			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099PC	23462780	Bronze, Green Accepted			2022-12-28	WOS:000315632700017
J	Brook, EJ				Brook, Edward J.			Leads and Lags at the End of the Last Ice Age	SCIENCE			English	Editorial Material							ANTARCTIC TEMPERATURE; ATMOSPHERIC CO2		Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	Oregon State University	Brook, EJ (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	brooke@geo.oregonstate.edu	Brook, Edward/AAB-7807-2021					Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Caillon N, 2003, SCIENCE, V299, P1728, DOI 10.1126/science.1078758; CRAIG H, 1988, SCIENCE, V242, P1675, DOI 10.1126/science.242.4886.1675; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Parrenin F, 2013, SCIENCE, V339, P1060, DOI 10.1126/science.1226368; Pedro JB, 2012, CLIM PAST, V8, P1213, DOI 10.5194/cp-8-1213-2012; Royer DL, 2006, GEOCHIM COSMOCHIM AC, V70, P5665, DOI 10.1016/j.gca.2005.11.031; Shakun JD, 2012, NATURE, V484, P49, DOI 10.1038/nature10915	9	8	11	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1042	1043		10.1126/science.1234239	http://dx.doi.org/10.1126/science.1234239			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23449585				2022-12-28	WOS:000315452000029
J	Bavelier, D; Davidson, RJ				Bavelier, Daphne; Davidson, Richard J.			Games to do you good	NATURE			English	Editorial Material									[Bavelier, Daphne] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; [Bavelier, Daphne] Univ Geneva, Dept Psychol & Educ Sci, CH-1211 Geneva 4, Switzerland; [Davidson, Richard J.] Univ Wisconsin, Ctr Invest Healthy Minds, Madison, WI 53705 USA	University of Rochester; University of Geneva; University of Wisconsin System; University of Wisconsin Madison	Bavelier, D (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	daphne@bcs.rochester.edu; rjdavids@wisc.edu		Davidson, Richard/0000-0002-8506-4964; Bavelier, Daphne/0000-0002-5904-1240				Bavelier D, 2011, NAT REV NEUROSCI, V12, P763, DOI 10.1038/nrn3135; Davidson RJ, 2012, NAT NEUROSCI, V15, P689, DOI 10.1038/nn.3093; Feng J, 2007, PSYCHOL SCI, V18, P850, DOI 10.1111/j.1467-9280.2007.01990.x; Green CS, 2012, CURR BIOL, V22, pR197, DOI 10.1016/j.cub.2012.02.012; Greitemeyer T, 2010, J PERS SOC PSYCHOL, V98, P211, DOI 10.1037/a0016997; Klimecki O. M., 2012, CEREBRAL CORTEX; Merry SN, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2598; Rideout V.J., 2010, HENRY J KAIS FAM FOU; Strasburger VC, 2010, PEDIATRICS, V125, P756, DOI 10.1542/peds.2009-2563	9	61	63	4	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2013	494	7438					425	426		10.1038/494425a	http://dx.doi.org/10.1038/494425a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099YI	23446401	Green Published, Bronze			2022-12-28	WOS:000315661500015
J	Atun, R; Jaffar, S; Nishtar, S; Knaul, FM; Barreto, ML; Nyirenda, M; Banatvala, N; Piot, P				Atun, Rifat; Jaffar, Shabbar; Nishtar, Sania; Knaul, Felicia M.; Barreto, Mauricio L.; Nyirenda, Moffat; Banatvala, Nicholas; Piot, Peter			Improving responsiveness of health systems to non-communicable diseases	LANCET			English	Editorial Material							FUND-SUPPORTED PROGRAMS; CASE-MANAGEMENT; CERVICAL-CANCER; PRIMARY-CARE; LOW-INCOME; SCALE-UP; HIV; MULTIMORBIDITY; INTERVENTIONS; PREVENTION		[Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Jaffar, Shabbar; Piot, Peter] London Sch Hyg & Trop Med, London WC1, England; [Nishtar, Sania] Heartfile, Islamabad, Pakistan; [Knaul, Felicia M.] Harvard Global Equ Initiat, Boston, MA USA; [Barreto, Mauricio L.] Univ Fed Bahia, Inst Saude Colet, BR-41170290 Salvador, BA, Brazil; [Nyirenda, Moffat] Coll Med, Blantyre, Malawi; [Banatvala, Nicholas] WHO, CH-1211 Geneva, Switzerland	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Universidade Federal da Bahia; University of Malawi; World Health Organization	Atun, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Imperial Coll Business Sch, S Kensington Campus, London SW7 2AZ, England.	r.atun@imperial.ac.uk	Atun, Rifat/AAH-5537-2021; Barreto, Mauricio L/B-1752-2008	Barreto, Mauricio L/0000-0002-0215-4930; Jaffar, Shabbar/0000-0002-9615-1588; Atun, Rifat/0000-0002-1531-5983; Banatvala, Nick/0000-0001-8130-154X; Knaul, Felicia/0000-0002-0512-4788	Medical Research Council [MR/K012126/1] Funding Source: researchfish; Wellcome Trust [098610] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 2011, FHI 360; Aquino R, 2009, AM J PUBLIC HEALTH, V99, P87, DOI 10.2105/AJPH.2007.127480; Atun RA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2165; Atun RA, 2005, THE WORLD BANK REPOR, VI; Atun R, 2012, LANCET, V380, P2044, DOI 10.1016/S0140-6736(12)61460-3; Atun R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-780; Atun R, 2011, JAIDS-J ACQ IMM DEF, V57, pS91, DOI 10.1097/QAI.0b013e3182218441; Atun R, 2010, LANCET, V375, P2169, DOI 10.1016/S0140-6736(10)60493-X; Atun R, 2010, HEALTH POLICY PLANN, V25, P1, DOI 10.1093/heapol/czp053; Atun RA, 2006, HEALTH POLICY, V79, P79, DOI 10.1016/j.healthpol.2005.12.005; Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Balabanova D, 2011, GOOD HEALTH AT LOW C; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bloom D., 2011, THE GLOBAL ECONOMIC; Celletti F, 2010, AIDS, V24, pS45, DOI 10.1097/01.aids.0000366082.68321.d6; DEBUSK RF, 1994, ANN INTERN MED, V120, P721, DOI 10.7326/0003-4819-120-9-199405010-00001; Desai M, 2010, HEALTH POLICY PLANN, V25, pi43, DOI 10.1093/heapol/czq057; Dourado I, 2011, MED CARE, V49, P577, DOI 10.1097/MLR.0b013e31820fc39f; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Farzadfar F, 2012, LANCET, V379, P47, DOI 10.1016/S0140-6736(11)61349-4; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Gilmer TP, 2007, HEALTH SERV RES, V42, P1943, DOI 10.1111/j.1475-6773.2007.00701.x; Howitt P, 2012, LANCET, V380, P507, DOI 10.1016/S0140-6736(12)61127-1; Huntley AL, 2012, ANN FAM MED, V10, P134, DOI 10.1370/afm.1363; Miranda JJ, 2011, HEART, V97, P787, DOI 10.1136/hrt.2010.218537; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; Kalk A, 2010, TROP MED INT HEALTH, V15, P94, DOI 10.1111/j.1365-3156.2009.02424.x; Knaul FM, 2012, CLOSING THE CANCER D; Krishnan Anand, 2009, Glob Health Action, V2, DOI 10.3402/gha.v2i0.1990; Lamptey P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001086; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Macinko J, 2010, HEALTH AFFAIR, V29, P2149, DOI 10.1377/hlthaff.2010.0251; Mamo Y, 2007, CLIN MED, V7, P228, DOI 10.7861/clinmedicine.7-3-228; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; Knaul FM, 2008, REPROD HEALTH MATTER, V16, P113, DOI 10.1016/S0968-8080(08)32414-8; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; Ministry of Health Malawi and WHO Country Office Malawi, MALAWI NATIONAL STEP; Mounier-Jack S, 2010, HEALTH POLICY PLANN, V25, pi37, DOI 10.1093/heapol/czq056; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Mwanahamuntu MH, 2009, AIDS, V23, pN1, DOI 10.1097/QAD.0b013e3283236e11; Mwangemi F, 2010, INTERNATIONAL AIDS C; Narayan KMV, 2011, NEW ENGL J MED, V365, P876, DOI 10.1056/NEJMp1107189; Nishtar S, 2005, AM J PREV MED, V29, P102, DOI 10.1016/j.amepre.2005.07.034; Nishtar S, 2010, 55 WHO; Nishtar S., 2004, NATIONAL ACTION PLAN; Nishtar S, 2010, CHOKED PIPES REFORMI; Nishtar Sania, 2006, Prev Chronic Dis, V3, pA14; Nishtar Sania, 2004, Health Res Policy Syst, V2, P7, DOI 10.1186/1478-4505-2-7; Nishtar S, 2011, LANCET, V378, P648, DOI 10.1016/S0140-6736(11)60606-5; Norris SL, 2002, AM J PREV MED, V22, P15, DOI 10.1016/S0749-3797(02)00423-3; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; PEPFAR, 2011, COTE DIVOIRE INTEGRA; Price JE, 2009, AIDS CARE, V21, P608, DOI 10.1080/09540120802310957; Rabkin M, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/137460; Rabkin Miriam, 2012, AIDS, V26 Suppl 1, pS77; Rabkin M, 2011, GLOB PUBLIC HEALTH, V6, P247, DOI 10.1080/17441692.2011.552068; Rasschaert Freya, 2011, J Int AIDS Soc, V14 Suppl 1, pS3, DOI 10.1186/1758-2652-14-S1-S3; Rocha R, 2012, HEALTH ECON, V19, P126; Rudge JW, 2010, HEALTH POLICY PLANN, V25, pi48, DOI 10.1093/heapol/czq058; Samb B, 2010, LANCET, V376, P1785, DOI 10.1016/S0140-6736(10)61353-0; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Schouten EJ, 2011, LANCET, V378, P282, DOI 10.1016/S0140-6736(10)62303-3; Srikantiah P, 2010, AIDS, V24, pS62, DOI 10.1097/01.aids.0000390091.45435.ea; Starfield Barbara, 2003, Ann Fam Med, V1, P8, DOI 10.1370/afm.1; Stevens G, 2008, PLOS MED, V5, P900, DOI 10.1371/journal.pmed.0050125; Sweeney S, 2012, SEX TRANSM INFECT, V88, P85, DOI 10.1136/sextrans-2011-050199; Tragard A, 2010, HEALTH POLICY PLANN, V25, pi58, DOI 10.1093/heapol/czq061; Ullrich A, 2011, LANCET, V377, P639, DOI 10.1016/S0140-6736(11)60233-X; United Nations General Assembly, 2011, POL DECL HIGH LEV M; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; WHO, 2011, GLOB STAT REP NONC D; WHO, 2010, PACKAGE OF ESSENTIAL; World Health Organization, 2012, PREVENTION CONTROL N; Yap IKS, 2010, J PROTEOME RES, V9, P6647, DOI 10.1021/pr100798r; Ziguras SJ, 2000, PSYCHIAT SERV, V51, P1410, DOI 10.1176/appi.ps.51.11.1410	76	168	168	2	63	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2013	381	9867					690	697		10.1016/S0140-6736(13)60063-X	http://dx.doi.org/10.1016/S0140-6736(13)60063-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	093JY	23410609				2022-12-28	WOS:000315189300039
J	Kacsoh, BZ; Lynch, ZR; Mortimer, NT; Schlenke, TA				Kacsoh, Balint Z.; Lynch, Zachary R.; Mortimer, Nathan T.; Schlenke, Todd A.			Fruit Flies Medicate Offspring After Seeing Parasites	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; ALCOHOL-DEHYDROGENASE; SELF-MEDICATION; CENTRAL COMPLEX; ETHANOL; RECEPTOR; CONSUMPTION; SIMULANS; MEMORY; SITES	Hosts have numerous defenses against parasites, of which behavioral immune responses are an important but underappreciated component. Here we describe a behavioral immune response that Drosophila melanogaster uses against endoparasitoid wasps. We found that when flies see wasps, they switch to laying eggs in alcohol-laden food sources that protect hatched larvae from infection. This change in oviposition behavior, mediated by neuropeptide F, is retained long after wasps are removed. Flies respond to diverse female larval endoparasitoids but not to males or pupal endoparasitoids, showing that they maintain specific wasp search images. Furthermore, the response evolved multiple times across the genus Drosophila. Our data reveal a behavioral immune response based on anticipatory medication of offspring and outline a nonassociative memory paradigm based on innate parasite recognition by the host.	[Kacsoh, Balint Z.; Lynch, Zachary R.; Mortimer, Nathan T.; Schlenke, Todd A.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Schlenke, TA (corresponding author), Emory Univ, Dept Biol, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	tschlen@emory.edu	Kacsoh, Balint/AAF-2165-2019	Kacsoh, Balint/0000-0001-9171-0611; Mortimer, Nathan/0000-0003-3787-9445; Schlenke, Todd/0000-0003-3091-3057; Lynch, Zachary/0000-0002-8802-3164	NIH [AI081879]; Integrated Cellular Imaging Microscopy Core of the Emory Neuroscience NINDS Core Facilities [P30NS055077]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Integrated Cellular Imaging Microscopy Core of the Emory Neuroscience NINDS Core Facilities; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Shen for NPF antiserum; P. Shen, K. Moberg, and S. Sanyal for Drosophila strains; and J. van Alphen and B. Wertheim for wasp strains. This work was supported by NIH grant AI081879 to T. A. S. and the Integrated Cellular Imaging Microscopy Core of the Emory Neuroscience NINDS Core Facilities grant, P30NS055077. Data are deposited in the Dryad Repository: http://dx.doi.org/10.5061/dryad.j5g7m.	Brown MR, 1999, PEPTIDES, V20, P1035, DOI 10.1016/S0196-9781(99)00097-2; CHAWLA SS, 1981, CAN ENTOMOL, V113, P315, DOI 10.4039/Ent113315-4; de Roode Jacobus C., 2012, Insects, V3, P789, DOI 10.3390/insects3030789; ENGLAND BP, 1990, J BIOL CHEM, V265, P5086; Fleury F, 2004, GENETICA, V120, P181, DOI 10.1023/B:GENE.0000017640.78087.9e; Fleury F, 2009, ADV PARASIT, V70, P3, DOI 10.1016/S0065-308X(09)70001-6; GIBSON JB, 1981, OECOLOGIA, V51, P191, DOI 10.1007/BF00540600; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; HARVEY PH, 1991, NATURE, V351, P619, DOI 10.1038/351619a0; Kacsoh BZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034721; Kong EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009954; Lefevre T, 2012, BIOL LETTERS, V8, P230, DOI 10.1098/rsbl.2011.0725; Lefevre T, 2010, ECOL LETT, V13, P1485, DOI 10.1111/j.1461-0248.2010.01537.x; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; MCKECHNIE SW, 1984, INSECT BIOCHEM, V14, P231, DOI 10.1016/0020-1790(84)90034-9; Menzel R, 1985, EXPT BEHAV ECOLOGY, P55; Milan NF, 2012, CURR BIOL, V22, P488, DOI 10.1016/j.cub.2012.01.045; PARSONS PA, 1979, AUST J ZOOL, V27, P747, DOI 10.1071/ZO9790747; PIETREWICZ AT, 1979, SCIENCE, V204, P1332, DOI 10.1126/science.204.4399.1332; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Thiele TE, 1998, NATURE, V396, P366, DOI 10.1038/24614; von Lintig J, 2001, P NATL ACAD SCI USA, V98, P1130, DOI 10.1073/pnas.031576398; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wen TQ, 2005, P NATL ACAD SCI USA, V102, P2141, DOI 10.1073/pnas.0406814102	26	112	118	5	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2013	339	6122					947	950		10.1126/science.1229625	http://dx.doi.org/10.1126/science.1229625			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23430653	Green Accepted			2022-12-28	WOS:000315149600046
J	Flynn, P				Flynn, Paul			Should the NHS work at weekends as it does in the week? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMA Consultants Comm, London, England		Flynn, P (corresponding author), BMA Consultants Comm, London, England.	PFlynn@bma.org.uk						Academy of Royal Colleges, 7 DAY CONS PRES CAR; [Anonymous], 2010, BMA SURV CONS CONTR; Cagnacci A, 1998, AM J OBSTET GYNECOL, V178, P140, DOI 10.1016/S0002-9378(98)70641-6; Mohammed MA, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-87; Pain A, 2012, EVENING GAZETTE 1005; Royal College of Obstetricians and Gynaecologists, 2011, HIGH QUAL WOM HEALTH; Royal College of Surgeons of England, 2013, RESH SURG SERV PRINC	7	7	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 21	2013	346								f622	10.1136/bmj.f622	http://dx.doi.org/10.1136/bmj.f622			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096HP	23430215				2022-12-28	WOS:000315395100009
J	de Leeuw, PW; Postma, CT; Kroon, AA				de Leeuw, Peter W.; Postma, Cornelis T.; Kroon, Abraham A.			Treatment of Atherosclerotic Renal Artery Stenosis Time for a New Approach	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RENOVASCULAR DISEASE		[de Leeuw, Peter W.; Kroon, Abraham A.] Univ Hosp Maastricht, Dept Med, NL-6202 AZ Maastricht, Netherlands; [de Leeuw, Peter W.; Kroon, Abraham A.] Cardiovasc Res Inst Maastricht CARIM, NL-6202 AZ Maastricht, Netherlands; [Postma, Cornelis T.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Radboud University Nijmegen	de Leeuw, PW (corresponding author), Univ Hosp Maastricht, Dept Med, POB 5800, NL-6202 AZ Maastricht, Netherlands.	p.deleeuw@maastrichtuniversity.nl	de Leeuw, Peter W./J-4552-2016; Postma, C.T./L-4585-2015	de Leeuw, Peter W./0000-0002-4949-5812; 				Caps MT, 1998, CIRCULATION, V98, P2866, DOI 10.1161/01.CIR.98.25.2866; Dechering DG, 2010, J INTERN MED, V267, P305, DOI 10.1111/j.1365-2796.2009.02144.x; Gross CM, 2001, RADIOLOGY, V220, P751, DOI 10.1148/radiol.2203001444; HAIMOVICI H, 1962, J CARDIOVASC SURG, V3, P259; Koivuviita N, 2012, NEPHROL DIAL TRANSPL, V27, P3843, DOI 10.1093/ndt/gfs301; Nordmann AJ, 2003, AM J MED, V114, P44, DOI 10.1016/S0002-9343(02)01396-7; Schreij G, 1996, J NUCL MED, V37, P594; Wheatley K, 2009, NEW ENGL J MED, V361, P1953, DOI 10.1056/NEJMoa0905368	8	14	14	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2013	309	7					663	664		10.1001/jama.2012.194145	http://dx.doi.org/10.1001/jama.2012.194145			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091EK	23423409				2022-12-28	WOS:000315032000018
J	Franson, JD				Franson, James D.			Beating Classical Computing Without a Quantum Computer	SCIENCE			English	Editorial Material									Univ Maryland Baltimore Cty, Dept Phys, Baltimore, MD 21250 USA	University System of Maryland; University of Maryland Baltimore County	Franson, JD (corresponding author), Univ Maryland Baltimore Cty, Dept Phys, 1000 Hilltop Circle, Baltimore, MD 21250 USA.	jfranson@umbc.edu						Aaronson S., 2011, P 43 ANN ACM S THEOR, P333; AHARONOV Y, 1993, PHYS REV A, V48, P1687, DOI 10.1103/PhysRevA.48.1687; Broome MA, 2013, SCIENCE, V339, P794, DOI 10.1126/science.1231440; Childs AM, 2013, SCIENCE, V339, P791, DOI 10.1126/science.1229957; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Pittman TB, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.032316; Spring JB, 2013, SCIENCE, V339, P798, DOI 10.1126/science.1231692	7	14	14	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2013	339	6121					767	768		10.1126/science.1234061	http://dx.doi.org/10.1126/science.1234061			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23413344				2022-12-28	WOS:000314874400033
J	De, S; Williams, GJ; Hayen, A; Macaskill, P; McCaskill, M; Isaacs, D; Craig, JC				De, Sukanya; Williams, Gabrielle J.; Hayen, Andrew; Macaskill, Petra; McCaskill, Mary; Isaacs, David; Craig, Jonathan C.			Accuracy of the "traffic light" clinical decision rule for serious bacterial infections in young children with fever: a retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FEBRILE INFANTS; OBSERVATION SCALES; LOW-RISK; ILLNESS; PROCALCITONIN; PERFORMANCE; MANAGEMENT; BACTEREMIA; MARKERS	Objectives To determine the accuracy of a clinical decision rule (the traffic light system developed by the National Institute for Health and Clinical Excellence (NICE)) for detecting three common serious bacterial infections (urinary tract infection, pneumonia, and bacteraemia) in young febrile children. Design Retrospective analysis of data from a two year prospective cohort study Setting A paediatric emergency department. Participants 15 781 cases of children under 5 years of age presenting with a febrile illness. Main outcome measures Clinical features were used to categorise each febrile episodes as low, intermediate, or high probability of serious bacterial infection (green, amber, and red zones of the traffic light system); these results were checked (using standard radiological and microbiological tests) for each of the infections of interest and for any serious bacterial infection. Results After combination of the intermediate and high risk categories, the NICE traffic light system had a test sensitivity of 85.8% (95% confidence interval 83.6% to 87.7%) and specificity of 28.5% (27.8% to 29.3%) for the detection of any serious bacterial infection. Of the 1140 cases of serious bacterial infection, 157 (13.8%) were test negative (in the green zone), and, of these, 108 (68.8%) were urinary tract infections. Adding urine analysis (leucocyte esterase or nitrite positive), reported in 3653 (23.1%) episodes, to the traffic light system improved the test performance: sensitivity 92.1% (89.3% to 94.1%), specificity 22.3% (20.9% to 23.8%), and relative positive likelihood ratio 1.10 (1.06 to 1.14). Conclusion The NICE traffic light system failed to identify a substantial proportion of serious bacterial infections, particularly urinary tract infections. The addition of urine analysis significantly improved test sensitivity, making the traffic light system a more useful triage tool for the detection of serious bacterial infections in young febrile children.	[De, Sukanya; Williams, Gabrielle J.; Hayen, Andrew; Macaskill, Petra; Craig, Jonathan C.] Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia; [Hayen, Andrew] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia; [McCaskill, Mary] Childrens Hosp Westmead, Dept Emergency Med, Sydney, NSW 2145, Australia; [Isaacs, David] Childrens Hosp, Dept Infect Dis & Microbiol, Westmead, NSW, Australia; [Craig, Jonathan C.] Childrens Hosp, Dept Nephrol, Westmead, NSW, Australia	University of Sydney; University of New South Wales Sydney; University of Sydney; University of Sydney; University of Sydney	De, S (corresponding author), Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia.	sukanya.de@health.nsw.gov.au	Craig, Jonathan/E-2813-2013	Craig, Jonathan/0000-0002-2548-4035; Hayen, Andrew/0000-0003-4046-8030; Macaskill, Petra/0000-0001-5879-6193	National Health and Medical Research Council of Australia [211205, 402764]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This is a sub-study of FEVER, which was funded by the National Health and Medical Research Council of Australia (grant Nos 211205 and 402764). The funding source had no influence on study design; collection, analysis, or interpretation of data; writing the report; or the decision to submit the paper for publication.	Andreola B, 2007, PEDIATR INFECT DIS J, V26, P672, DOI 10.1097/INF.0b013e31806215e3; Armon K, 2001, ARCH DIS CHILD, V84, P390, DOI 10.1136/adc.84.5.390; Avner JR, 2009, ACAD EMERG MED, V16, P258, DOI 10.1111/j.1553-2712.2008.00345.x; BAKER MD, 1990, PEDIATRICS, V85, P1040; Baraff LJ, 2008, PEDIATR ANN, V37, P673, DOI 10.3928/00904481-20081001-01; Berger RMF, 1996, EUR J PEDIATR, V155, P468, DOI 10.1007/BF01955183; Bleeker SE, 2007, ACTA PAEDIATR, V96, P100, DOI 10.1111/j.1651-2227.2006.00033.x; BONADIO WA, 1993, CLIN PEDIATR, V32, P401, DOI 10.1177/000992289303200703; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Browne G J, 2001, Emerg Med (Fremantle), V13, P426, DOI 10.1046/j.1035-6851.2001.00256.x; Considine J, 2004, ANN EMERG MED, V44, P516, DOI 10.1016/j.annemergmed.2004.04.007; Craig JC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1594; ESKERUD JR, 1992, FAM PRACT, V9, P263, DOI 10.1093/fampra/9.3.263; Hayen A, 2010, J CLIN EPIDEMIOL, V63, P883, DOI 10.1016/j.jclinepi.2009.08.024; Herr SM, 2001, PEDIATRICS, V108, P866, DOI 10.1542/peds.108.4.866; Hewson PH, 2000, J PAEDIATR CHILD H, V36, P221, DOI 10.1046/j.1440-1754.2000.00483.x; Isaacman DJ, 2000, PEDIATRICS, V106, P977, DOI 10.1542/peds.106.5.977; Jackson MA, 1996, PEDIATR INFECT DIS J, V15, P1049, DOI 10.1097/00006454-199611000-00026; JASKIEWICZ JA, 1994, PEDIATRICS, V94, P390; Macaskill P, 2002, STAT MED, V21, P2527, DOI 10.1002/sim.1227; MCCARTHY PL, 1982, PEDIATRICS, V70, P802; McCarthy PL, 1979, PEDIATR REV, V1, P51; MORLEY CJ, 1991, ARCH DIS CHILD, V66, P100, DOI 10.1136/adc.66.1.100; National Collaborating Centre for Women's and Children's Health, 2007, FEV ILLN CHILDR ASS; Richardson M, 2007, BRIT MED J, V334, P1163, DOI 10.1136/bmj.39218.495255.AE; Thayyil S, 2005, ACTA PAEDIATR, V94, P155, DOI 10.1080/08035250410025140; Thompson M, 2009, ARCH DIS CHILD, V94, P888, DOI 10.1136/adc.2009.159095; Waddle E, 2009, ARCH DIS CHILD, V94, P144, DOI 10.1136/adc.2007.130583; Watt K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012448; Welch SB, 2003, ARCH DIS CHILD, V88, P608, DOI 10.1136/adc.88.7.608; Williams GJ, 2010, LANCET INFECT DIS, V10, P240, DOI 10.1016/S1473-3099(10)70031-1	31	37	38	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	2013	346								f866	10.1136/bmj.f866	http://dx.doi.org/10.1136/bmj.f866			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091ZK	23407730	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000315088100022
J	Grohman, JK; Gorelick, RJ; Lickwar, CR; Lieb, JD; Bower, BD; Znosko, BM; Weeks, KM				Grohman, Jacob K.; Gorelick, Robert J.; Lickwar, Colin R.; Lieb, Jason D.; Bower, Brian D.; Znosko, Brent M.; Weeks, Kevin M.			A Guanosine-Centric Mechanism for RNA Chaperone Function	SCIENCE			English	Article							MURINE LEUKEMIA-VIRUS; NUCLEOCAPSID PROTEIN; SHAPE CHEMISTRY; PARAMETERS; DUPLEXES; GENOME; PAIRS	RNA chaperones are ubiquitous, heterogeneous proteins essential for RNA structural biogenesis and function. We investigated the mechanism of chaperone-mediated RNA folding by following the time-resolved dimerization of the packaging domain of a retroviral RNA at nucleotide resolution. In the absence of the nucleocapsid (NC) chaperone, dimerization proceeded through multiple, slow-folding intermediates. In the presence of NC, dimerization occurred rapidly through a single structural intermediate. The RNA binding domain of heterogeneous nuclear ribonucleoprotein A1 protein, a structurally unrelated chaperone, also accelerated dimerization. Both chaperones interacted primarily with guanosine residues. Replacing guanosine with more weakly pairing inosine yielded an RNA that folded rapidly without a facilitating chaperone. These results show that RNA chaperones can simplify RNA folding landscapes by weakening intramolecular interactions involving guanosine and explain many RNA chaperone activities.	[Grohman, Jacob K.; Weeks, Kevin M.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Grohman, Jacob K.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Lickwar, Colin R.; Lieb, Jason D.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Lickwar, Colin R.; Lieb, Jason D.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Bower, Brian D.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Gorelick, Robert J.] SAIC Frederick Inc, AIDS & Canc Virus Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Znosko, Brent M.] St Louis Univ, Dept Chem, St Louis, MO 63103 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Saint Louis University; Washington University (WUSTL)	Weeks, KM (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	weeks@unc.edu		Lieb, Jason/0000-0001-7601-8061	U.S. National Institutes of Health [GM064803, GM072518, GM031819]; National Cancer Institute [HHSN261200800001E]; SAIC-Frederick, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007092, R01GM072518, R01GM064803, R01GM031819] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); SAIC-Frederick, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to D. Grawoig for a critical review of the manuscript and to D. Johnson and C. Hixson for assistance in preparing MuLV NC protein. This work was supported by the U.S. National Institutes of Health (GM064803 to K.M.W., GM072518 to J.D.L., and GM031819 to Jack Griffith and B.D.B) and by the National Cancer Institute (under contract HHSN261200800001E with SAIC-Frederick, Inc. to R.J.G.). Data sets of representative clustered kinetic data are provided in the supplementary materials.	ADAM MA, 1988, J VIROL, V62, P3802, DOI 10.1128/JVI.62.10.3802-3806.1988; Badorrek CS, 2006, BIOCHEMISTRY-US, V45, P12664, DOI 10.1021/bi060521k; Coffin J, 1997, RETROVIRUSES; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Dey A, 2005, BIOCHEMISTRY-US, V44, P3735, DOI 10.1021/bi047639q; Ding JZ, 1999, GENE DEV, V13, P1102, DOI 10.1101/gad.13.9.1102; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gherghe C, 2010, P NATL ACAD SCI USA, V107, P19248, DOI 10.1073/pnas.1006897107; Gherghe C, 2010, J VIROL, V84, P898, DOI 10.1128/JVI.01602-09; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; Hibbert CS, 2004, J VIROL, V78, P10927, DOI 10.1128/JVI.78.20.10927-10938.2004; Li PTX, 2006, P NATL ACAD SCI USA, V103, P15847, DOI 10.1073/pnas.0607202103; Mortimer SA, 2009, NAT PROTOC, V4, P1413, DOI 10.1038/nprot.2009.126; Mortimer SA, 2008, J AM CHEM SOC, V130, P16178, DOI 10.1021/ja8061216; PORTMAN DS, 1994, EMBO J, V13, P213, DOI 10.1002/j.1460-2075.1994.tb06251.x; Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445; Rein A, 1998, TRENDS BIOCHEM SCI, V23, P297, DOI 10.1016/S0968-0004(98)01256-0; Rein A, 2010, RNA BIOL, V7, P700, DOI 10.4161/rna.7.6.13685; Thomas JA, 2008, VIRUS RES, V134, P39, DOI 10.1016/j.virusres.2007.12.006; Woodson SA, 2010, RNA BIOL, V7, P677, DOI 10.4161/rna.7.6.13615; Wright DJ, 2007, BIOCHEMISTRY-US, V46, P4625, DOI 10.1021/bi0616910; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425	22	37	37	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2013	340	6129					190	195		10.1126/science.1230715	http://dx.doi.org/10.1126/science.1230715			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23470731	Green Accepted, Green Submitted			2022-12-28	WOS:000317341400054
J	Leffler, EM; Gao, ZY; Pfeifer, S; Segurel, L; Auton, A; Venn, O; Bowden, R; Bontrop, R; Wall, JD; Sella, G; Donnelly, P; McVean, G; Przeworski, M				Leffler, Ellen M.; Gao, Ziyue; Pfeifer, Susanne; Segurel, Laure; Auton, Adam; Venn, Oliver; Bowden, Rory; Bontrop, Ronald; Wall, Jeffrey D.; Sella, Guy; Donnelly, Peter; McVean, Gilean; Przeworski, Molly			Multiple Instances of Ancient Balancing Selection Shared Between Humans and Chimpanzees	SCIENCE			English	Article							NATURAL-SELECTION; COLOR POLYMORPHISM; RESISTANCE; EVOLUTION; HOST	Instances in which natural selection maintains genetic variation in a population over millions of years are thought to be extremely rare. We conducted a genome-wide scan for long-lived balancing selection by looking for combinations of SNPs shared between humans and chimpanzees. In addition to the major histocompatibility complex, we identified 125 regions in which the same haplotypes are segregating in the two species, all but two of which are noncoding. In six cases, there is evidence for an ancestral polymorphism that persisted to the present in humans and chimpanzees. Regions with shared haplotypes are significantly enriched for membrane glycoproteins, and a similar trend is seen among shared coding polymorphisms. These findings indicate that ancient balancing selection has shaped human variation and point to genes involved in host-pathogen interactions as common targets.	[Leffler, Ellen M.; Segurel, Laure; Przeworski, Molly] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Gao, Ziyue] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Pfeifer, Susanne; Bowden, Rory; Donnelly, Peter; McVean, Gilean] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Segurel, Laure; Przeworski, Molly] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Auton, Adam; Venn, Oliver; Bowden, Rory; Donnelly, Peter; McVean, Gilean] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Bontrop, Ronald] Biomed Primate Res Ctr, Dept Comparat Genet & Refinement, NL-2288 GJ Rijswijk, Netherlands; [Wall, Jeffrey D.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Sella, Guy; Przeworski, Molly] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Sella, Guy] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Ecol Evolut & Behav, IL-91904 Jerusalem, Israel	University of Chicago; University of Chicago; University of Oxford; Howard Hughes Medical Institute; University of Chicago; University of Oxford; Wellcome Centre for Human Genetics; University of California System; University of California San Francisco; University of Chicago; Hebrew University of Jerusalem	Leffler, EM (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St, Chicago, IL 60637 USA.	emleffler@uchicago.edu; mfp@uchicago.edu	Leffler, Ellen/I-3010-2019; Bontrop, Ronald E/J-3628-2012	Leffler, Ellen/0000-0002-1614-9366; Bontrop, Ronald E/0000-0003-0874-6467; Pfeifer, Susanne/0000-0003-1378-2913; Segurel, Laure/0000-0001-7339-0976; McVean, Gil/0000-0002-5012-4162; Donnelly, Peter/0000-0001-9495-3408	NIH [T32 GM007197, HG005226, GM72861]; Israel Science Foundation [1492/10]; Wolfson Royal Society Merit Award; Wellcome Trust Senior Investigator award [095552/Z/11/Z]; Wellcome Trust [090532/Z/09/Z, 075491/Z/04/B, 086084/Z/08/Z]; Howard Hughes Medical Institute Early Career Scientist; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072861, T32GM007197] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Wolfson Royal Society Merit Award(Royal Society of London); Wellcome Trust Senior Investigator award(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); Howard Hughes Medical Institute Early Career Scientist(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Conrad, Y. Lee, M. Nobrega, J. Pickrell, and H. Shim as well as A. Kermany, A. Venkat, and other members of the PPS labs for helpful discussions; I. Aneas, M. Caliskan, M. Nobrega, and C. Ober for their assistance with experiments; and G. Coop for discussions and comments on an earlier version of this manuscript. E. M. L. was supported in part by NIH training grant T32 GM007197. This work was supported by NIH HG005226 to J. D. W.; Israel Science Foundation grant 1492/10 to G. S.; a Wolfson Royal Society Merit Award, a Wellcome Trust Senior Investigator award (095552/Z/11/Z), and Wellcome Trust grants 090532/Z/09/Z and 075491/Z/04/B to P. D.; Wellcome Trust grant 086084/Z/08/Z to G. M.; and NIH grant GM72861 to M. P. M. P. is a Howard Hughes Medical Institute Early Career Scientist. The data set of shared SNPs is available from http://przeworski.uchicago.edu/wordpress/?page_id=20. Data from the validation experiment are available from GenBank under accession nos. KC541701 to KC542146. The biological material obtained from the San Diego Zoo and used in this study is subject to a materials tranfer agreement.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Bubb KL, 2006, GENETICS, V173, P2165, DOI 10.1534/genetics.106.055715; Charlesworth B, 2010, ELEMENTS EVOLUTIONAR; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Day CJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00009; Dobzhansky T, 1970, GENETICS EVOLUTIONAR; Franchini Massimo, 2007, Thromb J, V5, P14; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Ghosh R, 2012, SCIENCE, V335, P574, DOI 10.1126/science.1214318; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Gigord LDB, 2001, P NATL ACAD SCI USA, V98, P6253, DOI 10.1073/pnas.111162598; Gillespie J.H., 1992, CAUSES MOL EVOLUTION; Hedrick PW, 2011, HEREDITY, V107, P283, DOI 10.1038/hdy.2011.16; Hiwatashi T, 2010, MOL BIOL EVOL, V27, P453, DOI 10.1093/molbev/msp262; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; HUDSON RR, 1988, GENETICS, V120, P831; Johnsen JM, 2009, MOL BIOL EVOL, V26, P567, DOI 10.1093/molbev/msn284; KLEIN J, 1993, ANNU REV IMMUNOL, V11, P269, DOI 10.1146/annurev.immunol.11.1.269; Ko WY, 2011, AM J HUM GENET, V88, P741, DOI 10.1016/j.ajhg.2011.05.005; KUDO S, 1990, J BIOL CHEM, V265, P1102; Lewontin RC, 1974, GENETIC BASIS EVOLUT; Monnier J, 2008, FEBS J, V275, P4014, DOI 10.1111/j.1742-4658.2008.06559.x; Nagakubo D, 2003, J IMMUNOL, V171, P553, DOI 10.4049/jimmunol.171.2.553; Olofsson S, 2005, ANN MED, V37, P154, DOI 10.1080/07853890510007340; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; REID DG, 1987, BIOL J LINN SOC, V30, P1, DOI 10.1111/j.1095-8312.1987.tb00284.x; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Segurel L, 2012, P NATL ACAD SCI USA, V109, P18493, DOI 10.1073/pnas.1210603109; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; TAKAHATA N, 1990, P NATL ACAD SCI USA, V87, P2419, DOI 10.1073/pnas.87.7.2419; Tellier A, 2007, P R SOC B, V274, P809, DOI 10.1098/rspb.2006.0281; Videira PA, 2008, GLYCOCONJUGATE J, V25, P259, DOI 10.1007/s10719-007-9092-6; Wiuf C, 2004, GENETICS, V168, P2363, DOI 10.1534/genetics.104.029488; Wright S, 1939, GENETICS, V24, P538; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	39	192	196	2	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1578	1582		10.1126/science.1234070	http://dx.doi.org/10.1126/science.1234070			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23413192	Green Accepted, Green Submitted			2022-12-28	WOS:000316731600041
J	Cruciat, CM; Dolde, C; de Groot, REA; Ohkawara, B; Reinhard, C; Korswagen, HC; Niehrs, C				Cruciat, Cristina-Maria; Dolde, Christine; de Groot, Reinoud E. A.; Ohkawara, Bisei; Reinhard, Carmen; Korswagen, Hendrik C.; Niehrs, Christof			RNA Helicase DDX3 Is a Regulatory Subunit of Casein Kinase 1 in Wnt-beta-Catenin Signaling	SCIENCE			English	Article							I-EPSILON; WNT/BETA-CATENIN; CELL-MIGRATION; PROMOTES; PATHWAY; FAMILY; EXPRESSION; MUTATIONS; INDUCTION; PROTEINS	Casein kinase 1 (CK1) members play key roles in numerous biological processes. They are considered "rogue" kinases, because their enzymatic activity appears unregulated. Contrary to this notion, we have identified the DEAD-box RNA helicase DDX3 as a regulator of the Wnt-beta-catenin network, where it acts as a regulatory subunit of CK1 epsilon: In a Wnt-dependent manner, DDX3 binds CK1 epsilon and directly stimulates its kinase activity, and promotes phosphorylation of the scaffold protein dishevelled. DDX3 is required for Wnt-beta-catenin signaling in mammalian cells and during Xenopus and Caenorhabditis elegans development. The results also suggest that the kinase-stimulatory function extends to other DDX and CK1 members, opening fresh perspectives for one of the longest-studied protein kinase families.	[Cruciat, Cristina-Maria; Dolde, Christine; Ohkawara, Bisei; Reinhard, Carmen; Niehrs, Christof] Deutsch Krebsforschungszentrum, DKFZ ZMBH Alliance, Div Mol Embryol, D-69120 Heidelberg, Germany; [de Groot, Reinoud E. A.; Korswagen, Hendrik C.] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Amsterdam, Netherlands; [de Groot, Reinoud E. A.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Niehrs, Christof] Inst Mol Biol, D-55128 Mainz, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Institute of Molecular Biology (IMB)	Niehrs, C (corresponding author), Deutsch Krebsforschungszentrum, DKFZ ZMBH Alliance, Div Mol Embryol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	niehrs@dkfz-heidelberg.de	Korswagen, Hendrik/I-8782-2012	Ohkawara, Bisei/0000-0002-1987-458X; de Groot, Reinoud/0000-0002-1905-6501	Deutsche Forschungsgemeinschaft; Grants-in-Aid for Scientific Research [23710253] Funding Source: KAKEN	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Bienz, H. Clevers, X. He, R. Moon, R. Nusse, Y. H. Wu Lee, and D. Wu for reagents; D. Ingelfinger and M. Boutros for assistance with siRNA screening; and R. Voit for help with kinase assays. We thank G. Roth and Aska Pharmaceuticals Tokyo for generous supply of human chorionic gonadotropin. This work was supported by the Deutsche Forschungsgemeinschaft.	Bernatik O, 2011, J BIOL CHEM, V286, P10396, DOI 10.1074/jbc.M110.169870; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; CARMEL G, 1994, J BIOL CHEM, V269, P7304; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Cheong JK, 2011, INT J BIOCHEM CELL B, V43, P465, DOI 10.1016/j.biocel.2010.12.004; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gao ZH, 2002, P NATL ACAD SCI USA, V99, P1182, DOI 10.1073/pnas.032468199; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Grietzen KF, 1999, J BIOL CHEM, V274, P32063, DOI 10.1074/jbc.274.45.32063; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Harterink M, 2011, NAT CELL BIOL, V13, P914, DOI 10.1038/ncb2281; Hassler C, 2007, DEVELOPMENT, V134, P4255, DOI 10.1242/dev.005942; Hino S, 2003, J BIOL CHEM, V278, P14066, DOI 10.1074/jbc.M213265200; Hogbom M, 2007, J MOL BIOL, V372, P150, DOI 10.1016/j.jmb.2007.06.050; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Klein TJ, 2006, CURR BIOL, V16, P1337, DOI 10.1016/j.cub.2006.06.030; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; Korswagen HC, 2002, GENE DEV, V16, P1291, DOI 10.1101/gad.981802; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Metcalfe C, 2011, J CELL SCI, V124, P3537, DOI 10.1242/jcs.091991; Ou GS, 2009, J CELL BIOL, V185, P77, DOI 10.1083/jcb.200812077; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; Schroder M, 2010, BIOCHEM PHARMACOL, V79, P297, DOI 10.1016/j.bcp.2009.08.032; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Shih JW, 2008, ONCOGENE, V27, P700, DOI 10.1038/sj.onc.1210687; Swiatek W, 2004, J BIOL CHEM, V279, P13011, DOI 10.1074/jbc.M304682200; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Traut T., 2008, REGULATORY ALLOSTERI; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Whangbo J, 1999, MOL CELL, V4, P851, DOI 10.1016/S1097-2765(00)80394-9; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869	41	153	171	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1436	1441		10.1126/science.1231499	http://dx.doi.org/10.1126/science.1231499			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23413191				2022-12-28	WOS:000316740700044
J	Toyoshima, C; Iwasawa, S; Ogawa, H; Hirata, A; Tsueda, J; Inesi, G				Toyoshima, Chikashi; Iwasawa, Shiho; Ogawa, Haruo; Hirata, Ayami; Tsueda, Junko; Inesi, Giuseppe			Crystal structures of the calcium pump and sarcolipin in the Mg2+-bound E1 state	NATURE			English	Article							SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; CA2+; PHOSPHOLAMBAN; BINDING; ATPASE; CA2+-ATPASE; ABSENCE; EXPRESSION; REGULATOR	P-type ATPases are ATP-powered ion pumps that establish ion concentration gradients across biological membranes, and are distinct from other ATPases in that the reaction cycle includes an autophosphorylation step. The best studied is Ca2+-ATPase from muscle sarcoplasmic reticulum (SERCA1a), a Ca2+ pump that relaxes muscle cells after contraction, and crystal structures have been determined for most of the reaction intermediates(1,2). An important outstanding structure is that of the El intermediate, which has empty high-affinity Ca2+-binding sites ready to accept new cytosolic Ca2+. In the absence of Ca2+ and at pH 7 or higher, the ATpase is predominantly in El, not in E2 (low affinity for ce(2+), and if millimolar Mg2+ is present, one Mg2+ is expected to occupy one of the Ca2+-binding sites with a millimolar dissociation constant(4,5). This Mg2+ accelerates the reaction cycle(4), not permitting phosphorylation without Ca2+ binding. Here we describe the crystal structure of native SERCA1a (from rabbit) in this El-Mg2+ state at 3.0 A resolution in addition to crystal structures of SERCA1a in E2 free from exogenous inhibitors, and address the structural basis of the activation signal for phosphoryl transfer. Unexpectedly, sarcolipin(6), a small regulatory membrane protein of Ca2+-ATPase, is bound, stabilizing the El Mg2+ state. Sarcolipin is a close homologue of phospholamban, which is a critical mediator of P-adrenergic signal in Ca2+ regulation in heart (for reviews, see, for example, refs 8-10), and seems to play an important role in muscle-based thermogenesis(11). We also determined the crystal structure of recombinant SERCA1a devoid of sarcolipin, and describe the structural basis of inhibition by sarcolipim/phospholamban. Thus, the crystal structures reported here fill a gap in the structural elucidation of the reaction cycle and provide a solid basis for understanding the physiological regulation of the calcium pump.	[Toyoshima, Chikashi; Iwasawa, Shiho; Ogawa, Haruo; Hirata, Ayami; Tsueda, Junko] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Inesi, Giuseppe] Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA	University of Tokyo; California Pacific Medical Center; California Pacific Medical Center Research Institute	Toyoshima, C (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.	ct@iam.u-tokyo.ac.jp	Toyoshima, Chikashi/R-4153-2019	Toyoshima, Chikashi/0000-0001-9640-0778	Ministry of Education, Culture, Sports, Science and Technology of Japan [2009B0025]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank H. Suzuki and S. Danko (Asahikawa Medical College) for providing us with much unpublished information. Thanks are also due to S. Hasegawa (JASRI) and H. Mimura for data collection at BL41XU of SPring-8, S. Yonekura for refinement of the E2 crystals and Y. Norimatsu for molecular dynamics simulations. We are grateful to D. B. McIntosh for help in improvingthe manuscript This work is partof a long-term project (2009B0025) at SPring-8, and was supported by a Specially Promoted Project Graht from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to-C.T.).	Afara MR, 2008, BIOCHEMISTRY-US, V47, P9522, DOI 10.1021/bi800880q; Akin BL, 2010, J BIOL CHEM, V285, P28540, DOI 10.1074/jbc.M110.151779; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bhupathy P, 2009, J MOL CELL CARDIOL, V47, P723, DOI 10.1016/j.yjmcc.2009.07.014; Bidwell P, 2011, J BIOL CHEM, V286, P35044, DOI 10.1074/jbc.M111.266759; Buffy JJ, 2006, J MOL BIOL, V358, P420, DOI 10.1016/j.jmb.2006.02.005; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; CHAMPEIL P, 1983, J BIOL CHEM, V258, P4453; Chen ZH, 2006, J BIOL CHEM, V281, P14163, DOI 10.1074/jbc.M601338200; Hayward S, 1999, PROTEINS, V36, P425, DOI 10.1002/(SICI)1097-0134(19990901)36:4<425::AID-PROT6>3.3.CO;2-J; HOLLOWAY CE, 1994, J ORGANOMET CHEM, V465, P1, DOI 10.1016/0022-328X(94)87036-5; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Liu YY, 2009, J MOL BIOL, V391, P858, DOI 10.1016/j.jmb.2009.06.044; Lubben M, 2007, J MOL BIOL, V369, P368, DOI 10.1016/j.jmb.2007.03.029; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Odermatt A, 1997, GENOMICS, V45, P541, DOI 10.1006/geno.1997.4967; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Periasamy M, 2008, CARDIOVASC RES, V77, P265, DOI 10.1093/cvr/cvm056; Tadini-Buoninsegni F, 2006, J BIOL CHEM, V281, P37720, DOI 10.1074/jbc.M606040200; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2011, P NATL ACAD SCI USA, V108, P1833, DOI 10.1073/pnas.1017659108; Tupling AR, 2011, AM J PHYSIOL-CELL PH, V301, pC841, DOI 10.1152/ajpcell.00409.2010	30	159	164	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2013	495	7440					260	264		10.1038/nature11899	http://dx.doi.org/10.1038/nature11899			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23455422				2022-12-28	WOS:000316652300056
J	Joshi, NS; Jacks, T				Joshi, Nikhil S.; Jacks, Tyler			Guilty by Association	SCIENCE			English	Editorial Material							REGULATORY T-CELLS; IMMUNOTHERAPY; CANCER		[Joshi, Nikhil S.] MIT, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Joshi, NS (corresponding author), MIT, Dept Biol, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tjacks@mit.edu		Joshi, Nikhil/0000-0002-7045-7837	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kerkar SP, 2012, CANCER RES, V72, P3125, DOI 10.1158/0008-5472.CAN-11-4094; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Wang HY, 2005, J IMMUNOL, V174, P2661, DOI 10.4049/jimmunol.174.5.2661; Wang HY, 2004, IMMUNITY, V20, P107, DOI 10.1016/S1074-7613(03)00359-5	8	2	2	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2013	339	6124					1160	1161		10.1126/science.1235528	http://dx.doi.org/10.1126/science.1235528			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471395				2022-12-28	WOS:000315709900034
J	Ashkenazy, Y; Gildor, H; Losch, M; Macdonald, FA; Schrag, DP; Tziperman, E				Ashkenazy, Yosef; Gildor, Hezi; Losch, Martin; Macdonald, Francis A.; Schrag, Daniel P.; Tziperman, Eli			Dynamics of a Snowball Earth ocean	NATURE			English	Article							BREAK-UP; CLIMATE; ICE; DEGLACIATION; SIMULATION; INITIATION; MODEL	Geological evidence suggests that marine ice extended to the Equator at least twice during the Neoproterozoic era (about 750 to 635 million years ago)(1,2), inspiring the Snowball Earth hypothesis that the Earth was globally ice-covered(3,4). In a possible Snowball Earth climate, ocean circulation and mixing processes would have set the melting and freezing rates that determine ice thickness(5,6), would have influenced the survival of photosynthetic life(4,5,7-9), and may provide important constraints for the interpretation of geochemical and sedimentological observations(4,10). Here we show that in a Snowball Earth, the ocean would have been well mixed and. characterized by a dynamic circulation(11), with vigorous equatorial meridional overturning circulation, zonal equatorial jets, a well developed eddy field, strong coastal upwelling and convective mixing. This is in contrast to the sluggish ocean often expected in a Snowball Earth scenario(3) owing to the insulation of the ocean from atmospheric forcing by the thick ice cover. As a result of vigorous convective mixing, the ocean temperature, salinity and density were either uniform in the vertical direction or weakly stratified in a few locations. Our results are based on a model that couples ice flow and ocean circulation, and is driven by a weak geothermal heat flux under a global ice cover about a kilometre thick. Compared with the modern ocean, the Snowball Earth ocean had far larger vertical mixing rates, and comparable horizontal mixing by ocean eddies. The strong circulation and coastal upwellimg resulted in melting rates near continents as much as ten times larger than previously estimated(6,7). Although we cannot resolve the debate over the existence of global ice cover(10,12,13), we discuss the implications for the nutrient supply of photosynthetic activity and for banded iron formations. Our insights and constraints on ocean dynamics may help resolve the Snowball Earth controversy when combined with future geochemical and geological observations.	[Ashkenazy, Yosef] Ben Gurion Univ Negev, Blaustein Inst Desert Res, Dept Solar Energy & Environm Phys, IL-84990 Midreshet Ben Gurion, Israel; [Gildor, Hezi] Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel; [Losch, Martin] Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany; [Macdonald, Francis A.; Schrag, Daniel P.; Tziperman, Eli] Harvard Univ, Cambridge, MA 02138 USA; [Schrag, Daniel P.; Tziperman, Eli] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Ben Gurion University; Hebrew University of Jerusalem; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Harvard University; Harvard University	Tziperman, E (corresponding author), Harvard Univ, 20 Oxford St, Cambridge, MA 02138 USA.	ashkena@bgu.ac.il; eli@eps.harvard.edu	Tziperman, Eli/A-1219-2008; Gildor, Hezi/AAZ-6602-2021; Losch, Martin/S-5896-2016; Ashkenazy, Yosef/AAV-3218-2020; ASHKENAZY, YOSEF/F-1483-2012	Gildor, Hezi/0000-0003-0898-6292; Losch, Martin/0000-0002-3824-5244; Ashkenazy, Yosef/0000-0001-9405-068X	NSF [ATM-0902844]; Div Atmospheric & Geospace Sciences [0902844] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank B. Rose for comments. This work was supported by the NSF Climate Dynamics P2C2 programme, grant number ATM-0902844 (to E.T. and Y.A.). E.T. thanks the Weizmann Institute for its hospitality during parts of this work. Y.A. thanks the Harvard EPS department for a most pleasant and productive sabbatical visit.	Abbot DS, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012007; Allen PA, 2008, NAT GEOSCI, V1, P817, DOI 10.1038/ngeo355; Bekker A, 2010, ECON GEOL, V105, P467, DOI 10.2113/gsecongeo.105.3.467; Campbell AJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048846; Corsetti FA, 2006, PALAEOGEOGR PALAEOCL, V232, P114, DOI 10.1016/j.palaeo.2005.10.030; Donnadieu Y, 2004, NATURE, V428, P303, DOI 10.1038/nature02408; Evans DAD, 2011, GEOL SOC MEM, V36, P93, DOI 10.1144/M36.7; Farrell BF, 2003, J ATMOS SCI, V60, P2101, DOI 10.1175/1520-0469(2003)060<2101:SSOTJ>2.0.CO;2; Ferreira D, 2011, J CLIMATE, V24, P992, DOI 10.1175/2010JCLI3580.1; Goodman JC, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001471; Harland W.B., 1964, INTERSCIENCE, P119; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; Kirschvink J. L., 1992, PROTEROZOIC BIOSPHER, P51; Le Hir G, 2007, CR GEOSCI, V339, P274, DOI 10.1016/j.crte.2006.09.002; Le Hir G, 2010, CLIM DYNAM, V35, P285, DOI 10.1007/s00382-010-0748-8; Li ZX, 2008, PRECAMBRIAN RES, V160, P179, DOI 10.1016/j.precamres.2007.04.021; Losch M, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004368; Marshall J, 1997, J GEOPHYS RES-OCEANS, V102, P5753, DOI 10.1029/96JC02775; McKay CP, 2000, GEOPHYS RES LETT, V27, P2153, DOI 10.1029/2000GL008525; Pierrehumbert RT, 2011, ANNU REV EARTH PL SC, V39, P417, DOI 10.1146/annurev-earth-040809-152447; Pierrehumbert RT, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005162; Pollard D, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002525; Poulsen CJ, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001056; Poulsen CJ, 2001, GEOPHYS RES LETT, V28, P1575, DOI 10.1029/2000GL012058; Runnegar B, 2000, NATURE, V405, P403, DOI 10.1038/35013168; Tziperman E, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007730; Voigt A, 2011, CLIM PAST, V7, P249, DOI 10.5194/cp-7-249-2011; Warren SG, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001123; Yang J, 2012, J CLIMATE, V25, P2737, DOI 10.1175/JCLI-D-11-00190.1; YOUNG GM, 1988, SEDIMENT GEOL, V58, P127, DOI 10.1016/0037-0738(88)90066-8	30	44	46	4	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2013	495	7439					90	93		10.1038/nature11894	http://dx.doi.org/10.1038/nature11894			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23467167	Green Submitted			2022-12-28	WOS:000316039800045
J	Maurer, M; Rosen, K; Hsieh, HJ; Saini, S; Grattan, C; Gimenez-Arnau, A; Agarwal, S; Doyle, R; Canvin, J; Kaplan, A; Casale, T				Maurer, Marcus; Rosen, Karin; Hsieh, Hsin-Ju; Saini, Sarbjit; Grattan, Clive; Gimenez-Arnau, Ana; Agarwal, Sunil; Doyle, Ramona; Canvin, Janice; Kaplan, Allen; Casale, Thomas			Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EPSILON-RI EXPRESSION; ANTI-IGE OMALIZUMAB; DAILY DIARY; IMPACT; LIFE	BACKGROUND Many patients with chronic idiopathic urticaria (also called chronic spontaneous urticaria) do not have a response to therapy with H-1-antihistamines, even at high doses. In phase 2 trials, omalizumab, an IgE monoclonal antibody that targets IgE and affects mast-cell and basophil function, has shown efficacy in such patients. METHODS In this phase 3, multicenter, randomized, double-blind study, we evaluated the efficacy and safety of omalizumab in patients with moderate-to-severe chronic idiopathic urticaria who remained symptomatic despite H-1-antihistamine therapy (licensed doses). We randomly assigned 323 patients to receive three subcutaneous injections, spaced 4 weeks apart, of omalizumab at doses of 75 mg, 150 mg, or 300 mg or placebo, followed by a 16-week observation period. The primary efficacy outcome was the change from baseline in a weekly itch-severity score (ranging from 0 to 21, with higher scores indicating more severe itching). RESULTS The baseline weekly itch-severity score was approximately 14 in all four study groups. At week 12, the mean (+/- SD) change from baseline in the weekly itch-severity score was -5.1 +/- 5.6 in the placebo group, -5.9 +/- 6.5 in the 75-mg group (P = 0.46), -8.1 +/- 6.4 in the 150-mg group (P = 0.001), and -9.8 +/- 6.0 in the 300-mg group (P<0.001). Most prespecified secondary outcomes at week 12 showed similar dose-dependent effects. The frequency of adverse events was similar across groups. The frequency of serious adverse events was low, although the rate was higher in the 300-mg group (6%) than in the placebo group (3%) or in either the 75-mg or 150-mg group (1% for each). CONCLUSIONS Omalizumab diminished clinical symptoms and signs of chronic idiopathic urticaria in patients who had remained symptomatic despite the use of approved doses of H-1-antihistamines. (Funded by Genentech and Novartis Pharma; ClinicalTrials.gov number, NCT01292473.)	[Maurer, Marcus] Charite, Dept Dermatol & Allergy, D-13353 Berlin, Germany; [Rosen, Karin; Hsieh, Hsin-Ju; Agarwal, Sunil; Doyle, Ramona] Genentech Inc, San Francisco, CA 94080 USA; [Saini, Sarbjit] Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD USA; [Grattan, Clive] Norfolk & Norwich Univ Hosp, Dept Dermatol, Norwich, Norfolk, England; [Canvin, Janice] Novartis Pharmaceut, Horsham, W Sussex, England; [Gimenez-Arnau, Ana] Univ Autonoma Barcelona, Hosp del Mar, Dept Dermatol, E-08193 Barcelona, Spain; [Kaplan, Allen] Med Univ S Carolina, Charleston, SC USA; [Casale, Thomas] Creighton Univ, Med Ctr, Omaha, NE USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Roche Holding; Genentech; Johns Hopkins University; Johns Hopkins Medicine; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Novartis; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Medical University of South Carolina; Creighton University	Rosen, K (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	rosen.karin@gene.com	Maurer, Marcus/ABG-2174-2020	Maurer, Marcus/0000-0002-4121-481X; Canvin, Janice/0000-0001-9609-7182	Genentech; Novartis Pharma; Uriach Pharma; UCB; Sanofi; Merck; FAES; Almirall; Array; Kendle; MedImmune; Parmacyclics; Regeneron; Bayer-Intendis; Inescop; Sanofi-Aventis; Dyax; ViroPharma; CSL Behring; Shire	Genentech(Roche HoldingGenentech); Novartis Pharma; Uriach Pharma(Dexcel Pharma); UCB(UCB Pharma SA); Sanofi; Merck(Merck & Company); FAES; Almirall(Almirall); Array; Kendle; MedImmune(AstraZenecaMedimmune); Parmacyclics; Regeneron(Regeneron); Bayer-Intendis; Inescop; Sanofi-Aventis(Sanofi-Aventis); Dyax; ViroPharma; CSL Behring; Shire	Funded by Genentech and Novartis Pharma; ClinicalTrials.gov number, NCT01292473.); Supported by Genentech and Novartis Pharma.; Dr. Maurer reports receiving consulting fees from Uriach Pharma and UCB, advisory board fees from Uriach Pharma, lecture fees from Sanofi, Merck, FAES, Uriach Pharma, and Almirall, and grant support through his institution from Uriach Pharma; Dr. Rosen, being an employee of Genentech and having an equity interest in Roche; Drs. Hsieh and Doyle, being employees of and having an equity interest in Genentech; Dr. Saini, receiving consulting fees from Array, Kendle, MedImmune, Parmacyclics, and Regeneron; Dr. Gimenez-Arnau, receiving payment for serving on advisory boards from Uriach Pharma, Almirall, Basilea, and Unilever, payment for expert testimony on Sara Lee products, lecture fees from Bayer-Intendis and Uriach Pharma, payment for the development of educational presentations from Menarini and GlaxoSmithKline, and grant support through her institution from Uriach Pharma, Bayer-Intendis, and Inescop; Dr. Agarwal, being an employee of and having an equity interest in Roche; Dr. Canvin, being an employee of and having an equity interest in Novartis; and Dr. Kaplan, receiving consulting fees from Sanofi-Aventis, lecture fees from Dyax and ViroPharma, and grant support through his institution from Dyax, CSL Behring, and Shire. No other potential conflict of interest relevant to this article was reported.	Asero R, 2007, CLIN EXP DERMATOL, V32, P34, DOI 10.1111/j.1365-2230.2006.02278.x; Beck LA, 2004, J ALLERGY CLIN IMMUN, V114, P527, DOI 10.1016/j.jaci.2004.06.032; Busse W, 2012, J ALLERGY CLIN IMMUN, V129, P983, DOI 10.1016/j.jaci.2012.01.033; Corren J, 2009, CLIN EXP ALLERGY, V39, P788, DOI 10.1111/j.1365-2222.2009.03214.x; Eckman JA, 2010, J ALLERGY CLIN IMMUN, V125, P889, DOI 10.1016/j.jaci.2009.09.012; European Medicines Agency, XOL SUMM PROD CHAR; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Gaig P, 2004, J INVEST ALLERG CLIN, V14, P214; Gober LM, 2008, J ALLERGY CLIN IMMUN, V121, pS147, DOI 10.1016/j.jaci.2007.12.1121; GREAVES MW, 1995, NEW ENGL J MED, V332, P1767, DOI 10.1056/NEJM199506293322608; Kang MJ, 2009, ANN DERMATOL, V21, P226, DOI 10.5021/ad.2009.21.3.226; Kaplan AP, 2008, J ALLERGY CLIN IMMUN, V122, P569, DOI 10.1016/j.jaci.2008.07.006; Kaplan AP, 2002, NEW ENGL J MED, V346, P175, DOI 10.1056/NEJMcp011186; MacGlashan DW, 1997, J IMMUNOL, V158, P1438; Mathias SD, 2012, ALLERGY ASTHMA PROC, V33, P186, DOI 10.2500/aap.2012.33.3508; Mathias SD, 2012, ANN ALLERG ASTHMA IM, V108, P20, DOI 10.1016/j.anai.2011.09.008; Mathias SD, 2010, ANN ALLERG ASTHMA IM, V105, P142, DOI 10.1016/j.anai.2010.06.011; Maurer M, 2011, ALLERGY, V66, P317, DOI 10.1111/j.1398-9995.2010.02496.x; Maurer M, 2011, J ALLERGY CLIN IMMUN, V128, P202, DOI 10.1016/j.jaci.2011.04.038; Novartis G, 2010, XOL OM; ODonnell BF, 1997, BRIT J DERMATOL, V136, P197; Ong YE, 2005, J ALLERGY CLIN IMMUN, V116, P558, DOI 10.1016/j.jaci.2005.05.035; Saini S, 2011, J ALLERGY CLIN IMMUN, V128, P567, DOI 10.1016/j.jaci.2011.06.010; Saini SS, 2002, CURR OPIN IMMUNOL, V14, P694, DOI 10.1016/S0952-7915(02)00404-1; Shikiar Richard, 2005, Health Qual Life Outcomes, V3, P36, DOI 10.1186/1477-7525-3-36; Staevska M, 2010, J ALLERGY CLIN IMMUN, V125, P676, DOI 10.1016/j.jaci.2009.11.047; Toubi E, 2004, ALLERGY, V59, P869, DOI 10.1111/j.1398-9995.2004.00473.x; Vonakis BM, 2008, CURR OPIN IMMUNOL, V20, P709, DOI 10.1016/j.coi.2008.09.005; Zuberbier T, 2009, ALLERGY, V64, P1427, DOI 10.1111/j.1398-9995.2009.02178.x; Zuberbier T, 2009, ALLERGY, V64, P1417, DOI 10.1111/j.1398-9995.2009.02179.x	30	643	671	3	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2013	368	10					924	935		10.1056/NEJMoa1215372	http://dx.doi.org/10.1056/NEJMoa1215372			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100BG	23432142				2022-12-28	WOS:000315669100008
J	Alford, DP				Alford, Daniel P.			Chronic Back Pain With Possible Prescription Opioid Misuse	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC NONCANCER PAIN; PRIMARY-CARE PHYSICIANS; DRUG-RELATED BEHAVIORS; NONMALIGNANT PAIN; ACTING OPIOIDS; MANAGEMENT; VALIDATION; ADDICTION; THERAPY; ABUSE	Importance Data on the effectiveness and safety of long-term opioid therapy for chronic pain are limited. Opioid adherence monitoring includes urine drug testing. Determining whether a patient's opioid prescription should be discontinued after an unexpected urine test result can be clinically complex. Objective To review safe opioid prescribing practices and appropriate interpretation and management of unexpected urine drug test results. Evidence Review Systematic reviews of the effectiveness and safety of long-term opioid therapy for chronic noncancer pain. Clinical management recommendations are derived from clinical guidelines generated by several professional medical organizations including the American Pain Society, the American Academy of Pain Medicine, and the Federation of State Medical Boards Findings Informed consent and patient-prescriber agreements are important strategies to ensure that patients understand treatment goals and potential opioid risks. Monitoring for benefit and opioid misuse is accomplished by having frequent face-to-face assessments, performing urine drug tests, monitoring pill counts, and reviewing prescription drug monitoring program data, when available. Conclusions and Relevance The underlying causes for worrisome behaviors such as urine drug test results that are negative for the prescribed opioid should be fully investigated. Subsequent opioid prescriptions should be based on the revised risk and benefit assessment. JAMA. 2013;309(9):919-925 www.jama.com	[Alford, Daniel P.] Boston Univ, Sch Med, Clin Addict Res & Educ Unit, Gen Internal Med Sect, Boston, MA 02118 USA; [Alford, Daniel P.] Boston Med Ctr, Boston, MA 02118 USA	Boston University; Boston Medical Center	Alford, DP (corresponding author), Boston Med Ctr, Crosstown 2,801 Massachusetts Ave, Boston, MA 02118 USA.	dan.alford@bmc.org		Alford, Daniel/0000-0002-6250-8390				Akbik H, 2006, J PAIN SYMPTOM MANAG, V32, P287, DOI 10.1016/j.jpainsymman.2006.03.010; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Argoff CE, 2009, MAYO CLIN PROC, V84, P602, DOI 10.1016/S0025-6196(11)60749-0; Arnold RM, 2006, AM J MED, V119, P292, DOI 10.1016/j.amjmed.2005.09.019; Ballantyne JC, 2007, PAIN, V129, P235, DOI 10.1016/j.pain.2007.03.028; Benyamin R, 2008, PAIN PHYSICIAN, V11, pS105; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; BOTNEY M, 1983, ANN NEUROL, V13, P160, DOI 10.1002/ana.410130209; Braden JB, 2010, ARCH INTERN MED, V170, P1425, DOI 10.1001/archinternmed.2010.273; Breuer B, 2007, J PAIN, V8, P244, DOI 10.1016/j.jpain.2006.08.009; Breuer B, 2010, SOUTH MED J, V103, P738, DOI 10.1097/SMJ.0b013e3181e74ede; Chang G, 2007, MED CLIN N AM, V91, P199, DOI 10.1016/j.mcna.2006.10.003; Chou R, 2009, J PAIN, V10, P131, DOI 10.1016/j.jpain.2008.10.009; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Evers GCM, 1997, SUPPORT CARE CANCER, V5, P457, DOI 10.1007/s005200050114; Executive Office of the President Office of National Drug Control Policy, 2004, PULS CHECK TRENDS DR; Fiellin DA, 2002, ANN INTERN MED, V137, P688, DOI 10.7326/0003-4819-137-8-200210150-00014; Fine PG, 2009, J PAIN SYMPTOM MANAG, V38, P418, DOI 10.1016/j.jpainsymman.2009.06.002; Fishbain DA, 1999, CLIN J PAIN, V15, P184, DOI 10.1097/00002508-199909000-00005; Fishman SM, 2002, CLIN J PAIN, V18, pS70, DOI 10.1097/00002508-200207001-00008; Fleming MF, 2007, J PAIN, V8, P573, DOI 10.1016/j.jpain.2007.02.432; Gilron I, 2005, NEW ENGL J MED, V352, P1324, DOI 10.1056/NEJMoa042580; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; Gourlay DL, 2005, PAIN MED, V6, P107, DOI 10.1111/j.1526-4637.2005.05031.x; Heit HA, 2004, J PAIN SYMPTOM MANAG, V27, P260, DOI 10.1016/j.jpainsymman.2003.07.008; Hojsted J, 2007, EUR J PAIN, V11, P490, DOI 10.1016/j.ejpain.2006.08.004; Isaacson JH, 2005, POSTGRAD MED, V118, P19, DOI 10.3810/pgm.2005.07.1669; Ives TJ, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-46; Katz N, 2009, CLIN J PAIN, V25, P170, DOI 10.1097/AJP.0b013e3181850df6; Krebs EE, 2009, J GEN INTERN MED, V24, P733, DOI 10.1007/s11606-009-0981-1; Liebschutz JM, 2010, J PAIN, V11, P1047, DOI 10.1016/j.jpain.2009.10.012; Malinoff Herbert L, 2005, Am J Ther, V12, P379, DOI 10.1097/01.mjt.0000160935.62883.ff; Manchikanti Laxmaiah, 2006, Pain Physician, V9, P123; Manchikanti L, 2008, PAIN PHYSICIAN, V11, pS155; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; McCleane G, 2007, MED CLIN N AM, V91, P177, DOI 10.1016/j.mcna.2006.10.013; Michna E, 2004, J PAIN SYMPTOM MANAG, V28, P250, DOI 10.1016/j.jpainsymman.2004.04.007; Nicolaidis C, 2011, PAIN MED, V12, P890, DOI 10.1111/j.1526-4637.2011.01117.x; Noble M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006605.pub2; Olsen Y, 2006, J PAIN, V7, P225, DOI 10.1016/j.jpain.2005.11.006; Panagiotou I, 2012, CURR PHARM DESIGN, V18, P6025, DOI 10.2174/138161212803582450; Passik SD, 2006, CLIN J PAIN, V22, P173, DOI 10.1097/01.ajp.0000161525.48245.aa; Passik SD, 2008, PAIN MED, V9, pS145, DOI 10.1111/j.1526-4637.2008.00486.x; Passik SD, 2009, MAYO CLIN PROC, V84, P593, DOI 10.1016/S0025-6196(11)60748-9; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Perrone J, 2012, NEW ENGL J MED, V366, P2341, DOI 10.1056/NEJMp1204493; Pesce A, 2011, PAIN PHYSICIAN, V14, P189; PORTENOY RK, 1986, PAIN, V25, P171, DOI 10.1016/0304-3959(86)90091-6; Reid MC, 2002, J GEN INTERN MED, V17, P173, DOI 10.1046/j.1525-1497.2002.10435.x; Reisfield Gary M, 2007, J Opioid Manag, V3, P333; Reisfield GM, 2009, BIOANALYSIS, V1, P937, DOI 10.4155/BIO.09.81; Saunders KW, 2010, J GEN INTERN MED, V25, P310, DOI 10.1007/s11606-009-1218-z; Savage SR, 2003, J PAIN SYMPTOM MANAG, V26, P655, DOI 10.1016/S0885-3924(03)00219-7; Simon LS, 2012, RELIEVING PAIN AM BL, V26; Smith HS, 2008, PAIN PHYSICIAN, V11, P237; Smith HS, 2009, MAYO CLIN PROC, V84, P613, DOI 10.1016/S0025-6196(11)60750-7; Stanos SP, 2012, MAYO CLIN PROC, V87, P683, DOI 10.1016/j.mayocp.2012.02.022; Starrels JL, 2010, ANN INTERN MED, V152, P712, DOI 10.7326/0003-4819-152-11-201006010-00004; Substance Abuse and Mental Health Services Administration, 2011, NSDUH SER H; Substance Abuse and Mental Health Services Administration Office of Applied Studies, 1998, DASIS SER S, VS-50; Tan G, 2004, J PAIN, V5, P133, DOI 10.1016/j.jpain.2003.12.005; Tremblay J, 2010, METABOLISM, V59, pS5, DOI 10.1016/j.metabol.2010.07.015; Trescot AM, 2008, PAIN PHYSICIAN, V11, pS5; Upshur CC, 2006, J GEN INTERN MED, V21, P652, DOI 10.1111/j.1525-1497.2006.00412.x; Webster LR, 2005, PAIN MED, V6, P432, DOI 10.1111/j.1526-4637.2005.00072.x; WEISSMAN DE, 1989, PAIN, V36, P363, DOI 10.1016/0304-3959(89)90097-3; Yanni Leanne M, 2010, J Grad Med Educ, V2, P260, DOI 10.4300/JGME-D-10-00006.1	68	27	27	0	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2013	309	9					919	925		10.1001/jama.2013.522	http://dx.doi.org/10.1001/jama.2013.522			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099PC	23462788				2022-12-28	WOS:000315632700027
J	Pescovitz, OH				Pescovitz, Ora Hirsch			Swimming in the Sea of Galilee	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Pescovitz, OH (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.	opescovi@umich.edu						Levinas Emmanue, 1969, TOTALITY INFINITY ES; Rand Ayn, 1994, FOUNTAINHEAD	2	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2013	309	9					885	886		10.1001/jama.2013.562	http://dx.doi.org/10.1001/jama.2013.562			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099PC	23462784				2022-12-28	WOS:000315632700023
J	Sun, YD; Joachimski, MM; Wignall, PB; Yan, CB; Chen, YL; Jiang, HS; Wang, LN; Lai, XL				Sun, Yadong; Joachimski, Michael M.; Wignall, Paul B.; Yan, Chunbo; Chen, Yanlong; Jiang, Haishui; Wang, Lina; Lai, Xulong			Response to Comment on "Lethally Hot Temperatures During the Early Triassic Greenhouse"	SCIENCE			English	Editorial Material							RECOVERY		[Sun, Yadong; Yan, Chunbo; Jiang, Haishui; Wang, Lina; Lai, Xulong] China Univ Geosci Wuhan, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Peoples R China; [Sun, Yadong; Wignall, Paul B.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Joachimski, Michael M.] Univ Erlangen Nurnberg, GeoZentrum Nordbayern, D-91054 Erlangen, Germany; [Chen, Yanlong] Graz Univ, Inst Earth Sci, A-8010 Graz, Austria	China University of Geosciences; University of Leeds; University of Erlangen Nuremberg; University of Graz	Sun, YD (corresponding author), China Univ Geosci Wuhan, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Peoples R China.	eeys@leeds.ac.uk	Joachimski, Michael M./B-9477-2011; Sun, Yadong/N-6907-2013; Sun, Yadong/AAG-8781-2019	Sun, Yadong/0000-0003-4032-2082; Sun, Yadong/0000-0003-4032-2082; Lai, Xulong/0000-0002-2837-0885; Chen, Yanlong/0000-0003-1110-9020; Joachimski, Michael/0000-0001-6088-3261				Beatty TW, 2008, GEOLOGY, V36, P771, DOI 10.1130/G24952A.1; Chen ZQ, 2012, NAT GEOSCI, V5, P375, DOI [10.1038/ngeo1475, 10.1038/NGEO1475]; Goudemand N, 2013, SCIENCE, V339, DOI 10.1126/science.1232924; Joachimski MM, 2009, EARTH PLANET SC LETT, V284, P599, DOI 10.1016/j.epsl.2009.05.028; Joachimski MM, 2012, GEOLOGY, V40, P195, DOI 10.1130/G32707.1; Lehrmann DJ, 2006, GEOLOGY, V34, P1053, DOI 10.1130/G22827A.1; Liu Guan-Bang, 2002, Acta Palaeontologica Sinica, V41, P27; Ogg JG, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P681, DOI 10.1016/B978-0-444-59425-9.00025-1; Payne JL, 2004, SCIENCE, V305, P506, DOI 10.1126/science.1097023; Sun YD, 2012, SCIENCE, V338, P366, DOI 10.1126/science.1224126; Tong JA, 2007, GEOL J, V42, P371, DOI 10.1002/gj.1084; Tong JN, 2006, J PALEONTOL, V80, P146, DOI 10.1666/0022-3360(2006)080[0146:FFFTLT]2.0.CO;2; Wang Z.-h., 1981, Acta Palaeontologica Sinica, V20, P363; Wignall PB, 2010, GLOBAL PLANET CHANGE, V71, P109, DOI 10.1016/j.gloplacha.2010.01.022; Yang S.R., 1986, ACTA SCI NAT U PEKIN, V4, P90	15	6	7	6	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123								10.1126/science.1233090	http://dx.doi.org/10.1126/science.1233090			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23449581				2022-12-28	WOS:000315452000022
J	van Nimwegen, M; Speelman, AD; Overeem, S; van de Warrenburg, BP; Smulders, K; Dontje, ML; Borm, GF; Backx, FJG; Bloem, BR; Munneke, M				van Nimwegen, Marlies; Speelman, Arlene D.; Overeem, Sebastiaan; van de Warrenburg, Bart P.; Smulders, Katrijn; Dontje, Manon L.; Borm, George F.; Backx, Frank J. G.; Bloem, Bastiaan R.; Munneke, Marten		ParkFit Study Grp	Promotion of physical activity and fitness in sedentary patients with Parkinson's disease: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; EXERCISE; HEALTH; INTERVENTION; THERAPY; PROGRAM; PEOPLE; QUESTIONNAIRE; TELEPHONE; BALANCE	Objective To evaluate whether a multifaceted behavioural change programme increases physical activities in patients with Parkinson's disease. Design Multicentre randomised controlled trial. Setting 32 community hospitals in the Netherlands, collaborating in a nationwide network (ParkinsonNet). Participants 586 sedentary patients with idiopathic Parkinson's disease aged between 40 and 75 years with mild to moderate disease severity (Hoehn and Yahr stage <= 3). Intervention Patients were randomly assigned to the ParkFit programme or a matched general physiotherapy intervention. ParkFit is a multifaceted behavioural change programme, designed specifically to achieve an enduring increase in the level of physical activity (coaches using motivational strategies; ambulatory feedback). Main outcome measures The primary endpoint was the level of physical activity, measured every six months with a standardised seven day recall (LASA physical activity questionnaire-LAPAQ). Secondary endpoints included two other measures of physical activity (activity diary and ambulatory activity monitor), quality of life (Parkinson's disease questionnaire-PDQ-39), and fitness (six minute walk test). Results 540 (92.2%) patients completed the primary outcome. During follow-up, overall time spent on physical activities (LAPAQ) was comparable between the groups (adjusted group difference 7%, 95% confidence interval -3 to 17%; P=0.19). Analyses of three secondary outcomes indicated increased physical activity in ParkFit patients, as suggested by the activity diary (difference 30%; P<0.001), the activity monitor (difference 12%; P<0.001), and the six minute walk test (difference 4.8 m; P=0.05). PDQ-39 did not differ between ParkFit patients and controls (difference -0.9 points; P=0.14). The number of fallers was comparable between ParkFit patients (184/299; 62%) and controls (191/287; 67%). Conclusions The ParkFit behavioural change programme did not increase overall physical activity, as measured with the LAPAQ. The analysis of the secondary endpoints justifies further work into the possible merits of behavioural change programmes to increase physical activities in daily life in Parkinson's disease.	[van Nimwegen, Marlies; Speelman, Arlene D.; Munneke, Marten] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Nijmegen Ctr Evidence Based Practice, NL-6525 ED Nijmegen, Netherlands; [Overeem, Sebastiaan; van de Warrenburg, Bart P.; Smulders, Katrijn; Bloem, Bastiaan R.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Smulders, Katrijn] HAN Univ Appl Sci, Nijmegen, Netherlands; [Dontje, Manon L.] Hanze Univ Appl Sci, Res & Innovat Grp Hlth Care & Nursing, Groningen, Netherlands; [Dontje, Manon L.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Borm, George F.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & HTA, NL-6525 ED Nijmegen, Netherlands; [Backx, Frank J. G.] Univ Med Ctr Utrecht, Dept Rehabil Nursing Sci & Sport, Utrecht, Netherlands; [Munneke, Marten] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, Nijmegen Ctr Evidence Based Practice, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen	Bloem, BR (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	B.Bloem@neuro.umcn.nl	Munneke, Marten/N-3583-2014; Bloem, Bastiaan/H-8013-2014; Nathalie, Zimmermann/M-2179-2014; van de Warrenburg, Bart PC/D-1935-2010; Smulders, Katrijn/K-9939-2019; Smulders, Katrijn/C-3942-2012; Overeem, Sebastiaan/D-2139-2010	Bloem, Bastiaan/0000-0002-6371-3337; van de Warrenburg, Bart PC/0000-0003-4412-1616; Smulders, Katrijn/0000-0001-9338-5277; Dontje, Manon/0000-0002-0348-9556; Overeem, Sebastiaan/0000-0002-6445-9836	ZonMw (the Netherlands Organization for Health Research and Development) [75020012]; Michael J Fox Foundation for Parkinson's research; VGZ (health insurance company); GlaxoSmithKline; National Parkinson Foundation	ZonMw (the Netherlands Organization for Health Research and Development)(Netherlands Organization for Health Research and DevelopmentNetherlands Government); Michael J Fox Foundation for Parkinson's research; VGZ (health insurance company); GlaxoSmithKline(GlaxoSmithKline); National Parkinson Foundation	This study was primarily funded by ZonMw (the Netherlands Organization for Health Research and Development (75020012)) and the Michael J Fox Foundation for Parkinson's research. Additional financial support was provided by VGZ (health insurance company), GlaxoSmithKline, and the National Parkinson Foundation. The study sponsors played no role in study design; in the data collection, analysis, and interpretation; or in the writing of the article and the decision to submit it for publication; all researchers' activities were independent of the funding source; the research team had full and unrestricted access to all the data.	Alonso-Frech Fernando, 2011, Neurologist, V17, pS47, DOI 10.1097/NRL.0b013e31823968ec; [Anonymous], 2006, PARK DIS NAT CLIN GU; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; Bonomi AG, 2010, OBESITY, V18, P1845, DOI 10.1038/oby.2010.34; Brodie DA, 2005, J ADV NURS, V50, P518, DOI 10.1111/j.1365-2648.2005.03422.x; Butler L, 2009, J CARDIOPULM REHABIL, V29, P105, DOI 10.1097/HCR.0b013e31819a01ff; Catellier DJ, 2005, MED SCI SPORT EXER, V37, pS555, DOI 10.1249/01.mss.0000185651.59486.4e; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Deane KH, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858; Ellis T, 2005, ARCH PHYS MED REHAB, V86, P626, DOI 10.1016/j.apmr.2004.08.008; Enright PL, 2003, CHEST, V123, P387, DOI 10.1378/chest.123.2.387; Furber S, 2010, PATIENT EDUC COUNS, V80, P212, DOI 10.1016/j.pec.2009.11.012; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Goodwin VA, 2008, MOVEMENT DISORD, V23, P631, DOI 10.1002/mds.21922; Haber D, 2004, GERONTOLOGIST, V44, P827, DOI 10.1093/geront/44.6.827; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hirsch MA, 2003, ARCH PHYS MED REHAB, V84, P1109, DOI 10.1016/S0003-9993(03)00046-7; Hospes G, 2009, PATIENT EDUC COUNS, V75, P274, DOI 10.1016/j.pec.2008.10.005; Jenkinson C, 1997, AGE AGEING, V26, P353, DOI 10.1093/ageing/26.5.353; Kalf JG, 2008, LOGOPEDIE BIJ ZIEKTE; Keus SHJ, 2007, MOVEMENT DISORD, V22, P451, DOI 10.1002/mds.21244; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; Mehrholz J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007830.pub2; Morris ME, 2009, MOVEMENT DISORD, V24, P64, DOI 10.1002/mds.22295; Munneke M, 2010, LANCET NEUROL, V9, P46, DOI 10.1016/S1474-4422(09)70327-8; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI 10.1161/CIRCULATIONAHA.107.185650; Nijkrake MJ, 2010, MOVEMENT DISORD, V25, P823, DOI 10.1002/mds.22813; Petzinger GM, 2007, J NEUROSCI, V27, P5291, DOI 10.1523/JNEUROSCI.1069-07.2007; Pinto BM, 2005, AM J PREV MED, V29, P247, DOI 10.1016/j.amepre.2005.06.016; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Ridgel AL, 2009, NEUROREHAB NEURAL RE, V23, P600, DOI 10.1177/1545968308328726; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Speelman AD, 2011, NAT REV NEUROL, V7, P528, DOI 10.1038/nrneurol.2011.107; Stel VS, 2004, J CLIN EPIDEMIOL, V57, P252, DOI 10.1016/j.jclinepi.2003.07.008; Sturkenboom IHWM, 2008, ERGOTHERAPIE BIJ ZIE; Sturkenboom IH, 2013, CLIN REHABIL, V27, P99, DOI 10.1177/0269215512448382; Tillerson JL, 2003, NEUROSCIENCE, V119, P899, DOI 10.1016/S0306-4522(03)00096-4; Tomlinson CL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5004; Toole T, 2005, NEUROREHABILITATION, V20, P307; Tudor-Locke C, 2004, INT J OBESITY, V28, P113, DOI 10.1038/sj.ijo.0802485; van der Marck MA, 2011, J AM GERIATR SOC, V59, P340, DOI 10.1111/j.1532-5415.2010.03263.x; van Nimwegen M, 2011, J NEUROL, V258, P2214, DOI 10.1007/s00415-011-6097-7; van Nimwegen M, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-70; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Welk G., 2002, PHYS ACTIVITY ASSESS; Wiles CM, 2006, J NEUROL NEUROSUR PS, V77, P393, DOI 10.1136/jnnp.2005.066258	49	96	97	0	33	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2013	346								f576	10.1136/bmj.f576	http://dx.doi.org/10.1136/bmj.f576			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	149WE	23457213	hybrid, Green Published			2022-12-28	WOS:000319351300019
J	Aparicio, S; Caldas, C				Aparicio, Samuel; Caldas, Carlos			The Implications of Clonal Genome Evolution for Cancer Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CHRONIC MYELOGENOUS LEUKEMIA; MUTATIONAL EVOLUTION; ACQUIRED-RESISTANCE; PIK3CA MUTATIONS; KRAS MUTATIONS; GENETIC-BASIS; HETEROGENEITY; CELLS; DNA; IDENTIFICATION	WITHIN THE NEXT 5 YEARS, INTERNATIONAL EFFORTS MAY CHARACTERize the distribution of clonally dominant somatic mutations (those present in the majority of cells within a cancer) in more than 21,000 cancers of diverse types.(1) A reduction in costs and improvements in technology have placed the sequencing of patients' tumors within practical reach. Preliminary results suggest that full characterization of cancer genomes can be accomplished in a clinically useful time frame.(2,3) Cancer genomics has been the subject of several recent reviews,(4-7) but these have not focused on the implications and opportunities afforded by the realization that cancers are composed of cellular clones. The notion that most cancers are ecosystems of evolving clones has implications for clinical application; we review these, with particular focus on epithelial cancers.	[Aparicio, Samuel] British Columbia Canc Res Ctr, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada; [Aparicio, Samuel] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Caldas, Carlos] Univ Cambridge, Dept Oncol, Cambridge, England; [Caldas, Carlos] Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England; [Caldas, Carlos] Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, Addenbrookes Hosp, Cambridge Breast Unit, Cambridge, England; [Caldas, Carlos] Cambridge Biomed Res Ctr, Natl Inst Hlth Res, Cambridge, England; [Caldas, Carlos] Cambridge Expt Canc Med Ctr, Cambridge, England	British Columbia Cancer Agency; University of British Columbia; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Aparicio, S (corresponding author), British Columbia Canc Res Ctr, Dept Mol Oncol, 675 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	saparicio@bccrc.ca	Caldas, Carlos/U-7250-2019	Caldas, Carlos/0000-0003-3547-1489; Aparicio, Samuel/0000-0002-0487-9599				Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Barretina J, 2012, NATURE, V492, P290, DOI 10.1038/nature11735; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/NNANO.2009.12, 10.1038/nnano.2009.12]; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dancey JE, 2012, CELL, V148, P409, DOI 10.1016/j.cell.2012.01.014; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Folprecht G, 2010, LANCET ONCOL, V11, P38, DOI 10.1016/S1470-2045(09)70330-4; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gupta PB, 2011, CELL, V147, P1197, DOI 10.1016/j.cell.2011.11.008; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harismendy O, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r124; HAUSCHKA TS, 1953, T NEW YORK ACAD SCI, V16, P64, DOI 10.1111/j.2164-0947.1953.tb01321.x; Hazarika M, 2008, CLIN CANCER RES, V14, P5325, DOI 10.1158/1078-0432.CCR-08-0308; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Heist Rebecca S, 2012, Cancer Cell, V21, DOI 10.1016/j.ccr.2012.03.007; Higgins MJ, 2012, CLIN CANCER RES, V18, P3462, DOI 10.1158/1078-0432.CCR-11-2696; Hochhaus A, 2008, LEUKEMIA, V22, P1200, DOI 10.1038/leu.2008.84; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Huyge V, 2010, CLIN ONCOL-UK, V22, P818, DOI 10.1016/j.clon.2010.05.021; Jensen JD, 2011, CLIN CANCER RES, V17, P667, DOI 10.1158/1078-0432.CCR-10-1133; Jones SJM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r82; Kidd EA, 2008, CLIN CANCER RES, V14, P5236, DOI 10.1158/1078-0432.CCR-07-5252; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Lipson D, 2009, NAT BIOTECHNOL, V27, P652, DOI 10.1038/nbt.1551; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; MAKINO S, 1953, J NATL CANCER I, V13, P1213; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; McBride DJ, 2010, GENE CHROMOSOME CANC, V49, P1062, DOI 10.1002/gcc.20815; McDermott U, 2011, NEW ENGL J MED, V364, P340, DOI 10.1056/NEJMra0907178; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Molinari F, 2011, CLIN CANCER RES, V17, P4901, DOI 10.1158/1078-0432.CCR-10-3137; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Press RD, 2006, BLOOD, V107, P4250, DOI 10.1182/blood-2005-11-4406; Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161; Ruiz C, 2011, P NATL ACAD SCI USA, V108, P12054, DOI 10.1073/pnas.1104009108; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; SIDRANSKY D, 1992, NATURE, V355, P846, DOI 10.1038/355846a0; Siegmund KD, 2009, P NATL ACAD SCI USA, V106, P4828, DOI 10.1073/pnas.0810276106; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; White AK, 2011, P NATL ACAD SCI USA, V108, P13999, DOI 10.1073/pnas.1019446108; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	69	261	269	1	84	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2013	368	9					842	851		10.1056/NEJMra1204892	http://dx.doi.org/10.1056/NEJMra1204892			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096ET	23445095				2022-12-28	WOS:000315387700010
J	Baker, SA; Chen, L; Wilkins, AD; Yu, P; Lichtarge, O; Zoghbi, HY				Baker, Steven Andrew; Chen, Lin; Wilkins, Angela Dawn; Yu, Peng; Lichtarge, Olivier; Zoghbi, Huda Yahya			An AT-Hook Domain in MeCP2 Determines the Clinical Course of Rett Syndrome and Related Disorders	CELL			English	Article							CPG-BINDING PROTEIN-2; METHYL-CPG; MOUSE MODEL; X SYNDROME; CHROMATIN; EXPRESSION; MUTATIONS; DNA; MICE; ENCEPHALOPATHY	Mutations in the X-linked MECP2 cause Rett syndrome, a devastating neurological disorder typified by a period of apparently normal development followed by loss of cognitive and psychomotor skills. Data from rare male patients suggest symptom onset and severity can be influenced by the location of the mutation, with amino acids 270 and 273 marking the difference between neonatal encephalopathy and death, on the one hand, and survival with deficits on the other. We therefore generated two mouse models expressing either MeCP2-R270X or MeCP2-G273X. The mice developed phenotypes at strikingly different rates and showed differential ATRX nuclear localization within the nervous system, over time, coinciding with phenotypic progression. We discovered that MeCP2 contains three AT-hook-like domains over a stretch of 250 amino acids, like HMGA DNA-bending proteins; one conserved AT-hook is disrupted in MeCP2-R270X, lending further support to the notion that one of MeCP2's key functions is to alter chromatin structure.	[Baker, Steven Andrew; Zoghbi, Huda Yahya] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Baker, Steven Andrew] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Chen, Lin; Wilkins, Angela Dawn; Yu, Peng; Lichtarge, Olivier; Zoghbi, Huda Yahya] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Zoghbi, Huda Yahya] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Zoghbi, Huda Yahya] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Baker, Steven Andrew; Lichtarge, Olivier; Zoghbi, Huda Yahya] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine	Zoghbi, HY (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	hzoghbi@bcm.edu		Zoghbi, Huda/0000-0002-0700-3349	Howard Hughes Medical Institute; NINDS [NS053862, F30NS066527]; cores of the Baylor College of Medicine IDDRC [HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057819, F30NS066527, P01NS053862] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); cores of the Baylor College of Medicine IDDRC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Christopher Woodcock for the pUC19-601x12 vector, Chris McGraw, Hsiao-Tuan Chao, Laura Lombardi, and Jeffrey Neul for critical reading of this manuscript, and Gabriele Schuster for pronuclear injections. This work was supported by the Howard Hughes Medical Institute, NINDS grant NS053862 (to H. Y. Z.), the cores of the Baylor College of Medicine IDDRC (HD024064), and NINDS F30NS066527 (to S.A.B.).	Agrawal A, 2011, IEEE ACM T COMPUT BI, V8, P194, DOI 10.1109/TCBB.2009.69; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Brocher J, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-64; Catez F, 2006, NAT STRUCT MOL BIOL, V13, P305, DOI 10.1038/nsmb1077; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Free A, 2001, J BIOL CHEM, V276, P3353, DOI 10.1074/jbc.M007224200; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Ghosh RP, 2010, BIOCHEMISTRY-US, V49, P4395, DOI 10.1021/bi9019753; Gibbons RJ, 2000, AM J MED GENET, V97, P204, DOI 10.1002/1096-8628(200023)97:3<204::AID-AJMG1038>3.0.CO;2-X; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Kankirawatana P, 2006, NEUROLOGY, V67, P164, DOI 10.1212/01.wnl.0000223318.28938.45; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; McGill BE, 2006, P NATL ACAD SCI USA, V103, P18267, DOI 10.1073/pnas.0608702103; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nikitina T, 2007, J BIOL CHEM, V282, P28237, DOI 10.1074/jbc.M704304200; Nikitina T, 2007, MOL CELL BIOL, V27, P864, DOI 10.1128/MCB.01593-06; Reeves R, 2010, BBA-GENE REGUL MECH, V1799, P3, DOI 10.1016/j.bbagrm.2009.09.001; Ritchie K, 2008, J CELL BIOL, V180, P315, DOI 10.1083/jcb.200706083; Samaco RC, 2012, NAT GENET, V44, P206, DOI 10.1038/ng.1066; Schule B, 2008, CLIN GENET, V74, P116, DOI 10.1111/j.1399-0004.2008.01005.x; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Turner B., 2001, MAPPING PROTEIN DNA; Venancio M, 2007, EUR J HUM GENET, V15, P902, DOI 10.1038/sj.ejhg.5201835; Villard L, 2007, J MED GENET, V44, P417, DOI 10.1136/jmg.2007.049452	38	157	161	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 28	2013	152	5					984	996		10.1016/j.cell.2013.01.038	http://dx.doi.org/10.1016/j.cell.2013.01.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452848	Green Accepted, Bronze			2022-12-28	WOS:000315710300008
J	Mercier, R; Kawai, Y; Errington, J				Mercier, Romain; Kawai, Yoshikazu; Errington, Jeff			Excess Membrane Synthesis Drives a Primitive Mode of Cell Proliferation	CELL			English	Article							CARRIER PROTEIN SYNTHASE; FATTY-ACID BIOSYNTHESIS; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; L-FORM; LIPID BIOSYNTHESIS; DIVISION; WALL; TRANSCRIPTION; PROTOPLAST	The peptidoglycan cell wall is a hallmark of the bacterial subkingdom. Surprisingly, many modern bacteria retain the ability to switch into a wall-free state called the L-form. L-form proliferation is remarkable in being independent of the normally essential FtsZ-based division machinery and in occurring by membrane blebbing and tubulation. We show that mutations leading to excess membrane synthesis are sufficient to drive L-form division in Bacillus subtilis. Artificially increasing the cell surface area to volume ratio in wild-type protoplasts generates similar shape changes and cell division. Our findings show that simple biophysical processes could have supported efficient cell proliferation during the evolution of early cells and provide an extant biological model for studying this problem.	[Mercier, Romain; Kawai, Yoshikazu; Errington, Jeff] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England	Newcastle University - UK	Errington, J (corresponding author), Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Richardson Rd, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England.	jeff.errington@ncl.ac.uk	Mercier, Romain/E-3642-2012; Errington, Jeff/G-1832-2011	Errington, Jeff/0000-0002-6977-9388	European Research Council [250363]; EMBO Long Term Fellowship; Marie-Curie Intra-European Fellowship	European Research Council(European Research Council (ERC)European Commission); EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); Marie-Curie Intra-European Fellowship(European Commission)	We thank Henrik Strahl for technical support and extensive discussions and Patricia Dominguez-Cuevas, Waldemar Vollmer, and Ling Juan Wu for critical reading of the manuscript. We thank Donald Zeigler (BGSC) for strain OBS20. This work was funded by European Research Council Advanced Investigator grant 250363 ("OPAL"; to J. E.). R. M. was supported by EMBO Long Term and Marie-Curie Intra-European Fellowships.	Adams DW, 2011, MOL MICROBIOL, V80, P68, DOI 10.1111/j.1365-2958.2011.07559.x; Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Allan EJ, 2009, ADV APPL MICROBIOL, V68, P1, DOI 10.1016/S0065-2164(09)01201-5; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Bendezu FO, 2008, J BACTERIOL, V190, P1792, DOI 10.1128/JB.01322-07; BOURNE N, 1986, J GEN MICROBIOL, V132, P251; Bozic B, 2007, EUR PHYS J E, V24, P79, DOI 10.1140/epje/i2007-10217-1; Briers Y, 2012, BIOESSAYS, V34, P1078, DOI 10.1002/bies.201200080; Briers Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038514; Chen IA, 2009, CURR BIOL, V19, pR327, DOI 10.1016/j.cub.2009.03.002; Choi KH, 2000, J BACTERIOL, V182, P365, DOI 10.1128/JB.182.2.365-370.2000; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; Dell'Era S, 2009, MOL MICROBIOL, V73, P306, DOI 10.1111/j.1365-2958.2009.06774.x; Domingue GJ, 1997, CLIN MICROBIOL REV, V10, P320, DOI 10.1128/CMR.10.2.320; Dominguez-Cuevas P, 2012, MOL MICROBIOL, V83, P52, DOI 10.1111/j.1365-2958.2011.07920.x; Errington J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120143; Hamoen LW, 2002, NUCLEIC ACIDS RES, V30, P5517, DOI 10.1093/nar/gkf698; Hanczyc MM, 2003, SCIENCE, V302, P618, DOI 10.1126/science.1089904; Ishikawa S, 2006, MOL MICROBIOL, V60, P1364, DOI 10.1111/j.1365-2958.2006.05184.x; KANDLER G, 1954, ARCH MIKROBIOL, V21, P178, DOI 10.1007/BF01816378; Leaver M, 2009, NATURE, V457, P849, DOI 10.1038/nature07742; Luisi PL, 2008, J PHYS CHEM B, V112, P14655, DOI 10.1021/jp8028598; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Mercier R, 2012, CELL REP, V1, P417, DOI 10.1016/j.celrep.2012.03.008; Moche M, 1999, J BIOL CHEM, V274, P6031, DOI 10.1074/jbc.274.10.6031; Peterlin P, 2009, CHEM PHYS LIPIDS, V159, P67, DOI 10.1016/j.chemphyslip.2009.03.005; Rock CO, 1996, BBA-LIPID LIPID MET, V1302, P1, DOI 10.1016/0005-2760(96)00056-2; Sambrook J., 2002, MOL CLONING LAB MANU; Schujman GE, 1998, MOL MICROBIOL, V29, P1215, DOI 10.1046/j.1365-2958.1998.01004.x; Schujman GE, 2003, DEV CELL, V4, P663, DOI 10.1016/S1534-5807(03)00123-0; Schujman GE, 2006, EMBO J, V25, P4074, DOI 10.1038/sj.emboj.7601284; Siddiqui RA, 2006, FEMS MICROBIOL LETT, V258, P305, DOI 10.1111/j.1574-6968.2006.00237.x; Svetina S, 2009, CHEMPHYSCHEM, V10, P2769, DOI 10.1002/cphc.200900577; Terasawa H, 2012, P NATL ACAD SCI USA, V109, P5942, DOI 10.1073/pnas.1120327109; Zhu TF, 2009, J AM CHEM SOC, V131, P5705, DOI 10.1021/ja900919c	35	128	129	1	79	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 28	2013	152	5					997	1007		10.1016/j.cell.2013.01.043	http://dx.doi.org/10.1016/j.cell.2013.01.043			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452849	Bronze			2022-12-28	WOS:000315710300009
J	Rehman, HU				Rehman, H. U.			CASE REPORT Recurrent hypoglycaemia in a young man without diabetes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NEUROENDOCRINE; MANAGEMENT; TUMORS		Regina QuAppelle Hlth Reg, Regina Gen Hosp, Dept Med, Regina, SK S4P 0W5, Canada	University of Saskatchewan	Rehman, HU (corresponding author), Regina QuAppelle Hlth Reg, Regina Gen Hosp, Dept Med, Regina, SK S4P 0W5, Canada.	habib31@sasktel.net						Batcher E, 2011, ENDOCR RES, V36, P35, DOI 10.3109/07435800.2010.525085; Crippa S, 2012, ARCH SURG-CHICAGO, V147, P261, DOI 10.1001/archsurg.2011.1843; Cryer PE, 2009, J CLIN ENDOCR METAB, V94, P709, DOI 10.1210/jc.2008-1410; Grant CS, 2005, BEST PRACT RES CL GA, V19, P783, DOI 10.1016/j.bpg.2005.05.008; Leotlela PD, 2003, ENDOCR-RELAT CANCER, V10, P437, DOI 10.1677/erc.0.0100437; Marks V, 1996, CLIN ENDOCRINOL, V44, P133, DOI 10.1046/j.1365-2265.1996.659478.x; PERRY RR, 1995, J CLIN ENDOCR METAB, V80, P2273, DOI 10.1210/jc.80.8.2273; Piovesan A, 2003, J ENDOCRINOL INVEST, V26, P758, DOI 10.1007/BF03347360; Whipple AO, 1938, J INT CHIR, V3, P237	9	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 28	2013	346								f1182	10.1136/bmj.f1182	http://dx.doi.org/10.1136/bmj.f1182			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100BM	23449674				2022-12-28	WOS:000315669700003
J	Snuderl, M; Batista, A; Kirkpatrick, ND; de Almodovar, CR; Riedemann, L; Walsh, EC; Anolik, R; Huang, YH; Martin, JD; Kamoun, W; Knevels, E; Schmidt, T; Farrar, CT; Vakoc, BJ; Mohan, N; Chung, EH; Roberge, S; Peterson, T; Bais, C; Zhelyazkova, BH; Yip, S; Hasselblatt, M; Rossig, C; Niemeyer, E; Ferrara, N; Klagsbrun, M; Duda, DG; Fukumura, D; Xu, L; Carmeliet, P; Jain, RK				Snuderl, Matija; Batista, Ana; Kirkpatrick, Nathaniel D.; de Almodovar, Carmen Ruiz; Riedemann, Lars; Walsh, Elisa C.; Anolik, Rachel; Huang, Yuhui; Martin, John D.; Kamoun, Walid; Knevels, Ellen; Schmidt, Thomas; Farrar, Christian T.; Vakoc, Benjamin J.; Mohan, Nishant; Chung, Euiheon; Roberge, Sylvie; Peterson, Teresa; Bais, Carlos; Zhelyazkova, Boryana H.; Yip, Stephen; Hasselblatt, Martin; Rossig, Claudia; Niemeyer, Elisabeth; Ferrara, Napoleone; Klagsbrun, Michael; Duda, Dan G.; Fukumura, Dai; Xu, Lei; Carmeliet, Peter; Jain, Rakesh K.			Targeting Placental Growth Factor/Neuropilin 1 Pathway Inhibits Growth and Spread of Medulloblastoma	CELL			English	Article							TUMOR-GROWTH; DOSE-ESCALATION; CELL-LINE; PHASE-I; ANGIOGENESIS; CANCER; PLGF; METASTASIS; RESISTANCE; TB-403	Medulloblastoma is the most common pediatric malignant brain tumor. Although current therapies improve survival, these regimens are highly toxic and are associated with significant morbidity. Here, we report that placental growth factor (PlGF) is expressed in the majority of medulloblastomas, independent of their subtype. Moreover, high expression of PlGF receptor neuropilin 1 (Nrp1) correlates with poor overall survival in patients. We demonstrate that PlGF and Nrp1 are required for the growth and spread of medulloblastoma: PlGF/Nrp1 blockade results in direct antitumor effects in vivo, resulting in medulloblastoma regression, decreased metastasis, and increased mouse survival. We reveal that PlGF is produced in the cerebellar stroma via tumor-derived Sonic hedgehog (Shh) and show that PlGF acts through Nrp1-and not vascular endothelial growth factor receptor 1-to promote tumor cell survival. This critical tumor-stroma interaction-mediated by Shh, PlGF, and Nrp1 across medulloblastoma subtypes-supports the development of therapies targeting PlGF/Nrp1 pathway.	[Snuderl, Matija; Zhelyazkova, Boryana H.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Batista, Ana; Kirkpatrick, Nathaniel D.; Riedemann, Lars; Walsh, Elisa C.; Anolik, Rachel; Huang, Yuhui; Martin, John D.; Kamoun, Walid; Chung, Euiheon; Roberge, Sylvie; Peterson, Teresa; Niemeyer, Elisabeth; Duda, Dan G.; Fukumura, Dai; Xu, Lei; Jain, Rakesh K.] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab, Boston, MA 02114 USA; [Vakoc, Benjamin J.; Mohan, Nishant] Massachusetts Gen Hosp, Dept Dermatol, Wellman Ctr Photomed, Boston, MA 02114 USA; [Snuderl, Matija; Batista, Ana; Kirkpatrick, Nathaniel D.; Riedemann, Lars; Walsh, Elisa C.; Anolik, Rachel; Huang, Yuhui; Martin, John D.; Kamoun, Walid; Farrar, Christian T.; Vakoc, Benjamin J.; Mohan, Nishant; Chung, Euiheon; Roberge, Sylvie; Peterson, Teresa; Niemeyer, Elisabeth; Klagsbrun, Michael; Duda, Dan G.; Fukumura, Dai; Xu, Lei; Jain, Rakesh K.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [de Almodovar, Carmen Ruiz] Katholieke Univ Leuven, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, B-3000 Louvain, Belgium; [de Almodovar, Carmen Ruiz; Knevels, Ellen; Schmidt, Thomas; Carmeliet, Peter] VIB, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, B-3000 Louvain, Belgium; [Farrar, Christian T.] Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Vakoc, Benjamin J.; Mohan, Nishant] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Bais, Carlos; Ferrara, Napoleone] Genentech Inc, San Francisco, CA 94080 USA; [Yip, Stephen] Univ British Columbia, Vancouver Gen Hosp, Dept Pathol & Lab Med, Vancouver, BC V5Z 4E6, Canada; [Hasselblatt, Martin] Univ Hosp Munster, Inst Neuropathol, D-48149 Munster, Germany; [Rossig, Claudia] Univ Hosp Munster, Dept Pediat Hematol & Oncol, D-48149 Munster, Germany; [Klagsbrun, Michael] Childrens Hosp Boston, Vasc Biol Program, Dept Surg, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); Harvard University; Roche Holding; Genentech; University of British Columbia; University of Munster; University of Munster; Harvard University; Boston Children's Hospital	Jain, RK (corresponding author), Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab, Boston, MA 02114 USA.	jain@steele.mgh.harvard.edu	Xu, Lei/GRR-9174-2022; Yip, Stephen/E-9994-2012; Jain, Rakesh K/I-1384-2017; Riedemann, Lars/Q-7944-2019; Carmeliet, Peter/AAQ-5140-2020; Chung, Euiheon/A-1801-2009; Riedemann, Lars/J-5725-2014; Martin, John D/L-6892-2016; Schmidt, Thomas/Y-8431-2019; Duda, Dan G/H-8523-2014	Yip, Stephen/0000-0002-8514-9861; Jain, Rakesh K/0000-0001-7571-3548; Carmeliet, Peter/0000-0001-7961-1821; Riedemann, Lars/0000-0002-9510-1845; Martin, John D/0000-0002-9828-8203; Schmidt, Thomas/0000-0002-7166-3675; Duda, Dan G/0000-0001-7065-8797; Farrar, Christian/0000-0001-6623-8220; Snuderl, Matija/0000-0003-0752-0917; Hasselblatt, Martin/0000-0003-2707-8484; Chung, Euiheon/0000-0002-3326-6927; Huang, Yuhui/0000-0003-1985-3575; Ruiz de Almodovar, Carmen/0000-0001-5975-7815	Hoffmann-La Roche; NIH [R01CA163815, P01CA080124, R01CA096915, S10RR027070, R01CA126642, R01CA159258, K25AG029415, R21CA155862, CA37392, CA45548, R01CA163528, P41-EB015903]; Department of Defense (DoD) [W81XWH-10-1-0016]; Belgian Government [IUAP06/30]; Flemish Government; Concerted Research Activities, Stichting Emmanuel van der Schueren (Belgium) [GOA2006/11]; American Cancer Society [120733-RSG-11-073-01-TBG, RSG-12-199-01-TBG]; BrainCare BC; DoD [W81XWH-11-1-0619]; Calabresi Career Development Award [2K12CA090354]; Mildred-Scheel-Fellowship (Deutsche Krebshilfe); Rolf Dierichs Stiftung;  [T32-CA073479]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA126642, R01CA163815, R37CA037392, P01CA045548, R01CA037392, K12CA090354, R21CA155862, P01CA080124, T32CA073479, R01CA159258, R01CA096915, R56CA037392, R01CA163528] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG029415] Funding Source: NIH RePORTER	Hoffmann-La Roche(Hoffmann-La Roche); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (DoD)(United States Department of Defense); Belgian Government; Flemish Government(European Commission); Concerted Research Activities, Stichting Emmanuel van der Schueren (Belgium); American Cancer Society(American Cancer Society); BrainCare BC; DoD(United States Department of Defense); Calabresi Career Development Award; Mildred-Scheel-Fellowship (Deutsche Krebshilfe)(Deutsche Krebshilfe); Rolf Dierichs Stiftung; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank Drs. J. M. Olson, M. Dewerchin, A. J. Iafrate, E. di Tomaso, M. Ancukiewicz, S. Goel, D. Kodack, K. Munro, B. Seed, R. Wechsler-Reya, and M. Weidner for invaluable suggestions and experimental assistance and Ms. C. J. Smith, A. Khachatryan, K. Kinzel, and B. Riesmeier for technical assistance. This study was supported by a grant from Hoffmann-La Roche and NIH grant R01CA163815 (to R. K. J.). The study was partially supported by NIH grants P01CA080124 (to R. K. J., D. G. D., D. F., and L. X.), R01CA096915 and S10RR027070 (to D. F.), R01CA126642 (to R. K. J.), and R01CA159258 (to D. G. D.); Department of Defense (DoD) Breast Cancer Research Innovator Award W81XWH-10-1-0016 (to R. K. J.); Belgian Government grant IUAP06/30 (to P. C.); Flemish Government long-term structural funding Methusalem (to P. C.); the Concerted Research Activities, Stichting Emmanuel van der Schueren (Belgium), GOA2006/11 (to P. C.); and American Cancer Society grants 120733-RSG-11-073-01-TBG (to D. G. D.) and RSG-12-199-01-TBG (to L. X.). C. T. F. is supported by NIH grants K25AG029415 and R21CA155862. M. K.'s work is supported by NIH grants CA37392 and CA45548. B. J. V.'s work is supported by NIH grants R01CA163528 and P41-EB015903. S. Y.'s work is supported by BrainCare BC. Y. H. is supported by DoD Research Fellowship W81XWH-11-1-0619. N. D. K. was supported by T32-CA073479. M. S. was supported by the Calabresi Career Development Award 2K12CA090354. L. R. received funding from Mildred-Scheel-Fellowship (Deutsche Krebshilfe) and from Rolf Dierichs Stiftung. P. C. has patent applications claiming subject matter related to this report, which may result in royalty payments. R. K. J. is a member of Board of Trustees of H& Q Healthcare Investors and H&Q Life Sciences Investors.	Bais C, 2010, CELL, V141, P166, DOI 10.1016/j.cell.2010.01.033; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Coenegrachts L, 2010, CANCER RES, V70, P6537, DOI 10.1158/0008-5472.CAN-09-4092; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Dewerchin M., 2012, PIGF MULTITASKING CY; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Fouladi M, 2005, J CLIN ONCOL, V23, P7152, DOI 10.1200/JCO.2005.01.214; FRIEDMAN HS, 1985, J NEUROPATH EXP NEUR, V44, P592, DOI 10.1097/00005072-198511000-00005; FRIEDMAN HS, 1988, AM J PATHOL, V130, P472; Fukumura D, 2010, MICROCIRCULATION, V17, P206, DOI 10.1111/j.1549-8719.2010.00029.x; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Goldstein AM, 1997, CANCER CAUSE CONTROL, V8, P865, DOI 10.1023/A:1018464328836; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hatton BA, 2008, CANCER RES, V68, P1768, DOI 10.1158/0008-5472.CAN-07-5092; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Jain RK, 2007, CELL, V131, P443, DOI 10.1016/j.cell.2007.10.023; Lassen U, 2012, BRIT J CANCER, V106, P678, DOI 10.1038/bjc.2011.609; Xu L, 2007, MOL CANCER RES, V5, P873, DOI 10.1158/1541-7786.MCR-06-0141; Martinsson-Niskanen T, 2011, CLIN THER, V33, P1142, DOI 10.1016/j.clinthera.2011.08.007; Metcalfe C, 2011, CANCER RES, V71, P5057, DOI 10.1158/0008-5472.CAN-11-0923; Nielsen DL, 2012, EXPERT OPIN BIOL TH, V12, P795, DOI 10.1517/14712598.2012.679655; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Pei YX, 2012, DEVELOPMENT, V139, P1724, DOI 10.1242/dev.050104; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Rutkowski S, 2007, CLIN CANCER RES, V13, P2651, DOI 10.1158/1078-0432.CCR-06-1779; Schmidt T, 2011, CANCER CELL, V19, P740, DOI 10.1016/j.ccr.2011.05.007; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; The WHO, 2020, CLASSIFICATION TUMOU; Van de Veire S, 2010, CELL, V141, P178, DOI 10.1016/j.cell.2010.02.039; Walter K, 2010, CLIN CANCER RES, V16, P1781, DOI 10.1158/1078-0432.CCR-09-1913; Weekes CD, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.3014; Xu L, 2006, CANCER RES, V66, P3971, DOI 10.1158/0008-5472.CAN-04-3085; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Ziche M, 1997, LAB INVEST, V76, P517	39	169	175	3	71	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 28	2013	152	5					1065	1076		10.1016/j.cell.2013.01.036	http://dx.doi.org/10.1016/j.cell.2013.01.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452854	Green Accepted, Bronze			2022-12-28	WOS:000315710300014
J	Tilburt, JC; Cassel, CK				Tilburt, Jon C.; Cassel, Christine K.			Why the Ethics of Parsimonious Medicine Is Not the Ethics of Rationing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Tilburt, Jon C.] Mayo Clin, Div Gen Internal Med, Biomed Eth Res Unit, Ctr Sci Healthcare Delivery, Rochester, MN 55905 USA; [Cassel, Christine K.] Amer Board Internal Med, Philadelphia, PA USA	Mayo Clinic; American Board of Internal Medicine	Tilburt, JC (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.	tilburt.jon@mayo.edu						Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Brett AS, 2012, JAMA-J AM MED ASSOC, V307, P149, DOI 10.1001/jama.2011.1999; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; DANIELS N, 1985, JUST HLTH CARE STUDI; GRABER GC, 1989, THEORY PRACTICE MED; Institute of Medicine, 2001, COV MATT INS HLTH CA; Sulmasy DP, 2007, J CLIN ONCOL, V25, P217, DOI 10.1200/JCO.2006.08.0481; UBEL PA, 1995, ARCH INTERN MED, V155, P1837, DOI 10.1001/archinte.155.17.1837	8	44	44	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2013	309	8					773	774		10.1001/jama.2013.368	http://dx.doi.org/10.1001/jama.2013.368			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095KD	23443438				2022-12-28	WOS:000315332200019
J	Steppke, A; Kuchler, R; Lausberg, S; Lengyel, E; Steinke, L; Borth, R; Luhmann, T; Krellner, C; Nicklas, M; Geibel, C; Steglich, F; Brando, M				Steppke, Alexander; Kuechler, Robert; Lausberg, Stefan; Lengyel, Edit; Steinke, Lucia; Borth, Robert; Luehmann, Thomas; Krellner, Cornelius; Nicklas, Michael; Geibel, Christoph; Steglich, Frank; Brando, Manuel			Ferromagnetic Quantum Critical Point in the Heavy-Fermion Metal YbNi4(P1-xAsx)(2)	SCIENCE			English	Article							PHASE-TRANSITIONS; ELECTRON	Unconventional superconductivity and other previously unknown phases of matter exist in the vicinity of a quantum critical point (QCP): a continuous phase change of matter at absolute zero. Intensive theoretical and experimental investigations on itinerant systems have shown that metallic ferromagnets tend to develop via either a first-order phase transition or through the formation of intermediate superconducting or inhomogeneous magnetic phases. Here, through precision low-temperature measurements, we show that the Gruneisen ratio of the heavy fermion metallic ferromagnet YbNi4(P0.92As0.08)(2) diverges upon cooling to T = 0, indicating a ferromagnetic QCP. Our observation that this kind of instability, which is forbidden in d-electron metals, occurs in a heavy fermion system will have a large impact on the studies of quantum critical materials.	[Steppke, Alexander; Kuechler, Robert; Lausberg, Stefan; Lengyel, Edit; Steinke, Lucia; Borth, Robert; Luehmann, Thomas; Krellner, Cornelius; Nicklas, Michael; Geibel, Christoph; Steglich, Frank; Brando, Manuel] Max Planck Inst Chem Phys Solids, D-01187 Dresden, Germany; [Krellner, Cornelius] Goethe Univ Frankfurt, Inst Phys, D-60438 Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt	Steppke, A (corresponding author), Max Planck Inst Chem Phys Solids, Nothnitzer Str 40, D-01187 Dresden, Germany.	steppke@cpfs.mpg.de; brando@cpfs.mpg.de	Steppke, Alexander/K-4171-2015; Nicklas, Michael/B-6344-2008; Brando, Manuel/B-4234-2009; Krellner, Cornelius/A-5389-2009	Steppke, Alexander/0000-0001-6495-3917; Nicklas, Michael/0000-0001-6272-2162; Krellner, Cornelius/0000-0002-0671-7729	DFG Research Unit 960 "Quantum Phase Transitions"	DFG Research Unit 960 "Quantum Phase Transitions"	We are indebted to D. Belitz, A. V. Chubukov, P. Coleman, R. Daou, S. Friedemann, M. Garst, P. Gegenwart, F. M. Grosche, S. Kirchner, G. G. Lonzarich, B. Schmidt, Q. Si, P. Thalmeier, M. Vojta, T. Vojta and S. Wirth for useful discussions and M. C. Schuman for language editing. Part of the work was supported by the DFG Research Unit 960 "Quantum Phase Transitions."	Belitz D, 2005, REV MOD PHYS, V77, P579, DOI 10.1103/RevModPhys.77.579; Belitz D, 1999, PHYS REV LETT, V82, P4707, DOI 10.1103/PhysRevLett.82.4707; Brando M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.026401; Chubukov AV, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.147003; Coleman P, 2005, NATURE, V433, P226, DOI 10.1038/nature03279; Conduit GJ, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.207201; Cornelius AL, 1995, PHYS REV B, V52, P15699, DOI 10.1103/PhysRevB.52.R15699; Custers J, 2003, NATURE, V424, P524, DOI 10.1038/nature01774; Garst M, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.205129; Gegenwart P, 2008, NAT PHYS, V4, P186, DOI 10.1038/nphys892; Hassinger E, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.073703; Huy NT, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.212405; Jia SA, 2011, NAT PHYS, V7, P207, DOI [10.1038/nphys1868, 10.1038/NPHYS1868]; Krellner C, 2012, J PHYS CONF SER, V391, DOI 10.1088/1742-6596/391/1/012032; Kuchler R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.066405; Pfau H, 2012, NATURE, V484, P493, DOI 10.1038/nature11072; Pfleiderer C, 2007, SCIENCE, V316, P1871, DOI 10.1126/science.1142644; Plessel J, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.180403; Saxena SS, 2000, NATURE, V406, P587, DOI 10.1038/35020500; SCHOTTE KD, 1975, PHYS LETT A, V55, P38, DOI 10.1016/0375-9601(75)90386-2; Si QM, 2010, SCIENCE, V329, P1161, DOI 10.1126/science.1191195; Spehling J, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.140406; Thalmeier P., 1991, HDB PHYS CHEM RARE E, V14, DOI [10.1016/S0168-1273(05)80102-3, DOI 10.1016/S0168-1273(05)80102-3]; von Lohneysen H, 2007, REV MOD PHYS, V79, P1015, DOI 10.1103/RevModPhys.79.1015; Westerkamp T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.206404; Yamamoto SJ, 2010, P NATL ACAD SCI USA, V107, P15704, DOI 10.1073/pnas.1009498107; Yeh A, 2002, NATURE, V419, P459, DOI 10.1038/nature01044; Zhu LJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.066404	29	120	123	1	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2013	339	6122					933	936		10.1126/science.1230583	http://dx.doi.org/10.1126/science.1230583			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23430650				2022-12-28	WOS:000315149600042
J	Keogh, B				Keogh, Bruce			Should the NHS work at weekends as it does in the week? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MORTALITY				Keogh, B (corresponding author), Richmond House, London SW1A 2NS, England.	Bruce.Keogh@dh.gsi.gov.uk						Academy of Royal Colleges, 7 DAY CONS PRES CAR; Aylin P, 2010, QUAL SAF HEALTH CARE, V19, P213, DOI 10.1136/qshc.2008.028639; Barba R, 2006, EUR J INTERN MED, V17, P322, DOI 10.1016/j.ejim.2006.01.003; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Clover B, 2013, HLTH SERV J     0102; Collins J., 2010, FDN EXCELLENCE EVALU; Freemantle N, 2012, J ROY SOC MED, V105, P74, DOI 10.1258/jrsm.2012.120009; General Medical Council, NAT TRAIN SURV 2012; Health Education England, BETT TRAIN BETT CAR; NHS Commissioning Board, 2012, EV COUNTS PLANN PAT; NHS Outcomes Framework, NHS OUTC FRAM; Royal College of Physicians, 2010, POS STAT CAR MED PAT; Temple J., 2010, TIME TRAINING	13	14	14	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 21	2013	346								f621	10.1136/bmj.f621	http://dx.doi.org/10.1136/bmj.f621			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096HP	23430214				2022-12-28	WOS:000315395100008
J	van der Oost, J				van der Oost, John			New Tool for Genome Surgery	SCIENCE			English	Editorial Material							ADAPTIVE IMMUNITY; DNA CLEAVAGE; RNA; ENDONUCLEASE; BACTERIA; SYSTEMS		Wageningen Univ, Microbiol Lab, NL-6703 HB Wageningen, Netherlands	Wageningen University & Research	van der Oost, J (corresponding author), Wageningen Univ, Microbiol Lab, NL-6703 HB Wageningen, Netherlands.	john.vanderoost@wur.nl	van+der+Oost, John/Y-2548-2019					Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Eisenschmidt K, 2005, NUCLEIC ACIDS RES, V33, P7039, DOI 10.1093/nar/gki1009; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Westra ER, 2012, ANNU REV GENET, V46, P311, DOI 10.1146/annurev-genet-110711-155447; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	12	38	81	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2013	339	6121					768	770		10.1126/science.1234726	http://dx.doi.org/10.1126/science.1234726			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23413345				2022-12-28	WOS:000314874400034
J	Vohr, SH; Green, RE				Vohr, Samuel H.; Green, Richard E.			A Mouse Following in the Footsteps of Human Prehistory	CELL			English	Editorial Material							GENOME; EDAR; GENE	One of the strongest signals of positive selection in humans surrounds the V370A variant of Ectodysplasin A receptor (EDAR). However, its phenotypic consequences and impetus for selection are not well understood. Kamberov et al. nail down when it originated and, using transgenic mice, delineate its phenotypic impacts.	[Vohr, Samuel H.; Green, Richard E.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Green, RE (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA.	ed@soe.ucsc.edu		Green, Richard/0000-0003-0516-5827; Vohr, Samuel/0000-0002-4338-3756				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Doyle A, 2012, TRANSGENIC RES, V21, P327, DOI 10.1007/s11248-011-9537-3; Fujimoto A, 2008, HUM GENET, V124, P179, DOI 10.1007/s00439-008-0537-1; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Kamberov YG, 2013, CELL, V152, P691, DOI 10.1016/j.cell.2013.01.016; Kimura R, 2009, AM J HUM GENET, V85, P528, DOI 10.1016/j.ajhg.2009.09.006; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072	10	0	0	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 14	2013	152	4					667	668		10.1016/j.cell.2013.01.039	http://dx.doi.org/10.1016/j.cell.2013.01.039			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415216	Bronze			2022-12-28	WOS:000314945600001
J	Wang, YP; Lu, CL				Wang, Yen-Po; Lu, Ching-Liang			Dysphagia in a young woman	LANCET			English	Editorial Material									[Wang, Yen-Po; Lu, Ching-Liang] Taipei Vet Gen Hosp, Div Gastroenterol, Taipei, Taiwan; [Wang, Yen-Po; Lu, Ching-Liang] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Lu, CL (corresponding author), Taipei Vet Gen Hosp, Div Gastroenterol, Taipei, Taiwan.	cllu@vghtpe.gov.tw		Wang, Yen-Po/0000-0002-3769-0020					0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 3	2013	382	9890					426	426		10.1016/S0140-6736(12)62161-8	http://dx.doi.org/10.1016/S0140-6736(12)62161-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194MX	23453141				2022-12-28	WOS:000322638500035
J	Jacobson, CA; Freedman, AS				Jacobson, Caron A.; Freedman, Arnold S.			First-line treatment of indolent lymphoma: axing CHOP?	LANCET			English	Editorial Material							NON-HODGKINS-LYMPHOMA; LARGE-CELL LYMPHOMA; FOLLICULAR LYMPHOMA; PLUS RITUXIMAB; LOW-GRADE; CHEMOTHERAPY; CYCLOPHOSPHAMIDE; MAINTENANCE; VINCRISTINE; SURVIVAL		[Jacobson, Caron A.; Freedman, Arnold S.] Dana Farber Canc Inst, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute	Freedman, AS (corresponding author), Dana Farber Canc Inst, Boston, MA 02215 USA.	arnold_freedman@dfci.harvard.edu						BARTLETT NL, 1994, J CLIN ONCOL, V12, P1349, DOI 10.1200/JCO.1994.12.7.1349; Friedberg JW, 2009, J CLIN ONCOL, V27, P1202, DOI 10.1200/JCO.2008.18.1495; Hiddemann W, 2005, BLOOD, V106, P3725, DOI 10.1182/blood-2005-01-0016; Hochster H, 2009, J CLIN ONCOL, V27, P1607, DOI 10.1200/JCO.2008.17.1561; JONES SE, 1983, CANCER, V51, P1083, DOI 10.1002/1097-0142(19830315)51:6<1083::AID-CNCR2820510619>3.0.CO;2-M; Leoni LM, 2008, CLIN CANCER RES, V14, P309, DOI 10.1158/1078-0432.CCR-07-1061; LISTER TA, 1978, BRIT MED J, V1, P533, DOI 10.1136/bmj.1.6112.533; Marcus R, 2005, BLOOD, V105, P1417, DOI 10.1182/blood-2004-08-3175; Martinelli G, 2010, J CLIN ONCOL, V28, P4480, DOI 10.1200/JCO.2010.28.4786; Robinson KS, 2008, J CLIN ONCOL, V26, P4473, DOI 10.1200/JCO.2008.17.0001; Rummel MJ, 2013, LANCET; Salles G, 2011, LANCET, V377, P42, DOI 10.1016/S0140-6736(10)62175-7	12	9	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 6	2013	381	9873					1163	1165		10.1016/S0140-6736(12)61965-5	http://dx.doi.org/10.1016/S0140-6736(12)61965-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122WU	23433738				2022-12-28	WOS:000317350100006
J	Tarter, L; Yazdany, J; Moyers, B; Barnett, C; Dhaliwal, G				Tarter, Laura; Yazdany, Jinoos; Moyers, Brian; Barnett, Christopher; Dhaliwal, Gurpreet			The Heart of the Matter	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; LIBMAN-SACKS ENDOCARDITIS; ANTIPHOSPHOLIPID ANTIBODIES; VALVE REPLACEMENT; DISEASE; INVOLVEMENT		[Tarter, Laura] Stanford Univ, Med Ctr, Dept Med, Div Rheumatol & Immunol, Palo Alto, CA 94304 USA; [Yazdany, Jinoos] Univ Calif San Francisco, Div Rheumatol, San Francisco, CA USA; [Moyers, Brian; Barnett, Christopher] Univ Calif San Francisco, Div Cardiol, San Francisco, CA USA; [Dhaliwal, Gurpreet] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Barnett, Christopher] San Francisco Gen Hosp, San Francisco, CA 94110 USA; [Dhaliwal, Gurpreet] San Francisco VA Med Ctr, San Francisco, CA USA	Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Tarter, L (corresponding author), Stanford Univ, Med Ctr, Dept Med, Div Rheumatol & Immunol, 1000 Welch Rd,Suite 203, Palo Alto, CA 94304 USA.	tarter@gmail.com	Barnett, Christopher/AAD-9872-2022	Barnett, Christopher/0000-0003-1095-5794				BULKLEY BH, 1975, AM J MED, V58, P243, DOI 10.1016/0002-9343(75)90575-6; Burke A, 1996, NEW ENGL J MED, V335, P1462; DAJEE H, 1983, J THORAC CARDIOV SUR, V85, P718; Eiken PW, 2001, MAYO CLIN PROC, V76, P1204, DOI 10.4065/76.12.1204; Gross L, 1940, AM J PATHOL, V16, P375; KHAMASHTA MA, 1990, LANCET, V335, P1541, DOI 10.1016/0140-6736(90)91373-I; Libman E, 1924, ARCH INTERN MED, V33, P701, DOI 10.1001/archinte.1924.00110300044002; MANDELL BF, 1987, SEMIN ARTHRITIS RHEU, V17, P126, DOI 10.1016/0049-0172(87)90035-7; Moyssakis I, 2007, AM J MED, V120, P636, DOI 10.1016/j.amjmed.2007.01.024; Perez-Villa F, 2005, ARTHRIT RHEUM-ARTHR, V53, P460, DOI 10.1002/art.21162; Roldan CA, 1996, NEW ENGL J MED, V335, P1424, DOI 10.1056/NEJM199611073351903; STRAATON KV, 1988, AM J MED, V85, P645; Tincani A, 2006, RHEUMATOLOGY, V45, P8, DOI 10.1093/rheumatology/kel308; VAUGHTON KC, 1979, BRIT HEART J, V41, P730; Zuily S, 2011, CIRCULATION, V124, P215, DOI 10.1161/CIRCULATIONAHA.111.028522	15	1	2	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2013	368	10					944	950		10.1056/NEJMcps1114207	http://dx.doi.org/10.1056/NEJMcps1114207			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100BG	23465105				2022-12-28	WOS:000315669100012
J	Ellis, O				Ellis, Oliver			On first name terms	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												oli.ellis@googlemail.com							0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2013	346								f1450	10.1136/bmj.f1450	http://dx.doi.org/10.1136/bmj.f1450			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104MS	23468294				2022-12-28	WOS:000315998300010
J	Nagpaul, C				Nagpaul, Chaand			Should GPs be fined for rises in avoidable emergency admissions to hospital? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONTROLLED-TRIAL					chaand.nagpaul@gmail.com						[Anonymous], 2012, FIT FUTURE FOSTER HO; Blunt I, 2010, TRENDS EMERGENCY ADM; Curry N, 2010, CLIN SERVICE INTEGRA; Fan VS, 2012, ANN INTERN MED, V156, P673, DOI 10.7326/0003-4819-156-10-201205150-00003; Ham C., 2011, NEXT NHS REFORMS CAS; NHS Commissioning Board, QUAL PREM 2013 14 DR; Purdy S., 2012, AVOIDING HOSP ADMISS; Roland M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6017; Royal College of Physicians, 2012, HOSP EDG; Takahashi PY, 2012, ARCH INTERN MED, V172, P773, DOI 10.1001/archinternmed.2012.256	10	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2013	346								f1391	10.1136/bmj.f1391	http://dx.doi.org/10.1136/bmj.f1391			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104MN	23463140				2022-12-28	WOS:000315997600018
J	Schmidt, E; Goldhaber-Fiebert, SN; Ho, LA; McDonald, KM				Schmidt, Eric; Goldhaber-Fiebert, Sara N.; Ho, Lawrence A.; McDonald, Kathryn M.			Simulation Exercises as a Patient Safety Strategy A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							VENOUS CATHETER INSERTION; MEDICAL-EDUCATION; OPERATING-ROOM; DELIBERATE PRACTICE; TRAINING IMPROVES; CARDIAC-ARREST; PERFORMANCE; CARE; RESIDENTS; TRIAL	Simulation is a versatile technique used in a variety of health care settings for a variety of purposes, but the extent to which simulation may improve patient safety remains unknown. This systematic review examined evidence on the effects of simulation techniques on patient safety outcomes. PubMed and the Cochrane Library were searched from their beginning to 31 October 2012 to identify relevant studies. A single reviewer screened 913 abstracts and selected and abstracted data from 38 studies that reported outcomes during care of real patients after patient-, team-, or system-level simulation interventions. Studies varied widely in the quality of methodological design and description of simulation activities, but in general, simulation interventions improved the technical performance of individual clinicians and teams during critical events and complex procedures. Limited evidence suggested improvements in patient outcomes attributable to simulation exercises at the health system level. Future studies would benefit from standardized reporting of simulation components and identification of robust patient safety targets. Ann Intern Med. 2013;158:426-432. www.annals.org	Ctr Primary Care & Outcomes Res, Stanford Ctr Hlth Policy, Stanford, CA USA; Stanford Univ, Sch Med, Stanford Univ Hosp & Clin, Stanford, CA 94305 USA	Stanford University	McDonald, KM (corresponding author), Stanford Univ, 117 Encina Commons, Stanford, CA 94305 USA.	Kathryn.McDonald@stanford.edu	Schmidt, Eric/AAX-1584-2020	Goldhaber-Fiebert, Sara/0000-0002-7551-4351; Schmidt, Eric/0000-0002-9181-6771	Agency for Healthcare and Quality, U.S. Department of Health and Human Services [HHSA-290-2007-10062I]; Agency for Healthcare Research and Quality	Agency for Healthcare and Quality, U.S. Department of Health and Human Services; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Financial Support: From the Agency for Healthcare and Quality, U.S. Department of Health and Human Services (contract HHSA-290-2007-10062I).; Potential Conflicts of Interest: Mr. Schmidt: Grant (money to institution): Agency for Healthcare Research and Quality. Ms. McDonald: Grant (money to institution): Agency for Healthcare Research and Quality. All other authors have no disclosures. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M12-2572.	Ahlberg G, 2005, ENDOSCOPY, V37, P1198, DOI 10.1055/s-2005-921049; Ahlberg G, 2007, AM J SURG, V193, P797, DOI 10.1016/j.amjsurg.2006.06.050; Andreatta P, 2011, SUPPORT CARE CANCER, V19, P539, DOI 10.1007/s00520-010-0849-2; Barsuk JH, 2009, CRIT CARE MED, V37, P2697, DOI 10.1097/CCM.0b013e3181a57bc1; Barsuk JH, 2009, AM J KIDNEY DIS, V54, P70, DOI 10.1053/j.ajkd.2008.12.041; Barsuk JH, 2009, J HOSP MED, V4, P397, DOI 10.1002/jhm.468; Barsuk JH, 2009, ARCH INTERN MED, V169, P1420, DOI 10.1001/archinternmed.2009.215; Blum MG, 2004, ANN THORAC SURG, V78, P287, DOI 10.1016/j.athoracsur.2003.11.058; Blum RH, 2005, ANESTH ANALG, V100, P1375, DOI 10.1213/01.ANE.0000148058.64834.80; Britt RC, 2009, AM J SURG, V197, P533, DOI 10.1016/j.amjsurg.2008.11.016; Bruppacher HR, 2010, ANESTHESIOLOGY, V112, P985, DOI 10.1097/ALN.0b013e3181d3e31c; Calatayud D, 2010, ANN SURG, V251, P1181, DOI 10.1097/SLA.0b013e3181deb630; Capella J, 2010, J SURG EDUC, V67, P439, DOI 10.1016/j.jsurg.2010.06.006; Cohen J, 2006, GASTROINTEST ENDOSC, V64, P361, DOI 10.1016/j.gie.2005.11.062; Cook DA, 2010, ACAD MED, V85, P1589, DOI 10.1097/ACM.0b013e3181edfe13; Draycott T, 2006, BJOG-INT J OBSTET GY, V113, P177, DOI 10.1111/j.1471-0528.2006.00800.x; Duncan DR, 2009, CHEST, V135, P1315, DOI 10.1378/chest.08-1227; Ericsson KA, 2008, ACAD EMERG MED, V15, P988, DOI 10.1111/j.1553-2712.2008.00227.x; Evans LV, 2010, ACAD MED, V85, P1462, DOI 10.1097/ACM.0b013e3181eac9a3; Fanning Ruth M, 2007, Simul Healthc, V2, P115, DOI 10.1097/SIH.0b013e3180315539; Ferlitsch A, 2010, ENDOSCOPY, V42, P1049, DOI 10.1055/s-0030-1255818; Gaba D. M., 2001, Simulation & Gaming, V32, P175, DOI 10.1177/104687810103200206; Gaba David M, 2006, Simul Healthc, V1 Spec no., P1; Gaba David M, 2007, Simul Healthc, V2, P126, DOI 10.1097/01.SIH.0000258411.38212.32; Gaies MG, 2009, PEDIATRICS, V124, P610, DOI 10.1542/peds.2008-2658; Grantcharov TP, 2004, BRIT J SURG, V91, P146, DOI 10.1002/bjs.4407; Griswold-Theodorson S, 2009, SIMUL HEALTHC, V4, P212, DOI 10.1097/SIH.0b013e3181b1b837; Gurusamy KS, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006575.pub2; Hall RE, 2005, ACAD EMERG MED, V12, P850, DOI 10.1197/j.aem.2005.04.007; Hamilton EC, 2001, AM J SURG, V182, P725, DOI 10.1016/S0002-9610(01)00800-5; Kallstrom R, 2010, J ENDOUROL, V24, P1521, DOI 10.1089/end.2009.0667; Khouli H, 2011, CHEST, V139, P80, DOI 10.1378/chest.10-0979; Lighthall GK, 2010, JT COMM J QUAL PATIE, V36, P209, DOI 10.1016/S1553-7250(10)36034-X; Lipman S, 2011, OBSTET GYNECOL, V118, P1090, DOI 10.1097/AOG.0b013e3182319a08; Ma IWY, 2011, ACAD MED, V86, P1137, DOI 10.1097/ACM.0b013e318226a204; Martin M, 2003, AM SURGEON, V69, P437; McGaghie WC, 2006, MED EDUC, V40, P792, DOI 10.1111/j.1365-2929.2006.02528.x; McGaghie WC, 2011, SIMUL HEALTHC, V6, pS42, DOI 10.1097/SIH.0b013e318222fde9; McGaghie WC, 2011, ACAD MED, V86, P706, DOI 10.1097/ACM.0b013e318217e119; McGaghie WC, 2010, MED EDUC, V44, P50, DOI 10.1111/j.1365-2923.2009.03547.x; Meltzer D, 2002, ANN INTERN MED, V137, P866, DOI 10.7326/0003-4819-137-11-200212030-00007; Miranda JA, 2007, J HOSP MED, V2, P135, DOI 10.1002/jhm.168; O'Connor PJ, 2009, DIABETES CARE, V32, P585, DOI 10.2337/dc08-0944; Park Christine S, 2011, Anesthesiol Clin, V29, P13, DOI 10.1016/j.anclin.2010.11.010; Park J, 2007, AM J SURG, V194, P205, DOI 10.1016/j.amjsurg.2006.11.032; Rogers GM, 2009, J CATARACT REFR SURG, V35, P1956, DOI 10.1016/j.jcrs.2009.05.046; Rosen MA, 2011, HDB HFE HLTH CARE PA, P571; Rudolph Jenny W, 2007, Anesthesiol Clin, V25, P361, DOI 10.1016/j.anclin.2007.03.007; Scott DJ, 2000, J AM COLL SURGEONS, V191, P272, DOI 10.1016/S1072-7515(00)00339-2; Sears K, 2010, J NURS EDUC, V49, P52, DOI 10.3928/01484834-20090918-12; Sedlack RE, 2004, AM J GASTROENTEROL, V99, P33, DOI 10.1111/j.1572-0241.2004.04007.x; Semeraro F, 2006, RESUSCITATION, V68, P101, DOI 10.1016/j.resuscitation.2005.06.011; Sherertz RJ, 2000, ANN INTERN MED, V132, P641, DOI 10.7326/0003-4819-132-8-200004180-00007; Smith CC, 2010, SIMUL HEALTHC, V5, P146, DOI 10.1097/SIH.0b013e3181dd9672; Sroka G, 2010, AM J SURG, V199, P115, DOI 10.1016/j.amjsurg.2009.07.035; Thomson M, 2006, J PEDIATR GASTR NUTR, V43, P699, DOI 10.1097/01.mpg.0000243431.09216.71; Tongprasert F, 2010, PRENATAL DIAG, V30, P467, DOI 10.1002/pd.2504; Velmahos GC, 2004, AM J SURG, V187, P114, DOI 10.1016/j.amjsurg.2002.12.005; Walsh CM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008237.pub2; Wayne DB, 2008, CHEST, V133, P56, DOI 10.1378/chest.07-0131; Weidman EK, 2010, RESUSCITATION, V81, P1556, DOI 10.1016/j.resuscitation.2010.05.021; Ziv A, 2003, ACAD MED, V78, P783, DOI 10.1097/00001888-200308000-00006	62	76	78	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2013	158	5	2				426	+		10.7326/0003-4819-158-5-201303051-00010	http://dx.doi.org/10.7326/0003-4819-158-5-201303051-00010			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105HX	23460100				2022-12-28	WOS:000316058600010
J	Fung, KY; Mangan, NE; Cumming, H; Horvat, JC; Mayall, JR; Stifter, SA; De Weerd, N; Roisman, LC; Rossjohn, J; Robertson, SA; Schjenken, JE; Parker, B; Gargett, CE; Nguyen, HPT; Carr, DJ; Hansbro, PM; Hertzog, PJ				Fung, Ka Yee; Mangan, Niamh E.; Cumming, Helen; Horvat, Jay C.; Mayall, Jemma R.; Stifter, Sebastian A.; De Weerd, Nicole; Roisman, Laila C.; Rossjohn, Jamie; Robertson, Sarah A.; Schjenken, John E.; Parker, Belinda; Gargett, Caroline E.; Nguyen, Hong P. T.; Carr, Daniel J.; Hansbro, Philip M.; Hertzog, Paul J.			Interferon-epsilon Protects the Female Reproductive Tract from Viral and Bacterial Infection	SCIENCE			English	Article							CELLS; ACTIVATION; INDUCTION; IMMUNITY; RISK; DNA	The innate immune system senses pathogens through pattern-recognition receptors (PRRs) that signal to induce effector cytokines, such as type I interferons (IFNs). We characterized IFN-epsilon as a type I IFN because it signaled via the Ifnar1 and Ifnar2 receptors to induce IFN-regulated genes. In contrast to other type I IFNs, IFN-epsilon was not induced by known PRR pathways; instead, IFN-epsilon was constitutively expressed by epithelial cells of the female reproductive tract (FRT) and was hormonally regulated. Ifn-epsilon-deficient mice had increased susceptibility to infection of the FRT by the common sexually transmitted infections (STIs) herpes simplex virus 2 and Chlamydia muridarum. Thus, IFN-epsilon is a potent antipathogen and immunoregulatory cytokine that may be important in combating STIs that represent a major global health and socioeconomic burden.	[Fung, Ka Yee; Mangan, Niamh E.; Cumming, Helen; Stifter, Sebastian A.; De Weerd, Nicole; Roisman, Laila C.; Hertzog, Paul J.] Monash Univ, Ctr Innate Immun & Infect Dis, Inst Med Res, Clayton, Vic, Australia; [Horvat, Jay C.; Mayall, Jemma R.; Hansbro, Philip M.] Univ Newcastle, Ctr Asthma & Resp Dis, Newcastle, NSW 2300, Australia; [Horvat, Jay C.; Mayall, Jemma R.; Hansbro, Philip M.] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2300, Australia; [Roisman, Laila C.; Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Robertson, Sarah A.; Schjenken, John E.] Univ Adelaide, Robinson Inst, Adelaide, SA 5005, Australia; [Robertson, Sarah A.; Schjenken, John E.] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia; [Parker, Belinda] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Parker, Belinda] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Gargett, Caroline E.; Nguyen, Hong P. T.] Monash Univ, Ritchie Ctr, Monash Inst Med Res, Clayton, Vic, Australia; [Gargett, Caroline E.] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia; [Carr, Daniel J.] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK USA; [Carr, Daniel J.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA	Monash University; University of Sydney; Westmead Institute for Medical Research; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; Monash University; Robinson Research Institute; University of Adelaide; University of Adelaide; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Monash University; Monash University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Hertzog, PJ (corresponding author), Monash Univ, Ctr Innate Immun & Infect Dis, Inst Med Res, Clayton, Vic, Australia.	paul.hertzog@monash.edu	Schjenken, John E/ABB-8754-2021; Rossjohn, Jamie/F-9032-2013; Hertzog, Paul J/I-7053-2013; Roisman, Laila C./P-9129-2019; Gargett, Caroline Eve/I-4895-2019; Gargett, Caroline E/Q-7911-2019; Hertzog, Paul J/G-6734-2013; Hansbro, Phil/G-7486-2013; de Weerd, Nicole/X-5886-2019; Robertson, Sarah A/C-8182-2009	Schjenken, John E/0000-0001-6293-6160; Rossjohn, Jamie/0000-0002-2020-7522; Hertzog, Paul J/0000-0002-1373-8472; Roisman, Laila C./0000-0001-8455-9327; Gargett, Caroline E/0000-0002-3590-2077; Hertzog, Paul J/0000-0002-1373-8472; Hansbro, Phil/0000-0002-4741-3035; de Weerd, Nicole/0000-0002-7985-189X; Robertson, Sarah A/0000-0002-9967-0084; Mayall, Jemma/0000-0002-0915-5020; Parker, Belinda/0000-0002-8333-1926; Horvat, Jay/0000-0002-8526-0631; Carr, Daniel JJ/0000-0003-1954-2478; Stifter, Sebastian/0000-0002-7825-222X; Mangan, Niamh/0000-0003-3844-0709	Australian National Health and Medical Research Council; Australian Research Council; NIH [R01 AI053108]; Victorian Government's Operational Infrastructure Support Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053108] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Victorian Government's Operational Infrastructure Support Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Mansell, R. Ferrero, and L. Salamonsen for their contributions; N. Bourke and S. Forster for helpful discussions and reading of the manuscript; K. Fitzgerald for reagents; and C. Berry for assistance with viral plaque assays. The data presented in this paper are tabulated in the main text and in the supplementary materials. This work was supported by funding from Australian National Health and Medical Research Council (P.J.H., N. E. M., P. M. H., J.R., C. E. G., and B. P.), the Australian Research Council (P.J.H., N. E. M., J.R.), the NIH via grant R01 AI053108 (D.J.C.), and the Victorian Government's Operational Infrastructure Support Program. P.J.H., N. E. M., K.Y.F., H. C., S. A. S., and N. D. W. hold International Patent Application number PCT/AU2011/000715, "Use of interferon epsilon in methods of diagnosis and treatment."	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Asquith KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001339; Austin BA, 2006, BIOL PROCED ONLINE, V8, P55, DOI 10.1251/bpo118; Baeten JM, 2001, AM J OBSTET GYNECOL, V185, P380, DOI 10.1067/mob.2001.115862; Beagley KW, 2009, CRIT REV IMMUNOL, V29, P275, DOI 10.1615/CritRevImmunol.v29.i4.10; Conrady CD, 2011, J VIROL, V85, P1625, DOI 10.1128/JVI.01715-10; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; Devitt A, 1996, INFECT IMMUN, V64, P3951, DOI 10.1128/IAI.64.10.3951-3956.1996; Doyle SE, 2003, J IMMUNOL, V170, P3565, DOI 10.4049/jimmunol.170.7.3565; Hardy MP, 2004, GENOMICS, V84, P331, DOI 10.1016/j.ygeno.2004.03.003; Hervas-Stubbs S, 2011, CLIN CANCER RES, V17, P2619, DOI 10.1158/1078-0432.CCR-10-1114; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Lad SP, 2005, J IMMUNOL, V174, P7186, DOI 10.4049/jimmunol.174.11.7186; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; Nagarajan UM, 2005, J IMMUNOL, V175, P450, DOI 10.4049/jimmunol.175.1.450; Nagarajan UM, 2008, INFECT IMMUN, V76, P4642, DOI 10.1128/IAI.00629-08; PARR MB, 1994, LAB INVEST, V70, P369; Patel MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035654; Salamonsen L., 2008, ENDOMETRIUM MOL CELL; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Thapa M, 2009, J VIROL, V83, P9486, DOI 10.1128/JVI.00854-09; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Tseng CTK, 1998, INFECT IMMUN, V66, P5867, DOI 10.1128/IAI.66.12.5867-5875.1998; Wang CC, 1999, J ACQ IMMUN DEF SYND, V21, P51, DOI 10.1097/00126334-199905010-00007; WHO World Health Organisation STD Statistics, 2001, GLOB PREV INC SEL CU	27	154	164	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1088	1092		10.1126/science.1233321	http://dx.doi.org/10.1126/science.1233321			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23449591	Green Published, Green Accepted			2022-12-28	WOS:000315452000045
J	Giovanoli, S; Engler, H; Engler, A; Richetto, J; Voget, M; Willi, R; Winter, C; Riva, MA; Mortensen, PB; Schedlowski, M; Meyer, U				Giovanoli, Sandra; Engler, Harald; Engler, Andrea; Richetto, Juliet; Voget, Mareike; Willi, Roman; Winter, Christine; Riva, Marco A.; Mortensen, Preben B.; Schedlowski, Manfred; Meyer, Urs			Stress in Puberty Unmasks Latent Neuropathological Consequences of Prenatal Immune Activation in Mice	SCIENCE			English	Article							CHILDHOOD ADVERSITIES; PSYCHIATRIC-DISORDERS; SCHIZOPHRENIA; EXPOSURE; AUTISM; RISK; PHYSIOLOGY	Prenatal infection and exposure to traumatizing experiences during peripuberty have each been associated with increased risk for neuropsychiatric disorders. Evidence is lacking for the cumulative impact of such prenatal and postnatal environmental challenges on brain functions and vulnerability to psychiatric disease. Here, we show in a translational mouse model that combined exposure to prenatal immune challenge and peripubertal stress induces synergistic pathological effects on adult behavioral functions and neurochemistry. We further demonstrate that the prenatal insult markedly increases the vulnerability of the pubescent offspring to brain immune changes in response to stress. Our findings reveal interactions between two adverse environmental factors that have individually been associated with neuropsychiatric disease and support theories that mental illnesses with delayed onsets involve multiple environmental hits.	[Giovanoli, Sandra; Meyer, Urs] Swiss Fed Inst Technol, Physiol & Behav Lab, CH-8603 Schwerzenbach, Switzerland; [Engler, Harald; Engler, Andrea; Schedlowski, Manfred] Univ Duisburg Essen, Inst Med Psychol & Behav Immunobiol, Univ Hosp Essen, D-45122 Essen, Germany; [Richetto, Juliet; Riva, Marco A.] Univ Milan, Ctr Neuropharmacol, Dept Pharmacol Sci, I-20133 Milan, Italy; [Richetto, Juliet; Riva, Marco A.] Univ Milan, Ctr Excellence Neurodegenerat Dis, Dept Pharmacol & Biomol Sci, I-20133 Milan, Italy; [Voget, Mareike] Charite, Int Grad Program Med Neurosci, D-10117 Berlin, Germany; [Voget, Mareike; Winter, Christine] Tech Univ Dresden, Dept Psychiat, D-01062 Dresden, Germany; [Willi, Roman] F Hoffmann La Roche Ltd, Neurosci Discovery, CH-4070 Basel, Switzerland; [Mortensen, Preben B.] Aarhus Univ, Natl Ctr Register Based Res, DK-8000 Aarhus C, Denmark; [Mortensen, Preben B.] IPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, DK-8000 Aarhus, Denmark	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Duisburg Essen; University of Milan; University of Milan; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technische Universitat Dresden; Roche Holding; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH)	Meyer, U (corresponding author), Swiss Fed Inst Technol, Physiol & Behav Lab, CH-8603 Schwerzenbach, Switzerland.	urmeyer@ethz.ch	Meyer, Urs/C-4602-2016; Engler, Harald/H-8773-2017; Richetto, Juliet/AAC-7285-2021; Riva, Marco Andrea/N-7418-2017; Mortensen, Preben B/D-2358-2015; Richetto, Juliet/Q-2865-2016	Meyer, Urs/0000-0001-7244-0345; Engler, Harald/0000-0001-6329-1990; Richetto, Juliet/0000-0002-8313-3348; Riva, Marco Andrea/0000-0002-1699-5060; Mortensen, Preben B/0000-0002-5230-9865; Richetto, Juliet/0000-0002-8313-3348; Willi, Roman/0000-0001-9612-9877	European Union [259679]; Lundbeck Foundation; Stanley Medical Research Institute; European Research Council; German Research Foundation [FOR 1581, SCHE 341/19-1, FOR 751, EN 814/1-2]	European Union(European Commission); Lundbeck Foundation(Lundbeckfonden); Stanley Medical Research Institute; European Research Council(European Research Council (ERC)European Commission); German Research Foundation(German Research Foundation (DFG))	We thank L. Weber and T. Wirth for their technical assistance in the immunohistochemical and flow cytometric analyses; U. Stadlbauer and M. Labouesse for assisting behavioral experimentation and animal care; and the laboratory animal technician team, Schwerzenbach, for animal husbandry. We also thank J. Feldon for his past mentoring and W. Langhans for the continuous infrastructural support. This work was supported by the European Union Seventh Framework Programme (FP7/2007-2011) under Grant Agreement no. 259679 awarded to U. M., and by the Lundbeck Foundation, the Stanley Medical Research Institute, and a European Research Council Advanced Grant awarded to P. B. M., and partially by the German Research Foundation (FOR 1581, SCHE 341/19-1; FOR 751, EN 814/1-2). All authors declare that they have no conflicts of interest to disclose. R. W. is employed by F. Hoffmann-La Roche, Ltd.	Bayer TA, 1999, J PSYCHIATR RES, V33, P543, DOI 10.1016/S0022-3956(99)00039-4; Bolton JL, 2012, FASEB J, V26, P4743, DOI 10.1096/fj.12-210989; Brown AS, 2011, SCHIZOPHRENIA BULL, V37, P284, DOI 10.1093/schbul/sbq146; Brown AS, 2011, PROG NEUROBIOL, V93, P23, DOI 10.1016/j.pneurobio.2010.09.003; Clarke MC, 2009, AM J PSYCHIAT, V166, P1025, DOI 10.1176/appi.ajp.2009.08010031; Fisher HL, 2010, PSYCHOL MED, V40, P1967, DOI 10.1017/S0033291710000231; Frank MG, 2007, BRAIN BEHAV IMMUN, V21, P47, DOI 10.1016/j.bbi.2006.03.005; Franklin TB, 2012, NEURON, V75, P747, DOI 10.1016/j.neuron.2012.08.016; Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186; Herbert MR, 2010, CURR OPIN NEUROL, V23, P103, DOI 10.1097/WCO.0b013e328336a01f; Holmes WC, 1998, JAMA-J AM MED ASSOC, V280, P1855, DOI 10.1001/jama.280.21.1855; Hsiao EY, 2012, P NATL ACAD SCI USA, V109, P12776, DOI 10.1073/pnas.1202556109; Maynard TM, 2001, SCHIZOPHRENIA BULL, V27, P457, DOI 10.1093/oxfordjournals.schbul.a006887; MEDNICK SA, 1988, ARCH GEN PSYCHIAT, V45, P189, DOI 10.1001/archpsyc.1988.01800260109013; Meyer U, 2011, PEDIATR RES, V69, p26R, DOI 10.1203/PDR.0b013e318212c196; Meyer U, 2009, NEUROSCI BIOBEHAV R, V33, P1061, DOI 10.1016/j.neubiorev.2009.05.001; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Pedersen CB, 2001, ARCH GEN PSYCHIAT, V58, P1039, DOI 10.1001/archpsyc.58.11.1039; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Selten JP, 2010, SCHIZOPHRENIA BULL, V36, P219, DOI 10.1093/schbul/sbp147; Spear LP, 2009, DEV PSYCHOPATHOL, V21, P87, DOI 10.1017/S0954579409000066; Tsuchiya KJ, 2003, BIPOLAR DISORD, V5, P231, DOI 10.1034/j.1399-5618.2003.00038.x; Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050	24	332	337	3	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1095	1099		10.1126/science.1228261	http://dx.doi.org/10.1126/science.1228261			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23449593	Green Published			2022-12-28	WOS:000315452000047
J	Wallingford, JB; Niswander, LA; Shaw, GM; Finnell, RH				Wallingford, John B.; Niswander, Lee A.; Shaw, Gary M.; Finnell, Richard H.			The Continuing Challenge of Understanding, Preventing, and Treating Neural Tube Defects	SCIENCE			English	Review							FOLIC-ACID FORTIFICATION; PLANAR-CELL-POLARITY; SPINA-BIFIDA; CONVERGENT EXTENSION; SONIC-HEDGEHOG; VALPROIC ACID; APICAL CONSTRICTION; HISTONE DEACETYLASE; DIABETES-MELLITUS; BIRTH PREVALENCE	Human birth defects are a major public health burden: The Center for Disease Control estimates that 1 of every 33 United States newborns presents with a birth defect, and worldwide the estimate approaches 6% of all births. Among the most common and debilitating of human birth defects are those affecting the formation of the neural tube, the precursor to the central nervous system. Neural tube defects (NTDs) arise from a complex combination of genetic and environmental interactions. Although substantial advances have been made in the prevention and treatment of these malformations, NTDs remain a substantial public health problem, and we are only now beginning to understand their etiology. Here, we review the process of neural tube development and how defects in this process lead to NTDs, both in humans and in the animal models that serve to inform our understanding of these processes. The insights we are gaining will help generate new intervention strategies to tackle the clinical challenges and to alleviate the personal and societal burdens that accompany these defects.	[Wallingford, John B.] Univ Texas Austin, Howard Hughes Med Inst, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; [Niswander, Lee A.] Univ Colorado, Howard Hughes Med Inst, Dept Pediat, Sch Med, Aurora, CO 80045 USA; [Shaw, Gary M.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Finnell, Richard H.] Univ Texas Austin, Dell Pediat Res Inst, Dept Nutr Sci, Austin, TX 78723 USA; [Finnell, Richard H.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78723 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Austin; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; Stanford University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Wallingford, JB (corresponding author), Univ Texas Austin, Howard Hughes Med Inst, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA.	wallingford@austin.utexas.edu	Niswander, Lee/D-3976-2013; Finnell, Richard/D-8174-2018	Niswander, Lee/0000-0002-9959-0594; Shaw, Gary/0000-0001-7438-4914; Finnell, Richard/0000-0002-5962-8754	Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [P01 HD067244, P01HD067244] Funding Source: Medline; NIGMS NIH HHS [R01 GM074104, 5R01GM074104] Funding Source: Medline; NINDS NIH HHS [R01 NS058979, R01NS050249, R01 NS050249, R01 NS076465, R01NS076465, R01NS058979] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD067244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058979, R01NS050249, R01NS076465] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adzick NS, 2012, J PEDIATR SURG, V47, P273, DOI 10.1016/j.jpedsurg.2011.11.021; Adzick NS, 2011, NEW ENGL J MED, V364, P993, DOI 10.1056/NEJMoa1014379; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Au KS, 2010, DEV DISABIL RES REV, V16, P6, DOI 10.1002/ddrr.93; Barbera JPM, 2002, HUM MOL GENET, V11, P283, DOI 10.1093/hmg/11.3.283; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Blom HJ, 2006, NAT REV NEUROSCI, V7, P724, DOI 10.1038/nrn1986; Bowman RM, 2001, PEDIATR NEUROSURG, V34, P114, DOI 10.1159/000056005; Canfield MA, 2005, BIRTH DEFECTS RES A, V73, P679, DOI 10.1002/bdra.20210; Castilla EE, 2003, AM J MED GENET A, V123A, P123, DOI 10.1002/ajmg.a.20230; Colas JF, 2001, DEV DYNAM, V221, P117, DOI 10.1002/dvdy.1144; Copp AJ, 2010, J PATHOL, V220, P217, DOI 10.1002/path.2643; De Wals P, 2007, NEW ENGL J MED, V357, P135, DOI 10.1056/NEJMoa067103; Deak KL, 2008, BIRTH DEFECTS RES A, V82, P662, DOI 10.1002/bdra.20511; Dennis M, 2010, DEV DISABIL RES REV, V16, P31, DOI 10.1002/ddrr.89; Dey AC, 2010, J HEALTH POPUL NUTR, V28, P343; Drugan A, 2001, CLIN PERINATOL, V28, P279, DOI 10.1016/S0095-5108(05)70083-X; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Fox DT, 2007, DEVELOPMENT, V134, P567, DOI 10.1242/dev.02748; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gray JD, 2010, HUM MOL GENET, V19, P4560, DOI 10.1093/hmg/ddq384; Gray RS, 2009, NAT CELL BIOL, V11, P1225, DOI 10.1038/ncb1966; Greene NDE, 1997, NAT MED, V3, P60, DOI 10.1038/nm0197-60; Greene NDE, 2011, EPIGENETICS-US, V6, P875, DOI 10.4161/epi.6.7.16400; Haigo SL, 2003, CURR BIOL, V13, P2125, DOI 10.1016/j.cub.2003.11.054; Hall JL, 1997, TERATOLOGY, V55, P306, DOI 10.1002/(SICI)1096-9926(199705)55:5<306::AID-TERA2>3.0.CO;2-X; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Harris MJ, 2007, BIRTH DEFECTS RES A, V79, P187, DOI 10.1002/bdra.20333; Harris MJ, 2010, BIRTH DEFECTS RES A, V88, P653, DOI 10.1002/bdra.20676; Harris MJ, 2009, BIRTH DEFECTS RES A, V85, P331, DOI 10.1002/bdra.20552; Hendricks KA, 2001, EPIDEMIOLOGY, V12, P630, DOI 10.1097/00001648-200111000-00009; Hildebrand JD, 1999, CELL, V99, P485, DOI 10.1016/S0092-8674(00)81537-8; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Honein MA, 2001, JAMA-J AM MED ASSOC, V285, P2981, DOI 10.1001/jama.285.23.2981; Hook EB, 1997, LANCET, V350, P513, DOI 10.1016/S0140-6736(97)01342-1; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Jones EAV, 2002, GENESIS, V34, P228, DOI 10.1002/gene.10162; Juriloff DM, 2012, BIRTH DEFECTS RES A, V94, P824, DOI 10.1002/bdra.23079; Juriloff DM, 2012, BIRTH DEFECTS RES A, V94, P849, DOI 10.1002/bdra.23036; Kanai H, 2004, PHARMACOGENOMICS J, V4, P336, DOI 10.1038/sj.tpj.6500269; Kibar Z, 2007, NEW ENGL J MED, V356, P1432, DOI 10.1056/NEJMoa060651; Kirillova I, 2000, TERATOLOGY, V61, P347, DOI 10.1002/(SICI)1096-9926(200005)61:5<347::AID-TERA6>3.3.CO;2-R; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; LAMMER EJ, 1987, TERATOLOGY, V35, P465, DOI 10.1002/tera.1420350319; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Lee C, 2007, DEVELOPMENT, V134, P1431, DOI 10.1242/dev.02828; Li CCY, 2011, PLOS GENET, V7, DOI [10.1371/journal.pgen.1001380, 10.1371/journal.pgen.1002196]; Li ZW, 2006, BIRTH DEFECTS RES A, V76, P237, DOI 10.1002/bdra.20248; Lin WC, 2008, DEV DYNAM, V237, P928, DOI 10.1002/dvdy.21479; Logan CV, 2011, MOL NEUROBIOL, V43, P12, DOI 10.1007/s12035-010-8154-0; Lopez-Camelo JS, 2005, AM J MED GENET A, V135A, P120, DOI 10.1002/ajmg.a.30651; Magdelijns FJH, 2011, PEDIATRICS, V128, pE135, DOI 10.1542/peds.2010-1690; Marean A, 2011, HUM MOL GENET, V20, P3678, DOI 10.1093/hmg/ddr289; MARINPADILLA M, 1966, ACTA ANAT, V63, P32; Massarwa R, 2013, DEVELOPMENT, V140, P226, DOI 10.1242/dev.085001; McLeod Lynne, 2002, Community Genet, V5, P33, DOI 10.1159/000064629; Meador KJ, 2006, NEUROLOGY, V67, P407, DOI 10.1212/01.wnl.0000227919.81208.b2; Molloy AM, 2009, BIRTH DEFECTS RES A, V85, P285, DOI 10.1002/bdra.20566; Momb J, 2013, P NATL ACAD SCI USA, V110, P549, DOI 10.1073/pnas.1211199110; MORITA H, 2012, XENOPUS, V139, P1417; Mosley BS, 2009, AM J EPIDEMIOL, V169, P9, DOI 10.1093/aje/kwn331; Murdoch JN, 2010, BIRTH DEFECTS RES A, V88, P633, DOI 10.1002/bdra.20686; Obican SG, 2010, FASEB J, V24, P4167, DOI 10.1096/fj.10-165084; Oh EC, 2012, DEVELOPMENT, V139, P443, DOI 10.1242/dev.050054; Olshan AF, 2005, AM J MED GENET A, V135A, P268, DOI 10.1002/ajmg.a.30713; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Piedrahita JA, 1999, NAT GENET, V23, P228, DOI 10.1038/13861; Pyrgaki C, 2010, DEV BIOL, V344, P941, DOI 10.1016/j.ydbio.2010.06.010; Ray JG, 2001, QJM-INT J MED, V94, P435, DOI 10.1093/qjmed/94.8.435; Ray JG, 2007, EPIDEMIOLOGY, V18, P362, DOI 10.1097/01.ede.0000257063.77411.e9; Roffers-Agarwal J, 2008, DEV BIOL, V314, P393, DOI 10.1016/j.ydbio.2007.12.010; Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217; Seo JH, 2011, HUM MOL GENET, V20, P4324, DOI 10.1093/hmg/ddr359; Shaw GM, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-49; Shaw GM, 2003, AM J CLIN NUTR, V78, P972, DOI 10.1093/ajcn/78.5.972; Shaw GM, 1996, JAMA-J AM MED ASSOC, V275, P1093, DOI 10.1001/jama.275.14.1093; Sheffield JS, 2002, OBSTET GYNECOL, V100, P925, DOI 10.1016/S0029-7844(02)02242-1; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; Tran PX, 2011, BIRTH DEFECTS RES A, V91, P39, DOI 10.1002/bdra.20744; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; van Straaten HWM, 2002, DEV DYNAM, V224, P103, DOI 10.1002/dvdy.10078; VanStraaten HWM, 1996, DEV DYNAM, V207, P309, DOI 10.1002/(SICI)1097-0177(199611)207:3<309::AID-AJA8>3.0.CO;2-L; Vogel TW, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.6.FOCUS12222; Waes JGV, 2008, BIRTH DEFECTS RES A, V82, P494, DOI 10.1002/bdra.20453; WALD N, 1991, LANCET, V338, P131; WALLER DK, 1994, AM J OBSTET GYNECOL, V170, P541, DOI 10.1016/S0002-9378(94)70224-1; Wallingford JB, 2005, AM J MED GENET C, V135C, P59, DOI 10.1002/ajmg.c.30054; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wallingford JB, 2001, DEVELOPMENT, V128, P2581; Wallingford JB, 2012, ANNU REV CELL DEV BI, V28, P627, DOI 10.1146/annurev-cellbio-092910-154208; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang L, 2010, AM J CLIN NUTR, V91, P1359, DOI 10.3945/ajcn.2009.28858; Werler MM, 1996, JAMA-J AM MED ASSOC, V275, P1089, DOI 10.1001/jama.275.14.1089; Whitrow MJ, 2009, AM J EPIDEMIOL, V170, P1486, DOI 10.1093/aje/kwp315; Williams LJ, 2002, TERATOLOGY, V66, P33, DOI 10.1002/tera.10060; Yamaguchi Y, 2012, CELL MOL LIFE SCI, V15; Ybot-Gonzalez P, 2002, DEVELOPMENT, V129, P2507; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P789, DOI 10.1242/dev.000380; Yildirim E, 2003, NEUROSCI LETT, V345, P141, DOI 10.1016/S0304-3940(03)00490-7; Yoon PW, 2001, PUBLIC HEALTH REP, V116, P32, DOI 10.1093/phr/116.S1.32; Zohn IE, 2005, BIRTH DEFECTS RES A, V73, P583, DOI 10.1002/bdra.20164	102	288	301	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1011	1011	1222002	10.1126/science.1222002	http://dx.doi.org/10.1126/science.1222002			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23449594	Green Accepted			2022-12-28	WOS:000315452000032
J	Bridgewater, B; Hickey, GL; Cooper, G; Deanfield, J; Roxburgh, J				Bridgewater, Ben; Hickey, Graeme L.; Cooper, Graham; Deanfield, John; Roxburgh, James		Soc Cardiothoracic Surg Great Brit; UCL	Publishing cardiac surgery mortality rates: lessons for other specialties	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PERFORMANCE		[Bridgewater, Ben] Univ S Manchester Hosp, Dept Cardiothorac Surg, Manchester M23 9LT, Lancs, England; [Bridgewater, Ben; Hickey, Graeme L.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Northwest Inst BioHlth Informat, Manchester, Lancs, England; [Cooper, Graham] No Gen Hosp, Dept Cardiothorac Surg, Sheffield, S Yorkshire, England; [Deanfield, John] Natl Inst Cardiovasc Outcomes Res, Inst Cardiovasc Sci, London, England; [Roxburgh, James] St Thomas Hosp, Dept Cardiothorac Surg, London, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; Northern General Hospital; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust	Bridgewater, B (corresponding author), Univ S Manchester Hosp, Dept Cardiothorac Surg, Manchester M23 9LT, Lancs, England.	ben.bridgewater@uhsm.nhs.uk		Cooper, Graham/0000-0002-1950-0078; Deanfield, John/0000-0001-8806-6052	Medical Research Council [MR/K006665/1, MR/K006584/1, MC_PC_13042] Funding Source: Medline; MRC [MR/K006665/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2005, GUARDIAN; Bridgewater B, 2011, MAINTAINING PATIENTS; Bridgewater B, 2009, DEMNOSTRATING QUALIT; Bridgewater B, 2007, HEART, V93, P744, DOI 10.1136/hrt.2006.106393; Bridgewater B, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2865; General Medical Council, 2012, MAK REV REC GMC RESP; Grant SW, 2008, HEART, V94, P1044, DOI 10.1136/hrt.2006.110478; Grant SW, CIRC CARDIO IN PRESS; Hickey GL, 2013, EUR J CARDIOTHORAC S; Hickey GL, 2012, EUR J CARDIOTHORAC S; NHS Commissioning Board, 2012, EV COUNTS PLANN PAT; Roques F, 2003, EUR HEART J, V24, P881, DOI 10.1016/S0195-668X(02)00799-6; Shekelle P, 2008, DOES PUBLIC RELEASE; Spiegelhalter DJ, 2005, QUAL SAF HEALTH CARE, V14, P347, DOI 10.1136/qshc.2005.013755; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; Tavare A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4464; The Society of Thoracic Surgeons, EXPL QUAL RAT COMP S	18	38	39	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 28	2013	346								f1139	10.1136/bmj.f1139	http://dx.doi.org/10.1136/bmj.f1139			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100BM	23449673				2022-12-28	WOS:000315669700001
J	Tooke, J; Wass, J				Tooke, John; Wass, John			Nurturing tomorrow's clinician scientists	LANCET			English	Editorial Material									[Tooke, John] Acad Med Sci, London, England; [Tooke, John] UCL, London, England; [Wass, John] Royal Coll Physicians, London NW1 4LE, England; [Wass, John] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England	University of London; University College London; Royal College of Physicians; University of Oxford	Tooke, J (corresponding author), Acad Med Sci, London, England.	John.tooke@acmedsci.ac.uk						[Anonymous], 2012, SUPP TOM LEAD TOD; [Anonymous], 2012, SURV STAFF LEV MED C; National Research Council (US) Committee on a framework for developing a new taxonomy of disease, 2011, PREC MED BUILD KNOWL; SMITH T, 2001, SURVEY CLIN ACAD STA; Tooke JE., 2008, ASPIRING EXCELLENCE; Wooding S, 2011, PROJECT RETROSIGHT U	6	12	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2013	381			1			1	2		10.1016/S0140-6736(13)60444-4	http://dx.doi.org/10.1016/S0140-6736(13)60444-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	300DY	23452932				2022-12-28	WOS:000330445800001
J	Sedgwick, P				Sedgwick, Philip			Case-control studies: measures of risk	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Ctr Med & Healthcare Educ, London, England	St Georges University London; University of London	Sedgwick, P (corresponding author), Univ London, Ctr Med & Healthcare Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Dumville JC, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b773; Feldkamp ML, 2008, BMJ-BRIT MED J, V336, P1420, DOI 10.1136/bmj.39567.509074.25; Sedgwick P, 2010, BMJ-BRIT MED J, V341, pc3983; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5980	4	6	6	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2013	346								f1185	10.1136/bmj.f1185	http://dx.doi.org/10.1136/bmj.f1185			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096HT	23435603				2022-12-28	WOS:000315395500008
J	Voloch-Bloch, N; Lereah, Y; Lilach, Y; Gover, A; Arie, A				Voloch-Bloch, Noa; Lereah, Yossi; Lilach, Yigal; Gover, Avraham; Arie, Ady			Generation of electron Airy beams	NATURE			English	Article							ORBITAL ANGULAR-MOMENTUM; VORTEX BEAMS; WAVE; LASER	Within the framework of quantum mechanics, a unique particle wave packet exists(1) in the form of the Airy function(2,3). Its counter-intuitive properties are revealed as it propagates in time or space; the quantum probability wave packet preserves its shape despite dispersion or diffraction and propagates along a parabolic caustic trajectory, even though no force is applied. This does not contradict Newton's laws of motion, because the wave packet centroid propagates along a straight line. Nearly 30 years later, this wave packet, known as an accelerating Airy beam, was realized(4) in the optical domain; later it was generalized to an orthogonal and complete family of beams(5) that propagate along parabolic trajectories, as well as to beams that propagate along arbitrary convex trajectories(6). Here we report the experimental generation and observation of the Airy beams of free electrons. These electron Airy beams were generated by diffraction of electrons through a nanoscale hologram(7-9), which imprinted on the electrons' wavefunction a cubic phase modulation in the transverse plane. The highest-intensity lobes of the generated beams indeed followed parabolic trajectories. We directly observed a non-spreading electron wavefunction that self-heals(10), restoring its original shape after passing an obstacle. This holographic generation of electron Airy beams opens up. new avenues for steering electronic wave packets like their photonic counterparts, because the wave packets can be imprinted with arbitrary shapes(5) or trajectories(6).	[Voloch-Bloch, Noa; Lereah, Yossi; Lilach, Yigal; Gover, Avraham; Arie, Ady] Tel Aviv Univ, Dept Phys Elect, Sch Elect Engn, Fleischman Fac Engn, IL-69978 Tel Aviv, Israel	Tel Aviv University	Voloch-Bloch, N (corresponding author), Tel Aviv Univ, Dept Phys Elect, Sch Elect Engn, Fleischman Fac Engn, IL-69978 Tel Aviv, Israel.	noavoloch@gmail.com	Lilach, Yigal/N-1091-2019		Israel Science Foundation; Israeli Ministry of Science	Israel Science Foundation(Israel Science Foundation); Israeli Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel)	N.V.-B. is an Eshkol scholar. This work was partly supported by the Israel Science Foundation and by the Israeli Ministry of Science. The author wishes to thank K. Shemer and D. Bloch for conversations.	Airy G. B., 1838, T CAMB PHILOS SOC, V6, P379; Bandres MA, 2008, OPT LETT, V33, P1678, DOI 10.1364/OL.33.001678; Baumgartl J, 2008, NAT PHOTONICS, V2, P675, DOI 10.1038/nphoton.2008.201; Berry M., 1980, CATASTROPHE OPTICS M; BERRY MV, 1979, AM J PHYS, V47, P264, DOI 10.1119/1.11855; Bliokh KY, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.174802; Bliokh KY, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.190404; Broky J, 2008, OPT EXPRESS, V16, P12880, DOI 10.1364/OE.16.012880; Dai HT, 2009, OPT EXPRESS, V17, P19365, DOI 10.1364/OE.17.019365; DURNIN J, 1987, PHYS REV LETT, V58, P1499, DOI 10.1103/PhysRevLett.58.1499; Ellenbogen T, 2009, NAT PHOTONICS, V3, P395, DOI 10.1038/NPHOTON.2009.95; Greenfield E, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.213902; Kaganovsky Y, 2010, OPT EXPRESS, V18, P8440, DOI 10.1364/OE.18.008440; LEE WH, 1979, APPL OPTICS, V18, P3661, DOI 10.1364/AO.18.003661; Lichte H, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/1/016102; Longhi S, 2011, OPT LETT, V36, P716, DOI 10.1364/OL.36.000716; McMorran BJ, 2011, SCIENCE, V331, P192, DOI 10.1126/science.1198804; Minovich A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.116802; Polynkin P, 2009, SCIENCE, V324, P229, DOI 10.1126/science.1169544; Porat G, 2011, OPT LETT, V36, P4119, DOI 10.1364/OL.36.004119; Salandrino A, 2010, OPT LETT, V35, P2082, DOI 10.1364/OL.35.002082; Siviloglou GA, 2008, OPT LETT, V33, P207, DOI 10.1364/OL.33.000207; Siviloglou GA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.213901; Sztul HI, 2008, OPT EXPRESS, V16, P9411, DOI 10.1364/OE.16.009411; Uchida M, 2010, NATURE, V464, P737, DOI 10.1038/nature08904; Verbeeck J, 2010, NATURE, V467, P301, DOI 10.1038/nature09366; Zhang P, 2011, OPT LETT, V36, P3191, DOI 10.1364/OL.36.003191	27	321	330	5	224	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					331	335		10.1038/nature11840	http://dx.doi.org/10.1038/nature11840			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23426323	Green Submitted			2022-12-28	WOS:000315312900033
J	Hoffman, A; Emanuel, EJ				Hoffman, Ari; Emanuel, Ezekiel J.			Reengineering US Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hoffman, Ari] Univ Calif San Francisco, Dept Internal Med, San Francisco, CA 94143 USA; [Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Off Provost, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA	University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Hoffman, A (corresponding author), Univ Calif San Francisco, 505 Parnassus Ave,Room 987, San Francisco, CA 94143 USA.	ari.hoffman@ucsf.edu						Champy J., 2003, REENGINEERING CORPOR; Nelson L., 2012, WORKING PAPER SERIES; Orszag P. R., 2008, EVIDENCE COSTS BENEF; Paul Ehrlich Bachalar N., 1908, NY TIMES; Pear Robert, 2010, NY TIMES	5	17	17	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2013	309	7					661	662		10.1001/jama.2012.214571	http://dx.doi.org/10.1001/jama.2012.214571			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091EK	23423408				2022-12-28	WOS:000315032000017
J	Arcelus, JI				Arcelus, Juan I.			A weighted risk index had moderate ability to predict VTE requiring treatment after outpatient surgery	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Granada, Sch Med, Granada, Spain	University of Granada	Arcelus, JI (corresponding author), Univ Granada, Sch Med, Granada, Spain.		Arcelus, Juan I./O-8142-2019						0	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2013	158	4							JC12	10.7326/0003-4819-158-4-201302190-02012	http://dx.doi.org/10.7326/0003-4819-158-4-201302190-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098WR	23420249				2022-12-28	WOS:000315580300011
J	Di Cesare, M; Khang, YH; Asaria, P; Blakely, T; Cowan, MJ; Farzadfar, F; Guerrero, R; Ikeda, N; Kyobutungi, C; Msyamboza, KP; Oum, S; Lynch, JW; Marmot, MG; Ezzati, M				Di Cesare, Mariachiara; Khang, Young-Ho; Asaria, Perviz; Blakely, Tony; Cowan, Melanie J.; Farzadfar, Farshad; Guerrero, Ramiro; Ikeda, Nayu; Kyobutungi, Catherine; Msyamboza, Kelias P.; Oum, Sophal; Lynch, John W.; Marmot, Michael G.; Ezzati, Majid		Lancet NCD Action Grp	Inequalities in non-communicable diseases and effective responses	LANCET			English	Article							CARDIOVASCULAR RISK-FACTORS; ISCHEMIC-HEART-DISEASE; SOCIOECONOMIC-STATUS; HEALTH INEQUALITIES; MYOCARDIAL-INFARCTION; LIFE EXPECTANCY; ECONOMIC-DEVELOPMENT; NUTRITION EDUCATION; SOCIAL INEQUALITIES; UNIVERSAL HEALTH	In most countries, people who have a low socioeconomic status and those who live in poor or marginalised communities have a higher risk of dying from non-communicable diseases (NCDs) than do more advantaged groups and communities. Smoking rates, blood pressure, and several other NCD risk factors are often higher in groups with low socioeconomic status than in those with high socioeconomic status; the social gradient also depends on the country's stage of economic development, cultural factors, and social and health policies. Social inequalities in risk factors account for more than half of inequalities in major NCDs, especially for cardiovascular diseases and lung cancer. People in low-income countries and those with low socioeconomic status also have worse access to health care for timely diagnosis and treatment of NCDs than do those in high-income countries or those with higher socioeconomic status. Reduction of NCDs in disadvantaged groups is necessary to achieve substantial decreases in the total NCD burden, making them mutually reinforcing priorities. Effective actions to reduce NCD inequalities include equitable early childhood development programmes and education; removal of barriers to secure employment in disadvantaged groups; comprehensive strategies for tobacco and alcohol control and for dietary salt reduction that target low socioeconomic status groups; universal, financially and physically accessible, high-quality primary care for delivery of preventive interventions and for early detection and treatment of NCDs; and universal insurance and other mechanisms to remove financial barriers to health care.	[Di Cesare, Mariachiara; Asaria, Perviz; Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, MRC HPA Ctr Environm & Hlth, Dept Epidemiol & Biostat, London W2 1PG, England; [Khang, Young-Ho] Univ Ulsan, Coll Med, Dept Prevent Med, Seoul, South Korea; [Blakely, Tony] Univ Otago, Dept Publ Hlth, Wellington, New Zealand; [Cowan, Melanie J.] WHO, Dept Chron Dis & Hlth Promot, CH-1211 Geneva, Switzerland; [Farzadfar, Farshad] Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Endocrinol & Metab Res Inst, Tehran, Iran; [Guerrero, Ramiro] Univ Icesi, PROESA Res Ctr Social Protect & Hlth Econ, Cali, Colombia; [Ikeda, Nayu] Univ Tokyo, Grad Sch Med, AXA Dept Hlth & Human Secur, Tokyo, Japan; [Kyobutungi, Catherine] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Msyamboza, Kelias P.] WHO, Malawi Country Off, Lilongwe, Malawi; [Oum, Sophal] Minist Hlth, Phnom Penh, Cambodia; [Lynch, John W.] Univ Adelaide, Sch Populat Hlth & Clin Practice, Adelaide, SA, Australia; [Lynch, John W.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Marmot, Michael G.] UCL, Dept Epidemiol & Publ Hlth, Inst Hlth Equ, London, England	Imperial College London; University of Ulsan; University of Otago; World Health Organization; Tehran University of Medical Sciences; Universidad ICESI; University of Tokyo; African Population & Health Research Centre; World Health Organization; University of Adelaide; University of Bristol; University of London; University College London	Ezzati, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC HPA Ctr Environm & Hlth, Dept Epidemiol & Biostat, Norfolk Pl, London W2 1PG, England.	majid.ezzati@imperial.ac.uk	Ikeda, Nayu/J-9890-2019; Marmot, M G/Y-3920-2019; Lynch, John W/A-4797-2008	Ikeda, Nayu/0000-0002-3424-1991; Marmot, M G/0000-0002-2431-6419; Lynch, John W/0000-0003-2781-7902; Khang, Young-Ho/0000-0002-9585-8266; Di Cesare, Mariachiara/0000-0002-3934-3364; Kyobutungi, Catherine/0000-0002-5344-5631; Farzadfar, Farshad/0000-0001-8288-4046; Blakely, Tony/0000-0002-6995-4369; Asaria, Perviz/0000-0002-9037-0894	Wellcome Trust; Health Research Council of New Zealand; Japan Society for the Promotion of Science; National Health and Medical Research Council; UK Medical Research Council; National Institute for Health Research Comprehensive Biomedical Research Centre at Imperial College Healthcare NHS Trust; Health Protection Agency in England as part of the Medical Research Council-Health Protection Agency Centre for Environment and Health at Imperial College London; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [MR/K005901/1, G0100222, G19/35, G0902037, G0801056B, G8802774] Funding Source: researchfish; MRC [MR/K005901/1, G0902037] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Health Research Council of New Zealand(Health Research Council of New Zealand); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Comprehensive Biomedical Research Centre at Imperial College Healthcare NHS Trust; Health Protection Agency in England as part of the Medical Research Council-Health Protection Agency Centre for Environment and Health at Imperial College London(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MJC is a staff member of WHO. The author alone is responsible for the views expressed in this publication and they do not necessarily represent the decisions, policy, or views of WHO. We thank June Atkinson and Peter Hambly for data, analysis, and methods related to mortality in England and New Zealand; Jorge Duarte for analysis of risk factors in Colombia; and Robert Beaglehole, Ruth Bonita, Pascal Bovet, Shah Ebrahim, Christopher Millett, participants in The Lancet Non-Communicable Disease Series review meetings, and anonymous reviewers for valuable comments on earlier drafts. PA is supported by a Wellcome Trust Clinical PhD Fellowship. TB is supported by the Health Research Council of New Zealand. NI is supported by a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science. CK is supported by a Wellcome Trust research training fellowship. JL is supported by an Australia Fellowship awarded by the National Health and Medical Research Council. ME is supported by a Strategic Award from the UK Medical Research Council and by the National Institute for Health Research Comprehensive Biomedical Research Centre at Imperial College Healthcare NHS Trust. Analysis of data from England was done by the Small Area Health Statistics Units, funded by the Health Protection Agency in England as part of the Medical Research Council-Health Protection Agency Centre for Environment and Health at Imperial College London.	Abegunde DO, 2008, SOC SCI MED, V66, P2296, DOI 10.1016/j.socscimed.2008.01.041; American Cancer Society, 2008, CANC FACTS FIG 2008; [Anonymous], 2010, HLTH NUTR POPUL SER; Atun R, 2013, LANCET, V381, P690, DOI 10.1016/S0140-6736(13)60063-X; Avendano M, 2006, HEART, V92, P461, DOI 10.1136/hrt.2005.065532; Bartley M, 2000, J EPIDEMIOL COMMUN H, V54, P806, DOI 10.1136/jech.54.11.806; Bauld L., 2011, TOBACCO CONTROL INEQ; Beaglehole R, 2013, LANCET; Beaglehole R, 2012, LANCET, V380, P1283, DOI 10.1016/S0140-6736(12)61692-4; BENNETT S, 1995, J EPIDEMIOL COMMUN H, V49, P363, DOI 10.1136/jech.49.4.363; Blakely T, 2008, BRIT MED J, V336, P371, DOI 10.1136/bmj.39455.596181.25; Blakely T, 2011, J EPIDEMIOL COMMUN H, V65, P902, DOI 10.1136/jech.2010.118588; Bleich SN, 2012, ANNU REV PUBL HEALTH, V33, P7, DOI 10.1146/annurev-publhealth-031811-124658; Boerma JT, 2007, LANCET, V369, P779, DOI 10.1016/S0140-6736(07)60364-X; Bovet P, 2008, OBES REV, V9, P511, DOI 10.1111/j.1467-789X.2008.00513.x; Bramley Dale, 2004, N Z Med J, V117, pU1215; Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002; Chang CL, 2002, J CLIN EPIDEMIOL, V55, P741, DOI 10.1016/S0895-4356(02)00413-4; Chapin CV, 1924, AM J PUBLIC HEALTH, V14, P647, DOI 10.2105/AJPH.14.8.647-a; Chartier K, 2010, ALCOHOL RES HEALTH, V33, P152; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; Cox AM, 2006, LANCET NEUROL, V5, P181, DOI 10.1016/S1474-4422(06)70351-9; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Danaei G, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000248; de Camargo KR, 2011, GLOB PUBLIC HEALTH, V6, P102, DOI 10.1080/17441692.2010.514617; Denney JT, 2010, SOC SCI RES, V39, P662, DOI 10.1016/j.ssresearch.2010.02.007; Department of Economic and Social Affairs, 2009, STAT WORLDS IND PEOP; Durkin S, 2012, TOB CONTROL, V21, P127, DOI 10.1136/tobaccocontrol-2011-050345; EAMES M, 1993, BRIT MED J, V307, P1097, DOI 10.1136/bmj.307.6912.1097; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Ezzati M, 2008, PLOS MED, V5, P557, DOI 10.1371/journal.pmed.0050066; Ezzati M, 2012, SCIENCE, V337, P1482, DOI 10.1126/science.1227001; Farzadfar F, 2012, LANCET, V379, P47, DOI 10.1016/S0140-6736(11)61349-4; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; FELDMAN JJ, 1989, AM J EPIDEMIOL, V129, P919, DOI 10.1093/oxfordjournals.aje.a115225; Ferrario M, 2001, INT J EPIDEMIOL, V30, P285, DOI 10.1093/ije/30.2.285; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fujino Y, 2005, PREV MED, V40, P444, DOI 10.1016/j.ypmed.2004.07.002; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; Gakidou E, 2007, JAMA-J AM MED ASSOC, V298, P1876, DOI 10.1001/jama.298.16.1876; Galobardes B, 2003, AM J PUBLIC HEALTH, V93, P1302, DOI 10.2105/AJPH.93.8.1302; Gornick ME, 1996, NEW ENGL J MED, V335, P791, DOI 10.1056/NEJM199609123351106; HAHN RA, 1995, EPIDEMIOLOGY, V6, P350, DOI 10.1097/00001648-199507000-00004; Hall G, 2006, INDIGENOUS PEOPLES P; Harper S, 2007, JAMA-J AM MED ASSOC, V297, P1224, DOI 10.1001/jama.297.11.1224; Hill S, 2010, J EPIDEMIOL COMMUN H, V64, P117, DOI 10.1136/jech.2008.083816; Hiscock R, 2012, ANN NY ACAD SCI, V1248, P107, DOI 10.1111/j.1749-6632.2011.06202.x; Hogerzeil HV, 2013, LANCET, V381, P680, DOI 10.1016/S0140-6736(12)62128-X; Hozawa A, 2007, ARCH INTERN MED, V167, P573, DOI 10.1001/archinte.167.6.573; IARC Working Group on the Effectiveness of Tax and Price Policies for Tobacco Control International Agency for Research on Cancer, 2011, EFF TAX PRIC POL TOB; Jakovljevic D, 2001, STROKE, V32, P1492, DOI 10.1161/01.STR.32.7.1492; Jha P., 1999, CURBING EPIDEMIC GOV; Jha P, 2006, LANCET, V368, P367, DOI 10.1016/S0140-6736(06)68975-7; Kagamimori S, 2009, SOC SCI MED, V68, P2152, DOI 10.1016/j.socscimed.2009.03.030; Kanjilal S, 2006, ARCH INTERN MED, V166, P2348, DOI 10.1001/archinte.166.21.2348; Khang YH, 2008, HEART, V94, P75, DOI 10.1136/hrt.2007.117747; Khang YH, 2004, INT J EPIDEMIOL, V33, P299, DOI 10.1093/ije/dyg244; Khang YH, 2010, INT J EPIDEMIOL, V39, P1656, DOI 10.1093/ije/dyq117; Khang YH, 2009, SOC SCI MED, V68, P858, DOI 10.1016/j.socscimed.2008.12.003; Kilander L, 2001, INT J EPIDEMIOL, V30, P1119, DOI 10.1093/ije/30.5.1119; Kivimaki M, 2008, LANCET, V372, P1648, DOI 10.1016/S0140-6736(08)61688-8; Kogevinas M, 1997, IARC Sci Publ, P177; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; Lagomarsino G, 2012, LANCET, V380, P933, DOI 10.1016/S0140-6736(12)61147-7; Law MR, 1998, J EPIDEMIOL COMMUN H, V52, P344, DOI 10.1136/jech.52.6.344; Lewin S, 2008, LANCET, V372, P928, DOI 10.1016/S0140-6736(08)61403-8; Lopez A., 2001, GPE DISCUSSION PAPER; Lorenc T, 2013, J EPIDEMIOL COMMUN H, V67, P190, DOI 10.1136/jech-2012-201257; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lynch J, 2006, J EPIDEMIOL COMMUN H, V60, P436, DOI 10.1136/jech.2005.041350; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mackenbach JP, 2012, SOC SCI MED, V75, P761, DOI 10.1016/j.socscimed.2012.02.031; Mackenbach JP, 2000, EUR HEART J, V21, P1141, DOI 10.1053/euhj.1999.1990; Mackillop WJ, 1997, J CLIN ONCOL, V15, P1680, DOI 10.1200/JCO.1997.15.4.1680; MARMOT MG, 1984, LANCET, V1, P1003; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; Massing MW, 2004, SOUTH MED J, V97, P475, DOI 10.1097/00007611-200405000-00012; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; McWilliams JM, 2009, ANN INTERN MED, V150, P505, DOI 10.7326/0003-4819-150-8-200904210-00005; Mendis S, 2005, B WORLD HEALTH ORGAN, V83, P820; Monteiro C, 2004, INT J OBESITY, V28, P1181, DOI 10.1038/sj.ijo.0802716; Moreno-Serra R, 2012, LANCET, V380, P917, DOI 10.1016/S0140-6736(12)61039-3; Mozaffarian D, 2012, CIRCULATION, V126, P1514, DOI 10.1161/CIR.0b013e318260a20b; Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260; Nelson AR, 2002, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Ni Mhurchu C, 2010, AM J CLIN NUTR, V91, P736, DOI 10.3945/ajcn.2009.28742; Nnoaham KE, 2009, INT J EPIDEMIOL, V38, P1324, DOI 10.1093/ije/dyp214; Osler M, 2000, J EPIDEMIOL COMMUN H, V54, P108, DOI 10.1136/jech.54.2.108; Pampel FC, 2012, SOC SCI MED, V74, P1073, DOI 10.1016/j.socscimed.2011.12.028; Pampel FC, 2011, DEMOGRAPHY, V48, P653, DOI 10.1007/s13524-011-0027-2; PAPPAS G, 1993, NEW ENGL J MED, V329, P103, DOI 10.1056/NEJM199307083290207; Peltonen M, 1998, J INTERN MED, V244, P1, DOI 10.1046/j.1365-2796.1998.00289.x; Regidor E, 2006, AM J PUBLIC HEALTH, V96, P102, DOI 10.2105/AJPH.2004.053983; Salomaa V, 2000, CIRCULATION, V101, P1913, DOI 10.1161/01.CIR.101.16.1913; Sankaranarayanan R, 1998, IARC Sci Publ, P135; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; Scholes S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-129; Singh GK, 2003, AM J PUBLIC HEALTH, V93, P1137, DOI 10.2105/AJPH.93.7.1137; Smith GD, 1998, LANCET, V351, P934, DOI 10.1016/S0140-6736(05)60603-4; Stevens G, 2008, PLOS MED, V5, P900, DOI 10.1371/journal.pmed.0050125; Stringhini S, 2013, INT J CARDIOL, V168, P1201, DOI 10.1016/j.ijcard.2012.11.064; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; Thomas AJ, 2005, AM J PUBLIC HEALTH, V95, P1417, DOI 10.2105/AJPH.2004.048165; Thomas S, 2008, TOB CONTROL, V17, DOI 10.1136/tc.2007.023911; Tobias M, 2009, INT J EPIDEMIOL, V38, P1711, DOI 10.1093/ije/dyp156; United Nations Human Rights, 2012, ECIAL RAPPORTEUR RIG; US Department of Health and Human Services, 2005, NAT HEALTHC DISP REP; Wada K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1191; Webster PC, 2012, LANCET, V379, P2137, DOI 10.1016/S0140-6736(12)60928-3; WHO, 2011, GLOB STAT REP NONC D; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	114	397	403	10	159	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2013	381	9866					585	597		10.1016/S0140-6736(12)61851-0	http://dx.doi.org/10.1016/S0140-6736(12)61851-0			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089RK	23410608				2022-12-28	WOS:000314927500034
J	Wang, Y; Wong, D; Shytov, AV; Brar, VW; Choi, S; Wu, Q; Tsai, HZ; Regan, W; Zettl, A; Kawakami, RK; Louie, SG; Levitov, LS; Crommie, MF				Wang, Yang; Wong, Dillon; Shytov, Andrey V.; Brar, Victor W.; Choi, Sangkook; Wu, Qiong; Tsai, Hsin-Zon; Regan, William; Zettl, Alex; Kawakami, Roland K.; Louie, Steven G.; Levitov, Leonid S.; Crommie, Michael F.			Observing Atomic Collapse Resonances in Artificial Nuclei on Graphene	SCIENCE			English	Article							SCANNING TUNNELING SPECTROSCOPY; ELECTRONIC-PROPERTIES; BORON-NITRIDE; HIGH-QUALITY; MICROSCOPY; SCATTERING; STATES	Relativistic quantum mechanics predicts that when the charge of a superheavy atomic nucleus surpasses a certain threshold, the resulting strong Coulomb field causes an unusual atomic collapse state; this state exhibits an electron wave function component that falls toward the nucleus, as well as a positron component that escapes to infinity. In graphene, where charge carriers behave as massless relativistic particles, it has been predicted that highly charged impurities should exhibit resonances corresponding to these atomic collapse states. We have observed the formation of such resonances around artificial nuclei (clusters of charged calcium dimers) fabricated on gated graphene devices via atomic manipulation with a scanning tunneling microscope. The energy and spatial dependence of the atomic collapse state measured with scanning tunneling microscopy revealed unexpected behavior when occupied by electrons.	[Wang, Yang; Wong, Dillon; Brar, Victor W.; Choi, Sangkook; Wu, Qiong; Tsai, Hsin-Zon; Regan, William; Zettl, Alex; Louie, Steven G.; Crommie, Michael F.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Wang, Yang; Wong, Dillon; Brar, Victor W.; Wu, Qiong; Regan, William; Zettl, Alex; Louie, Steven G.; Crommie, Michael F.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Shytov, Andrey V.] Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England; [Levitov, Leonid S.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Kawakami, Roland K.] Univ Calif Riverside, Dept Phys & Astron, Riverside, CA 92521 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Exeter; Massachusetts Institute of Technology (MIT); University of California System; University of California Riverside	Crommie, MF (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	crommie@berkeley.edu	Tsai, Hsin-Zon/J-1682-2016; Zettl, Alex K/O-4925-2016; Wong, Dillon/G-8530-2013	Tsai, Hsin-Zon/0000-0003-2097-0170; Zettl, Alex K/0000-0001-6330-136X; Wong, Dillon/0000-0002-4931-4188; Shytov, Andrey/0000-0002-4674-8124; Regan, William/0000-0003-0143-9827; Levitov, Leonid/0000-0002-4268-731X; Brar, Victor/0000-0002-5383-4178	Office of Naval Research Multidisciplinary University Research Initiative [N00014-09-1-1066]; Office of Science, Office of Basic Energy Sciences of the U.S. Department of Energy (DOE) [DE-AC02-05CH11231]; NSF [EEC-0832819, DMR10-1006184]; Engineering and Physical Sciences Research Council [EP/G036101/1]; EPSRC [EP/G036101/1] Funding Source: UKRI	Office of Naval Research Multidisciplinary University Research Initiative(MURIOffice of Naval Research); Office of Science, Office of Basic Energy Sciences of the U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Our research was supported by the Office of Naval Research Multidisciplinary University Research Initiative award no. N00014-09-1-1066 (graphene device preparation, characterization, and imaging); the Director, Office of Science, Office of Basic Energy Sciences of the U.S. Department of Energy (DOE) under contract no. DE-AC02-05CH11231 (STM instrumentation development and spectroscopy); NSF award nos. EEC-0832819 (dI/dV simulations) and DMR10-1006184 (DFT calculations); and Engineering and Physical Sciences Research Council grant EP/G036101/1 (Dirac equation calculations). Computational resources were provided by DOE at the LBNL National Energy Research Scientific Computing Center.	Ando T, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.074716; Boyer TH, 2004, AM J PHYS, V72, P992, DOI 10.1119/1.1737396; Brar VW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.036805; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; COWAN T, 1985, PHYS REV LETT, V54, P1761, DOI 10.1103/PhysRevLett.54.1761; Darwin CO, 1913, PHILOS MAG, V25, P201, DOI 10.1080/14786440208634017; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Decker R, 2011, NANO LETT, V11, P2291, DOI 10.1021/nl2005115; Greiner W., 1985, QUANTUM ELECTRODYNAM, V1st edn; HELLER EJ, 1994, NATURE, V369, P464, DOI 10.1038/369464a0; Hwang EH, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.205418; Kotov VN, 2012, REV MOD PHYS, V84, P1067, DOI 10.1103/RevModPhys.84.1067; Li JT, 1997, PHYS REV B, V56, P7656, DOI 10.1103/PhysRevB.56.7656; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Pereira VM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.166802; Pomeranchuk I., 1945, J PHYS-USSR, V9, P97; SCHWEPPE J, 1983, PHYS REV LETT, V51, P2261, DOI 10.1103/PhysRevLett.51.2261; Shytov AV, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.236801; Shytov AV, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.246802; Wang Y, 2012, NAT PHYS, V8, P653, DOI [10.1038/nphys2379, 10.1038/NPHYS2379]; Wittneven C, 1998, PHYS REV LETT, V81, P5616, DOI 10.1103/PhysRevLett.81.5616; Xue JM, 2011, NAT MATER, V10, P282, DOI 10.1038/NMAT2968; ZELDOVICH YB, 1972, SOV PHYS USPEKHI, V14, P673, DOI 10.1070/PU1972v014n06ABEH004735; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Zhang YB, 2008, NAT PHYS, V4, P627, DOI 10.1038/nphys1022	26	165	170	1	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					734	737		10.1126/science.1234320	http://dx.doi.org/10.1126/science.1234320			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23470728	Green Submitted			2022-12-28	WOS:000318619000036
J	Kim, HJ; Kim, NC; Wang, YD; Scarborough, EA; Moore, J; Diaz, Z; MacLea, KS; Freibaum, B; Li, SQ; Molliex, A; Kanagaraj, AP; Carter, R; Boylan, KB; Wojtas, AM; Rademakers, R; Pinkus, JL; Greenberg, SA; Trojanowski, JQ; Traynor, BJ; Smith, BN; Topp, S; Gkazi, AS; Miller, J; Shaw, CE; Kottlors, M; Kirschner, J; Pestronk, A; Li, YR; Ford, AF; Gitler, AD; Benatar, M; King, OD; Kimonis, VE; Ross, ED; Weihl, CC; Shorter, J; Taylor, JP				Kim, Hong Joo; Kim, Nam Chul; Wang, Yong-Dong; Scarborough, Emily A.; Moore, Jennifer; Diaz, Zamia; MacLea, Kyle S.; Freibaum, Brian; Li, Songqing; Molliex, Amandine; Kanagaraj, Anderson P.; Carter, Robert; Boylan, Kevin B.; Wojtas, Aleksandra M.; Rademakers, Rosa; Pinkus, Jack L.; Greenberg, Steven A.; Trojanowski, John Q.; Traynor, Bryan J.; Smith, Bradley N.; Topp, Simon; Gkazi, Athina-Soragia; Miller, Jack; Shaw, Christopher E.; Kottlors, Michael; Kirschner, Janbernd; Pestronk, Alan; Li, Yun R.; Ford, Alice Flynn; Gitler, Aaron D.; Benatar, Michael; King, Oliver D.; Kimonis, Virginia E.; Ross, Eric D.; Weihl, Conrad C.; Shorter, James; Taylor, J. Paul			Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS	NATURE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; RNA-BINDING PROTEINS; DROSOPHILA MODEL; SACCHAROMYCES-CEREVISIAE; FRONTOTEMPORAL DEMENTIA; MULTIPLE ALIGNMENT; STRESS GRANULES; VCP MUTATIONS; TDP-43; DISEASE	Algorithms designed to identify canonical yeast prions predict that around 250 human proteins, including several RNA-binding proteins associated with neurodegenerative disease, harbour a distinctive prion-like domain (PrLD) enriched in uncharged polar amino acids and glycine. PrLDs in RNA-binding proteins are essential for the assembly of ribonucleoprotein granules. However, the interplay between human PrLD function and disease is not understood. Here we define pathogenic mutations in PrLDs of heterogeneous nuclear ribonucleoproteins (hnRNPs) A2B1 and A1 in families with inherited degeneration affecting muscle, brain, motor neuron and bone, and in one case of familial amyotrophic lateral sclerosis. Wild-type hnRNPA2 (the most abundant isoform of hnRNPA2B1) and hnRNPA1 show an intrinsic tendency to assemble into self-seeding fibrils, which is exacerbated by the disease mutations. Indeed, the pathogenic mutations strengthen a 'steric zipper' motif in the PrLD, which accelerates the formation of self-seeding fibrils that cross-seed polymerization of wild-type hnRNP. Notably, the disease mutations promote excess incorporation of hnRNPA2 and hnRNPA1 into stress granules and drive the formation of cytoplasmic inclusions in animal models that recapitulate the human pathology. Thus, dysregulated polymerization caused by a potent mutant steric zipper motif in a PrLD can initiate degenerative disease. Related proteins with PrLDs should therefore be considered candidates for initiating and perhaps propagating proteinopathies of muscle, brain, motor neuron and bone.	[Kim, Hong Joo; Kim, Nam Chul; Moore, Jennifer; Freibaum, Brian; Li, Songqing; Molliex, Amandine; Kanagaraj, Anderson P.; Taylor, J. Paul] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38120 USA; [Wang, Yong-Dong] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38120 USA; [Scarborough, Emily A.; Diaz, Zamia; Ford, Alice Flynn; Shorter, James] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [MacLea, Kyle S.; Ross, Eric D.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Carter, Robert] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38120 USA; [Boylan, Kevin B.; Wojtas, Aleksandra M.; Rademakers, Rosa] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Pinkus, Jack L.; Greenberg, Steven A.] Harvard Univ, Brigham & Womens Hosp, Dept Neurol, Sch Med, Boston, MA 02115 USA; [Trojanowski, John Q.; Smith, Bradley N.] Univ Penn, Dept Pathol & Lab Med, Inst Aging, Philadelphia, PA 19104 USA; [Trojanowski, John Q.; Smith, Bradley N.] Univ Penn, Ctr Neurodegenerat Dis Res, Perelman Sch Med, Philadelphia, PA 19104 USA; [Traynor, Bryan J.] NIA, Neuromuscular Dis Res Grp, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Topp, Simon; Gkazi, Athina-Soragia; Miller, Jack; Shaw, Christopher E.] Kings Coll London, Ctr Neurodegenerat Res, Dept Clin Neurosci, Inst Psychiat, London SE5 8AF, England; [Kottlors, Michael; Kirschner, Janbernd] Univ Childrens Hosp Freiburg, Div Neuropediat & Muscle Disorders, D-79106 Freiburg, Germany; [Pestronk, Alan; Weihl, Conrad C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Li, Yun R.] Univ Penn, Med Sci Training Program, Perelman Sch Med, Philadelphia, PA 19104 USA; [Gitler, Aaron D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Benatar, Michael] Univ Miami, Neurol Dept, Miller Sch Med, Miami, FL 33136 USA; [King, Oliver D.] Boston Biomed Res Inst, Watertown, MA 02472 USA; [Kimonis, Virginia E.] Univ Calif Irvine, Dept Pediat, Div Genet & Metab, Irvine, CA 92696 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Pennsylvania; Pennsylvania Medicine; Colorado State University; St Jude Children's Research Hospital; Mayo Clinic; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; King's College London; University of Freiburg; Washington University (WUSTL); University of Pennsylvania; Pennsylvania Medicine; Stanford University; University of Miami; Boston Biomedical Research Institute; University of California System; University of California Irvine	Taylor, JP (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38120 USA.	jshorter@mail.med.upenn.edu; JPaul.Taylor@STJUDE.ORG	Traynor, Bryan J/G-5690-2010; Shorter, James/ABE-7307-2020; Benatar, Michael/AAF-6605-2019; Wang, Yong-Dong/K-3563-2013; KANAGARAJ, A/GZG-4720-2022; Smith, Bradley/H-6107-2013; Taylor, J. Paul/N-2482-2018; MacLea, Kyle/S-3269-2019; Kirschner, Janbernd/Q-1493-2019; Kirschner, Janbernd/H-7418-2016	Shorter, James/0000-0001-5269-8533; Benatar, Michael/0000-0003-4241-5135; Taylor, J. Paul/0000-0002-5794-0349; MacLea, Kyle/0000-0001-7086-1074; Kirschner, Janbernd/0000-0003-1618-7386; Kirschner, Janbernd/0000-0003-1618-7386; Shaw, Christopher/0000-0003-0251-0146; topp, simon/0000-0002-5200-3284; Kim, Nam Chul/0000-0003-1332-3071; Kim, Hong Joo/0000-0002-9157-1612; Ross, Eric/0000-0002-6473-9977; , Palsamy Kanagaraj/0000-0003-3297-3125; Gitler, Aaron/0000-0001-8603-1526; Li, Yun Rose/0000-0002-8077-4975	ALSAC; Packard Foundation; National Institutes of Health (NIH) [NS053825]; ALS Association; NIH [AG032953, DP2OD002177, NS067354, AG031867]; Ellison Medical Foundation; National Science Foundation [MCB-1023771]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067354, R01NS053825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG042095, ZIAAG000933, R01AG031867, P01AG032953] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002177] Funding Source: NIH RePORTER; Direct For Biological Sciences [1023771] Funding Source: National Science Foundation; MRC [G0900688, MC_G1000733] Funding Source: UKRI; Medical Research Council [G0900688, MC_G1000733, G0500289B] Funding Source: researchfish	ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); Packard Foundation(The David & Lucile Packard Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALS Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the patients whose participation made this work possible. We thank the St Jude Pediatric Cancer Genome Project and J. Zhang in particular for providing access to control sequencing data. We thank C. Gellera, B. Baloh, M. Harms, S. Krause, G. Dreyfuss and T. Cundy for sharing reagents. We thank S. Donkervoort and S. Mumm for coordinating samples, and A. Taylor for editorial assistance. J.P.T. was supported by ALSAC, the Packard Foundation and the National Institutes of Health (NIH) (NS053825); J.P.T. and M. B. were supported by the ALS Association; J.Q.T. was supported by the NIH (AG032953); J.S. was supported by the NIH (DP2OD002177 and NS067354) and the Ellison Medical Foundation; E. D. R. was supported by the National Science Foundation (MCB-1023771). C. C. W. was supported by the NIH (AG031867).	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Chung PYJ, 2011, MOL GENET METAB, V103, P287, DOI 10.1016/j.ymgme.2011.03.021; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Goode MG, 2007, BIOINFORMATICS, V23, P1553, DOI 10.1093/bioinformatics/btm128; Guthrie C., 2002, METHODS EZYMOLOGY GU, V169; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kottlors M, 2010, J NEUROL SCI, V291, P79, DOI 10.1016/j.jns.2009.12.008; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; Nalbandian A, 2011, J MOL NEUROSCI, V45, P522, DOI 10.1007/s12031-011-9627-y; Neumann M, 2011, BRAIN, V134, P2595, DOI 10.1093/brain/awr201; Neumann M, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001136; Ritson GP, 2010, J NEUROSCI, V30, P7729, DOI 10.1523/JNEUROSCI.5894-09.2010; Ross CD, 2009, GENETICS, V183, P929, DOI 10.1534/genetics.109.109322; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Salajegheh M, 2009, MUSCLE NERVE, V40, P19, DOI 10.1002/mus.21386; Shi Z, 2012, EUR J NEUROL, V19, P501, DOI 10.1111/j.1468-1331.2011.03575.x; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Song YT, 2005, EUKARYOT CELL, V4, P289, DOI 10.1128/EC.4.2.289-297.2005; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Teng PK, 2009, PROTEIN ENG DES SEL, V22, P531, DOI 10.1093/protein/gzp037; Toombs JA, 2010, MOL CELL BIOL, V30, P319, DOI 10.1128/MCB.01140-09; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Wolozin B, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-56; Zwickl DJ, 2006, THESIS	37	933	953	6	296	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2013	495	7442					467	+		10.1038/nature11922	http://dx.doi.org/10.1038/nature11922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113QN	23455423	Green Submitted, Green Accepted			2022-12-28	WOS:000316682800037
J	Rosenbaum, L				Rosenbaum, Lisa			The Whole Ball Game - Overcoming the Blind Spots in Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rosenbaum, Lisa] Univ Penn, Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; [Rosenbaum, Lisa] Univ Penn, Robert Wood Johnson Fdn Clin Scholars Program, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; Robert Wood Johnson Foundation (RWJF); University of Pennsylvania	Rosenbaum, L (corresponding author), Univ Penn, Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA.							Ash LM, 2008, AM J NEURORADIOL, V29, P1098, DOI 10.3174/ajnr.A0999; Baumann BM, 2011, ANN EMERG MED, V58, P1, DOI 10.1016/j.annemergmed.2010.10.018; Berwick DM., 2012, IN HEALTH CARE CHEAP; BRUNER JS, 1964, SCIENCE, V144, P424, DOI 10.1126/science.144.3617.424; Chabris C, 2010, THE INVISIBLE GORILL; GILBERT DT, 1991, AM PSYCHOL, V46, P107, DOI 10.1037/0003-066X.46.2.107; Kendrick D, 2001, BRIT MED J, V322, P400, DOI 10.1136/bmj.322.7283.400; Medicare Payment Advisory Commission, 2006, MEDPAC RECOMMENDATIO; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; Rozanski A, 2011, J AM COLL CARDIOL, V57, P1622, DOI 10.1016/j.jacc.2011.01.019; SOX HC, 1981, ANN INTERN MED, V95, P680, DOI 10.7326/0003-4819-95-6-680	11	25	25	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2013	368	10					959	962		10.1056/NEJMms1301576	http://dx.doi.org/10.1056/NEJMms1301576			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100BG	23465107				2022-12-28	WOS:000315669100015
J	Tucker, ME				Tucker, Miriam E.			Physician pay is changing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												miriametucker@aol.com						National Commission on Physician Payment Reform, REP NAT COMM PHYS PA	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2013	346								f1540	10.1136/bmj.f1540	http://dx.doi.org/10.1136/bmj.f1540			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104MT	23471442				2022-12-28	WOS:000315998500005
J	Xu, Y; Ma, PJ; Shah, P; Rokas, A; Liu, Y; Johnson, CH				Xu, Yao; Ma, Peijun; Shah, Premal; Rokas, Antonis; Liu, Yi; Johnson, Carl Hirschie			Non-optimal codon usage is a mechanism to achieve circadian clock conditionality	NATURE			English	Article							GENE-EXPRESSION; ESCHERICHIA-COLI; CYANOBACTERIA; SELECTION; BIAS; TEMPERATURE; PROKARYOTES; ADAPTATION; EFFICIENCY; DROSOPHILA	Circadian rhythms are oscillations in biological processes that function as a key adaptation to the daily rhythms of most environments. In the model cyanobacterial circadian clock system, the core oscillator proteins are encoded by the gene cluster kaiABC(1). Genes with high expression and functional importance, such as the kai genes, are usually encoded by optimal codons, yet the codon-usage bias of the kaiBC genes is not optimized for translational efficiency. We discovered a relationship between codon usage and a general property of circadian rhythms called conditionality; namely, that endogenous rhythmicity is robustly expressed under some environmental conditions but not others(2). Despite the generality of circadian conditionality, however, its molecular basis is unknown for any system. Here we show that in the cyanobacterium Synechococcus elongate, non-optimal codon usage was selected as a post-transcriptional. mechanism to switch between circadian and non-circadian regulation of gene expression as an adaptive response to environmental conditions. When the kaiBC sequence was experimentally optimized to enhance expression of the KaiB and KaiC proteins, intrinsic rhythmicity was enhanced at cool temperatures that are experienced by this organism in. its natural habitat. However, fitness at those temperatures was highest in cells hi which the endogenous rhythms were suppressed at cool temperatures as compared with cells exhibiting high-amplitude rhythmicity. These results indicate natural selection against circadian systems in cyanobacteria that are intrinsically robust at cool temperatures. Modulation of circadian amplitude is therefore crucial to its adaptive significance(3). Moreover, these results show the direct effects of codon usage on a complex phenotype and organismal fitness. Our work also challenges the long-standing view of directional selection towards optimal codons(4-7), and provides a key example of natural selection against optimal codons to achieve adaptive responses to environmental changes.	[Xu, Yao; Ma, Peijun; Rokas, Antonis; Johnson, Carl Hirschie] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Shah, Premal] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Liu, Yi] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	Vanderbilt University; University of Pennsylvania; University of Texas System; University of Texas Southwestern Medical Center Dallas	Johnson, CH (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	carl.h.johnson@vanderbilt.edu	Rokas, Antonis/A-9775-2008; Johnson, Carl H/I-4655-2014	Rokas, Antonis/0000-0002-7248-6551; Shah, Premal/0000-0002-8424-4218	National Institute of General Medical Science [R01 GM067152, R01 GM088595, GM068496, GM062591]; Welch Foundation [I-1560]; National Science Foundation [DEB-0844968]; Searle Scholars Program; Burroughs Wellcome Fund Career Award; David & Lucille Packard Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM067152, R35GM118118, R01GM107434, R01GM084283, R01GM067152, R01GM062591, R01GM068496, R01GM088595] Funding Source: NIH RePORTER	National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); National Science Foundation(National Science Foundation (NSF)); Searle Scholars Program; Burroughs Wellcome Fund Career Award(Burroughs Wellcome Fund); David & Lucille Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful for the suggestions of M. Woelfle and the technical assistance of D. Zelli and C. Chintanaphol. This research was supported by grants from the National Institute of General Medical Science to C.H.J. (R01 GM067152 and R01 GM088595) and to Y.L. (GM068496 and GM062591), the Welch Foundation (I-1560) to Y.L., and the National Science Foundation (DEB-0844968) and the Searle Scholars Program to A.R. P.S. acknowledges support from a Burroughs Wellcome Fund Career Award and a David & Lucille Packard Foundation Fellowship awarded to Joshua B. Plotkin.	AKASHI H, 1994, GENETICS, V136, P927; BULMER M, 1991, GENETICS, V129, P897; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; EYREWALKER A, 1993, NUCLEIC ACIDS RES, V21, P4599, DOI 10.1093/nar/21.19.4599; Gu WJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000664; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Ito H, 2009, P NATL ACAD SCI USA, V106, P14168, DOI 10.1073/pnas.0902587106; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; KONIGSBERG W, 1983, P NATL ACAD SCI-BIOL, V80, P687, DOI 10.1073/pnas.80.3.687; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Liu Y, 1997, CELL, V89, P477, DOI 10.1016/S0092-8674(00)80228-7; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; Lynn DJ, 2002, NUCLEIC ACIDS RES, V30, P4272, DOI 10.1093/nar/gkf546; Nakajima M, 2010, FEBS LETT, V584, P898, DOI 10.1016/j.febslet.2010.01.016; NJUS D, 1977, J COMP PHYSIOL, V117, P335, DOI 10.1007/BF00691559; Paul S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r70; PITTENDRIGH CS, 1954, P NATL ACAD SCI USA, V40, P1018, DOI 10.1073/pnas.40.10.1018; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Shah P, 2011, P NATL ACAD SCI USA, V108, P10231, DOI 10.1073/pnas.1016719108; Shah P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001128; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Vijayan V, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r47; Vijayan V, 2009, P NATL ACAD SCI USA, V106, P22564, DOI 10.1073/pnas.0912673106; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023; Woelfle MA, 2007, P NATL ACAD SCI USA, V104, P18819, DOI 10.1073/pnas.0706069104; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Zhou T, 2009, MOL BIOL EVOL, V26, P1571, DOI 10.1093/molbev/msp070	30	129	131	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2013	495	7439					116	120		10.1038/nature11942	http://dx.doi.org/10.1038/nature11942			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23417065	Green Accepted			2022-12-28	WOS:000316039800051
J	[Anonymous]				[Anonymous]			After Mid Staffs: the NHS must do more to care for the health of its staff	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Boorman S., 2009, NHS HLTH WELL BEING; Health and Safety Executive, 2011, SELF REP WORK REL IL; Jones JR, 2001, SELF REPORTED WORK R	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2013	346								f1503	10.1136/bmj.f1503	http://dx.doi.org/10.1136/bmj.f1503			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104MT	23471441				2022-12-28	WOS:000315998500002
J	Karatas, H; Erdener, SE; Gursoy-Ozdemir, Y; Lule, S; Eren-Kocak, E; Sen, ZD; Dalkara, T				Karatas, Hulya; Erdener, Sefik Evren; Gursoy-Ozdemir, Yasemin; Lule, Sevda; Eren-Kocak, Emine; Sen, Zumrut Duygu; Dalkara, Turgay			Spreading Depression Triggers Headache by Activating Neuronal Panx1 Channels	SCIENCE			English	Article							MENINGEAL NOCICEPTORS; CHROMATIN PROTEIN; MIGRAINE AURA; EXPRESSION; HMGB1; MECHANISMS; PAIN; DEGRANULATION; SENSITIZATION; INFLAMMASOME	The initial phase in the development of a migraine is still poorly understood. Here, we describe a previously unknown signaling pathway between stressed neurons and trigeminal afferents during cortical spreading depression (CSD), the putative cause of migraine aura and headache. CSD caused neuronal Pannexin1 (Panx1) megachannel opening and caspase-1 activation followed by high-mobility group box 1 (HMGB1) release from neurons and nuclear factor kappa B activation in astrocytes. Suppression of this cascade abolished CSD-induced trigeminovascular activation, dural mast cell degranulation, and headache. CSD-induced neuronal megachannel opening may promote sustained activation of trigeminal afferents via parenchymal inflammatory cascades reaching glia limitans. This pathway may function to alarm an organism with headache when neurons are stressed.	[Karatas, Hulya; Erdener, Sefik Evren; Gursoy-Ozdemir, Yasemin; Lule, Sevda; Eren-Kocak, Emine; Sen, Zumrut Duygu; Dalkara, Turgay] Hacettepe Univ, Inst Neurol Sci & Psychiat, TR-06100 Ankara, Turkey; [Karatas, Hulya; Erdener, Sefik Evren; Gursoy-Ozdemir, Yasemin; Dalkara, Turgay] Hacettepe Univ, Dept Neurol, Fac Med, TR-06100 Ankara, Turkey; [Eren-Kocak, Emine; Sen, Zumrut Duygu] Hacettepe Univ, Dept Psychiat, Fac Med, TR-06100 Ankara, Turkey	Hacettepe University; Hacettepe University; Hacettepe University	Dalkara, T (corresponding author), Hacettepe Univ, Inst Neurol Sci & Psychiat, TR-06100 Ankara, Turkey.	tdalkara@hacettepe.edu.tr	Lule, Sevda/N-8229-2017; Karatas, Hulya/J-1459-2013; Gursoy-Ozdemir, Yasemin/X-2778-2019; ERDENER, SEFIK EVREN/I-9202-2013; Erdener, Sefik Evren/B-2924-2014	Lule, Sevda/0000-0001-7066-6471; Karatas, Hulya/0000-0003-4838-6320; Gursoy-Ozdemir, Yasemin/0000-0002-0860-8964; ERDENER, SEFIK EVREN/0000-0002-5141-7899; Erdener, Sefik Evren/0000-0002-5141-7899; Dalkara, Turgay/0000-0003-3943-7819	Turkish Academy of Sciences; Hacettepe University Research Fund [08-D07-101-011]; Brain Research Association	Turkish Academy of Sciences(Turkish Academy of Sciences); Hacettepe University Research Fund(Hacettepe University); Brain Research Association	We are grateful to M. A. Moskowitz for helpful discussions, K. Kilic and E. Lule for their expert help with the figures, and to A. Can for his help with confocal microscopy. This work was supported by the Turkish Academy of Sciences (T. D.), Hacettepe University Research Fund 08-D07-101-011 (Y.G.-O.), and the Brain Research Association (H. K.).	Bolay H, 2002, NAT MED, V8, P136, DOI 10.1038/nm0202-136; Dalkara T, 2006, NEUROL SCI, V27, pS86, DOI 10.1007/s10072-006-0577-z; Faraco G, 2007, J NEUROCHEM, V103, P590, DOI 10.1111/j.1471-4159.2007.04788.x; Goadsby PJ, 2007, TRENDS MOL MED, V13, P39, DOI 10.1016/j.molmed.2006.11.005; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Jander S, 2001, J CEREBR BLOOD F MET, V21, P218, DOI 10.1097/00004647-200103000-00005; Kunkler PE, 2004, J CEREBR BLOOD F MET, V24, P829, DOI 10.1097/01.WCB.0000126566.34753.30; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Levy D, 2007, PAIN, V130, P166, DOI 10.1016/j.pain.2007.03.012; Levy D, 2012, CURR PAIN HEADACHE R, V16, P270, DOI 10.1007/s11916-012-0255-1; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; MARKOWITZ S, 1989, BRAIN RES, V477, P157, DOI 10.1016/0006-8993(89)91403-0; MOSKOWITZ MA, 1984, ANN NEUROL, V16, P157, DOI 10.1002/ana.410160202; MOSKOWITZ MA, 1993, J NEUROSCI, V13, P1167, DOI 10.1523/jneurosci.13-03-01167.1993; Moskowitz MA, 2008, HEADACHE, V48, P688, DOI 10.1111/j.1526-4610.2008.01110.x; Muller S, 2004, J INTERN MED, V255, P332, DOI 10.1111/j.1365-2796.2003.01296.x; OLESEN J, 1990, ANN NEUROL, V28, P791, DOI 10.1002/ana.410280610; Olesen J, 2009, LANCET NEUROL, V8, P679, DOI 10.1016/S1474-4422(09)70090-0; Pedrazzi M, 2007, J IMMUNOL, V179, P8525, DOI 10.4049/jimmunol.179.12.8525; Pisetsky DS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2440; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Strassman AM, 1996, NATURE, V384, P560, DOI 10.1038/384560a0; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Zhang XC, 2011, ANN NEUROL, V69, P855, DOI 10.1002/ana.22329; Zhang XC, 2010, J NEUROSCI, V30, P8807, DOI 10.1523/JNEUROSCI.0511-10.2010	29	301	304	6	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1092	1095		10.1126/science.1231897	http://dx.doi.org/10.1126/science.1231897			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23449592				2022-12-28	WOS:000315452000046
J	Collins, JJ; Wang, B; Lambrus, BG; Tharp, ME; Iyer, H; Newmark, PA				Collins, James J., III; Wang, Bo; Lambrus, Bramwell G.; Tharp, Marla E.; Iyer, Harini; Newmark, Phillip A.			Adult somatic stem cells in the human parasite Schistosoma mansoni	NATURE			English	Article							DNA-SYNTHESIS; PLANARIAN; REGENERATION; GROWTH; PLURIPOTENCY; REGULATORS; GENOME; MODEL; SEX	Schistosomiasis is among the most prevalent human parasitic diseases, affecting more than 200 million people worldwide(1). The aetiological agents of this disease are trematode flatworms (Schistosoma) that live and lay eggs within the vasculature of the host. These eggs lodge in host tissues, causing inflammatory responses that are the primary cause of morbidity. Because these parasites can live and reproduce within human hosts for decades', elucidating the mechanisms that promote their longevity is of fundamental importance. Although adult pluripotent stem cells, called neoblasts, drive long-term homeostatic tissue maintenance in long-lived free-living flatworms(3,4) (for example, planarians), and neoblast-like cells have been described in some parasitic tapeworms', little is known about whether similar cell types exist in any trematode species. Here we describe a population of neoblast-like cells in the trematode Schistosoma mansoni. These cells resemble planarian neoblasts morphologically and share their ability to proliferate and differentiate into derivatives of multiple germ layers. Capitalizing on available genomic resources(6,7) and RNA-seq-based gene expression profiling, we find that these schistosome neoblast-like cells express a fibroblast growth factor receptor orthologue. Using RNA interference we demonstrate that this gene is required for the maintenance of these neoblast-like cells. Our observations indicate that adaptation of developmental strategies shared by free-living ancestors to modern-day schistosomes probably contributed to the success of these animals as long-lived obligate parasites. We expect that future studies deciphering the function of these neoblast-like cells will have important implications for understanding the biology of these devastating parasites.	[Collins, James J., III; Wang, Bo; Lambrus, Bramwell G.; Tharp, Marla E.; Iyer, Harini; Newmark, Phillip A.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA; [Collins, James J., III; Wang, Bo; Lambrus, Bramwell G.; Tharp, Marla E.; Iyer, Harini; Newmark, Phillip A.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Collins, James J., III; Newmark, Phillip A.] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; [Wang, Bo] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Newmark, PA (corresponding author), Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA.	pnewmark@life.illinois.edu		Newmark, Phillip/0000-0003-0793-022X; Tharp, Marla/0000-0002-0653-1123	NIAID [HHSN272201000005I]; NIH [F32 HD062124, R21 AI099642]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD062124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI099642] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Roberts-Galbraith, M. Issigonis and L. Rouhana for comments on the manuscript; R. King for sharing the cathepsin B plasmid and unpublished protocols; and A. Hernandez for assistance with Illumina sequencing. Schistosome-infected mice were provided by the NIAID Schistosomiasis Resource Center and the Biomedical Research Institute through NIAID contract no. HHSN272201000005I. This work was supported by: NIH F32 HD062124 (JJ.C.) and NIH R21 AI099642 (PAN.). PAN. is an investigator of the Howard Hughes Medical Institute.	BAGUNA J, 1981, HYDROBIOLOGIA, V84, P181, DOI 10.1007/BF00026179; Basch P, 1991, SCHISTOSOMES DEV REP; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Brehm K, 2010, PARASITOLOGY, V137, P537, DOI 10.1017/S0031182009991727; Caffrey CR, 2004, TRENDS PARASITOL, V20, P241, DOI 10.1016/j.pt.2004.03.004; Chitsulo L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4; Collins JJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001009; Collins JJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000509; Davies SJ, 2001, SCIENCE, V294, P1358, DOI 10.1126/science.1064462; DENHOLLANDER JE, 1984, PARASITOLOGY, V88, P463, DOI 10.1017/S0031182000054731; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Forsthoefel DJ, 2011, DEV BIOL, V356, P445, DOI 10.1016/j.ydbio.2011.05.669; Juliano C, 2010, SCIENCE, V329, P640, DOI 10.1126/science.1194037; Labbe RM, 2012, STEM CELLS, V30, P1734, DOI 10.1002/stem.1144; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; NOLLEN PM, 1976, J PARASITOL, V62, P227, DOI 10.2307/3279273; Onal P, 2012, EMBO J, V31, P2755, DOI 10.1038/emboj.2012.110; Ogawa K, 2002, DEV GROWTH DIFFER, V44, P191; Pearson BJ, 2010, DEVELOPMENT, V137, P213, DOI 10.1242/dev.044297; Protasio AV, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001455; Rouhana L, 2010, DEV BIOL, V341, P429, DOI 10.1016/j.ydbio.2010.02.037; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Severinghaus AE, 1928, Q J MICROSC SCI, V71, P653; SHAW MK, 1987, PARASITOLOGY, V94, P243, DOI 10.1017/S0031182000053920; Skinner DE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001686; Solana J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r19; Wagner DE, 2012, CELL STEM CELL, V10, P299, DOI 10.1016/j.stem.2012.01.016; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983	30	142	142	1	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2013	494	7438					476	479		10.1038/nature11924	http://dx.doi.org/10.1038/nature11924			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23426263	Green Accepted			2022-12-28	WOS:000315661500038
J	Bown, MJ; Sweeting, MJ; Brown, LC; Powell, JT; Thompson, SG				Bown, Matthew J.; Sweeting, Michael J.; Brown, Louise C.; Powell, Janet T.; Thompson, Simon G.		RESCAN Collaborators	Surveillance Intervals for Small Abdominal Aortic Aneurysms A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VASCULAR-SURGERY; EXPANSION RATE; GROWTH-RATES; OPEN REPAIR; MORTALITY; WOMEN; TRIAL; RISK; MEN; RUPTURE	Importance Small abdominal aortic aneurysms (AAAs [3.0 cm-5.4 cm in diameter]) are monitored by ultrasound surveillance. The intervals between surveillance scans should be chosen to detect an expanding aneurysm prior to rupture. Objective To limit risk of aneurysm rupture or excessive growth by optimizing ultrasound surveillance intervals. Data Sources and Study Selection Individual patient data from studies of small AAA growth and rupture were assessed. Studies were identified for inclusion through a systematic literature search through December 2010. Study authors were contacted, which yielded 18 data sets providing repeated ultrasound measurements of AAA diameter over time in 15 471 patients. Data Extraction AAA diameters were analyzed using a random-effects model that allowed for between-patient variability in size and growth rate. Rupture rates were analyzed by proportional hazards regression using the modeled AAA diameter as a time-varying covariate. Predictions of the risks of exceeding 5.5-cm diameter and of rupture within given time intervals were estimated and pooled across studies by random effects meta-analysis. Results AAA growth and rupture rates varied considerably across studies. For each 0.5-cm increase in AAA diameter, growth rates increased on average by 0.59 mm per year (95% CI, 0.51-0.66) and rupture rates increased by a factor of 1.91 (95% CI, 1.61-2.25). For example, to control the AAA growth risk in men of exceeding 5.5 cm to below 10%, on average, a 7.4-year surveillance interval (95% CI, 6.7-8.1) is sufficient for a 3.0-cm AAA, while an 8-month interval (95% CI, 7-10) is necessary for a 5.0-cm AAA. To control the risk of rupture in men to below 1%, the corresponding estimated surveillance intervals are 8.5 years (95% CI, 7.0-10.5) and 17 months (95% CI, 14-22). Conclusion and Relevance In contrast to the commonly adopted surveillance intervals in current AAA screening programs, surveillance intervals of several years may be clinically acceptable for the majority of patients with small AAA. JAMA. 2013;309(8):806-813	[Bown, Matthew J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Bown, Matthew J.] Univ Leicester, Natl Inst Hlth Res, Leicester Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Sweeting, Michael J.] MRC, Biostat Unit, Cambridge CB2 2BW, England; [Brown, Louise C.] MRC, Clin Trials Unit, London, England; [Powell, Janet T.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Vasc Surg Res Grp, London, England; [Thompson, Simon G.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, Cambridge, England	University of Leicester; University of Leicester; MRC Biostatistics Unit; Medical Research Council Clinical Trials Unit; Imperial College London; University of Cambridge	Thompson, SG (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, Cambridge, England.	sgt27@medschl.cam.ac.uk	Bown, Matthew/P-1957-2016; Sweeting, Michael John/U-3917-2019; Powell, Janet/AAW-8669-2021; Lindholt, Jes/J-2907-2014	Bown, Matthew/0000-0002-6180-3611; Sweeting, Michael John/0000-0003-0980-8965; Powell, Janet/0000-0002-3905-1468; Lindholt, Jes/0000-0001-9536-4488; Sharples, Linda/0000-0003-0894-966X	Higher Education Funding Council for England; National Institute for Health Research (NIHR) Health Technology Assessment; UK government; NIHR; UK NIHR Health Technology Assessment Programme [08/30/02]; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/L003120/1, MC_U105260792, MC_U105232027] Funding Source: researchfish; National Institute for Health Research [08/30/02, 09/91/39, NF-SI-0512-10165] Funding Source: researchfish; MRC [MC_U105232027, MC_U105260792, MR/L003120/1] Funding Source: UKRI	Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); National Institute for Health Research (NIHR) Health Technology Assessment(National Institute for Health Research (NIHR)); UK government; NIHR(National Institute for Health Research (NIHR)); UK NIHR Health Technology Assessment Programme(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Bown reports holding a personal fellowship with the Higher Education Funding Council for England. Drs Sweeting, Powell, and Thompson report receipt of a grant to their institution from the National Institute for Health Research (NIHR) Health Technology Assessment. Dr Brown reports receipt of a grant to her institution for a UK government-funded study and receipt of fees for participation in review activities such as data monitoring boards, statistical analysis, and end point committees. Dr Powell reports receipt of a consulting fee or honorarium from the NIHR grant (previously mentioned), and receipt of a grant or pending grant for the IMPROVE, EVAR, STAT (small thoracic aortic aneurysm), and AARDVARK trials and with a thoracic aortic trial. Dr Thompson reports receipt of support for travel to meetings from the NIHR grant (previously mentioned).; This project was supported by the UK NIHR Health Technology Assessment Programme (project 08/30/02).	Abedi NN, 2009, J VASC SURG, V50, P486, DOI 10.1016/j.jvs.2009.04.047; Anjum A, 2012, BRIT J SURG, V99, P637, DOI 10.1002/bjs.8698; [Anonymous], 2005, AHRQ PUBL; Ashton HA, 2007, BRIT J SURG, V94, P696, DOI 10.1002/bjs.5780; Ashton HA, 2002, LANCET, V360, P1531, DOI 10.1016/S0140-6736(02)11522-4; Badger SA, 2011, VASC MED, V16, P415, DOI 10.1177/1358863X11423971; Barretta, 1998, Int J Angiol, V7, P280, DOI 10.1007/BF01623868; Beasley LE, 2009, OBESITY, V17, P1062, DOI 10.1038/oby.2008.627; Bergqvist D, 2011, EUR J VASC ENDOVASC, V41, P663, DOI 10.1016/j.ejvs.2011.01.009; Brady AR, 2004, CIRCULATION, V110, P16, DOI 10.1161/01.CIR.0000133279.07468.9F; Brewster DC, 2003, J VASC SURG, V37, P1106, DOI 10.1067/mva.2003.363; Centers for Disease Control and Prevention, CDC MORT STAT ICD 10; Chaikof EL, 2009, J VASC SURG, V50, p2S, DOI 10.1016/j.jvs.2009.07.002; Choke E, 2012, CIRCULATION, V125, P1617, DOI 10.1161/CIRCULATIONAHA.111.077503; de Ceniga MV, 2006, EUR J VASC ENDOVASC, V31, P231, DOI 10.1016/j.ejvs.2005.10.007; De Haro J, 2012, J VASC SURG, V56, P45, DOI 10.1016/j.jvs.2012.01.003; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egorova NN, 2011, J VASC SURG, V54, P1, DOI 10.1016/j.jvs.2010.12.049; Filardo G, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001835.pub3, 10.1002/14651858.CD001835.pub4]; Giardina S, 2011, J VASC SURG, V54, P938, DOI 10.1016/j.jvs.2011.03.264; Greenhalgh RM, 2004, LANCET, V364, P843, DOI 10.1016/S0140-6736(04)16979-1; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1863, DOI 10.1056/NEJMoa0909305; Guessous I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001895; Heikkinen M, 2002, J VASC SURG, V36, P291, DOI 10.1067/mva.2002.125479; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Karlsson L, 2009, J VASC SURG, V50, P23, DOI 10.1016/j.jvs.2008.12.048; Laupacis A, 2002, J VASC SURG, V35, P72, DOI 10.1067/mva.2002.121308; Lindholt JS, 2005, BMJ-BRIT MED J, V330, P750, DOI 10.1136/bmj.38369.620162.82; McCarthy RJ, 2003, BRIT J SURG, V90, P821, DOI 10.1002/bjs.4216; Mehta M, 2012, J VASC SURG, V55, P906, DOI 10.1016/j.jvs.2011.11.047; Mofidi R, 2007, BRIT J SURG, V94, P310, DOI 10.1002/bjs.5573; Moll FL, 2011, EUR J VASC ENDOVASC, V41, pS1, DOI 10.1016/j.ejvs.2010.09.011; National Health Service, NHS ABD AORT AN SCRE; Norman PE, 2007, CIRCULATION, V115, P2865, DOI 10.1161/CIRCULATIONAHA.106.671859; Norman PE, 2011, J VASC SURG, V53, P274, DOI 10.1016/j.jvs.2010.08.087; Norman PE, 2004, BRIT MED J, V329, P1259, DOI 10.1136/bmj.38272.478438.55; Ouriel K, 2010, J VASC SURG, V51, P1081, DOI 10.1016/j.jvs.2009.10.113; Parry DJ, 2009, BRIT J SURG, V96, P870, DOI 10.1002/bjs.6632; Powell JT, 2011, BRIT J SURG, V98, P609, DOI 10.1002/bjs.7465; Powell JT, 2011, EUR J VASC ENDOVASC, V41, P2, DOI 10.1016/j.ejvs.2010.09.005; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Salem MK, 2009, EUR J VASC ENDOVASC, V38, P748, DOI 10.1016/j.ejvs.2009.07.012; Solberg S, 2005, EUR J VASC ENDOVASC, V29, P145, DOI 10.1016/j.ejvs.2004.11.015; Stather PW, EUR J VASC ENDOVASC; Sweeting MJ, 2012, BRIT J SURG, V99, P655, DOI 10.1002/bjs.8707; Sweeting MJ, 2012, J R STAT SOC A STAT, V175, P569, DOI 10.1111/j.1467-985X.2011.01005.x; Sweeting MJ, 2011, BIOMETRICAL J, V53, P750, DOI 10.1002/bimj.201100052; Thompson SG, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2307; UK National Institute of Health and Clinical Excellence, NICE IMPL UPT REP ST; Vardulaki KA, 1998, BRIT J SURG, V85, P1674; Wells G., NEWCASTLE OTTAWA SCA	52	126	129	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2013	309	8					806	813		10.1001/jama.2013.950	http://dx.doi.org/10.1001/jama.2013.950			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095KD	23443444	Green Published, Bronze			2022-12-28	WOS:000315332200026
J	Pennington, M; Grieve, R; Sekhon, JS; Gregg, P; Black, N; van der Meulen, JH				Pennington, Mark; Grieve, Richard; Sekhon, Jasjeet S.; Gregg, Paul; Black, Nick; van der Meulen, Jan H.			Cemented, cementless, and hybrid prostheses for total hip replacement: cost effectiveness analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; ARTHROPLASTY; MORTALITY; REGISTRY; RATES	Objective To compare the cost effectiveness of the three most commonly chosen types of prosthesis for total hip replacement. Design Lifetime cost effectiveness model with parameters estimated from individual patient data obtained from three large national databases. Setting English National Health Service. Participants Adults aged 55 to 84 undergoing primary total hip replacement for osteoarthritis. Interventions Total hip replacement using either cemented, cementless, or hybrid prostheses. Main outcome measures Cost () pound, quality of life (EQ-5D-3L, where 0 represents death and 1 perfect health), quality adjusted life years (QALYs), incremental cost effectiveness ratios, and the probability that each prosthesis type is the most cost effective at alternative thresholds of willingness to pay for a QALY gain. Results Lifetime costs were generally lowest with cemented prostheses, and postoperative quality of life and lifetime QALYs were highest with hybrid prostheses. For example, in women aged 70 mean costs were 6900 pound ($11 000; (sic)8200) for cemented prostheses, 7800 pound for cementless prostheses, and 7500 pound for hybrid prostheses; mean postoperative EQ-5D scores were 0.78, 0.80, and 0.81, and the corresponding lifetime QALYs were 9.0, 9.2, and 9.3 years. The incremental cost per QALY for hybrid compared with cemented prostheses was 2500 pound. If the threshold willingness to pay for a QALY gain exceeded 10 pound 000, the probability that hybrid prostheses were most cost effective was about 70%. Hybrid prostheses have the highest probability of being the most cost effective in all subgroups, except in women aged 80, where cemented prostheses were most cost effective. Conclusions Cemented prostheses were the least costly type for total hip replacement, but for most patient groups hybrid prostheses were the most cost effective. Cementless prostheses did not provide sufficient improvement in health outcomes to justify their additional costs.	[Pennington, Mark; Grieve, Richard; Black, Nick; van der Meulen, Jan H.] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England; [Sekhon, Jasjeet S.] Univ Calif Berkeley, Dept Stat, Ctr Causal Inference & Program Evaluat, Travers Dept Polit Sci,Inst Govt Studies, Berkeley, CA 94720 USA; [Gregg, Paul] South Tees Hosp NHS Fdn Trust, James Cook Hosp, Middlesbrough, Cleveland, England; [Gregg, Paul] Healthcare Qual Improvement Partnership, Natl Joint Registry England & Wales, London, England	University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California Berkeley; James Cook University	Pennington, M (corresponding author), London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England.	mark.pennington@lshtm.ac.uk	Pennington, Mark/AAS-9946-2020	Pennington, Mark/0000-0002-1392-8700; van der Meulen, Jan/0000-0002-9451-2335; Grieve, Richard/0000-0001-8899-1301	Department of Health; ESRC [ES/G00188X/1] Funding Source: UKRI	Department of Health; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the Department of Health (Commissioning Development).	American Society of Anesthesiologists, ASA PHYS STAT CLASS; [Anonymous], 2008, LENGTH STAY RED LENG; [Anonymous], 2009, HIP KNEE REPL CAN CA; [Anonymous], 2008, ORTHOPEDIC NETWORK N, V19, P1; [Anonymous], 2011, HIP REPL IMPL GLOB P; [Anonymous], 2010, PROV MONTHL PAT REP; Briggs A, 1998, PHARMACOECONOMICS, V13, P397, DOI 10.2165/00019053-199813040-00003; Briggs Andrew, 2004, Appl Health Econ Health Policy, V3, P79, DOI 10.2165/00148365-200403020-00004; Davies C, 2009, HLTH EC STUD GROUP M; Dawson J, 1996, J BONE JOINT SURG BR, V78B, P185, DOI 10.1302/0301-620X.78B2.0780185; Di Tanna GL, 2011, J SURG RES, V169, P227, DOI 10.1016/j.jss.2009.10.031; Diamond A, 2012, GENETIC MATCHING EST; Fevang BTS, 2010, ACTA ORTHOP, V81, P649, DOI 10.3109/17453674.2010.537807; Fryback D, 2005, DO LARGE NATL SURVEY; Givon U, 1998, INT J TECHNOL ASSESS, V14, P735, DOI 10.1017/S0266462300012046; Graves S, 2011, ANN REPORT AOA; Grieve R, 2008, HEALTH SERV RES, V43, P1204, DOI 10.1111/j.1475-6773.2008.00834.x; Hospital Episode Statistics for England, 2009, HOSP EP STAT ENGL IN; Klouche S, 2010, ORTHOP TRAUMATOL-SUR, V96, P124, DOI [10.1016/j.rcot.2010.02.005, 10.1016/j.otsr.2009.11.004]; Kreif N, 2012, MED DECIS MAKING; Lemon MA, 2008, BR J HEALTHCARE MANA, V14, P108; Lie SA, 2000, ACTA ORTHOP SCAND, V71, P19, DOI 10.1080/00016470052943838; Marinelli M, 2008, J ORTHOP TRAUMATOL, V9, P23, DOI 10.1007/s10195-008-0100-9; McMinn DJW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3319; Mendenhall S, 2004, ORTHOPEDIC NEWS NETW, V14, P1; Metz CM, 1998, J ARTHROPLASTY, V13, P296, DOI 10.1016/S0883-5403(98)90175-9; Morshed S, 2007, ACTA ORTHOP, V78, P315, DOI 10.1080/17453670710013861; National Joint Registry for England and Wales, 2011, 8 NJR ENGL WAL; Ng CY, 2007, J BONE JOINT SURG BR, V89B, P868, DOI 10.1302/0301-620X.89B7.18482; Noble M, 2007, ENGLISH INDICES DEPR; Radice R, 2012, INT J BIOSTAT, V8, DOI 10.1515/1557-4679.1382; Sekhon J, 2011, HEALTH ECON, V21, P695, DOI DOI 10.1002/HEC.1748; Smith AJ, 2012, LANCET, V379, P1199, DOI 10.1016/S0140-6736(12)60353-5; Stea S, 2009, INT ORTHOP, V33, P339, DOI 10.1007/s00264-007-0465-z; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	36	79	79	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2013	346								f1026	10.1136/bmj.f1026	http://dx.doi.org/10.1136/bmj.f1026			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100BL	23447338	Green Submitted, hybrid, Green Published, Green Accepted			2022-12-28	WOS:000315669600001
J	Moodie, R; Stuckler, D; Monteiro, C; Sheron, N; Neal, B; Thamarangsi, T; Lincoln, P; Casswell, S				Moodie, Rob; Stuckler, David; Monteiro, Carlos; Sheron, Nick; Neal, Bruce; Thamarangsi, Thaksaphon; Lincoln, Paul; Casswell, Sally		Lancet NCD Action Grp	Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries	LANCET			English	Article							SUGAR-SWEETENED BEVERAGES; COMPARATIVE COST-EFFECTIVENESS; GLOBAL BURDEN; BIG TOBACCO; NONCOMMUNICABLE DISEASES; ADDICTION RESEARCH; VESTED INTERESTS; SELF-REGULATION; RISK-FACTORS; HEALTH	The 2011 UN high-level meeting on non-communicable diseases (NCDs) called for multisectoral action including with the private sector and industry. However, through the sale and promotion of tobacco, alcohol, and ultra-processed food and drink (unhealthy commodities), transnational corporations are major drivers of global epidemics of NCDs. What role then should these industries have in NCD prevention and control? We emphasise the rise in sales of these unhealthy commodities in low-income and middle-income countries, and consider the common strategies that the transnational corporations use to undermine NCD prevention and control. We assess the effectiveness of self-regulation, public-private partnerships, and public regulation models of interaction with these industries and conclude that unhealthy commodity industries should have no role in the formation of national or international NCD policy. Despite the common reliance on industry self-regulation and public-private partnerships, there is no evidence of their effectiveness or safety. Public regulation and market intervention are the only evidence-based mechanisms to prevent harm caused by the unhealthy commodity industries.	[Moodie, Rob] Univ Melbourne, Melbourne Sch Populat Hlth, Melbourne, Vic 3010, Australia; [Stuckler, David] Univ Cambridge, Dept Sociol, Cambridge CB2 1TN, England; [Monteiro, Carlos] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil; [Sheron, Nick] Univ Southampton, Fac Med, Div Infect Inflammat & Immun, Southampton SO9 5NH, Hants, England; [Neal, Bruce] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Thamarangsi, Thaksaphon] Minist Publ Hlth, Int Hlth Policy Program, Bangkok, Thailand; [Lincoln, Paul] Natl Heart Forum, London, England; [Casswell, Sally] Massey Univ, Sch Publ Hlth, SHORE, Auckland, New Zealand; [Casswell, Sally] Massey Univ, Sch Publ Hlth, Whariki Res Ctr, Auckland, New Zealand	University of Melbourne; University of Cambridge; Universidade de Sao Paulo; University of Southampton; George Institute for Global Health; University of Sydney; Ministry of Public Health - Thailand; Massey University; Massey University	Moodie, R (corresponding author), Univ Melbourne, Melbourne Sch Populat Hlth, Melbourne, Vic 3010, Australia.	r.moodie@unimelb.edu.au	Monteiro, Carlos Augusto/F-9892-2012	Monteiro, Carlos Augusto/0000-0002-3777-1533; Neal, Bruce/0000-0002-0490-7465; Sheron, Nick/0000-0002-6156-8367; Moodie, Alan/0000-0002-8425-7975; Casswell, Sally/0000-0002-2211-7096; Sheron, Nick/0000-0001-5232-8292; Stuckler, David/0000-0002-1288-8401	Abbott; Amgen; AstraZeneca; GeorgeClinical; GlaxoSmithKline; Novartis; PepsiCo; Pfizer; Pharmacy Guild of Australia; Roche; Sanofi-Aventis; Servier; Tanabe; Australian Food and Grocery Council; Bupa Australia; Johnson and Johnson; Merck Schering Plough; United Healthcare Group; Australian Research Council; Medical Research Council [MR/K023195/1B, MR/K023195/1] Funding Source: researchfish	Abbott(Abbott Laboratories); Amgen(Amgen); AstraZeneca(AstraZeneca); GeorgeClinical; GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); PepsiCo; Pfizer(Pfizer); Pharmacy Guild of Australia; Roche(Roche Holding); Sanofi-Aventis(Sanofi-Aventis); Servier(Servier); Tanabe; Australian Food and Grocery Council; Bupa Australia; Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Merck Schering Plough(Merck & CompanySchering Plough Corporation); United Healthcare Group; Australian Research Council(Australian Research Council); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	BN is the Chair of the Australian Division of World Action on Salt and Health (2007-ongoing). He has consulted to Roche (2010) and Takeda (2010). He has received lecture fees, travel fees, or reimbursements from Abbott (2012), Amgen (2007), AstraZeneca (2010), GeorgeClinical (2012), GlaxoSmithKline (2007), Novartis (2012), PepsiCo (2011), Pfizer (2011), Pharmacy Guild of Australia (2012), Roche (2012), Sanofi-Aventis (2006), Servier (2008), and Tanabe (2007). He holds research support from the Australian Food and Grocery Council (2012), Bupa Australia (2012), Johnson and Johnson (2012), Merck Schering Plough (2011), Roche (2012), Servier (2012), and United Healthcare Group (2012). He is not employed by a commercial entity; has no equity ownership or stock options, patents, or royalties; and has no other financial or non-financial support that might be viewed as creating potential conflicts of interest. NS is co-chair of the UK Government Responsibility Deal network, trustee of the Drinkaware Trust, member of the EU Alcohol and Health Forum, and was a member of the Public Health Commission-all bodies with alcohol industry representation. NS is also a member of the Alcohol Health Alliance UK executive board, Royal College of Physicians' alcohol committee, and is involved in other health NGOs including Alcohol Concern. None of these commitments included financial gain but some have reimbursed travelling expenses.; BN is supported by an Australian Research Council Future Fellowship. CM acknowledges discussions with and suggestions from Geoffrey Cannon and other colleagues at the Centre for Epidemiological Studies in Health and Nutrition at the University of Sao Paulo, Brazil. The authors would like to acknowledge the assistance of Robert Beaglehole and Ruth Bonita in the preparation of this paper.	Alexander E, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-26; Alfranca O, 2003, INT FOOD AGRIBUS MAN, V05, P114; [Anonymous], 2012, REVERSING EPIDEMIC N; [Anonymous], 2011, AUSTRALIAN FOOD 0519; [Anonymous], 1970, NEW YORK TIMES; [Anonymous], 2011, WORLD NUTR, V2, P458; [Anonymous], 2012, NESTL CONTR FIGHT NO; Babor T.F., 2010, ALCHOL NO ORDINARY C, V2nd, DOI DOI 10.1093/ACPROF:OSO/9780199551149.003.002; Babor TF, 2003, ALCOHOL NO ORDINARY; Bakke O, 2010, ADDICTION, V105, P22, DOI 10.1111/j.1360-0443.2009.02695.x; Basu S, 2013, PUBLIC HEALTH NUTR, V16, P179, DOI [10.1017/S1368980012002881, 10.1017/S1368980012003758]; Basu SMM, AM J PUBLIC IN PRESS; Bond L, 2010, AUSTRALAS MED J, V3, P325, DOI 10.4066/AMJ.2010.363; Bond L, 2009, AUSTRALAS MED J, V2, DOI 10.4066/AMJ.2009.43; Boseley S, 2003, INT J HEALTH SERV, V33, P831, DOI 10.2190/U0MW-WM82-N5BH-E20C; Brownell KD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001254; Brownell KD, 2009, MILBANK Q, V87, P259, DOI 10.1111/j.1468-0009.2009.00555.x; Brownson R D, 1998, Monaldi Arch Chest Dis, V53, P181; Center for Responsive Politics, 2010, PEPSICO INC FUNDR SP; Center for Responsive Politics, 2010, PEPSICO INC ANN LOBB; Center for Responsive Politics, 2010, FOOD BEV IND PROF; Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782; Chisholm D, 2006, DRUG ALCOHOL REV, V25, P553, DOI 10.1080/09595230600944487; Coca Cola, 2010, COMPL 2010 ANN REP F; Daube M, 2012, AUST NZ J PUBL HEAL, V36, P108, DOI 10.1111/j.1753-6405.2012.00855.x; Department of Health, 2011, PUBL HLTH RESP DEAL; Department of Health, 2012, F2 SALT RED PUBL HLT; Diageo, 2011, DIAG ANN REP 2011; Dorfman L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001241; EuroMonitor International, 2011, PASS GLOB MARK INF; European Alcohol Policy Alliance (Eurocare), 2012, EUR LAB; Fooks GJ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001076; Grynbaum MM, 2012, NY TIMES; Hastings G, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5650; Hawkes C, 2003, GLOBALIZATION DIETS; Hawkes C, 2012, FOOD POLICY, V37, P343, DOI 10.1016/j.foodpol.2012.02.011; Hawkes C, 2011, EUR J PUBLIC HEALTH, V21, P400, DOI 10.1093/eurpub/ckr077; HM Government, 2012, GOV ALC STRAT; Holden C, 2009, GLOB SOC POLICY, V9, P328, DOI 10.1177/1468018109343638; House of Commons Health Committee, 2009, ALC 1 REP SESS 2009; Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036; International Center For Alcohol Polcies, 2006, STRUCT BEV ALC IND; International Center for Alcohol Policies (ICAP), 2012, GUID IND CONTR WHO G; Jahiel RI, 2007, ADDICTION, V102, P1335, DOI 10.1111/j.1360-0443.2007.01900.x; Jernigan DH, 2012, AM J PUBLIC HEALTH, V102, P80, DOI 10.2105/AJPH.2011.300269; Jernigan DH, 2009, ADDICTION, V104, P6, DOI 10.1111/j.1360-0443.2008.02430.x; Jernigan DH, 2006, ARCH PEDIAT ADOL MED, V160, P100, DOI 10.1001/archpedi.160.1.100; Joint WHO/FAO Expert Consultation, 2003, WHO TECHN REP SER; Kessler D., 2001, QUESTION INTENT GREA; Kessler DA, 2009, END OV TAK CONTR INS, P320; Kleiman S, 2012, OBES REV, V13, P258, DOI 10.1111/j.1467-789X.2011.00949.x; Lawrence Felicity, 2010, GUARDIAN; Lesser LI, 2007, PLOS MED, V4, P41, DOI 10.1371/journal.pmed.0040005; LILIENFELD DE, 1991, AM J PUBLIC HEALTH, V81, P791, DOI 10.2105/AJPH.81.6.791; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lincoln P, 2011, LANCET, V378, pE6, DOI 10.1016/S0140-6736(11)61463-3; Ludwig DS, 2008, JAMA-J AM MED ASSOC, V300, P1808, DOI 10.1001/jama.300.15.1808; Ludwig DS, 2011, JAMA-J AM MED ASSOC, V305, P1352, DOI 10.1001/jama.2011.380; Lyson T. A., 2000, Agriculture and Human Values, V17, P199, DOI 10.1023/A:1007613219447; MACLENNAN C A, 1988, Medical Anthropology Quarterly, V2, P233, DOI 10.1525/maq.1988.2.3.02a00040; Majnoni dIntignano, 1995, COMMENTAIRE, V71, P557; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Markowitz G, 2003, DENIAL DECEIT DEADLY; MARWICK C, 1994, JAMA-J AM MED ASSOC, V271, P1562, DOI 10.1001/jama.271.20.1562; McDaniel PA, 2009, WOMEN HEALTH, V49, P441, DOI 10.1080/03630240903238800; Miller PG, 2011, ADDICTION, V106, P1560, DOI 10.1111/j.1360-0443.2011.03499.x; Monteiro CA., 2011, WORLD NUTR J, V2, P333, DOI [10.1177/146642405707700818, DOI 10.1177/146642405707700818]; Monteiro CA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001252; Monteiro CA, 2009, PUBLIC HEALTH NUTR, V12, P729, DOI 10.1017/S1368980009005291; Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241; Monteiro CA, 2010, CAD SAUDE PUBLICA, V26, P2039, DOI 10.1590/S0102-311X2010001100005; Moodie R, 2011, NANNY KNOWS BEST WHY; Moreno LA, 2007, CURR OPIN CLIN NUTR, V10, P336, DOI 10.1097/MCO.0b013e3280a94f59; Muggli ME, 2003, NICOTINE TOB RES, V5, P303, DOI 10.1080/1462220031000094169; National Institute for Health and Clinical Excellence, 2010, ALC US DIS PREV DEV; National Institute for Health and Clinical Excellence, 2007, SCH BAS INT ALC CONS; Nestle M, 2010, FOOD POLITICS; Organization WH, 2016, GLOBAL STATUS REPORT; Parry CD, 2011, ADDICTION, V106, P1718, DOI 10.1111/j.1360-0443.2011.03605.x; PepsiCo, 2012, PEPSICOS POL CONTR P; Pernod Ricard, 2011, RESPONSIBALLY DAY 24; Phillip Moris, 1999, PRPOSAL ORG WHITECOA; Phillip Morris International, DOM VIOL; Rayner G, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2177; Regmi A., 2005, Amber Waves, V3, P12; Rose G, 2003, STRATEGY PREVENTIVE; SAB Miller plc, 2012, Q DIV SEM SER AFR 20; SAB Miller plc, ANN REP 2011; Sacks G, 2011, INT J OBESITY, V35, P1001, DOI 10.1038/ijo.2010.228; Sadler K, 2012, NAT DIET NUTR SURV A; Samet JM, 2011, NEW ENGL J MED, V365, P198, DOI 10.1056/NEJMp1103332; Shah A, 2009, PEPSICO TAPS EDELMAN; Sharma LL, 2010, AM J PUBLIC HEALTH, V100, P240, DOI 10.2105/AJPH.2009.160960; SLADE J, 1989, J PSYCHOACTIVE DRUGS, V21, P281, DOI 10.1080/02791072.1989.10472169; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001242, 10.1371/journal.pmed.1001235]; Stuckler D, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001020; Thaler RH., 2021, NUDGE FINAL EDITION; Wallack L, 1992, BR J ADDICT, V87, P175; WHO, 2008, GUID IMPL ART 5 3 WH; Wiist WH, 2012, SICK SOC RESPONDING, P204; World Health Organization, 2012, MON FRAM TARG PREV C; Wright O., 2012, INDEPENDENT	103	925	940	12	310	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2013	381	9867					670	679		10.1016/S0140-6736(12)62089-3	http://dx.doi.org/10.1016/S0140-6736(12)62089-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	093JY	23410611				2022-12-28	WOS:000315189300037
J	Duggal, P; Thio, CL; Wojcik, GL; Goedert, JJ; Mangia, A; Latanich, R; Kim, AY; Lauer, GM; Chung, RT; Peters, MG; Kirk, GD; Mehta, SH; Cox, AL; Khakoo, SI; Alric, L; Cramp, ME; Donfield, SM; Edlin, BR; Tobler, LH; Busch, MP; Alexander, G; Rosen, HR; Gao, XJ; Abdel-Hamid, M; Apps, R; Carrington, M; Thomas, DL				Duggal, Priya; Thio, Chloe L.; Wojcik, Genevieve L.; Goedert, James J.; Mangia, Alessandra; Latanich, Rachel; Kim, Arthur Y.; Lauer, Georg M.; Chung, Raymond T.; Peters, Marion G.; Kirk, Gregory D.; Mehta, Shruti H.; Cox, Andrea L.; Khakoo, Salim I.; Alric, Laurent; Cramp, Matthew E.; Donfield, Sharyne M.; Edlin, Brian R.; Tobler, Leslie H.; Busch, Michael P.; Alexander, Graeme; Rosen, Hugo R.; Gao, Xiaojiang; Abdel-Hamid, Mohamed; Apps, Richard; Carrington, Mary; Thomas, David L.			Genome-Wide Association Study of Spontaneous Resolution of Hepatitis C Virus Infection: Data From Multiple Cohorts	ANNALS OF INTERNAL MEDICINE			English	Article							SPONTANEOUS CLEARANCE; GENETIC-VARIATION; HCV INFECTION; VIRAL LOAD; HLA; VIREMIA; GENOTYPE; PERSISTENCE; POPULATION; VARIANTS	Background: Hepatitis C virus (HCV) infections occur worldwide and either spontaneously resolve or persist and markedly increase the person's lifetime risk for cirrhosis and hepatocellular carcinoma. Although HCV persistence occurs more often in persons of African ancestry and persons with genetic variants near interleukin-28B (IL-28B), the genetic basis is not well-understood. Objective: To evaluate the host genetic basis for spontaneous resolution of HCV infection. Design: 2-stage, genome-wide association study. Setting: 13 international multicenter study sites. Patients: 919 persons with serum HCV antibodies but no HCV RNA (spontaneous resolution) and 1482 persons with serum HCV antibodies and HCV RNA (persistence). Measurements: Frequencies of 792 721 single nucleotide polymorphisms (SNPs). Results: Differences in allele frequencies between persons with spontaneous resolution and persistence were identified on chromosomes 19q13.13 and 6p21.32. On chromosome 19, allele frequency differences localized near IL-28B and included rs12979860 (overall per-allele OR, 0.45; P = 2.17 x 10(-30)) and 10 additional SNPs spanning 55 000 base pairs. On chromosome 6, allele frequency differences localized near genes for HLA class II and included rs4273729 (overall per-allele OR, 0.59; P = 1.71 x 10(-16)) near DQB1*03:01 and an additional 116 SNPs spanning 1 090 000 base pairs. The associations in chromosomes 19 and 6 were independent and additive and explain an estimated 14.9% (95% CI, 8.5% to 22.6%) and 15.8% (CI, 4.4% to 31.0%) of the variation in HCV resolution in persons of European and African ancestry, respectively. Replication of the chromosome 6 SNP, rs4272729, in an additional 745 persons confirmed the findings (P = 0.015). Limitation: Epigenetic effects were not studied. Conclusion: IL-28B and HLA class II are independently associated with spontaneous resolution of HCV infection, and SNPs marking IL-28B and DQB1*03:01 may explain approximately 15% of spontaneous resolution of HCV infection.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; NCI, Rockville, MD 20852 USA; IRCCS Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02114 USA; Ragon Inst Harvard, Boston, MA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Blood Syst Res Inst, Viral Reference Lab, San Francisco, CA 94118 USA; Blood Syst Res Inst, Repository Core, San Francisco, CA 94118 USA; Univ Southampton, Southampton, Hants, England; Southampton Gen Hosp, Southampton SO9 4XY, Hants, England; Univ Toulouse 3, F-31062 Toulouse, France; Plymouth Hosp NHS Trust, SW Liver Unit, Plymouth, Devon, England; Rho, Chapel Hill, NC USA; State Univ New York Downstate Coll Med, Brooklyn, NY USA; Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England; Addenbrookes Hosp, Cambridge, England; Univ Colorado, Denver, CO 80045 USA; Menia Univ, Al Minya, Egypt; Natl Hepatol & Trop Dis Res Inst, Viral Hepatitis Res Lab, Cairo, Egypt; Frederick Natl Lab Canc Res, Canc & Inflammat Program, Expt Immunol Lab, Sci Applicat Int Corp Frederick, Frederick, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); IRCCS Casa Sollievo Della Sofferenza; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of California System; University of California San Francisco; Vitalant; Vitalant Research Institute; Vitalant; Vitalant Research Institute; University of Southampton; University of Southampton; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Plymouth; Rho; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Colorado System; University of Colorado Denver; Egyptian Knowledge Bank (EKB); Minia University; Egyptian Knowledge Bank (EKB); National Hepatology & Tropical Medicine Research Institute (NHTMRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Thomas, DL (corresponding author), Johns Hopkins Sch Med, 1830 E Monument St,Suite 437, Baltimore, MD 21287 USA.	pduggal@jhsph.edu; dthomas@jhmi.edu	Edlin, Brian R/F-2966-2018; Mangia, A/AAL-5357-2020; Lauer, Georg/J-1467-2018	Edlin, Brian R/0000-0001-8172-8797; Mangia, A/0000-0002-2600-3555; Duggal, Priya/0000-0001-5809-2081; Cox, Andrea/0000-0002-9331-2462; Lauer, Georg/0000-0002-9792-4271; Khakoo, Salim/0000-0002-4057-9091	Office of AIDS Research, National Institutes of Health; Frederick National Laboratory for Cancer Research; Office of AIDS Research through the Center for Inherited Diseases at Johns Hopkins University; National Institute on Drug Abuse [R01013324, DA033541, DA12568, DA04334]; National Institute of Allergy and Infectious Diseases [U19AI088791, AI082630]; Frederick National Laboratory for Cancer Research [HHSN261200800001E]; National Institutes of Health; National Institute of Allergy and Infectious Diseases; National Cancer Institute [UO1-AI-35042, UL1-RR025005, UO1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041]; National Institute of Allery and Infectious Diseases [UO1-AI35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI34993, UO1-AI-42590]; National Institute of Child Health and Human Development [UO1-HD-32632];  [R01HL076902];  [R01-DA16159];  [R01-DA21550];  [UL1-RR024996]; MRC [G1001738] Funding Source: UKRI; Medical Research Council [G1001738] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010791] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005, UL1RR024996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082630, U01AI034989, U19AI066345, U01AI035041, U01AI035040, U01AI031834, U01AI035004, U01AI042590, U01AI034994, U01AI035039, U01AI035042, U01AI035043, U19AI088791, U01AI034993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004334, R01DA013324, U01DA036297, R56DA004334, R01DA033541, R56DA012568, R01DA021550, R01DA012568, R01DA016159, R37DA004334] Funding Source: NIH RePORTER	Office of AIDS Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frederick National Laboratory for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Office of AIDS Research through the Center for Inherited Diseases at Johns Hopkins University; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Frederick National Laboratory for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allery and Infectious Diseases; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); ; ; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Office of AIDS Research, National Institutes of Health, and Frederick National Laboratory for Cancer Research.; This project was funded in whole or in part by the Office of AIDS Research through the Center for Inherited Diseases at Johns Hopkins University, the National Institute on Drug Abuse (R01013324, DA033541, DA12568, and DA04334), the National Institute of Allergy and Infectious Diseases (U19AI088791 and AI082630), and the Frederick National Laboratory for Cancer Research (contract HHSN261200800001E). This research was supported in part by the Intramural Research Programs of the National Institutes of Health and the Frederick National Laboratory for Cancer Research. The MACS is funded by the National Institute of Allergy and Infectious Diseases, with additional supplemental funding from the National Cancer Institute (UO1-AI-35042, UL1-RR025005, UO1-AI-35043, UO1-AI-35039, UO1-AI-35040, and UO1-AI-35041). The WIHS is funded by the National Institute of Allery and Infectious Diseases (UO1-AI35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI34993, and UO1-AI-42590) and by the National Institute of Child Health and Human Development (UO1-HD-32632). The REVELL cohort was funded by R01HL076902. Swann cohort was funded by R01-DA16159, R01-DA21550, and UL1-RR024996.	Alric L, 1997, GASTROENTEROLOGY, V113, P1675, DOI 10.1053/gast.1997.v113.pm9352872; Cox AL, 2005, CLIN INFECT DIS, V40, P951, DOI 10.1086/428578; Cramp ME, 1998, J HEPATOL, V29, P207, DOI 10.1016/S0168-8278(98)80005-6; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Duggal P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-516; Edlin BR, 2009, GASTROENTEROLOGY, V136, P2412, DOI 10.1053/j.gastro.2009.04.040; Fanning LJ, 2001, HEPATOLOGY, V33, P224, DOI 10.1053/jhep.2001.20642; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Goedert JJ, 2007, AM J EPIDEMIOL, V165, P1443, DOI 10.1093/aje/kwm030; HILGARTNER MW, 1993, AM J PEDIAT HEMATOL, V15, P208; Hindorff LA, CATALOG PUBLISHED GE; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960; Kim AY, 2011, GASTROENTEROLOGY, V140, P686, DOI 10.1053/j.gastro.2010.09.042; Kuniholm MH, 2011, J INFECT DIS, V203, P1807, DOI 10.1093/infdis/jir192; Kuniholm MH, 2010, HEPATOLOGY, V51, P1514, DOI 10.1002/hep.23515; Mangia A, 1999, J HEPATOL, V30, P984, DOI 10.1016/S0168-8278(99)80250-5; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Ray SC, 2005, J EXP MED, V201, P1753, DOI 10.1084/jem.20050122; Rhodes SL, 2008, GENES IMMUN, V9, P328, DOI 10.1038/gene.2008.21; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; So HC, 2011, GENET EPIDEMIOL, V35, P447, DOI 10.1002/gepi.20593; Thio CL, 2001, J INFECT DIS, V184, P16, DOI 10.1086/321005; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Timm J, 2004, J EXP MED, V200, P1593, DOI 10.1084/jem.20041006; Tobler LH, 2010, TRANSFUSION, V50, P1513, DOI 10.1111/j.1537-2995.2010.02634.x; Villano SA, 1999, HEPATOLOGY, V29, P908, DOI 10.1002/hep.510290311; VLAHOV D, 1990, AM J EPIDEMIOL, V132, P847, DOI 10.1093/oxfordjournals.aje.a115727; zur Wiesch JS, 2012, J EXP MED, V209, P61, DOI 10.1084/jem.20100388	38	165	167	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2013	158	4					235	245		10.7326/0003-4819-158-4-201302190-00003	http://dx.doi.org/10.7326/0003-4819-158-4-201302190-00003			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098WR	23420232	Green Accepted			2022-12-28	WOS:000315580300014
J	Ren, XF; Farias, GG; Canagarajah, BJ; Bonifacino, JS; Hurley, JH				Ren, Xuefeng; Farias, Ginny G.; Canagarajah, Bertram J.; Bonifacino, Juan S.; Hurley, James H.			Structural Basis for Recruitment and Activation of the AP-1 Clathrin Adaptor Complex by Arf1	CELL			English	Article							ADP-RIBOSYLATION FACTOR; CARGO-SORTING SIGNALS; GTP-BINDING PROTEIN; COATED VESICLES; MEMBRANE RECRUITMENT; GOLGI MEMBRANES; AP2 COMPLEX; HIV-1 NEF; RECOGNITION; SUBUNIT	AP-1 is a clathrin adaptor complex that sorts cargo between the trans-Golgi network and endosomes. AP-1 recruitment to these compartments requires Arf1-GTP. The crystal structure of the tetrameric core of AP-1 in complex with Arf1-GTP, together with biochemical analyses, shows that Arf1 activates cargo binding by unlocking AP-1. Unlocking is driven by two molecules of Arf1 that bridge two copies of AP-1 at two interaction sites. The GTP-dependent switch I and II regions of Arf1 bind to the N terminus of the beta 1 subunit of one AP-1 complex, while the back side of Arf1 binds to the central part of the gamma subunit trunk of a second AP-1 complex. A third Arf1 interaction site near the N terminus of the gamma subunit is important for recruitment, but not activation. These observations lead to a model for the recruitment and activation of AP-1 by Arf1.	[Ren, Xuefeng; Farias, Ginny G.; Bonifacino, Juan S.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Canagarajah, Bertram J.; Hurley, James H.] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bonifacino, JS (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA.	bonifacinoj@helix.nih.gov; james.hurley@nih.gov		Bonifacino, Juan S./0000-0002-5673-6370	U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NICHD; NIDDK, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036130] Funding Source: NIH RePORTER	U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G. Mardones for assistance with constructs and W. Yang for critically reading the manuscript. Crystallographic data were collected at Southeast Regional Collaborative Access Team 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38. This research was supported by the Intramural Programs of NICHD (J.S.B.) and NIDDK (J.H.H.), NIH.	AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Brunger AT, 2012, STRUCTURE, V20, P957, DOI 10.1016/j.str.2012.04.020; Carvajal-Gonzalez JM, 2012, P NATL ACAD SCI USA, V109, P3820, DOI 10.1073/pnas.1117949109; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Crottet P, 2002, MOL BIOL CELL, V13, P3672, DOI 10.1091/mbc.E02-05-0309; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farias GG, 2012, NEURON, V75, P810, DOI 10.1016/j.neuron.2012.07.007; Gaidarov I, 1996, J BIOL CHEM, V271, P20922, DOI 10.1074/jbc.271.34.20922; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Huang FT, 2001, TRAFFIC, V2, P345, DOI 10.1034/j.1600-0854.2001.25020506.x; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Janvier K, 2003, J CELL BIOL, V163, P1281, DOI 10.1083/jcb.200307157; Jia XF, 2012, NAT STRUCT MOL BIOL, V19, P701, DOI 10.1038/nsmb.2328; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; LeBorgne R, 1996, J BIOL CHEM, V271, P2162; Lee I, 2008, ARCH BIOCHEM BIOPHYS, V479, P63, DOI 10.1016/j.abb.2008.08.009; Lee I, 2008, J CELL BIOL, V180, P467, DOI 10.1083/jcb.200709037; Liang JO, 1997, J BIOL CHEM, V272, P33001, DOI 10.1074/jbc.272.52.33001; Mattera R, 2011, J BIOL CHEM, V286, P2022, DOI 10.1074/jbc.M110.197178; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Montagnac G, 2011, CURR BIOL, V21, P574, DOI 10.1016/j.cub.2011.02.034; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Ooi CE, 1998, J CELL BIOL, V142, P391, DOI 10.1083/jcb.142.2.391; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Paleotti O, 2005, J BIOL CHEM, V280, P21661, DOI 10.1074/jbc.m503099200; Peden AA, 2001, J BIOL CHEM, V276, P49183, DOI 10.1074/jbc.M106646200; Poupart ME, 2007, CELL SIGNAL, V19, P2370, DOI 10.1016/j.cellsig.2007.07.015; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rohde G, 2002, J CELL BIOL, V158, P209, DOI 10.1083/jcb.200203103; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Seaman MNJ, 1996, J BIOL CHEM, V271, P25446, DOI 10.1074/jbc.271.41.25446; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; Shiba T, 2003, NAT STRUCT BIOL, V10, P386, DOI 10.1038/nsb920; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; TRAUB LM, 1993, J CELL BIOL, V123, P561, DOI 10.1083/jcb.123.3.561; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Yu XC, 2012, CELL, V148, P530, DOI 10.1016/j.cell.2012.01.015	48	102	105	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 14	2013	152	4					755	767		10.1016/j.cell.2012.12.042	http://dx.doi.org/10.1016/j.cell.2012.12.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415225	Green Accepted, Bronze			2022-12-28	WOS:000314945600011
J	Wu, C; Yosef, N; Thalhamer, T; Zhu, C; Xiao, S; Kishi, Y; Regev, A; Kuchroo, VK				Wu, Chuan; Yosef, Nir; Thalhamer, Theresa; Zhu, Chen; Xiao, Sheng; Kishi, Yasuhiro; Regev, Aviv; Kuchroo, Vijay K.			Induction of pathogenic T(H)17 cells by inducible salt-sensing kinase SGK1	NATURE			English	Article							PROTEIN-KINASE; SERUM; ACTIVATION; DIFFERENTIATION; TRANSCRIPTION; SYSTEM	T(H)17 cells (interleukin-17 (IL-17)-producing helper T cells) are highly proinflammatory cells that are critical for clearing extracellular pathogens and for inducing multiple autoimmune diseases(1). IL-23 has a critical role in stabilizing and reinforcing the T(H)17 phenotype by increasing expression of IL-23 receptor (IL-23R) and endowing T(H)17 cells with pathogenic effector functions(2,3). However, the precise molecular mechanism by which IL-23 sustains the T(H)17 response and induces pathogenic effector functions has not been elucidated. Here we used transcriptional profiling of developing T(H)17 cells to construct a model of their signalling network and nominate major nodes that regulate T(H)17 development. We identified serum glucocorticoid kinase 1 (SGK1), a serine/threonine kinase(4), as an essential node downstream of IL-23 signalling. SGK1 is critical for regulating IL-23R expression and stabilizing the T(H)17 cell phenotype by deactivation of mouse Foxo1, a direct repressor of IL-23R expression. SGK1 has been shown to govern Na+ transport and salt (NaCl) homeostasis in other cells(5-8). We show here that a modest increase in salt concentration induces SGK1 expression, promotes IL-23R expression and enhances T(H)17 cell differentiation in vitro and in vivo, accelerating the development of autoimmunity. Loss of SGK1 abrogated Na+-mediated T(H)17 differentiation in an IL-23-dependent manner. These data demonstrate that SGK1 has a critical role in the induction of pathogenic T(H)17 cells and provide a molecular insight into a mechanism by which an environmental factor such as a high salt diet triggers T(H)17 development and promotes tissue inflammation.	[Wu, Chuan; Yosef, Nir; Thalhamer, Theresa; Zhu, Chen; Xiao, Sheng; Kishi, Yasuhiro; Kuchroo, Vijay K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Yosef, Nir; Regev, Aviv; Kuchroo, Vijay K.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Regev, Aviv] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02140 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Regev, A (corresponding author), Broad Inst MIT & Harvard, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	aregev@broad.mit.edu; vkuchroo@rics.bwh.harvard.edu	Wu, Chuan/H-6379-2013	Wu, Chuan/0000-0003-2288-353X	US National Institutes of Health [NS030843, NS045937, AI073748, AI045757, 1P01HG005062-01, 1P50HG006193-01, DP1-OD003958-01, K01DK090105]; National MS Society [RG2571]; Howard Hughes Medical Institute; Klarman Cell Observatory; Guthy Jackson Foundation; Austrian Science Fund (FWF) [J 3091-B12]; NATIONAL CANCER INSTITUTE [DP1CA174427] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG005062, P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045757, P01AI073748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK090105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045937, R29NS030843, R37NS030843, R01NS030843] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National MS Society(National Multiple Sclerosis Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Klarman Cell Observatory; Guthy Jackson Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Kozoriz for cell sorting and A. Waisman for providing Il17f<SUP>Cre</SUP> mice. L. Zhou, D. Accili, J. Demoulin and K. Sato provided reagents. This work was supported by the US National Institutes of Health (NS030843, NS045937, AI073748 and AI045757 to V. K. K.; 1P01HG005062-01, 1P50HG006193-01 and DP1-OD003958-01 to A. R.; and K01DK090105 to S. X.); the National MS Society (RG2571 to V. K. K.); the Howard Hughes Medical Institute (A. R.); the Klarman Cell Observatory; Guthy Jackson Foundation; and the Austrian Science Fund (FWF, J 3091-B12 to T.T.).	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Chechik G, 2009, J COMPUT BIOL, V16, P279, DOI 10.1089/cmb.2008.13TT; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Di Pietro N, 2010, MOL ENDOCRINOL, V24, P370, DOI 10.1210/me.2009-0265; Diakov A, 2004, J BIOL CHEM, V279, P38134, DOI 10.1074/jbc.M403260200; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Herrada AA, 2010, J IMMUNOL, V184, P191, DOI 10.4049/jimmunol.0802886; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Loffing J, 2001, AM J PHYSIOL-RENAL, V280, pF675, DOI 10.1152/ajprenal.2001.280.4.F675; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Salker MS, 2011, NAT MED, V17, P1509, DOI 10.1038/nm.2498; Sczesnak A, 2011, CELL HOST MICROBE, V10, P260, DOI 10.1016/j.chom.2011.08.005; Shelly C, 2002, J CELL SCI, V115, P1985; Stegbauer J, 2009, P NATL ACAD SCI USA, V106, P14942, DOI 10.1073/pnas.0903602106; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wulff P, 2002, J CLIN INVEST, V110, P1263, DOI 10.1172/JCI200215696; Yosef N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001935; Zhang LP, 2005, CANCER RES, V65, P457; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	23	671	693	2	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2013	496	7446					513	517		10.1038/nature11984	http://dx.doi.org/10.1038/nature11984			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23467085	Green Accepted, Green Submitted			2022-12-28	WOS:000317984400043
J	McShane, M				McShane, Martin			Should GPs be fined for rises in avoidable emergency admissions to hospital? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Natl Commissioning Board, Leeds LS2 7UE, W Yorkshire, England		McShane, M (corresponding author), Natl Commissioning Board, Leeds LS2 7UE, W Yorkshire, England.	martin.mcshane@btinternet.com						Bardsley M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002007; Department of Health, 2012, BAS SPEND EST NEW NH; Francis R., 2013, FINAL REPORT MIDSTAF; Imison C, 2012, OLDER PEOPLE EMERGEN	4	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2013	346								f1389	10.1136/bmj.f1389	http://dx.doi.org/10.1136/bmj.f1389			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104MN	23463139				2022-12-28	WOS:000315997600017
J	Weaver, SJ; Lubomksi, LH; Wilson, RF; Pfoh, ER; Martinez, KA; Dy, SM				Weaver, Sallie J.; Lubomksi, Lisa H.; Wilson, Renee F.; Pfoh, Elizabeth R.; Martinez, Kathryn A.; Dy, Sydney M.			Promoting a Culture of Safety as a Patient Safety Strategy A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Article							STRUCTURED INTERDISCIPLINARY ROUNDS; HEALTH-CARE; OPERATING-ROOM; CLIMATE; PERFORMANCE; TEAMWORK; IMPACT; INTERVENTIONS; FRAMEWORK; ATTITUDES	Developing a culture of safety is a core element of many efforts to improve patient safety and care quality. This systematic review identifies and assesses interventions used to promote safety culture or climate in acute care settings. The authors searched MEDLINE, CINAHL, PsycINFO, Cochrane, and EMBASE to identify relevant English-language studies published from January 2000 to October 2012. They selected studies that targeted health care workers practicing in inpatient settings and included data about change in patient safety culture or climate after a targeted intervention. Two raters independently screened 3679 abstracts (which yielded 33 eligible studies in 35 articles), extracted study data, and rated study quality and strength of evidence. Eight studies included executive walk rounds or interdisciplinary rounds; 8 evaluated multicomponent, unit-based interventions; and 20 included team training or communication initiatives. Twenty-nine studies reported some improvement in safety culture or patient outcomes, but measured outcomes were highly heterogeneous. Strength of evidence was low, and most studies were pre-post evaluations of low to moderate quality. Within these limits, evidence suggests that interventions can improve perceptions of safety culture and potentially reduce patient harm. Ann Intern Med. 2013;158:369-374. www.annals.org	Johns Hopkins Univ, Baltimore, MD 21202 USA; Univ Michigan, Ann Arbor, MI 48109 USA	Johns Hopkins University; University of Michigan System; University of Michigan	Weaver, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, 750 East Pratt St,15th Floor,Room 1544, Baltimore, MD 21202 USA.	sjweaver@jhu.edu	Weaver, Sallie J./AAH-1453-2020; Hefner, Jennifer/P-5962-2014	Weaver, Sallie J./0000-0002-5859-7669; Hefner, Jennifer/0000-0001-8083-8038	AHRQ, U.S. Department of Health and Human Services [HHSA-290-2007-10062I]; AHRQ; Improvement Science Research Network; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	AHRQ, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Improvement Science Research Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Financial Support: From the AHRQ, U.S. Department of Health and Human Services (contract HHSA-290-2007-10062I).; Potential Conflicts of Interest: Dr. Weaver: Grant (money to institution): AHRQ, U.S. Department of Health and Human Services; Travel/accommodations/meeting expenses unrelated to activities listed (money to author): Improvement Science Research Network. Dr. Lubomski: Grant (money to institution): AHRQ. Ms. Wilson: Grant (money to institution): AHRQ. Ms. Pfoh: Grant (money to institution): AHRQ. Dr. Martinez: None disclosed. Dr. Dy: Grant (money to institution): AHRQ. Disclosures can be also viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M12-2567.	Abstoss KM, 2011, BMJ QUAL SAF, V20, P914, DOI 10.1136/bmjqs.2010.047233; [Anonymous], 2001, MAKING HLTH CARE SAF; Blegen MA, 2010, QUAL SAF HEALTH CARE, V19, P346, DOI 10.1136/qshc.2008.031252; Braithwaite J, 2010, QUAL SAF HEALTH CARE, V19, P14, DOI 10.1136/qshc.2009.033928; Colla JB, 2005, QUAL SAF HEALTH CARE, V14, P364, DOI 10.1136/qshc.2005.014217; Estabrooks CA, 2002, RES NURS HEALTH, V25, P256, DOI 10.1002/nur.10043; Flin R, 2006, QUAL SAF HEALTH CARE, V15, P109, DOI 10.1136/qshc.2005.014761; Flin R, 2007, SAFETY SCI, V45, P653, DOI 10.1016/j.ssci.2007.04.003; Frankel A, 2008, HEALTH SERV RES, V43, P2050, DOI 10.1111/j.1475-6773.2008.00878.x; Haynes AB, 2011, BMJ QUAL SAF, V20, P102, DOI 10.1136/bmjqs.2009.040022; Jackson J, 2010, CURR OPIN CRIT CARE; Kirk S, 2007, QUAL SAF HEALTH CARE, V16, P313, DOI 10.1136/qshc.2006.018366; Kohn KT, 2000, ERR IS HUMAN BUILDIN; Mardon Russell E, 2010, J Patient Saf, V6, P226, DOI 10.1097/PTS.0b013e3181fd1a00; McCulloch P, 2009, QUAL SAF HEALTH CARE, V18, P109, DOI 10.1136/qshc.2008.032045; Morello RT, 2012, BMJ QUAL SAF; Muething SE, 2012, PEDIATRICS, V130, pE423, DOI 10.1542/peds.2011-3566; O'Leary KJ, 2011, J HOSP MED, V6, P88, DOI 10.1002/jhm.714; O'Leary KJ, 2010, J GEN INTERN MED, V25, P826, DOI 10.1007/s11606-010-1345-6; Parmelli E, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-33; Pettker CM, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.11.004; Pettker CM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.022; Pronovost P, 2005, J PATIENT SAF, V1, P33, DOI DOI 10.1097/01209203-200503000-00008; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2006, HEALTH SERV RES, V41, P1599, DOI 10.1111/j.1475-6773.2006.00567.x; Reiman T, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2008.029793; Riley W, 2011, JT COMM J QUAL PATIE, V37, P357, DOI 10.1016/S1553-7250(11)37046-8; Romig Mark, 2010, Hosp Pract (1995), V38, P114, DOI 10.3810/hp.2010.11.348; Saladino L, 2012, J NURS CARE QUAL; Salas E, 2008, ACAD EMERG MED, V15, P1002, DOI 10.1111/j.1553-2712.2008.00254.x; Schein EH., 2010, ORG CULTURE LEADERSH; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Sexton JB, 2011, CRIT CARE MED, V39, P934, DOI 10.1097/CCM.0b013e318206d26c; Sexton JB, 2002, MATTER LIFE DEATH SO; Sexton JB, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-44; Shojania K G, 2001, Evid Rep Technol Assess (Summ), pi; Simpson KR, 2011, JT COMM J QUAL PATIE, V37, P544, DOI 10.1016/S1553-7250(11)37070-5; Singer S, 2007, HEALTH SERV RES, V42, P1999, DOI 10.1111/j.1475-6773.2007.00706.x; Singer S, 2009, HEALTH SERV RES, V44, P399, DOI 10.1111/j.1475-6773.2008.00918.x; Singer SJ, 2012, BMJ QUAL SAF; Sorra J, 2012, AHRQ PUBLICATION, V12-0017; Sorra JS, 2004, AHRQ PUBLICATION, V04-0041; Thomas EJ, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-28; Tiessen Barbara, 2008, Healthc Q, V11, P58; Timmel J, 2010, JT COMM J QUAL PATIE, V36, P252, DOI 10.1016/S1553-7250(10)36040-5; Vigorito MC, 2011, JT COMM J QUAL PATIE, V37, P509, DOI 10.1016/S1553-7250(11)37065-1; Weaver SJ, 2010, ACAD MED, V85, P1746, DOI 10.1097/ACM.0b013e3181f2e907; Weaver SJ, 2010, JT COMM J QUAL PATIE, V36, P133, DOI 10.1016/S1553-7250(10)36022-3; Wolf FA, 2010, ANN SURG, V252, P477, DOI 10.1097/SLA.0b013e3181f1c091; Zohar D, 2007, CRIT CARE MED, V35, P1312, DOI 10.1097/01.CCM.0000262404.10203.C9	50	304	311	6	73	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2013	158	5	2				369	+		10.7326/0003-4819-158-5-201303051-00002	http://dx.doi.org/10.7326/0003-4819-158-5-201303051-00002			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	105HX	23460092	Green Accepted			2022-12-28	WOS:000316058600002
J	Clevers, H; Batlle, E				Clevers, Hans; Batlle, Eduard			SnapShot: The Intestinal Crypt	CELL			English	Editorial Material							LGR5 STEM-CELLS; WNT RECEPTORS; HOMEOSTASIS		[Clevers, Hans] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Batlle, Eduard] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Batlle, Eduard] ICREA, Barcelona 08010, Spain	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA	Clevers, H (corresponding author), KNAW, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.		Batlle, Eduard/K-8080-2014	Batlle, Eduard/0000-0003-2422-0326	ICREA Funding Source: Custom	ICREA(ICREA)		Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Buczacki SJ, 2013, NATURE; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464	10	39	40	2	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 28	2013	152	5					1198	+		10.1016/j.cell.2013.02.030	http://dx.doi.org/10.1016/j.cell.2013.02.030			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452862	Bronze			2022-12-28	WOS:000315710300027
J	Koonin, EV; Mulkidjanian, AY				Koonin, Eugene V.; Mulkidjanian, Armen Y.			Evolution of Cell Division: From Shear Mechanics to Complex Molecular Machineries	CELL			English	Editorial Material								Cell division depends on sophisticated molecular machinery. However, wall-less forms of bacteria use a much simpler mechanism that mimics spontaneous division of synthetic lipid vesicles. Mercier et al. (2013) show that this "mechanical" division can be activated by increased lipid synthesis. Conceivably, the first cells divided via this route.	[Koonin, Eugene V.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Mulkidjanian, Armen Y.] Univ Osnabruck, Sch Phys, D-49069 Osnabruck, Germany; [Mulkidjanian, Armen Y.] Moscow MV Lomonosov State Univ, Sch Bioengn & Bioinformat, Moscow 119992, Russia; [Mulkidjanian, Armen Y.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119992, Russia	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University Osnabruck; Lomonosov Moscow State University; Lomonosov Moscow State University	Koonin, EV (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA.	koonin@ncbi.nlm.nih.gov	Mulkidjanian, Armen/AAH-3608-2021; Mulkidjanian, Armen Y/J-8086-2013	Mulkidjanian, Armen Y/0000-0001-5844-3064				Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Albers SV, 2011, NAT REV MICROBIOL, V9, P414, DOI 10.1038/nrmicro2576; Bernander R, 2010, CURR OPIN MICROBIOL, V13, P747, DOI 10.1016/j.mib.2010.10.005; Budin I, 2012, J AM CHEM SOC, V134, P20812, DOI 10.1021/ja310382d; Dibrova DV, 2012, ORIGINS LIFE EVOL B, V42, P459, DOI 10.1007/s11084-012-9308-z; Errington J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120143; Makarova KS, 2010, NAT REV MICROBIOL, V8, P731, DOI 10.1038/nrmicro2406; Mercier R, 2013, CELL, V152, P997, DOI 10.1016/j.cell.2013.01.043; Mulkidjanian AY, 2012, P NATL ACAD SCI USA, V109, pE821, DOI 10.1073/pnas.1117774109; Zhu TF, 2009, J AM CHEM SOC, V131, P5705, DOI 10.1021/ja900919c	10	15	15	1	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 28	2013	152	5					942	944		10.1016/j.cell.2013.02.008	http://dx.doi.org/10.1016/j.cell.2013.02.008			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452845	Bronze			2022-12-28	WOS:000315710300004
J	Purvis, JE; Lahav, G				Purvis, Jeremy E.; Lahav, Galit			Encoding and Decoding Cellular Information through Signaling Dynamics	CELL			English	Review							NERVE GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; P53-MDM2 FEEDBACK LOOP; KAPPA-B DYNAMICS; TEMPORAL CONTROL; MAP KINASE; PC12 CELLS; SPATIOTEMPORAL CONTROL; CALCIUM OSCILLATIONS; CANCER-CELLS	A growing number of studies are revealing that cells can send and receive information by controlling the temporal behavior (dynamics) of their signaling molecules. In this Review, we discuss what is known about the dynamics of various signaling networks and their role in controlling cellular responses. We identify general principles that are emerging in the field, focusing specifically on how the identity and quantity of a stimulus is encoded in temporal patterns, how signaling dynamics influence cellular outcomes, and how specific dynamical patterns are both shaped and interpreted by the structure of molecular networks. We conclude by discussing potential functional roles for transmitting cellular information through the dynamics of signaling molecules and possible applications for the treatment of disease.	[Purvis, Jeremy E.; Lahav, Galit] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Lahav, G (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	galit@hms.harvard.edu			Novartis Institutes for Biomedical Research; National Institutes of Health [GM083303, K99-GM102372]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083303, R00GM102372, K99GM102372] Funding Source: NIH RePORTER	Novartis Institutes for Biomedical Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. J. Rahi, W. Forrester, L. Murphy, R. Dolmetsch, A. Hoffmann, S. Santos, A. Aderam, V. Litvak, M. R. White, and all members of our laboratory for helpful discussions, comments, and reference suggestions. We thank our colleagues and friends at Harvard Medical School and the Department of Systems Biology for creating an inspiring environment that encourages thinking about temporal aspects of cell signaling. This research was supported by the Novartis Institutes for Biomedical Research and by National Institutes of Health grants GM083303 and K99-GM102372 (J.E.P.).	Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Bakstad D, 2012, CURR OPIN BIOTECH, V23, P103, DOI 10.1016/j.copbio.2011.11.007; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Barken D, 2005, SCIENCE, V308, DOI 10.1126/science.1107904; Basak S, 2012, IMMUNOL REV, V246, P221, DOI 10.1111/j.1600-065X.2011.01092.x; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Batchelor E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.20; Behar M, 2007, P NATL ACAD SCI USA, V104, P16146, DOI 10.1073/pnas.0703894104; Behar M, 2010, CURR OPIN GENET DEV, V20, P684, DOI 10.1016/j.gde.2010.09.007; Behar M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000197; Birtwistle MR, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-109; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Chandra A, 2012, NAT CELL BIOL, V14, P148, DOI 10.1038/ncb2394; Chatterjee MS, 2010, NAT BIOTECHNOL, V28, P727, DOI 10.1038/nbt.1642; Cheong R, 2006, J BIOL CHEM, V281, P2945, DOI 10.1074/jbc.M510085200; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; Cotterell J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.74; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; DARMON M, 1975, P NATL ACAD SCI USA, V72, P3163, DOI 10.1073/pnas.72.8.3163; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Francisco DC, 2008, FREE RADICAL BIO MED, V44, P558, DOI 10.1016/j.freeradbiomed.2007.10.045; Garmaroudi FS, 2010, P NATL ACAD SCI USA, V107, P17053, DOI 10.1073/pnas.1006478107; Geva-Zatorsky N, 2010, CELL, V140, P643, DOI 10.1016/j.cell.2010.02.011; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; Grammer TC, 1997, ONCOGENE, V14, P1635, DOI 10.1038/sj.onc.1201000; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hamstra DA, 2006, CANCER RES, V66, P7482, DOI 10.1158/0008-5472.CAN-06-1405; Hao N, 2012, NAT STRUCT MOL BIOL, V19, P31, DOI 10.1038/nsmb.2192; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kholodenko BN, 2002, P NATL ACAD SCI USA, V99, P12841, DOI 10.1073/pnas.192442699; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kubota H, 2012, MOL CELL, V46, P820, DOI 10.1016/j.molcel.2012.04.018; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; Levine JH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001252; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Malcuit C, 2006, J CELL PHYSIOL, V206, P565, DOI 10.1002/jcp.20471; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Nakakuki T, 2010, CELL, V141, P884, DOI 10.1016/j.cell.2010.03.054; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Neves SR, 2008, CELL, V133, P666, DOI 10.1016/j.cell.2008.04.025; NGUYEN TT, 1993, J BIOL CHEM, V268, P9803; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Sung MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007163; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Toettcher JE, 2011, NAT METHODS, V8, P837, DOI [10.1038/NMETH.1700, 10.1038/nmeth.1700]; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Tyas L, 2000, EMBO REP, V1, P266, DOI 10.1093/embo-reports/kvd050; Welch CM, 2011, NAT REV MOL CELL BIO, V12, P749, DOI 10.1038/nrm3212; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Yissachar N, 2013, MOL CELL, V49, P322, DOI 10.1016/j.molcel.2012.11.003; Yosef N, 2011, CELL, V144, P886, DOI 10.1016/j.cell.2011.02.015	69	477	485	13	164	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 28	2013	152	5					945	956		10.1016/j.cell.2013.02.005	http://dx.doi.org/10.1016/j.cell.2013.02.005			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452846	Bronze, Green Accepted			2022-12-28	WOS:000315710300005
J	Ward, AB; Sali, A; Wilson, IA				Ward, Andrew B.; Sali, Andrej; Wilson, Ian A.			Integrative Structural Biology	SCIENCE			English	Editorial Material							MODEL		[Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, Int AIDS Vaccine Initiat, Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Sali, Andrej] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Sali, Andrej] Univ Calif San Francisco, Calif Inst Quantitat Biosci QB3, San Francisco, CA 94158 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Scripps Research Institute	Ward, AB (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, Int AIDS Vaccine Initiat, Neutralizing Antibody Ctr, La Jolla, CA 92037 USA.	abward@scripps.edu	Ward, Andrew B/F-9203-2014; Ward, Andrew/ABD-7728-2021; Cheng, Yushao/E-6256-2011	Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769; 	NIAID NIH HHS [UM1 AI100663, P01 AI082362] Funding Source: Medline; NIGMS NIH HHS [U54 GM094586] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663, P01AI082362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094586] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alber F, 2008, ANNU REV BIOCHEM, V77, P443, DOI 10.1146/annurev.biochem.77.060407.135530; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; Lander GC, 2012, CURR OPIN STRUC BIOL, V22, P627, DOI 10.1016/j.sbi.2012.07.006; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Loquet A, 2012, NATURE, V486, P276, DOI 10.1038/nature11079; Rieping W, 2005, SCIENCE, V309, P303, DOI 10.1126/science.1110428; Russel D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001244; Sgourakis NG, 2011, J AM CHEM SOC, V133, P6288, DOI 10.1021/ja111318m; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673	12	170	172	0	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2013	339	6122					913	915		10.1126/science.1228565	http://dx.doi.org/10.1126/science.1228565			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23430643	Green Accepted			2022-12-28	WOS:000315149600035
J	Zumla, A; Raviglione, M; Hafner, R; von Reyn, CF				Zumla, Alimuddin; Raviglione, Mario; Hafner, Richard; von Reyn, C. Fordham			CURRENT CONCEPTS Tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MULTIDRUG-RESISTANT TUBERCULOSIS; HIV-INFECTED ADULTS; ANTIRETROVIRAL THERAPY; PREVENTION; DIAGNOSIS; RISK; REINFECTION; EFFICACY; OUTCOMES; MDR		[Zumla, Alimuddin] UCL, Sch Med, Dept Infect, Div Infect & Immun, London W1N 8AA, England; [Raviglione, Mario] WHO, STOP TB Dept, Geneva, Switzerland; [Hafner, Richard] NIAID, TB Clin Res Branch, Div Aids, NIH, Bethesda, MD 20892 USA; [von Reyn, C. Fordham] Geisel Sch Med Dartmouth, Sect Infect Dis & Int Hlth, Hanover, NH USA	University of London; University College London; UCL Medical School; World Health Organization; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Dartmouth College	Zumla, A (corresponding author), Ctr Clin Microbiol, Div Infect & Immun, 2nd Fl,UCL Royal Free Campus,Rowland Hill St, London NW3 OPE, England.	a.zumla@ucl.ac.uk	Rivet, Catherine A/M-7978-2014; ZUMLA, Alimuddin/ABA-8208-2020	ZUMLA, Alimuddin/0000-0002-5111-5735; RAVIGLIONE, Mario/0000-0002-9331-2067	Oxford Immunotec	Oxford Immunotec	Dr. von Reyn reports receiving consulting fees from Oxford Immunotec. No other potential conflict of interest relevant to this article was reported.	Abubakar I, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4281; Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951; [Anonymous], RIF BAS TUB TREATM V; [Anonymous], TOT DRUG RES TB WHO; [Anonymous], REMEMBER RED EARL MO; [Anonymous], PREV EARL MORT PRES; [Anonymous], SURV REP TUB SURV MO; [Anonymous], 2011, GUID INT TUB CAS FIN; [Anonymous], 2011, STREAM EVALUATION ST; Bates M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040774; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; COMBS DL, 1990, ANN INTERN MED, V112, P397, DOI 10.7326/0003-4819-76-3-112-6-397; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Diacon AH, 2012, LANCET, V380, P986, DOI 10.1016/S0140-6736(12)61080-0; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; European Centre for Disease Prevention and Control, 2011, US INT GAMM REL ASS; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611; Ferrara G, 2012, CURR OPIN PULM MED, V18, P233, DOI 10.1097/MCP.0b013e328351f9d6; Foundation for Innovative New Diagnostics, 2011, PERF XPERT MTB RIF V; Frieden TR, 2007, INT J TUBERC LUNG D, V11, P116; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Gler MT, 2012, NEW ENGL J MED, V366, P2151, DOI 10.1056/NEJMoa1112433; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Hill AN, 2012, EPIDEMIOL INFECT, V140, P1862, DOI 10.1017/S095026881100286X; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; Horsburgh CR, 2011, NEW ENGL J MED, V364, P1441, DOI 10.1056/NEJMcp1005750; Jacobson KR, 2010, CLIN INFECT DIS, V51, P6, DOI 10.1086/653115; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Lahey T, 2013, CLIN INFECT DIS, V56, P151, DOI 10.1093/cid/cis798; Lawn SD, 2012, CLIN INFECT DIS, V54, P1071, DOI 10.1093/cid/cir1039; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lawn SD, 2010, AM J RESP CRIT CARE, V182, P1567, DOI 10.1164/ajrccm.182.12.1567; Lee M, 2012, NEW ENGL J MED, V367, P1508, DOI 10.1056/NEJMoa1201964; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; McNerney R, 2012, J INFECT DIS, V205, pS147, DOI 10.1093/infdis/jir860; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Mtei L, 2005, CLIN INFECT DIS, V40, P1500, DOI 10.1086/429825; Mudenda V, 2012, J INFECT DIS, V205, pS340, DOI 10.1093/infdis/jir859; Naidoo K, 2012, ANN INTERN MED, V157, P313, DOI 10.7326/0003-4819-157-5-201209040-00004; Nathanson E, 2010, NEW ENGL J MED, V363, P1050, DOI 10.1056/NEJMra0908076; National Institute for Health and Clinical Excellence, 2011, TUB CLIN DIAGN MAN T, V117; O'Grady J, 2011, CURR OPIN PULM MED, V17, P134, DOI 10.1097/MCP.0b013e3283452346; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; Stop TB Partnership, 2011, TUB VACC CAND; Swaminathan S, 2011, CLIN INFECT DIS, V53, P716, DOI 10.1093/cid/cir447; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Van Deun A, 2004, INT J TUBERC LUNG D, V8, P560; Verver S, 2005, AM J RESP CRIT CARE, V171, P1430, DOI 10.1164/rccm.200409-1200OC; von Reyn CF, 2011, INT J TUBERC LUNG D, V15, P1087, DOI 10.5588/ijtld.10.0517; von Reyn CF, 2011, J INFECT DIS, V204, P817, DOI 10.1093/infdis/jir418; von Reyn CF, 2001, INT J TUBERC LUNG D, V5, P1122; von Reyn CF, 2010, AIDS, V24, P675, DOI 10.1097/QAD.0b013e3283350f1b; WHO, 2011, TUB MDR TB XDR TB 20; Word Health Organization, GLOB TUB REP 2012; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health Organization, 2012, WHO POL COLL TB HIV; World Health Organization, 2011, RAP IMPL XPERT MTB R; World Health organization, 2008, POL GUID DRUG SUSC T; Zignol M, 2012, B WORLD HEALTH ORGAN, V90, P111, DOI 10.2471/BLT.11.092585	71	545	570	5	166	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2013	368	8					745	755		10.1056/NEJMra1200894	http://dx.doi.org/10.1056/NEJMra1200894			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092CG	23425167				2022-12-28	WOS:000315095800009
J	Kim, HJ; Jeon, BS; Yang, HJ; Cho, JY				Kim, Han-Joon; Jeon, Beom S.; Yang, Hui-Jun; Cho, Joong-Yang			In need of something better than sleep	LANCET			English	Editorial Material							POSTENCEPHALITIC PARKINSONISM; ENCEPHALITIS		[Kim, Han-Joon; Jeon, Beom S.; Yang, Hui-Jun] Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea; [Kim, Han-Joon; Jeon, Beom S.; Yang, Hui-Jun] Seoul Natl Univ Hosp, Movement Disorder Ctr, Parkinson Dis Study Grp, Seoul 110744, South Korea; [Kim, Han-Joon; Jeon, Beom S.; Yang, Hui-Jun] Seoul Natl Univ Hosp, Neurosci Res Inst, Seoul 110744, South Korea; [Cho, Joong-Yang] Inje Univ, Ilsan Paik Hosp, Dept Neurol, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Inje University	Jeon, BS (corresponding author), Seoul Natl Univ, Coll Med, Dept Neurol, 28 Yongon Dong, Seoul 110744, South Korea.	brain@snu.ac.kr		Kim, Han-Joon/0000-0001-8219-9663				Calne D, 1969, LANCET, V293, P744; Ghaemi M, 2000, J NEURAL TRANSM, V107, P1289, DOI 10.1007/s007020070018; Savant CS, 2003, MOVEMENT DISORD, V18, P213, DOI 10.1002/mds.10339; Vilensky JA, 2010, MOVEMENT DISORD, V25, P1124, DOI 10.1002/mds.22991	4	1	1	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 16	2013	381	9866					598	598		10.1016/S0140-6736(12)61892-3	http://dx.doi.org/10.1016/S0140-6736(12)61892-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089RK	23415305				2022-12-28	WOS:000314927500035
J	Zheng, YX; Iglesias, PA				Zheng, Yixian; Iglesias, Pablo A.			Nucleating New Branches from Old	CELL			English	Editorial Material							SPINDLE; ORGANIZATION; GRADIENT; COMPLEX	Centrosome- and chromatin-based microtubule nucleation pathways have been implicated in spindle assembly. Using total internal reflection fluorescent microscopy and Xenopus egg extracts, Petry et al. demonstrate that new microtubules can also nucleate and branch out from existing ones in animal cells.	[Zheng, Yixian] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; [Iglesias, Pablo A.] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA	Carnegie Institution for Science; Johns Hopkins University	Zheng, YX (corresponding author), Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA.	zheng@ciwemb.edu	Iglesias, Pablo A/A-5202-2008	Iglesias, Pablo A/0000-0002-0840-155X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056312, R01GM086704] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM56312, GM086704, R01 GM056312] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Clausen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000244; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Li HY, 2004, GENE DEV, V18, P512, DOI 10.1101/gad.1177304; Loughlin R, 2010, J CELL BIOL, V191, P1239, DOI 10.1083/jcb.201006076; Petry S, 2013, CELL, V152, P768, DOI 10.1016/j.cell.2012.12.044; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	10	6	6	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 14	2013	152	4					669	670		10.1016/j.cell.2013.01.040	http://dx.doi.org/10.1016/j.cell.2013.01.040			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415217	Green Accepted, Bronze			2022-12-28	WOS:000314945600002
J	Cottrell, EB; Chou, R; Wasson, N; Rahman, B; Guise, JM				Cottrell, Erika Barth; Chou, Roger; Wasson, Ngoc; Rahman, Basmah; Guise, Jeanne-Marie			Reducing Risk for Mother-to-Infant Transmission of Hepatitis C Virus: A Systematic Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							CHILD TRANSMISSION; VERTICAL TRANSMISSION; HCV INFECTION; PREGNANT-WOMEN; PREVALENCE; COHORT; QUALITY; BORN	Background: Mother-to-infant transmission is the leading cause of childhood hepatitis C virus (HCV) infection, with up to 4000 new cases each year in the United States. Purpose: To evaluate effects of mode of delivery, labor management strategies, and breastfeeding practices on risk for mother-to-infant transmission of HCV. Data Sources: MEDLINE (1947 to May 2012), the Cochrane Library Database, clinical trial registries, and reference lists. Study Selection: Randomized trials and observational studies on mode of delivery, labor management strategies, and breastfeeding practices and risk for mother-to-infant transmission of HCV. Data Extraction: Investigators abstracted and reviewed study details and quality using predefined criteria. Data Synthesis: Eighteen observational studies evaluated the association between mode of delivery, labor management strategies, or breastfeeding practices and risk for mother-to-infant HCV transmission. Fourteen studies (2 good-quality, 4 fair-quality, and 8 poorquality studies) found no clear association between mode of delivery (vaginal versus cesarean delivery) and risk for transmission. Two studies (1 good-quality and 1 poor-quality study) reported an association between prolonged duration of ruptured membranes and increased risk for transmission. Fourteen studies (2 good-quality, 2 fair-quality, and 10 poor-quality studies) found no association between breastfeeding and risk for transmission. Limitations: Only English-language articles were included. Studies were observational, and most had important methodological shortcomings, including failure to adjust for potential confounders and small sample sizes. Conclusion: No intervention has been clearly demonstrated to reduce the risk for mother-to-infant HCV transmission. Avoidance of breastfeeding does not seem to be indicated for reducing transmission risk.	[Cottrell, Erika Barth; Chou, Roger; Wasson, Ngoc; Rahman, Basmah; Guise, Jeanne-Marie] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Chou, R (corresponding author), 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA.	chour@ohsu.edu		Rahman, Basmah/0000-0002-3576-2086; Guise, Jeanne-Marie/0000-0002-8961-488X; Chou, Roger/0000-0001-9889-8610	AHRQ Rockville, Maryland [290-2007-10057-I]	AHRQ Rockville, Maryland	By AHRQ (contract 290-2007-10057-I, task order 8), Rockville, Maryland.	Agency for Healthcare Research and Quality, 2012, AHRQ PUBL; American College of Obstetricians and Gynecologists, 2007, ACOG PRACT B; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Boaz Kathy, 2003, Infect Dis Obstet Gynecol, V11, P39, DOI 10.1155/S106474490300005X; Ceci O, 2001, J HEPATOL, V35, P687, DOI 10.1016/S0168-8278(01)00205-7; Chou R, 2012, SCREENING HEPATITIS; Conte D, 2000, HEPATOLOGY, V31, P751, DOI 10.1002/hep.510310328; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; England K, 2006, LANCET INFECT DIS, V6, P83, DOI 10.1016/S1473-3099(06)70381-4; European Paediatric Hepatitis C Virus Network, 2001, BJOG, V108, P371; Garland SM, 1998, AUST NZ J OBSTET GYN, V38, P424, DOI 10.1111/j.1479-828X.1998.tb03102.x; Gibb DM, 2000, LANCET, V356, P904, DOI 10.1016/S0140-6736(00)02681-7; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; La Torre A, 1998, ACTA OBSTET GYN SCAN, V77, P889, DOI 10.1034/j.1600-0412.1998.770903.x; LIN HH, 1995, J PEDIATR-US, V126, P589, DOI 10.1016/S0022-3476(95)70356-X; Mast EE, 2005, J INFECT DIS, V192, P1880, DOI 10.1086/497701; McIntrye PG, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005546.pub2; McMenamin MB, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.05.021; Mok J, 2005, ARCH DIS CHILD-FETAL, V90, P156, DOI 10.1136/adc.2004.059436; MORIYA T, 1995, BIOMED PHARMACOTHER, V49, P59, DOI 10.1016/0753-3322(96)82587-X; Okamoto M, 1999, PEDIATR INT, V41, P369, DOI 10.1046/j.1442-200x.1999.01086.x; Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, 2011, REC ANT DRUGS PREGN; Pembrey L, 2005, CLIN INFECT DIS, V41, P45, DOI 10.1086/430601; Pembrey L, 2005, J HEPATOL, V43, P515, DOI 10.1016/j.jhep.2005.06.002; Pipan C, 1996, EUR J CLIN MICROBIOL, V15, P116, DOI 10.1007/BF01591483; Resti M, 1998, BMJ-BRIT MED J, V317, P437, DOI 10.1136/bmj.317.7156.437; Spencer JD, 1997, J VIRAL HEPATITIS, V4, P395, DOI 10.1046/j.1365-2893.1997.00073.x; Syriopoulou V, 2005, SCAND J INFECT DIS, V37, P350, DOI 10.1080/00365540510032105; Tajiri H, 2001, PEDIATR INFECT DIS J, V20, P10, DOI 10.1097/00006454-200101000-00003; Tanzi M, 1997, EUR J EPIDEMIOL, V13, P517, DOI 10.1023/A:1007374810981; Tovo PA, 2005, J INFECT DIS, V192, P1872, DOI 10.1086/497695; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Yeung LTF, 2001, HEPATOLOGY, V34, P223, DOI 10.1053/jhep.2001.25885; Zanetti AR, 1999, J HEPATOL, V31, P96, DOI 10.1016/S0168-8278(99)80383-3; Zanetti AR, 1998, INTERVIROLOGY, V41, P208, DOI 10.1159/000024938	35	124	126	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2013	158	2					109	113		10.7326/0003-4819-158-2-201301150-00575	http://dx.doi.org/10.7326/0003-4819-158-2-201301150-00575			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077LO	23437438				2022-12-28	WOS:000314029400017
J	Teles, RMB; Graeber, TG; Krutzik, SR; Montoya, D; Schenk, M; Lee, DJ; Komisopoulou, E; Kelly-Scumpia, K; Chun, R; Iyer, SS; Sarno, EN; Rea, TH; Hewison, M; Adams, JS; Popper, SJ; Relman, DA; Stenger, S; Bloom, BR; Cheng, GH; Modlin, RL				Teles, Rosane M. B.; Graeber, Thomas G.; Krutzik, Stephan R.; Montoya, Dennis; Schenk, Mirjam; Lee, Delphine J.; Komisopoulou, Evangelia; Kelly-Scumpia, Kindra; Chun, Rene; Iyer, Shankar S.; Sarno, Euzenir N.; Rea, Thomas H.; Hewison, Martin; Adams, John S.; Popper, Stephen J.; Relman, David A.; Stenger, Steffen; Bloom, Barry R.; Cheng, Genhong; Modlin, Robert L.			Type I Interferon Suppresses Type II Interferon-Triggered Human Anti-Mycobacterial Responses	SCIENCE			English	Article							LISTERIA-MONOCYTOGENES; TUBERCULOSIS; LEPROSY; ACTIVATION; IL-1-BETA; INDUCTION; PROFILES; PATTERNS; PROGRAMS; DISEASE	Type I interferons (IFN-alpha and IFN-beta) are important for protection against many viral infections, whereas type II interferon (IFN-gamma) is essential for host defense against some bacterial and parasitic pathogens. Study of IFN responses in human leprosy revealed an inverse correlation between IFN-beta and IFN-gamma gene expression programs. IFN-gamma and its downstream vitamin D-dependent antimicrobial genes were preferentially expressed in self-healing tuberculoid lesions and mediated antimicrobial activity against the pathogen Mycobacterium leprae in vitro. In contrast, IFN-beta and its downstream genes, including interleukin-10 (IL-10), were induced in monocytes by M. leprae in vitro and preferentially expressed in disseminated and progressive lepromatous lesions. The IFN-gamma-induced macrophage vitamin D-dependent antimicrobial peptide response was inhibited by IFN-beta and by IL-10, suggesting that the differential production of IFNs contributes to protection versus pathogenesis in some human bacterial infections.	[Teles, Rosane M. B.; Krutzik, Stephan R.; Montoya, Dennis; Schenk, Mirjam; Kelly-Scumpia, Kindra; Modlin, Robert L.] Univ Calif Los Angeles, David Geffen Sch Med, Div Dermatol, Los Angeles, CA 90095 USA; [Iyer, Shankar S.; Cheng, Genhong; Modlin, Robert L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Chun, Rene; Hewison, Martin; Adams, John S.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Orthoped Hosp Dept Orthoped Surg, Los Angeles, CA 90095 USA; [Graeber, Thomas G.; Komisopoulou, Evangelia] Univ Calif Los Angeles, Johnson Comprehens Canc Ctr, Dept Mol & Med Pharmacol, Crump Inst Mol Imaging,Inst Mol Med,Calif NanoSys, Los Angeles, CA 90095 USA; [Lee, Delphine J.] John Wayne Canc Inst, Dept Translat Immunol, Santa Monica, CA USA; [Sarno, Euzenir N.] Fundacao Oswaldo Cruz, Dept Mycobacteriosis, Rio De Janeiro, RJ, Brazil; [Rea, Thomas H.] Univ So Calif, Sch Med, Dept Dermatol, Los Angeles, CA 90033 USA; [Popper, Stephen J.; Relman, David A.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Popper, Stephen J.; Relman, David A.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Stenger, Steffen] Univ Hosp Ulm, Inst Med Microbiol & Hyg, Ulm, Germany; [Bloom, Barry R.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; John Wayne Cancer Institute; Fundacao Oswaldo Cruz; University of Southern California; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Ulm University; Harvard University; Harvard T.H. Chan School of Public Health	Modlin, RL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Dermatol, Los Angeles, CA 90095 USA.	rmodlin@mednet.ucla.edu	Adams, John S/I-3365-2013; Chun, Rene/A-9415-2010; Teles, Rosane/E-9607-2017; Teles, Rosane/AAQ-3436-2020; Modlin, Robert L/M-7941-2014	Adams, John S/0000-0001-9607-5020; Chun, Rene/0000-0002-0190-0807; Teles, Rosane/0000-0003-2908-3244; Teles, Rosane/0000-0003-2908-3244; Modlin, Robert L/0000-0003-4720-031X; Nunes Sarno, Euzenir/0000-0003-0129-2159; Graeber, Thomas/0000-0001-8574-9181; Relman, David A./0000-0001-8331-1354; Schenk, Mirjam/0000-0002-1637-0730	NIH [P50 AR063020, R01 AI022553, R01 AR040312, R01 AI047868, UL1TR000124]; NATIONAL CANCER INSTITUTE [T32CA009120] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047868, R01AI056154, R01AI022553, R37AI047868, R01AI082575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040312, R01AR059126, P50AR063020] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank P. Liu for advice with the M. leprae viability assays and helpful discussion; M. So for help in the bioinformatic analysis; K. Zavala for help with the high-performance liquid chromatography (HPLC) assays; A. Legaspi and A. DeLeon for help with the immunohistochemistry; M. Schibler and the University of California-Los Angeles, California NanoSystems Institute, Advanced Light Microscopy Core Facility for assistance with the confocal studies; D. Elashoff for help with the statistical analysis; and A. Steinmeyer, E. May, and U. Zugel from Bayer Pharma AG for the VDR antagonist ZK 159 222 (VAZ). The live M. leprae was provided by the U.S. National Hansen's Disease Programs through the generous support of the American Leprosy Missions and Society of St. Lazarus of Jerusalem. The data presented in this manuscript are tabulated in the main paper and supplementary materials. Gene expression files containing array data are available under the accession nos. GSE17763 and GSE43700 in the Gene Expression Omnibus (GEO) database. This work was supported in parts by NIH grants (P50 AR063020; R01s AI022553, AR040312, and AI047868; and Clinical and Translational Science Award grant UL1TR000124).	ADAMS JS, 1985, J EXP MED, V161, P755, DOI 10.1084/jem.161.4.755; BARNES PF, 1993, INFECT IMMUN, V61, P3482, DOI 10.1128/IAI.61.8.3482-3489.1993; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; COOPER CL, 1989, J EXP MED, V169, P1565, DOI 10.1084/jem.169.5.1565; Edfeldt K, 2010, P NATL ACAD SCI USA, V107, P22593, DOI 10.1073/pnas.1011624108; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; HERRERA G, 1949, Int J Lepr, V17, P35; Iyer SS, 2010, J IMMUNOL, V185, P6599, DOI 10.4049/jimmunol.1002041; Krutzik SR, 2008, J IMMUNOL, V181, P7115, DOI 10.4049/jimmunol.181.10.7115; Liu PT, 2012, NAT MED, V18, P267, DOI 10.1038/nm.2584; Liu PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005810; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Maertzdorf J, 2012, P NATL ACAD SCI USA, V109, P7853, DOI 10.1073/pnas.1121072109; Martinez AN, 2009, J CLIN MICROBIOL, V47, P2124, DOI 10.1128/JCM.00512-09; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Montoya D, 2009, CELL HOST MICROBE, V6, P343, DOI 10.1016/j.chom.2009.09.002; Novikov A, 2011, J IMMUNOL, V187, P2540, DOI 10.4049/jimmunol.1100926; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746; Roy S, 1999, J INFECT DIS, V179, P187, DOI 10.1086/314536; SALGAME P, 1991, SCIENCE, V254, P279, DOI 10.1126/science.1681588; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Waddell SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009753; YAMAMURA M, 1992, J IMMUNOL, V149, P1470; YAMAMURA M, 1991, SCIENCE, V254, P277, DOI 10.1126/science.1925582	29	260	262	0	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1448	1453		10.1126/science.1233665	http://dx.doi.org/10.1126/science.1233665			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23449998	Green Accepted, Green Published			2022-12-28	WOS:000316740700047
J	Bouchard, KE; Mesgarani, N; Johnson, K; Chang, EF				Bouchard, Kristofer E.; Mesgarani, Nima; Johnson, Keith; Chang, Edward F.			Functional organization of human sensorimotor cortex for speech articulation	NATURE			English	Article							HUMAN MOTOR CORTEX; LARYNX AREA; REPRESENTATION; DYNAMICS; VOCALIZATION; GENERATION; MOVEMENT	Speaking is one of the most complex actions that we perform, but nearly all of us learn to do it effortlessly. Production of fluent speech requires the precise, coordinated movement of multiple articulators (for example, the lips, jaw, tongue and larynx) over rapid time scales. Here we used high-resolution, multi-electrode cortical recordings during the production of consonant-vowel syllables to determine the organization of speech sensorimotor cortex in humans. We found speech-articulator representations that are arranged somatotopically on ventral pre- and post-central gyri, and that partially overlap at individual electrodes. These representations were coordinated temporally as sequences during syllable production. Spatial patterns of cortical activity showed an emergent, population-level representation, which was organized by phonetic features. Over tens of milliseconds, the spatial patterns transitioned between distinct representations for different consonants and vowels. These results reveal the dynamic organization of speech sensorimotor cortex during the generation of multi-articulator movements that underlies our ability to speak.	[Bouchard, Kristofer E.; Mesgarani, Nima; Chang, Edward F.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Bouchard, Kristofer E.; Mesgarani, Nima; Chang, Edward F.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Bouchard, Kristofer E.; Mesgarani, Nima; Chang, Edward F.] Univ Calif San Francisco, Ctr Integrat Neurosci, San Francisco, CA 94158 USA; [Johnson, Keith] Univ Calif Berkeley, Dept Linguist, Berkeley, CA 94720 USA; [Chang, Edward F.] Univ Calif San Francisco, UCSF Epilepsy Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Chang, EF (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 505 Parnassus Ave, San Francisco, CA 94143 USA.	ChangEd@neurosurg.ucsf.edu	Johnson, Keith/AAM-6322-2020	Johnson, Keith/0000-0002-2569-8121	US National Institutes of Health [R00-NS065120, DP2-OD00862, R01-DC012379]; Ester A. and Joseph Klingenstein Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS065120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012379] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008627] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ester A. and Joseph Klingenstein Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Ren for technical help with data collection and pre-processing, and M. Babiak for audio transcription. J. Houde, C. Niziolek, S. Lisberger, K. Chaisanguanthum, C. Cheung and I. Garner provided helpful comments on the manuscript. E.F.C. was funded by the US National Institutes of Health grants R00-NS065120, DP2-OD00862 and R01-DC012379, and the Ester A. and Joseph Klingenstein Foundation.	Afshar A, 2011, NEURON, V71, P555, DOI 10.1016/j.neuron.2011.05.047; Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; Briggman KL, 2008, ANNU REV NEUROSCI, V31, P271, DOI 10.1146/annurev.neuro.31.060407.125552; Brodmann K., 1994, VERGLEICHENDE LOKALI; Browman CP, 1989, HASKINS LAB STATUS R, V99, P69; Brown S, 2008, CEREB CORTEX, V18, P837, DOI 10.1093/cercor/bhm131; Brown S, 2009, BRAIN COGNITION, V70, P31, DOI 10.1016/j.bandc.2008.12.006; Chomsky, 1991, SOUND PATTERN ENGLIS; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Churchland MM, 2010, NEURON, V68, P387, DOI 10.1016/j.neuron.2010.09.015; Clements G. Nick, 1995, HDB PHONOLOGICAL THE, P245; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; DELL GS, 1993, COGNITIVE SCI, V17, P149, DOI 10.1207/s15516709cog1702_1; Edwards E, 2010, NEUROIMAGE, V50, P291, DOI 10.1016/j.neuroimage.2009.12.035; FOERSTER O, 1931, LANCET, V2, P309; Fowler C., 1980, LANGUAGE PRODUCTION, P373; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; GRACCO VL, 1985, J NEUROPHYSIOL, V54, P418, DOI 10.1152/jn.1985.54.2.418; GRACCO VL, 1994, J NEUROSCI, V14, P6585; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; HAST MH, 1974, BRAIN RES, V73, P229, DOI 10.1016/0006-8993(74)91046-4; Hatsopoulos NG, 2011, NEURON, V72, P477, DOI 10.1016/j.neuron.2011.10.020; Jakobson R., 1969, PRELIMINARIES SPEECH; JURGENS U, 1974, BRAIN RES, V81, P564, DOI 10.1016/0006-8993(74)90853-1; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; Keating P.A., 1990, WINDOW MODEL COARTIC; Kent R. D., 1983, PRODUCTION SPEECH; KUYPERS HGJ, 1958, BRAIN, V81, P364, DOI 10.1093/brain/81.3.364; Ladefoged Peter., 2010, COURSE PHONETICS; Levelt W.J., 1993, SPEAKING INTENTION A; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; MCCARTHY G, 1993, J NEUROSURG, V79, P874, DOI 10.3171/jns.1993.79.6.0874; MCCARTHY JJ, 1988, PHONETICA, V45, P84, DOI 10.1159/000261820; Mesgarani N, 2012, NATURE, V485, P233, DOI 10.1038/nature11020; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Penfield W., 1959, SPEECH BRAIN MECH; Pruszynski JA, 2011, NATURE, V478, P387, DOI 10.1038/nature10436; Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Saltzman E., 1989, ECOL PSYCHOL, V1, P333, DOI [10.1207/s15326969eco0104_2, DOI 10.1207/S15326969EC00104_]; SCHONER G, 1988, SCIENCE, V239, P1513, DOI 10.1126/science.3281253; Schulz GM, 2005, CEREB CORTEX, V15, P1835, DOI 10.1093/cercor/bhi061; Sherrington Charles Scott, 1911, INTEGRATIVE ACTION N; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Terumitsu M, 2006, NEUROREPORT, V17, P1091, DOI 10.1097/01.wnr.0000224778.97399.c4; Tremblay S, 2003, NATURE, V423, P866, DOI 10.1038/nature01710	47	328	333	5	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					327	332		10.1038/nature11911	http://dx.doi.org/10.1038/nature11911			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23426266	Green Accepted, Green Submitted			2022-12-28	WOS:000316650500034
J	Lehman, EP; Guercio, JR				Lehman, Elmer Philip; Guercio, Jason Ross			The Step 2 Clinical Skills Exam - A Poor Value Proposition	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lehman, Elmer Philip] Duke Univ, Sch Med, Dept Internal Med, Durham, NC 27710 USA; [Guercio, Jason Ross] Duke Univ, Sch Med, Dept Anesthesiol, Durham, NC USA; [Lehman, Elmer Philip; Guercio, Jason Ross] Duke Univ, Sch Med, Management & Leadership Pathway Residents, Durham, NC USA	Duke University; Duke University; Duke University	Lehman, EP (corresponding author), Duke Univ, Sch Med, Dept Internal Med, Durham, NC 27710 USA.							[Anonymous], 2012 B INF; [Anonymous], PERF DAT; National Board of Medical Examiners, USMLE EX FEES	3	20	20	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2013	368	10					889	891		10.1056/NEJMp1213760	http://dx.doi.org/10.1056/NEJMp1213760			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100BG	23465102				2022-12-28	WOS:000315669100004
J	Bhaumik, S				Bhaumik, Soumyadeep			Child mortality: will India achieve the 2015 target?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												soumyadeepbhaumik@rediffmail.com		Bhaumik, Soumyadeep/0000-0001-9579-4453				Bansal CP, 2013, INDIAN PEDIATR, V50, P17, DOI 10.1007/s13312-013-0026-z; Behl AS, 2013, INDIAN PEDIATR, V50, P143, DOI 10.1007/s13312-013-0028-x; National Commission on Macroeconomics and Health, 2005, PRIV SECT HEALTHC DE; Press Information Bureau, ACH MDG COMM MAD NRH; The World Breastfeeding Trends Initiative, 2012, AR OUR BAB FALL GAPS; UN, MILL DEV GOALS; Unicef, 2012, INF CHILD MORT IND L; Unicef, 2012, LEV TRENDS CHILD MOR; USAID, HLTH OV; World Bank, GLOB MON REP 2012 FO	10	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2013	346								f1502	10.1136/bmj.f1502	http://dx.doi.org/10.1136/bmj.f1502			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104MS	23468365				2022-12-28	WOS:000315998300017
J	Rennke, S; Nguyen, OK; Shoeb, MH; Magan, Y; Wachter, RM; Ranji, SR				Rennke, Stephanie; Nguyen, Oanh K.; Shoeb, Marwa H.; Magan, Yimdriuska; Wachter, Robert M.; Ranji, Sumant R.			Hospital-Initiated Transitional Care Interventions as a Patient Safety Strategy A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED-CONTROLLED-TRIAL; INTEGRATED MEDICINES MANAGEMENT; PATIENTS AFTER-DISCHARGE; ADVERSE DRUG EVENTS; ELDERLY-PATIENTS; MEDICATION RECONCILIATION; GERIATRIC ASSESSMENT; READMISSION RATES; FOLLOW-UP; OLDER-ADULTS	Hospitals now have the responsibility to implement strategies to prevent adverse outcomes after discharge. This systematic review addressed the effectiveness of hospital-initiated care transition strategies aimed at preventing clinical adverse events (AEs), emergency department (ED) visits, and readmissions after discharge in general medical patients. MEDLINE, CINAHL, EMBASE, and Cochrane Database of Clinical Trials (January 1990 to September 2012) were searched, and 47 controlled studies of fair methodological quality were identified. Forty-six studies reported readmission rates, 26 reported ED visit rates, and 9 reported AE rates. A "bridging" strategy (incorporating both predischarge and postdischarge interventions) with a dedicated transition provider reduced readmission or ED visit rates in 10 studies, but the overall strength of evidence for this strategy was low. Because of scant evidence, no conclusions could be reached on methods to prevent postdischarge AEs. Most studies did not report intervention context, implementation, or cost. The strategies hospitals should implement to improve patient safety at hospital discharge remain unclear. Ann Intern Med. 2013;158:433-440. www.annals.org	[Rennke, Stephanie; Nguyen, Oanh K.; Shoeb, Marwa H.; Magan, Yimdriuska; Wachter, Robert M.; Ranji, Sumant R.] Univ Calif San Francisco, San Francisco, CA 94115 USA	University of California System; University of California San Francisco	Rennke, S (corresponding author), Univ Calif San Francisco, UCSF Mt Zion Med Ctr, 1600 Divisadero St, San Francisco, CA 94115 USA.	srennke@medicine.ucsf.edu			Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services [HHSA-290-2007-10062I]; AHRQ; QuantiaMD; IPC-The Hospitalist Company; US-UK Fulbright Commission	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); QuantiaMD; IPC-The Hospitalist Company; US-UK Fulbright Commission	Financial Support: From the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services (contract HHSA-290-2007-10062I).; Potential Conflicts of Interest: Dr. Rennke: Grant (money to self and to institution): AHRQ; Support for travel to meetings for the study or other purposes: AHRQ; Payment for writing or reviewing the manuscript (money to self and to institution): AHRQ; Provision of writing assistance, medicines, equipment, or administrative support (money to institution): AHRQ; Consultancy: Society Hospital of Medicine. Dr. Ranji: Grant (money to institution): AHRQ. Dr. Magan: Grant (money to institution): AHRQ. Dr. Wachter: Grant (money to institution): AHRQ; Support for travel to meetings for the study or other purposes (money to institution): AHRQ; Board membership: Chair of the American Board of Internal Medicine; Grants/grants pending (money to institution): AHRQ; Payment for lectures including service on speakers' bureaus: honorarium for lectures from more than 100 health care organizations, mostly on patient safety, health care quality, and hospitalists; Royalties: Lippincott Williams & Wilkins, McGraw-Hill; Payment for development of educational presentations: QuantiaMD; Payment for development of educational presentations (money to institution): IPC-The Hospitalist Company; Stock/stock options: PatientSafe Solutions, CRISI, EarlySense; Other: Compensation from John Wiley & Sons for writing "Wachter's World" blog, Benioff endowed chair in hospital medicine, funded by the US-UK Fulbright Commission for a sabbatical at Imperial College London from July to December 2011, unpaid member of the Board of Directors, Quality Committee of Salem Hospital. All other authors have no dislosures. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M12-2573.	Adler Alan, 2009, Manag Care, V18, P50; Al-Ghamdi SA, 2012, ANN SAUDI MED, V32, P492, DOI 10.5144/0256-4947.2012.492; Al-Rashed SA, 2002, BRIT J CLIN PHARMACO, V54, P657, DOI 10.1046/j.1365-2125.2002.01707.x; Balaban RB, 2008, J GEN INTERN MED, V23, P1228, DOI 10.1007/s11606-008-0618-9; Bettger JP, 2012, ANN INTERN MED, V157, P407, DOI 10.7326/0003-4819-157-6-201209180-00004; Bolas H, 2004, PHARM WORLD SCI, V26, P114, DOI 10.1023/B:PHAR.0000018601.11248.89; Brand Caroline A, 2004, Aust Health Rev, V28, P275; Bray-Hall ST, 2012, ANN INTERN MED, V157, P448, DOI 10.7326/0003-4819-157-6-201209180-00010; Chiu WK, 2007, PROF CASE MANAG, V12, P330; Coleman EA, 2004, J AM GERIATR SOC, V52, P1817, DOI 10.1111/j.1532-5415.2004.52504.x; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Courtney M, 2009, J AM GERIATR SOC, V57, P395, DOI 10.1111/j.1532-5415.2009.02138.x; Cowan MJ, 2006, J NURS ADMIN, V36, P79, DOI 10.1097/00005110-200602000-00006; Dellasega C A, 2000, Clin Excell Nurse Pract, V4, P286; Einstadter D, 1996, J GEN INTERN MED, V11, P684, DOI 10.1007/BF02600160; Epstein AM, 2011, NEW ENGL J MED, V365, P2287, DOI 10.1056/NEJMsa1101942; Finn KM, 2011, J HOSP MED, V6, P494, DOI 10.1002/jhm.924; FISHER ES, 1994, NEW ENGL J MED, V331, P989, DOI 10.1056/NEJM199410133311506; Forster AJ, 2005, AM J MED, V118, P1148, DOI 10.1016/j.amjmed.2005.04.019; Forster AJ, 2004, CAN MED ASSOC J, V170, P345; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Gallagher PF, 2011, CLIN PHARMACOL THER, V89, P845, DOI 10.1038/clpt.2011.44; Gillespie U, 2009, ARCH INTERN MED, V169, P894, DOI 10.1001/archinternmed.2009.71; Gleason KM, 2010, J GEN INTERN MED, V25, P441, DOI 10.1007/s11606-010-1256-6; Gow P, 1999, J Qual Clin Pract, V19, P107, DOI 10.1046/j.1440-1762.1999.00312.x; Graumlich JF, 2009, J HOSP MED, V4, P356, DOI [10.1002/jhm.469, 10.1002/jhm.565]; Hansen LO, 2011, ANN INTERN MED, V155, P520, DOI 10.7326/0003-4819-155-8-201110180-00008; Hasan O, 2010, J GEN INTERN MED, V25, P211, DOI 10.1007/s11606-009-1196-1; HealthCare.gov, 2012, PARTN PAT BETT CAR L; Hellstrom LM, 2011, EUR J CLIN PHARMACOL, V67, P741, DOI 10.1007/s00228-010-0982-3; Hesselink G, 2012, ANN INTERN MED, V157, P417, DOI 10.7326/0003-4819-157-6-201209180-00006; HOGAN DB, 1990, AGE AGEING, V19, P107, DOI 10.1093/ageing/19.2.107; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Karapinar-Carkit F, 2009, ANN PHARMACOTHER, V43, P1001, DOI 10.1345/aph.1L597; Kirby SE, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-216; Koehler BE, 2009, J HOSP MED, V4, P211, DOI 10.1002/jhm.427; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Legrain S, 2011, J AM GERIATR SOC, V59, P2017, DOI 10.1111/j.1532-5415.2011.03628.x; Lim WK, 2003, MED J AUSTRALIA, V178, P262, DOI 10.5694/j.1326-5377.2003.tb05191.x; LIPTON HL, 1994, GERONTOLOGIST, V34, P307, DOI 10.1093/geront/34.3.307; Makaryus AN, 2005, MAYO CLIN PROC, V80, P991, DOI 10.4065/80.8.991; Makowsky Mark J, 2009, Med Care, V47, P642, DOI 10.1097/MLR.0b013e3181926032; MARTIN F, 1994, AGE AGEING, V23, P228, DOI 10.1093/ageing/23.3.228; Marusic S, 2012, INT J CLIN PHARM; Maynard GA, 2012, JT COMM J QUAL PATIE, V38, P301, DOI 10.1016/S1553-7250(12)38040-9; Mistiaen P, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-47; Moore C, 2007, ARCH INTERN MED, V167, P1305, DOI 10.1001/archinte.167.12.1305; Mudge A, 2006, INTERN MED J, V36, P558, DOI 10.1111/j.1445-5994.2006.01135.x; Naylor MD, 2011, HEALTH AFFAIR, V30, P746, DOI 10.1377/hlthaff.2011.0041; NAYLOR MD, 1990, NURS RES, V39, P156; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; Nazareth I, 2001, AGE AGEING, V30, P33, DOI 10.1093/ageing/30.1.33; Nikolaus T, 1999, AGE AGEING, V28, P543, DOI 10.1093/ageing/28.6.543; Palmer HC, 2002, SOUTHERN MED J, V95, P1318, DOI 10.1097/00007611-200211000-00016; Parker S G, 2002, Health Technol Assess, V6, P1; Parry Carla, 2009, Home Health Care Serv Q, V28, P84, DOI 10.1080/01621420903155924; Philbin EF, 2001, AM J CARDIOL, V87, P1367, DOI 10.1016/S0002-9149(01)01554-5; Rau J., 2012, KAISER HLTH NEW 0813; Richards Suzanne, 2003, J Health Serv Res Policy, V8, P171, DOI 10.1258/135581903322029539; Robinson S, 2012, POPUL HEALTH MANAG, V15, P338, DOI 10.1089/pop.2011.0095; Schnipper JL, 2009, ARCH INTERN MED, V169, P771, DOI 10.1001/archinternmed.2009.51; Schnipper JL, 2006, ARCH INTERN MED, V166, P565, DOI 10.1001/archinte.166.5.565; Scullin C, 2007, J EVAL CLIN PRACT, V13, P781, DOI 10.1111/j.1365-2753.2006.00753.x; Scullin C, 2012, J EVAL CLIN PRACT, V18, P807, DOI 10.1111/j.1365-2753.2011.01682.x; Shekelle PG, MAKING HLTH CARE SAF; Shepperd S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000313.pub3; Siu AL, 1996, ARCH INTERN MED, V156, P76, DOI 10.1001/archinte.156.1.76; Steeman E, 2006, INT J QUAL HEALTH C, V18, P352, DOI 10.1093/intqhc/mzl026; Stewart S, 1998, J AM GERIATR SOC, V46, P174, DOI 10.1111/j.1532-5415.1998.tb02535.x; Styrborn K, 1995, SCAND J SOC MED, V23, P273, DOI 10.1177/140349489502300409; Takeda A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002752.pub3; THOMAS DR, 1993, J AM GERIATR SOC, V41, P101, DOI 10.1111/j.1532-5415.1993.tb02040.x; U. S. Department of Health and Human Services, 2012, HOSP COMP; van Walraven C, 2011, CAN MED ASSOC J, V183, pE1067, DOI 10.1503/cmaj.110400; Voss R, 2011, ARCH INTERN MED, V171, P1232, DOI 10.1001/archinternmed.2011.278; Walker PC, 2009, ARCH INTERN MED, V169, P2003, DOI 10.1001/archinternmed.2009.398; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206; Wilkinson ST, 2011, HOSP PHARM, V46, P876, DOI [DOI 10.1310/hpj4611-876, 10.1310/hpj4611-876]	82	159	160	1	46	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2013	158	5	2				433	+		10.7326/0003-4819-158-5-201303051-00011	http://dx.doi.org/10.7326/0003-4819-158-5-201303051-00011			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105HX	23460101	Green Submitted			2022-12-28	WOS:000316058600011
J	Arcuri, P; Campos, L				Arcuri, Plinio; Campos, Luana			Torus Mandibularis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Arcuri, Plinio] Hosp Reg Osasco, Sao Paulo, Brazil; [Campos, Luana] Univ Sao Paulo, Sao Paulo, Brazil	Universidade de Sao Paulo	Arcuri, P (corresponding author), Hosp Reg Osasco, Sao Paulo, Brazil.	plinio_miguel@hotmail.com	Campos, Luana/J-9150-2012	Campos, Luana/0000-0002-2747-2812					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2013	368	9					E11	E11		10.1056/NEJMicm1207099	http://dx.doi.org/10.1056/NEJMicm1207099			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096ET	23445112				2022-12-28	WOS:000315387700012
J	Findlay, GM; Smith, MJ; Lanner, F; Hsiung, MS; Gish, GD; Petsalaki, E; Cockburn, K; Kaneko, T; Huang, HM; Bagshaw, RD; Ketela, T; Tucholska, M; Taylor, L; Bowtell, DD; Moffat, J; Ikura, M; Li, SSC; Sidhu, SS; Rossant, J; Pawson, T				Findlay, Greg M.; Smith, Matthew J.; Lanner, Fredrik; Hsiung, Marilyn S.; Gish, Gerald D.; Petsalaki, Evangelia; Cockburn, Katie; Kaneko, Tomonori; Huang, Haiming; Bagshaw, Richard D.; Ketela, Troy; Tucholska, Monika; Taylor, Lorne; Bowtell, David D.; Moffat, Jason; Ikura, Mitsuhiko; Li, Shawn S. C.; Sidhu, Sachdev S.; Rossant, Janet; Pawson, Tony			Interaction Domains of Sos1/Grb2 Are Finely Tuned for Cooperative Control of Embryonic Stem Cell Fate	CELL			English	Article							RAS ACTIVATOR SON; SRC SH2 DOMAIN; REAL-TIME NMR; COMPARATIVE GENOMICS; NUCLEOTIDE EXCHANGE; VISCERAL ENDODERM; NOONAN-SYNDROME; HISTONE DOMAIN; BINDING; SEVENLESS	Metazoan evolution involves increasing protein domain complexity, but how this relates to control of biological decisions remains uncertain. The Ras guanine nucleotide exchange factor (RasGEF) Sos1 and its adaptor Grb2 are multidomain proteins that couple fibroblast growth factor (FGF) signaling to activation of the Ras-Erk pathway during mammalian development and drive embryonic stem cells toward the primitive endoderm (PrE) lineage. We show that the ability of Sos1/Grb2 to appropriately regulate pluripotency and differentiation factors and to initiate PrE development requires collective binding of multiple Sos1/Grb2 domains to their protein and phospholipid ligands. This provides a cooperative system that only allows lineage commitment when all ligand-binding domains are occupied. Furthermore, our results indicate that the interaction domains of Sos1 and Grb2 have evolved so as to bind ligands not with maximal strength but with specificities and affinities that maintain cooperativity. This optimized system ensures that PrE lineage commitment occurs in a timely and selective manner during embryogenesis.	[Findlay, Greg M.; Hsiung, Marilyn S.; Gish, Gerald D.; Petsalaki, Evangelia; Bagshaw, Richard D.; Tucholska, Monika; Taylor, Lorne; Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Smith, Matthew J.; Ikura, Mitsuhiko] Univ Toronto, Ontario Canc Inst, Toronto, ON M5S 1A8, Canada; [Smith, Matthew J.; Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada; [Sidhu, Sachdev S.; Rossant, Janet; Pawson, Tony] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Lanner, Fredrik; Cockburn, Katie; Rossant, Janet] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada; [Kaneko, Tomonori; Li, Shawn S. C.] Univ Western Ontario, Siebens Drake Med Res Inst, London, ON N6A 5C1, Canada; [Huang, Haiming; Ketela, Troy; Moffat, Jason; Sidhu, Sachdev S.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Huang, Haiming; Ketela, Troy; Moffat, Jason; Sidhu, Sachdev S.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Bowtell, David D.] Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Western University (University of Western Ontario); University of Toronto; University of Toronto; Peter Maccallum Cancer Center	Pawson, T (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada.	pawson@lunenfeld.ca	Bowtell, David/H-1007-2016; Petsalaki, Evangelia/ABC-3561-2020; Smith, Matthew J/AAI-8060-2020; Bagshaw, Rick/B-7739-2009; Pawson, Tony J/E-4578-2013; Gish, Gerald D/C-7228-2017; Moffat, Jason/AAC-1110-2020	Bowtell, David/0000-0001-9089-7525; Petsalaki, Evangelia/0000-0002-8294-2995; Smith, Matthew J/0000-0003-2896-9350; Bagshaw, Rick/0000-0001-5013-4291; Moffat, Jason/0000-0002-5663-8586; Cockburn, Katie/0000-0002-2997-0153; Lanner, Fredrik/0000-0002-2771-7445; Kaneko, Tomonori/0000-0001-5448-9639; Findlay, Greg/0000-0002-7222-4965	Terry Fox Foundation/CIHR [TFF-105268]; CCSRI; ORF; CIHR [MOP-6849, FRN-77803, MOP-93684]; CRS; CFI; CBCF; OICR; Terry Fox Research Institute	Terry Fox Foundation/CIHR(Canadian Institutes of Health Research (CIHR)); CCSRI; ORF; CIHR(Canadian Institutes of Health Research (CIHR)); CRS; CFI(Canada Foundation for Innovation); CBCF; OICR; Terry Fox Research Institute	The authors thank Ivica Letunic, Derek Ceccarelli, Bernard Liu, and Geraldine Mbamalu for technical input. We also thank Edvard Smith, Cheryl Seguin, Michael Kofler, Oliver Rocks, Nicolas Bisson, John Kuriyan, and Jody Gureasko for helpful discussions. G. M. F. and T. P. conceived the study, interpreted the data, and wrote the paper. Experiments were performed primarily by G. M. F. and by M. J. S., F. L., M. S. H., G. D. G., and M. T. T. Kaneko, H. H., R. D. B., T. Ketela, J. M., M. I., S. S. C. L., S. S. S., and J. R. provided conceptual insights and reagents. Mass spectrometry was supported by AB SCIEX. This work was supported by grants to T. P. from the Terry Fox Foundation/CIHR (#TFF-105268), the CCSRI, and the ORF; to T. P., J. R., and S. S. S. from the CIHR (#MOP-6849, #FRN-77803, and #MOP-93684); and to M. I. from the CRS. A 600 MHz NMR spectrometer was funded by the CFI. Support for the lentiviral shRNA platform was from the CFI, ORF, OICR, and the Terry Fox Research Institute. M. J. S. is supported by a CBCF fellowship.	Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Bisson N, 2011, NAT BIOTECHNOL, V29, P653, DOI 10.1038/nbt.1905; Carnegie GK, 2009, IUBMB LIFE, V61, P394, DOI 10.1002/iub.168; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen RH, 1997, EMBO J, V16, P1351, DOI 10.1093/emboj/16.6.1351; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; Findlay GM, 2008, NAT STRUCT MOL BIOL, V15, P538, DOI 10.1038/nsmb0608-538; Gasmi-Seabrook GMC, 2010, J BIOL CHEM, V285, P5137, DOI 10.1074/jbc.M109.064691; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Gureasko J, 2010, P NATL ACAD SCI USA, V107, P3430, DOI 10.1073/pnas.0913915107; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Hirasawa R, 2009, GENE EXPR PATTERNS, V9, P27, DOI 10.1016/j.gep.2008.09.002; Howard PL, 2003, P NATL ACAD SCI USA, V100, P11267, DOI 10.1073/pnas.1934711100; Jin J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000546; Kaneko T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003021; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Kimber MS, 2000, MOL CELL, V5, P1043, DOI 10.1016/S1097-2765(00)80269-5; Koonin EV, 2000, CELL, V101, P573, DOI 10.1016/S0092-8674(00)80867-3; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Kubiseski TJ, 1997, J BIOL CHEM, V272, P1799, DOI 10.1074/jbc.272.3.1799; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; MARENGERE LEM, 1994, NATURE, V369, P502, DOI 10.1038/369502a0; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Marshall CB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000029; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; SOUDAIS C, 1995, DEVELOPMENT, V121, P3877; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020; Yadav KK, 2010, P NATL ACAD SCI USA, V107, P3436, DOI 10.1073/pnas.0914315107	41	45	45	0	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 28	2013	152	5					1008	1020		10.1016/j.cell.2013.01.056	http://dx.doi.org/10.1016/j.cell.2013.01.056			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452850	Bronze			2022-12-28	WOS:000315710300010
J	Hresko, MT				Hresko, M. Timothy			Idiopathic Scoliosis in Adolescents	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SURGICAL-TREATMENT; CURVE PROGRESSION; SPINAL-FUSION; BACK-PAIN; BRACE; INSTRUMENTATION; INFECTIONS	A 12-year-old girl presents with her parents after a positive school screening for scoliosis. Physical examination reveals shoulder and torso asymmetry with trunk imbalance (i.e., shift from the midline). Neurologic and skin examinations are normal. How should the patient be evaluated and treated?	[Hresko, M. Timothy] Boston Childrens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Hresko, M. Timothy] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Hresko, MT (corresponding author), Boston Childrens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA.							Akbarnia BA, 2008, SPINE, V33, P984, DOI 10.1097/BRS.0b013e31816c8b4e; [Anonymous], 2003, SPINE PHILA PA 1976, V28, pE373; BUNNELL WP, 1993, SPINE, V18, P1572, DOI 10.1097/00007632-199309000-00001; COCHRAN T, 1983, SPINE, V8, P576, DOI 10.1097/00007632-198309000-00003; Danielsson AJ, 2003, SPINE, V28, P2078; Diab M, 2007, SPINE, V32, P2759, DOI 10.1097/BRS.0b013e31815a5970; Diab M, 2011, SPINE, V36, P667, DOI 10.1097/BRS.0b013e3181da218c; Dimeglio A, 2012, EUR SPINE J, V21, P64, DOI 10.1007/s00586-011-1983-3; Do T, 2001, J BONE JOINT SURG AM, V83A, P577, DOI 10.2106/00004623-200104000-00014; Gorman KF, 2012, EUR SPINE J, V21, P1905, DOI 10.1007/s00586-012-2389-6; Hedequist D, 2009, SPINE, V34, P60, DOI 10.1097/BRS.0b013e31818ed75e; Ho C, 2007, SPINE, V32, P2739, DOI 10.1097/BRS.0b013e31815a5a86; Ho C, 2007, SPINE, V32, P2272, DOI 10.1097/BRS.0b013e31814b1c0b; Janicki JA, 2007, J PEDIATR ORTHOPED, V27, P369, DOI 10.1097/01.bpb.0000271331.71857.9a; Johnston CE, 2011, SPINE, V36, P1096, DOI 10.1097/BRS.0b013e3181f8c931; Katz DE, 2010, J BONE JOINT SURG AM, V92A, P1343, DOI 10.2106/JBJS.I.01142; Kuklo TR, 2007, SPINE, V32, P2258, DOI 10.1097/BRS.0b013e31814b1ba6; Morton A, 2008, J PEDIATR ORTHOPED, V28, P336, DOI 10.1097/BPO.0b013e318168d154; NACHEMSON AL, 1995, J BONE JOINT SURG AM, V77A, P815, DOI 10.2106/00004623-199506000-00001; Ramo BA, 2012, SPINE, V37, P1211, DOI 10.1097/BRS.0b013e31824b6b05; Richards BS, 2008, J BONE JOINT SURG AM, V90A, P195, DOI 10.2106/JBJS.G.01276; RISEBOROUGH EJ, 1973, J BONE JOINT SURG AM, VA 55, P974, DOI 10.2106/00004623-197355050-00006; Sanders JO, 2008, J BONE JOINT SURG AM, V90A, P540, DOI 10.2106/JBJS.G.00004; SCHWEND RM, 1995, J BONE JOINT SURG AM, V77A, P46, DOI 10.2106/00004623-199501000-00007; Sharma S, 2011, HUM MOL GENET, V20, P1456, DOI 10.1093/hmg/ddq571; Smith JS, 2011, SPINE, V36, P817, DOI 10.1097/BRS.0b013e3181e21783; U. S. Preventive Services Task Force, 2004, SCREEN ID SCOL AD BR; Ward K, 2010, SPINE, V35, pE1455, DOI 10.1097/BRS.0b013e3181ed2de1; WEINSTEIN SL, 1981, J BONE JOINT SURG AM, V63, P702, DOI 10.2106/00004623-198163050-00003; WEINSTEIN SL, BRACING ADOLESCENT I; WYNNE-DAVIES R, 1968, Journal of Bone and Joint Surgery British Volume, V50B, P24; Yawn BP, 1999, JAMA-J AM MED ASSOC, V282, P1427, DOI 10.1001/jama.282.15.1427	32	138	153	5	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2013	368	9					834	841		10.1056/NEJMcp1209063	http://dx.doi.org/10.1056/NEJMcp1209063			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096ET	23445094				2022-12-28	WOS:000315387700009
J	Oaklander, AL; Long, DM; Larvie, M; Davidson, CJ				Oaklander, Anne Louise; Long, Donlin M.; Larvie, Mykol; Davidson, Christian J.			Case 7-2013: A 77-Year-Old Woman with Long-Standing Unilateral Thoracic Pain and Incontinence	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SACRAL PERINEURIAL CYSTS; TARLOV CYSTS; MENINGEAL CYSTS; MICROSURGICAL TREATMENT; PREVALENCE		[Oaklander, Anne Louise] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Larvie, Mykol] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Oaklander, Anne Louise; Davidson, Christian J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Oaklander, Anne Louise] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Larvie, Mykol] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Davidson, Christian J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Long, Donlin M.] Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Johns Hopkins University	Oaklander, AL (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.				Aptiv Solutions; Seikagaku	Aptiv Solutions; Seikagaku	Dr. Long reports receiving consulting fees from Aptiv Solutions and Seikagaku. No other potential conflict of interest relevant to this article was reported.	Acosta Frank L Jr, 2003, Neurosurg Focus, V15, pE15; Caspar W, 2003, SURG NEUROL, V59, P101, DOI 10.1016/S0090-3019(02)00981-3; Cattaneo L, 2001, J NEUROL, V248, P623, DOI 10.1007/s004150170144; Guo DS, 2007, NEUROSURGERY, V60, P1059, DOI 10.1227/01.NEU.0000255457.12978.78; Hiers RH, 2010, J PAIN, V11, P833, DOI 10.1016/j.jpain.2010.07.007; Isono M, 1999, NEUROL MED-CHIR, V39, P380, DOI 10.2176/nmc.39.380; Joo J, 2010, ANAESTHESIA, V65, P23, DOI 10.1111/j.1365-2044.2009.06168.x; Krings T, 2009, AM J NEURORADIOL, V30, P639, DOI 10.3174/ajnr.A1485; Langdown AJ, 2005, J SPINAL DISORD TECH, V18, P29, DOI 10.1097/01.bsd.0000133495.78245.71; Lee JY, 2004, ACTA NEUROCHIR, V146, P667, DOI 10.1007/s00701-004-0274-8; Mummaneni PV, 2000, NEUROSURGERY, V47, P74, DOI 10.1097/00006123-200007000-00016; Murphy K, 2008, J VASC INTERV RADIOL, V19, P771, DOI 10.1016/j.jvir.2008.02.001; Murphy KJ, 2011, SEMIN MUSCULOSKEL R, V15, P163, DOI 10.1055/s-0031-1275599; Neulen A, 2011, ACTA NEUROCHIR, V153, P1427, DOI 10.1007/s00701-011-1043-0; Park HJ, 2011, AM J ROENTGENOL, V196, P1151, DOI 10.2214/AJR.10.5457; PARRY GJ, 1985, NEUROLOGY, V35, P1466, DOI 10.1212/WNL.35.10.1466; PAULSEN RD, 1994, AM J NEURORADIOL, V15, P293; PYERITZ RE, 1988, AM J HUM GENET, V43, P726; REXED B, 1947, J NEUROSURG, V4, P414, DOI 10.3171/jns.1947.4.5.0414; Tanaka M, 2006, ACTA MED OKAYAMA, V60, P65; TARLOV IM, 1948, JAMA-J AM MED ASSOC, V138, P740, DOI 10.1001/jama.1948.02900100020005; TARLOV IM, 1970, J NEUROL NEUROSUR PS, V33, P833, DOI 10.1136/jnnp.33.6.833; Tarlov IM, 1938, ARCH NEURO PSYCHIATR, V40, P1067, DOI 10.1001/archneurpsyc.1938.02270120017001; Tarlov IM, 1953, J NEUROPATH EXP NEUR, V11, P22; VANDEKELFT E, 1993, LANCET, V341, P500, DOI 10.1016/0140-6736(93)90260-N; Voyadzis JM, 2001, J NEUROSURG, V95, P25, DOI 10.3171/spi.2001.95.1.0025	26	9	10	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2013	368	9					853	861		10.1056/NEJMcpc1114034	http://dx.doi.org/10.1056/NEJMcpc1114034			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096ET	23445097				2022-12-28	WOS:000315387700013
J	Van de Vosse, DW; Wan, YK; Lapetina, DL; Chen, WM; Chiang, JH; Aitchison, JD; Wozniak, RW				Van de Vosse, David W.; Wan, Yakun; Lapetina, Diego L.; Chen, Wei-Ming; Chiang, Jung-Hsien; Aitchison, John D.; Wozniak, Richard W.			A Role for the Nucleoporin Nup170p in Chromatin Structure and Gene Silencing	CELL			English	Article							NUCLEAR-PORE COMPLEX; YEAST TELOMERES; REMODELER RSC; EXPRESSION; GENOME; LOCALIZATION; ARCHITECTURE; PROTEINS; REVEALS; SIR4	Embedded in the nuclear envelope, nuclear pore complexes (NPCs) not only regulate nuclear transport but also interface with transcriptionally active euchromatin, largely silenced heterochromatin, as well as the boundaries between these regions. It is unclear what functional role NPCs play in establishing or maintaining these distinct chromatin domains. We report that the yeast NPC protein Nup170p interacts with regions of the genome that contain ribosomal protein and subtelomeric genes, where it functions in nucleosome positioning and as a repressor of transcription. We show that the role of Nup170p in subtelomeric gene silencing is linked to its association with the RSC chromatin-remodeling complex and the silencing factor Sir4p, and that the binding of Nup170p and Sir4p to subtelomeric chromatin is cooperative and necessary for the association of telomeres with the nuclear envelope. Our results establish the NPC as an active participant in silencing and the formation of peripheral heterochromatin.	[Van de Vosse, David W.; Lapetina, Diego L.; Wozniak, Richard W.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada; [Wan, Yakun; Chen, Wei-Ming; Aitchison, John D.] Inst Syst Biol, Seattle, WA 98109 USA; [Wan, Yakun] Southeast Univ, Inst Life Sci, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing 210096, Jiangsu, Peoples R China; [Chen, Wei-Ming; Chiang, Jung-Hsien] Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan 701, Taiwan; [Aitchison, John D.] Seattle Biomed Res Inst, Seattle, WA 98109 USA	University of Alberta; Institute for Systems Biology (ISB); Southeast University - China; National Cheng Kung University; Center for Infectious Disease Research	Aitchison, JD (corresponding author), Inst Syst Biol, Seattle, WA 98109 USA.	john.aitchison@systemsbiology.org; rick.wozniak@ualberta.ca		Chiang, Jung-Hsien/0000-0002-4657-6705	CIHR [MOP 36519, MOP 106502]; AIHS; HHMI; NIH [P50 GM076547, U54 GM103511]; CIHR Canada Graduate Doctoral Scholarship; National Natural Science Foundation of China [31071146, 31271365]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103511, U01GM098256, P50GM076547] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); AIHS; HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR Canada Graduate Doctoral Scholarship(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. M. Gasser, D. E. Gottschling, C. Boone, S. L. Jaspersen, R. Rachubinski, and B. R. Cairns for providing reagents. We thank T. Makio for construction of the TMY1452 and TMY1798 strains, and Y. Sydorskyy and N. Arens for technical assistance. We also thank E. Hurt, L. Cairo, N. Adames, S. Danziger, and members of the Wozniak and Aitchison laboratories for thoughtful discussions. We thank Allison Kudla for the graphical abstract. Funds for this work were provided to R. W. W. by the CIHR (MOP 36519 MOP 106502), AIHS, and HHMI, and to J. D. A. by the NIH (P50 GM076547 and U54 GM103511). D. W. V. d. V. was supported by a CIHR Canada Graduate Doctoral Scholarship, and Y. W. was supported by the National Natural Science Foundation of China (31071146 and 31271365).	AITCHISON JD, 1995, J CELL BIOL, V131, P1133, DOI 10.1083/jcb.131.5.1133; Aitchison JD, 2012, GENETICS, V190, P855, DOI 10.1534/genetics.111.127803; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Angus-Hill ML, 2001, MOL CELL, V7, P741, DOI 10.1016/S1097-2765(01)00219-2; Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Bosio MC, 2011, TRANSCR-AUSTIN, V2, P71, DOI 10.4161/trns.2.2.14486; BUCK SW, 1995, GENE DEV, V9, P370, DOI 10.1101/gad.9.3.370; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; COCKELL M, 1995, J CELL BIOL, V129, P909, DOI 10.1083/jcb.129.4.909; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; de Vosse DWV, 2011, WIRES SYST BIOL MED, V3, P147, DOI 10.1002/wsbm.101; DIFFLEY JFX, 1989, NATURE, V342, P24, DOI 10.1038/342024a0; Dilworth DJ, 2005, J CELL BIOL, V171, P955, DOI 10.1083/jcb.200509061; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Ebrahimi H, 2008, GENE DEV, V22, P3363, DOI 10.1101/gad.486208; Ehrentraut S, 2010, P NATL ACAD SCI USA, V107, P5522, DOI 10.1073/pnas.0909169107; Feuerbach F, 2002, NAT CELL BIOL, V4, P214, DOI 10.1038/ncb756; Galy V, 2000, NATURE, V403, P108, DOI 10.1038/47528; Gasser SM, 2004, COLD SPRING HARB SYM, P327; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hawryluk-Gara LA, 2005, MOL BIOL CELL, V16, P2382, DOI 10.1091/mbc.e04-10-0857; Hediger F, 2002, CURR BIOL, V12, P2076, DOI 10.1016/S0960-9822(02)01338-6; Hediger F, 2002, J STRUCT BIOL, V140, P79, DOI 10.1016/S1047-8477(02)00533-6; Hiraga S, 2006, EMBO J, V25, P1505, DOI 10.1038/sj.emboj.7601038; Hiraga S, 2008, J CELL BIOL, V183, P641, DOI 10.1083/jcb.200806065; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; Kehat I, 2011, J CELL BIOL, V193, P21, DOI 10.1083/jcb.201101046; Kerscher O, 2001, GENETICS, V157, P1543; Laroche T, 2000, J STRUCT BIOL, V129, P159, DOI 10.1006/jsbi.2000.4240; Liu Q, 2007, J CELL BIOL, V178, P785, DOI 10.1083/jcb.200704108; Lusk CP, 2002, J CELL BIOL, V159, P267, DOI 10.1083/jcb.200203079; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Mitchell JM, 2010, J CELL BIOL, V191, P505, DOI 10.1083/jcb.201007098; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Ptak C, 2009, TRAFFIC, V10, P1619, DOI 10.1111/j.1600-0854.2009.00978.x; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Shim EY, 2005, MOL CELL BIOL, V25, P3934, DOI 10.1128/MCB.25.10.3934-3944.2005; Shulga N, 2000, J CELL BIOL, V149, P1027, DOI 10.1083/jcb.149.5.1027; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Taddei A, 2004, EMBO J, V23, P1301, DOI 10.1038/sj.emboj.7600144; Taddei A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000612; Talamas JA, 2011, J CELL BIOL, V194, P27, DOI 10.1083/jcb.201012154; Therizols P, 2006, J CELL BIOL, V172, P189, DOI 10.1083/jcb.200505159; Titus LC, 2010, MOL BIOL CELL, V21, P1072, DOI 10.1091/mbc.E09-07-0615; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Wan YK, 2009, MOL CELL BIOL, V29, P2346, DOI 10.1128/MCB.01233-08; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Yoshida T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000910; Young TJ, 2012, BBA-GENE REGUL MECH, V1819, P303, DOI 10.1016/j.bbagrm.2011.10.006; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	56	97	97	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 28	2013	152	5					969	983		10.1016/j.cell.2013.01.049	http://dx.doi.org/10.1016/j.cell.2013.01.049			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23452847	Green Accepted, Bronze			2022-12-28	WOS:000315710300007
J	Lapner, ST; Kearon, C				Lapner, S. Takach; Kearon, C.			Diagnosis and management of pulmonary embolism	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ED AMERICAN-COLLEGE; VENOUS THROMBOEMBOLISM; D-DIMER; COMPUTED-TOMOGRAPHY; ANTICOAGULANT TREATMENT; ANTITHROMBOTIC THERAPY; CLINICAL PRESENTATION; RECURRENCE; THROMBOSIS; METAANALYSIS		[Lapner, S. Takach; Kearon, C.] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University	Kearon, C (corresponding author), Hamilton Hlth Sci, Juravinski Hosp Div, 711 Concess St, Hamilton, ON L8V 1C3, Canada.	kearonc@mcmaster.ca			Heart and Stroke Foundation of Ontario	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	Both authors have completed the ICMJE uniform disclosure form (www.icmje.org/coi_disclosure.pdf) and declare: CK has been a consultant to Boehringer Ingelheim, Bayer, Diagnostica Stago, and Alere; he was supported by the Heart and Stroke Foundation of Ontario; and he is an author of the current American College of Chest Physician's guidelines on the treatment of venous thromboembolism. Provenance and peer review: Commissioned; externally peer reviewed.	Agnelli G, 2013, NEW ENGL J MED, V368, P699, DOI 10.1056/NEJMoa1207541; Akl EA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006650.pub3; Aujesky D, 2011, LANCET, V378, P41, DOI 10.1016/S0140-6736(11)60824-6; Baglin T, 2010, J THROMB HAEMOST, V8, P2436, DOI 10.1111/j.1538-7836.2010.04022.x; Bates SM, 2012, CHEST, V141, pE351S, DOI 10.1378/chest.11-2299; Becattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238; Boutitie F, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3036; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; Carrier M, 2010, J THROMB HAEMOST, V8, P1716, DOI 10.1111/j.1538-7836.2010.03938.x; Chan WS, 2002, ARCH INTERN MED, V162, P1170, DOI 10.1001/archinte.162.10.1170; Chong LY, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3979; Decousus H, 2005, CIRCULATION, V112, P416, DOI 10.1161/CIRCULATIONHA.104.512834; Dentali F, 2010, THROMB RES, V125, P518, DOI 10.1016/j.thromres.2010.03.016; Di Nisio M, 2007, J THROMB HAEMOST, V5, P296, DOI 10.1111/j.1538-7836.2007.02328.x; Dong B, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004437; Douketis J, 2011, BMJ-BRIT MED J, V342, pd813, DOI DOI 10.1136/BMJ.D813; Douketis J, 2010, ANN INTERN MED, V153, P523, DOI 10.7326/0003-4819-153-8-201010190-00009; Fox BD, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7498; Gandhi R, 2012, J ARTHROPLASTY, V27, P730, DOI 10.1016/j.arth.2011.10.019; Geersing Geert-Jan, 2012, BMJ, V345, pe6564, DOI 10.1136/bmj.e6564; Heit JA, 2008, ARTERIOSCL THROM VAS, V28, P370, DOI 10.1161/ATVBAHA.108.162545; Jaff MR, 2011, CIRCULATION, V123, P1788, DOI 10.1161/CIR.0b013e318214914f; Kearon C, 2012, J THROMB HAEMOST, V10, P507, DOI 10.1111/j.1538-7836.2012.04629.x; Kearon C, 2003, CAN MED ASSOC J, V168, P183; Kearon C, 2006, ANN INTERN MED, V144, P812, DOI 10.7326/0003-4819-144-11-200606060-00007; Kearon C, 2012, CURR OPIN HEMATOL, V19, P363, DOI 10.1097/MOH.0b013e328356745b; Kearon Clive, 2012, Chest, V141, pe419S, DOI 10.1378/chest.11-2301; Kucher N, 2006, CIRCULATION, V113, P577, DOI 10.1161/CIRCULATIONAHA.105.592592; Kuo WT, 2009, J VASC INTERV RADIOL, V20, P1431, DOI 10.1016/j.jvir.2009.08.002; Lucassen W, 2011, ANN INTERN MED, V155, P448, DOI 10.7326/0003-4819-155-7-201110040-00007; Mos ICM, 2009, J THROMB HAEMOST, V7, P1491, DOI 10.1111/j.1538-7836.2009.03518.x; Naess IA, 2007, J THROMB HAEMOST, V5, P692, DOI 10.1111/j.1538-7836.2007.02450.x; Schulman S, 2013, NEW ENGL J MED, V368, P709, DOI 10.1056/NEJMoa1113697; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Stein PD, 2012, AM J MED, V125, P478, DOI 10.1016/j.amjmed.2011.05.025; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; Vinson DR, 2012, ANN EMERG MED, V60, P651, DOI 10.1016/j.annemergmed.2012.05.041; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753	39	65	68	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 20	2013	346								f757	10.1136/bmj.f757	http://dx.doi.org/10.1136/bmj.f757			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096HL	23427133				2022-12-28	WOS:000315394700009
J	Brinkhaus, B; Ortiz, M; Witt, CM; Roll, S; Linde, K; Pfab, F; Niggemann, B; Hummelsberger, J; Treszl, A; Ring, J; Zuberbier, T; Wegscheider, K; Willich, SN				Brinkhaus, Benno; Ortiz, Miriam; Witt, Claudia M.; Roll, Stephanie; Linde, Klaus; Pfab, Florian; Niggemann, Bodo; Hummelsberger, Josef; Treszl, Andras; Ring, Johannes; Zuberbier, Torsten; Wegscheider, Karl; Willich, Stefan N.			Acupuncture in Patients With Seasonal Allergic Rhinitis A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							CONTROLLED CLINICAL-TRIAL; EXPERIMENTALLY INDUCED ITCH; I HYPERSENSITIVITY ITCH; QUALITY-OF-LIFE; CROSSOVER TRIAL; ATOPIC ECZEMA; ALTERNATIVE MEDICINE; RHINOCONJUNCTIVITIS; COMPLEMENTARY; QUESTIONNAIRE	Background: Acupuncture is frequently used to treat seasonal allergic rhinitis (SAR) despite limited scientific evidence. Objective: To evaluate the effects of acupuncture in patients with SAR. Design: Randomized, controlled multicenter trial. (ClinicalTrials.gov:NCT00610584) Setting: 46 specialized physicians in 6 hospital clinics and 32 private outpatient clinics. Patients: 422 persons with SAR and IgE sensitization to birch and grass pollen. Intervention: Acupuncture plus rescue medication (RM) (cetirizine) (n = 212), sham acupuncture plus RM (n = 102), or RM alone (n = 108). Twelve treatments were provided over 8 weeks in the first year. Measurements: Changes in the Rhinitis Quality of Life Questionnaire (RQLQ) overall score and the RM score (RMS) from baseline to weeks 7 and 8 and week 16 in the first year and week 8 in the second year after randomization, with predefined noninferiority margins of -0.5 point (RQLQ) and -1.5 points (RMS). Results: Compared with sham acupuncture and with RM, acupuncture was associated with improvement in RQLQ score (sham vs. acupuncture mean difference, 0.5 point [97.5% CI, 0.2 to 0.8 point; P < 0.001]; RM vs. acupuncture mean difference, 0.7 point [97.5% CI, 0.4 to 1.0 point; P < 0.001]) and RMS (sham vs. acupuncture mean difference, 1.1 points [97.5% CI, 0.4 to 1.9 points; P < 0.001]; RM vs. acupuncture mean difference, 1.5 points [97.5% CI, 0.8 to 2.2 points; P < 0.001]). There were no differences after 16 weeks in the first year. After the 8-week follow-up phase in the second year, small improvements favoring real acupuncture over the sham procedure were noted (RQLQ mean difference, 0.3 point [95% CI, 0.03 to 0.6 point; P = 0.032]; RMS mean difference, 1.0 point [95% CI, 0.2 to 1.9 points; P = 0.018]). Limitation: The study was not powered to detect rare adverse events, and the RQLQ and RMS values were low at baseline. Conclusion: Acupuncture led to statistically significant improvements in disease-specific quality of life and antihistamine use measures after 8 weeks of treatment compared with sham acupuncture and with RM alone, but the improvements may not be clinically significant.	[Brinkhaus, Benno; Ortiz, Miriam; Witt, Claudia M.; Roll, Stephanie; Zuberbier, Torsten; Willich, Stefan N.] Charite Univ Med Ctr, D-10098 Berlin, Germany; [Niggemann, Bodo] German Red Cross Hosp Westend, D-14050 Berlin, Germany; Univ Maryland, Sch Med, Baltimore, MD 21201 USA; Tech Univ Munich, Helmholtz Ctr Munich, D-80290 Munich, Germany; Int Soc Chinese Med, Munich, Germany; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; Univ Med Ctr Eppendorf, Hamburg, Germany; [Linde, Klaus] Tech Univ Munich, Klinikum Rechts Isar, Inst Gen Practice, D-81667 Munich, Germany; [Pfab, Florian; Ring, Johannes] Christine Kuhne Ctr Allergy Res & Educ, D-80797 Munich, Germany; [Treszl, Andras; Wegscheider, Karl] Univ Med Ctr Eppendorf, Dept Med Biometry & Epidemiol, D-20246 Hamburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University System of Maryland; University of Maryland Baltimore; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf	Brinkhaus, B (corresponding author), Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, D-10098 Berlin, Germany.	stephanie.roll@charite.de	Ring, Johannes/GLN-4341-2022; Brinkhaus, Benno/AAU-2428-2021; Witt, Claudia M./AAX-2370-2021	Ring, Johannes/0000-0001-8236-3152; Brinkhaus, Benno/0000-0001-6290-744X; Witt, Claudia M./0000-0002-5440-7805; Zuberbier, Torsten/0000-0002-1466-8875; Linde, Klaus/0000-0002-2902-970X; Roll, Stephanie/0000-0003-1191-3289; Ortiz, Miriam/0000-0002-0889-7890	German Research Foundation [WI 957/16-1]	German Research Foundation(German Research Foundation (DFG))	By grant WI 957/16-1 from the German Research Foundation.	Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; BELGRADE MJ, 1984, ACTA DERM-VENEREOL, V64, P129; Birch S., 2003, CLIN ACUPUNCT ORIENT, V4, P59, DOI DOI 10.1016/S1461-1449(03)00025-2; BOUSQUET J, 1994, J ALLERGY CLIN IMMUN, V94, P182, DOI 10.1016/0091-6749(94)90038-8; Brinkhaus B, 2006, ARCH INTERN MED, V166, P450; Brinkhaus B, 2004, ALLERGY, V59, P953, DOI 10.1111/j.1398-9995.2004.00540.x; Brinkhaus B, 2008, ANN ALLERG ASTHMA IM, V101, P535, DOI 10.1016/S1081-1206(10)60294-3; Brinkhaus B, 2010, FORSCH KOMPLEMENTMED, V17, P95, DOI 10.1159/000303012; Bullinger M, 1998, SF 36 FRAGEBOGEN ZUM; Carlsson CP, 2010, J EUR ACAD DERMATOL, V24, P1013, DOI 10.1111/j.1468-3083.2010.03585.x; Dincer F, 2003, COMPLEMENT THER MED, V11, P235, DOI 10.1016/S0965-2299(03)00124-9; Dmitrienko A, 2007, STAT MED, V26, P2465, DOI 10.1002/sim.2716; Elashoff JD, 2000, NQUERY ADVISOR VERSI; Hou W, 2011, TREATING AUTOIMMUNE; Juniper EF, 1996, J ALLERGY CLIN IMMUN, V98, P843, DOI 10.1016/S0091-6749(96)70135-5; Kenward MG, 2008, PUBLICATION NATL I H; Krouse JH, 1999, LARYNGOSCOPE, V109, P1223, DOI 10.1097/00005537-199908000-00007; Kuehr J, 2002, J ALLERGY CLIN IMMUN, V109, P274, DOI 10.1067/mai.2002.121949; Lee MS, 2009, ANN ALLERG ASTHMA IM, V102, P269, DOI 10.1016/S1081-1206(10)60330-4; Liang K-Y, 2000, SANKHYA INDIAN J S B, P134, DOI [DOI 10.2307/25053123, DOI 10.2337/DB12-0868]; Linde K, 2005, JAMA-J AM MED ASSOC, V293, P2118, DOI 10.1001/jama.293.17.2118; Linde K, 2004, J ALTERN COMPLEM MED, V10, P379, DOI 10.1089/107555304323062374; Linde K, 2007, PAIN, V128, P264, DOI 10.1016/j.pain.2006.12.006; Liu GHF, 2009, STAT MED, V28, P2509, DOI 10.1002/sim.3639; Lund Irene, 2009, Chin Med, V4, P1, DOI 10.1186/1749-8546-4-1; LUNDEBERG T, 1987, BRIT J DERMATOL, V117, P771, DOI 10.1111/j.1365-2133.1987.tb07359.x; Magnusson AL, 2004, AM J CHINESE MED, V32, P105, DOI 10.1142/S0192415X04001813; Maurer W, 1995, BIOMETRIE CHEM PHARM, V6, P13; Melchart D, 2005, BMJ-BRIT MED J, V331, P376, DOI 10.1136/bmj.38512.405440.8F; Melchart D, 2004, ARCH INTERN MED, V164, P104, DOI 10.1001/archinte.164.1.104; Niggemann B, 2003, ALLERGY, V58, P707, DOI 10.1034/j.1398-9995.2003.00219.x; Pfab F, 2005, J ALLERGY CLIN IMMUN, V116, P1386, DOI 10.1016/j.jaci.2005.08.055; Pfab F, 2012, ALLERGY, V67, P566, DOI 10.1111/j.1398-9995.2012.02789.x; Pfab F, 2010, ALLERGY, V65, P903, DOI 10.1111/j.1398-9995.2009.02284.x; Pfab F, 2011, J ALTERN COMPLEM MED, V17, P309, DOI 10.1089/acm.2009.0684; Roberts J, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-13; Schafer T, 2002, ALLERGY, V57, P694, DOI 10.1034/j.1398-9995.2002.23469.x; van Cauwenberge P, 2000, ALLERGY, V55, P116, DOI 10.1034/j.1398-9995.2000.00526.x; Vincent C, 1990, COMPLEMENT MED RES, V4, P8; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Weiss KB, 2001, J ALLERGY CLIN IMMUN, V107, P3, DOI 10.1067/mai.2001.112262; Williamson L, 1996, ACUPUNCT MED, V14, P6; Witt C, 2005, LANCET, V366, P136, DOI 10.1016/S0140-6736(05)66871-7; Witt CM, 2009, FORSCH KOMPLEMENTMED, V16, P91, DOI 10.1159/000209315; Witt CM, 2009, AM J EPIDEMIOL, V169, P562, DOI 10.1093/aje/kwn370; Xue CCL, 2002, AM J CHINESE MED, V30, P1, DOI 10.1142/S0192415X0200020X	46	79	84	1	38	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2013	158	4					225	234		10.7326/0003-4819-158-4-201302190-00002	http://dx.doi.org/10.7326/0003-4819-158-4-201302190-00002			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098WR	23420231				2022-12-28	WOS:000315580300013
J	Kleinewietfeld, M; Manzel, A; Titze, J; Kvakan, H; Yosef, N; Linker, RA; Muller, DN; Hafler, DA				Kleinewietfeld, Markus; Manzel, Arndt; Titze, Jens; Kvakan, Heda; Yosef, Nir; Linker, Ralf A.; Muller, Dominik N.; Hafler, David A.			Sodium chloride drives autoimmune disease by the induction of pathogenic T(H)17 cells	NATURE			English	Article							THREONINE PROTEIN-KINASE; T-CELLS; OSMOTIC-STRESS; TRANSCRIPTIONAL TARGET; P38 MAPK; TGF-BETA; SGK; GENE; INFLAMMATION; ACTIVATION	There has been a marked increase in the incidence of autoimmune diseases in the past half-century. Although the underlying genetic basis of this class of diseases has recently been elucidated, implicating predominantly immune-response genes(1), changes in environmental factors must ultimately be driving this increase. The newly identified population of interleukin (IL)-17-producing CD4(+) helper T cells (T(H)17 cells) has a pivotal role in autoimmune diseases(2). Pathogenic IL-23-dependent T(H)17 cells have been shown to be critical for the development of experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis, and genetic risk factors associated with multiple sclerosis are related to the IL-23-T(H)17 pathway(1,2). However, little is known about the environmental factors that directly influence T(H)17 cells. Here we show that increased salt (sodium chloride, NaCl) concentrations found locally under physiological conditions in vivo markedly boost the induction of murine and human T(H)17 cells. High-salt conditions activate the p38/MAPK pathway involving nuclear factor of activated T cells 5 (NFAT5; also called TONEBP) and serum/glucocorticoid-regulated kinase 1 (SGK1) during cytokine-induced T(H)17 polarization. Gene silencing or chemical inhibition of p38/MAPK, NFAT5 or SGK1 abrogates the high-salt-induced T(H)17 cell development. The T(H)17 cells generated under high-salt conditions display a highly pathogenic and stable phenotype characterized by the upregulation of the pro-inflammatory cytokines GM-CSF, TNF-alpha and IL-2. Moreover, mice fed with a high-salt diet develop a more severe form of EAE, in line with augmented central nervous system infiltrating and peripherally induced antigen-specific T(H)17 cells. Thus, increased dietary salt intake might represent an environmental risk factor for the development of autoimmune diseases through the induction of pathogenic T(H)17 cells.	[Kleinewietfeld, Markus; Hafler, David A.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; [Kleinewietfeld, Markus; Hafler, David A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Kleinewietfeld, Markus; Yosef, Nir; Hafler, David A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Manzel, Arndt; Linker, Ralf A.] Univ Erlangen Nurnberg, Dept Neurol, D-91054 Erlangen, Germany; [Manzel, Arndt] Ruhr Univ Bochum, Int Grad Sch Neurosci, D-44801 Bochum, Germany; [Titze, Jens] Vanderbilt Univ, Div Clin Pharmacol, Nashville, TN 37232 USA; [Titze, Jens] Univ Erlangen Nurnberg, Interdisciplinary Ctr Clin Res, D-91054 Erlangen, Germany; [Titze, Jens] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany; [Kvakan, Heda; Muller, Dominik N.] Expt & Clin Res Ctr, D-13125 Berlin, Germany; [Kvakan, Heda] Helios Klinikum Berlin Buch, D-13125 Berlin, Germany; [Muller, Dominik N.] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Germany	Yale University; Yale University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Erlangen Nuremberg; Ruhr University Bochum; Vanderbilt University; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Helios Kliniken; University of Erlangen Nuremberg	Kleinewietfeld, M (corresponding author), Yale Univ, Sch Med, Dept Neurol, 15 York St, New Haven, CT 06520 USA.	markus.kleinewietfeld@yale.edu; david.hafler@yale.edu	Linker, Ralf/AAD-8884-2020; Titze, Jens/GXV-1636-2022; Kleinewietfeld, Markus/AAI-4497-2021	Muller, Dominik N/0000-0003-3650-5644; Kleinewietfeld, Markus/0000-0002-2832-3149; Titze, Jens/0000-0001-8463-8404	National MS Society Collaborative Research Center [CA1061-A-18]; National Institutes of Health [P01 AI045757, U19 AI046130, U19 AI070352, P01 AI039671]; National Institute of Neurological Disorders and Stroke [NS2427]; Penates Foundation; Nancy Taylor Foundation for Chronic Diseases, Inc.; ELAN programme, University of Erlangen; German Research Foundation (DFG); German Center for Cardiovascular Research (DZHK); Interdisciplinary Center for Clinical Research at University of Erlangen; German Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI046130, R01AI091568, U19AI070352, U01AI102011, P01AI039671, P01AI045757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024247] Funding Source: NIH RePORTER	National MS Society Collaborative Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Penates Foundation; Nancy Taylor Foundation for Chronic Diseases, Inc.; ELAN programme, University of Erlangen; German Research Foundation (DFG)(German Research Foundation (DFG)); German Center for Cardiovascular Research (DZHK); Interdisciplinary Center for Clinical Research at University of Erlangen; German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank S. Bhela, M. Zaidi, P. Quass, M. Mroz and S. Seubert for technical assistance and F. C. Luft for critical reading of the manuscript. We are grateful to J.-P. David and S. Teufel for providing Mx-Cre1 p38 alpha<SUP>fl/fl</SUP> mice. This work was supported by a National MS Society Collaborative Research Center Award CA1061-A-18, National Institutes of Health Grants P01 AI045757, U19 AI046130, U19 AI070352, and P01 AI039671, and by a Jacob Javits Merit award (NS2427) from the National Institute of Neurological Disorders and Stroke, the Penates Foundation and the Nancy Taylor Foundation for Chronic Diseases, Inc. (to D. A. H.). R. A. L. was supported by the ELAN programme, University of Erlangen. D.N.M. was supported by the German Research Foundation (DFG) and the German Center for Cardiovascular Research (DZHK). J.T. was supported by the Interdisciplinary Center for Clinical Research at University of Erlangen and the German Research Foundation.	Appel LJ, 2011, CIRCULATION, V123, P1138, DOI 10.1161/CIR.0b013e31820d0793; Ascherio A, 2007, ANN NEUROL, V61, P504, DOI 10.1002/ana.21141; Astier AL, 2010, J IMMUNOL, V184, P685, DOI 10.4049/jimmunol.0902443; Bell LM, 2000, J BIOL CHEM, V275, P25262, DOI 10.1074/jbc.M002076200; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Ortells MC, 2012, NUCLEIC ACIDS RES, V40, P4368, DOI 10.1093/nar/gks038; Chen SC, 2009, J CLIN INVEST, V119, P1647, DOI 10.1172/JCI35314; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JUNGER WG, 1994, CIRC SHOCK, V42, P190; Kino T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000081; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; McGuire S, 2010, ADV NUTR, V1, P49, DOI 10.3945/an.110.1002; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Noubade R, 2011, BLOOD, V118, P3290, DOI 10.1182/blood-2011-02-336552; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Platten M, 2009, P NATL ACAD SCI USA, V106, P14948, DOI 10.1073/pnas.0903958106; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Shapiro L, 1995, P NATL ACAD SCI USA, V92, P12230, DOI 10.1073/pnas.92.26.12230; Sherk AB, 2008, CANCER RES, V68, P7475, DOI 10.1158/0008-5472.CAN-08-1047; Stegbauer J, 2009, P NATL ACAD SCI USA, V106, P14942, DOI 10.1073/pnas.0903602106; Waldegger S, 1999, GASTROENTEROLOGY, V116, P1081, DOI 10.1016/S0016-5085(99)70011-9; Waldegger S, 1997, P NATL ACAD SCI USA, V94, P4440, DOI 10.1073/pnas.94.9.4440; Waldegger S, 2000, CELL PHYSIOL BIOCHEM, V10, P203, DOI 10.1159/000016351; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; Wenzel K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003742; Woehrle T, 2010, J LEUKOCYTE BIOL, V88, P1181, DOI 10.1189/jlb.0410211; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	38	865	893	7	225	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2013	496	7446					518	+		10.1038/nature11868	http://dx.doi.org/10.1038/nature11868			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23467095	Green Accepted			2022-12-28	WOS:000317984400044
J	Hoogland, JL				Hoogland, John L.			Prairie Dogs Disperse When All Close Kin Have Disappeared	SCIENCE			English	Article							GROUND-SQUIRRELS; NATAL DISPERSAL; PHILOPATRY; COMPETITION; COOPERATION; EVOLUTION; CYNOMYS; MAMMALS	Because competition decreases inclusive fitness among kin, Hamilton and May predicted that the presence of nearby kin should induce the dispersal of individuals from the natal territory, independent of pressures to avoid inbreeding. Many studies support this landmark prediction, but research over 31 years with prairie dogs reveals the opposite pattern: Young females are 12.5 times more likely to disperse in the absence of mother and siblings for one species, and 5.5 times more likely for another species. Such striking patterns probably occur because cooperation among kin is more important than competition among kin for young prairie dogs. The inability to cooperate with close kin, due to their absence, prompts a search for a new territory where cooperation might be less crucial for survival and reproduction.	Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD 21532 USA	University System of Maryland; University of Maryland Center for Environmental Science	Hoogland, JL (corresponding author), Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD 21532 USA.	hoogland@al.umces.edu	Hoogland, John/B-3950-2015; Hoogland, John/AAC-9808-2021		Colorado Parks and Wildlife; Denver Zoological Foundation; Environmental Defense; Eppley Foundation; Harry Frank Guggenheim Foundation; National Fish and Wildlife Foundation; National Geographic Society; NSF; Princeton University; Ted Turner Foundation; UMCES; University of Michigan; University of Minnesota	Colorado Parks and Wildlife; Denver Zoological Foundation; Environmental Defense; Eppley Foundation; Harry Frank Guggenheim Foundation; National Fish and Wildlife Foundation; National Geographic Society(National Geographic Society); NSF(National Science Foundation (NSF)); Princeton University(Princeton University); Ted Turner Foundation; UMCES; University of Michigan(University of Michigan System); University of Minnesota(University of Minnesota System)	I thank J. Hoogland for encouraging me to reexamine my information on dispersal; my 150+ research assistants over the 31 years of research (especially my four offspring); and D. Boesch, K. Fuller, R. Gardner, R. Morgan, and L. Pitelka of the University of the Maryland Center for Environmental Science (UMCES) for the opportunity for long-term comparative research. Financial support was provided by Colorado Parks and Wildlife, the Denver Zoological Foundation, Environmental Defense, the Eppley Foundation, the Harry Frank Guggenheim Foundation, the National Fish and Wildlife Foundation, the National Geographic Society, NSF, Princeton University, the Ted Turner Foundation, UMCES, and the Universities of Michigan and Minnesota. For help with the manuscript, I thank R. Alexander, D. Blumstein, D. Bowler, C. Brown, J. Clobert, T. H. Clutton-Brock, A. Davis-Robosky, F. S. Dobson, L. Handley, K. Holekamp, A. Hoogland, S. Keller, X. Lambin, M. Oli, P. Sherman, N. Solomon, and D. Van Vuren. Data for this report are archived as supplementary materials on Science Online.	Armitage KB, 2011, ECOLOGY, V92, P218, DOI 10.1890/10-0109.1; Arnaud CM, 2012, MOL ECOL, V21, P493, DOI 10.1111/j.1365-294X.2011.05219.x; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Clutton-Brock TH, 2012, MOL ECOL, V21, P472, DOI 10.1111/j.1365-294X.2011.05232.x; Cote J, 2007, P NATL ACAD SCI USA, V104, P9703, DOI 10.1073/pnas.0703601104; Davis AR, 2012, BEHAV ECOL, V23, P18, DOI 10.1093/beheco/arr144; Dobson FS, 1998, BEHAV ECOL, V9, P622, DOI 10.1093/beheco/9.6.622; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; HOLEKAMP KE, 1986, ECOL MONOGR, V56, P365, DOI 10.2307/1942552; Hoogland J. L., 1995, BLACK TAILED PRAIRIE; HOOGLAND JL, 1982, SCIENCE, V215, P1639, DOI 10.1126/science.215.4540.1639; HOOGLAND JL, 1979, BEHAVIOUR, V69, P1, DOI 10.1163/156853979X00377; Hoogland JL, 1999, J MAMMAL, V80, P243, DOI 10.2307/1383224; Hoogland John L., 2007, P438; Hoogland JL, 2009, BEHAV ECOL SOCIOBIOL, V63, P1621, DOI 10.1007/s00265-009-0763-0; JACQUOT JJ, 1995, BEHAV ECOL SOCIOBIOL, V37, P407, DOI 10.1007/BF00170588; Koenig WD, 1996, TRENDS ECOL EVOL, V11, P514, DOI 10.1016/S0169-5347(96)20074-6; Lambin Xavier, 2001, P110; Mitani J., 2012, EVOLUTION PRIMATE SO; Moore JC, 2006, BIOL LETT-UK, V2, P17, DOI 10.1098/rsbl.2005.0370; Platt TG, 2009, TRENDS ECOL EVOL, V24, P370, DOI 10.1016/j.tree.2009.02.009; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; Stenseth N. C., 2012, ANIMAL DISPERSAL SMA; WASER PM, 1983, Q REV BIOL, V58, P355, DOI 10.1086/413385; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507	29	41	43	1	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2013	339	6124					1205	1207		10.1126/science.1231689	http://dx.doi.org/10.1126/science.1231689			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471407				2022-12-28	WOS:000315709900047
J	Stern, A; Lindner, NH				Stern, Ady; Lindner, Netanel H.			Topological Quantum Computation-From Basic Concepts to First Experiments	SCIENCE			English	Review							NON-ABELIAN STATISTICS; MAJORANA FERMIONS; HALL STATES; NANOWIRE; SUPERCONDUCTOR; ANYONS; PARTICLES; SIGNATURE; VORTICES; MODES	Quantum computation requires controlled engineering of quantum states to perform tasks that go beyond those possible with classical computers. Topological quantum computation aims to achieve this goal by using non-Abelian quantum phases of matter. Such phases allow for quantum information to be stored and manipulated in a nonlocal manner, which protects it from imperfections in the implemented protocols and from interactions with the environment. Recently, substantial progress in this field has been made on both theoretical and experimental fronts. We review the basic concepts of non-Abelian phases and their topologically protected use in quantum information processing tasks. We discuss different possible realizations of these concepts in experimentally available solid-state systems, including systems hosting Majorana fermions, their recently proposed fractional counterparts, and non-Abelian quantum Hall states.	[Stern, Ady] Weizmann Inst Sci, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel; [Lindner, Netanel H.] CALTECH, Inst Quantum Informat & Matter, Pasadena, CA 91125 USA; [Lindner, Netanel H.] CALTECH, Dept Phys, Pasadena, CA 91125 USA	Weizmann Institute of Science; California Institute of Technology; California Institute of Technology	Stern, A (corresponding author), Weizmann Inst Sci, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel.	adiel.stern@weizmann.ac.il			U.S.-Israel Binational Science Foundation; Minerva foundation; Microsoft Station Q; Defense Advanced Research Projects Agency [N66001-12-1-4034]; Institute for Quantum Information and Matter, an NSF Physics Frontiers Center; Gordon and Betty Moore Foundation; NSF [PHY11-25915]	U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Minerva foundation; Microsoft Station Q(Microsoft); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Institute for Quantum Information and Matter, an NSF Physics Frontiers Center(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF))	We thank C. Nayak and J. Preskill for helpful discussions, and the Kavli Institute for Theoretical Physics for their hospitality. Supported by the U.S.-Israel Binational Science Foundation, the Minerva foundation, and Microsoft Station Q (A.S.); Defense Advanced Research Projects Agency award N66001-12-1-4034 and the Institute for Quantum Information and Matter, an NSF Physics Frontiers Center, with support of the Gordon and Betty Moore Foundation (N.H.L.); and NSF grant PHY11-25915.	AHARONOV Y, 1984, PHYS REV LETT, V53, P319, DOI 10.1103/PhysRevLett.53.319; Alicea J, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/7/076501; Alicea J, 2011, NAT PHYS, V7, P412, DOI 10.1038/NPHYS1915; Barkeshli M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.045130; Bid A, 2010, NATURE, V466, P585, DOI 10.1038/nature09277; Bonderson P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.016803; Bonderson P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.130505; Bonderson P, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.180505; Bonderson P, 2009, ANN PHYS-NEW YORK, V324, P787, DOI 10.1016/j.aop.2008.09.009; Bravyi S, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.042313; Bravyi S, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.022316; Cheng M, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.195126; Clarke DJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2340; Das A, 2012, NAT PHYS, V8, P887, DOI [10.1038/NPHYS2479, 10.1038/nphys2479]; Das Sarma S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.166802; Deng MT, 2012, NANO LETT, V12, P6414, DOI 10.1021/nl303758w; Dennis E, 2002, J MATH PHYS, V43, P4452, DOI 10.1063/1.1499754; Freedman M, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.245307; Fu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096407; Fu L, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.161408; Grosfeld E, 2011, P NATL ACAD SCI USA, V108, P11810, DOI 10.1073/pnas.1101469108; Halperin BI, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.144501; Hassler F, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/9/095004; Hassler F, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/125002; Ivanov DA, 2001, PHYS REV LETT, V86, P268, DOI 10.1103/PhysRevLett.86.268; Jiang LA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.130504; Kitaev A, 2006, ANN PHYS-NEW YORK, V321, P2, DOI 10.1016/j.aop.2005.10.005; Kitaev AY, 2003, ANN PHYS-NEW YORK, V303, P2, DOI 10.1016/S0003-4916(02)00018-0; Kitaev AY., 2001, PHYS-USP+, V44, P131, DOI [10.1070/1063-7869/44/10S/S29, DOI 10.1070/1063-7869/44/10S/S29]; Lindner NH, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.041002; Lutchyn RM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.077001; MOORE G, 1991, NUCL PHYS B, V360, P362, DOI 10.1016/0550-3213(91)90407-O; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; Nayak C, 1996, NUCL PHYS B, V479, P529, DOI 10.1016/0550-3213(96)00430-0; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Oreg Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.177002; Preskill J., LECT NOTES QUANTUM C; Read N, 2000, PHYS REV B, V61, P10267, DOI 10.1103/PhysRevB.61.10267; Read N, 1996, PHYS REV B, V54, P16864, DOI 10.1103/PhysRevB.54.16864; Rokhinson LP, 2012, NAT PHYS, V8, P795, DOI [10.1038/NPHYS2429, 10.1038/nphys2429]; Sau JD, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.094505; Sau JD, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.040502; Stern A, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.205338; Stern A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.016802; Stern A, 2010, NATURE, V464, P187, DOI 10.1038/nature08915; Storni M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.076803; Vaezi A, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.035132; Willett RL, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.205301	51	147	148	6	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2013	339	6124					1179	1184		10.1126/science.1231473	http://dx.doi.org/10.1126/science.1231473			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471401				2022-12-28	WOS:000315709900040
J	Zhou, M				Zhou, Min			Exceptional Properties by Design	SCIENCE			English	Editorial Material							NANOWIRES		[Zhou, Min] Georgia Inst Technol, Sch Mech Engn, Atlanta, GA 30332 USA; [Zhou, Min] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA; [Zhou, Min] Seoul Natl Univ, Sch Mech & Aerosp Engn, World Class Univ WCU Program Multiscale Mech Desi, Seoul 151744, South Korea	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Seoul National University (SNU)	Zhou, M (corresponding author), Georgia Inst Technol, Sch Mech Engn, Atlanta, GA 30332 USA.	min.zhou@gatech.edu		Zhou, Min/0000-0002-8993-5675				Ashby M. F., 2005, MAT SELECTION MECH D; Dzenis Y, 2008, SCIENCE, V319, P419, DOI 10.1126/science.1151434; Hao SJ, 2013, SCIENCE, V339, P1191, DOI 10.1126/science.1228602; Jones TE, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.125506; Kulkarni AJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.105502; Liang WW, 2005, NANO LETT, V5, P2039, DOI 10.1021/nl0515910; McDowell DL, 2008, SCI MODEL SIMUL, V15, P207, DOI 10.1007/s10820-008-9100-6; Olson GB, 1997, SCIENCE, V277, P1237, DOI 10.1126/science.277.5330.1237; Park HS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.255504; Wang J, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.172103; Yue YH, 2011, NANO LETT, V11, P3151, DOI 10.1021/nl201233u; [No title captured]	12	31	32	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2013	339	6124					1161	1162		10.1126/science.1236378	http://dx.doi.org/10.1126/science.1236378			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23471396				2022-12-28	WOS:000315709900035
J	Zhou, M; Guo, JH; Cha, J; Chae, M; Chen, S; Barral, JM; Sachs, MS; Liu, Y				Zhou, Mian; Guo, Jinhu; Cha, Joonseok; Chae, Michael; Chen, She; Barral, Jose M.; Sachs, Matthew S.; Liu, Yi			Non-optimal codon usage affects expression, structure and function of clock protein FRQ	NATURE			English	Article							NEUROSPORA CIRCADIAN CLOCK; FEEDBACK LOOPS; PHOSPHORYLATION; TRANSLATION; GENE; LUCIFERASE; MECHANISM; FREQUENCY; RHYTHMS; SYSTEM	Codon-usage bias has been observed in almost all genomes and is thought to result from selection for efficient and accurate translation of highly expressed genes(1-3). Codon usage is also implicated in the control of transcription, splicing and RNA structure(4-6). Many genes exhibit little codon-usage bias, which is thought to reflect a lack of selection for messenger RNA translation. Alternatively, however, non-optimal codon usage may be of biological importance. The rhythmic expression and the proper function of the Neurospora FREQUENCY (FRQ) protein are essential for circadian clock function. Here we show that, unlike most genes in Neurospora, frq exhibits non-optimal codon usage across its entire open reading frame. Optimization of frq codon usage abolishes both overt and molecular circadian rhythms. Codon optimization not only increases FRQ levels but, unexpectedly, also results in conformational changes in FRQ protein, altered FRQ phosphorylation profile and stability, and impaired functions in the circadian feedback loops. These results indicate that non-optimal codon usage of frq is essential for its circadian clock function. Our study provides an example of how non-optimal codon usage functions to regulate protein expression and to achieve optimal protein structure and function.	[Zhou, Mian; Guo, Jinhu; Cha, Joonseok; Chae, Michael; Liu, Yi] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Chen, She] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Barral, Jose M.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Barral, Jose M.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Sachs, Matthew S.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institute of Biological Sciences, Beijing; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Texas A&M University System; Texas A&M University College Station	Liu, Y (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Yi.Liu@UTsouthwestern.edu	Cha, Joonseok/AAE-9918-2020	Chae, Michael/0000-0002-5594-4450; Cha, Joonseok/0000-0001-9362-5285; Sachs, Matthew/0000-0001-9891-9223	National Institutes of Health [GM068496, GM062591, GM47498]; Welch Foundation [I-1560]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM068087, R01GM084283, R35GM118118, R01GM047498, R29GM047498, R01GM068496, R01GM062591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank H. Yuan and Q. Ye,for technical assistance, J. Dunlap for providing the pfrq-luc-I construct and M. Rosbash for suggesting the temperature experiments. We apologize to those colleagues whose studies we could not cite owing to space limitations. This work was supported by grants from the National Institutes of Health to Y.L. (GM068496 & GM062591) and M.S.S. (GM47498), and from the Welch Foundation (I-1560) to Y.L.	Baker CL, 2012, FEMS MICROBIOL REV, V36, P95, DOI 10.1111/j.1574-6976.2011.00288.x; Baker CL, 2009, MOL CELL, V34, P354, DOI 10.1016/j.molcel.2009.04.023; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3026; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Colot HV, 2005, MOL BIOL CELL, V16, P5563, DOI 10.1091/mbc.E05-08-0756; Diernfellner A, 2007, FEBS LETT, V581, P5759, DOI 10.1016/j.febslet.2007.11.043; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Gooch VD, 2008, EUKARYOT CELL, V7, P28, DOI 10.1128/EC.00257-07; Gu WJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000664; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Huang GC, 2006, EMBO J, V25, P5349, DOI 10.1038/sj.emboj.7601397; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Johnson CH, 2011, ANNU REV BIOPHYS, V40, P143, DOI 10.1146/annurev-biophys-042910-155317; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Liu Y, 1998, SCIENCE, V281, P825, DOI 10.1126/science.281.5378.825; Liu Y, 1997, CELL, V89, P477, DOI 10.1016/S0092-8674(00)80228-7; Morgan LW, 2003, FUNGAL GENET BIOL, V38, P327, DOI 10.1016/S1087-1845(02)00562-5; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Siller E, 2010, J MOL BIOL, V396, P1310, DOI 10.1016/j.jmb.2009.12.042; Spencer PS, 2012, J MOL BIOL, V422, P328, DOI 10.1016/j.jmb.2012.06.010; Tang CT, 2009, P NATL ACAD SCI USA, V106, P10722, DOI 10.1073/pnas.0904898106; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Zhou T, 2009, MOL BIOL EVOL, V26, P1571, DOI 10.1093/molbev/msp070	29	266	273	0	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2013	495	7439					111	115		10.1038/nature11833	http://dx.doi.org/10.1038/nature11833			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23417067	Green Accepted			2022-12-28	WOS:000316039800050
J	Winters, BD; Weaver, SJ; Pfoh, ER; Yang, T; Pham, JC; Dy, SM				Winters, Bradford D.; Weaver, Sallie J.; Pfoh, Elizabeth R.; Yang, Ting; Pham, Julius Cuong; Dy, Sydney M.			Rapid-Response Systems as a Patient Safety Strategy A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Article							MEDICAL EMERGENCY TEAM; HOSPITAL-WIDE MORTALITY; CARDIAC ARRESTS; INTENSIVE-CARE; CARDIOPULMONARY ARRESTS; CLINICAL INSTABILITY; CODE RATES; IMPLEMENTATION; REDUCTION; IMPACT	Rapid-response systems (RRSs) are a popular intervention in U. S. hospitals and are supported by accreditors and quality improvement organizations. The purpose of this review is to evaluate the effectiveness and implementation of these systems in acute care settings. A literature search was performed between 1 January 2000 through 30 October 2012 using PubMed, PsycINFO, CINAHL, and the Cochrane Central Register of Controlled Trials. Studies published in any language evaluating outcome changes that occurred after implementing an RRS and differences between groups using and not using an RRS (effectiveness) or describing methods used by RRSs (implementation) were reviewed. A single reviewer (checked by a second reviewer) abstracted data and rated study quality and strength of evidence. Moderate-strength evidence from a high-quality meta-analysis of 18 studies and 26 lower-quality before-and-after studies published after that meta-analysis showed that RRSs are associated with reduced rates of cardiorespiratory arrest outside of the intensive care unit and reduced mortality. Eighteen studies examining facilitators of and barriers to implementation suggested that the rate of use of RRSs could be improved. Ann Intern Med. 2013;158:417-425. www.annals.org	Johns Hopkins Sch Med, Baltimore, MD USA; Johns Hopkins Univ, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Winters, BD (corresponding author), Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Sch Med, Zayed 9127,1800 Orleans St, Baltimore, MD 21287 USA.	bwinters@jhmi.edu	Weaver, Sallie J./AAH-1453-2020	Weaver, Sallie J./0000-0002-5859-7669	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services [HHSA-290-2007-10062I]; Agency for Healthcare Research and Quality; 3M; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); 3M(3M); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Financial Support: From the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services (contract HHSA-290-2007-10062I).; Potential Conflicts of Interest: Dr. Winters: Grant (money to institution): Agency for Healthcare Research and Quality; Employment: Johns Hopkins University; Expert testimony: several law firms; Payment for lectures including service on speakers bureaus: 3M; Royalties: Lippincott. Dr. Weaver: Grant (money to institution): Agency for Healthcare Research and Quality; Travel/accommodations/meeting expenses unrelated to activities listed: Improvement Science Research Network. Ms. Pfoh: Grant (money to institution): Agency for Healthcare Research and Quality. Dr. Dy: Grant (money to institution): Agency for Healthcare Research and Quality. All other authors have no disclosures. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M12-2568.	Adelstein BA, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2011.03.013; [Anonymous], 5 MILL LIV CAMP OV; [Anonymous], 2007, JOINT COMMISSION PER, V27, P10; Anwar-ul-Haque, 2010, INDIAN J PEDIATR, V77, P273, DOI 10.1007/s12098-010-0032-2; Bader MK, 2009, JT COMM J QUAL PATIE, V35, P199, DOI 10.1016/S1553-7250(09)35027-8; Baxter AD, 2008, CAN J ANAESTH, V55, P223, DOI 10.1007/BF03021506; Beitler JR, 2011, CRIT CARE, V15, DOI 10.1186/cc10547; Bellomo R, 2003, MED J AUSTRALIA, V179, P283, DOI 10.5694/j.1326-5377.2003.tb05548.x; Benning A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d199; Benson L, 2008, JT COMM J QUAL PATIE, V34, P743, DOI 10.1016/S1553-7250(08)34097-5; Bosch FH, 2008, NETHERLANDS J CRITIC, V12, P256; Brilli RJ, 2007, PEDIATR CRIT CARE ME, V8, P236, DOI 10.1097/01.PCC.0000262947.72442.EA; Bristow PJ, 2000, MED J AUSTRALIA, V173, P236, DOI 10.5694/j.1326-5377.2000.tb125627.x; Buist MD, 1999, MED J AUSTRALIA, V171, P22, DOI 10.5694/j.1326-5377.1999.tb123492.x; Buist MD, 2002, BRIT MED J, V324, P387, DOI 10.1136/bmj.324.7334.387; Buist M, 2007, BMJ-BRIT MED J, V335, P1210, DOI 10.1136/bmj.39385.534236.47; Calzavacca P, 2010, RESUSCITATION, V81, P31, DOI 10.1016/j.resuscitation.2009.09.026; Campello G, 2009, CRIT CARE MED, V37, P3054, DOI 10.1097/CCM.0b013e3181b02183; Chan PS, 2008, JAMA-J AM MED ASSOC, V300, P2506, DOI 10.1001/jama.2008.715; Chan PS, 2010, ARCH INTERN MED, V170, P18, DOI 10.1001/archinternmed.2009.424; Chen J, 2010, RADIAT PROT DOSIM, V142, P1, DOI 10.1093/rpd/ncq205; Cretikos Michelle A, 2007, Crit Care Resusc, V9, P205; Dacey MJ, 2007, CRIT CARE MED, V35, P2076, DOI 10.1097/01.CCM.0000281518.17482.EE; DeVita MA, 2004, QUAL SAF HEALTH CARE, V13, P251, DOI 10.1136/qshc.2003.006585; Donaldson N, 2009, J NURS ADMIN, V39, P176, DOI 10.1097/NNA.0b013e31819c9ce9; Foraida MI, 2003, J CRIT CARE, V18, P87, DOI 10.1053/jcrc.2003.50002; Genardi ME, 2008, DIMENS CRIT CARE NUR, V27, P104, DOI 10.1097/01.DCC.0000286837.95720.8c; Gerdik C, 2010, RESUSCITATION, V81, P1676, DOI 10.1016/j.resuscitation.2010.06.020; Hanson CC, 2009, QUAL SAF HEALTH CARE, V18, P500, DOI 10.1136/qshc.2007.026054; HATLER C, 2009, MEDSURG NURS, V18, P126; Hatler Carol, 2009, Medsurg Nurs, V18, P84; Hillman K, 2005, LANCET, V365, P2091; Howell MD, 2012, CRIT CARE MED, V40, P2562, DOI 10.1097/CCM.0b013e318259007b; Hunt EA, 2008, ARCH PEDIAT ADOL MED, V162, P117, DOI 10.1001/archpediatrics.2007.33; Jolley J, 2007, DIMENS CRIT CARE NUR, V26, P253, DOI 10.1097/01.DCC.0000297401.67854.78; Jones CM, 2010, JT COMM J QUAL PATIE, V36, P266, DOI 10.1016/S1553-7250(10)36042-9; Jones D, 2006, INTERN MED J, V36, P231, DOI 10.1111/j.1445-5994.2006.01045.x; Jones D, 2005, CRIT CARE, V9, pR808, DOI 10.1186/cc3906; Jones DA, 2006, ANAESTH INTENS CARE, V34, P731, DOI 10.1177/0310057X0603400606; Jones DA, 2011, NEW ENGL J MED, V365, P139, DOI 10.1056/NEJMra0910926; Jones L, 2009, J CLIN NURS, V18, P3379, DOI 10.1111/j.1365-2702.2009.02944.x; Karvellas CJ, 2012, BMJ QUAL SAF, V21, P152, DOI 10.1136/bmjqs-2011-000393; Kenward G, 2004, RESUSCITATION, V61, P257, DOI 10.1016/j.resuscitation.2004.01.021; Konrad D, 2010, INTENS CARE MED, V36, P100, DOI 10.1007/s00134-009-1634-x; Kotsakis A, 2011, PEDIATRICS, V128, P72, DOI 10.1542/peds.2010-0756; Laurens N, 2011, RESUSCITATION, V82, P707, DOI 10.1016/j.resuscitation.2010.11.031; Lighthall GK, 2010, ANESTH ANALG, V111, P679, DOI 10.1213/ANE.0b013e3181e9c3f3; Litvak E, 2010, JAMA-J AM MED ASSOC, V304, P1375, DOI 10.1001/jama.2010.1385; Mackintosh N, 2012, BMJ QUAL SAF, V21, P135, DOI 10.1136/bmjqs-2011-000147; Medina-Rivera B, 2010, CRIT CARE SHOCK, V13, P98; Offner PJ, 2007, J TRAUMA, V62, P1223, DOI 10.1097/TA.0b013e31804d4968; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Peebles E, 2012, RESUSCITATION, V83, P782, DOI 10.1016/j.resuscitation.2011.12.019; Priestley G, 2004, INTENS CARE MED, V30, P1398, DOI 10.1007/s00134-004-2268-7; Rothberg MB, 2012, J HOSP MED, V7, P98, DOI 10.1002/jhm.953; Santamaria J, 2010, CRIT CARE MED, V38, P445, DOI 10.1097/CCM.0b013e3181cb0ff1; Sarani B, 2011, RESUSCITATION, V82, P415, DOI 10.1016/j.resuscitation.2010.12.005; Scherr K, 2012, AACN ADV CRIT CARE, V23, P32, DOI 10.1097/NCI.0b013e318240e2f9; Scott SS, 2009, CRIT CARE NURSE, V29, P66, DOI 10.4037/ccn2009802; Shah SK, 2011, CHEST, V139, P1361, DOI 10.1378/chest.10-0556; Shapiro SE, 2010, AM J NURS, V110, P28, DOI 10.1097/01.NAJ.0000377686.64479.84; Sharek PJ, 2007, JAMA-J AM MED ASSOC, V298, P2267, DOI 10.1001/jama.298.19.2267; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shearer B, 2012, BMJ QUAL SAF, V21, P569, DOI 10.1136/bmjqs-2011-000692; Soo Stephanie, 2009, Healthc Q, V12 Spec No Patient, P123; Thomas K, 2007, CRIT CARE NURSE, V27, P20; Tibballs J, 2009, PEDIATR CRIT CARE ME, V10, P306, DOI 10.1097/PCC.0b013e318198b02c; Tobin AE, 2012, CRIT CARE, V16, DOI 10.1186/cc11843; Williams DJ, 2011, J NURS CARE QUAL, V26, P265, DOI 10.1097/NCQ.0b013e318209f135; Zenker P, 2007, JT COMM J QUAL PATIE, V33, P418, DOI 10.1016/S1553-7250(07)33048-1	70	265	270	3	53	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2013	158	5	2				417	+		10.7326/0003-4819-158-5-201303051-00009	http://dx.doi.org/10.7326/0003-4819-158-5-201303051-00009			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105HX	23460099	Green Accepted			2022-12-28	WOS:000316058600009
J	Langer, A; Horton, R; Chalamilla, G				Langer, Ana; Horton, Richard; Chalamilla, Guerino			A manifesto for maternal health post-2015	LANCET			English	Editorial Material									[Langer, Ana] Harvard Univ, Sch Publ Hlth, Women & Hlth Initiat, Boston, MA 02115 USA; [Horton, Richard] The Lancet, London NW1 7BY, England; [Chalamilla, Guerino] Management & Dev Hlth, Dar Es Salaam, Tanzania	Harvard University; Harvard T.H. Chan School of Public Health	Horton, R (corresponding author), The Lancet, London NW1 7BY, England.	richard.horton@lancet.com						Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8	1	29	31	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 23	2013	381	9867					601	602		10.1016/S0140-6736(13)60259-7	http://dx.doi.org/10.1016/S0140-6736(13)60259-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	093JY	23439088				2022-12-28	WOS:000315189300004
J	Fields, E; Chard, J; James, D; Treasure, T				Fields, Ella; Chard, Jiri; James, David; Treasure, Tom		Guideline Dev Grp	GUIDELINES Fertility (update): summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Fields, Ella; Chard, Jiri; James, David] Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England; [Treasure, Tom] UCL, London WC1H 0BT, England	University of London; University College London	Chard, J (corresponding author), Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England.	jchard@ncc-wch.org.uk	iheozor-ejiofor, zipporah/N-3012-2013	iheozor-ejiofor, zipporah/0000-0003-2597-3266				Brkovich AM, 1998, J PSYCHOSOM OBST GYN, V19, P218, DOI 10.3109/01674829809025700; Human Fertilisation and Embryology Authority, 2012, COD PRACT; Human Fertilisation and Embryology Authority, 2011, FERT TREATM 2010 TRE; Human Fertilisation and Embryology Authority, 2008, LONG TERM AN HFEA RE; Human Fertilisation and Embryology Authority, 2006, FACTS FIG; National Institute for Health and Clinical Excellence, 2013, NAT I HLTH CLIN EXC, V156; National Institute for Health and Clinical Excellence, 2004, NAT I HLTH CLIN EXC, V11	7	22	22	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 20	2013	346								f650	10.1136/bmj.f650	http://dx.doi.org/10.1136/bmj.f650			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096HL	23427132				2022-12-28	WOS:000315394700010
J	Yildirim, E; Kirby, JE; Brown, DE; Mercier, FE; Sadreyev, RI; Scadden, DT; Lee, JT				Yildirim, Eda; Kirby, James E.; Brown, Diane E.; Mercier, Francois E.; Sadreyev, Ruslan I.; Scadden, David T.; Lee, Jeannie T.			Xist RNA Is a Potent Suppressor of Hematologic Cancer in Mice	CELL			English	Article							X-CHROMOSOME INACTIVATION; HEMATOPOIETIC STEM; DOSAGE COMPENSATION; MYELOID-LEUKEMIA; C-KIT; CELLS; GENE; MAINTENANCE; EXPRESSION; LOCALIZATION	X chromosome aneuploidies have long been associated with human cancers, but causality has not been established. In mammals, X chromosome inactivation (XCI) is triggered by Xist RNA to equalize gene expression between the sexes. Here we delete Xist in the blood compartment of mice and demonstrate that mutant females develop a highly aggressive myeloproliferative neoplasm and myelodysplastic syndrome (mixed MPN/MDS) with 100% penetrance. Significant disease components include primary myelofibrosis, leukemia, histiocytic sarcoma, and vasculitis. Xist-deficient hematopoietic stem cells (HSCs) show aberrant maturation and age-dependent loss. Reconstitution experiments indicate that MPN/MDS and myelofibrosis are of hematopoietic rather than stromal origin. We propose that Xist loss results in X reactivation and consequent genome-wide changes that lead to cancer, thereby causally linking the X chromosome to cancer in mice. Thus, Xist RNA not only is required to maintain XCI but also suppresses cancer in vivo.	[Yildirim, Eda; Sadreyev, Ruslan I.; Lee, Jeannie T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02114 USA; [Yildirim, Eda; Sadreyev, Ruslan I.; Lee, Jeannie T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol, Boston, MA 02114 USA; [Brown, Diane E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Comparat Med, Boston, MA 02114 USA; [Mercier, Francois E.; Scadden, David T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA; [Brown, Diane E.; Sadreyev, Ruslan I.; Lee, Jeannie T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pathol, Boston, MA 02114 USA; [Yildirim, Eda; Sadreyev, Ruslan I.; Lee, Jeannie T.] Harvard Univ, Dept Genet, Sch Med, Boston, MA 02114 USA; [Kirby, James E.] Harvard Univ, Dept Pathol, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02114 USA; [Mercier, Francois E.; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Mercier, Francois E.; Scadden, David T.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard University	Lee, JT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu	Kirby, James/K-4438-2019	Yildirim, Eda/0000-0002-4796-3854	MGH ECOR Medical Discovery Fund; Clinician-Scientist Training Award from the Canadian Institutes of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044851] Funding Source: NIH RePORTER	MGH ECOR Medical Discovery Fund; Clinician-Scientist Training Award from the Canadian Institutes of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to members of the Lee lab for stimulating discussions. We thank R. Jaenisch for Xist<SUP>2lox</SUP>/Xist<SUP>2lox</SUP> mice, G. Pihan and A. Sohani for hematopathology advice, H. Hock for advice on Vav-Cre mice, W. Press for maintenance of Xist<SUP>2lox</SUP>/Xist<SUP>2lox</SUP> mice colony, the MGH CCM-Clinical Pathology laboratory for assistance on hematological analysis, D. Dombkowski for FACS assistance, and A.J. Zall for survival bleed collections. This work was supported by the MGH ECOR Medical Discovery Fund (E.Y.), Clinician-Scientist Training Award from the Canadian Institutes of Health Research (F.E.M.),	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Anguera MC, 2012, CELL STEM CELL, V11, P75, DOI 10.1016/j.stem.2012.03.008; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Bennett JM, 2009, HAEMATOL-HEMATOL J, V94, P264, DOI 10.3324/haematol.13755; Brecqueville M, 2012, GENE CHROMOSOME CANC, V51, P743, DOI 10.1002/gcc.21960; BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; DEWALD GW, 1989, CANCER GENET CYTOGEN, V42, P173, DOI 10.1016/0165-4608(89)90085-X; DIERLAMM J, 1995, BRIT J HAEMATOL, V91, P885, DOI 10.1111/j.1365-2141.1995.tb05405.x; DOLL D C, 1987, Hematologic Pathology, V1, P183; Feldman AL, 2004, LANCET ONCOL, V5, P248, DOI 10.1016/S1470-2045(04)01428-7; Fentiman IS, 2006, LANCET, V367, P595, DOI 10.1016/S0140-6736(06)68226-3; HARRISON DE, 1980, BLOOD, V55, P77; Heinonen K, 1999, MED PEDIATR ONCOL, V32, P360, DOI 10.1002/(SICI)1096-911X(199905)32:5<360::AID-MPO9>3.0.CO;2-7; Higgins ME, 2007, NUCLEIC ACIDS RES, V35, pD721, DOI 10.1093/nar/gkl811; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang S, 1998, EMBO J, V17, P4358, DOI 10.1093/emboj/17.15.4358; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Kalantry S, 2009, NATURE, V460, P647, DOI 10.1038/nature08161; Kawakami T, 2003, J UROLOGY, V169, P1546, DOI 10.1097/01.ju.0000044927.23323.5a; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; LAURENCET FM, 1994, LEUKEMIA, V8, P502; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Lee JT, 2011, NAT REV MOL CELL BIO, V12, P815, DOI 10.1038/nrm3231; Li L, 2011, BLOOD, V118, P4935, DOI 10.1182/blood-2011-01-328096; Liao DZJ, 2003, CANCER INVEST, V21, P641, DOI 10.1081/CNV-120022385; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Mazumdar M, 2011, NUCLEUS-AUSTIN, V2, P591, DOI 10.4161/nucl.2.6.18044; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; MOORE K L, 1955, Br J Cancer, V9, P246, DOI 10.1038/bjc.1955.21; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; Muramatsu H, 2012, SEMIN ONCOL, V39, P67, DOI 10.1053/j.seminoncol.2011.11.004; Namekawa SH, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.195; Namekawa SH, 2010, MOL CELL BIOL, V30, P3187, DOI 10.1128/MCB.00227-10; OKADA S, 1992, BLOOD, V80, P3044; Pageau GJ, 2007, NAT REV CANCER, V7, P628, DOI 10.1038/nrc2172; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Paulsson K, 2010, HUM MOL GENET, V19, P1507, DOI 10.1093/hmg/ddq024; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Pellagatti A, 2010, LEUKEMIA, V24, P756, DOI 10.1038/leu.2010.31; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Percy D.H., 2007, MOUSE; RACK KA, 1994, HUM MOL GENET, V3, P1053, DOI 10.1093/hmg/3.7.1053; SANDBERG AA, 1983, CYTOGENETICS MAMMA B, P459; Savarese F, 2006, MOL CELL BIOL, V26, P7167, DOI 10.1128/MCB.00810-06; Schmitt A, 2001, EXP HEMATOL, V29, P1295, DOI 10.1016/S0301-472X(01)00733-0; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Suttie AW, 2006, TOXICOL PATHOL, V34, P466, DOI 10.1080/01926230600867750; Tefferi A, 2011, AM J HEMATOL, V86, P1018, DOI 10.1002/ajh.22210; Vainchenker W, 2011, BLOOD, V118, P1723, DOI 10.1182/blood-2011-02-292102; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Yamamoto K, 2002, CANCER GENET CYTOGEN, V134, P84, DOI 10.1016/S0165-4608(01)00603-3; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zheng Rena, 2010, Genes Cancer, V1, P1178, DOI 10.1177/1947601911404223	63	351	364	2	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 14	2013	152	4					727	742		10.1016/j.cell.2013.01.034	http://dx.doi.org/10.1016/j.cell.2013.01.034			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415223	Green Accepted, Bronze			2022-12-28	WOS:000314945600009
J	Halligan, S; Wooldrage, K; Dadswell, E; Kralj-Hans, I; von Wagner, C; Edwards, R; Yao, GQ; Kay, C; Burling, D; Faiz, O; Teare, J; Lilford, RJ; Morton, D; Wardle, J; Atkin, W				Halligan, Steve; Wooldrage, Kate; Dadswell, Edward; Kralj-Hans, Ines; von Wagner, Christian; Edwards, Rob; Yao, Guiqing; Kay, Clive; Burling, David; Faiz, Omar; Teare, Julian; Lilford, Richard J.; Morton, Dion; Wardle, Jane; Atkin, Wendy		SIGGAR Investigators	Computed tomographic colonography versus barium enema for diagnosis of colorectal cancer or large polyps in symptomatic patients (SIGGAR): a multicentre randomised trial	LANCET			English	Article							CT COLONOGRAPHY; VIRTUAL COLONOSCOPY; ACCEPTABILITY; METAANALYSIS; SENSITIVITY; PERFORMANCE	Background Barium enema (BE) is widely available for diagnosis of colorectal cancer despite concerns about its accuracy and acceptability. Computed tomographic colonography (CTC) might be a more sensitive and acceptable alternative. We aimed to compare CTC and BE for diagnosis of colorectal cancer or large polyps in symptomatic patients in clinical practice. Methods This pragmatic multicentre randomised trial recruited patients with symptoms suggestive of colorectal cancer from 21 UK hospitals. Eligible patients were aged 55 years or older and regarded by their referring clinician as suitable for radiological investigation of the colon. Patients were randomly assigned (2: 1) to BE or CTC by computer-generated random numbers, in blocks of six, stratified by trial centre and sex. We analysed the primary outcome-diagnosis of colorectal cancer or large (>= 10 mm) polyps-by intention to treat. The trial is an International Standard Randomised Controlled Trial, number 95152621. Findings 3838 patients were randomly assigned to receive either BE (n=2553) or CTC (n=1285). 34 patients withdrew consent, leaving for analysis 2527 assigned to BE and 1277 assigned to CTC. The detection rate of colorectal cancer or large polyps was significantly higher in patients assigned to CTC than in those assigned to BE (93 [7.3%] of 1277 vs 141 [5.6%] of 2527, relative risk 1.31, 95% CI 1.01-1.68; p=0.0390). CTC missed three of 45 colorectal cancers and BE missed 12 of 85. The rate of additional colonic investigation was higher after CTC than after BE (283 [23.5%] of 1206 CTC patients had additional investigation vs 422 [18.3%] of 2300 BE patients; p=0.0003), due mainly to a higher polyp detection rate. Serious adverse events were rare. Interpretation CTC is a more sensitive test than BE. Our results suggest that CTC should be the preferred radiological test for patients with symptoms suggestive of colorectal cancer.	[Halligan, Steve; von Wagner, Christian; Wardle, Jane] UCL, London NW1 2BU, England; [Wooldrage, Kate; Dadswell, Edward; Kralj-Hans, Ines; Atkin, Wendy] Univ London Imperial Coll Sci Technol & Med, London, England; [Edwards, Rob] Univ London, London, England; [Yao, Guiqing; Lilford, Richard J.; Morton, Dion] Univ Birmingham, Birmingham, W Midlands, England; [Kay, Clive] Bradford Teaching Hosp NHS Fdn Trust, Bradford, W Yorkshire, England; [Burling, David; Faiz, Omar] St Marks Hosp, Harrow, Middx, England; [Teare, Julian] Imperial Coll Healthcare NHS Trust, London, England	University of London; University College London; Imperial College London; University of London; University of Birmingham; Imperial College London; Imperial College London	Halligan, S (corresponding author), UCL, Ctr Med Imaging, Podium Level 2,235 Euston Rd, London NW1 2BU, England.	s.halligan@ucl.ac.uk	Halligan, Steve/C-5875-2009	Halligan, Steve/0000-0003-0632-5108; Taylor, Stuart/0000-0002-6765-8806; teare, Julian/0000-0003-3551-9139; Atkin, Wendy/0000-0001-9073-9658; Wooldrage, Kate/0000-0001-8209-3113; Kralj-Hans, Ines/0000-0001-7401-6281; Von Wagner, Christian/0000-0002-7971-0691; Lilford, Richard/0000-0002-0634-984X; Buchanan, Gordon/0000-0003-3797-2121; Travis, Simon/0000-0002-2690-4361	NIHR Health Technology Assessment (HTA) Programme [02/02/01]; NIHR Biomedical Research Centres funding scheme; Cancer Research UK Population Research Committee Programme Grant [C8171/A10391]; NIHR HTA Programme; EPSRC Multidisciplinary Assessment of Technology Centre for Healthcare (MATCH); NIHR Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country; NIHR Health Technology Assessment Programme; Cancer Research UK; EPSRC Multidisciplinary Assessment of Technology Centre for Healthcare; NIHR Collaborations for Leadership in Applied Health Research and Care; Cancer Research UK [14134] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/F063822/1] Funding Source: researchfish; Medical Research Council [G0800808] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10008, 02/02/01] Funding Source: researchfish; EPSRC [EP/F063822/1] Funding Source: UKRI; MRC [G0800808] Funding Source: UKRI	NIHR Health Technology Assessment (HTA) Programme; NIHR Biomedical Research Centres funding scheme; Cancer Research UK Population Research Committee Programme Grant; NIHR HTA Programme; EPSRC Multidisciplinary Assessment of Technology Centre for Healthcare (MATCH)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NIHR Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country; NIHR Health Technology Assessment Programme(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); EPSRC Multidisciplinary Assessment of Technology Centre for Healthcare(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NIHR Collaborations for Leadership in Applied Health Research and Care; Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the radiologists and endoscopists who completed the case report forms, the research nurses who were responsible for data collection, and the trial participants and referring clinicians for their support of the study. We also thank Willie Hamilton (Professor of Primary Care Diagnostics, University of Exeter), Brian Saunders (Consultant Gastroenterologist, The North West London Hospitals NHS Trust), and Roland Valori (Consultant Gastroenterologist, Gloucestershire Hospitals NHS Foundation Trust) for many helpful discussions and advice. This research was undertaken jointly by Imperial College London and University College London. It was funded mainly by the NIHR Health Technology Assessment (HTA) Programme (project number 02/02/01), and will be published in full in Health Technology Assessment. Researchers at University College received a proportion of funding from the NIHR Biomedical Research Centres funding scheme, and additional funding for researchers at Imperial College was provided by a Cancer Research UK Population Research Committee Programme Grant (number C8171/A10391). The economic analysis was funded by the NIHR HTA Programme, the EPSRC Multidisciplinary Assessment of Technology Centre for Healthcare (MATCH), and the NIHR Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of Cancer Research UK, MATCH, EPSRC, the HTA Programme, NIHR, NHS, or the Department of Health. Medicsight, Viatronix, Bracco UK, and Barco provided equipment.; NIHR Health Technology Assessment Programme, NIHR Biomedical Research Centres funding scheme, Cancer Research UK, EPSRC Multidisciplinary Assessment of Technology Centre for Healthcare, and NIHR Collaborations for Leadership in Applied Health Research and Care.	[Anonymous], 2009, ACR RPACT GUID PERF; Atkin W, 2013, LANCET; Barish MA, 2005, AM J ROENTGENOL, V184, P786, DOI 10.2214/ajr.184.3.01840786; Bosworth HB, 2006, AM J MED, V119, P791, DOI 10.1016/j.amjmed.2006.02.013; Burling D, 2010, CLIN RADIOL, V65, P474, DOI 10.1016/j.crad.2009.12.003; Cotton PB, 2004, JAMA-J AM MED ASSOC, V291, P1713, DOI 10.1001/jama.291.14.1713; Department of Health, DIAGN WAIT TIM ACT I; Doshi T, 2007, RADIOLOGY, V244, P165, DOI 10.1148/radiol.2441061122; Ferrucci J, 2005, LANCET, V365, P1464, DOI 10.1016/S0140-6736(05)66413-6; Fisichella VA, 2010, ACTA RADIOL, V51, P4, DOI 10.3109/02841850903292735; Fletcher JG, 2010, AM J ROENTGENOL, V195, P117, DOI 10.2214/AJR.09.3659; Gluecker TM, 2003, RADIOLOGY, V227, P378, DOI 10.1148/radiol.2272020293; Halligan S, 2005, RADIOLOGY, V237, P893, DOI 10.1148/radiol.2373050176; Halligan S, HLTH TECHNO IN PRESS; Halligan S, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-32; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Lee KJ, 2005, BRIT MED J, V330, P142, DOI 10.1136/bmj.330.7483.142; Medicines and Healthcare products Regulatory Agency, 2011, DEV B REP ADV INC DI; Moll FL, 2011, EUR J VASC ENDOVASC, V41, pS1, DOI 10.1016/j.ejvs.2010.09.011; Mulhall BP, 2005, ANN INTERN MED, V142, P635, DOI 10.7326/0003-4819-142-8-200504190-00013; National Institute for Health and Clinical Excellence, 2011, DIAGN MAN COL CANC F; NHS Quality Improvement Scotland, 2007, COMP TOM CT COL HTA; Office for National Statistics, 2011, INF PAP SUMM QUAL RE; Office for National Statistics, 2012, INF PAP SUMM QUAL RE; Office for National Statistics, 2009, CANC STAT REG EN MB1, VMB1; Pickhardt PJ, 2011, RADIOLOGY, V259, P393, DOI 10.1148/radiol.11101887; Pickhardt PJ, 2004, JAMA-J AM MED ASSOC, V292, P431, DOI 10.1001/jama.292.4.431-a; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Rex DK, 1997, GASTROENTEROLOGY, V112, P17, DOI 10.1016/S0016-5085(97)70213-0; Rockey DC, 2005, LANCET, V365, P305; Shariff MK, 2011, FRONTLINE GASTROENTE, V2, P105, DOI 10.1136/fg.2010.003616; Stoop EM, 2012, LANCET ONCOL, V13, P55, DOI 10.1016/S1470-2045(11)70283-2; Tawn DJ, 2005, CLIN RADIOL, V60, P558, DOI 10.1016/j.crad.2004.09.014; Taylor SA, 2005, CLIN RADIOL, V60, P207, DOI 10.1016/j.crad.2004.07.006; Toma J, 2008, AM J GASTROENTEROL, V103, P3142, DOI 10.1111/j.1572-0241.2008.02199.x; Von Wagner C, 2009, BRIT J RADIOL, V82, P13, DOI 10.1259/bjr/61732956; von Wagner C, 2012, RADIOLOGY, V263, P723, DOI 10.1148/radiol.12111523; von Wagner C, 2011, EUR RADIOL, V21, P2046, DOI 10.1007/s00330-011-2154-y	38	105	109	0	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 6	2013	381	9873					1185	1193		10.1016/S0140-6736(12)62124-2	http://dx.doi.org/10.1016/S0140-6736(12)62124-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122WU	23414648				2022-12-28	WOS:000317350100028
J	Ferner, R				Ferner, Robin			Divination	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Birmingham City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England		Ferner, R (corresponding author), Birmingham City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England.	R.E.Ferner@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346				Australian Government Therapeutic Goods Administration, 2013, LAB PACK PRACT SUMM; Flynn EA, 2006, TROUBLING AMINE; Garrett D, TALL MAN LETT; Kondrak G, 2006, ARTIF INTELL MED, V36, P29, DOI 10.1016/j.artmed.2005.07.005; MACINTYRE IM, 1972, LANCET, V1, P1094; Nelson RL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003431.pub3; Smith VM, 2012, BRIT J DERMATOL, V167, P1048, DOI 10.1111/j.1365-2133.2012.11185.x; Timur, LEVENSHTEIN DISTANCE; US Food and Drug Administration, FDA DRUG SAF COMM ME; US Food and Drug Administration, MED ERR NAM DIFF PRO	10	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2013	346								f1536	10.1136/bmj.f1536	http://dx.doi.org/10.1136/bmj.f1536			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104MT	23471365				2022-12-28	WOS:000315998500004
J	Vernos, I				Vernos, Isabelle			Quotas are questionable	NATURE			English	Editorial Material									[Vernos, Isabelle] Ctr Genom Regulat, ERC GBWG, Barcelona 08003, Spain; [Vernos, Isabelle] Ctr Genom Regulat, ICREA, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Vernos, I (corresponding author), Ctr Genom Regulat, ERC GBWG, Barcelona 08003, Spain.	isabelle.vernos@crg.eu	Vernos, Isabelle/C-1687-2015	Vernos, Isabelle/0000-0003-1469-9214	ICREA Funding Source: Custom	ICREA(ICREA)		European Commission, 2009, SHE FIG 2009 STAT IN; Langfeldt L., 2006, 262006 NIFU STEP; Ledin A, 2007, EMBO REP, V8, P982, DOI 10.1038/sj.embor.7401109; Martinez ED, 2007, EMBO REP, V8, P977, DOI 10.1038/sj.embor.7401110; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109	5	27	28	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2013	495	7439					39	39		10.1038/495039a	http://dx.doi.org/10.1038/495039a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	105BE	23467154	Bronze			2022-12-28	WOS:000316039800019
J	Schonenberger, C				Schoenenberger, Christian			Two Indistinguishable Electrons Interfere in an Electronic Device	SCIENCE			English	Editorial Material							HANBURY-BROWN; QUANTUM; PHOTONS		Univ Basel, Dept Phys, CH-4052 Basel, Switzerland	University of Basel	Schonenberger, C (corresponding author), Univ Basel, Dept Phys, Klingelberg Str 82, CH-4052 Basel, Switzerland.	christian.schoenenberger@unibas.ch	Schönenberger, Christian/N-3187-2017	Schönenberger, Christian/0000-0002-5652-460X				Alicea J, 2011, NAT PHYS, V7, P412, DOI 10.1038/NPHYS1915; ASPECT A, 1982, PHYS REV LETT, V49, P91, DOI 10.1103/PhysRevLett.49.91; Beenakker C, 2003, PHYS TODAY, V56, P37, DOI 10.1063/1.1583532; Bocquillon E, 2013, SCIENCE, V339, P1054, DOI 10.1126/science.1232572; BUTTIKER M, 1988, PHYS REV B, V38, P9375, DOI 10.1103/PhysRevB.38.9375; Feve G, 2007, SCIENCE, V316, P1169, DOI 10.1126/science.1141243; Henny M, 1999, SCIENCE, V284, P296, DOI 10.1126/science.284.5412.296; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Liu RC, 1998, NATURE, V391, P263, DOI 10.1038/34611; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; Neder I, 2007, NATURE, V448, P333, DOI 10.1038/nature05955; Oliver WD, 1999, SCIENCE, V284, P299, DOI 10.1126/science.284.5412.299; TWISS RQ, 1957, NATURE, V180, P324, DOI 10.1038/180324a0; vanHouten H, 1996, PHYS TODAY, V49, P22, DOI 10.1063/1.881503; VANWEES BJ, 1988, PHYS REV LETT, V60, P848, DOI 10.1103/PhysRevLett.60.848	15	2	3	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1041	1042		10.1126/science.1234199	http://dx.doi.org/10.1126/science.1234199			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23449584				2022-12-28	WOS:000315452000028
J	Mo, W; Chen, J; Patel, A; Zhang, L; Chau, V; Li, YJ; Cho, W; Lim, K; Xu, J; Lazar, AJ; Creighton, CJ; Bolshakov, S; McKay, RM; Lev, D; Le, LQ; Parada, LF				Mo, Wei; Chen, Jian; Patel, Amish; Zhang, Liang; Chau, Vincent; Li, Yanjiao; Cho, Woosung; Lim, Kyun; Xu, Jing; Lazar, Alexander J.; Creighton, Chad J.; Bolshakov, Svetlana; McKay, Renee M.; Lev, Dina; Le, Lu Q.; Parada, Luis F.			CXCR4/CXCL12 Mediate Autocrine Cell- Cycle Progression in NF1-Associated Malignant Peripheral Nerve Sheath Tumors	CELL			English	Article							CHEMOKINE RECEPTOR CXCR4; NEUROFIBROMATOSIS TYPE-1; SCHWANN-CELLS; THERAPEUTIC APPROACH; PANCREATIC-CANCER; MAMMALIAN TARGET; EXPRESSION; PROLIFERATION; METASTASIS; SURVIVAL	Malignant peripheral nerve sheath tumors (MPNSTs) are soft tissue sarcomas that arise in connective tissue surrounding peripheral nerves. They occur sporadically in a subset of patients with neurofibromatosis type 1 (NF1). MPNSTs are highly aggressive, therapeutically resistant, and typically fatal. Using comparative transcriptome analysis, we identified CXCR4, a G-protein-coupled receptor, as highly expressed in mouse models of NF1-deficient MPNSTs, but not in nontransformed precursor cells. The chemokine receptor CXCR4 and its ligand, CXCL12, promote MPNST growth by stimulating cyclin D1 expression and cell-cycle progression through PI3-kinase (PI3K) and beta-catenin signaling. Suppression of CXCR4 activity either by shRNA or pharmacological inhibition decreases MPNST cell growth in culture and inhibits tumorigenesis in allografts and in spontaneous genetic mouse models of MPNST. We further demonstrate conservation of these activated molecular pathways in human MPNSTs. Our findings indicate a role for CXCR4 in NF1-associated MPNST development and identify a therapeutic target.	[Mo, Wei; Chen, Jian; Chau, Vincent; Li, Yanjiao; Cho, Woosung; Lim, Kyun; Xu, Jing; McKay, Renee M.; Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Patel, Amish; Chau, Vincent; Le, Lu Q.] Univ Texas SW Med Ctr Dallas, Dept Dermatol, Dallas, TX 75390 USA; [Zhang, Liang] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Lazar, Alexander J.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77054 USA; [Bolshakov, Svetlana; Lev, Dina] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77054 USA; [Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Le, LQ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dermatol, Dallas, TX 75390 USA.	lu.le@utsouthwestern.edu; luis.parada@utsouthwestern.edu	Parada, luis F/B-9400-2014; Lazar, Alexander J/A-3416-2008	Lazar, Alexander J/0000-0002-6395-4499; Le, Lu/0000-0003-2817-5382; Patel, Amish/0000-0002-4214-2619	National Cancer Institute [R01 CA166593]; Department of Defense [W81XWH-12-1-0161, W81XWH-11-1-0184]; National Institutes of Health [P50NS052606]; Career Award for Medical Scientists from the Burroughs Wellcome Fund; NATIONAL CANCER INSTITUTE [R01CA166593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS052606] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Award for Medical Scientists from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Karen Cichowski for the generous gift of the human MPNST cell lines. This work was partially supported by funding from the National Cancer Institute (grant R01 CA166593 to L. Q. L.), Department of Defense (grant W81XWH-12-1-0161 to L. Q. L. and Postdoctoral Fellowship Award grant W81XWH-11-1-0184 to W. M.), and the National Institutes of Health (grant P50NS052606 to L. F. P.). L. Q. L. is a Disease-Oriented Clinical Scholar and holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. L. F. P. is an American Cancer Society Research Professor.	Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Bertolini F, 2002, CANCER RES, V62, P3106; Bian XW, 2007, NEUROSURGERY, V61, P570, DOI 10.1227/01.NEU.0000290905.53685.A2; Burger JA, 1999, BLOOD, V94, P3658, DOI 10.1182/blood.V94.11.3658.423k11_3658_3667; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; Ferner RE, 2007, EUR J HUM GENET, V15, P131, DOI 10.1038/sj.ejhg.5201676; Ghadimi MP, 2012, CLIN CANCER RES, V18, P2545, DOI 10.1158/1078-0432.CCR-11-2592; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Johannessen CM, 2008, CURR BIOL, V18, P56, DOI 10.1016/j.cub.2007.11.066; Johansson G, 2008, MOL CANCER THER, V7, P1237, DOI 10.1158/1535-7163.MCT-07-2335; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Joseph NM, 2008, CANCER CELL, V13, P129, DOI 10.1016/j.ccr.2008.01.003; Kijima T, 2002, CANCER RES, V62, P6304; Koshiba T, 2000, CLIN CANCER RES, V6, P3530; Laverdiere C, 2005, CLIN CANCER RES, V11, P2561, DOI 10.1158/1078-0432.CCR-04-1089; Le LQ, 2007, ONCOGENE, V26, P4609, DOI 10.1038/sj.onc.1210261; Le LQ, 2011, CANCER RES, V71, P4686, DOI 10.1158/0008-5472.CAN-10-4577; Le LQ, 2009, CELL STEM CELL, V4, P453, DOI 10.1016/j.stem.2009.03.017; Lee MH, 2003, CANCER METAST REV, V22, P435, DOI 10.1023/A:1023785332315; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Mantripragada KK, 2008, CLIN CANCER RES, V14, P1015, DOI 10.1158/1078-0432.CCR-07-1305; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1; Oh JW, 2001, J IMMUNOL, V166, P2695, DOI 10.4049/jimmunol.166.4.2695; Peled A, 2012, EXPERT OPIN INV DRUG, V21, P341, DOI 10.1517/13543784.2012.656197; Righi E, 2011, CANCER RES, V71, P5522, DOI 10.1158/0008-5472.CAN-10-3143; Rubin JB, 2005, NAT REV CANCER, V5, P557, DOI 10.1038/nrc1653; Schrader AJ, 2002, BRIT J CANCER, V86, P1250, DOI 10.1038/sj.bjc.6600221; Sehgal A, 1998, J SURG ONCOL, V69, P99, DOI 10.1002/(SICI)1096-9098(199810)69:2<99::AID-JSO10>3.0.CO;2-M; Sengupta R, 2012, CANCER RES, V72, P122, DOI 10.1158/0008-5472.CAN-11-1701; Serra E, 2000, HUM MOL GENET, V9, P3055, DOI 10.1093/hmg/9.20.3055; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Srivastava AK, 1998, MOL CELL BIOCHEM, V182, P135, DOI 10.1023/A:1006857527588; Taichman RS, 2002, CANCER RES, V62, P1832; Vogel KS, 1999, SCIENCE, V286, P2176, DOI 10.1126/science.286.5447.2176; Wang Y, 2012, CELL, V150, P816, DOI 10.1016/j.cell.2012.06.034; Wang Z, 2008, BRIT J CANCER, V99, P1695, DOI 10.1038/sj.bjc.6604745; Warrington NM, 2007, CANCER RES, V67, P8588, DOI 10.1158/0008-5472.CAN-06-2220; Zeelenberg IS, 2003, CANCER RES, V63, P3833; Zheng H, 2008, CANCER CELL, V13, P117, DOI 10.1016/j.ccr.2008.01.002; Zhou Y, 2002, J BIOL CHEM, V277, P49481, DOI 10.1074/jbc.M206222200; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452; Zhu Y, 2001, EXP CELL RES, V264, P19, DOI 10.1006/excr.2000.5138; Zou CYY, 2009, MOL CANCER THER, V8, P1157, DOI 10.1158/1535-7163.MCT-08-1008	48	114	120	0	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 28	2013	152	5					1077	1090		10.1016/j.cell.2013.01.053	http://dx.doi.org/10.1016/j.cell.2013.01.053			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	100OK	23434321	Bronze, Green Accepted			2022-12-28	WOS:000315710300015
J	Wright, T				Wright, Thomas			William Harvey goes back to the future	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Wright, T (corresponding author), The Lancet, London NW1 7BY, England.	teeheew@yahoo.co.uk							0	1	1	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 23	2013	381	9867					620	621		10.1016/S0140-6736(13)60335-9	http://dx.doi.org/10.1016/S0140-6736(13)60335-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	093JY	23444490				2022-12-28	WOS:000315189300014
J	Chiyaka, C; Tatem, AJ; Cohen, JM; Gething, PW; Johnston, G; Gosling, R; Laxminarayan, R; Hay, SI; Smith, DL				Chiyaka, C.; Tatem, A. J.; Cohen, J. M.; Gething, P. W.; Johnston, G.; Gosling, R.; Laxminarayan, R.; Hay, S. I.; Smith, D. L.			The Stability of Malaria Elimination	SCIENCE			English	Editorial Material							FEASIBILITY; POPULATION; STRATEGIES		[Chiyaka, C.; Tatem, A. J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA; [Tatem, A. J.] Univ Southampton, Dept Geog & Environm, Southampton SO17 1BJ, Hants, England; [Tatem, A. J.; Hay, S. I.; Smith, D. L.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Cohen, J. M.] Clinton Hlth Access Initiat, Boston, MA 02127 USA; [Gething, P. W.; Hay, S. I.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England; [Johnston, G.; Smith, D. L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Johnston, G.; Smith, D. L.] Johns Hopkins Bloomberg Sch Publ Hlth, Malaria Res Inst, Baltimore, MD 21205 USA; [Gosling, R.] Univ Calif San Francisco, Malaria Eliminat Initiat, Global Hlth Grp, San Francisco, CA 94105 USA; [Hay, S. I.; Smith, D. L.] Ctr Dis Dynam Econ & Policy, Washington, DC 20036 USA	State University System of Florida; University of Florida; University of Southampton; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of Oxford; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California San Francisco	Smith, DL (corresponding author), NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.	dlsmith@jhsph.edu	Gething, Peter/ABD-2110-2020; Smith, David L/L-8850-2013; Laxminarayan, Ramanan/ABD-5050-2021; Hay, Simon Iain/F-8967-2015; Gething, Peter/GQR-1884-2022	Smith, David L/0000-0003-4367-3849; Hay, Simon Iain/0000-0002-0611-7272; Gething, Peter/0000-0001-6759-5449; Chi-Johnston, Geoffrey/0000-0002-0397-3508; Cohen, Justin/0000-0003-4481-6784; Tatem, Andrew/0000-0002-7270-941X	Medical Research Council [MR/K00669X/1] Funding Source: Medline; NIAID NIH HHS [U19AI089674] Funding Source: Medline; Wellcome Trust [095066] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089674] Funding Source: NIH RePORTER; MRC [MR/K00669X/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Breman JG, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000405; Bretscher MT, 2011, EPIDEMICS-NETH, V3, P109, DOI 10.1016/j.epidem.2011.03.002; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-213; Feachem R, 2008, LANCET, V371, P1633, DOI 10.1016/S0140-6736(08)60424-9; Feachem RGA, 2010, LANCET, V376, P1517, DOI 10.1016/S0140-6736(10)61500-0; Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241; GRAMICCIA G, 1988, PRINCIPLES PRACTICE, V2, P1335; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; MacDONALD G., 1956, BULL WORLD HEALTH ORGAN, V15, P613; MacDONALD G., 1956, BULL WORLD HEALTH ORGAN, V15, P369; Moonen B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-322; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; Najera JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000412; Pigott DM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-246; Roll Back Malaria Partnership, 2008, GLOB MAL ACT PLAN MA; Sabot O, 2010, LANCET, V376, P1604, DOI 10.1016/S0140-6736(10)61355-4; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Smith DL, 2011, SCIENCE, V332, P1384, DOI 10.1126/science.1201398; Tatem AJ, 2010, P NATL ACAD SCI USA, V107, P12222, DOI 10.1073/pnas.1002971107; *UCSF GLOB HLTH GR, 2012, ATL MAL EL COUNTR; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; *WHO, 1957, 6 WHO EXP COMM MAL; Yekutiel P, 1980, ERADICATION INFECT D, P34; Zanzibar Malaria Control Program, 2009, MAL EL ZANZ FEAS ASS	25	36	36	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2013	339	6122					909	910		10.1126/science.1229509	http://dx.doi.org/10.1126/science.1229509			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092UX	23430640				2022-12-28	WOS:000315149600032
J	Bindman, AB; Blum, JD; Kronick, R				Bindman, Andrew B.; Blum, Jonathan D.; Kronick, Richard			Medicare's Transitional Care Payment - A Step toward the Medical Home	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bindman, Andrew B.; Kronick, Richard] US Dept HHS, Off Assistant Secretary Planning & Evaluat, Washington, DC 20201 USA; [Blum, Jonathan D.] US Dept HHS, Ctr Medicare & Medicaid Serv, Washington, DC 20201 USA; [Bindman, Andrew B.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Centers for Medicare & Medicaid Services; University of California System; University of California San Francisco	Bindman, AB (corresponding author), US Dept HHS, Off Assistant Secretary Planning & Evaluat, Washington, DC 20201 USA.							[Anonymous], 2012, GAO REPORT THE OBAMA; Centers for Medicare & Medicaid Services (CMS) HHS, 2012, Fed Regist, V77, P68891; Grumbach K, 2010, OUTCOMES OF IMPLEMEN; Hesselink G, 2012, ANN INTERN MED, V157, P417, DOI 10.7326/0003-4819-157-6-201209180-00006; The Commonwealth Fund Commission on a High Performance Health System, 2009, THE PATH TO A HIGH P	5	34	36	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2013	368	8					692	694		10.1056/NEJMp1214122	http://dx.doi.org/10.1056/NEJMp1214122			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	092CG	23425161	Green Published			2022-12-28	WOS:000315095800002
J	Diard, M; Garcia, V; Maier, L; Remus-Emsermann, MNP; Regoes, RR; Ackermann, M; Hardt, WD				Diard, Mederic; Garcia, Victor; Maier, Lisa; Remus-Emsermann, Mitja N. P.; Regoes, Roland R.; Ackermann, Martin; Hardt, Wolf-Dietrich			Stabilization of cooperative virulence by the expression of an avirulent phenotype	NATURE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; III SECRETION SYSTEM; BACTERIAL VIRULENCE; MULTIPLE INFECTION; SOCIAL EVOLUTION; DYNAMICS; PATHOGENICITY; POPULATIONS; MICROBIOTA	Pathogens often infect hosts through collective actions: they secrete growth-promoting compounds or virulence factors, or evoke host reactions that fuel the colonization of the host. Such behaviours are vulnerable to the rise of mutants that benefit from the collective action without contributing to it; how these behaviours can be evolutionarily stable is not well understood(1). We address this question using the intestinal pathogen Salmonella enterica serovar Typhimurium (hereafter termed S. typhimurium), which manipulates its host to induce inflammation, and thereby outcompetes the commensal microbiota(2,3). Notably, the virulence factors needed for host manipulation are expressed in a bistable fashion, leading to a slow-growing subpopulation that expresses virulence genes, and a fast-growing subpopulation that is phenotypically avirulent(4,5). Here we show that the expression of the genetically identical but phenotypically avirulent subpopulation is essential for the evolutionary stability of virulence in this pathogen. Using a combination of mathematical modelling, experimental evolution and competition experiments we found that within-host evolution leads to the emergence of mutants that are genetically avirulent and fast-growing. These mutants are defectors that exploit inflammation without contributing to it. In infection experiments initiated with wild-type S. typhimurium, defectors increase only slowly in frequency. In a genetically modified S. typhimurium strain in which the phenotypically avirulent subpopulation is reduced in size, defectors rise more rapidly, inflammation ceases prematurely, and S. typhimurium is quickly cleared from the gut. Our results establish that host manipulation by S. typhimurium is a cooperative trait that is vulnerable to the rise of avirulent defectors; the expression of a phenotypically avirulent subpopulation that grows as fast as defectors slows down this process, and thereby promotes the evolutionary stability of virulence. This points to a key role of bistable virulence gene expression in stabilizing cooperative virulence and may lead the way to new approaches, for controlling pathogens.	[Diard, Mederic; Maier, Lisa; Remus-Emsermann, Mitja N. P.; Hardt, Wolf-Dietrich] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Garcia, Victor; Regoes, Roland R.] ETH, Inst Integrat Biol, CH-8092 Zurich, Switzerland; [Ackermann, Martin] Swiss Fed Inst Technol, Dept Environm Syst Sci, CH-8600 Dubendorf, Switzerland; [Ackermann, Martin] Dept Environm Microbiol Eawag, CH-8600 Dubendorf, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Regoes, RR (corresponding author), ETH, Inst Integrat Biol, Univ Str 16, CH-8092 Zurich, Switzerland.	roland.regoes@env.ethz.ch; martin.ackermann@env.ethz.ch; wolf-dietrich.hardt@micro.biol.ethz.ch	Diard, Mederic/AAA-3067-2020; Remus-Emsermann, Mitja NP/R-3776-2016; Garcia, Victor/H-4403-2019; Regoes, Roland R/A-6538-2008; Maier, Lisa/ABH-1893-2021; Ackermann, Martin/V-4554-2017	Remus-Emsermann, Mitja NP/0000-0002-6378-9526; Regoes, Roland R/0000-0001-8319-5293; Maier, Lisa/0000-0002-6473-4762; Ackermann, Martin/0000-0003-0087-4819; Hardt, Wolf-Dietrich/0000-0002-9892-6420; Mederic R.J., Diard/0000-0003-0851-4391	Fondation pour la Recherche Medicale; Swiss National Science Foundation	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank E Slack, R. Kummerli, M. Sellin and L. Robert for comments on the manuscript, G. Paul for input on the modelling, and Hardt laboratory members for discussions. M.D. was supported in part by the Fondation pour la Recherche Medicale. M.A., R.R.R. and W.-D.H. were supported by grants from the Swiss National Science Foundation.	Ackermann M, 2008, NATURE, V454, P987, DOI 10.1038/nature07067; Baxter MA, 2003, INFECT IMMUN, V71, P1295, DOI 10.1128/IAI.71.3.1295-1305.2003; Brown SP, 2008, ECOL LETT, V11, P44, DOI 10.1111/j.1461-0248.2007.01125.x; Brown SP, 1999, P ROY SOC B-BIOL SCI, V266, P1899, DOI 10.1098/rspb.1999.0864; Brown SP, 2002, TRENDS MICROBIOL, V10, P401, DOI 10.1016/S0966-842X(02)02413-7; Buckling A, 2008, HEREDITY, V100, P484, DOI 10.1038/sj.hdy.6801093; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Casadevall A, 1999, INFECT IMMUN, V67, P3703, DOI 10.1128/IAI.67.8.3703-3713.1999; Cremer J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00281; Endt K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001097; Golubeva YA, 2012, GENETICS, V190, P79, DOI 10.1534/genetics.111.132779; Harrison F, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-21; Kaiser P, 2012, IMMUNOL REV, V245, P56, DOI 10.1111/j.1600-065X.2011.01070.x; Kohler T, 2009, P NATL ACAD SCI USA, V106, P6339, DOI 10.1073/pnas.0811741106; Lawley TD, 2008, INFECT IMMUN, V76, P403, DOI 10.1128/IAI.01189-07; Lysenko ES, 2010, CURR BIOL, V20, P1222, DOI 10.1016/j.cub.2010.05.051; Raymond B, 2012, SCIENCE, V337, P85, DOI 10.1126/science.1218196; Rumbaugh KP, 2009, CURR BIOL, V19, P341, DOI 10.1016/j.cub.2009.01.050; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Sturm A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002143; Suar M, 2009, INFECT IMMUN, V77, P3569, DOI 10.1128/IAI.00511-09; vanBaalen M, 1995, AM NAT, V146, P881, DOI 10.1086/285830; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461	24	200	200	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					353	356		10.1038/nature11913	http://dx.doi.org/10.1038/nature11913			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23426324				2022-12-28	WOS:000315312900038
J	Hornschemeyer, T; Haug, JT; Bethoux, O; Beutel, RG; Charbonnier, S; Hegna, TA; Koch, M; Rust, J; Wedmann, S; Bradler, S; Willmann, R				Hornschemeyer, Thomas; Haug, Joachim T.; Bethoux, Olivier; Beutel, Rolf G.; Charbonnier, Sylvain; Hegna, Thomas A.; Koch, Markus; Rust, Jes; Wedmann, Sonja; Bradler, Sven; Willmann, Rainer			Is Strudiella a Devonian insect? Arising from R. Garrouste et.al. (vol 488, pg 82, 2012)	NATURE			English	Letter									[Hornschemeyer, Thomas; Bradler, Sven; Willmann, Rainer] Georg August Univ Gottingen, Johann Friedrich Blumenbach Inst Zool Anthrop, D-37073 Gottingen, Germany; [Haug, Joachim T.] Ernst Moritz Arndt Univ Greifswald, Zool Inst & Museum, Dept Cytol & Evolut Biol, D-17487 Greifswald, Germany; [Bethoux, Olivier; Charbonnier, Sylvain] Museum Natl Histoire Nat, UMR 7207, CNRS (CR2P) CP38, F-75231 Paris 05, France; [Beutel, Rolf G.] Friedrich Schiller Univ Jena, Entomol Grp, Inst Spezielle Zool & Evolutionsbiol, D-07743 Jena, Germany; [Hegna, Thomas A.] Western Illinois Univ, Geol Dept, Macomb, IL 61455 USA; [Koch, Markus] Univ Hamburg, Bioctr Grindel & Zool Museum, D-20146 Hamburg, Germany; [Rust, Jes] Univ Bonn, Steinmann Inst, Dept Paleontol, D-53115 Bonn, Germany; [Wedmann, Sonja] Forschungsstation Grube Messel, Senckenberg Forschungsinst & Naturmuseum, D-64409 Messel, Germany	University of Gottingen; Ernst Moritz Arndt Universitat Greifswald; Museum National d'Histoire Naturelle (MNHN); Friedrich Schiller University of Jena; Western Illinois University; University of Hamburg; University of Bonn; Senckenberg Gesellschaft fur Naturforschung (SGN)	Willmann, R (corresponding author), Georg August Univ Gottingen, Johann Friedrich Blumenbach Inst Zool Anthrop, D-37073 Gottingen, Germany.	rwillma1@qwdg.de	Hörnschemeyer, Thomas/AAU-9813-2020; Koch, Markus/P-5074-2017; /ABG-2074-2021; Bradler, Sven/D-8655-2015; Koch, Markus/O-4616-2019; Béthoux, Olivier/C-7308-2009; Hegna, Thomas/X-3568-2019; Charbonnier, Sylvain/AAU-9571-2020	Hörnschemeyer, Thomas/0000-0002-4924-5389; Koch, Markus/0000-0003-3247-2988; Bradler, Sven/0000-0001-9307-1032; Koch, Markus/0000-0003-3247-2988; Hegna, Thomas/0000-0001-9067-8787; Beutel, Rolf Georg/0000-0002-0433-7626; Wedmann, Sonja/0000-0002-9778-4125				HENNIG W, 1981, INSECT PHYLOG; JERAM AJ, 1990, SCIENCE, V250, P658, DOI 10.1126/science.250.4981.658; Kuhl G, 2009, ORG DIVERS EVOL, V9, P215, DOI 10.1016/j.ode.2009.03.002; LABANDEIRA CC, 1988, SCIENCE, V242, P913, DOI 10.1126/science.242.4880.913; Shear WA, 2012, NATURE, V488, P34, DOI 10.1038/488034a; Willmann R, 2005, ORG DIVERS EVOL, V5, P199, DOI 10.1016/j.ode.2004.11.011	6	17	18	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					E3	E4		10.1038/nature11887	http://dx.doi.org/10.1038/nature11887			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23426326				2022-12-28	WOS:000315312900050
J	Assuncao, JNR; Rabelo, GD				Rosa Assuncao, Jose Narciso; Rabelo, Gustavo Davi			Lesions in the Oral Cavity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rosa Assuncao, Jose Narciso; Rabelo, Gustavo Davi] Univ Sao Paulo, Sao Paulo, Brazil	Universidade de Sao Paulo	Assuncao, JNR (corresponding author), Univ Sao Paulo, Sao Paulo, Brazil.		Rabelo, Gustavo Davi/E-4427-2010	Rabelo, Gustavo Davi/0000-0001-9511-5078					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2013	368	8					E10	E10		10.1056/NEJMicm1205661	http://dx.doi.org/10.1056/NEJMicm1205661			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	092CG	23425188				2022-12-28	WOS:000315095800011
J	Simmons, LH; Guimaraes, AR; Zukerberg, LR				Simmons, Leigh H.; Guimaraes, Alexander R.; Zukerberg, Lawrence R.			Case 6-2013: A 54-Year-Old Man with Recurrent Diarrhea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ZOLLINGER-ELLISON-SYNDROME; CELIAC-DISEASE; DIAGNOSIS		[Simmons, Leigh H.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Guimaraes, Alexander R.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Zukerberg, Lawrence R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Simmons, Leigh H.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Guimaraes, Alexander R.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Zukerberg, Lawrence R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Simmons, LH (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Simmons, Leigh/AAQ-3009-2021	Simmons, Leigh/0000-0002-2375-8485	New England Research Institute; Immunogen	New England Research Institute; Immunogen	Dr. Simmons reports receiving consulting fees from New England Research Institute; and Dr. Zukerberg, receiving consulting fees from Immunogen and providing expert testimony for law firms and insurance groups on cases related to leukemia, lymphoma, and gastrointestinal cancers. No other potential conflict of interest relevant to this article was reported.	Amin OM, 2006, RES J PARASITOL, V1, P1, DOI DOI 10.3923/jp.2006.1.10; Berna MJ, 2006, MEDICINE, V85, P295, DOI 10.1097/01.md.0000236956.74128.76; Brandi ML, 2001, J CLIN ENDOCR METAB, V86, P5658, DOI 10.1210/jc.86.12.5658; Ciociola AA, 1999, AM J GASTROENTEROL, V94, P1834, DOI 10.1111/j.1572-0241.1999.01214.x; DEVENEY CW, 1977, ANN INTERN MED, V87, P680, DOI 10.7326/0003-4819-87-6-680; FARRELL RJ, 2010, SLEISENGER FORDTRANS, P1797; Fine KD, 1999, GASTROENTEROLOGY, V116, P1464, DOI 10.1016/S0016-5085(99)70513-5; Jensen RT, 2000, HEMATOL ONCOL CLIN N, V14, P579, DOI 10.1016/S0889-8588(05)70298-7; Jensen RT, 2010, SLEISENGER FORDTRANS, P491; Roy PK, 2000, MEDICINE, V79, P379, DOI 10.1097/00005792-200011000-00004; Schiller L.R., 2010, SLEISENGER FORDTRANS, V1, P211; Stern M, 2000, J PEDIATR GASTR NUTR, V31, P513, DOI 10.1097/00005176-200011000-00012; Sulkanen S, 1998, GASTROENTEROLOGY, V115, P1322, DOI 10.1016/S0016-5085(98)70008-3; Tan KSW, 2008, CLIN MICROBIOL REV, V21, P639, DOI 10.1128/CMR.00022-08; Thielman NM, 2004, NEW ENGL J MED, V350, P38, DOI 10.1056/NEJMcp031534; ZOLLINGER RM, 1955, ANN SURG, V142, P709, DOI 10.1097/00000658-195510000-00015	16	4	4	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2013	368	8					757	765		10.1056/NEJMcpc1208149	http://dx.doi.org/10.1056/NEJMcpc1208149			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092CG	23425169				2022-12-28	WOS:000315095800012
J	Cohen, S; Janicki-Deverts, D; Turner, RB; Casselbrant, ML; Li-Korotky, HS; Epel, ES; Doyle, WJ				Cohen, Sheldon; Janicki-Deverts, Denise; Turner, Ronald B.; Casselbrant, Margaretha L.; Li-Korotky, Ha-Sheng; Epel, Elissa S.; Doyle, William J.			Association Between Telomere Length and Experimentally Induced Upper Respiratory Viral Infection in Healthy Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REPLICATIVE SENESCENCE; T-CELLS; SHORTENED TELOMERES; HIV-INFECTION; MORTALITY; DISEASE; AGE; LYMPHOCYTES; MARKERS; STRESS	Importance Although leukocyte telomere length is associated with mortality and many chronic diseases thought to be manifestations of age-related functional decline, it is not known whether it relates to acute disease in younger healthy populations. Objective To determine whether shorter telomeres in leukocytes, especially CD8CD28- T cells, are associated with decreased resistance to upper respiratory infection and clinical illness in young to midlife adults. Design, Setting, and Participants Between 2008 and 2011, telomere length was assessed in peripheral blood mononuclear cells (PBMCs) and T-cell subsets (CD4, CD8CD28-, CD8CD28-) from 152 healthy 18- to 55-year-old residents of Pittsburgh, Pennsylvania. Participants were subsequently quarantined (single rooms), administered nasal drops containing a common cold virus (rhinovirus 39), and monitored for 5 days for development of infection and clinical illness. Main Outcome Measures Infection (virus shedding or 4-fold increase in virus-specific antibody titer) and clinical illness (verified infection plus objective signs of illness). Results Rates of infections and clinical illness were 69% (n=105) and 22% (n=33), respectively. Shorter telomeres were associated with greater odds of infection, independent of prechallenge virus-specific antibody, demographics, contraceptive use, season, and body mass index (PBMC: odds ratio [OR] per 1-SD decrease in telomere length, 1.71 [95% CI, 1.08-2.72]; n=128 [shortest tertile 77% infected; middle, 66%; longest, 57%]; CD4: OR, 1.76 [95% CI, 1.15-2.70]; n=146 [shortest tertile 80% infected; middle, 71%; longest, 54%]; CD8CD28+ : OR, 1.93 [95% CI, 1.21-3.09], n=132 [shortest tertile 84% infected; middle, 64%; longest, 58%]; CD8CD28+ : OR, 2.02 [95% CI, 1.29-3.16]; n=144 [shortest tertile 77% infected; middle, 75%; longest, 50%]). CD8CD28- was the only cell population in which shorter telomeres were associated with greater risk of clinical illness (OR, 1.69 [95% CI, 1.01-2.84]; n=144 [shortest tertile, 26%; middle, 22%; longest, 13%]). The association between CD8CD28- telomere length and infection increased with age (CD8CD28- telomere length x age interaction, b=0.09 [95% CI, 0.02-0.16], P=.01, n=144). Conclusion and Relevance In this preliminary study among a cohort of healthy 18- to 55-year-olds, shorter CD8CD28- T-cell telomere length was associated with increased risk for experimentally induced acute upper respiratory infection and clinical illness. JAMA. 2013;309(7):699-705 www.jama.com	[Cohen, Sheldon; Janicki-Deverts, Denise] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Turner, Ronald B.] Univ Virginia, Hlth Sci Ctr, Dept Pediat, Charlottesville, VA USA; [Casselbrant, Margaretha L.; Li-Korotky, Ha-Sheng; Doyle, William J.] Childrens Hosp Pittsburgh, Dept Otolaryngol ENT, Pittsburgh, PA 15213 USA; [Epel, Elissa S.] Univ Calif San Francisco, Hlth Psychol Program, San Francisco, CA 94143 USA	Carnegie Mellon University; University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco	Cohen, S (corresponding author), Carnegie Mellon Univ, Dept Psychol, 5000 Forbes Ave, Pittsburgh, PA 15213 USA.	scohen@cmu.edu		Cohen, Sheldon/0000-0003-2248-4600	National Center for Complementary and Alternative Medicine [AT006694]; National Institute of Allergy and Infectious Diseases [AI066367]; John D. and Catherine T. MacArthur Foundation's Research Network on Social Economic Status and Health; Eberly Foundation; Hamburg Fellowship; National Institutes of Health [UL1 RR024153, UL1TR000005]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [RC1AT005799] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT006694] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI100799, R01AI066367] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); John D. and Catherine T. MacArthur Foundation's Research Network on Social Economic Status and Health; Eberly Foundation; Hamburg Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the National Center for Complementary and Alternative Medicine (AT006694) and the National Institute of Allergy and Infectious Diseases (AI066367) and through supplemental support from the John D. and Catherine T. MacArthur Foundation's Research Network on Social Economic Status and Health, the Eberly Foundation, the Hamburg Fellowship, and National Institutes of Health funding to the University of Pittsburgh Clinical and Translational Science Institute (UL1 RR024153 and UL1TR000005).	Alexander GC, 2003, JAMA-J AM MED ASSOC, V290, P953, DOI 10.1001/jama.290.7.953; AZUMA M, 1993, J IMMUNOL, V150, P1147; Bestilny LJ, 2000, AIDS, V14, P771, DOI 10.1097/00002030-200005050-00002; Brydon L, 2012, BIOL PSYCHIAT, V71, P767, DOI 10.1016/j.biopsych.2011.08.020; Butler MG, 1998, CANCER GENET CYTOGEN, V105, P138, DOI 10.1016/S0165-4608(98)00029-6; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Chen W, 2011, J GERONTOL A-BIOL, V66, P312, DOI 10.1093/gerona/glq223; Cohen S, 1997, JAMA-J AM MED ASSOC, V277, P1940; Damjanovic AK, 2007, J IMMUNOL, V179, P4249, DOI 10.4049/jimmunol.179.6.4249; Dock JN, 2011, AGING DIS, V2, P382; Doyle W. J., 1988, AM J RHINOL, V2, P149, DOI DOI 10.2500/105065888781692961; Effros R B, 2001, Novartis Found Symp, V235, P130; Effros RB, 2005, IMMUNOL REV, V205, P147, DOI 10.1111/j.0105-2896.2005.00259.x; Effros RB, 1997, IMMUNOL TODAY, V18, P450, DOI 10.1016/S0167-5699(97)01079-7; Effros RB, 1996, AIDS, V10, pF17, DOI 10.1097/00002030-199607000-00001; Ehrlenbach S, 2009, INT J EPIDEMIOL, V38, P1725, DOI 10.1093/ije/dyp273; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Fitzpatrick AL, 2011, J GERONTOL A-BIOL, V66, P421, DOI 10.1093/gerona/glq224; Goronzy JJ, 2001, J VIROL, V75, P12182, DOI 10.1128/JVI.75.24.12182-12187.2001; Gwaltney J.M., 1989, DIAGNOSTIC PROCEDURE, P579; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HOSMER DW, 1989, APPL LOGISTIC REGRES; Kipling D, 1999, NAT BIOTECHNOL, V17, P313, DOI 10.1038/7827; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; Monteiro J, 1996, J IMMUNOL, V156, P3587; O'Callaghan NJ, 2008, BIOTECHNIQUES, V44, P807, DOI 10.2144/000112761; O'Donovan A, 2009, BRAIN BEHAV IMMUN, V23, P446, DOI 10.1016/j.bbi.2008.11.006; Palmer LD, 1997, J EXP MED, V185, P1381, DOI 10.1084/jem.185.7.1381; Parish ST, 2010, J CLIN IMMUNOL, V30, P798, DOI 10.1007/s10875-010-9449-7; Saurwein-Teissl M, 2002, J IMMUNOL, V168, P5893, DOI 10.4049/jimmunol.168.11.5893; Schmid I, 2002, CYTOMETRY, V49, P96, DOI 10.1002/cyto.10163; Soerensen M, 2012, AGING CELL, V11, P223, DOI 10.1111/j.1474-9726.2011.00775.x; Steptoe A, 2011, BRAIN BEHAV IMMUN, V25, P1292, DOI 10.1016/j.bbi.2011.04.010; Tyrrell DAJ, 1988, LAB DIAGNOSIS INFECT, V2, P723; Unryn BM, 2005, AGING CELL, V4, P97, DOI 10.1111/j.1474-9728.2005.00144.x; Valenzuela HF, 2002, CLIN IMMUNOL, V105, P117, DOI 10.1006/clim.2002.5271; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Weischer M, 2012, ARTERIOSCL THROM VAS, V32, P822, DOI 10.1161/ATVBAHA.111.237271; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	41	93	95	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2013	309	7					699	705		10.1001/jama.2013.613	http://dx.doi.org/10.1001/jama.2013.613			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091EK	23423415	Green Accepted, Bronze			2022-12-28	WOS:000315032000025
J	Shilagardi, K; Li, S; Luo, FB; Marikar, F; Duan, R; Jin, P; Kim, JH; Murnen, K; Chen, EH				Shilagardi, Khurts; Li, Shuo; Luo, Fengbao; Marikar, Faiz; Duan, Rui; Jin, Peng; Kim, Ji Hoon; Murnen, Katherine; Chen, Elizabeth H.			Actin-Propelled Invasive Membrane Protrusions Promote Fusogenic Protein Engagement During Cell-Cell Fusion	SCIENCE			English	Article							MYOBLAST FUSION; S2 CELLS; INTEGRINS; IDENTIFICATION; CYTOSKELETON; DYNAMICS; EFF-1; FUSE; WASP; SNS	Cell-cell fusion is critical for the conception, development, and physiology of multicellular organisms. Although cellular fusogenic proteins and the actin cytoskeleton are implicated in cell-cell fusion, it remains unclear whether and how they coordinate to promote plasma membrane fusion. We reconstituted a high-efficiency, inducible cell fusion culture system in the normally nonfusing Drosophila S2R+ cells. Both fusogenic proteins and actin cytoskeletal rearrangements were necessary for cell fusion, and in combination they were sufficient to impart fusion competence. Localized actin polymerization triggered by specific cell-cell or cell-matrix adhesion molecules propelled invasive cell membrane protrusions, which in turn promoted fusogenic protein engagement and plasma membrane fusion. This de novo cell fusion culture system reveals a general role for actin-propelled invasive membrane protrusions in driving fusogenic protein engagement during cell-cell fusion.	[Shilagardi, Khurts; Li, Shuo; Luo, Fengbao; Marikar, Faiz; Duan, Rui; Jin, Peng; Kim, Ji Hoon; Murnen, Katherine; Chen, Elizabeth H.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Johns Hopkins University	Chen, EH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	echen@jhmi.edu	duan, rui/AAK-8037-2020; Duan, Rui/I-9015-2018	Duan, Rui/0000-0001-5035-5633	National Institutes of Health [R01 GM098816]; Packard Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Beachy for the S2R+ cell line and G. Seydoux for the C. elegans cDNA; M. Delannoy at Johns Hopkins Microscope Facility for advice on cell culture TEM and immunoEM; J. Reidler, J. Hill, and J. DeWitt at Nikon Instruments Inc. for advice on STORM; and S. Craig, J. Nathans, E. Olson, D. Pan, D. Robinson, G. Seydoux, J. Yang, and members of the Chen lab for discussions and critical reading of the manuscript. K.S. was a postdoctoral fellow of the American Heart Association. Supported by the National Institutes of Health (R01 GM098816) and the Packard Foundation (E.H.C.).	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Avinoam O, 2011, CURR TOP MEMBR, V68, P209, DOI 10.1016/B978-0-12-385891-7.00009-X; Avinoam O, 2011, SCIENCE, V332, P589, DOI 10.1126/science.1202333; Bour BA, 2000, GENE DEV, V14, P1498; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Chen EH, 2003, CELL, V114, P751, DOI 10.1016/S0092-8674(03)00720-7; Chen EH, 2011, CURR TOP MEMBR, V68, P235, DOI [10.1016/B978-0-12-385891-7.00010-6, 1016/B978-0-12-385891-7.00010-6]; Duan R, 2012, J CELL BIOL, V199, P169, DOI 10.1083/jcb.201204065; Dworak HA, 2001, DEVELOPMENT, V128, P4265; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Fenichel P, 1998, HUM REPROD, V13, P31, DOI 10.1093/humrep/13.suppl_4.31; Galletta BJ, 2004, MECH DEVELOP, V121, P1455, DOI 10.1016/j.mod.2004.08.001; GOTWALS PJ, 1994, CURR OPIN CELL BIOL, V6, P734, DOI 10.1016/0955-0674(94)90101-5; Haralalka S, 2011, DEVELOPMENT, V138, P1551, DOI 10.1242/dev.057653; Islam R, 2003, DEVELOPMENT, V130, P2051, DOI 10.1242/dev.00415; ITO M, 1994, J IMMUNOL, V153, P3256; Jin P, 2011, DEV CELL, V20, P623, DOI 10.1016/j.devcel.2011.04.007; Johnston CA, 2009, CELL, V138, P1150, DOI 10.1016/j.cell.2009.07.041; Kim S, 2007, DEV CELL, V12, P571, DOI 10.1016/j.devcel.2007.02.019; Massarwa R, 2007, DEV CELL, V12, P557, DOI 10.1016/j.devcel.2007.01.016; McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1; Mohler WA, 2002, DEV CELL, V2, P355, DOI 10.1016/S1534-5807(02)00129-6; Ogle BM, 2005, NAT REV MOL CELL BIO, V6, P567, DOI 10.1038/nrm1678; Oren-Suissa M, 2007, TRENDS CELL BIOL, V17, P537, DOI 10.1016/j.tcb.2007.09.004; Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004; Richardson BE, 2007, DEVELOPMENT, V134, P4357, DOI 10.1242/dev.010678; Rochlin K, 2010, DEV BIOL, V341, P66, DOI 10.1016/j.ydbio.2009.10.024; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schafer G, 2007, DEV BIOL, V304, P664, DOI 10.1016/j.ydbio.2007.01.015; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Sens KL, 2010, J CELL BIOL, V191, P1013, DOI 10.1083/jcb.201006006; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353	33	92	94	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					359	363		10.1126/science.1234781	http://dx.doi.org/10.1126/science.1234781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23470732	Green Accepted			2022-12-28	WOS:000317657500058
J	Hansen, TB; Jensen, TI; Clausen, BH; Bramsen, JB; Finsen, B; Damgaard, CK; Kjems, J				Hansen, Thomas B.; Jensen, Trine I.; Clausen, Bettina H.; Bramsen, Jesper B.; Finsen, Bente; Damgaard, Christian K.; Kjems, Jorgen			Natural RNA circles function as efficient microRNA sponges	NATURE			English	Article							MESSENGER-RNAS; MOUSE TESTIS; TARGET; GENE; CIRCULARIZATION; IDENTIFICATION; GLIOBLASTOMA; TRANSCRIPT; EXPRESSION; RECEPTOR	MicroRNAs (miRNAs) are important post-transcriptional regulators of gene expression that act by direct base pairing to target sites within untranslated regions of messenger RNAs1. Recently, miRNA activity has been shown to be affected by the presence of miRNA sponge transcripts, the so-called competing endogenous RNA in humans and target mimicry in plants(2-7). We previously identified a highly expressed circular RNA (circRNA) in human and mouse brain(8). Here we show that this circRNA acts as a miR-7 sponge; we term this circular transcript ciRS-7 (circular RNA sponge for miR-7). ciRS-7 contains more than 70 selectively conserved miRNA target sites, and it is highly and widely associated with Argonaute (AGO) proteins in a miR-7-dependent manner. Although the circRNA is completely resistant to miRNA-mediated target destabilization, it strongly suppresses miR-7 activity, resulting in increased levels of miR-7 targets. In the mouse brain, we observe overlapping co-expression of ciRS-7 and miR-7, particularly in neocortical and hippocampal neurons, suggesting a high degree of endogenous interaction. We further show that the testis-specific circRNA, sex-determining region Y (Sry)(9), serves as a miR-138 sponge, suggesting that miRNA sponge effects achieved by circRNA formation are a general phenomenon. This study serves as the first, to our knowledge, functional analysis of a naturally expressed circRNA.	[Hansen, Thomas B.; Jensen, Trine I.; Bramsen, Jesper B.; Damgaard, Christian K.; Kjems, Jorgen] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Clausen, Bettina H.; Finsen, Bente] Univ Southern Denmark, Inst Mol Med, DK-5000 Odense C, Denmark; [Bramsen, Jesper B.; Kjems, Jorgen] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark	Aarhus University; University of Southern Denmark; Aarhus University	Kjems, J (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, CF Mollers Alle 3, DK-8000 Aarhus C, Denmark.	tbh@mb.au.dk; jk@mb.au.dk	Damgaard, Christian/AAR-4075-2020; Kjems, Jorgen/I-3490-2016; ravegnini, gloria/K-1330-2016; Damgaard, Christian K/G-7360-2015; Damgaard, Christian/AAP-3147-2021	Kjems, Jorgen/0000-0003-4128-9317; ravegnini, gloria/0000-0002-7774-402X; Damgaard, Christian/0000-0003-4940-0868; Ilso Jensen, Trine/0000-0002-9224-5376; Hansen, Thomas/0000-0002-7573-9657; Clausen, Bettina Hjelm/0000-0003-3302-2022; Finsen, Bente/0000-0002-8323-9329	SIROCCO EU consortium; Lundbeck Foundation; Danish Council for Independent Research - Natural Sciences; Lundbeck Foundation [R83-2011-8232] Funding Source: researchfish	SIROCCO EU consortium; Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research - Natural Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden)	We thank C. Bus and R. Rosendahl for technical assistance and R. M. Zadegan for art work. We also thank the G. Hannon laboratory for providing us with the Myc-tagged AGO2 expression vector, J. Lykke-Andersen for the DCP1A antibody, and K. L. Lambertsen and C. U. von Linstow for their assistance with confocal microscopy. This work was supported by the SIROCCO EU consortium, the Lundbeck Foundation, and the Danish Council for Independent Research - Natural Sciences. T.B.H. and B.H.C. were supported by the Lundbeck Foundation.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Dubin RA, 1995, GENE, V167, P245, DOI 10.1016/0378-1119(95)00639-7; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Iioka H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1316; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Junn E, 2009, P NATL ACAD SCI USA, V106, P13052, DOI 10.1073/pnas.0906277106; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Pasman Z, 1996, RNA, V2, P603; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029	25	4899	5274	44	1077	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					384	388		10.1038/nature11993	http://dx.doi.org/10.1038/nature11993			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23446346				2022-12-28	WOS:000316650500046
J	Martin, EG; Schackman, BR				Martin, Erika G.; Schackman, Bruce R.			Updating the HIV-Testing Guidelines - A Modest Change with Major Consequences	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE		[Martin, Erika G.] SUNY Albany, Rockefeller Coll Publ Affairs & Policy, Albany, NY 12222 USA; [Martin, Erika G.] SUNY Albany, Nelson A Rockefeller Inst Govt, Albany, NY 12222 USA; [Schackman, Bruce R.] Weill Cornell Med Coll, Dept Publ Hlth, Div Hlth Policy, New York, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Cornell University	Martin, EG (corresponding author), SUNY Albany, Rockefeller Coll Publ Affairs & Policy, Albany, NY 12222 USA.		Schackman, Bruce R./J-8208-2019	Schackman, Bruce R./0000-0002-1132-2932; Martin, Erika/0000-0003-2607-8933				Branson B, 2007, J MED VIROL, V79, pS6, DOI 10.1002/jmv.20972; Chou R, 2012, ANN INTERN MED, V157, P706, DOI 10.7326/0003-4819-157-10-201211200-00007; Martin EG, 2012, JAIDS-J ACQ IMM DEF, V60, P72, DOI 10.1097/QAI.0b013e31824c0dd4; Martin EG, 2010, VALUE HEALTH, V13, P893, DOI 10.1111/j.1524-4733.2010.00763.x	4	21	21	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2013	368	10					884	886		10.1056/NEJMp1214630	http://dx.doi.org/10.1056/NEJMp1214630			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100BG	23425132				2022-12-28	WOS:000315669100002
J	Lai, F; Orom, UA; Cesaroni, M; Beringer, M; Taatjes, DJ; Blobel, GA; Shiekhattar, R				Lai, Fan; Orom, Ulf A.; Cesaroni, Matteo; Beringer, Malte; Taatjes, Dylan J.; Blobel, Gerd A.; Shiekhattar, Ramin			Activating RNAs associate with Mediator to enhance chromatin architecture and transcription	NATURE			English	Article							OPITZ-KAVEGGIA-SYNDROME; LONG NONCODING RNAS; GENE-EXPRESSION; HISTONE H3; GENOME; IDENTIFICATION; MED12; MUTATION; COMPLEX	Recent advances in genomic research have revealed the existence of a large number of transcripts devoid of protein-coding potential in multiple organisms(1-8). Although the functional role for long non-coding RNAs (lncRNAs) has been best defined in epigenetic phenomena such as X-chromosome inactivation and imprinting, different classes of lncRNAs may have varied biological functions(8-13). We and others have identified a class of lncRNAs, termed ncRNA-activating (ncRNA-a), that function to activate their neighbouring genes using a cis-mediated mechanism(5,14-16). To define the precise mode by which such enhancer-like RNAs function, we depleted factors with known roles in transcriptional activation and assessed their role in RNA-dependent activation. Here we report that depletion of the components of the co-activator complex, Mediator, specifically and potently diminished the ncRNA-induced activation of transcription in a heterologous reporter assay using human HEK293 cells. In vivo, Mediator is recruited to ncRNA-a target genes and regulates their expression. We show that ncRNA-a interact with Mediator to regulate its chromatin localization and kinase activity towards histone H3 serine 10. The Mediator complex harbouring disease-causing MED12 mutations(17,18) displays diminished ability to associate with activating ncRNAs. Chromosome conformation capture confirmed the presence of DNA looping between the ncRNA-a loci and its targets. Importantly, depletion of Mediator subunits or ncRNA-a reduced the chromatin looping between the two loci. Our results identify the human Mediator complex as the transducer of activating ncRNAs and highlight the importance of Mediator and activating ncRNA association in human disease.	[Lai, Fan; Cesaroni, Matteo; Shiekhattar, Ramin] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Orom, Ulf A.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Beringer, Malte] Ctr Regulacio Genom, Barcelona 08003, Spain; [Beringer, Malte] UPF, Barcelona 08003, Spain; [Taatjes, Dylan J.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Blobel, Gerd A.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA	The Wistar Institute; Max Planck Society; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; University of Colorado System; University of Colorado Boulder; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Shiekhattar, R (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	shiekhattar@wistar.org	Beringer, Malte/AAC-5734-2020; Beringer, Malte/N-3766-2015; Lai, Fan/ABD-2862-2021	Beringer, Malte/0000-0003-1958-9786; Orom, Ulf/0000-0002-0643-0592; Lai, Fan/0000-0002-0568-2616	NIH [P30 CA 010815]; NCI [R01 CA127364];  [5R37DK058044]; NATIONAL CANCER INSTITUTE [R01CA127364, P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058044, R01DK058044] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Shiekhattar laboratory members for support and discussions. We thank W. Dang (Blobel laboratory) and I. Tempera for suggestions and technical help on 3C experiments. R.S. was partially supported by a cancer core grant from NIH (P30 CA 010815). D.J.T. was supported by a grant from the NCI (R01 CA127364). GAB. was supported by 5R37DK058044.	Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Knuesel MT, 2009, MOL CELL BIOL, V29, P650, DOI 10.1128/MCB.00993-08; Lee JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003749; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Rump P, 2011, CLIN GENET, V79, P183, DOI 10.1111/j.1399-0004.2010.01449.x; Sopher BL, 2011, NEURON, V70, P1071, DOI 10.1016/j.neuron.2011.05.027; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	27	623	646	3	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2013	494	7438					497	501		10.1038/nature11884	http://dx.doi.org/10.1038/nature11884			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23417068	Green Accepted, Green Published			2022-12-28	WOS:000315661500043
J	Treasure, T; Utley, M				Treasure, Tom; Utley, Martin			Surgical removal of asymptomatic pulmonary metastases: time for better evidence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COLORECTAL-CANCER; LUNG METASTASECTOMY; OSTEOGENIC-SARCOMA; EUROPEAN-SOCIETY; RADICAL SURGERY; MESOTHELIOMA; RESECTIONS		[Treasure, Tom; Utley, Martin] UCL, Clin Operat Res Unit, London, England	University of London; University College London	Treasure, T (corresponding author), UCL, Clin Operat Res Unit, London, England.	tom.treasure@gmail.com		Utley, Martin/0000-0001-9928-1516				Antunes M, 1999, EUR J CARDIO-THORAC, V15, P592, DOI 10.1016/S1010-7940(99)00098-6; Aradhana G, 2022, P 2022 IEEE INT C CO, P25; Beattie E J Jr, 1984, Cancer, V54, P2729, DOI 10.1002/1097-0142(19841201)54:2+<2729::AID-CNCR2820541420>3.0.CO;2-U; BEATTIE EJ, 1991, J SURG ONCOL, V46, P154, DOI 10.1002/jso.2930460305; Burt BM, 2011, ANN THORAC SURG, V92, P1202, DOI 10.1016/j.athoracsur.2011.05.052; Fiorentino F, 2010, J ROY SOC MED, V103, P60, DOI 10.1258/jrsm.2009.090299; Gelderblom H, 2011, EUR J CANCER, V47, P895, DOI 10.1016/j.ejca.2010.11.036; Gonzalez M, 2013, ANN SURG ONCOL, V20, P572, DOI 10.1245/s10434-012-2726-3; Internullo E, 2008, J THORAC ONCOL, V3, P1257, DOI 10.1097/JTO.0b013e31818bd9da; Lilford RJ, 1995, BMJ-BRIT MED J, V311, P1621, DOI 10.1136/bmj.311.7020.1621; Martini N, 1971, Ann Thorac Surg, V12, P271; Nauenheim KS, 2007, DIFFICULT DECISIONS, P151; Russell RCG, 2012, BRIT J SURG, V99, P449, DOI 10.1002/bjs.8695; Treasure T, 2004, BMJ-BRIT MED J, V328, P237, DOI 10.1136/bmj.328.7434.237; Treasure T, 2008, CANCER IMAGING, V8, P121, DOI 10.1102/1470-7330.2008.0017; Treasure T, 2007, J THORAC CARDIOV SUR, V133, P1414, DOI 10.1016/j.jtcvs.2007.02.014; Treasure T, 2007, BMJ-BRIT MED J, V334, P831, DOI 10.1136/bmj.39161.403218.AD; Treasure T, 2012, BMJ OPEN, V2, DOI [10.1136/bmjopen-2011-000725, 10.1136/bmjopen-2012-001736]; Treasure T, 2012, J ROY SOC MED, V105, P140, DOI 10.1258/jrsm.2011.110307; Treasure T, 2012, THORAX, V67, P185, DOI 10.1136/thoraxjnl-2011-200015; Treasure T, 2011, LANCET ONCOL, V12, P763, DOI 10.1016/S1470-2045(11)70149-8; Utley M, 2010, J THORAC ONCOL, V5, pS200, DOI 10.1097/JTO.0b013e3181dd0a8d; Van Raemdonck D, 2010, J THORAC ONCOL, V5, pS127, DOI 10.1097/JTO.0b013e3181dcf59c	23	9	9	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 21	2013	346								f824	10.1136/bmj.f824	http://dx.doi.org/10.1136/bmj.f824			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096HP	23430330				2022-12-28	WOS:000315395100004
J	Brodin, T; Fick, J; Jonsson, M; Klaminder, J				Brodin, T.; Fick, J.; Jonsson, M.; Klaminder, J.			Dilute Concentrations of a Psychiatric Drug Alter Behavior of Fish from Natural Populations	SCIENCE			English	Article							RISK TRADE-OFF; ENVIRONMENTAL RISK; PERSONALITY; BOLDNESS; PHARMACEUTICALS; PLASTICITY; PREDATORS; MORTALITY; PRODUCTS; ECOLOGY	Environmental pollution by pharmaceuticals is increasingly recognized as a major threat to aquatic ecosystems worldwide. A variety of pharmaceuticals enter waterways by way of treated wastewater effluents and remain biochemically active in aquatic systems. Several ecotoxicological studies have been done, but generally, little is known about the ecological effects of pharmaceuticals. Here we show that a benzodiazepine anxiolytic drug (oxazepam) alters behavior and feeding rate of wild European perch (Perca fluviatilis) at concentrations encountered in effluent-influenced surface waters. Individuals exposed to water with dilute drug concentrations (1.8 micrograms liter(-1)) exhibited increased activity, reduced sociality, and higher feeding rate. As such, our results show that anxiolytic drugs in surface waters alter animal behaviors that are known to have ecological and evolutionary consequences.	[Brodin, T.; Jonsson, M.; Klaminder, J.] Umea Univ, Dept Ecol & Environm Sci, S-90187 Umea, Sweden; [Fick, J.] Umea Univ, Dept Chem, S-90187 Umea, Sweden	Umea University; Umea University	Brodin, T (corresponding author), Umea Univ, Dept Ecol & Environm Sci, S-90187 Umea, Sweden.	tomas.brodin@emg.umu.se	Berglund Fick, Jerker/HDO-5788-2022; Jonsson, Micael/E-6839-2012	Brodin, Tomas/0000-0003-1086-7567; Fick, Jerker/0000-0002-3949-7371	Umea University; Swedish Research Council Vetenskapsradet; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; strong research environment, "The environment's chemistry-from molecules to the ecosystem"	Umea University; Swedish Research Council Vetenskapsradet(Swedish Research Council); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); strong research environment, "The environment's chemistry-from molecules to the ecosystem"	This study was supported by Umea University via a Young Researcher Award to T. B., J.F., and J.K. Financial support for M.J. was provided by the Swedish Research Council Vetenskapsradet and The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning. Support for this study was also provided by a small starting grant from the strong research environment, "The environment's chemistry-from molecules to the ecosystem." The data reported in this paper are archived at the research database at the Department of Ecology and Environmental Science, Umea University, and are also included in the online supplementary materials. The authors declare no competing financial interests. All procedures involving handling of fish were permitted by the Ethical Committee on Animal Experiments in Umea and comply with current Swedish law.	[Anonymous], WORLD MED SIT; Boxall ABA, 2012, ENVIRON HEALTH PERSP, V120, P1221, DOI 10.1289/ehp.1104477; Brodin T, 2004, ECOLOGY, V85, P2927, DOI 10.1890/03-3120; Calisto V, 2011, WATER RES, V45, P6097, DOI 10.1016/j.watres.2011.09.008; Calisto V, 2009, CHEMOSPHERE, V77, P1257, DOI 10.1016/j.chemosphere.2009.09.021; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; DUGATKIN LA, 1992, BEHAV ECOL, V3, P124, DOI 10.1093/beheco/3.2.124; ELLIOTT JM, 1976, J ANIM ECOL, V45, P923, DOI 10.2307/3590; Frost AJ, 2007, P ROY SOC B-BIOL SCI, V274, P333, DOI 10.1098/rspb.2006.3751; Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173; Hummel D, 2006, ENVIRON SCI TECHNOL, V40, P7321, DOI 10.1021/es061740w; Johansson F, 2003, J FRESHWATER ECOL, V18, P415, DOI 10.1080/02705060.2003.9663977; Kosjek T, 2012, WATER RES, V46, P355, DOI 10.1016/j.watres.2011.10.056; Krause J, 2002, LIVING GROUPS; PERSSON L, 1990, ECOLOGY, V71, P1699, DOI 10.2307/1937579; POST JR, 1989, CAN J FISH AQUAT SCI, V46, P1958, DOI 10.1139/f89-246; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Thomson JS, 2012, HORM BEHAV, V61, P750, DOI 10.1016/j.yhbeh.2012.03.014; Verlicchi P, 2012, SCI TOTAL ENVIRON, V429, P123, DOI 10.1016/j.scitotenv.2012.04.028; Ward AJW, 2004, BEHAV ECOL SOCIOBIOL, V55, P561, DOI 10.1007/s00265-003-0751-8; WERNER EE, 1988, ECOLOGY, V69, P1352, DOI 10.2307/1941633	23	526	535	12	742	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2013	339	6121					814	815		10.1126/science.1226850	http://dx.doi.org/10.1126/science.1226850			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23413353				2022-12-28	WOS:000314874400047
J	Tropberger, P; Pott, S; Keller, C; Kamieniarz-Gdula, K; Caron, M; Richter, F; Li, GH; Mittler, G; Liu, ET; Buhler, M; Margueron, R; Schneider, R				Tropberger, Philipp; Pott, Sebastian; Keller, Claudia; Kamieniarz-Gdula, Kinga; Caron, Matthieu; Richter, Florian; Li, Guohong; Mittler, Gerhard; Liu, Edison T.; Buehler, Marc; Margueron, Raphael; Schneider, Robert			Regulation of Transcription through Acetylation of H3K122 on the Lateral Surface of the Histone Octamer	CELL			English	Article							NUCLEOSOME EVICTION; FISSION YEAST; IN-VITRO; CHROMATIN; IDENTIFICATION; DISTINCT; P300; H3; ACTIVATION; STABILITY	Histone modifications are key regulators of chromatin function. However, little is known to what extent histone modifications can directly impact on chromatin. Here, we address how a modification within the globular domain of histones regulates chromatin function. We demonstrate that H3K122ac can be sufficient to stimulate transcription and that mutation of H3K122 impairs transcriptional activation, which we attribute to a direct effect of H3K122ac on histone-DNA binding. In line with this, we find that H3K122ac defines genome-wide genetic elements and chromatin features associated with active transcription. Furthermore, H3K122ac is catalyzed by the coactivators p300/CBP and can be induced by nuclear hormone receptor signaling. Collectively, this suggests that transcriptional regulators elicit their effects not only via signaling to histone tails but also via direct structural perturbation of nucleosomes by directing acetylation to their lateral surface.	[Tropberger, Philipp; Kamieniarz-Gdula, Kinga; Richter, Florian; Mittler, Gerhard; Schneider, Robert] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Tropberger, Philipp; Schneider, Robert] Univ Strasbourg, INSERM,U964, CNRS UMR 7104, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Pott, Sebastian; Liu, Edison T.] Genome Inst Singapore, Singapore 138672, Singapore; [Keller, Claudia; Buehler, Marc] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Keller, Claudia; Buehler, Marc] Univ Basel, CH-4003 Basel, Switzerland; [Caron, Matthieu; Margueron, Raphael] Inst Curie, F-75005 Paris, France; [Caron, Matthieu; Margueron, Raphael] CNRS, UMR 3215, F-75005 Paris, France; [Caron, Matthieu; Buehler, Marc] INSERM, U934, F-75005 Paris, France; [Li, Guohong] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Friedrich Miescher Institute for Biomedical Research; University of Basel; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Chinese Academy of Sciences; Institute of Biophysics, CAS	Schneider, R (corresponding author), Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany.	schneidr@igbmc.fr	Margueron, Raphael F/B-9996-2015; Buehler, Marc/S-5866-2019	Margueron, Raphael F/0000-0002-9093-7977; Buehler, Marc/0000-0001-6661-9795; Kamieniarz-Gdula, Kinga/0000-0003-3789-5381; Caron, Matthieu/0000-0002-6905-7545; Keller Valsecchi, Claudia Isabelle/0000-0003-4135-5927	Max Planck Society; DFG [SFB 746]; Fondation pour la Recherche Medicale; ERC; Institut Nationale du Cancer; Swiss National Science Foundation; Gebert Ruf Foundation; Novartis Research Foundation; EMBO Young Investigator Programme	Max Planck Society(Max Planck SocietyFoundation CELLEX); DFG(German Research Foundation (DFG)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); ERC(European Research Council (ERC)European Commission); Institut Nationale du Cancer; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gebert Ruf Foundation; Novartis Research Foundation; EMBO Young Investigator Programme(European Molecular Biology Organization (EMBO))	We thank S. Daujat and all members of the Schneider and Margueron laboratories. We are grateful to H. Neumann for providing expression plasmids and advice and to G. Langst for ACF remodeling complex. We would like to thank I. del Valle for cell pellets for histone extraction. We thank H. Holz for advice and help for protein purification and M. Cohen for quantification of acetylated peptides. Work in the Schneider laboratory was supported by the Max Planck Society, the DFG (through SFB 746), the Fondation pour la Recherche Medicale, and an ERC starting grant; the R. Margueron laboratory was supported by the Institut Nationale du Cancer and Fondation pour la Recherche Medicale. Research in the laboratory of M. Buhler was supported by funds from the Swiss National Science Foundation, the ERC, the Gebert Ruf Foundation, the Novartis Research Foundation, and the EMBO Young Investigator Programme.	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; An WJ, 2002, MOL CELL, V9, P811, DOI 10.1016/S1097-2765(02)00497-5; Andrews AJ, 2011, ANNU REV BIOPHYS, V40, P99, DOI 10.1146/annurev-biophys-042910-155329; AUSIO J, 1989, J MOL BIOL, V206, P451, DOI 10.1016/0022-2836(89)90493-2; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bintu L, 2012, CELL, V151, P738, DOI 10.1016/j.cell.2012.10.009; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Fenley AT, 2010, BIOPHYS J, V99, P1577, DOI 10.1016/j.bpj.2010.06.046; Freitas MA, 2004, J CELL BIOCHEM, V92, P691, DOI 10.1002/jcb.20106; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Garcia Benjamin A, 2009, Front Biosci (Schol Ed), V1, P142, DOI 10.2741/s14; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Hainer SJ, 2011, MOL CELL BIOL, V31, P3557, DOI 10.1128/MCB.05195-11; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; Hyndman BD, 2012, BBA-GENE REGUL MECH, V1819, P446, DOI 10.1016/j.bbagrm.2012.02.009; Ito T, 2000, GENE DEV, V14, P1899; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Iwasaki W, 2011, BIOCHEMISTRY-US, V50, P7822, DOI 10.1021/bi201021h; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Koopmans WJA, 2009, BIOPHYS J, V97, P195, DOI 10.1016/j.bpj.2009.04.030; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li GH, 2010, MOL CELL, V38, P41, DOI 10.1016/j.molcel.2010.01.042; Lin JJ, 2011, GENE DEV, V25, P2198, DOI 10.1101/gad.17554711; Luebben WR, 2010, P NATL ACAD SCI USA, V107, P19254, DOI 10.1073/pnas.1009650107; Luger K, 1999, METHOD ENZYMOL, V304, P3; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Mellone BG, 2003, CURR BIOL, V13, P1748, DOI 10.1016/j.cub.2003.09.031; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Nightingale KP, 1998, EMBO J, V17, P2865, DOI 10.1093/emboj/17.10.2865; OwenHughes T, 1996, EMBO J, V15, P4702, DOI 10.1002/j.1460-2075.1996.tb00847.x; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Reynoird N, 2010, EMBO J, V29, P2943, DOI 10.1038/emboj.2010.176; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Sewack GF, 1997, J BIOL CHEM, V272, P31118, DOI 10.1074/jbc.272.49.31118; Sewack GF, 2001, MOL CELL BIOL, V21, P1404, DOI 10.1128/MCB.21.4.1404-1415.2001; Sharma N, 2008, P NATL ACAD SCI USA, V105, P7959, DOI 10.1073/pnas.0800534105; Sheridan PL, 1997, GENE DEV, V11, P3327, DOI 10.1101/gad.11.24.3327; Simon M, 2011, P NATL ACAD SCI USA, V108, P12711, DOI 10.1073/pnas.1106264108; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Tropberger P, 2010, EPIGENETICS-US, V5, P112, DOI 10.4161/epi.5.2.11075; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Valdes-Mora F, 2012, GENOME RES, V22, P307, DOI 10.1101/gr.118919.110; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wagschal A., 2007, CSH PROTOC 2007, V2007; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; WORKMAN JL, 1992, SCIENCE, V258, P1780, DOI 10.1126/science.1465613; Zhang LW, 2003, CHROMOSOMA, V112, P77, DOI 10.1007/s00412-003-0244-6; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	65	155	163	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 14	2013	152	4					859	872		10.1016/j.cell.2013.01.032	http://dx.doi.org/10.1016/j.cell.2013.01.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23415232	Bronze			2022-12-28	WOS:000314945600019
J	Stein, EA; Raal, FJ				Stein, Evan A.; Raal, Frederick J.			Polygenic familial hypercholesterolaemia: does it matter?	LANCET			English	Editorial Material							CORONARY-HEART-DISEASE; LDL RECEPTOR GENE		[Stein, Evan A.] Metab & Atherosclerosis Res Ctr, Cincinnati, OH 45227 USA; [Raal, Frederick J.] Univ Witwatersrand, Dept Med, Fac Hlth Sci, ZA-2001 Johannesburg, South Africa	University of Witwatersrand	Stein, EA (corresponding author), Metab & Atherosclerosis Res Ctr, Cincinnati, OH 45227 USA.	esteinmrl@aol.com	Raal, FJ/ABD-5111-2021	Raal, FJ/0000-0002-9170-7938				Elis A, 2011, AM J CARDIOL, V108, P223, DOI 10.1016/j.amjcard.2011.03.027; Ference BA, 2012, J AM COLL CARDIOL, V60, P2631, DOI 10.1016/j.jacc.2012.09.017; FERRIERES J, 1995, CIRCULATION, V92, P290, DOI 10.1161/01.CIR.92.3.290; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; ILLINGWORTH DR, 1984, J CLIN INVEST, V74, P1972, DOI 10.1172/JCI111618; Kajinami K, 2004, ATHEROSCLEROSIS, V177, P219, DOI 10.1016/j.atherosclerosis.2004.09.004; Muller C, 1938, ACTA MED SCAND, P75; Neil HAW, 1999, ATHEROSCLEROSIS, V142, P105; Pimstone SN, 1998, ARTERIOSCL THROM VAS, V18, P309, DOI 10.1161/01.ATV.18.2.309; Schmidt HHJ, 1996, AM J CARDIOL, V77, P575, DOI 10.1016/S0002-9149(97)89309-5; SLACK J, 1969, LANCET, V2, P1380; Starr B, 2008, CLIN CHEM LAB MED, V46, P791, DOI 10.1515/CCLM.2008.135; Talmud PJ, 2013, LANCET; Usifo E, 2012, ANN HUM GENET, V76, P387, DOI 10.1111/j.1469-1809.2012.00724.x; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wierzbicki AS, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1095	16	17	18	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2013	381	9874					1255	1257		10.1016/S0140-6736(13)60187-7	http://dx.doi.org/10.1016/S0140-6736(13)60187-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122XD	23433574				2022-12-28	WOS:000317351000008
J	Avorn, J				Avorn, Jerry			Approval of a Tuberculosis Drug Based on a Paradoxical Surrogate Measure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Avorn, J (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, Boston, MA 02120 USA.	javorn@medsoc.harvard.edu						[Anonymous], 2012, JANSS BRIEF DOC TMC2; Carome M., 2012, COMMUNICATION; Carpenter D, 2008, NEW ENGL J MED, V358, P1354, DOI 10.1056/NEJMsa0706341; Cox EM., 2012, COMMUNICATION; Hirschler B, 2012, REUTERS; Kesselheim AS, 2008, NEW ENGL J MED, V359, P1981, DOI 10.1056/NEJMp0806684; Ridley DB, 2006, HEALTH AFFAIR, V25, P313, DOI 10.1377/hlthaff.25.2.313; US Food and Drug Administration, 2012, BRIEF PACK NDA 204 3	8	55	57	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2013	309	13					1349	1350		10.1001/jama.2013.623	http://dx.doi.org/10.1001/jama.2013.623			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EC	23430122				2022-12-28	WOS:000316934500020
J	Buczacki, SJA; Zecchini, HI; Nicholson, AM; Russell, R; Vermeulen, L; Kemp, R; Winton, DJ				Buczacki, Simon J. A.; Zecchini, Heather Ireland; Nicholson, Anna M.; Russell, Roslin; Vermeulen, Louis; Kemp, Richard; Winton, Douglas J.			Intestinal label-retaining cells are secretory precursors expressing Lgr5	NATURE			English	Article							STEM-CELLS; MARKER; SEGREGATION; HOMEOSTASIS; POLYPOSIS; QUIESCENT; RENEWAL; LRIG1; GENE; DNA	The rapid cell turnover of the intestinal epithelium is achieved from small numbers of stem cells located in the base of glandular crypts. These stem cells have been variously described as rapidly cycling or. quiescent. A functional arrangement of stem cells that reconciles both of these behaviours has so far been difficult to obtain. Alternative explanations for quiescent cells have been that they act as a parallel or reserve population that replace rapidly cycling stem cells periodically or after injury; their exact nature remains unknown. Here we show mouse intestinal quiescent cells to be precursors that are committed to mature into differentiated secretory cells of the Paneth and enteroendocrine lineage. However, crucially we find that after intestinal injury they are capable of extensive proliferation and can give rise to clones comprising the main epithelial cell types. Thus, quiescent cells can be recalled to the-stem-cell state. These findings establish quiescent cells as an effective clonogenic reserve and provide a motivation for investigating their role in pathologies such as colorectal cancers and intestinal inflammation.	[Winton, Douglas J.] Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Buczacki, Simon J. A.; Zecchini, Heather Ireland; Nicholson, Anna M.; Russell, Roslin; Vermeulen, Louis; Kemp, Richard; Winton, Douglas J.] Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England	Cancer Research UK; CRUK Cambridge Institute; Cancer Research UK; CRUK Cambridge Institute	Winton, DJ (corresponding author), Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England.	doug.winton@cruk.cam.ac.uk	Vermeulen, Louis/B-7488-2008; Parry, Lee/A-9623-2011	Vermeulen, Louis/0000-0002-6066-789X; Parry, Lee/0000-0002-4467-9196; Buczacki, Simon/0000-0002-2975-416X; Kemp, Richard/0000-0002-0121-7709	Cancer Research UK; KWF fellowship; Cancer Research UK [22310, 17044] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); KWF fellowship; Cancer Research UK(Cancer Research UK)	This research was supported by Cancer Research UK (S.J.A.B., H.I.Z., A.M.N., R.R., R.K. and D.J.W.). L.V. was supported by a KWF fellowship. We thank D. Tan for providing the single-cell RNA amplification protocol. We also thank M. de la Roche, R. von Furstenberg and S. Henning for advice with the in vitro culture work. We acknowledge the following core facilities at CRUK/CRI: The Transgenic Laboratory, Biological Resource Unit, Flow Cytometry, Histopathology, Microscopy, Genomics and Bioinformatics and the CRUK Paterson Institute Microarray Facility. We thank R. J. Davies, A. Klein and A. Ibrahim for manuscript discussions.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Demidov ON, 2007, CELL STEM CELL, V1, P180, DOI 10.1016/j.stem.2007.05.020; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Ireland H, 2005, DEV DYNAM, V233, P1332, DOI 10.1002/dvdy.20446; Jullien N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng131; Lewis A, 2010, GUT, V59, P1680, DOI 10.1136/gut.2009.193680; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Potten CS, 2002, J CELL SCI, V115, P2381; POTTEN CS, 1978, CELL, V15, P899, DOI 10.1016/0092-8674(78)90274-X; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Roth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038965; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464	25	525	542	6	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2013	495	7439					65	69		10.1038/nature11965	http://dx.doi.org/10.1038/nature11965			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23446353				2022-12-28	WOS:000316039800040
J	de Korte, N; de Monye, W; Stockmann, HBAC				de Korte, N.; de Monye, W.; Stockmann, H. B. A. C.			Suspected left sided diverticulitis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE COLONIC DIVERTICULITIS; COMPUTED-TOMOGRAPHY; DIAGNOSIS; MANAGEMENT; ACCURACY; DISEASE	This series provides an update on the best use of different imaging methods for common or important clinical presentations. The series advisers are Fergus Gleeson, consultant radiologist, Churchill Hospital, Oxford, and Kamini Patel, consultant radiologist, Homerton University Hospital, London. To suggest a topic for this series, please email us at practice@bmj.com.	[de Korte, N.] Spaarne Ziekenhuis, Dept Surg, NL-2134 TM Hoofddorp, Netherlands; [de Monye, W.] Kennemer Gasthuis, Dept Radiol, Haarlem, Netherlands; [Stockmann, H. B. A. C.] Kennemer Gasthuis, Dept Surg, Haarlem, Netherlands	Spaarne Hospital; Spaarne Hospital; Spaarne Hospital	de Korte, N (corresponding author), Spaarne Ziekenhuis, Dept Surg, Spaarnepoort 1, NL-2134 TM Hoofddorp, Netherlands.	ndekorte@yahoo.com						Andeweg CS, 2011, ANN SURG, V253, P940, DOI 10.1097/SLA.0b013e3182113614; de Korte N, 2012, COLORECTAL DIS, V14, P325, DOI 10.1111/j.1463-1318.2011.02609.x; de Korte N, 2011, BRIT J SURG, V98, P761, DOI 10.1002/bjs.7376; Destigter Kristen K, 2009, Clin Colon Rectal Surg, V22, P147, DOI 10.1055/s-0029-1236158; Jacobs DO, 2007, NEW ENGL J MED, V357, P2057, DOI 10.1056/NEJMcp073228; Kohler L, 1999, SURG ENDOSC-ULTRAS, V13, P430, DOI 10.1007/s004649901007; Lameris W, 2008, EUR RADIOL, V18, P2498, DOI 10.1007/s00330-008-1018-6; Lameris W, 2010, DIS COLON RECTUM, V53, P896, DOI 10.1007/DCR.0b013e3181d98d86; Lameris W, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2431; Pradel JA, 1997, RADIOLOGY, V205, P503, DOI 10.1148/radiology.205.2.9356636; Rafferty J, 2006, DIS COLON RECTUM, V49, P939, DOI 10.1007/s10350-006-0578-2; Soumian S, 2008, WORLD J GASTROENTERO, V14, P7163, DOI 10.3748/wjg.14.7163; Stollman NH, 1999, AM J GASTROENTEROL, V94, P3110, DOI 10.1111/j.1572-0241.1999.01501.x; Tack D, 2005, RADIOLOGY, V237, P189, DOI 10.1148/radiol.2371041432; Toorenvliet BR, 2010, COLORECTAL DIS, V12, P179, DOI 10.1111/j.1463-1318.2009.01778.x; van Randen A, 2011, EUR RADIOL, V21, P1535, DOI 10.1007/s00330-011-2087-5	16	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2013	346								f928	10.1136/bmj.f928	http://dx.doi.org/10.1136/bmj.f928			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100BL	23447355				2022-12-28	WOS:000315669600018
J	Hughes, JD				Hughes, J. David			A reality check on the shale revolution	NATURE			English	Editorial Material									Post Carbon Inst, Santa Rosa, CA 95404 USA		Hughes, JD (corresponding author), Post Carbon Inst, Santa Rosa, CA 95404 USA.	davehughes@twincomm.ca						BP, 2013, BP EN OUTL 2030; Hughes J.D., 2013, DRILL BABY DRILL; IEA, 2012, WORLD EN OUTL 2012; Jacoby HD, 2012, ECON ENERGY ENV POL, V1, P37, DOI 10.5547/2160-5890.1.1.5; Krauss C., 2012, NY TIMES; Morse E. L., 2012, ENERGY 2020; Nature, 2011, NATURE, V477, P271; U.S. Energy Information Administratio, 2012, ANN EN OUTL 2013 EAR; US Energy Information Administration, 2012, ANN EN OUTL 2012; US Geological Survey, 2012, 20121118 USGS	10	316	333	7	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					307	308		10.1038/494307a	http://dx.doi.org/10.1038/494307a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	095CS	23426309	Bronze			2022-12-28	WOS:000315312900016
J	Bonita, R; Magnusson, R; Bovet, P; Zhao, D; Malta, DC; Geneau, R; Suh, I; Thankappan, KR; McKee, M; Hospedales, J; de Courten, M; Capewell, S; Beaglehole, R				Bonita, Ruth; Magnusson, Roger; Bovet, Pascal; Zhao, Dong; Malta, Deborah C.; Geneau, Robert; Suh, Il; Thankappan, Kavumpurathu Raman; McKee, Martin; Hospedales, James; de Courten, Maximilian; Capewell, Simon; Beaglehole, Robert		Lancet NCD Action Grp	Country actions to meet UN commitments on non-communicable diseases: a stepwise approach	LANCET			English	Article							CARDIOVASCULAR-DISEASE; MIDDLE-INCOME; RISK-FACTORS; PREVENTION; STROKE; MORTALITY; COMMUNITY; DRUGS; HEART; LAW	Strong leadership from heads of state is needed to meet national commitments to the UN political declaration on non-communicable diseases (NCDs) and to achieve the goal of a 25% reduction in premature NCD mortality by 2025 (the 25 by 25 goal). A simple, phased, national response to the political declaration is suggested, with three key steps: planning, implementation, and accountability. Planning entails mobilisation of a multisectoral response to develop and support the national action plan, and to build human, financial, and regulatory capacity for change. Implementation of a few priority and feasible cost-effective interventions for the prevention and treatment of NCDs will achieve the 25 by 25 goal and will need only few additional financial resources. Accountability incorporates three dimensions: monitoring of progress, reviewing of progress, and appropriate responses to accelerate progress. A national NCD commission or equivalent, which is independent of government, is needed to ensure that all relevant stakeholders are held accountable for the UN commitments to NCDs.	[Bonita, Ruth; Beaglehole, Robert] Univ Auckland, Auckland 0624, New Zealand; [Magnusson, Roger] Univ Sydney, Sydney Law Sch, Sydney, NSW 2006, Australia; [Bovet, Pascal] Inst Univ Med Sociale & Prevent, CH-1005 Lausanne, Switzerland; [Zhao, Dong] Capital Med Univ, Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [Malta, Deborah C.] Minist Hlth, Brasilia, DF, Brazil; [Geneau, Robert] Int Dev Res Ctr, Ottawa, ON, Canada; [Suh, Il] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Thankappan, Kavumpurathu Raman] Sree Chitra Tirunal Inst Med Sci & Technol, Trivandrum, Kerala, India; [McKee, Martin] London Sch Hyg & Trop Med, London WC1, England; [Hospedales, James] WHO, Reg Off Amer, Washington, DC USA; [de Courten, Maximilian] Univ Copenhagen, Copenhagen, Denmark; [Capewell, Simon] Univ Liverpool, Liverpool L69 3BX, Merseyside, England	University of Auckland; University of Sydney; Capital Medical University; Yonsei University; Yonsei University Health System; Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); University of London; London School of Hygiene & Tropical Medicine; World Health Organization; University of Copenhagen; University of Liverpool	Bonita, R (corresponding author), Univ Auckland, 42 Albert Rd, Auckland 0624, New Zealand.	r.bonita@auckland.ac.nz	McKee, Marc D/E-2187-2011; de Courten, Maximilian/B-3300-2012; de Courten, Maximilian P. J./AAH-5104-2020; Malta, Deborah Carvalho/L-2491-2019; Malta, Deborah Carvalho/GNM-8218-2022; Bovet, Pascal/F-4477-2011; Zhao, D/AAX-5040-2021; Mckee, Martin/E-6673-2018; Malta, Deborah C/H-7880-2012; Thankappan, Kr/ABC-9551-2021	McKee, Marc D/0000-0001-8349-965X; de Courten, Maximilian/0000-0001-9997-9359; Malta, Deborah Carvalho/0000-0002-8214-5734; Malta, Deborah Carvalho/0000-0002-8214-5734; Bovet, Pascal/0000-0002-0242-4259; Mckee, Martin/0000-0002-0121-9683; Malta, Deborah C/0000-0002-8214-5734; Geneau, Robert/0000-0001-6180-2515; Suh, Il/0000-0002-9689-7849; , KR/0000-0002-4536-2684	Australian Research Council; MRC [G0900847] Funding Source: UKRI	Australian Research Council(Australian Research Council); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	RM holds a Discovery Grant from the Australian Research Council. The authors wish to acknowledge Dr Cherian Varghese for his useful comments and for providing the figure in the appendix.	[Anonymous], 2011, WHO DISC PAP INT ACT; [Anonymous], STEPWISE APPR CHRON; [Anonymous], 2012, 65 WORLD HLTH ASS CL; [Anonymous], 2005, PREV CHRON DIS VIT I; [Anonymous], 2012, REPORT WORK GOVT; Armstrong Thimothy, 2003, ETHNIC DIS, V13, P2; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Attaran A, 2012, LANCET, V379, P283, DOI 10.1016/S0140-6736(11)60069-X; Balabanova D, 2011, GOOD HLTH LOW COST 2; Bandosz P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8136; Beaglehole R, 2013, LANCET; Beaglehole R, 2012, LANCET, V380, P1283, DOI 10.1016/S0140-6736(12)61692-4; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Blas E, 2011, SOCIAL DETERMINANTS APPROACHES TO PUBLIC HEALTH: FROM CONCEPT TO PRACTICE, P1; Bloom DE, 2011, GLOBAL EC BURDEN NON; Brazil. Ministerio da Saude, 2011, STRAT ACT PLAN TACKL; Campbell NRC, 2011, J HUM HYPERTENS, V25, P705, DOI 10.1038/jhh.2011.25; Capewell S, 2011, LANCET, V378, P752, DOI 10.1016/S0140-6736(10)62302-1; Chaloupka FJ, 2012, TOB CONTROL, V21, P172, DOI 10.1136/tobaccocontrol-2011-050417; Chen L, 2012, LANCET, V379, P782, DOI 10.1016/S0140-6736(12)60285-2; Chinese Center for Disease Control and Prevention, CHIN NAT PLAN NCD PR; Dunford E, 2012, CAN MED ASSOC J, V184, P1023, DOI 10.1503/cmaj.111895; Edwards P, 2009, INT J EPIDEMIOL, V38, P1137, DOI 10.1093/ije/dyp172; Epping-Jordan JE, 2005, LANCET, V366, P1667, DOI 10.1016/S0140-6736(05)67342-4; Friel S, 2011, ANNU REV PUBL HEALTH, V32, P133, DOI 10.1146/annurev-publhealth-071910-140612; Garg CC, 2011, 3 WHO; Healthy Beijing, 12 5 YEAR DEV PLAN; IOM, 2012, COUNTR LEV DEC MAK C; Johns B, 2007, B WORLD HEALTH ORGAN, V85, P256, DOI 10.2471/BLT.06.032037; Kelly BB, 2012, GLOB HEART, V7, P7, DOI 10.1016/j.gheart.2012.02.004; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lonn E, 2010, CIRCULATION, V122, P2078, DOI 10.1161/CIRCULATIONAHA.109.873232; Magnusson R, 2011, LANCET, V378, P859, DOI 10.1016/S0140-6736(11)60975-6; Malta DC, 2011, EPIDEMIOL SERV SAUDE, V20, P425, DOI [10.5123/S1679-49742011000400002, DOI 10.5123/S1679-49742011000400002]; Malta DC, 2012, LANCET, V380, P195, DOI 10.1016/S0140-6736(12)61041-1; Mendis S, 2007, J HYPERTENS, V25, P1578, DOI 10.1097/HJH.0b013e3282861fd3; Moodie R, 2013, LANCET; Morrison AC, 2011, ANNU REV PUBL HEALTH, V32, P71, DOI 10.1146/annurev-publhealth-031210-101209; Nikolic I. A., 2011, Chronic emergency: why NCDs matter; Nugent R, 2012, GLOB HEART, V7, P3, DOI 10.1016/j.gheart.2012.02.003; Organization W. H, 2009, 2008 2013 ACT PLAN G; Organization WH, 2016, GLOBAL STATUS REPORT; Palar K, 2009, AM J HEALTH PROMOT, V24, P49, DOI 10.4278/ajhp.080826-QUAN-164; Pan American Health Organization, CARMEN POL OBS NONC; Penney S., 2009, DROPPING SALT PRACTI; Nguyen QN, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/560397; Reddy KS, 2009, SHOULDNT EVERY MINIS; Ruger JP, 2012, J EPIDEMIOL COMMUN H, V66, P653, DOI 10.1136/jech.2009.101097; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Smith SC, 2004, CIRCULATION, V109, P3112, DOI 10.1161/01.CIR.0000133427.35111.67; Strazzullo Pasquale, 2009, BMJ, V339, pb4567, DOI 10.1136/bmj.b4567; Stringhini S, 2012, STROKE, V43, P2283, DOI 10.1161/STROKEAHA.112.658468; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001242, 10.1371/journal.pmed.1001235]; Suhrcke M, 2010, HEALTH ECON, V19, P1478, DOI 10.1002/hec.1565; Tang JL, 2005, BRIT MED J, V330, P610, DOI 10.1136/bmj.330.7492.610; Thankappan KR, 2010, INDIAN J MED RES, V131, P53; Venkatapuram S, 2012, B WORLD HEALTH ORGAN, V90, P241, DOI 10.2471/BLT.11.094789; Viswanathan B, 2008, PREV MED, V47, pS33, DOI 10.1016/j.ypmed.2008.02.008; Viswanathan B, 2011, TOB CONTROL, V20, P427, DOI 10.1136/tc.2010.041590; Wang SY, 2011, HLTH HARMONIOUS LIFE; WHO, 2010, WHO TECHNICAL MANUAL ON TOBACCO TAX ADMINISTRARTION, P1; WHO, WHO FCTC REP INSTR; WHO, 2012, REP FORM M MEMB STAT; WHO, 2011, SCAL ACT NONC DIS MU; WHO Expert Committee on Problems Related to Alcohol Consumption, 2007, World Health Organ Tech Rep Ser, P1; WHO World Economic Forum, 2011, BURD BEST BUYS RED E; World Health Organization, 2011, NONCOMMUNICABLE DIS; World Health Organization, 2010, PACK ESS NONC PEN DI; World Health Organization, 2007, PREV CARD DIS POCK G; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	73	141	156	0	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2013	381	9866					575	584		10.1016/S0140-6736(12)61993-X	http://dx.doi.org/10.1016/S0140-6736(12)61993-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089RK	23410607				2022-12-28	WOS:000314927500033
J	Gillett, G; Franz, E				Gillett, Grant; Franz, Elizabeth			The art of medicine John Hughlings Jackson: bridging theory and clinical observation	LANCET			English	Editorial Material									[Gillett, Grant] Univ Otago, Sch Med, Otago Bioeth Ctr, Dunedin, New Zealand; [Franz, Elizabeth] Univ Otago, Dept Psychol, Dunedin, New Zealand; [Franz, Elizabeth] Univ Otago, fMRIotago, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	Gillett, G (corresponding author), Univ Otago, Sch Med, Otago Bioeth Ctr, Dunedin, New Zealand.	grant.gillett@otago.ac.nz							0	5	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 16	2013	381	9866					528	529		10.1016/S0140-6736(13)60268-8	http://dx.doi.org/10.1016/S0140-6736(13)60268-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089RK	23424729				2022-12-28	WOS:000314927500014
J	Haase, N; Perner, A; Inkeri, L; Siegemund, M; Lauridsen, B; Wetterslev, M; Wetterslev, J				Haase, Nicolai; Perner, Anders; Inkeri, Louise; Siegemund, Martin; Lauridsen, Bo; Wetterslev, Mik; Wetterslev, Jorn			Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CRITICALLY-ILL PATIENTS; ACUTE-RENAL-FAILURE; ACUTE KIDNEY INJURY; VOLUME REPLACEMENT; 6-PERCENT HYDROXYETHYLSTARCH; PULMONARY PERMEABILITY; LIVER-TRANSPLANTATION; FLUID RESUSCITATION; INFORMATION SIZE; MOLECULAR-WEIGHT	Objective To assess the effects of fluid therapy with hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin on mortality, kidney injury, bleeding, and serious adverse events in patients with sepsis. Design Systematic review with meta-analyses and trial sequential analyses of randomised clinical trials. Data sources Cochrane Library, Medline, Embase, Biosis Previews, Science Citation Index Expanded, CINAHL, Current Controlled Trials, Clinicaltrials.gov, and Centerwatch to September 2012; hand search of reference lists and other systematic reviews; contact with authors and relevant pharmaceutical companies. Study selection Eligible trials were randomised clinical trials comparing hydroxyethyl starch 130/0.38-0.45 with either crystalloid or human albumin in patients with sepsis. Published and unpublished trials were included irrespective of language and predefined outcomes. Data extraction Two reviewers independently assessed studies for inclusion and extracted data on methods, interventions, outcomes, and risk of bias. Risk ratios and mean differences with 95% confidence intervals were estimated with fixed and random effects models. Results Nine trials that randomised 3456 patients with sepsis were included. Overall, hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin did not affect the relative risk of death (1.04, 95% confidence interval 0.89 to 1.22, 3414 patients, eight trials), but in the predefined analysis of trials with low risk of bias the relative risk of death was 1.11 (1.00 to 1.23, trial sequential analysis (TSA) adjusted 95% confidence interval 0.95 to 1.29, 3016 patients, four trials). In the hydroxyethyl starch group, renal replacement therapy was used more (1.36, 1.08 to 1.72, TSA adjusted 1.03 to 1.80, 1311 patients, five trials), and the relative risk of acute kidney injury was 1.18 (0.99 to 1.40, TSA adjusted 0.90 to 1.54, 994 patients, four trials). More patients in the hydroxyethyl starch group were transfused with red blood cells (1.29, 1.13 to 1.48, TSA adjusted 1.10 to 1.51, 973 patients, three trials), and more patients had serious adverse events (1.30, 1.02 to 1.67, TSA adjusted 0.93 to 1.83, 1069 patients, four trials). The transfused volume of red blood cells did not differ between the groups (mean difference 65 mL, 95% confidence interval -20 to 149 mL, three trials). Conclusion In conventional meta-analyses including recent trial data, hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin increased the use of renal replacement therapy and transfusion with red blood cells, and resulted in more serious adverse events in patients with sepsis. It seems unlikely that hydroxyethyl starch 130/0.38-0.45 provides overall clinical benefit for patients with sepsis.	[Haase, Nicolai; Perner, Anders; Inkeri, Louise; Lauridsen, Bo; Wetterslev, Mik] Rigshosp, Dept Intens Care, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [Siegemund, Martin] Baden State Hosp AG, Dept Anaesthesia Intens Care & Rescue Med, Baden, Switzerland; [Wetterslev, Jorn] Rigshosp, Copenhagen Trial Unit, Ctr Clin Intervent Res, Copenhagen Univ Hosp, DK-2200 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Haase, N (corresponding author), Rigshosp, Dept Intens Care, Copenhagen Univ Hosp, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	nicolai.haase@rh.regionh.dk	Wetterslev, Jørn/ABF-1251-2020; Siegemund, Martin/AAM-8929-2020	Wetterslev, Jørn/0000-0001-7778-1771; Siegemund, Martin/0000-0002-2013-4140; Perner, Anders/0000-0002-4668-0123; Hennings, Louise/0000-0001-8383-776X	Danish Research Council; Rigshospitalet Research Council; Scandinavian Society of Anaesthesiology and Intensive Care Medicine (the ACTA foundation); Fresenius Kabi; BioPorto; Department of Anaesthesia and Intensive Care of the University Hospital Basel	Danish Research Council(Det Frie Forskningsrad (DFF)); Rigshospitalet Research Council; Scandinavian Society of Anaesthesiology and Intensive Care Medicine (the ACTA foundation); Fresenius Kabi; BioPorto; Department of Anaesthesia and Intensive Care of the University Hospital Basel	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: AP was principal investigator for the Scandinavian Starch for Severe Sepsis/Septic Shock (6S) trial and NH and JW were members of the steering committee. The 6S trial was funded by the Danish Research Council, the Rigshospitalet Research Council, and the Scandinavian Society of Anaesthesiology and Intensive Care Medicine (the ACTA foundation). B Braun Melsungen delivered trial fluid to all sites free of charge. Neither the funders nor B Braun Melsungen had an influence on the protocol, trial conduct, data analyses, or reporting of the 6S trial. AP is head of research in his intensive care unit, which receives research funds from Fresenius Kabi and BioPorto. B Braun Melsungen has covered his travel expenses for presenting 6S data at the German Anaesthetic Congress 2012. MS was principal investigator for the Basel starch evaluation in sepsis (BaSES) trial. The BaSES trial was funded by the Department of Anaesthesia and Intensive Care of the University Hospital Basel. Fresenius Kabi delivered study fluids for free and paid for the packaging and blinding process. A signed contract between Fresenius Kabi and MS stated that MS was free to publish all data without influence from Fresenius Kabi. Fresenius Kabi covered travel expenses for MS's participation in meetings about fluid resuscitation.	Ando Y, 2008, J ANESTH, V22, P391, DOI 10.1007/s00540-008-0659-6; [Anonymous], 2012, BASEL STARCH EVALUAT; Asfar P, 2000, INTENS CARE MED, V26, P1282, DOI 10.1007/s001340000606; Bagshaw SM, 2007, CLIN J AM SOC NEPHRO, V2, P431, DOI 10.2215/CJN.03681106; Bellmann R, 2012, CLIN PHARMACOKINET, V51, P225, DOI 10.2165/11594700-000000000-00000; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Boldt J, 1998, INTENS CARE MED, V24, P28, DOI 10.1007/s001340050511; BOLDT J, 1995, BRIT J ANAESTH, V75, P740, DOI 10.1093/bja/75.6.740; Boldt J, 1996, CRIT CARE MED, V24, P385, DOI 10.1097/00003246-199603000-00005; Boldt J, 2004, INTENS CARE MED, V30, P416, DOI 10.1007/s00134-003-2110-7; Boldt J, 1996, BRIT J ANAESTH, V77, P480, DOI 10.1093/bja/77.4.480; Boldt J, 2002, BRIT J ANAESTH, V89, P722, DOI 10.1093/bja/aef242; Boldt J, 2001, INFUS THER TRANSFUS, V28, P144; Boldt J, 2006, ANESTH ANALG, V103, P191, DOI 10.1213/01.ane.0000221179.07006.06; Brok J, 2008, J CLIN EPIDEMIOL, V61, P763, DOI 10.1016/j.jclinepi.2007.10.007; Bulanov A Iu, 2004, Anesteziol Reanimatol, P25; Bunn F, 2012, COCHRANE DATABASE SY; Chen Feng, 2006, Wuhan Daxue Xuebao (Yixue Ban), V27, P520; Christidis C, 2001, J HEPATOL, V35, P726, DOI 10.1016/S0168-8278(01)00200-8; Clermont G, 2002, KIDNEY INT, V62, P986, DOI 10.1046/j.1523-1755.2002.00509.x; Dart AB, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007594.pub2; Dolecek M, 2009, HEPATO-GASTROENTEROL, V56, P1622; Du XJ, 2011, PANCREAS, V40, P1220, DOI 10.1097/MPA.0b013e3182217f17; Dubin Arnaldo, 2010, J Crit Care, V25, DOI 10.1016/j.jcrc.2010.04.007; Expert Working Group International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2009, ICH HARMONIZATION TR, V51; Finfer S, 2011, INTENS CARE MED, V37, P86, DOI 10.1007/s00134-010-2039-6; Finfer S, 2010, CRIT CARE, V14, DOI 10.1186/cc9293; Franz A, 2001, ANESTH ANALG, V92, P1402, DOI 10.1097/00000539-200106000-00008; Gattas DJ, 2012, ANESTH ANALG, V114, P159, DOI 10.1213/ANE.0b013e318236b4d6; Gondos T, 2010, EUR J ANAESTH, V27, P794, DOI 10.1097/EJA.0b013e32833b3504; Guidet B, 2012, CRIT CARE, V16, DOI 10.1186/cc11358; Haas T, 2007, ANAESTHESIA, V62, P1000, DOI 10.1111/j.1365-2044.2007.05186.x; Harten J, 2008, Int J Surg, V6, P197, DOI 10.1016/j.ijsu.2008.03.002; Hartog CS, 2011, ANESTH ANALG, V112, P635, DOI 10.1213/ANE.0b013e31820ad607; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Higgins JPT, 2011, STAT MED, V30, P903, DOI 10.1002/sim.4088; Jones SB, 2003, ANESTH ANALG, V96, P363, DOI 10.1097/00000539-200302000-00012; Jover JL, 2009, REV ESP ANEST REANIM, V56, P27, DOI 10.1016/S0034-9356(09)70317-2; Kim DH, 2005, TRANSFUS ALTERN TRAN, V7, P79; Kumle B, 1999, ANESTH ANALG, V89, P1124, DOI 10.1213/00000539-199911000-00009; Li Feng, 2008, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V20, P472; Lv Jie, 2012, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V24, P38; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mukhtar A, 2009, ANESTH ANALG, V109, P924, DOI 10.1213/ane.0b013e3181aed54f; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Palumbo D, 2006, MINERVA ANESTESIOL, V72, P655; Pape L, 2008, PEDIATR NEPHROL, V23, P1630; Perel P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub4; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Pillebout E, 2005, AM J TRANSPLANT, V5, P1120, DOI 10.1111/j.1600-6143.2005.00852.x; Protsenko D. N., 2009, Anesteziologiya i Reanimatologiya, P9; Reine PA, 2008, ACTA ANAESTH SCAND, V52, P406, DOI 10.1111/j.1399-6576.2007.01555.x; Schmidt-Hieber M, 2006, EUR J HAEMATOL, V77, P83, DOI 10.1111/j.1600-0609.2006.00657.x; Schramko AA, 2010, PERFUSION-UK, V25, P283, DOI 10.1177/0267659110377819; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Thomas-Rueddel DO, 2012, INTENS CARE MED, V38, P1134, DOI 10.1007/s00134-012-2560-x; Thorlund K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025491; Trof RJ, 2010, INTENS CARE MED, V36, P697, DOI 10.1007/s00134-010-1776-x; van der Heijden M, 2009, CRIT CARE MED, V37, P1275, DOI 10.1097/CCM.0b013e31819cedfd; Veneman TF, 2004, WIEN KLIN WOCHENSCHR, V116, P305, DOI 10.1007/BF03040900; Verheij J, 2006, BRIT J ANAESTH, V96, P21, DOI 10.1093/bja/aei286; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Wetterslev J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-86; Wills BA, 2005, NEW ENGL J MED, V353, P877, DOI 10.1056/NEJMoa044057; Zhu Guo-chao, 2011, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V23, P150	67	204	217	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 15	2013	346								f839	10.1136/bmj.f839	http://dx.doi.org/10.1136/bmj.f839			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091ZW	23418281	Green Published, hybrid			2022-12-28	WOS:000315089600008
J	Trempolec, N; Dave-Coll, N; Nebreda, AR				Trempolec, Natalia; Dave-Coll, Natalia; Nebreda, Angel R.			SnapShot: p38 MAPK Signaling	CELL			English	Editorial Material							ACTIVATED PROTEIN-KINASE; PATHWAY		[Trempolec, Natalia; Dave-Coll, Natalia; Nebreda, Angel R.] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Nebreda, Angel R.] Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA	Trempolec, N (corresponding author), Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain.		Nebreda, Angel Rodriguez/R-9594-2019		ICREA Funding Source: Custom	ICREA(ICREA)		Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Oeztuerk-Winder F, 2012, BIOCHEM J, V445, P1, DOI 10.1042/BJ20120401; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Rincon M, 2009, IMMUNOL REV, V228, P212, DOI 10.1111/j.1600-065X.2008.00744.x; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694	10	86	90	5	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 31	2013	152	3					656	+	656.e1	10.1016/j.cell.2013.01.029	http://dx.doi.org/10.1016/j.cell.2013.01.029			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23415236	Bronze			2022-12-28	WOS:000314362800032
J	Shen, H				Shen, Helen			MIND THE GENDER GAP	NATURE			English	News Item							SEXISM											[Anonymous], 2010, BARR WOM SCI SURV RE; [Anonymous], 2008, CHANG HEART; [Anonymous], 2011, WHIT PAP POS WOM SCI; Ecklund EH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022590; European Commission, 2009, SHE FIG 2009; Friesen HG, 1998, NATURE, V391, P326, DOI 10.1038/34768; Goulden M., 2009, STAYING COMPETITIVE, P52; Grant J, 1997, NATURE, V390, P438, DOI 10.1038/37213; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; 2010, GEND DIFF CRIT TRANS; Newsome JessicaLober., 2008, CHEM PHD IMPACT WOME; Wenneras C, 1997, NATURE, V387, P341, DOI 10.1038/387341a0	12	239	241	1	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2013	495	7439					22	24		10.1038/495022a	http://dx.doi.org/10.1038/495022a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23467149	Bronze			2022-12-28	WOS:000316039800011
